data_2kls_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kls _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 502' ' ' ALA . . . . . 0.539 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . . . . . . 0 C--O 1.211 -0.95 0 N-CA-C 113.316 0.858 . . . . 70.340000000000003 113.316 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 124.58 -155.85 18.44 Favored Glycine 0 C--N 1.287 -2.167 0 C-N-CA 119.215 -1.469 . . . . 40.229999999999997 111.705 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.405 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.7 mp -114.66 110.96 33.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 112.069 0.396 . . . . 74.299999999999997 112.069 -172.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -92.52 119.98 32.53 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.068 -1.086 . . . . 75.019999999999996 108.068 168.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.5 t -160.41 171.79 18.43 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.122 -0.696 . . . . 74.510000000000005 109.122 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -76.83 147.06 37.39 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 122.513 -0.117 . . . . 75.340000000000003 111.149 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 524' ' ' LYS . 0.3 OUTLIER -65.9 -33.8 76.66 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 122.116 0.96 . . . . 72.540000000000006 108.69 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -130.23 140.17 37.86 Favored Pre-proline 0 C--N 1.291 -1.96 0 N-CA-C 108.008 -1.108 . . . . 72.5 108.008 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.81 -27.4 10.43 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.288 1.992 . . . . 62.509999999999998 111.672 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 60.0 t -140.63 134.52 33.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 106.232 -1.766 . . . . 75.430000000000007 106.232 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.2 t -128.95 139.91 51.9 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.952 -0.758 . . . . 73.120000000000005 108.952 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -106.39 136.3 46.38 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.563 -1.273 . . . . 71.099999999999994 107.563 175.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.2 m -125.9 147.24 30.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 108.897 -0.779 . . . . 73.430000000000007 108.897 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.404 ' O ' HG21 ' A' ' 518' ' ' ILE . 27.1 m -79.29 143.64 35.03 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 112.709 0.633 . . . . 75.230000000000004 112.709 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -56.2 -39.5 72.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.196 0.998 . . . . 73.140000000000001 110.374 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 27.5 t -116.01 73.25 0.84 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.905 0.859 . . . . 71.510000000000005 109.757 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.404 HG21 ' O ' ' A' ' 515' ' ' SER . 9.8 tt -120.16 -25.49 2.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.653 -0.703 . . . . 72.540000000000006 110.73 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . 0.439 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 91.74 -82.02 1.22 Allowed Glycine 0 N--CA 1.421 -2.342 0 N-CA-C 109.983 -1.247 . . . . 75.030000000000001 109.983 -175.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 49.8 mm -127.96 135.13 63.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 107.993 -1.114 . . . . 74.430000000000007 107.993 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.44 ' HE2' ' CG2' ' A' ' 573' ' ' VAL . 0.0 OUTLIER -112.19 143.3 43.47 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.132 -1.062 . . . . 62.43 108.132 176.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.7 mt-10 -124.93 126.75 46.0 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 123.796 0.685 . . . . 74.299999999999997 111.358 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 570' ' ' THR . 24.2 t -105.53 125.34 60.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.908 -0.775 . . . . 75.25 108.908 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 508' ' ' GLU . 20.6 mmmt -81.34 130.18 34.93 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.328 -0.99 . . . . 74.040000000000006 108.328 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.491 ' O ' HG21 ' A' ' 568' ' ' VAL . 58.5 t -105.38 137.85 33.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 109.829 -0.434 . . . . 74.140000000000001 109.829 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.91 123.18 27.0 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.011 -0.541 . . . . 72.109999999999999 110.177 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 34.7 ttp85 -78.78 155.83 29.1 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.686 -1.143 . . . . 70.319999999999993 110.433 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 0.9 OUTLIER -58.37 140.4 53.65 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 124.438 1.095 . . . . 62.539999999999999 112.482 177.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.7 t -54.73 -35.33 63.59 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.934 1.294 . . . . 71.010000000000005 110.034 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -117.76 95.64 0.65 Allowed Glycine 0 N--CA 1.418 -2.501 0 N-CA-C 110.141 -1.184 . . . . 52.240000000000002 110.141 176.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -84.57 111.85 19.89 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.804 -0.813 . . . . 70.420000000000002 108.804 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -121.28 107.87 13.05 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.304 -0.862 . . . . 74.209999999999994 110.835 -173.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 74.76 -124.25 7.87 Favored Glycine 0 N--CA 1.441 -1.0 0 O-C-N 123.633 0.583 . . . . 72.129999999999995 112.92 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.527 HD21 ' HG2' ' A' ' 563' ' ' GLN . 2.5 t-20 -134.17 126.38 29.83 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.299 0.64 . . . . 71.310000000000002 109.851 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.47 137.94 54.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 109.027 -0.731 . . . . 74.219999999999999 109.027 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.496 HG12 ' CG2' ' A' ' 597' ' ' VAL . 40.5 mm -107.76 136.65 42.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 109.358 -0.608 . . . . 74.109999999999999 109.358 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.25 108.07 38.55 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 109.488 -0.56 . . . . 65.519999999999996 109.488 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 53.5 Cg_endo -72.71 155.97 53.65 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.373 2.049 . . . . 75.030000000000001 111.752 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.433 ' HB3' HG21 ' A' ' 591' ' ' ILE . 54.2 p90 -152.87 163.0 40.59 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 110.481 -0.192 . . . . 74.030000000000001 110.481 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -158.03 158.36 34.69 Favored 'General case' 0 C--O 1.25 1.079 0 O-C-N 123.735 0.647 . . . . 73.530000000000001 109.457 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 5.2 p -84.35 158.15 21.23 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.145 -0.48 . . . . 75.540000000000006 110.05 172.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 89.6 mt -133.54 121.28 40.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.644 -1.243 . . . . 74.349999999999994 107.644 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -71.37 107.28 4.25 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 110.154 -0.313 . . . . 71.030000000000001 110.154 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -83.82 -89.75 0.76 Allowed Glycine 0 C--N 1.309 -0.93 0 N-CA-C 109.53 -1.428 . . . . 74.120000000000005 109.53 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 14.8 p -112.76 6.11 17.92 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.819 0.818 . . . . 75.140000000000001 109.112 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -99.45 142.76 30.52 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.635 -1.166 . . . . 71.519999999999996 110.281 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.423 ' HB3' ' OE1' ' A' ' 551' ' ' GLU . 76.9 mtt180 -79.34 127.0 31.54 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.694 0.759 . . . . 72.129999999999995 111.321 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -90.3 176.09 41.61 Favored Glycine 0 C--N 1.289 -2.074 0 CA-C-N 114.81 -1.086 . . . . 61.310000000000002 112.19 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 82.34 19.29 64.75 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.057 -0.592 . . . . 65.340000000000003 113.255 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 81.94 25.81 51.36 Favored Glycine 0 CA--C 1.504 -0.64 0 N-CA-C 110.458 -1.057 . . . . 54.140000000000001 110.458 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.423 ' OE1' ' HB3' ' A' ' 547' ' ' ARG . 21.3 tt0 -93.32 -60.81 1.7 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 108.801 -0.815 . . . . 72.5 108.801 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -102.12 -34.44 9.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.852 -1.166 . . . . 73.409999999999997 107.852 168.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -143.95 148.72 35.73 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.518 -0.919 . . . . 73.349999999999994 108.518 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -85.57 112.29 20.82 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 105.498 -2.038 . . . . 72.439999999999998 105.498 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -76.55 146.37 38.41 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.256 -0.429 . . . . 73.299999999999997 110.168 -175.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.5 t -145.55 157.0 44.05 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-O 121.411 0.624 . . . . 64.120000000000005 110.519 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.9 p -154.52 153.19 31.05 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.498 -1.297 . . . . 72.040000000000006 107.498 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 169.81 -160.64 33.75 Favored Glycine 0 N--CA 1.418 -2.503 0 N-CA-C 110.032 -1.227 . . . . 62.329999999999998 110.032 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.478 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.6 mt-10 -129.79 142.36 50.7 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 122.663 0.385 . . . . 75.420000000000002 110.631 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' A' ' 569' ' ' LYS . 74.9 mt -107.82 139.48 42.35 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.046 -0.525 . . . . 75.340000000000003 109.617 175.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -102.79 117.25 34.23 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 116.031 -0.531 . . . . 71.030000000000001 110.913 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -116.56 149.02 40.31 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.548 -0.908 . . . . 74.340000000000003 108.548 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.527 ' HG2' HD21 ' A' ' 534' ' ' ASN . 14.0 mt-30 -148.19 -175.01 4.73 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.941 -1.133 . . . . 73.219999999999999 107.941 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -69.18 -27.44 65.52 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.545 -0.909 . . . . 73.239999999999995 108.545 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.27 -51.66 5.06 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.136 -0.938 . . . . 51.439999999999998 112.317 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.459 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 51.0 mm-40 -55.67 125.77 22.6 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 122.349 0.259 . . . . 70.439999999999998 110.815 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.557 HG13 ' H ' ' A' ' 568' ' ' VAL . 7.1 pt -91.01 -78.67 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 112.855 0.687 . . . . 73.519999999999996 112.855 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.557 ' H ' HG13 ' A' ' 567' ' ' ILE . 10.9 p -119.71 150.18 22.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.813 -0.555 . . . . 73.430000000000007 110.004 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.437 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -122.83 160.32 26.28 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.911 -0.774 . . . . 70.519999999999996 108.911 173.489 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 6.8 p -127.33 144.61 51.02 Favored 'General case' 0 C--N 1.288 -2.095 0 O-C-N 123.898 0.749 . . . . 73.010000000000005 112.696 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.0 mp -94.66 122.74 46.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 106.369 -1.715 . . . . 74.430000000000007 106.369 171.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 15.6 m -100.92 119.24 38.42 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 123.731 0.645 . . . . 60.0 109.332 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.44 ' CG2' ' HE2' ' A' ' 521' ' ' MET . 89.4 t -124.18 128.81 74.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 109.927 -0.397 . . . . 72.340000000000003 109.927 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.439 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 20.5 tptm -77.97 113.22 15.67 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.183 -0.673 . . . . 70.140000000000001 109.183 175.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.3 120.97 36.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 106.89 -1.522 . . . . 70.510000000000005 106.89 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 35.7 mm . . . . . 0 C--N 1.292 -1.922 0 N-CA-C 108.911 -0.774 . . . . 73.140000000000001 108.911 -176.565 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt . . . . . 0 CA--C 1.482 -1.648 0 N-CA-C 109.443 -0.577 . . . . 74.219999999999999 109.443 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 586' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 644' ' ' VAL . 10.0 t -149.33 138.75 21.57 Favored 'General case' 0 N--CA 1.416 -2.143 0 C-N-CA 120.034 -0.666 . . . . 71.319999999999993 110.937 174.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 49.0 p90 -135.08 167.7 20.47 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.651 -1.241 . . . . 70.109999999999999 107.651 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.457 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 80.3 m-85 -114.44 159.39 20.38 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 120.572 -0.451 . . . . 74.430000000000007 109.889 -175.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.33 128.22 47.86 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 106.243 -1.762 . . . . 74.129999999999995 106.243 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -122.19 123.37 41.35 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 110.238 -0.282 . . . . 75.319999999999993 110.238 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . 0.433 HG21 ' HB3' ' A' ' 539' ' ' TYR . 23.5 pt -95.86 135.19 30.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.859 -1.163 . . . . 74.400000000000006 107.859 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -84.38 -177.55 51.29 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 111.429 -0.669 . . . . 75.430000000000007 111.429 -177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.75 133.95 92.37 Favored Pre-proline 0 N--CA 1.435 -1.19 0 C-N-CA 120.931 -0.308 . . . . 73.349999999999994 111.435 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.7 129.48 26.44 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.947 2.432 . . . . 73.530000000000001 111.513 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . 0.409 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.1 ptp180 -107.81 119.95 40.89 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.458 -0.792 . . . . 74.439999999999998 109.902 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -66.07 132.1 47.74 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.967 -1.123 . . . . 74.530000000000001 107.967 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.496 ' CG2' HG12 ' A' ' 536' ' ' ILE . 98.1 t . . . . . 0 C--N 1.307 -1.255 0 CA-C-O 121.707 0.765 . . . . 73.420000000000002 112.385 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 N--CA 1.43 -2.213 0 N-CA-C 108.876 -1.24 . . . . 74.519999999999996 108.876 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.86 168.18 17.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 120.894 -0.323 . . . . 73.010000000000005 110.217 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.21 175.91 5.34 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 112.14 0.422 . . . . 73.319999999999993 112.14 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . 0.405 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -72.53 -177.58 31.3 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 114.948 0.739 . . . . 74.439999999999998 114.948 -176.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -58.48 -47.35 84.36 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.476 1.111 . . . . 70.219999999999999 110.172 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -140.44 121.83 15.0 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.006 -0.739 . . . . 62.25 109.006 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 10.1 p -114.32 96.21 5.66 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 120.899 0.381 . . . . 73.209999999999994 111.004 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -171.16 134.0 0.9 Allowed 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.572 -0.74 . . . . 72.519999999999996 109.662 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.408 HD21 HG13 ' A' ' 523' ' ' VAL . 25.6 tp -117.42 132.35 56.59 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.896 -1.047 . . . . 74.140000000000001 108.769 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -99.71 111.91 24.2 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.946 -1.502 . . . . 75.510000000000005 106.946 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 586' ' ' THR . 41.3 t -100.41 111.1 29.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 109.338 -0.615 . . . . 74.319999999999993 109.338 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 51.1 mt -99.48 118.45 46.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 N-CA-C 109.177 -0.675 . . . . 74.319999999999993 109.177 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 69.0 mt -87.5 107.86 17.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 106.792 -1.559 . . . . 73.409999999999997 106.792 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? . . . . . 0 C--N 1.292 -1.921 0 CA-C-N 116.098 -0.501 . . . . 75.450000000000003 110.93 -178.648 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 502' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 121.782 0.801 . . . . 75.439999999999998 109.158 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 174.9 -161.88 31.53 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 109.033 -1.627 . . . . 74.450000000000003 109.033 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.466 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.4 mp -116.25 121.37 67.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 117.202 0.501 . . . . 73.25 111.359 -174.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.547 ' CD2' HG22 ' A' ' 528' ' ' THR . 30.7 m-85 -95.86 135.65 37.31 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.011 -0.737 . . . . 73.200000000000003 109.011 168.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.6 t -167.32 179.66 4.93 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.088 -0.708 . . . . 73.150000000000006 109.088 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.07 152.05 22.3 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.455 -0.572 . . . . 74.120000000000005 109.455 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.66 -37.12 84.13 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.79 -0.448 . . . . 74.540000000000006 109.79 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -125.97 149.73 67.08 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 109.62 -0.511 . . . . 73.140000000000001 109.62 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.01 -27.67 6.68 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.678 1.585 . . . . 75.219999999999999 111.771 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 47.4 t -135.48 135.26 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.883 -0.784 . . . . 74.140000000000001 108.883 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.9 t -132.28 140.45 48.62 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.724 -0.843 . . . . 70.25 108.724 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 44.9 p-80 -112.71 127.51 56.15 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.383 0.611 . . . . 75.049999999999997 109.496 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.7 m -112.18 165.2 7.33 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.453 -0.794 . . . . 64.439999999999998 109.211 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 15.4 t -101.2 166.35 10.82 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.666 0.746 . . . . 75.340000000000003 112.134 -172.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -80.11 -19.67 46.8 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.101 -1.409 . . . . 75.319999999999993 107.991 173.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 19.3 m -114.15 29.65 7.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.991 -0.55 . . . . 61.299999999999997 111.763 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.2 tt -97.86 -39.26 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 119.763 -0.775 . . . . 65.450000000000003 113.044 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 90.28 -72.95 1.94 Allowed Glycine 0 CA--C 1.506 -0.529 0 C-N-CA 120.662 -0.78 . . . . 52.119999999999997 111.645 -176.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . 0.475 ' CD1' ' HE3' ' A' ' 574' ' ' LYS . 33.8 mm -128.03 126.87 67.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.65 -1.241 . . . . 75.120000000000005 107.65 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.434 ' HE2' ' CG2' ' A' ' 573' ' ' VAL . 0.0 OUTLIER -107.21 147.96 29.5 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.273 -1.01 . . . . 63.310000000000002 108.273 177.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 51.4 mp0 -122.41 131.9 54.1 Favored 'General case' 0 N--CA 1.434 -1.252 0 O-C-N 123.716 0.635 . . . . 73.400000000000006 110.304 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 570' ' ' THR . 25.3 t -110.95 129.51 66.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.785 -0.643 . . . . 73.120000000000005 109.47 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 6.5 mmmm -86.28 120.28 27.46 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 123.744 0.818 . . . . 74.239999999999995 109.437 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 568' ' ' VAL . 47.9 t -100.65 122.88 53.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 109.184 -0.673 . . . . 72.0 109.184 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.1 mt -69.82 126.7 30.5 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.855 -0.611 . . . . 71.340000000000003 110.173 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.41 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 57.0 ttp180 -74.32 160.82 30.55 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.69 -1.141 . . . . 72.099999999999994 108.997 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.547 HG22 ' CD2' ' A' ' 505' ' ' PHE . 2.5 p -56.98 139.09 53.18 Favored 'General case' 0 N--CA 1.421 -1.881 0 C-N-CA 123.125 0.57 . . . . 75.299999999999997 111.843 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.9 m -51.07 -33.84 27.47 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.863 1.265 . . . . 73.109999999999999 110.059 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -119.78 107.39 1.33 Allowed Glycine 0 N--CA 1.416 -2.646 0 N-CA-C 108.456 -1.858 . . . . 72.519999999999996 108.456 171.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -88.69 101.28 13.84 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.081 -0.711 . . . . 71.200000000000003 109.081 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -116.9 102.02 9.02 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.674 -0.694 . . . . 75.219999999999999 110.798 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 86.1 -157.33 30.58 Favored Glycine 0 C--N 1.311 -0.818 0 C-N-CA 120.826 -0.702 . . . . 43.439999999999998 112.87 174.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -107.0 127.69 53.68 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.606 -0.887 . . . . 72.319999999999993 108.606 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.21 141.68 45.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 C-N-CA 122.768 0.427 . . . . 71.439999999999998 109.981 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.567 HG12 ' CG2' ' A' ' 597' ' ' VAL . 42.4 mm -108.79 134.28 51.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.571 -0.9 . . . . 75.239999999999995 108.571 173.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.55 107.2 43.21 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 109.106 -0.701 . . . . 75.430000000000007 109.106 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -70.36 152.17 66.07 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.871 1.714 . . . . 64.439999999999998 110.999 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -148.52 157.88 43.76 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.674 -0.491 . . . . 64.120000000000005 109.674 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.11 152.6 24.67 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.914 0.759 . . . . 74.430000000000007 110.441 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.9 p -85.22 143.4 28.78 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.0 -0.545 . . . . 74.239999999999995 109.965 176.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 82.5 mt -105.59 122.2 58.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 108.368 -0.975 . . . . 73.430000000000007 108.368 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -81.45 145.35 30.81 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 123.754 0.659 . . . . 71.230000000000004 109.909 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -175.03 -99.76 0.12 Allowed Glycine 0 CA--C 1.483 -1.921 0 N-CA-C 111.038 -0.825 . . . . 51.109999999999999 111.038 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.43 29.17 0.51 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.148 0.979 . . . . 74.310000000000002 110.37 -175.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -165.66 145.3 6.49 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.563 -1.643 . . . . 72.129999999999995 106.563 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -86.3 127.22 34.75 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 113.0 0.741 . . . . 74.230000000000004 113.0 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.79 -164.09 38.68 Favored Glycine 0 C--N 1.302 -1.324 0 CA-C-N 114.446 -1.252 . . . . 55.340000000000003 110.755 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.95 18.4 76.24 Favored Glycine 0 C--N 1.318 -0.441 0 CA-C-N 117.509 0.654 . . . . 75.349999999999994 112.796 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 75.71 44.8 19.25 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.627 -0.797 . . . . 71.540000000000006 111.133 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -114.75 -59.25 2.04 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.609 -0.436 . . . . 54.149999999999999 110.074 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -100.82 -37.12 8.83 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 107.417 -1.327 . . . . 73.239999999999995 107.417 171.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -141.38 150.88 42.97 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 114.661 -1.154 . . . . 75.510000000000005 107.939 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.58 113.67 20.45 Favored 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 106.446 -1.687 . . . . 60.130000000000003 106.446 174.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -76.21 131.89 39.59 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.752 -0.833 . . . . 61.119999999999997 108.752 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.9 t -128.34 148.21 50.67 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 121.688 0.756 . . . . 63.130000000000003 110.965 -172.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 25.3 p -141.39 151.39 43.44 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 106.294 -1.743 . . . . 74.400000000000006 106.294 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 171.48 -161.12 33.41 Favored Glycine 0 N--CA 1.417 -2.587 0 C-N-CA 119.972 -1.109 . . . . 65.310000000000002 110.978 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.526 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 47.1 mt-10 -139.39 130.96 27.17 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 122.497 0.319 . . . . 65.329999999999998 110.745 -176.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 98.7 mt -95.56 142.21 28.17 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.918 -0.771 . . . . 74.450000000000003 108.918 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -108.9 118.73 37.55 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.294 0.568 . . . . 74.530000000000001 110.824 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -117.53 156.49 27.97 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.538 -0.756 . . . . 74.400000000000006 109.51 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 533' ' ' GLY . 47.3 mt-30 -148.54 178.74 8.36 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.118 -1.067 . . . . 70.129999999999995 108.118 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -67.83 -30.79 70.27 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.683 -0.858 . . . . 64.230000000000004 108.683 172.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -84.22 -44.86 13.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.228 -0.897 . . . . 74.140000000000001 110.429 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.433 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 70.5 mm-40 -65.72 136.97 56.95 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 123.587 0.755 . . . . 75.010000000000005 111.021 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.548 HG13 ' H ' ' A' ' 568' ' ' VAL . 9.5 pt -89.78 -92.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 114.055 1.131 . . . . 75.340000000000003 114.055 -177.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.548 ' H ' HG13 ' A' ' 567' ' ' ILE . 8.5 p -119.41 149.82 21.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.62 -0.511 . . . . 74.430000000000007 109.62 -176.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -115.1 157.05 24.1 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.175 -0.676 . . . . 74.340000000000003 109.175 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.6 p -122.5 137.75 54.78 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.232 -0.895 . . . . 74.530000000000001 110.925 177.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 24.3 mt -94.71 118.98 42.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 107.898 -1.149 . . . . 75.319999999999993 107.898 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 11.8 p -94.66 115.61 27.75 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 124.002 0.814 . . . . 72.010000000000005 110.611 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.434 ' CG2' ' HE2' ' A' ' 521' ' ' MET . 89.2 t -119.79 129.61 75.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 CA-C-O 120.712 0.291 . . . . 63.420000000000002 110.46 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.475 ' HE3' ' CD1' ' A' ' 520' ' ' ILE . 4.1 tppp? -83.88 119.08 24.44 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.844 0.857 . . . . 75.400000000000006 110.158 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 29.9 t -88.49 121.78 39.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 106.03 -1.841 . . . . 74.439999999999998 106.03 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 48.3 mm . . . . . 0 C--N 1.304 -1.396 0 CA-C-O 121.241 0.543 . . . . 73.549999999999997 111.191 -173.191 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm . . . . . 0 C--O 1.21 -1.015 0 N-CA-C 110.282 -0.266 . . . . 74.439999999999998 110.282 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.0 t -156.65 136.6 12.63 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.188 0.518 . . . . 74.109999999999999 111.27 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -131.6 179.13 6.23 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.325 -0.991 . . . . 75.340000000000003 108.325 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.446 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 82.1 m-85 -125.2 155.33 40.2 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 109.19 -0.671 . . . . 75.340000000000003 109.19 -176.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.51 131.1 53.95 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.613 -1.625 . . . . 74.239999999999995 106.613 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.409 ' HB2' HD12 ' A' ' 542' ' ' ILE . 33.4 tt0 -126.0 137.43 53.66 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.547 -0.538 . . . . 73.010000000000005 109.547 176.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 14.9 pt -104.53 142.1 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.175 0 N-CA-C 107.772 -1.195 . . . . 74.420000000000002 107.772 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.37 176.4 49.98 Favored Glycine 0 N--CA 1.414 -2.795 0 N-CA-C 110.398 -1.081 . . . . 74.099999999999994 110.398 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.97 128.62 92.71 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-O 120.883 0.373 . . . . 75.340000000000003 111.047 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.13 128.24 24.61 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.728 2.952 . . . . 72.209999999999994 112.521 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -110.23 119.04 37.97 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.316 -0.856 . . . . 71.409999999999997 109.81 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.17 134.31 53.45 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.415 -0.957 . . . . 73.010000000000005 108.415 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.567 ' CG2' HG12 ' A' ' 536' ' ' ILE . 34.7 t . . . . . 0 C--N 1.298 -1.652 0 CA-C-O 121.396 0.617 . . . . 72.420000000000002 109.853 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.43 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 43.9 Cg_endo . . . . . 0 N--CA 1.457 -0.669 0 N-CA-C 110.252 -0.711 . . . . 71.150000000000006 110.252 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.86 162.87 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 108.928 -0.767 . . . . 74.519999999999996 108.928 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.417 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.8 OUTLIER -96.89 166.57 11.56 Favored 'General case' 0 N--CA 1.424 -1.733 0 C-N-CA 119.377 -0.929 . . . . 75.510000000000005 111.813 178.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . 0.466 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -69.36 -168.25 5.86 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 116.182 1.233 . . . . 72.230000000000004 116.182 -175.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -70.83 -39.5 72.98 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.085 -1.058 . . . . 65.120000000000005 108.452 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -138.73 121.92 16.94 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.354 -0.839 . . . . 75.319999999999993 110.05 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 640' ' ' THR . . . . . 0.417 HG21 ' HB2' ' A' ' 636' ' ' LEU . 17.8 p -121.92 92.87 3.83 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.789 -0.641 . . . . 73.450000000000003 109.735 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . 0.49 ' HZ3' ' HB2' ' A' ' 641' ' ' LYS . 4.9 ttmp? -161.95 143.01 10.75 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.627 -1.249 . . . . 72.319999999999993 107.627 -175.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.423 HD21 HG13 ' A' ' 523' ' ' VAL . 16.4 tp -128.69 125.7 38.56 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 107.726 -1.212 . . . . 74.430000000000007 107.726 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -93.86 111.48 23.19 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.098 -1.445 . . . . 73.120000000000005 107.098 176.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.86 113.56 39.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.208 -0.664 . . . . 71.349999999999994 109.208 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 38.3 mt -100.43 128.62 52.28 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.554 0 N-CA-C 108.298 -1.001 . . . . 73.540000000000006 108.298 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 57.9 mt -104.51 107.61 22.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 106.894 -1.521 . . . . 65.200000000000003 106.894 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 C--N 1.29 -2.014 0 C-N-CA 120.327 -0.549 . . . . 74.430000000000007 111.934 179.464 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 502' ' ' ALA . . . . . 0.498 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.438 -1.07 0 N-CA-C 113.864 1.061 . . . . 73.129999999999995 113.864 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 159.32 -135.42 4.16 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 118.383 -1.865 . . . . 61.240000000000002 113.145 -173.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.4 120.08 55.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 122.075 0.15 . . . . 74.530000000000001 110.968 -173.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.443 ' CE2' ' HB ' ' A' ' 528' ' ' THR . 23.8 m-85 -108.68 126.53 53.09 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.25 -1.019 . . . . 72.099999999999994 108.25 169.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.6 t -171.2 -178.82 2.51 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.671 -0.863 . . . . 75.140000000000001 108.671 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -87.79 152.12 22.36 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 110.444 -0.206 . . . . 73.409999999999997 110.444 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -59.64 -41.11 89.78 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.648 0.737 . . . . 74.120000000000005 110.165 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -135.16 146.59 58.91 Favored Pre-proline 0 N--CA 1.42 -1.96 0 CA-C-N 114.741 -1.118 . . . . 73.5 108.227 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -71.08 -29.89 17.08 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.167 1.911 . . . . 74.310000000000002 112.665 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.13 136.79 55.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.639 -0.874 . . . . 54.329999999999998 108.639 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.2 t -133.65 141.24 47.53 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 108.39 -0.966 . . . . 74.329999999999998 108.39 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -109.44 132.94 53.66 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.073 -1.051 . . . . 54.240000000000002 109.352 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.3 m -124.34 165.99 20.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 109.044 -0.724 . . . . 73.510000000000005 109.044 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.444 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 72.4 m -93.78 152.61 18.81 Favored 'General case' 0 N--CA 1.394 -3.25 0 CA-C-N 115.649 -0.705 . . . . 75.430000000000007 110.774 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -68.22 -56.74 7.62 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.623 0.725 . . . . 72.200000000000003 109.073 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.69 40.68 0.6 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 125.121 1.368 . . . . 74.120000000000005 111.69 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.444 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 12.0 tt -104.71 -26.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.155 0.503 . . . . 73.450000000000003 111.73 -175.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . 0.423 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 91.76 -79.06 1.28 Allowed Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 110.839 -0.904 . . . . 65.230000000000004 110.839 -175.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 37.2 mm -129.79 133.45 64.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.674 -1.232 . . . . 75.430000000000007 107.674 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.541 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -109.91 146.5 35.06 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.445 -0.946 . . . . 74.120000000000005 108.445 175.456 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 26.4 mt-10 -125.7 120.12 29.83 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 123.645 0.591 . . . . 74.530000000000001 111.544 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.541 HG23 ' SD ' ' A' ' 521' ' ' MET . 65.9 t -112.55 129.23 68.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.628 -0.878 . . . . 74.329999999999998 108.628 177.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . 0.49 ' HB3' HG22 ' A' ' 568' ' ' VAL . 29.1 mtmt -86.76 143.13 27.67 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 123.808 0.692 . . . . 75.329999999999998 110.698 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.528 ' O ' HG23 ' A' ' 568' ' ' VAL . 43.3 t -105.02 141.63 19.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.755 -0.657 . . . . 74.519999999999996 109.322 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.96 118.51 17.99 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.69 -0.856 . . . . 74.150000000000006 108.69 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -73.76 153.21 40.1 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.072 -0.714 . . . . 73.450000000000003 109.072 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.443 ' HB ' ' CE2' ' A' ' 505' ' ' PHE . 12.0 t -60.16 157.52 13.07 Favored 'General case' 0 N--CA 1.41 -2.435 0 C-N-CA 123.857 0.863 . . . . 73.420000000000002 110.727 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.0 t -72.01 -26.95 62.42 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.711 0.767 . . . . 61.420000000000002 109.775 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.85 82.91 0.33 Allowed Glycine 0 N--CA 1.428 -1.842 0 CA-C-N 115.688 -0.687 . . . . 73.349999999999994 111.486 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.64 100.31 13.18 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.655 -1.239 . . . . 73.540000000000006 107.655 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -111.86 96.84 6.29 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.627 0.727 . . . . 73.340000000000003 111.882 -176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 101.96 -122.84 7.69 Favored Glycine 0 N--CA 1.428 -1.859 0 CA-C-N 114.576 -1.193 . . . . 73.230000000000004 110.417 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -133.13 127.98 35.09 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.13 0.49 . . . . 73.099999999999994 110.295 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 64.5 t -130.39 136.54 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 108.837 -0.801 . . . . 72.010000000000005 108.837 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.511 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 40.3 mm -106.69 138.46 32.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 109.088 -0.708 . . . . 74.129999999999995 109.088 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.1 t -122.91 110.08 31.66 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 109.598 -0.519 . . . . 65.219999999999999 109.598 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.28 155.19 51.56 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.362 2.041 . . . . 71.409999999999997 111.903 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.407 ' HB3' HG23 ' A' ' 591' ' ' ILE . 31.5 p90 -150.84 156.15 40.66 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 110.153 -0.314 . . . . 73.109999999999999 110.153 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.59 156.21 40.93 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 123.714 0.634 . . . . 73.030000000000001 111.922 175.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 18.9 p -79.35 153.59 29.68 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 109.373 -0.603 . . . . 74.430000000000007 109.373 175.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 81.8 mt -117.54 113.91 43.95 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 107.313 -1.365 . . . . 74.420000000000002 107.313 176.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -84.2 147.58 27.21 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.305 -0.861 . . . . 75.400000000000006 108.732 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 178.31 -91.82 0.08 OUTLIER Glycine 0 C--N 1.307 -1.046 0 C-N-CA 120.601 -0.809 . . . . 73.409999999999997 111.526 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -2.6 30.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.679 0.752 . . . . 74.040000000000006 112.045 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -144.43 141.52 29.68 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 104.536 -2.394 . . . . 72.340000000000003 104.536 171.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.48 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 71.9 mtt180 -104.05 145.69 29.81 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 121.912 0.863 . . . . 72.319999999999993 112.635 -173.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.73 -153.23 27.83 Favored Glycine 0 N--CA 1.421 -2.303 0 N-CA-C 109.371 -1.492 . . . . 63.25 109.371 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 78.0 8.75 87.3 Favored Glycine 0 C--N 1.292 -1.891 0 N-CA-C 111.429 -0.668 . . . . 65.239999999999995 111.429 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 79.05 29.6 50.36 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 110.647 -0.981 . . . . 73.430000000000007 110.647 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.48 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 32.1 tt0 -96.86 -60.99 1.48 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.712 -0.477 . . . . 73.340000000000003 109.712 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -103.3 -43.71 5.36 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 108.609 -0.886 . . . . 72.420000000000002 108.609 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -135.11 158.1 45.23 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.377 -0.829 . . . . 73.430000000000007 109.013 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.459 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 13.9 tt0 -84.19 138.3 33.06 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.604 -1.258 . . . . 74.010000000000005 107.604 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.81 121.19 18.53 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 109.682 -0.488 . . . . 61.520000000000003 109.682 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.435 ' CG2' HG23 ' A' ' 573' ' ' VAL . 13.5 t -130.13 146.11 51.75 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-O 121.468 0.651 . . . . 73.099999999999994 109.411 176.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 5.0 p -167.52 155.27 8.94 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.973 -1.492 . . . . 73.319999999999993 106.973 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 165.01 -153.44 23.63 Favored Glycine 0 N--CA 1.41 -3.086 0 C-N-CA 119.789 -1.196 . . . . 72.340000000000003 110.484 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.511 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 46.7 mt-10 -139.55 133.09 30.31 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.117 0.484 . . . . 72.439999999999998 110.466 -175.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 569' ' ' LYS . 96.5 mt -97.36 137.91 35.62 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.827 -0.624 . . . . 72.420000000000002 109.468 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -99.18 115.47 29.16 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 121.203 0.525 . . . . 45.109999999999999 110.706 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -111.63 145.05 39.89 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.604 -0.887 . . . . 74.340000000000003 108.604 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.434 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 46.7 mt-30 -147.25 -176.3 5.17 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.582 -0.896 . . . . 73.230000000000004 108.582 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -68.4 -31.69 71.21 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.452 -0.944 . . . . 55.049999999999997 108.452 172.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -84.49 -38.39 20.15 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.572 -1.195 . . . . 74.049999999999997 111.671 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.434 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 36.5 mm-40 -75.67 129.33 36.96 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 116.674 -0.239 . . . . 74.030000000000001 111.064 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.56 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.8 pt -90.02 -72.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.897 -0.592 . . . . 61.210000000000001 111.804 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.56 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.5 p -130.96 149.23 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 CA-C-O 121.204 0.526 . . . . 75.519999999999996 110.347 -177.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.415 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -120.29 156.43 31.26 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 109.387 -0.597 . . . . 74.530000000000001 109.387 175.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.43 ' CG2' ' HG2' ' A' ' 524' ' ' LYS . 3.3 p -119.81 147.28 44.84 Favored 'General case' 0 C--N 1.283 -2.285 0 O-C-N 124.161 0.913 . . . . 71.349999999999994 112.721 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.2 mp -94.41 122.6 46.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 106.353 -1.721 . . . . 74.430000000000007 106.353 172.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 572' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 521' ' ' MET . 18.7 m -102.94 116.81 33.27 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 123.813 0.696 . . . . 75.329999999999998 109.127 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.453 ' CG2' ' HE2' ' A' ' 521' ' ' MET . 86.2 t -119.47 128.46 75.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 109.144 -0.688 . . . . 73.340000000000003 109.144 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.459 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 23.9 tptm -83.97 124.1 30.68 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.752 -0.832 . . . . 75.540000000000006 108.752 176.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 47.9 t -94.26 127.36 46.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 108.61 -0.885 . . . . 72.230000000000004 108.61 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 45.5 mm . . . . . 0 C--N 1.304 -1.37 0 N-CA-C 108.658 -0.867 . . . . 73.239999999999995 108.658 -178.517 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp . . . . . 0 C--O 1.211 -0.949 0 CA-C-O 121.152 0.501 . . . . 73.5 111.098 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.0 t -153.32 135.73 15.04 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 109.48 -0.563 . . . . 73.010000000000005 109.48 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -129.37 178.1 6.69 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.786 -1.19 . . . . 72.120000000000005 107.786 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.481 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 67.4 m-85 -123.43 154.59 38.84 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.806 -0.813 . . . . 75.319999999999993 108.806 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.81 131.3 53.56 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 106.191 -1.781 . . . . 72.129999999999995 106.191 178.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -126.97 139.06 53.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.589 -0.523 . . . . 73.540000000000006 109.589 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . 0.407 HG23 ' HB3' ' A' ' 539' ' ' TYR . 20.3 pt -106.0 141.57 21.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.322 -0.992 . . . . 75.420000000000002 108.322 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.12 179.54 49.67 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 111.236 -0.746 . . . . 72.219999999999999 111.236 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.78 134.26 86.08 Favored Pre-proline 0 N--CA 1.435 -1.225 0 C-N-CA 120.912 -0.315 . . . . 75.519999999999996 110.632 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.36 146.94 96.72 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.255 2.636 . . . . 74.230000000000004 112.064 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -124.47 125.04 43.6 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.024 -0.534 . . . . 73.25 109.562 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -72.08 129.17 37.86 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.664 -1.236 . . . . 75.129999999999995 107.664 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.488 ' CG2' HG12 ' A' ' 536' ' ' ILE . 48.6 t . . . . . 0 C--N 1.3 -1.56 0 N-CA-C 108.766 -0.827 . . . . 65.049999999999997 108.766 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.498 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 53.3 Cg_endo . . . . . 0 N--CA 1.444 -1.435 0 N-CA-C 110.922 -0.453 . . . . 65.319999999999993 110.922 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.95 175.93 6.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.535 -0.913 . . . . 75.340000000000003 108.535 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.59 -176.3 3.03 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.267 -0.573 . . . . 74.329999999999998 112.086 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -80.62 -153.39 9.21 Favored Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 115.893 -0.594 . . . . 42.020000000000003 113.351 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . 0.511 ' HG2' ' CD2' ' A' ' 639' ' ' HIS . 37.4 tt0 -71.87 -57.13 4.59 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 123.392 0.677 . . . . 74.219999999999999 110.224 -177.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . 0.511 ' CD2' ' HG2' ' A' ' 638' ' ' GLU . 96.6 m-70 -135.06 139.13 44.53 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 109.556 -0.535 . . . . 72.549999999999997 109.556 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 29.7 p -124.47 99.83 6.38 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.206 0.526 . . . . 74.519999999999996 111.249 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -165.8 150.73 8.57 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.082 -1.081 . . . . 74.420000000000002 108.082 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.401 HD21 HG22 ' A' ' 523' ' ' VAL . 34.8 tp -130.95 131.34 44.37 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.021 -1.103 . . . . 72.209999999999994 108.021 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -97.04 104.52 16.54 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.915 -1.513 . . . . 74.519999999999996 106.915 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 40.8 t -99.47 113.53 34.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 109.982 -0.377 . . . . 74.540000000000006 109.982 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 59.6 mt -99.11 126.97 52.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 109.027 -0.731 . . . . 71.019999999999996 109.027 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 57.2 mt -104.06 110.39 30.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.264 -1.013 . . . . 75.439999999999998 108.264 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 C--N 1.288 -2.068 0 CA-C-N 116.443 -0.344 . . . . 72.010000000000005 110.241 178.136 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 502' ' ' ALA . . . . . 0.505 ' HB1' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.421 -1.925 0 N-CA-C 111.656 0.243 . . . . 75.349999999999994 111.656 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 160.94 -153.24 24.05 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 111.241 -0.743 . . . . 74.340000000000003 111.241 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.86 130.94 67.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 123.148 0.579 . . . . 75.329999999999998 112.049 -167.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -108.51 132.57 53.69 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.315 -0.624 . . . . 63.509999999999998 109.315 168.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.7 t -168.69 173.72 7.1 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.405 -0.591 . . . . 63.409999999999997 109.405 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -77.25 147.26 36.43 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 120.939 0.399 . . . . 73.200000000000003 110.751 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -67.98 -35.65 78.72 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.487 -0.779 . . . . 61.350000000000001 109.906 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -127.76 144.4 51.12 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.115 -1.069 . . . . 74.340000000000003 108.115 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.03 -31.34 6.24 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.146 1.897 . . . . 73.540000000000006 111.986 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.97 138.04 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 106.511 -1.663 . . . . 74.420000000000002 106.511 -177.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.4 t -132.19 140.82 48.86 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 108.06 -1.089 . . . . 73.510000000000005 108.06 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -120.28 124.19 45.03 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 109.253 -0.647 . . . . 74.439999999999998 109.253 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.8 m -115.7 167.34 8.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.001 -1.0 . . . . 75.239999999999995 109.398 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.643 ' O ' HG23 ' A' ' 518' ' ' ILE . 23.2 t -97.04 153.89 17.65 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 120.96 0.41 . . . . 65.340000000000003 110.229 -176.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -65.51 -42.2 92.35 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.143 -1.429 . . . . 74.129999999999995 107.143 169.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.4 m -90.66 23.98 2.85 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.995 -1.002 . . . . 72.230000000000004 112.432 -173.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 515' ' ' SER . 8.8 tt -90.94 -22.08 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 121.575 -0.703 . . . . 75.430000000000007 109.825 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 83.97 -75.6 2.35 Favored Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.677 -0.773 . . . . 74.030000000000001 111.234 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.0 mm -129.83 130.2 66.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 106.983 -1.488 . . . . 74.219999999999999 106.983 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.593 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -106.39 147.34 29.38 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 109.131 -0.692 . . . . 74.5 109.131 178.612 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.3 mt-10 -127.91 114.84 17.69 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 123.852 0.72 . . . . 65.299999999999997 110.945 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 570' ' ' THR . 90.7 t -102.33 127.96 55.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.778 -0.823 . . . . 74.430000000000007 108.778 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -87.6 138.91 31.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 121.442 0.639 . . . . 73.5 110.667 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 61.0 t -108.2 129.93 61.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.443 -0.799 . . . . 75.519999999999996 108.847 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.5 130.01 41.77 Favored 'General case' 0 CA--C 1.501 -0.915 0 O-C-N 123.862 0.726 . . . . 75.430000000000007 109.87 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -82.65 155.1 24.56 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 115.151 -0.931 . . . . 74.439999999999998 110.024 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.2 t -56.05 145.48 25.51 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 124.763 1.225 . . . . 75.5 111.538 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.9 t -60.53 -31.77 70.84 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 124.375 1.07 . . . . 70.420000000000002 109.042 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -122.26 99.51 0.67 Allowed Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 109.71 -1.356 . . . . 53.439999999999998 109.71 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.44 101.6 12.76 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.948 -1.13 . . . . 63.5 107.948 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -107.75 100.77 10.13 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.261 -0.881 . . . . 74.25 110.389 -172.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 75.53 -114.68 4.33 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.395 -0.907 . . . . 74.340000000000003 112.36 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.449 HD21 ' HG2' ' A' ' 563' ' ' GLN . 2.7 t-20 -133.99 129.18 35.8 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.143 0.577 . . . . 72.109999999999999 109.459 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 93.1 t -130.24 135.64 60.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 C-N-CA 123.56 0.744 . . . . 72.140000000000001 109.126 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.484 HG12 ' CG2' ' A' ' 597' ' ' VAL . 38.0 mm -108.74 131.25 59.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.88 -0.415 . . . . 73.409999999999997 109.88 176.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 26.6 t -119.23 105.9 43.79 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 109.21 -0.663 . . . . 75.109999999999999 109.21 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.86 153.19 58.57 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.317 2.011 . . . . 74.040000000000006 112.048 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.435 ' HB3' HG21 ' A' ' 591' ' ' ILE . 52.1 p90 -151.02 159.64 44.42 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.642 0.258 . . . . 74.400000000000006 110.786 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.03 157.05 33.94 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.463 -0.79 . . . . 75.340000000000003 112.084 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.6 p -84.86 139.68 31.71 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.866 -0.607 . . . . 75.120000000000005 109.828 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.413 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 69.1 mt -107.63 134.37 49.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.132 -0.692 . . . . 74.239999999999995 109.132 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -85.62 142.97 28.71 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.923 -0.58 . . . . 62.310000000000002 110.337 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 151.77 141.58 3.35 Favored Glycine 0 CA--C 1.471 -2.678 0 N-CA-C 107.924 -2.07 . . . . 61.310000000000002 107.924 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . 0.357 1.0 OUTLIER 61.11 -47.17 0.12 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 115.377 1.621 . . . . 70.430000000000007 115.377 -174.066 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -107.87 150.38 27.12 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.193 -1.04 . . . . 75.319999999999993 108.193 174.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -92.37 128.74 38.33 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.745 0.783 . . . . 75.209999999999994 111.347 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.78 -153.5 21.68 Favored Glycine 0 C--N 1.3 -1.421 0 CA-C-N 115.056 -0.975 . . . . 74.129999999999995 112.96 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 57.12 30.84 61.24 Favored Glycine 0 C--N 1.317 -0.48 0 N-CA-C 113.76 0.264 . . . . 65.230000000000004 113.76 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 73.31 39.68 50.98 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.735 -0.745 . . . . 70.150000000000006 111.991 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -112.88 -51.77 2.81 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 122.363 -0.492 . . . . 74.340000000000003 110.869 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.531 ' CG ' ' HZ3' ' A' ' 585' ' ' LYS . 73.6 m-20 -111.14 -35.31 5.93 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.385 -1.339 . . . . 74.519999999999996 107.385 169.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -139.54 148.94 43.29 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.781 -1.192 . . . . 75.310000000000002 107.781 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.77 136.0 37.26 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.337 -1.357 . . . . 72.230000000000004 107.337 175.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -90.69 119.9 31.31 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.592 -0.521 . . . . 63.329999999999998 109.592 -174.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 10.3 t -128.02 155.03 44.97 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.263 0.554 . . . . 64.120000000000005 111.04 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 26.4 p -149.79 158.37 44.11 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.955 -1.498 . . . . 73.109999999999999 106.955 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 168.78 -167.7 40.57 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 109.893 -1.283 . . . . 74.400000000000006 109.893 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 43.6 mt-10 -132.64 138.42 47.34 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.804 -0.443 . . . . 70.040000000000006 109.804 -178.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.489 HD21 ' HB3' ' A' ' 569' ' ' LYS . 76.6 mt -95.7 133.93 39.22 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.726 -0.472 . . . . 72.519999999999996 109.726 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.402 ' HA ' HD12 ' A' ' 536' ' ' ILE . 24.8 tt0 -101.25 106.43 17.64 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.847 -0.615 . . . . 75.349999999999994 110.279 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -105.04 148.22 27.01 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.007 -0.738 . . . . 74.319999999999993 109.007 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.449 ' HG2' HD21 ' A' ' 534' ' ' ASN . 8.8 mt-30 -145.02 -178.04 5.84 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.944 -1.132 . . . . 73.510000000000005 107.944 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -68.84 -31.89 71.19 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.117 -1.068 . . . . 73.129999999999995 108.117 173.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.42 -52.33 7.79 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.109 -0.95 . . . . 72.109999999999999 111.809 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.406 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 14.7 mm-40 -55.25 125.62 21.45 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 123.449 0.7 . . . . 74.510000000000005 111.743 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.582 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.7 pt -84.63 -63.03 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.266 -0.879 . . . . 75.299999999999997 112.646 -175.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.582 ' H ' HG13 ' A' ' 567' ' ' ILE . 10.0 p -143.48 150.57 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 109.213 -0.662 . . . . 64.030000000000001 109.213 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.489 ' HB3' HD21 ' A' ' 560' ' ' LEU . 6.1 mmpt? -118.05 165.57 13.58 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.728 -0.471 . . . . 71.109999999999999 109.728 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.6 p -135.14 147.43 49.47 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 123.962 0.789 . . . . 73.430000000000007 112.363 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.0 mp -100.47 118.1 46.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 106.941 -1.503 . . . . 72.310000000000002 106.941 172.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 572' ' ' SER . . . . . 0.593 ' HA ' ' O ' ' A' ' 521' ' ' MET . 3.3 p -95.95 117.0 29.78 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 124.099 0.874 . . . . 64.319999999999993 110.399 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.44 ' CG2' ' HE3' ' A' ' 521' ' ' MET . 89.0 t -124.79 132.17 71.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 O-C-N 122.239 -0.288 . . . . 71.120000000000005 110.792 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -79.62 123.0 27.22 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 123.856 0.723 . . . . 75.209999999999994 109.703 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 49.0 t -90.2 126.96 43.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.555 -0.905 . . . . 73.120000000000005 108.555 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 26.2 mm . . . . . 0 C--N 1.315 -0.93 0 N-CA-C 109.9 -0.407 . . . . 71.409999999999997 109.9 -177.682 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . 0.531 ' HZ3' ' CG ' ' A' ' 552' ' ' ASP . 34.5 mmtp . . . . . 0 N--CA 1.422 -1.838 0 CA-C-O 121.448 0.642 . . . . 75.030000000000001 110.087 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.7 t -150.0 146.89 27.26 Favored 'General case' 0 N--CA 1.402 -2.872 0 CA-C-N 114.696 -1.138 . . . . 64.439999999999998 107.93 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -138.03 178.77 6.87 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.788 -1.19 . . . . 74.030000000000001 107.788 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.413 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 85.5 m-85 -121.03 152.03 39.09 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.188 -0.605 . . . . 74.430000000000007 109.954 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.45 131.02 54.57 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.032 -1.84 . . . . 74.140000000000001 106.032 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -127.69 136.31 51.39 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.065 0.459 . . . . 75.310000000000002 110.316 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . 0.435 HG21 ' HB3' ' A' ' 539' ' ' TYR . 23.8 pt -105.56 142.45 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.12 0 N-CA-C 107.547 -1.279 . . . . 74.340000000000003 107.547 175.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -88.17 -176.0 47.68 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.665 -0.974 . . . . 60.109999999999999 110.665 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.47 130.38 89.19 Favored Pre-proline 0 C--N 1.301 -1.541 0 CA-C-O 120.809 0.338 . . . . 73.310000000000002 110.931 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.97 130.88 23.98 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.103 2.535 . . . . 65.329999999999998 111.335 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -111.88 134.34 53.5 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.936 -0.394 . . . . 74.129999999999995 109.936 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.56 132.1 43.35 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.485 -1.302 . . . . 65.109999999999999 107.485 177.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.484 ' CG2' HG12 ' A' ' 536' ' ' ILE . 47.5 t . . . . . 0 C--N 1.302 -1.49 0 N-CA-C 109.146 -0.687 . . . . 63.119999999999997 109.146 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.505 ' HA ' ' HB1' ' A' ' 502' ' ' ALA . 36.2 Cg_endo . . . . . 0 N--CA 1.451 -1.02 0 N-CA-C 110.111 -0.765 . . . . 72.310000000000002 110.111 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.64 174.6 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 116.227 -0.442 . . . . 74.510000000000005 110.722 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.65 172.58 6.81 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 120.184 -0.607 . . . . 74.25 112.507 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -82.68 -164.86 35.95 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 115.166 0.826 . . . . 64.5 115.166 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -67.91 -50.19 57.63 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.965 -1.117 . . . . 75.120000000000005 110.514 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -129.06 120.64 26.31 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.946 -0.761 . . . . 74.209999999999994 108.946 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 14.0 p -118.68 80.76 1.59 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 122.567 1.175 . . . . 73.019999999999996 110.293 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -154.44 141.79 19.6 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 114.057 -1.428 . . . . 71.040000000000006 108.889 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.453 HD23 HG21 ' A' ' 523' ' ' VAL . 33.4 tp -129.93 122.96 29.59 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 108.787 -0.82 . . . . 72.140000000000001 108.787 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -92.54 112.32 24.23 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.132 -1.433 . . . . 73.310000000000002 107.132 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.68 110.33 28.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.514 -0.55 . . . . 73.519999999999996 109.514 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 50.5 mt -96.47 135.37 30.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 109.332 -0.618 . . . . 72.530000000000001 109.332 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 84.8 mt -103.05 110.01 28.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 109.034 -0.728 . . . . 75.340000000000003 109.034 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 C--N 1.289 -2.038 0 N-CA-C 108.202 -1.036 . . . . 75.310000000000002 108.202 176.855 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 502' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.428 -1.57 0 N-CA-C 108.921 -0.77 . . . . 75.120000000000005 108.921 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -172.26 -144.36 4.5 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 109.595 -1.402 . . . . 24.010000000000002 109.595 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.6 mp -103.53 114.29 42.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 116.79 0.295 . . . . 73.439999999999998 111.522 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -100.16 126.4 46.42 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.401 -0.963 . . . . 70.010000000000005 108.401 169.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.0 t -169.88 174.41 5.64 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.902 -0.777 . . . . 75.540000000000006 108.902 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -80.55 147.83 30.63 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 110.325 -0.25 . . . . 74.400000000000006 110.325 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -63.5 -40.78 97.96 Favored 'General case' 0 CA--C 1.492 -1.282 0 CA-C-O 122.238 1.018 . . . . 75.5 109.083 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -123.28 135.71 26.29 Favored Pre-proline 0 N--CA 1.401 -2.904 0 CA-C-N 113.948 -1.478 . . . . 73.540000000000006 107.218 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.34 -24.84 11.91 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.806 2.337 . . . . 61.020000000000003 111.519 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 61.7 t -136.25 132.99 49.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 107.142 -1.429 . . . . 75.140000000000001 107.142 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 7.1 t -128.48 133.07 48.4 Favored 'General case' 0 N--CA 1.402 -2.828 0 N-CA-C 108.569 -0.9 . . . . 70.319999999999993 108.569 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -105.8 121.87 44.92 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 109.045 -0.724 . . . . 74.019999999999996 109.045 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.6 m -113.56 174.52 2.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.418 -0.586 . . . . 64.510000000000005 109.418 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.53 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 57.9 m -92.43 165.6 12.97 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 123.254 0.621 . . . . 71.140000000000001 110.993 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.99 -50.72 10.66 Favored 'General case' 0 CA--C 1.57 1.74 0 C-N-CA 124.789 1.236 . . . . 74.430000000000007 112.918 -175.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 48.9 m -105.89 27.32 8.65 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.05 0.94 . . . . 73.239999999999995 110.448 -176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 12.1 tt -63.25 -32.92 58.19 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-N 115.447 -0.797 . . . . 74.25 112.831 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 103.79 -83.8 0.42 Allowed Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 109.927 -1.269 . . . . 74.310000000000002 109.927 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 34.8 mm -133.9 136.57 53.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 105.979 -1.859 . . . . 72.409999999999997 105.979 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.489 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -112.96 141.5 46.72 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.45 -0.574 . . . . 75.439999999999998 109.45 177.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 7.3 mp0 -114.55 132.55 56.28 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 124.194 0.934 . . . . 74.519999999999996 110.08 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.489 HG23 ' SD ' ' A' ' 521' ' ' MET . 87.7 t -124.06 129.09 74.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 108.746 -0.835 . . . . 74.340000000000003 108.746 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . 0.453 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 24.6 mtmm -86.51 139.07 31.22 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.146 0.498 . . . . 73.450000000000003 111.898 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.565 ' O ' HG23 ' A' ' 568' ' ' VAL . 39.6 t -104.18 126.26 58.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.255 -0.646 . . . . 74.439999999999998 109.255 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.18 121.46 12.59 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 123.777 0.673 . . . . 75.420000000000002 110.206 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 562' ' ' PHE . 10.2 tpt180 -68.93 148.37 50.29 Favored 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 115.198 -0.91 . . . . 71.109999999999999 110.91 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 11.4 p -56.97 139.1 53.12 Favored 'General case' 0 N--CA 1.408 -2.525 0 CA-C-N 114.749 -1.114 . . . . 74.120000000000005 111.916 175.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.7 m -56.19 -24.4 41.39 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 125.777 1.631 . . . . 73.109999999999999 110.746 175.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -122.99 114.25 2.37 Favored Glycine 0 N--CA 1.419 -2.446 0 N-CA-C 108.842 -1.703 . . . . 74.310000000000002 108.842 172.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -106.14 101.26 10.76 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.91 -0.774 . . . . 52.450000000000003 108.91 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -129.73 116.2 18.42 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.966 -0.561 . . . . 74.120000000000005 109.748 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 78.26 -164.64 51.3 Favored Glycine 0 C--N 1.316 -0.571 0 C-N-CA 120.901 -0.666 . . . . 72.340000000000003 112.379 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.576 ' ND2' ' HG2' ' A' ' 563' ' ' GLN . 2.5 t-20 -103.47 123.08 46.23 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.244 0.545 . . . . 73.340000000000003 109.878 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 48.1 t -126.48 136.97 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 N-CA-C 108.071 -1.085 . . . . 74.239999999999995 108.071 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.481 HG12 ' CG2' ' A' ' 597' ' ' VAL . 40.2 mm -107.98 135.29 47.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 109.205 -0.665 . . . . 73.420000000000002 109.205 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.51 109.74 36.23 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 109.232 -0.655 . . . . 75.420000000000002 109.232 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -75.9 159.24 38.26 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.124 1.883 . . . . 61.530000000000001 111.45 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -143.92 162.83 35.13 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.233 -0.655 . . . . 73.129999999999995 109.233 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -153.39 157.23 39.67 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 123.882 0.738 . . . . 75.040000000000006 109.739 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.3 p -93.41 139.25 30.9 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.626 0.727 . . . . 73.25 111.605 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 89.7 mt -109.53 122.74 64.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.573 -1.269 . . . . 74.319999999999993 107.573 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -78.81 117.73 20.2 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.677 -0.49 . . . . 53.409999999999997 109.677 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -102.85 -111.58 3.56 Favored Glycine 0 C--N 1.302 -1.355 0 N-CA-C 109.892 -1.283 . . . . 70.150000000000006 109.892 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 28.4 p -78.93 -32.63 45.66 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.508 -0.923 . . . . 64.319999999999993 108.508 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -84.46 141.48 30.76 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.753 -1.112 . . . . 73.230000000000004 109.207 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.471 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 64.6 mtt180 -101.58 146.2 28.01 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-O 121.334 0.588 . . . . 74.120000000000005 111.144 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -94.37 -161.18 34.75 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 114.993 -1.003 . . . . 65.109999999999999 112.137 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 74.65 8.08 80.78 Favored Glycine 0 C--N 1.315 -0.621 0 N-CA-C 112.386 -0.286 . . . . 62.399999999999999 112.386 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . 0.405 ' C ' HG13 ' A' ' 576' ' ' ILE . . . 103.71 10.09 36.16 Favored Glycine 0 N--CA 1.419 -2.476 0 C-N-CA 120.263 -0.97 . . . . 73.099999999999994 112.865 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.471 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 28.0 tt0 -83.46 -66.29 0.91 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 118.991 -1.084 . . . . 73.310000000000002 110.355 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -101.37 -41.63 6.59 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.229 -1.026 . . . . 74.409999999999997 108.229 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -137.34 158.78 43.67 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.809 -1.182 . . . . 73.430000000000007 107.809 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.78 137.16 33.86 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 107.513 -1.292 . . . . 73.329999999999998 107.513 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 33.0 t70 -84.46 103.84 13.95 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.787 -0.82 . . . . 72.150000000000006 108.787 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.473 ' CG2' HG21 ' A' ' 573' ' ' VAL . 11.5 t -110.72 146.01 37.03 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-O 122.234 1.016 . . . . 64.120000000000005 111.873 -172.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 21.8 p -145.56 147.5 32.16 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 105.931 -1.878 . . . . 64.409999999999997 105.931 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -170.06 -179.76 41.84 Favored Glycine 0 CA--C 1.477 -2.317 0 N-CA-C 110.199 -1.16 . . . . 73.340000000000003 110.199 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.448 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 39.2 mt-10 -129.6 114.4 16.0 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.103 0.478 . . . . 75.200000000000003 110.731 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 88.1 mt -85.5 138.29 32.32 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.311 -0.859 . . . . 62.210000000000001 109.448 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.412 ' HA ' HD13 ' A' ' 536' ' ' ILE . 34.4 tt0 -104.52 118.49 36.71 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.99 -0.55 . . . . 73.349999999999994 110.23 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 527' ' ' ARG . 97.9 m-85 -124.44 107.51 11.18 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.704 -0.48 . . . . 73.120000000000005 109.704 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.576 ' HG2' ' ND2' ' A' ' 534' ' ' ASN . 5.5 mt-30 -109.03 178.46 4.46 Favored 'General case' 0 C--O 1.197 -1.67 0 N-CA-C 108.752 -0.833 . . . . 75.409999999999997 108.752 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -52.93 -44.81 67.3 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 123.439 0.462 . . . . 71.329999999999998 110.82 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.52 -49.04 35.55 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.207 0.447 . . . . 75.319999999999993 112.207 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.547 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 14.0 mp0 -54.68 141.9 30.41 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.638 0.775 . . . . 75.219999999999999 111.804 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.518 HG13 ' H ' ' A' ' 568' ' ' VAL . 5.5 pt -101.8 -89.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 112.923 0.712 . . . . 70.200000000000003 112.923 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 525' ' ' VAL . 10.5 p -115.34 152.22 17.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 110.281 -0.266 . . . . 73.510000000000005 110.281 -175.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -126.96 164.56 21.21 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 122.824 0.45 . . . . 72.430000000000007 110.253 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.5 p -123.21 150.56 43.24 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 123.655 0.597 . . . . 72.420000000000002 112.071 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.1 mp -94.41 125.98 46.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 106.784 -1.562 . . . . 75.230000000000004 106.784 172.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 572' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 521' ' ' MET . 51.5 m -104.9 115.56 30.5 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 123.905 0.753 . . . . 75.400000000000006 110.155 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.473 HG21 ' CG2' ' A' ' 556' ' ' THR . 93.7 t -116.84 128.51 74.2 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 116.244 -0.435 . . . . 74.430000000000007 110.447 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -80.27 111.96 17.14 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 108.654 -0.869 . . . . 74.430000000000007 108.654 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 61.9 t -86.65 124.39 40.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 106.056 -1.831 . . . . 72.409999999999997 106.056 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . 0.405 HG13 ' C ' ' A' ' 550' ' ' GLY . 40.7 mm . . . . . 0 C--N 1.296 -1.725 0 CA-C-O 121.903 0.859 . . . . 74.420000000000002 109.27 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt . . . . . 0 CA--C 1.499 -0.987 0 N-CA-C 114.556 1.317 . . . . 74.530000000000001 114.556 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.0 t -146.18 159.02 43.88 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 114.254 -1.339 . . . . 72.120000000000005 109.976 -174.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 46.8 p90 -141.26 176.9 8.47 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.13 -1.433 . . . . 72.5 107.13 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.491 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 85.1 m-85 -121.79 154.7 36.63 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.659 -0.816 . . . . 75.420000000000002 109.614 -177.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.52 131.05 54.52 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.171 -1.788 . . . . 75.430000000000007 106.171 177.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -125.91 134.12 51.68 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.269 -0.641 . . . . 73.150000000000006 109.269 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 13.9 pt -99.14 143.35 13.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.682 -0.859 . . . . 74.450000000000003 108.682 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.7 171.94 45.79 Favored Glycine 0 N--CA 1.413 -2.89 0 N-CA-C 111.452 -0.659 . . . . 75.140000000000001 111.452 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.63 131.57 89.66 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 123.615 0.244 . . . . 73.540000000000006 110.484 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.25 125.99 19.62 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.381 2.721 . . . . 73.430000000000007 112.896 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -104.46 119.55 39.22 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.307 -0.86 . . . . 73.329999999999998 109.328 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.95 129.81 41.06 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.094 -0.957 . . . . 75.209999999999994 108.67 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.481 ' CG2' HG12 ' A' ' 536' ' ' ILE . 50.2 t . . . . . 0 C--N 1.3 -1.55 0 N-CA-C 108.223 -1.029 . . . . 73.510000000000005 108.223 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.457 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 44.6 Cg_endo . . . . . 0 N--CA 1.436 -1.891 0 CA-C-O 121.344 0.477 . . . . 75.430000000000007 111.279 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -124.84 171.13 14.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 115.403 -0.817 . . . . 75.129999999999995 110.176 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.91 -178.26 3.43 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 112.289 0.478 . . . . 63.25 112.289 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.49 -172.07 27.61 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 114.843 0.697 . . . . 74.129999999999995 114.843 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -68.3 -53.78 22.03 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.147 0.979 . . . . 72.129999999999995 110.385 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -120.12 121.34 38.61 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.954 -0.758 . . . . 72.530000000000001 108.954 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 18.3 p -120.75 94.08 4.24 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.498 0.666 . . . . 73.010000000000005 110.747 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -166.4 152.18 8.55 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.294 -1.373 . . . . 74.019999999999996 107.294 -177.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 48.5 tp -134.57 132.9 39.64 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.243 -1.021 . . . . 73.409999999999997 108.243 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -100.11 110.27 22.55 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 106.906 -1.516 . . . . 74.310000000000002 106.906 174.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . 0.408 HG11 ' HE3' ' A' ' 521' ' ' MET . 44.5 t -101.82 110.99 30.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 109.219 -0.66 . . . . 74.349999999999994 109.219 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 26.8 mt -98.67 127.47 51.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 108.315 -0.994 . . . . 74.430000000000007 108.315 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 66.6 mt -97.15 103.55 14.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 107.798 -1.186 . . . . 75.400000000000006 107.798 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 . . . . . 0 C--N 1.303 -1.43 0 C-N-CA 120.421 -0.511 . . . . 75.209999999999994 111.573 -173.724 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 502' ' ' ALA . . . . . 0.417 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.437 -1.105 0 CA-C-O 120.887 0.375 . . . . 64.140000000000001 111.417 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 160.11 -153.43 24.39 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 109.892 -1.283 . . . . 65.200000000000003 109.892 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -121.94 124.51 71.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 117.034 0.417 . . . . 74.439999999999998 111.503 -171.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -107.3 124.36 49.67 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.95 -0.759 . . . . 71.329999999999998 108.95 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.6 t -168.19 172.73 8.4 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.446 -0.575 . . . . 75.299999999999997 109.446 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -75.26 145.04 42.23 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.565 -0.289 . . . . 75.530000000000001 111.054 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.06 -29.63 70.01 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.53 0.681 . . . . 72.140000000000001 110.068 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -137.87 141.66 33.48 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 107.768 -1.197 . . . . 74.129999999999995 107.768 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.84 -24.65 15.24 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.697 2.265 . . . . 71.030000000000001 111.608 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 57.2 t -135.35 133.72 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 N-CA-C 106.611 -1.626 . . . . 72.25 106.611 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 7.1 t -125.11 140.7 52.65 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.51 -1.292 . . . . 73.319999999999993 107.51 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . 0.41 ' NE2' ' HG2' ' A' ' 647' ' ' GLU . 57.4 t-80 -110.6 137.92 47.65 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 107.596 -1.261 . . . . 74.120000000000005 107.596 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.77 158.13 43.25 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 N-CA-C 109.072 -0.714 . . . . 70.239999999999995 109.072 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.501 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 48.1 m -87.09 173.57 9.19 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-N 115.037 -0.983 . . . . 71.420000000000002 109.566 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -94.07 -59.11 2.05 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.922 -0.711 . . . . 75.329999999999998 110.017 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.6 m -84.55 53.99 2.86 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.763 0.792 . . . . 63.549999999999997 109.929 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 10.5 tt -102.87 -32.49 3.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.544 -0.753 . . . . 74.409999999999997 111.49 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 92.85 -78.39 1.15 Allowed Glycine 0 N--CA 1.425 -2.036 0 C-N-CA 120.717 -0.754 . . . . 75.450000000000003 111.356 -176.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.3 mm -126.93 123.93 63.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.934 -0.765 . . . . 74.430000000000007 108.934 -176.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.445 ' HE2' ' CG2' ' A' ' 573' ' ' VAL . 0.0 OUTLIER -103.73 149.43 25.0 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 107.383 -1.34 . . . . 75.109999999999999 107.383 175.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 31.3 mt-10 -130.8 132.54 45.32 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.32 0.581 . . . . 74.140000000000001 111.088 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 570' ' ' THR . 40.1 t -112.01 126.47 69.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.098 -1.075 . . . . 72.409999999999997 108.098 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -81.96 128.8 34.44 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.203 -0.666 . . . . 74.310000000000002 109.203 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 568' ' ' VAL . 48.4 t -105.78 129.21 59.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 109.853 -0.425 . . . . 75.400000000000006 109.853 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.41 126.88 30.82 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.257 -0.646 . . . . 75.349999999999994 109.257 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.655 ' CZ ' ' HD1' ' A' ' 562' ' ' PHE . 15.2 ttm180 -87.64 160.07 18.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 109.178 -0.675 . . . . 73.109999999999999 109.178 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.7 t -56.1 141.47 40.29 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 124.4 1.08 . . . . 64.430000000000007 111.813 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.5 t -54.76 -37.4 65.93 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.93 -1.032 . . . . 73.430000000000007 109.355 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -119.54 96.0 0.62 Allowed Glycine 0 N--CA 1.423 -2.209 0 N-CA-C 109.029 -1.628 . . . . 61.43 109.029 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.61 101.0 12.34 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.003 -1.11 . . . . 75.109999999999999 108.003 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -107.49 92.37 4.04 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.596 -0.729 . . . . 73.430000000000007 110.441 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 86.32 -139.33 16.63 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 119.56 -1.305 . . . . 53.420000000000002 111.774 174.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -113.39 121.1 43.31 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.265 0.555 . . . . 71.310000000000002 110.876 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 59.5 t -123.63 143.87 35.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 107.972 -1.121 . . . . 70.340000000000003 107.972 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.519 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 41.7 mm -117.28 137.09 52.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 109.596 -0.52 . . . . 71.540000000000006 109.596 177.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 594' ' ' PRO . 44.1 t -122.89 110.79 31.28 Favored Pre-proline 0 N--CA 1.44 -0.945 0 N-CA-C 109.853 -0.425 . . . . 74.219999999999999 109.853 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.7 156.83 48.78 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.769 2.313 . . . . 74.140000000000001 112.517 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.432 ' HB3' HG23 ' A' ' 591' ' ' ILE . 45.0 p90 -149.4 163.3 38.14 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 122.383 -0.198 . . . . 73.150000000000006 110.649 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -158.43 156.67 30.82 Favored 'General case' 0 C--O 1.252 1.211 0 O-C-N 123.966 0.791 . . . . 72.340000000000003 110.089 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.2 p -90.62 138.53 31.49 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 123.531 0.519 . . . . 72.299999999999997 111.342 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 51.2 mt -111.09 115.77 50.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.821 -0.807 . . . . 70.540000000000006 108.821 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.82 99.61 5.21 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.35 -0.611 . . . . 74.420000000000002 109.35 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -104.56 -89.17 2.1 Favored Glycine 0 CA--C 1.482 -2.008 0 C-N-CA 119.981 -1.104 . . . . 61.340000000000003 110.667 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 3.8 m -102.53 29.86 5.0 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-O 122.324 1.059 . . . . 75.129999999999995 108.54 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -157.4 144.73 18.58 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 106.815 -1.55 . . . . 71.120000000000005 106.815 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.431 ' HD2' ' OE1' ' A' ' 551' ' ' GLU . 82.0 mtm180 -92.29 131.1 37.76 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.75 0.786 . . . . 65.120000000000005 112.126 -175.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -96.62 -167.15 33.64 Favored Glycine 0 C--N 1.294 -1.779 0 CA-C-N 114.908 -1.042 . . . . 54.310000000000002 112.93 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 77.28 9.15 86.98 Favored Glycine 0 C--N 1.313 -0.734 0 CA-C-N 115.721 -0.24 . . . . 72.439999999999998 112.995 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 98.14 23.73 12.59 Favored Glycine 0 N--CA 1.427 -1.924 0 C-N-CA 120.368 -0.92 . . . . 71.400000000000006 111.422 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.431 ' OE1' ' HD2' ' A' ' 547' ' ' ARG . 26.3 tt0 -98.63 -63.27 1.14 Allowed 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.096 -0.641 . . . . 64.040000000000006 109.825 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -100.72 -42.01 6.67 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 107.411 -1.329 . . . . 75.150000000000006 107.411 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -132.9 155.09 49.69 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.006 -1.109 . . . . 73.510000000000005 108.006 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.79 137.38 35.32 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.476 -1.305 . . . . 74.25 107.476 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . 0.46 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 29.4 t70 -87.3 121.36 29.65 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.682 -0.859 . . . . 71.430000000000007 108.682 -176.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.8 t -130.65 164.98 23.81 Favored 'General case' 0 N--CA 1.414 -2.254 0 CA-C-O 121.742 0.782 . . . . 62.420000000000002 110.787 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 19.9 p -161.2 163.55 31.08 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.316 -1.735 . . . . 63.340000000000003 106.316 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 167.18 -169.59 41.05 Favored Glycine 0 N--CA 1.421 -2.329 0 C-N-CA 119.929 -1.129 . . . . 54.0 111.054 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.519 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 42.3 mt-10 -136.07 119.75 17.2 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 123.338 0.655 . . . . 72.5 110.196 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 77.3 mt -86.82 128.75 35.05 Favored 'General case' 0 CA--C 1.484 -1.592 0 CA-C-N 115.745 -0.661 . . . . 73.519999999999996 110.087 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.417 ' HA ' HD13 ' A' ' 536' ' ' ILE . 25.5 tt0 -87.79 123.39 32.53 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.455 -0.793 . . . . 71.120000000000005 109.911 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.655 ' HD1' ' CZ ' ' A' ' 527' ' ' ARG . 82.2 m-85 -123.3 98.2 5.76 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 121.463 0.649 . . . . 73.299999999999997 110.612 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 533' ' ' GLY . 42.3 mt-30 -96.78 -175.87 3.41 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.722 -0.672 . . . . 71.150000000000006 110.44 174.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -78.92 -21.75 46.86 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.631 -0.713 . . . . 74.230000000000004 109.428 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -72.57 -52.38 15.81 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.076 -0.966 . . . . 65.109999999999999 112.768 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.43 ' HB3' ' NH2' ' A' ' 527' ' ' ARG . 41.4 mm-40 -69.7 169.29 13.17 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.441 1.274 . . . . 73.150000000000006 114.441 -177.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.565 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.0 pt -105.95 -63.3 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 114.574 -1.193 . . . . 75.219999999999999 112.465 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.565 ' H ' HG13 ' A' ' 567' ' ' ILE . 14.4 p -139.88 162.56 25.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 108.834 -0.802 . . . . 73.120000000000005 108.834 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -131.1 164.04 26.32 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.445 -0.946 . . . . 72.209999999999994 108.445 171.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 12.9 p -129.7 152.57 49.06 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 123.794 0.683 . . . . 70.120000000000005 111.153 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.5 mp -94.59 121.76 45.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 105.545 -2.02 . . . . 74.540000000000006 105.545 170.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 5.9 m -99.45 114.89 28.11 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.596 -0.89 . . . . 75.120000000000005 108.596 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.445 ' CG2' ' HE2' ' A' ' 521' ' ' MET . 91.3 t -118.89 127.65 75.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.771 -0.455 . . . . 72.439999999999998 109.771 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 16.1 tppt? -77.42 108.84 10.85 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.207 -1.035 . . . . 75.409999999999997 108.207 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.75 122.52 36.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 104.55 -2.389 . . . . 74.030000000000001 104.55 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 42.1 mm . . . . . 0 C--N 1.295 -1.796 0 CA-C-O 121.352 0.596 . . . . 75.25 109.467 -174.072 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp . . . . . 0 N--CA 1.425 -1.676 0 N-CA-C 107.474 -1.306 . . . . 75.530000000000001 107.474 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.4 t -135.18 125.18 25.8 Favored 'General case' 0 C--N 1.281 -2.413 0 CA-C-O 121.946 0.879 . . . . 75.310000000000002 111.582 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 44.3 p90 -119.94 177.78 4.85 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.131 -0.94 . . . . 73.329999999999998 109.235 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -123.19 149.66 44.34 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 109.404 -0.591 . . . . 63.5 109.404 -176.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.4 131.81 54.98 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.442 -1.688 . . . . 74.340000000000003 106.442 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -125.58 128.47 47.98 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.022 -0.671 . . . . 71.230000000000004 110.341 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . 0.432 HG23 ' HB3' ' A' ' 539' ' ' TYR . 26.5 pt -99.84 139.77 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 107.911 -1.144 . . . . 73.430000000000007 107.911 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.34 -178.08 50.65 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 115.825 -0.625 . . . . 64.129999999999995 112.083 -176.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.05 129.63 86.07 Favored Pre-proline 0 N--CA 1.426 -1.641 0 CA-C-N 115.499 -0.35 . . . . 75.340000000000003 110.772 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.513 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 11.7 Cg_endo -59.6 129.07 29.33 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.197 2.598 . . . . 61.520000000000003 112.666 -176.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -104.72 119.65 39.51 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.09 -0.959 . . . . 71.0 109.008 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.28 128.88 38.05 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.082 -1.451 . . . . 75.349999999999994 107.082 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.446 ' CG2' HG12 ' A' ' 536' ' ' ILE . 51.5 t . . . . . 0 C--N 1.299 -1.629 0 CA-C-O 121.397 0.618 . . . . 72.420000000000002 110.835 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.513 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 33.3 Cg_endo . . . . . 0 N--CA 1.427 -2.388 0 N-CA-C 105.352 -2.595 . . . . 73.430000000000007 105.352 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.04 168.74 16.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 118.502 -1.279 . . . . 74.5 112.678 -173.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.26 171.93 7.68 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.57 -0.741 . . . . 74.25 111.959 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -71.69 -171.99 15.3 Favored Glycine 0 N--CA 1.431 -1.7 0 CA-C-N 115.307 -0.861 . . . . 71.319999999999993 113.144 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -62.12 -41.29 98.09 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 122.365 0.266 . . . . 74.25 110.331 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -140.89 133.23 28.27 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.969 0.414 . . . . 75.340000000000003 110.039 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 15.4 p -120.88 95.4 4.69 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-O 121.709 0.766 . . . . 73.439999999999998 109.985 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . 0.482 ' HZ1' ' HB2' ' A' ' 641' ' ' LYS . 5.1 ttmp? -162.58 142.98 9.75 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.523 -1.288 . . . . 61.539999999999999 107.523 -176.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.402 HD23 HG22 ' A' ' 523' ' ' VAL . 34.7 tp -132.65 132.81 42.83 Favored 'General case' 0 N--CA 1.416 -2.167 0 O-C-N 123.658 0.599 . . . . 64.120000000000005 109.423 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -98.35 118.59 35.34 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.057 -1.46 . . . . 71.340000000000003 107.057 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 44.3 t -106.7 117.43 52.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 109.006 -0.738 . . . . 71.430000000000007 109.006 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 58.1 mt -103.4 123.11 56.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 110.62 -0.141 . . . . 73.219999999999999 110.62 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 41.6 mt -107.43 107.65 23.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.153 -0.684 . . . . 73.25 109.153 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.41 ' HG2' ' NE2' ' A' ' 513' ' ' HIS . 8.0 pt-20 . . . . . 0 C--N 1.296 -1.753 0 N-CA-C 105.383 -2.081 . . . . 75.150000000000006 105.383 166.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 502' ' ' ALA . . . . . 0.603 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 107.967 -1.123 . . . . 65.450000000000003 107.967 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 116.26 -159.64 13.79 Favored Glycine 0 N--CA 1.416 -2.655 0 C-N-CA 120.167 -1.016 . . . . 74.010000000000005 111.619 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.34 111.39 28.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 122.388 0.275 . . . . 74.140000000000001 110.569 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.59 ' CD2' HG23 ' A' ' 528' ' ' THR . 5.8 m-85 -92.35 126.11 37.3 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 109.093 -0.706 . . . . 74.519999999999996 109.093 170.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.4 t -167.54 176.33 6.57 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.831 -0.803 . . . . 74.030000000000001 108.831 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -81.11 147.05 30.27 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 110.147 -0.316 . . . . 72.140000000000001 110.147 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.78 -33.53 75.88 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.36 0.6 . . . . 72.129999999999995 109.879 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -136.28 140.93 34.19 Favored Pre-proline 0 N--CA 1.427 -1.605 0 N-CA-C 107.573 -1.269 . . . . 74.340000000000003 107.573 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . 0.422 ' O ' ' HA ' ' A' ' 642' ' ' LEU . 59.2 Cg_endo -75.26 -26.01 10.93 Favored 'Trans proline' 0 C--N 1.33 -0.414 0 C-N-CA 122.447 2.098 . . . . 75.099999999999994 112.258 -178.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 59.8 t -134.77 136.59 52.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 106.715 -1.587 . . . . 75.319999999999993 106.715 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 15.0 t -129.18 135.39 48.79 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 108.591 -0.892 . . . . 74.439999999999998 108.591 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -108.03 119.04 38.34 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.915 -0.772 . . . . 73.409999999999997 108.915 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.37 160.28 14.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.419 -0.81 . . . . 72.340000000000003 109.194 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.445 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 74.4 m -88.17 159.84 18.0 Favored 'General case' 0 N--CA 1.411 -2.413 0 C-N-CA 123.345 0.658 . . . . 62.210000000000001 110.486 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -49.22 16.32 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 120.731 -0.388 . . . . 75.230000000000004 110.692 176.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 9.8 m -86.83 39.84 0.87 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.27 0.557 . . . . 54.310000000000002 111.5 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 13.4 tt -97.67 -25.15 4.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.305 0.574 . . . . 71.519999999999996 111.626 -176.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . 0.429 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 86.86 -74.28 2.35 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.86 -0.896 . . . . 71.219999999999999 110.86 -176.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 43.4 mm -129.97 132.2 65.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.459 -1.312 . . . . 75.420000000000002 107.459 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.414 ' HE3' ' CG2' ' A' ' 573' ' ' VAL . 0.0 OUTLIER -114.4 150.47 34.6 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.002 -1.481 . . . . 73.510000000000005 107.002 175.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 31.7 mt-10 -130.09 142.53 50.59 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.227 0.537 . . . . 73.439999999999998 111.631 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 570' ' ' THR . 42.7 t -121.24 127.7 75.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.397 -0.964 . . . . 74.140000000000001 108.397 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -82.51 127.8 33.66 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.746 -0.835 . . . . 73.200000000000003 108.746 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.39 123.92 58.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 108.806 -0.812 . . . . 74.439999999999998 108.806 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.03 115.63 10.38 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.542 -0.754 . . . . 70.040000000000006 109.928 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.471 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 50.9 ttp180 -67.85 155.28 39.71 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.6 -1.182 . . . . 75.200000000000003 108.9 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.603 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 0.7 OUTLIER -56.55 141.99 40.95 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-O 121.786 0.803 . . . . 72.230000000000004 111.37 176.182 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.2 m -61.92 -16.93 54.63 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 125.996 1.718 . . . . 74.129999999999995 110.769 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -139.47 79.16 0.29 Allowed Glycine 0 N--CA 1.425 -2.084 0 N-CA-C 110.304 -1.118 . . . . 63.100000000000001 110.304 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -83.73 101.49 11.6 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.232 -1.025 . . . . 74.099999999999994 108.232 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -100.83 93.13 5.38 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.908 -1.042 . . . . 74.329999999999998 110.217 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 97.53 -119.55 6.44 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.162 -1.018 . . . . 75.430000000000007 111.277 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.411 ' HB3' ' HB ' ' A' ' 597' ' ' VAL . 3.3 t-20 -133.52 134.25 43.19 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.084 -0.71 . . . . 71.150000000000006 109.084 177.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 62.1 t -132.83 137.98 52.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.111 -1.07 . . . . 72.140000000000001 108.111 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.465 HG12 ' CG2' ' A' ' 597' ' ' VAL . 41.3 mm -107.35 136.46 42.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 109.563 -0.532 . . . . 71.430000000000007 109.563 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.34 110.94 32.12 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 110.046 -0.353 . . . . 64.310000000000002 110.046 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -73.5 150.6 46.27 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.205 1.937 . . . . 72.140000000000001 111.468 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -149.08 163.45 37.52 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 110.405 -0.22 . . . . 74.439999999999998 110.405 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -157.93 158.33 34.8 Favored 'General case' 0 C--O 1.252 1.236 0 O-C-N 123.923 0.764 . . . . 74.409999999999997 109.745 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.7 p -87.36 154.12 20.92 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 109.038 -0.727 . . . . 74.349999999999994 109.038 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.51 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 60.1 mt -128.39 119.01 49.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.204 -1.406 . . . . 71.329999999999998 107.204 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -66.41 120.99 14.3 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 122.631 0.372 . . . . 74.340000000000003 110.453 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -102.71 -104.54 2.85 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 108.663 -1.775 . . . . 72.209999999999994 108.663 176.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 34.3 p -89.91 -22.51 21.96 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.276 -1.009 . . . . 74.310000000000002 108.276 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -81.91 136.95 35.28 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.423 -1.262 . . . . 73.109999999999999 110.067 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -90.49 144.25 25.97 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.382 0.611 . . . . 74.349999999999994 111.912 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.7 -158.03 33.87 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.005 -1.238 . . . . 54.100000000000001 110.005 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.75 26.47 73.98 Favored Glycine 0 C--N 1.315 -0.594 0 C-N-CA 120.929 -0.653 . . . . 73.450000000000003 112.257 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . 0.408 ' C ' HG13 ' A' ' 576' ' ' ILE . . . 67.92 34.55 82.48 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 121.597 -0.335 . . . . 72.049999999999997 112.264 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -104.48 -63.43 1.21 Allowed 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 120.814 -0.355 . . . . 73.420000000000002 111.409 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -101.77 -45.61 5.18 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 108.179 -1.045 . . . . 75.340000000000003 108.179 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -133.93 152.31 51.81 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 107.639 -1.245 . . . . 64.439999999999998 107.639 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -85.6 112.69 21.21 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 105.858 -1.904 . . . . 73.439999999999998 105.858 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.26 140.7 56.02 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 120.941 0.401 . . . . 73.409999999999997 110.203 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.6 t -142.65 148.3 37.18 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-O 121.506 0.67 . . . . 75.400000000000006 111.33 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 11.8 p -148.62 157.28 43.35 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.093 -1.447 . . . . 61.43 107.093 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 168.3 -163.43 37.16 Favored Glycine 0 N--CA 1.421 -2.338 0 C-N-CA 120.114 -1.041 . . . . 62.43 110.665 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.439 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 40.5 mt-10 -132.72 124.91 29.06 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 122.869 0.468 . . . . 74.430000000000007 110.697 -177.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 76.0 mt -91.04 135.09 33.99 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 115.713 -0.676 . . . . 74.239999999999995 109.403 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.403 ' HG2' HD22 ' A' ' 534' ' ' ASN . 32.1 tt0 -102.06 109.48 21.2 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.837 -0.619 . . . . 73.420000000000002 110.54 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -106.07 104.4 14.09 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.661 0.743 . . . . 74.510000000000005 110.534 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.467 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 8.2 mm100 -87.75 173.3 9.07 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.469 -1.308 . . . . 74.349999999999994 107.469 174.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -72.03 -25.91 61.99 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.498 -0.927 . . . . 75.549999999999997 108.498 172.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.66 -46.22 39.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.592 -1.185 . . . . 73.340000000000003 110.822 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.467 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 37.0 mm-40 -61.01 130.58 47.11 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 123.72 0.808 . . . . 72.120000000000005 111.663 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.544 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.3 pt -86.74 -59.69 2.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 116.004 -0.544 . . . . 71.120000000000005 111.746 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.544 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.2 p -141.78 155.17 19.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.769 -0.456 . . . . 75.439999999999998 109.769 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.19 157.28 33.38 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.988 -0.745 . . . . 73.140000000000001 108.988 171.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.0 OUTLIER -125.36 149.85 47.74 Favored 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 115.351 -0.841 . . . . 64.129999999999995 111.574 179.049 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.3 mp -98.91 120.56 48.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 106.662 -1.607 . . . . 63.32 106.662 169.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 5.1 p -96.11 115.09 26.89 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 123.747 0.654 . . . . 71.019999999999996 109.405 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.414 ' CG2' ' HE3' ' A' ' 521' ' ' MET . 93.4 t -114.62 128.58 71.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.705 -0.398 . . . . 74.120000000000005 109.935 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.429 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 22.2 tptm -79.84 115.23 19.32 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.985 -1.007 . . . . 74.219999999999999 109.226 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.66 126.28 40.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 104.935 -2.246 . . . . 63.340000000000003 104.935 174.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . 0.408 HG13 ' C ' ' A' ' 550' ' ' GLY . 45.2 mm . . . . . 0 C--N 1.298 -1.639 0 CA-C-O 122.272 1.034 . . . . 74.150000000000006 110.771 -173.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 109.511 -0.552 . . . . 72.319999999999993 109.511 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 9.2 t -140.53 145.94 37.46 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 120.411 -0.515 . . . . 73.239999999999995 109.912 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 49.8 p90 -141.81 175.92 9.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.837 -1.172 . . . . 74.049999999999997 107.837 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.51 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 79.1 m-85 -121.4 160.64 23.66 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.73 -0.47 . . . . 73.450000000000003 109.73 -176.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.97 131.27 49.28 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 105.798 -1.927 . . . . 73.219999999999999 105.798 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -129.68 137.98 50.92 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.893 -0.41 . . . . 74.510000000000005 109.893 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 21.3 pt -108.74 142.81 20.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 108.103 -1.073 . . . . 72.010000000000005 108.103 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.52 -177.4 45.62 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 111.004 -0.838 . . . . 74.219999999999999 111.004 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -69.74 132.18 89.12 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 120.895 0.378 . . . . 72.219999999999999 111.345 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.97 129.47 26.04 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.488 2.792 . . . . 75.430000000000007 112.759 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 536' ' ' ILE . 1.2 ptm85 -106.54 119.49 39.42 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.967 -0.561 . . . . 74.129999999999995 110.212 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.39 137.9 57.79 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 124.567 1.147 . . . . 65.349999999999994 111.025 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.465 ' CG2' HG12 ' A' ' 536' ' ' ILE . 21.6 t . . . . . 0 C--N 1.303 -1.447 0 N-CA-C 105.838 -1.912 . . . . 61.43 105.838 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.432 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 73.8 Cg_endo . . . . . 0 N--CA 1.427 -2.398 0 CA-C-O 121.119 0.383 . . . . 63.329999999999998 111.333 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.5 pp -129.85 168.94 21.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-N 115.807 -0.633 . . . . 75.109999999999999 110.675 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.83 178.92 4.81 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 112.249 0.463 . . . . 73.409999999999997 112.249 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -77.79 -156.06 8.08 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 114.888 0.715 . . . . 74.239999999999995 114.888 -175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -70.77 -48.57 53.59 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.156 0.582 . . . . 74.120000000000005 109.794 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -140.2 144.15 36.44 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.295 -1.002 . . . . 64.319999999999993 108.295 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 14.0 p -133.23 95.88 3.62 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 123.604 0.565 . . . . 73.239999999999995 109.849 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -164.1 138.46 5.66 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.75 -0.833 . . . . 74.510000000000005 108.75 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 510' ' ' PRO . 26.6 tp -125.75 134.44 51.75 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.442 -0.947 . . . . 73.420000000000002 108.442 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -104.3 113.8 27.6 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.391 -1.337 . . . . 72.219999999999999 107.391 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.36 110.15 28.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.144 -0.688 . . . . 73.150000000000006 109.144 -178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 59.2 mt -102.24 120.39 51.88 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 108.619 -0.882 . . . . 73.349999999999994 108.619 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 45.5 mt -95.38 106.95 18.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 107.979 -1.119 . . . . 73.209999999999994 107.979 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 . . . . . 0 C--N 1.296 -1.759 0 CA-C-O 121.243 0.544 . . . . 70.140000000000001 110.463 178.725 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 109.552 -0.536 . . . . 60.310000000000002 109.552 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.427 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . 165.03 -150.91 19.45 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 120.477 -0.868 . . . . 73.239999999999995 111.119 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.419 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.9 mp -126.13 113.32 33.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 116.852 0.326 . . . . 65.230000000000004 110.67 -173.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -97.33 130.34 44.51 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.487 -0.931 . . . . 75.120000000000005 108.487 170.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.7 t -166.31 175.29 8.36 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.147 -0.686 . . . . 75.219999999999999 109.147 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . 0.452 ' CZ ' HG21 ' A' ' 591' ' ' ILE . 79.9 m-85 -84.55 152.9 23.59 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 110.135 -0.32 . . . . 72.430000000000007 110.135 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -64.68 -37.67 88.39 Favored 'General case' 0 C--O 1.245 0.821 0 O-C-N 123.544 0.528 . . . . 54.539999999999999 110.367 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.65 149.98 75.0 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 108.942 -0.762 . . . . 73.109999999999999 108.942 174.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -74.39 -28.73 10.06 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.894 1.729 . . . . 73.319999999999993 112.154 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 46.0 t -137.57 132.51 45.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 107.802 -1.185 . . . . 75.409999999999997 107.802 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 13.2 t -128.92 140.8 51.51 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 109.623 -0.51 . . . . 65.120000000000005 109.623 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -108.98 127.87 54.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.481 -0.563 . . . . 73.400000000000006 109.481 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 23.9 m -123.06 177.33 4.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.097 -0.705 . . . . 73.120000000000005 109.097 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 647' ' ' GLU . 32.7 t -103.99 159.28 15.8 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.129 0.49 . . . . 74.129999999999995 110.902 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -70.29 -39.22 75.02 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.877 -1.056 . . . . 72.230000000000004 109.776 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 68.1 m -104.19 20.85 17.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.606 0.595 . . . . 72.129999999999995 112.606 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.495 HG23 ' O ' ' A' ' 515' ' ' SER . 11.3 tt -70.01 -35.59 64.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 C-N-CA 119.762 -0.775 . . . . 71.319999999999993 110.229 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 95.06 -78.86 0.87 Allowed Glycine 0 CA--C 1.479 -2.156 0 N-CA-C 110.858 -0.897 . . . . 74.349999999999994 110.858 -177.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 573' ' ' VAL . 33.8 mm -127.63 133.18 68.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.966 -1.494 . . . . 75.310000000000002 106.966 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.508 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -118.59 144.77 45.89 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.432 -0.581 . . . . 74.150000000000006 109.432 177.499 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -112.1 125.06 53.7 Favored 'General case' 0 C--O 1.241 0.643 0 O-C-N 123.638 0.586 . . . . 73.010000000000005 110.996 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 570' ' ' THR . 47.3 t -104.64 126.29 59.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 109.298 -0.631 . . . . 62.130000000000003 109.298 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -80.38 128.32 33.43 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.538 0.524 . . . . 75.430000000000007 109.686 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.498 ' O ' HG23 ' A' ' 568' ' ' VAL . 62.3 t -106.66 115.39 48.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.798 -0.816 . . . . 72.010000000000005 108.798 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.05 123.8 19.5 Favored 'General case' 0 C--O 1.251 1.144 0 O-C-N 123.991 0.807 . . . . 73.549999999999997 110.206 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -73.59 159.62 32.83 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 114.947 -1.024 . . . . 74.409999999999997 110.238 -177.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.427 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 4.3 t -62.46 140.89 58.59 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.687 -0.688 . . . . 70.040000000000006 110.387 175.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.6 t -59.3 -37.06 76.77 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 123.644 0.778 . . . . 72.510000000000005 109.381 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -110.84 87.66 0.48 Allowed Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.132 -1.187 . . . . 62.25 110.132 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.0 100.46 13.28 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.994 -0.743 . . . . 52.43 108.994 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -108.58 92.22 3.97 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.617 -0.72 . . . . 73.409999999999997 111.044 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 95.72 -122.15 7.17 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.317 -0.944 . . . . 65.230000000000004 112.796 175.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -132.9 130.83 40.18 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 123.062 0.545 . . . . 73.519999999999996 109.755 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 60.3 t -134.26 138.36 50.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 123.841 0.856 . . . . 74.109999999999999 109.228 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.523 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 46.6 mm -106.7 133.96 49.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.261 -0.644 . . . . 74.239999999999995 109.261 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 594' ' ' PRO . 21.8 t -122.5 110.85 31.91 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 108.983 -0.747 . . . . 73.019999999999996 108.983 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -72.53 157.65 52.37 Favored 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.283 1.989 . . . . 74.25 111.893 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.419 ' HB3' HG22 ' A' ' 591' ' ' ILE . 47.4 p90 -149.65 160.55 43.42 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.645 -0.502 . . . . 73.200000000000003 109.645 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -158.42 154.69 27.32 Favored 'General case' 0 C--O 1.248 1.024 0 O-C-N 123.709 0.631 . . . . 75.450000000000003 111.121 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.3 p -86.95 140.69 29.34 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.884 -0.598 . . . . 74.239999999999995 110.449 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.441 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 49.0 mt -114.54 125.54 71.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.436 -0.95 . . . . 75.040000000000006 108.436 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.77 154.61 19.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.312 0.577 . . . . 74.310000000000002 112.454 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 176.4 -73.32 0.08 OUTLIER Glycine 0 C--N 1.305 -1.16 0 N-CA-C 110.731 -0.948 . . . . 73.209999999999994 110.731 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.32 5.86 18.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.101 0.953 . . . . 72.129999999999995 111.342 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -153.5 142.18 20.94 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 105.447 -2.057 . . . . 52.439999999999998 105.447 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 38.6 mtp85 -96.05 130.25 43.12 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.115 0.484 . . . . 74.400000000000006 111.452 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.4 -145.8 12.8 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 120.477 -0.868 . . . . 71.120000000000005 112.726 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 65.05 10.1 44.8 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 113.982 0.353 . . . . 71.25 113.982 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 100.43 15.94 28.45 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.164 -1.017 . . . . 63.140000000000001 111.847 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -91.95 -72.48 0.59 Allowed 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 119.713 -0.795 . . . . 60.329999999999998 110.178 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -89.77 -39.16 13.31 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 108.527 -0.916 . . . . 64.420000000000002 108.527 175.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -140.98 155.2 46.27 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.92 -1.037 . . . . 71.530000000000001 108.363 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.04 137.09 33.28 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.779 -1.563 . . . . 64.120000000000005 106.779 177.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -87.17 132.09 33.98 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 110.188 -0.301 . . . . 72.109999999999999 110.188 -172.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 15.0 t -136.43 145.48 45.31 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.685 0.755 . . . . 75.329999999999998 110.841 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 52.1 t -154.29 148.15 25.52 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.985 -1.858 . . . . 52.229999999999997 105.985 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 175.27 -164.82 35.49 Favored Glycine 0 C--N 1.287 -2.191 0 N-CA-C 109.997 -1.241 . . . . 72.409999999999997 109.997 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.523 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 87.0 mt-10 -135.56 127.8 30.09 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.987 0.394 . . . . 74.310000000000002 110.646 -177.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 91.7 mt -92.01 134.18 35.04 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.78 -0.645 . . . . 75.030000000000001 109.469 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -98.84 116.33 30.83 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.775 -0.648 . . . . 73.319999999999993 109.57 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -111.56 145.65 38.75 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.335 -0.617 . . . . 74.519999999999996 109.335 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.437 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 49.7 mt-30 -142.7 179.58 6.91 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 109.183 -0.673 . . . . 72.049999999999997 109.183 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -70.52 -37.92 74.18 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.571 -0.9 . . . . 75.109999999999999 108.571 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.68 -27.29 37.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.729 -1.123 . . . . 75.329999999999998 111.979 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 8.7 mm-40 -78.62 146.97 33.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.283 -0.636 . . . . 71.420000000000002 109.283 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.544 HG13 ' H ' ' A' ' 568' ' ' VAL . 4.0 pt -95.57 -80.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 112.45 0.537 . . . . 65.099999999999994 112.45 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.544 ' H ' HG13 ' A' ' 567' ' ' ILE . 8.3 p -135.73 148.97 27.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 108.619 -0.882 . . . . 72.530000000000001 108.619 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -114.95 159.96 20.12 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.545 -0.539 . . . . 74.420000000000002 109.545 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 16.2 p -128.26 150.15 50.17 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.877 -0.601 . . . . 74.230000000000004 111.009 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.3 mp -99.51 123.28 52.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 106.518 -1.66 . . . . 75.299999999999997 106.518 171.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 572' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 521' ' ' MET . 4.6 p -97.77 115.98 29.08 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.913 0.758 . . . . 74.019999999999996 109.502 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 520' ' ' ILE . 95.9 t -117.33 133.92 62.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 116.619 -0.264 . . . . 74.219999999999999 110.807 -178.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 46.7 tptt -85.6 112.46 20.99 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 109.054 -0.721 . . . . 73.310000000000002 109.054 175.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.63 125.62 40.29 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 104.924 -2.25 . . . . 72.109999999999999 104.924 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 37.9 mm . . . . . 0 N--CA 1.425 -1.688 0 CA-C-O 122.054 0.93 . . . . 74.439999999999998 109.978 -175.261 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 CA--C 1.49 -1.334 0 CA-C-O 120.899 0.38 . . . . 75.340000000000003 111.016 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.5 t -153.14 138.44 17.51 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.879 -0.415 . . . . 74.120000000000005 109.879 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -135.25 176.0 9.07 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.479 -0.934 . . . . 74.040000000000006 108.479 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.441 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 74.0 m-85 -122.47 152.67 40.05 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.042 -0.663 . . . . 64.099999999999994 109.872 -175.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.07 130.86 53.64 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.484 -1.672 . . . . 63.240000000000002 106.484 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -121.63 136.48 54.94 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.745 -0.465 . . . . 75.219999999999999 109.745 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . 0.452 HG21 ' CZ ' ' A' ' 507' ' ' PHE . 21.1 pt -107.94 132.93 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 107.04 -1.467 . . . . 74.109999999999999 107.04 169.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.52 -166.48 42.01 Favored Glycine 0 N--CA 1.423 -2.206 0 CA-C-N 115.577 -0.738 . . . . 63.039999999999999 112.713 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.69 131.71 73.4 Favored Pre-proline 0 N--CA 1.427 -1.603 0 CA-C-O 120.997 0.427 . . . . 70.25 111.629 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.449 ' HB3' HG21 ' A' ' 537' ' ' VAL . 47.3 Cg_endo -69.42 147.3 64.73 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.952 2.434 . . . . 72.239999999999995 111.973 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -125.03 137.3 54.23 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.934 -0.765 . . . . 74.140000000000001 108.934 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.99 128.68 33.57 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 107.122 -1.436 . . . . 75.439999999999998 107.122 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.443 ' CG2' HG12 ' A' ' 536' ' ' ILE . 37.8 t . . . . . 0 C--N 1.29 -2.007 0 N-CA-C 109.056 -0.72 . . . . 75.430000000000007 109.056 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo . . . . . 0 N--CA 1.436 -1.868 0 CA-C-O 121.25 0.437 . . . . 74.340000000000003 111.041 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.39 167.46 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-N 115.179 -0.918 . . . . 75.299999999999997 109.545 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.35 -176.24 3.16 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 112.199 0.444 . . . . 73.140000000000001 112.199 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . 0.419 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -77.83 -150.18 4.26 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-O 121.646 0.581 . . . . 73.239999999999995 113.84 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -80.97 -48.34 12.41 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.09 0.472 . . . . 75.239999999999995 109.947 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -133.12 131.64 40.75 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.821 -0.807 . . . . 71.219999999999999 108.821 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 23.9 p -119.97 88.95 3.03 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 121.755 0.788 . . . . 71.409999999999997 110.136 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -159.79 137.6 9.99 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.286 -0.87 . . . . 75.299999999999997 109.567 -175.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.428 HD23 HG11 ' A' ' 523' ' ' VAL . 15.6 tp -123.32 128.64 50.21 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 107.974 -1.121 . . . . 74.319999999999993 107.974 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -97.71 111.7 23.88 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.396 -1.335 . . . . 74.349999999999994 107.396 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.7 112.86 34.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.448 -0.575 . . . . 72.230000000000004 109.448 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 68.6 mt -101.6 121.42 52.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 109.636 -0.505 . . . . 72.530000000000001 109.636 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 69.1 mt -95.17 113.89 30.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.877 -1.157 . . . . 74.409999999999997 107.877 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 515' ' ' SER . 40.3 mt-10 . . . . . 0 C--N 1.285 -2.199 0 N-CA-C 107.627 -1.249 . . . . 72.319999999999993 107.627 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 502' ' ' ALA . . . . . 0.532 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 121.158 0.504 . . . . 73.099999999999994 112.293 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 128.02 -136.78 9.36 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 119.417 -1.373 . . . . 64.409999999999997 112.186 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.74 112.48 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 111.171 0.063 . . . . 71.200000000000003 111.171 -174.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.467 ' CD2' HG21 ' A' ' 528' ' ' THR . 11.4 m-85 -99.75 120.69 40.13 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.666 -1.235 . . . . 71.420000000000002 107.666 167.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.3 t -163.96 178.65 7.57 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.647 -0.501 . . . . 73.120000000000005 109.647 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -81.39 143.61 32.03 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.885 -0.413 . . . . 74.340000000000003 109.885 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -61.31 -37.78 84.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 123.723 0.639 . . . . 74.430000000000007 109.89 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -125.34 144.83 48.87 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 108.089 -1.078 . . . . 72.439999999999998 108.089 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.88 -27.68 2.96 Favored 'Trans proline' 0 C--N 1.329 -0.448 0 C-N-CA 122.163 1.909 . . . . 72.129999999999995 112.389 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.6 t -137.39 135.32 46.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.901 -1.518 . . . . 72.140000000000001 106.901 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.6 t -133.68 136.53 44.79 Favored 'General case' 0 N--CA 1.409 -2.49 0 N-CA-C 108.99 -0.745 . . . . 61.149999999999999 108.99 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -109.48 120.09 41.43 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.135 -0.691 . . . . 74.430000000000007 109.135 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 25.2 m -108.19 174.48 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 115.548 -0.751 . . . . 71.510000000000005 109.983 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.425 ' OG ' ' HB ' ' A' ' 518' ' ' ILE . 0.0 OUTLIER -96.8 164.06 12.72 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.4 -0.818 . . . . 72.549999999999997 110.495 -178.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -82.24 -54.29 5.37 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.248 -1.019 . . . . 62.450000000000003 108.248 171.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 12.1 m -80.71 31.79 0.3 Allowed 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.512 0.725 . . . . 74.540000000000006 112.1 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.425 ' HB ' ' OG ' ' A' ' 515' ' ' SER . 10.1 tt -94.34 -24.81 4.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 O-C-N 121.762 -0.586 . . . . 75.340000000000003 111.062 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.81 -80.53 1.79 Allowed Glycine 0 N--CA 1.417 -2.597 0 C-N-CA 120.329 -0.938 . . . . 71.340000000000003 111.128 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 43.0 mm -128.12 131.5 69.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.739 -1.208 . . . . 71.140000000000001 107.739 -174.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.535 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -109.41 145.1 36.69 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.093 -0.706 . . . . 70.120000000000005 109.093 176.11 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 23.9 mt-10 -124.19 119.57 29.76 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 123.667 0.604 . . . . 74.109999999999999 111.747 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 570' ' ' THR . 95.5 t -103.56 128.86 56.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 116.029 -0.532 . . . . 74.120000000000005 110.423 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -80.31 137.45 36.59 Favored 'General case' 0 C--O 1.248 0.981 0 O-C-N 123.515 0.51 . . . . 74.5 110.502 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.554 ' O ' HG22 ' A' ' 568' ' ' VAL . 59.9 t -112.75 132.82 60.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 116.147 -0.479 . . . . 73.549999999999997 109.741 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.81 126.68 31.4 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 122.928 0.491 . . . . 71.230000000000004 110.074 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -81.32 157.09 25.2 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.307 -0.861 . . . . 63.140000000000001 109.314 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 0.9 OUTLIER -59.97 145.8 44.84 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 123.333 0.653 . . . . 64.209999999999994 112.295 177.623 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 41.4 t -60.15 -34.98 74.3 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.153 -0.931 . . . . 75.310000000000002 110.093 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.41 81.04 0.35 Allowed Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.638 -0.985 . . . . 74.030000000000001 110.638 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.06 114.02 21.9 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.305 -0.998 . . . . 70.409999999999997 108.305 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -119.15 97.91 5.91 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.499 0.666 . . . . 75.109999999999999 110.711 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 108.89 -130.8 10.22 Favored Glycine 0 N--CA 1.427 -1.965 0 CA-C-N 115.397 -0.82 . . . . 55.25 112.772 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.493 HD21 ' HG2' ' A' ' 563' ' ' GLN . 2.6 t-20 -133.15 127.74 34.53 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.892 -0.781 . . . . 70.439999999999998 108.892 -177.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 61.3 t -132.18 141.82 44.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 123.185 0.594 . . . . 74.319999999999993 110.135 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.42 HG12 ' CG2' ' A' ' 597' ' ' VAL . 36.8 mm -111.35 129.99 65.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.197 -0.668 . . . . 74.25 109.197 175.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.04 105.96 52.19 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 109.203 -0.666 . . . . 75.340000000000003 109.203 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.82 152.35 36.95 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.319 2.013 . . . . 70.530000000000001 112.287 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.515 ' HB3' HG23 ' A' ' 591' ' ' ILE . 49.9 p90 -147.33 164.97 31.56 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.526 -0.306 . . . . 72.439999999999998 111.057 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -156.39 158.1 36.76 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.709 0.63 . . . . 72.239999999999995 109.916 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.3 p -87.78 141.75 28.36 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 115.656 -0.702 . . . . 71.25 110.102 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 90.3 mt -116.84 132.53 66.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.555 -1.276 . . . . 73.219999999999999 107.555 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -81.0 148.22 29.84 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 109.801 -0.444 . . . . 62.020000000000003 109.801 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -141.88 -117.3 1.3 Allowed Glycine 0 C--N 1.292 -1.88 0 N-CA-C 108.671 -1.772 . . . . 72.030000000000001 108.671 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 545' ' ' THR . . . . . 0.414 ' O ' ' HD3' ' A' ' 585' ' ' LYS . 16.7 p -78.34 -23.87 46.78 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.127 -1.064 . . . . 75.209999999999994 108.127 173.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -91.84 135.52 33.86 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 106.982 -1.488 . . . . 71.329999999999998 106.982 172.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -106.81 151.99 24.46 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 113.717 1.006 . . . . 72.239999999999995 113.717 -174.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -91.24 -176.41 43.47 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 114.899 -1.046 . . . . 75.319999999999993 111.707 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 91.63 22.77 30.32 Favored Glycine 0 C--N 1.294 -1.77 0 N-CA-C 110.152 -1.179 . . . . 63.43 110.152 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 70.54 33.98 67.62 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 109.539 -1.424 . . . . 74.430000000000007 109.539 -176.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -95.66 -66.88 0.88 Allowed 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 110.08 -0.341 . . . . 74.120000000000005 110.08 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -104.41 -38.29 6.88 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.19 -1.041 . . . . 62.240000000000002 108.19 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -132.91 158.35 42.8 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.246 -0.888 . . . . 73.319999999999993 108.693 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.53 129.12 37.56 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.589 -1.263 . . . . 73.439999999999998 107.589 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.36 136.99 50.16 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 123.367 0.667 . . . . 74.409999999999997 110.175 -175.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.0 t -139.76 144.87 37.63 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.413 0.625 . . . . 65.0 110.03 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 14.2 p -143.94 133.29 23.24 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 106.275 -1.75 . . . . 73.400000000000006 106.275 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -159.49 -169.89 23.38 Favored Glycine 0 N--CA 1.404 -3.459 0 C-N-CA 118.602 -1.761 . . . . 74.129999999999995 112.385 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -139.82 115.23 9.91 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 124.659 0.858 . . . . 75.5 108.751 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 86.7 mt -89.54 133.55 34.54 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.571 -0.529 . . . . 71.319999999999993 109.571 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -101.95 119.34 38.63 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.173 0.511 . . . . 73.030000000000001 110.815 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -119.03 150.06 40.6 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.826 -0.805 . . . . 74.140000000000001 108.826 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.493 ' HG2' HD21 ' A' ' 534' ' ' ASN . 16.9 mt-30 -146.42 179.01 7.82 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.364 -1.347 . . . . 73.019999999999996 107.364 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -70.19 -25.77 63.58 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 123.64 0.588 . . . . 65.219999999999999 110.423 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -90.75 -33.61 15.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.988 -0.551 . . . . 72.549999999999997 111.915 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.453 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 72.5 mm-40 -66.84 152.61 45.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.918 0.39 . . . . 73.540000000000006 111.706 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.538 HG13 ' H ' ' A' ' 568' ' ' VAL . 5.8 pt -103.52 -86.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 113.38 0.881 . . . . 72.25 113.38 -177.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 525' ' ' VAL . 13.2 p -132.26 148.87 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 120.789 0.328 . . . . 71.400000000000006 110.221 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -120.66 160.97 22.2 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 116.105 -0.498 . . . . 74.140000000000001 109.66 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 5.5 p -125.61 153.78 43.23 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.69 -0.687 . . . . 74.019999999999996 111.033 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.4 mp -100.91 122.74 53.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.21 -1.774 . . . . 70.030000000000001 106.21 170.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 572' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 521' ' ' MET . 14.8 p -100.91 115.11 29.65 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 123.622 0.577 . . . . 74.219999999999999 109.948 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 84.3 t -119.43 134.23 63.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.066 -0.515 . . . . 74.420000000000002 110.405 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -84.54 118.86 24.59 Favored 'General case' 0 N--CA 1.428 -1.567 0 O-C-N 123.645 0.591 . . . . 73.219999999999999 109.568 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.05 120.71 36.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 105.953 -1.869 . . . . 73.349999999999994 105.953 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 48.2 mm . . . . . 0 C--N 1.305 -1.358 0 CA-C-O 121.484 0.659 . . . . 73.310000000000002 109.883 -176.066 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 545' ' ' THR . 94.8 mttt . . . . . 0 N--CA 1.425 -1.678 0 N-CA-C 106.647 -1.612 . . . . 75.340000000000003 106.647 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.8 t -143.1 148.77 37.18 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 121.248 0.546 . . . . 72.439999999999998 110.721 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.527 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 43.1 p90 -130.57 172.4 11.97 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 106.747 -1.575 . . . . 72.120000000000005 106.747 176.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.454 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 87.2 m-85 -120.24 154.51 34.79 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.195 -0.602 . . . . 73.239999999999995 109.981 -175.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.49 128.7 51.16 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 105.418 -2.067 . . . . 72.450000000000003 105.418 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -129.19 137.08 50.93 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.598 -0.519 . . . . 74.219999999999999 109.598 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . 0.515 HG23 ' HB3' ' A' ' 539' ' ' TYR . 15.1 pt -104.9 141.58 19.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.535 -0.913 . . . . 74.349999999999994 108.535 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -87.78 -176.58 48.12 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.66 -0.976 . . . . 74.519999999999996 110.66 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -68.47 130.97 91.81 Favored Pre-proline 0 N--CA 1.434 -1.251 0 C-N-CA 120.543 -0.463 . . . . 74.200000000000003 110.847 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.465 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 24.8 Cg_endo -66.95 137.24 44.1 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.013 2.475 . . . . 73.230000000000004 111.642 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -112.94 133.61 54.83 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.332 -0.395 . . . . 74.420000000000002 110.425 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -76.02 130.55 38.57 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.066 -1.457 . . . . 72.140000000000001 107.066 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.42 ' CG2' HG12 ' A' ' 536' ' ' ILE . 39.0 t . . . . . 0 C--N 1.293 -1.886 0 N-CA-C 107.84 -1.17 . . . . 71.129999999999995 107.84 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.465 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 24.9 Cg_endo . . . . . 0 N--CA 1.44 -1.623 0 N-CA-C 110.293 -0.695 . . . . 74.530000000000001 110.293 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.61 160.72 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 116.397 -0.365 . . . . 73.239999999999995 111.208 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.1 -176.36 3.97 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.822 -0.626 . . . . 74.329999999999998 112.278 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.66 -163.16 9.97 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 116.447 -0.342 . . . . 75.239999999999995 113.455 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -76.14 -46.62 27.85 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.789 -0.449 . . . . 75.420000000000002 109.789 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -136.57 120.94 18.06 Favored 'General case' 0 CA--C 1.49 -1.354 0 CA-C-O 121.063 0.459 . . . . 75.510000000000005 109.822 174.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 31.3 p -108.14 94.65 5.18 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-O 121.778 0.799 . . . . 65.329999999999998 109.774 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -151.31 146.73 26.22 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.972 -1.013 . . . . 73.129999999999995 108.638 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.425 HD23 HG12 ' A' ' 523' ' ' VAL . 26.3 tp -134.92 120.4 19.21 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 107.924 -1.139 . . . . 74.519999999999996 107.924 175.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -91.38 108.56 19.97 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.206 -1.405 . . . . 72.230000000000004 107.206 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 39.5 t -100.42 109.46 25.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 109.526 -0.546 . . . . 64.409999999999997 109.526 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 47.3 mt -93.87 129.64 43.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.343 -0.984 . . . . 73.439999999999998 108.343 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 77.1 mt -99.91 107.33 20.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.973 -0.751 . . . . 72.209999999999994 108.973 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 . . . . . 0 C--N 1.307 -1.245 0 CA-C-O 121.628 0.728 . . . . 70.510000000000005 111.725 178.552 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.633 0 N-CA-C 111.48 0.178 . . . . 63.210000000000001 111.48 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 163.36 -145.76 10.89 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.695 -1.24 . . . . 74.510000000000005 112.134 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.15 121.69 58.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 122.428 0.291 . . . . 65.540000000000006 110.923 -174.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -105.44 125.44 50.99 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.204 -0.665 . . . . 72.430000000000007 109.204 169.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' THR . . . . . 0.411 ' HA ' HG21 ' A' ' 640' ' ' THR . 9.0 t -162.79 169.01 20.58 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.393 -0.595 . . . . 72.319999999999993 109.393 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -74.6 148.36 40.82 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.477 0.18 . . . . 74.439999999999998 110.714 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -68.13 -26.8 65.97 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.529 0.681 . . . . 72.519999999999996 110.124 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -140.76 141.01 23.18 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 107.33 -1.359 . . . . 73.209999999999994 107.33 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.48 -28.86 8.05 Favored 'Trans proline' 0 C--N 1.328 -0.539 0 C-N-CA 122.426 2.084 . . . . 74.299999999999997 111.637 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.9 t -132.69 136.34 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 106.293 -1.743 . . . . 74.310000000000002 106.293 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 7.5 t -131.71 140.76 49.37 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 108.82 -0.807 . . . . 74.540000000000006 108.82 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -113.07 123.35 50.09 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.073 -0.651 . . . . 74.0 109.677 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 20.8 m -112.66 174.34 2.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 115.249 -0.887 . . . . 74.200000000000003 108.897 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.565 ' O ' HG21 ' A' ' 518' ' ' ILE . 36.1 t -107.29 151.17 25.83 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.652 0.739 . . . . 73.129999999999995 111.882 -175.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -62.19 -23.51 66.66 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 125.732 1.613 . . . . 62.210000000000001 109.705 170.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 4.2 t -123.17 26.35 8.05 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 120.977 0.418 . . . . 75.25 111.402 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.565 HG21 ' O ' ' A' ' 515' ' ' SER . 8.5 tt -84.11 -27.87 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.55 -0.719 . . . . 74.420000000000002 110.664 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.21 -80.04 1.57 Allowed Glycine 0 N--CA 1.428 -1.856 0 N-CA-C 111.056 -0.817 . . . . 71.129999999999995 111.056 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.2 mm -127.92 133.17 67.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 106.471 -1.677 . . . . 72.109999999999999 106.471 -177.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.599 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -109.86 144.07 38.85 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.767 -0.457 . . . . 72.430000000000007 109.767 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 7.8 mp0 -117.9 118.12 31.11 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 124.185 0.928 . . . . 74.0 109.916 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.511 HG21 ' SD ' ' A' ' 521' ' ' MET . 87.4 t -109.45 130.71 62.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.176 -0.676 . . . . 75.230000000000004 109.176 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -88.75 145.16 25.79 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 121.942 0.877 . . . . 74.120000000000005 112.626 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 38.9 t -113.26 137.55 45.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-N 114.437 -1.256 . . . . 72.540000000000006 107.926 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.7 mt -78.22 114.64 17.3 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.813 -0.81 . . . . 73.319999999999993 108.813 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -68.65 157.44 36.19 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.595 -1.184 . . . . 71.409999999999997 109.24 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.1 t -55.57 133.01 50.1 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 123.825 0.703 . . . . 55.439999999999998 111.568 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.7 m -54.59 -28.06 43.55 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.611 1.564 . . . . 55.340000000000003 111.026 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.58 91.93 0.48 Allowed Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 108.748 -1.741 . . . . 75.430000000000007 108.748 174.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -92.7 104.13 16.44 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.972 0.415 . . . . 63.409999999999997 110.411 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -130.27 104.68 7.43 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.069 -0.514 . . . . 74.030000000000001 109.85 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 101.18 -138.79 14.06 Favored Glycine 0 C--N 1.307 -1.08 0 C-N-CA 120.86 -0.686 . . . . 70.510000000000005 112.16 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -133.24 130.56 39.18 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.419 -0.585 . . . . 74.030000000000001 109.419 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.28 134.04 57.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.03 -1.1 . . . . 73.329999999999998 108.03 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.496 HG12 ' CG2' ' A' ' 597' ' ' VAL . 46.3 mm -102.95 135.11 41.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.205 -0.665 . . . . 75.109999999999999 109.205 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 42.8 t -120.11 108.79 37.94 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.577 -0.527 . . . . 73.209999999999994 109.577 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.3 154.06 45.89 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.277 1.984 . . . . 74.329999999999998 111.748 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.415 ' HB3' HG21 ' A' ' 591' ' ' ILE . 33.1 p90 -145.59 164.2 32.44 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.942 -0.303 . . . . 73.319999999999993 110.709 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -157.02 156.85 33.61 Favored 'General case' 0 C--O 1.248 0.978 0 O-C-N 123.835 0.709 . . . . 74.439999999999998 110.225 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.2 p -89.15 139.84 30.06 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 116.075 -0.511 . . . . 73.120000000000005 110.109 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.449 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 78.0 mt -112.01 129.24 67.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.812 -0.81 . . . . 74.540000000000006 108.812 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -83.02 164.7 20.19 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.156 -0.683 . . . . 74.209999999999994 109.156 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 172.1 -82.73 0.08 OUTLIER Glycine 0 CA--C 1.474 -2.469 0 C-N-CA 120.031 -1.081 . . . . 60.109999999999999 111.749 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.8 m -101.92 19.4 18.44 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.513 1.149 . . . . 70.239999999999995 108.402 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -162.84 148.82 12.29 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 106.169 -1.789 . . . . 63.329999999999998 106.169 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -104.59 141.07 37.07 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 123.712 0.805 . . . . 75.439999999999998 112.116 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.63 -160.41 36.46 Favored Glycine 0 C--N 1.306 -1.116 0 CA-C-N 115.433 -0.803 . . . . 64.329999999999998 112.704 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 71.65 12.66 74.2 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.751 -0.261 . . . . 43.109999999999999 113.499 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 90.11 19.36 46.85 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.459 -0.877 . . . . 64.439999999999998 111.043 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -89.18 -67.32 0.85 Allowed 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.59 -0.522 . . . . 74.439999999999998 109.59 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -102.13 -33.69 9.57 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.657 -1.238 . . . . 72.209999999999994 107.657 172.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -141.33 154.99 45.99 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.591 -0.892 . . . . 74.219999999999999 108.591 176.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.14 120.28 27.35 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.596 -1.631 . . . . 74.450000000000003 106.596 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -80.66 124.58 29.12 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.064 -0.516 . . . . 73.340000000000003 110.531 -171.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.7 t -136.2 168.68 18.95 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.35 0.595 . . . . 72.239999999999995 111.199 -172.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 14.8 p -158.52 164.44 36.13 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.97 -1.122 . . . . 64.430000000000007 107.97 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 173.57 -169.44 42.53 Favored Glycine 0 CA--C 1.482 -1.982 0 C-N-CA 120.156 -1.021 . . . . 74.010000000000005 110.853 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.443 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 46.1 mt-10 -137.14 125.42 23.22 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 123.428 0.691 . . . . 74.109999999999999 109.319 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 96.5 mt -96.05 132.42 41.44 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.257 -0.429 . . . . 75.109999999999999 109.862 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -94.91 111.23 23.04 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.22 0.534 . . . . 72.209999999999994 110.806 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 81.9 m-85 -107.98 142.59 37.87 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.063 0.459 . . . . 75.230000000000004 110.002 177.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -140.42 179.9 6.39 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.45 -0.574 . . . . 75.439999999999998 109.45 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -68.36 -34.61 76.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.82 -1.082 . . . . 72.549999999999997 108.894 173.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -85.14 -39.99 17.25 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.033 -0.985 . . . . 73.549999999999997 111.692 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -65.49 135.08 54.72 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.084 0.402 . . . . 74.439999999999998 112.084 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.562 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.8 pt -83.76 -81.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.227 0.825 . . . . 75.319999999999993 113.227 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.562 ' H ' HG13 ' A' ' 567' ' ' ILE . 9.0 p -128.79 158.48 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 109.555 -0.535 . . . . 70.120000000000005 109.555 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 4.5 mmpt? -125.94 159.26 33.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.078 -1.082 . . . . 73.409999999999997 108.078 172.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 5.8 p -130.14 149.07 52.01 Favored 'General case' 0 C--N 1.286 -2.194 0 O-C-N 123.832 0.707 . . . . 72.219999999999999 111.673 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.9 mp -94.79 125.53 47.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 106.825 -1.546 . . . . 75.409999999999997 106.825 172.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 572' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 521' ' ' MET . 48.6 m -107.07 118.36 36.5 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 123.958 0.786 . . . . 73.409999999999997 110.068 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.448 ' HB ' ' HE1' ' A' ' 521' ' ' MET . 76.4 t -125.45 134.42 66.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.097 -0.501 . . . . 74.340000000000003 109.874 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -79.87 115.02 19.22 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.883 -0.784 . . . . 74.329999999999998 108.883 174.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.24 130.19 36.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.604 -1.258 . . . . 72.25 107.604 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 44.1 mm . . . . . 0 N--CA 1.421 -1.895 0 N-CA-C 108.174 -1.047 . . . . 73.340000000000003 108.174 179.144 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp . . . . . 0 N--CA 1.421 -1.915 0 N-CA-C 107.819 -1.178 . . . . 72.340000000000003 107.819 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.7 t -132.73 130.64 40.27 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.626 0.727 . . . . 65.319999999999993 111.402 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -121.37 172.42 8.05 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.418 -0.956 . . . . 72.219999999999999 108.418 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.449 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 90.8 m-85 -118.7 152.48 36.05 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.947 -0.701 . . . . 75.030000000000001 109.855 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.54 130.22 54.14 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.304 -1.739 . . . . 73.519999999999996 106.304 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -127.02 134.44 50.32 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.624 -0.43 . . . . 73.340000000000003 109.865 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . 0.415 HG21 ' HB3' ' A' ' 539' ' ' TYR . 21.3 pt -102.56 139.78 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 107.673 -1.232 . . . . 72.519999999999996 107.673 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.45 177.2 52.73 Favored Glycine 0 N--CA 1.421 -2.343 0 C-N-CA 120.997 -0.62 . . . . 43.450000000000003 111.622 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.16 129.06 94.18 Favored Pre-proline 0 N--CA 1.428 -1.531 0 CA-C-O 120.86 0.362 . . . . 73.319999999999993 110.631 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -60.24 132.94 46.72 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.485 2.79 . . . . 73.129999999999995 112.291 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -110.41 119.96 40.9 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 120.993 0.425 . . . . 64.120000000000005 110.658 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.49 131.82 47.38 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.731 0.813 . . . . 74.420000000000002 108.858 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.496 ' CG2' HG12 ' A' ' 536' ' ' ILE . 61.0 t . . . . . 0 C--N 1.298 -1.672 0 N-CA-C 109.46 -0.57 . . . . 74.409999999999997 109.46 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.435 -1.913 0 N-CA-C 111.016 -0.417 . . . . 72.349999999999994 111.016 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.93 170.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 116.174 -0.466 . . . . 73.540000000000006 110.876 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.34 170.65 7.82 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 112.786 0.661 . . . . 75.349999999999994 112.786 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -78.51 -158.08 11.38 Favored Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 114.834 -1.075 . . . . 73.329999999999998 115.283 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -66.78 -54.52 21.83 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.082 -1.059 . . . . 71.409999999999997 110.853 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -126.81 137.49 53.21 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.56 -0.904 . . . . 73.019999999999996 108.56 175.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 640' ' ' THR . . . . . 0.411 HG21 ' HA ' ' A' ' 506' ' ' THR . 8.7 p -127.12 73.68 1.44 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 122.344 1.069 . . . . 72.120000000000005 111.336 174.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -157.42 141.2 15.88 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 114.475 -1.239 . . . . 74.319999999999993 107.962 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.402 HD21 HG12 ' A' ' 523' ' ' VAL . 38.5 tp -124.4 130.24 52.12 Favored 'General case' 0 C--N 1.279 -2.484 0 O-C-N 124.181 0.926 . . . . 75.219999999999999 109.35 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -94.46 107.38 19.35 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.059 -1.46 . . . . 72.200000000000003 107.059 174.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.1 109.63 24.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.269 -0.641 . . . . 74.329999999999998 109.269 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 52.6 mt -96.76 122.91 48.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 109.012 -0.736 . . . . 75.439999999999998 109.012 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 82.2 mt -87.72 111.82 22.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 106.9 -1.519 . . . . 74.430000000000007 106.9 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 N--CA 1.422 -1.83 0 N-CA-C 109.364 -0.606 . . . . 71.120000000000005 109.364 178.342 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 502' ' ' ALA . . . . . 0.532 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 121.385 0.612 . . . . 75.019999999999996 110.993 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 139.88 -149.51 20.86 Favored Glycine 0 N--CA 1.419 -2.486 0 C-N-CA 120.304 -0.95 . . . . 72.049999999999997 110.875 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.8 mp -117.24 113.43 42.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 123.687 0.287 . . . . 73.349999999999994 111.237 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.428 ' CD2' HG22 ' A' ' 528' ' ' THR . 21.8 m-85 -92.04 124.82 36.43 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.725 -1.213 . . . . 72.129999999999995 107.725 169.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.7 t -168.72 171.46 8.64 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 120.554 -0.458 . . . . 71.409999999999997 109.883 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -80.55 157.39 26.1 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.839 -0.801 . . . . 71.25 108.839 175.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.74 -35.51 80.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.506 0.67 . . . . 74.420000000000002 110.32 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -140.18 149.36 57.92 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.487 -0.931 . . . . 75.420000000000002 108.487 -176.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 642' ' ' LEU . 60.9 Cg_endo -75.53 -24.97 11.51 Favored 'Trans proline' 0 C--O 1.219 -0.437 0 C-N-CA 122.158 1.906 . . . . 75.129999999999995 112.77 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.75 135.76 58.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.981 -0.748 . . . . 74.230000000000004 108.981 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 644' ' ' VAL . 9.5 t -135.03 140.08 45.32 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 107.714 -1.217 . . . . 64.239999999999995 107.714 177.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -108.73 138.41 45.09 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.651 -0.87 . . . . 73.540000000000006 108.651 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.8 m -128.65 156.38 41.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.953 -0.758 . . . . 65.049999999999997 108.953 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.596 ' O ' HG21 ' A' ' 518' ' ' ILE . 33.0 t -83.48 150.84 25.76 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.795 -0.639 . . . . 75.019999999999996 109.323 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -66.89 -32.64 74.04 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.494 -0.558 . . . . 71.409999999999997 109.494 170.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.7 m -99.29 20.46 13.56 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 112.117 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.596 HG21 ' O ' ' A' ' 515' ' ' SER . 9.9 tt -79.23 -27.52 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.542 -0.724 . . . . 74.209999999999994 111.529 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 92.3 -77.16 1.26 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.29 -0.957 . . . . 51.229999999999997 111.327 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 42.4 mm -130.53 123.58 55.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 106.719 -1.586 . . . . 72.319999999999993 106.719 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.507 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -101.43 150.52 22.95 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.798 -0.816 . . . . 74.219999999999999 108.798 177.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.595 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.7 mt-10 -132.06 129.18 39.68 Favored 'General case' 0 CA--C 1.493 -1.247 0 O-C-N 123.702 0.626 . . . . 73.230000000000004 111.033 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 570' ' ' THR . 60.9 t -116.4 132.04 67.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.282 -0.872 . . . . 54.200000000000003 108.978 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -85.45 127.82 34.52 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 124.138 0.975 . . . . 71.340000000000003 110.252 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 60.3 t -110.41 128.57 66.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.885 -0.598 . . . . 74.200000000000003 109.645 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 77.9 mt -81.75 127.97 33.5 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.012 -0.994 . . . . 74.349999999999994 112.031 -173.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -72.12 162.18 29.83 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.387 -0.968 . . . . 74.310000000000002 108.387 172.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 19.4 p -58.7 154.52 14.45 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 123.503 0.721 . . . . 74.25 112.341 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 41.0 t -53.83 -35.18 61.18 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.793 1.237 . . . . 62.32 109.498 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -114.82 103.7 1.29 Allowed Glycine 0 N--CA 1.42 -2.407 0 N-CA-C 108.841 -1.704 . . . . 74.099999999999994 108.841 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.71 101.7 12.99 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.194 -0.669 . . . . 73.209999999999994 109.194 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -127.02 117.99 23.57 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.796 -0.816 . . . . 72.340000000000003 108.796 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 77.22 172.04 36.56 Favored Glycine 0 C--N 1.298 -1.562 0 N-CA-C 115.016 0.767 . . . . 75.420000000000002 115.016 173.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.403 HD21 ' HG2' ' A' ' 563' ' ' GLN . 2.7 t-20 -86.01 123.23 31.1 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.519 -0.84 . . . . 74.200000000000003 109.127 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 58.0 t -132.01 132.9 61.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 114.8 -1.091 . . . . 72.129999999999995 108.204 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.475 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 43.8 mm -102.81 132.25 49.34 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 109.375 -0.602 . . . . 73.310000000000002 109.375 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.53 105.77 43.27 Favored Pre-proline 0 N--CA 1.427 -1.594 0 N-CA-C 108.736 -0.839 . . . . 75.140000000000001 108.736 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -72.55 151.98 53.54 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.169 1.912 . . . . 73.109999999999999 111.672 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -142.6 163.27 33.28 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.459 -0.496 . . . . 73.010000000000005 110.104 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -153.67 151.37 29.59 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 123.929 0.768 . . . . 75.239999999999995 110.01 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 11.1 p -85.78 133.13 34.01 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 109.377 -0.601 . . . . 75.319999999999993 109.377 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.476 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 67.5 mt -108.08 124.2 64.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 108.178 -1.045 . . . . 73.209999999999994 108.178 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -73.14 136.03 44.77 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 120.945 0.402 . . . . 74.5 110.321 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -126.61 -104.43 1.35 Allowed Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 109.352 -1.499 . . . . 55.219999999999999 109.352 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.7 p -94.57 -21.32 18.92 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.489 0.662 . . . . 71.409999999999997 109.61 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -84.01 142.29 30.58 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 108.44 -0.948 . . . . 72.209999999999994 108.44 175.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -87.32 123.3 32.15 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 114.305 1.224 . . . . 74.140000000000001 114.305 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -81.92 -158.8 23.26 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 115.043 -0.981 . . . . 64.430000000000007 112.101 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.36 14.36 71.66 Favored Glycine 0 C--N 1.306 -1.1 0 C-N-CA 121.312 -0.471 . . . . 52.439999999999998 112.837 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 77.92 39.02 25.4 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.905 -0.664 . . . . 65.120000000000005 111.836 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -111.9 -50.97 2.88 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.441 0.639 . . . . 75.140000000000001 109.949 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.432 ' CG ' ' HZ2' ' A' ' 585' ' ' LYS . 16.3 t0 -104.07 -47.14 4.25 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 105.821 -1.918 . . . . 74.430000000000007 105.821 177.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -134.11 154.21 51.34 Favored 'General case' 0 C--O 1.256 1.421 0 CA-C-N 114.329 -1.305 . . . . 75.030000000000001 108.152 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -81.21 119.38 23.54 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.25 -1.389 . . . . 74.310000000000002 107.25 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.88 125.15 28.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.093 -1.077 . . . . 74.349999999999994 108.093 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 12.0 t -140.02 159.41 42.25 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-O 121.618 0.723 . . . . 70.030000000000001 110.609 -171.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 23.0 p -147.22 165.74 29.12 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 107.331 -1.359 . . . . 75.420000000000002 107.331 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 176.16 -174.32 46.86 Favored Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 120.044 -1.074 . . . . 63.229999999999997 110.82 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.475 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 51.7 mt-10 -134.38 119.55 18.75 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 123.271 0.628 . . . . 75.420000000000002 109.325 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 88.7 mt -86.53 132.47 33.91 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.985 -0.552 . . . . 62.109999999999999 109.811 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.4 ' HA ' HD11 ' A' ' 536' ' ' ILE . 34.9 tt0 -101.53 106.38 17.47 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.745 -0.661 . . . . 73.409999999999997 110.019 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -105.42 149.68 25.93 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.75 -0.833 . . . . 72.25 108.75 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.513 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 6.3 mt-30 -143.96 -169.16 3.04 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.204 -1.406 . . . . 72.430000000000007 107.204 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -76.12 -19.48 58.48 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.595 -0.891 . . . . 71.219999999999999 108.595 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -88.54 -45.1 10.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.31 -1.314 . . . . 62.409999999999997 110.521 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.513 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 6.0 mm-40 -74.9 122.51 23.53 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.943 0.401 . . . . 74.409999999999997 111.817 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.434 HD11 ' N ' ' A' ' 568' ' ' VAL . 1.8 pp -106.99 -32.51 2.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 115.122 -0.944 . . . . 65.329999999999998 113.16 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.434 ' N ' HD11 ' A' ' 567' ' ' ILE . 9.4 p -143.43 145.76 22.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 120.275 -0.57 . . . . 73.530000000000001 110.494 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.59 162.18 27.09 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.798 -0.637 . . . . 75.510000000000005 109.612 174.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.7 p -122.32 143.33 49.7 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.588 0.588 . . . . 71.329999999999998 112.588 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.6 mp -94.63 117.84 39.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 106.591 -1.633 . . . . 74.099999999999994 106.591 170.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 572' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 521' ' ' MET . 8.1 p -98.31 115.52 28.59 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.712 0.632 . . . . 75.400000000000006 109.498 178.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.465 HG23 HG23 ' A' ' 571' ' ' ILE . 60.1 t -121.52 124.66 72.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 116.295 -0.412 . . . . 74.430000000000007 110.66 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -71.91 120.83 18.07 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.965 -1.016 . . . . 73.530000000000001 108.678 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 28.2 t -92.37 130.33 41.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 104.73 -2.322 . . . . 73.030000000000001 104.73 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 44.0 mm . . . . . 0 C--N 1.289 -2.031 0 N-CA-C 108.762 -0.829 . . . . 73.230000000000004 108.762 -173.418 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . 0.432 ' HZ2' ' CG ' ' A' ' 552' ' ' ASP 0.289 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.314 0 N-CA-C 114.196 1.184 . . . . 74.030000000000001 114.196 . . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 586' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 644' ' ' VAL . 5.9 t -141.79 159.02 43.08 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.767 -1.106 . . . . 70.25 110.349 -172.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 40.3 p90 -132.79 168.69 17.91 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 106.693 -1.595 . . . . 75.200000000000003 106.693 175.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.476 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 63.6 m-85 -115.74 155.74 27.23 Favored 'General case' 0 C--N 1.283 -2.284 0 C-N-CA 120.34 -0.544 . . . . 75.400000000000006 110.342 -175.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.21 126.19 46.51 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 105.717 -1.957 . . . . 73.340000000000003 105.717 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -127.16 129.77 48.5 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 120.534 -0.467 . . . . 75.340000000000003 109.871 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 21.5 pt -98.96 136.2 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 N-CA-C 108.046 -1.094 . . . . 71.430000000000007 108.046 175.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.03 -177.87 52.13 Favored Glycine 0 N--CA 1.421 -2.365 0 CA-C-N 115.496 -0.775 . . . . 62.219999999999999 111.369 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -64.82 133.71 95.82 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 120.742 0.306 . . . . 74.340000000000003 111.497 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -69.01 124.09 11.02 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 122.697 2.265 . . . . 75.019999999999996 110.558 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -111.41 125.1 53.51 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 109.65 -0.5 . . . . 74.319999999999993 109.65 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -66.33 133.13 49.88 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 105.204 -2.147 . . . . 74.230000000000004 105.204 174.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 63.4 t . . . . . 0 C--N 1.3 -1.567 0 CA-C-O 121.759 0.79 . . . . 75.109999999999999 110.861 -177.761 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo . . . . . 0 C--O 1.243 0.756 0 CA-C-O 121.415 0.506 . . . . 75.430000000000007 112.389 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -126.71 164.08 27.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.591 -0.732 . . . . 72.140000000000001 109.89 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.53 173.56 7.56 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 112.875 0.694 . . . . 73.140000000000001 112.875 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.88 -171.89 28.8 Favored Glycine 0 N--CA 1.43 -1.709 0 CA-C-N 115.579 -0.737 . . . . 74.329999999999998 114.354 -176.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.73 -40.52 88.39 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.168 0.987 . . . . 74.25 109.744 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -133.3 138.51 46.44 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.904 -0.776 . . . . 73.409999999999997 108.904 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 19.1 p -136.53 88.17 2.35 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.746 0.784 . . . . 74.430000000000007 109.217 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -159.73 145.19 15.58 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.019 -0.991 . . . . 74.409999999999997 108.797 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.44 HD21 HG21 ' A' ' 523' ' ' VAL . 25.8 tp -136.14 120.55 18.08 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 108.717 -0.845 . . . . 73.439999999999998 108.717 176.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -91.68 105.33 17.65 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.831 -1.544 . . . . 72.400000000000006 106.831 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . 0.431 ' C ' ' HG1' ' A' ' 586' ' ' THR . 36.7 t -98.69 106.25 18.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.468 -0.567 . . . . 72.120000000000005 109.468 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 53.6 mt -89.94 128.98 41.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 109.014 -0.736 . . . . 74.209999999999994 109.014 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 55.3 mt -104.4 103.55 15.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.238 -0.652 . . . . 74.450000000000003 109.238 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--N 1.288 -2.076 0 CA-C-N 115.892 -0.595 . . . . 74.420000000000002 109.478 178.544 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.085 0 N-CA-C 112.205 0.446 . . . . 62.149999999999999 112.205 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 135.91 -141.53 12.68 Favored Glycine 0 C--N 1.313 -0.697 0 C-N-CA 118.892 -1.623 . . . . 64.409999999999997 113.424 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.7 119.52 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 C-N-CA 122.893 0.477 . . . . 75.510000000000005 110.327 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -98.57 135.15 40.52 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.254 -1.387 . . . . 75.329999999999998 107.254 168.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.9 t -169.41 -179.96 3.65 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.959 -0.756 . . . . 73.450000000000003 108.959 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . 0.448 ' CZ ' HG23 ' A' ' 591' ' ' ILE . 67.4 m-85 -84.4 151.84 24.42 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.937 -0.394 . . . . 75.030000000000001 109.937 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -67.0 -31.75 72.53 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.439 0.638 . . . . 62.450000000000003 110.059 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -135.0 141.53 38.66 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.532 -1.285 . . . . 71.099999999999994 107.532 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.59 -26.32 7.2 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 122.289 1.993 . . . . 73.219999999999999 112.459 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 61.1 t -139.73 132.31 35.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 106.853 -1.536 . . . . 65.400000000000006 106.853 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.8 t -127.68 138.71 52.89 Favored 'General case' 0 N--CA 1.414 -2.226 0 C-N-CA 120.252 -0.579 . . . . 72.209999999999994 109.994 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -103.64 116.44 32.35 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.541 -0.911 . . . . 75.010000000000005 108.541 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.6 m -117.44 165.5 12.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.418 -0.956 . . . . 75.109999999999999 108.418 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.622 ' O ' HG23 ' A' ' 518' ' ' ILE . 27.3 t -95.95 153.8 17.57 Favored 'General case' 0 N--CA 1.418 -2.072 0 C-N-CA 120.556 -0.457 . . . . 73.120000000000005 109.792 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.76 -34.45 75.61 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.176 -1.046 . . . . 70.129999999999995 108.176 170.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.7 m -98.39 20.34 12.83 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.77 -1.105 . . . . 75.239999999999995 111.966 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 515' ' ' SER . 9.4 tt -82.97 -26.68 7.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 CA-C-O 121.622 0.725 . . . . 73.219999999999999 109.372 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 91.97 -78.66 1.26 Allowed Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.305 -1.118 . . . . 72.319999999999993 110.305 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 32.3 mm -128.99 141.14 47.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 106.839 -1.541 . . . . 74.219999999999999 106.839 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.512 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -122.72 144.82 48.91 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.289 -0.634 . . . . 74.150000000000006 109.289 178.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 10.6 mp0 -115.33 130.5 56.92 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 123.819 0.699 . . . . 74.329999999999998 109.589 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 570' ' ' THR . 59.3 t -116.07 128.41 73.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 109.303 -0.629 . . . . 73.439999999999998 109.303 175.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -81.95 129.91 34.91 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 123.733 0.813 . . . . 74.329999999999998 109.839 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.514 ' O ' HG22 ' A' ' 568' ' ' VAL . 60.0 t -106.1 118.7 54.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.504 -0.924 . . . . 73.319999999999993 108.504 175.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.7 mt -67.44 122.44 17.96 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 123.863 0.727 . . . . 74.040000000000006 111.461 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 567' ' ' ILE . 21.7 tpt180 -68.01 145.69 54.24 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.518 -1.219 . . . . 75.439999999999998 108.946 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 12.4 t -56.5 143.41 35.32 Favored 'General case' 0 N--CA 1.406 -2.637 0 C-N-CA 124.917 1.287 . . . . 72.329999999999998 109.984 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 18.8 t -52.53 -36.14 54.9 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.737 0.815 . . . . 72.049999999999997 111.437 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -116.46 96.15 0.71 Allowed Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.022 -1.231 . . . . 61.140000000000001 110.022 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -84.87 101.67 12.49 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.648 -0.871 . . . . 75.530000000000001 108.648 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -124.77 116.88 23.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.822 -0.807 . . . . 74.319999999999993 108.822 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.402 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 77.72 -178.72 51.8 Favored Glycine 0 C--O 1.258 1.602 0 O-C-N 123.695 0.622 . . . . 75.150000000000006 113.84 176.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -90.95 125.83 35.89 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.893 -0.654 . . . . 74.049999999999997 109.522 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 72.6 t -133.16 134.58 57.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.745 -0.661 . . . . 61.229999999999997 109.26 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.566 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 37.8 mm -106.51 134.75 47.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 109.219 -0.66 . . . . 75.400000000000006 109.219 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.65 110.25 32.01 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.741 -0.466 . . . . 74.030000000000001 109.741 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -70.65 158.04 56.94 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.338 2.026 . . . . 74.239999999999995 111.583 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -151.99 155.56 38.24 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.331 -0.618 . . . . 72.430000000000007 109.331 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.64 149.1 28.08 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 123.87 0.731 . . . . 72.530000000000001 112.174 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.1 p -83.44 131.16 35.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 116.003 -0.544 . . . . 75.540000000000006 109.933 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.438 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 57.9 mt -103.07 119.91 52.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.003 -1.11 . . . . 74.140000000000001 108.003 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.91 160.61 27.19 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.133 -0.692 . . . . 75.049999999999997 109.133 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 177.69 -97.6 0.11 Allowed Glycine 0 CA--C 1.473 -2.533 0 N-CA-C 110.504 -1.038 . . . . 74.230000000000004 110.504 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 545' ' ' THR . . . . . 0.431 ' HB ' ' H ' ' A' ' 586' ' ' THR . 0.2 OUTLIER -71.37 -31.53 67.44 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 109.355 -0.609 . . . . 74.319999999999993 109.355 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -107.67 155.75 19.82 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 108.494 -0.928 . . . . 61.109999999999999 108.494 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -101.01 137.85 38.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.543 0.687 . . . . 75.420000000000002 112.457 -176.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.98 -150.47 12.45 Favored Glycine 0 C--N 1.299 -1.498 0 C-N-CA 120.663 -0.779 . . . . 73.299999999999997 112.716 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 61.02 7.28 8.3 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 115.749 1.06 . . . . 65.010000000000005 115.749 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 90.44 14.59 58.37 Favored Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 118.209 1.005 . . . . 73.349999999999994 110.991 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -87.52 -55.44 3.79 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.165 -0.68 . . . . 71.530000000000001 109.165 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -107.04 -42.26 4.94 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.112 -1.44 . . . . 73.219999999999999 107.112 177.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -140.07 152.38 46.13 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.809 -1.182 . . . . 75.439999999999998 107.809 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.74 112.94 20.53 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.311 -0.996 . . . . 73.150000000000006 108.311 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.99 122.5 17.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.38 1.072 . . . . 73.319999999999993 111.675 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.7 t -131.66 142.35 49.82 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 121.786 0.803 . . . . 72.200000000000003 110.577 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 21.4 p -151.71 150.16 29.9 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.559 -1.275 . . . . 71.319999999999993 107.559 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 172.62 -164.03 36.16 Favored Glycine 0 CA--C 1.482 -2.013 0 N-CA-C 109.979 -1.248 . . . . 70.129999999999995 109.979 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.566 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 45.3 mt-10 -133.24 128.06 35.06 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.986 0.393 . . . . 73.219999999999999 111.134 -177.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 569' ' ' LYS . 95.8 mt -89.44 141.18 28.8 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 123.463 0.705 . . . . 72.310000000000002 109.201 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -103.54 118.28 36.37 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.292 0.568 . . . . 74.420000000000002 110.884 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -116.39 148.75 40.35 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.777 -0.823 . . . . 73.329999999999998 108.777 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.547 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 45.7 mt-30 -140.86 -178.97 5.8 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.826 -0.805 . . . . 62.039999999999999 108.826 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . 0.402 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 3.6 p-10 -71.48 -36.0 71.0 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.597 -0.441 . . . . 74.319999999999993 110.617 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -79.81 -39.3 31.09 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.109 -0.496 . . . . 75.319999999999993 110.167 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.547 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 64.5 mm-40 -63.64 151.86 40.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.556 -0.747 . . . . 73.120000000000005 111.736 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.523 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.2 pt -114.62 -92.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 113.447 0.906 . . . . 70.450000000000003 113.447 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.523 ' H ' HG13 ' A' ' 567' ' ' ILE . 11.7 p -107.86 146.64 13.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 120.885 0.374 . . . . 72.150000000000006 111.331 -174.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.402 ' HB3' HD21 ' A' ' 560' ' ' LEU . 5.3 mmpt? -114.99 165.19 13.15 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.146 -0.687 . . . . 73.140000000000001 109.146 173.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.2 p -131.41 140.35 49.62 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.973 -0.558 . . . . 52.439999999999998 112.088 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.0 mp -95.28 121.03 45.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.811 -1.181 . . . . 73.409999999999997 107.811 173.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 572' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 521' ' ' MET . 70.0 m -96.64 117.74 31.63 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 123.981 0.801 . . . . 64.310000000000002 109.035 176.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.408 ' HB ' ' HE2' ' A' ' 521' ' ' MET . 89.6 t -119.31 133.42 66.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 110.239 -0.282 . . . . 75.340000000000003 110.239 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -86.37 120.71 28.0 Favored 'General case' 0 N--CA 1.435 -1.218 0 O-C-N 123.684 0.615 . . . . 72.329999999999998 109.363 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 31.0 t -96.05 127.39 48.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.81 -1.182 . . . . 75.129999999999995 107.81 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 34.5 mm . . . . . 0 C--N 1.306 -1.31 0 CA-C-O 120.999 0.428 . . . . 75.519999999999996 110.123 -175.459 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.414 0 CA-C-O 121.497 0.665 . . . . 73.219999999999999 112.448 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 586' ' ' THR . . . . . 0.431 ' H ' ' HB ' ' A' ' 545' ' ' THR . 5.3 t -153.47 153.3 32.2 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 115.434 -0.803 . . . . 74.299999999999997 109.02 -173.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -133.03 168.38 18.6 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.233 -1.395 . . . . 74.219999999999999 107.233 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.438 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 72.5 m-85 -117.73 151.27 37.61 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 120.084 -0.646 . . . . 74.030000000000001 109.451 -174.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.39 128.1 51.87 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 106.378 -1.712 . . . . 73.400000000000006 106.378 178.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -124.93 133.94 52.85 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.991 -0.744 . . . . 74.349999999999994 108.991 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . 0.448 HG23 ' CZ ' ' A' ' 507' ' ' PHE . 18.3 pt -97.84 135.84 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 N-CA-C 107.878 -1.156 . . . . 75.219999999999999 107.878 173.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -81.83 173.07 53.53 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 111.017 -0.833 . . . . 75.109999999999999 111.017 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 593' ' ' GLU . 6.1 mp0 -59.41 135.08 88.66 Favored Pre-proline 0 C--N 1.287 -2.122 0 C-N-CA 123.945 0.898 . . . . 75.019999999999996 110.688 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -70.87 122.06 8.47 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 122.495 2.13 . . . . 71.209999999999994 111.074 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -104.51 119.57 39.29 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.591 -0.731 . . . . 75.409999999999997 109.134 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . 0.4 ' HB2' ' CD ' ' A' ' 634' ' ' PRO . 2.3 tm? -66.2 134.55 52.94 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.898 -1.149 . . . . 74.049999999999997 107.898 178.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.438 ' CG2' HG12 ' A' ' 536' ' ' ILE . 25.8 t . . . . . 0 C--N 1.297 -1.695 0 N-CA-C 105.875 -1.898 . . . . 75.120000000000005 105.875 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.4 ' CD ' ' HB2' ' A' ' 596' ' ' LEU . 72.3 Cg_endo . . . . . 0 N--CA 1.429 -2.281 0 N-CA-C 110.4 -0.654 . . . . 62.340000000000003 110.4 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.54 162.46 26.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.256 -1.016 . . . . 74.140000000000001 108.256 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.02 -178.43 3.71 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 120.056 -0.658 . . . . 74.549999999999997 111.928 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -75.1 -169.13 24.24 Favored Glycine 0 N--CA 1.445 -0.704 0 O-C-N 123.455 0.472 . . . . 74.010000000000005 112.794 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -68.99 -51.84 35.16 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.181 -0.674 . . . . 73.150000000000006 109.181 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -122.56 131.62 53.92 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.814 0.816 . . . . 75.109999999999999 111.937 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 16.8 p -126.64 90.06 3.1 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.394 -1.276 . . . . 75.409999999999997 109.781 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . 0.4 ' HZ3' ' HB3' ' A' ' 641' ' ' LYS . 5.7 ttpm? -159.54 148.18 17.75 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.519 -0.764 . . . . 75.109999999999999 109.609 -176.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.451 HD23 HG11 ' A' ' 523' ' ' VAL . 30.9 tp -129.51 129.17 44.19 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 108.025 -1.102 . . . . 73.310000000000002 108.025 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -97.58 106.25 18.53 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.894 -1.521 . . . . 63.240000000000002 106.894 175.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 39.6 t -98.55 106.86 19.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.358 -0.608 . . . . 62.119999999999997 109.358 -176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 73.0 mt -91.2 125.3 43.95 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.559 0 N-CA-C 109.35 -0.611 . . . . 74.409999999999997 109.35 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 69.8 mt -100.9 103.92 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 109.056 -0.72 . . . . 74.549999999999997 109.056 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 515' ' ' SER . 14.2 pt-20 . . . . . 0 C--N 1.284 -2.275 0 N-CA-C 108.317 -0.994 . . . . 73.299999999999997 108.317 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.937 0 N-CA-C 108.798 -0.816 . . . . 72.310000000000002 108.798 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 169.3 -159.13 31.94 Favored Glycine 0 N--CA 1.42 -2.376 0 N-CA-C 108.672 -1.771 . . . . 74.510000000000005 108.672 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.444 HG21 ' CA ' ' A' ' 637' ' ' GLY . 3.5 mp -114.23 110.83 33.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 117.211 0.505 . . . . 71.530000000000001 110.834 -175.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.463 ' CE2' HG23 ' A' ' 528' ' ' THR . 31.5 m-85 -90.67 124.5 35.12 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.655 -0.868 . . . . 74.109999999999999 108.655 169.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.1 t -162.47 170.57 18.49 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.78 -0.822 . . . . 74.439999999999998 108.78 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -76.11 146.62 39.17 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 110.27 -0.27 . . . . 74.349999999999994 110.27 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.28 -30.78 71.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.267 0.556 . . . . 74.200000000000003 109.785 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -137.41 145.73 50.71 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 108.735 -0.839 . . . . 75.150000000000006 108.735 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -81.14 -22.64 5.82 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.654 2.236 . . . . 75.329999999999998 112.819 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 47.2 t -141.79 135.11 29.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 106.92 -1.511 . . . . 74.319999999999993 106.92 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.1 t -131.61 141.04 49.56 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 109.494 -0.558 . . . . 73.409999999999997 109.494 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -107.01 124.89 50.28 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.075 0.464 . . . . 75.219999999999999 110.207 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 17.6 m -124.3 163.42 24.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.177 -0.675 . . . . 73.310000000000002 109.177 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 19.2 t -93.64 154.42 17.84 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.954 -0.388 . . . . 74.299999999999997 109.954 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -59.59 -32.74 70.66 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 123.773 0.671 . . . . 75.030000000000001 109.523 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 23.3 t -129.43 65.39 1.47 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.907 0.861 . . . . 72.109999999999999 110.84 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 6.4 tt -98.3 -25.0 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 115.072 -0.967 . . . . 72.310000000000002 109.168 172.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 95.04 -81.05 0.87 Allowed Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.55 -0.75 . . . . 62.030000000000001 111.283 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.5 mm -129.36 127.52 65.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.002 -1.481 . . . . 74.519999999999996 107.002 -176.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.466 ' HE1' ' CG2' ' A' ' 573' ' ' VAL . 0.0 OUTLIER -111.69 148.08 34.19 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.707 -1.22 . . . . 73.409999999999997 107.707 177.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 33.2 mt-10 -126.75 132.16 51.15 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 123.576 0.547 . . . . 74.129999999999995 111.989 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 570' ' ' THR . 21.5 t -112.91 129.3 68.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.944 -1.132 . . . . 75.219999999999999 107.944 178.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -86.04 134.77 33.82 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.795 -0.817 . . . . 72.25 108.795 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 44.8 t -108.8 127.89 65.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.845 -0.798 . . . . 73.230000000000004 108.845 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.96 126.45 29.79 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.869 -0.605 . . . . 73.329999999999998 110.314 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -79.33 161.41 26.26 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.486 -1.234 . . . . 71.420000000000002 109.926 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.463 HG23 ' CE2' ' A' ' 505' ' ' PHE . 6.4 p -59.74 147.27 38.48 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 123.384 0.674 . . . . 72.530000000000001 111.633 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 29.5 t -59.14 -36.98 76.17 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.918 -0.771 . . . . 74.540000000000006 108.918 175.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -112.56 101.6 1.24 Allowed Glycine 0 N--CA 1.416 -2.683 0 N-CA-C 108.981 -1.647 . . . . 71.140000000000001 108.981 174.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -92.03 101.48 14.03 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.753 -1.203 . . . . 73.540000000000006 107.753 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -122.21 104.29 9.35 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.741 -0.466 . . . . 71.450000000000003 109.741 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 89.33 -151.39 21.95 Favored Glycine 0 C--N 1.304 -1.215 0 C-N-CA 120.456 -0.878 . . . . 70.140000000000001 112.031 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.424 HD22 ' CG ' ' A' ' 561' ' ' GLU . 2.5 t-20 -113.09 127.69 56.28 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.394 0.616 . . . . 73.319999999999993 110.297 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 66.4 t -129.67 138.51 54.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 108.81 -0.811 . . . . 75.120000000000005 108.81 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.57 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 44.8 mm -107.94 133.84 51.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 109.35 -0.611 . . . . 74.140000000000001 109.35 177.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 25.6 t -120.45 109.06 36.96 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 109.208 -0.664 . . . . 64.230000000000004 109.208 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.61 153.94 54.68 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.108 1.872 . . . . 74.319999999999993 111.83 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.429 ' HB3' HG23 ' A' ' 591' ' ' ILE . 52.9 p90 -148.81 161.56 41.56 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.738 -0.467 . . . . 73.120000000000005 109.738 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -158.17 162.35 37.92 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.106 -0.497 . . . . 72.120000000000005 109.714 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.8 p -88.39 149.29 23.8 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 116.027 -0.533 . . . . 64.200000000000003 110.677 173.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 86.7 mt -121.26 109.99 26.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.858 -1.164 . . . . 71.310000000000002 107.858 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.34 111.24 2.94 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 123.854 0.721 . . . . 72.549999999999997 110.593 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -100.54 -108.24 3.02 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.34 -1.104 . . . . 54.420000000000002 110.34 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 67.5 p -93.24 8.87 38.51 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 122.517 1.151 . . . . 70.439999999999998 107.967 175.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -119.88 136.53 54.46 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.148 -1.387 . . . . 73.310000000000002 109.509 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.523 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 82.0 mtm180 -82.9 135.4 34.93 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.543 1.137 . . . . 75.129999999999995 110.831 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -87.73 -161.28 36.6 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 115.153 -0.931 . . . . 74.209999999999994 113.533 -175.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 77.06 -55.99 3.57 Favored Glycine 0 C--O 1.224 -0.51 0 CA-C-N 115.488 -0.356 . . . . 64.129999999999995 113.576 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 554' ' ' GLU . . . 157.99 42.45 0.02 OUTLIER Glycine 0 C--N 1.284 -2.341 0 N-CA-C 109.415 -1.474 . . . . 72.129999999999995 109.415 -173.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.523 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 8.4 tt0 -116.92 -61.74 1.68 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.559 -0.534 . . . . 73.140000000000001 109.559 -176.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -98.57 -43.74 6.73 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.887 -1.523 . . . . 75.310000000000002 106.887 169.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -132.87 156.42 47.23 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 107.195 -1.409 . . . . 71.209999999999994 107.195 174.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.411 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 10.2 tt0 -84.3 131.11 34.75 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.635 -0.876 . . . . 75.219999999999999 108.635 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 9.6 t70 -58.24 131.1 49.6 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.525 -0.546 . . . . 74.310000000000002 109.525 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.435 HG21 HG22 ' A' ' 573' ' ' VAL . 14.6 t -133.32 141.33 47.9 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-O 121.702 0.763 . . . . 75.439999999999998 109.146 174.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 3.2 p -156.55 161.32 39.98 Favored 'General case' 0 C--N 1.272 -2.763 0 N-CA-C 107.264 -1.384 . . . . 74.219999999999999 107.264 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 149.24 -167.11 29.56 Favored Glycine 0 N--CA 1.41 -3.071 0 N-CA-C 110.395 -1.082 . . . . 71.349999999999994 110.395 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.57 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 52.9 mt-10 -131.7 132.77 44.19 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 120.965 0.412 . . . . 70.219999999999999 110.567 -176.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.428 HD21 ' HB3' ' A' ' 569' ' ' LYS . 89.7 mt -92.94 140.81 29.1 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.883 -0.599 . . . . 74.439999999999998 109.512 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.469 ' HG3' ' CD1' ' A' ' 536' ' ' ILE . 27.9 tt0 -106.28 113.74 27.44 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 116.094 -0.503 . . . . 74.530000000000001 109.872 -177.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -111.92 149.31 32.07 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.128 -0.693 . . . . 72.129999999999995 109.128 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.505 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 49.4 mt-30 -146.99 -177.65 5.77 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.249 -0.648 . . . . 72.5 109.249 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -70.07 -31.17 68.64 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.629 -1.249 . . . . 72.519999999999996 107.629 170.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -77.0 -52.76 8.79 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.8 -1.091 . . . . 72.540000000000006 111.176 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.505 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 42.4 mm-40 -64.77 124.18 21.29 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 123.616 0.767 . . . . 73.549999999999997 111.854 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.556 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.2 pt -81.08 -62.24 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 124.159 0.912 . . . . 63.420000000000002 112.638 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.556 ' H ' HG13 ' A' ' 567' ' ' ILE . 7.8 p -143.31 160.24 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 109.522 -0.548 . . . . 64.510000000000005 109.522 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.428 ' HB3' HD21 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -127.6 158.69 36.83 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.43 -0.952 . . . . 73.349999999999994 108.43 171.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.5 p -127.34 144.58 51.03 Favored 'General case' 0 C--N 1.278 -2.504 0 O-C-N 124.03 0.831 . . . . 74.409999999999997 111.096 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.2 mp -94.68 119.31 42.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 106.829 -1.545 . . . . 72.219999999999999 106.829 172.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 24.4 p -92.34 116.14 28.71 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.543 -0.91 . . . . 75.299999999999997 108.543 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.466 ' CG2' ' HE1' ' A' ' 521' ' ' MET . 55.5 t -116.43 123.16 71.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.372 -0.603 . . . . 74.329999999999998 109.372 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.411 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 29.4 tptp -76.91 113.99 15.21 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.124 -0.944 . . . . 74.409999999999997 109.235 176.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.94 128.82 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 N-CA-C 104.887 -2.264 . . . . 72.310000000000002 104.887 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 46.5 mm . . . . . 0 C--N 1.301 -1.517 0 CA-C-O 122.35 1.071 . . . . 65.219999999999999 111.761 -175.379 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt . . . . . 0 C--O 1.211 -0.941 0 N-CA-C 106.346 -1.724 . . . . 73.510000000000005 106.346 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 11.4 t -131.41 137.96 48.89 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.578 -1.249 . . . . 74.310000000000002 111.012 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 44.2 p90 -135.07 179.13 6.51 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 107.74 -1.208 . . . . 74.299999999999997 107.74 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.477 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 92.6 m-85 -123.77 155.68 37.47 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 109.318 -0.623 . . . . 74.349999999999994 109.318 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.83 133.54 54.43 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 105.167 -2.16 . . . . 74.140000000000001 105.167 176.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -133.92 136.5 44.3 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.613 -0.835 . . . . 74.239999999999995 110.328 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . 0.429 HG23 ' HB3' ' A' ' 539' ' ' TYR . 16.0 pt -99.69 138.34 24.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 114.987 -1.006 . . . . 75.200000000000003 108.343 174.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.42 -173.55 49.78 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 111.225 -0.75 . . . . 64.400000000000006 111.225 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.94 130.35 88.48 Favored Pre-proline 0 C--N 1.305 -1.328 0 C-N-CA 120.702 -0.399 . . . . 74.5 111.168 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.516 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 17.8 Cg_endo -64.85 135.69 45.66 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.138 2.558 . . . . 65.420000000000002 112.21 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . 0.471 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 14.6 ptm180 -111.99 127.96 56.03 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.586 -0.733 . . . . 73.25 109.81 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -73.48 128.92 36.84 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 106.468 -1.679 . . . . 72.310000000000002 106.468 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.468 ' CG2' HG12 ' A' ' 536' ' ' ILE . 62.0 t . . . . . 0 C--N 1.299 -1.627 0 N-CA-C 109.155 -0.683 . . . . 73.209999999999994 109.155 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.516 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 17.4 Cg_endo . . . . . 0 N--CA 1.44 -1.647 0 N-CA-C 107.9 -1.615 . . . . 74.219999999999999 107.9 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.87 163.74 24.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 119.524 -0.871 . . . . 65.109999999999999 112.385 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.04 174.83 6.56 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.322 -0.854 . . . . 72.400000000000006 111.144 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . 0.444 ' CA ' HG21 ' A' ' 504' ' ' ILE . . . -75.5 -169.28 25.89 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 116.018 -0.537 . . . . 51.240000000000002 113.876 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.53 -27.67 60.63 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.473 0.654 . . . . 75.430000000000007 109.686 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -139.82 133.56 30.53 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.03 -0.729 . . . . 75.519999999999996 109.03 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 22.6 p -133.81 90.27 2.68 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.398 0.618 . . . . 74.400000000000006 110.175 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . 0.444 ' HB2' ' HZ2' ' A' ' 641' ' ' LYS . 5.0 ttmp? -163.13 142.74 8.78 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.519 -0.919 . . . . 73.209999999999994 108.519 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.439 HD21 HG11 ' A' ' 523' ' ' VAL . 21.3 tp -126.52 128.65 47.22 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 108.872 -0.788 . . . . 70.200000000000003 108.872 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -95.34 110.07 22.14 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.639 -1.245 . . . . 74.140000000000001 107.639 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.07 114.16 36.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 109.02 -0.733 . . . . 73.129999999999995 109.02 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 55.7 mt -102.9 113.85 40.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 109.104 -0.702 . . . . 63.409999999999997 109.104 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 50.3 mt -93.7 107.56 19.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.598 -1.631 . . . . 73.409999999999997 106.598 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.291 -1.968 0 C-N-CA 119.381 -0.927 . . . . 70.140000000000001 110.538 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 502' ' ' ALA . . . . . 0.47 ' HB1' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.442 -0.874 0 N-CA-C 109.403 -0.592 . . . . 75.450000000000003 109.403 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 172.34 -160.2 31.45 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 110.88 -0.888 . . . . 54.399999999999999 110.88 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.26 126.98 71.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 O-C-N 124.003 0.472 . . . . 73.219999999999999 111.364 -170.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.437 ' CE2' ' HB ' ' A' ' 528' ' ' THR . 61.9 m-85 -103.56 133.94 47.75 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.427 -0.583 . . . . 64.409999999999997 109.427 170.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.0 t -169.32 169.8 8.88 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.332 -0.988 . . . . 64.409999999999997 108.332 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -78.01 149.41 34.05 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.073 0.397 . . . . 73.540000000000006 111.53 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.93 -36.4 80.07 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.46 -0.941 . . . . 74.310000000000002 108.46 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -129.68 146.23 60.32 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 108.253 -1.017 . . . . 73.310000000000002 108.253 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.49 -29.03 2.54 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.153 1.902 . . . . 71.519999999999996 112.934 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 55.9 t -139.6 135.11 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 107.015 -1.476 . . . . 74.540000000000006 107.015 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.1 t -134.17 140.38 46.5 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 108.867 -0.79 . . . . 73.519999999999996 108.867 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -114.87 129.06 56.63 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.769 -1.197 . . . . 73.219999999999999 107.769 175.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.0 m -116.21 170.52 5.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 121.182 0.515 . . . . 70.450000000000003 110.607 -175.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.525 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 75.3 m -87.03 150.11 24.26 Favored 'General case' 0 N--CA 1.398 -3.066 0 CA-C-N 115.069 -0.968 . . . . 73.319999999999993 108.632 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -75.31 -41.94 55.76 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 120.922 0.391 . . . . 73.129999999999995 111.077 177.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 6.4 t -99.31 51.06 0.94 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.553 0.692 . . . . 73.230000000000004 109.743 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 10.2 tt -103.41 -20.76 5.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.466 0.651 . . . . 74.109999999999999 111.29 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.53 -75.41 2.32 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 110.584 -1.006 . . . . 44.530000000000001 110.584 -175.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 47.7 mm -132.02 127.82 58.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 107.939 -1.134 . . . . 75.150000000000006 107.939 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.472 ' HE1' ' CG2' ' A' ' 573' ' ' VAL . 0.0 OUTLIER -107.58 150.86 26.37 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.78 -1.193 . . . . 72.5 107.78 176.372 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 30.7 mt-10 -131.66 123.11 27.12 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 123.654 0.596 . . . . 74.109999999999999 111.878 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 570' ' ' THR . 58.6 t -112.17 130.22 66.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.509 -0.922 . . . . 75.230000000000004 108.509 176.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . 0.423 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 21.0 mtmm -87.39 134.87 33.52 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.43 0.633 . . . . 75.409999999999997 111.884 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.421 ' O ' HG22 ' A' ' 568' ' ' VAL . 59.0 t -105.64 127.85 60.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.805 -0.813 . . . . 73.510000000000005 108.805 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.22 124.19 22.41 Favored 'General case' 0 N--CA 1.432 -1.365 0 O-C-N 123.726 0.641 . . . . 74.400000000000006 109.725 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -72.27 158.56 35.61 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.663 -1.153 . . . . 74.150000000000006 109.417 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.437 ' HB ' ' CE2' ' A' ' 505' ' ' PHE . 2.9 t -56.01 133.1 51.53 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.429 -0.805 . . . . 73.349999999999994 109.904 175.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 5.1 m -51.17 -31.38 19.74 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.475 1.51 . . . . 72.010000000000005 111.165 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.0 95.39 0.4 Allowed Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 109.031 -1.628 . . . . 74.340000000000003 109.031 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.98 104.37 15.54 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.177 -0.675 . . . . 73.219999999999999 109.177 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -119.09 105.09 11.06 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.082 -0.508 . . . . 75.030000000000001 109.748 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 92.97 -139.24 14.52 Favored Glycine 0 N--CA 1.436 -1.356 0 O-C-N 123.747 0.655 . . . . 63.539999999999999 112.221 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.43 HD22 ' CG ' ' A' ' 561' ' ' GLU . 2.8 t-20 -126.63 129.35 48.32 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.822 -0.806 . . . . 72.140000000000001 108.822 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 65.3 t -132.44 140.28 48.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.243 -0.435 . . . . 71.209999999999994 109.889 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.455 HG12 ' CG2' ' A' ' 597' ' ' VAL . 43.4 mm -109.24 137.59 40.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.078 -0.712 . . . . 74.040000000000006 109.078 176.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.98 110.47 29.32 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 109.666 -0.494 . . . . 75.230000000000004 109.666 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.58 155.28 59.43 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.389 2.059 . . . . 74.209999999999994 112.269 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.448 ' HB3' HG23 ' A' ' 591' ' ' ILE . 39.8 p90 -151.73 161.75 42.14 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.861 -0.422 . . . . 74.200000000000003 109.861 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -154.76 151.77 29.08 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.439 0.462 . . . . 70.019999999999996 110.974 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.3 p -85.91 132.49 34.07 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.222 -0.899 . . . . 74.120000000000005 110.088 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 59.0 mt -112.02 115.41 49.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.054 -1.091 . . . . 75.299999999999997 108.054 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.03 106.28 2.31 Favored 'General case' 0 C--N 1.312 -1.035 0 O-C-N 123.369 0.418 . . . . 74.329999999999998 110.979 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -85.14 -98.75 0.69 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 108.626 -1.789 . . . . 65.25 108.626 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 38.3 p -95.25 -25.61 16.28 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.767 -1.198 . . . . 73.5 107.767 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 587' ' ' PHE . . . -75.71 128.38 35.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.545 -1.207 . . . . 72.150000000000006 107.839 175.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -109.12 159.36 16.95 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 115.287 1.588 . . . . 71.150000000000006 115.287 -171.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . 63.87 -174.2 12.18 Favored Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 112.361 -2.2 . . . . 43.409999999999997 117.454 168.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -115.97 66.86 0.3 Allowed Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 108.163 -1.975 . . . . 72.349999999999994 108.163 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 132.17 5.04 3.51 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 111.524 -0.631 . . . . 71.230000000000004 111.524 -174.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -90.85 -74.38 0.5 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.851 -0.739 . . . . 75.349999999999994 109.904 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -94.77 -35.56 12.06 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 122.218 1.009 . . . . 74.109999999999999 108.471 175.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -137.57 157.79 45.78 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.187 -1.783 . . . . 73.530000000000001 106.187 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -91.2 135.84 33.51 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.624 -1.251 . . . . 75.209999999999994 107.624 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.37 141.7 47.02 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 120.431 0.158 . . . . 73.219999999999999 110.71 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.9 t -144.12 127.42 16.76 Favored 'General case' 0 N--CA 1.408 -2.569 0 CA-C-O 122.618 1.199 . . . . 72.439999999999998 108.525 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 5.3 p -149.89 115.69 5.61 Favored 'General case' 0 C--N 1.255 -3.505 0 CA-C-N 113.78 -1.554 . . . . 72.040000000000006 108.851 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -168.35 -142.7 3.57 Favored Glycine 0 N--CA 1.408 -3.2 0 N-CA-C 109.787 -1.325 . . . . 64.439999999999998 109.787 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.451 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.2 mt-10 -143.81 147.46 34.15 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.969 0.385 . . . . 71.299999999999997 110.776 -174.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 95.6 mt -106.02 144.95 32.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.806 -0.813 . . . . 75.299999999999997 108.806 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.43 ' CG ' HD22 ' A' ' 534' ' ' ASN . 29.6 tt0 -109.98 120.46 42.54 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.041 0.448 . . . . 73.230000000000004 110.341 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -115.4 147.59 40.35 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.999 -0.741 . . . . 73.230000000000004 108.999 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -138.36 177.92 7.52 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 109.479 -0.563 . . . . 75.519999999999996 109.479 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -68.71 -37.51 79.55 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.11 -0.95 . . . . 62.32 110.392 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -92.45 -12.0 33.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.459 -0.791 . . . . 73.299999999999997 111.733 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.3 172.8 5.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.881 -0.6 . . . . 75.319999999999993 110.095 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.56 HG13 ' H ' ' A' ' 568' ' ' VAL . 5.9 pt -115.91 -82.82 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 112.671 0.619 . . . . 73.239999999999995 112.671 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.56 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.9 p -143.84 151.73 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 N-CA-C 108.88 -0.785 . . . . 75.120000000000005 108.88 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.06 156.34 24.32 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.192 0.52 . . . . 71.439999999999998 110.519 175.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.4 p -125.01 147.94 48.7 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.564 -1.198 . . . . 73.140000000000001 110.96 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.6 mp -94.94 117.04 37.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 106.437 -1.69 . . . . 74.5 106.437 171.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 572' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 521' ' ' MET . 45.2 m -93.42 115.26 27.81 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 108.498 -0.927 . . . . 70.349999999999994 108.498 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.472 ' CG2' ' HE1' ' A' ' 521' ' ' MET . 67.6 t -118.51 132.35 68.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.627 -0.509 . . . . 64.099999999999994 109.627 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -81.81 117.65 22.26 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.936 -1.135 . . . . 73.510000000000005 107.936 175.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 47.1 t -91.26 131.04 39.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 106.262 -1.755 . . . . 62.329999999999998 106.262 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 40.3 mm . . . . . 0 C--N 1.296 -1.737 0 CA-C-O 121.84 0.829 . . . . 73.450000000000003 109.528 -178.16 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp . . . . . 0 N--CA 1.432 -1.326 0 N-CA-C 109.878 -0.416 . . . . 75.540000000000006 109.878 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.7 t -141.93 143.14 33.12 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 109.025 -0.731 . . . . 75.109999999999999 109.025 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 46.7 p90 -135.76 174.65 10.38 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.154 -1.054 . . . . 74.430000000000007 108.154 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.434 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 78.2 m-85 -119.21 156.35 30.03 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 109.401 -0.592 . . . . 64.109999999999999 109.401 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.86 123.2 38.14 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 105.607 -1.997 . . . . 73.400000000000006 105.607 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.38 136.07 55.0 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.427 -0.583 . . . . 75.409999999999997 109.427 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . 0.448 HG23 ' HB3' ' A' ' 539' ' ' TYR . 26.3 pt -106.06 137.79 34.56 Favored 'Isoleucine or valine' 0 C--O 1.261 1.695 0 N-CA-C 108.305 -0.998 . . . . 74.400000000000006 108.305 175.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.22 -177.01 49.85 Favored Glycine 0 N--CA 1.418 -2.54 0 CA-C-N 115.603 -0.726 . . . . 61.100000000000001 111.447 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.7 137.94 97.3 Favored Pre-proline 0 C--N 1.303 -1.416 0 CA-C-O 120.91 0.386 . . . . 75.219999999999999 111.371 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.469 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 32.0 Cg_endo -68.39 138.84 43.67 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 122.35 2.033 . . . . 72.340000000000003 111.083 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . 0.428 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.9 ptm180 -116.21 122.52 45.26 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.035 -0.728 . . . . 73.129999999999995 109.035 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.88 131.9 46.37 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.431 -1.322 . . . . 74.25 107.431 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.455 ' CG2' HG12 ' A' ' 536' ' ' ILE . 65.4 t . . . . . 0 C--N 1.304 -1.395 0 CA-C-O 121.226 0.536 . . . . 72.430000000000007 110.667 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.47 ' HA ' ' HB1' ' A' ' 502' ' ' ALA . 57.4 Cg_endo . . . . . 0 N--CA 1.442 -1.505 0 N-CA-C 108.345 -1.444 . . . . 74.439999999999998 108.345 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.3 166.3 21.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 C-N-CA 120.452 -0.499 . . . . 74.430000000000007 110.828 -177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.13 166.55 10.96 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.206 -0.598 . . . . 74.430000000000007 112.075 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -75.72 -166.96 21.73 Favored Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 115.234 -0.893 . . . . 60.219999999999999 113.584 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -68.08 -46.81 69.98 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 122.99 0.516 . . . . 74.219999999999999 110.382 -177.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -125.34 135.24 52.25 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.968 -0.753 . . . . 72.120000000000005 108.968 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 640' ' ' THR . . . . . 0.444 ' HB ' ' CG1' ' A' ' 591' ' ' ILE . 34.7 p -130.99 85.75 2.3 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.551 0.691 . . . . 75.319999999999993 110.01 175.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . 0.461 ' HB3' ' HZ3' ' A' ' 641' ' ' LYS . 7.3 ttpm? -163.38 143.59 8.86 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.155 -0.929 . . . . 64.400000000000006 109.782 -175.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.432 HD22 HG21 ' A' ' 523' ' ' VAL . 29.6 tp -128.43 142.96 50.94 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.412 -0.958 . . . . 75.019999999999996 108.412 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -110.19 111.35 22.62 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.527 -1.286 . . . . 73.040000000000006 107.527 176.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 47.6 t -102.45 117.15 47.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.985 -0.376 . . . . 65.129999999999995 109.985 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 52.5 mt -101.87 130.87 50.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 108.626 -0.879 . . . . 75.329999999999998 108.626 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 67.5 mt -105.06 112.19 37.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.654 -0.869 . . . . 75.530000000000001 108.654 178.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--N 1.298 -1.657 0 N-CA-C 107.439 -1.319 . . . . 74.319999999999993 107.439 175.44 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 502' ' ' ALA . . . . . 0.511 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 121.195 0.522 . . . . 64.519999999999996 111.719 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 133.37 -146.63 18.53 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.023 -1.084 . . . . 75.010000000000005 111.101 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.1 mp -120.88 110.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 116.857 0.328 . . . . 75.420000000000002 111.055 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.501 ' CD2' HG21 ' A' ' 528' ' ' THR . 10.0 m-85 -90.0 131.31 35.95 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.128 -1.434 . . . . 75.200000000000003 107.128 168.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.2 t -168.77 171.38 8.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.422 -0.584 . . . . 73.340000000000003 109.422 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -77.24 148.76 35.63 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 116.062 -0.517 . . . . 74.519999999999996 110.204 177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -65.6 -32.1 73.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.387 0.613 . . . . 75.439999999999998 110.113 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -135.83 141.42 36.77 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 107.474 -1.306 . . . . 64.209999999999994 107.474 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.57 -28.21 10.19 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 122.425 2.084 . . . . 71.010000000000005 112.359 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 49.6 t -136.97 139.69 44.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 107.016 -1.476 . . . . 74.239999999999995 107.016 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.3 t -133.36 140.48 47.4 Favored 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 109.384 -0.599 . . . . 74.109999999999999 109.384 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -106.73 129.91 54.54 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.111 -1.07 . . . . 74.0 108.111 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.7 m -119.82 150.67 22.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 109.032 -0.729 . . . . 74.439999999999998 109.032 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.4 ' O ' HG22 ' A' ' 518' ' ' ILE . 9.5 t -82.76 167.57 18.02 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.762 0.792 . . . . 71.439999999999998 110.816 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -90.54 -9.24 47.94 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.419 -1.697 . . . . 73.430000000000007 106.419 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 20.5 m -121.83 24.75 9.53 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 121.175 -0.953 . . . . 63.5 110.855 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 515' ' ' SER . 8.2 tt -88.63 -32.89 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.999 0.428 . . . . 71.409999999999997 111.532 -177.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . 0.404 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 89.27 -80.08 1.56 Allowed Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 110.656 -0.978 . . . . 63.409999999999997 110.656 -176.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.1 mm -124.56 123.74 66.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.533 -0.914 . . . . 72.409999999999997 108.533 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -101.69 149.36 24.22 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 108.705 -0.85 . . . . 70.209999999999994 108.705 177.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 31.1 mt-10 -133.41 130.1 38.25 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 123.611 0.765 . . . . 75.340000000000003 110.242 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 570' ' ' THR . 38.8 t -113.9 126.35 71.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 108.265 -1.013 . . . . 75.530000000000001 108.265 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -77.84 131.16 37.43 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 124.053 0.846 . . . . 73.530000000000001 110.077 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.502 ' O ' HG21 ' A' ' 568' ' ' VAL . 46.0 t -110.46 125.44 67.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.266 -0.642 . . . . 75.329999999999998 109.266 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.7 mt -78.28 129.3 34.89 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.344 -0.844 . . . . 75.239999999999995 111.861 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' A' ' 567' ' ' ILE . 15.6 tpt180 -76.58 153.01 35.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.716 -1.129 . . . . 75.099999999999994 108.853 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 5.5 p -59.28 146.2 40.34 Favored 'General case' 0 N--CA 1.426 -1.663 0 O-C-N 123.784 0.678 . . . . 65.230000000000004 111.813 176.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 28.1 t -55.6 -28.62 56.16 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.254 1.022 . . . . 74.349999999999994 110.285 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -112.66 99.13 1.01 Allowed Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 109.037 -1.625 . . . . 71.420000000000002 109.037 172.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.97 100.98 12.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.737 -0.838 . . . . 75.120000000000005 108.737 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -120.29 116.38 25.45 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.731 -0.668 . . . . 74.519999999999996 110.054 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 68.83 -169.54 41.95 Favored Glycine 0 N--CA 1.445 -0.744 0 O-C-N 123.95 0.781 . . . . 73.319999999999993 114.399 173.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -92.51 124.21 36.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 123.249 0.62 . . . . 72.549999999999997 109.749 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 57.7 t -132.5 133.68 59.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.734 -0.839 . . . . 73.319999999999993 108.734 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 42.4 mm -107.13 132.4 54.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 109.996 -0.372 . . . . 73.450000000000003 109.996 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.12 110.21 34.77 Favored Pre-proline 0 N--CA 1.439 -1.01 0 N-CA-C 109.688 -0.486 . . . . 73.239999999999995 109.688 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 57.1 Cg_endo -75.03 158.57 42.02 Favored 'Trans proline' 0 C--N 1.334 -0.227 0 C-N-CA 122.505 2.137 . . . . 74.439999999999998 112.441 178.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.433 ' HB3' HG21 ' A' ' 591' ' ' ILE . 53.1 p90 -150.32 162.91 39.61 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.648 0.261 . . . . 73.510000000000005 110.557 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -155.33 150.32 26.69 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.605 -0.725 . . . . 75.239999999999995 110.092 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 15.0 p -83.45 134.65 34.85 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.175 -0.676 . . . . 75.200000000000003 109.175 173.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.478 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 87.1 mt -105.14 118.87 53.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.152 -1.055 . . . . 74.340000000000003 108.152 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -75.45 138.05 41.38 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 123.405 0.441 . . . . 75.239999999999995 110.029 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -138.72 -103.59 0.6 Allowed Glycine 0 CA--C 1.502 -0.757 0 N-CA-C 110.675 -0.97 . . . . 54.310000000000002 110.675 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 25.0 p -90.27 -9.06 49.32 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.88 0.848 . . . . 73.120000000000005 109.16 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -112.32 136.56 51.63 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 106.757 -1.571 . . . . 73.019999999999996 106.757 173.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 10.8 mtm-85 -108.0 149.9 27.8 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.265 0.839 . . . . 75.019999999999996 113.265 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -90.66 -147.25 18.25 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 114.71 -1.132 . . . . 73.140000000000001 111.048 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 63.54 28.33 72.28 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 111.858 -0.497 . . . . 73.030000000000001 111.858 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 71.97 24.99 75.77 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 121.61 -0.328 . . . . 74.150000000000006 112.422 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -89.92 -77.53 0.39 Allowed 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 117.508 0.654 . . . . 64.340000000000003 110.879 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -96.14 -34.67 11.6 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 108.218 -1.03 . . . . 65.5 108.218 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -144.24 159.11 43.23 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 108.254 -1.017 . . . . 74.319999999999993 108.254 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -89.1 112.24 23.17 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 104.983 -2.228 . . . . 73.200000000000003 104.983 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.0 129.47 35.32 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.545 0.688 . . . . 74.329999999999998 110.417 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 15.0 t -129.37 161.2 30.85 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 115.546 -0.752 . . . . 65.430000000000007 110.563 -171.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.6 p -151.99 161.93 41.87 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.392 -1.336 . . . . 73.340000000000003 107.392 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 165.01 -167.47 38.71 Favored Glycine 0 N--CA 1.419 -2.442 0 C-N-CA 120.103 -1.046 . . . . 54.299999999999997 110.579 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 538' ' ' PRO . 27.1 mt-10 -130.86 137.59 49.44 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 123.136 0.574 . . . . 73.109999999999999 109.614 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 94.6 mt -102.87 133.63 47.63 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.205 -0.665 . . . . 72.129999999999995 109.205 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -96.74 119.26 34.89 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.912 -0.585 . . . . 72.430000000000007 110.801 -177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -116.04 148.4 40.23 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.622 -0.881 . . . . 63.229999999999997 108.622 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.418 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 46.0 mt-30 -141.77 -172.32 3.53 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.098 -1.075 . . . . 73.420000000000002 108.098 -178.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -80.08 -28.17 39.17 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.559 -0.904 . . . . 74.150000000000006 108.559 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -84.24 -32.87 24.23 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.242 -0.89 . . . . 53.420000000000002 111.021 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.418 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 40.5 mm-40 -79.5 143.49 34.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.773 0.321 . . . . 73.120000000000005 111.38 177.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.559 ' O ' ' HB2' ' A' ' 527' ' ' ARG . 3.9 pt -112.0 -77.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 113.029 0.751 . . . . 72.219999999999999 113.029 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.534 ' H ' HG13 ' A' ' 567' ' ' ILE . 13.1 p -113.38 144.37 21.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.913 0.863 . . . . 75.409999999999997 112.171 -174.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.86 169.69 10.2 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.378 -0.828 . . . . 74.120000000000005 109.251 173.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.4 p -135.62 146.87 48.34 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 123.591 0.557 . . . . 71.409999999999997 112.443 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.2 mp -95.29 119.32 43.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.041 -1.466 . . . . 72.530000000000001 107.041 170.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 572' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 521' ' ' MET . 26.4 m -98.75 116.09 30.2 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.432 -0.581 . . . . 72.439999999999998 109.432 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.438 ' CG2' ' HE3' ' A' ' 521' ' ' MET . 89.3 t -121.6 131.45 73.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 N-CA-C 109.92 -0.4 . . . . 74.239999999999995 109.92 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.404 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 23.4 tptm -85.83 115.6 23.57 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.974 -0.75 . . . . 75.030000000000001 108.974 176.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 36.4 t -86.62 125.31 40.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.15 -1.426 . . . . 71.209999999999994 107.15 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 35.8 mm . . . . . 0 CA--C 1.494 -1.194 0 N-CA-C 108.518 -0.919 . . . . 72.329999999999998 108.518 -175.943 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 13.5 pttt . . . . . 0 CA--C 1.484 -1.577 0 N-CA-C 108.829 -0.804 . . . . 73.239999999999995 108.829 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.7 t -144.29 150.07 37.28 Favored 'General case' 0 C--N 1.279 -2.457 0 C-N-CA 119.641 -0.824 . . . . 64.439999999999998 112.243 -175.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 45.4 p90 -133.59 166.79 21.78 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 106.317 -1.735 . . . . 75.209999999999994 106.317 175.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -115.54 159.4 21.29 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 120.115 -0.634 . . . . 75.400000000000006 109.832 -175.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.09 124.71 42.46 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 106.227 -1.768 . . . . 73.299999999999997 106.227 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -122.65 129.68 52.11 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 120.961 0.41 . . . . 73.5 110.071 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . 0.433 HG21 ' HB3' ' A' ' 539' ' ' TYR . 25.2 pt -100.23 143.83 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 107.868 -1.16 . . . . 75.140000000000001 107.868 175.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -84.88 -177.31 51.01 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 111.338 -0.705 . . . . 73.319999999999993 111.338 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -78.31 129.17 75.86 Favored Pre-proline 0 N--CA 1.416 -2.13 0 CA-C-O 120.889 0.376 . . . . 72.109999999999999 110.525 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.49 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.0 Cg_endo -59.56 127.74 24.75 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.615 2.877 . . . . 74.299999999999997 112.309 -175.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -106.26 131.98 52.85 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.378 -0.601 . . . . 64.129999999999995 109.378 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -73.75 134.54 43.48 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 105.034 -2.21 . . . . 73.049999999999997 105.034 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 19.2 t . . . . . 0 C--N 1.294 -1.817 0 CA-C-O 122.287 1.041 . . . . 75.129999999999995 108.842 179.552 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.49 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 21.3 Cg_endo . . . . . 0 N--CA 1.433 -2.066 0 N-CA-C 108.096 -1.54 . . . . 75.010000000000005 108.096 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.41 167.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 120.361 -0.535 . . . . 73.109999999999999 111.287 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.87 175.57 5.45 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.013 -0.539 . . . . 64.319999999999993 112.357 -177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.18 -176.92 35.94 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.699 -0.682 . . . . 74.109999999999999 112.405 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.4 -39.94 77.66 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.985 0.422 . . . . 74.530000000000001 110.217 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -112.87 121.49 44.84 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.89 -0.595 . . . . 75.140000000000001 110.62 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 19.6 p -134.75 81.32 1.9 Allowed 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 122.149 0.976 . . . . 73.430000000000007 110.895 174.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . 0.516 ' HB3' ' HZ1' ' A' ' 641' ' ' LYS . 7.0 ttpm? -163.14 150.97 13.4 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.477 -1.305 . . . . 72.340000000000003 107.477 -175.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.429 HD23 HG12 ' A' ' 523' ' ' VAL . 27.8 tp -133.69 139.85 46.67 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 108.334 -0.988 . . . . 71.230000000000004 108.334 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.84 114.5 28.68 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.079 -1.452 . . . . 72.239999999999995 107.079 174.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 41.1 t -103.49 110.03 28.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 109.12 -0.696 . . . . 71.109999999999999 109.12 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 47.2 mt -96.65 120.8 46.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 109.413 -0.588 . . . . 74.219999999999999 109.413 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 63.4 mt -97.2 113.99 33.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 107.631 -1.248 . . . . 75.299999999999997 107.631 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 C--N 1.283 -2.3 0 N-CA-C 105.248 -2.13 . . . . 74.319999999999993 105.248 173.107 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 502' ' ' ALA . . . . . 0.5 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.435 -1.191 0 N-CA-C 109.715 -0.476 . . . . 75.230000000000004 109.715 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.432 ' C ' HG22 ' A' ' 528' ' ' THR . . . -178.12 -166.37 34.41 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.814 -0.914 . . . . 65.420000000000002 110.814 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.5 mp -112.6 128.81 69.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 123.521 0.729 . . . . 73.450000000000003 110.928 -173.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.564 ' CE2' HG21 ' A' ' 528' ' ' THR . 41.7 m-85 -102.13 139.75 37.34 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.725 -0.472 . . . . 72.140000000000001 109.725 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.0 t -169.89 175.99 4.95 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.056 -1.09 . . . . 74.450000000000003 108.056 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -80.96 154.92 26.69 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 117.988 0.358 . . . . 74.010000000000005 110.734 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.92 -41.8 77.69 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.852 -0.613 . . . . 52.140000000000001 109.5 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -121.93 146.48 46.27 Favored Pre-proline 0 N--CA 1.417 -2.081 0 N-CA-C 108.376 -0.972 . . . . 75.420000000000002 108.376 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -77.63 -23.51 9.68 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.547 1.498 . . . . 74.120000000000005 111.249 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.0 t -141.01 132.92 29.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 107.764 -1.199 . . . . 62.119999999999997 107.764 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.7 t -126.46 139.73 53.02 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.633 -0.877 . . . . 74.329999999999998 108.633 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -108.24 118.03 35.71 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.228 -1.027 . . . . 74.430000000000007 108.228 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.64 153.94 17.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 121.138 0.494 . . . . 75.439999999999998 110.156 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.486 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 65.3 m -79.49 152.91 29.96 Favored 'General case' 0 N--CA 1.42 -1.928 0 C-N-CA 124.391 1.076 . . . . 53.43 111.133 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 517' ' ' SER . 15.6 pt-20 -63.14 -49.89 72.61 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 120.954 0.407 . . . . 74.129999999999995 111.167 177.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 517' ' ' SER . . . . . 0.492 ' N ' ' HG3' ' A' ' 516' ' ' GLU . 52.5 m -109.34 69.21 0.7 Allowed 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.962 0.887 . . . . 73.109999999999999 110.108 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 13.3 tt -110.64 -27.24 2.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.058 -0.973 . . . . 74.540000000000006 110.836 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 90.63 -70.76 2.1 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.561 -0.828 . . . . 63.030000000000001 111.55 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.9 mm -135.42 125.07 42.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.049 -0.723 . . . . 73.519999999999996 109.049 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.476 ' SD ' HG21 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -108.09 150.06 27.67 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.898 -1.149 . . . . 75.040000000000006 107.898 176.436 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.8 mt-10 -129.56 121.75 27.78 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.588 0.708 . . . . 72.140000000000001 112.767 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 570' ' ' THR . 99.4 t -110.06 131.43 61.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.101 -0.954 . . . . 74.230000000000004 109.086 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -89.97 136.44 33.04 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.678 0.751 . . . . 72.219999999999999 111.931 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 47.3 t -105.54 124.53 60.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 114.649 -1.16 . . . . 72.519999999999996 108.109 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.4 mt -70.74 127.21 31.89 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 123.759 0.662 . . . . 71.109999999999999 110.703 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -74.7 162.55 28.61 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.426 -1.261 . . . . 73.409999999999997 110.346 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.564 HG21 ' CE2' ' A' ' 505' ' ' PHE . 1.0 OUTLIER -55.83 139.05 46.92 Favored 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 124.892 1.277 . . . . 73.340000000000003 111.852 177.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 4.0 m -51.5 -37.8 50.91 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 125.434 1.494 . . . . 74.349999999999994 110.188 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -124.8 96.2 0.51 Allowed Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 108.701 -1.76 . . . . 55.329999999999998 108.701 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.18 107.95 17.48 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.945 -0.761 . . . . 74.319999999999993 108.945 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -124.51 108.09 11.75 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.034 -0.53 . . . . 72.400000000000006 109.898 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 89.69 -132.0 11.03 Favored Glycine 0 C--N 1.312 -0.761 0 C-N-CA 120.36 -0.924 . . . . 73.329999999999998 112.665 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -133.39 131.68 40.31 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 123.212 0.605 . . . . 74.299999999999997 109.492 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.0 t -132.55 143.72 38.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 123.631 0.772 . . . . 74.019999999999996 109.313 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.565 HG12 ' CG2' ' A' ' 597' ' ' VAL . 33.8 mm -112.56 132.1 62.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.891 -0.781 . . . . 73.319999999999993 108.891 173.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 25.7 t -120.67 110.3 35.45 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 109.019 -0.734 . . . . 75.129999999999995 109.019 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -74.7 158.38 43.38 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.221 1.947 . . . . 75.120000000000005 111.578 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.437 ' HB3' HG23 ' A' ' 591' ' ' ILE . 54.5 p90 -146.34 170.22 17.24 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 122.202 -0.311 . . . . 75.340000000000003 111.173 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -158.17 150.92 22.49 Favored 'General case' 0 C--O 1.245 0.822 0 O-C-N 123.614 0.571 . . . . 74.150000000000006 110.874 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.0 p -90.5 131.55 36.18 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.897 -0.592 . . . . 75.420000000000002 109.746 172.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 91.5 mt -105.08 116.14 48.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 109.169 -0.678 . . . . 74.230000000000004 109.169 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -75.66 103.35 5.73 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.54 -0.911 . . . . 75.019999999999996 108.54 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -113.8 -83.71 1.22 Allowed Glycine 0 CA--C 1.481 -2.086 0 C-N-CA 119.442 -1.361 . . . . 74.099999999999994 112.188 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.3 m -109.98 32.53 5.03 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 108.652 -0.869 . . . . 75.430000000000007 108.652 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -158.23 149.0 20.59 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.093 -0.958 . . . . 63.130000000000003 108.894 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 26.8 mtm180 -81.28 116.99 21.41 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.569 0.7 . . . . 74.219999999999999 112.522 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.29 -167.18 42.6 Favored Glycine 0 N--CA 1.437 -1.248 0 CA-C-N 115.27 -0.877 . . . . 64.329999999999998 111.515 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.7 20.01 79.76 Favored Glycine 0 C--N 1.312 -0.805 0 C-N-CA 120.805 -0.712 . . . . 61.130000000000003 111.841 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.0 43.95 6.93 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 120.45 -0.881 . . . . 70.510000000000005 111.959 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -118.0 -61.24 1.71 Allowed 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 119.453 -0.899 . . . . 43.32 109.961 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -99.36 -34.81 10.15 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 107.073 -1.454 . . . . 54.210000000000001 107.073 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -143.29 152.04 41.21 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.847 -1.168 . . . . 75.349999999999994 107.847 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -84.89 142.06 29.97 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.677 -1.231 . . . . 74.510000000000005 107.677 177.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -82.11 139.2 34.53 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.723 -0.843 . . . . 75.200000000000003 108.723 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.1 t -148.02 152.47 37.49 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.569 0.699 . . . . 74.230000000000004 110.458 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 25.6 p -156.11 169.48 24.4 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.964 -1.495 . . . . 73.540000000000006 106.964 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 159.75 -164.84 34.35 Favored Glycine 0 N--CA 1.419 -2.473 0 N-CA-C 110.106 -1.198 . . . . 65.430000000000007 110.106 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.409 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 43.4 mt-10 -131.75 130.65 42.17 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 123.845 0.379 . . . . 73.109999999999999 110.627 -176.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.414 HD22 ' HB3' ' A' ' 569' ' ' LYS . 86.4 mt -100.12 132.79 45.28 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.377 -0.601 . . . . 71.200000000000003 109.377 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -99.17 121.01 40.45 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.648 -0.705 . . . . 74.109999999999999 110.708 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -118.36 151.96 36.74 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.185 -0.672 . . . . 75.510000000000005 109.185 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.558 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 50.5 mt-30 -149.51 -177.49 5.89 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.054 -0.721 . . . . 74.310000000000002 109.054 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -70.68 -37.65 73.66 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.06 -1.459 . . . . 62.409999999999997 107.06 171.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.66 -48.43 16.81 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.361 -1.29 . . . . 63.310000000000002 111.881 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.558 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 27.9 mm-40 -58.99 133.55 56.19 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 123.829 0.852 . . . . 72.430000000000007 111.392 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.557 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.1 pt -85.14 -81.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 112.723 0.638 . . . . 53.420000000000002 112.723 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.557 ' H ' HG13 ' A' ' 567' ' ' ILE . 7.6 p -134.44 160.96 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 108.907 -0.775 . . . . 71.219999999999999 108.907 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.414 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -126.6 159.6 33.07 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.767 0.317 . . . . 72.439999999999998 110.299 176.263 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.1 p -127.95 148.86 50.52 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.118 -0.946 . . . . 65.109999999999999 112.007 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.3 mp -99.32 127.94 51.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 106.7 -1.593 . . . . 71.450000000000003 106.7 172.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 17.0 m -100.96 115.13 29.73 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.693 -0.855 . . . . 71.319999999999993 108.693 178.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.441 ' CG2' ' HE3' ' A' ' 521' ' ' MET . 96.9 t -117.51 130.0 73.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 120.7 -0.4 . . . . 75.5 110.659 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 16.2 tppt? -79.13 120.76 24.12 Favored 'General case' 0 N--CA 1.437 -1.102 0 O-C-N 124.037 0.835 . . . . 75.120000000000005 109.282 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 55.7 t -94.32 128.12 45.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 107.284 -1.376 . . . . 72.319999999999993 107.284 176.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 24.5 mm . . . . . 0 C--N 1.298 -1.64 0 N-CA-C 109.334 -0.617 . . . . 72.5 109.334 -175.128 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 N--CA 1.432 -1.372 0 CA-C-O 120.46 0.171 . . . . 73.439999999999998 110.6 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 7.5 t -152.88 135.07 14.92 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-O 121.375 0.607 . . . . 74.230000000000004 110.933 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 42.8 p90 -126.84 174.17 9.0 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.57 -1.27 . . . . 73.510000000000005 107.57 178.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.506 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 59.0 m-85 -119.83 151.6 38.6 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 109.267 -0.642 . . . . 75.239999999999995 109.267 -176.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.81 130.82 54.13 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 105.083 -2.191 . . . . 75.329999999999998 105.083 176.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -132.25 144.3 50.52 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.075 -0.713 . . . . 74.120000000000005 109.075 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . 0.437 HG23 ' HB3' ' A' ' 539' ' ' TYR . 13.0 pt -107.43 155.24 8.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.069 -0.715 . . . . 75.439999999999998 109.069 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -100.25 -174.68 30.13 Favored Glycine 0 C--N 1.295 -1.721 0 C-N-CA 121.055 -0.593 . . . . 73.230000000000004 112.035 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -61.91 126.96 88.42 Favored Pre-proline 0 C--N 1.313 -0.992 0 C-N-CA 123.198 0.599 . . . . 71.200000000000003 112.1 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -70.0 118.67 5.82 Favored 'Trans proline' 0 N--CA 1.428 -2.351 0 C-N-CA 122.175 1.917 . . . . 75.010000000000005 110.311 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -104.3 119.56 39.24 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.15 -0.932 . . . . 74.140000000000001 109.328 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.8 129.27 40.2 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.922 -1.14 . . . . 72.109999999999999 107.922 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.565 ' CG2' HG12 ' A' ' 536' ' ' ILE . 45.0 t . . . . . 0 C--N 1.292 -1.935 0 N-CA-C 108.82 -0.808 . . . . 73.439999999999998 108.82 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.5 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 43.6 Cg_endo . . . . . 0 N--CA 1.447 -1.215 0 N-CA-C 108.934 -1.218 . . . . 64.200000000000003 108.934 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.03 161.17 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 109.686 -0.487 . . . . 74.530000000000001 109.686 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.424 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.6 OUTLIER -101.33 165.95 11.0 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 119.72 -0.792 . . . . 74.349999999999994 111.175 176.323 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.85 -172.19 29.23 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 115.654 -0.703 . . . . 75.340000000000003 114.645 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -67.93 -41.66 82.21 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.371 -0.915 . . . . 72.519999999999996 109.392 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -125.99 127.47 45.96 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.279 -0.873 . . . . 74.319999999999993 109.132 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 640' ' ' THR . . . . . 0.424 HG21 ' HB2' ' A' ' 636' ' ' LEU . 16.8 p -130.27 89.93 2.86 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.429 -0.582 . . . . 74.409999999999997 109.429 175.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . 0.575 ' HZ1' ' HB2' ' A' ' 641' ' ' LYS . 4.2 ttmp? -170.37 139.09 1.64 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.444 -0.798 . . . . 73.040000000000006 109.468 -175.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.465 HD23 HG11 ' A' ' 523' ' ' VAL . 28.0 tp -120.41 131.0 54.6 Favored 'General case' 0 C--N 1.273 -2.725 0 CA-C-N 114.985 -1.007 . . . . 73.209999999999994 109.06 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -93.87 110.8 22.44 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.52 -1.659 . . . . 74.319999999999993 106.52 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 43.7 t -101.6 110.37 28.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.914 -0.773 . . . . 74.219999999999999 108.914 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 67.1 mt -97.95 124.22 50.86 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 N-CA-C 108.819 -0.808 . . . . 74.400000000000006 108.819 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 54.2 mt -100.2 103.36 14.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 106.876 -1.527 . . . . 70.239999999999995 106.876 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 . . . . . 0 C--N 1.285 -2.216 0 CA-C-N 115.885 -0.598 . . . . 73.209999999999994 109.545 -176.531 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.534 0 N-CA-C 108.196 -1.039 . . . . 62.109999999999999 108.196 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.448 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . 160.36 -148.5 16.86 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.085 -1.206 . . . . 65.099999999999994 110.085 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.409 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.7 mp -123.3 130.02 74.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 117.131 0.466 . . . . 72.540000000000006 110.75 -174.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.418 ' H ' ' HA ' ' A' ' 636' ' ' LEU . 57.4 m-85 -112.24 136.48 51.61 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.47 -0.937 . . . . 74.329999999999998 108.47 169.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.2 t -170.71 -179.34 2.86 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.787 -0.82 . . . . 61.109999999999999 108.787 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -83.62 155.45 23.22 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 110.308 -0.256 . . . . 75.319999999999993 110.308 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.09 -45.25 85.99 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.551 -1.278 . . . . 51.32 107.551 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.74 146.14 51.93 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 108.606 -0.887 . . . . 74.0 108.606 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.91 -17.35 15.57 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.801 1.667 . . . . 74.040000000000006 111.949 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 58.4 t -141.64 127.74 19.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 107.92 -1.141 . . . . 73.450000000000003 107.92 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 13.8 t -123.65 140.54 52.89 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 109.398 -0.593 . . . . 73.030000000000001 109.398 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -109.52 119.33 39.1 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.977 -0.556 . . . . 75.340000000000003 109.705 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.2 m -115.74 162.28 13.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.809 -0.812 . . . . 75.319999999999993 108.809 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.558 ' O ' HG23 ' A' ' 518' ' ' ILE . 12.1 t -87.55 149.77 24.14 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.533 0.682 . . . . 71.120000000000005 111.157 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -60.98 -29.56 69.76 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 124.941 1.296 . . . . 71.409999999999997 109.166 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 32.1 t -116.53 26.02 10.18 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.758 -0.655 . . . . 70.450000000000003 111.231 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 515' ' ' SER . 7.9 tt -80.21 -30.28 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 119.437 -0.905 . . . . 71.299999999999997 111.026 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 88.31 -76.91 1.88 Allowed Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 119.89 -1.148 . . . . 73.519999999999996 111.335 -177.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.1 mm -123.63 124.98 70.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.139 -1.06 . . . . 74.239999999999995 108.139 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.478 ' SD ' HG21 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -109.89 147.66 32.98 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 108.451 -0.944 . . . . 72.409999999999997 108.451 177.536 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.598 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 39.3 mt-10 -123.54 134.03 53.91 Favored 'General case' 0 CA--C 1.497 -1.088 0 O-C-N 123.846 0.717 . . . . 73.109999999999999 111.198 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 570' ' ' THR . 66.7 t -118.69 125.1 74.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 107.931 -1.137 . . . . 75.510000000000005 107.931 176.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . 0.416 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 36.1 mtmt -86.81 133.15 33.67 Favored 'General case' 0 N--CA 1.427 -1.617 0 O-C-N 123.638 0.586 . . . . 72.019999999999996 110.205 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 39.4 t -101.56 120.9 51.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.301 -0.999 . . . . 74.010000000000005 108.301 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.31 129.05 38.62 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 124.029 0.83 . . . . 74.150000000000006 110.169 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -85.09 158.89 20.3 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.635 -1.166 . . . . 73.439999999999998 109.18 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.448 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 1.6 t -56.22 147.57 20.45 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.725 1.21 . . . . 74.239999999999995 112.854 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.9 t -59.23 -35.43 73.63 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.696 1.199 . . . . 75.219999999999999 109.089 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.76 98.13 0.63 Allowed Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 109.13 -1.588 . . . . 75.420000000000002 109.13 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.36 103.91 16.55 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 109.36 -0.607 . . . . 74.519999999999996 109.36 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -123.53 119.86 31.19 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 116.077 -0.511 . . . . 71.409999999999997 110.557 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 87.19 -136.61 14.08 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.277 -0.874 . . . . 75.430000000000007 112.948 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -133.17 126.58 31.97 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.061 -1.088 . . . . 73.140000000000001 108.061 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 61.0 t -131.55 133.66 61.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.074 -0.713 . . . . 73.310000000000002 109.074 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.551 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 37.3 mm -104.73 136.06 39.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 109.096 -0.705 . . . . 74.340000000000003 109.096 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 40.5 t -120.93 108.32 36.86 Favored Pre-proline 0 C--N 1.306 -1.289 0 N-CA-C 109.948 -0.39 . . . . 63.049999999999997 109.948 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.2 156.95 50.9 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.567 2.178 . . . . 70.109999999999999 111.943 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -153.83 161.41 42.07 Favored 'General case' 0 C--O 1.25 1.11 0 N-CA-C 110.212 -0.292 . . . . 73.120000000000005 110.212 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -153.81 154.05 33.26 Favored 'General case' 0 C--O 1.25 1.111 0 O-C-N 123.657 0.598 . . . . 75.310000000000002 110.805 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.8 p -87.14 136.5 32.9 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.321 -0.854 . . . . 71.530000000000001 110.966 175.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.47 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 69.7 mt -109.92 123.92 66.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.108 -1.071 . . . . 75.219999999999999 108.108 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -76.23 105.82 7.5 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.855 -0.424 . . . . 75.239999999999995 109.855 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -90.2 -119.64 2.03 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 109.844 -1.302 . . . . 71.439999999999998 109.844 177.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 13.4 t -86.16 -5.93 59.1 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.905 0.86 . . . . 74.430000000000007 109.311 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -97.75 137.28 36.87 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.578 -1.267 . . . . 74.129999999999995 107.578 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.533 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 76.5 mtm180 -86.26 137.07 32.89 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 123.738 0.815 . . . . 74.109999999999999 111.353 -176.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -91.83 -164.49 38.79 Favored Glycine 0 C--N 1.29 -2.0 0 CA-C-N 115.36 -0.836 . . . . 71.109999999999999 111.644 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.71 14.32 79.91 Favored Glycine 0 C--N 1.305 -1.165 0 CA-C-O 120.07 -0.295 . . . . 75.129999999999995 113.345 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 88.25 24.66 33.51 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.059 -0.816 . . . . 65.129999999999995 111.059 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.533 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 17.5 tt0 -96.39 -56.85 2.48 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.335 -0.617 . . . . 75.329999999999998 109.335 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -111.59 -33.07 6.47 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 108.579 -0.897 . . . . 75.420000000000002 108.579 171.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -140.32 149.8 43.2 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 108.302 -0.999 . . . . 75.530000000000001 108.302 175.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -88.93 123.71 33.54 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 106.18 -1.785 . . . . 73.310000000000002 106.18 177.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -67.87 154.01 42.49 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 112.643 0.609 . . . . 71.140000000000001 112.643 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.7 t -147.72 139.4 23.93 Favored 'General case' 0 N--CA 1.406 -2.628 0 CA-C-O 121.725 0.774 . . . . 63.329999999999998 108.934 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.6 p -148.88 143.81 26.49 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 107.197 -1.409 . . . . 65.120000000000005 107.197 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 161.63 -158.79 30.66 Favored Glycine 0 N--CA 1.413 -2.871 0 C-N-CA 119.69 -1.243 . . . . 72.510000000000005 110.57 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.551 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.7 mt-10 -137.28 140.13 41.38 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 120.784 0.325 . . . . 74.030000000000001 110.967 -174.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.5 139.31 36.37 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.418 0.687 . . . . 74.400000000000006 109.769 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.418 ' HA ' HD13 ' A' ' 536' ' ' ILE . 33.1 tt0 -100.85 110.02 22.04 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.167 0.508 . . . . 64.450000000000003 111.516 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -107.44 148.7 28.8 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.891 -0.595 . . . . 75.420000000000002 109.496 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.459 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 43.9 mt-30 -144.1 -177.28 5.37 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.734 -0.839 . . . . 71.030000000000001 108.734 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.88 -38.28 82.85 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 124.092 0.87 . . . . 74.219999999999999 108.655 177.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -85.25 -38.01 19.4 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.414 -0.812 . . . . 73.299999999999997 111.786 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.459 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 47.0 mm-40 -60.82 135.48 57.79 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.902 0.481 . . . . 65.340000000000003 112.079 -178.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.56 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.6 pt -78.51 -83.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 113.929 1.085 . . . . 74.109999999999999 113.929 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.56 ' H ' HG13 ' A' ' 567' ' ' ILE . 13.3 p -143.05 150.72 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.57 -0.9 . . . . 64.540000000000006 108.57 -177.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 524' ' ' LYS . 5.3 mmpt? -113.15 159.57 19.12 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.884 0.373 . . . . 74.329999999999998 110.134 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.1 p -128.87 147.39 50.82 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.159 -0.928 . . . . 74.439999999999998 112.088 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.8 mp -99.86 126.59 53.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 106.773 -1.565 . . . . 75.540000000000006 106.773 171.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 11.3 p -100.7 115.53 30.47 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.004 -0.739 . . . . 74.150000000000006 109.004 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 60.9 t -119.2 130.19 74.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 109.846 -0.427 . . . . 73.319999999999993 109.846 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 15.8 tppt? -82.87 122.13 27.84 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 123.731 0.645 . . . . 72.25 109.969 176.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 89.8 t -89.15 123.22 41.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 107.967 -1.123 . . . . 73.540000000000006 107.967 176.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 33.7 mm . . . . . 0 C--N 1.304 -1.391 0 CA-C-O 121.293 0.568 . . . . 75.120000000000005 109.604 -179.122 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . 0.478 ' HB2' ' HB ' ' A' ' 646' ' ' ILE . 35.7 mmtp . . . . . 0 C--O 1.215 -0.754 0 N-CA-C 108.951 -0.759 . . . . 75.519999999999996 108.951 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 10.0 t -149.97 144.94 26.17 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.494 -0.482 . . . . 64.340000000000003 109.974 176.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 47.8 p90 -140.46 175.88 9.24 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.621 -1.251 . . . . 75.239999999999995 107.621 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -122.6 153.97 38.59 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.451 -0.5 . . . . 74.450000000000003 110.601 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.53 128.25 51.84 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 106.316 -1.735 . . . . 73.150000000000006 106.316 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -124.57 131.79 53.47 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.807 -0.812 . . . . 74.319999999999993 108.807 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 17.8 pt -100.5 147.15 8.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.794 -0.817 . . . . 65.310000000000002 108.794 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.59 172.97 39.81 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 109.925 -1.27 . . . . 75.239999999999995 109.925 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.0 131.79 88.86 Favored Pre-proline 0 N--CA 1.426 -1.664 0 C-N-CA 120.665 -0.414 . . . . 72.030000000000001 110.838 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.431 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.2 Cg_endo -59.57 136.84 73.82 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.317 2.678 . . . . 72.349999999999994 112.03 -176.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . 0.41 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 3.1 ptm180 -116.63 125.09 51.28 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.305 -0.861 . . . . 74.140000000000001 110.152 -177.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -70.19 136.34 49.94 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.09 -1.078 . . . . 73.219999999999999 108.09 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.534 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.3 t . . . . . 0 C--N 1.305 -1.367 0 CA-C-O 121.649 0.738 . . . . 72.319999999999993 110.873 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.431 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 23.3 Cg_endo . . . . . 0 CA--C 1.512 -0.581 0 CA-C-O 120.541 0.142 . . . . 64.450000000000003 112.395 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 3.1 pt -124.07 177.5 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 0 CA-C-O 120.937 0.399 . . . . 73.409999999999997 110.03 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.418 ' HA ' ' H ' ' A' ' 505' ' ' PHE . 0.8 OUTLIER -113.86 174.52 5.89 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 115.665 -0.698 . . . . 72.019999999999996 112.322 177.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . 0.409 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -74.31 174.13 50.29 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 115.415 -0.811 . . . . 70.349999999999994 113.923 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -66.79 -34.47 77.89 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 124.033 0.933 . . . . 71.420000000000002 110.408 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -124.06 121.48 35.3 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.33 -0.618 . . . . 73.420000000000002 109.33 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 7.8 p -134.78 95.4 3.33 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.752 -0.658 . . . . 74.120000000000005 110.013 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . 0.446 ' HB2' ' HZ2' ' A' ' 641' ' ' LYS . 4.3 ttmp? -166.54 143.34 4.88 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.75 -1.204 . . . . 75.510000000000005 107.75 -177.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.432 HD21 HG23 ' A' ' 523' ' ' VAL . 26.7 tp -129.66 116.16 18.42 Favored 'General case' 0 N--CA 1.417 -2.084 0 O-C-N 123.825 0.703 . . . . 75.129999999999995 109.668 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -87.18 110.61 20.27 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.604 -1.628 . . . . 75.109999999999999 106.604 173.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 55.8 t -99.19 107.76 21.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.736 -0.838 . . . . 73.200000000000003 108.736 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 27.8 mt -99.28 121.47 49.94 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 N-CA-C 108.42 -0.956 . . . . 73.349999999999994 108.42 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 585' ' ' LYS . 62.6 mt -97.46 107.55 20.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.165 -1.42 . . . . 74.319999999999993 107.165 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 C--N 1.295 -1.77 0 N-CA-C 108.408 -0.96 . . . . 71.319999999999993 108.408 -179.168 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 502' ' ' ALA . . . . . 0.436 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.41 -2.441 0 CA-C-O 121.174 0.512 . . . . 71.319999999999993 109.951 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -103.43 -114.72 3.97 Favored Glycine 0 C--N 1.278 -2.657 0 CA-C-N 114.672 -1.149 . . . . 50.25 112.955 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.81 127.69 70.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.219 -0.491 . . . . 72.230000000000004 110.573 -173.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -117.03 123.14 46.14 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.729 -1.211 . . . . 74.400000000000006 107.729 170.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.3 t -167.63 177.65 5.76 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.552 -0.536 . . . . 74.319999999999993 109.552 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -85.77 150.74 24.36 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.886 -0.412 . . . . 74.209999999999994 109.886 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 44.1 mt-10 -66.54 -34.03 77.0 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.348 0.594 . . . . 74.150000000000006 110.18 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -132.21 145.61 58.06 Favored Pre-proline 0 N--CA 1.421 -1.909 0 CA-C-N 114.959 -1.019 . . . . 74.120000000000005 108.499 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.0 -29.29 3.36 Favored 'Trans proline' 0 C--N 1.327 -0.557 0 C-N-CA 122.151 1.9 . . . . 62.340000000000003 112.127 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 26.0 t -134.92 131.79 53.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 107.909 -1.145 . . . . 72.310000000000002 107.909 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 15.3 t -126.68 136.43 52.46 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 109.42 -0.585 . . . . 72.25 109.42 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -109.98 109.42 20.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.793 0.806 . . . . 73.230000000000004 109.297 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.7 m -104.77 151.69 7.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 115.636 -0.711 . . . . 75.430000000000007 110.309 -175.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.462 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 67.4 m -79.56 155.06 28.34 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 115.349 -0.842 . . . . 74.310000000000002 110.328 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -67.08 -62.45 1.42 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.525 0.679 . . . . 71.400000000000006 111.068 176.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.3 m -79.09 26.85 0.25 Allowed 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.709 0.803 . . . . 74.040000000000006 112.666 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 12.8 tt -79.92 -27.91 12.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 122.021 -0.425 . . . . 72.129999999999995 110.509 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 89.2 -74.78 1.96 Allowed Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 110.467 -1.053 . . . . 73.439999999999998 110.467 -177.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.3 mm -129.41 122.88 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 108.425 -0.954 . . . . 75.109999999999999 108.425 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.472 ' HE3' ' CG2' ' A' ' 573' ' ' VAL . 0.0 OUTLIER -103.37 147.51 27.02 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.695 -1.594 . . . . 65.420000000000002 106.695 175.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 35.1 mt-10 -133.64 128.26 34.71 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 123.655 0.597 . . . . 70.439999999999998 111.175 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.44 HG23 HD21 ' A' ' 642' ' ' LEU . 59.9 t -116.36 124.21 72.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 106.831 -1.544 . . . . 73.349999999999994 106.831 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . 0.461 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 29.1 mtmm -84.65 139.88 31.74 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.071 0.462 . . . . 74.450000000000003 110.187 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 43.9 t -107.46 126.56 63.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 115.638 -0.71 . . . . 72.150000000000006 109.173 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.25 116.84 7.01 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 123.998 0.811 . . . . 75.420000000000002 110.093 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -77.79 150.53 34.28 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.022 -0.99 . . . . 73.439999999999998 109.96 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.3 t -55.34 132.93 49.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 124.904 1.282 . . . . 75.109999999999999 111.84 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 44.9 t -54.01 -35.5 61.98 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.538 1.135 . . . . 72.030000000000001 109.32 173.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -107.45 85.52 0.42 Allowed Glycine 0 N--CA 1.42 -2.403 0 N-CA-C 109.641 -1.384 . . . . 72.450000000000003 109.641 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.93 109.77 18.97 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.261 -1.015 . . . . 70.530000000000001 108.261 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -112.73 106.68 15.1 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.119 -0.491 . . . . 73.420000000000002 110.589 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 73.1 -116.76 5.67 Favored Glycine 0 N--CA 1.434 -1.47 0 CA-C-N 115.678 -0.692 . . . . 75.019999999999996 112.457 175.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -133.17 127.05 33.0 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.276 -0.638 . . . . 64.140000000000001 109.276 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.05 137.55 55.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.924 -0.769 . . . . 72.519999999999996 108.924 -177.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 36.4 mm -107.84 135.04 47.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.265 -0.643 . . . . 75.329999999999998 109.265 177.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 57.3 t -120.51 109.8 36.18 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.391 -0.596 . . . . 71.349999999999994 109.391 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -71.43 153.72 60.83 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.993 1.795 . . . . 72.120000000000005 111.338 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -150.97 155.71 39.66 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.958 -0.756 . . . . 74.239999999999995 108.958 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.8 152.93 30.42 Favored 'General case' 0 C--O 1.254 1.335 0 O-C-N 123.807 0.692 . . . . 72.010000000000005 112.354 177.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.6 p -82.83 134.06 35.11 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.471 -0.786 . . . . 64.430000000000007 110.024 174.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 70.8 mt -108.72 113.92 45.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 107.316 -1.364 . . . . 72.329999999999998 107.316 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.54 132.54 47.12 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.165 0.507 . . . . 71.540000000000006 111.638 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -124.1 -114.74 2.11 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 108.408 -1.877 . . . . 63.32 108.408 177.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 45.6 p -80.36 -23.89 40.18 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 122.084 0.945 . . . . 75.430000000000007 108.736 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -82.8 128.99 34.91 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 114.396 -1.275 . . . . 71.310000000000002 108.766 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.3 mtm105 -88.6 135.13 33.65 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 124.066 0.854 . . . . 74.239999999999995 110.651 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -83.42 -152.07 12.21 Favored Glycine 0 C--N 1.297 -1.619 0 CA-C-N 115.232 -0.895 . . . . 70.109999999999999 111.916 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 62.17 22.97 63.57 Favored Glycine 0 C--N 1.308 -0.978 0 N-CA-C 114.796 0.679 . . . . 73.140000000000001 114.796 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 79.54 22.4 64.67 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.307 -0.949 . . . . 61.399999999999999 111.533 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -96.62 -62.83 1.21 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.996 -0.372 . . . . 74.420000000000002 109.996 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -98.77 -42.69 7.09 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 107.196 -1.409 . . . . 75.420000000000002 107.196 171.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -137.76 149.88 46.79 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 114.911 -1.04 . . . . 72.439999999999998 108.677 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.401 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 0.7 OUTLIER -76.69 122.65 25.0 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.678 -1.601 . . . . 65.120000000000005 106.678 173.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -74.71 117.99 17.16 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.244 -0.435 . . . . 70.530000000000001 111.234 -173.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.1 t -121.04 138.83 53.99 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 122.517 1.151 . . . . 74.340000000000003 111.664 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 12.2 p -145.54 143.52 30.0 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 105.606 -1.998 . . . . 74.129999999999995 105.606 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 176.13 -155.25 18.84 Favored Glycine 0 N--CA 1.413 -2.873 0 C-N-CA 119.278 -1.439 . . . . 73.129999999999995 110.746 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.526 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 51.4 mt-10 -143.69 129.93 19.79 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 123.985 0.462 . . . . 62.229999999999997 110.582 -175.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 98.1 mt -92.51 140.77 29.22 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.937 -0.764 . . . . 72.530000000000001 108.937 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.404 ' HA ' HD13 ' A' ' 536' ' ' ILE . 27.1 tt0 -105.09 113.35 26.9 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.842 -0.429 . . . . 73.519999999999996 109.842 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -111.11 142.65 43.0 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.272 -0.64 . . . . 75.219999999999999 109.272 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -133.88 176.28 8.71 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.67 -0.493 . . . . 75.319999999999993 109.67 177.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -67.16 -37.51 83.87 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 124.464 1.102 . . . . 72.049999999999997 111.676 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -92.11 -13.92 30.0 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.707 -0.678 . . . . 54.450000000000003 112.035 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -73.59 167.49 21.23 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.422 0.527 . . . . 75.319999999999993 112.422 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.551 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.3 pt -105.27 -85.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 113.245 0.831 . . . . 73.439999999999998 113.245 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.551 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.3 p -142.96 153.24 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 109.338 -0.616 . . . . 73.340000000000003 109.338 -174.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -115.79 160.76 19.7 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.989 -0.374 . . . . 75.310000000000002 109.989 177.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.461 ' CG2' ' HG2' ' A' ' 524' ' ' LYS . 4.4 p -126.82 145.59 50.58 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.617 -0.719 . . . . 70.510000000000005 111.026 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 1.9 mp -94.11 114.7 31.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 105.36 -2.089 . . . . 73.430000000000007 105.36 170.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 16.5 m -94.33 115.21 27.4 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.232 -1.025 . . . . 75.299999999999997 108.232 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.472 ' CG2' ' HE3' ' A' ' 521' ' ' MET . 98.5 t -117.06 127.67 74.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.268 -0.642 . . . . 73.150000000000006 109.268 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 24.2 tptm -78.21 107.58 10.9 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.389 -0.967 . . . . 74.120000000000005 108.389 175.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 45.9 t -85.38 124.74 40.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 106.24 -1.763 . . . . 65.049999999999997 106.24 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 29.8 mm . . . . . 0 C--N 1.291 -1.952 0 CA-C-O 122.035 0.921 . . . . 75.409999999999997 111.648 -173.652 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp . . . . . 0 CA--C 1.483 -1.6 0 N-CA-C 110.339 -0.245 . . . . 63.140000000000001 110.339 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 2.9 t -141.82 142.57 33.17 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 120.185 -0.606 . . . . 74.150000000000006 111.257 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 46.2 p90 -137.33 171.77 13.98 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 107.499 -1.297 . . . . 75.430000000000007 107.499 178.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.442 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 45.0 m-85 -117.52 153.05 33.85 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 109.239 -0.652 . . . . 72.420000000000002 109.239 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.29 126.78 51.42 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 106.033 -1.84 . . . . 71.120000000000005 106.033 177.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -127.92 124.44 37.38 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 120.055 -0.658 . . . . 60.039999999999999 110.313 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 20.3 pt -88.86 140.93 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.297 0 CA-C-N 114.836 -1.075 . . . . 74.430000000000007 108.132 174.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.79 173.24 47.04 Favored Glycine 0 N--CA 1.409 -3.164 0 N-CA-C 109.838 -1.305 . . . . 74.230000000000004 109.838 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -67.14 136.15 93.92 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 110.343 -0.243 . . . . 70.219999999999999 110.343 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.2 131.33 31.9 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.258 2.638 . . . . 75.409999999999997 112.311 -176.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -109.59 120.45 42.54 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.035 -0.984 . . . . 75.299999999999997 108.919 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . 0.436 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 2.7 tm? -66.15 135.3 54.35 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.752 -1.203 . . . . 65.530000000000001 107.752 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.493 ' CG2' HG12 ' A' ' 536' ' ' ILE . 47.0 t . . . . . 0 C--N 1.303 -1.449 0 N-CA-C 108.254 -1.017 . . . . 72.530000000000001 108.254 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.436 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 29.9 Cg_endo . . . . . 0 N--CA 1.449 -1.094 0 CA-C-O 121.318 0.466 . . . . 73.549999999999997 112.423 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . 0.413 ' H ' HD13 ' A' ' 635' ' ' ILE . 0.1 OUTLIER -127.72 178.71 4.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.692 -1.225 . . . . 74.340000000000003 107.692 179.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.86 -173.9 2.37 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 112.828 0.677 . . . . 73.340000000000003 112.828 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -77.8 -159.25 11.67 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.95 -0.568 . . . . 64.129999999999995 114.376 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -78.59 -48.62 14.79 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.452 0.644 . . . . 74.140000000000001 109.603 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -129.6 130.47 45.69 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.931 -1.137 . . . . 75.409999999999997 107.931 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 18.7 p -129.94 96.09 4.12 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 120.9 0.381 . . . . 74.530000000000001 110.887 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -163.97 148.48 10.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.495 -1.298 . . . . 63.539999999999999 107.495 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.44 HD21 HG23 ' A' ' 523' ' ' VAL . 34.0 tp -133.65 127.85 33.84 Favored 'General case' 0 N--CA 1.414 -2.271 0 N-CA-C 108.379 -0.971 . . . . 71.099999999999994 108.379 175.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -98.0 109.92 22.59 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 107.484 -1.302 . . . . 72.409999999999997 107.484 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 46.0 t -101.17 119.33 49.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.361 -0.607 . . . . 75.230000000000004 109.361 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 49.9 mt -106.12 126.7 61.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.327 -0.99 . . . . 73.310000000000002 108.327 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 73.8 mt -97.82 112.01 28.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.841 -1.17 . . . . 73.420000000000002 107.841 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 515' ' ' SER . 14.3 pt-20 . . . . . 0 C--N 1.286 -2.166 0 CA-C-N 115.505 -0.77 . . . . 72.450000000000003 110.129 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 502' ' ' ALA . . . . . 0.424 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.435 -1.211 0 N-CA-C 107.7 -1.222 . . . . 73.549999999999997 107.7 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 168.85 -146.87 10.66 Favored Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 109.811 -1.316 . . . . 74.239999999999995 109.811 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -126.04 117.6 49.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 117.129 0.464 . . . . 74.209999999999994 110.469 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -102.4 124.69 48.42 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.261 -1.015 . . . . 72.200000000000003 108.261 169.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.7 t -165.07 -179.17 5.53 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.893 -0.78 . . . . 64.530000000000001 108.893 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -80.35 149.04 30.39 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.357 0.598 . . . . 71.510000000000005 112.534 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -74.18 -24.71 59.42 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 114.793 -1.094 . . . . 74.030000000000001 109.003 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.65 142.88 27.29 Favored Pre-proline 0 N--CA 1.435 -1.198 0 N-CA-C 107.474 -1.306 . . . . 75.099999999999994 107.474 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.81 -27.68 4.63 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.215 1.944 . . . . 73.030000000000001 112.483 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 53.7 t -137.96 136.37 45.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 107.007 -1.479 . . . . 74.430000000000007 107.007 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.6 t -130.42 139.55 50.6 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 109.371 -0.603 . . . . 74.239999999999995 109.371 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -106.11 124.05 48.97 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.964 -1.124 . . . . 73.150000000000006 107.964 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.6 m -120.99 155.74 24.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 108.267 -1.012 . . . . 73.120000000000005 108.267 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.501 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 68.1 m -80.88 166.5 20.84 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 108.676 -0.861 . . . . 73.439999999999998 108.676 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -89.8 -55.72 3.52 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.429 -0.908 . . . . 71.510000000000005 109.795 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 31.1 m -81.44 46.7 0.97 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.382 0.61 . . . . 54.240000000000002 110.843 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 11.5 tt -96.05 -29.91 3.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.306 0.574 . . . . 73.319999999999993 111.028 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 96.0 -82.25 0.81 Allowed Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.953 -1.259 . . . . 73.310000000000002 109.953 -176.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 573' ' ' VAL . 27.7 mm -129.67 134.96 62.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.885 -1.154 . . . . 75.340000000000003 107.885 -176.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.517 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -115.06 144.62 43.35 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.098 -0.705 . . . . 63.119999999999997 109.098 176.145 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 21.5 mp0 -116.22 128.45 55.62 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.723 0.639 . . . . 65.019999999999996 111.185 176.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 570' ' ' THR . 99.5 t -120.87 131.57 72.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.921 -0.77 . . . . 74.120000000000005 108.921 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 569' ' ' LYS . 26.5 mtmm -85.62 145.32 27.38 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.438 0.637 . . . . 73.140000000000001 112.023 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.412 ' O ' HG21 ' A' ' 568' ' ' VAL . 52.5 t -117.71 127.59 75.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.879 -0.786 . . . . 62.340000000000003 108.879 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 97.1 mt -70.39 124.88 25.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 123.762 0.664 . . . . 72.430000000000007 110.29 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -73.84 158.43 34.54 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.567 -1.197 . . . . 73.409999999999997 109.215 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.4 t -56.09 135.79 52.69 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 124.013 0.821 . . . . 61.229999999999997 110.643 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 3.7 m -60.09 -27.42 66.98 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 124.822 1.249 . . . . 74.219999999999999 110.108 177.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -122.23 90.38 0.44 Allowed Glycine 0 N--CA 1.424 -2.157 0 N-CA-C 109.098 -1.601 . . . . 71.519999999999996 109.098 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.54 105.25 17.69 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.716 -0.476 . . . . 72.530000000000001 109.716 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -120.2 101.97 8.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.852 -0.795 . . . . 74.099999999999994 108.852 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 90.93 -145.21 17.69 Favored Glycine 0 C--N 1.299 -1.489 0 CA-C-N 115.668 -0.696 . . . . 63.140000000000001 112.258 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.531 ' ND2' ' HG2' ' A' ' 563' ' ' GLN . 2.6 t-20 -118.39 131.07 56.31 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.149 -0.685 . . . . 74.219999999999999 109.149 -178.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . 0.454 HG22 HD22 ' A' ' 596' ' ' LEU . 49.4 t -131.58 139.94 49.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 108.497 -0.927 . . . . 63.439999999999998 108.497 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 42.5 mm -109.6 135.79 47.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 109.036 -0.727 . . . . 70.310000000000002 109.036 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.7 t -122.98 108.43 32.54 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 108.957 -0.757 . . . . 63.009999999999998 108.957 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -73.61 153.86 49.41 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.92 1.747 . . . . 65.510000000000005 111.465 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -140.46 155.87 46.54 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.951 -0.468 . . . . 73.420000000000002 109.888 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -147.31 148.83 31.8 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 123.714 0.634 . . . . 73.0 109.911 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.5 p -90.21 129.27 36.49 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.405 -0.361 . . . . 71.329999999999998 110.16 174.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.498 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 64.2 mt -102.62 119.75 51.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 107.162 -1.421 . . . . 74.349999999999994 107.162 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -72.86 114.95 11.58 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.522 -0.548 . . . . 75.439999999999998 109.522 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -96.8 -100.11 1.96 Allowed Glycine 0 CA--C 1.5 -0.874 0 N-CA-C 109.958 -1.257 . . . . 71.430000000000007 109.958 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 31.5 p -94.6 -22.21 18.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.984 -1.117 . . . . 65.150000000000006 107.984 173.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -86.05 135.64 33.55 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.758 -1.11 . . . . 73.299999999999997 108.468 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -98.72 143.55 28.96 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.217 0.532 . . . . 75.409999999999997 112.163 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.7 -150.65 17.61 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.1 -0.954 . . . . 73.430000000000007 111.442 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.93 -0.67 28.21 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 116.978 0.389 . . . . 72.319999999999993 113.383 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 93.54 29.09 10.4 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 111.041 -0.824 . . . . 62.450000000000003 111.041 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -99.91 -67.66 0.84 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 110.365 -0.235 . . . . 64.510000000000005 110.365 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -94.35 -45.62 7.39 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 107.979 -1.119 . . . . 73.420000000000002 107.979 174.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -136.77 158.95 43.26 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 114.965 -1.016 . . . . 74.109999999999999 108.453 177.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -85.52 112.65 21.12 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 104.658 -2.349 . . . . 70.230000000000004 104.658 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -73.25 145.92 45.81 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.576 -0.85 . . . . 73.319999999999993 108.87 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.0 t -142.64 168.98 18.45 Favored 'General case' 0 N--CA 1.414 -2.227 0 C-N-CA 120.372 -0.531 . . . . 72.450000000000003 110.714 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 11.2 p -162.72 160.35 25.36 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 106.017 -1.846 . . . . 75.540000000000006 106.017 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 171.22 -172.98 44.72 Favored Glycine 0 CA--C 1.483 -1.934 0 N-CA-C 110.493 -1.043 . . . . 74.430000000000007 110.493 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.526 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 48.5 mt-10 -130.78 120.11 23.28 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.141 0.496 . . . . 75.150000000000006 111.532 -177.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 92.1 mt -85.75 135.92 33.54 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 115.459 -0.791 . . . . 75.5 109.259 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -104.04 119.24 38.52 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-O 121.051 0.453 . . . . 74.439999999999998 110.035 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -118.81 139.22 51.95 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.517 -0.549 . . . . 65.5 109.517 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.531 ' HG2' ' ND2' ' A' ' 534' ' ' ASN . 6.6 mt-30 -134.95 172.23 13.29 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.743 -0.836 . . . . 73.439999999999998 108.743 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -62.19 -30.22 70.92 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 123.85 0.719 . . . . 74.540000000000006 109.734 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.01 -24.21 21.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.606 -1.179 . . . . 73.319999999999993 112.381 -177.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.488 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 68.5 mm-40 -75.38 173.37 11.01 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.139 -0.351 . . . . 65.340000000000003 111.28 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.575 HG13 ' H ' ' A' ' 568' ' ' VAL . 7.6 pt -117.06 -77.24 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 113.59 0.959 . . . . 75.239999999999995 113.59 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.575 ' H ' HG13 ' A' ' 567' ' ' ILE . 11.8 p -142.99 153.09 16.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 107.711 -1.218 . . . . 73.239999999999995 107.711 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 524' ' ' LYS . 17.0 mtpp -121.55 168.32 11.87 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.7 -0.4 . . . . 74.219999999999999 111.112 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 0.9 OUTLIER -129.92 147.09 51.64 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 123.853 0.72 . . . . 74.120000000000005 111.441 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 1.9 mp -94.91 128.08 46.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.033 -1.469 . . . . 75.129999999999995 107.033 172.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 572' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 521' ' ' MET . 10.1 p -106.74 115.32 29.99 Favored 'General case' 0 N--CA 1.428 -1.562 0 O-C-N 123.715 0.634 . . . . 73.219999999999999 109.835 176.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 520' ' ' ILE . 71.6 t -117.82 135.97 56.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 116.366 -0.379 . . . . 73.230000000000004 110.12 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 24.4 tptm -90.46 123.51 34.22 Favored 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 124.085 0.866 . . . . 75.120000000000005 109.0 177.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.07 136.18 31.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 106.445 -1.687 . . . . 73.329999999999998 106.445 176.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 41.5 mm . . . . . 0 C--N 1.303 -1.439 0 CA-C-O 121.401 0.62 . . . . 75.219999999999999 111.258 -173.618 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp . . . . . 0 C--O 1.215 -0.735 0 N-CA-C 107.164 -1.421 . . . . 75.030000000000001 107.164 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 7.8 t -149.97 146.09 26.83 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.08 -0.648 . . . . 74.530000000000001 110.643 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 48.5 p90 -140.43 172.06 13.26 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.643 -1.243 . . . . 72.209999999999994 107.643 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.45 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 85.7 m-85 -116.97 153.59 32.36 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.781 -0.451 . . . . 74.209999999999994 109.781 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.81 125.49 46.63 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 105.657 -1.979 . . . . 73.329999999999998 105.657 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -126.15 136.68 53.16 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.599 -0.889 . . . . 74.109999999999999 108.599 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 12.3 pt -100.4 139.79 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.225 0 N-CA-C 108.45 -0.944 . . . . 72.230000000000004 108.45 175.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.25 173.16 51.67 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-N 115.167 -0.924 . . . . 63.340000000000003 111.426 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.08 125.85 91.96 Favored Pre-proline 0 N--CA 1.433 -1.307 0 CA-C-O 120.836 0.351 . . . . 75.040000000000006 111.556 -177.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.403 ' HB3' HG22 ' A' ' 537' ' ' VAL . 26.2 Cg_endo -62.1 139.71 80.01 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.692 2.928 . . . . 74.129999999999995 113.101 -174.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -116.52 128.68 55.66 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.901 -1.045 . . . . 74.420000000000002 109.562 -177.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . 0.454 HD22 HG22 ' A' ' 535' ' ' VAL . 0.6 OUTLIER -74.58 135.86 42.07 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.953 -1.129 . . . . 72.430000000000007 107.953 179.585 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.501 ' CG2' HG12 ' A' ' 536' ' ' ILE . 37.4 t . . . . . 0 C--N 1.299 -1.611 0 N-CA-C 108.701 -0.852 . . . . 73.109999999999999 108.701 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.424 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 67.7 Cg_endo . . . . . 0 N--CA 1.434 -2.016 0 N-CA-C 110.565 -0.59 . . . . 75.329999999999998 110.565 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.8 pp -126.61 158.33 36.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.623 -0.717 . . . . 73.230000000000004 109.787 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.06 177.19 5.82 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 116.384 -0.371 . . . . 73.450000000000003 110.939 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -69.8 172.7 39.3 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 111.424 -0.67 . . . . 73.420000000000002 111.424 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -56.7 -50.02 73.4 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.791 0.805 . . . . 73.510000000000005 110.192 -175.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -123.63 125.85 45.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.076 -0.965 . . . . 63.229999999999997 109.618 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 19.9 p -123.06 95.28 4.55 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 115.733 -0.667 . . . . 73.349999999999994 110.005 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -158.52 138.05 11.81 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.907 -0.588 . . . . 75.099999999999994 109.811 -176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.423 ' CD2' HG11 ' A' ' 523' ' ' VAL . 36.5 tp -122.56 129.27 51.75 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.124 -1.065 . . . . 74.519999999999996 108.124 177.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -95.67 108.86 21.18 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.19 -1.411 . . . . 71.120000000000005 107.19 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 43.3 t -99.02 108.86 23.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 109.314 -0.624 . . . . 72.530000000000001 109.314 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 65.3 mt -98.13 122.8 50.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 108.809 -0.811 . . . . 65.409999999999997 108.809 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 32.7 mt -99.74 108.31 22.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.486 -0.931 . . . . 74.5 108.486 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 515' ' ' SER . 10.4 pt-20 . . . . . 0 C--N 1.29 -1.992 0 CA-C-O 121.311 0.577 . . . . 74.129999999999995 110.753 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.784 0 CA-C-O 121.309 0.576 . . . . 71.340000000000003 110.332 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 162.07 -159.79 31.86 Favored Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 109.904 -1.278 . . . . 70.540000000000006 109.904 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.53 110.86 33.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 116.687 0.244 . . . . 71.209999999999994 110.814 -176.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.714 ' CE1' ' HA ' ' A' ' 527' ' ' ARG . 5.8 m-85 -95.46 120.59 35.98 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.099 -0.704 . . . . 75.420000000000002 109.099 169.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.1 t -170.22 179.52 3.44 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.612 -0.884 . . . . 73.150000000000006 108.612 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -84.37 153.48 23.43 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.614 -0.513 . . . . 74.319999999999993 109.614 178.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -66.84 -36.04 81.43 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.575 0.702 . . . . 72.239999999999995 109.93 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.36 146.36 61.67 Favored Pre-proline 0 N--CA 1.42 -1.963 0 CA-C-N 115.014 -0.994 . . . . 75.409999999999997 108.444 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.67 -25.2 12.81 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.761 1.641 . . . . 74.109999999999999 112.007 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.05 135.37 54.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.454 -0.943 . . . . 75.430000000000007 108.454 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.6 t -129.33 139.18 51.83 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 109.239 -0.652 . . . . 63.100000000000001 109.239 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -103.66 123.2 46.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.661 -1.237 . . . . 73.140000000000001 107.661 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.6 m -113.11 151.92 14.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 120.463 -0.495 . . . . 73.099999999999994 109.912 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.509 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 0.4 OUTLIER -72.96 162.55 29.36 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 114.845 -1.071 . . . . 73.340000000000003 111.43 -178.256 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -83.78 -48.27 10.27 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.264 -1.384 . . . . 73.530000000000001 107.264 170.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.4 m -81.68 28.51 0.41 Allowed 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.685 -1.143 . . . . 71.400000000000006 112.297 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.509 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 15.2 tt -96.9 -32.15 4.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 112.6 0.593 . . . . 74.109999999999999 112.6 -174.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . 0.423 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 87.98 -78.49 1.79 Allowed Glycine 0 N--CA 1.428 -1.864 0 C-N-CA 120.011 -1.09 . . . . 63.439999999999998 110.532 -175.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 35.1 mm -126.74 131.4 71.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 107.523 -1.288 . . . . 74.209999999999994 107.523 -175.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.523 ' SD ' HG22 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -108.55 146.68 32.9 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 109.349 -0.611 . . . . 74.019999999999996 109.349 177.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 15.1 mp0 -123.15 127.25 48.42 Favored 'General case' 0 CA--C 1.505 -0.764 0 O-C-N 123.955 0.784 . . . . 73.530000000000001 110.329 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.523 HG22 ' SD ' ' A' ' 521' ' ' MET . 66.0 t -112.09 130.64 65.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.98 -1.118 . . . . 74.420000000000002 107.98 173.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . 0.462 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 35.8 mtmt -90.72 141.81 28.41 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.236 0.541 . . . . 75.439999999999998 110.833 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.409 ' O ' HG22 ' A' ' 568' ' ' VAL . 43.8 t -107.77 128.01 63.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.738 -0.664 . . . . 72.049999999999997 109.525 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 95.2 mt -66.5 116.49 7.53 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.276 0.63 . . . . 73.319999999999993 110.25 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.714 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 56.3 ttt-85 -73.26 154.14 40.31 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 124.619 1.167 . . . . 75.349999999999994 109.974 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.63 HG23 ' CD2' ' A' ' 505' ' ' PHE . 1.4 p -58.52 131.28 50.29 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 122.992 0.517 . . . . 72.430000000000007 110.415 175.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 46.4 t -47.39 -35.56 8.48 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 125.362 1.465 . . . . 75.040000000000006 110.917 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.56 85.85 0.32 Allowed Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.857 -1.297 . . . . 74.230000000000004 109.857 175.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -84.83 102.14 12.83 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.648 -0.871 . . . . 64.25 108.648 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -102.07 96.73 7.2 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.234 -0.894 . . . . 73.329999999999998 109.939 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 111.43 -145.16 17.64 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.997 -0.621 . . . . 61.350000000000001 112.294 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.524 HD21 ' HG2' ' A' ' 563' ' ' GLN . 2.4 t-20 -118.86 131.92 56.09 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.803 -1.554 . . . . 74.340000000000003 106.803 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 42.8 t -133.94 140.59 46.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 110.104 -0.332 . . . . 70.129999999999995 110.104 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.512 HG12 ' CG2' ' A' ' 597' ' ' VAL . 38.3 mm -113.52 135.36 53.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 109.29 -0.633 . . . . 74.310000000000002 109.29 174.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 34.8 t -121.13 109.44 35.35 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 109.166 -0.679 . . . . 74.209999999999994 109.166 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.04 150.5 38.07 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.21 1.94 . . . . 74.209999999999994 112.27 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.429 ' HB3' HG21 ' A' ' 591' ' ' ILE . 46.1 p90 -145.18 167.43 22.78 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.835 0.35 . . . . 75.420000000000002 111.013 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -158.42 147.95 19.47 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-N 115.387 -0.824 . . . . 73.140000000000001 110.206 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 15.3 p -84.0 136.26 34.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.826 -0.805 . . . . 71.420000000000002 108.826 172.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 75.0 mt -104.43 114.68 44.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 108.942 -0.762 . . . . 72.209999999999994 108.942 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.63 99.12 2.48 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.843 -0.617 . . . . 75.430000000000007 109.927 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -112.13 -105.78 2.81 Favored Glycine 0 CA--C 1.479 -2.172 0 N-CA-C 110.411 -1.075 . . . . 75.219999999999999 110.411 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.24 42.69 1.05 Allowed 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 123.485 0.714 . . . . 75.140000000000001 109.473 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . 0.466 ' HA ' ' HD2' ' A' ' 585' ' ' LYS . . . -160.1 147.13 16.17 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.475 0.71 . . . . 63.240000000000002 109.864 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.473 HH11 ' HG3' ' A' ' 551' ' ' GLU . 33.1 mtm105 -77.82 120.36 22.61 Favored 'General case' 0 C--O 1.251 1.157 0 CA-C-O 121.356 0.598 . . . . 75.340000000000003 111.727 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.28 -163.04 35.33 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.04 -0.982 . . . . 73.439999999999998 110.687 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 65.5 28.85 74.03 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 121.388 -0.434 . . . . 64.140000000000001 113.255 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 69.42 40.25 79.69 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 121.164 -0.541 . . . . 61.240000000000002 112.006 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.473 ' HG3' HH11 ' A' ' 547' ' ' ARG . 3.6 tp10 -113.05 -53.93 2.67 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 119.954 -0.698 . . . . 74.409999999999997 110.188 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -98.62 -39.54 8.64 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.459 -1.311 . . . . 74.450000000000003 107.459 169.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -142.56 149.0 38.48 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.753 -1.112 . . . . 75.400000000000006 108.629 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.66 111.93 21.13 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 105.361 -2.089 . . . . 75.129999999999995 105.361 176.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -75.19 146.7 41.02 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.176 -0.466 . . . . 72.030000000000001 109.976 -173.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.0 t -143.17 150.93 40.06 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.358 0.599 . . . . 75.120000000000005 110.502 -172.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.0 p -153.18 134.57 14.29 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.504 -0.924 . . . . 73.25 108.504 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -175.54 -168.32 35.8 Favored Glycine 0 N--CA 1.411 -2.987 0 N-CA-C 110.179 -1.169 . . . . 52.420000000000002 110.179 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.454 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 39.9 mt-10 -127.32 131.86 50.36 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.972 -0.381 . . . . 75.109999999999999 109.972 -175.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.436 HD22 ' HB3' ' A' ' 569' ' ' LYS . 86.1 mt -94.63 132.11 39.7 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.564 -0.532 . . . . 70.120000000000005 109.564 177.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.412 ' HA ' HD13 ' A' ' 536' ' ' ILE . 19.4 tt0 -98.75 120.21 38.8 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.941 -0.572 . . . . 74.310000000000002 110.198 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 89.5 m-85 -120.71 156.55 31.54 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.671 -0.863 . . . . 61.43 108.671 177.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.524 ' HG2' HD21 ' A' ' 534' ' ' ASN . 16.8 mt-30 -150.11 -177.43 5.92 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.21 -1.033 . . . . 71.129999999999995 108.21 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -66.34 -42.67 87.78 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.397 -0.964 . . . . 73.439999999999998 108.397 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -81.8 -24.63 35.81 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.972 0.731 . . . . 74.299999999999997 112.972 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.404 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 37.1 mm-40 -76.34 146.5 38.77 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.857 -0.527 . . . . 74.519999999999996 112.062 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.555 HG13 ' H ' ' A' ' 568' ' ' VAL . 12.6 pt -90.47 -89.99 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 114.869 1.433 . . . . 75.519999999999996 114.869 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.555 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.7 p -134.76 145.64 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 109.664 -0.495 . . . . 74.420000000000002 109.664 -177.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.436 ' HB3' HD22 ' A' ' 560' ' ' LEU . 4.2 mmpt? -113.04 157.11 21.97 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 116.267 -0.424 . . . . 74.209999999999994 110.21 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.8 p -126.25 151.76 47.01 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.19 -0.914 . . . . 74.310000000000002 111.926 -177.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.3 mp -101.37 120.97 51.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.104 -1.443 . . . . 72.409999999999997 107.104 171.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 572' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 521' ' ' MET . 70.0 m -99.3 115.96 30.38 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 123.81 0.694 . . . . 74.150000000000006 109.967 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.433 ' CG2' ' HE3' ' A' ' 521' ' ' MET . 68.1 t -122.63 128.27 75.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.462 -0.335 . . . . 72.310000000000002 110.291 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 29.1 tptp -80.66 118.2 22.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.67 -0.493 . . . . 74.239999999999995 109.67 176.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 58.3 t -81.27 117.22 26.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 105.557 -2.016 . . . . 72.340000000000003 105.557 174.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 C--N 1.298 -1.639 0 CA-C-O 121.762 0.791 . . . . 64.450000000000003 109.97 -174.193 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . 0.466 ' HD2' ' HA ' ' A' ' 546' ' ' ALA . 34.2 mmtp . . . . . 0 N--CA 1.439 -0.987 0 CA-C-O 121.09 0.471 . . . . 74.519999999999996 111.416 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 7.0 t -153.93 135.5 14.33 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.436 0.636 . . . . 72.219999999999999 110.407 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -127.16 172.18 10.77 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.323 -0.991 . . . . 74.140000000000001 108.323 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.432 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 79.4 m-85 -118.96 153.8 34.05 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 109.515 -0.55 . . . . 72.010000000000005 109.515 -175.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.86 129.86 52.17 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.206 -1.775 . . . . 71.140000000000001 106.206 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -128.0 134.4 49.25 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.05 -0.66 . . . . 74.540000000000006 109.924 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . 0.429 HG21 ' HB3' ' A' ' 539' ' ' TYR . 25.2 pt -106.84 140.51 24.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.39 -0.967 . . . . 72.219999999999999 108.39 176.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.21 -175.31 49.78 Favored Glycine 0 N--CA 1.425 -2.065 0 O-C-N 123.813 0.695 . . . . 63.240000000000002 111.469 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.81 137.3 82.63 Favored Pre-proline 0 N--CA 1.428 -1.529 0 C-N-CA 121.034 -0.266 . . . . 74.319999999999993 110.521 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.65 142.94 60.26 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 122.58 2.187 . . . . 72.439999999999998 111.08 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -121.93 123.42 41.66 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.674 -0.491 . . . . 74.230000000000004 109.674 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 2.2 tm? -67.97 125.56 26.7 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.844 -0.799 . . . . 74.140000000000001 108.844 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.512 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.6 t . . . . . 0 C--N 1.286 -2.179 0 N-CA-C 105.197 -2.149 . . . . 75.409999999999997 105.197 176.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 596' ' ' LEU . 33.6 Cg_endo . . . . . 0 CA--C 1.512 -0.595 0 CA-C-O 121.148 0.395 . . . . 70.030000000000001 112.622 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.8 pp -134.56 157.97 41.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.139 -1.059 . . . . 74.230000000000004 108.139 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.54 172.84 8.42 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.314 -0.554 . . . . 70.25 111.725 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -73.01 -157.25 3.9 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-O 121.912 0.729 . . . . 74.049999999999997 114.475 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.93 -45.84 59.7 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.624 -0.788 . . . . 71.420000000000002 109.333 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -135.4 142.98 45.76 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.231 -0.895 . . . . 74.129999999999995 108.822 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 35.2 p -134.75 103.21 5.54 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.011 0.434 . . . . 71.310000000000002 111.034 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -170.22 150.65 3.68 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.822 -1.177 . . . . 74.140000000000001 107.822 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.437 HD21 HG21 ' A' ' 523' ' ' VAL . 26.1 tp -137.81 132.13 32.18 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.48 -0.933 . . . . 74.340000000000003 108.48 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -101.16 110.95 23.04 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.529 -1.286 . . . . 75.140000000000001 107.529 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 45.7 t -101.11 110.97 29.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.556 -0.535 . . . . 73.549999999999997 109.556 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 74.0 mt -96.58 125.66 49.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 N-CA-C 109.471 -0.566 . . . . 62.100000000000001 109.471 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 64.9 mt -101.17 107.59 21.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.823 -1.177 . . . . 73.310000000000002 107.823 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--N 1.283 -2.307 0 CA-C-O 121.173 0.511 . . . . 73.430000000000007 110.014 -179.935 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 74.1 t60 . . . . . 0 C--O 1.241 0.648 0 CA-C-O 121.697 0.76 . . . . 72.120000000000005 109.929 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.539 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . -85.21 -32.04 22.85 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.953 -1.022 . . . . 70.340000000000003 113.316 -175.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 124.58 -155.85 18.44 Favored Glycine 0 C--N 1.287 -2.167 0 C-N-CA 119.215 -1.469 . . . . 40.229999999999997 111.705 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.405 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.7 mp -114.66 110.96 33.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 112.069 0.396 . . . . 74.299999999999997 112.069 -172.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -92.52 119.98 32.53 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.068 -1.086 . . . . 75.019999999999996 108.068 168.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.5 t -160.41 171.79 18.43 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.122 -0.696 . . . . 74.510000000000005 109.122 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -76.83 147.06 37.39 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 122.513 -0.117 . . . . 75.340000000000003 111.149 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 524' ' ' LYS . 0.3 OUTLIER -65.9 -33.8 76.66 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 122.116 0.96 . . . . 72.540000000000006 108.69 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -130.23 140.17 37.86 Favored Pre-proline 0 C--N 1.291 -1.96 0 N-CA-C 108.008 -1.108 . . . . 72.5 108.008 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.81 -27.4 10.43 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.288 1.992 . . . . 62.509999999999998 111.672 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 60.0 t -140.63 134.52 33.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 106.232 -1.766 . . . . 75.430000000000007 106.232 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.2 t -128.95 139.91 51.9 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.952 -0.758 . . . . 73.120000000000005 108.952 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -106.39 136.3 46.38 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.563 -1.273 . . . . 71.099999999999994 107.563 175.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.2 m -125.9 147.24 30.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 108.897 -0.779 . . . . 73.430000000000007 108.897 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.404 ' O ' HG21 ' A' ' 518' ' ' ILE . 27.1 m -79.29 143.64 35.03 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 112.709 0.633 . . . . 75.230000000000004 112.709 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -56.2 -39.5 72.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.196 0.998 . . . . 73.140000000000001 110.374 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 27.5 t -116.01 73.25 0.84 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.905 0.859 . . . . 71.510000000000005 109.757 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.404 HG21 ' O ' ' A' ' 515' ' ' SER . 9.8 tt -120.16 -25.49 2.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.653 -0.703 . . . . 72.540000000000006 110.73 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . 0.439 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 91.74 -82.02 1.22 Allowed Glycine 0 N--CA 1.421 -2.342 0 N-CA-C 109.983 -1.247 . . . . 75.030000000000001 109.983 -175.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 49.8 mm -127.96 135.13 63.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 107.993 -1.114 . . . . 74.430000000000007 107.993 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.44 ' HE2' ' CG2' ' A' ' 573' ' ' VAL . 0.0 OUTLIER -112.19 143.3 43.47 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.132 -1.062 . . . . 62.43 108.132 176.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.7 mt-10 -124.93 126.75 46.0 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 123.796 0.685 . . . . 74.299999999999997 111.358 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 570' ' ' THR . 24.2 t -105.53 125.34 60.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.908 -0.775 . . . . 75.25 108.908 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 508' ' ' GLU . 20.6 mmmt -81.34 130.18 34.93 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.328 -0.99 . . . . 74.040000000000006 108.328 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.491 ' O ' HG21 ' A' ' 568' ' ' VAL . 58.5 t -105.38 137.85 33.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 109.829 -0.434 . . . . 74.140000000000001 109.829 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.91 123.18 27.0 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.011 -0.541 . . . . 72.109999999999999 110.177 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 34.7 ttp85 -78.78 155.83 29.1 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.686 -1.143 . . . . 70.319999999999993 110.433 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 0.9 OUTLIER -58.37 140.4 53.65 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 124.438 1.095 . . . . 62.539999999999999 112.482 177.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.7 t -54.73 -35.33 63.59 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.934 1.294 . . . . 71.010000000000005 110.034 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -117.76 95.64 0.65 Allowed Glycine 0 N--CA 1.418 -2.501 0 N-CA-C 110.141 -1.184 . . . . 52.240000000000002 110.141 176.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -84.57 111.85 19.89 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.804 -0.813 . . . . 70.420000000000002 108.804 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -121.28 107.87 13.05 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.304 -0.862 . . . . 74.209999999999994 110.835 -173.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 74.76 -124.25 7.87 Favored Glycine 0 N--CA 1.441 -1.0 0 O-C-N 123.633 0.583 . . . . 72.129999999999995 112.92 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.527 HD21 ' HG2' ' A' ' 563' ' ' GLN . 2.5 t-20 -134.17 126.38 29.83 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.299 0.64 . . . . 71.310000000000002 109.851 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.47 137.94 54.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 109.027 -0.731 . . . . 74.219999999999999 109.027 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.496 HG12 ' CG2' ' A' ' 597' ' ' VAL . 40.5 mm -107.76 136.65 42.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 109.358 -0.608 . . . . 74.109999999999999 109.358 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.25 108.07 38.55 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 109.488 -0.56 . . . . 65.519999999999996 109.488 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 53.5 Cg_endo -72.71 155.97 53.65 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.373 2.049 . . . . 75.030000000000001 111.752 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.433 ' HB3' HG21 ' A' ' 591' ' ' ILE . 54.2 p90 -152.87 163.0 40.59 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 110.481 -0.192 . . . . 74.030000000000001 110.481 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -158.03 158.36 34.69 Favored 'General case' 0 C--O 1.25 1.079 0 O-C-N 123.735 0.647 . . . . 73.530000000000001 109.457 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 5.2 p -84.35 158.15 21.23 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.145 -0.48 . . . . 75.540000000000006 110.05 172.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 89.6 mt -133.54 121.28 40.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.644 -1.243 . . . . 74.349999999999994 107.644 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -71.37 107.28 4.25 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 110.154 -0.313 . . . . 71.030000000000001 110.154 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -83.82 -89.75 0.76 Allowed Glycine 0 C--N 1.309 -0.93 0 N-CA-C 109.53 -1.428 . . . . 74.120000000000005 109.53 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 14.8 p -112.76 6.11 17.92 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.819 0.818 . . . . 75.140000000000001 109.112 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -99.45 142.76 30.52 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.635 -1.166 . . . . 71.519999999999996 110.281 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.423 ' HB3' ' OE1' ' A' ' 551' ' ' GLU . 76.9 mtt180 -79.34 127.0 31.54 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.694 0.759 . . . . 72.129999999999995 111.321 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -90.3 176.09 41.61 Favored Glycine 0 C--N 1.289 -2.074 0 CA-C-N 114.81 -1.086 . . . . 61.310000000000002 112.19 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 82.34 19.29 64.75 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.057 -0.592 . . . . 65.340000000000003 113.255 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 81.94 25.81 51.36 Favored Glycine 0 CA--C 1.504 -0.64 0 N-CA-C 110.458 -1.057 . . . . 54.140000000000001 110.458 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.423 ' OE1' ' HB3' ' A' ' 547' ' ' ARG . 21.3 tt0 -93.32 -60.81 1.7 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 108.801 -0.815 . . . . 72.5 108.801 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -102.12 -34.44 9.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.852 -1.166 . . . . 73.409999999999997 107.852 168.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -143.95 148.72 35.73 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.518 -0.919 . . . . 73.349999999999994 108.518 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -85.57 112.29 20.82 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 105.498 -2.038 . . . . 72.439999999999998 105.498 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -76.55 146.37 38.41 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.256 -0.429 . . . . 73.299999999999997 110.168 -175.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.5 t -145.55 157.0 44.05 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-O 121.411 0.624 . . . . 64.120000000000005 110.519 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.9 p -154.52 153.19 31.05 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.498 -1.297 . . . . 72.040000000000006 107.498 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 169.81 -160.64 33.75 Favored Glycine 0 N--CA 1.418 -2.503 0 N-CA-C 110.032 -1.227 . . . . 62.329999999999998 110.032 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.478 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.6 mt-10 -129.79 142.36 50.7 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 122.663 0.385 . . . . 75.420000000000002 110.631 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' A' ' 569' ' ' LYS . 74.9 mt -107.82 139.48 42.35 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.046 -0.525 . . . . 75.340000000000003 109.617 175.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -102.79 117.25 34.23 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 116.031 -0.531 . . . . 71.030000000000001 110.913 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -116.56 149.02 40.31 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.548 -0.908 . . . . 74.340000000000003 108.548 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.527 ' HG2' HD21 ' A' ' 534' ' ' ASN . 14.0 mt-30 -148.19 -175.01 4.73 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.941 -1.133 . . . . 73.219999999999999 107.941 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -69.18 -27.44 65.52 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.545 -0.909 . . . . 73.239999999999995 108.545 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.27 -51.66 5.06 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.136 -0.938 . . . . 51.439999999999998 112.317 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.459 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 51.0 mm-40 -55.67 125.77 22.6 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 122.349 0.259 . . . . 70.439999999999998 110.815 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.557 HG13 ' H ' ' A' ' 568' ' ' VAL . 7.1 pt -91.01 -78.67 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 112.855 0.687 . . . . 73.519999999999996 112.855 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.557 ' H ' HG13 ' A' ' 567' ' ' ILE . 10.9 p -119.71 150.18 22.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.813 -0.555 . . . . 73.430000000000007 110.004 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.437 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -122.83 160.32 26.28 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.911 -0.774 . . . . 70.519999999999996 108.911 173.489 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 6.8 p -127.33 144.61 51.02 Favored 'General case' 0 C--N 1.288 -2.095 0 O-C-N 123.898 0.749 . . . . 73.010000000000005 112.696 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.0 mp -94.66 122.74 46.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 106.369 -1.715 . . . . 74.430000000000007 106.369 171.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 15.6 m -100.92 119.24 38.42 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 123.731 0.645 . . . . 60.0 109.332 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.44 ' CG2' ' HE2' ' A' ' 521' ' ' MET . 89.4 t -124.18 128.81 74.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 109.927 -0.397 . . . . 72.340000000000003 109.927 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.439 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 20.5 tptm -77.97 113.22 15.67 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.183 -0.673 . . . . 70.140000000000001 109.183 175.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.3 120.97 36.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 106.89 -1.522 . . . . 70.510000000000005 106.89 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 35.7 mm -84.96 149.75 4.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.911 -0.774 . . . . 73.140000000000001 108.911 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -65.17 143.33 57.93 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.802 -1.09 . . . . 75.530000000000001 110.614 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -51.51 146.88 6.8 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.493 1.121 . . . . 75.340000000000003 113.757 -173.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -74.57 -94.66 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 115.295 1.591 . . . . 72.319999999999993 115.295 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.8 -54.43 1.94 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.721 1.378 . . . . 74.219999999999999 114.721 -176.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -142.33 28.7 1.65 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.63 0.728 . . . . 74.219999999999999 110.233 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -71.32 139.95 50.09 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.619 -1.173 . . . . 71.140000000000001 110.973 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -83.37 -56.39 3.78 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.513 -0.767 . . . . 73.209999999999994 109.409 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -165.36 164.7 19.71 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.086 -1.45 . . . . 74.310000000000002 107.086 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -134.18 159.36 41.14 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.443 -0.577 . . . . 74.219999999999999 109.443 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 586' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 644' ' ' VAL . 10.0 t -149.33 138.75 21.57 Favored 'General case' 0 N--CA 1.416 -2.143 0 C-N-CA 120.034 -0.666 . . . . 71.319999999999993 110.937 174.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 49.0 p90 -135.08 167.7 20.47 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.651 -1.241 . . . . 70.109999999999999 107.651 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.457 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 80.3 m-85 -114.44 159.39 20.38 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 120.572 -0.451 . . . . 74.430000000000007 109.889 -175.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.33 128.22 47.86 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 106.243 -1.762 . . . . 74.129999999999995 106.243 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -122.19 123.37 41.35 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 110.238 -0.282 . . . . 75.319999999999993 110.238 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . 0.433 HG21 ' HB3' ' A' ' 539' ' ' TYR . 23.5 pt -95.86 135.19 30.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.859 -1.163 . . . . 74.400000000000006 107.859 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -84.38 -177.55 51.29 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 111.429 -0.669 . . . . 75.430000000000007 111.429 -177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.75 133.95 92.37 Favored Pre-proline 0 N--CA 1.435 -1.19 0 C-N-CA 120.931 -0.308 . . . . 73.349999999999994 111.435 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.7 129.48 26.44 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.947 2.432 . . . . 73.530000000000001 111.513 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . 0.409 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.1 ptp180 -107.81 119.95 40.89 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.458 -0.792 . . . . 74.439999999999998 109.902 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -66.07 132.1 47.74 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.967 -1.123 . . . . 74.530000000000001 107.967 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.496 ' CG2' HG12 ' A' ' 536' ' ' ILE . 98.1 t -81.99 115.7 24.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.707 0.765 . . . . 73.420000000000002 112.385 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -82.88 131.44 35.19 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 105.68 -1.97 . . . . 71.010000000000005 105.68 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 26.5 mmt -88.67 -12.35 42.68 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 120.947 0.403 . . . . 73.549999999999997 110.869 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 33.1 m -136.03 97.01 3.51 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.17 0.509 . . . . 54.32 111.941 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -30.22 22.8 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 105.63 -1.989 . . . . 74.010000000000005 105.63 170.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -83.49 100.02 10.48 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 113.577 -1.647 . . . . 71.209999999999994 108.19 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . 0.483 ' HB3' ' HZ3' ' A' ' 603' ' ' LYS . 9.9 mtpm? -99.92 -16.27 18.04 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.062 0.458 . . . . 75.200000000000003 110.428 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 161.75 -102.53 0.21 Allowed Glycine 0 N--CA 1.419 -2.476 0 N-CA-C 110.876 -0.889 . . . . 74.439999999999998 110.876 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 83.43 19.38 62.31 Favored Glycine 0 C--N 1.306 -1.103 0 C-N-CA 121.083 -0.58 . . . . 52.32 111.909 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -105.18 93.27 4.6 Favored 'General case' 0 CA--C 1.489 -1.397 0 CA-C-O 121.462 0.649 . . . . 71.200000000000003 109.717 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 6.4 t -132.65 141.2 48.52 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 107.93 -1.137 . . . . 74.239999999999995 107.93 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 10.7 tt -65.77 115.0 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 121.872 0.844 . . . . 72.140000000000001 111.552 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 21.0 m -90.89 107.51 19.24 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 105.244 -2.132 . . . . 75.299999999999997 105.244 174.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.96 76.31 10.05 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 122.317 1.056 . . . . 72.439999999999998 108.536 -175.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -166.66 134.97 2.77 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 104.721 -2.325 . . . . 72.239999999999995 104.721 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -86.04 101.47 12.97 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.548 0.689 . . . . 74.430000000000007 111.244 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 30.1 t70 72.98 88.43 0.1 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.231 -1.804 . . . . 72.200000000000003 112.508 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -157.46 144.6 18.4 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.727 -1.583 . . . . 71.099999999999994 106.727 172.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . 0.498 ' O ' ' HD3' ' A' ' 617' ' ' PRO . 15.5 ptmm? -104.0 3.59 33.57 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.36 0.874 . . . . 74.209999999999994 113.36 -173.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -107.89 98.87 27.44 Favored Pre-proline 0 C--O 1.241 0.636 0 C-N-CA 120.235 -0.586 . . . . 73.140000000000001 112.111 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 615' ' ' LYS . 1.0 OUTLIER -87.17 -7.79 6.82 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.383 2.055 . . . . 72.430000000000007 110.948 175.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 58.98 82.54 0.14 Allowed 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.994 1.317 . . . . 74.109999999999999 112.195 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 58.3 m -93.92 97.44 10.37 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.834 -1.172 . . . . 71.329999999999998 107.834 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 17.2 m -82.53 86.09 6.85 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.979 -0.555 . . . . 62.030000000000001 109.817 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -128.73 149.08 50.85 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 115.838 -0.619 . . . . 70.310000000000002 110.175 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -168.37 90.15 0.27 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.332 -0.988 . . . . 74.049999999999997 108.332 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -115.82 133.86 55.6 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.348 -0.612 . . . . 74.439999999999998 109.348 175.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -86.16 52.62 2.53 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 122.365 1.078 . . . . 72.129999999999995 108.285 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -66.6 -26.02 66.9 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.719 -1.128 . . . . 64.510000000000005 110.742 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -61.87 -36.63 81.8 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.971 -0.292 . . . . 75.239999999999995 111.364 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . 0.548 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 3.0 tmt_? -75.11 -34.23 61.69 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.624 -0.88 . . . . 74.200000000000003 108.624 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.516 ' O ' ' HG2' ' A' ' 631' ' ' MET . 70.4 mt -63.11 -38.01 80.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.564 0.697 . . . . 74.349999999999994 109.551 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -78.06 -21.41 50.67 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.623 -0.717 . . . . 73.319999999999993 111.541 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.548 ' HG3' ' O ' ' A' ' 627' ' ' ARG . 0.0 OUTLIER -71.6 -11.52 60.89 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 111.762 0.282 . . . . 72.140000000000001 111.762 -175.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.516 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 25.0 ptt? -58.93 -23.76 61.75 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.243 0.544 . . . . 72.530000000000001 109.747 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -131.08 54.04 0.79 Allowed Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 108.541 -1.824 . . . . 74.299999999999997 108.541 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . 0.521 ' HB3' ' HA ' ' A' ' 630' ' ' GLU . 6.6 ptp180 -86.05 147.21 44.77 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-O 121.129 0.49 . . . . 75.540000000000006 111.066 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -77.81 138.76 17.08 Favored 'Trans proline' 0 N--CA 1.43 -2.213 0 C-N-CA 121.281 1.32 . . . . 74.519999999999996 108.876 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.86 168.18 17.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 120.894 -0.323 . . . . 73.010000000000005 110.217 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.21 175.91 5.34 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 112.14 0.422 . . . . 73.319999999999993 112.14 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . 0.405 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -72.53 -177.58 31.3 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 114.948 0.739 . . . . 74.439999999999998 114.948 -176.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -58.48 -47.35 84.36 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.476 1.111 . . . . 70.219999999999999 110.172 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -140.44 121.83 15.0 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.006 -0.739 . . . . 62.25 109.006 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 10.1 p -114.32 96.21 5.66 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 120.899 0.381 . . . . 73.209999999999994 111.004 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -171.16 134.0 0.9 Allowed 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.572 -0.74 . . . . 72.519999999999996 109.662 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.408 HD21 HG13 ' A' ' 523' ' ' VAL . 25.6 tp -117.42 132.35 56.59 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.896 -1.047 . . . . 74.140000000000001 108.769 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -99.71 111.91 24.2 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.946 -1.502 . . . . 75.510000000000005 106.946 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 586' ' ' THR . 41.3 t -100.41 111.1 29.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 109.338 -0.615 . . . . 74.319999999999993 109.338 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 51.1 mt -99.48 118.45 46.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 N-CA-C 109.177 -0.675 . . . . 74.319999999999993 109.177 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 69.0 mt -87.5 107.86 17.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 106.792 -1.559 . . . . 73.409999999999997 106.792 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -112.41 146.78 37.76 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 116.098 -0.501 . . . . 75.450000000000003 110.93 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -80.13 119.14 22.52 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 122.191 0.996 . . . . 71.430000000000007 112.304 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 47.3 m -138.17 98.53 3.64 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 114.263 -1.335 . . . . 55.0 107.57 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -93.25 -3.99 52.69 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.322 -0.992 . . . . 73.230000000000004 108.322 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -65.41 -46.28 80.61 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.878 -1.056 . . . . 72.409999999999997 108.367 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -101.68 110.28 22.24 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 105.254 -2.128 . . . . 74.510000000000005 105.254 171.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -112.1 133.74 54.07 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 109.212 -0.662 . . . . 74.200000000000003 109.212 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 29.7 p -63.7 -31.87 73.18 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.845 -0.616 . . . . 73.340000000000003 110.767 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 26.8 m -74.77 103.25 4.96 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.615 -1.254 . . . . 74.319999999999993 107.615 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 61.1 t -73.29 131.34 35.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.727 -0.669 . . . . 72.340000000000003 111.561 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 C--N 1.304 -1.397 0 N-CA-C 108.387 -0.968 . . . . 75.030000000000001 108.387 175.367 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 11.9 t60 . . . . . 0 N--CA 1.445 -0.685 0 CA-C-O 121.326 0.584 . . . . 74.420000000000002 110.361 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -80.29 -45.78 17.3 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.782 0.801 . . . . 75.439999999999998 109.158 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 174.9 -161.88 31.53 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 109.033 -1.627 . . . . 74.450000000000003 109.033 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.466 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.4 mp -116.25 121.37 67.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 117.202 0.501 . . . . 73.25 111.359 -174.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.547 ' CD2' HG22 ' A' ' 528' ' ' THR . 30.7 m-85 -95.86 135.65 37.31 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.011 -0.737 . . . . 73.200000000000003 109.011 168.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.6 t -167.32 179.66 4.93 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.088 -0.708 . . . . 73.150000000000006 109.088 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.07 152.05 22.3 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.455 -0.572 . . . . 74.120000000000005 109.455 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.66 -37.12 84.13 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.79 -0.448 . . . . 74.540000000000006 109.79 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -125.97 149.73 67.08 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 109.62 -0.511 . . . . 73.140000000000001 109.62 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.01 -27.67 6.68 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.678 1.585 . . . . 75.219999999999999 111.771 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 47.4 t -135.48 135.26 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.883 -0.784 . . . . 74.140000000000001 108.883 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.9 t -132.28 140.45 48.62 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.724 -0.843 . . . . 70.25 108.724 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 44.9 p-80 -112.71 127.51 56.15 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.383 0.611 . . . . 75.049999999999997 109.496 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.7 m -112.18 165.2 7.33 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.453 -0.794 . . . . 64.439999999999998 109.211 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 15.4 t -101.2 166.35 10.82 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.666 0.746 . . . . 75.340000000000003 112.134 -172.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.423 ' CB ' ' HA ' ' A' ' 648' ' ' GLU . 12.6 tp10 -80.11 -19.67 46.8 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.101 -1.409 . . . . 75.319999999999993 107.991 173.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 650' ' ' TYR . 19.3 m -114.15 29.65 7.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.991 -0.55 . . . . 61.299999999999997 111.763 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.2 tt -97.86 -39.26 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 119.763 -0.775 . . . . 65.450000000000003 113.044 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 90.28 -72.95 1.94 Allowed Glycine 0 CA--C 1.506 -0.529 0 C-N-CA 120.662 -0.78 . . . . 52.119999999999997 111.645 -176.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . 0.475 ' CD1' ' HE3' ' A' ' 574' ' ' LYS . 33.8 mm -128.03 126.87 67.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.65 -1.241 . . . . 75.120000000000005 107.65 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.434 ' HE2' ' CG2' ' A' ' 573' ' ' VAL . 0.0 OUTLIER -107.21 147.96 29.5 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.273 -1.01 . . . . 63.310000000000002 108.273 177.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 51.4 mp0 -122.41 131.9 54.1 Favored 'General case' 0 N--CA 1.434 -1.252 0 O-C-N 123.716 0.635 . . . . 73.400000000000006 110.304 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 570' ' ' THR . 25.3 t -110.95 129.51 66.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.785 -0.643 . . . . 73.120000000000005 109.47 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 6.5 mmmm -86.28 120.28 27.46 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 123.744 0.818 . . . . 74.239999999999995 109.437 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 568' ' ' VAL . 47.9 t -100.65 122.88 53.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 109.184 -0.673 . . . . 72.0 109.184 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.1 mt -69.82 126.7 30.5 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.855 -0.611 . . . . 71.340000000000003 110.173 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.41 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 57.0 ttp180 -74.32 160.82 30.55 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.69 -1.141 . . . . 72.099999999999994 108.997 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.547 HG22 ' CD2' ' A' ' 505' ' ' PHE . 2.5 p -56.98 139.09 53.18 Favored 'General case' 0 N--CA 1.421 -1.881 0 C-N-CA 123.125 0.57 . . . . 75.299999999999997 111.843 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.9 m -51.07 -33.84 27.47 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.863 1.265 . . . . 73.109999999999999 110.059 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -119.78 107.39 1.33 Allowed Glycine 0 N--CA 1.416 -2.646 0 N-CA-C 108.456 -1.858 . . . . 72.519999999999996 108.456 171.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -88.69 101.28 13.84 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.081 -0.711 . . . . 71.200000000000003 109.081 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -116.9 102.02 9.02 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.674 -0.694 . . . . 75.219999999999999 110.798 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 86.1 -157.33 30.58 Favored Glycine 0 C--N 1.311 -0.818 0 C-N-CA 120.826 -0.702 . . . . 43.439999999999998 112.87 174.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -107.0 127.69 53.68 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.606 -0.887 . . . . 72.319999999999993 108.606 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.21 141.68 45.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 C-N-CA 122.768 0.427 . . . . 71.439999999999998 109.981 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.567 HG12 ' CG2' ' A' ' 597' ' ' VAL . 42.4 mm -108.79 134.28 51.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.571 -0.9 . . . . 75.239999999999995 108.571 173.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.55 107.2 43.21 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 109.106 -0.701 . . . . 75.430000000000007 109.106 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -70.36 152.17 66.07 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.871 1.714 . . . . 64.439999999999998 110.999 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -148.52 157.88 43.76 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.674 -0.491 . . . . 64.120000000000005 109.674 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.11 152.6 24.67 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.914 0.759 . . . . 74.430000000000007 110.441 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.9 p -85.22 143.4 28.78 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.0 -0.545 . . . . 74.239999999999995 109.965 176.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 82.5 mt -105.59 122.2 58.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 108.368 -0.975 . . . . 73.430000000000007 108.368 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -81.45 145.35 30.81 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 123.754 0.659 . . . . 71.230000000000004 109.909 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -175.03 -99.76 0.12 Allowed Glycine 0 CA--C 1.483 -1.921 0 N-CA-C 111.038 -0.825 . . . . 51.109999999999999 111.038 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.43 29.17 0.51 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.148 0.979 . . . . 74.310000000000002 110.37 -175.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -165.66 145.3 6.49 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.563 -1.643 . . . . 72.129999999999995 106.563 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -86.3 127.22 34.75 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 113.0 0.741 . . . . 74.230000000000004 113.0 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.79 -164.09 38.68 Favored Glycine 0 C--N 1.302 -1.324 0 CA-C-N 114.446 -1.252 . . . . 55.340000000000003 110.755 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.95 18.4 76.24 Favored Glycine 0 C--N 1.318 -0.441 0 CA-C-N 117.509 0.654 . . . . 75.349999999999994 112.796 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 75.71 44.8 19.25 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.627 -0.797 . . . . 71.540000000000006 111.133 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -114.75 -59.25 2.04 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.609 -0.436 . . . . 54.149999999999999 110.074 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -100.82 -37.12 8.83 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 107.417 -1.327 . . . . 73.239999999999995 107.417 171.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -141.38 150.88 42.97 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 114.661 -1.154 . . . . 75.510000000000005 107.939 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.58 113.67 20.45 Favored 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 106.446 -1.687 . . . . 60.130000000000003 106.446 174.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -76.21 131.89 39.59 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.752 -0.833 . . . . 61.119999999999997 108.752 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.9 t -128.34 148.21 50.67 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 121.688 0.756 . . . . 63.130000000000003 110.965 -172.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 25.3 p -141.39 151.39 43.44 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 106.294 -1.743 . . . . 74.400000000000006 106.294 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 171.48 -161.12 33.41 Favored Glycine 0 N--CA 1.417 -2.587 0 C-N-CA 119.972 -1.109 . . . . 65.310000000000002 110.978 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.526 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 47.1 mt-10 -139.39 130.96 27.17 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 122.497 0.319 . . . . 65.329999999999998 110.745 -176.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 98.7 mt -95.56 142.21 28.17 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.918 -0.771 . . . . 74.450000000000003 108.918 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -108.9 118.73 37.55 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.294 0.568 . . . . 74.530000000000001 110.824 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -117.53 156.49 27.97 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.538 -0.756 . . . . 74.400000000000006 109.51 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 533' ' ' GLY . 47.3 mt-30 -148.54 178.74 8.36 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.118 -1.067 . . . . 70.129999999999995 108.118 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -67.83 -30.79 70.27 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.683 -0.858 . . . . 64.230000000000004 108.683 172.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -84.22 -44.86 13.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.228 -0.897 . . . . 74.140000000000001 110.429 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.433 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 70.5 mm-40 -65.72 136.97 56.95 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 123.587 0.755 . . . . 75.010000000000005 111.021 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.548 HG13 ' H ' ' A' ' 568' ' ' VAL . 9.5 pt -89.78 -92.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 114.055 1.131 . . . . 75.340000000000003 114.055 -177.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.548 ' H ' HG13 ' A' ' 567' ' ' ILE . 8.5 p -119.41 149.82 21.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.62 -0.511 . . . . 74.430000000000007 109.62 -176.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -115.1 157.05 24.1 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.175 -0.676 . . . . 74.340000000000003 109.175 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.6 p -122.5 137.75 54.78 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.232 -0.895 . . . . 74.530000000000001 110.925 177.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 24.3 mt -94.71 118.98 42.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 107.898 -1.149 . . . . 75.319999999999993 107.898 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 11.8 p -94.66 115.61 27.75 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 124.002 0.814 . . . . 72.010000000000005 110.611 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.434 ' CG2' ' HE2' ' A' ' 521' ' ' MET . 89.2 t -119.79 129.61 75.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 CA-C-O 120.712 0.291 . . . . 63.420000000000002 110.46 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.475 ' HE3' ' CD1' ' A' ' 520' ' ' ILE . 4.1 tppp? -83.88 119.08 24.44 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.844 0.857 . . . . 75.400000000000006 110.158 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 29.9 t -88.49 121.78 39.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 106.03 -1.841 . . . . 74.439999999999998 106.03 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 48.3 mm -79.91 141.01 15.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.241 0.543 . . . . 73.549999999999997 111.191 -173.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -93.15 110.42 21.92 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.921 -1.14 . . . . 54.039999999999999 107.921 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -129.74 130.91 46.03 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 120.929 0.395 . . . . 70.420000000000002 110.586 -174.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -94.22 94.55 8.4 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.409 0.624 . . . . 74.430000000000007 109.728 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -141.12 -166.77 2.24 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 125.09 1.356 . . . . 72.25 107.425 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -118.95 67.19 0.78 Allowed 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 122.25 1.024 . . . . 73.510000000000005 108.513 174.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -95.06 145.35 25.02 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 115.24 1.57 . . . . 73.230000000000004 115.24 -171.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -89.95 170.54 10.28 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 112.843 -1.98 . . . . 75.310000000000002 107.756 175.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . 0.476 ' ND2' ' HB3' ' A' ' 647' ' ' GLU . 27.0 t-20 -44.21 115.54 0.85 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.333 1.453 . . . . 73.400000000000006 112.51 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -97.15 145.74 25.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.395 -0.82 . . . . 74.439999999999998 110.282 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.0 t -156.65 136.6 12.63 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.188 0.518 . . . . 74.109999999999999 111.27 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -131.6 179.13 6.23 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.325 -0.991 . . . . 75.340000000000003 108.325 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.446 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 82.1 m-85 -125.2 155.33 40.2 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 109.19 -0.671 . . . . 75.340000000000003 109.19 -176.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.51 131.1 53.95 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.613 -1.625 . . . . 74.239999999999995 106.613 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.409 ' HB2' HD12 ' A' ' 542' ' ' ILE . 33.4 tt0 -126.0 137.43 53.66 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.547 -0.538 . . . . 73.010000000000005 109.547 176.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 14.9 pt -104.53 142.1 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.175 0 N-CA-C 107.772 -1.195 . . . . 74.420000000000002 107.772 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.37 176.4 49.98 Favored Glycine 0 N--CA 1.414 -2.795 0 N-CA-C 110.398 -1.081 . . . . 74.099999999999994 110.398 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.97 128.62 92.71 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-O 120.883 0.373 . . . . 75.340000000000003 111.047 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.13 128.24 24.61 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.728 2.952 . . . . 72.209999999999994 112.521 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -110.23 119.04 37.97 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.316 -0.856 . . . . 71.409999999999997 109.81 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.17 134.31 53.45 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.415 -0.957 . . . . 73.010000000000005 108.415 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.567 ' CG2' HG12 ' A' ' 536' ' ' ILE . 34.7 t -91.2 100.59 11.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.396 0.617 . . . . 72.420000000000002 109.853 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.49 117.9 28.74 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 105.454 -2.054 . . . . 63.439999999999998 105.454 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 23.6 ttt -66.17 -19.34 65.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.895 0.378 . . . . 74.409999999999997 111.451 -174.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 36.4 t -73.99 110.2 8.09 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 105.258 -2.127 . . . . 73.140000000000001 105.258 170.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -76.14 106.8 7.95 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-O 121.869 0.842 . . . . 72.230000000000004 109.933 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -102.85 119.32 38.63 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.376 -1.284 . . . . 75.510000000000005 109.961 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . 0.486 ' HA ' ' HE2' ' A' ' 603' ' ' LYS . 11.0 mmpt? -89.44 -38.74 13.85 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.707 -1.22 . . . . 74.109999999999999 107.707 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 68.78 -152.31 52.22 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 114.878 -1.055 . . . . 71.430000000000007 111.528 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 607' ' ' THR . . . -85.37 90.32 1.65 Allowed Glycine 0 N--CA 1.418 -2.526 0 N-CA-C 110.113 -1.195 . . . . 73.420000000000002 110.113 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -76.4 44.01 0.33 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-O 122.716 1.246 . . . . 74.549999999999997 110.659 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 607' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 621' ' ' LYS . 24.1 m -78.15 141.34 38.77 Favored 'General case' 0 N--CA 1.41 -2.467 0 CA-C-N 114.089 -1.414 . . . . 74.430000000000007 108.947 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 30.0 pt -95.74 151.59 3.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.769 -0.826 . . . . 75.219999999999999 108.769 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 19.5 m -68.36 -43.27 77.78 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.771 -0.826 . . . . 75.299999999999997 108.771 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 62.21 15.16 7.28 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.631 1.172 . . . . 72.129999999999995 112.23 174.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -86.03 112.57 21.36 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.346 -1.353 . . . . 73.129999999999995 107.346 175.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -76.4 89.78 3.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.342 -0.984 . . . . 73.420000000000002 108.342 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -146.19 -68.69 0.27 Allowed 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 107.076 -1.453 . . . . 71.140000000000001 107.076 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 4.5 p30 44.23 34.38 1.0 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.609 1.564 . . . . 71.239999999999995 114.342 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -78.15 2.65 17.38 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.102 0.953 . . . . 72.239999999999995 110.111 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -160.03 147.27 12.57 Favored Pre-proline 0 N--CA 1.425 -1.704 0 N-CA-C 105.33 -2.1 . . . . 62.210000000000001 105.33 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -69.02 92.6 0.45 Allowed 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 121.427 1.418 . . . . 71.109999999999999 110.719 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.5 tp -109.66 106.08 15.6 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.873 -0.603 . . . . 73.140000000000001 110.932 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 25.4 m -96.49 95.1 7.78 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.922 -0.581 . . . . 75.430000000000007 109.715 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 49.1 m -106.46 112.87 26.06 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.549 -0.537 . . . . 75.310000000000002 109.549 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 607' ' ' THR . 68.7 mttm -132.24 -176.32 4.04 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.629 -0.714 . . . . 75.420000000000002 109.302 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -75.28 130.1 38.52 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 123.636 0.585 . . . . 74.209999999999994 110.654 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.75 116.85 22.89 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.778 0.799 . . . . 75.109999999999999 109.866 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . 0.476 ' OE1' ' HD3' ' A' ' 626' ' ' ARG . 0.0 OUTLIER -96.93 73.38 2.58 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.041 -0.981 . . . . 74.099999999999994 111.472 -177.082 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 59.43 26.4 15.31 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.721 0.772 . . . . 75.519999999999996 109.46 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.476 ' HD3' ' OE1' ' A' ' 624' ' ' GLU . 13.3 tpt180 -56.94 -57.93 10.36 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 125.506 1.522 . . . . 73.239999999999995 112.377 -170.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . 0.534 ' HD3' ' O ' ' A' ' 627' ' ' ARG . 0.0 OUTLIER -62.15 -34.13 75.81 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.895 0.378 . . . . 71.239999999999995 110.373 -175.313 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.421 ' O ' ' HG2' ' A' ' 631' ' ' MET . 61.5 mt -70.22 -43.1 78.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.241 -0.652 . . . . 74.420000000000002 109.241 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' A' ' 633' ' ' ARG . . . -63.95 -45.28 89.87 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.31 -0.859 . . . . 75.109999999999999 111.363 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.497 ' HA ' ' CG ' ' A' ' 633' ' ' ARG . 51.6 mt-10 -59.64 -11.08 4.26 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 116.508 2.04 . . . . 74.540000000000006 116.508 -173.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 25.4 ptt? -79.64 -10.38 59.78 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.888 -0.725 . . . . 75.040000000000006 109.784 176.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -134.38 48.03 0.96 Allowed Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.283 -1.127 . . . . 65.430000000000007 110.283 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 629' ' ' ALA . 9.6 mmm180 -127.81 155.81 76.8 Favored Pre-proline 0 C--N 1.316 -0.887 0 N-CA-C 109.979 -0.378 . . . . 72.349999999999994 109.979 -176.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.43 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 43.9 Cg_endo -67.55 133.96 31.53 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.095 1.864 . . . . 71.150000000000006 110.252 174.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.86 162.87 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 108.928 -0.767 . . . . 74.519999999999996 108.928 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.417 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.8 OUTLIER -96.89 166.57 11.56 Favored 'General case' 0 N--CA 1.424 -1.733 0 C-N-CA 119.377 -0.929 . . . . 75.510000000000005 111.813 178.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . 0.466 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -69.36 -168.25 5.86 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 116.182 1.233 . . . . 72.230000000000004 116.182 -175.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -70.83 -39.5 72.98 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.085 -1.058 . . . . 65.120000000000005 108.452 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -138.73 121.92 16.94 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.354 -0.839 . . . . 75.319999999999993 110.05 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 640' ' ' THR . . . . . 0.417 HG21 ' HB2' ' A' ' 636' ' ' LEU . 17.8 p -121.92 92.87 3.83 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.789 -0.641 . . . . 73.450000000000003 109.735 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . 0.49 ' HZ3' ' HB2' ' A' ' 641' ' ' LYS . 4.9 ttmp? -161.95 143.01 10.75 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.627 -1.249 . . . . 72.319999999999993 107.627 -175.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.423 HD21 HG13 ' A' ' 523' ' ' VAL . 16.4 tp -128.69 125.7 38.56 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 107.726 -1.212 . . . . 74.430000000000007 107.726 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -93.86 111.48 23.19 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.098 -1.445 . . . . 73.120000000000005 107.098 176.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.86 113.56 39.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.208 -0.664 . . . . 71.349999999999994 109.208 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 38.3 mt -100.43 128.62 52.28 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.554 0 N-CA-C 108.298 -1.001 . . . . 73.540000000000006 108.298 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 57.9 mt -104.51 107.61 22.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 106.894 -1.521 . . . . 65.200000000000003 106.894 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.476 ' HB3' ' ND2' ' A' ' 584' ' ' ASN . 6.7 pt-20 -128.81 145.01 51.31 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 120.327 -0.549 . . . . 74.430000000000007 111.934 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.423 ' HA ' ' CB ' ' A' ' 516' ' ' GLU . 35.9 mt-10 -71.09 118.41 13.83 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.853 -0.612 . . . . 72.540000000000006 111.979 -174.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.5 p -144.47 78.29 1.57 Allowed 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.044 -0.98 . . . . 70.310000000000002 108.826 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . 0.46 ' HA ' ' OG ' ' A' ' 517' ' ' SER . 35.7 m-85 -63.54 -54.99 27.5 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 114.414 -1.266 . . . . 72.219999999999999 112.463 -174.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -79.88 -27.06 40.06 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.734 -0.839 . . . . 74.129999999999995 108.734 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 34.5 t80 71.32 20.23 5.05 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.581 1.553 . . . . 73.319999999999993 108.592 -177.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -112.43 128.74 56.4 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.792 -1.549 . . . . 63.420000000000002 107.448 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 35.7 m -78.23 84.24 4.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.996 -0.742 . . . . 63.43 108.996 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 25.9 m -73.12 -41.43 64.01 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 108.673 -0.862 . . . . 65.120000000000005 108.673 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 55.0 t -121.37 116.11 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 N-CA-C 107.445 -1.317 . . . . 74.129999999999995 107.445 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 . . . . . 0 C--N 1.31 -1.136 0 N-CA-C 109.962 -0.384 . . . . 74.5 109.962 179.759 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 76.3 t60 . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 121.069 0.461 . . . . 73.209999999999994 110.195 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.498 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . -71.69 -91.58 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 113.864 1.061 . . . . 73.129999999999995 113.864 -174.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 159.32 -135.42 4.16 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 118.383 -1.865 . . . . 61.240000000000002 113.145 -173.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.4 120.08 55.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 122.075 0.15 . . . . 74.530000000000001 110.968 -173.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.443 ' CE2' ' HB ' ' A' ' 528' ' ' THR . 23.8 m-85 -108.68 126.53 53.09 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.25 -1.019 . . . . 72.099999999999994 108.25 169.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.6 t -171.2 -178.82 2.51 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.671 -0.863 . . . . 75.140000000000001 108.671 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -87.79 152.12 22.36 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 110.444 -0.206 . . . . 73.409999999999997 110.444 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -59.64 -41.11 89.78 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.648 0.737 . . . . 74.120000000000005 110.165 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -135.16 146.59 58.91 Favored Pre-proline 0 N--CA 1.42 -1.96 0 CA-C-N 114.741 -1.118 . . . . 73.5 108.227 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -71.08 -29.89 17.08 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.167 1.911 . . . . 74.310000000000002 112.665 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.13 136.79 55.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.639 -0.874 . . . . 54.329999999999998 108.639 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.2 t -133.65 141.24 47.53 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 108.39 -0.966 . . . . 74.329999999999998 108.39 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -109.44 132.94 53.66 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.073 -1.051 . . . . 54.240000000000002 109.352 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.3 m -124.34 165.99 20.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 109.044 -0.724 . . . . 73.510000000000005 109.044 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.444 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 72.4 m -93.78 152.61 18.81 Favored 'General case' 0 N--CA 1.394 -3.25 0 CA-C-N 115.649 -0.705 . . . . 75.430000000000007 110.774 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -68.22 -56.74 7.62 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.623 0.725 . . . . 72.200000000000003 109.073 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.69 40.68 0.6 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 125.121 1.368 . . . . 74.120000000000005 111.69 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.444 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 12.0 tt -104.71 -26.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.155 0.503 . . . . 73.450000000000003 111.73 -175.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . 0.423 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 91.76 -79.06 1.28 Allowed Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 110.839 -0.904 . . . . 65.230000000000004 110.839 -175.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 37.2 mm -129.79 133.45 64.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.674 -1.232 . . . . 75.430000000000007 107.674 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.541 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -109.91 146.5 35.06 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.445 -0.946 . . . . 74.120000000000005 108.445 175.456 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 26.4 mt-10 -125.7 120.12 29.83 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 123.645 0.591 . . . . 74.530000000000001 111.544 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.541 HG23 ' SD ' ' A' ' 521' ' ' MET . 65.9 t -112.55 129.23 68.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.628 -0.878 . . . . 74.329999999999998 108.628 177.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . 0.49 ' HB3' HG22 ' A' ' 568' ' ' VAL . 29.1 mtmt -86.76 143.13 27.67 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 123.808 0.692 . . . . 75.329999999999998 110.698 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.528 ' O ' HG23 ' A' ' 568' ' ' VAL . 43.3 t -105.02 141.63 19.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.755 -0.657 . . . . 74.519999999999996 109.322 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.96 118.51 17.99 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.69 -0.856 . . . . 74.150000000000006 108.69 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -73.76 153.21 40.1 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.072 -0.714 . . . . 73.450000000000003 109.072 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.443 ' HB ' ' CE2' ' A' ' 505' ' ' PHE . 12.0 t -60.16 157.52 13.07 Favored 'General case' 0 N--CA 1.41 -2.435 0 C-N-CA 123.857 0.863 . . . . 73.420000000000002 110.727 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.0 t -72.01 -26.95 62.42 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.711 0.767 . . . . 61.420000000000002 109.775 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.85 82.91 0.33 Allowed Glycine 0 N--CA 1.428 -1.842 0 CA-C-N 115.688 -0.687 . . . . 73.349999999999994 111.486 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.64 100.31 13.18 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.655 -1.239 . . . . 73.540000000000006 107.655 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -111.86 96.84 6.29 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.627 0.727 . . . . 73.340000000000003 111.882 -176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 101.96 -122.84 7.69 Favored Glycine 0 N--CA 1.428 -1.859 0 CA-C-N 114.576 -1.193 . . . . 73.230000000000004 110.417 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -133.13 127.98 35.09 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.13 0.49 . . . . 73.099999999999994 110.295 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 64.5 t -130.39 136.54 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 108.837 -0.801 . . . . 72.010000000000005 108.837 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.511 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 40.3 mm -106.69 138.46 32.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 109.088 -0.708 . . . . 74.129999999999995 109.088 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.1 t -122.91 110.08 31.66 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 109.598 -0.519 . . . . 65.219999999999999 109.598 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.28 155.19 51.56 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.362 2.041 . . . . 71.409999999999997 111.903 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.407 ' HB3' HG23 ' A' ' 591' ' ' ILE . 31.5 p90 -150.84 156.15 40.66 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 110.153 -0.314 . . . . 73.109999999999999 110.153 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.59 156.21 40.93 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 123.714 0.634 . . . . 73.030000000000001 111.922 175.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 18.9 p -79.35 153.59 29.68 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 109.373 -0.603 . . . . 74.430000000000007 109.373 175.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 81.8 mt -117.54 113.91 43.95 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 107.313 -1.365 . . . . 74.420000000000002 107.313 176.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -84.2 147.58 27.21 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.305 -0.861 . . . . 75.400000000000006 108.732 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 178.31 -91.82 0.08 OUTLIER Glycine 0 C--N 1.307 -1.046 0 C-N-CA 120.601 -0.809 . . . . 73.409999999999997 111.526 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -2.6 30.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.679 0.752 . . . . 74.040000000000006 112.045 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -144.43 141.52 29.68 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 104.536 -2.394 . . . . 72.340000000000003 104.536 171.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.48 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 71.9 mtt180 -104.05 145.69 29.81 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 121.912 0.863 . . . . 72.319999999999993 112.635 -173.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.73 -153.23 27.83 Favored Glycine 0 N--CA 1.421 -2.303 0 N-CA-C 109.371 -1.492 . . . . 63.25 109.371 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 78.0 8.75 87.3 Favored Glycine 0 C--N 1.292 -1.891 0 N-CA-C 111.429 -0.668 . . . . 65.239999999999995 111.429 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 79.05 29.6 50.36 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 110.647 -0.981 . . . . 73.430000000000007 110.647 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.48 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 32.1 tt0 -96.86 -60.99 1.48 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.712 -0.477 . . . . 73.340000000000003 109.712 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -103.3 -43.71 5.36 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 108.609 -0.886 . . . . 72.420000000000002 108.609 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -135.11 158.1 45.23 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.377 -0.829 . . . . 73.430000000000007 109.013 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.459 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 13.9 tt0 -84.19 138.3 33.06 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.604 -1.258 . . . . 74.010000000000005 107.604 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.81 121.19 18.53 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 109.682 -0.488 . . . . 61.520000000000003 109.682 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.435 ' CG2' HG23 ' A' ' 573' ' ' VAL . 13.5 t -130.13 146.11 51.75 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-O 121.468 0.651 . . . . 73.099999999999994 109.411 176.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 5.0 p -167.52 155.27 8.94 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.973 -1.492 . . . . 73.319999999999993 106.973 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 165.01 -153.44 23.63 Favored Glycine 0 N--CA 1.41 -3.086 0 C-N-CA 119.789 -1.196 . . . . 72.340000000000003 110.484 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.511 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 46.7 mt-10 -139.55 133.09 30.31 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.117 0.484 . . . . 72.439999999999998 110.466 -175.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 569' ' ' LYS . 96.5 mt -97.36 137.91 35.62 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.827 -0.624 . . . . 72.420000000000002 109.468 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -99.18 115.47 29.16 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 121.203 0.525 . . . . 45.109999999999999 110.706 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -111.63 145.05 39.89 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.604 -0.887 . . . . 74.340000000000003 108.604 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.434 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 46.7 mt-30 -147.25 -176.3 5.17 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.582 -0.896 . . . . 73.230000000000004 108.582 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -68.4 -31.69 71.21 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.452 -0.944 . . . . 55.049999999999997 108.452 172.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -84.49 -38.39 20.15 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.572 -1.195 . . . . 74.049999999999997 111.671 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.434 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 36.5 mm-40 -75.67 129.33 36.96 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 116.674 -0.239 . . . . 74.030000000000001 111.064 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.56 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.8 pt -90.02 -72.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.897 -0.592 . . . . 61.210000000000001 111.804 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.56 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.5 p -130.96 149.23 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 CA-C-O 121.204 0.526 . . . . 75.519999999999996 110.347 -177.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.415 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -120.29 156.43 31.26 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 109.387 -0.597 . . . . 74.530000000000001 109.387 175.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.43 ' CG2' ' HG2' ' A' ' 524' ' ' LYS . 3.3 p -119.81 147.28 44.84 Favored 'General case' 0 C--N 1.283 -2.285 0 O-C-N 124.161 0.913 . . . . 71.349999999999994 112.721 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.2 mp -94.41 122.6 46.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 106.353 -1.721 . . . . 74.430000000000007 106.353 172.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 572' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 521' ' ' MET . 18.7 m -102.94 116.81 33.27 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 123.813 0.696 . . . . 75.329999999999998 109.127 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.453 ' CG2' ' HE2' ' A' ' 521' ' ' MET . 86.2 t -119.47 128.46 75.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 109.144 -0.688 . . . . 73.340000000000003 109.144 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.459 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 23.9 tptm -83.97 124.1 30.68 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.752 -0.832 . . . . 75.540000000000006 108.752 176.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 47.9 t -94.26 127.36 46.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 108.61 -0.885 . . . . 72.230000000000004 108.61 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 45.5 mm -81.61 149.77 4.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.658 -0.867 . . . . 73.239999999999995 108.658 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -73.77 89.75 1.82 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.384 -0.969 . . . . 74.430000000000007 108.384 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -75.35 134.88 40.89 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.447 0.642 . . . . 72.230000000000004 112.448 -175.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -106.82 -19.57 13.6 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.206 -0.907 . . . . 73.430000000000007 109.246 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.484 ' C ' ' H ' ' A' ' 582' ' ' GLU . 2.0 mp0 -96.19 44.08 1.07 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.296 -0.865 . . . . 74.239999999999995 109.495 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -75.06 34.17 0.1 Allowed 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 124.24 1.016 . . . . 74.329999999999998 112.111 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.484 ' H ' ' C ' ' A' ' 580' ' ' GLU . 32.8 mt-10 -61.53 -41.83 97.92 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.587 1.555 . . . . 74.230000000000004 108.709 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 584' ' ' ASN . 8.4 tmtt? -118.62 141.34 48.69 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 105.918 -1.882 . . . . 74.230000000000004 105.918 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . 0.466 ' N ' ' HD3' ' A' ' 583' ' ' LYS . 3.8 t-20 -60.31 120.02 9.05 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.367 -0.975 . . . . 74.230000000000004 108.367 174.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -85.75 136.84 33.18 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.152 0.501 . . . . 73.5 111.098 -171.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.0 t -153.32 135.73 15.04 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 109.48 -0.563 . . . . 73.010000000000005 109.48 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -129.37 178.1 6.69 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.786 -1.19 . . . . 72.120000000000005 107.786 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.481 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 67.4 m-85 -123.43 154.59 38.84 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.806 -0.813 . . . . 75.319999999999993 108.806 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.81 131.3 53.56 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 106.191 -1.781 . . . . 72.129999999999995 106.191 178.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -126.97 139.06 53.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.589 -0.523 . . . . 73.540000000000006 109.589 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . 0.407 HG23 ' HB3' ' A' ' 539' ' ' TYR . 20.3 pt -106.0 141.57 21.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.322 -0.992 . . . . 75.420000000000002 108.322 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.12 179.54 49.67 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 111.236 -0.746 . . . . 72.219999999999999 111.236 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.78 134.26 86.08 Favored Pre-proline 0 N--CA 1.435 -1.225 0 C-N-CA 120.912 -0.315 . . . . 75.519999999999996 110.632 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.36 146.94 96.72 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.255 2.636 . . . . 74.230000000000004 112.064 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -124.47 125.04 43.6 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.024 -0.534 . . . . 73.25 109.562 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -72.08 129.17 37.86 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.664 -1.236 . . . . 75.129999999999995 107.664 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.488 ' CG2' HG12 ' A' ' 536' ' ' ILE . 48.6 t -82.07 106.07 12.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.766 -0.827 . . . . 65.049999999999997 108.766 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.476 ' HA ' ' OE1' ' A' ' 598' ' ' GLU . 4.4 mm-40 -80.04 118.32 21.66 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 114.939 -1.028 . . . . 73.409999999999997 113.725 -176.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 92.4 mmm -97.23 -2.21 43.26 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.29 -1.323 . . . . 73.549999999999997 107.452 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 52.3 m -131.78 132.87 44.15 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.277 -1.379 . . . . 72.540000000000006 107.277 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -84.06 154.02 23.46 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 110.343 -0.243 . . . . 74.230000000000004 110.343 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -81.6 147.0 29.81 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.87 -0.789 . . . . 72.109999999999999 108.87 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -72.5 107.56 5.1 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.849 -0.797 . . . . 72.030000000000001 108.849 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 143.95 -33.17 1.75 Allowed Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 108.565 -1.814 . . . . 63.350000000000001 108.565 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 102.39 -156.96 18.41 Favored Glycine 0 N--CA 1.429 -1.807 0 N-CA-C 111.487 -0.645 . . . . 55.030000000000001 111.487 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 59.24 17.35 5.65 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.717 1.207 . . . . 75.329999999999998 113.474 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 32.8 m -71.57 -8.01 51.3 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-O 121.481 0.658 . . . . 74.310000000000002 112.314 -174.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 24.8 pt -72.26 -5.73 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.628 -0.67 . . . . 75.340000000000003 111.24 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 21.3 m -145.94 158.54 43.86 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.69 -1.596 . . . . 75.299999999999997 106.69 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -82.06 -64.74 1.12 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 118.837 -1.145 . . . . 74.530000000000001 108.91 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -143.21 157.11 44.79 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.54 -0.541 . . . . 74.420000000000002 109.54 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -57.25 -65.89 0.55 Allowed 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.316 0.858 . . . . 74.209999999999994 113.316 -175.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 34.2 t70 176.69 117.56 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.474 -0.936 . . . . 75.140000000000001 108.474 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -158.23 170.37 22.42 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.426 -0.583 . . . . 75.030000000000001 109.426 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . 0.43 ' HZ2' ' HB3' ' A' ' 615' ' ' LYS . 0.2 OUTLIER -140.9 163.42 33.01 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.874 -1.158 . . . . 70.310000000000002 107.874 177.084 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 69.8 165.66 0.13 Allowed Pre-proline 0 N--CA 1.485 1.308 0 O-C-N 124.401 1.063 . . . . 73.319999999999993 111.546 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.98 144.21 57.83 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.127 1.885 . . . . 75.430000000000007 110.726 172.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 94.0 mt -83.88 179.47 7.55 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.754 0.788 . . . . 62.119999999999997 113.009 -174.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 37.6 m -101.8 152.93 20.29 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 114.473 -1.239 . . . . 74.340000000000003 108.134 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 620' ' ' SER . . . . . 0.4 ' HA ' ' OE2' ' A' ' 625' ' ' GLU . 14.2 t -65.64 142.58 58.01 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.221 0.534 . . . . 71.030000000000001 111.266 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -144.14 155.43 43.93 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.125 -1.065 . . . . 73.019999999999996 108.125 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -87.08 73.43 9.84 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.625 0.726 . . . . 72.219999999999999 109.315 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -167.49 -173.02 2.09 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.246 -2.131 . . . . 72.430000000000007 105.246 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -73.38 93.08 1.9 Allowed 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 108.922 -0.77 . . . . 74.409999999999997 108.922 173.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.4 ' OE2' ' HA ' ' A' ' 620' ' ' SER . 40.3 mt-10 -60.81 155.59 19.11 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 108.521 -0.918 . . . . 74.099999999999994 108.521 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 65.1 ttt180 -62.86 -36.86 84.65 Favored 'General case' 0 C--O 1.2 -1.534 0 C-N-CA 119.968 -0.693 . . . . 73.040000000000006 111.072 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -62.27 -27.63 69.15 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 121.128 0.49 . . . . 74.400000000000006 110.607 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.512 ' O ' ' HG2' ' A' ' 631' ' ' MET . 69.7 mt -79.49 -44.85 23.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.208 -1.034 . . . . 71.140000000000001 108.208 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 633' ' ' ARG . . . -64.01 -37.63 88.14 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.933 -1.03 . . . . 73.400000000000006 111.887 -177.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 65.0 mm-40 -58.42 -18.43 28.28 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.902 1.075 . . . . 75.239999999999995 113.902 -178.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 24.6 ptt? -91.96 -10.5 39.15 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.711 -0.795 . . . . 74.150000000000006 110.331 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -110.4 -38.5 1.62 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.487 -0.863 . . . . 75.519999999999996 111.902 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . 0.503 ' HD2' ' OE2' ' A' ' 630' ' ' GLU . 4.9 ptp180 -79.29 158.24 74.46 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 110.158 -0.312 . . . . 72.019999999999996 110.158 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.498 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 53.3 Cg_endo -68.13 133.28 28.31 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 122.129 1.886 . . . . 65.319999999999993 110.922 174.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.95 175.93 6.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.535 -0.913 . . . . 75.340000000000003 108.535 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.59 -176.3 3.03 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.267 -0.573 . . . . 74.329999999999998 112.086 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -80.62 -153.39 9.21 Favored Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 115.893 -0.594 . . . . 42.020000000000003 113.351 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . 0.511 ' HG2' ' CD2' ' A' ' 639' ' ' HIS . 37.4 tt0 -71.87 -57.13 4.59 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 123.392 0.677 . . . . 74.219999999999999 110.224 -177.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . 0.511 ' CD2' ' HG2' ' A' ' 638' ' ' GLU . 96.6 m-70 -135.06 139.13 44.53 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 109.556 -0.535 . . . . 72.549999999999997 109.556 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 29.7 p -124.47 99.83 6.38 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.206 0.526 . . . . 74.519999999999996 111.249 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -165.8 150.73 8.57 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.082 -1.081 . . . . 74.420000000000002 108.082 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.401 HD21 HG22 ' A' ' 523' ' ' VAL . 34.8 tp -130.95 131.34 44.37 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.021 -1.103 . . . . 72.209999999999994 108.021 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -97.04 104.52 16.54 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.915 -1.513 . . . . 74.519999999999996 106.915 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 40.8 t -99.47 113.53 34.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 109.982 -0.377 . . . . 74.540000000000006 109.982 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 59.6 mt -99.11 126.97 52.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 109.027 -0.731 . . . . 71.019999999999996 109.027 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 57.2 mt -104.06 110.39 30.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.264 -1.013 . . . . 75.439999999999998 108.264 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -119.17 150.64 39.7 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 116.443 -0.344 . . . . 72.010000000000005 110.241 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -81.85 118.09 22.63 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.95 0.881 . . . . 74.530000000000001 109.34 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 17.8 m -122.15 79.42 1.59 Allowed 'General case' 0 N--CA 1.406 -2.66 0 CA-C-N 115.259 -0.882 . . . . 71.120000000000005 110.756 -173.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -94.03 -57.26 2.58 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.164 -1.421 . . . . 64.409999999999997 107.164 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -75.68 -46.22 32.54 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.566 -1.272 . . . . 72.129999999999995 107.566 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 51.9 t80 58.16 80.36 0.18 Allowed 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 114.119 -1.4 . . . . 63.100000000000001 111.035 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -95.71 95.76 8.54 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.006 -0.739 . . . . 74.450000000000003 109.006 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 5.9 t -97.09 85.55 3.75 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 106.737 -1.579 . . . . 74.540000000000006 106.737 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 91.2 m -153.18 137.26 16.39 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.32 -0.855 . . . . 70.430000000000007 109.015 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 48.4 t -90.3 112.45 24.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.749 -0.834 . . . . 72.200000000000003 108.749 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 120.891 0.377 . . . . 72.319999999999993 111.251 -179.541 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 80.6 t60 . . . . . 0 N--CA 1.432 -1.344 0 N-CA-C 107.533 -1.284 . . . . 62.210000000000001 107.533 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.505 ' HB1' ' HA ' ' A' ' 634' ' ' PRO . . . -93.62 -90.84 0.19 Allowed 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 116.44 -0.346 . . . . 75.349999999999994 111.656 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 160.94 -153.24 24.05 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 111.241 -0.743 . . . . 74.340000000000003 111.241 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.86 130.94 67.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 123.148 0.579 . . . . 75.329999999999998 112.049 -167.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -108.51 132.57 53.69 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.315 -0.624 . . . . 63.509999999999998 109.315 168.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.7 t -168.69 173.72 7.1 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.405 -0.591 . . . . 63.409999999999997 109.405 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -77.25 147.26 36.43 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 120.939 0.399 . . . . 73.200000000000003 110.751 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -67.98 -35.65 78.72 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.487 -0.779 . . . . 61.350000000000001 109.906 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -127.76 144.4 51.12 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.115 -1.069 . . . . 74.340000000000003 108.115 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.03 -31.34 6.24 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.146 1.897 . . . . 73.540000000000006 111.986 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.97 138.04 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 106.511 -1.663 . . . . 74.420000000000002 106.511 -177.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.4 t -132.19 140.82 48.86 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 108.06 -1.089 . . . . 73.510000000000005 108.06 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -120.28 124.19 45.03 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 109.253 -0.647 . . . . 74.439999999999998 109.253 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.8 m -115.7 167.34 8.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.001 -1.0 . . . . 75.239999999999995 109.398 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.643 ' O ' HG23 ' A' ' 518' ' ' ILE . 23.2 t -97.04 153.89 17.65 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 120.96 0.41 . . . . 65.340000000000003 110.229 -176.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.5 ' CB ' ' HA ' ' A' ' 648' ' ' GLU . 4.3 tm-20 -65.51 -42.2 92.35 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.143 -1.429 . . . . 74.129999999999995 107.143 169.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' SER . . . . . 0.478 ' OG ' ' HB3' ' A' ' 649' ' ' SER . 14.4 m -90.66 23.98 2.85 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.995 -1.002 . . . . 72.230000000000004 112.432 -173.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 515' ' ' SER . 8.8 tt -90.94 -22.08 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 121.575 -0.703 . . . . 75.430000000000007 109.825 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 83.97 -75.6 2.35 Favored Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.677 -0.773 . . . . 74.030000000000001 111.234 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.0 mm -129.83 130.2 66.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 106.983 -1.488 . . . . 74.219999999999999 106.983 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.593 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -106.39 147.34 29.38 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 109.131 -0.692 . . . . 74.5 109.131 178.612 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.3 mt-10 -127.91 114.84 17.69 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 123.852 0.72 . . . . 65.299999999999997 110.945 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 570' ' ' THR . 90.7 t -102.33 127.96 55.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.778 -0.823 . . . . 74.430000000000007 108.778 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -87.6 138.91 31.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 121.442 0.639 . . . . 73.5 110.667 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 61.0 t -108.2 129.93 61.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.443 -0.799 . . . . 75.519999999999996 108.847 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.5 130.01 41.77 Favored 'General case' 0 CA--C 1.501 -0.915 0 O-C-N 123.862 0.726 . . . . 75.430000000000007 109.87 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -82.65 155.1 24.56 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 115.151 -0.931 . . . . 74.439999999999998 110.024 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.2 t -56.05 145.48 25.51 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 124.763 1.225 . . . . 75.5 111.538 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.9 t -60.53 -31.77 70.84 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 124.375 1.07 . . . . 70.420000000000002 109.042 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -122.26 99.51 0.67 Allowed Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 109.71 -1.356 . . . . 53.439999999999998 109.71 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.44 101.6 12.76 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.948 -1.13 . . . . 63.5 107.948 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -107.75 100.77 10.13 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.261 -0.881 . . . . 74.25 110.389 -172.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 75.53 -114.68 4.33 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.395 -0.907 . . . . 74.340000000000003 112.36 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.449 HD21 ' HG2' ' A' ' 563' ' ' GLN . 2.7 t-20 -133.99 129.18 35.8 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.143 0.577 . . . . 72.109999999999999 109.459 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 93.1 t -130.24 135.64 60.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 C-N-CA 123.56 0.744 . . . . 72.140000000000001 109.126 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.484 HG12 ' CG2' ' A' ' 597' ' ' VAL . 38.0 mm -108.74 131.25 59.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.88 -0.415 . . . . 73.409999999999997 109.88 176.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 26.6 t -119.23 105.9 43.79 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 109.21 -0.663 . . . . 75.109999999999999 109.21 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.86 153.19 58.57 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.317 2.011 . . . . 74.040000000000006 112.048 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.435 ' HB3' HG21 ' A' ' 591' ' ' ILE . 52.1 p90 -151.02 159.64 44.42 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.642 0.258 . . . . 74.400000000000006 110.786 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.03 157.05 33.94 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.463 -0.79 . . . . 75.340000000000003 112.084 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.6 p -84.86 139.68 31.71 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.866 -0.607 . . . . 75.120000000000005 109.828 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.413 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 69.1 mt -107.63 134.37 49.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.132 -0.692 . . . . 74.239999999999995 109.132 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -85.62 142.97 28.71 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.923 -0.58 . . . . 62.310000000000002 110.337 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 151.77 141.58 3.35 Favored Glycine 0 CA--C 1.471 -2.678 0 N-CA-C 107.924 -2.07 . . . . 61.310000000000002 107.924 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . 0.357 1.0 OUTLIER 61.11 -47.17 0.12 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 115.377 1.621 . . . . 70.430000000000007 115.377 -174.066 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -107.87 150.38 27.12 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.193 -1.04 . . . . 75.319999999999993 108.193 174.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -92.37 128.74 38.33 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.745 0.783 . . . . 75.209999999999994 111.347 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.78 -153.5 21.68 Favored Glycine 0 C--N 1.3 -1.421 0 CA-C-N 115.056 -0.975 . . . . 74.129999999999995 112.96 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 57.12 30.84 61.24 Favored Glycine 0 C--N 1.317 -0.48 0 N-CA-C 113.76 0.264 . . . . 65.230000000000004 113.76 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 73.31 39.68 50.98 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.735 -0.745 . . . . 70.150000000000006 111.991 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -112.88 -51.77 2.81 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 122.363 -0.492 . . . . 74.340000000000003 110.869 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.531 ' CG ' ' HZ3' ' A' ' 585' ' ' LYS . 73.6 m-20 -111.14 -35.31 5.93 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.385 -1.339 . . . . 74.519999999999996 107.385 169.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -139.54 148.94 43.29 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.781 -1.192 . . . . 75.310000000000002 107.781 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.77 136.0 37.26 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.337 -1.357 . . . . 72.230000000000004 107.337 175.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -90.69 119.9 31.31 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.592 -0.521 . . . . 63.329999999999998 109.592 -174.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 10.3 t -128.02 155.03 44.97 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.263 0.554 . . . . 64.120000000000005 111.04 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 26.4 p -149.79 158.37 44.11 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.955 -1.498 . . . . 73.109999999999999 106.955 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 168.78 -167.7 40.57 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 109.893 -1.283 . . . . 74.400000000000006 109.893 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 43.6 mt-10 -132.64 138.42 47.34 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.804 -0.443 . . . . 70.040000000000006 109.804 -178.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.489 HD21 ' HB3' ' A' ' 569' ' ' LYS . 76.6 mt -95.7 133.93 39.22 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.726 -0.472 . . . . 72.519999999999996 109.726 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.402 ' HA ' HD12 ' A' ' 536' ' ' ILE . 24.8 tt0 -101.25 106.43 17.64 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.847 -0.615 . . . . 75.349999999999994 110.279 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -105.04 148.22 27.01 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.007 -0.738 . . . . 74.319999999999993 109.007 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.449 ' HG2' HD21 ' A' ' 534' ' ' ASN . 8.8 mt-30 -145.02 -178.04 5.84 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.944 -1.132 . . . . 73.510000000000005 107.944 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -68.84 -31.89 71.19 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.117 -1.068 . . . . 73.129999999999995 108.117 173.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.42 -52.33 7.79 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.109 -0.95 . . . . 72.109999999999999 111.809 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.406 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 14.7 mm-40 -55.25 125.62 21.45 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 123.449 0.7 . . . . 74.510000000000005 111.743 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.582 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.7 pt -84.63 -63.03 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.266 -0.879 . . . . 75.299999999999997 112.646 -175.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.582 ' H ' HG13 ' A' ' 567' ' ' ILE . 10.0 p -143.48 150.57 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 109.213 -0.662 . . . . 64.030000000000001 109.213 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.489 ' HB3' HD21 ' A' ' 560' ' ' LEU . 6.1 mmpt? -118.05 165.57 13.58 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.728 -0.471 . . . . 71.109999999999999 109.728 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.6 p -135.14 147.43 49.47 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 123.962 0.789 . . . . 73.430000000000007 112.363 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.0 mp -100.47 118.1 46.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 106.941 -1.503 . . . . 72.310000000000002 106.941 172.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 572' ' ' SER . . . . . 0.593 ' HA ' ' O ' ' A' ' 521' ' ' MET . 3.3 p -95.95 117.0 29.78 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 124.099 0.874 . . . . 64.319999999999993 110.399 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.44 ' CG2' ' HE3' ' A' ' 521' ' ' MET . 89.0 t -124.79 132.17 71.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 O-C-N 122.239 -0.288 . . . . 71.120000000000005 110.792 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -79.62 123.0 27.22 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 123.856 0.723 . . . . 75.209999999999994 109.703 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 49.0 t -90.2 126.96 43.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.555 -0.905 . . . . 73.120000000000005 108.555 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 26.2 mm -96.66 153.11 3.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.9 -0.407 . . . . 71.409999999999997 109.9 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -75.75 123.95 26.46 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.122 -0.49 . . . . 54.210000000000001 111.181 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -73.77 141.82 46.25 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 105.598 -2.001 . . . . 64.439999999999998 105.598 171.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -50.96 -48.12 61.12 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 123.771 0.669 . . . . 75.409999999999997 111.028 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.407 ' HB2' ' H ' ' A' ' 581' ' ' TYR . 27.1 mm-40 -128.83 -76.35 0.56 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.533 -1.654 . . . . 71.219999999999999 106.533 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . 0.407 ' H ' ' HB2' ' A' ' 580' ' ' GLU . 26.0 t80 166.38 80.8 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 128.325 2.65 . . . . 73.209999999999994 104.409 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -64.19 -47.41 79.88 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.533 -1.212 . . . . 74.430000000000007 111.718 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.71 160.91 43.52 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 105.207 -2.145 . . . . 73.099999999999994 105.207 -172.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -62.55 105.58 0.65 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 104.9 -2.259 . . . . 63.030000000000001 104.9 168.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . 0.531 ' HZ3' ' CG ' ' A' ' 552' ' ' ASP . 34.5 mmtp -85.25 121.1 27.5 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-O 121.448 0.642 . . . . 75.030000000000001 110.087 -171.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.7 t -150.0 146.89 27.26 Favored 'General case' 0 N--CA 1.402 -2.872 0 CA-C-N 114.696 -1.138 . . . . 64.439999999999998 107.93 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -138.03 178.77 6.87 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.788 -1.19 . . . . 74.030000000000001 107.788 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.413 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 85.5 m-85 -121.03 152.03 39.09 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.188 -0.605 . . . . 74.430000000000007 109.954 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.45 131.02 54.57 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.032 -1.84 . . . . 74.140000000000001 106.032 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -127.69 136.31 51.39 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.065 0.459 . . . . 75.310000000000002 110.316 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . 0.435 HG21 ' HB3' ' A' ' 539' ' ' TYR . 23.8 pt -105.56 142.45 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.12 0 N-CA-C 107.547 -1.279 . . . . 74.340000000000003 107.547 175.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -88.17 -176.0 47.68 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.665 -0.974 . . . . 60.109999999999999 110.665 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.47 130.38 89.19 Favored Pre-proline 0 C--N 1.301 -1.541 0 CA-C-O 120.809 0.338 . . . . 73.310000000000002 110.931 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.97 130.88 23.98 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.103 2.535 . . . . 65.329999999999998 111.335 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -111.88 134.34 53.5 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.936 -0.394 . . . . 74.129999999999995 109.936 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.56 132.1 43.35 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.485 -1.302 . . . . 65.109999999999999 107.485 177.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.484 ' CG2' HG12 ' A' ' 536' ' ' ILE . 47.5 t -82.94 91.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 109.146 -0.687 . . . . 63.119999999999997 109.146 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -82.29 133.27 35.23 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.917 -1.038 . . . . 72.219999999999999 108.393 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 97.0 mmm -71.07 -28.22 64.2 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.297 0.57 . . . . 55.520000000000003 109.667 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 47.7 t 70.0 20.55 6.5 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.627 -1.17 . . . . 72.099999999999994 111.402 177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -71.18 -20.75 62.25 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 107.928 -1.138 . . . . 73.25 107.928 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -119.71 87.6 2.77 Favored 'General case' 0 N--CA 1.403 -2.786 0 N-CA-C 106.4 -1.704 . . . . 74.209999999999994 106.4 166.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -85.36 121.46 28.12 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.557 -0.905 . . . . 73.400000000000006 108.557 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -79.3 -51.1 5.44 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 109.02 -1.632 . . . . 70.5 109.02 176.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 143.37 -178.49 21.52 Favored Glycine 0 N--CA 1.414 -2.823 0 N-CA-C 109.628 -1.389 . . . . 74.150000000000006 109.628 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -115.89 157.6 24.24 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.481 -0.933 . . . . 74.310000000000002 108.481 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 24.2 m -91.93 147.27 23.09 Favored 'General case' 0 N--CA 1.408 -2.533 0 N-CA-C 106.638 -1.616 . . . . 64.239999999999995 106.638 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 23.5 pt -70.39 100.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.822 -1.177 . . . . 74.219999999999999 107.822 172.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . 0.258 29.0 p 64.84 101.67 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.597 1.559 . . . . 74.140000000000001 113.566 -174.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -77.44 -167.1 0.85 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.99 -0.745 . . . . 74.319999999999993 108.99 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -93.49 123.17 36.62 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.223 -1.029 . . . . 72.409999999999997 108.223 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -142.42 24.07 1.95 Allowed 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 112.133 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -99.38 -44.46 6.19 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.134 0.492 . . . . 72.340000000000003 111.796 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -84.29 145.42 28.29 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.797 -0.638 . . . . 73.549999999999997 111.559 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -133.79 30.48 3.73 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.832 0.825 . . . . 75.430000000000007 109.909 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -124.4 179.21 1.14 Allowed Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 108.443 -0.947 . . . . 75.140000000000001 108.443 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.25 118.27 5.38 Favored 'Trans proline' 0 C--N 1.349 0.588 0 N-CA-C 108.325 -1.452 . . . . 75.120000000000005 108.325 169.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 60.3 tp -98.27 122.74 41.8 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 122.278 -0.264 . . . . 74.340000000000003 111.118 -174.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 20.1 p -89.49 102.02 14.7 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.725 -0.472 . . . . 63.340000000000003 109.725 176.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 71.1 m -151.63 83.78 1.29 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.07 0.462 . . . . 72.420000000000002 111.754 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -92.92 69.86 4.6 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.895 0.855 . . . . 71.0 109.197 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -98.71 149.7 22.57 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.057 -1.429 . . . . 73.230000000000004 107.675 -178.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.43 73.02 10.21 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 122.094 0.95 . . . . 71.400000000000006 109.998 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . 0.513 ' OE1' ' HG3' ' A' ' 626' ' ' ARG . 0.3 OUTLIER -142.14 158.24 43.97 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 105.683 -1.969 . . . . 74.230000000000004 105.683 -177.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.22 -20.41 65.68 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.528 0.566 . . . . 73.319999999999993 112.528 -175.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.513 ' HG3' ' OE1' ' A' ' 624' ' ' GLU . 27.8 mtm180 -57.27 -54.48 46.36 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 110.114 -0.328 . . . . 73.319999999999993 110.114 175.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -41.84 81.16 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.844 -0.799 . . . . 75.340000000000003 108.844 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 64.5 mt -56.52 -42.85 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.971 -0.559 . . . . 75.549999999999997 111.098 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -75.08 -44.89 44.92 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.199 0.524 . . . . 73.099999999999994 110.66 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -64.22 -20.19 65.86 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.588 -0.733 . . . . 70.349999999999994 112.815 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -89.7 -17.38 28.43 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.656 -0.418 . . . . 72.010000000000005 111.226 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -100.19 -26.96 8.0 Favored Glycine 0 CA--C 1.5 -0.889 0 C-N-CA 120.139 -1.029 . . . . 74.109999999999999 111.712 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -69.35 161.22 75.11 Favored Pre-proline 0 C--N 1.307 -1.277 0 C-N-CA 123.143 0.577 . . . . 75.439999999999998 111.282 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.505 ' HA ' ' HB1' ' A' ' 502' ' ' ALA . 36.2 Cg_endo -67.29 141.03 55.2 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.56 2.174 . . . . 72.310000000000002 110.111 170.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.64 174.6 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 116.227 -0.442 . . . . 74.510000000000005 110.722 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.65 172.58 6.81 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 120.184 -0.607 . . . . 74.25 112.507 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -82.68 -164.86 35.95 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 115.166 0.826 . . . . 64.5 115.166 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -67.91 -50.19 57.63 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.965 -1.117 . . . . 75.120000000000005 110.514 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -129.06 120.64 26.31 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.946 -0.761 . . . . 74.209999999999994 108.946 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 14.0 p -118.68 80.76 1.59 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 122.567 1.175 . . . . 73.019999999999996 110.293 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -154.44 141.79 19.6 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 114.057 -1.428 . . . . 71.040000000000006 108.889 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.453 HD23 HG21 ' A' ' 523' ' ' VAL . 33.4 tp -129.93 122.96 29.59 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 108.787 -0.82 . . . . 72.140000000000001 108.787 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -92.54 112.32 24.23 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.132 -1.433 . . . . 73.310000000000002 107.132 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.68 110.33 28.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.514 -0.55 . . . . 73.519999999999996 109.514 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 50.5 mt -96.47 135.37 30.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 109.332 -0.618 . . . . 72.530000000000001 109.332 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 84.8 mt -103.05 110.01 28.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 109.034 -0.728 . . . . 75.340000000000003 109.034 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -107.28 132.86 52.63 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.202 -1.036 . . . . 75.310000000000002 108.202 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.752 ' O ' ' HA ' ' A' ' 653' ' ' LYS . 0.3 OUTLIER -68.5 176.7 2.75 Favored 'General case' 0 C--O 1.201 -1.492 0 C-N-CA 123.179 0.592 . . . . 74.209999999999994 112.479 -177.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 649' ' ' SER . . . . . 0.478 ' HB3' ' OG ' ' A' ' 517' ' ' SER . 8.5 t -149.4 32.01 0.73 Allowed 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.715 -0.794 . . . . 72.129999999999995 109.158 174.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -84.86 -61.27 1.82 Allowed 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.064 -0.717 . . . . 74.129999999999995 109.064 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -80.33 -47.75 14.03 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.706 -0.679 . . . . 73.299999999999997 111.218 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -146.56 -83.18 0.13 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.01 -1.107 . . . . 72.430000000000007 108.01 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . 0.752 ' HA ' ' O ' ' A' ' 648' ' ' GLU . 4.2 ttmp? 174.22 -57.38 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.198 0.999 . . . . 71.540000000000006 109.699 176.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 11.7 m -84.85 26.07 0.87 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.461 -0.791 . . . . 75.230000000000004 110.543 -177.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 1.5 m -77.32 88.75 3.73 Favored 'General case' 0 N--CA 1.424 -1.735 0 C-N-CA 123.63 0.772 . . . . 75.409999999999997 109.099 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 60.8 t -113.2 121.77 66.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 109.211 -0.663 . . . . 72.430000000000007 109.211 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 C--N 1.301 -1.533 0 CA-C-N 115.885 -0.598 . . . . 51.450000000000003 109.795 -179.755 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 61.0 m80 . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 109.318 -0.623 . . . . 73.530000000000001 109.318 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . -142.37 -139.46 0.12 Allowed 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 108.921 -0.77 . . . . 75.120000000000005 108.921 -178.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -172.26 -144.36 4.5 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 109.595 -1.402 . . . . 24.010000000000002 109.595 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.6 mp -103.53 114.29 42.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 116.79 0.295 . . . . 73.439999999999998 111.522 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -100.16 126.4 46.42 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.401 -0.963 . . . . 70.010000000000005 108.401 169.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.0 t -169.88 174.41 5.64 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.902 -0.777 . . . . 75.540000000000006 108.902 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -80.55 147.83 30.63 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 110.325 -0.25 . . . . 74.400000000000006 110.325 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -63.5 -40.78 97.96 Favored 'General case' 0 CA--C 1.492 -1.282 0 CA-C-O 122.238 1.018 . . . . 75.5 109.083 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -123.28 135.71 26.29 Favored Pre-proline 0 N--CA 1.401 -2.904 0 CA-C-N 113.948 -1.478 . . . . 73.540000000000006 107.218 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.34 -24.84 11.91 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.806 2.337 . . . . 61.020000000000003 111.519 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 61.7 t -136.25 132.99 49.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 107.142 -1.429 . . . . 75.140000000000001 107.142 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 7.1 t -128.48 133.07 48.4 Favored 'General case' 0 N--CA 1.402 -2.828 0 N-CA-C 108.569 -0.9 . . . . 70.319999999999993 108.569 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -105.8 121.87 44.92 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 109.045 -0.724 . . . . 74.019999999999996 109.045 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.6 m -113.56 174.52 2.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.418 -0.586 . . . . 64.510000000000005 109.418 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.53 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 57.9 m -92.43 165.6 12.97 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 123.254 0.621 . . . . 71.140000000000001 110.993 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.473 ' OE1' ' HA ' ' A' ' 648' ' ' GLU . 0.9 OUTLIER -78.99 -50.72 10.66 Favored 'General case' 0 CA--C 1.57 1.74 0 C-N-CA 124.789 1.236 . . . . 74.430000000000007 112.918 -175.163 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 48.9 m -105.89 27.32 8.65 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.05 0.94 . . . . 73.239999999999995 110.448 -176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 12.1 tt -63.25 -32.92 58.19 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-N 115.447 -0.797 . . . . 74.25 112.831 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 103.79 -83.8 0.42 Allowed Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 109.927 -1.269 . . . . 74.310000000000002 109.927 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 34.8 mm -133.9 136.57 53.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 105.979 -1.859 . . . . 72.409999999999997 105.979 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.489 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -112.96 141.5 46.72 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.45 -0.574 . . . . 75.439999999999998 109.45 177.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 7.3 mp0 -114.55 132.55 56.28 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 124.194 0.934 . . . . 74.519999999999996 110.08 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.489 HG23 ' SD ' ' A' ' 521' ' ' MET . 87.7 t -124.06 129.09 74.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 108.746 -0.835 . . . . 74.340000000000003 108.746 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . 0.453 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 24.6 mtmm -86.51 139.07 31.22 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.146 0.498 . . . . 73.450000000000003 111.898 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.565 ' O ' HG23 ' A' ' 568' ' ' VAL . 39.6 t -104.18 126.26 58.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.255 -0.646 . . . . 74.439999999999998 109.255 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.18 121.46 12.59 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 123.777 0.673 . . . . 75.420000000000002 110.206 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 562' ' ' PHE . 10.2 tpt180 -68.93 148.37 50.29 Favored 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 115.198 -0.91 . . . . 71.109999999999999 110.91 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 11.4 p -56.97 139.1 53.12 Favored 'General case' 0 N--CA 1.408 -2.525 0 CA-C-N 114.749 -1.114 . . . . 74.120000000000005 111.916 175.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.7 m -56.19 -24.4 41.39 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 125.777 1.631 . . . . 73.109999999999999 110.746 175.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -122.99 114.25 2.37 Favored Glycine 0 N--CA 1.419 -2.446 0 N-CA-C 108.842 -1.703 . . . . 74.310000000000002 108.842 172.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -106.14 101.26 10.76 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.91 -0.774 . . . . 52.450000000000003 108.91 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -129.73 116.2 18.42 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.966 -0.561 . . . . 74.120000000000005 109.748 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 78.26 -164.64 51.3 Favored Glycine 0 C--N 1.316 -0.571 0 C-N-CA 120.901 -0.666 . . . . 72.340000000000003 112.379 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.576 ' ND2' ' HG2' ' A' ' 563' ' ' GLN . 2.5 t-20 -103.47 123.08 46.23 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.244 0.545 . . . . 73.340000000000003 109.878 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 48.1 t -126.48 136.97 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 N-CA-C 108.071 -1.085 . . . . 74.239999999999995 108.071 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.481 HG12 ' CG2' ' A' ' 597' ' ' VAL . 40.2 mm -107.98 135.29 47.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 109.205 -0.665 . . . . 73.420000000000002 109.205 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.51 109.74 36.23 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 109.232 -0.655 . . . . 75.420000000000002 109.232 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -75.9 159.24 38.26 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.124 1.883 . . . . 61.530000000000001 111.45 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -143.92 162.83 35.13 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.233 -0.655 . . . . 73.129999999999995 109.233 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -153.39 157.23 39.67 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 123.882 0.738 . . . . 75.040000000000006 109.739 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.3 p -93.41 139.25 30.9 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.626 0.727 . . . . 73.25 111.605 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 89.7 mt -109.53 122.74 64.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.573 -1.269 . . . . 74.319999999999993 107.573 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -78.81 117.73 20.2 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.677 -0.49 . . . . 53.409999999999997 109.677 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -102.85 -111.58 3.56 Favored Glycine 0 C--N 1.302 -1.355 0 N-CA-C 109.892 -1.283 . . . . 70.150000000000006 109.892 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 28.4 p -78.93 -32.63 45.66 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.508 -0.923 . . . . 64.319999999999993 108.508 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -84.46 141.48 30.76 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.753 -1.112 . . . . 73.230000000000004 109.207 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.471 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 64.6 mtt180 -101.58 146.2 28.01 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-O 121.334 0.588 . . . . 74.120000000000005 111.144 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -94.37 -161.18 34.75 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 114.993 -1.003 . . . . 65.109999999999999 112.137 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 74.65 8.08 80.78 Favored Glycine 0 C--N 1.315 -0.621 0 N-CA-C 112.386 -0.286 . . . . 62.399999999999999 112.386 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . 0.405 ' C ' HG13 ' A' ' 576' ' ' ILE . . . 103.71 10.09 36.16 Favored Glycine 0 N--CA 1.419 -2.476 0 C-N-CA 120.263 -0.97 . . . . 73.099999999999994 112.865 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.471 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 28.0 tt0 -83.46 -66.29 0.91 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 118.991 -1.084 . . . . 73.310000000000002 110.355 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -101.37 -41.63 6.59 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.229 -1.026 . . . . 74.409999999999997 108.229 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -137.34 158.78 43.67 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.809 -1.182 . . . . 73.430000000000007 107.809 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.78 137.16 33.86 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 107.513 -1.292 . . . . 73.329999999999998 107.513 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 33.0 t70 -84.46 103.84 13.95 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.787 -0.82 . . . . 72.150000000000006 108.787 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.473 ' CG2' HG21 ' A' ' 573' ' ' VAL . 11.5 t -110.72 146.01 37.03 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-O 122.234 1.016 . . . . 64.120000000000005 111.873 -172.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 21.8 p -145.56 147.5 32.16 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 105.931 -1.878 . . . . 64.409999999999997 105.931 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -170.06 -179.76 41.84 Favored Glycine 0 CA--C 1.477 -2.317 0 N-CA-C 110.199 -1.16 . . . . 73.340000000000003 110.199 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.448 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 39.2 mt-10 -129.6 114.4 16.0 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.103 0.478 . . . . 75.200000000000003 110.731 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 88.1 mt -85.5 138.29 32.32 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.311 -0.859 . . . . 62.210000000000001 109.448 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.412 ' HA ' HD13 ' A' ' 536' ' ' ILE . 34.4 tt0 -104.52 118.49 36.71 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.99 -0.55 . . . . 73.349999999999994 110.23 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 527' ' ' ARG . 97.9 m-85 -124.44 107.51 11.18 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.704 -0.48 . . . . 73.120000000000005 109.704 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.576 ' HG2' ' ND2' ' A' ' 534' ' ' ASN . 5.5 mt-30 -109.03 178.46 4.46 Favored 'General case' 0 C--O 1.197 -1.67 0 N-CA-C 108.752 -0.833 . . . . 75.409999999999997 108.752 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -52.93 -44.81 67.3 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 123.439 0.462 . . . . 71.329999999999998 110.82 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.52 -49.04 35.55 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.207 0.447 . . . . 75.319999999999993 112.207 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.547 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 14.0 mp0 -54.68 141.9 30.41 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.638 0.775 . . . . 75.219999999999999 111.804 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.518 HG13 ' H ' ' A' ' 568' ' ' VAL . 5.5 pt -101.8 -89.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 112.923 0.712 . . . . 70.200000000000003 112.923 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 525' ' ' VAL . 10.5 p -115.34 152.22 17.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 110.281 -0.266 . . . . 73.510000000000005 110.281 -175.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -126.96 164.56 21.21 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 122.824 0.45 . . . . 72.430000000000007 110.253 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.5 p -123.21 150.56 43.24 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 123.655 0.597 . . . . 72.420000000000002 112.071 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.1 mp -94.41 125.98 46.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 106.784 -1.562 . . . . 75.230000000000004 106.784 172.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 572' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 521' ' ' MET . 51.5 m -104.9 115.56 30.5 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 123.905 0.753 . . . . 75.400000000000006 110.155 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.473 HG21 ' CG2' ' A' ' 556' ' ' THR . 93.7 t -116.84 128.51 74.2 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 116.244 -0.435 . . . . 74.430000000000007 110.447 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -80.27 111.96 17.14 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 108.654 -0.869 . . . . 74.430000000000007 108.654 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 61.9 t -86.65 124.39 40.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 106.056 -1.831 . . . . 72.409999999999997 106.056 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . 0.405 HG13 ' C ' ' A' ' 550' ' ' GLY . 40.7 mm -78.28 124.45 36.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-O 121.903 0.859 . . . . 74.420000000000002 109.27 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 578' ' ' ASP . 9.9 t70 -106.45 94.3 5.06 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 114.539 -1.21 . . . . 74.129999999999995 111.909 -174.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 577' ' ' ASP . 33.0 t70 169.26 103.05 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.348 1.03 . . . . 70.099999999999994 111.554 170.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 63.31 85.8 0.13 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 116.294 1.961 . . . . 75.230000000000004 116.294 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.17 -53.77 3.83 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.266 -1.753 . . . . 74.129999999999995 106.266 167.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 21.4 t80 52.54 24.93 3.31 Favored 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 125.973 1.709 . . . . 74.430000000000007 115.605 164.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 583' ' ' LYS . 13.5 pt-20 -134.11 -50.45 0.82 Allowed 'General case' 0 C--N 1.31 -1.124 0 O-C-N 120.706 -1.246 . . . . 75.299999999999997 113.876 -176.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.449 ' N ' ' HG3' ' A' ' 582' ' ' GLU . 14.0 tppt? -154.75 153.55 31.42 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.939 -1.134 . . . . 72.219999999999999 107.939 -170.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -72.46 93.33 1.54 Allowed 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.592 -2.003 . . . . 74.319999999999993 105.592 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -90.04 158.79 17.17 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 114.556 1.317 . . . . 74.530000000000001 114.556 -170.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.0 t -146.18 159.02 43.88 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 114.254 -1.339 . . . . 72.120000000000005 109.976 -174.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 46.8 p90 -141.26 176.9 8.47 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.13 -1.433 . . . . 72.5 107.13 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.491 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 85.1 m-85 -121.79 154.7 36.63 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.659 -0.816 . . . . 75.420000000000002 109.614 -177.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.52 131.05 54.52 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.171 -1.788 . . . . 75.430000000000007 106.171 177.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -125.91 134.12 51.68 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.269 -0.641 . . . . 73.150000000000006 109.269 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 13.9 pt -99.14 143.35 13.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.682 -0.859 . . . . 74.450000000000003 108.682 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.7 171.94 45.79 Favored Glycine 0 N--CA 1.413 -2.89 0 N-CA-C 111.452 -0.659 . . . . 75.140000000000001 111.452 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.63 131.57 89.66 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 123.615 0.244 . . . . 73.540000000000006 110.484 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.25 125.99 19.62 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.381 2.721 . . . . 73.430000000000007 112.896 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -104.46 119.55 39.22 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.307 -0.86 . . . . 73.329999999999998 109.328 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.95 129.81 41.06 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.094 -0.957 . . . . 75.209999999999994 108.67 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.481 ' CG2' HG12 ' A' ' 536' ' ' ILE . 50.2 t -87.46 118.97 34.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.223 -1.029 . . . . 73.510000000000005 108.223 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.414 ' OE1' ' HG3' ' A' ' 602' ' ' LYS . 37.1 tt0 -54.46 107.98 0.33 Allowed 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 124.91 1.381 . . . . 74.150000000000006 111.173 -175.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -73.83 -48.43 31.29 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.682 -1.145 . . . . 74.040000000000006 109.275 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 13.4 t -89.63 68.58 7.68 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 105.593 -2.003 . . . . 72.430000000000007 105.593 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -63.58 120.59 12.03 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 113.692 -1.594 . . . . 71.129999999999995 111.197 -173.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . 0.414 ' HG3' ' OE1' ' A' ' 598' ' ' GLU . 0.0 OUTLIER -74.56 168.04 20.55 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.136 -0.938 . . . . 74.420000000000002 110.669 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -124.61 120.96 33.41 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 120.378 -0.529 . . . . 75.239999999999995 110.203 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -92.25 79.61 1.2 Allowed Glycine 0 C--N 1.301 -1.39 0 N-CA-C 107.964 -2.054 . . . . 64.530000000000001 107.964 173.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -66.08 151.15 52.03 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 121.411 -0.423 . . . . 74.450000000000003 113.665 -174.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -73.06 141.36 47.6 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 123.015 0.526 . . . . 74.409999999999997 110.224 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 2.3 p -85.42 -162.65 0.74 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 124.014 0.926 . . . . 73.140000000000001 111.117 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 35.5 pt -61.82 155.29 4.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.307 0.575 . . . . 71.230000000000004 111.966 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 9.0 p -77.46 130.03 36.5 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.741 -0.663 . . . . 71.049999999999997 110.687 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -157.66 175.13 14.32 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.389 -1.708 . . . . 64.150000000000006 106.389 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -87.22 107.13 18.35 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 119.673 -0.811 . . . . 72.299999999999997 109.109 173.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -118.4 163.69 16.36 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.921 -0.581 . . . . 75.219999999999999 110.196 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -95.67 154.35 17.26 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.049 -1.093 . . . . 61.0 108.049 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -65.41 101.62 0.6 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.476 -0.565 . . . . 74.439999999999998 109.476 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -127.95 116.32 19.89 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.092 -0.504 . . . . 74.209999999999994 111.87 -174.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -85.94 167.88 22.07 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 106.885 -1.524 . . . . 73.209999999999994 106.885 172.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.49 90.08 0.18 Allowed 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.853 1.702 . . . . 74.329999999999998 113.044 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 5.4 tt -91.38 -52.41 4.81 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 105.756 -1.942 . . . . 73.019999999999996 105.756 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 28.7 m -86.23 96.19 9.85 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.121 -0.945 . . . . 73.310000000000002 108.629 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 55.0 m -111.16 86.66 2.37 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 112.931 0.715 . . . . 71.310000000000002 112.931 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -96.36 32.64 1.94 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.157 -1.423 . . . . 74.510000000000005 107.157 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -82.83 124.8 30.64 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 114.038 -1.437 . . . . 74.120000000000005 108.823 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -94.81 97.02 9.74 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.653 -1.24 . . . . 73.049999999999997 107.653 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -80.03 167.06 20.92 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.318 0.58 . . . . 74.049999999999997 109.704 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.78 25.51 7.17 Favored 'General case' 0 C--N 1.276 -2.6 0 CA-C-N 116.142 -0.481 . . . . 73.340000000000003 110.737 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -73.02 -28.52 62.41 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 109.017 -0.734 . . . . 72.319999999999993 109.017 -177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . 0.637 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 3.0 tmm_? -74.0 -35.08 64.39 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 107.78 -1.193 . . . . 74.510000000000005 107.78 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.441 ' O ' ' HG3' ' A' ' 631' ' ' MET . 59.6 mt -73.06 -38.9 56.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.071 -0.714 . . . . 73.209999999999994 109.071 -178.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -81.08 -14.88 57.36 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.185 -0.916 . . . . 71.030000000000001 112.222 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.637 ' HG2' ' O ' ' A' ' 627' ' ' ARG . 9.7 pt-20 -67.77 -11.63 58.85 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.525 0.565 . . . . 75.549999999999997 112.525 -175.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.441 ' HG3' ' O ' ' A' ' 628' ' ' ILE . 0.0 OUTLIER -74.31 -13.52 60.77 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.082 0.467 . . . . 73.129999999999995 110.997 176.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -150.82 51.46 0.52 Allowed Glycine 0 N--CA 1.429 -1.801 0 N-CA-C 110.433 -1.067 . . . . 60.25 110.433 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -100.87 158.14 32.37 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 109.293 -0.632 . . . . 73.219999999999999 109.293 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.457 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 44.6 Cg_endo -69.58 137.6 36.38 Favored 'Trans proline' 0 N--CA 1.436 -1.891 0 C-N-CA 121.502 1.468 . . . . 75.430000000000007 111.279 175.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -124.84 171.13 14.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 115.403 -0.817 . . . . 75.129999999999995 110.176 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.91 -178.26 3.43 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 112.289 0.478 . . . . 63.25 112.289 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.49 -172.07 27.61 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 114.843 0.697 . . . . 74.129999999999995 114.843 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -68.3 -53.78 22.03 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.147 0.979 . . . . 72.129999999999995 110.385 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -120.12 121.34 38.61 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.954 -0.758 . . . . 72.530000000000001 108.954 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 18.3 p -120.75 94.08 4.24 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.498 0.666 . . . . 73.010000000000005 110.747 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -166.4 152.18 8.55 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.294 -1.373 . . . . 74.019999999999996 107.294 -177.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 48.5 tp -134.57 132.9 39.64 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.243 -1.021 . . . . 73.409999999999997 108.243 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -100.11 110.27 22.55 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 106.906 -1.516 . . . . 74.310000000000002 106.906 174.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . 0.408 HG11 ' HE3' ' A' ' 521' ' ' MET . 44.5 t -101.82 110.99 30.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 109.219 -0.66 . . . . 74.349999999999994 109.219 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 26.8 mt -98.67 127.47 51.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 108.315 -0.994 . . . . 74.430000000000007 108.315 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 66.6 mt -97.15 103.55 14.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 107.798 -1.186 . . . . 75.400000000000006 107.798 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -115.98 135.0 54.38 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.421 -0.511 . . . . 75.209999999999994 111.573 -173.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.473 ' HA ' ' OE1' ' A' ' 516' ' ' GLU . 36.9 tt0 -70.06 118.26 12.67 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.721 -0.844 . . . . 75.329999999999998 108.721 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 18.4 m -138.63 32.47 2.26 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 115.596 -0.729 . . . . 75.010000000000005 112.342 -170.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -53.87 -42.06 68.2 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.067 0.46 . . . . 75.049999999999997 110.936 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.59 -40.59 97.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.98 -1.009 . . . . 71.329999999999998 111.028 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -84.31 -65.32 1.02 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.995 -1.002 . . . . 71.140000000000001 111.406 -173.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -168.7 126.97 1.07 Allowed 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.719 -0.845 . . . . 74.310000000000002 108.719 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 50.4 m -83.43 -65.2 1.04 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.976 -0.556 . . . . 65.239999999999995 111.172 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 15.3 t -148.08 160.37 42.94 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.938 -0.705 . . . . 72.439999999999998 109.322 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.19 116.17 22.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.23 -1.396 . . . . 73.129999999999995 107.23 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 C--O 1.254 1.312 0 N-CA-C 110.163 -0.31 . . . . 73.340000000000003 110.163 179.342 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 51.7 t60 . . . . . 0 C--O 1.245 0.831 0 CA-C-O 121.344 0.593 . . . . 73.230000000000004 109.661 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.417 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . -115.33 -59.98 1.94 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.702 -0.681 . . . . 64.140000000000001 111.417 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 160.11 -153.43 24.39 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 109.892 -1.283 . . . . 65.200000000000003 109.892 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -121.94 124.51 71.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 117.034 0.417 . . . . 74.439999999999998 111.503 -171.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -107.3 124.36 49.67 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.95 -0.759 . . . . 71.329999999999998 108.95 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.6 t -168.19 172.73 8.4 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.446 -0.575 . . . . 75.299999999999997 109.446 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -75.26 145.04 42.23 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.565 -0.289 . . . . 75.530000000000001 111.054 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.06 -29.63 70.01 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.53 0.681 . . . . 72.140000000000001 110.068 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -137.87 141.66 33.48 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 107.768 -1.197 . . . . 74.129999999999995 107.768 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.84 -24.65 15.24 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.697 2.265 . . . . 71.030000000000001 111.608 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 57.2 t -135.35 133.72 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 N-CA-C 106.611 -1.626 . . . . 72.25 106.611 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 7.1 t -125.11 140.7 52.65 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.51 -1.292 . . . . 73.319999999999993 107.51 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . 0.41 ' NE2' ' HG2' ' A' ' 647' ' ' GLU . 57.4 t-80 -110.6 137.92 47.65 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 107.596 -1.261 . . . . 74.120000000000005 107.596 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.77 158.13 43.25 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 N-CA-C 109.072 -0.714 . . . . 70.239999999999995 109.072 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.501 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 48.1 m -87.09 173.57 9.19 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-N 115.037 -0.983 . . . . 71.420000000000002 109.566 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -94.07 -59.11 2.05 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.922 -0.711 . . . . 75.329999999999998 110.017 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.6 m -84.55 53.99 2.86 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.763 0.792 . . . . 63.549999999999997 109.929 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 10.5 tt -102.87 -32.49 3.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.544 -0.753 . . . . 74.409999999999997 111.49 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 92.85 -78.39 1.15 Allowed Glycine 0 N--CA 1.425 -2.036 0 C-N-CA 120.717 -0.754 . . . . 75.450000000000003 111.356 -176.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.3 mm -126.93 123.93 63.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.934 -0.765 . . . . 74.430000000000007 108.934 -176.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.445 ' HE2' ' CG2' ' A' ' 573' ' ' VAL . 0.0 OUTLIER -103.73 149.43 25.0 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 107.383 -1.34 . . . . 75.109999999999999 107.383 175.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 31.3 mt-10 -130.8 132.54 45.32 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.32 0.581 . . . . 74.140000000000001 111.088 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 570' ' ' THR . 40.1 t -112.01 126.47 69.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.098 -1.075 . . . . 72.409999999999997 108.098 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -81.96 128.8 34.44 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.203 -0.666 . . . . 74.310000000000002 109.203 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 568' ' ' VAL . 48.4 t -105.78 129.21 59.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 109.853 -0.425 . . . . 75.400000000000006 109.853 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.41 126.88 30.82 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.257 -0.646 . . . . 75.349999999999994 109.257 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.655 ' CZ ' ' HD1' ' A' ' 562' ' ' PHE . 15.2 ttm180 -87.64 160.07 18.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 109.178 -0.675 . . . . 73.109999999999999 109.178 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.7 t -56.1 141.47 40.29 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 124.4 1.08 . . . . 64.430000000000007 111.813 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.5 t -54.76 -37.4 65.93 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.93 -1.032 . . . . 73.430000000000007 109.355 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -119.54 96.0 0.62 Allowed Glycine 0 N--CA 1.423 -2.209 0 N-CA-C 109.029 -1.628 . . . . 61.43 109.029 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.61 101.0 12.34 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.003 -1.11 . . . . 75.109999999999999 108.003 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -107.49 92.37 4.04 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.596 -0.729 . . . . 73.430000000000007 110.441 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 86.32 -139.33 16.63 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 119.56 -1.305 . . . . 53.420000000000002 111.774 174.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -113.39 121.1 43.31 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.265 0.555 . . . . 71.310000000000002 110.876 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 59.5 t -123.63 143.87 35.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 107.972 -1.121 . . . . 70.340000000000003 107.972 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.519 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 41.7 mm -117.28 137.09 52.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 109.596 -0.52 . . . . 71.540000000000006 109.596 177.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 594' ' ' PRO . 44.1 t -122.89 110.79 31.28 Favored Pre-proline 0 N--CA 1.44 -0.945 0 N-CA-C 109.853 -0.425 . . . . 74.219999999999999 109.853 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.7 156.83 48.78 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.769 2.313 . . . . 74.140000000000001 112.517 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.432 ' HB3' HG23 ' A' ' 591' ' ' ILE . 45.0 p90 -149.4 163.3 38.14 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 122.383 -0.198 . . . . 73.150000000000006 110.649 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -158.43 156.67 30.82 Favored 'General case' 0 C--O 1.252 1.211 0 O-C-N 123.966 0.791 . . . . 72.340000000000003 110.089 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.2 p -90.62 138.53 31.49 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 123.531 0.519 . . . . 72.299999999999997 111.342 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 51.2 mt -111.09 115.77 50.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.821 -0.807 . . . . 70.540000000000006 108.821 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.82 99.61 5.21 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.35 -0.611 . . . . 74.420000000000002 109.35 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -104.56 -89.17 2.1 Favored Glycine 0 CA--C 1.482 -2.008 0 C-N-CA 119.981 -1.104 . . . . 61.340000000000003 110.667 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 3.8 m -102.53 29.86 5.0 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-O 122.324 1.059 . . . . 75.129999999999995 108.54 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -157.4 144.73 18.58 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 106.815 -1.55 . . . . 71.120000000000005 106.815 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.431 ' HD2' ' OE1' ' A' ' 551' ' ' GLU . 82.0 mtm180 -92.29 131.1 37.76 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.75 0.786 . . . . 65.120000000000005 112.126 -175.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -96.62 -167.15 33.64 Favored Glycine 0 C--N 1.294 -1.779 0 CA-C-N 114.908 -1.042 . . . . 54.310000000000002 112.93 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 77.28 9.15 86.98 Favored Glycine 0 C--N 1.313 -0.734 0 CA-C-N 115.721 -0.24 . . . . 72.439999999999998 112.995 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 98.14 23.73 12.59 Favored Glycine 0 N--CA 1.427 -1.924 0 C-N-CA 120.368 -0.92 . . . . 71.400000000000006 111.422 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.431 ' OE1' ' HD2' ' A' ' 547' ' ' ARG . 26.3 tt0 -98.63 -63.27 1.14 Allowed 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.096 -0.641 . . . . 64.040000000000006 109.825 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -100.72 -42.01 6.67 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 107.411 -1.329 . . . . 75.150000000000006 107.411 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -132.9 155.09 49.69 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.006 -1.109 . . . . 73.510000000000005 108.006 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.79 137.38 35.32 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.476 -1.305 . . . . 74.25 107.476 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . 0.46 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 29.4 t70 -87.3 121.36 29.65 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.682 -0.859 . . . . 71.430000000000007 108.682 -176.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.8 t -130.65 164.98 23.81 Favored 'General case' 0 N--CA 1.414 -2.254 0 CA-C-O 121.742 0.782 . . . . 62.420000000000002 110.787 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 19.9 p -161.2 163.55 31.08 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.316 -1.735 . . . . 63.340000000000003 106.316 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 167.18 -169.59 41.05 Favored Glycine 0 N--CA 1.421 -2.329 0 C-N-CA 119.929 -1.129 . . . . 54.0 111.054 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.519 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 42.3 mt-10 -136.07 119.75 17.2 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 123.338 0.655 . . . . 72.5 110.196 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 77.3 mt -86.82 128.75 35.05 Favored 'General case' 0 CA--C 1.484 -1.592 0 CA-C-N 115.745 -0.661 . . . . 73.519999999999996 110.087 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.417 ' HA ' HD13 ' A' ' 536' ' ' ILE . 25.5 tt0 -87.79 123.39 32.53 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.455 -0.793 . . . . 71.120000000000005 109.911 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.655 ' HD1' ' CZ ' ' A' ' 527' ' ' ARG . 82.2 m-85 -123.3 98.2 5.76 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 121.463 0.649 . . . . 73.299999999999997 110.612 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 533' ' ' GLY . 42.3 mt-30 -96.78 -175.87 3.41 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.722 -0.672 . . . . 71.150000000000006 110.44 174.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -78.92 -21.75 46.86 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.631 -0.713 . . . . 74.230000000000004 109.428 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -72.57 -52.38 15.81 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.076 -0.966 . . . . 65.109999999999999 112.768 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.43 ' HB3' ' NH2' ' A' ' 527' ' ' ARG . 41.4 mm-40 -69.7 169.29 13.17 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.441 1.274 . . . . 73.150000000000006 114.441 -177.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.565 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.0 pt -105.95 -63.3 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 114.574 -1.193 . . . . 75.219999999999999 112.465 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.565 ' H ' HG13 ' A' ' 567' ' ' ILE . 14.4 p -139.88 162.56 25.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 108.834 -0.802 . . . . 73.120000000000005 108.834 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -131.1 164.04 26.32 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.445 -0.946 . . . . 72.209999999999994 108.445 171.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 12.9 p -129.7 152.57 49.06 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 123.794 0.683 . . . . 70.120000000000005 111.153 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.5 mp -94.59 121.76 45.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 105.545 -2.02 . . . . 74.540000000000006 105.545 170.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 5.9 m -99.45 114.89 28.11 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.596 -0.89 . . . . 75.120000000000005 108.596 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.445 ' CG2' ' HE2' ' A' ' 521' ' ' MET . 91.3 t -118.89 127.65 75.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.771 -0.455 . . . . 72.439999999999998 109.771 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 16.1 tppt? -77.42 108.84 10.85 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.207 -1.035 . . . . 75.409999999999997 108.207 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.75 122.52 36.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 104.55 -2.389 . . . . 74.030000000000001 104.55 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 42.1 mm -67.04 127.75 29.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-O 121.352 0.596 . . . . 75.25 109.467 -174.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.66 82.8 5.72 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.55 -1.205 . . . . 73.329999999999998 107.85 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -127.03 106.89 9.58 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.438 -1.255 . . . . 65.239999999999995 109.943 -175.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -74.57 87.68 2.14 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.366 -0.834 . . . . 73.120000000000005 109.817 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.415 ' HG3' ' HG3' ' A' ' 582' ' ' GLU . 11.1 tp10 -153.8 136.83 15.51 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.67 -0.863 . . . . 75.450000000000003 108.67 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -120.33 102.05 8.21 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.752 -1.203 . . . . 73.310000000000002 107.752 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.415 ' HG3' ' HG3' ' A' ' 580' ' ' GLU . 34.9 mt-10 -117.77 -58.74 1.99 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.925 0.869 . . . . 71.319999999999993 109.643 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -158.74 149.95 20.52 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 105.42 -2.067 . . . . 65.319999999999993 105.42 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -59.82 117.37 4.93 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 108.499 -0.926 . . . . 64.230000000000004 108.499 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -86.72 119.83 27.37 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.474 -1.306 . . . . 75.530000000000001 107.474 -176.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.4 t -135.18 125.18 25.8 Favored 'General case' 0 C--N 1.281 -2.413 0 CA-C-O 121.946 0.879 . . . . 75.310000000000002 111.582 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 44.3 p90 -119.94 177.78 4.85 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.131 -0.94 . . . . 73.329999999999998 109.235 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -123.19 149.66 44.34 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 109.404 -0.591 . . . . 63.5 109.404 -176.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.4 131.81 54.98 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.442 -1.688 . . . . 74.340000000000003 106.442 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -125.58 128.47 47.98 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.022 -0.671 . . . . 71.230000000000004 110.341 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . 0.432 HG23 ' HB3' ' A' ' 539' ' ' TYR . 26.5 pt -99.84 139.77 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 107.911 -1.144 . . . . 73.430000000000007 107.911 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.34 -178.08 50.65 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 115.825 -0.625 . . . . 64.129999999999995 112.083 -176.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.05 129.63 86.07 Favored Pre-proline 0 N--CA 1.426 -1.641 0 CA-C-N 115.499 -0.35 . . . . 75.340000000000003 110.772 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.513 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 11.7 Cg_endo -59.6 129.07 29.33 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.197 2.598 . . . . 61.520000000000003 112.666 -176.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -104.72 119.65 39.51 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.09 -0.959 . . . . 71.0 109.008 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.28 128.88 38.05 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.082 -1.451 . . . . 75.349999999999994 107.082 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.446 ' CG2' HG12 ' A' ' 536' ' ' ILE . 51.5 t -83.26 95.63 3.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 121.397 0.618 . . . . 72.420000000000002 110.835 -177.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.75 132.92 48.35 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 103.983 -2.599 . . . . 74.450000000000003 103.983 172.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -60.76 -30.21 69.88 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.667 0.617 . . . . 71.530000000000001 112.667 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 53.9 m 51.87 54.51 10.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.125 0.97 . . . . 73.530000000000001 113.42 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.13 138.92 37.0 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 120.02 -0.672 . . . . 64.140000000000001 109.538 177.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . 0.52 ' HA ' ' HE2' ' A' ' 602' ' ' LYS . 10.5 mmpt? -81.77 112.47 18.96 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 114.62 1.341 . . . . 74.310000000000002 114.62 -170.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -95.57 -19.41 19.8 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 113.453 -1.703 . . . . 73.400000000000006 109.001 174.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -124.85 -119.17 2.37 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 110.509 -1.036 . . . . 72.329999999999998 110.509 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -155.88 39.33 0.6 Allowed Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.447 -0.882 . . . . 74.230000000000004 112.445 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -126.98 103.75 7.64 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.07 -0.715 . . . . 75.219999999999999 109.07 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 12.4 t -96.69 177.13 5.75 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.683 -0.858 . . . . 72.200000000000003 108.683 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 48.1 mm -80.72 115.25 22.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.982 -1.118 . . . . 73.129999999999995 107.982 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 6.5 t -105.11 89.36 3.11 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-O 122.343 1.068 . . . . 72.120000000000005 110.218 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -97.61 151.46 20.05 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 114.853 -1.067 . . . . 72.299999999999997 108.485 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -134.18 -64.75 0.68 Allowed 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 120.966 -0.293 . . . . 72.5 110.571 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -129.35 127.08 40.33 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.296 0.569 . . . . 73.530000000000001 111.567 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . 0.424 ' HA ' HE21 ' A' ' 616' ' ' GLN . 24.8 t70 -101.27 77.61 1.81 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.407 1.098 . . . . 72.420000000000002 109.741 175.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -131.56 92.82 3.22 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.715 -1.584 . . . . 64.430000000000007 107.907 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 64.15 78.74 0.28 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.388 -1.278 . . . . 74.040000000000006 112.108 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . 0.424 HE21 ' HA ' ' A' ' 613' ' ' ASP . 65.5 mt-30 -108.76 135.98 20.03 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 115.622 -0.717 . . . . 71.25 109.739 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.65 138.92 33.01 Favored 'Trans proline' 0 C--O 1.256 1.395 0 C-N-CA 121.829 1.686 . . . . 75.400000000000006 109.736 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -86.05 -175.65 5.64 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.67 -0.492 . . . . 74.329999999999998 109.67 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 22.6 p -70.9 122.13 19.39 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 120.889 0.376 . . . . 72.129999999999995 110.533 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 14.3 m -69.02 141.94 54.73 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.338 -0.846 . . . . 74.010000000000005 110.094 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.59 89.12 3.31 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.506 0.67 . . . . 73.040000000000006 112.334 -176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.09 156.49 38.19 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.308 -1.367 . . . . 74.540000000000006 107.308 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -81.71 67.01 7.52 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.564 0.697 . . . . 65.349999999999994 112.079 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -93.75 172.29 8.34 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 105.237 -2.134 . . . . 73.099999999999994 105.237 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -63.03 -16.99 61.72 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 119.61 -0.836 . . . . 71.209999999999994 110.607 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 626' ' ' ARG . 18.2 mtp-105 -57.69 -25.42 60.27 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 114.996 -1.002 . . . . 74.400000000000006 111.784 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -60.22 -26.51 66.45 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.856 0.36 . . . . 72.310000000000002 110.847 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 68.4 mt -73.51 -40.96 56.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.74 -0.837 . . . . 74.519999999999996 108.74 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.13 -30.08 68.27 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.723 -0.671 . . . . 73.400000000000006 111.019 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -58.22 -35.96 72.46 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.188 0.595 . . . . 75.109999999999999 112.007 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -93.14 -12.37 30.56 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.261 -0.576 . . . . 74.010000000000005 109.551 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -104.66 26.1 23.59 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 115.122 -0.945 . . . . 74.010000000000005 111.009 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -95.37 161.57 27.48 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 108.184 -1.043 . . . . 75.120000000000005 108.184 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.513 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 33.3 Cg_endo -70.81 137.74 33.02 Favored 'Trans proline' 0 N--CA 1.427 -2.388 0 N-CA-C 105.352 -2.595 . . . . 73.430000000000007 105.352 161.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.04 168.74 16.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 118.502 -1.279 . . . . 74.5 112.678 -173.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.26 171.93 7.68 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.57 -0.741 . . . . 74.25 111.959 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -71.69 -171.99 15.3 Favored Glycine 0 N--CA 1.431 -1.7 0 CA-C-N 115.307 -0.861 . . . . 71.319999999999993 113.144 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -62.12 -41.29 98.09 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 122.365 0.266 . . . . 74.25 110.331 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -140.89 133.23 28.27 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.969 0.414 . . . . 75.340000000000003 110.039 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 15.4 p -120.88 95.4 4.69 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-O 121.709 0.766 . . . . 73.439999999999998 109.985 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . 0.482 ' HZ1' ' HB2' ' A' ' 641' ' ' LYS . 5.1 ttmp? -162.58 142.98 9.75 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.523 -1.288 . . . . 61.539999999999999 107.523 -176.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.402 HD23 HG22 ' A' ' 523' ' ' VAL . 34.7 tp -132.65 132.81 42.83 Favored 'General case' 0 N--CA 1.416 -2.167 0 O-C-N 123.658 0.599 . . . . 64.120000000000005 109.423 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -98.35 118.59 35.34 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.057 -1.46 . . . . 71.340000000000003 107.057 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 44.3 t -106.7 117.43 52.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 109.006 -0.738 . . . . 71.430000000000007 109.006 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 58.1 mt -103.4 123.11 56.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 110.62 -0.141 . . . . 73.219999999999999 110.62 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 41.6 mt -107.43 107.65 23.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.153 -0.684 . . . . 73.25 109.153 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.41 ' HG2' ' NE2' ' A' ' 513' ' ' HIS . 8.0 pt-20 -136.14 150.08 48.91 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 105.383 -2.081 . . . . 75.150000000000006 105.383 166.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -63.47 128.8 37.47 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.056 -1.058 . . . . 72.299999999999997 110.674 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 649' ' ' SER . . . . . 0.539 ' HB2' ' O ' ' A' ' 652' ' ' PHE . 5.2 p -150.3 107.91 3.66 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 114.881 -1.054 . . . . 54.43 111.035 -173.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -93.64 -53.6 3.98 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.082 -0.508 . . . . 73.420000000000002 110.571 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -74.78 -39.53 61.71 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.376 -0.829 . . . . 74.420000000000002 111.001 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . 0.539 ' O ' ' HB2' ' A' ' 649' ' ' SER . 96.2 m-85 -109.91 162.32 14.62 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.293 -0.632 . . . . 73.099999999999994 109.293 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . 0.437 ' HB3' ' HZ3' ' A' ' 653' ' ' LYS . 0.1 OUTLIER -136.53 7.56 3.05 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.417 -0.956 . . . . 74.5 108.417 172.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 21.9 m -138.78 162.05 35.7 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.702 -1.221 . . . . 74.430000000000007 107.702 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 13.3 t -124.5 144.03 50.33 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.626 -0.879 . . . . 75.420000000000002 108.626 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.51 116.69 26.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 108.553 -0.906 . . . . 73.120000000000005 108.553 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 C--N 1.304 -1.405 0 CA-C-N 115.824 -0.625 . . . . 72.5 111.054 -178.014 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.435 ' CG ' ' HA ' ' A' ' 631' ' ' MET . 85.3 m-70 . . . . . 0 CA--C 1.506 -0.712 0 CA-C-O 122.461 1.124 . . . . 72.319999999999993 108.306 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.603 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . -125.12 2.61 7.93 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 113.601 -1.636 . . . . 65.450000000000003 107.967 173.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 116.26 -159.64 13.79 Favored Glycine 0 N--CA 1.416 -2.655 0 C-N-CA 120.167 -1.016 . . . . 74.010000000000005 111.619 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.34 111.39 28.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 122.388 0.275 . . . . 74.140000000000001 110.569 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.59 ' CD2' HG23 ' A' ' 528' ' ' THR . 5.8 m-85 -92.35 126.11 37.3 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 109.093 -0.706 . . . . 74.519999999999996 109.093 170.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.4 t -167.54 176.33 6.57 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.831 -0.803 . . . . 74.030000000000001 108.831 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -81.11 147.05 30.27 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 110.147 -0.316 . . . . 72.140000000000001 110.147 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.78 -33.53 75.88 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.36 0.6 . . . . 72.129999999999995 109.879 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -136.28 140.93 34.19 Favored Pre-proline 0 N--CA 1.427 -1.605 0 N-CA-C 107.573 -1.269 . . . . 74.340000000000003 107.573 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . 0.422 ' O ' ' HA ' ' A' ' 642' ' ' LEU . 59.2 Cg_endo -75.26 -26.01 10.93 Favored 'Trans proline' 0 C--N 1.33 -0.414 0 C-N-CA 122.447 2.098 . . . . 75.099999999999994 112.258 -178.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 59.8 t -134.77 136.59 52.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 106.715 -1.587 . . . . 75.319999999999993 106.715 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 15.0 t -129.18 135.39 48.79 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 108.591 -0.892 . . . . 74.439999999999998 108.591 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -108.03 119.04 38.34 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.915 -0.772 . . . . 73.409999999999997 108.915 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.37 160.28 14.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.419 -0.81 . . . . 72.340000000000003 109.194 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.445 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 74.4 m -88.17 159.84 18.0 Favored 'General case' 0 N--CA 1.411 -2.413 0 C-N-CA 123.345 0.658 . . . . 62.210000000000001 110.486 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -49.22 16.32 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 120.731 -0.388 . . . . 75.230000000000004 110.692 176.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 9.8 m -86.83 39.84 0.87 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.27 0.557 . . . . 54.310000000000002 111.5 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 13.4 tt -97.67 -25.15 4.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.305 0.574 . . . . 71.519999999999996 111.626 -176.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . 0.429 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 86.86 -74.28 2.35 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.86 -0.896 . . . . 71.219999999999999 110.86 -176.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 43.4 mm -129.97 132.2 65.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.459 -1.312 . . . . 75.420000000000002 107.459 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.414 ' HE3' ' CG2' ' A' ' 573' ' ' VAL . 0.0 OUTLIER -114.4 150.47 34.6 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.002 -1.481 . . . . 73.510000000000005 107.002 175.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 31.7 mt-10 -130.09 142.53 50.59 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.227 0.537 . . . . 73.439999999999998 111.631 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 570' ' ' THR . 42.7 t -121.24 127.7 75.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.397 -0.964 . . . . 74.140000000000001 108.397 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -82.51 127.8 33.66 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.746 -0.835 . . . . 73.200000000000003 108.746 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.39 123.92 58.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 108.806 -0.812 . . . . 74.439999999999998 108.806 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.03 115.63 10.38 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.542 -0.754 . . . . 70.040000000000006 109.928 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.471 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 50.9 ttp180 -67.85 155.28 39.71 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.6 -1.182 . . . . 75.200000000000003 108.9 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.603 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 0.7 OUTLIER -56.55 141.99 40.95 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-O 121.786 0.803 . . . . 72.230000000000004 111.37 176.182 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.2 m -61.92 -16.93 54.63 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 125.996 1.718 . . . . 74.129999999999995 110.769 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -139.47 79.16 0.29 Allowed Glycine 0 N--CA 1.425 -2.084 0 N-CA-C 110.304 -1.118 . . . . 63.100000000000001 110.304 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -83.73 101.49 11.6 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.232 -1.025 . . . . 74.099999999999994 108.232 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -100.83 93.13 5.38 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.908 -1.042 . . . . 74.329999999999998 110.217 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 97.53 -119.55 6.44 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.162 -1.018 . . . . 75.430000000000007 111.277 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.411 ' HB3' ' HB ' ' A' ' 597' ' ' VAL . 3.3 t-20 -133.52 134.25 43.19 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.084 -0.71 . . . . 71.150000000000006 109.084 177.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 62.1 t -132.83 137.98 52.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.111 -1.07 . . . . 72.140000000000001 108.111 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.465 HG12 ' CG2' ' A' ' 597' ' ' VAL . 41.3 mm -107.35 136.46 42.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 109.563 -0.532 . . . . 71.430000000000007 109.563 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.34 110.94 32.12 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 110.046 -0.353 . . . . 64.310000000000002 110.046 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -73.5 150.6 46.27 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.205 1.937 . . . . 72.140000000000001 111.468 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -149.08 163.45 37.52 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 110.405 -0.22 . . . . 74.439999999999998 110.405 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -157.93 158.33 34.8 Favored 'General case' 0 C--O 1.252 1.236 0 O-C-N 123.923 0.764 . . . . 74.409999999999997 109.745 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.7 p -87.36 154.12 20.92 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 109.038 -0.727 . . . . 74.349999999999994 109.038 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.51 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 60.1 mt -128.39 119.01 49.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.204 -1.406 . . . . 71.329999999999998 107.204 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -66.41 120.99 14.3 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 122.631 0.372 . . . . 74.340000000000003 110.453 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -102.71 -104.54 2.85 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 108.663 -1.775 . . . . 72.209999999999994 108.663 176.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 34.3 p -89.91 -22.51 21.96 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.276 -1.009 . . . . 74.310000000000002 108.276 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -81.91 136.95 35.28 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.423 -1.262 . . . . 73.109999999999999 110.067 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -90.49 144.25 25.97 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.382 0.611 . . . . 74.349999999999994 111.912 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.7 -158.03 33.87 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.005 -1.238 . . . . 54.100000000000001 110.005 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.75 26.47 73.98 Favored Glycine 0 C--N 1.315 -0.594 0 C-N-CA 120.929 -0.653 . . . . 73.450000000000003 112.257 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . 0.408 ' C ' HG13 ' A' ' 576' ' ' ILE . . . 67.92 34.55 82.48 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 121.597 -0.335 . . . . 72.049999999999997 112.264 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -104.48 -63.43 1.21 Allowed 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 120.814 -0.355 . . . . 73.420000000000002 111.409 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -101.77 -45.61 5.18 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 108.179 -1.045 . . . . 75.340000000000003 108.179 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -133.93 152.31 51.81 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 107.639 -1.245 . . . . 64.439999999999998 107.639 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -85.6 112.69 21.21 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 105.858 -1.904 . . . . 73.439999999999998 105.858 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.26 140.7 56.02 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 120.941 0.401 . . . . 73.409999999999997 110.203 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.6 t -142.65 148.3 37.18 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-O 121.506 0.67 . . . . 75.400000000000006 111.33 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 11.8 p -148.62 157.28 43.35 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.093 -1.447 . . . . 61.43 107.093 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 168.3 -163.43 37.16 Favored Glycine 0 N--CA 1.421 -2.338 0 C-N-CA 120.114 -1.041 . . . . 62.43 110.665 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.439 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 40.5 mt-10 -132.72 124.91 29.06 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 122.869 0.468 . . . . 74.430000000000007 110.697 -177.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 76.0 mt -91.04 135.09 33.99 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 115.713 -0.676 . . . . 74.239999999999995 109.403 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.403 ' HG2' HD22 ' A' ' 534' ' ' ASN . 32.1 tt0 -102.06 109.48 21.2 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.837 -0.619 . . . . 73.420000000000002 110.54 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -106.07 104.4 14.09 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.661 0.743 . . . . 74.510000000000005 110.534 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.467 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 8.2 mm100 -87.75 173.3 9.07 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.469 -1.308 . . . . 74.349999999999994 107.469 174.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -72.03 -25.91 61.99 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.498 -0.927 . . . . 75.549999999999997 108.498 172.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.66 -46.22 39.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.592 -1.185 . . . . 73.340000000000003 110.822 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.467 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 37.0 mm-40 -61.01 130.58 47.11 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 123.72 0.808 . . . . 72.120000000000005 111.663 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.544 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.3 pt -86.74 -59.69 2.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 116.004 -0.544 . . . . 71.120000000000005 111.746 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.544 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.2 p -141.78 155.17 19.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.769 -0.456 . . . . 75.439999999999998 109.769 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.19 157.28 33.38 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.988 -0.745 . . . . 73.140000000000001 108.988 171.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.0 OUTLIER -125.36 149.85 47.74 Favored 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 115.351 -0.841 . . . . 64.129999999999995 111.574 179.049 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.3 mp -98.91 120.56 48.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 106.662 -1.607 . . . . 63.32 106.662 169.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 5.1 p -96.11 115.09 26.89 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 123.747 0.654 . . . . 71.019999999999996 109.405 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.414 ' CG2' ' HE3' ' A' ' 521' ' ' MET . 93.4 t -114.62 128.58 71.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.705 -0.398 . . . . 74.120000000000005 109.935 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.429 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 22.2 tptm -79.84 115.23 19.32 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.985 -1.007 . . . . 74.219999999999999 109.226 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.66 126.28 40.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 104.935 -2.246 . . . . 63.340000000000003 104.935 174.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . 0.408 HG13 ' C ' ' A' ' 550' ' ' GLY . 45.2 mm -74.16 123.17 28.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 122.272 1.034 . . . . 74.150000000000006 110.771 -173.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -98.19 80.77 2.71 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-N 113.801 -1.545 . . . . 75.129999999999995 108.648 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 32.5 t70 176.23 136.19 0.05 Allowed 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 123.952 0.783 . . . . 73.430000000000007 110.182 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 66.19 22.01 11.05 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 115.273 1.583 . . . . 73.430000000000007 115.273 173.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -79.6 94.52 5.68 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 118.396 -1.322 . . . . 65.510000000000005 108.772 173.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -145.68 27.01 1.24 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.659 -1.978 . . . . 75.450000000000003 105.659 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -112.4 -70.91 0.78 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.782 -0.645 . . . . 62.32 112.303 -172.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.419 ' HB2' ' HZ2' ' A' ' 583' ' ' LYS . 0.0 OUTLIER -173.72 171.04 3.88 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.787 -1.19 . . . . 75.310000000000002 107.787 -171.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -61.7 128.21 35.17 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.942 -0.762 . . . . 74.400000000000006 108.942 172.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -107.87 135.31 49.47 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.511 -0.552 . . . . 72.319999999999993 109.511 -175.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 9.2 t -140.53 145.94 37.46 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 120.411 -0.515 . . . . 73.239999999999995 109.912 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 49.8 p90 -141.81 175.92 9.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.837 -1.172 . . . . 74.049999999999997 107.837 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.51 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 79.1 m-85 -121.4 160.64 23.66 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.73 -0.47 . . . . 73.450000000000003 109.73 -176.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.97 131.27 49.28 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 105.798 -1.927 . . . . 73.219999999999999 105.798 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -129.68 137.98 50.92 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.893 -0.41 . . . . 74.510000000000005 109.893 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 21.3 pt -108.74 142.81 20.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 108.103 -1.073 . . . . 72.010000000000005 108.103 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.52 -177.4 45.62 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 111.004 -0.838 . . . . 74.219999999999999 111.004 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -69.74 132.18 89.12 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 120.895 0.378 . . . . 72.219999999999999 111.345 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.97 129.47 26.04 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.488 2.792 . . . . 75.430000000000007 112.759 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 536' ' ' ILE . 1.2 ptm85 -106.54 119.49 39.42 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.967 -0.561 . . . . 74.129999999999995 110.212 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.39 137.9 57.79 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 124.567 1.147 . . . . 65.349999999999994 111.025 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.465 ' CG2' HG12 ' A' ' 536' ' ' ILE . 21.6 t -113.86 114.79 47.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 105.838 -1.912 . . . . 61.43 105.838 174.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.458 ' C ' ' H ' ' A' ' 600' ' ' SER . 32.5 tt0 -60.83 157.08 15.77 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 122.908 0.483 . . . . 74.140000000000001 110.837 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 23.1 ptp -71.66 12.22 0.4 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.386 1.074 . . . . 74.409999999999997 112.572 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 600' ' ' SER . . . . . 0.458 ' H ' ' C ' ' A' ' 598' ' ' GLU . 40.4 t -102.81 -160.75 0.8 Allowed 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 105.92 -1.881 . . . . 75.310000000000002 105.92 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.92 153.72 27.4 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 120.119 -0.632 . . . . 71.239999999999995 109.537 173.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -64.67 107.51 1.44 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.341 -0.985 . . . . 73.25 108.341 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -135.83 158.37 44.57 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.691 -0.686 . . . . 75.239999999999995 109.513 -174.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 115.73 150.12 9.59 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.84 -0.695 . . . . 74.049999999999997 111.426 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -85.54 82.46 1.67 Allowed Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.592 -1.003 . . . . 61.399999999999999 110.592 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -81.08 70.43 7.91 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.797 0.808 . . . . 71.329999999999998 111.173 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 21.2 m -79.9 145.53 32.63 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 107.519 -1.289 . . . . 72.230000000000004 107.519 176.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 7.0 tp -69.95 98.9 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.802 -0.814 . . . . 74.230000000000004 108.802 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 2.3 p -74.98 -23.17 58.23 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.611 -0.722 . . . . 73.310000000000002 112.265 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -82.45 117.48 22.51 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.756 -0.831 . . . . 72.319999999999993 108.756 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -96.82 -8.59 30.67 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.212 0.53 . . . . 74.439999999999998 110.965 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -118.51 115.95 25.65 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 107.733 -1.21 . . . . 73.430000000000007 107.733 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.85 -21.27 62.45 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 120.801 0.334 . . . . 75.349999999999994 110.891 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -85.02 -3.58 58.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.065 -0.516 . . . . 75.120000000000005 110.884 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -132.5 28.31 4.33 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.786 -1.19 . . . . 74.430000000000007 107.786 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -73.13 -53.07 5.12 Favored Pre-proline 0 N--CA 1.427 -1.605 0 CA-C-N 113.965 -1.47 . . . . 73.409999999999997 110.536 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -85.28 137.65 6.17 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 N-CA-C 107.539 -1.754 . . . . 72.329999999999998 107.539 164.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 58.0 mt -68.67 124.77 24.55 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.023 -0.671 . . . . 74.329999999999998 110.928 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 8.9 t -88.09 5.28 41.89 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.341 -0.845 . . . . 74.120000000000005 110.389 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 15.0 m -71.2 104.96 3.25 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.915 -0.584 . . . . 72.340000000000003 110.568 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 621' ' ' LYS . 0.3 OUTLIER -98.47 74.04 2.13 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.134 -1.061 . . . . 75.230000000000004 108.134 175.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -164.78 155.39 14.38 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.039 -1.437 . . . . 75.239999999999995 107.594 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.28 160.95 21.61 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 120.215 -0.594 . . . . 72.239999999999995 111.94 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . 0.4 ' O ' HG13 ' A' ' 628' ' ' ILE . 36.1 tt0 -163.1 154.51 17.36 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.051 -1.833 . . . . 73.349999999999994 106.051 -178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -66.61 -31.01 71.42 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 118.622 0.646 . . . . 74.109999999999999 112.191 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.57 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 4.1 tmm_? -63.47 -37.7 88.32 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 109.398 -0.593 . . . . 72.120000000000005 109.398 173.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . 0.49 ' HA ' ' OE1' ' A' ' 630' ' ' GLU . 0.0 OUTLIER -69.39 -31.41 69.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.763 -0.829 . . . . 75.439999999999998 108.763 -177.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 624' ' ' GLU . 66.2 mt -74.32 -40.59 50.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.154 -0.684 . . . . 74.409999999999997 109.154 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.09 -15.89 63.55 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.535 -0.757 . . . . 74.129999999999995 110.996 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 45.9 mt-10 -63.63 -9.83 15.72 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 113.31 0.855 . . . . 74.519999999999996 113.31 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.435 ' HA ' ' CG ' ' A' ' 501' ' ' HIS . 0.0 OUTLIER -53.62 -23.29 10.64 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.276 0.843 . . . . 75.439999999999998 113.276 178.174 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -91.99 -10.79 60.88 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.917 -0.658 . . . . 61.0 112.966 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -110.63 167.21 9.39 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.637 -0.875 . . . . 74.409999999999997 108.637 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.432 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 73.8 Cg_endo -84.14 142.87 9.98 Favored 'Trans proline' 0 N--CA 1.427 -2.398 0 C-N-CA 121.384 1.39 . . . . 63.329999999999998 111.333 174.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.5 pp -129.85 168.94 21.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-N 115.807 -0.633 . . . . 75.109999999999999 110.675 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.83 178.92 4.81 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 112.249 0.463 . . . . 73.409999999999997 112.249 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -77.79 -156.06 8.08 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 114.888 0.715 . . . . 74.239999999999995 114.888 -175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -70.77 -48.57 53.59 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.156 0.582 . . . . 74.120000000000005 109.794 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -140.2 144.15 36.44 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.295 -1.002 . . . . 64.319999999999993 108.295 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 14.0 p -133.23 95.88 3.62 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 123.604 0.565 . . . . 73.239999999999995 109.849 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -164.1 138.46 5.66 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.75 -0.833 . . . . 74.510000000000005 108.75 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 510' ' ' PRO . 26.6 tp -125.75 134.44 51.75 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.442 -0.947 . . . . 73.420000000000002 108.442 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -104.3 113.8 27.6 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.391 -1.337 . . . . 72.219999999999999 107.391 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.36 110.15 28.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.144 -0.688 . . . . 73.150000000000006 109.144 -178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 59.2 mt -102.24 120.39 51.88 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 108.619 -0.882 . . . . 73.349999999999994 108.619 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 45.5 mt -95.38 106.95 18.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 107.979 -1.119 . . . . 73.209999999999994 107.979 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -112.45 130.49 55.97 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.243 0.544 . . . . 70.140000000000001 110.463 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.14 118.05 8.63 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.738 1.256 . . . . 74.439999999999998 110.702 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 24.2 m -136.65 106.68 6.31 Favored 'General case' 0 N--CA 1.4 -2.951 0 CA-C-N 113.651 -1.613 . . . . 73.530000000000001 107.367 -172.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -93.7 11.36 29.29 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.034 -0.985 . . . . 75.299999999999997 108.452 -173.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.2 -47.7 83.3 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.613 -1.176 . . . . 75.349999999999994 111.14 -170.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -96.66 100.72 12.26 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-O 122.355 1.074 . . . . 72.129999999999995 112.029 -177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -169.14 -48.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.153 -1.84 . . . . 72.519999999999996 106.174 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 11.3 p -87.96 -53.31 4.81 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 107.5 -1.296 . . . . 64.129999999999995 107.5 172.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 20.6 m -111.23 97.75 7.01 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 115.806 -0.634 . . . . 72.540000000000006 110.021 176.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 47.7 t -98.25 -34.47 4.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.986 -1.116 . . . . 75.140000000000001 107.986 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 17.9 t70 . . . . . 0 C--N 1.311 -1.096 0 CA-C-N 114.824 -1.08 . . . . 65.209999999999994 109.496 178.35 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 61.7 t60 . . . . . 0 N--CA 1.443 -0.804 0 CA-C-O 121.297 0.57 . . . . 65.540000000000006 110.215 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -86.21 -59.66 2.23 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.466 -0.788 . . . . 60.310000000000002 109.552 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.427 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . 165.03 -150.91 19.45 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 120.477 -0.868 . . . . 73.239999999999995 111.119 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.419 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.9 mp -126.13 113.32 33.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 116.852 0.326 . . . . 65.230000000000004 110.67 -173.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -97.33 130.34 44.51 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.487 -0.931 . . . . 75.120000000000005 108.487 170.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.7 t -166.31 175.29 8.36 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.147 -0.686 . . . . 75.219999999999999 109.147 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . 0.452 ' CZ ' HG21 ' A' ' 591' ' ' ILE . 79.9 m-85 -84.55 152.9 23.59 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 110.135 -0.32 . . . . 72.430000000000007 110.135 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -64.68 -37.67 88.39 Favored 'General case' 0 C--O 1.245 0.821 0 O-C-N 123.544 0.528 . . . . 54.539999999999999 110.367 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.65 149.98 75.0 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 108.942 -0.762 . . . . 73.109999999999999 108.942 174.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -74.39 -28.73 10.06 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.894 1.729 . . . . 73.319999999999993 112.154 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 46.0 t -137.57 132.51 45.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 107.802 -1.185 . . . . 75.409999999999997 107.802 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 13.2 t -128.92 140.8 51.51 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 109.623 -0.51 . . . . 65.120000000000005 109.623 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -108.98 127.87 54.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.481 -0.563 . . . . 73.400000000000006 109.481 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 23.9 m -123.06 177.33 4.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.097 -0.705 . . . . 73.120000000000005 109.097 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 647' ' ' GLU . 32.7 t -103.99 159.28 15.8 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.129 0.49 . . . . 74.129999999999995 110.902 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -70.29 -39.22 75.02 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.877 -1.056 . . . . 72.230000000000004 109.776 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 68.1 m -104.19 20.85 17.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.606 0.595 . . . . 72.129999999999995 112.606 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.495 HG23 ' O ' ' A' ' 515' ' ' SER . 11.3 tt -70.01 -35.59 64.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 C-N-CA 119.762 -0.775 . . . . 71.319999999999993 110.229 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 95.06 -78.86 0.87 Allowed Glycine 0 CA--C 1.479 -2.156 0 N-CA-C 110.858 -0.897 . . . . 74.349999999999994 110.858 -177.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 573' ' ' VAL . 33.8 mm -127.63 133.18 68.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.966 -1.494 . . . . 75.310000000000002 106.966 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.508 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -118.59 144.77 45.89 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.432 -0.581 . . . . 74.150000000000006 109.432 177.499 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -112.1 125.06 53.7 Favored 'General case' 0 C--O 1.241 0.643 0 O-C-N 123.638 0.586 . . . . 73.010000000000005 110.996 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 570' ' ' THR . 47.3 t -104.64 126.29 59.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 109.298 -0.631 . . . . 62.130000000000003 109.298 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -80.38 128.32 33.43 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.538 0.524 . . . . 75.430000000000007 109.686 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.498 ' O ' HG23 ' A' ' 568' ' ' VAL . 62.3 t -106.66 115.39 48.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.798 -0.816 . . . . 72.010000000000005 108.798 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.05 123.8 19.5 Favored 'General case' 0 C--O 1.251 1.144 0 O-C-N 123.991 0.807 . . . . 73.549999999999997 110.206 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -73.59 159.62 32.83 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 114.947 -1.024 . . . . 74.409999999999997 110.238 -177.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.427 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 4.3 t -62.46 140.89 58.59 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.687 -0.688 . . . . 70.040000000000006 110.387 175.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.6 t -59.3 -37.06 76.77 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 123.644 0.778 . . . . 72.510000000000005 109.381 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -110.84 87.66 0.48 Allowed Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.132 -1.187 . . . . 62.25 110.132 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.0 100.46 13.28 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.994 -0.743 . . . . 52.43 108.994 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -108.58 92.22 3.97 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.617 -0.72 . . . . 73.409999999999997 111.044 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 95.72 -122.15 7.17 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.317 -0.944 . . . . 65.230000000000004 112.796 175.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -132.9 130.83 40.18 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 123.062 0.545 . . . . 73.519999999999996 109.755 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 60.3 t -134.26 138.36 50.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 123.841 0.856 . . . . 74.109999999999999 109.228 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.523 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 46.6 mm -106.7 133.96 49.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.261 -0.644 . . . . 74.239999999999995 109.261 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 594' ' ' PRO . 21.8 t -122.5 110.85 31.91 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 108.983 -0.747 . . . . 73.019999999999996 108.983 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -72.53 157.65 52.37 Favored 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.283 1.989 . . . . 74.25 111.893 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.419 ' HB3' HG22 ' A' ' 591' ' ' ILE . 47.4 p90 -149.65 160.55 43.42 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.645 -0.502 . . . . 73.200000000000003 109.645 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -158.42 154.69 27.32 Favored 'General case' 0 C--O 1.248 1.024 0 O-C-N 123.709 0.631 . . . . 75.450000000000003 111.121 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.3 p -86.95 140.69 29.34 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.884 -0.598 . . . . 74.239999999999995 110.449 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.441 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 49.0 mt -114.54 125.54 71.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.436 -0.95 . . . . 75.040000000000006 108.436 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.77 154.61 19.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.312 0.577 . . . . 74.310000000000002 112.454 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 176.4 -73.32 0.08 OUTLIER Glycine 0 C--N 1.305 -1.16 0 N-CA-C 110.731 -0.948 . . . . 73.209999999999994 110.731 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.32 5.86 18.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.101 0.953 . . . . 72.129999999999995 111.342 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -153.5 142.18 20.94 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 105.447 -2.057 . . . . 52.439999999999998 105.447 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 38.6 mtp85 -96.05 130.25 43.12 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.115 0.484 . . . . 74.400000000000006 111.452 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.4 -145.8 12.8 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 120.477 -0.868 . . . . 71.120000000000005 112.726 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 65.05 10.1 44.8 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 113.982 0.353 . . . . 71.25 113.982 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 100.43 15.94 28.45 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.164 -1.017 . . . . 63.140000000000001 111.847 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -91.95 -72.48 0.59 Allowed 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 119.713 -0.795 . . . . 60.329999999999998 110.178 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -89.77 -39.16 13.31 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 108.527 -0.916 . . . . 64.420000000000002 108.527 175.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -140.98 155.2 46.27 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.92 -1.037 . . . . 71.530000000000001 108.363 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.04 137.09 33.28 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.779 -1.563 . . . . 64.120000000000005 106.779 177.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -87.17 132.09 33.98 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 110.188 -0.301 . . . . 72.109999999999999 110.188 -172.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 15.0 t -136.43 145.48 45.31 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.685 0.755 . . . . 75.329999999999998 110.841 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 52.1 t -154.29 148.15 25.52 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.985 -1.858 . . . . 52.229999999999997 105.985 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 175.27 -164.82 35.49 Favored Glycine 0 C--N 1.287 -2.191 0 N-CA-C 109.997 -1.241 . . . . 72.409999999999997 109.997 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.523 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 87.0 mt-10 -135.56 127.8 30.09 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.987 0.394 . . . . 74.310000000000002 110.646 -177.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 91.7 mt -92.01 134.18 35.04 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.78 -0.645 . . . . 75.030000000000001 109.469 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -98.84 116.33 30.83 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.775 -0.648 . . . . 73.319999999999993 109.57 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -111.56 145.65 38.75 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.335 -0.617 . . . . 74.519999999999996 109.335 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.437 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 49.7 mt-30 -142.7 179.58 6.91 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 109.183 -0.673 . . . . 72.049999999999997 109.183 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -70.52 -37.92 74.18 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.571 -0.9 . . . . 75.109999999999999 108.571 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.68 -27.29 37.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.729 -1.123 . . . . 75.329999999999998 111.979 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 8.7 mm-40 -78.62 146.97 33.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.283 -0.636 . . . . 71.420000000000002 109.283 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.544 HG13 ' H ' ' A' ' 568' ' ' VAL . 4.0 pt -95.57 -80.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 112.45 0.537 . . . . 65.099999999999994 112.45 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.544 ' H ' HG13 ' A' ' 567' ' ' ILE . 8.3 p -135.73 148.97 27.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 108.619 -0.882 . . . . 72.530000000000001 108.619 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -114.95 159.96 20.12 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.545 -0.539 . . . . 74.420000000000002 109.545 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 16.2 p -128.26 150.15 50.17 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.877 -0.601 . . . . 74.230000000000004 111.009 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.3 mp -99.51 123.28 52.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 106.518 -1.66 . . . . 75.299999999999997 106.518 171.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 572' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 521' ' ' MET . 4.6 p -97.77 115.98 29.08 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.913 0.758 . . . . 74.019999999999996 109.502 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 520' ' ' ILE . 95.9 t -117.33 133.92 62.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 116.619 -0.264 . . . . 74.219999999999999 110.807 -178.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 46.7 tptt -85.6 112.46 20.99 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 109.054 -0.721 . . . . 73.310000000000002 109.054 175.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.63 125.62 40.29 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 104.924 -2.25 . . . . 72.109999999999999 104.924 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 37.9 mm -77.82 120.8 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-O 122.054 0.93 . . . . 74.439999999999998 109.978 -175.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.04 130.21 34.88 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 113.186 -1.824 . . . . 73.040000000000006 108.373 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -156.34 -83.54 0.06 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.703 -0.681 . . . . 75.340000000000003 111.655 -174.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -154.85 164.82 38.28 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.374 -0.973 . . . . 64.439999999999998 108.374 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -104.33 15.16 28.83 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 123.41 0.684 . . . . 72.510000000000005 109.484 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -74.76 -13.63 60.62 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 113.787 1.032 . . . . 72.400000000000006 113.787 -170.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.462 ' CD ' ' H ' ' A' ' 583' ' ' LYS 0.316 0.0 OUTLIER -79.47 -95.73 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 116.163 1.912 . . . . 73.219999999999999 116.163 -175.206 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.462 ' H ' ' CD ' ' A' ' 582' ' ' GLU . 54.3 tttm -147.94 -71.18 0.22 Allowed 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.333 -0.854 . . . . 72.109999999999999 110.747 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 169.1 110.1 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 103.874 -2.639 . . . . 75.519999999999996 103.874 -173.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -96.87 147.09 24.31 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.554 -0.858 . . . . 75.340000000000003 111.016 -176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.5 t -153.14 138.44 17.51 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.879 -0.415 . . . . 74.120000000000005 109.879 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -135.25 176.0 9.07 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.479 -0.934 . . . . 74.040000000000006 108.479 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.441 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 74.0 m-85 -122.47 152.67 40.05 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.042 -0.663 . . . . 64.099999999999994 109.872 -175.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.07 130.86 53.64 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.484 -1.672 . . . . 63.240000000000002 106.484 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -121.63 136.48 54.94 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.745 -0.465 . . . . 75.219999999999999 109.745 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . 0.452 HG21 ' CZ ' ' A' ' 507' ' ' PHE . 21.1 pt -107.94 132.93 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 107.04 -1.467 . . . . 74.109999999999999 107.04 169.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.52 -166.48 42.01 Favored Glycine 0 N--CA 1.423 -2.206 0 CA-C-N 115.577 -0.738 . . . . 63.039999999999999 112.713 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.69 131.71 73.4 Favored Pre-proline 0 N--CA 1.427 -1.603 0 CA-C-O 120.997 0.427 . . . . 70.25 111.629 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.449 ' HB3' HG21 ' A' ' 537' ' ' VAL . 47.3 Cg_endo -69.42 147.3 64.73 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.952 2.434 . . . . 72.239999999999995 111.973 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -125.03 137.3 54.23 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.934 -0.765 . . . . 74.140000000000001 108.934 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.99 128.68 33.57 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 107.122 -1.436 . . . . 75.439999999999998 107.122 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.443 ' CG2' HG12 ' A' ' 536' ' ' ILE . 37.8 t -85.96 89.07 2.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 109.056 -0.72 . . . . 75.430000000000007 109.056 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -115.24 -77.81 0.57 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.466 -1.309 . . . . 64.010000000000005 107.466 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 65.0 mtt -78.89 -16.92 56.39 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.924 -0.769 . . . . 75.400000000000006 108.924 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 11.7 m 66.01 24.52 11.06 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.195 1.398 . . . . 50.030000000000001 111.196 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -88.09 99.89 12.53 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.832 -0.622 . . . . 72.129999999999995 110.85 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.05 104.95 10.04 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.079 -1.823 . . . . 71.120000000000005 106.079 173.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -70.16 -34.38 72.94 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.334 -0.394 . . . . 74.439999999999998 111.809 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 157.39 -47.38 0.47 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 119.628 -1.272 . . . . 74.239999999999995 111.99 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 87.24 53.63 2.76 Favored Glycine 0 C--N 1.305 -1.176 0 N-CA-C 109.21 -1.556 . . . . 65.310000000000002 109.21 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -68.8 105.01 2.18 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.395 0.617 . . . . 64.420000000000002 110.556 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 14.9 m -107.27 110.1 22.05 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 107.291 -1.374 . . . . 74.209999999999994 107.291 177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 16.8 tt -87.87 -31.28 5.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.273 0.559 . . . . 71.25 110.284 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 36.3 m -94.91 100.53 12.38 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.92 -1.511 . . . . 75.420000000000002 106.92 175.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -91.89 -25.13 19.07 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.291 -0.413 . . . . 72.5 111.403 -174.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.53 116.7 32.55 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 104.989 -2.226 . . . . 74.409999999999997 104.989 172.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -137.0 112.87 9.58 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 113.562 0.949 . . . . 74.25 113.562 -177.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -84.51 -16.07 43.69 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.568 -1.271 . . . . 74.010000000000005 107.568 172.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -108.12 94.54 5.13 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.7 -1.222 . . . . 73.329999999999998 107.7 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -68.47 -45.02 73.53 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.006 -0.543 . . . . 73.420000000000002 111.953 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -133.74 146.04 58.61 Favored Pre-proline 0 C--N 1.303 -1.439 0 CA-C-N 116.113 -0.494 . . . . 73.319999999999993 109.837 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -50.76 123.64 11.98 Favored 'Trans proline' 0 C--O 1.252 1.181 0 C-N-CA 123.505 2.804 . . . . 75.049999999999997 112.463 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 60.9 tp -70.97 -61.54 1.73 Allowed 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.13 -0.941 . . . . 75.519999999999996 110.528 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 3.0 p -138.89 118.57 13.07 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.377 0.608 . . . . 73.540000000000006 112.533 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 38.7 t -87.25 117.07 25.77 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 105.554 -2.017 . . . . 64.340000000000003 105.554 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 621' ' ' LYS . 9.9 mptt -82.49 -59.8 2.41 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.273 -1.38 . . . . 73.349999999999994 107.273 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -91.74 123.33 35.05 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 105.36 -2.089 . . . . 72.530000000000001 105.36 171.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -59.13 108.72 0.72 Allowed 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 123.624 0.578 . . . . 73.510000000000005 111.293 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -59.22 120.59 9.51 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.071 -0.968 . . . . 72.430000000000007 110.08 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -25.62 63.18 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.452 0.644 . . . . 74.329999999999998 110.753 177.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -52.37 -54.75 27.8 Favored 'General case' 0 C--O 1.196 -1.718 0 CA-C-N 114.349 -1.296 . . . . 74.420000000000002 110.82 171.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . 0.439 ' HA ' ' HB2' ' A' ' 630' ' ' GLU . 7.3 tmm_? -69.21 -25.07 64.13 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.993 0.425 . . . . 73.030000000000001 110.473 -175.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.502 ' O ' ' HG2' ' A' ' 631' ' ' MET . 65.0 mt -69.77 -29.99 42.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.787 0.803 . . . . 73.239999999999995 109.248 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -86.94 -34.59 19.28 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.433 0.635 . . . . 74.400000000000006 109.607 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 627' ' ' ARG . 45.3 mt-10 -74.48 -11.41 60.22 Favored 'General case' 0 C--O 1.211 -0.968 0 N-CA-C 112.712 0.634 . . . . 74.140000000000001 112.712 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 26.4 ptt? -73.17 -15.01 61.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.119 -1.067 . . . . 75.140000000000001 108.119 173.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -87.46 8.25 77.85 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 115.136 -0.938 . . . . 64.340000000000003 111.39 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 33.9 ptt85 -130.46 161.17 62.29 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 107.043 -1.465 . . . . 75.329999999999998 107.043 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -68.81 137.12 37.49 Favored 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 121.154 1.236 . . . . 74.340000000000003 111.041 174.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.39 167.46 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-N 115.179 -0.918 . . . . 75.299999999999997 109.545 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.35 -176.24 3.16 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 112.199 0.444 . . . . 73.140000000000001 112.199 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . 0.419 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -77.83 -150.18 4.26 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-O 121.646 0.581 . . . . 73.239999999999995 113.84 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -80.97 -48.34 12.41 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.09 0.472 . . . . 75.239999999999995 109.947 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -133.12 131.64 40.75 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.821 -0.807 . . . . 71.219999999999999 108.821 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 23.9 p -119.97 88.95 3.03 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 121.755 0.788 . . . . 71.409999999999997 110.136 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -159.79 137.6 9.99 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.286 -0.87 . . . . 75.299999999999997 109.567 -175.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.428 HD23 HG11 ' A' ' 523' ' ' VAL . 15.6 tp -123.32 128.64 50.21 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 107.974 -1.121 . . . . 74.319999999999993 107.974 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -97.71 111.7 23.88 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.396 -1.335 . . . . 74.349999999999994 107.396 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.7 112.86 34.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.448 -0.575 . . . . 72.230000000000004 109.448 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 68.6 mt -101.6 121.42 52.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 109.636 -0.505 . . . . 72.530000000000001 109.636 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 69.1 mt -95.17 113.89 30.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.877 -1.157 . . . . 74.409999999999997 107.877 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 515' ' ' SER . 40.3 mt-10 -118.63 156.28 29.49 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.627 -1.249 . . . . 72.319999999999993 107.627 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -77.7 145.39 36.63 Favored 'General case' 0 N--CA 1.404 -2.73 0 N-CA-C 106.902 -1.518 . . . . 73.150000000000006 106.902 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 649' ' ' SER . . . . . 0.485 ' HB2' ' OG ' ' A' ' 515' ' ' SER . 66.2 m -133.74 49.09 2.3 Favored 'General case' 0 C--N 1.252 -3.634 0 C-N-CA 119.564 -0.854 . . . . 75.430000000000007 110.684 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -84.06 -52.31 6.4 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 105.865 -1.902 . . . . 73.010000000000005 105.865 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -77.54 -48.32 17.3 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.727 -1.579 . . . . 73.319999999999993 110.55 -175.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 25.1 t80 35.1 73.45 0.08 Allowed 'General case' 0 C--O 1.242 0.67 0 O-C-N 125.456 1.722 . . . . 74.540000000000006 110.866 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -147.81 155.53 41.75 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.594 -0.73 . . . . 73.420000000000002 110.793 -170.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 47.4 t -87.03 103.62 15.54 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.312 -0.996 . . . . 74.120000000000005 108.312 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 15.2 t -156.46 130.32 8.42 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 121.59 0.71 . . . . 73.420000000000002 110.997 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.84 162.1 19.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 106.735 -1.58 . . . . 63.340000000000003 106.735 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 C--N 1.304 -1.394 0 C-N-CA 120.039 -0.664 . . . . 61.32 110.404 179.749 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 7.3 t60 . . . . . 0 N--CA 1.439 -1.003 0 N-CA-C 107.344 -1.354 . . . . 74.040000000000006 107.344 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.532 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . -90.29 -43.45 10.36 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.158 0.504 . . . . 73.099999999999994 112.293 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 128.02 -136.78 9.36 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 119.417 -1.373 . . . . 64.409999999999997 112.186 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.74 112.48 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 111.171 0.063 . . . . 71.200000000000003 111.171 -174.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.467 ' CD2' HG21 ' A' ' 528' ' ' THR . 11.4 m-85 -99.75 120.69 40.13 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.666 -1.235 . . . . 71.420000000000002 107.666 167.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.3 t -163.96 178.65 7.57 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.647 -0.501 . . . . 73.120000000000005 109.647 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -81.39 143.61 32.03 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.885 -0.413 . . . . 74.340000000000003 109.885 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -61.31 -37.78 84.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 123.723 0.639 . . . . 74.430000000000007 109.89 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -125.34 144.83 48.87 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 108.089 -1.078 . . . . 72.439999999999998 108.089 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.88 -27.68 2.96 Favored 'Trans proline' 0 C--N 1.329 -0.448 0 C-N-CA 122.163 1.909 . . . . 72.129999999999995 112.389 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.6 t -137.39 135.32 46.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.901 -1.518 . . . . 72.140000000000001 106.901 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.6 t -133.68 136.53 44.79 Favored 'General case' 0 N--CA 1.409 -2.49 0 N-CA-C 108.99 -0.745 . . . . 61.149999999999999 108.99 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -109.48 120.09 41.43 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.135 -0.691 . . . . 74.430000000000007 109.135 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 25.2 m -108.19 174.48 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 115.548 -0.751 . . . . 71.510000000000005 109.983 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.425 ' OG ' ' HB ' ' A' ' 518' ' ' ILE . 0.0 OUTLIER -96.8 164.06 12.72 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.4 -0.818 . . . . 72.549999999999997 110.495 -178.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -82.24 -54.29 5.37 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.248 -1.019 . . . . 62.450000000000003 108.248 171.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 12.1 m -80.71 31.79 0.3 Allowed 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.512 0.725 . . . . 74.540000000000006 112.1 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.425 ' HB ' ' OG ' ' A' ' 515' ' ' SER . 10.1 tt -94.34 -24.81 4.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 O-C-N 121.762 -0.586 . . . . 75.340000000000003 111.062 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.81 -80.53 1.79 Allowed Glycine 0 N--CA 1.417 -2.597 0 C-N-CA 120.329 -0.938 . . . . 71.340000000000003 111.128 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 43.0 mm -128.12 131.5 69.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.739 -1.208 . . . . 71.140000000000001 107.739 -174.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.535 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -109.41 145.1 36.69 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.093 -0.706 . . . . 70.120000000000005 109.093 176.11 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 23.9 mt-10 -124.19 119.57 29.76 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 123.667 0.604 . . . . 74.109999999999999 111.747 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 570' ' ' THR . 95.5 t -103.56 128.86 56.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 116.029 -0.532 . . . . 74.120000000000005 110.423 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -80.31 137.45 36.59 Favored 'General case' 0 C--O 1.248 0.981 0 O-C-N 123.515 0.51 . . . . 74.5 110.502 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.554 ' O ' HG22 ' A' ' 568' ' ' VAL . 59.9 t -112.75 132.82 60.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 116.147 -0.479 . . . . 73.549999999999997 109.741 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.81 126.68 31.4 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 122.928 0.491 . . . . 71.230000000000004 110.074 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -81.32 157.09 25.2 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.307 -0.861 . . . . 63.140000000000001 109.314 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 0.9 OUTLIER -59.97 145.8 44.84 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 123.333 0.653 . . . . 64.209999999999994 112.295 177.623 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 41.4 t -60.15 -34.98 74.3 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.153 -0.931 . . . . 75.310000000000002 110.093 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.41 81.04 0.35 Allowed Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.638 -0.985 . . . . 74.030000000000001 110.638 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.06 114.02 21.9 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.305 -0.998 . . . . 70.409999999999997 108.305 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -119.15 97.91 5.91 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.499 0.666 . . . . 75.109999999999999 110.711 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 108.89 -130.8 10.22 Favored Glycine 0 N--CA 1.427 -1.965 0 CA-C-N 115.397 -0.82 . . . . 55.25 112.772 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.493 HD21 ' HG2' ' A' ' 563' ' ' GLN . 2.6 t-20 -133.15 127.74 34.53 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.892 -0.781 . . . . 70.439999999999998 108.892 -177.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 61.3 t -132.18 141.82 44.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 123.185 0.594 . . . . 74.319999999999993 110.135 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.42 HG12 ' CG2' ' A' ' 597' ' ' VAL . 36.8 mm -111.35 129.99 65.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.197 -0.668 . . . . 74.25 109.197 175.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.04 105.96 52.19 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 109.203 -0.666 . . . . 75.340000000000003 109.203 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.82 152.35 36.95 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.319 2.013 . . . . 70.530000000000001 112.287 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.515 ' HB3' HG23 ' A' ' 591' ' ' ILE . 49.9 p90 -147.33 164.97 31.56 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.526 -0.306 . . . . 72.439999999999998 111.057 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -156.39 158.1 36.76 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.709 0.63 . . . . 72.239999999999995 109.916 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.3 p -87.78 141.75 28.36 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 115.656 -0.702 . . . . 71.25 110.102 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 90.3 mt -116.84 132.53 66.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.555 -1.276 . . . . 73.219999999999999 107.555 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -81.0 148.22 29.84 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 109.801 -0.444 . . . . 62.020000000000003 109.801 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -141.88 -117.3 1.3 Allowed Glycine 0 C--N 1.292 -1.88 0 N-CA-C 108.671 -1.772 . . . . 72.030000000000001 108.671 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 545' ' ' THR . . . . . 0.414 ' O ' ' HD3' ' A' ' 585' ' ' LYS . 16.7 p -78.34 -23.87 46.78 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.127 -1.064 . . . . 75.209999999999994 108.127 173.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -91.84 135.52 33.86 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 106.982 -1.488 . . . . 71.329999999999998 106.982 172.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -106.81 151.99 24.46 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 113.717 1.006 . . . . 72.239999999999995 113.717 -174.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -91.24 -176.41 43.47 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 114.899 -1.046 . . . . 75.319999999999993 111.707 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 91.63 22.77 30.32 Favored Glycine 0 C--N 1.294 -1.77 0 N-CA-C 110.152 -1.179 . . . . 63.43 110.152 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 70.54 33.98 67.62 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 109.539 -1.424 . . . . 74.430000000000007 109.539 -176.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -95.66 -66.88 0.88 Allowed 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 110.08 -0.341 . . . . 74.120000000000005 110.08 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -104.41 -38.29 6.88 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.19 -1.041 . . . . 62.240000000000002 108.19 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -132.91 158.35 42.8 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.246 -0.888 . . . . 73.319999999999993 108.693 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.53 129.12 37.56 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.589 -1.263 . . . . 73.439999999999998 107.589 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.36 136.99 50.16 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 123.367 0.667 . . . . 74.409999999999997 110.175 -175.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.0 t -139.76 144.87 37.63 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.413 0.625 . . . . 65.0 110.03 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 14.2 p -143.94 133.29 23.24 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 106.275 -1.75 . . . . 73.400000000000006 106.275 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -159.49 -169.89 23.38 Favored Glycine 0 N--CA 1.404 -3.459 0 C-N-CA 118.602 -1.761 . . . . 74.129999999999995 112.385 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -139.82 115.23 9.91 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 124.659 0.858 . . . . 75.5 108.751 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 86.7 mt -89.54 133.55 34.54 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.571 -0.529 . . . . 71.319999999999993 109.571 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -101.95 119.34 38.63 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.173 0.511 . . . . 73.030000000000001 110.815 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -119.03 150.06 40.6 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.826 -0.805 . . . . 74.140000000000001 108.826 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.493 ' HG2' HD21 ' A' ' 534' ' ' ASN . 16.9 mt-30 -146.42 179.01 7.82 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.364 -1.347 . . . . 73.019999999999996 107.364 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -70.19 -25.77 63.58 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 123.64 0.588 . . . . 65.219999999999999 110.423 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -90.75 -33.61 15.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.988 -0.551 . . . . 72.549999999999997 111.915 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.453 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 72.5 mm-40 -66.84 152.61 45.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.918 0.39 . . . . 73.540000000000006 111.706 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.538 HG13 ' H ' ' A' ' 568' ' ' VAL . 5.8 pt -103.52 -86.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 113.38 0.881 . . . . 72.25 113.38 -177.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 525' ' ' VAL . 13.2 p -132.26 148.87 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 120.789 0.328 . . . . 71.400000000000006 110.221 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -120.66 160.97 22.2 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 116.105 -0.498 . . . . 74.140000000000001 109.66 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 5.5 p -125.61 153.78 43.23 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.69 -0.687 . . . . 74.019999999999996 111.033 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.4 mp -100.91 122.74 53.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.21 -1.774 . . . . 70.030000000000001 106.21 170.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 572' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 521' ' ' MET . 14.8 p -100.91 115.11 29.65 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 123.622 0.577 . . . . 74.219999999999999 109.948 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 84.3 t -119.43 134.23 63.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.066 -0.515 . . . . 74.420000000000002 110.405 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -84.54 118.86 24.59 Favored 'General case' 0 N--CA 1.428 -1.567 0 O-C-N 123.645 0.591 . . . . 73.219999999999999 109.568 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.05 120.71 36.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 105.953 -1.869 . . . . 73.349999999999994 105.953 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 48.2 mm -69.58 132.2 33.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.484 0.659 . . . . 73.310000000000002 109.883 -176.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -76.51 152.68 35.98 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.167 -1.378 . . . . 71.109999999999999 108.046 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -45.98 121.56 3.3 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.837 1.051 . . . . 75.140000000000001 113.837 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -129.3 -55.21 1.18 Allowed 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 125.218 1.407 . . . . 70.450000000000003 109.849 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -103.13 -70.74 0.75 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.443 -0.799 . . . . 73.340000000000003 110.118 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -178.22 75.42 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 125.311 1.445 . . . . 74.040000000000006 108.17 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -80.92 147.73 30.17 Favored 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 113.958 -1.473 . . . . 74.409999999999997 107.358 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -145.81 177.47 8.89 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.471 -1.307 . . . . 75.140000000000001 107.471 -170.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -63.11 98.23 0.13 Allowed 'General case' 0 C--O 1.246 0.878 0 N-CA-C 107.703 -1.221 . . . . 61.229999999999997 107.703 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 545' ' ' THR . 94.8 mttt -131.54 169.0 16.71 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.647 -1.612 . . . . 75.340000000000003 106.647 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.8 t -143.1 148.77 37.18 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 121.248 0.546 . . . . 72.439999999999998 110.721 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.527 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 43.1 p90 -130.57 172.4 11.97 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 106.747 -1.575 . . . . 72.120000000000005 106.747 176.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.454 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 87.2 m-85 -120.24 154.51 34.79 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.195 -0.602 . . . . 73.239999999999995 109.981 -175.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.49 128.7 51.16 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 105.418 -2.067 . . . . 72.450000000000003 105.418 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -129.19 137.08 50.93 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.598 -0.519 . . . . 74.219999999999999 109.598 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . 0.515 HG23 ' HB3' ' A' ' 539' ' ' TYR . 15.1 pt -104.9 141.58 19.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.535 -0.913 . . . . 74.349999999999994 108.535 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -87.78 -176.58 48.12 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.66 -0.976 . . . . 74.519999999999996 110.66 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -68.47 130.97 91.81 Favored Pre-proline 0 N--CA 1.434 -1.251 0 C-N-CA 120.543 -0.463 . . . . 74.200000000000003 110.847 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.465 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 24.8 Cg_endo -66.95 137.24 44.1 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.013 2.475 . . . . 73.230000000000004 111.642 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -112.94 133.61 54.83 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.332 -0.395 . . . . 74.420000000000002 110.425 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -76.02 130.55 38.57 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.066 -1.457 . . . . 72.140000000000001 107.066 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.42 ' CG2' HG12 ' A' ' 536' ' ' ILE . 39.0 t -84.61 87.86 2.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 107.84 -1.17 . . . . 71.129999999999995 107.84 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -91.46 141.22 28.98 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 114.492 -1.231 . . . . 74.209999999999994 109.8 -176.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 82.2 mmm -88.95 -35.4 16.46 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.493 -1.299 . . . . 63.530000000000001 107.493 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 33.6 t -97.26 42.07 1.1 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.192 -1.41 . . . . 64.510000000000005 107.192 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.68 119.89 7.93 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.343 -0.844 . . . . 73.129999999999995 112.597 -175.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -107.41 121.88 45.49 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 108.033 -1.099 . . . . 72.400000000000006 108.033 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -58.12 126.72 28.68 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 124.09 0.869 . . . . 64.310000000000002 110.561 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -71.03 -50.73 21.74 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 107.248 -2.341 . . . . 51.219999999999999 107.248 171.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 73.57 -66.18 1.68 Allowed Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 114.351 -0.924 . . . . 64.25 114.474 172.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -85.03 81.79 8.73 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.506 0.67 . . . . 73.409999999999997 111.698 -173.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 36.9 p -109.26 156.29 20.11 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.424 -1.324 . . . . 71.120000000000005 107.424 173.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . 0.426 ' C ' ' HG1' ' A' ' 609' ' ' THR . 42.4 mm -87.1 72.97 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.927 -1.138 . . . . 73.430000000000007 107.927 177.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 609' ' ' THR . . . . . 0.426 ' HG1' ' C ' ' A' ' 608' ' ' ILE . 29.2 m -155.01 108.93 2.9 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.702 -1.135 . . . . 73.140000000000001 108.356 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -106.45 13.67 28.2 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.749 -0.834 . . . . 74.519999999999996 108.749 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -96.79 117.99 32.27 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.761 -1.109 . . . . 65.530000000000001 108.593 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -67.04 -29.35 69.13 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.398 0.679 . . . . 75.299999999999997 111.104 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.11 -31.07 69.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.046 -0.525 . . . . 73.129999999999995 112.118 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 57.42 42.81 24.13 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 123.837 0.71 . . . . 74.5 109.482 -172.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -78.07 -56.51 4.42 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.543 -1.28 . . . . 74.340000000000003 107.543 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -135.99 96.94 12.63 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-N 115.735 -0.666 . . . . 74.549999999999997 110.578 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.15 158.61 55.91 Favored 'Trans proline' 0 C--O 1.244 0.803 0 C-N-CA 122.554 2.17 . . . . 74.140000000000001 111.25 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.2 173.26 7.81 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.32 -1.363 . . . . 74.349999999999994 107.32 175.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 54.7 p -69.3 124.72 24.6 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.334 -0.547 . . . . 65.230000000000004 109.79 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 19.3 m -105.44 87.64 2.66 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.509 -1.293 . . . . 74.239999999999995 107.509 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . 0.417 ' HB2' ' HZ2' ' A' ' 621' ' ' LYS . 9.8 mtmp? -104.72 91.24 3.77 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.781 -1.1 . . . . 75.409999999999997 111.024 -174.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . 0.465 ' HB2' ' HD3' ' A' ' 626' ' ' ARG . 1.1 mp0 -74.29 167.39 21.72 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.852 -1.166 . . . . 75.409999999999997 107.852 173.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -77.08 -5.59 49.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.507 0.67 . . . . 75.109999999999999 111.143 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.9 166.29 23.61 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.791 -1.095 . . . . 72.140000000000001 109.662 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -77.42 90.47 3.83 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.22 -1.029 . . . . 71.310000000000002 108.22 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.465 ' HD3' ' HB2' ' A' ' 622' ' ' GLU . 28.5 mmm180 -69.27 -43.75 73.25 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 111.904 0.335 . . . . 73.019999999999996 111.904 -173.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . 0.639 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 16.3 mmt180 -63.7 -31.28 72.4 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.457 0.646 . . . . 74.140000000000001 111.697 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.506 ' O ' ' HG2' ' A' ' 631' ' ' MET . 52.3 mt -88.62 -26.55 5.57 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-O 121.701 0.762 . . . . 71.439999999999998 110.219 -177.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -78.0 -20.08 53.24 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.093 -0.503 . . . . 61.399999999999999 110.2 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.639 ' HG2' ' O ' ' A' ' 627' ' ' ARG . 5.5 pt-20 -69.72 -10.97 60.4 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 116.09 -0.505 . . . . 72.099999999999994 111.737 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 27.1 ptt? -78.73 -18.41 54.3 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.785 -0.45 . . . . 64.310000000000002 109.785 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -86.89 0.17 86.16 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.584 -0.606 . . . . 73.230000000000004 111.584 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -126.93 149.16 68.29 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 106.63 -1.618 . . . . 73.120000000000005 106.63 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.465 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 24.9 Cg_endo -69.64 136.41 33.23 Favored 'Trans proline' 0 N--CA 1.44 -1.623 0 C-N-CA 121.119 1.212 . . . . 74.530000000000001 110.293 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.61 160.72 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 116.397 -0.365 . . . . 73.239999999999995 111.208 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.1 -176.36 3.97 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.822 -0.626 . . . . 74.329999999999998 112.278 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.66 -163.16 9.97 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 116.447 -0.342 . . . . 75.239999999999995 113.455 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -76.14 -46.62 27.85 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.789 -0.449 . . . . 75.420000000000002 109.789 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -136.57 120.94 18.06 Favored 'General case' 0 CA--C 1.49 -1.354 0 CA-C-O 121.063 0.459 . . . . 75.510000000000005 109.822 174.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 31.3 p -108.14 94.65 5.18 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-O 121.778 0.799 . . . . 65.329999999999998 109.774 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -151.31 146.73 26.22 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.972 -1.013 . . . . 73.129999999999995 108.638 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.425 HD23 HG12 ' A' ' 523' ' ' VAL . 26.3 tp -134.92 120.4 19.21 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 107.924 -1.139 . . . . 74.519999999999996 107.924 175.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -91.38 108.56 19.97 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.206 -1.405 . . . . 72.230000000000004 107.206 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 39.5 t -100.42 109.46 25.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 109.526 -0.546 . . . . 64.409999999999997 109.526 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 47.3 mt -93.87 129.64 43.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.343 -0.984 . . . . 73.439999999999998 108.343 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 77.1 mt -99.91 107.33 20.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.973 -0.751 . . . . 72.209999999999994 108.973 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -114.31 125.99 54.5 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.628 0.728 . . . . 70.510000000000005 111.725 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -70.86 118.25 13.39 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.762 -1.199 . . . . 73.420000000000002 107.762 175.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 44.8 t -147.76 110.2 4.64 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.547 -1.279 . . . . 74.239999999999995 107.547 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -94.77 -12.08 27.78 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.474 0.654 . . . . 74.409999999999997 109.507 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -58.66 -26.78 64.14 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.312 0.856 . . . . 64.019999999999996 113.312 -174.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -89.07 -14.94 35.2 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 120.568 -0.453 . . . . 74.420000000000002 110.87 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -161.67 98.96 1.12 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.711 -0.848 . . . . 75.409999999999997 108.711 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 26.3 m -107.84 -163.94 0.93 Allowed 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.786 -0.82 . . . . 61.32 108.786 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 28.4 m -71.47 -41.76 68.96 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 108.82 -0.807 . . . . 74.010000000000005 108.82 176.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 23.7 m -137.61 165.06 27.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 115.248 -0.887 . . . . 73.519999999999996 108.651 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 C--N 1.306 -1.298 0 N-CA-C 109.586 -0.524 . . . . 75.230000000000004 109.586 179.693 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 631' ' ' MET . 8.1 t60 . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 106.528 -1.656 . . . . 71.400000000000006 106.528 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -70.23 -78.27 0.08 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 121.128 -0.229 . . . . 63.210000000000001 111.48 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 163.36 -145.76 10.89 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.695 -1.24 . . . . 74.510000000000005 112.134 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.15 121.69 58.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 122.428 0.291 . . . . 65.540000000000006 110.923 -174.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -105.44 125.44 50.99 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.204 -0.665 . . . . 72.430000000000007 109.204 169.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' THR . . . . . 0.411 ' HA ' HG21 ' A' ' 640' ' ' THR . 9.0 t -162.79 169.01 20.58 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.393 -0.595 . . . . 72.319999999999993 109.393 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -74.6 148.36 40.82 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.477 0.18 . . . . 74.439999999999998 110.714 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -68.13 -26.8 65.97 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.529 0.681 . . . . 72.519999999999996 110.124 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -140.76 141.01 23.18 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 107.33 -1.359 . . . . 73.209999999999994 107.33 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.48 -28.86 8.05 Favored 'Trans proline' 0 C--N 1.328 -0.539 0 C-N-CA 122.426 2.084 . . . . 74.299999999999997 111.637 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.9 t -132.69 136.34 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 106.293 -1.743 . . . . 74.310000000000002 106.293 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 7.5 t -131.71 140.76 49.37 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 108.82 -0.807 . . . . 74.540000000000006 108.82 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -113.07 123.35 50.09 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.073 -0.651 . . . . 74.0 109.677 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 20.8 m -112.66 174.34 2.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 115.249 -0.887 . . . . 74.200000000000003 108.897 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.565 ' O ' HG21 ' A' ' 518' ' ' ILE . 36.1 t -107.29 151.17 25.83 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.652 0.739 . . . . 73.129999999999995 111.882 -175.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.523 ' CB ' ' HA ' ' A' ' 648' ' ' GLU . 14.2 tt0 -62.19 -23.51 66.66 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 125.732 1.613 . . . . 62.210000000000001 109.705 170.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 4.2 t -123.17 26.35 8.05 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 120.977 0.418 . . . . 75.25 111.402 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.565 HG21 ' O ' ' A' ' 515' ' ' SER . 8.5 tt -84.11 -27.87 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.55 -0.719 . . . . 74.420000000000002 110.664 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.21 -80.04 1.57 Allowed Glycine 0 N--CA 1.428 -1.856 0 N-CA-C 111.056 -0.817 . . . . 71.129999999999995 111.056 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.2 mm -127.92 133.17 67.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 106.471 -1.677 . . . . 72.109999999999999 106.471 -177.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.599 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -109.86 144.07 38.85 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.767 -0.457 . . . . 72.430000000000007 109.767 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 7.8 mp0 -117.9 118.12 31.11 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 124.185 0.928 . . . . 74.0 109.916 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.511 HG21 ' SD ' ' A' ' 521' ' ' MET . 87.4 t -109.45 130.71 62.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.176 -0.676 . . . . 75.230000000000004 109.176 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -88.75 145.16 25.79 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 121.942 0.877 . . . . 74.120000000000005 112.626 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 38.9 t -113.26 137.55 45.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-N 114.437 -1.256 . . . . 72.540000000000006 107.926 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.7 mt -78.22 114.64 17.3 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.813 -0.81 . . . . 73.319999999999993 108.813 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -68.65 157.44 36.19 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.595 -1.184 . . . . 71.409999999999997 109.24 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.1 t -55.57 133.01 50.1 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 123.825 0.703 . . . . 55.439999999999998 111.568 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.7 m -54.59 -28.06 43.55 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.611 1.564 . . . . 55.340000000000003 111.026 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.58 91.93 0.48 Allowed Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 108.748 -1.741 . . . . 75.430000000000007 108.748 174.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -92.7 104.13 16.44 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.972 0.415 . . . . 63.409999999999997 110.411 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -130.27 104.68 7.43 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.069 -0.514 . . . . 74.030000000000001 109.85 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 101.18 -138.79 14.06 Favored Glycine 0 C--N 1.307 -1.08 0 C-N-CA 120.86 -0.686 . . . . 70.510000000000005 112.16 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -133.24 130.56 39.18 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.419 -0.585 . . . . 74.030000000000001 109.419 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.28 134.04 57.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.03 -1.1 . . . . 73.329999999999998 108.03 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.496 HG12 ' CG2' ' A' ' 597' ' ' VAL . 46.3 mm -102.95 135.11 41.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.205 -0.665 . . . . 75.109999999999999 109.205 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 42.8 t -120.11 108.79 37.94 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.577 -0.527 . . . . 73.209999999999994 109.577 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.3 154.06 45.89 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.277 1.984 . . . . 74.329999999999998 111.748 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.415 ' HB3' HG21 ' A' ' 591' ' ' ILE . 33.1 p90 -145.59 164.2 32.44 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.942 -0.303 . . . . 73.319999999999993 110.709 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -157.02 156.85 33.61 Favored 'General case' 0 C--O 1.248 0.978 0 O-C-N 123.835 0.709 . . . . 74.439999999999998 110.225 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.2 p -89.15 139.84 30.06 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 116.075 -0.511 . . . . 73.120000000000005 110.109 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.449 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 78.0 mt -112.01 129.24 67.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.812 -0.81 . . . . 74.540000000000006 108.812 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -83.02 164.7 20.19 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.156 -0.683 . . . . 74.209999999999994 109.156 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 172.1 -82.73 0.08 OUTLIER Glycine 0 CA--C 1.474 -2.469 0 C-N-CA 120.031 -1.081 . . . . 60.109999999999999 111.749 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.8 m -101.92 19.4 18.44 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.513 1.149 . . . . 70.239999999999995 108.402 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -162.84 148.82 12.29 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 106.169 -1.789 . . . . 63.329999999999998 106.169 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -104.59 141.07 37.07 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 123.712 0.805 . . . . 75.439999999999998 112.116 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.63 -160.41 36.46 Favored Glycine 0 C--N 1.306 -1.116 0 CA-C-N 115.433 -0.803 . . . . 64.329999999999998 112.704 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 71.65 12.66 74.2 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.751 -0.261 . . . . 43.109999999999999 113.499 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 90.11 19.36 46.85 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.459 -0.877 . . . . 64.439999999999998 111.043 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -89.18 -67.32 0.85 Allowed 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.59 -0.522 . . . . 74.439999999999998 109.59 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -102.13 -33.69 9.57 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.657 -1.238 . . . . 72.209999999999994 107.657 172.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -141.33 154.99 45.99 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.591 -0.892 . . . . 74.219999999999999 108.591 176.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.14 120.28 27.35 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.596 -1.631 . . . . 74.450000000000003 106.596 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -80.66 124.58 29.12 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.064 -0.516 . . . . 73.340000000000003 110.531 -171.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.7 t -136.2 168.68 18.95 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.35 0.595 . . . . 72.239999999999995 111.199 -172.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 14.8 p -158.52 164.44 36.13 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.97 -1.122 . . . . 64.430000000000007 107.97 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 173.57 -169.44 42.53 Favored Glycine 0 CA--C 1.482 -1.982 0 C-N-CA 120.156 -1.021 . . . . 74.010000000000005 110.853 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.443 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 46.1 mt-10 -137.14 125.42 23.22 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 123.428 0.691 . . . . 74.109999999999999 109.319 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 96.5 mt -96.05 132.42 41.44 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.257 -0.429 . . . . 75.109999999999999 109.862 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -94.91 111.23 23.04 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.22 0.534 . . . . 72.209999999999994 110.806 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 81.9 m-85 -107.98 142.59 37.87 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.063 0.459 . . . . 75.230000000000004 110.002 177.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -140.42 179.9 6.39 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.45 -0.574 . . . . 75.439999999999998 109.45 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -68.36 -34.61 76.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.82 -1.082 . . . . 72.549999999999997 108.894 173.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -85.14 -39.99 17.25 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.033 -0.985 . . . . 73.549999999999997 111.692 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -65.49 135.08 54.72 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.084 0.402 . . . . 74.439999999999998 112.084 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.562 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.8 pt -83.76 -81.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.227 0.825 . . . . 75.319999999999993 113.227 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.562 ' H ' HG13 ' A' ' 567' ' ' ILE . 9.0 p -128.79 158.48 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 109.555 -0.535 . . . . 70.120000000000005 109.555 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 4.5 mmpt? -125.94 159.26 33.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.078 -1.082 . . . . 73.409999999999997 108.078 172.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 5.8 p -130.14 149.07 52.01 Favored 'General case' 0 C--N 1.286 -2.194 0 O-C-N 123.832 0.707 . . . . 72.219999999999999 111.673 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.9 mp -94.79 125.53 47.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 106.825 -1.546 . . . . 75.409999999999997 106.825 172.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 572' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 521' ' ' MET . 48.6 m -107.07 118.36 36.5 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 123.958 0.786 . . . . 73.409999999999997 110.068 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.448 ' HB ' ' HE1' ' A' ' 521' ' ' MET . 76.4 t -125.45 134.42 66.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.097 -0.501 . . . . 74.340000000000003 109.874 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -79.87 115.02 19.22 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.883 -0.784 . . . . 74.329999999999998 108.883 174.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.24 130.19 36.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.604 -1.258 . . . . 72.25 107.604 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 44.1 mm -87.49 129.57 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.895 0 N-CA-C 108.174 -1.047 . . . . 73.340000000000003 108.174 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -83.36 80.31 9.13 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 122.951 1.358 . . . . 64.109999999999999 109.577 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 580' ' ' GLU . 36.9 t70 -84.26 140.62 31.54 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 113.344 -1.753 . . . . 70.120000000000005 110.204 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -93.9 -0.34 55.74 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.973 -0.558 . . . . 63.130000000000003 111.395 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.477 ' HB3' ' OD2' ' A' ' 578' ' ' ASP . 28.2 tt0 -98.49 85.31 3.35 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.713 -0.847 . . . . 71.120000000000005 108.713 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . 0.309 7.1 p90 -114.19 65.55 0.67 Allowed 'General case' 0 C--N 1.28 -2.426 0 CA-C-O 122.767 1.27 . . . . 75.439999999999998 112.042 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -80.02 -34.03 38.7 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 112.953 -1.931 . . . . 64.349999999999994 108.032 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -145.98 141.76 28.01 Favored 'General case' 0 N--CA 1.409 -2.52 0 N-CA-C 104.891 -2.263 . . . . 75.019999999999996 104.891 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 647' ' ' GLU . 14.3 m120 -60.13 131.92 52.32 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 123.902 0.751 . . . . 73.430000000000007 110.636 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -86.02 120.6 27.58 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 107.819 -1.178 . . . . 72.340000000000003 107.819 -176.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.7 t -132.73 130.64 40.27 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.626 0.727 . . . . 65.319999999999993 111.402 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -121.37 172.42 8.05 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.418 -0.956 . . . . 72.219999999999999 108.418 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.449 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 90.8 m-85 -118.7 152.48 36.05 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.947 -0.701 . . . . 75.030000000000001 109.855 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.54 130.22 54.14 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.304 -1.739 . . . . 73.519999999999996 106.304 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -127.02 134.44 50.32 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.624 -0.43 . . . . 73.340000000000003 109.865 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . 0.415 HG21 ' HB3' ' A' ' 539' ' ' TYR . 21.3 pt -102.56 139.78 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 107.673 -1.232 . . . . 72.519999999999996 107.673 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.45 177.2 52.73 Favored Glycine 0 N--CA 1.421 -2.343 0 C-N-CA 120.997 -0.62 . . . . 43.450000000000003 111.622 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.16 129.06 94.18 Favored Pre-proline 0 N--CA 1.428 -1.531 0 CA-C-O 120.86 0.362 . . . . 73.319999999999993 110.631 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -60.24 132.94 46.72 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.485 2.79 . . . . 73.129999999999995 112.291 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -110.41 119.96 40.9 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 120.993 0.425 . . . . 64.120000000000005 110.658 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.49 131.82 47.38 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.731 0.813 . . . . 74.420000000000002 108.858 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.496 ' CG2' HG12 ' A' ' 536' ' ' ILE . 61.0 t -92.81 103.95 15.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.46 -0.57 . . . . 74.409999999999997 109.46 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.78 114.81 18.03 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.538 -1.653 . . . . 63.32 106.538 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 25.2 mmt -84.54 -64.9 1.08 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.024 0.44 . . . . 75.519999999999996 110.333 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 39.3 t -165.68 87.38 0.39 Allowed 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.578 -0.737 . . . . 74.239999999999995 109.109 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -133.24 142.77 48.72 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.353 -1.351 . . . . 73.209999999999994 107.353 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -81.19 78.69 7.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.866 0.841 . . . . 74.430000000000007 110.184 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 603' ' ' LYS . 37.3 ttmt -155.08 106.83 2.65 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.347 -1.353 . . . . 73.349999999999994 107.347 -175.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -128.47 175.69 18.51 Favored Glycine 0 N--CA 1.427 -1.937 0 C-N-CA 120.717 -0.754 . . . . 71.25 112.376 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 152.53 -162.15 29.8 Favored Glycine 0 N--CA 1.422 -2.236 0 N-CA-C 109.136 -1.586 . . . . 70.400000000000006 109.136 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -115.89 118.46 33.03 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 117.255 0.528 . . . . 70.010000000000005 110.982 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 5.1 p -60.29 -33.62 72.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.34 -0.845 . . . . 73.400000000000006 110.814 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 59.4 mt -86.01 80.24 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 106.885 -1.524 . . . . 71.319999999999993 106.885 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 7.1 m -83.2 -37.19 23.95 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.489 -0.56 . . . . 74.439999999999998 109.489 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -79.4 105.82 10.99 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.251 -1.018 . . . . 55.420000000000002 108.251 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -97.36 85.13 3.58 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 107.944 -1.132 . . . . 62.25 107.944 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.403 ' HD2' ' O ' ' A' ' 614' ' ' ASP . 15.8 p90 -92.43 132.7 36.56 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.094 -0.957 . . . . 74.129999999999995 111.484 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -90.54 -12.65 36.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.873 -0.603 . . . . 72.140000000000001 110.95 -177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . 0.403 ' O ' ' HD2' ' A' ' 612' ' ' TYR . 14.8 t70 -95.96 179.11 5.2 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.123 -1.806 . . . . 64.010000000000005 106.123 173.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -87.49 -14.48 40.26 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 119.137 0.881 . . . . 65.450000000000003 109.914 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . 0.406 ' HA ' ' HD3' ' A' ' 617' ' ' PRO . 0.9 OUTLIER -141.3 128.54 11.79 Favored Pre-proline 0 N--CA 1.431 -1.387 0 N-CA-C 113.66 0.985 . . . . 73.510000000000005 113.66 177.817 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . 0.41 ' HG2' ' OG1' ' A' ' 619' ' ' THR . 19.2 Cg_endo -100.83 173.06 0.32 Allowed 'Trans proline' 0 N--CA 1.44 -1.659 0 C-N-CA 122.198 1.932 . . . . 73.319999999999993 109.83 167.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.2 pp -91.36 32.85 1.02 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.481 -0.762 . . . . 74.109999999999999 111.477 178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 619' ' ' THR . . . . . 0.56 ' HA ' ' OE2' ' A' ' 622' ' ' GLU . 25.0 m -46.66 99.64 0.02 OUTLIER 'General case' 0 C--O 1.24 0.565 0 C-N-CA 125.517 1.527 . . . . 74.409999999999997 112.442 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 24.1 p -178.02 -19.5 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.739 0.644 . . . . 74.030000000000001 112.739 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -138.53 19.99 2.72 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.278 -0.569 . . . . 73.230000000000004 112.344 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . 0.56 ' OE2' ' HA ' ' A' ' 619' ' ' THR . 1.3 mp0 -74.84 -66.84 0.7 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.84 0.352 . . . . 74.549999999999997 110.651 -177.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 626' ' ' ARG . 16.1 mm-40 -143.02 114.96 8.25 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 109.086 -0.709 . . . . 75.219999999999999 109.086 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -67.51 -8.26 32.36 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.648 0.737 . . . . 71.299999999999997 110.999 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -51.45 -33.37 30.64 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.776 0.83 . . . . 75.430000000000007 110.556 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 623' ' ' GLU . 5.9 ptp180 -64.57 -28.8 69.88 Favored 'General case' 0 C--O 1.195 -1.802 0 CA-C-N 116.444 -0.344 . . . . 74.239999999999995 111.128 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . 0.488 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 64.8 ttt180 -74.37 -19.63 60.37 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.863 0.84 . . . . 74.409999999999997 109.667 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.647 ' O ' ' HG2' ' A' ' 631' ' ' MET . 57.1 mt -88.22 -46.25 15.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.426 -1.324 . . . . 71.120000000000005 107.426 175.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -66.17 -20.12 66.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.54 -0.754 . . . . 75.450000000000003 112.265 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 627' ' ' ARG . 10.4 pt-20 -67.61 -16.68 64.3 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 116.586 -0.279 . . . . 74.319999999999993 111.262 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.647 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 24.7 ptt? -78.83 -16.81 56.63 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.595 -0.442 . . . . 74.109999999999999 109.823 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -82.02 -14.11 77.88 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 111.053 -0.819 . . . . 64.239999999999995 111.053 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -115.03 159.32 38.17 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 106.771 -1.566 . . . . 73.530000000000001 106.771 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -76.39 135.46 16.62 Favored 'Trans proline' 0 N--CA 1.435 -1.913 0 C-N-CA 120.77 0.98 . . . . 72.349999999999994 111.016 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.93 170.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 116.174 -0.466 . . . . 73.540000000000006 110.876 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.34 170.65 7.82 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 112.786 0.661 . . . . 75.349999999999994 112.786 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -78.51 -158.08 11.38 Favored Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 114.834 -1.075 . . . . 73.329999999999998 115.283 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -66.78 -54.52 21.83 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.082 -1.059 . . . . 71.409999999999997 110.853 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -126.81 137.49 53.21 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.56 -0.904 . . . . 73.019999999999996 108.56 175.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 640' ' ' THR . . . . . 0.411 HG21 ' HA ' ' A' ' 506' ' ' THR . 8.7 p -127.12 73.68 1.44 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 122.344 1.069 . . . . 72.120000000000005 111.336 174.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -157.42 141.2 15.88 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 114.475 -1.239 . . . . 74.319999999999993 107.962 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.402 HD21 HG12 ' A' ' 523' ' ' VAL . 38.5 tp -124.4 130.24 52.12 Favored 'General case' 0 C--N 1.279 -2.484 0 O-C-N 124.181 0.926 . . . . 75.219999999999999 109.35 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -94.46 107.38 19.35 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.059 -1.46 . . . . 72.200000000000003 107.059 174.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.1 109.63 24.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.269 -0.641 . . . . 74.329999999999998 109.269 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 52.6 mt -96.76 122.91 48.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 109.012 -0.736 . . . . 75.439999999999998 109.012 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 82.2 mt -87.72 111.82 22.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 106.9 -1.519 . . . . 74.430000000000007 106.9 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.465 ' HA ' ' ND2' ' A' ' 584' ' ' ASN . 46.2 mt-10 -107.94 138.86 43.46 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 109.364 -0.606 . . . . 71.120000000000005 109.364 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.523 ' HA ' ' CB ' ' A' ' 516' ' ' GLU . 0.2 OUTLIER -73.78 120.61 19.61 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 115.034 -0.984 . . . . 73.129999999999995 109.013 178.539 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 649' ' ' SER . . . . . 0.432 ' HB3' ' O ' ' A' ' 652' ' ' PHE . 58.1 m -155.78 84.68 1.03 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 112.862 0.69 . . . . 53.109999999999999 112.862 -173.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -89.89 -42.96 10.92 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.546 -1.279 . . . . 71.230000000000004 107.546 167.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -79.27 -46.26 18.12 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.644 -1.162 . . . . 74.109999999999999 109.476 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . 0.432 ' O ' ' HB3' ' A' ' 649' ' ' SER . 60.6 t80 -78.39 144.09 36.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.636 -0.711 . . . . 73.310000000000002 109.705 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -154.37 174.1 15.3 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.033 -1.099 . . . . 71.230000000000004 108.033 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 17.3 m -69.86 85.75 0.5 Allowed 'General case' 0 C--N 1.314 -0.949 0 O-C-N 123.465 0.478 . . . . 73.109999999999999 110.318 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 35.8 m -103.17 121.23 42.23 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.179 0.514 . . . . 72.200000000000003 110.795 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 15.8 m -95.64 114.97 33.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 121.571 0.701 . . . . 71.25 110.418 177.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 15.8 t70 . . . . . 0 C--N 1.299 -1.628 0 CA-C-N 115.447 -0.797 . . . . 75.420000000000002 110.669 -179.359 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 75.3 m80 . . . . . 0 C--O 1.242 0.709 0 N-CA-C 110.522 -0.177 . . . . 74.430000000000007 110.522 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.532 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . -58.48 -46.29 86.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.385 0.612 . . . . 75.019999999999996 110.993 178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 139.88 -149.51 20.86 Favored Glycine 0 N--CA 1.419 -2.486 0 C-N-CA 120.304 -0.95 . . . . 72.049999999999997 110.875 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.8 mp -117.24 113.43 42.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 123.687 0.287 . . . . 73.349999999999994 111.237 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.428 ' CD2' HG22 ' A' ' 528' ' ' THR . 21.8 m-85 -92.04 124.82 36.43 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.725 -1.213 . . . . 72.129999999999995 107.725 169.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.7 t -168.72 171.46 8.64 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 120.554 -0.458 . . . . 71.409999999999997 109.883 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -80.55 157.39 26.1 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.839 -0.801 . . . . 71.25 108.839 175.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.74 -35.51 80.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.506 0.67 . . . . 74.420000000000002 110.32 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -140.18 149.36 57.92 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.487 -0.931 . . . . 75.420000000000002 108.487 -176.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 642' ' ' LEU . 60.9 Cg_endo -75.53 -24.97 11.51 Favored 'Trans proline' 0 C--O 1.219 -0.437 0 C-N-CA 122.158 1.906 . . . . 75.129999999999995 112.77 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.75 135.76 58.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.981 -0.748 . . . . 74.230000000000004 108.981 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 644' ' ' VAL . 9.5 t -135.03 140.08 45.32 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 107.714 -1.217 . . . . 64.239999999999995 107.714 177.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -108.73 138.41 45.09 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.651 -0.87 . . . . 73.540000000000006 108.651 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.8 m -128.65 156.38 41.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.953 -0.758 . . . . 65.049999999999997 108.953 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.596 ' O ' HG21 ' A' ' 518' ' ' ILE . 33.0 t -83.48 150.84 25.76 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.795 -0.639 . . . . 75.019999999999996 109.323 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.529 ' CB ' ' HA ' ' A' ' 648' ' ' GLU . 1.8 tm-20 -66.89 -32.64 74.04 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.494 -0.558 . . . . 71.409999999999997 109.494 170.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.7 m -99.29 20.46 13.56 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 112.117 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.596 HG21 ' O ' ' A' ' 515' ' ' SER . 9.9 tt -79.23 -27.52 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.542 -0.724 . . . . 74.209999999999994 111.529 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 92.3 -77.16 1.26 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.29 -0.957 . . . . 51.229999999999997 111.327 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 42.4 mm -130.53 123.58 55.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 106.719 -1.586 . . . . 72.319999999999993 106.719 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.507 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -101.43 150.52 22.95 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.798 -0.816 . . . . 74.219999999999999 108.798 177.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.595 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.7 mt-10 -132.06 129.18 39.68 Favored 'General case' 0 CA--C 1.493 -1.247 0 O-C-N 123.702 0.626 . . . . 73.230000000000004 111.033 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 570' ' ' THR . 60.9 t -116.4 132.04 67.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.282 -0.872 . . . . 54.200000000000003 108.978 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -85.45 127.82 34.52 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 124.138 0.975 . . . . 71.340000000000003 110.252 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 60.3 t -110.41 128.57 66.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.885 -0.598 . . . . 74.200000000000003 109.645 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 77.9 mt -81.75 127.97 33.5 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.012 -0.994 . . . . 74.349999999999994 112.031 -173.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -72.12 162.18 29.83 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.387 -0.968 . . . . 74.310000000000002 108.387 172.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 19.4 p -58.7 154.52 14.45 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 123.503 0.721 . . . . 74.25 112.341 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 41.0 t -53.83 -35.18 61.18 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.793 1.237 . . . . 62.32 109.498 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -114.82 103.7 1.29 Allowed Glycine 0 N--CA 1.42 -2.407 0 N-CA-C 108.841 -1.704 . . . . 74.099999999999994 108.841 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.71 101.7 12.99 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.194 -0.669 . . . . 73.209999999999994 109.194 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -127.02 117.99 23.57 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.796 -0.816 . . . . 72.340000000000003 108.796 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 77.22 172.04 36.56 Favored Glycine 0 C--N 1.298 -1.562 0 N-CA-C 115.016 0.767 . . . . 75.420000000000002 115.016 173.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.403 HD21 ' HG2' ' A' ' 563' ' ' GLN . 2.7 t-20 -86.01 123.23 31.1 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.519 -0.84 . . . . 74.200000000000003 109.127 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 58.0 t -132.01 132.9 61.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 114.8 -1.091 . . . . 72.129999999999995 108.204 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.475 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 43.8 mm -102.81 132.25 49.34 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 109.375 -0.602 . . . . 73.310000000000002 109.375 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.53 105.77 43.27 Favored Pre-proline 0 N--CA 1.427 -1.594 0 N-CA-C 108.736 -0.839 . . . . 75.140000000000001 108.736 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -72.55 151.98 53.54 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.169 1.912 . . . . 73.109999999999999 111.672 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -142.6 163.27 33.28 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.459 -0.496 . . . . 73.010000000000005 110.104 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -153.67 151.37 29.59 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 123.929 0.768 . . . . 75.239999999999995 110.01 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 11.1 p -85.78 133.13 34.01 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 109.377 -0.601 . . . . 75.319999999999993 109.377 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.476 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 67.5 mt -108.08 124.2 64.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 108.178 -1.045 . . . . 73.209999999999994 108.178 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -73.14 136.03 44.77 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 120.945 0.402 . . . . 74.5 110.321 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -126.61 -104.43 1.35 Allowed Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 109.352 -1.499 . . . . 55.219999999999999 109.352 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.7 p -94.57 -21.32 18.92 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.489 0.662 . . . . 71.409999999999997 109.61 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -84.01 142.29 30.58 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 108.44 -0.948 . . . . 72.209999999999994 108.44 175.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -87.32 123.3 32.15 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 114.305 1.224 . . . . 74.140000000000001 114.305 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -81.92 -158.8 23.26 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 115.043 -0.981 . . . . 64.430000000000007 112.101 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.36 14.36 71.66 Favored Glycine 0 C--N 1.306 -1.1 0 C-N-CA 121.312 -0.471 . . . . 52.439999999999998 112.837 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 77.92 39.02 25.4 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.905 -0.664 . . . . 65.120000000000005 111.836 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -111.9 -50.97 2.88 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.441 0.639 . . . . 75.140000000000001 109.949 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.432 ' CG ' ' HZ2' ' A' ' 585' ' ' LYS . 16.3 t0 -104.07 -47.14 4.25 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 105.821 -1.918 . . . . 74.430000000000007 105.821 177.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -134.11 154.21 51.34 Favored 'General case' 0 C--O 1.256 1.421 0 CA-C-N 114.329 -1.305 . . . . 75.030000000000001 108.152 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -81.21 119.38 23.54 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.25 -1.389 . . . . 74.310000000000002 107.25 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.88 125.15 28.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.093 -1.077 . . . . 74.349999999999994 108.093 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 12.0 t -140.02 159.41 42.25 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-O 121.618 0.723 . . . . 70.030000000000001 110.609 -171.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 23.0 p -147.22 165.74 29.12 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 107.331 -1.359 . . . . 75.420000000000002 107.331 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 176.16 -174.32 46.86 Favored Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 120.044 -1.074 . . . . 63.229999999999997 110.82 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.475 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 51.7 mt-10 -134.38 119.55 18.75 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 123.271 0.628 . . . . 75.420000000000002 109.325 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 88.7 mt -86.53 132.47 33.91 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.985 -0.552 . . . . 62.109999999999999 109.811 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.4 ' HA ' HD11 ' A' ' 536' ' ' ILE . 34.9 tt0 -101.53 106.38 17.47 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.745 -0.661 . . . . 73.409999999999997 110.019 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -105.42 149.68 25.93 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.75 -0.833 . . . . 72.25 108.75 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.513 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 6.3 mt-30 -143.96 -169.16 3.04 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.204 -1.406 . . . . 72.430000000000007 107.204 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -76.12 -19.48 58.48 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.595 -0.891 . . . . 71.219999999999999 108.595 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -88.54 -45.1 10.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.31 -1.314 . . . . 62.409999999999997 110.521 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.513 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 6.0 mm-40 -74.9 122.51 23.53 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.943 0.401 . . . . 74.409999999999997 111.817 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.434 HD11 ' N ' ' A' ' 568' ' ' VAL . 1.8 pp -106.99 -32.51 2.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 115.122 -0.944 . . . . 65.329999999999998 113.16 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.434 ' N ' HD11 ' A' ' 567' ' ' ILE . 9.4 p -143.43 145.76 22.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 120.275 -0.57 . . . . 73.530000000000001 110.494 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.59 162.18 27.09 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.798 -0.637 . . . . 75.510000000000005 109.612 174.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.7 p -122.32 143.33 49.7 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.588 0.588 . . . . 71.329999999999998 112.588 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.6 mp -94.63 117.84 39.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 106.591 -1.633 . . . . 74.099999999999994 106.591 170.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 572' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 521' ' ' MET . 8.1 p -98.31 115.52 28.59 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.712 0.632 . . . . 75.400000000000006 109.498 178.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.465 HG23 HG23 ' A' ' 571' ' ' ILE . 60.1 t -121.52 124.66 72.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 116.295 -0.412 . . . . 74.430000000000007 110.66 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -71.91 120.83 18.07 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.965 -1.016 . . . . 73.530000000000001 108.678 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 28.2 t -92.37 130.33 41.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 104.73 -2.322 . . . . 73.030000000000001 104.73 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 44.0 mm -83.31 152.09 3.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 108.762 -0.829 . . . . 73.230000000000004 108.762 -173.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.9 88.95 0.76 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.201 -1.407 . . . . 74.340000000000003 107.201 174.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.14 105.12 2.8 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.11 -1.404 . . . . 73.319999999999993 112.191 -173.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -78.88 -44.61 22.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.278 -1.328 . . . . 75.150000000000006 109.918 -175.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -85.67 -167.95 2.04 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.086 -1.45 . . . . 75.519999999999996 107.086 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -169.48 170.06 8.5 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 118.845 0.748 . . . . 75.340000000000003 111.605 176.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -147.11 147.98 31.13 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 104.443 -2.428 . . . . 75.109999999999999 104.443 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -63.34 100.12 0.23 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 123.752 0.657 . . . . 75.150000000000006 111.7 -177.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 57.78 84.83 0.09 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.846 1.258 . . . . 73.540000000000006 111.404 177.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . 0.432 ' HZ2' ' CG ' ' A' ' 552' ' ' ASP 0.289 0.0 OUTLIER -111.02 147.87 33.82 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 114.196 1.184 . . . . 74.030000000000001 114.196 -178.552 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 586' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 644' ' ' VAL . 5.9 t -141.79 159.02 43.08 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.767 -1.106 . . . . 70.25 110.349 -172.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 40.3 p90 -132.79 168.69 17.91 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 106.693 -1.595 . . . . 75.200000000000003 106.693 175.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.476 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 63.6 m-85 -115.74 155.74 27.23 Favored 'General case' 0 C--N 1.283 -2.284 0 C-N-CA 120.34 -0.544 . . . . 75.400000000000006 110.342 -175.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.21 126.19 46.51 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 105.717 -1.957 . . . . 73.340000000000003 105.717 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -127.16 129.77 48.5 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 120.534 -0.467 . . . . 75.340000000000003 109.871 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 21.5 pt -98.96 136.2 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 N-CA-C 108.046 -1.094 . . . . 71.430000000000007 108.046 175.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.03 -177.87 52.13 Favored Glycine 0 N--CA 1.421 -2.365 0 CA-C-N 115.496 -0.775 . . . . 62.219999999999999 111.369 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -64.82 133.71 95.82 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 120.742 0.306 . . . . 74.340000000000003 111.497 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -69.01 124.09 11.02 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 122.697 2.265 . . . . 75.019999999999996 110.558 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -111.41 125.1 53.51 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 109.65 -0.5 . . . . 74.319999999999993 109.65 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -66.33 133.13 49.88 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 105.204 -2.147 . . . . 74.230000000000004 105.204 174.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 63.4 t -65.5 100.76 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.759 0.79 . . . . 75.109999999999999 110.861 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -149.88 152.89 35.81 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 104.921 -2.252 . . . . 74.450000000000003 104.921 -174.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 41.0 ttp -101.74 12.54 36.92 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.481 0.658 . . . . 75.430000000000007 111.228 -175.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 15.7 m -71.83 96.86 1.71 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.247 0.546 . . . . 74.239999999999995 110.524 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -141.94 172.68 12.35 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.993 -0.549 . . . . 74.310000000000002 109.775 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -144.89 93.66 2.43 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.992 -1.484 . . . . 73.239999999999995 106.992 172.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -118.8 92.68 3.87 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.478 0.656 . . . . 71.219999999999999 109.704 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -116.94 -94.81 1.82 Allowed Glycine 0 C--N 1.293 -1.849 0 N-CA-C 110.23 -1.148 . . . . 71.430000000000007 110.23 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 141.82 -99.15 0.23 Allowed Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 110.768 -0.933 . . . . 62.030000000000001 110.768 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' A' ' 619' ' ' THR . 20.9 p90 -93.63 104.99 17.07 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.424 0.631 . . . . 74.129999999999995 111.088 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 23.9 m -80.15 -48.92 12.42 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.315 -0.857 . . . . 75.510000000000005 109.545 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . 0.574 ' O ' ' HB ' ' A' ' 619' ' ' THR . 67.1 mt -118.52 138.34 49.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 107.077 -1.453 . . . . 71.230000000000004 107.077 178.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 6.3 m -146.27 35.13 0.98 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.69 -1.596 . . . . 64.140000000000001 106.69 176.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.5 -46.28 64.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.15 -1.841 . . . . 74.340000000000003 109.743 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -113.71 141.77 46.85 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 115.621 -0.718 . . . . 74.430000000000007 109.444 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -107.11 101.44 10.85 Favored 'General case' 0 N--CA 1.405 -2.686 0 CA-C-O 122.242 1.02 . . . . 63.020000000000003 110.529 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -86.67 13.77 8.11 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 123.073 1.416 . . . . 73.040000000000006 109.143 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -156.19 -166.98 2.31 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 101.82 -3.4 . . . . 71.219999999999999 101.82 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -82.02 -53.88 5.76 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 121.035 1.743 . . . . 63.310000000000002 107.744 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -132.49 91.66 30.03 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 106.47 -1.678 . . . . 63.420000000000002 106.47 171.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -81.62 -37.79 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.04 1.826 . . . . 73.340000000000003 114.172 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 54.44 70.66 0.59 Allowed 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.864 0.727 . . . . 73.040000000000006 109.202 -171.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 619' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 606' ' ' PHE . 4.1 m -50.9 101.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.387 1.475 . . . . 71.030000000000001 111.735 -175.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 620' ' ' SER . . . . . 0.483 ' O ' ' HD2' ' A' ' 621' ' ' LYS . 13.8 m -87.89 108.91 19.4 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.549 -0.75 . . . . 72.109999999999999 112.249 -172.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . 0.483 ' HD2' ' O ' ' A' ' 620' ' ' SER . 14.3 mptt -136.22 141.68 43.99 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.488 0.715 . . . . 72.120000000000005 110.41 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.48 -177.74 6.82 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.075 -1.824 . . . . 75.230000000000004 106.075 175.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.31 159.31 42.49 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.274 -1.38 . . . . 74.340000000000003 107.274 170.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -111.96 124.27 52.04 Favored 'General case' 0 N--CA 1.403 -2.793 0 C-N-CA 119.078 -1.049 . . . . 74.299999999999997 108.366 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -115.96 18.34 15.58 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 106.214 -1.773 . . . . 73.340000000000003 106.214 174.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 38.8 mtt180 -73.69 -37.96 65.03 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.357 -1.747 . . . . 72.329999999999998 109.032 -175.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . 0.606 ' HD3' ' O ' ' A' ' 627' ' ' ARG . 0.9 OUTLIER -56.03 -33.77 65.24 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.627 0.771 . . . . 72.450000000000003 111.37 -177.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 62.5 mt -58.53 -31.69 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-O 121.724 0.773 . . . . 75.019999999999996 109.807 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 633' ' ' ARG . . . -91.43 -39.57 11.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.857 -0.61 . . . . 65.200000000000003 109.827 175.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.573 ' HA ' ' CG ' ' A' ' 633' ' ' ARG . 50.6 mt-10 -63.45 -11.03 20.26 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.876 1.065 . . . . 71.219999999999999 113.876 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -66.66 -15.63 63.62 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.814 0.34 . . . . 73.430000000000007 110.845 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -142.07 59.01 0.55 Allowed Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.589 -1.004 . . . . 60.350000000000001 110.589 177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . 0.573 ' CG ' ' HA ' ' A' ' 630' ' ' GLU . 36.1 mmt180 -131.73 168.01 19.45 Favored Pre-proline 0 C--N 1.32 -0.715 0 C-N-CA 123.301 0.64 . . . . 74.549999999999997 110.138 -176.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 633' ' ' ARG . 36.7 Cg_endo -65.57 140.11 61.34 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.399 2.066 . . . . 75.430000000000007 112.389 175.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -126.71 164.08 27.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.591 -0.732 . . . . 72.140000000000001 109.89 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.53 173.56 7.56 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 112.875 0.694 . . . . 73.140000000000001 112.875 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.88 -171.89 28.8 Favored Glycine 0 N--CA 1.43 -1.709 0 CA-C-N 115.579 -0.737 . . . . 74.329999999999998 114.354 -176.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.73 -40.52 88.39 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.168 0.987 . . . . 74.25 109.744 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -133.3 138.51 46.44 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.904 -0.776 . . . . 73.409999999999997 108.904 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 19.1 p -136.53 88.17 2.35 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.746 0.784 . . . . 74.430000000000007 109.217 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -159.73 145.19 15.58 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.019 -0.991 . . . . 74.409999999999997 108.797 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.44 HD21 HG21 ' A' ' 523' ' ' VAL . 25.8 tp -136.14 120.55 18.08 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 108.717 -0.845 . . . . 73.439999999999998 108.717 176.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -91.68 105.33 17.65 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.831 -1.544 . . . . 72.400000000000006 106.831 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . 0.431 ' C ' ' HG1' ' A' ' 586' ' ' THR . 36.7 t -98.69 106.25 18.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.468 -0.567 . . . . 72.120000000000005 109.468 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 53.6 mt -89.94 128.98 41.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 109.014 -0.736 . . . . 74.209999999999994 109.014 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 55.3 mt -104.4 103.55 15.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.238 -0.652 . . . . 74.450000000000003 109.238 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -95.33 129.9 42.31 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.892 -0.595 . . . . 74.420000000000002 109.478 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.529 ' HA ' ' CB ' ' A' ' 516' ' ' GLU . 0.4 OUTLIER -72.66 143.09 48.26 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.62 -0.718 . . . . 75.519999999999996 111.316 -174.402 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 66.8 m -138.86 41.28 2.14 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 112.471 0.545 . . . . 73.540000000000006 112.471 -168.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -57.12 -37.44 71.98 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 123.029 0.531 . . . . 75.329999999999998 111.553 176.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.77 -20.3 58.37 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.461 -0.791 . . . . 74.219999999999999 111.39 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 70.04 71.84 0.22 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 124.919 1.288 . . . . 74.109999999999999 111.618 -174.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -151.46 75.5 1.17 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.62 -1.173 . . . . 75.120000000000005 109.967 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 35.3 t -176.9 -168.45 0.22 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.053 -1.091 . . . . 74.409999999999997 108.053 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 3.9 t -81.0 75.27 7.98 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 122.282 1.039 . . . . 71.200000000000003 109.802 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 40.8 t -77.27 -22.13 14.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.753 -1.112 . . . . 74.129999999999995 108.92 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 . . . . . 0 C--O 1.258 1.529 0 CA-C-N 115.214 -0.903 . . . . 63.229999999999997 109.23 177.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 33.3 t60 . . . . . 0 C--O 1.241 0.626 0 N-CA-C 108.72 -0.844 . . . . 73.099999999999994 108.72 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -68.75 -51.09 45.06 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.954 -1.021 . . . . 62.149999999999999 112.205 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 135.91 -141.53 12.68 Favored Glycine 0 C--N 1.313 -0.697 0 C-N-CA 118.892 -1.623 . . . . 64.409999999999997 113.424 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.7 119.52 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 C-N-CA 122.893 0.477 . . . . 75.510000000000005 110.327 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -98.57 135.15 40.52 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.254 -1.387 . . . . 75.329999999999998 107.254 168.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.9 t -169.41 -179.96 3.65 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.959 -0.756 . . . . 73.450000000000003 108.959 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . 0.448 ' CZ ' HG23 ' A' ' 591' ' ' ILE . 67.4 m-85 -84.4 151.84 24.42 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.937 -0.394 . . . . 75.030000000000001 109.937 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -67.0 -31.75 72.53 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.439 0.638 . . . . 62.450000000000003 110.059 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -135.0 141.53 38.66 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.532 -1.285 . . . . 71.099999999999994 107.532 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.59 -26.32 7.2 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 122.289 1.993 . . . . 73.219999999999999 112.459 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 61.1 t -139.73 132.31 35.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 106.853 -1.536 . . . . 65.400000000000006 106.853 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.8 t -127.68 138.71 52.89 Favored 'General case' 0 N--CA 1.414 -2.226 0 C-N-CA 120.252 -0.579 . . . . 72.209999999999994 109.994 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -103.64 116.44 32.35 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.541 -0.911 . . . . 75.010000000000005 108.541 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.6 m -117.44 165.5 12.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.418 -0.956 . . . . 75.109999999999999 108.418 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.622 ' O ' HG23 ' A' ' 518' ' ' ILE . 27.3 t -95.95 153.8 17.57 Favored 'General case' 0 N--CA 1.418 -2.072 0 C-N-CA 120.556 -0.457 . . . . 73.120000000000005 109.792 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.76 -34.45 75.61 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.176 -1.046 . . . . 70.129999999999995 108.176 170.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.7 m -98.39 20.34 12.83 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.77 -1.105 . . . . 75.239999999999995 111.966 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 515' ' ' SER . 9.4 tt -82.97 -26.68 7.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 CA-C-O 121.622 0.725 . . . . 73.219999999999999 109.372 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 91.97 -78.66 1.26 Allowed Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.305 -1.118 . . . . 72.319999999999993 110.305 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 32.3 mm -128.99 141.14 47.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 106.839 -1.541 . . . . 74.219999999999999 106.839 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.512 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -122.72 144.82 48.91 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.289 -0.634 . . . . 74.150000000000006 109.289 178.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 10.6 mp0 -115.33 130.5 56.92 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 123.819 0.699 . . . . 74.329999999999998 109.589 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 570' ' ' THR . 59.3 t -116.07 128.41 73.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 109.303 -0.629 . . . . 73.439999999999998 109.303 175.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -81.95 129.91 34.91 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 123.733 0.813 . . . . 74.329999999999998 109.839 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.514 ' O ' HG22 ' A' ' 568' ' ' VAL . 60.0 t -106.1 118.7 54.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.504 -0.924 . . . . 73.319999999999993 108.504 175.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.7 mt -67.44 122.44 17.96 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 123.863 0.727 . . . . 74.040000000000006 111.461 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 567' ' ' ILE . 21.7 tpt180 -68.01 145.69 54.24 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.518 -1.219 . . . . 75.439999999999998 108.946 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 12.4 t -56.5 143.41 35.32 Favored 'General case' 0 N--CA 1.406 -2.637 0 C-N-CA 124.917 1.287 . . . . 72.329999999999998 109.984 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 18.8 t -52.53 -36.14 54.9 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.737 0.815 . . . . 72.049999999999997 111.437 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -116.46 96.15 0.71 Allowed Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.022 -1.231 . . . . 61.140000000000001 110.022 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -84.87 101.67 12.49 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.648 -0.871 . . . . 75.530000000000001 108.648 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -124.77 116.88 23.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.822 -0.807 . . . . 74.319999999999993 108.822 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.402 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 77.72 -178.72 51.8 Favored Glycine 0 C--O 1.258 1.602 0 O-C-N 123.695 0.622 . . . . 75.150000000000006 113.84 176.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -90.95 125.83 35.89 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.893 -0.654 . . . . 74.049999999999997 109.522 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 72.6 t -133.16 134.58 57.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.745 -0.661 . . . . 61.229999999999997 109.26 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.566 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 37.8 mm -106.51 134.75 47.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 109.219 -0.66 . . . . 75.400000000000006 109.219 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.65 110.25 32.01 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.741 -0.466 . . . . 74.030000000000001 109.741 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -70.65 158.04 56.94 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.338 2.026 . . . . 74.239999999999995 111.583 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -151.99 155.56 38.24 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.331 -0.618 . . . . 72.430000000000007 109.331 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.64 149.1 28.08 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 123.87 0.731 . . . . 72.530000000000001 112.174 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.1 p -83.44 131.16 35.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 116.003 -0.544 . . . . 75.540000000000006 109.933 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.438 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 57.9 mt -103.07 119.91 52.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.003 -1.11 . . . . 74.140000000000001 108.003 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.91 160.61 27.19 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.133 -0.692 . . . . 75.049999999999997 109.133 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 177.69 -97.6 0.11 Allowed Glycine 0 CA--C 1.473 -2.533 0 N-CA-C 110.504 -1.038 . . . . 74.230000000000004 110.504 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 545' ' ' THR . . . . . 0.431 ' HB ' ' H ' ' A' ' 586' ' ' THR . 0.2 OUTLIER -71.37 -31.53 67.44 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 109.355 -0.609 . . . . 74.319999999999993 109.355 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -107.67 155.75 19.82 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 108.494 -0.928 . . . . 61.109999999999999 108.494 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -101.01 137.85 38.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.543 0.687 . . . . 75.420000000000002 112.457 -176.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.98 -150.47 12.45 Favored Glycine 0 C--N 1.299 -1.498 0 C-N-CA 120.663 -0.779 . . . . 73.299999999999997 112.716 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 61.02 7.28 8.3 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 115.749 1.06 . . . . 65.010000000000005 115.749 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 90.44 14.59 58.37 Favored Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 118.209 1.005 . . . . 73.349999999999994 110.991 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -87.52 -55.44 3.79 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.165 -0.68 . . . . 71.530000000000001 109.165 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -107.04 -42.26 4.94 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.112 -1.44 . . . . 73.219999999999999 107.112 177.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -140.07 152.38 46.13 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.809 -1.182 . . . . 75.439999999999998 107.809 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.74 112.94 20.53 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.311 -0.996 . . . . 73.150000000000006 108.311 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.99 122.5 17.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.38 1.072 . . . . 73.319999999999993 111.675 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.7 t -131.66 142.35 49.82 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 121.786 0.803 . . . . 72.200000000000003 110.577 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 21.4 p -151.71 150.16 29.9 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.559 -1.275 . . . . 71.319999999999993 107.559 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 172.62 -164.03 36.16 Favored Glycine 0 CA--C 1.482 -2.013 0 N-CA-C 109.979 -1.248 . . . . 70.129999999999995 109.979 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.566 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 45.3 mt-10 -133.24 128.06 35.06 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.986 0.393 . . . . 73.219999999999999 111.134 -177.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 569' ' ' LYS . 95.8 mt -89.44 141.18 28.8 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 123.463 0.705 . . . . 72.310000000000002 109.201 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -103.54 118.28 36.37 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.292 0.568 . . . . 74.420000000000002 110.884 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -116.39 148.75 40.35 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.777 -0.823 . . . . 73.329999999999998 108.777 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.547 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 45.7 mt-30 -140.86 -178.97 5.8 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.826 -0.805 . . . . 62.039999999999999 108.826 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . 0.402 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 3.6 p-10 -71.48 -36.0 71.0 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.597 -0.441 . . . . 74.319999999999993 110.617 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -79.81 -39.3 31.09 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.109 -0.496 . . . . 75.319999999999993 110.167 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.547 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 64.5 mm-40 -63.64 151.86 40.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.556 -0.747 . . . . 73.120000000000005 111.736 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.523 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.2 pt -114.62 -92.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 113.447 0.906 . . . . 70.450000000000003 113.447 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.523 ' H ' HG13 ' A' ' 567' ' ' ILE . 11.7 p -107.86 146.64 13.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 120.885 0.374 . . . . 72.150000000000006 111.331 -174.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.402 ' HB3' HD21 ' A' ' 560' ' ' LEU . 5.3 mmpt? -114.99 165.19 13.15 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.146 -0.687 . . . . 73.140000000000001 109.146 173.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.2 p -131.41 140.35 49.62 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.973 -0.558 . . . . 52.439999999999998 112.088 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.0 mp -95.28 121.03 45.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.811 -1.181 . . . . 73.409999999999997 107.811 173.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 572' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 521' ' ' MET . 70.0 m -96.64 117.74 31.63 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 123.981 0.801 . . . . 64.310000000000002 109.035 176.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.408 ' HB ' ' HE2' ' A' ' 521' ' ' MET . 89.6 t -119.31 133.42 66.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 110.239 -0.282 . . . . 75.340000000000003 110.239 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -86.37 120.71 28.0 Favored 'General case' 0 N--CA 1.435 -1.218 0 O-C-N 123.684 0.615 . . . . 72.329999999999998 109.363 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 31.0 t -96.05 127.39 48.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.81 -1.182 . . . . 75.129999999999995 107.81 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 34.5 mm -87.07 147.87 5.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-O 120.999 0.428 . . . . 75.519999999999996 110.123 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -65.68 138.65 58.12 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 124.88 1.272 . . . . 75.409999999999997 110.624 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -89.58 -164.85 1.21 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.63 -0.878 . . . . 74.349999999999994 108.63 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -90.77 -43.46 10.07 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.936 -1.135 . . . . 72.349999999999994 107.936 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -158.32 -67.26 0.09 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 105.798 -1.927 . . . . 75.310000000000002 105.798 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -173.83 69.19 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 124.696 1.248 . . . . 74.299999999999997 110.216 176.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -51.83 -62.97 1.3 Allowed 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.624 0.726 . . . . 65.019999999999996 111.766 -177.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -143.16 150.05 38.88 Favored 'General case' 0 N--CA 1.408 -2.533 0 N-CA-C 107.849 -1.167 . . . . 75.400000000000006 107.849 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -75.59 87.11 2.68 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.341 -1.725 . . . . 74.299999999999997 106.341 169.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.47 161.96 14.01 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.888 -1.051 . . . . 73.219999999999999 112.448 -176.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 586' ' ' THR . . . . . 0.431 ' H ' ' HB ' ' A' ' 545' ' ' THR . 5.3 t -153.47 153.3 32.2 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 115.434 -0.803 . . . . 74.299999999999997 109.02 -173.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -133.03 168.38 18.6 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.233 -1.395 . . . . 74.219999999999999 107.233 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.438 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 72.5 m-85 -117.73 151.27 37.61 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 120.084 -0.646 . . . . 74.030000000000001 109.451 -174.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.39 128.1 51.87 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 106.378 -1.712 . . . . 73.400000000000006 106.378 178.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -124.93 133.94 52.85 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.991 -0.744 . . . . 74.349999999999994 108.991 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . 0.448 HG23 ' CZ ' ' A' ' 507' ' ' PHE . 18.3 pt -97.84 135.84 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 N-CA-C 107.878 -1.156 . . . . 75.219999999999999 107.878 173.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -81.83 173.07 53.53 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 111.017 -0.833 . . . . 75.109999999999999 111.017 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 593' ' ' GLU . 6.1 mp0 -59.41 135.08 88.66 Favored Pre-proline 0 C--N 1.287 -2.122 0 C-N-CA 123.945 0.898 . . . . 75.019999999999996 110.688 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -70.87 122.06 8.47 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 122.495 2.13 . . . . 71.209999999999994 111.074 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -104.51 119.57 39.29 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.591 -0.731 . . . . 75.409999999999997 109.134 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . 0.4 ' HB2' ' CD ' ' A' ' 634' ' ' PRO . 2.3 tm? -66.2 134.55 52.94 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.898 -1.149 . . . . 74.049999999999997 107.898 178.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.438 ' CG2' HG12 ' A' ' 536' ' ' ILE . 25.8 t -82.73 85.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 105.875 -1.898 . . . . 75.120000000000005 105.875 175.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -80.0 120.29 23.98 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 114.747 -1.115 . . . . 74.420000000000002 112.309 -169.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 27.7 ttt -114.85 -20.55 10.54 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.549 -1.205 . . . . 73.430000000000007 109.853 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 19.9 m -87.74 -4.87 58.88 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 112.464 0.542 . . . . 72.400000000000006 112.464 -173.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -96.33 147.4 23.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.651 -0.87 . . . . 75.329999999999998 108.651 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.33 81.1 7.59 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 106.438 -1.69 . . . . 73.099999999999994 106.438 172.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.74 119.0 10.42 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 114.165 -1.38 . . . . 75.150000000000006 111.825 -177.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -142.04 20.68 2.48 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 110.075 -1.21 . . . . 64.219999999999999 110.075 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -137.44 118.33 1.67 Allowed Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 109.784 -1.326 . . . . 75.430000000000007 109.784 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -71.08 121.16 17.76 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.204 -0.665 . . . . 74.219999999999999 109.204 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 19.2 p -78.41 85.7 4.51 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.325 0.584 . . . . 74.230000000000004 109.819 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 5.4 tp -77.68 88.13 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 122.076 0.941 . . . . 73.030000000000001 109.51 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 9.7 t -98.96 94.29 6.47 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 122.323 1.058 . . . . 73.439999999999998 110.695 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -105.08 -68.55 0.85 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.585 -1.265 . . . . 70.549999999999997 107.585 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -164.74 101.51 0.79 Allowed 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 106.411 -1.7 . . . . 74.340000000000003 106.411 -176.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -88.46 145.86 25.53 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.066 -0.516 . . . . 71.400000000000006 110.54 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -64.87 -41.67 95.46 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.587 0.554 . . . . 72.420000000000002 109.971 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -125.38 91.66 3.46 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 106.868 -1.531 . . . . 72.099999999999994 106.868 171.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -84.95 -21.26 29.66 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 119.867 -0.733 . . . . 71.040000000000006 109.767 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -67.85 160.3 74.46 Favored Pre-proline 0 C--O 1.245 0.845 0 CA-C-N 115.289 -0.869 . . . . 74.209999999999994 109.853 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.18 118.16 5.44 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.842 1.695 . . . . 73.430000000000007 109.36 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 49.7 tp -161.24 153.46 20.01 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.063 -0.717 . . . . 71.049999999999997 109.063 -177.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 39.4 m -144.85 132.93 21.46 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.818 -1.919 . . . . 74.010000000000005 105.818 175.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 10.7 t -113.43 -7.67 13.44 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.091 -0.644 . . . . 72.420000000000002 111.717 -176.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -106.3 162.75 13.4 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.943 -1.132 . . . . 73.409999999999997 107.943 174.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -88.66 62.25 6.4 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 122.508 1.147 . . . . 75.540000000000006 111.031 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -97.0 -155.92 0.51 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.291 -1.744 . . . . 71.420000000000002 106.291 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.97 104.01 8.27 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 104.885 -2.265 . . . . 63.240000000000002 104.885 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -58.17 129.64 42.92 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.712 -0.847 . . . . 74.439999999999998 108.712 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -52.84 -42.09 64.84 Favored 'General case' 0 C--O 1.187 -2.197 0 N-CA-C 113.097 0.777 . . . . 75.319999999999993 113.097 -173.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.74 -27.59 29.46 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.543 0.737 . . . . 75.450000000000003 111.233 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 71.7 mt -80.71 -47.92 20.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.851 0.358 . . . . 75.540000000000006 110.5 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -84.26 -24.49 29.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.221 0.534 . . . . 74.200000000000003 111.632 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . 0.287 62.3 mt-10 -65.84 -8.75 23.51 Favored 'General case' 0 C--O 1.2 -1.538 0 N-CA-C 114.465 1.283 . . . . 64.109999999999999 114.465 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -58.69 -21.57 54.91 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 121.512 0.672 . . . . 72.230000000000004 109.371 172.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -83.42 5.75 76.03 Favored Glycine 0 C--O 1.222 -0.636 0 CA-C-N 116.218 -0.446 . . . . 72.230000000000004 112.491 178.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . 0.414 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 11.2 ptm180 -134.11 167.72 21.47 Favored Pre-proline 0 C--N 1.311 -1.09 0 N-CA-C 106.956 -1.498 . . . . 73.340000000000003 106.956 175.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 633' ' ' ARG . 72.3 Cg_endo -80.94 136.42 10.45 Favored 'Trans proline' 0 N--CA 1.429 -2.281 0 C-N-CA 121.012 1.142 . . . . 62.340000000000003 110.4 174.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.54 162.46 26.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.256 -1.016 . . . . 74.140000000000001 108.256 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.02 -178.43 3.71 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 120.056 -0.658 . . . . 74.549999999999997 111.928 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -75.1 -169.13 24.24 Favored Glycine 0 N--CA 1.445 -0.704 0 O-C-N 123.455 0.472 . . . . 74.010000000000005 112.794 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -68.99 -51.84 35.16 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.181 -0.674 . . . . 73.150000000000006 109.181 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -122.56 131.62 53.92 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.814 0.816 . . . . 75.109999999999999 111.937 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 16.8 p -126.64 90.06 3.1 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.394 -1.276 . . . . 75.409999999999997 109.781 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . 0.4 ' HZ3' ' HB3' ' A' ' 641' ' ' LYS . 5.7 ttpm? -159.54 148.18 17.75 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.519 -0.764 . . . . 75.109999999999999 109.609 -176.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.451 HD23 HG11 ' A' ' 523' ' ' VAL . 30.9 tp -129.51 129.17 44.19 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 108.025 -1.102 . . . . 73.310000000000002 108.025 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -97.58 106.25 18.53 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.894 -1.521 . . . . 63.240000000000002 106.894 175.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 39.6 t -98.55 106.86 19.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.358 -0.608 . . . . 62.119999999999997 109.358 -176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 73.0 mt -91.2 125.3 43.95 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.559 0 N-CA-C 109.35 -0.611 . . . . 74.409999999999997 109.35 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 69.8 mt -100.9 103.92 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 109.056 -0.72 . . . . 74.549999999999997 109.056 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 515' ' ' SER . 14.2 pt-20 -119.39 150.36 40.31 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.317 -0.994 . . . . 73.299999999999997 108.317 175.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.96 141.15 30.56 Favored 'General case' 0 N--CA 1.41 -2.473 0 CA-C-O 122.026 0.917 . . . . 73.540000000000006 112.331 -177.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 70.5 m -155.99 87.7 1.08 Allowed 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 104.823 -2.288 . . . . 74.140000000000001 104.823 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -55.81 -48.09 76.01 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 114.997 -1.002 . . . . 72.519999999999996 112.969 -170.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -72.38 -32.51 66.48 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.783 -0.644 . . . . 74.319999999999993 110.324 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 59.3 t80 54.78 66.64 1.18 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.388 -1.278 . . . . 73.310000000000002 108.398 -172.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -74.14 -69.03 0.47 Allowed 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 113.799 -1.546 . . . . 75.219999999999999 108.006 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 16.6 m 50.19 37.51 14.94 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.578 0.704 . . . . 71.310000000000002 111.588 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 27.3 m -84.43 111.89 19.87 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.783 -0.644 . . . . 71.409999999999997 110.014 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 29.9 m -86.39 141.73 14.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.881 -0.599 . . . . 64.420000000000002 109.433 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--N 1.292 -1.926 0 N-CA-C 109.403 -0.591 . . . . 71.319999999999993 109.403 -179.942 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 47.8 t60 . . . . . 0 N--CA 1.438 -1.044 0 CA-C-O 121.265 0.555 . . . . 72.219999999999999 109.793 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -93.92 -63.03 1.24 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.798 -0.816 . . . . 72.310000000000002 108.798 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 169.3 -159.13 31.94 Favored Glycine 0 N--CA 1.42 -2.376 0 N-CA-C 108.672 -1.771 . . . . 74.510000000000005 108.672 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.444 HG21 ' CA ' ' A' ' 637' ' ' GLY . 3.5 mp -114.23 110.83 33.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 117.211 0.505 . . . . 71.530000000000001 110.834 -175.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.463 ' CE2' HG23 ' A' ' 528' ' ' THR . 31.5 m-85 -90.67 124.5 35.12 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.655 -0.868 . . . . 74.109999999999999 108.655 169.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.1 t -162.47 170.57 18.49 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.78 -0.822 . . . . 74.439999999999998 108.78 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -76.11 146.62 39.17 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 110.27 -0.27 . . . . 74.349999999999994 110.27 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.28 -30.78 71.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.267 0.556 . . . . 74.200000000000003 109.785 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -137.41 145.73 50.71 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 108.735 -0.839 . . . . 75.150000000000006 108.735 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -81.14 -22.64 5.82 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.654 2.236 . . . . 75.329999999999998 112.819 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 47.2 t -141.79 135.11 29.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 106.92 -1.511 . . . . 74.319999999999993 106.92 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.1 t -131.61 141.04 49.56 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 109.494 -0.558 . . . . 73.409999999999997 109.494 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -107.01 124.89 50.28 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.075 0.464 . . . . 75.219999999999999 110.207 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 17.6 m -124.3 163.42 24.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.177 -0.675 . . . . 73.310000000000002 109.177 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 19.2 t -93.64 154.42 17.84 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.954 -0.388 . . . . 74.299999999999997 109.954 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -59.59 -32.74 70.66 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 123.773 0.671 . . . . 75.030000000000001 109.523 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 23.3 t -129.43 65.39 1.47 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.907 0.861 . . . . 72.109999999999999 110.84 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 6.4 tt -98.3 -25.0 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 115.072 -0.967 . . . . 72.310000000000002 109.168 172.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 95.04 -81.05 0.87 Allowed Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.55 -0.75 . . . . 62.030000000000001 111.283 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.5 mm -129.36 127.52 65.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.002 -1.481 . . . . 74.519999999999996 107.002 -176.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.466 ' HE1' ' CG2' ' A' ' 573' ' ' VAL . 0.0 OUTLIER -111.69 148.08 34.19 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.707 -1.22 . . . . 73.409999999999997 107.707 177.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 33.2 mt-10 -126.75 132.16 51.15 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 123.576 0.547 . . . . 74.129999999999995 111.989 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 570' ' ' THR . 21.5 t -112.91 129.3 68.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.944 -1.132 . . . . 75.219999999999999 107.944 178.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -86.04 134.77 33.82 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.795 -0.817 . . . . 72.25 108.795 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 44.8 t -108.8 127.89 65.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.845 -0.798 . . . . 73.230000000000004 108.845 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.96 126.45 29.79 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.869 -0.605 . . . . 73.329999999999998 110.314 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -79.33 161.41 26.26 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.486 -1.234 . . . . 71.420000000000002 109.926 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.463 HG23 ' CE2' ' A' ' 505' ' ' PHE . 6.4 p -59.74 147.27 38.48 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 123.384 0.674 . . . . 72.530000000000001 111.633 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 29.5 t -59.14 -36.98 76.17 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.918 -0.771 . . . . 74.540000000000006 108.918 175.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -112.56 101.6 1.24 Allowed Glycine 0 N--CA 1.416 -2.683 0 N-CA-C 108.981 -1.647 . . . . 71.140000000000001 108.981 174.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -92.03 101.48 14.03 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.753 -1.203 . . . . 73.540000000000006 107.753 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -122.21 104.29 9.35 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.741 -0.466 . . . . 71.450000000000003 109.741 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 89.33 -151.39 21.95 Favored Glycine 0 C--N 1.304 -1.215 0 C-N-CA 120.456 -0.878 . . . . 70.140000000000001 112.031 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.424 HD22 ' CG ' ' A' ' 561' ' ' GLU . 2.5 t-20 -113.09 127.69 56.28 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.394 0.616 . . . . 73.319999999999993 110.297 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 66.4 t -129.67 138.51 54.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 108.81 -0.811 . . . . 75.120000000000005 108.81 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.57 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 44.8 mm -107.94 133.84 51.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 109.35 -0.611 . . . . 74.140000000000001 109.35 177.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 25.6 t -120.45 109.06 36.96 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 109.208 -0.664 . . . . 64.230000000000004 109.208 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.61 153.94 54.68 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.108 1.872 . . . . 74.319999999999993 111.83 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.429 ' HB3' HG23 ' A' ' 591' ' ' ILE . 52.9 p90 -148.81 161.56 41.56 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.738 -0.467 . . . . 73.120000000000005 109.738 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -158.17 162.35 37.92 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.106 -0.497 . . . . 72.120000000000005 109.714 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.8 p -88.39 149.29 23.8 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 116.027 -0.533 . . . . 64.200000000000003 110.677 173.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 86.7 mt -121.26 109.99 26.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.858 -1.164 . . . . 71.310000000000002 107.858 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.34 111.24 2.94 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 123.854 0.721 . . . . 72.549999999999997 110.593 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -100.54 -108.24 3.02 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.34 -1.104 . . . . 54.420000000000002 110.34 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 67.5 p -93.24 8.87 38.51 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 122.517 1.151 . . . . 70.439999999999998 107.967 175.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -119.88 136.53 54.46 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.148 -1.387 . . . . 73.310000000000002 109.509 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.523 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 82.0 mtm180 -82.9 135.4 34.93 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.543 1.137 . . . . 75.129999999999995 110.831 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -87.73 -161.28 36.6 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 115.153 -0.931 . . . . 74.209999999999994 113.533 -175.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 77.06 -55.99 3.57 Favored Glycine 0 C--O 1.224 -0.51 0 CA-C-N 115.488 -0.356 . . . . 64.129999999999995 113.576 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 554' ' ' GLU . . . 157.99 42.45 0.02 OUTLIER Glycine 0 C--N 1.284 -2.341 0 N-CA-C 109.415 -1.474 . . . . 72.129999999999995 109.415 -173.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.523 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 8.4 tt0 -116.92 -61.74 1.68 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.559 -0.534 . . . . 73.140000000000001 109.559 -176.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -98.57 -43.74 6.73 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.887 -1.523 . . . . 75.310000000000002 106.887 169.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -132.87 156.42 47.23 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 107.195 -1.409 . . . . 71.209999999999994 107.195 174.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.411 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 10.2 tt0 -84.3 131.11 34.75 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.635 -0.876 . . . . 75.219999999999999 108.635 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 9.6 t70 -58.24 131.1 49.6 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.525 -0.546 . . . . 74.310000000000002 109.525 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.435 HG21 HG22 ' A' ' 573' ' ' VAL . 14.6 t -133.32 141.33 47.9 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-O 121.702 0.763 . . . . 75.439999999999998 109.146 174.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 3.2 p -156.55 161.32 39.98 Favored 'General case' 0 C--N 1.272 -2.763 0 N-CA-C 107.264 -1.384 . . . . 74.219999999999999 107.264 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 149.24 -167.11 29.56 Favored Glycine 0 N--CA 1.41 -3.071 0 N-CA-C 110.395 -1.082 . . . . 71.349999999999994 110.395 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.57 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 52.9 mt-10 -131.7 132.77 44.19 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 120.965 0.412 . . . . 70.219999999999999 110.567 -176.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.428 HD21 ' HB3' ' A' ' 569' ' ' LYS . 89.7 mt -92.94 140.81 29.1 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.883 -0.599 . . . . 74.439999999999998 109.512 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.469 ' HG3' ' CD1' ' A' ' 536' ' ' ILE . 27.9 tt0 -106.28 113.74 27.44 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 116.094 -0.503 . . . . 74.530000000000001 109.872 -177.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -111.92 149.31 32.07 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.128 -0.693 . . . . 72.129999999999995 109.128 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.505 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 49.4 mt-30 -146.99 -177.65 5.77 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.249 -0.648 . . . . 72.5 109.249 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -70.07 -31.17 68.64 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.629 -1.249 . . . . 72.519999999999996 107.629 170.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -77.0 -52.76 8.79 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.8 -1.091 . . . . 72.540000000000006 111.176 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.505 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 42.4 mm-40 -64.77 124.18 21.29 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 123.616 0.767 . . . . 73.549999999999997 111.854 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.556 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.2 pt -81.08 -62.24 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 124.159 0.912 . . . . 63.420000000000002 112.638 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.556 ' H ' HG13 ' A' ' 567' ' ' ILE . 7.8 p -143.31 160.24 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 109.522 -0.548 . . . . 64.510000000000005 109.522 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.428 ' HB3' HD21 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -127.6 158.69 36.83 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.43 -0.952 . . . . 73.349999999999994 108.43 171.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.5 p -127.34 144.58 51.03 Favored 'General case' 0 C--N 1.278 -2.504 0 O-C-N 124.03 0.831 . . . . 74.409999999999997 111.096 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.2 mp -94.68 119.31 42.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 106.829 -1.545 . . . . 72.219999999999999 106.829 172.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 24.4 p -92.34 116.14 28.71 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.543 -0.91 . . . . 75.299999999999997 108.543 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.466 ' CG2' ' HE1' ' A' ' 521' ' ' MET . 55.5 t -116.43 123.16 71.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.372 -0.603 . . . . 74.329999999999998 109.372 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.411 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 29.4 tptp -76.91 113.99 15.21 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.124 -0.944 . . . . 74.409999999999997 109.235 176.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.94 128.82 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 N-CA-C 104.887 -2.264 . . . . 72.310000000000002 104.887 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 46.5 mm -69.28 123.0 21.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 122.35 1.071 . . . . 65.219999999999999 111.761 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -115.57 109.8 18.31 Favored 'General case' 0 C--N 1.274 -2.675 0 CA-C-N 112.752 -2.022 . . . . 73.349999999999994 107.804 -175.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -157.47 156.47 32.16 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.485 -1.302 . . . . 71.439999999999998 107.485 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -74.37 76.43 1.88 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.008 0.908 . . . . 74.329999999999998 112.766 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -140.1 130.65 25.57 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 105.079 -2.193 . . . . 71.340000000000003 105.079 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -90.02 95.49 10.24 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.287 -0.635 . . . . 74.239999999999995 109.287 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -99.79 -162.35 0.94 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.396 -0.82 . . . . 75.140000000000001 111.358 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 585' ' ' LYS . 0.5 OUTLIER -148.82 -171.47 3.87 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.565 -1.272 . . . . 72.040000000000006 107.565 -174.337 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 646' ' ' ILE . 35.4 t-20 -52.88 115.67 1.95 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.733 1.213 . . . . 73.310000000000002 112.301 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 583' ' ' LYS . 73.5 mmtt -121.3 133.01 55.12 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.346 -1.724 . . . . 73.510000000000005 106.346 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 11.4 t -131.41 137.96 48.89 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.578 -1.249 . . . . 74.310000000000002 111.012 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 44.2 p90 -135.07 179.13 6.51 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 107.74 -1.208 . . . . 74.299999999999997 107.74 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.477 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 92.6 m-85 -123.77 155.68 37.47 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 109.318 -0.623 . . . . 74.349999999999994 109.318 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.83 133.54 54.43 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 105.167 -2.16 . . . . 74.140000000000001 105.167 176.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -133.92 136.5 44.3 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.613 -0.835 . . . . 74.239999999999995 110.328 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . 0.429 HG23 ' HB3' ' A' ' 539' ' ' TYR . 16.0 pt -99.69 138.34 24.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 114.987 -1.006 . . . . 75.200000000000003 108.343 174.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.42 -173.55 49.78 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 111.225 -0.75 . . . . 64.400000000000006 111.225 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.94 130.35 88.48 Favored Pre-proline 0 C--N 1.305 -1.328 0 C-N-CA 120.702 -0.399 . . . . 74.5 111.168 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.516 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 17.8 Cg_endo -64.85 135.69 45.66 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.138 2.558 . . . . 65.420000000000002 112.21 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . 0.471 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 14.6 ptm180 -111.99 127.96 56.03 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.586 -0.733 . . . . 73.25 109.81 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -73.48 128.92 36.84 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 106.468 -1.679 . . . . 72.310000000000002 106.468 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.468 ' CG2' HG12 ' A' ' 536' ' ' ILE . 62.0 t -75.48 121.46 27.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.155 -0.683 . . . . 73.209999999999994 109.155 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 68.67 85.58 0.14 Allowed 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 125.097 1.359 . . . . 73.540000000000006 109.417 -171.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 17.1 tpt -66.99 -38.27 85.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 113.32 -1.764 . . . . 71.109999999999999 111.379 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 34.7 t -130.24 177.76 7.08 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.68 -1.6 . . . . 73.140000000000001 106.68 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -69.59 -29.42 66.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.754 0.787 . . . . 73.230000000000004 109.394 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . 0.451 ' H ' ' HD2' ' A' ' 602' ' ' LYS . 0.0 OUTLIER -105.23 167.08 9.96 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.05 -1.463 . . . . 71.319999999999993 107.05 174.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -80.17 95.78 6.36 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 120.25 -0.58 . . . . 74.349999999999994 109.741 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -70.33 138.9 29.84 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 114.693 -1.139 . . . . 72.530000000000001 112.607 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 110.76 -138.43 14.93 Favored Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 109.641 -1.384 . . . . 71.450000000000003 109.641 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 59.16 83.64 0.12 Allowed 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.256 1.022 . . . . 74.340000000000003 112.411 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 9.8 t -151.45 168.28 25.36 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 105.377 -2.083 . . . . 74.420000000000002 105.377 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.61 97.19 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 CA-C-O 122.481 1.134 . . . . 74.420000000000002 110.2 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 91.1 m -149.91 121.09 7.78 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.049 -1.093 . . . . 73.329999999999998 108.049 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -137.58 109.9 7.38 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.686 0.624 . . . . 73.510000000000005 112.686 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -103.43 111.74 24.32 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.143 -1.429 . . . . 74.230000000000004 107.143 170.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -88.16 -17.98 29.74 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.235 -0.439 . . . . 74.230000000000004 111.897 -172.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -88.87 117.36 27.82 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 116.367 -0.379 . . . . 72.030000000000001 110.953 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -100.44 71.75 1.55 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.188 0.994 . . . . 65.030000000000001 109.314 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.11 90.1 2.01 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 106.23 -1.767 . . . . 74.510000000000005 106.23 174.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 78.23 98.69 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 114.214 -1.357 . . . . 72.400000000000006 109.704 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.57 112.12 1.86 Allowed 'Trans proline' 0 C--O 1.256 1.389 0 C-N-CA 122.723 2.282 . . . . 75.349999999999994 110.779 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.2 pp -75.07 152.94 38.57 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.68 -0.691 . . . . 75.349999999999994 111.389 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 4.9 t -107.58 129.1 55.02 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.754 -0.462 . . . . 65.340000000000003 109.754 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 15.2 m -79.34 107.31 12.0 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.044 -1.095 . . . . 75.120000000000005 108.044 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -108.38 101.61 10.79 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.768 0.794 . . . . 73.420000000000002 111.681 -175.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -140.1 140.6 36.09 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 104.382 -2.451 . . . . 74.209999999999994 104.382 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.62 70.29 2.43 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.75 0.786 . . . . 73.019999999999996 111.872 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.62 173.67 6.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.942 -1.503 . . . . 64.420000000000002 106.942 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.21 -23.57 64.83 Favored 'General case' 0 C--O 1.214 -0.774 0 C-N-CA 119.825 -0.75 . . . . 74.239999999999995 109.701 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 40.3 tpt85 -63.41 -38.63 91.9 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.642 -0.708 . . . . 74.129999999999995 110.461 173.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . 0.688 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 0.0 OUTLIER -75.59 -36.05 60.43 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.883 -0.784 . . . . 74.120000000000005 108.883 177.149 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 71.2 mt -59.67 -45.58 94.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.498 0.666 . . . . 74.219999999999999 109.327 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -71.92 -16.54 62.11 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.371 -0.831 . . . . 75.019999999999996 112.618 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.688 ' HG2' ' O ' ' A' ' 627' ' ' ARG . 20.0 pt-20 -72.88 -10.72 60.11 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 120.407 -0.517 . . . . 72.340000000000003 112.096 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -60.79 -31.98 71.34 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 108.71 -0.848 . . . . 63.420000000000002 108.71 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -93.05 55.81 2.52 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 115.663 -0.699 . . . . 61.229999999999997 111.514 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -126.61 151.99 73.94 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 107.701 -1.222 . . . . 75.540000000000006 107.701 175.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.516 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 17.4 Cg_endo -63.34 142.35 85.32 Favored 'Trans proline' 0 N--CA 1.44 -1.647 0 C-N-CA 121.97 1.78 . . . . 74.219999999999999 107.9 170.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.87 163.74 24.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 119.524 -0.871 . . . . 65.109999999999999 112.385 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.04 174.83 6.56 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.322 -0.854 . . . . 72.400000000000006 111.144 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . 0.444 ' CA ' HG21 ' A' ' 504' ' ' ILE . . . -75.5 -169.28 25.89 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 116.018 -0.537 . . . . 51.240000000000002 113.876 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.53 -27.67 60.63 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.473 0.654 . . . . 75.430000000000007 109.686 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -139.82 133.56 30.53 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.03 -0.729 . . . . 75.519999999999996 109.03 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 22.6 p -133.81 90.27 2.68 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.398 0.618 . . . . 74.400000000000006 110.175 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . 0.444 ' HB2' ' HZ2' ' A' ' 641' ' ' LYS . 5.0 ttmp? -163.13 142.74 8.78 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.519 -0.919 . . . . 73.209999999999994 108.519 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.439 HD21 HG11 ' A' ' 523' ' ' VAL . 21.3 tp -126.52 128.65 47.22 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 108.872 -0.788 . . . . 70.200000000000003 108.872 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -95.34 110.07 22.14 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.639 -1.245 . . . . 74.140000000000001 107.639 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.07 114.16 36.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 109.02 -0.733 . . . . 73.129999999999995 109.02 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 55.7 mt -102.9 113.85 40.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 109.104 -0.702 . . . . 63.409999999999997 109.104 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 584' ' ' ASN . 50.3 mt -93.7 107.56 19.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.598 -1.631 . . . . 73.409999999999997 106.598 176.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.4 150.52 37.65 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.381 -0.927 . . . . 70.140000000000001 110.538 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.75 118.07 19.75 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-O 122.289 1.042 . . . . 71.340000000000003 110.76 -175.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 1.7 p -143.02 29.35 1.49 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 113.209 -1.814 . . . . 64.540000000000006 106.293 175.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.91 -37.93 11.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.542 -2.117 . . . . 71.129999999999995 109.679 -175.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -71.16 -27.76 63.77 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.67 -0.695 . . . . 72.120000000000005 109.492 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -72.27 -29.32 63.78 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.422 -0.808 . . . . 74.439999999999998 111.669 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . 0.453 ' HE2' ' HA ' ' A' ' 653' ' ' LYS . 6.1 mmpt? -126.75 98.8 5.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.644 0.735 . . . . 74.200000000000003 112.776 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 22.8 t -109.99 134.91 51.61 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.077 -1.083 . . . . 74.230000000000004 108.077 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 15.2 p -116.11 -77.71 0.57 Allowed 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 120.708 0.29 . . . . 72.299999999999997 110.586 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 30.6 m -134.1 149.64 30.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 116.533 -0.303 . . . . 72.420000000000002 110.237 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 18.5 t70 . . . . . 0 C--N 1.307 -1.265 0 CA-C-N 116.153 -0.476 . . . . 73.430000000000007 109.724 177.568 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.468 ' CD2' ' HA ' ' A' ' 631' ' ' MET . 80.5 m80 . . . . . 0 CA--C 1.5 -0.981 0 N-CA-C 108.686 -0.857 . . . . 75.400000000000006 108.686 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.47 ' HB1' ' HA ' ' A' ' 634' ' ' PRO . . . -63.02 -60.77 3.0 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.403 -0.592 . . . . 75.450000000000003 109.403 177.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 172.34 -160.2 31.45 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 110.88 -0.888 . . . . 54.399999999999999 110.88 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.26 126.98 71.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 O-C-N 124.003 0.472 . . . . 73.219999999999999 111.364 -170.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.437 ' CE2' ' HB ' ' A' ' 528' ' ' THR . 61.9 m-85 -103.56 133.94 47.75 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.427 -0.583 . . . . 64.409999999999997 109.427 170.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.0 t -169.32 169.8 8.88 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.332 -0.988 . . . . 64.409999999999997 108.332 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -78.01 149.41 34.05 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.073 0.397 . . . . 73.540000000000006 111.53 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.93 -36.4 80.07 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.46 -0.941 . . . . 74.310000000000002 108.46 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -129.68 146.23 60.32 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 108.253 -1.017 . . . . 73.310000000000002 108.253 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.49 -29.03 2.54 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.153 1.902 . . . . 71.519999999999996 112.934 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 55.9 t -139.6 135.11 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 107.015 -1.476 . . . . 74.540000000000006 107.015 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.1 t -134.17 140.38 46.5 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 108.867 -0.79 . . . . 73.519999999999996 108.867 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -114.87 129.06 56.63 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.769 -1.197 . . . . 73.219999999999999 107.769 175.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.0 m -116.21 170.52 5.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 121.182 0.515 . . . . 70.450000000000003 110.607 -175.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.525 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 75.3 m -87.03 150.11 24.26 Favored 'General case' 0 N--CA 1.398 -3.066 0 CA-C-N 115.069 -0.968 . . . . 73.319999999999993 108.632 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.59 ' CB ' ' HA ' ' A' ' 648' ' ' GLU . 3.8 tm-20 -75.31 -41.94 55.76 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 120.922 0.391 . . . . 73.129999999999995 111.077 177.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 6.4 t -99.31 51.06 0.94 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.553 0.692 . . . . 73.230000000000004 109.743 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 10.2 tt -103.41 -20.76 5.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.466 0.651 . . . . 74.109999999999999 111.29 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.53 -75.41 2.32 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 110.584 -1.006 . . . . 44.530000000000001 110.584 -175.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 47.7 mm -132.02 127.82 58.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 107.939 -1.134 . . . . 75.150000000000006 107.939 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.472 ' HE1' ' CG2' ' A' ' 573' ' ' VAL . 0.0 OUTLIER -107.58 150.86 26.37 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.78 -1.193 . . . . 72.5 107.78 176.372 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 30.7 mt-10 -131.66 123.11 27.12 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 123.654 0.596 . . . . 74.109999999999999 111.878 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 570' ' ' THR . 58.6 t -112.17 130.22 66.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.509 -0.922 . . . . 75.230000000000004 108.509 176.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . 0.423 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 21.0 mtmm -87.39 134.87 33.52 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.43 0.633 . . . . 75.409999999999997 111.884 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.421 ' O ' HG22 ' A' ' 568' ' ' VAL . 59.0 t -105.64 127.85 60.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.805 -0.813 . . . . 73.510000000000005 108.805 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.22 124.19 22.41 Favored 'General case' 0 N--CA 1.432 -1.365 0 O-C-N 123.726 0.641 . . . . 74.400000000000006 109.725 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -72.27 158.56 35.61 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.663 -1.153 . . . . 74.150000000000006 109.417 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.437 ' HB ' ' CE2' ' A' ' 505' ' ' PHE . 2.9 t -56.01 133.1 51.53 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.429 -0.805 . . . . 73.349999999999994 109.904 175.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 5.1 m -51.17 -31.38 19.74 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.475 1.51 . . . . 72.010000000000005 111.165 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.0 95.39 0.4 Allowed Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 109.031 -1.628 . . . . 74.340000000000003 109.031 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.98 104.37 15.54 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.177 -0.675 . . . . 73.219999999999999 109.177 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -119.09 105.09 11.06 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.082 -0.508 . . . . 75.030000000000001 109.748 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 92.97 -139.24 14.52 Favored Glycine 0 N--CA 1.436 -1.356 0 O-C-N 123.747 0.655 . . . . 63.539999999999999 112.221 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.43 HD22 ' CG ' ' A' ' 561' ' ' GLU . 2.8 t-20 -126.63 129.35 48.32 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.822 -0.806 . . . . 72.140000000000001 108.822 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 65.3 t -132.44 140.28 48.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.243 -0.435 . . . . 71.209999999999994 109.889 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.455 HG12 ' CG2' ' A' ' 597' ' ' VAL . 43.4 mm -109.24 137.59 40.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.078 -0.712 . . . . 74.040000000000006 109.078 176.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.98 110.47 29.32 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 109.666 -0.494 . . . . 75.230000000000004 109.666 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.58 155.28 59.43 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.389 2.059 . . . . 74.209999999999994 112.269 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.448 ' HB3' HG23 ' A' ' 591' ' ' ILE . 39.8 p90 -151.73 161.75 42.14 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.861 -0.422 . . . . 74.200000000000003 109.861 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -154.76 151.77 29.08 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.439 0.462 . . . . 70.019999999999996 110.974 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.3 p -85.91 132.49 34.07 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.222 -0.899 . . . . 74.120000000000005 110.088 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 59.0 mt -112.02 115.41 49.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.054 -1.091 . . . . 75.299999999999997 108.054 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.03 106.28 2.31 Favored 'General case' 0 C--N 1.312 -1.035 0 O-C-N 123.369 0.418 . . . . 74.329999999999998 110.979 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -85.14 -98.75 0.69 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 108.626 -1.789 . . . . 65.25 108.626 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 38.3 p -95.25 -25.61 16.28 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.767 -1.198 . . . . 73.5 107.767 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 587' ' ' PHE . . . -75.71 128.38 35.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.545 -1.207 . . . . 72.150000000000006 107.839 175.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -109.12 159.36 16.95 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 115.287 1.588 . . . . 71.150000000000006 115.287 -171.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . 63.87 -174.2 12.18 Favored Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 112.361 -2.2 . . . . 43.409999999999997 117.454 168.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -115.97 66.86 0.3 Allowed Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 108.163 -1.975 . . . . 72.349999999999994 108.163 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 132.17 5.04 3.51 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 111.524 -0.631 . . . . 71.230000000000004 111.524 -174.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -90.85 -74.38 0.5 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.851 -0.739 . . . . 75.349999999999994 109.904 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -94.77 -35.56 12.06 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 122.218 1.009 . . . . 74.109999999999999 108.471 175.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -137.57 157.79 45.78 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.187 -1.783 . . . . 73.530000000000001 106.187 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -91.2 135.84 33.51 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.624 -1.251 . . . . 75.209999999999994 107.624 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.37 141.7 47.02 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 120.431 0.158 . . . . 73.219999999999999 110.71 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.9 t -144.12 127.42 16.76 Favored 'General case' 0 N--CA 1.408 -2.569 0 CA-C-O 122.618 1.199 . . . . 72.439999999999998 108.525 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 5.3 p -149.89 115.69 5.61 Favored 'General case' 0 C--N 1.255 -3.505 0 CA-C-N 113.78 -1.554 . . . . 72.040000000000006 108.851 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -168.35 -142.7 3.57 Favored Glycine 0 N--CA 1.408 -3.2 0 N-CA-C 109.787 -1.325 . . . . 64.439999999999998 109.787 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.451 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.2 mt-10 -143.81 147.46 34.15 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.969 0.385 . . . . 71.299999999999997 110.776 -174.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 95.6 mt -106.02 144.95 32.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.806 -0.813 . . . . 75.299999999999997 108.806 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.43 ' CG ' HD22 ' A' ' 534' ' ' ASN . 29.6 tt0 -109.98 120.46 42.54 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.041 0.448 . . . . 73.230000000000004 110.341 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -115.4 147.59 40.35 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.999 -0.741 . . . . 73.230000000000004 108.999 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -138.36 177.92 7.52 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 109.479 -0.563 . . . . 75.519999999999996 109.479 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -68.71 -37.51 79.55 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.11 -0.95 . . . . 62.32 110.392 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -92.45 -12.0 33.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.459 -0.791 . . . . 73.299999999999997 111.733 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.3 172.8 5.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.881 -0.6 . . . . 75.319999999999993 110.095 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.56 HG13 ' H ' ' A' ' 568' ' ' VAL . 5.9 pt -115.91 -82.82 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 112.671 0.619 . . . . 73.239999999999995 112.671 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.56 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.9 p -143.84 151.73 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 N-CA-C 108.88 -0.785 . . . . 75.120000000000005 108.88 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.06 156.34 24.32 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.192 0.52 . . . . 71.439999999999998 110.519 175.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.4 p -125.01 147.94 48.7 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.564 -1.198 . . . . 73.140000000000001 110.96 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.6 mp -94.94 117.04 37.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 106.437 -1.69 . . . . 74.5 106.437 171.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 572' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 521' ' ' MET . 45.2 m -93.42 115.26 27.81 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 108.498 -0.927 . . . . 70.349999999999994 108.498 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.472 ' CG2' ' HE1' ' A' ' 521' ' ' MET . 67.6 t -118.51 132.35 68.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.627 -0.509 . . . . 64.099999999999994 109.627 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -81.81 117.65 22.26 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.936 -1.135 . . . . 73.510000000000005 107.936 175.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 47.1 t -91.26 131.04 39.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 106.262 -1.755 . . . . 62.329999999999998 106.262 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 40.3 mm -77.96 123.63 35.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.84 0.829 . . . . 73.450000000000003 109.528 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -77.45 119.13 20.62 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 113.811 -1.54 . . . . 74.209999999999994 107.973 -176.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -164.24 148.02 9.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.712 0.292 . . . . 72.430000000000007 110.508 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -128.46 13.47 6.54 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.643 0.609 . . . . 75.510000000000005 112.643 -175.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -115.71 123.22 47.75 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 114.864 1.431 . . . . 73.310000000000002 114.864 -171.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 34.1 t80 75.43 -43.13 0.49 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 116.415 2.006 . . . . 73.120000000000005 116.415 166.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -70.33 148.15 48.8 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.17 0.509 . . . . 73.510000000000005 111.48 -175.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -98.84 -61.76 1.33 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.25 -0.886 . . . . 72.140000000000001 111.347 -174.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -153.65 134.92 14.11 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 108.773 -0.825 . . . . 75.530000000000001 108.773 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -127.23 139.33 53.0 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.878 -0.416 . . . . 75.540000000000006 109.878 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.7 t -141.93 143.14 33.12 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 109.025 -0.731 . . . . 75.109999999999999 109.025 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 46.7 p90 -135.76 174.65 10.38 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.154 -1.054 . . . . 74.430000000000007 108.154 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.434 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 78.2 m-85 -119.21 156.35 30.03 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 109.401 -0.592 . . . . 64.109999999999999 109.401 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.86 123.2 38.14 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 105.607 -1.997 . . . . 73.400000000000006 105.607 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.38 136.07 55.0 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.427 -0.583 . . . . 75.409999999999997 109.427 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . 0.448 HG23 ' HB3' ' A' ' 539' ' ' TYR . 26.3 pt -106.06 137.79 34.56 Favored 'Isoleucine or valine' 0 C--O 1.261 1.695 0 N-CA-C 108.305 -0.998 . . . . 74.400000000000006 108.305 175.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.22 -177.01 49.85 Favored Glycine 0 N--CA 1.418 -2.54 0 CA-C-N 115.603 -0.726 . . . . 61.100000000000001 111.447 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.7 137.94 97.3 Favored Pre-proline 0 C--N 1.303 -1.416 0 CA-C-O 120.91 0.386 . . . . 75.219999999999999 111.371 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.469 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 32.0 Cg_endo -68.39 138.84 43.67 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 122.35 2.033 . . . . 72.340000000000003 111.083 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . 0.428 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.9 ptm180 -116.21 122.52 45.26 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.035 -0.728 . . . . 73.129999999999995 109.035 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.88 131.9 46.37 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.431 -1.322 . . . . 74.25 107.431 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.455 ' CG2' HG12 ' A' ' 536' ' ' ILE . 65.4 t -76.09 114.11 15.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.226 0.536 . . . . 72.430000000000007 110.667 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -72.44 104.32 3.75 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.12 -0.946 . . . . 74.340000000000003 112.491 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 49.5 tpp -69.04 -27.65 65.84 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.525 -1.216 . . . . 75.040000000000006 107.914 175.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 47.8 t -87.99 86.91 7.19 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.581 -1.637 . . . . 75.010000000000005 106.581 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -79.78 132.61 36.19 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.016 -0.538 . . . . 75.519999999999996 110.135 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -95.79 161.94 13.81 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.695 -1.224 . . . . 74.409999999999997 107.695 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -85.22 90.9 8.01 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.843 0.83 . . . . 74.030000000000001 110.557 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -120.9 -50.24 0.27 Allowed Glycine 0 N--CA 1.422 -2.281 0 CA-C-N 114.484 -1.234 . . . . 72.019999999999996 110.875 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 73.88 -77.06 0.98 Allowed Glycine 0 N--CA 1.434 -1.478 0 O-C-N 123.879 0.399 . . . . 72.430000000000007 112.359 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -77.81 108.01 10.73 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 121.581 0.705 . . . . 75.420000000000002 111.482 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 46.4 m -104.28 94.98 5.65 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 105.568 -2.012 . . . . 75.25 105.568 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 66.3 mt -71.26 113.48 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 115.382 -0.826 . . . . 72.310000000000002 109.735 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 27.6 m -90.28 -36.91 14.43 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.185 -0.916 . . . . 72.200000000000003 109.628 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -90.32 86.41 6.48 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.087 -1.079 . . . . 72.230000000000004 108.087 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -113.89 -39.13 4.04 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.85 -1.068 . . . . 73.209999999999994 111.37 -173.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -158.6 169.66 23.91 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.123 -1.066 . . . . 75.510000000000005 108.123 -177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -67.77 -41.28 83.53 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.899 0.857 . . . . 70.400000000000006 109.108 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -98.31 -156.36 0.54 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.851 -1.537 . . . . 74.439999999999998 106.851 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -73.91 173.2 10.29 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.028 0.442 . . . . 75.450000000000003 111.519 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -107.42 144.52 29.39 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 116.361 -0.381 . . . . 73.120000000000005 110.308 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -71.97 107.39 2.21 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 122.233 1.955 . . . . 73.239999999999995 111.56 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 94.9 mt -80.32 155.23 27.34 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.876 -0.602 . . . . 72.510000000000005 111.034 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 10.1 t -95.13 14.66 21.31 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.311 1.053 . . . . 72.409999999999997 108.337 177.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 15.7 m -88.45 14.62 9.32 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 114.632 -1.167 . . . . 72.239999999999995 110.182 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.05 -49.02 71.74 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.416 -0.957 . . . . 74.319999999999993 108.416 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -84.35 110.23 18.44 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 106.495 -1.668 . . . . 74.349999999999994 106.495 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -125.35 169.48 12.28 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.796 -0.638 . . . . 73.200000000000003 110.785 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -118.06 83.3 1.98 Allowed 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.809 -0.812 . . . . 74.219999999999999 108.809 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 58.55 28.21 16.72 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.376 1.071 . . . . 72.340000000000003 110.885 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -64.43 -34.7 78.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 73.129999999999995 111.899 -174.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . 0.541 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 0.7 OUTLIER -66.58 -37.64 85.36 Favored 'General case' 0 C--O 1.203 -1.373 0 C-N-CA 120.292 -0.563 . . . . 74.230000000000004 109.905 176.291 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.605 ' O ' ' HG3' ' A' ' 631' ' ' MET . 59.0 mt -65.02 -34.33 69.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.619 -0.882 . . . . 73.010000000000005 108.619 177.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -68.21 -14.57 63.08 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.207 -0.906 . . . . 61.43 112.584 178.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 627' ' ' ARG . 8.5 pt-20 -60.97 -27.26 68.14 Favored 'General case' 0 C--N 1.362 1.147 0 CA-C-N 118.302 0.501 . . . . 75.030000000000001 111.275 -177.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.605 ' HG3' ' O ' ' A' ' 628' ' ' ILE . 0.0 OUTLIER -73.9 -7.71 53.33 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.952 -0.567 . . . . 62.229999999999997 112.23 -179.5 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -107.63 -0.56 34.62 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.09 -0.804 . . . . 40.439999999999998 111.09 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . 0.504 ' HG3' ' HA ' ' A' ' 630' ' ' GLU . 60.9 mtt180 -92.79 165.86 17.97 Favored Pre-proline 0 C--O 1.248 1.001 0 N-CA-C 108.704 -0.85 . . . . 75.099999999999994 108.704 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.47 ' HA ' ' HB1' ' A' ' 502' ' ' ALA . 57.4 Cg_endo -73.86 131.87 16.3 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 N-CA-C 108.345 -1.444 . . . . 74.439999999999998 108.345 166.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.3 166.3 21.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 C-N-CA 120.452 -0.499 . . . . 74.430000000000007 110.828 -177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.13 166.55 10.96 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.206 -0.598 . . . . 74.430000000000007 112.075 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -75.72 -166.96 21.73 Favored Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 115.234 -0.893 . . . . 60.219999999999999 113.584 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -68.08 -46.81 69.98 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 122.99 0.516 . . . . 74.219999999999999 110.382 -177.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -125.34 135.24 52.25 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.968 -0.753 . . . . 72.120000000000005 108.968 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 640' ' ' THR . . . . . 0.444 ' HB ' ' CG1' ' A' ' 591' ' ' ILE . 34.7 p -130.99 85.75 2.3 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.551 0.691 . . . . 75.319999999999993 110.01 175.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . 0.461 ' HB3' ' HZ3' ' A' ' 641' ' ' LYS . 7.3 ttpm? -163.38 143.59 8.86 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.155 -0.929 . . . . 64.400000000000006 109.782 -175.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.432 HD22 HG21 ' A' ' 523' ' ' VAL . 29.6 tp -128.43 142.96 50.94 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.412 -0.958 . . . . 75.019999999999996 108.412 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -110.19 111.35 22.62 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.527 -1.286 . . . . 73.040000000000006 107.527 176.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 47.6 t -102.45 117.15 47.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.985 -0.376 . . . . 65.129999999999995 109.985 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 52.5 mt -101.87 130.87 50.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 108.626 -0.879 . . . . 75.329999999999998 108.626 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 67.5 mt -105.06 112.19 37.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.654 -0.869 . . . . 75.530000000000001 108.654 178.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -109.83 148.78 30.89 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.439 -1.319 . . . . 74.319999999999993 107.439 175.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.59 ' HA ' ' CB ' ' A' ' 516' ' ' GLU . 0.1 OUTLIER -80.87 172.1 14.16 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 118.162 0.437 . . . . 72.230000000000004 111.855 -172.429 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 64.9 m -145.85 16.58 1.42 Allowed 'General case' 0 N--CA 1.416 -2.168 0 C-N-CA 119.12 -1.032 . . . . 71.430000000000007 112.822 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -93.89 -60.62 1.71 Allowed 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 120.394 -0.522 . . . . 74.450000000000003 111.424 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -79.92 -48.44 13.43 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 107.988 -1.115 . . . . 74.019999999999996 107.988 -175.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 52.5 t80 16.13 63.96 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.566 2.347 . . . . 73.430000000000007 114.645 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . 0.468 ' HB2' ' HZ2' ' A' ' 653' ' ' LYS . 0.0 OUTLIER -110.64 2.08 18.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 123.043 1.402 . . . . 75.120000000000005 107.742 175.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 52.5 p -166.9 -170.91 1.67 Allowed 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 101.131 -3.655 . . . . 62.200000000000003 101.131 174.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 18.9 m -78.64 119.89 22.53 Favored 'General case' 0 C--N 1.283 -2.306 0 C-N-CA 118.071 -1.452 . . . . 71.129999999999995 107.901 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.472 ' HA ' ' CG ' ' A' ' 648' ' ' GLU 0.381 8.8 p 71.66 -32.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 126.997 2.119 . . . . 75.310000000000002 114.647 178.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 17.5 t70 . . . . . 0 C--N 1.29 -1.979 0 O-C-N 121.732 -0.605 . . . . 74.400000000000006 110.624 178.304 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 . . . . . 0 CA--C 1.498 -1.043 0 N-CA-C 108.619 -0.882 . . . . 74.409999999999997 108.619 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.511 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . -71.29 -30.59 66.44 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.036 -1.438 . . . . 64.519999999999996 111.719 -177.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 133.37 -146.63 18.53 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.023 -1.084 . . . . 75.010000000000005 111.101 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.1 mp -120.88 110.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 116.857 0.328 . . . . 75.420000000000002 111.055 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.501 ' CD2' HG21 ' A' ' 528' ' ' THR . 10.0 m-85 -90.0 131.31 35.95 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.128 -1.434 . . . . 75.200000000000003 107.128 168.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.2 t -168.77 171.38 8.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.422 -0.584 . . . . 73.340000000000003 109.422 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -77.24 148.76 35.63 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 116.062 -0.517 . . . . 74.519999999999996 110.204 177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -65.6 -32.1 73.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.387 0.613 . . . . 75.439999999999998 110.113 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -135.83 141.42 36.77 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 107.474 -1.306 . . . . 64.209999999999994 107.474 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.57 -28.21 10.19 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 122.425 2.084 . . . . 71.010000000000005 112.359 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 49.6 t -136.97 139.69 44.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 107.016 -1.476 . . . . 74.239999999999995 107.016 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.3 t -133.36 140.48 47.4 Favored 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 109.384 -0.599 . . . . 74.109999999999999 109.384 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -106.73 129.91 54.54 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.111 -1.07 . . . . 74.0 108.111 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.7 m -119.82 150.67 22.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 109.032 -0.729 . . . . 74.439999999999998 109.032 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.4 ' O ' HG22 ' A' ' 518' ' ' ILE . 9.5 t -82.76 167.57 18.02 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.762 0.792 . . . . 71.439999999999998 110.816 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -90.54 -9.24 47.94 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.419 -1.697 . . . . 73.430000000000007 106.419 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 20.5 m -121.83 24.75 9.53 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 121.175 -0.953 . . . . 63.5 110.855 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 515' ' ' SER . 8.2 tt -88.63 -32.89 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.999 0.428 . . . . 71.409999999999997 111.532 -177.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . 0.404 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 89.27 -80.08 1.56 Allowed Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 110.656 -0.978 . . . . 63.409999999999997 110.656 -176.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.1 mm -124.56 123.74 66.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.533 -0.914 . . . . 72.409999999999997 108.533 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -101.69 149.36 24.22 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 108.705 -0.85 . . . . 70.209999999999994 108.705 177.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 31.1 mt-10 -133.41 130.1 38.25 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 123.611 0.765 . . . . 75.340000000000003 110.242 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 570' ' ' THR . 38.8 t -113.9 126.35 71.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 108.265 -1.013 . . . . 75.530000000000001 108.265 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -77.84 131.16 37.43 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 124.053 0.846 . . . . 73.530000000000001 110.077 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.502 ' O ' HG21 ' A' ' 568' ' ' VAL . 46.0 t -110.46 125.44 67.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.266 -0.642 . . . . 75.329999999999998 109.266 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.7 mt -78.28 129.3 34.89 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.344 -0.844 . . . . 75.239999999999995 111.861 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' A' ' 567' ' ' ILE . 15.6 tpt180 -76.58 153.01 35.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.716 -1.129 . . . . 75.099999999999994 108.853 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 5.5 p -59.28 146.2 40.34 Favored 'General case' 0 N--CA 1.426 -1.663 0 O-C-N 123.784 0.678 . . . . 65.230000000000004 111.813 176.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 28.1 t -55.6 -28.62 56.16 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.254 1.022 . . . . 74.349999999999994 110.285 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -112.66 99.13 1.01 Allowed Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 109.037 -1.625 . . . . 71.420000000000002 109.037 172.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.97 100.98 12.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.737 -0.838 . . . . 75.120000000000005 108.737 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -120.29 116.38 25.45 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.731 -0.668 . . . . 74.519999999999996 110.054 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 68.83 -169.54 41.95 Favored Glycine 0 N--CA 1.445 -0.744 0 O-C-N 123.95 0.781 . . . . 73.319999999999993 114.399 173.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -92.51 124.21 36.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 123.249 0.62 . . . . 72.549999999999997 109.749 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 57.7 t -132.5 133.68 59.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.734 -0.839 . . . . 73.319999999999993 108.734 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 42.4 mm -107.13 132.4 54.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 109.996 -0.372 . . . . 73.450000000000003 109.996 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.12 110.21 34.77 Favored Pre-proline 0 N--CA 1.439 -1.01 0 N-CA-C 109.688 -0.486 . . . . 73.239999999999995 109.688 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 57.1 Cg_endo -75.03 158.57 42.02 Favored 'Trans proline' 0 C--N 1.334 -0.227 0 C-N-CA 122.505 2.137 . . . . 74.439999999999998 112.441 178.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.433 ' HB3' HG21 ' A' ' 591' ' ' ILE . 53.1 p90 -150.32 162.91 39.61 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.648 0.261 . . . . 73.510000000000005 110.557 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -155.33 150.32 26.69 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.605 -0.725 . . . . 75.239999999999995 110.092 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 15.0 p -83.45 134.65 34.85 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.175 -0.676 . . . . 75.200000000000003 109.175 173.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.478 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 87.1 mt -105.14 118.87 53.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.152 -1.055 . . . . 74.340000000000003 108.152 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -75.45 138.05 41.38 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 123.405 0.441 . . . . 75.239999999999995 110.029 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -138.72 -103.59 0.6 Allowed Glycine 0 CA--C 1.502 -0.757 0 N-CA-C 110.675 -0.97 . . . . 54.310000000000002 110.675 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 25.0 p -90.27 -9.06 49.32 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.88 0.848 . . . . 73.120000000000005 109.16 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -112.32 136.56 51.63 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 106.757 -1.571 . . . . 73.019999999999996 106.757 173.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 10.8 mtm-85 -108.0 149.9 27.8 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.265 0.839 . . . . 75.019999999999996 113.265 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -90.66 -147.25 18.25 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 114.71 -1.132 . . . . 73.140000000000001 111.048 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 63.54 28.33 72.28 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 111.858 -0.497 . . . . 73.030000000000001 111.858 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 71.97 24.99 75.77 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 121.61 -0.328 . . . . 74.150000000000006 112.422 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -89.92 -77.53 0.39 Allowed 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 117.508 0.654 . . . . 64.340000000000003 110.879 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -96.14 -34.67 11.6 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 108.218 -1.03 . . . . 65.5 108.218 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -144.24 159.11 43.23 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 108.254 -1.017 . . . . 74.319999999999993 108.254 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -89.1 112.24 23.17 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 104.983 -2.228 . . . . 73.200000000000003 104.983 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.0 129.47 35.32 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.545 0.688 . . . . 74.329999999999998 110.417 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 15.0 t -129.37 161.2 30.85 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 115.546 -0.752 . . . . 65.430000000000007 110.563 -171.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.6 p -151.99 161.93 41.87 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.392 -1.336 . . . . 73.340000000000003 107.392 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 165.01 -167.47 38.71 Favored Glycine 0 N--CA 1.419 -2.442 0 C-N-CA 120.103 -1.046 . . . . 54.299999999999997 110.579 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 538' ' ' PRO . 27.1 mt-10 -130.86 137.59 49.44 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 123.136 0.574 . . . . 73.109999999999999 109.614 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 94.6 mt -102.87 133.63 47.63 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.205 -0.665 . . . . 72.129999999999995 109.205 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -96.74 119.26 34.89 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.912 -0.585 . . . . 72.430000000000007 110.801 -177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -116.04 148.4 40.23 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.622 -0.881 . . . . 63.229999999999997 108.622 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.418 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 46.0 mt-30 -141.77 -172.32 3.53 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.098 -1.075 . . . . 73.420000000000002 108.098 -178.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -80.08 -28.17 39.17 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.559 -0.904 . . . . 74.150000000000006 108.559 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -84.24 -32.87 24.23 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.242 -0.89 . . . . 53.420000000000002 111.021 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.418 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 40.5 mm-40 -79.5 143.49 34.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.773 0.321 . . . . 73.120000000000005 111.38 177.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.559 ' O ' ' HB2' ' A' ' 527' ' ' ARG . 3.9 pt -112.0 -77.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 113.029 0.751 . . . . 72.219999999999999 113.029 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.534 ' H ' HG13 ' A' ' 567' ' ' ILE . 13.1 p -113.38 144.37 21.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.913 0.863 . . . . 75.409999999999997 112.171 -174.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.86 169.69 10.2 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.378 -0.828 . . . . 74.120000000000005 109.251 173.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.4 p -135.62 146.87 48.34 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 123.591 0.557 . . . . 71.409999999999997 112.443 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.2 mp -95.29 119.32 43.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.041 -1.466 . . . . 72.530000000000001 107.041 170.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 572' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 521' ' ' MET . 26.4 m -98.75 116.09 30.2 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.432 -0.581 . . . . 72.439999999999998 109.432 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.438 ' CG2' ' HE3' ' A' ' 521' ' ' MET . 89.3 t -121.6 131.45 73.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 N-CA-C 109.92 -0.4 . . . . 74.239999999999995 109.92 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.404 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 23.4 tptm -85.83 115.6 23.57 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.974 -0.75 . . . . 75.030000000000001 108.974 176.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 36.4 t -86.62 125.31 40.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.15 -1.426 . . . . 71.209999999999994 107.15 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 35.8 mm -84.21 152.39 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 108.518 -0.919 . . . . 72.329999999999998 108.518 -175.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -59.31 130.19 45.74 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 123.812 0.695 . . . . 75.329999999999998 110.017 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -39.5 115.29 0.49 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 116.304 1.964 . . . . 64.239999999999995 116.304 -171.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -80.29 143.46 33.62 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.98 -1.009 . . . . 71.230000000000004 110.113 171.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.62 -10.02 56.52 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 115.298 1.592 . . . . 73.140000000000001 115.298 -169.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -64.33 -65.3 0.7 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 118.049 0.386 . . . . 72.409999999999997 111.851 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -114.2 144.11 43.74 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.94 -1.133 . . . . 75.140000000000001 107.94 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -88.41 -66.14 0.95 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.331 -0.988 . . . . 75.109999999999999 108.331 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -101.16 132.02 46.84 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 107.03 -1.47 . . . . 71.209999999999994 107.03 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -151.21 163.29 39.2 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 115.151 -0.931 . . . . 73.239999999999995 108.829 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.7 t -144.29 150.07 37.28 Favored 'General case' 0 C--N 1.279 -2.457 0 C-N-CA 119.641 -0.824 . . . . 64.439999999999998 112.243 -175.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 45.4 p90 -133.59 166.79 21.78 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 106.317 -1.735 . . . . 75.209999999999994 106.317 175.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -115.54 159.4 21.29 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 120.115 -0.634 . . . . 75.400000000000006 109.832 -175.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.09 124.71 42.46 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 106.227 -1.768 . . . . 73.299999999999997 106.227 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -122.65 129.68 52.11 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 120.961 0.41 . . . . 73.5 110.071 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . 0.433 HG21 ' HB3' ' A' ' 539' ' ' TYR . 25.2 pt -100.23 143.83 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 107.868 -1.16 . . . . 75.140000000000001 107.868 175.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -84.88 -177.31 51.01 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 111.338 -0.705 . . . . 73.319999999999993 111.338 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -78.31 129.17 75.86 Favored Pre-proline 0 N--CA 1.416 -2.13 0 CA-C-O 120.889 0.376 . . . . 72.109999999999999 110.525 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.49 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.0 Cg_endo -59.56 127.74 24.75 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.615 2.877 . . . . 74.299999999999997 112.309 -175.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -106.26 131.98 52.85 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.378 -0.601 . . . . 64.129999999999995 109.378 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -73.75 134.54 43.48 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 105.034 -2.21 . . . . 73.049999999999997 105.034 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 19.2 t -82.57 71.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.287 1.041 . . . . 75.129999999999995 108.842 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.78 164.71 21.5 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.432 -1.258 . . . . 74.420000000000002 107.667 -176.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -110.63 -23.29 11.17 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 120.81 0.338 . . . . 74.519999999999996 111.233 -174.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 11.5 m -98.3 139.17 34.47 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.999 0.428 . . . . 65.230000000000004 111.459 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -95.52 145.23 25.36 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.597 -1.631 . . . . 72.049999999999997 106.597 171.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -78.81 113.39 16.86 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.665 -0.814 . . . . 74.120000000000005 109.867 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -117.49 23.81 11.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.759 -0.655 . . . . 74.239999999999995 111.054 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -80.68 2.24 79.87 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.985 -0.626 . . . . 73.530000000000001 111.8 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -85.14 66.93 3.75 Favored Glycine 0 N--CA 1.425 -2.065 0 N-CA-C 112.335 -0.306 . . . . 71.329999999999998 112.335 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -77.55 153.78 33.02 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.602 -1.259 . . . . 72.129999999999995 107.602 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 9.0 t -67.31 107.6 2.45 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 122.044 0.926 . . . . 73.209999999999994 109.65 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 11.2 tt -140.31 10.01 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.424 -0.807 . . . . 74.239999999999995 110.566 -173.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 28.5 m -66.85 128.87 37.94 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.276 -0.638 . . . . 72.150000000000006 109.276 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -126.42 -170.53 2.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.438 -0.346 . . . . 63.450000000000003 110.567 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -63.27 128.78 37.43 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.768 -0.651 . . . . 73.049999999999997 111.726 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -87.23 -35.6 18.44 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 105.099 -2.186 . . . . 75.150000000000006 105.099 171.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 35.0 t70 41.02 90.47 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 126.752 2.021 . . . . 73.340000000000003 114.531 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 36.6 t70 172.56 -50.29 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 106.212 -1.773 . . . . 72.409999999999997 106.212 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -173.13 105.82 0.14 Allowed 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 105.646 -1.983 . . . . 73.25 105.646 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -67.71 130.64 92.97 Favored Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 120.363 -0.535 . . . . 73.450000000000003 109.786 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . 0.414 ' HB2' ' O ' ' A' ' 619' ' ' THR . 55.3 Cg_endo -69.18 114.39 3.59 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.493 2.129 . . . . 71.340000000000003 114.039 -174.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.23 -41.09 90.54 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.793 -0.817 . . . . 73.349999999999994 108.793 174.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 619' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 617' ' ' PRO . 10.3 t -87.3 122.06 30.57 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 105.346 -2.094 . . . . 74.329999999999998 105.346 172.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 7.9 t -80.23 175.54 10.55 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-O 122.613 1.197 . . . . 61.130000000000003 113.169 -166.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . 0.625 ' HD2' ' O ' ' A' ' 621' ' ' LYS . 0.1 OUTLIER -119.75 162.8 18.44 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 113.177 -1.828 . . . . 74.450000000000003 109.574 -173.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -118.65 102.98 9.27 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.718 -1.215 . . . . 62.200000000000003 107.718 173.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.43 ' HG2' ' OE2' ' A' ' 624' ' ' GLU 0.254 1.0 OUTLIER -75.32 -18.95 59.9 Favored 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 120.145 -0.622 . . . . 64.400000000000006 112.335 179.424 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . 0.43 ' OE2' ' HG2' ' A' ' 623' ' ' GLU . 9.6 mp0 -110.69 89.71 3.12 Favored 'General case' 0 C--O 1.248 0.979 0 N-CA-C 106.314 -1.735 . . . . 75.349999999999994 106.314 168.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.86 126.75 30.75 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.925 -0.58 . . . . 74.420000000000002 111.002 -175.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -56.82 -36.72 70.27 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.623 1.169 . . . . 75.310000000000002 111.006 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . 0.459 ' HA ' ' OE1' ' A' ' 630' ' ' GLU . 2.7 tmt_? -57.65 -26.89 62.28 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.679 0.792 . . . . 73.409999999999997 111.816 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.474 ' O ' ' HG2' ' A' ' 631' ' ' MET . 69.8 mt -65.74 -27.37 41.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.548 0.69 . . . . 71.030000000000001 110.445 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -85.89 -22.88 27.28 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.291 0.567 . . . . 72.140000000000001 109.737 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.459 ' OE1' ' HA ' ' A' ' 627' ' ' ARG . 45.0 mt-10 -81.83 -15.42 54.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.376 -0.829 . . . . 75.25 111.728 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 26.9 ptt? -76.27 -16.89 59.7 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.299 -0.63 . . . . 73.430000000000007 109.299 176.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -110.37 37.31 3.81 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.461 -1.055 . . . . 72.540000000000006 110.461 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 630' ' ' GLU . 63.3 mtp180 -125.81 155.16 73.19 Favored Pre-proline 0 N--CA 1.425 -1.688 0 C-N-CA 123.033 0.533 . . . . 74.430000000000007 109.636 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.49 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 21.3 Cg_endo -66.26 137.71 48.57 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 C-N-CA 122.064 1.843 . . . . 75.010000000000005 108.096 169.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.41 167.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 120.361 -0.535 . . . . 73.109999999999999 111.287 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.87 175.57 5.45 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.013 -0.539 . . . . 64.319999999999993 112.357 -177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.18 -176.92 35.94 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.699 -0.682 . . . . 74.109999999999999 112.405 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.4 -39.94 77.66 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.985 0.422 . . . . 74.530000000000001 110.217 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -112.87 121.49 44.84 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.89 -0.595 . . . . 75.140000000000001 110.62 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 19.6 p -134.75 81.32 1.9 Allowed 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 122.149 0.976 . . . . 73.430000000000007 110.895 174.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . 0.516 ' HZ1' ' HB3' ' A' ' 641' ' ' LYS . 7.0 ttpm? -163.14 150.97 13.4 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.477 -1.305 . . . . 72.340000000000003 107.477 -175.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.429 HD23 HG12 ' A' ' 523' ' ' VAL . 27.8 tp -133.69 139.85 46.67 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 108.334 -0.988 . . . . 71.230000000000004 108.334 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.84 114.5 28.68 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.079 -1.452 . . . . 72.239999999999995 107.079 174.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 41.1 t -103.49 110.03 28.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 109.12 -0.696 . . . . 71.109999999999999 109.12 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 47.2 mt -96.65 120.8 46.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 109.413 -0.588 . . . . 74.219999999999999 109.413 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 63.4 mt -97.2 113.99 33.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 107.631 -1.248 . . . . 75.299999999999997 107.631 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -147.32 -179.5 6.89 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 105.248 -2.13 . . . . 74.319999999999993 105.248 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -83.56 135.62 34.56 Favored 'General case' 0 C--N 1.289 -2.054 0 C-N-CA 117.093 -1.843 . . . . 73.329999999999998 110.45 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.3 t -114.5 23.79 12.45 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.391 -2.077 . . . . 73.0 105.391 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -63.33 -53.59 50.36 Favored 'General case' 0 N--CA 1.387 -3.578 0 C-N-CA 126.633 1.973 . . . . 74.340000000000003 110.697 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.46 -34.25 41.68 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.388 -0.925 . . . . 75.319999999999993 112.301 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -126.83 132.01 51.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.779 -0.452 . . . . 74.340000000000003 109.779 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -91.61 -25.21 19.29 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.302 0.572 . . . . 74.219999999999999 110.407 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 25.4 m -133.12 141.93 48.42 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.422 -0.585 . . . . 71.010000000000005 109.422 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 12.3 m -78.67 138.0 38.08 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.0 -0.741 . . . . 74.25 109.0 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 56.5 t -77.32 -38.03 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 107.998 -1.112 . . . . 64.510000000000005 107.998 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--N 1.311 -1.102 0 CA-C-N 114.799 -1.091 . . . . 64.409999999999997 111.068 176.783 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.577 ' N ' ' HA2' ' A' ' 632' ' ' GLY . 43.3 t60 . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 109.903 -0.406 . . . . 74.439999999999998 109.903 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.5 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -93.59 -68.23 0.81 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.715 -0.476 . . . . 75.230000000000004 109.715 175.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.432 ' C ' HG22 ' A' ' 528' ' ' THR . . . -178.12 -166.37 34.41 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.814 -0.914 . . . . 65.420000000000002 110.814 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.5 mp -112.6 128.81 69.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 123.521 0.729 . . . . 73.450000000000003 110.928 -173.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.564 ' CE2' HG21 ' A' ' 528' ' ' THR . 41.7 m-85 -102.13 139.75 37.34 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.725 -0.472 . . . . 72.140000000000001 109.725 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.0 t -169.89 175.99 4.95 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.056 -1.09 . . . . 74.450000000000003 108.056 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -80.96 154.92 26.69 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 117.988 0.358 . . . . 74.010000000000005 110.734 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.92 -41.8 77.69 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.852 -0.613 . . . . 52.140000000000001 109.5 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -121.93 146.48 46.27 Favored Pre-proline 0 N--CA 1.417 -2.081 0 N-CA-C 108.376 -0.972 . . . . 75.420000000000002 108.376 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -77.63 -23.51 9.68 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.547 1.498 . . . . 74.120000000000005 111.249 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.0 t -141.01 132.92 29.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 107.764 -1.199 . . . . 62.119999999999997 107.764 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.7 t -126.46 139.73 53.02 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.633 -0.877 . . . . 74.329999999999998 108.633 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -108.24 118.03 35.71 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.228 -1.027 . . . . 74.430000000000007 108.228 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.64 153.94 17.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 121.138 0.494 . . . . 75.439999999999998 110.156 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.486 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 65.3 m -79.49 152.91 29.96 Favored 'General case' 0 N--CA 1.42 -1.928 0 C-N-CA 124.391 1.076 . . . . 53.43 111.133 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 648' ' ' GLU . 15.6 pt-20 -63.14 -49.89 72.61 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 120.954 0.407 . . . . 74.129999999999995 111.167 177.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' SER . . . . . 0.492 ' N ' ' HG3' ' A' ' 516' ' ' GLU . 52.5 m -109.34 69.21 0.7 Allowed 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.962 0.887 . . . . 73.109999999999999 110.108 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 13.3 tt -110.64 -27.24 2.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.058 -0.973 . . . . 74.540000000000006 110.836 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 90.63 -70.76 2.1 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.561 -0.828 . . . . 63.030000000000001 111.55 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.9 mm -135.42 125.07 42.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.049 -0.723 . . . . 73.519999999999996 109.049 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.476 ' SD ' HG21 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -108.09 150.06 27.67 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.898 -1.149 . . . . 75.040000000000006 107.898 176.436 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.8 mt-10 -129.56 121.75 27.78 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.588 0.708 . . . . 72.140000000000001 112.767 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 570' ' ' THR . 99.4 t -110.06 131.43 61.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.101 -0.954 . . . . 74.230000000000004 109.086 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -89.97 136.44 33.04 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.678 0.751 . . . . 72.219999999999999 111.931 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 47.3 t -105.54 124.53 60.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 114.649 -1.16 . . . . 72.519999999999996 108.109 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.4 mt -70.74 127.21 31.89 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 123.759 0.662 . . . . 71.109999999999999 110.703 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -74.7 162.55 28.61 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.426 -1.261 . . . . 73.409999999999997 110.346 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.564 HG21 ' CE2' ' A' ' 505' ' ' PHE . 1.0 OUTLIER -55.83 139.05 46.92 Favored 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 124.892 1.277 . . . . 73.340000000000003 111.852 177.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 4.0 m -51.5 -37.8 50.91 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 125.434 1.494 . . . . 74.349999999999994 110.188 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -124.8 96.2 0.51 Allowed Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 108.701 -1.76 . . . . 55.329999999999998 108.701 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.18 107.95 17.48 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.945 -0.761 . . . . 74.319999999999993 108.945 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -124.51 108.09 11.75 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.034 -0.53 . . . . 72.400000000000006 109.898 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 89.69 -132.0 11.03 Favored Glycine 0 C--N 1.312 -0.761 0 C-N-CA 120.36 -0.924 . . . . 73.329999999999998 112.665 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -133.39 131.68 40.31 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 123.212 0.605 . . . . 74.299999999999997 109.492 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.0 t -132.55 143.72 38.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 123.631 0.772 . . . . 74.019999999999996 109.313 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.565 HG12 ' CG2' ' A' ' 597' ' ' VAL . 33.8 mm -112.56 132.1 62.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.891 -0.781 . . . . 73.319999999999993 108.891 173.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 25.7 t -120.67 110.3 35.45 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 109.019 -0.734 . . . . 75.129999999999995 109.019 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -74.7 158.38 43.38 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.221 1.947 . . . . 75.120000000000005 111.578 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.437 ' HB3' HG23 ' A' ' 591' ' ' ILE . 54.5 p90 -146.34 170.22 17.24 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 122.202 -0.311 . . . . 75.340000000000003 111.173 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -158.17 150.92 22.49 Favored 'General case' 0 C--O 1.245 0.822 0 O-C-N 123.614 0.571 . . . . 74.150000000000006 110.874 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.0 p -90.5 131.55 36.18 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.897 -0.592 . . . . 75.420000000000002 109.746 172.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 91.5 mt -105.08 116.14 48.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 109.169 -0.678 . . . . 74.230000000000004 109.169 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -75.66 103.35 5.73 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.54 -0.911 . . . . 75.019999999999996 108.54 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -113.8 -83.71 1.22 Allowed Glycine 0 CA--C 1.481 -2.086 0 C-N-CA 119.442 -1.361 . . . . 74.099999999999994 112.188 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.3 m -109.98 32.53 5.03 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 108.652 -0.869 . . . . 75.430000000000007 108.652 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -158.23 149.0 20.59 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.093 -0.958 . . . . 63.130000000000003 108.894 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 26.8 mtm180 -81.28 116.99 21.41 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.569 0.7 . . . . 74.219999999999999 112.522 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.29 -167.18 42.6 Favored Glycine 0 N--CA 1.437 -1.248 0 CA-C-N 115.27 -0.877 . . . . 64.329999999999998 111.515 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.7 20.01 79.76 Favored Glycine 0 C--N 1.312 -0.805 0 C-N-CA 120.805 -0.712 . . . . 61.130000000000003 111.841 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.0 43.95 6.93 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 120.45 -0.881 . . . . 70.510000000000005 111.959 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -118.0 -61.24 1.71 Allowed 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 119.453 -0.899 . . . . 43.32 109.961 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -99.36 -34.81 10.15 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 107.073 -1.454 . . . . 54.210000000000001 107.073 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -143.29 152.04 41.21 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.847 -1.168 . . . . 75.349999999999994 107.847 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -84.89 142.06 29.97 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.677 -1.231 . . . . 74.510000000000005 107.677 177.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -82.11 139.2 34.53 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.723 -0.843 . . . . 75.200000000000003 108.723 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.1 t -148.02 152.47 37.49 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.569 0.699 . . . . 74.230000000000004 110.458 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 25.6 p -156.11 169.48 24.4 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.964 -1.495 . . . . 73.540000000000006 106.964 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 159.75 -164.84 34.35 Favored Glycine 0 N--CA 1.419 -2.473 0 N-CA-C 110.106 -1.198 . . . . 65.430000000000007 110.106 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.409 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 43.4 mt-10 -131.75 130.65 42.17 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 123.845 0.379 . . . . 73.109999999999999 110.627 -176.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.414 HD22 ' HB3' ' A' ' 569' ' ' LYS . 86.4 mt -100.12 132.79 45.28 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.377 -0.601 . . . . 71.200000000000003 109.377 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -99.17 121.01 40.45 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.648 -0.705 . . . . 74.109999999999999 110.708 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -118.36 151.96 36.74 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.185 -0.672 . . . . 75.510000000000005 109.185 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.558 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 50.5 mt-30 -149.51 -177.49 5.89 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.054 -0.721 . . . . 74.310000000000002 109.054 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -70.68 -37.65 73.66 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.06 -1.459 . . . . 62.409999999999997 107.06 171.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.66 -48.43 16.81 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.361 -1.29 . . . . 63.310000000000002 111.881 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.558 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 27.9 mm-40 -58.99 133.55 56.19 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 123.829 0.852 . . . . 72.430000000000007 111.392 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.557 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.1 pt -85.14 -81.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 112.723 0.638 . . . . 53.420000000000002 112.723 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.557 ' H ' HG13 ' A' ' 567' ' ' ILE . 7.6 p -134.44 160.96 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 108.907 -0.775 . . . . 71.219999999999999 108.907 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.414 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -126.6 159.6 33.07 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.767 0.317 . . . . 72.439999999999998 110.299 176.263 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.1 p -127.95 148.86 50.52 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.118 -0.946 . . . . 65.109999999999999 112.007 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.3 mp -99.32 127.94 51.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 106.7 -1.593 . . . . 71.450000000000003 106.7 172.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 17.0 m -100.96 115.13 29.73 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.693 -0.855 . . . . 71.319999999999993 108.693 178.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.441 ' CG2' ' HE3' ' A' ' 521' ' ' MET . 96.9 t -117.51 130.0 73.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 120.7 -0.4 . . . . 75.5 110.659 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 16.2 tppt? -79.13 120.76 24.12 Favored 'General case' 0 N--CA 1.437 -1.102 0 O-C-N 124.037 0.835 . . . . 75.120000000000005 109.282 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 55.7 t -94.32 128.12 45.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 107.284 -1.376 . . . . 72.319999999999993 107.284 176.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 24.5 mm -94.66 138.35 20.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 109.334 -0.617 . . . . 72.5 109.334 -175.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -91.25 83.28 5.49 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.963 -0.562 . . . . 74.230000000000004 111.509 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -96.11 102.76 14.59 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.895 -1.52 . . . . 53.439999999999998 106.895 172.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.19 81.23 6.49 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.757 0.789 . . . . 72.319999999999993 111.389 -174.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -140.65 123.23 16.12 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.379 -1.282 . . . . 74.109999999999999 108.03 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -75.16 109.69 8.86 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 122.066 0.936 . . . . 65.019999999999996 110.357 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.591 ' OE2' ' HE2' ' A' ' 585' ' ' LYS . 37.9 tt0 -140.14 -174.06 3.83 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 104.446 -2.428 . . . . 74.430000000000007 104.446 -176.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.483 ' H ' ' HG2' ' A' ' 582' ' ' GLU . 41.0 ttmt -67.65 147.83 52.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.272 -0.64 . . . . 72.019999999999996 109.272 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -46.8 124.32 6.05 Favored 'General case' 0 C--O 1.247 0.931 0 O-C-N 124.52 1.137 . . . . 71.329999999999998 109.354 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . 0.591 ' HE2' ' OE2' ' A' ' 582' ' ' GLU . 32.9 mmtp -86.83 134.88 33.51 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.459 -1.246 . . . . 73.439999999999998 110.6 -167.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 7.5 t -152.88 135.07 14.92 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-O 121.375 0.607 . . . . 74.230000000000004 110.933 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 42.8 p90 -126.84 174.17 9.0 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.57 -1.27 . . . . 73.510000000000005 107.57 178.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.506 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 59.0 m-85 -119.83 151.6 38.6 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 109.267 -0.642 . . . . 75.239999999999995 109.267 -176.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.81 130.82 54.13 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 105.083 -2.191 . . . . 75.329999999999998 105.083 176.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -132.25 144.3 50.52 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.075 -0.713 . . . . 74.120000000000005 109.075 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . 0.437 HG23 ' HB3' ' A' ' 539' ' ' TYR . 13.0 pt -107.43 155.24 8.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.069 -0.715 . . . . 75.439999999999998 109.069 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -100.25 -174.68 30.13 Favored Glycine 0 C--N 1.295 -1.721 0 C-N-CA 121.055 -0.593 . . . . 73.230000000000004 112.035 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -61.91 126.96 88.42 Favored Pre-proline 0 C--N 1.313 -0.992 0 C-N-CA 123.198 0.599 . . . . 71.200000000000003 112.1 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -70.0 118.67 5.82 Favored 'Trans proline' 0 N--CA 1.428 -2.351 0 C-N-CA 122.175 1.917 . . . . 75.010000000000005 110.311 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -104.3 119.56 39.24 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.15 -0.932 . . . . 74.140000000000001 109.328 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.8 129.27 40.2 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.922 -1.14 . . . . 72.109999999999999 107.922 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.565 ' CG2' HG12 ' A' ' 536' ' ' ILE . 45.0 t -85.81 94.85 4.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 108.82 -0.808 . . . . 73.439999999999998 108.82 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -89.54 123.99 34.13 Favored 'General case' 0 N--CA 1.402 -2.846 0 N-CA-C 106.774 -1.565 . . . . 63.200000000000003 106.774 174.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 48.0 ttm -76.72 -17.09 59.29 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.393 0.616 . . . . 75.510000000000005 109.613 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 47.7 t -75.72 -10.21 59.25 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.433 -0.803 . . . . 60.32 110.408 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . 0.442 ' CD ' ' HZ2' ' A' ' 621' ' ' LYS . 8.9 tp10 -58.85 113.65 2.16 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 107.497 -1.297 . . . . 75.209999999999994 107.497 176.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -101.02 131.08 47.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.395 0.617 . . . . 72.209999999999994 112.326 -170.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.93 175.44 9.58 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.409 -1.33 . . . . 75.329999999999998 107.409 171.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 169.85 -158.62 30.87 Favored Glycine 0 N--CA 1.421 -2.345 0 C-N-CA 120.124 -1.036 . . . . 73.299999999999997 111.307 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -155.26 59.25 0.38 Allowed Glycine 0 N--CA 1.425 -2.095 0 N-CA-C 110.514 -1.034 . . . . 74.420000000000002 110.514 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -76.08 167.29 22.14 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-O 120.604 0.24 . . . . 74.329999999999998 110.609 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 607' ' ' THR . . . . . 0.419 ' HA ' ' OE1' ' A' ' 610' ' ' GLU . 89.9 m -74.23 78.97 1.8 Allowed 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 122.457 1.122 . . . . 72.310000000000002 110.941 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 68.0 mt -137.45 99.31 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 106.986 -1.487 . . . . 71.120000000000005 106.986 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 5.8 m 68.08 21.94 8.55 Favored 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 121.653 0.74 . . . . 74.549999999999997 111.646 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . 0.419 ' OE1' ' HA ' ' A' ' 607' ' ' THR . 9.3 pt-20 -83.29 -5.93 59.3 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.331 -0.989 . . . . 74.420000000000002 108.331 175.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -67.01 97.61 0.51 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.768 1.627 . . . . 71.129999999999995 107.886 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . 0.265 54.9 m-85 70.31 69.89 0.21 Allowed 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.154 1.382 . . . . 74.329999999999998 112.242 -173.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -174.95 138.1 0.45 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 105.582 -2.007 . . . . 74.299999999999997 105.582 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -114.47 -31.4 6.24 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 114.211 1.189 . . . . 75.319999999999993 114.211 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -89.12 -66.52 0.91 Allowed 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 118.97 -1.092 . . . . 73.140000000000001 113.163 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -139.32 122.26 10.54 Favored Pre-proline 0 C--N 1.296 -1.724 0 C-N-CA 120.738 -0.385 . . . . 72.209999999999994 110.625 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.04 153.41 67.67 Favored 'Trans proline' 0 C--O 1.25 1.098 0 C-N-CA 122.095 1.863 . . . . 74.209999999999994 111.361 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 76.4 mt -68.27 90.14 0.34 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 122.01 0.909 . . . . 75.439999999999998 110.899 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 25.9 m -142.79 98.17 3.24 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 107.119 -1.437 . . . . 75.319999999999993 107.119 175.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 21.8 t -91.96 152.8 19.85 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.293 -1.002 . . . . 75.450000000000003 108.293 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . 0.442 ' HZ2' ' CD ' ' A' ' 601' ' ' GLU . 49.7 mtmt -75.24 103.67 5.49 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.427 0.632 . . . . 65.510000000000005 110.661 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -112.28 157.19 21.24 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.328 -1.36 . . . . 74.519999999999996 107.328 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 63.6 41.8 6.95 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.797 0.686 . . . . 72.209999999999994 111.287 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -74.03 -173.89 1.73 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.326 -0.852 . . . . 65.420000000000002 110.915 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -134.81 34.74 3.14 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.747 0.784 . . . . 72.030000000000001 110.725 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -63.71 -41.61 98.08 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.035 -0.984 . . . . 74.329999999999998 108.644 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -64.68 -25.04 67.77 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.137 -0.938 . . . . 75.530000000000001 111.446 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.585 ' O ' ' HG3' ' A' ' 631' ' ' MET . 54.3 mt -74.86 -37.17 41.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 108.688 -0.856 . . . . 70.329999999999998 108.688 175.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -70.7 -25.66 63.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.081 -0.509 . . . . 72.409999999999997 110.679 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -55.72 -24.06 32.56 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.108 1.151 . . . . 73.230000000000004 114.108 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.585 ' HG3' ' O ' ' A' ' 628' ' ' ILE . 0.0 OUTLIER -75.15 -11.19 60.03 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.281 -0.568 . . . . 74.120000000000005 112.189 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . 0.577 ' HA2' ' N ' ' A' ' 501' ' ' HIS . . . -165.45 56.36 0.26 Allowed Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 111.102 -0.799 . . . . 72.329999999999998 111.102 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -89.82 148.18 39.22 Favored Pre-proline 0 C--O 1.245 0.841 0 C-N-CA 120.323 -0.551 . . . . 75.109999999999999 111.469 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.5 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 43.6 Cg_endo -71.35 133.73 23.27 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.62 2.213 . . . . 64.200000000000003 108.934 172.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.03 161.17 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 109.686 -0.487 . . . . 74.530000000000001 109.686 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.424 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.6 OUTLIER -101.33 165.95 11.0 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 119.72 -0.792 . . . . 74.349999999999994 111.175 176.323 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.85 -172.19 29.23 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 115.654 -0.703 . . . . 75.340000000000003 114.645 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -67.93 -41.66 82.21 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.371 -0.915 . . . . 72.519999999999996 109.392 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -125.99 127.47 45.96 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.279 -0.873 . . . . 74.319999999999993 109.132 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 640' ' ' THR . . . . . 0.424 HG21 ' HB2' ' A' ' 636' ' ' LEU . 16.8 p -130.27 89.93 2.86 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.429 -0.582 . . . . 74.409999999999997 109.429 175.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . 0.575 ' HZ1' ' HB2' ' A' ' 641' ' ' LYS . 4.2 ttmp? -170.37 139.09 1.64 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.444 -0.798 . . . . 73.040000000000006 109.468 -175.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.465 HD23 HG11 ' A' ' 523' ' ' VAL . 28.0 tp -120.41 131.0 54.6 Favored 'General case' 0 C--N 1.273 -2.725 0 CA-C-N 114.985 -1.007 . . . . 73.209999999999994 109.06 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -93.87 110.8 22.44 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.52 -1.659 . . . . 74.319999999999993 106.52 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 43.7 t -101.6 110.37 28.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.914 -0.773 . . . . 74.219999999999999 108.914 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 67.1 mt -97.95 124.22 50.86 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 N-CA-C 108.819 -0.808 . . . . 74.400000000000006 108.819 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 54.2 mt -100.2 103.36 14.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 106.876 -1.527 . . . . 70.239999999999995 106.876 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -100.44 129.26 46.38 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.885 -0.598 . . . . 73.209999999999994 109.545 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 516' ' ' GLU . 0.0 OUTLIER -68.92 117.8 11.04 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-O 122.016 0.912 . . . . 64.0 109.374 174.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 25.9 m -134.7 99.5 4.34 Favored 'General case' 0 N--CA 1.404 -2.731 0 CA-C-N 114.676 -1.147 . . . . 70.120000000000005 108.874 -168.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -91.99 -33.72 14.73 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.14 -1.059 . . . . 75.450000000000003 108.14 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -74.63 -46.4 38.55 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.354 -1.294 . . . . 73.120000000000005 108.798 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -92.89 105.69 17.77 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.665 -0.698 . . . . 73.150000000000006 109.498 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -95.36 158.47 15.44 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.178 -0.919 . . . . 74.430000000000007 110.149 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 15.0 m -140.27 149.07 42.37 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.184 -1.043 . . . . 64.040000000000006 108.184 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 8.3 t -141.64 131.01 23.66 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.544 -0.539 . . . . 74.010000000000005 109.544 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 48.6 t -101.45 89.07 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.565 -1.272 . . . . 72.030000000000001 107.565 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--N 1.301 -1.521 0 CA-C-N 115.181 -0.918 . . . . 63.020000000000003 110.16 -176.555 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 108.289 -1.004 . . . . 72.540000000000006 108.289 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . 175.88 -53.48 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 125.48 1.512 . . . . 62.109999999999999 108.196 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.448 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . 160.36 -148.5 16.86 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.085 -1.206 . . . . 65.099999999999994 110.085 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.409 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.7 mp -123.3 130.02 74.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 117.131 0.466 . . . . 72.540000000000006 110.75 -174.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.418 ' H ' ' HA ' ' A' ' 636' ' ' LEU . 57.4 m-85 -112.24 136.48 51.61 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.47 -0.937 . . . . 74.329999999999998 108.47 169.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.2 t -170.71 -179.34 2.86 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.787 -0.82 . . . . 61.109999999999999 108.787 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -83.62 155.45 23.22 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 110.308 -0.256 . . . . 75.319999999999993 110.308 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.09 -45.25 85.99 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.551 -1.278 . . . . 51.32 107.551 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.74 146.14 51.93 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 108.606 -0.887 . . . . 74.0 108.606 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.91 -17.35 15.57 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.801 1.667 . . . . 74.040000000000006 111.949 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 58.4 t -141.64 127.74 19.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 107.92 -1.141 . . . . 73.450000000000003 107.92 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 13.8 t -123.65 140.54 52.89 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 109.398 -0.593 . . . . 73.030000000000001 109.398 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -109.52 119.33 39.1 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.977 -0.556 . . . . 75.340000000000003 109.705 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.2 m -115.74 162.28 13.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.809 -0.812 . . . . 75.319999999999993 108.809 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.558 ' O ' HG23 ' A' ' 518' ' ' ILE . 12.1 t -87.55 149.77 24.14 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.533 0.682 . . . . 71.120000000000005 111.157 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -60.98 -29.56 69.76 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 124.941 1.296 . . . . 71.409999999999997 109.166 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 32.1 t -116.53 26.02 10.18 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.758 -0.655 . . . . 70.450000000000003 111.231 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 515' ' ' SER . 7.9 tt -80.21 -30.28 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 119.437 -0.905 . . . . 71.299999999999997 111.026 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 88.31 -76.91 1.88 Allowed Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 119.89 -1.148 . . . . 73.519999999999996 111.335 -177.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.1 mm -123.63 124.98 70.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.139 -1.06 . . . . 74.239999999999995 108.139 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.478 ' SD ' HG21 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -109.89 147.66 32.98 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 108.451 -0.944 . . . . 72.409999999999997 108.451 177.536 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.598 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 39.3 mt-10 -123.54 134.03 53.91 Favored 'General case' 0 CA--C 1.497 -1.088 0 O-C-N 123.846 0.717 . . . . 73.109999999999999 111.198 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 570' ' ' THR . 66.7 t -118.69 125.1 74.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 107.931 -1.137 . . . . 75.510000000000005 107.931 176.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . 0.416 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 36.1 mtmt -86.81 133.15 33.67 Favored 'General case' 0 N--CA 1.427 -1.617 0 O-C-N 123.638 0.586 . . . . 72.019999999999996 110.205 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 39.4 t -101.56 120.9 51.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.301 -0.999 . . . . 74.010000000000005 108.301 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.31 129.05 38.62 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 124.029 0.83 . . . . 74.150000000000006 110.169 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -85.09 158.89 20.3 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.635 -1.166 . . . . 73.439999999999998 109.18 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.448 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 1.6 t -56.22 147.57 20.45 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.725 1.21 . . . . 74.239999999999995 112.854 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.9 t -59.23 -35.43 73.63 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.696 1.199 . . . . 75.219999999999999 109.089 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.76 98.13 0.63 Allowed Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 109.13 -1.588 . . . . 75.420000000000002 109.13 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.36 103.91 16.55 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 109.36 -0.607 . . . . 74.519999999999996 109.36 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -123.53 119.86 31.19 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 116.077 -0.511 . . . . 71.409999999999997 110.557 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 87.19 -136.61 14.08 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.277 -0.874 . . . . 75.430000000000007 112.948 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -133.17 126.58 31.97 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.061 -1.088 . . . . 73.140000000000001 108.061 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 61.0 t -131.55 133.66 61.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.074 -0.713 . . . . 73.310000000000002 109.074 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.551 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 37.3 mm -104.73 136.06 39.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 109.096 -0.705 . . . . 74.340000000000003 109.096 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 40.5 t -120.93 108.32 36.86 Favored Pre-proline 0 C--N 1.306 -1.289 0 N-CA-C 109.948 -0.39 . . . . 63.049999999999997 109.948 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.2 156.95 50.9 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.567 2.178 . . . . 70.109999999999999 111.943 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -153.83 161.41 42.07 Favored 'General case' 0 C--O 1.25 1.11 0 N-CA-C 110.212 -0.292 . . . . 73.120000000000005 110.212 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -153.81 154.05 33.26 Favored 'General case' 0 C--O 1.25 1.111 0 O-C-N 123.657 0.598 . . . . 75.310000000000002 110.805 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.8 p -87.14 136.5 32.9 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.321 -0.854 . . . . 71.530000000000001 110.966 175.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.47 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 69.7 mt -109.92 123.92 66.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.108 -1.071 . . . . 75.219999999999999 108.108 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -76.23 105.82 7.5 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.855 -0.424 . . . . 75.239999999999995 109.855 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -90.2 -119.64 2.03 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 109.844 -1.302 . . . . 71.439999999999998 109.844 177.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 13.4 t -86.16 -5.93 59.1 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.905 0.86 . . . . 74.430000000000007 109.311 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -97.75 137.28 36.87 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.578 -1.267 . . . . 74.129999999999995 107.578 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.533 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 76.5 mtm180 -86.26 137.07 32.89 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 123.738 0.815 . . . . 74.109999999999999 111.353 -176.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -91.83 -164.49 38.79 Favored Glycine 0 C--N 1.29 -2.0 0 CA-C-N 115.36 -0.836 . . . . 71.109999999999999 111.644 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.71 14.32 79.91 Favored Glycine 0 C--N 1.305 -1.165 0 CA-C-O 120.07 -0.295 . . . . 75.129999999999995 113.345 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 88.25 24.66 33.51 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.059 -0.816 . . . . 65.129999999999995 111.059 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.533 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 17.5 tt0 -96.39 -56.85 2.48 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.335 -0.617 . . . . 75.329999999999998 109.335 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -111.59 -33.07 6.47 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 108.579 -0.897 . . . . 75.420000000000002 108.579 171.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -140.32 149.8 43.2 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 108.302 -0.999 . . . . 75.530000000000001 108.302 175.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -88.93 123.71 33.54 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 106.18 -1.785 . . . . 73.310000000000002 106.18 177.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -67.87 154.01 42.49 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 112.643 0.609 . . . . 71.140000000000001 112.643 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.7 t -147.72 139.4 23.93 Favored 'General case' 0 N--CA 1.406 -2.628 0 CA-C-O 121.725 0.774 . . . . 63.329999999999998 108.934 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.6 p -148.88 143.81 26.49 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 107.197 -1.409 . . . . 65.120000000000005 107.197 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 161.63 -158.79 30.66 Favored Glycine 0 N--CA 1.413 -2.871 0 C-N-CA 119.69 -1.243 . . . . 72.510000000000005 110.57 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.551 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.7 mt-10 -137.28 140.13 41.38 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 120.784 0.325 . . . . 74.030000000000001 110.967 -174.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.5 139.31 36.37 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.418 0.687 . . . . 74.400000000000006 109.769 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.418 ' HA ' HD13 ' A' ' 536' ' ' ILE . 33.1 tt0 -100.85 110.02 22.04 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.167 0.508 . . . . 64.450000000000003 111.516 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -107.44 148.7 28.8 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.891 -0.595 . . . . 75.420000000000002 109.496 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.459 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 43.9 mt-30 -144.1 -177.28 5.37 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.734 -0.839 . . . . 71.030000000000001 108.734 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.88 -38.28 82.85 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 124.092 0.87 . . . . 74.219999999999999 108.655 177.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -85.25 -38.01 19.4 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.414 -0.812 . . . . 73.299999999999997 111.786 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.459 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 47.0 mm-40 -60.82 135.48 57.79 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.902 0.481 . . . . 65.340000000000003 112.079 -178.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.56 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.6 pt -78.51 -83.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 113.929 1.085 . . . . 74.109999999999999 113.929 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.56 ' H ' HG13 ' A' ' 567' ' ' ILE . 13.3 p -143.05 150.72 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.57 -0.9 . . . . 64.540000000000006 108.57 -177.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 524' ' ' LYS . 5.3 mmpt? -113.15 159.57 19.12 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.884 0.373 . . . . 74.329999999999998 110.134 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.1 p -128.87 147.39 50.82 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.159 -0.928 . . . . 74.439999999999998 112.088 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.8 mp -99.86 126.59 53.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 106.773 -1.565 . . . . 75.540000000000006 106.773 171.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 11.3 p -100.7 115.53 30.47 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.004 -0.739 . . . . 74.150000000000006 109.004 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 60.9 t -119.2 130.19 74.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 109.846 -0.427 . . . . 73.319999999999993 109.846 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 15.8 tppt? -82.87 122.13 27.84 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 123.731 0.645 . . . . 72.25 109.969 176.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 89.8 t -89.15 123.22 41.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 107.967 -1.123 . . . . 73.540000000000006 107.967 176.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 33.7 mm -90.09 132.39 34.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.293 0.568 . . . . 75.120000000000005 109.604 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -73.81 110.38 8.06 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.51 -1.223 . . . . 75.120000000000005 108.984 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -134.19 125.35 27.66 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.06 0.393 . . . . 73.409999999999997 112.06 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -136.01 78.68 1.73 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.693 -0.685 . . . . 63.439999999999998 111.583 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -99.87 -46.82 5.25 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.588 -0.893 . . . . 73.109999999999999 108.588 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -178.91 -91.76 0.0 OUTLIER 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.911 -1.144 . . . . 74.150000000000006 107.911 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 54.81 -174.6 0.04 OUTLIER 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.571 1.148 . . . . 73.420000000000002 113.757 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -123.39 -53.68 1.8 Allowed 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 115.796 -0.638 . . . . 75.040000000000006 109.57 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -153.61 139.34 17.97 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.459 -0.571 . . . . 43.509999999999998 109.459 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . 0.478 ' HB2' ' HB ' ' A' ' 646' ' ' ILE . 35.7 mmtp -103.54 120.65 41.28 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.951 -0.759 . . . . 75.519999999999996 108.951 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 10.0 t -149.97 144.94 26.17 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.494 -0.482 . . . . 64.340000000000003 109.974 176.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 47.8 p90 -140.46 175.88 9.24 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.621 -1.251 . . . . 75.239999999999995 107.621 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -122.6 153.97 38.59 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.451 -0.5 . . . . 74.450000000000003 110.601 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.53 128.25 51.84 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 106.316 -1.735 . . . . 73.150000000000006 106.316 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -124.57 131.79 53.47 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.807 -0.812 . . . . 74.319999999999993 108.807 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 17.8 pt -100.5 147.15 8.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.794 -0.817 . . . . 65.310000000000002 108.794 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.59 172.97 39.81 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 109.925 -1.27 . . . . 75.239999999999995 109.925 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.0 131.79 88.86 Favored Pre-proline 0 N--CA 1.426 -1.664 0 C-N-CA 120.665 -0.414 . . . . 72.030000000000001 110.838 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.431 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.2 Cg_endo -59.57 136.84 73.82 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.317 2.678 . . . . 72.349999999999994 112.03 -176.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . 0.41 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 3.1 ptm180 -116.63 125.09 51.28 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.305 -0.861 . . . . 74.140000000000001 110.152 -177.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . 0.4 HD11 ' HB2' ' A' ' 598' ' ' GLU . 1.4 tm? -70.19 136.34 49.94 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.09 -1.078 . . . . 73.219999999999999 108.09 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.534 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.3 t -94.08 94.8 4.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.649 0.738 . . . . 72.319999999999993 110.873 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.4 ' HB2' HD11 ' A' ' 596' ' ' LEU . 0.2 OUTLIER -151.38 164.05 37.57 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 105.005 -2.22 . . . . 75.150000000000006 105.005 178.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 22.0 ptp -78.3 -8.68 58.68 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.069 0.462 . . . . 65.109999999999999 111.001 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 17.3 m -92.73 100.76 13.19 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 121.202 0.525 . . . . 74.409999999999997 111.009 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -147.99 97.24 2.77 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.83 -0.804 . . . . 72.430000000000007 108.83 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -68.92 115.83 8.69 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.369 -0.975 . . . . 74.120000000000005 108.369 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -125.89 121.24 32.61 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.602 -0.726 . . . . 70.420000000000002 109.803 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -105.67 -179.71 23.65 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.657 -0.701 . . . . 73.439999999999998 113.119 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.16 157.23 10.5 Favored Glycine 0 N--CA 1.433 -1.502 0 N-CA-C 109.814 -1.314 . . . . 74.340000000000003 109.814 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -159.69 122.36 3.48 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.856 -0.794 . . . . 75.230000000000004 108.856 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 25.4 p -93.38 104.04 16.22 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 121.002 0.429 . . . . 74.099999999999994 110.147 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 64.0 mt -66.01 96.26 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.453 -0.943 . . . . 73.420000000000002 108.453 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 18.7 m -84.79 93.42 8.47 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 108.146 -1.057 . . . . 74.510000000000005 108.146 -177.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 179.44 -37.38 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 105.438 -2.06 . . . . 75.109999999999999 105.438 -173.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -98.0 124.97 42.73 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 105.239 -2.134 . . . . 75.540000000000006 105.239 172.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -100.04 96.1 7.29 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.188 -0.605 . . . . 74.450000000000003 111.682 -171.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -175.12 -179.85 1.43 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 106.39 -1.707 . . . . 73.150000000000006 106.39 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -76.4 102.27 5.89 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.1 0.476 . . . . 65.040000000000006 109.957 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -93.78 40.74 1.08 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.014 0.911 . . . . 71.310000000000002 109.706 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -67.27 -55.72 14.76 Favored Pre-proline 0 CA--C 1.561 1.392 0 CA-C-N 114.609 -1.178 . . . . 75.340000000000003 112.705 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -83.71 38.65 0.73 Allowed 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 122.231 1.954 . . . . 72.140000000000001 112.608 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.58 107.5 8.91 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.109 -0.7 . . . . 62.439999999999998 109.109 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 619' ' ' THR . . . . . 0.406 ' OG1' ' HG2' ' A' ' 622' ' ' GLU . 5.7 t -153.18 131.79 12.26 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.378 -0.828 . . . . 74.439999999999998 109.633 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 19.8 m -95.56 -32.24 12.93 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.266 -1.753 . . . . 75.329999999999998 106.266 172.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 22.4 tptm 167.05 66.66 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 127.517 2.327 . . . . 75.239999999999995 105.634 172.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . 0.406 ' HG2' ' OG1' ' A' ' 619' ' ' THR . 7.0 mm-40 -76.43 134.71 39.5 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 107.172 -1.418 . . . . 75.439999999999998 107.172 -178.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -55.27 126.74 26.21 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 124.299 0.999 . . . . 73.030000000000001 111.638 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . 0.402 ' OE1' ' HB2' ' A' ' 627' ' ' ARG . 0.5 OUTLIER -91.29 93.52 9.11 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 105.701 -1.963 . . . . 64.299999999999997 105.701 178.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -108.97 3.06 21.79 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.412 -1.267 . . . . 73.030000000000001 111.03 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.576 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 97.7 mtt180 -64.44 -34.54 78.43 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 108.128 -1.064 . . . . 74.25 108.128 177.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' A' ' 627' ' ' ARG . 1.5 tmt_? -59.95 -34.0 72.68 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.271 1.029 . . . . 73.150000000000006 109.87 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 65.4 mt -68.37 -35.99 73.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.12 -0.696 . . . . 74.129999999999995 109.12 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -78.42 -27.24 46.55 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.829 -0.623 . . . . 52.009999999999998 111.1 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 7.0 mm-40 -53.08 -36.88 61.16 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.881 0.872 . . . . 72.010000000000005 112.445 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -81.65 -8.72 59.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.151 0.5 . . . . 74.019999999999996 111.054 -177.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -119.1 6.05 13.31 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.905 -0.664 . . . . 61.329999999999998 112.056 -177.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -123.51 151.65 63.63 Favored Pre-proline 0 N--CA 1.433 -1.291 0 N-CA-C 109.379 -0.6 . . . . 73.129999999999995 109.379 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.431 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 23.3 Cg_endo -59.51 139.83 91.17 Favored 'Trans proline' 0 CA--C 1.512 -0.581 0 C-N-CA 123.43 2.754 . . . . 64.450000000000003 112.395 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 3.1 pt -124.07 177.5 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 0 CA-C-O 120.937 0.399 . . . . 73.409999999999997 110.03 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.418 ' HA ' ' H ' ' A' ' 505' ' ' PHE . 0.8 OUTLIER -113.86 174.52 5.89 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 115.665 -0.698 . . . . 72.019999999999996 112.322 177.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . 0.409 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -74.31 174.13 50.29 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 115.415 -0.811 . . . . 70.349999999999994 113.923 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -66.79 -34.47 77.89 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 124.033 0.933 . . . . 71.420000000000002 110.408 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -124.06 121.48 35.3 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.33 -0.618 . . . . 73.420000000000002 109.33 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 7.8 p -134.78 95.4 3.33 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.752 -0.658 . . . . 74.120000000000005 110.013 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . 0.446 ' HB2' ' HZ2' ' A' ' 641' ' ' LYS . 4.3 ttmp? -166.54 143.34 4.88 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.75 -1.204 . . . . 75.510000000000005 107.75 -177.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.432 HD21 HG23 ' A' ' 523' ' ' VAL . 26.7 tp -129.66 116.16 18.42 Favored 'General case' 0 N--CA 1.417 -2.084 0 O-C-N 123.825 0.703 . . . . 75.129999999999995 109.668 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -87.18 110.61 20.27 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.604 -1.628 . . . . 75.109999999999999 106.604 173.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 55.8 t -99.19 107.76 21.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.736 -0.838 . . . . 73.200000000000003 108.736 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 27.8 mt -99.28 121.47 49.94 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 N-CA-C 108.42 -0.956 . . . . 73.349999999999994 108.42 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 585' ' ' LYS . 62.6 mt -97.46 107.55 20.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.165 -1.42 . . . . 74.319999999999993 107.165 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -119.4 145.54 46.13 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.408 -0.96 . . . . 71.319999999999993 108.408 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -77.19 115.03 16.63 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.138 -1.801 . . . . 72.299999999999997 106.138 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 649' ' ' SER . . . . . 0.48 ' HB3' ' HA ' ' A' ' 652' ' ' PHE . 57.4 m -164.15 112.33 1.14 Allowed 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 114.564 -1.198 . . . . 65.420000000000002 107.82 -176.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -93.69 -42.11 9.34 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.263 -1.754 . . . . 74.439999999999998 106.263 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 651' ' ' GLU . 0.2 OUTLIER -79.01 -32.79 45.21 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 112.518 -2.128 . . . . 62.219999999999999 110.888 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . 0.48 ' HA ' ' HB3' ' A' ' 649' ' ' SER . 76.1 m-85 67.97 68.07 0.34 Allowed 'General case' 0 CA--C 1.495 -1.164 0 CA-C-O 122.426 1.108 . . . . 73.409999999999997 110.677 -173.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 655' ' ' THR . 27.2 tptp -68.18 122.78 19.03 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 112.714 -2.039 . . . . 73.319999999999993 107.554 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 15.0 m -64.25 -51.64 62.62 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.045 0.45 . . . . 63.299999999999997 110.876 -175.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 655' ' ' THR . . . . . 0.432 ' O ' ' HG3' ' A' ' 653' ' ' LYS . 5.2 t -121.89 138.79 54.26 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 107.781 -1.192 . . . . 73.120000000000005 107.781 175.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 31.7 m -117.4 150.86 19.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 120.818 0.342 . . . . 64.430000000000007 111.439 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 . . . . . 0 C--N 1.307 -1.255 0 N-CA-C 109.495 -0.557 . . . . 75.510000000000005 109.495 178.681 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 . . . . . 0 N--CA 1.434 -1.253 0 N-CA-C 107.272 -1.381 . . . . 74.329999999999998 107.272 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.436 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . -136.61 -163.72 1.46 Allowed 'General case' 0 N--CA 1.41 -2.441 0 CA-C-O 121.174 0.512 . . . . 71.319999999999993 109.951 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -103.43 -114.72 3.97 Favored Glycine 0 C--N 1.278 -2.657 0 CA-C-N 114.672 -1.149 . . . . 50.25 112.955 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.81 127.69 70.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.219 -0.491 . . . . 72.230000000000004 110.573 -173.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -117.03 123.14 46.14 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.729 -1.211 . . . . 74.400000000000006 107.729 170.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.3 t -167.63 177.65 5.76 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.552 -0.536 . . . . 74.319999999999993 109.552 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -85.77 150.74 24.36 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.886 -0.412 . . . . 74.209999999999994 109.886 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 44.1 mt-10 -66.54 -34.03 77.0 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.348 0.594 . . . . 74.150000000000006 110.18 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -132.21 145.61 58.06 Favored Pre-proline 0 N--CA 1.421 -1.909 0 CA-C-N 114.959 -1.019 . . . . 74.120000000000005 108.499 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.0 -29.29 3.36 Favored 'Trans proline' 0 C--N 1.327 -0.557 0 C-N-CA 122.151 1.9 . . . . 62.340000000000003 112.127 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 26.0 t -134.92 131.79 53.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 107.909 -1.145 . . . . 72.310000000000002 107.909 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 15.3 t -126.68 136.43 52.46 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 109.42 -0.585 . . . . 72.25 109.42 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -109.98 109.42 20.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.793 0.806 . . . . 73.230000000000004 109.297 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.7 m -104.77 151.69 7.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 115.636 -0.711 . . . . 75.430000000000007 110.309 -175.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.462 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 67.4 m -79.56 155.06 28.34 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 115.349 -0.842 . . . . 74.310000000000002 110.328 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -67.08 -62.45 1.42 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.525 0.679 . . . . 71.400000000000006 111.068 176.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.3 m -79.09 26.85 0.25 Allowed 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.709 0.803 . . . . 74.040000000000006 112.666 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 12.8 tt -79.92 -27.91 12.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 122.021 -0.425 . . . . 72.129999999999995 110.509 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 89.2 -74.78 1.96 Allowed Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 110.467 -1.053 . . . . 73.439999999999998 110.467 -177.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.3 mm -129.41 122.88 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 108.425 -0.954 . . . . 75.109999999999999 108.425 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.472 ' HE3' ' CG2' ' A' ' 573' ' ' VAL . 0.0 OUTLIER -103.37 147.51 27.02 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.695 -1.594 . . . . 65.420000000000002 106.695 175.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 35.1 mt-10 -133.64 128.26 34.71 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 123.655 0.597 . . . . 70.439999999999998 111.175 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.44 HG23 HD21 ' A' ' 642' ' ' LEU . 59.9 t -116.36 124.21 72.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 106.831 -1.544 . . . . 73.349999999999994 106.831 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . 0.461 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 29.1 mtmm -84.65 139.88 31.74 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.071 0.462 . . . . 74.450000000000003 110.187 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 43.9 t -107.46 126.56 63.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 115.638 -0.71 . . . . 72.150000000000006 109.173 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.25 116.84 7.01 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 123.998 0.811 . . . . 75.420000000000002 110.093 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -77.79 150.53 34.28 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.022 -0.99 . . . . 73.439999999999998 109.96 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.3 t -55.34 132.93 49.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 124.904 1.282 . . . . 75.109999999999999 111.84 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 44.9 t -54.01 -35.5 61.98 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.538 1.135 . . . . 72.030000000000001 109.32 173.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -107.45 85.52 0.42 Allowed Glycine 0 N--CA 1.42 -2.403 0 N-CA-C 109.641 -1.384 . . . . 72.450000000000003 109.641 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.93 109.77 18.97 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.261 -1.015 . . . . 70.530000000000001 108.261 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -112.73 106.68 15.1 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.119 -0.491 . . . . 73.420000000000002 110.589 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 73.1 -116.76 5.67 Favored Glycine 0 N--CA 1.434 -1.47 0 CA-C-N 115.678 -0.692 . . . . 75.019999999999996 112.457 175.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -133.17 127.05 33.0 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.276 -0.638 . . . . 64.140000000000001 109.276 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.05 137.55 55.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.924 -0.769 . . . . 72.519999999999996 108.924 -177.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 36.4 mm -107.84 135.04 47.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.265 -0.643 . . . . 75.329999999999998 109.265 177.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 57.3 t -120.51 109.8 36.18 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.391 -0.596 . . . . 71.349999999999994 109.391 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -71.43 153.72 60.83 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.993 1.795 . . . . 72.120000000000005 111.338 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -150.97 155.71 39.66 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.958 -0.756 . . . . 74.239999999999995 108.958 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.8 152.93 30.42 Favored 'General case' 0 C--O 1.254 1.335 0 O-C-N 123.807 0.692 . . . . 72.010000000000005 112.354 177.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.6 p -82.83 134.06 35.11 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.471 -0.786 . . . . 64.430000000000007 110.024 174.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 70.8 mt -108.72 113.92 45.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 107.316 -1.364 . . . . 72.329999999999998 107.316 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.54 132.54 47.12 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.165 0.507 . . . . 71.540000000000006 111.638 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -124.1 -114.74 2.11 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 108.408 -1.877 . . . . 63.32 108.408 177.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 45.6 p -80.36 -23.89 40.18 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 122.084 0.945 . . . . 75.430000000000007 108.736 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -82.8 128.99 34.91 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 114.396 -1.275 . . . . 71.310000000000002 108.766 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.3 mtm105 -88.6 135.13 33.65 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 124.066 0.854 . . . . 74.239999999999995 110.651 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -83.42 -152.07 12.21 Favored Glycine 0 C--N 1.297 -1.619 0 CA-C-N 115.232 -0.895 . . . . 70.109999999999999 111.916 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 62.17 22.97 63.57 Favored Glycine 0 C--N 1.308 -0.978 0 N-CA-C 114.796 0.679 . . . . 73.140000000000001 114.796 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 79.54 22.4 64.67 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.307 -0.949 . . . . 61.399999999999999 111.533 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -96.62 -62.83 1.21 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.996 -0.372 . . . . 74.420000000000002 109.996 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -98.77 -42.69 7.09 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 107.196 -1.409 . . . . 75.420000000000002 107.196 171.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -137.76 149.88 46.79 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 114.911 -1.04 . . . . 72.439999999999998 108.677 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.401 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 0.7 OUTLIER -76.69 122.65 25.0 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.678 -1.601 . . . . 65.120000000000005 106.678 173.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -74.71 117.99 17.16 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.244 -0.435 . . . . 70.530000000000001 111.234 -173.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.1 t -121.04 138.83 53.99 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 122.517 1.151 . . . . 74.340000000000003 111.664 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 12.2 p -145.54 143.52 30.0 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 105.606 -1.998 . . . . 74.129999999999995 105.606 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 176.13 -155.25 18.84 Favored Glycine 0 N--CA 1.413 -2.873 0 C-N-CA 119.278 -1.439 . . . . 73.129999999999995 110.746 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.526 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 51.4 mt-10 -143.69 129.93 19.79 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 123.985 0.462 . . . . 62.229999999999997 110.582 -175.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 98.1 mt -92.51 140.77 29.22 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.937 -0.764 . . . . 72.530000000000001 108.937 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.404 ' HA ' HD13 ' A' ' 536' ' ' ILE . 27.1 tt0 -105.09 113.35 26.9 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.842 -0.429 . . . . 73.519999999999996 109.842 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -111.11 142.65 43.0 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.272 -0.64 . . . . 75.219999999999999 109.272 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -133.88 176.28 8.71 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.67 -0.493 . . . . 75.319999999999993 109.67 177.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -67.16 -37.51 83.87 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 124.464 1.102 . . . . 72.049999999999997 111.676 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -92.11 -13.92 30.0 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.707 -0.678 . . . . 54.450000000000003 112.035 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -73.59 167.49 21.23 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.422 0.527 . . . . 75.319999999999993 112.422 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.551 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.3 pt -105.27 -85.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 113.245 0.831 . . . . 73.439999999999998 113.245 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.551 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.3 p -142.96 153.24 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 109.338 -0.616 . . . . 73.340000000000003 109.338 -174.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -115.79 160.76 19.7 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.989 -0.374 . . . . 75.310000000000002 109.989 177.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.461 ' CG2' ' HG2' ' A' ' 524' ' ' LYS . 4.4 p -126.82 145.59 50.58 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.617 -0.719 . . . . 70.510000000000005 111.026 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 1.9 mp -94.11 114.7 31.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 105.36 -2.089 . . . . 73.430000000000007 105.36 170.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 16.5 m -94.33 115.21 27.4 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.232 -1.025 . . . . 75.299999999999997 108.232 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.472 ' CG2' ' HE3' ' A' ' 521' ' ' MET . 98.5 t -117.06 127.67 74.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.268 -0.642 . . . . 73.150000000000006 109.268 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 24.2 tptm -78.21 107.58 10.9 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.389 -0.967 . . . . 74.120000000000005 108.389 175.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 45.9 t -85.38 124.74 40.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 106.24 -1.763 . . . . 65.049999999999997 106.24 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 29.8 mm -79.04 123.07 35.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 122.035 0.921 . . . . 75.409999999999997 111.648 -173.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -89.3 101.8 14.46 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 113.507 -1.679 . . . . 75.420000000000002 108.33 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -116.64 -65.09 1.22 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.276 -0.569 . . . . 74.310000000000002 109.628 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 581' ' ' TYR . 13.3 pt-20 173.6 169.22 0.18 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.999 1.319 . . . . 75.129999999999995 107.966 177.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.09 20.31 0.11 Allowed 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 113.253 0.834 . . . . 75.519999999999996 113.253 -178.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . 0.433 ' H ' ' C ' ' A' ' 579' ' ' GLU . 43.4 t80 -71.22 -34.45 70.81 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 123.633 0.773 . . . . 72.409999999999997 109.205 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -80.26 113.04 18.15 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.513 -0.767 . . . . 71.530000000000001 110.523 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -82.16 103.53 11.83 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.348 -0.842 . . . . 72.140000000000001 111.889 -176.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 43.86 86.71 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.067 1.747 . . . . 62.409999999999997 112.504 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -98.02 135.56 39.55 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.259 -0.577 . . . . 63.140000000000001 110.339 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 2.9 t -141.82 142.57 33.17 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 120.185 -0.606 . . . . 74.150000000000006 111.257 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 46.2 p90 -137.33 171.77 13.98 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 107.499 -1.297 . . . . 75.430000000000007 107.499 178.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.442 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 45.0 m-85 -117.52 153.05 33.85 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 109.239 -0.652 . . . . 72.420000000000002 109.239 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.29 126.78 51.42 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 106.033 -1.84 . . . . 71.120000000000005 106.033 177.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -127.92 124.44 37.38 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 120.055 -0.658 . . . . 60.039999999999999 110.313 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 20.3 pt -88.86 140.93 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.297 0 CA-C-N 114.836 -1.075 . . . . 74.430000000000007 108.132 174.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.79 173.24 47.04 Favored Glycine 0 N--CA 1.409 -3.164 0 N-CA-C 109.838 -1.305 . . . . 74.230000000000004 109.838 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -67.14 136.15 93.92 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 110.343 -0.243 . . . . 70.219999999999999 110.343 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.2 131.33 31.9 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.258 2.638 . . . . 75.409999999999997 112.311 -176.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -109.59 120.45 42.54 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.035 -0.984 . . . . 75.299999999999997 108.919 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . 0.436 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 2.7 tm? -66.15 135.3 54.35 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.752 -1.203 . . . . 65.530000000000001 107.752 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.493 ' CG2' HG12 ' A' ' 536' ' ' ILE . 47.0 t -81.08 81.69 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.254 -1.017 . . . . 72.530000000000001 108.254 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -79.26 124.12 28.08 Favored 'General case' 0 N--CA 1.403 -2.812 0 CA-C-N 113.907 -1.497 . . . . 72.0 108.316 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 64.9 mtt -91.88 -16.76 26.23 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.119 -0.946 . . . . 65.209999999999994 109.366 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 27.3 t -78.56 87.23 4.53 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.156 -1.424 . . . . 74.230000000000004 107.156 174.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -113.54 175.03 5.63 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.034 -0.985 . . . . 75.319999999999993 109.52 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -113.35 152.92 29.35 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.314 -0.995 . . . . 72.420000000000002 108.314 175.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -89.39 166.71 13.55 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.121 -0.696 . . . . 74.209999999999994 109.121 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -72.34 -69.92 1.31 Allowed Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 108.419 -1.873 . . . . 74.109999999999999 108.419 174.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 66.35 22.03 70.83 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.285 -0.458 . . . . 73.430000000000007 113.307 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -91.96 98.9 11.86 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 108.94 -0.763 . . . . 74.209999999999994 108.94 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 41.7 m -75.09 100.57 4.26 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 107.44 -1.319 . . . . 73.140000000000001 107.44 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 2.5 pp -94.91 153.57 3.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.262 -0.881 . . . . 72.409999999999997 112.021 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 8.8 t -108.27 154.54 21.64 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.144 -1.798 . . . . 74.329999999999998 106.144 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . 0.339 10.3 pt-20 -83.23 66.03 8.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 122.593 1.187 . . . . 55.240000000000002 114.114 -177.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -115.03 111.99 21.96 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 105.546 -2.02 . . . . 64.420000000000002 105.546 174.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . 0.256 8.9 p90 -83.65 61.09 6.09 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.306 1.051 . . . . 74.040000000000006 113.044 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 19.7 t70 159.3 104.16 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 128.987 2.915 . . . . 74.030000000000001 106.073 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -139.74 134.43 31.86 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.448 -0.575 . . . . 72.239999999999995 109.448 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -71.66 107.4 4.49 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.183 0.516 . . . . 73.049999999999997 111.052 -173.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -136.15 114.06 10.66 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 107.692 -1.225 . . . . 73.019999999999996 107.692 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.32 113.91 1.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.694 2.263 . . . . 73.239999999999995 111.451 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.62 136.7 45.77 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.552 -0.536 . . . . 74.319999999999993 109.552 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 30.3 m -108.35 113.78 27.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.106 0.479 . . . . 62.409999999999997 110.404 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 1.7 p -87.21 -167.21 1.81 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.462 -0.79 . . . . 73.299999999999997 109.581 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -81.65 79.91 8.11 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.848 0.833 . . . . 74.040000000000006 108.981 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.43 159.64 24.23 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.673 -1.149 . . . . 71.239999999999995 109.598 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.86 78.64 2.77 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.391 0.615 . . . . 74.030000000000001 112.419 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -92.58 -167.55 1.77 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.979 -1.01 . . . . 63.219999999999999 108.986 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -83.21 29.97 0.47 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.466 1.106 . . . . 71.239999999999995 111.391 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -63.27 -40.09 96.41 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.099 0.407 . . . . 75.140000000000001 112.099 -175.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . 0.578 ' O ' ' HD2' ' A' ' 627' ' ' ARG . 2.5 tmm_? -73.95 -24.18 59.61 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.413 -0.588 . . . . 74.0 109.413 -175.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.93 -31.87 55.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.394 -0.595 . . . . 73.150000000000006 109.394 176.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -80.21 -49.34 11.78 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.033 -0.728 . . . . 74.239999999999995 109.033 175.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.464 ' HA ' ' CG ' ' A' ' 633' ' ' ARG . 12.3 mm-40 -64.7 -11.79 39.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 114.233 1.198 . . . . 71.420000000000002 114.233 -176.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -19.42 58.77 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.218 -0.593 . . . . 75.010000000000005 110.815 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -116.84 45.9 1.22 Allowed Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 109.078 -1.609 . . . . 75.049999999999997 109.078 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . 0.464 ' CG ' ' HA ' ' A' ' 630' ' ' GLU . 24.8 mmt85 -134.47 161.05 66.06 Favored Pre-proline 0 C--N 1.311 -1.077 0 C-N-CA 123.83 0.852 . . . . 73.420000000000002 108.823 -177.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.436 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 29.9 Cg_endo -62.42 139.1 74.91 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.759 2.306 . . . . 73.549999999999997 112.423 177.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . 0.413 ' H ' HD13 ' A' ' 635' ' ' ILE . 0.1 OUTLIER -127.72 178.71 4.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.692 -1.225 . . . . 74.340000000000003 107.692 179.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.86 -173.9 2.37 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 112.828 0.677 . . . . 73.340000000000003 112.828 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -77.8 -159.25 11.67 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.95 -0.568 . . . . 64.129999999999995 114.376 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -78.59 -48.62 14.79 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.452 0.644 . . . . 74.140000000000001 109.603 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -129.6 130.47 45.69 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.931 -1.137 . . . . 75.409999999999997 107.931 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 18.7 p -129.94 96.09 4.12 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 120.9 0.381 . . . . 74.530000000000001 110.887 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -163.97 148.48 10.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.495 -1.298 . . . . 63.539999999999999 107.495 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.44 HD21 HG23 ' A' ' 523' ' ' VAL . 34.0 tp -133.65 127.85 33.84 Favored 'General case' 0 N--CA 1.414 -2.271 0 N-CA-C 108.379 -0.971 . . . . 71.099999999999994 108.379 175.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -98.0 109.92 22.59 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 107.484 -1.302 . . . . 72.409999999999997 107.484 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 46.0 t -101.17 119.33 49.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.361 -0.607 . . . . 75.230000000000004 109.361 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 49.9 mt -106.12 126.7 61.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.327 -0.99 . . . . 73.310000000000002 108.327 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 73.8 mt -97.82 112.01 28.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.841 -1.17 . . . . 73.420000000000002 107.841 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 515' ' ' SER . 14.3 pt-20 -121.49 142.5 49.99 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.505 -0.77 . . . . 72.450000000000003 110.129 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.44 127.13 32.25 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 108.921 -0.77 . . . . 73.510000000000005 108.921 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 56.0 m -148.18 93.83 2.23 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.147 -1.057 . . . . 71.340000000000003 108.147 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -93.69 -10.35 34.69 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.793 -0.639 . . . . 75.319999999999993 109.306 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -77.91 -34.71 51.29 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.3 -0.863 . . . . 73.430000000000007 112.704 -174.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -85.88 79.89 9.09 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.622 0.725 . . . . 70.099999999999994 110.606 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -88.04 69.72 9.34 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 122.727 1.251 . . . . 72.129999999999995 113.284 -175.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 24.2 m -157.67 -41.36 0.07 Allowed 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 104.879 -2.267 . . . . 65.340000000000003 104.879 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 34.6 m -71.49 -38.67 71.18 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.229 -1.397 . . . . 74.319999999999993 107.229 170.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 96.3 t -70.61 110.78 3.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.075 0 N-CA-C 106.989 -1.486 . . . . 53.020000000000003 106.989 169.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 108.132 -1.062 . . . . 70.030000000000001 108.132 -176.04 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 56.9 m80 . . . . . 0 CA--C 1.499 -1.002 0 N-CA-C 110.085 -0.339 . . . . 72.409999999999997 110.085 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.424 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . -87.98 -59.67 2.18 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.7 -1.222 . . . . 73.549999999999997 107.7 170.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 168.85 -146.87 10.66 Favored Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 109.811 -1.316 . . . . 74.239999999999995 109.811 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.483 HD11 ' HA ' ' A' ' 609' ' ' THR . 3.4 mp -126.04 117.6 49.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 117.129 0.464 . . . . 74.209999999999994 110.469 -175.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -102.4 124.69 48.42 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.261 -1.015 . . . . 72.200000000000003 108.261 169.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.7 t -165.07 -179.17 5.53 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.893 -0.78 . . . . 64.530000000000001 108.893 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -80.35 149.04 30.39 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.357 0.598 . . . . 71.510000000000005 112.534 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -74.18 -24.71 59.42 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 114.793 -1.094 . . . . 74.030000000000001 109.003 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.65 142.88 27.29 Favored Pre-proline 0 N--CA 1.435 -1.198 0 N-CA-C 107.474 -1.306 . . . . 75.099999999999994 107.474 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.81 -27.68 4.63 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.215 1.944 . . . . 73.030000000000001 112.483 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 53.7 t -137.96 136.37 45.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 107.007 -1.479 . . . . 74.430000000000007 107.007 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.6 t -130.42 139.55 50.6 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 109.371 -0.603 . . . . 74.239999999999995 109.371 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -106.11 124.05 48.97 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.964 -1.124 . . . . 73.150000000000006 107.964 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.6 m -120.99 155.74 24.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 108.267 -1.012 . . . . 73.120000000000005 108.267 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.501 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 68.1 m -80.88 166.5 20.84 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 108.676 -0.861 . . . . 73.439999999999998 108.676 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.42 ' OE2' ' HB3' ' A' ' 580' ' ' GLU . 20.1 tt0 -89.8 -55.72 3.52 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.429 -0.908 . . . . 71.510000000000005 109.795 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 31.1 m -81.44 46.7 0.97 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.382 0.61 . . . . 54.240000000000002 110.843 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 11.5 tt -96.05 -29.91 3.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.306 0.574 . . . . 73.319999999999993 111.028 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 96.0 -82.25 0.81 Allowed Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.953 -1.259 . . . . 73.310000000000002 109.953 -176.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 573' ' ' VAL . 27.7 mm -129.67 134.96 62.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.885 -1.154 . . . . 75.340000000000003 107.885 -176.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.517 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -115.06 144.62 43.35 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.098 -0.705 . . . . 63.119999999999997 109.098 176.145 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 21.5 mp0 -116.22 128.45 55.62 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.723 0.639 . . . . 65.019999999999996 111.185 176.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 570' ' ' THR . 99.5 t -120.87 131.57 72.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.921 -0.77 . . . . 74.120000000000005 108.921 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 569' ' ' LYS . 26.5 mtmm -85.62 145.32 27.38 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.438 0.637 . . . . 73.140000000000001 112.023 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.412 ' O ' HG21 ' A' ' 568' ' ' VAL . 52.5 t -117.71 127.59 75.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.879 -0.786 . . . . 62.340000000000003 108.879 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 97.1 mt -70.39 124.88 25.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 123.762 0.664 . . . . 72.430000000000007 110.29 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -73.84 158.43 34.54 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.567 -1.197 . . . . 73.409999999999997 109.215 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.4 t -56.09 135.79 52.69 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 124.013 0.821 . . . . 61.229999999999997 110.643 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 3.7 m -60.09 -27.42 66.98 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 124.822 1.249 . . . . 74.219999999999999 110.108 177.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -122.23 90.38 0.44 Allowed Glycine 0 N--CA 1.424 -2.157 0 N-CA-C 109.098 -1.601 . . . . 71.519999999999996 109.098 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.54 105.25 17.69 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.716 -0.476 . . . . 72.530000000000001 109.716 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -120.2 101.97 8.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.852 -0.795 . . . . 74.099999999999994 108.852 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 90.93 -145.21 17.69 Favored Glycine 0 C--N 1.299 -1.489 0 CA-C-N 115.668 -0.696 . . . . 63.140000000000001 112.258 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.531 ' ND2' ' HG2' ' A' ' 563' ' ' GLN . 2.6 t-20 -118.39 131.07 56.31 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.149 -0.685 . . . . 74.219999999999999 109.149 -178.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . 0.454 HG22 HD22 ' A' ' 596' ' ' LEU . 49.4 t -131.58 139.94 49.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 108.497 -0.927 . . . . 63.439999999999998 108.497 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 42.5 mm -109.6 135.79 47.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 109.036 -0.727 . . . . 70.310000000000002 109.036 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.7 t -122.98 108.43 32.54 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 108.957 -0.757 . . . . 63.009999999999998 108.957 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -73.61 153.86 49.41 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.92 1.747 . . . . 65.510000000000005 111.465 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -140.46 155.87 46.54 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.951 -0.468 . . . . 73.420000000000002 109.888 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -147.31 148.83 31.8 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 123.714 0.634 . . . . 73.0 109.911 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.5 p -90.21 129.27 36.49 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.405 -0.361 . . . . 71.329999999999998 110.16 174.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.498 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 64.2 mt -102.62 119.75 51.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 107.162 -1.421 . . . . 74.349999999999994 107.162 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -72.86 114.95 11.58 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.522 -0.548 . . . . 75.439999999999998 109.522 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -96.8 -100.11 1.96 Allowed Glycine 0 CA--C 1.5 -0.874 0 N-CA-C 109.958 -1.257 . . . . 71.430000000000007 109.958 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 31.5 p -94.6 -22.21 18.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.984 -1.117 . . . . 65.150000000000006 107.984 173.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -86.05 135.64 33.55 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.758 -1.11 . . . . 73.299999999999997 108.468 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -98.72 143.55 28.96 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.217 0.532 . . . . 75.409999999999997 112.163 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.7 -150.65 17.61 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.1 -0.954 . . . . 73.430000000000007 111.442 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.93 -0.67 28.21 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 116.978 0.389 . . . . 72.319999999999993 113.383 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 93.54 29.09 10.4 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 111.041 -0.824 . . . . 62.450000000000003 111.041 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -99.91 -67.66 0.84 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 110.365 -0.235 . . . . 64.510000000000005 110.365 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -94.35 -45.62 7.39 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 107.979 -1.119 . . . . 73.420000000000002 107.979 174.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -136.77 158.95 43.26 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 114.965 -1.016 . . . . 74.109999999999999 108.453 177.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -85.52 112.65 21.12 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 104.658 -2.349 . . . . 70.230000000000004 104.658 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -73.25 145.92 45.81 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.576 -0.85 . . . . 73.319999999999993 108.87 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.0 t -142.64 168.98 18.45 Favored 'General case' 0 N--CA 1.414 -2.227 0 C-N-CA 120.372 -0.531 . . . . 72.450000000000003 110.714 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 11.2 p -162.72 160.35 25.36 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 106.017 -1.846 . . . . 75.540000000000006 106.017 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 171.22 -172.98 44.72 Favored Glycine 0 CA--C 1.483 -1.934 0 N-CA-C 110.493 -1.043 . . . . 74.430000000000007 110.493 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.526 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 48.5 mt-10 -130.78 120.11 23.28 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.141 0.496 . . . . 75.150000000000006 111.532 -177.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 92.1 mt -85.75 135.92 33.54 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 115.459 -0.791 . . . . 75.5 109.259 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -104.04 119.24 38.52 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-O 121.051 0.453 . . . . 74.439999999999998 110.035 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -118.81 139.22 51.95 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.517 -0.549 . . . . 65.5 109.517 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.531 ' HG2' ' ND2' ' A' ' 534' ' ' ASN . 6.6 mt-30 -134.95 172.23 13.29 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.743 -0.836 . . . . 73.439999999999998 108.743 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -62.19 -30.22 70.92 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 123.85 0.719 . . . . 74.540000000000006 109.734 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.01 -24.21 21.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.606 -1.179 . . . . 73.319999999999993 112.381 -177.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.488 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 68.5 mm-40 -75.38 173.37 11.01 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.139 -0.351 . . . . 65.340000000000003 111.28 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.575 HG13 ' H ' ' A' ' 568' ' ' VAL . 7.6 pt -117.06 -77.24 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 113.59 0.959 . . . . 75.239999999999995 113.59 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.575 ' H ' HG13 ' A' ' 567' ' ' ILE . 11.8 p -142.99 153.09 16.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 107.711 -1.218 . . . . 73.239999999999995 107.711 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 524' ' ' LYS . 17.0 mtpp -121.55 168.32 11.87 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.7 -0.4 . . . . 74.219999999999999 111.112 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 0.9 OUTLIER -129.92 147.09 51.64 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 123.853 0.72 . . . . 74.120000000000005 111.441 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 1.9 mp -94.91 128.08 46.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.033 -1.469 . . . . 75.129999999999995 107.033 172.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 572' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 521' ' ' MET . 10.1 p -106.74 115.32 29.99 Favored 'General case' 0 N--CA 1.428 -1.562 0 O-C-N 123.715 0.634 . . . . 73.219999999999999 109.835 176.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 520' ' ' ILE . 71.6 t -117.82 135.97 56.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 116.366 -0.379 . . . . 73.230000000000004 110.12 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 24.4 tptm -90.46 123.51 34.22 Favored 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 124.085 0.866 . . . . 75.120000000000005 109.0 177.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.07 136.18 31.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 106.445 -1.687 . . . . 73.329999999999998 106.445 176.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 41.5 mm -84.27 135.31 25.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.401 0.62 . . . . 75.219999999999999 111.258 -173.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -98.29 80.83 2.69 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.076 -0.966 . . . . 74.310000000000002 108.967 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 28.6 t70 178.84 159.69 0.6 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.49 0.716 . . . . 75.299999999999997 109.175 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.408 ' C ' ' H ' ' A' ' 581' ' ' TYR . 46.0 mt-10 61.8 24.57 14.64 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.197 0.999 . . . . 72.120000000000005 112.615 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.42 ' HB3' ' OE2' ' A' ' 516' ' ' GLU . 0.0 OUTLIER -75.08 28.69 0.09 Allowed 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 124.752 1.221 . . . . 71.400000000000006 112.766 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . 0.408 ' H ' ' C ' ' A' ' 579' ' ' GLU . 86.1 t80 -85.3 -16.69 39.21 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 123.31 0.644 . . . . 73.010000000000005 109.868 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -84.49 -160.82 0.5 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.266 -0.425 . . . . 73.329999999999998 111.782 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.457 ' HG2' ' H ' ' A' ' 584' ' ' ASN . 58.4 tttp -112.17 -179.71 3.76 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.154 -1.054 . . . . 75.209999999999994 108.154 -174.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . 0.457 ' H ' ' HG2' ' A' ' 583' ' ' LYS . 24.5 t-20 -37.99 128.0 1.26 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.19 1.796 . . . . 73.140000000000001 113.224 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -109.18 148.18 31.33 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.164 -1.421 . . . . 75.030000000000001 107.164 -176.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 7.8 t -149.97 146.09 26.83 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.08 -0.648 . . . . 74.530000000000001 110.643 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 48.5 p90 -140.43 172.06 13.26 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.643 -1.243 . . . . 72.209999999999994 107.643 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.45 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 85.7 m-85 -116.97 153.59 32.36 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.781 -0.451 . . . . 74.209999999999994 109.781 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.81 125.49 46.63 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 105.657 -1.979 . . . . 73.329999999999998 105.657 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -126.15 136.68 53.16 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.599 -0.889 . . . . 74.109999999999999 108.599 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 12.3 pt -100.4 139.79 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.225 0 N-CA-C 108.45 -0.944 . . . . 72.230000000000004 108.45 175.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.25 173.16 51.67 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-N 115.167 -0.924 . . . . 63.340000000000003 111.426 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.08 125.85 91.96 Favored Pre-proline 0 N--CA 1.433 -1.307 0 CA-C-O 120.836 0.351 . . . . 75.040000000000006 111.556 -177.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.403 ' HB3' HG22 ' A' ' 537' ' ' VAL . 26.2 Cg_endo -62.1 139.71 80.01 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.692 2.928 . . . . 74.129999999999995 113.101 -174.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -116.52 128.68 55.66 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.901 -1.045 . . . . 74.420000000000002 109.562 -177.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . 0.454 HD22 HG22 ' A' ' 535' ' ' VAL . 0.6 OUTLIER -74.58 135.86 42.07 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.953 -1.129 . . . . 72.430000000000007 107.953 179.585 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.501 ' CG2' HG12 ' A' ' 536' ' ' ILE . 37.4 t -97.86 101.07 11.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.701 -0.852 . . . . 73.109999999999999 108.701 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -142.84 156.8 45.0 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.194 -0.457 . . . . 73.549999999999997 111.12 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 65.5 mtm -112.76 -5.67 13.9 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.379 -0.828 . . . . 74.040000000000006 109.832 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 49.9 m -143.68 -72.27 0.29 Allowed 'General case' 0 C--O 1.247 0.966 0 N-CA-C 112.502 0.556 . . . . 64.430000000000007 112.502 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -152.52 149.73 28.83 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.143 -0.348 . . . . 74.420000000000002 110.135 -172.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . 0.442 ' HD3' ' H ' ' A' ' 602' ' ' LYS . 0.0 OUTLIER -118.36 -179.12 3.69 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.735 0.302 . . . . 75.120000000000005 111.808 -174.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -132.13 157.9 43.05 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.635 -0.876 . . . . 73.230000000000004 108.635 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -104.13 174.13 22.02 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 110.979 -0.848 . . . . 73.230000000000004 110.979 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -104.32 -34.2 3.72 Favored Glycine 0 C--N 1.306 -1.128 0 N-CA-C 111.338 -0.705 . . . . 65.540000000000006 111.338 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 59.41 89.75 0.06 Allowed 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.717 1.207 . . . . 74.510000000000005 112.427 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 8.8 t -146.95 162.64 38.32 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.804 -1.554 . . . . 74.230000000000004 106.804 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.68 134.7 26.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.953 -1.128 . . . . 74.310000000000002 107.953 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 609' ' ' THR . . . . . 0.483 ' HA ' HD11 ' A' ' 504' ' ' ILE . 7.2 p -73.18 92.74 1.76 Allowed 'General case' 0 N--CA 1.434 -1.267 0 CA-C-O 121.317 0.579 . . . . 52.439999999999998 111.911 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -70.09 128.8 37.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.283 -0.871 . . . . 54.200000000000003 111.461 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.524 ' OE2' ' HA ' ' A' ' 614' ' ' ASP . 10.6 pt-20 -122.09 145.86 47.75 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.662 -0.866 . . . . 53.149999999999999 108.662 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -79.71 -33.37 41.01 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.917 0.865 . . . . 74.019999999999996 109.448 -177.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -148.29 146.19 28.48 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.697 -1.223 . . . . 71.530000000000001 107.697 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . 0.524 ' HA ' ' OE2' ' A' ' 611' ' ' GLU . 6.8 p-10 -59.92 109.95 1.06 Allowed 'General case' 0 C--O 1.218 -0.582 0 O-C-N 124.057 0.848 . . . . 72.239999999999995 108.976 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . 0.489 ' HD3' ' CE1' ' A' ' 639' ' ' HIS . 0.0 OUTLIER -139.1 156.28 47.28 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 121.247 0.546 . . . . 74.439999999999998 110.72 -175.716 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -125.0 124.68 25.41 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 105.774 -1.936 . . . . 72.120000000000005 105.774 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . 0.402 ' HD3' ' OE1' ' A' ' 638' ' ' GLU . 9.2 Cg_endo -50.5 133.37 37.51 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 123.7 2.933 . . . . 72.310000000000002 114.355 -171.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 84.4 mt -82.98 -17.51 43.21 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.951 -1.022 . . . . 73.140000000000001 109.292 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 6.5 p -71.42 -68.77 0.42 Allowed 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.424 -0.807 . . . . 74.120000000000005 110.642 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 15.0 p -159.78 125.8 4.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 116.039 -0.528 . . . . 65.030000000000001 110.88 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -129.01 151.84 49.26 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.941 -1.503 . . . . 75.329999999999998 106.941 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -151.07 177.52 10.1 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.758 -0.777 . . . . 75.409999999999997 112.054 -174.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -142.13 82.83 1.81 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 106.289 -1.745 . . . . 64.010000000000005 106.289 170.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . 0.458 ' CD ' ' H ' ' A' ' 625' ' ' GLU . 0.9 OUTLIER -153.67 -175.06 5.19 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.492 -1.67 . . . . 73.219999999999999 106.492 -176.205 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.458 ' H ' ' CD ' ' A' ' 624' ' ' GLU . 47.3 mt-10 -79.01 -16.77 56.43 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 122.43 0.292 . . . . 73.239999999999995 111.274 -176.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -70.33 -31.69 69.09 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.541 -0.54 . . . . 72.120000000000005 109.541 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -66.67 -44.4 81.95 Favored 'General case' 0 C--O 1.177 -2.723 0 CA-C-N 115.121 -0.945 . . . . 74.329999999999998 109.651 171.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.33 -38.75 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.337 0.589 . . . . 74.150000000000006 110.231 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.01 -13.93 62.74 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.169 0.987 . . . . 74.409999999999997 113.429 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -51.84 -27.29 12.1 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.04 0.936 . . . . 74.150000000000006 110.948 -177.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -16.12 63.93 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.464 0.913 . . . . 63.219999999999999 113.464 -175.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -111.11 8.66 29.16 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 119.98 -1.105 . . . . 65.099999999999994 113.342 -176.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -134.3 162.1 59.71 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 109.023 -0.732 . . . . 73.120000000000005 109.023 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.424 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 67.7 Cg_endo -77.35 130.1 10.74 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 121.406 1.404 . . . . 75.329999999999998 110.565 174.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.8 pp -126.61 158.33 36.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.623 -0.717 . . . . 73.230000000000004 109.787 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.06 177.19 5.82 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 116.384 -0.371 . . . . 73.450000000000003 110.939 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -69.8 172.7 39.3 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 111.424 -0.67 . . . . 73.420000000000002 111.424 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . 0.402 ' OE1' ' HD3' ' A' ' 617' ' ' PRO . 4.2 tp10 -56.7 -50.02 73.4 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.791 0.805 . . . . 73.510000000000005 110.192 -175.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . 0.489 ' CE1' ' HD3' ' A' ' 615' ' ' LYS . 8.2 m170 -123.63 125.85 45.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.076 -0.965 . . . . 63.229999999999997 109.618 176.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 19.9 p -123.06 95.28 4.55 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 115.733 -0.667 . . . . 73.349999999999994 110.005 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -158.52 138.05 11.81 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.907 -0.588 . . . . 75.099999999999994 109.811 -176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.423 ' CD2' HG11 ' A' ' 523' ' ' VAL . 36.5 tp -122.56 129.27 51.75 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.124 -1.065 . . . . 74.519999999999996 108.124 177.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -95.67 108.86 21.18 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.19 -1.411 . . . . 71.120000000000005 107.19 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 43.3 t -99.02 108.86 23.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 109.314 -0.624 . . . . 72.530000000000001 109.314 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 65.3 mt -98.13 122.8 50.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 108.809 -0.811 . . . . 65.409999999999997 108.809 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 32.7 mt -99.74 108.31 22.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.486 -0.931 . . . . 74.5 108.486 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 515' ' ' SER . 10.4 pt-20 -111.38 119.9 40.37 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.311 0.577 . . . . 74.129999999999995 110.753 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -74.6 117.16 16.11 Favored 'General case' 0 CA--C 1.479 -1.778 0 CA-C-O 122.456 1.122 . . . . 74.430000000000007 108.927 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 40.4 m -112.52 105.1 13.24 Favored 'General case' 0 C--N 1.252 -3.644 0 N-CA-C 105.547 -2.02 . . . . 70.530000000000001 105.547 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -67.94 -47.67 68.04 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.569 -0.741 . . . . 73.319999999999993 112.368 -172.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -75.14 -26.39 59.14 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 119.848 -0.741 . . . . 74.519999999999996 109.183 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 39.6 t80 74.95 8.42 4.14 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.976 1.71 . . . . 64.439999999999998 111.171 176.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -85.68 102.46 13.63 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.688 -1.597 . . . . 75.439999999999998 106.688 177.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 33.3 m -74.22 86.36 1.92 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.951 0.882 . . . . 71.400000000000006 112.861 -174.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 3.4 t -160.52 92.24 0.96 Allowed 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.339 -1.301 . . . . 74.430000000000007 108.303 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . 0.353 14.7 p 49.76 70.05 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 126.212 1.805 . . . . 74.219999999999999 113.9 -177.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 C--O 1.248 1.019 0 CA-C-N 114.035 -1.439 . . . . 74.340000000000003 108.895 176.775 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 14.7 t60 . . . . . 0 N--CA 1.436 -1.148 0 CA-C-O 121.568 0.699 . . . . 74.450000000000003 109.852 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -74.47 -34.62 63.17 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.679 -0.691 . . . . 71.340000000000003 110.332 178.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 162.07 -159.79 31.86 Favored Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 109.904 -1.278 . . . . 70.540000000000006 109.904 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.53 110.86 33.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 116.687 0.244 . . . . 71.209999999999994 110.814 -176.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.714 ' CE1' ' HA ' ' A' ' 527' ' ' ARG . 5.8 m-85 -95.46 120.59 35.98 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.099 -0.704 . . . . 75.420000000000002 109.099 169.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.1 t -170.22 179.52 3.44 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.612 -0.884 . . . . 73.150000000000006 108.612 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -84.37 153.48 23.43 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.614 -0.513 . . . . 74.319999999999993 109.614 178.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -66.84 -36.04 81.43 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.575 0.702 . . . . 72.239999999999995 109.93 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.36 146.36 61.67 Favored Pre-proline 0 N--CA 1.42 -1.963 0 CA-C-N 115.014 -0.994 . . . . 75.409999999999997 108.444 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.67 -25.2 12.81 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.761 1.641 . . . . 74.109999999999999 112.007 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.05 135.37 54.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.454 -0.943 . . . . 75.430000000000007 108.454 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.6 t -129.33 139.18 51.83 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 109.239 -0.652 . . . . 63.100000000000001 109.239 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -103.66 123.2 46.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.661 -1.237 . . . . 73.140000000000001 107.661 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.6 m -113.11 151.92 14.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 120.463 -0.495 . . . . 73.099999999999994 109.912 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.509 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 0.4 OUTLIER -72.96 162.55 29.36 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 114.845 -1.071 . . . . 73.340000000000003 111.43 -178.256 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -83.78 -48.27 10.27 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.264 -1.384 . . . . 73.530000000000001 107.264 170.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.4 m -81.68 28.51 0.41 Allowed 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.685 -1.143 . . . . 71.400000000000006 112.297 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.509 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 15.2 tt -96.9 -32.15 4.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 112.6 0.593 . . . . 74.109999999999999 112.6 -174.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . 0.423 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 87.98 -78.49 1.79 Allowed Glycine 0 N--CA 1.428 -1.864 0 C-N-CA 120.011 -1.09 . . . . 63.439999999999998 110.532 -175.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 35.1 mm -126.74 131.4 71.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 107.523 -1.288 . . . . 74.209999999999994 107.523 -175.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.523 ' SD ' HG22 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -108.55 146.68 32.9 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 109.349 -0.611 . . . . 74.019999999999996 109.349 177.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 15.1 mp0 -123.15 127.25 48.42 Favored 'General case' 0 CA--C 1.505 -0.764 0 O-C-N 123.955 0.784 . . . . 73.530000000000001 110.329 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.523 HG22 ' SD ' ' A' ' 521' ' ' MET . 66.0 t -112.09 130.64 65.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.98 -1.118 . . . . 74.420000000000002 107.98 173.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . 0.462 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 35.8 mtmt -90.72 141.81 28.41 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.236 0.541 . . . . 75.439999999999998 110.833 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.409 ' O ' HG22 ' A' ' 568' ' ' VAL . 43.8 t -107.77 128.01 63.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.738 -0.664 . . . . 72.049999999999997 109.525 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 95.2 mt -66.5 116.49 7.53 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.276 0.63 . . . . 73.319999999999993 110.25 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.714 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 56.3 ttt-85 -73.26 154.14 40.31 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 124.619 1.167 . . . . 75.349999999999994 109.974 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.63 HG23 ' CD2' ' A' ' 505' ' ' PHE . 1.4 p -58.52 131.28 50.29 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 122.992 0.517 . . . . 72.430000000000007 110.415 175.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 46.4 t -47.39 -35.56 8.48 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 125.362 1.465 . . . . 75.040000000000006 110.917 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.56 85.85 0.32 Allowed Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.857 -1.297 . . . . 74.230000000000004 109.857 175.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -84.83 102.14 12.83 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.648 -0.871 . . . . 64.25 108.648 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -102.07 96.73 7.2 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.234 -0.894 . . . . 73.329999999999998 109.939 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 111.43 -145.16 17.64 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.997 -0.621 . . . . 61.350000000000001 112.294 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.524 HD21 ' HG2' ' A' ' 563' ' ' GLN . 2.4 t-20 -118.86 131.92 56.09 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.803 -1.554 . . . . 74.340000000000003 106.803 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 42.8 t -133.94 140.59 46.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 110.104 -0.332 . . . . 70.129999999999995 110.104 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.512 HG12 ' CG2' ' A' ' 597' ' ' VAL . 38.3 mm -113.52 135.36 53.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 109.29 -0.633 . . . . 74.310000000000002 109.29 174.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 34.8 t -121.13 109.44 35.35 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 109.166 -0.679 . . . . 74.209999999999994 109.166 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.04 150.5 38.07 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.21 1.94 . . . . 74.209999999999994 112.27 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.429 ' HB3' HG21 ' A' ' 591' ' ' ILE . 46.1 p90 -145.18 167.43 22.78 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.835 0.35 . . . . 75.420000000000002 111.013 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -158.42 147.95 19.47 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-N 115.387 -0.824 . . . . 73.140000000000001 110.206 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 15.3 p -84.0 136.26 34.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.826 -0.805 . . . . 71.420000000000002 108.826 172.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 75.0 mt -104.43 114.68 44.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 108.942 -0.762 . . . . 72.209999999999994 108.942 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.63 99.12 2.48 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.843 -0.617 . . . . 75.430000000000007 109.927 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -112.13 -105.78 2.81 Favored Glycine 0 CA--C 1.479 -2.172 0 N-CA-C 110.411 -1.075 . . . . 75.219999999999999 110.411 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.24 42.69 1.05 Allowed 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 123.485 0.714 . . . . 75.140000000000001 109.473 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . 0.466 ' HA ' ' HD2' ' A' ' 585' ' ' LYS . . . -160.1 147.13 16.17 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.475 0.71 . . . . 63.240000000000002 109.864 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.473 HH11 ' HG3' ' A' ' 551' ' ' GLU . 33.1 mtm105 -77.82 120.36 22.61 Favored 'General case' 0 C--O 1.251 1.157 0 CA-C-O 121.356 0.598 . . . . 75.340000000000003 111.727 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.28 -163.04 35.33 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.04 -0.982 . . . . 73.439999999999998 110.687 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 65.5 28.85 74.03 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 121.388 -0.434 . . . . 64.140000000000001 113.255 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 69.42 40.25 79.69 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 121.164 -0.541 . . . . 61.240000000000002 112.006 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.473 ' HG3' HH11 ' A' ' 547' ' ' ARG . 3.6 tp10 -113.05 -53.93 2.67 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 119.954 -0.698 . . . . 74.409999999999997 110.188 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -98.62 -39.54 8.64 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.459 -1.311 . . . . 74.450000000000003 107.459 169.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -142.56 149.0 38.48 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.753 -1.112 . . . . 75.400000000000006 108.629 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.66 111.93 21.13 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 105.361 -2.089 . . . . 75.129999999999995 105.361 176.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -75.19 146.7 41.02 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.176 -0.466 . . . . 72.030000000000001 109.976 -173.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.0 t -143.17 150.93 40.06 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.358 0.599 . . . . 75.120000000000005 110.502 -172.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.0 p -153.18 134.57 14.29 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.504 -0.924 . . . . 73.25 108.504 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -175.54 -168.32 35.8 Favored Glycine 0 N--CA 1.411 -2.987 0 N-CA-C 110.179 -1.169 . . . . 52.420000000000002 110.179 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.454 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 39.9 mt-10 -127.32 131.86 50.36 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.972 -0.381 . . . . 75.109999999999999 109.972 -175.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.436 HD22 ' HB3' ' A' ' 569' ' ' LYS . 86.1 mt -94.63 132.11 39.7 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.564 -0.532 . . . . 70.120000000000005 109.564 177.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.412 ' HA ' HD13 ' A' ' 536' ' ' ILE . 19.4 tt0 -98.75 120.21 38.8 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.941 -0.572 . . . . 74.310000000000002 110.198 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 89.5 m-85 -120.71 156.55 31.54 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.671 -0.863 . . . . 61.43 108.671 177.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.524 ' HG2' HD21 ' A' ' 534' ' ' ASN . 16.8 mt-30 -150.11 -177.43 5.92 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.21 -1.033 . . . . 71.129999999999995 108.21 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -66.34 -42.67 87.78 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.397 -0.964 . . . . 73.439999999999998 108.397 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -81.8 -24.63 35.81 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.972 0.731 . . . . 74.299999999999997 112.972 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.404 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 37.1 mm-40 -76.34 146.5 38.77 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.857 -0.527 . . . . 74.519999999999996 112.062 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.555 HG13 ' H ' ' A' ' 568' ' ' VAL . 12.6 pt -90.47 -89.99 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 114.869 1.433 . . . . 75.519999999999996 114.869 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.555 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.7 p -134.76 145.64 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 109.664 -0.495 . . . . 74.420000000000002 109.664 -177.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.436 ' HB3' HD22 ' A' ' 560' ' ' LEU . 4.2 mmpt? -113.04 157.11 21.97 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 116.267 -0.424 . . . . 74.209999999999994 110.21 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.8 p -126.25 151.76 47.01 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.19 -0.914 . . . . 74.310000000000002 111.926 -177.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.3 mp -101.37 120.97 51.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.104 -1.443 . . . . 72.409999999999997 107.104 171.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 572' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 521' ' ' MET . 70.0 m -99.3 115.96 30.38 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 123.81 0.694 . . . . 74.150000000000006 109.967 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.433 ' CG2' ' HE3' ' A' ' 521' ' ' MET . 68.1 t -122.63 128.27 75.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.462 -0.335 . . . . 72.310000000000002 110.291 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 29.1 tptp -80.66 118.2 22.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.67 -0.493 . . . . 74.239999999999995 109.67 176.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 58.3 t -81.27 117.22 26.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 105.557 -2.016 . . . . 72.340000000000003 105.557 174.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 43.5 mm -76.28 139.04 19.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.762 0.791 . . . . 64.450000000000003 109.97 -174.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.59 80.03 7.11 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-N 114.282 -1.327 . . . . 63.009999999999998 108.038 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -82.61 135.94 34.93 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.614 -1.176 . . . . 75.400000000000006 108.865 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -86.02 -42.42 14.0 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 110.13 -0.322 . . . . 74.209999999999994 110.13 -175.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.16 168.06 18.02 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.412 0.625 . . . . 65.120000000000005 111.442 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -136.56 133.07 36.03 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.152 -0.684 . . . . 73.319999999999993 109.152 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -131.14 -65.04 0.79 Allowed 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.15 0.5 . . . . 71.510000000000005 109.912 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -158.92 170.38 22.23 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.81 -1.552 . . . . 74.140000000000001 106.81 -173.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -61.86 118.61 7.44 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.459 -0.571 . . . . 64.340000000000003 109.459 174.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . 0.466 ' HD2' ' HA ' ' A' ' 546' ' ' ALA . 34.2 mmtp -90.58 136.31 33.14 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.995 -0.548 . . . . 74.519999999999996 111.416 -175.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 7.0 t -153.93 135.5 14.33 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.436 0.636 . . . . 72.219999999999999 110.407 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -127.16 172.18 10.77 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.323 -0.991 . . . . 74.140000000000001 108.323 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.432 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 79.4 m-85 -118.96 153.8 34.05 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 109.515 -0.55 . . . . 72.010000000000005 109.515 -175.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.86 129.86 52.17 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.206 -1.775 . . . . 71.140000000000001 106.206 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -128.0 134.4 49.25 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.05 -0.66 . . . . 74.540000000000006 109.924 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . 0.429 HG21 ' HB3' ' A' ' 539' ' ' TYR . 25.2 pt -106.84 140.51 24.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.39 -0.967 . . . . 72.219999999999999 108.39 176.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.21 -175.31 49.78 Favored Glycine 0 N--CA 1.425 -2.065 0 O-C-N 123.813 0.695 . . . . 63.240000000000002 111.469 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.81 137.3 82.63 Favored Pre-proline 0 N--CA 1.428 -1.529 0 C-N-CA 121.034 -0.266 . . . . 74.319999999999993 110.521 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.65 142.94 60.26 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 122.58 2.187 . . . . 72.439999999999998 111.08 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -121.93 123.42 41.66 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.674 -0.491 . . . . 74.230000000000004 109.674 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 2.2 tm? -67.97 125.56 26.7 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.844 -0.799 . . . . 74.140000000000001 108.844 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.512 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.6 t -93.41 107.77 19.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 105.197 -2.149 . . . . 75.409999999999997 105.197 176.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' A' ' 601' ' ' GLU . 34.7 mt-10 -61.59 112.86 2.4 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.912 -1.04 . . . . 73.219999999999999 108.843 -176.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -67.11 -28.44 68.16 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.463 0.649 . . . . 74.519999999999996 110.906 -175.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 8.4 t -104.51 90.34 3.49 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 102.541 -3.133 . . . . 63.43 102.541 168.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . 0.533 ' HB3' ' O ' ' A' ' 598' ' ' GLU . 9.0 pt-20 -99.95 153.9 18.81 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 114.601 1.334 . . . . 74.120000000000005 114.601 -166.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -102.64 130.46 49.54 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 104.886 -2.264 . . . . 53.450000000000003 104.886 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -71.52 94.1 1.26 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.062 0.934 . . . . 74.430000000000007 110.611 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 150.18 -139.48 7.36 Favored Glycine 0 N--CA 1.415 -2.762 0 N-CA-C 108.289 -1.924 . . . . 72.239999999999995 108.289 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 71.19 33.57 64.84 Favored Glycine 0 C--N 1.315 -0.603 0 N-CA-C 110.585 -1.006 . . . . 71.129999999999995 110.585 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -155.06 139.52 16.84 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 109.087 -0.709 . . . . 74.420000000000002 109.087 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 7.6 t -138.47 141.28 39.45 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.131 -1.433 . . . . 71.299999999999997 107.131 174.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 64.3 mt -75.4 110.01 9.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.19 -0.67 . . . . 71.230000000000004 109.19 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 8.9 t -163.06 140.96 7.99 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 109.772 -0.455 . . . . 70.5 109.772 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -136.27 107.83 6.96 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 104.691 -2.337 . . . . 65.140000000000001 104.691 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -73.02 125.23 27.14 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.391 -0.524 . . . . 71.109999999999999 111.859 -172.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -75.72 141.63 42.62 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 108.502 -0.925 . . . . 73.340000000000003 108.502 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . 0.428 ' OD1' ' HD3' ' A' ' 617' ' ' PRO . 20.9 t70 -143.34 130.2 20.47 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.943 -0.571 . . . . 74.420000000000002 111.089 -174.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -113.46 -7.42 13.43 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.109 -0.496 . . . . 74.340000000000003 110.46 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' A' ' 615' ' ' LYS . 0.6 OUTLIER 174.54 -47.41 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.751 1.22 . . . . 74.150000000000006 108.454 178.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -162.62 121.21 1.34 Allowed Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 115.455 -0.793 . . . . 75.519999999999996 109.136 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . 0.428 ' HD3' ' OD1' ' A' ' 613' ' ' ASP . 6.3 Cg_exo -74.29 108.06 2.59 Favored 'Trans proline' 0 N--CA 1.44 -1.647 0 C-N-CA 121.564 1.509 . . . . 75.120000000000005 109.303 174.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 88.9 mt -76.23 -12.29 60.06 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.442 0.639 . . . . 61.149999999999999 111.111 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 26.8 m -76.23 -18.83 58.84 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.7 -0.852 . . . . 71.099999999999994 108.7 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 38.3 t -100.49 117.81 35.41 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 108.073 -1.084 . . . . 75.150000000000006 108.073 178.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -94.27 134.76 36.4 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.192 -0.67 . . . . 72.439999999999998 109.192 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -80.65 86.68 5.86 Favored 'General case' 0 C--O 1.25 1.097 0 CA-C-O 122.04 0.924 . . . . 72.209999999999994 109.125 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 626' ' ' ARG . 10.1 tp10 -74.66 116.42 15.34 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 113.948 -1.478 . . . . 73.430000000000007 111.156 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . 0.434 ' O ' HG13 ' A' ' 628' ' ' ILE . 40.1 mt-10 -66.65 -27.82 67.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.669 -0.696 . . . . 73.310000000000002 110.942 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.97 -31.43 72.61 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 120.825 0.345 . . . . 62.219999999999999 110.313 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.634 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 28.1 mmt180 -63.76 -47.41 81.1 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 109.03 -0.729 . . . . 74.519999999999996 109.03 174.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -58.89 -41.07 86.29 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.666 0.604 . . . . 73.5 111.646 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 624' ' ' GLU . 69.0 mt -65.24 -35.37 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.416 0.627 . . . . 71.519999999999996 109.873 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -75.31 -29.33 60.0 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.37 -0.377 . . . . 73.120000000000005 111.007 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 7.6 mm-40 -61.55 -29.68 70.17 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 116.215 -0.448 . . . . 71.219999999999999 111.896 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 628' ' ' ILE . 0.0 OUTLIER -75.87 -1.59 26.06 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.173 0.805 . . . . 64.219999999999999 113.173 -177.683 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -101.2 1.7 54.48 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.775 -0.93 . . . . 74.239999999999995 110.775 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . 0.461 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 5.3 ptp180 -135.03 168.88 15.54 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 123.572 0.749 . . . . 75.299999999999997 109.06 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 633' ' ' ARG . 33.6 Cg_endo -60.04 139.5 87.99 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.586 2.191 . . . . 70.030000000000001 112.622 177.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.8 pp -134.56 157.97 41.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.139 -1.059 . . . . 74.230000000000004 108.139 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.54 172.84 8.42 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.314 -0.554 . . . . 70.25 111.725 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -73.01 -157.25 3.9 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-O 121.912 0.729 . . . . 74.049999999999997 114.475 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.93 -45.84 59.7 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.624 -0.788 . . . . 71.420000000000002 109.333 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -135.4 142.98 45.76 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.231 -0.895 . . . . 74.129999999999995 108.822 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 35.2 p -134.75 103.21 5.54 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.011 0.434 . . . . 71.310000000000002 111.034 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -170.22 150.65 3.68 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.822 -1.177 . . . . 74.140000000000001 107.822 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.437 HD21 HG21 ' A' ' 523' ' ' VAL . 26.1 tp -137.81 132.13 32.18 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.48 -0.933 . . . . 74.340000000000003 108.48 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -101.16 110.95 23.04 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.529 -1.286 . . . . 75.140000000000001 107.529 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 45.7 t -101.11 110.97 29.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.556 -0.535 . . . . 73.549999999999997 109.556 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 74.0 mt -96.58 125.66 49.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 N-CA-C 109.471 -0.566 . . . . 62.100000000000001 109.471 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 64.9 mt -101.17 107.59 21.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.823 -1.177 . . . . 73.310000000000002 107.823 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.491 ' CD ' ' HZ3' ' A' ' 653' ' ' LYS . 8.5 pt-20 -121.18 153.16 37.92 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.173 0.511 . . . . 73.430000000000007 110.014 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.35 138.72 45.28 Favored 'General case' 0 N--CA 1.387 -3.578 0 N-CA-C 106.66 -1.607 . . . . 75.239999999999995 106.66 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 50.0 m 69.52 43.4 1.02 Allowed 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.906 -1.516 . . . . 72.420000000000002 106.906 -172.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . 0.452 ' HA ' ' OE1' ' A' ' 647' ' ' GLU . 0.1 OUTLIER -59.04 -35.45 73.34 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 113.44 -1.709 . . . . 72.299999999999997 112.72 -174.27 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -20.58 61.46 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.744 -0.662 . . . . 75.540000000000006 111.702 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -87.41 77.88 8.79 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 122.248 1.023 . . . . 75.319999999999993 111.589 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . 0.491 ' HZ3' ' CD ' ' A' ' 647' ' ' GLU . 8.6 ptpp? -163.55 -169.43 1.93 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 105.581 -2.007 . . . . 75.239999999999995 105.581 176.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 15.0 m -86.51 89.5 7.92 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.556 -0.905 . . . . 73.530000000000001 108.556 174.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 34.9 m -76.5 115.76 16.55 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 108.984 -0.747 . . . . 73.209999999999994 108.984 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.81 116.82 10.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.13 -0.487 . . . . 73.420000000000002 111.672 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 C--O 1.253 1.278 0 CA-C-N 114.924 -1.035 . . . . 73.310000000000002 112.317 177.384 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 502' ' ' ALA . . . . . 0.56 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . . . . . . 0 C--O 1.211 -0.95 0 N-CA-C 113.316 0.858 . . . . 63.109999999999999 113.316 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 124.58 -155.85 18.44 Favored Glycine 0 C--N 1.287 -2.167 0 C-N-CA 119.215 -1.469 . . . . 40.229999999999997 111.705 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.417 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.7 mp -114.66 110.96 33.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 112.069 0.396 . . . . 64.010000000000005 112.069 -172.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -92.52 119.98 32.53 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.068 -1.086 . . . . 75.019999999999996 108.068 168.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.5 t -160.41 171.79 18.43 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.122 -0.696 . . . . 74.510000000000005 109.122 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -76.83 147.06 37.39 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 122.513 -0.117 . . . . 71.209999999999994 111.149 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 524' ' ' LYS . 0.3 OUTLIER -65.9 -33.8 76.66 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 122.116 0.96 . . . . 64.439999999999998 108.69 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -130.23 140.17 37.86 Favored Pre-proline 0 C--N 1.291 -1.96 0 N-CA-C 108.008 -1.108 . . . . 72.5 108.008 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.81 -27.4 10.43 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.288 1.992 . . . . 62.509999999999998 111.672 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 60.0 t -140.63 134.52 33.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 106.232 -1.766 . . . . 75.430000000000007 106.232 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.2 t -128.95 139.91 51.9 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.952 -0.758 . . . . 72.540000000000006 108.952 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -106.39 136.3 46.38 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.563 -1.273 . . . . 71.099999999999994 107.563 175.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.2 m -125.9 147.24 30.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 108.897 -0.779 . . . . 62.530000000000001 108.897 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.478 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 27.1 m -79.29 143.64 35.03 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 112.709 0.633 . . . . 61.43 112.709 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -56.2 -39.5 72.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.196 0.998 . . . . 73.140000000000001 110.374 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 27.5 t -116.01 73.25 0.84 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.905 0.859 . . . . 52.149999999999999 109.757 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 9.8 tt -120.16 -25.49 2.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.653 -0.703 . . . . 72.540000000000006 110.73 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 519' ' ' GLY . . . . . 0.457 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 91.74 -82.02 1.22 Allowed Glycine 0 N--CA 1.421 -2.342 0 N-CA-C 109.983 -1.247 . . . . 60.130000000000003 109.983 -175.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 520' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 574' ' ' LYS . 49.8 mm -127.96 135.13 63.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 107.993 -1.114 . . . . 64.209999999999994 107.993 -175.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.19 143.3 43.47 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.132 -1.062 . . . . 45.119999999999997 108.132 176.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.7 mt-10 -124.93 126.75 46.0 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 123.796 0.685 . . . . 74.299999999999997 111.358 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.545 HG11 HD22 ' A' ' 642' ' ' LEU . 24.2 t -105.53 125.34 60.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.908 -0.775 . . . . 75.25 108.908 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 508' ' ' GLU . 20.6 mmmt -81.34 130.18 34.93 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.328 -0.99 . . . . 64.340000000000003 108.328 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.501 ' O ' HG23 ' A' ' 568' ' ' VAL . 58.5 t -105.38 137.85 33.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 109.829 -0.434 . . . . 64.530000000000001 109.829 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.91 123.18 27.0 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.011 -0.541 . . . . 72.109999999999999 110.177 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 34.7 ttp85 -78.78 155.83 29.1 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.686 -1.143 . . . . 70.319999999999993 110.433 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 0.9 OUTLIER -58.37 140.4 53.65 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 124.438 1.095 . . . . 60.310000000000002 112.482 177.684 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.7 t -54.73 -35.33 63.59 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.934 1.294 . . . . 71.010000000000005 110.034 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -117.76 95.64 0.65 Allowed Glycine 0 N--CA 1.418 -2.501 0 N-CA-C 110.141 -1.184 . . . . 34.149999999999999 110.141 176.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -84.57 111.85 19.89 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.804 -0.813 . . . . 33.240000000000002 108.804 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -121.28 107.87 13.05 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.304 -0.862 . . . . 71.209999999999994 110.835 -173.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 74.76 -124.25 7.87 Favored Glycine 0 N--CA 1.441 -1.0 0 O-C-N 123.633 0.583 . . . . 72.129999999999995 112.92 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -134.17 126.38 29.83 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.299 0.64 . . . . 71.310000000000002 109.851 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.47 137.94 54.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 109.027 -0.731 . . . . 74.219999999999999 109.027 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.512 HG12 ' CG2' ' A' ' 597' ' ' VAL . 40.5 mm -107.76 136.65 42.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 109.358 -0.608 . . . . 74.109999999999999 109.358 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.25 108.07 38.55 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 109.488 -0.56 . . . . 62.450000000000003 109.488 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 53.5 Cg_endo -72.71 155.97 53.65 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.373 2.049 . . . . 63.030000000000001 111.752 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.497 ' HB3' HG22 ' A' ' 591' ' ' ILE . 54.2 p90 -152.87 163.0 40.59 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 110.481 -0.192 . . . . 71.129999999999995 110.481 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -158.03 158.36 34.69 Favored 'General case' 0 C--O 1.25 1.079 0 O-C-N 123.735 0.647 . . . . 72.299999999999997 109.457 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 5.2 p -84.35 158.15 21.23 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.145 -0.48 . . . . 75.540000000000006 110.05 172.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 89.6 mt -133.54 121.28 40.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.644 -1.243 . . . . 74.349999999999994 107.644 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -71.37 107.28 4.25 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 110.154 -0.313 . . . . 63.409999999999997 110.154 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -83.82 -89.75 0.76 Allowed Glycine 0 C--N 1.309 -0.93 0 N-CA-C 109.53 -1.428 . . . . 63.299999999999997 109.53 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 14.8 p -112.76 6.11 17.92 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.819 0.818 . . . . 75.140000000000001 109.112 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -99.45 142.76 30.52 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.635 -1.166 . . . . 71.519999999999996 110.281 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.427 ' HB3' ' OE1' ' A' ' 551' ' ' GLU . 76.9 mtt180 -79.34 127.0 31.54 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.694 0.759 . . . . 72.129999999999995 111.321 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -90.3 176.09 41.61 Favored Glycine 0 C--N 1.289 -2.074 0 CA-C-N 114.81 -1.086 . . . . 60.520000000000003 112.19 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 82.34 19.29 64.75 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.057 -0.592 . . . . 62.109999999999999 113.255 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 81.94 25.81 51.36 Favored Glycine 0 CA--C 1.504 -0.64 0 N-CA-C 110.458 -1.057 . . . . 54.140000000000001 110.458 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.427 ' OE1' ' HB3' ' A' ' 547' ' ' ARG . 21.3 tt0 -93.32 -60.81 1.7 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 108.801 -0.815 . . . . 72.5 108.801 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -102.12 -34.44 9.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.852 -1.166 . . . . 73.409999999999997 107.852 168.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -143.95 148.72 35.73 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.518 -0.919 . . . . 73.349999999999994 108.518 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -85.57 112.29 20.82 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 105.498 -2.038 . . . . 72.439999999999998 105.498 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -76.55 146.37 38.41 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.256 -0.429 . . . . 73.299999999999997 110.168 -175.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.5 t -145.55 157.0 44.05 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-O 121.411 0.624 . . . . 64.120000000000005 110.519 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.9 p -154.52 153.19 31.05 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.498 -1.297 . . . . 72.040000000000006 107.498 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 169.81 -160.64 33.75 Favored Glycine 0 N--CA 1.418 -2.503 0 N-CA-C 110.032 -1.227 . . . . 62.329999999999998 110.032 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.491 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.6 mt-10 -129.79 142.36 50.7 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 122.663 0.385 . . . . 75.420000000000002 110.631 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.574 HD22 ' HB3' ' A' ' 569' ' ' LYS . 74.9 mt -107.82 139.48 42.35 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.046 -0.525 . . . . 74.430000000000007 109.617 175.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.507 ' HA ' HD13 ' A' ' 536' ' ' ILE . 31.4 tt0 -102.79 117.25 34.23 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 116.031 -0.531 . . . . 71.030000000000001 110.913 -177.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -116.56 149.02 40.31 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.548 -0.908 . . . . 73.129999999999995 108.548 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.514 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 58.4 mt-30 -148.19 -175.01 4.73 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.941 -1.133 . . . . 71.329999999999998 107.941 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -69.18 -27.44 65.52 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.545 -0.909 . . . . 73.239999999999995 108.545 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.27 -51.66 5.06 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.136 -0.938 . . . . 51.420000000000002 112.317 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.514 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 51.0 mm-40 -55.67 125.77 22.6 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 122.349 0.259 . . . . 70.129999999999995 110.815 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.603 HG13 ' H ' ' A' ' 568' ' ' VAL . 7.1 pt -91.01 -78.67 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 112.855 0.687 . . . . 71.329999999999998 112.855 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.603 ' H ' HG13 ' A' ' 567' ' ' ILE . 10.9 p -119.71 150.18 22.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.813 -0.555 . . . . 63.439999999999998 110.004 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.574 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -122.83 160.32 26.28 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.911 -0.774 . . . . 70.519999999999996 108.911 173.489 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 6.8 p -127.33 144.61 51.02 Favored 'General case' 0 C--N 1.288 -2.095 0 O-C-N 123.898 0.749 . . . . 71.340000000000003 112.696 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.0 mp -94.66 122.74 46.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 106.369 -1.715 . . . . 74.430000000000007 106.369 171.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 15.6 m -100.92 119.24 38.42 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 123.731 0.645 . . . . 60.0 109.332 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.403 HG23 HG22 ' A' ' 571' ' ' ILE . 89.4 t -124.18 128.81 74.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 109.927 -0.397 . . . . 71.409999999999997 109.927 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.457 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 20.5 tptm -77.97 113.22 15.67 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.183 -0.673 . . . . 55.0 109.183 175.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.3 120.97 36.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 106.89 -1.522 . . . . 70.510000000000005 106.89 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 35.7 mm . . . . . 0 C--N 1.292 -1.922 0 N-CA-C 108.911 -0.774 . . . . 72.409999999999997 108.911 -176.565 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 74.9 mmtt . . . . . 0 CA--C 1.482 -1.648 0 N-CA-C 109.443 -0.577 . . . . 73.409999999999997 109.443 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 586' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 644' ' ' VAL . 10.0 t -149.33 138.75 21.57 Favored 'General case' 0 N--CA 1.416 -2.143 0 C-N-CA 120.034 -0.666 . . . . 52.310000000000002 110.937 174.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 49.0 p90 -135.08 167.7 20.47 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.651 -1.241 . . . . 70.109999999999999 107.651 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.517 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 80.3 m-85 -114.44 159.39 20.38 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 120.572 -0.451 . . . . 74.430000000000007 109.889 -175.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.33 128.22 47.86 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 106.243 -1.762 . . . . 74.129999999999995 106.243 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.462 ' HB2' HD11 ' A' ' 542' ' ' ILE . 29.5 tt0 -122.19 123.37 41.35 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 110.238 -0.282 . . . . 75.319999999999993 110.238 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.497 HG22 ' HB3' ' A' ' 539' ' ' TYR . 23.5 pt -95.86 135.19 30.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.859 -1.163 . . . . 71.150000000000006 107.859 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -84.38 -177.55 51.29 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 111.429 -0.669 . . . . 75.430000000000007 111.429 -177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.75 133.95 92.37 Favored Pre-proline 0 N--CA 1.435 -1.19 0 C-N-CA 120.931 -0.308 . . . . 73.349999999999994 111.435 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.413 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 20.3 Cg_endo -62.7 129.48 26.44 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.947 2.432 . . . . 72.219999999999999 111.513 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 595' ' ' ARG . . . . . 0.466 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.1 ptp180 -107.81 119.95 40.89 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.458 -0.792 . . . . 71.239999999999995 109.902 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -66.07 132.1 47.74 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.967 -1.123 . . . . 74.530000000000001 107.967 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.512 ' CG2' HG12 ' A' ' 536' ' ' ILE . 98.1 t . . . . . 0 C--N 1.307 -1.255 0 CA-C-O 121.707 0.765 . . . . 61.240000000000002 112.385 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.453 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 42.6 Cg_endo . . . . . 0 N--CA 1.43 -2.213 0 N-CA-C 108.876 -1.24 . . . . 74.519999999999996 108.876 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.86 168.18 17.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 120.894 -0.323 . . . . 72.319999999999993 110.217 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.21 175.91 5.34 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 112.14 0.422 . . . . 73.319999999999993 112.14 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.417 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -72.53 -177.58 31.3 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 114.948 0.739 . . . . 74.439999999999998 114.948 -176.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -58.48 -47.35 84.36 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.476 1.111 . . . . 63.020000000000003 110.172 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -140.44 121.83 15.0 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.006 -0.739 . . . . 62.25 109.006 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 10.1 p -114.32 96.21 5.66 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 120.899 0.381 . . . . 73.209999999999994 111.004 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -171.16 134.0 0.9 Allowed 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.572 -0.74 . . . . 72.019999999999996 109.662 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.545 HD22 HG11 ' A' ' 523' ' ' VAL . 25.6 tp -117.42 132.35 56.59 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.896 -1.047 . . . . 70.310000000000002 108.769 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -99.71 111.91 24.2 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.946 -1.502 . . . . 73.349999999999994 106.946 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 586' ' ' THR . 41.3 t -100.41 111.1 29.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 109.338 -0.615 . . . . 74.319999999999993 109.338 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 51.1 mt -99.48 118.45 46.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 N-CA-C 109.177 -0.675 . . . . 74.319999999999993 109.177 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 69.0 mt -87.5 107.86 17.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 106.792 -1.559 . . . . 73.409999999999997 106.792 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? . . . . . 0 C--N 1.292 -1.921 0 CA-C-N 116.098 -0.501 . . . . 75.450000000000003 110.93 -178.648 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 502' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 121.782 0.801 . . . . 75.439999999999998 109.158 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 174.9 -161.88 31.53 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 109.033 -1.627 . . . . 51.140000000000001 109.033 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.513 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.4 mp -116.25 121.37 67.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 117.202 0.501 . . . . 73.25 111.359 -174.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.558 ' CD2' HG23 ' A' ' 528' ' ' THR . 30.7 m-85 -95.86 135.65 37.31 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.011 -0.737 . . . . 73.099999999999994 109.011 168.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 506' ' ' THR . . . . . 0.435 ' HA ' HG22 ' A' ' 640' ' ' THR . 13.6 t -167.32 179.66 4.93 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.088 -0.708 . . . . 73.150000000000006 109.088 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.07 152.05 22.3 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.455 -0.572 . . . . 74.120000000000005 109.455 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.66 -37.12 84.13 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.79 -0.448 . . . . 74.540000000000006 109.79 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -125.97 149.73 67.08 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 109.62 -0.511 . . . . 70.109999999999999 109.62 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.01 -27.67 6.68 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.678 1.585 . . . . 75.219999999999999 111.771 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 47.4 t -135.48 135.26 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.883 -0.784 . . . . 74.140000000000001 108.883 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.9 t -132.28 140.45 48.62 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.724 -0.843 . . . . 64.230000000000004 108.724 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 44.9 p-80 -112.71 127.51 56.15 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.383 0.611 . . . . 75.049999999999997 109.496 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.7 m -112.18 165.2 7.33 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.453 -0.794 . . . . 64.439999999999998 109.211 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 15.4 t -101.2 166.35 10.82 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.666 0.746 . . . . 63.340000000000003 112.134 -172.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -80.11 -19.67 46.8 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.101 -1.409 . . . . 75.319999999999993 107.991 173.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 19.3 m -114.15 29.65 7.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.991 -0.55 . . . . 53.130000000000003 111.763 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.2 tt -97.86 -39.26 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 119.763 -0.775 . . . . 54.240000000000002 113.044 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 90.28 -72.95 1.94 Allowed Glycine 0 CA--C 1.506 -0.529 0 C-N-CA 120.662 -0.78 . . . . 52.119999999999997 111.645 -176.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 520' ' ' ILE . . . . . 0.543 HD11 ' HE3' ' A' ' 574' ' ' LYS . 33.8 mm -128.03 126.87 67.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.65 -1.241 . . . . 65.540000000000006 107.65 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.21 147.96 29.5 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.273 -1.01 . . . . 54.340000000000003 108.273 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 51.4 mp0 -122.41 131.9 54.1 Favored 'General case' 0 N--CA 1.434 -1.252 0 O-C-N 123.716 0.635 . . . . 61.009999999999998 110.304 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 570' ' ' THR . 25.3 t -110.95 129.51 66.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.785 -0.643 . . . . 73.120000000000005 109.47 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.407 ' HE3' HG11 ' A' ' 568' ' ' VAL . 6.5 mmmm -86.28 120.28 27.46 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 123.744 0.818 . . . . 74.239999999999995 109.437 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 568' ' ' VAL . 47.9 t -100.65 122.88 53.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 109.184 -0.673 . . . . 61.109999999999999 109.184 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.1 mt -69.82 126.7 30.5 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.855 -0.611 . . . . 71.340000000000003 110.173 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.434 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 57.0 ttp180 -74.32 160.82 30.55 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.69 -1.141 . . . . 64.019999999999996 108.997 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.558 HG23 ' CD2' ' A' ' 505' ' ' PHE . 2.5 p -56.98 139.09 53.18 Favored 'General case' 0 N--CA 1.421 -1.881 0 C-N-CA 123.125 0.57 . . . . 73.200000000000003 111.843 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.9 m -51.07 -33.84 27.47 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.863 1.265 . . . . 73.109999999999999 110.059 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -119.78 107.39 1.33 Allowed Glycine 0 N--CA 1.416 -2.646 0 N-CA-C 108.456 -1.858 . . . . 72.519999999999996 108.456 171.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 564' ' ' ASN . . . -88.69 101.28 13.84 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.081 -0.711 . . . . 71.200000000000003 109.081 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -116.9 102.02 9.02 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.674 -0.694 . . . . 75.219999999999999 110.798 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 86.1 -157.33 30.58 Favored Glycine 0 C--N 1.311 -0.818 0 C-N-CA 120.826 -0.702 . . . . 43.439999999999998 112.87 174.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -107.0 127.69 53.68 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.606 -0.887 . . . . 70.140000000000001 108.606 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.21 141.68 45.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 C-N-CA 122.768 0.427 . . . . 52.140000000000001 109.981 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.592 HG12 ' CG2' ' A' ' 597' ' ' VAL . 42.4 mm -108.79 134.28 51.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.571 -0.9 . . . . 72.439999999999998 108.571 173.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.55 107.2 43.21 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 109.106 -0.701 . . . . 64.329999999999998 109.106 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -70.36 152.17 66.07 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.871 1.714 . . . . 53.030000000000001 110.999 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -148.52 157.88 43.76 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.674 -0.491 . . . . 64.120000000000005 109.674 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 540' ' ' LYS . . . . . 0.441 ' HE2' ' HB3' ' A' ' 590' ' ' GLU . 0.0 OUTLIER -158.11 152.6 24.67 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.914 0.759 . . . . 74.349999999999994 110.441 178.289 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.9 p -85.22 143.4 28.78 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.0 -0.545 . . . . 63.240000000000002 109.965 176.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.562 HD11 ' HB2' ' A' ' 590' ' ' GLU . 82.5 mt -105.59 122.2 58.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 108.368 -0.975 . . . . 73.430000000000007 108.368 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -81.45 145.35 30.81 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 123.754 0.659 . . . . 71.230000000000004 109.909 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -175.03 -99.76 0.12 Allowed Glycine 0 CA--C 1.483 -1.921 0 N-CA-C 111.038 -0.825 . . . . 51.109999999999999 111.038 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 545' ' ' THR . . . . . 0.439 ' HB ' HG23 ' A' ' 586' ' ' THR . 0.9 OUTLIER -83.43 29.17 0.51 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.148 0.979 . . . . 74.310000000000002 110.37 -175.471 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.457 ' HA ' ' HD2' ' A' ' 585' ' ' LYS . . . -165.66 145.3 6.49 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.563 -1.643 . . . . 72.129999999999995 106.563 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -86.3 127.22 34.75 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 113.0 0.741 . . . . 74.230000000000004 113.0 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.79 -164.09 38.68 Favored Glycine 0 C--N 1.302 -1.324 0 CA-C-N 114.446 -1.252 . . . . 55.340000000000003 110.755 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.95 18.4 76.24 Favored Glycine 0 C--N 1.318 -0.441 0 CA-C-N 117.509 0.654 . . . . 73.430000000000007 112.796 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 75.71 44.8 19.25 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.627 -0.797 . . . . 71.540000000000006 111.133 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -114.75 -59.25 2.04 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.609 -0.436 . . . . 54.149999999999999 110.074 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -100.82 -37.12 8.83 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 107.417 -1.327 . . . . 73.239999999999995 107.417 171.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -141.38 150.88 42.97 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 114.661 -1.154 . . . . 75.510000000000005 107.939 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.58 113.67 20.45 Favored 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 106.446 -1.687 . . . . 52.409999999999997 106.446 174.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -76.21 131.89 39.59 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.752 -0.833 . . . . 61.119999999999997 108.752 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.9 t -128.34 148.21 50.67 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 121.688 0.756 . . . . 63.130000000000003 110.965 -172.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 25.3 p -141.39 151.39 43.44 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 106.294 -1.743 . . . . 74.400000000000006 106.294 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 171.48 -161.12 33.41 Favored Glycine 0 N--CA 1.417 -2.587 0 C-N-CA 119.972 -1.109 . . . . 63.340000000000003 110.978 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.537 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 47.1 mt-10 -139.39 130.96 27.17 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 122.497 0.319 . . . . 65.329999999999998 110.745 -176.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 98.7 mt -95.56 142.21 28.17 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.918 -0.771 . . . . 74.450000000000003 108.918 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -108.9 118.73 37.55 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.294 0.568 . . . . 74.530000000000001 110.824 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -117.53 156.49 27.97 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.538 -0.756 . . . . 65.200000000000003 109.51 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.498 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 47.3 mt-30 -148.54 178.74 8.36 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.118 -1.067 . . . . 52.119999999999997 108.118 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 564' ' ' ASN . . . . . 0.412 ' HA ' ' HB1' ' A' ' 531' ' ' ALA . 4.0 p-10 -67.83 -30.79 70.27 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.683 -0.858 . . . . 53.549999999999997 108.683 172.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -84.22 -44.86 13.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.228 -0.897 . . . . 74.140000000000001 110.429 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.498 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 70.5 mm-40 -65.72 136.97 56.95 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 123.587 0.755 . . . . 71.239999999999995 111.021 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.592 HG13 ' H ' ' A' ' 568' ' ' VAL . 9.5 pt -89.78 -92.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 114.055 1.131 . . . . 53.229999999999997 114.055 -177.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.592 ' H ' HG13 ' A' ' 567' ' ' ILE . 8.5 p -119.41 149.82 21.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.62 -0.511 . . . . 64.549999999999997 109.62 -176.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -115.1 157.05 24.1 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.175 -0.676 . . . . 63.119999999999997 109.175 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.6 p -122.5 137.75 54.78 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.232 -0.895 . . . . 54.149999999999999 110.925 177.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 24.3 mt -94.71 118.98 42.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 107.898 -1.149 . . . . 75.319999999999993 107.898 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 11.8 p -94.66 115.61 27.75 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 124.002 0.814 . . . . 72.010000000000005 110.611 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 89.2 t -119.79 129.61 75.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 CA-C-O 120.712 0.291 . . . . 63.420000000000002 110.46 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.543 ' HE3' HD11 ' A' ' 520' ' ' ILE . 4.1 tppp? -83.88 119.08 24.44 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.844 0.857 . . . . 64.140000000000001 110.158 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 29.9 t -88.49 121.78 39.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 106.03 -1.841 . . . . 74.439999999999998 106.03 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 48.3 mm . . . . . 0 C--N 1.304 -1.396 0 CA-C-O 121.241 0.543 . . . . 64.430000000000007 111.191 -173.191 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.457 ' HD2' ' HA ' ' A' ' 546' ' ' ALA . 38.5 mmtm . . . . . 0 C--O 1.21 -1.015 0 N-CA-C 110.282 -0.266 . . . . 73.140000000000001 110.282 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 586' ' ' THR . . . . . 0.439 HG23 ' HB ' ' A' ' 545' ' ' THR . 5.0 t -156.65 136.6 12.63 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.188 0.518 . . . . 74.109999999999999 111.27 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -131.6 179.13 6.23 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.325 -0.991 . . . . 73.219999999999999 108.325 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.519 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 82.1 m-85 -125.2 155.33 40.2 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 109.19 -0.671 . . . . 64.310000000000002 109.19 -176.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.2 OUTLIER -121.51 131.1 53.95 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.613 -1.625 . . . . 63.32 106.613 178.113 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.562 ' HB2' HD11 ' A' ' 542' ' ' ILE . 33.4 tt0 -126.0 137.43 53.66 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.547 -0.538 . . . . 73.010000000000005 109.547 176.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 14.9 pt -104.53 142.1 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.175 0 N-CA-C 107.772 -1.195 . . . . 72.430000000000007 107.772 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.37 176.4 49.98 Favored Glycine 0 N--CA 1.414 -2.795 0 N-CA-C 110.398 -1.081 . . . . 74.099999999999994 110.398 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.97 128.62 92.71 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-O 120.883 0.373 . . . . 75.340000000000003 111.047 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.405 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 27.8 Cg_endo -61.13 128.24 24.61 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.728 2.952 . . . . 72.209999999999994 112.521 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -110.23 119.04 37.97 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.316 -0.856 . . . . 71.409999999999997 109.81 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.17 134.31 53.45 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.415 -0.957 . . . . 73.010000000000005 108.415 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.592 ' CG2' HG12 ' A' ' 536' ' ' ILE . 34.7 t . . . . . 0 C--N 1.298 -1.652 0 CA-C-O 121.396 0.617 . . . . 72.420000000000002 109.853 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.468 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 43.9 Cg_endo . . . . . 0 N--CA 1.457 -0.669 0 N-CA-C 110.252 -0.711 . . . . 62.009999999999998 110.252 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.86 162.87 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 108.928 -0.767 . . . . 74.519999999999996 108.928 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.548 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.8 OUTLIER -96.89 166.57 11.56 Favored 'General case' 0 N--CA 1.424 -1.733 0 C-N-CA 119.377 -0.929 . . . . 63.299999999999997 111.813 178.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.513 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -69.36 -168.25 5.86 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 116.182 1.233 . . . . 62.549999999999997 116.182 -175.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -70.83 -39.5 72.98 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.085 -1.058 . . . . 65.120000000000005 108.452 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -138.73 121.92 16.94 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.354 -0.839 . . . . 55.329999999999998 110.05 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 640' ' ' THR . . . . . 0.548 HG21 ' HB2' ' A' ' 636' ' ' LEU . 17.8 p -121.92 92.87 3.83 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.789 -0.641 . . . . 73.450000000000003 109.735 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -161.95 143.01 10.75 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.627 -1.249 . . . . 72.319999999999993 107.627 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.579 HD22 HG11 ' A' ' 523' ' ' VAL . 16.4 tp -128.69 125.7 38.56 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 107.726 -1.212 . . . . 71.299999999999997 107.726 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -93.86 111.48 23.19 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.098 -1.445 . . . . 64.140000000000001 107.098 176.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.86 113.56 39.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.208 -0.664 . . . . 71.219999999999999 109.208 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 38.3 mt -100.43 128.62 52.28 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.554 0 N-CA-C 108.298 -1.001 . . . . 73.540000000000006 108.298 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 57.9 mt -104.51 107.61 22.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 106.894 -1.521 . . . . 54.140000000000001 106.894 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 C--N 1.29 -2.014 0 C-N-CA 120.327 -0.549 . . . . 74.430000000000007 111.934 179.464 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 502' ' ' ALA . . . . . 0.491 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.438 -1.07 0 N-CA-C 113.864 1.061 . . . . 62.119999999999997 113.864 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.433 ' HA3' ' H ' ' A' ' 529' ' ' SER . . . 159.32 -135.42 4.16 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 118.383 -1.865 . . . . 61.240000000000002 113.145 -173.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.4 120.08 55.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 122.075 0.15 . . . . 73.420000000000002 110.968 -173.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.445 ' CE2' ' HB ' ' A' ' 528' ' ' THR . 23.8 m-85 -108.68 126.53 53.09 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.25 -1.019 . . . . 72.099999999999994 108.25 169.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.6 t -171.2 -178.82 2.51 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.671 -0.863 . . . . 75.140000000000001 108.671 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -87.79 152.12 22.36 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 110.444 -0.206 . . . . 73.409999999999997 110.444 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -59.64 -41.11 89.78 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.648 0.737 . . . . 74.010000000000005 110.165 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -135.16 146.59 58.91 Favored Pre-proline 0 N--CA 1.42 -1.96 0 CA-C-N 114.741 -1.118 . . . . 73.420000000000002 108.227 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -71.08 -29.89 17.08 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.167 1.911 . . . . 74.310000000000002 112.665 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.13 136.79 55.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.639 -0.874 . . . . 54.329999999999998 108.639 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.2 t -133.65 141.24 47.53 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 108.39 -0.966 . . . . 74.329999999999998 108.39 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -109.44 132.94 53.66 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.073 -1.051 . . . . 54.240000000000002 109.352 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.3 m -124.34 165.99 20.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 109.044 -0.724 . . . . 73.200000000000003 109.044 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.539 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 72.4 m -93.78 152.61 18.81 Favored 'General case' 0 N--CA 1.394 -3.25 0 CA-C-N 115.649 -0.705 . . . . 75.430000000000007 110.774 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 516' ' ' GLU . . . . . 0.428 ' HA ' HG11 ' A' ' 575' ' ' VAL . 1.8 tm-20 -68.22 -56.74 7.62 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.623 0.725 . . . . 65.030000000000001 109.073 173.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.69 40.68 0.6 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 125.121 1.368 . . . . 65.519999999999996 111.69 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 12.0 tt -104.71 -26.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.155 0.503 . . . . 60.32 111.73 -175.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 519' ' ' GLY . . . . . 0.437 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 91.76 -79.06 1.28 Allowed Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 110.839 -0.904 . . . . 65.230000000000004 110.839 -175.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 37.2 mm -129.79 133.45 64.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.674 -1.232 . . . . 75.099999999999994 107.674 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.584 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -109.91 146.5 35.06 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.445 -0.946 . . . . 74.120000000000005 108.445 175.456 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 26.4 mt-10 -125.7 120.12 29.83 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 123.645 0.591 . . . . 74.530000000000001 111.544 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.584 HG23 ' SD ' ' A' ' 521' ' ' MET . 65.9 t -112.55 129.23 68.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.628 -0.878 . . . . 74.329999999999998 108.628 177.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.613 ' HB3' HG21 ' A' ' 568' ' ' VAL . 29.1 mtmt -86.76 143.13 27.67 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 123.808 0.692 . . . . 75.329999999999998 110.698 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.546 ' O ' HG23 ' A' ' 568' ' ' VAL . 43.3 t -105.02 141.63 19.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.755 -0.657 . . . . 74.519999999999996 109.322 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.96 118.51 17.99 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.69 -0.856 . . . . 74.150000000000006 108.69 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -73.76 153.21 40.1 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.072 -0.714 . . . . 71.409999999999997 109.072 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.445 ' HB ' ' CE2' ' A' ' 505' ' ' PHE . 12.0 t -60.16 157.52 13.07 Favored 'General case' 0 N--CA 1.41 -2.435 0 C-N-CA 123.857 0.863 . . . . 72.239999999999995 110.727 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 529' ' ' SER . . . . . 0.433 ' H ' ' HA3' ' A' ' 503' ' ' GLY . 47.0 t -72.01 -26.95 62.42 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.711 0.767 . . . . 60.109999999999999 109.775 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.85 82.91 0.33 Allowed Glycine 0 N--CA 1.428 -1.842 0 CA-C-N 115.688 -0.687 . . . . 73.349999999999994 111.486 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.64 100.31 13.18 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.655 -1.239 . . . . 73.540000000000006 107.655 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.42 ' HD3' ' HA ' ' A' ' 532' ' ' ARG . 39.2 mmt180 -111.86 96.84 6.29 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.627 0.727 . . . . 55.299999999999997 111.882 -176.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 101.96 -122.84 7.69 Favored Glycine 0 N--CA 1.428 -1.859 0 CA-C-N 114.576 -1.193 . . . . 72.129999999999995 110.417 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -133.13 127.98 35.09 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.13 0.49 . . . . 52.43 110.295 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 64.5 t -130.39 136.54 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 108.837 -0.801 . . . . 72.010000000000005 108.837 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.521 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 40.3 mm -106.69 138.46 32.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 109.088 -0.708 . . . . 72.450000000000003 109.088 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.1 t -122.91 110.08 31.66 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 109.598 -0.519 . . . . 65.219999999999999 109.598 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.28 155.19 51.56 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.362 2.041 . . . . 71.409999999999997 111.903 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.456 ' HB3' HG22 ' A' ' 591' ' ' ILE . 31.5 p90 -150.84 156.15 40.66 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 110.153 -0.314 . . . . 55.340000000000003 110.153 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.59 156.21 40.93 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 123.714 0.634 . . . . 73.030000000000001 111.922 175.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 18.9 p -79.35 153.59 29.68 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 109.373 -0.603 . . . . 71.219999999999999 109.373 175.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 81.8 mt -117.54 113.91 43.95 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 107.313 -1.365 . . . . 74.420000000000002 107.313 176.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -84.2 147.58 27.21 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.305 -0.861 . . . . 75.400000000000006 108.732 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 178.31 -91.82 0.08 OUTLIER Glycine 0 C--N 1.307 -1.046 0 C-N-CA 120.601 -0.809 . . . . 73.409999999999997 111.526 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -2.6 30.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.679 0.752 . . . . 74.040000000000006 112.045 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 587' ' ' PHE . . . -144.43 141.52 29.68 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 104.536 -2.394 . . . . 31.010000000000002 104.536 171.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.498 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 71.9 mtt180 -104.05 145.69 29.81 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 121.912 0.863 . . . . 50.43 112.635 -173.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.73 -153.23 27.83 Favored Glycine 0 N--CA 1.421 -2.303 0 N-CA-C 109.371 -1.492 . . . . 63.25 109.371 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 549' ' ' GLY . . . . . 0.409 ' H ' ' CG ' ' A' ' 555' ' ' ASP . . . 78.0 8.75 87.3 Favored Glycine 0 C--N 1.292 -1.891 0 N-CA-C 111.429 -0.668 . . . . 65.239999999999995 111.429 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 79.05 29.6 50.36 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 110.647 -0.981 . . . . 73.099999999999994 110.647 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.498 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 32.1 tt0 -96.86 -60.99 1.48 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.712 -0.477 . . . . 64.109999999999999 109.712 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -103.3 -43.71 5.36 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 108.609 -0.886 . . . . 72.420000000000002 108.609 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -135.11 158.1 45.23 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.377 -0.829 . . . . 65.439999999999998 109.013 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.471 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 13.9 tt0 -84.19 138.3 33.06 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.604 -1.258 . . . . 71.239999999999995 107.604 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 555' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 549' ' ' GLY . 7.5 m-20 -71.81 121.19 18.53 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 109.682 -0.488 . . . . 61.520000000000003 109.682 -177.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.489 HG21 HG22 ' A' ' 573' ' ' VAL . 13.5 t -130.13 146.11 51.75 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-O 121.468 0.651 . . . . 73.099999999999994 109.411 176.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 5.0 p -167.52 155.27 8.94 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.973 -1.492 . . . . 73.319999999999993 106.973 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 165.01 -153.44 23.63 Favored Glycine 0 N--CA 1.41 -3.086 0 C-N-CA 119.789 -1.196 . . . . 72.340000000000003 110.484 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.521 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 46.7 mt-10 -139.55 133.09 30.31 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.117 0.484 . . . . 72.439999999999998 110.466 -175.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' ' 569' ' ' LYS . 96.5 mt -97.36 137.91 35.62 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.827 -0.624 . . . . 71.219999999999999 109.468 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.485 ' HA ' HD13 ' A' ' 536' ' ' ILE . 33.3 tt0 -99.18 115.47 29.16 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 121.203 0.525 . . . . 45.109999999999999 110.706 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -111.63 145.05 39.89 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.604 -0.887 . . . . 74.340000000000003 108.604 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.495 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 46.7 mt-30 -147.25 -176.3 5.17 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.582 -0.896 . . . . 73.230000000000004 108.582 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -68.4 -31.69 71.21 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.452 -0.944 . . . . 55.049999999999997 108.452 172.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -84.49 -38.39 20.15 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.572 -1.195 . . . . 61.43 111.671 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.495 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 36.5 mm-40 -75.67 129.33 36.96 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 116.674 -0.239 . . . . 74.030000000000001 111.064 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.584 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.8 pt -90.02 -72.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.897 -0.592 . . . . 55.399999999999999 111.804 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' ' 524' ' ' LYS . 12.5 p -130.96 149.23 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 CA-C-O 121.204 0.526 . . . . 54.329999999999998 110.347 -177.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.537 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -120.29 156.43 31.26 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 109.387 -0.597 . . . . 74.530000000000001 109.387 175.549 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.442 ' CG2' ' HG2' ' A' ' 524' ' ' LYS . 3.3 p -119.81 147.28 44.84 Favored 'General case' 0 C--N 1.283 -2.285 0 O-C-N 124.161 0.913 . . . . 43.329999999999998 112.721 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.2 mp -94.41 122.6 46.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 106.353 -1.721 . . . . 74.049999999999997 106.353 172.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 572' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 521' ' ' MET . 18.7 m -102.94 116.81 33.27 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 123.813 0.696 . . . . 62.140000000000001 109.127 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.489 HG22 HG21 ' A' ' 556' ' ' THR . 86.2 t -119.47 128.46 75.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 109.144 -0.688 . . . . 73.340000000000003 109.144 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 23.9 tptm -83.97 124.1 30.68 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.752 -0.832 . . . . 75.540000000000006 108.752 176.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 575' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 516' ' ' GLU . 47.9 t -94.26 127.36 46.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 108.61 -0.885 . . . . 72.230000000000004 108.61 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 45.5 mm . . . . . 0 C--N 1.304 -1.37 0 N-CA-C 108.658 -0.867 . . . . 71.409999999999997 108.658 -178.517 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp . . . . . 0 C--O 1.211 -0.949 0 CA-C-O 121.152 0.501 . . . . 73.5 111.098 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.0 t -153.32 135.73 15.04 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 109.48 -0.563 . . . . 70.310000000000002 109.48 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.407 ' HB3' ' HB3' ' A' ' 546' ' ' ALA . 40.9 p90 -129.37 178.1 6.69 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.786 -1.19 . . . . 72.120000000000005 107.786 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.55 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 67.4 m-85 -123.43 154.59 38.84 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.806 -0.813 . . . . 75.319999999999993 108.806 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.81 131.3 53.56 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 106.191 -1.781 . . . . 53.32 106.191 178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.508 ' HB2' HD11 ' A' ' 542' ' ' ILE . 42.6 tt0 -126.97 139.06 53.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.589 -0.523 . . . . 72.510000000000005 109.589 177.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.456 HG22 ' HB3' ' A' ' 539' ' ' TYR . 20.3 pt -106.0 141.57 21.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.322 -0.992 . . . . 75.010000000000005 108.322 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.12 179.54 49.67 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 111.236 -0.746 . . . . 72.140000000000001 111.236 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.78 134.26 86.08 Favored Pre-proline 0 N--CA 1.435 -1.225 0 C-N-CA 120.912 -0.315 . . . . 73.519999999999996 110.632 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.415 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 21.7 Cg_endo -61.36 146.94 96.72 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.255 2.636 . . . . 74.230000000000004 112.064 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -124.47 125.04 43.6 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.024 -0.534 . . . . 71.219999999999999 109.562 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -72.08 129.17 37.86 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.664 -1.236 . . . . 75.129999999999995 107.664 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.51 ' CG2' HG12 ' A' ' 536' ' ' ILE . 48.6 t . . . . . 0 C--N 1.3 -1.56 0 N-CA-C 108.766 -0.827 . . . . 65.049999999999997 108.766 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.491 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 53.3 Cg_endo . . . . . 0 N--CA 1.444 -1.435 0 N-CA-C 110.922 -0.453 . . . . 65.319999999999993 110.922 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 635' ' ' ILE . . . . . 0.501 HD13 ' H ' ' A' ' 635' ' ' ILE . 0.1 OUTLIER -124.95 175.93 6.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.535 -0.913 . . . . 42.420000000000002 108.535 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.59 -176.3 3.03 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.267 -0.573 . . . . 73.519999999999996 112.086 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -80.62 -153.39 9.21 Favored Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 115.893 -0.594 . . . . 42.020000000000003 113.351 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -71.87 -57.13 4.59 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 123.392 0.677 . . . . 71.430000000000007 110.224 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -135.06 139.13 44.53 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 109.556 -0.535 . . . . 72.549999999999997 109.556 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 29.7 p -124.47 99.83 6.38 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.206 0.526 . . . . 73.310000000000002 111.249 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -165.8 150.73 8.57 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.082 -1.081 . . . . 74.420000000000002 108.082 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.479 HD21 HG21 ' A' ' 523' ' ' VAL . 34.8 tp -130.95 131.34 44.37 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.021 -1.103 . . . . 44.32 108.021 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -97.04 104.52 16.54 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.915 -1.513 . . . . 74.519999999999996 106.915 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 40.8 t -99.47 113.53 34.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 109.982 -0.377 . . . . 74.540000000000006 109.982 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 59.6 mt -99.11 126.97 52.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 109.027 -0.731 . . . . 52.039999999999999 109.027 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 57.2 mt -104.06 110.39 30.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.264 -1.013 . . . . 75.439999999999998 108.264 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 C--N 1.288 -2.068 0 CA-C-N 116.443 -0.344 . . . . 72.010000000000005 110.241 178.136 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 502' ' ' ALA . . . . . 0.54 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.421 -1.925 0 N-CA-C 111.656 0.243 . . . . 75.349999999999994 111.656 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 160.94 -153.24 24.05 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 111.241 -0.743 . . . . 74.340000000000003 111.241 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.86 130.94 67.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 123.148 0.579 . . . . 72.340000000000003 112.049 -167.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -108.51 132.57 53.69 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.315 -0.624 . . . . 63.509999999999998 109.315 168.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.7 t -168.69 173.72 7.1 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.405 -0.591 . . . . 63.409999999999997 109.405 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -77.25 147.26 36.43 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 120.939 0.399 . . . . 73.200000000000003 110.751 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -67.98 -35.65 78.72 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.487 -0.779 . . . . 61.350000000000001 109.906 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -127.76 144.4 51.12 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.115 -1.069 . . . . 74.010000000000005 108.115 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.03 -31.34 6.24 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.146 1.897 . . . . 73.540000000000006 111.986 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.97 138.04 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 106.511 -1.663 . . . . 72.129999999999995 106.511 -177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.4 t -132.19 140.82 48.86 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 108.06 -1.089 . . . . 55.219999999999999 108.06 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -120.28 124.19 45.03 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 109.253 -0.647 . . . . 74.209999999999994 109.253 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.8 m -115.7 167.34 8.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.001 -1.0 . . . . 75.239999999999995 109.398 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.631 ' O ' HG22 ' A' ' 518' ' ' ILE . 23.2 t -97.04 153.89 17.65 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 120.96 0.41 . . . . 64.409999999999997 110.229 -176.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -65.51 -42.2 92.35 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.143 -1.429 . . . . 74.129999999999995 107.143 169.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.4 m -90.66 23.98 2.85 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.995 -1.002 . . . . 64.420000000000002 112.432 -173.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 515' ' ' SER . 8.8 tt -90.94 -22.08 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 121.575 -0.703 . . . . 75.430000000000007 109.825 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 83.97 -75.6 2.35 Favored Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.677 -0.773 . . . . 71.310000000000002 111.234 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.0 mm -129.83 130.2 66.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 106.983 -1.488 . . . . 62.509999999999998 106.983 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.616 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -106.39 147.34 29.38 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 109.131 -0.692 . . . . 74.5 109.131 178.612 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.3 mt-10 -127.91 114.84 17.69 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 123.852 0.72 . . . . 54.439999999999998 110.945 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.55 HG21 HD21 ' A' ' 642' ' ' LEU . 90.7 t -102.33 127.96 55.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.778 -0.823 . . . . 73.099999999999994 108.778 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.409 ' HB3' HG21 ' A' ' 568' ' ' VAL . 25.7 mtmm -87.6 138.91 31.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 121.442 0.639 . . . . 53.240000000000002 110.667 -177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 61.0 t -108.2 129.93 61.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.443 -0.799 . . . . 63.299999999999997 108.847 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.5 130.01 41.77 Favored 'General case' 0 CA--C 1.501 -0.915 0 O-C-N 123.862 0.726 . . . . 74.109999999999999 109.87 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -82.65 155.1 24.56 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 115.151 -0.931 . . . . 74.239999999999995 110.024 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.2 t -56.05 145.48 25.51 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 124.763 1.225 . . . . 64.200000000000003 111.538 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.9 t -60.53 -31.77 70.84 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 124.375 1.07 . . . . 70.420000000000002 109.042 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -122.26 99.51 0.67 Allowed Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 109.71 -1.356 . . . . 53.439999999999998 109.71 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.44 101.6 12.76 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.948 -1.13 . . . . 63.5 107.948 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -107.75 100.77 10.13 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.261 -0.881 . . . . 52.030000000000001 110.389 -172.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 75.53 -114.68 4.33 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.395 -0.907 . . . . 62.439999999999998 112.36 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -133.99 129.18 35.8 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.143 0.577 . . . . 72.109999999999999 109.459 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 93.1 t -130.24 135.64 60.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 C-N-CA 123.56 0.744 . . . . 51.340000000000003 109.126 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.502 HG12 ' CG2' ' A' ' 597' ' ' VAL . 38.0 mm -108.74 131.25 59.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.88 -0.415 . . . . 63.399999999999999 109.88 176.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.43 HG22 ' HB3' ' A' ' 594' ' ' PRO . 26.6 t -119.23 105.9 43.79 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 109.21 -0.663 . . . . 75.109999999999999 109.21 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.86 153.19 58.57 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.317 2.011 . . . . 72.439999999999998 112.048 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.487 ' HB3' HG22 ' A' ' 591' ' ' ILE . 52.1 p90 -151.02 159.64 44.42 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.642 0.258 . . . . 72.140000000000001 110.786 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.03 157.05 33.94 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.463 -0.79 . . . . 75.340000000000003 112.084 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.6 p -84.86 139.68 31.71 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.866 -0.607 . . . . 75.120000000000005 109.828 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.528 HD11 ' HB2' ' A' ' 590' ' ' GLU . 69.1 mt -107.63 134.37 49.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.132 -0.692 . . . . 71.439999999999998 109.132 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -85.62 142.97 28.71 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.923 -0.58 . . . . 62.310000000000002 110.337 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 151.77 141.58 3.35 Favored Glycine 0 CA--C 1.471 -2.678 0 N-CA-C 107.924 -2.07 . . . . 61.310000000000002 107.924 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . 0.357 1.0 OUTLIER 61.11 -47.17 0.12 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 115.377 1.621 . . . . 64.409999999999997 115.377 -174.066 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.451 ' HA ' ' HD2' ' A' ' 585' ' ' LYS . . . -107.87 150.38 27.12 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.193 -1.04 . . . . 75.319999999999993 108.193 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -92.37 128.74 38.33 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.745 0.783 . . . . 75.209999999999994 111.347 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.78 -153.5 21.68 Favored Glycine 0 C--N 1.3 -1.421 0 CA-C-N 115.056 -0.975 . . . . 52.210000000000001 112.96 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 549' ' ' GLY . . . . . 0.467 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 57.12 30.84 61.24 Favored Glycine 0 C--N 1.317 -0.48 0 N-CA-C 113.76 0.264 . . . . 65.230000000000004 113.76 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 73.31 39.68 50.98 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.735 -0.745 . . . . 70.150000000000006 111.991 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -112.88 -51.77 2.81 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 122.363 -0.492 . . . . 74.340000000000003 110.869 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -111.14 -35.31 5.93 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.385 -1.339 . . . . 74.519999999999996 107.385 169.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -139.54 148.94 43.29 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.781 -1.192 . . . . 74.420000000000002 107.781 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.77 136.0 37.26 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.337 -1.357 . . . . 72.230000000000004 107.337 175.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 555' ' ' ASP . . . . . 0.467 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 17.5 t70 -90.69 119.9 31.31 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.592 -0.521 . . . . 63.329999999999998 109.592 -174.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.403 HG21 HG22 ' A' ' 573' ' ' VAL . 10.3 t -128.02 155.03 44.97 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.263 0.554 . . . . 64.120000000000005 111.04 -174.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 26.4 p -149.79 158.37 44.11 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.955 -1.498 . . . . 73.109999999999999 106.955 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 168.78 -167.7 40.57 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 109.893 -1.283 . . . . 74.400000000000006 109.893 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.478 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 43.6 mt-10 -132.64 138.42 47.34 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.804 -0.443 . . . . 70.040000000000006 109.804 -178.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.595 HD22 ' HB3' ' A' ' 569' ' ' LYS . 76.6 mt -95.7 133.93 39.22 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.726 -0.472 . . . . 44.340000000000003 109.726 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.495 ' HA ' HD13 ' A' ' 536' ' ' ILE . 24.8 tt0 -101.25 106.43 17.64 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.847 -0.615 . . . . 72.219999999999999 110.279 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -105.04 148.22 27.01 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.007 -0.738 . . . . 73.340000000000003 109.007 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.484 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 44.5 mt-30 -145.02 -178.04 5.84 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.944 -1.132 . . . . 72.109999999999999 107.944 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -68.84 -31.89 71.19 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.117 -1.068 . . . . 72.099999999999994 108.117 173.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.42 -52.33 7.79 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.109 -0.95 . . . . 71.409999999999997 111.809 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.484 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 14.7 mm-40 -55.25 125.62 21.45 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 123.449 0.7 . . . . 70.239999999999995 111.743 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.613 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.7 pt -84.63 -63.03 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.266 -0.879 . . . . 73.209999999999994 112.646 -175.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.613 ' H ' HG13 ' A' ' 567' ' ' ILE . 10.0 p -143.48 150.57 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 109.213 -0.662 . . . . 41.439999999999998 109.213 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.595 ' HB3' HD22 ' A' ' 560' ' ' LEU . 6.1 mmpt? -118.05 165.57 13.58 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.728 -0.471 . . . . 71.010000000000005 109.728 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.6 p -135.14 147.43 49.47 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 123.962 0.789 . . . . 45.329999999999998 112.363 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.463 HG22 HG23 ' A' ' 573' ' ' VAL . 3.0 mp -100.47 118.1 46.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 106.941 -1.503 . . . . 62.549999999999997 106.941 172.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 572' ' ' SER . . . . . 0.616 ' HA ' ' O ' ' A' ' 521' ' ' MET . 3.3 p -95.95 117.0 29.78 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 124.099 0.874 . . . . 55.409999999999997 110.399 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.463 HG23 HG22 ' A' ' 571' ' ' ILE . 89.0 t -124.79 132.17 71.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 O-C-N 122.239 -0.288 . . . . 62.439999999999998 110.792 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -79.62 123.0 27.22 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 123.856 0.723 . . . . 73.010000000000005 109.703 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 49.0 t -90.2 126.96 43.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.555 -0.905 . . . . 65.540000000000006 108.555 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 26.2 mm . . . . . 0 C--N 1.315 -0.93 0 N-CA-C 109.9 -0.407 . . . . 71.409999999999997 109.9 -177.682 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.451 ' HD2' ' HA ' ' A' ' 546' ' ' ALA . 34.5 mmtp . . . . . 0 N--CA 1.422 -1.838 0 CA-C-O 121.448 0.642 . . . . 75.030000000000001 110.087 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.7 t -150.0 146.89 27.26 Favored 'General case' 0 N--CA 1.402 -2.872 0 CA-C-N 114.696 -1.138 . . . . 44.140000000000001 107.93 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -138.03 178.77 6.87 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.788 -1.19 . . . . 74.030000000000001 107.788 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.455 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 85.5 m-85 -121.03 152.03 39.09 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.188 -0.605 . . . . 71.030000000000001 109.954 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.45 131.02 54.57 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.032 -1.84 . . . . 71.209999999999994 106.032 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.528 ' HB2' HD11 ' A' ' 542' ' ' ILE . 36.8 tt0 -127.69 136.31 51.39 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.065 0.459 . . . . 75.310000000000002 110.316 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.487 HG22 ' HB3' ' A' ' 539' ' ' TYR . 23.8 pt -105.56 142.45 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.12 0 N-CA-C 107.547 -1.279 . . . . 74.340000000000003 107.547 175.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -88.17 -176.0 47.68 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.665 -0.974 . . . . 60.109999999999999 110.665 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.47 130.38 89.19 Favored Pre-proline 0 C--N 1.301 -1.541 0 CA-C-O 120.809 0.338 . . . . 73.310000000000002 110.931 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.43 ' HB3' HG22 ' A' ' 537' ' ' VAL . 34.6 Cg_endo -66.97 130.88 23.98 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.103 2.535 . . . . 64.310000000000002 111.335 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -111.88 134.34 53.5 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.936 -0.394 . . . . 74.129999999999995 109.936 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.424 HD23 ' HD3' ' A' ' 634' ' ' PRO . 1.7 tm? -72.56 132.1 43.35 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.485 -1.302 . . . . 54.130000000000003 107.485 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.502 ' CG2' HG12 ' A' ' 536' ' ' ILE . 47.5 t . . . . . 0 C--N 1.302 -1.49 0 N-CA-C 109.146 -0.687 . . . . 40.399999999999999 109.146 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.54 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 36.2 Cg_endo . . . . . 0 N--CA 1.451 -1.02 0 N-CA-C 110.111 -0.765 . . . . 54.25 110.111 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.64 174.6 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 116.227 -0.442 . . . . 53.049999999999997 110.722 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.65 172.58 6.81 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 120.184 -0.607 . . . . 72.540000000000006 112.507 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -82.68 -164.86 35.95 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 115.166 0.826 . . . . 64.5 115.166 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -67.91 -50.19 57.63 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.965 -1.117 . . . . 75.120000000000005 110.514 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -129.06 120.64 26.31 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.946 -0.761 . . . . 73.439999999999998 108.946 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 14.0 p -118.68 80.76 1.59 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 122.567 1.175 . . . . 52.539999999999999 110.293 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -154.44 141.79 19.6 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 114.057 -1.428 . . . . 61.5 108.889 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.55 HD21 HG21 ' A' ' 523' ' ' VAL . 33.4 tp -129.93 122.96 29.59 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 108.787 -0.82 . . . . 72.140000000000001 108.787 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -92.54 112.32 24.23 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.132 -1.433 . . . . 73.310000000000002 107.132 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.68 110.33 28.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.514 -0.55 . . . . 54.109999999999999 109.514 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 50.5 mt -96.47 135.37 30.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 109.332 -0.618 . . . . 72.230000000000004 109.332 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 84.8 mt -103.05 110.01 28.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 109.034 -0.728 . . . . 73.25 109.034 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 C--N 1.289 -2.038 0 N-CA-C 108.202 -1.036 . . . . 74.519999999999996 108.202 176.855 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 502' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.428 -1.57 0 N-CA-C 108.921 -0.77 . . . . 75.120000000000005 108.921 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -172.26 -144.36 4.5 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 109.595 -1.402 . . . . 12.539999999999999 109.595 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.6 mp -103.53 114.29 42.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 116.79 0.295 . . . . 73.439999999999998 111.522 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -100.16 126.4 46.42 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.401 -0.963 . . . . 64.140000000000001 108.401 169.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.0 t -169.88 174.41 5.64 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.902 -0.777 . . . . 75.540000000000006 108.902 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -80.55 147.83 30.63 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 110.325 -0.25 . . . . 73.430000000000007 110.325 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -63.5 -40.78 97.96 Favored 'General case' 0 CA--C 1.492 -1.282 0 CA-C-O 122.238 1.018 . . . . 75.5 109.083 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -123.28 135.71 26.29 Favored Pre-proline 0 N--CA 1.401 -2.904 0 CA-C-N 113.948 -1.478 . . . . 73.540000000000006 107.218 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.34 -24.84 11.91 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.806 2.337 . . . . 45.549999999999997 111.519 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 61.7 t -136.25 132.99 49.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 107.142 -1.429 . . . . 75.140000000000001 107.142 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 7.1 t -128.48 133.07 48.4 Favored 'General case' 0 N--CA 1.402 -2.828 0 N-CA-C 108.569 -0.9 . . . . 44.130000000000003 108.569 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -105.8 121.87 44.92 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 109.045 -0.724 . . . . 74.019999999999996 109.045 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.6 m -113.56 174.52 2.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.418 -0.586 . . . . 64.510000000000005 109.418 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.634 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 57.9 m -92.43 165.6 12.97 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 123.254 0.621 . . . . 71.140000000000001 110.993 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.99 -50.72 10.66 Favored 'General case' 0 CA--C 1.57 1.74 0 C-N-CA 124.789 1.236 . . . . 74.430000000000007 112.918 -175.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 48.9 m -105.89 27.32 8.65 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.05 0.94 . . . . 60.149999999999999 110.448 -176.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.634 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 12.1 tt -63.25 -32.92 58.19 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-N 115.447 -0.797 . . . . 74.25 112.831 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 103.79 -83.8 0.42 Allowed Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 109.927 -1.269 . . . . 74.310000000000002 109.927 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 520' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 574' ' ' LYS . 34.8 mm -133.9 136.57 53.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 105.979 -1.859 . . . . 61.520000000000003 105.979 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.524 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -112.96 141.5 46.72 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.45 -0.574 . . . . 75.439999999999998 109.45 177.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 7.3 mp0 -114.55 132.55 56.28 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 124.194 0.934 . . . . 74.519999999999996 110.08 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.524 HG23 ' SD ' ' A' ' 521' ' ' MET . 87.7 t -124.06 129.09 74.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 108.746 -0.835 . . . . 64.230000000000004 108.746 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.472 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 24.6 mtmm -86.51 139.07 31.22 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.146 0.498 . . . . 73.450000000000003 111.898 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.575 ' O ' HG23 ' A' ' 568' ' ' VAL . 39.6 t -104.18 126.26 58.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.255 -0.646 . . . . 74.439999999999998 109.255 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.18 121.46 12.59 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 123.777 0.673 . . . . 75.420000000000002 110.206 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.523 ' CZ ' ' HB3' ' A' ' 562' ' ' PHE . 10.2 tpt180 -68.93 148.37 50.29 Favored 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 115.198 -0.91 . . . . 71.109999999999999 110.91 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 11.4 p -56.97 139.1 53.12 Favored 'General case' 0 N--CA 1.408 -2.525 0 CA-C-N 114.749 -1.114 . . . . 74.120000000000005 111.916 175.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.7 m -56.19 -24.4 41.39 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 125.777 1.631 . . . . 73.109999999999999 110.746 175.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -122.99 114.25 2.37 Favored Glycine 0 N--CA 1.419 -2.446 0 N-CA-C 108.842 -1.703 . . . . 51.32 108.842 172.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -106.14 101.26 10.76 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.91 -0.774 . . . . 44.240000000000002 108.91 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -129.73 116.2 18.42 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.966 -0.561 . . . . 62.039999999999999 109.748 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 78.26 -164.64 51.3 Favored Glycine 0 C--N 1.316 -0.571 0 C-N-CA 120.901 -0.666 . . . . 61.329999999999998 112.379 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 534' ' ' ASN . . . . . 0.44 ' OD1' ' HG2' ' A' ' 563' ' ' GLN . 41.8 t30 -103.47 123.08 46.23 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.244 0.545 . . . . 73.340000000000003 109.878 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 48.1 t -126.48 136.97 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 N-CA-C 108.071 -1.085 . . . . 72.239999999999995 108.071 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.508 HG12 ' CG2' ' A' ' 597' ' ' VAL . 40.2 mm -107.98 135.29 47.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 109.205 -0.665 . . . . 71.129999999999995 109.205 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.51 109.74 36.23 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 109.232 -0.655 . . . . 70.049999999999997 109.232 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -75.9 159.24 38.26 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.124 1.883 . . . . 34.210000000000001 111.45 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -143.92 162.83 35.13 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.233 -0.655 . . . . 73.129999999999995 109.233 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -153.39 157.23 39.67 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 123.882 0.738 . . . . 73.329999999999998 109.739 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.3 p -93.41 139.25 30.9 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.626 0.727 . . . . 72.239999999999995 111.605 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 89.7 mt -109.53 122.74 64.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.573 -1.269 . . . . 71.329999999999998 107.573 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -78.81 117.73 20.2 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.677 -0.49 . . . . 53.409999999999997 109.677 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -102.85 -111.58 3.56 Favored Glycine 0 C--N 1.302 -1.355 0 N-CA-C 109.892 -1.283 . . . . 70.150000000000006 109.892 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 28.4 p -78.93 -32.63 45.66 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.508 -0.923 . . . . 64.319999999999993 108.508 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -84.46 141.48 30.76 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.753 -1.112 . . . . 72.219999999999999 109.207 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.481 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 64.6 mtt180 -101.58 146.2 28.01 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-O 121.334 0.588 . . . . 73.340000000000003 111.144 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -94.37 -161.18 34.75 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 114.993 -1.003 . . . . 65.109999999999999 112.137 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 549' ' ' GLY . . . . . 0.478 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 74.65 8.08 80.78 Favored Glycine 0 C--N 1.315 -0.621 0 N-CA-C 112.386 -0.286 . . . . 62.399999999999999 112.386 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 550' ' ' GLY . . . . . 0.412 ' C ' HG13 ' A' ' 576' ' ' ILE . . . 103.71 10.09 36.16 Favored Glycine 0 N--CA 1.419 -2.476 0 C-N-CA 120.263 -0.97 . . . . 73.099999999999994 112.865 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.481 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 28.0 tt0 -83.46 -66.29 0.91 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 118.991 -1.084 . . . . 73.219999999999999 110.355 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -101.37 -41.63 6.59 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.229 -1.026 . . . . 74.409999999999997 108.229 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -137.34 158.78 43.67 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.809 -1.182 . . . . 73.019999999999996 107.809 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.78 137.16 33.86 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 107.513 -1.292 . . . . 73.329999999999998 107.513 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 555' ' ' ASP . . . . . 0.478 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 33.0 t70 -84.46 103.84 13.95 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.787 -0.82 . . . . 72.150000000000006 108.787 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.484 ' CG2' HG22 ' A' ' 573' ' ' VAL . 11.5 t -110.72 146.01 37.03 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-O 122.234 1.016 . . . . 62.200000000000003 111.873 -172.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 21.8 p -145.56 147.5 32.16 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 105.931 -1.878 . . . . 64.140000000000001 105.931 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -170.06 -179.76 41.84 Favored Glycine 0 CA--C 1.477 -2.317 0 N-CA-C 110.199 -1.16 . . . . 63.229999999999997 110.199 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 39.2 mt-10 -129.6 114.4 16.0 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.103 0.478 . . . . 75.200000000000003 110.731 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 88.1 mt -85.5 138.29 32.32 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.311 -0.859 . . . . 62.210000000000001 109.448 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.498 ' HA ' HD13 ' A' ' 536' ' ' ILE . 34.4 tt0 -104.52 118.49 36.71 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.99 -0.55 . . . . 61.240000000000002 110.23 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 527' ' ' ARG . 97.9 m-85 -124.44 107.51 11.18 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.704 -0.48 . . . . 73.120000000000005 109.704 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.606 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 29.8 mt-30 -109.03 178.46 4.46 Favored 'General case' 0 C--O 1.197 -1.67 0 N-CA-C 108.752 -0.833 . . . . 71.420000000000002 108.752 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -52.93 -44.81 67.3 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 123.439 0.462 . . . . 51.219999999999999 110.82 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.52 -49.04 35.55 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.207 0.447 . . . . 75.319999999999993 112.207 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.606 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 14.0 mp0 -54.68 141.9 30.41 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.638 0.775 . . . . 75.219999999999999 111.804 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.549 HG13 ' H ' ' A' ' 568' ' ' VAL . 5.5 pt -101.8 -89.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 112.923 0.712 . . . . 61.329999999999998 112.923 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 525' ' ' VAL . 10.5 p -115.34 152.22 17.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 110.281 -0.266 . . . . 40.329999999999998 110.281 -175.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -126.96 164.56 21.21 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 122.824 0.45 . . . . 71.140000000000001 110.253 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.5 p -123.21 150.56 43.24 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 123.655 0.597 . . . . 72.420000000000002 112.071 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.1 mp -94.41 125.98 46.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 106.784 -1.562 . . . . 74.120000000000005 106.784 172.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 572' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 521' ' ' MET . 51.5 m -104.9 115.56 30.5 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 123.905 0.753 . . . . 62.420000000000002 110.155 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.484 HG22 ' CG2' ' A' ' 556' ' ' THR . 93.7 t -116.84 128.51 74.2 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 116.244 -0.435 . . . . 74.430000000000007 110.447 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.431 ' HA ' HD13 ' A' ' 520' ' ' ILE . 52.8 tptt -80.27 111.96 17.14 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 108.654 -0.869 . . . . 61.109999999999999 108.654 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 61.9 t -86.65 124.39 40.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 106.056 -1.831 . . . . 72.409999999999997 106.056 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 576' ' ' ILE . . . . . 0.412 HG13 ' C ' ' A' ' 550' ' ' GLY . 40.7 mm . . . . . 0 C--N 1.296 -1.725 0 CA-C-O 121.903 0.859 . . . . 71.200000000000003 109.27 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt . . . . . 0 CA--C 1.499 -0.987 0 N-CA-C 114.556 1.317 . . . . 62.409999999999997 114.556 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.0 t -146.18 159.02 43.88 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 114.254 -1.339 . . . . 72.120000000000005 109.976 -174.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 46.8 p90 -141.26 176.9 8.47 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.13 -1.433 . . . . 72.310000000000002 107.13 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.567 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 85.1 m-85 -121.79 154.7 36.63 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.659 -0.816 . . . . 75.099999999999994 109.614 -177.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.1 OUTLIER -120.52 131.05 54.52 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.171 -1.788 . . . . 72.239999999999995 106.171 177.694 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.542 ' HB2' HD11 ' A' ' 542' ' ' ILE . 39.5 tt0 -125.91 134.12 51.68 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.269 -0.641 . . . . 64.409999999999997 109.269 177.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 13.9 pt -99.14 143.35 13.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.682 -0.859 . . . . 74.450000000000003 108.682 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.7 171.94 45.79 Favored Glycine 0 N--CA 1.413 -2.89 0 N-CA-C 111.452 -0.659 . . . . 70.400000000000006 111.452 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.63 131.57 89.66 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 123.615 0.244 . . . . 73.540000000000006 110.484 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.414 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.3 Cg_endo -59.25 125.99 19.62 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.381 2.721 . . . . 73.430000000000007 112.896 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -104.46 119.55 39.22 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.307 -0.86 . . . . 73.329999999999998 109.328 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.95 129.81 41.06 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.094 -0.957 . . . . 64.450000000000003 108.67 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.508 ' CG2' HG12 ' A' ' 536' ' ' ILE . 50.2 t . . . . . 0 C--N 1.3 -1.55 0 N-CA-C 108.223 -1.029 . . . . 73.510000000000005 108.223 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.45 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 44.6 Cg_endo . . . . . 0 N--CA 1.436 -1.891 0 CA-C-O 121.344 0.477 . . . . 75.430000000000007 111.279 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -124.84 171.13 14.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 115.403 -0.817 . . . . 64.040000000000006 110.176 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.91 -178.26 3.43 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 112.289 0.478 . . . . 62.049999999999997 112.289 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.49 -172.07 27.61 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 114.843 0.697 . . . . 74.129999999999995 114.843 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -68.3 -53.78 22.03 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.147 0.979 . . . . 72.129999999999995 110.385 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -120.12 121.34 38.61 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.954 -0.758 . . . . 62.43 108.954 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 18.3 p -120.75 94.08 4.24 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.498 0.666 . . . . 72.219999999999999 110.747 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -166.4 152.18 8.55 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.294 -1.373 . . . . 64.430000000000007 107.294 -177.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.447 HD21 HG21 ' A' ' 523' ' ' VAL . 48.5 tp -134.57 132.9 39.64 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.243 -1.021 . . . . 72.109999999999999 108.243 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -100.11 110.27 22.55 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 106.906 -1.516 . . . . 74.310000000000002 106.906 174.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 44.5 t -101.82 110.99 30.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 109.219 -0.66 . . . . 71.239999999999995 109.219 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 26.8 mt -98.67 127.47 51.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 108.315 -0.994 . . . . 74.430000000000007 108.315 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 66.6 mt -97.15 103.55 14.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 107.798 -1.186 . . . . 75.400000000000006 107.798 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 515' ' ' SER . 34.5 mt-10 . . . . . 0 C--N 1.303 -1.43 0 C-N-CA 120.421 -0.511 . . . . 75.209999999999994 111.573 -173.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 502' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.437 -1.105 0 CA-C-O 120.887 0.375 . . . . 51.109999999999999 111.417 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 160.11 -153.43 24.39 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 109.892 -1.283 . . . . 61.329999999999998 109.892 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -121.94 124.51 71.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 117.034 0.417 . . . . 74.439999999999998 111.503 -171.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -107.3 124.36 49.67 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.95 -0.759 . . . . 71.239999999999995 108.95 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.6 t -168.19 172.73 8.4 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.446 -0.575 . . . . 75.299999999999997 109.446 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -75.26 145.04 42.23 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.565 -0.289 . . . . 75.530000000000001 111.054 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.06 -29.63 70.01 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.53 0.681 . . . . 70.540000000000006 110.068 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -137.87 141.66 33.48 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 107.768 -1.197 . . . . 74.129999999999995 107.768 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.84 -24.65 15.24 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.697 2.265 . . . . 70.450000000000003 111.608 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 57.2 t -135.35 133.72 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 N-CA-C 106.611 -1.626 . . . . 61.149999999999999 106.611 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 512' ' ' THR . . . . . 0.429 ' HB ' HD11 ' A' ' 642' ' ' LEU . 7.1 t -125.11 140.7 52.65 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.51 -1.292 . . . . 70.439999999999998 107.51 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 513' ' ' HIS . . . . . 0.427 ' NE2' ' HG2' ' A' ' 647' ' ' GLU . 57.4 t-80 -110.6 137.92 47.65 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 107.596 -1.261 . . . . 74.120000000000005 107.596 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.77 158.13 43.25 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 N-CA-C 109.072 -0.714 . . . . 64.319999999999993 109.072 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.557 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 48.1 m -87.09 173.57 9.19 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-N 115.037 -0.983 . . . . 71.420000000000002 109.566 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -94.07 -59.11 2.05 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.922 -0.711 . . . . 75.329999999999998 110.017 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.6 m -84.55 53.99 2.86 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.763 0.792 . . . . 63.549999999999997 109.929 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 10.5 tt -102.87 -32.49 3.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.544 -0.753 . . . . 72.140000000000001 111.49 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 519' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 92.85 -78.39 1.15 Allowed Glycine 0 N--CA 1.425 -2.036 0 C-N-CA 120.717 -0.754 . . . . 75.450000000000003 111.356 -176.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 520' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 574' ' ' LYS . 40.3 mm -126.93 123.93 63.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.934 -0.765 . . . . 74.430000000000007 108.934 -176.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.73 149.43 25.0 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 107.383 -1.34 . . . . 75.109999999999999 107.383 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 31.3 mt-10 -130.8 132.54 45.32 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.32 0.581 . . . . 74.140000000000001 111.088 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 570' ' ' THR . 40.1 t -112.01 126.47 69.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.098 -1.075 . . . . 72.409999999999997 108.098 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -81.96 128.8 34.44 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.203 -0.666 . . . . 70.120000000000005 109.203 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 568' ' ' VAL . 48.4 t -105.78 129.21 59.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 109.853 -0.425 . . . . 75.400000000000006 109.853 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.41 126.88 30.82 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.257 -0.646 . . . . 62.039999999999999 109.257 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.649 ' CZ ' ' HD1' ' A' ' 562' ' ' PHE . 15.2 ttm180 -87.64 160.07 18.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 109.178 -0.675 . . . . 65.040000000000006 109.178 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.7 t -56.1 141.47 40.29 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 124.4 1.08 . . . . 63.049999999999997 111.813 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.5 t -54.76 -37.4 65.93 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.93 -1.032 . . . . 73.430000000000007 109.355 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -119.54 96.0 0.62 Allowed Glycine 0 N--CA 1.423 -2.209 0 N-CA-C 109.029 -1.628 . . . . 42.140000000000001 109.029 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.61 101.0 12.34 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.003 -1.11 . . . . 75.109999999999999 108.003 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -107.49 92.37 4.04 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.596 -0.729 . . . . 72.109999999999999 110.441 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 86.32 -139.33 16.63 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 119.56 -1.305 . . . . 53.420000000000002 111.774 174.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -113.39 121.1 43.31 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.265 0.555 . . . . 71.310000000000002 110.876 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 59.5 t -123.63 143.87 35.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 107.972 -1.121 . . . . 63.119999999999997 107.972 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.54 HD13 ' HA ' ' A' ' 561' ' ' GLU . 41.7 mm -117.28 137.09 52.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 109.596 -0.52 . . . . 71.540000000000006 109.596 177.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 594' ' ' PRO . 44.1 t -122.89 110.79 31.28 Favored Pre-proline 0 N--CA 1.44 -0.945 0 N-CA-C 109.853 -0.425 . . . . 74.219999999999999 109.853 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.7 156.83 48.78 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.769 2.313 . . . . 71.129999999999995 112.517 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.497 ' HB3' HG22 ' A' ' 591' ' ' ILE . 45.0 p90 -149.4 163.3 38.14 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 122.383 -0.198 . . . . 73.150000000000006 110.649 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -158.43 156.67 30.82 Favored 'General case' 0 C--O 1.252 1.211 0 O-C-N 123.966 0.791 . . . . 62.509999999999998 110.089 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.2 p -90.62 138.53 31.49 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 123.531 0.519 . . . . 72.299999999999997 111.342 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 51.2 mt -111.09 115.77 50.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.821 -0.807 . . . . 70.540000000000006 108.821 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.82 99.61 5.21 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.35 -0.611 . . . . 74.420000000000002 109.35 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -104.56 -89.17 2.1 Favored Glycine 0 CA--C 1.482 -2.008 0 C-N-CA 119.981 -1.104 . . . . 61.340000000000003 110.667 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 545' ' ' THR . . . . . 0.435 ' HB ' HG23 ' A' ' 586' ' ' THR . 3.8 m -102.53 29.86 5.0 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-O 122.324 1.059 . . . . 61.409999999999997 108.54 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -157.4 144.73 18.58 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 106.815 -1.55 . . . . 64.430000000000007 106.815 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.406 ' HD2' ' OE1' ' A' ' 551' ' ' GLU . 82.0 mtm180 -92.29 131.1 37.76 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.75 0.786 . . . . 65.120000000000005 112.126 -175.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -96.62 -167.15 33.64 Favored Glycine 0 C--N 1.294 -1.779 0 CA-C-N 114.908 -1.042 . . . . 14.44 112.93 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 549' ' ' GLY . . . . . 0.532 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 77.28 9.15 86.98 Favored Glycine 0 C--N 1.313 -0.734 0 CA-C-N 115.721 -0.24 . . . . 65.329999999999998 112.995 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 98.14 23.73 12.59 Favored Glycine 0 N--CA 1.427 -1.924 0 C-N-CA 120.368 -0.92 . . . . 63.299999999999997 111.422 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.406 ' OE1' ' HD2' ' A' ' 547' ' ' ARG . 26.3 tt0 -98.63 -63.27 1.14 Allowed 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.096 -0.641 . . . . 64.040000000000006 109.825 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -100.72 -42.01 6.67 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 107.411 -1.329 . . . . 75.150000000000006 107.411 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -132.9 155.09 49.69 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.006 -1.109 . . . . 73.510000000000005 108.006 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.79 137.38 35.32 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.476 -1.305 . . . . 74.25 107.476 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 555' ' ' ASP . . . . . 0.532 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 29.4 t70 -87.3 121.36 29.65 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.682 -0.859 . . . . 71.430000000000007 108.682 -176.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.8 t -130.65 164.98 23.81 Favored 'General case' 0 N--CA 1.414 -2.254 0 CA-C-O 121.742 0.782 . . . . 62.420000000000002 110.787 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 19.9 p -161.2 163.55 31.08 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.316 -1.735 . . . . 63.340000000000003 106.316 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 167.18 -169.59 41.05 Favored Glycine 0 N--CA 1.421 -2.329 0 C-N-CA 119.929 -1.129 . . . . 42.210000000000001 111.054 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.526 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 42.3 mt-10 -136.07 119.75 17.2 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 123.338 0.655 . . . . 72.5 110.196 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 569' ' ' LYS . 77.3 mt -86.82 128.75 35.05 Favored 'General case' 0 CA--C 1.484 -1.592 0 CA-C-N 115.745 -0.661 . . . . 72.239999999999995 110.087 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.54 ' HA ' HD13 ' A' ' 536' ' ' ILE . 25.5 tt0 -87.79 123.39 32.53 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.455 -0.793 . . . . 71.120000000000005 109.911 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.649 ' HD1' ' CZ ' ' A' ' 527' ' ' ARG . 82.2 m-85 -123.3 98.2 5.76 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 121.463 0.649 . . . . 73.299999999999997 110.612 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 533' ' ' GLY . 42.3 mt-30 -96.78 -175.87 3.41 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.722 -0.672 . . . . 70.439999999999998 110.44 174.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -78.92 -21.75 46.86 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.631 -0.713 . . . . 73.409999999999997 109.428 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -72.57 -52.38 15.81 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.076 -0.966 . . . . 65.109999999999999 112.768 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.496 ' HB2' HH12 ' A' ' 527' ' ' ARG . 41.4 mm-40 -69.7 169.29 13.17 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.441 1.274 . . . . 73.150000000000006 114.441 -177.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.589 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.0 pt -105.95 -63.3 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 114.574 -1.193 . . . . 74.099999999999994 112.465 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.589 ' H ' HG13 ' A' ' 567' ' ' ILE . 14.4 p -139.88 162.56 25.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 108.834 -0.802 . . . . 73.120000000000005 108.834 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.415 ' HB3' HD22 ' A' ' 560' ' ' LEU . 1.8 mtpt -131.1 164.04 26.32 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.445 -0.946 . . . . 72.209999999999994 108.445 171.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 12.9 p -129.7 152.57 49.06 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 123.794 0.683 . . . . 63.210000000000001 111.153 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.498 HG22 HG23 ' A' ' 573' ' ' VAL . 2.5 mp -94.59 121.76 45.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 105.545 -2.02 . . . . 72.540000000000006 105.545 170.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 5.9 m -99.45 114.89 28.11 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.596 -0.89 . . . . 53.43 108.596 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.498 HG23 HG22 ' A' ' 571' ' ' ILE . 91.3 t -118.89 127.65 75.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.771 -0.455 . . . . 72.439999999999998 109.771 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 16.1 tppt? -77.42 108.84 10.85 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.207 -1.035 . . . . 75.409999999999997 108.207 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.75 122.52 36.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 104.55 -2.389 . . . . 71.099999999999994 104.55 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 42.1 mm . . . . . 0 C--N 1.295 -1.796 0 CA-C-O 121.352 0.596 . . . . 71.209999999999994 109.467 -174.072 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp . . . . . 0 N--CA 1.425 -1.676 0 N-CA-C 107.474 -1.306 . . . . 75.530000000000001 107.474 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 586' ' ' THR . . . . . 0.435 HG23 ' HB ' ' A' ' 545' ' ' THR . 4.4 t -135.18 125.18 25.8 Favored 'General case' 0 C--N 1.281 -2.413 0 CA-C-O 121.946 0.879 . . . . 75.310000000000002 111.582 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 44.3 p90 -119.94 177.78 4.85 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.131 -0.94 . . . . 64.310000000000002 109.235 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.424 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 77.9 m-85 -123.19 149.66 44.34 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 109.404 -0.591 . . . . 63.5 109.404 -176.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.2 OUTLIER -120.4 131.81 54.98 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.442 -1.688 . . . . 45.539999999999999 106.442 179.216 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -125.58 128.47 47.98 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.022 -0.671 . . . . 71.140000000000001 110.341 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.497 HG22 ' HB3' ' A' ' 539' ' ' TYR . 26.5 pt -99.84 139.77 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 107.911 -1.144 . . . . 72.049999999999997 107.911 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.34 -178.08 50.65 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 115.825 -0.625 . . . . 64.120000000000005 112.083 -176.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.05 129.63 86.07 Favored Pre-proline 0 N--CA 1.426 -1.641 0 CA-C-N 115.499 -0.35 . . . . 75.340000000000003 110.772 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.517 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 11.7 Cg_endo -59.6 129.07 29.33 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.197 2.598 . . . . 61.310000000000002 112.666 -176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 595' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 536' ' ' ILE . 8.3 ptm180 -104.72 119.65 39.51 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.09 -0.959 . . . . 71.0 109.008 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.403 HD23 ' HD3' ' A' ' 634' ' ' PRO . 2.1 tm? -67.28 128.88 38.05 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.082 -1.451 . . . . 72.209999999999994 107.082 175.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.468 ' CG2' HG12 ' A' ' 536' ' ' ILE . 51.5 t . . . . . 0 C--N 1.299 -1.629 0 CA-C-O 121.397 0.618 . . . . 61.539999999999999 110.835 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 33.3 Cg_endo . . . . . 0 N--CA 1.427 -2.388 0 N-CA-C 105.352 -2.595 . . . . 73.430000000000007 105.352 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.04 168.74 16.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 118.502 -1.279 . . . . 74.5 112.678 -173.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.26 171.93 7.68 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.57 -0.741 . . . . 74.25 111.959 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -71.69 -171.99 15.3 Favored Glycine 0 N--CA 1.431 -1.7 0 CA-C-N 115.307 -0.861 . . . . 64.340000000000003 113.144 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -62.12 -41.29 98.09 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 122.365 0.266 . . . . 74.25 110.331 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -140.89 133.23 28.27 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.969 0.414 . . . . 64.120000000000005 110.039 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 15.4 p -120.88 95.4 4.69 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-O 121.709 0.766 . . . . 70.400000000000006 109.985 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -162.58 142.98 9.75 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.523 -1.288 . . . . 33.240000000000002 107.523 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.5 HD21 HG21 ' A' ' 523' ' ' VAL . 34.7 tp -132.65 132.81 42.83 Favored 'General case' 0 N--CA 1.416 -2.167 0 O-C-N 123.658 0.599 . . . . 52.240000000000002 109.423 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -98.35 118.59 35.34 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.057 -1.46 . . . . 71.340000000000003 107.057 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 44.3 t -106.7 117.43 52.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 109.006 -0.738 . . . . 71.430000000000007 109.006 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 58.1 mt -103.4 123.11 56.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 110.62 -0.141 . . . . 73.219999999999999 110.62 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 41.6 mt -107.43 107.65 23.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.153 -0.684 . . . . 72.540000000000006 109.153 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.427 ' HG2' ' NE2' ' A' ' 513' ' ' HIS . 8.0 pt-20 . . . . . 0 C--N 1.296 -1.753 0 N-CA-C 105.383 -2.081 . . . . 75.150000000000006 105.383 166.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 502' ' ' ALA . . . . . 0.631 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 107.967 -1.123 . . . . 63.329999999999998 107.967 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 116.26 -159.64 13.79 Favored Glycine 0 N--CA 1.416 -2.655 0 C-N-CA 120.167 -1.016 . . . . 62.219999999999999 111.619 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.34 111.39 28.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 122.388 0.275 . . . . 74.140000000000001 110.569 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.604 ' CD2' HG23 ' A' ' 528' ' ' THR . 5.8 m-85 -92.35 126.11 37.3 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 109.093 -0.706 . . . . 72.239999999999995 109.093 170.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.4 t -167.54 176.33 6.57 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.831 -0.803 . . . . 74.030000000000001 108.831 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -81.11 147.05 30.27 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 110.147 -0.316 . . . . 72.140000000000001 110.147 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.78 -33.53 75.88 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.36 0.6 . . . . 72.129999999999995 109.879 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -136.28 140.93 34.19 Favored Pre-proline 0 N--CA 1.427 -1.605 0 N-CA-C 107.573 -1.269 . . . . 54.409999999999997 107.573 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 510' ' ' PRO . . . . . 0.438 ' O ' ' HA ' ' A' ' 642' ' ' LEU . 59.2 Cg_endo -75.26 -26.01 10.93 Favored 'Trans proline' 0 C--N 1.33 -0.414 0 C-N-CA 122.447 2.098 . . . . 60.340000000000003 112.258 -178.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 59.8 t -134.77 136.59 52.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 106.715 -1.587 . . . . 51.100000000000001 106.715 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 15.0 t -129.18 135.39 48.79 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 108.591 -0.892 . . . . 72.109999999999999 108.591 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -108.03 119.04 38.34 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.915 -0.772 . . . . 63.350000000000001 108.915 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.37 160.28 14.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.419 -0.81 . . . . 64.040000000000006 109.194 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.534 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 74.4 m -88.17 159.84 18.0 Favored 'General case' 0 N--CA 1.411 -2.413 0 C-N-CA 123.345 0.658 . . . . 61.420000000000002 110.486 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -49.22 16.32 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 120.731 -0.388 . . . . 75.230000000000004 110.692 176.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 9.8 m -86.83 39.84 0.87 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.27 0.557 . . . . 51.140000000000001 111.5 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 13.4 tt -97.67 -25.15 4.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.305 0.574 . . . . 71.519999999999996 111.626 -176.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 519' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 86.86 -74.28 2.35 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.86 -0.896 . . . . 71.219999999999999 110.86 -176.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 43.4 mm -129.97 132.2 65.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.459 -1.312 . . . . 75.420000000000002 107.459 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.4 150.47 34.6 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.002 -1.481 . . . . 73.510000000000005 107.002 175.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 31.7 mt-10 -130.09 142.53 50.59 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.227 0.537 . . . . 73.439999999999998 111.631 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.586 HG11 HD22 ' A' ' 642' ' ' LEU . 42.7 t -121.24 127.7 75.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.397 -0.964 . . . . 64.340000000000003 108.397 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -82.51 127.8 33.66 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.746 -0.835 . . . . 63.310000000000002 108.746 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.39 123.92 58.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 108.806 -0.812 . . . . 74.439999999999998 108.806 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.03 115.63 10.38 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.542 -0.754 . . . . 70.040000000000006 109.928 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.481 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 50.9 ttp180 -67.85 155.28 39.71 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.6 -1.182 . . . . 74.109999999999999 108.9 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 0.7 OUTLIER -56.55 141.99 40.95 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-O 121.786 0.803 . . . . 63.310000000000002 111.37 176.182 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.2 m -61.92 -16.93 54.63 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 125.996 1.718 . . . . 60.25 110.769 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -139.47 79.16 0.29 Allowed Glycine 0 N--CA 1.425 -2.084 0 N-CA-C 110.304 -1.118 . . . . 61.210000000000001 110.304 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -83.73 101.49 11.6 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.232 -1.025 . . . . 63.229999999999997 108.232 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -100.83 93.13 5.38 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.908 -1.042 . . . . 63.439999999999998 110.217 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 97.53 -119.55 6.44 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.162 -1.018 . . . . 75.430000000000007 111.277 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 534' ' ' ASN . . . . . 0.456 ' HB3' ' HB ' ' A' ' 597' ' ' VAL . 50.5 t30 -133.52 134.25 43.19 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.084 -0.71 . . . . 71.150000000000006 109.084 177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 62.1 t -132.83 137.98 52.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.111 -1.07 . . . . 65.109999999999999 108.111 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.482 HG12 ' CG2' ' A' ' 597' ' ' VAL . 41.3 mm -107.35 136.46 42.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 109.563 -0.532 . . . . 63.409999999999997 109.563 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.34 110.94 32.12 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 110.046 -0.353 . . . . 64.310000000000002 110.046 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -73.5 150.6 46.27 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.205 1.937 . . . . 72.140000000000001 111.468 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.423 ' HB3' HG22 ' A' ' 591' ' ' ILE . 53.2 p90 -149.08 163.45 37.52 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 110.405 -0.22 . . . . 74.310000000000002 110.405 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -157.93 158.33 34.8 Favored 'General case' 0 C--O 1.252 1.236 0 O-C-N 123.923 0.764 . . . . 62.109999999999999 109.745 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.7 p -87.36 154.12 20.92 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 109.038 -0.727 . . . . 61.509999999999998 109.038 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 60.1 mt -128.39 119.01 49.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.204 -1.406 . . . . 65.209999999999994 107.204 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -66.41 120.99 14.3 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 122.631 0.372 . . . . 63.340000000000003 110.453 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -102.71 -104.54 2.85 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 108.663 -1.775 . . . . 72.209999999999994 108.663 176.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 34.3 p -89.91 -22.51 21.96 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.276 -1.009 . . . . 72.049999999999997 108.276 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.613 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -81.91 136.95 35.28 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.423 -1.262 . . . . 44.399999999999999 110.067 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -90.49 144.25 25.97 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.382 0.611 . . . . 71.409999999999997 111.912 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.7 -158.03 33.87 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.005 -1.238 . . . . 32.039999999999999 110.005 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.75 26.47 73.98 Favored Glycine 0 C--N 1.315 -0.594 0 C-N-CA 120.929 -0.653 . . . . 73.450000000000003 112.257 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 550' ' ' GLY . . . . . 0.416 ' C ' HG13 ' A' ' 576' ' ' ILE . . . 67.92 34.55 82.48 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 121.597 -0.335 . . . . 72.049999999999997 112.264 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -104.48 -63.43 1.21 Allowed 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 120.814 -0.355 . . . . 63.149999999999999 111.409 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -101.77 -45.61 5.18 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 108.179 -1.045 . . . . 75.340000000000003 108.179 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -133.93 152.31 51.81 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 107.639 -1.245 . . . . 64.439999999999998 107.639 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.403 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 8.4 tt0 -85.6 112.69 21.21 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 105.858 -1.904 . . . . 73.439999999999998 105.858 176.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.26 140.7 56.02 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 120.941 0.401 . . . . 64.340000000000003 110.203 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.6 t -142.65 148.3 37.18 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-O 121.506 0.67 . . . . 75.400000000000006 111.33 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 11.8 p -148.62 157.28 43.35 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.093 -1.447 . . . . 54.439999999999998 107.093 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 168.3 -163.43 37.16 Favored Glycine 0 N--CA 1.421 -2.338 0 C-N-CA 120.114 -1.041 . . . . 62.43 110.665 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.448 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 40.5 mt-10 -132.72 124.91 29.06 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 122.869 0.468 . . . . 74.430000000000007 110.697 -177.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.533 HD22 ' HB3' ' A' ' 569' ' ' LYS . 76.0 mt -91.04 135.09 33.99 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 115.713 -0.676 . . . . 34.130000000000003 109.403 177.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.475 ' HA ' HD13 ' A' ' 536' ' ' ILE . 32.1 tt0 -102.06 109.48 21.2 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.837 -0.619 . . . . 64.109999999999999 110.54 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -106.07 104.4 14.09 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.661 0.743 . . . . 70.340000000000003 110.534 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.536 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 64.9 mm-40 -87.75 173.3 9.07 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.469 -1.308 . . . . 63.310000000000002 107.469 174.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -72.03 -25.91 61.99 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.498 -0.927 . . . . 65.329999999999998 108.498 172.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.66 -46.22 39.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.592 -1.185 . . . . 73.340000000000003 110.822 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.536 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 37.0 mm-40 -61.01 130.58 47.11 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 123.72 0.808 . . . . 72.120000000000005 111.663 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.548 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.3 pt -86.74 -59.69 2.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 116.004 -0.544 . . . . 61.350000000000001 111.746 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.548 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.2 p -141.78 155.17 19.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.769 -0.456 . . . . 75.439999999999998 109.769 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.533 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -123.19 157.28 33.38 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.988 -0.745 . . . . 73.140000000000001 108.988 171.132 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.0 OUTLIER -125.36 149.85 47.74 Favored 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 115.351 -0.841 . . . . 62.310000000000002 111.574 179.049 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.3 mp -98.91 120.56 48.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 106.662 -1.607 . . . . 60.25 106.662 169.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 5.1 p -96.11 115.09 26.89 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 123.747 0.654 . . . . 71.019999999999996 109.405 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.435 HG23 HG22 ' A' ' 571' ' ' ILE . 93.4 t -114.62 128.58 71.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.705 -0.398 . . . . 64.209999999999994 109.935 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 22.2 tptm -79.84 115.23 19.32 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.985 -1.007 . . . . 74.219999999999999 109.226 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.66 126.28 40.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 104.935 -2.246 . . . . 51.329999999999998 104.935 174.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 576' ' ' ILE . . . . . 0.416 HG13 ' C ' ' A' ' 550' ' ' GLY . 45.2 mm . . . . . 0 C--N 1.298 -1.639 0 CA-C-O 122.272 1.034 . . . . 74.150000000000006 110.771 -173.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.613 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 30.1 mmtp . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 109.511 -0.552 . . . . 72.319999999999993 109.511 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 9.2 t -140.53 145.94 37.46 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 120.411 -0.515 . . . . 73.239999999999995 109.912 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 49.8 p90 -141.81 175.92 9.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.837 -1.172 . . . . 74.049999999999997 107.837 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.576 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 79.1 m-85 -121.4 160.64 23.66 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.73 -0.47 . . . . 73.450000000000003 109.73 -176.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.2 OUTLIER -127.97 131.27 49.28 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 105.798 -1.927 . . . . 55.340000000000003 105.798 177.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.405 ' HB2' HD11 ' A' ' 542' ' ' ILE . 42.5 tt0 -129.68 137.98 50.92 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.893 -0.41 . . . . 74.510000000000005 109.893 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.423 HG22 ' HB3' ' A' ' 539' ' ' TYR . 21.3 pt -108.74 142.81 20.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 108.103 -1.073 . . . . 65.049999999999997 108.103 176.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.52 -177.4 45.62 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 111.004 -0.838 . . . . 74.219999999999999 111.004 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -69.74 132.18 89.12 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 120.895 0.378 . . . . 65.019999999999996 111.345 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.97 129.47 26.04 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.488 2.792 . . . . 64.010000000000005 112.759 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 595' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 536' ' ' ILE . 1.2 ptm85 -106.54 119.49 39.42 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.967 -0.561 . . . . 74.129999999999995 110.212 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.39 137.9 57.79 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 124.567 1.147 . . . . 53.32 111.025 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.482 ' CG2' HG12 ' A' ' 536' ' ' ILE . 21.6 t . . . . . 0 C--N 1.303 -1.447 0 N-CA-C 105.838 -1.912 . . . . 51.140000000000001 105.838 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.463 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 73.8 Cg_endo . . . . . 0 N--CA 1.427 -2.398 0 CA-C-O 121.119 0.383 . . . . 62.439999999999998 111.333 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.5 pp -129.85 168.94 21.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-N 115.807 -0.633 . . . . 75.109999999999999 110.675 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.83 178.92 4.81 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 112.249 0.463 . . . . 73.409999999999997 112.249 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -77.79 -156.06 8.08 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 114.888 0.715 . . . . 74.239999999999995 114.888 -175.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -70.77 -48.57 53.59 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.156 0.582 . . . . 74.120000000000005 109.794 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -140.2 144.15 36.44 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.295 -1.002 . . . . 64.319999999999993 108.295 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 14.0 p -133.23 95.88 3.62 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 123.604 0.565 . . . . 62.340000000000003 109.849 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -164.1 138.46 5.66 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.75 -0.833 . . . . 74.510000000000005 108.75 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.586 HD22 HG11 ' A' ' 523' ' ' VAL . 26.6 tp -125.75 134.44 51.75 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.442 -0.947 . . . . 71.129999999999995 108.442 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -104.3 113.8 27.6 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.391 -1.337 . . . . 71.209999999999994 107.391 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.36 110.15 28.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.144 -0.688 . . . . 73.150000000000006 109.144 -178.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 59.2 mt -102.24 120.39 51.88 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 108.619 -0.882 . . . . 62.43 108.619 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 45.5 mt -95.38 106.95 18.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 107.979 -1.119 . . . . 73.209999999999994 107.979 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 515' ' ' SER . 8.9 pt-20 . . . . . 0 C--N 1.296 -1.759 0 CA-C-O 121.243 0.544 . . . . 70.140000000000001 110.463 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 109.552 -0.536 . . . . 44.350000000000001 109.552 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.422 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . 165.03 -150.91 19.45 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 120.477 -0.868 . . . . 73.239999999999995 111.119 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.434 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.9 mp -126.13 113.32 33.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 116.852 0.326 . . . . 65.010000000000005 110.67 -173.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -97.33 130.34 44.51 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.487 -0.931 . . . . 74.439999999999998 108.487 170.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 506' ' ' THR . . . . . 0.413 ' HA ' HG22 ' A' ' 640' ' ' THR . 13.7 t -166.31 175.29 8.36 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.147 -0.686 . . . . 72.099999999999994 109.147 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 507' ' ' PHE . . . . . 0.458 ' CZ ' HG23 ' A' ' 591' ' ' ILE . 79.9 m-85 -84.55 152.9 23.59 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 110.135 -0.32 . . . . 72.430000000000007 110.135 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -64.68 -37.67 88.39 Favored 'General case' 0 C--O 1.245 0.821 0 O-C-N 123.544 0.528 . . . . 53.530000000000001 110.367 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.65 149.98 75.0 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 108.942 -0.762 . . . . 73.109999999999999 108.942 174.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -74.39 -28.73 10.06 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.894 1.729 . . . . 73.319999999999993 112.154 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 46.0 t -137.57 132.51 45.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 107.802 -1.185 . . . . 63.43 107.802 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 13.2 t -128.92 140.8 51.51 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 109.623 -0.51 . . . . 44.219999999999999 109.623 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -108.98 127.87 54.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.481 -0.563 . . . . 72.349999999999994 109.481 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 23.9 m -123.06 177.33 4.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.097 -0.705 . . . . 73.120000000000005 109.097 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.537 ' HB3' ' HB ' ' A' ' 518' ' ' ILE . 32.7 t -103.99 159.28 15.8 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.129 0.49 . . . . 73.439999999999998 110.902 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -70.29 -39.22 75.02 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.877 -1.056 . . . . 55.420000000000002 109.776 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 68.1 m -104.19 20.85 17.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.606 0.595 . . . . 72.129999999999995 112.606 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' A' ' 515' ' ' SER . 11.3 tt -70.01 -35.59 64.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 C-N-CA 119.762 -0.775 . . . . 64.120000000000005 110.229 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 519' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 95.06 -78.86 0.87 Allowed Glycine 0 CA--C 1.479 -2.156 0 N-CA-C 110.858 -0.897 . . . . 74.349999999999994 110.858 -177.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 520' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 573' ' ' VAL . 33.8 mm -127.63 133.18 68.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.966 -1.494 . . . . 75.310000000000002 106.966 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.516 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -118.59 144.77 45.89 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.432 -0.581 . . . . 74.109999999999999 109.432 177.499 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -112.1 125.06 53.7 Favored 'General case' 0 C--O 1.241 0.643 0 O-C-N 123.638 0.586 . . . . 73.010000000000005 110.996 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.632 HG11 HD22 ' A' ' 642' ' ' LEU . 47.3 t -104.64 126.29 59.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 109.298 -0.631 . . . . 54.340000000000003 109.298 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -80.38 128.32 33.43 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.538 0.524 . . . . 75.430000000000007 109.686 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 568' ' ' VAL . 62.3 t -106.66 115.39 48.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.798 -0.816 . . . . 70.319999999999993 108.798 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.05 123.8 19.5 Favored 'General case' 0 C--O 1.251 1.144 0 O-C-N 123.991 0.807 . . . . 64.219999999999999 110.206 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -73.59 159.62 32.83 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 114.947 -1.024 . . . . 74.409999999999997 110.238 -177.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.422 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 4.3 t -62.46 140.89 58.59 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.687 -0.688 . . . . 62.210000000000001 110.387 175.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.6 t -59.3 -37.06 76.77 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 123.644 0.778 . . . . 71.510000000000005 109.381 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -110.84 87.66 0.48 Allowed Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.132 -1.187 . . . . 52.039999999999999 110.132 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.0 100.46 13.28 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.994 -0.743 . . . . 52.43 108.994 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -108.58 92.22 3.97 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.617 -0.72 . . . . 64.230000000000004 111.044 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 95.72 -122.15 7.17 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.317 -0.944 . . . . 65.230000000000004 112.796 175.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -132.9 130.83 40.18 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 123.062 0.545 . . . . 73.519999999999996 109.755 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.467 HG22 HD22 ' A' ' 596' ' ' LEU . 60.3 t -134.26 138.36 50.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 123.841 0.856 . . . . 74.109999999999999 109.228 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.535 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 46.6 mm -106.7 133.96 49.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.261 -0.644 . . . . 74.049999999999997 109.261 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.475 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.8 t -122.5 110.85 31.91 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 108.983 -0.747 . . . . 73.019999999999996 108.983 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 51.6 Cg_endo -72.53 157.65 52.37 Favored 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.283 1.989 . . . . 74.25 111.893 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.476 ' HB3' HG22 ' A' ' 591' ' ' ILE . 47.4 p90 -149.65 160.55 43.42 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.645 -0.502 . . . . 64.540000000000006 109.645 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -158.42 154.69 27.32 Favored 'General case' 0 C--O 1.248 1.024 0 O-C-N 123.709 0.631 . . . . 75.450000000000003 111.121 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.3 p -86.95 140.69 29.34 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.884 -0.598 . . . . 63.310000000000002 110.449 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 49.0 mt -114.54 125.54 71.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.436 -0.95 . . . . 73.209999999999994 108.436 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.77 154.61 19.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.312 0.577 . . . . 74.310000000000002 112.454 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 176.4 -73.32 0.08 OUTLIER Glycine 0 C--N 1.305 -1.16 0 N-CA-C 110.731 -0.948 . . . . 72.519999999999996 110.731 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.32 5.86 18.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.101 0.953 . . . . 72.129999999999995 111.342 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -153.5 142.18 20.94 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 105.447 -2.057 . . . . 50.43 105.447 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 38.6 mtp85 -96.05 130.25 43.12 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.115 0.484 . . . . 63.340000000000003 111.452 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.4 -145.8 12.8 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 120.477 -0.868 . . . . 40.119999999999997 112.726 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 549' ' ' GLY . . . . . 0.429 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 65.05 10.1 44.8 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 113.982 0.353 . . . . 71.25 113.982 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 100.43 15.94 28.45 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.164 -1.017 . . . . 51.229999999999997 111.847 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -91.95 -72.48 0.59 Allowed 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 119.713 -0.795 . . . . 60.329999999999998 110.178 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -89.77 -39.16 13.31 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 108.527 -0.916 . . . . 64.420000000000002 108.527 175.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -140.98 155.2 46.27 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.92 -1.037 . . . . 71.530000000000001 108.363 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.04 137.09 33.28 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.779 -1.563 . . . . 41.240000000000002 106.779 177.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 555' ' ' ASP . . . . . 0.429 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 19.5 t70 -87.17 132.09 33.98 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 110.188 -0.301 . . . . 72.109999999999999 110.188 -172.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 15.0 t -136.43 145.48 45.31 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.685 0.755 . . . . 73.209999999999994 110.841 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 52.1 t -154.29 148.15 25.52 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.985 -1.858 . . . . 42.329999999999998 105.985 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 175.27 -164.82 35.49 Favored Glycine 0 C--N 1.287 -2.191 0 N-CA-C 109.997 -1.241 . . . . 61.039999999999999 109.997 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.535 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 87.0 mt-10 -135.56 127.8 30.09 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.987 0.394 . . . . 74.310000000000002 110.646 -177.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.416 HD22 ' HB3' ' A' ' 569' ' ' LYS . 91.7 mt -92.01 134.18 35.04 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.78 -0.645 . . . . 75.010000000000005 109.469 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.415 ' HA ' HD13 ' A' ' 536' ' ' ILE . 31.3 tt0 -98.84 116.33 30.83 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.775 -0.648 . . . . 71.409999999999997 109.57 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -111.56 145.65 38.75 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.335 -0.617 . . . . 74.519999999999996 109.335 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.514 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 49.7 mt-30 -142.7 179.58 6.91 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 109.183 -0.673 . . . . 71.430000000000007 109.183 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -70.52 -37.92 74.18 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.571 -0.9 . . . . 74.209999999999994 108.571 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.68 -27.29 37.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.729 -1.123 . . . . 75.329999999999998 111.979 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.514 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 8.7 mm-40 -78.62 146.97 33.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.283 -0.636 . . . . 71.140000000000001 109.283 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.596 HG13 ' H ' ' A' ' 568' ' ' VAL . 4.0 pt -95.57 -80.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 112.45 0.537 . . . . 65.099999999999994 112.45 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.596 ' H ' HG13 ' A' ' 567' ' ' ILE . 8.3 p -135.73 148.97 27.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 108.619 -0.882 . . . . 72.120000000000005 108.619 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.416 ' HB3' HD22 ' A' ' 560' ' ' LEU . 1.8 mtpt -114.95 159.96 20.12 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.545 -0.539 . . . . 74.420000000000002 109.545 175.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 16.2 p -128.26 150.15 50.17 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.877 -0.601 . . . . 74.230000000000004 111.009 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.42 HG22 HG23 ' A' ' 573' ' ' VAL . 3.3 mp -99.51 123.28 52.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 106.518 -1.66 . . . . 72.209999999999994 106.518 171.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 572' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 521' ' ' MET . 4.6 p -97.77 115.98 29.08 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.913 0.758 . . . . 70.239999999999995 109.502 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 520' ' ' ILE . 95.9 t -117.33 133.92 62.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 116.619 -0.264 . . . . 74.219999999999999 110.807 -178.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 46.7 tptt -85.6 112.46 20.99 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 109.054 -0.721 . . . . 73.310000000000002 109.054 175.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.63 125.62 40.29 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 104.924 -2.25 . . . . 72.109999999999999 104.924 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 37.9 mm . . . . . 0 N--CA 1.425 -1.688 0 CA-C-O 122.054 0.93 . . . . 72.510000000000005 109.978 -175.261 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 CA--C 1.49 -1.334 0 CA-C-O 120.899 0.38 . . . . 75.340000000000003 111.016 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.5 t -153.14 138.44 17.51 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.879 -0.415 . . . . 74.120000000000005 109.879 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -135.25 176.0 9.07 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.479 -0.934 . . . . 74.040000000000006 108.479 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.487 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 74.0 m-85 -122.47 152.67 40.05 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.042 -0.663 . . . . 53.350000000000001 109.872 -175.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.07 130.86 53.64 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.484 -1.672 . . . . 63.240000000000002 106.484 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.424 ' HB2' HD11 ' A' ' 542' ' ' ILE . 30.2 tt0 -121.63 136.48 54.94 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.745 -0.465 . . . . 75.219999999999999 109.745 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.476 HG22 ' HB3' ' A' ' 539' ' ' TYR . 21.1 pt -107.94 132.93 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 107.04 -1.467 . . . . 63.340000000000003 107.04 169.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.52 -166.48 42.01 Favored Glycine 0 N--CA 1.423 -2.206 0 CA-C-N 115.577 -0.738 . . . . 61.5 112.713 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.69 131.71 73.4 Favored Pre-proline 0 N--CA 1.427 -1.603 0 CA-C-O 120.997 0.427 . . . . 70.25 111.629 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.475 ' HB3' HG22 ' A' ' 537' ' ' VAL . 47.3 Cg_endo -69.42 147.3 64.73 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.952 2.434 . . . . 63.039999999999999 111.973 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -125.03 137.3 54.23 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.934 -0.765 . . . . 72.329999999999998 108.934 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.467 HD22 HG22 ' A' ' 535' ' ' VAL . 0.8 OUTLIER -78.99 128.68 33.57 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 107.122 -1.436 . . . . 64.120000000000005 107.122 179.087 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.459 ' CG2' HG12 ' A' ' 536' ' ' ILE . 37.8 t . . . . . 0 C--N 1.29 -2.007 0 N-CA-C 109.056 -0.72 . . . . 61.420000000000002 109.056 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo . . . . . 0 N--CA 1.436 -1.868 0 CA-C-O 121.25 0.437 . . . . 72.420000000000002 111.041 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.39 167.46 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-N 115.179 -0.918 . . . . 75.299999999999997 109.545 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.35 -176.24 3.16 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 112.199 0.444 . . . . 72.120000000000005 112.199 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.434 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -77.83 -150.18 4.26 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-O 121.646 0.581 . . . . 32.229999999999997 113.84 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -80.97 -48.34 12.41 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.09 0.472 . . . . 75.239999999999995 109.947 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -133.12 131.64 40.75 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.821 -0.807 . . . . 71.099999999999994 108.821 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 640' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 506' ' ' THR . 23.9 p -119.97 88.95 3.03 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 121.755 0.788 . . . . 54.140000000000001 110.136 175.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -159.79 137.6 9.99 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.286 -0.87 . . . . 75.299999999999997 109.567 -175.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.632 HD22 HG11 ' A' ' 523' ' ' VAL . 15.6 tp -123.32 128.64 50.21 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 107.974 -1.121 . . . . 74.319999999999993 107.974 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -97.71 111.7 23.88 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.396 -1.335 . . . . 74.349999999999994 107.396 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.7 112.86 34.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.448 -0.575 . . . . 72.049999999999997 109.448 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 68.6 mt -101.6 121.42 52.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 109.636 -0.505 . . . . 72.530000000000001 109.636 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 69.1 mt -95.17 113.89 30.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.877 -1.157 . . . . 50.130000000000003 107.877 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 515' ' ' SER . 40.3 mt-10 . . . . . 0 C--N 1.285 -2.199 0 N-CA-C 107.627 -1.249 . . . . 72.319999999999993 107.627 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 502' ' ' ALA . . . . . 0.551 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 121.158 0.504 . . . . 71.219999999999999 112.293 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 128.02 -136.78 9.36 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 119.417 -1.373 . . . . 63.539999999999999 112.186 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.74 112.48 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 111.171 0.063 . . . . 64.239999999999995 111.171 -174.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.483 ' CD2' HG23 ' A' ' 528' ' ' THR . 11.4 m-85 -99.75 120.69 40.13 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.666 -1.235 . . . . 71.420000000000002 107.666 167.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.3 t -163.96 178.65 7.57 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.647 -0.501 . . . . 65.209999999999994 109.647 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -81.39 143.61 32.03 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.885 -0.413 . . . . 71.25 109.885 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -61.31 -37.78 84.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 123.723 0.639 . . . . 74.430000000000007 109.89 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -125.34 144.83 48.87 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 108.089 -1.078 . . . . 72.409999999999997 108.089 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.88 -27.68 2.96 Favored 'Trans proline' 0 C--N 1.329 -0.448 0 C-N-CA 122.163 1.909 . . . . 72.129999999999995 112.389 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.6 t -137.39 135.32 46.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.901 -1.518 . . . . 72.140000000000001 106.901 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.6 t -133.68 136.53 44.79 Favored 'General case' 0 N--CA 1.409 -2.49 0 N-CA-C 108.99 -0.745 . . . . 54.229999999999997 108.99 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -109.48 120.09 41.43 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.135 -0.691 . . . . 74.430000000000007 109.135 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 25.2 m -108.19 174.48 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 115.548 -0.751 . . . . 71.340000000000003 109.983 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.432 ' OG ' ' HB ' ' A' ' 518' ' ' ILE . 0.0 OUTLIER -96.8 164.06 12.72 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.4 -0.818 . . . . 65.140000000000001 110.495 -178.845 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -82.24 -54.29 5.37 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.248 -1.019 . . . . 61.32 108.248 171.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 12.1 m -80.71 31.79 0.3 Allowed 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.512 0.725 . . . . 74.530000000000001 112.1 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.432 ' HB ' ' OG ' ' A' ' 515' ' ' SER . 10.1 tt -94.34 -24.81 4.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 O-C-N 121.762 -0.586 . . . . 72.510000000000005 111.062 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.81 -80.53 1.79 Allowed Glycine 0 N--CA 1.417 -2.597 0 C-N-CA 120.329 -0.938 . . . . 71.340000000000003 111.128 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 43.0 mm -128.12 131.5 69.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.739 -1.208 . . . . 71.140000000000001 107.739 -174.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.546 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -109.41 145.1 36.69 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.093 -0.706 . . . . 60.43 109.093 176.11 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 23.9 mt-10 -124.19 119.57 29.76 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 123.667 0.604 . . . . 72.420000000000002 111.747 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.62 HG11 HD22 ' A' ' 642' ' ' LEU . 95.5 t -103.56 128.86 56.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 116.029 -0.532 . . . . 74.120000000000005 110.423 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -80.31 137.45 36.59 Favored 'General case' 0 C--O 1.248 0.981 0 O-C-N 123.515 0.51 . . . . 65.209999999999994 110.502 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 568' ' ' VAL . 59.9 t -112.75 132.82 60.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 116.147 -0.479 . . . . 73.549999999999997 109.741 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.81 126.68 31.4 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 122.928 0.491 . . . . 65.450000000000003 110.074 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -81.32 157.09 25.2 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.307 -0.861 . . . . 62.039999999999999 109.314 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 0.9 OUTLIER -59.97 145.8 44.84 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 123.333 0.653 . . . . 63.140000000000001 112.295 177.623 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 41.4 t -60.15 -34.98 74.3 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.153 -0.931 . . . . 74.239999999999995 110.093 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.41 81.04 0.35 Allowed Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.638 -0.985 . . . . 34.43 110.638 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.06 114.02 21.9 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.305 -0.998 . . . . 61.340000000000003 108.305 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -119.15 97.91 5.91 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.499 0.666 . . . . 75.109999999999999 110.711 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 108.89 -130.8 10.22 Favored Glycine 0 N--CA 1.427 -1.965 0 CA-C-N 115.397 -0.82 . . . . 55.25 112.772 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -133.15 127.74 34.53 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.892 -0.781 . . . . 70.439999999999998 108.892 -177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 61.3 t -132.18 141.82 44.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 123.185 0.594 . . . . 74.140000000000001 110.135 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.434 HG12 ' CG2' ' A' ' 597' ' ' VAL . 36.8 mm -111.35 129.99 65.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.197 -0.668 . . . . 74.030000000000001 109.197 175.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.407 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.2 t -115.04 105.96 52.19 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 109.203 -0.666 . . . . 73.140000000000001 109.203 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.82 152.35 36.95 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.319 2.013 . . . . 43.0 112.287 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.643 ' HB3' HG22 ' A' ' 591' ' ' ILE . 49.9 p90 -147.33 164.97 31.56 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.526 -0.306 . . . . 72.439999999999998 111.057 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -156.39 158.1 36.76 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.709 0.63 . . . . 72.219999999999999 109.916 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.3 p -87.78 141.75 28.36 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 115.656 -0.702 . . . . 71.25 110.102 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.533 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 90.3 mt -116.84 132.53 66.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.555 -1.276 . . . . 73.219999999999999 107.555 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -81.0 148.22 29.84 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 109.801 -0.444 . . . . 62.020000000000003 109.801 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -141.88 -117.3 1.3 Allowed Glycine 0 C--N 1.292 -1.88 0 N-CA-C 108.671 -1.772 . . . . 72.030000000000001 108.671 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 545' ' ' THR . . . . . 0.412 ' O ' ' HD3' ' A' ' 585' ' ' LYS . 16.7 p -78.34 -23.87 46.78 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.127 -1.064 . . . . 72.409999999999997 108.127 173.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 587' ' ' PHE . . . -91.84 135.52 33.86 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 106.982 -1.488 . . . . 71.329999999999998 106.982 172.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -106.81 151.99 24.46 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 113.717 1.006 . . . . 65.129999999999995 113.717 -174.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -91.24 -176.41 43.47 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 114.899 -1.046 . . . . 51.509999999999998 111.707 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 91.63 22.77 30.32 Favored Glycine 0 C--N 1.294 -1.77 0 N-CA-C 110.152 -1.179 . . . . 62.100000000000001 110.152 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 70.54 33.98 67.62 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 109.539 -1.424 . . . . 74.430000000000007 109.539 -176.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -95.66 -66.88 0.88 Allowed 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 110.08 -0.341 . . . . 64.329999999999998 110.08 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -104.41 -38.29 6.88 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.19 -1.041 . . . . 62.240000000000002 108.19 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -132.91 158.35 42.8 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.246 -0.888 . . . . 65.230000000000004 108.693 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.53 129.12 37.56 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.589 -1.263 . . . . 73.439999999999998 107.589 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.36 136.99 50.16 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 123.367 0.667 . . . . 74.409999999999997 110.175 -175.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.405 HG21 HG22 ' A' ' 573' ' ' VAL . 9.0 t -139.76 144.87 37.63 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.413 0.625 . . . . 65.0 110.03 176.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 14.2 p -143.94 133.29 23.24 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 106.275 -1.75 . . . . 41.219999999999999 106.275 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -159.49 -169.89 23.38 Favored Glycine 0 N--CA 1.404 -3.459 0 C-N-CA 118.602 -1.761 . . . . 74.129999999999995 112.385 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -139.82 115.23 9.91 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 124.659 0.858 . . . . 63.43 108.751 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.481 HD22 ' HB3' ' A' ' 569' ' ' LYS . 86.7 mt -89.54 133.55 34.54 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.571 -0.529 . . . . 63.229999999999997 109.571 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -101.95 119.34 38.63 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.173 0.511 . . . . 73.030000000000001 110.815 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -119.03 150.06 40.6 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.826 -0.805 . . . . 71.230000000000004 108.826 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.539 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 64.4 mt-30 -146.42 179.01 7.82 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.364 -1.347 . . . . 61.229999999999997 107.364 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -70.19 -25.77 63.58 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 123.64 0.588 . . . . 60.509999999999998 110.423 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -90.75 -33.61 15.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.988 -0.551 . . . . 60.340000000000003 111.915 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.539 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 72.5 mm-40 -66.84 152.61 45.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.918 0.39 . . . . 72.25 111.706 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.561 HG13 ' H ' ' A' ' 568' ' ' VAL . 5.8 pt -103.52 -86.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 113.38 0.881 . . . . 63.149999999999999 113.38 -177.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.561 ' H ' HG13 ' A' ' 567' ' ' ILE . 13.2 p -132.26 148.87 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 120.789 0.328 . . . . 71.400000000000006 110.221 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.481 ' HB3' HD22 ' A' ' 560' ' ' LEU . 1.5 mtpt -120.66 160.97 22.2 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 116.105 -0.498 . . . . 74.140000000000001 109.66 175.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 5.5 p -125.61 153.78 43.23 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.69 -0.687 . . . . 61.25 111.033 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.4 mp -100.91 122.74 53.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.21 -1.774 . . . . 60.549999999999997 106.21 170.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 572' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 521' ' ' MET . 14.8 p -100.91 115.11 29.65 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 123.622 0.577 . . . . 74.219999999999999 109.948 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.42 HG23 HG22 ' A' ' 571' ' ' ILE . 84.3 t -119.43 134.23 63.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.066 -0.515 . . . . 74.420000000000002 110.405 -177.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -84.54 118.86 24.59 Favored 'General case' 0 N--CA 1.428 -1.567 0 O-C-N 123.645 0.591 . . . . 73.219999999999999 109.568 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.05 120.71 36.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 105.953 -1.869 . . . . 73.349999999999994 105.953 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 48.2 mm . . . . . 0 C--N 1.305 -1.358 0 CA-C-O 121.484 0.659 . . . . 43.509999999999998 109.883 -176.066 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.412 ' HD3' ' O ' ' A' ' 545' ' ' THR . 94.8 mttt . . . . . 0 N--CA 1.425 -1.678 0 N-CA-C 106.647 -1.612 . . . . 75.340000000000003 106.647 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.8 t -143.1 148.77 37.18 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 121.248 0.546 . . . . 62.219999999999999 110.721 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.533 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 43.1 p90 -130.57 172.4 11.97 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 106.747 -1.575 . . . . 70.040000000000006 106.747 176.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.514 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 87.2 m-85 -120.24 154.51 34.79 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.195 -0.602 . . . . 73.239999999999995 109.981 -175.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.49 128.7 51.16 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 105.418 -2.067 . . . . 71.109999999999999 105.418 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.517 ' HB2' HD11 ' A' ' 542' ' ' ILE . 35.0 tt0 -129.19 137.08 50.93 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.598 -0.519 . . . . 74.219999999999999 109.598 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.643 HG22 ' HB3' ' A' ' 539' ' ' TYR . 15.1 pt -104.9 141.58 19.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.535 -0.913 . . . . 74.349999999999994 108.535 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -87.78 -176.58 48.12 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.66 -0.976 . . . . 74.519999999999996 110.66 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -68.47 130.97 91.81 Favored Pre-proline 0 N--CA 1.434 -1.251 0 C-N-CA 120.543 -0.463 . . . . 72.030000000000001 110.847 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.459 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 24.8 Cg_endo -66.95 137.24 44.1 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.013 2.475 . . . . 62.32 111.642 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -112.94 133.61 54.83 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.332 -0.395 . . . . 74.420000000000002 110.425 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -76.02 130.55 38.57 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.066 -1.457 . . . . 72.140000000000001 107.066 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.434 ' CG2' HG12 ' A' ' 536' ' ' ILE . 39.0 t . . . . . 0 C--N 1.293 -1.886 0 N-CA-C 107.84 -1.17 . . . . 65.25 107.84 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.459 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 24.9 Cg_endo . . . . . 0 N--CA 1.44 -1.623 0 N-CA-C 110.293 -0.695 . . . . 72.319999999999993 110.293 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.61 160.72 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 116.397 -0.365 . . . . 70.329999999999998 111.208 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.1 -176.36 3.97 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.822 -0.626 . . . . 62.229999999999997 112.278 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.66 -163.16 9.97 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 116.447 -0.342 . . . . 75.239999999999995 113.455 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -76.14 -46.62 27.85 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.789 -0.449 . . . . 75.420000000000002 109.789 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -136.57 120.94 18.06 Favored 'General case' 0 CA--C 1.49 -1.354 0 CA-C-O 121.063 0.459 . . . . 62.039999999999999 109.822 174.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 31.3 p -108.14 94.65 5.18 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-O 121.778 0.799 . . . . 60.109999999999999 109.774 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -151.31 146.73 26.22 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.972 -1.013 . . . . 72.439999999999998 108.638 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.62 HD22 HG11 ' A' ' 523' ' ' VAL . 26.3 tp -134.92 120.4 19.21 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 107.924 -1.139 . . . . 64.530000000000001 107.924 175.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -91.38 108.56 19.97 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.206 -1.405 . . . . 72.230000000000004 107.206 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 39.5 t -100.42 109.46 25.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 109.526 -0.546 . . . . 61.039999999999999 109.526 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 47.3 mt -93.87 129.64 43.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.343 -0.984 . . . . 61.509999999999998 108.343 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 77.1 mt -99.91 107.33 20.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.973 -0.751 . . . . 72.209999999999994 108.973 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 515' ' ' SER . 38.2 mt-10 . . . . . 0 C--N 1.307 -1.245 0 CA-C-O 121.628 0.728 . . . . 60.130000000000003 111.725 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.633 0 N-CA-C 111.48 0.178 . . . . 63.100000000000001 111.48 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 163.36 -145.76 10.89 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.695 -1.24 . . . . 74.510000000000005 112.134 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.15 121.69 58.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 122.428 0.291 . . . . 65.129999999999995 110.923 -174.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -105.44 125.44 50.99 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.204 -0.665 . . . . 72.430000000000007 109.204 169.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 506' ' ' THR . . . . . 0.466 ' HA ' HG22 ' A' ' 640' ' ' THR . 9.0 t -162.79 169.01 20.58 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.393 -0.595 . . . . 72.319999999999993 109.393 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -74.6 148.36 40.82 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.477 0.18 . . . . 74.439999999999998 110.714 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -68.13 -26.8 65.97 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.529 0.681 . . . . 72.519999999999996 110.124 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -140.76 141.01 23.18 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 107.33 -1.359 . . . . 53.350000000000001 107.33 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.48 -28.86 8.05 Favored 'Trans proline' 0 C--N 1.328 -0.539 0 C-N-CA 122.426 2.084 . . . . 70.150000000000006 111.637 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.9 t -132.69 136.34 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 106.293 -1.743 . . . . 62.32 106.293 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 7.5 t -131.71 140.76 49.37 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 108.82 -0.807 . . . . 74.540000000000006 108.82 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -113.07 123.35 50.09 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.073 -0.651 . . . . 44.43 109.677 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 20.8 m -112.66 174.34 2.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 115.249 -0.887 . . . . 62.020000000000003 108.897 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.568 ' O ' HG22 ' A' ' 518' ' ' ILE . 36.1 t -107.29 151.17 25.83 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.652 0.739 . . . . 21.210000000000001 111.882 -175.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -62.19 -23.51 66.66 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 125.732 1.613 . . . . 44.340000000000003 109.705 170.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 4.2 t -123.17 26.35 8.05 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 120.977 0.418 . . . . 71.409999999999997 111.402 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 515' ' ' SER . 8.5 tt -84.11 -27.87 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.55 -0.719 . . . . 63.219999999999999 110.664 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.21 -80.04 1.57 Allowed Glycine 0 N--CA 1.428 -1.856 0 N-CA-C 111.056 -0.817 . . . . 71.129999999999995 111.056 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 520' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 574' ' ' LYS . 40.2 mm -127.92 133.17 67.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 106.471 -1.677 . . . . 63.140000000000001 106.471 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.607 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -109.86 144.07 38.85 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.767 -0.457 . . . . 64.140000000000001 109.767 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 7.8 mp0 -117.9 118.12 31.11 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 124.185 0.928 . . . . 62.43 109.916 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.577 HG23 ' SD ' ' A' ' 521' ' ' MET . 87.4 t -109.45 130.71 62.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.176 -0.676 . . . . 61.409999999999997 109.176 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -88.75 145.16 25.79 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 121.942 0.877 . . . . 74.120000000000005 112.626 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 38.9 t -113.26 137.55 45.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-N 114.437 -1.256 . . . . 65.310000000000002 107.926 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.7 mt -78.22 114.64 17.3 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.813 -0.81 . . . . 73.319999999999993 108.813 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -68.65 157.44 36.19 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.595 -1.184 . . . . 71.239999999999995 109.24 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.1 t -55.57 133.01 50.1 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 123.825 0.703 . . . . 55.439999999999998 111.568 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.7 m -54.59 -28.06 43.55 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.611 1.564 . . . . 55.340000000000003 111.026 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.58 91.93 0.48 Allowed Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 108.748 -1.741 . . . . 71.420000000000002 108.748 174.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -92.7 104.13 16.44 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.972 0.415 . . . . 63.409999999999997 110.411 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -130.27 104.68 7.43 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.069 -0.514 . . . . 71.129999999999995 109.85 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 101.18 -138.79 14.06 Favored Glycine 0 C--N 1.307 -1.08 0 C-N-CA 120.86 -0.686 . . . . 42.240000000000002 112.16 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -133.24 130.56 39.18 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.419 -0.585 . . . . 74.030000000000001 109.419 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.28 134.04 57.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.03 -1.1 . . . . 73.329999999999998 108.03 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.513 HG12 ' CG2' ' A' ' 597' ' ' VAL . 46.3 mm -102.95 135.11 41.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.205 -0.665 . . . . 53.310000000000002 109.205 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 42.8 t -120.11 108.79 37.94 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.577 -0.527 . . . . 73.209999999999994 109.577 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 48.4 Cg_endo -74.3 154.06 45.89 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.277 1.984 . . . . 74.329999999999998 111.748 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.478 ' HB3' HG22 ' A' ' 591' ' ' ILE . 33.1 p90 -145.59 164.2 32.44 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.942 -0.303 . . . . 60.210000000000001 110.709 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -157.02 156.85 33.61 Favored 'General case' 0 C--O 1.248 0.978 0 O-C-N 123.835 0.709 . . . . 74.439999999999998 110.225 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.2 p -89.15 139.84 30.06 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 116.075 -0.511 . . . . 73.120000000000005 110.109 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 78.0 mt -112.01 129.24 67.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.812 -0.81 . . . . 74.540000000000006 108.812 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -83.02 164.7 20.19 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.156 -0.683 . . . . 65.099999999999994 109.156 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 172.1 -82.73 0.08 OUTLIER Glycine 0 CA--C 1.474 -2.469 0 C-N-CA 120.031 -1.081 . . . . 60.109999999999999 111.749 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.8 m -101.92 19.4 18.44 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.513 1.149 . . . . 63.439999999999998 108.402 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -162.84 148.82 12.29 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 106.169 -1.789 . . . . 51.200000000000003 106.169 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -104.59 141.07 37.07 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 123.712 0.805 . . . . 75.439999999999998 112.116 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.63 -160.41 36.46 Favored Glycine 0 C--N 1.306 -1.116 0 CA-C-N 115.433 -0.803 . . . . 64.329999999999998 112.704 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 71.65 12.66 74.2 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.751 -0.261 . . . . 30.129999999999999 113.499 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 90.11 19.36 46.85 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.459 -0.877 . . . . 64.439999999999998 111.043 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -89.18 -67.32 0.85 Allowed 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.59 -0.522 . . . . 74.439999999999998 109.59 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -102.13 -33.69 9.57 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.657 -1.238 . . . . 72.209999999999994 107.657 172.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -141.33 154.99 45.99 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.591 -0.892 . . . . 72.430000000000007 108.591 176.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.14 120.28 27.35 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.596 -1.631 . . . . 74.450000000000003 106.596 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -80.66 124.58 29.12 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.064 -0.516 . . . . 73.340000000000003 110.531 -171.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.7 t -136.2 168.68 18.95 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.35 0.595 . . . . 64.349999999999994 111.199 -172.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 14.8 p -158.52 164.44 36.13 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.97 -1.122 . . . . 64.430000000000007 107.97 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 173.57 -169.44 42.53 Favored Glycine 0 CA--C 1.482 -1.982 0 C-N-CA 120.156 -1.021 . . . . 74.010000000000005 110.853 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 46.1 mt-10 -137.14 125.42 23.22 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 123.428 0.691 . . . . 73.209999999999994 109.319 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.485 HD22 ' HB3' ' A' ' 569' ' ' LYS . 96.5 mt -96.05 132.42 41.44 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.257 -0.429 . . . . 75.109999999999999 109.862 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.43 ' HA ' HD13 ' A' ' 536' ' ' ILE . 29.0 tt0 -94.91 111.23 23.04 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.22 0.534 . . . . 72.209999999999994 110.806 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 81.9 m-85 -107.98 142.59 37.87 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.063 0.459 . . . . 75.230000000000004 110.002 177.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.486 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 43.0 mt-30 -140.42 179.9 6.39 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.45 -0.574 . . . . 74.420000000000002 109.45 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -68.36 -34.61 76.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.82 -1.082 . . . . 72.549999999999997 108.894 173.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -85.14 -39.99 17.25 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.033 -0.985 . . . . 73.549999999999997 111.692 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.486 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 52.2 mm-40 -65.49 135.08 54.72 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.084 0.402 . . . . 64.299999999999997 112.084 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.617 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.8 pt -83.76 -81.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.227 0.825 . . . . 73.319999999999993 113.227 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.617 ' H ' HG13 ' A' ' 567' ' ' ILE . 9.0 p -128.79 158.48 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 109.555 -0.535 . . . . 70.120000000000005 109.555 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.485 ' HB3' HD22 ' A' ' 560' ' ' LEU . 4.5 mmpt? -125.94 159.26 33.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.078 -1.082 . . . . 72.340000000000003 108.078 172.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 5.8 p -130.14 149.07 52.01 Favored 'General case' 0 C--N 1.286 -2.194 0 O-C-N 123.832 0.707 . . . . 71.030000000000001 111.673 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.9 mp -94.79 125.53 47.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 106.825 -1.546 . . . . 73.400000000000006 106.825 172.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 572' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 521' ' ' MET . 48.6 m -107.07 118.36 36.5 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 123.958 0.786 . . . . 73.409999999999997 110.068 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.401 HG23 HG22 ' A' ' 571' ' ' ILE . 76.4 t -125.45 134.42 66.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.097 -0.501 . . . . 54.109999999999999 109.874 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.408 ' HA ' HD13 ' A' ' 520' ' ' ILE . 27.5 tptp -79.87 115.02 19.22 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.883 -0.784 . . . . 64.239999999999995 108.883 174.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.24 130.19 36.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.604 -1.258 . . . . 72.25 107.604 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 44.1 mm . . . . . 0 N--CA 1.421 -1.895 0 N-CA-C 108.174 -1.047 . . . . 73.340000000000003 108.174 179.144 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp . . . . . 0 N--CA 1.421 -1.915 0 N-CA-C 107.819 -1.178 . . . . 71.219999999999999 107.819 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.7 t -132.73 130.64 40.27 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.626 0.727 . . . . 64.140000000000001 111.402 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -121.37 172.42 8.05 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.418 -0.956 . . . . 72.219999999999999 108.418 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.506 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 90.8 m-85 -118.7 152.48 36.05 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.947 -0.701 . . . . 75.030000000000001 109.855 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.54 130.22 54.14 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.304 -1.739 . . . . 72.109999999999999 106.304 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.474 ' HB2' HD11 ' A' ' 542' ' ' ILE . 43.3 tt0 -127.02 134.44 50.32 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.624 -0.43 . . . . 62.310000000000002 109.865 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.478 HG22 ' HB3' ' A' ' 539' ' ' TYR . 21.3 pt -102.56 139.78 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 107.673 -1.232 . . . . 72.010000000000005 107.673 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.45 177.2 52.73 Favored Glycine 0 N--CA 1.421 -2.343 0 C-N-CA 120.997 -0.62 . . . . 43.450000000000003 111.622 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.16 129.06 94.18 Favored Pre-proline 0 N--CA 1.428 -1.531 0 CA-C-O 120.86 0.362 . . . . 73.319999999999993 110.631 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.405 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 23.3 Cg_endo -60.24 132.94 46.72 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.485 2.79 . . . . 71.519999999999996 112.291 -175.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 595' ' ' ARG . . . . . 0.403 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.0 ptp180 -110.41 119.96 40.9 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 120.993 0.425 . . . . 64.109999999999999 110.658 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.49 131.82 47.38 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.731 0.813 . . . . 70.140000000000001 108.858 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.513 ' CG2' HG12 ' A' ' 536' ' ' ILE . 61.0 t . . . . . 0 C--N 1.298 -1.672 0 N-CA-C 109.46 -0.57 . . . . 74.409999999999997 109.46 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.405 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 55.5 Cg_endo . . . . . 0 N--CA 1.435 -1.913 0 N-CA-C 111.016 -0.417 . . . . 70.319999999999993 111.016 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.93 170.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 116.174 -0.466 . . . . 73.540000000000006 110.876 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.34 170.65 7.82 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 112.786 0.661 . . . . 75.349999999999994 112.786 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -78.51 -158.08 11.38 Favored Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 114.834 -1.075 . . . . 73.329999999999998 115.283 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -66.78 -54.52 21.83 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.082 -1.059 . . . . 71.409999999999997 110.853 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -126.81 137.49 53.21 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.56 -0.904 . . . . 73.019999999999996 108.56 175.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 640' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 506' ' ' THR . 8.7 p -127.12 73.68 1.44 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 122.344 1.069 . . . . 72.120000000000005 111.336 174.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -157.42 141.2 15.88 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 114.475 -1.239 . . . . 60.149999999999999 107.962 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.544 HD22 HG11 ' A' ' 523' ' ' VAL . 38.5 tp -124.4 130.24 52.12 Favored 'General case' 0 C--N 1.279 -2.484 0 O-C-N 124.181 0.926 . . . . 75.219999999999999 109.35 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -94.46 107.38 19.35 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.059 -1.46 . . . . 63.140000000000001 107.059 174.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.1 109.63 24.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.269 -0.641 . . . . 74.0 109.269 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 52.6 mt -96.76 122.91 48.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 109.012 -0.736 . . . . 73.310000000000002 109.012 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 82.2 mt -87.72 111.82 22.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 106.9 -1.519 . . . . 74.430000000000007 106.9 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 N--CA 1.422 -1.83 0 N-CA-C 109.364 -0.606 . . . . 65.310000000000002 109.364 178.342 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 502' ' ' ALA . . . . . 0.533 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 121.385 0.612 . . . . 75.019999999999996 110.993 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 139.88 -149.51 20.86 Favored Glycine 0 N--CA 1.419 -2.486 0 C-N-CA 120.304 -0.95 . . . . 72.049999999999997 110.875 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.43 HG23 ' HA3' ' A' ' 637' ' ' GLY . 3.8 mp -117.24 113.43 42.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 123.687 0.287 . . . . 51.100000000000001 111.237 -174.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.435 ' CD2' HG23 ' A' ' 528' ' ' THR . 21.8 m-85 -92.04 124.82 36.43 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.725 -1.213 . . . . 71.109999999999999 107.725 169.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.7 t -168.72 171.46 8.64 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 120.554 -0.458 . . . . 62.439999999999998 109.883 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -80.55 157.39 26.1 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.839 -0.801 . . . . 71.25 108.839 175.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.74 -35.51 80.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.506 0.67 . . . . 64.239999999999995 110.32 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -140.18 149.36 57.92 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.487 -0.931 . . . . 75.420000000000002 108.487 -176.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 510' ' ' PRO . . . . . 0.434 ' O ' ' HA ' ' A' ' 642' ' ' LEU . 60.9 Cg_endo -75.53 -24.97 11.51 Favored 'Trans proline' 0 C--O 1.219 -0.437 0 C-N-CA 122.158 1.906 . . . . 75.129999999999995 112.77 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.75 135.76 58.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.981 -0.748 . . . . 74.230000000000004 108.981 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 9.5 t -135.03 140.08 45.32 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 107.714 -1.217 . . . . 64.239999999999995 107.714 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -108.73 138.41 45.09 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.651 -0.87 . . . . 73.540000000000006 108.651 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.8 m -128.65 156.38 41.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.953 -0.758 . . . . 62.310000000000002 108.953 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.592 ' O ' HG22 ' A' ' 518' ' ' ILE . 33.0 t -83.48 150.84 25.76 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.795 -0.639 . . . . 75.019999999999996 109.323 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -66.89 -32.64 74.04 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.494 -0.558 . . . . 64.530000000000001 109.494 170.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.7 m -99.29 20.46 13.56 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 116.142 -0.481 . . . . 65.409999999999997 112.117 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 515' ' ' SER . 9.9 tt -79.23 -27.52 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.542 -0.724 . . . . 74.209999999999994 111.529 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 92.3 -77.16 1.26 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.29 -0.957 . . . . 51.229999999999997 111.327 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 520' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 574' ' ' LYS . 42.4 mm -130.53 123.58 55.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 106.719 -1.586 . . . . 72.319999999999993 106.719 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -101.43 150.52 22.95 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.798 -0.816 . . . . 74.219999999999999 108.798 177.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.7 mt-10 -132.06 129.18 39.68 Favored 'General case' 0 CA--C 1.493 -1.247 0 O-C-N 123.702 0.626 . . . . 73.230000000000004 111.033 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.582 HG21 HD21 ' A' ' 642' ' ' LEU . 60.9 t -116.4 132.04 67.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.282 -0.872 . . . . 54.200000000000003 108.978 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -85.45 127.82 34.52 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 124.138 0.975 . . . . 71.340000000000003 110.252 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 60.3 t -110.41 128.57 66.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.885 -0.598 . . . . 72.219999999999999 109.645 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 77.9 mt -81.75 127.97 33.5 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.012 -0.994 . . . . 62.420000000000002 112.031 -173.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -72.12 162.18 29.83 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.387 -0.968 . . . . 74.310000000000002 108.387 172.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 19.4 p -58.7 154.52 14.45 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 123.503 0.721 . . . . 71.299999999999997 112.341 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 41.0 t -53.83 -35.18 61.18 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.793 1.237 . . . . 62.32 109.498 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -114.82 103.7 1.29 Allowed Glycine 0 N--CA 1.42 -2.407 0 N-CA-C 108.841 -1.704 . . . . 54.509999999999998 108.841 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.71 101.7 12.99 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.194 -0.669 . . . . 70.329999999999998 109.194 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -127.02 117.99 23.57 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.796 -0.816 . . . . 64.439999999999998 108.796 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 77.22 172.04 36.56 Favored Glycine 0 C--N 1.298 -1.562 0 N-CA-C 115.016 0.767 . . . . 63.009999999999998 115.016 173.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 534' ' ' ASN . . . . . 0.513 ' ND2' HG21 ' A' ' 597' ' ' VAL . 49.9 t30 -86.01 123.23 31.1 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.519 -0.84 . . . . 72.519999999999996 109.127 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.402 HG22 HD22 ' A' ' 596' ' ' LEU . 58.0 t -132.01 132.9 61.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 114.8 -1.091 . . . . 72.129999999999995 108.204 -175.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.484 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 43.8 mm -102.81 132.25 49.34 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 109.375 -0.602 . . . . 71.209999999999994 109.375 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.53 105.77 43.27 Favored Pre-proline 0 N--CA 1.427 -1.594 0 N-CA-C 108.736 -0.839 . . . . 75.140000000000001 108.736 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 34.8 Cg_endo -72.55 151.98 53.54 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.169 1.912 . . . . 71.120000000000005 111.672 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.42 ' HB3' HG22 ' A' ' 591' ' ' ILE . 32.3 p90 -142.6 163.27 33.28 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.459 -0.496 . . . . 72.310000000000002 110.104 177.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -153.67 151.37 29.59 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 123.929 0.768 . . . . 75.239999999999995 110.01 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 11.1 p -85.78 133.13 34.01 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 109.377 -0.601 . . . . 75.319999999999993 109.377 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 67.5 mt -108.08 124.2 64.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 108.178 -1.045 . . . . 73.209999999999994 108.178 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -73.14 136.03 44.77 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 120.945 0.402 . . . . 74.5 110.321 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -126.61 -104.43 1.35 Allowed Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 109.352 -1.499 . . . . 54.219999999999999 109.352 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.7 p -94.57 -21.32 18.92 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.489 0.662 . . . . 64.420000000000002 109.61 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -84.01 142.29 30.58 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 108.44 -0.948 . . . . 72.209999999999994 108.44 175.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -87.32 123.3 32.15 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 114.305 1.224 . . . . 73.230000000000004 114.305 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -81.92 -158.8 23.26 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 115.043 -0.981 . . . . 53.109999999999999 112.101 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.36 14.36 71.66 Favored Glycine 0 C--N 1.306 -1.1 0 C-N-CA 121.312 -0.471 . . . . 52.439999999999998 112.837 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 550' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 554' ' ' GLU . . . 77.92 39.02 25.4 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.905 -0.664 . . . . 33.409999999999997 111.836 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -111.9 -50.97 2.88 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.441 0.639 . . . . 62.409999999999997 109.949 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -104.07 -47.14 4.25 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 105.821 -1.918 . . . . 63.009999999999998 105.821 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -134.11 154.21 51.34 Favored 'General case' 0 C--O 1.256 1.421 0 CA-C-N 114.329 -1.305 . . . . 75.030000000000001 108.152 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.417 ' HA ' ' HA2' ' A' ' 550' ' ' GLY . 16.4 tt0 -81.21 119.38 23.54 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.25 -1.389 . . . . 70.420000000000002 107.25 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.88 125.15 28.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.093 -1.077 . . . . 74.349999999999994 108.093 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.409 HG21 HG22 ' A' ' 573' ' ' VAL . 12.0 t -140.02 159.41 42.25 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-O 121.618 0.723 . . . . 45.009999999999998 110.609 -171.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 23.0 p -147.22 165.74 29.12 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 107.331 -1.359 . . . . 75.420000000000002 107.331 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 176.16 -174.32 46.86 Favored Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 120.044 -1.074 . . . . 42.229999999999997 110.82 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.484 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 51.7 mt-10 -134.38 119.55 18.75 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 123.271 0.628 . . . . 75.420000000000002 109.325 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' A' ' 569' ' ' LYS . 88.7 mt -86.53 132.47 33.91 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.985 -0.552 . . . . 62.109999999999999 109.811 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.483 ' HA ' HD13 ' A' ' 536' ' ' ILE . 34.9 tt0 -101.53 106.38 17.47 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.745 -0.661 . . . . 73.409999999999997 110.019 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -105.42 149.68 25.93 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.75 -0.833 . . . . 72.25 108.75 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.576 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 37.3 mt-30 -143.96 -169.16 3.04 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.204 -1.406 . . . . 64.010000000000005 107.204 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -76.12 -19.48 58.48 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.595 -0.891 . . . . 71.219999999999999 108.595 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -88.54 -45.1 10.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.31 -1.314 . . . . 62.25 110.521 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.576 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 6.0 mm-40 -74.9 122.51 23.53 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.943 0.401 . . . . 74.409999999999997 111.817 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.493 HD12 HG12 ' A' ' 568' ' ' VAL . 1.8 pp -106.99 -32.51 2.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 115.122 -0.944 . . . . 54.25 113.16 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.493 HG12 HD12 ' A' ' 567' ' ' ILE . 9.4 p -143.43 145.76 22.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 120.275 -0.57 . . . . 71.129999999999995 110.494 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.443 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.1 OUTLIER -127.59 162.18 27.09 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.798 -0.637 . . . . 64.420000000000002 109.612 174.06 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.7 p -122.32 143.33 49.7 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.588 0.588 . . . . 53.009999999999998 112.588 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.6 mp -94.63 117.84 39.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 106.591 -1.633 . . . . 63.210000000000001 106.591 170.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 572' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 521' ' ' MET . 8.1 p -98.31 115.52 28.59 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.712 0.632 . . . . 65.310000000000002 109.498 178.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.557 HG23 HG22 ' A' ' 571' ' ' ILE . 60.1 t -121.52 124.66 72.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 116.295 -0.412 . . . . 74.430000000000007 110.66 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.42 ' HA ' HD13 ' A' ' 520' ' ' ILE . 13.6 tppt? -71.91 120.83 18.07 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.965 -1.016 . . . . 72.040000000000006 108.678 173.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 28.2 t -92.37 130.33 41.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 104.73 -2.322 . . . . 53.140000000000001 104.73 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 44.0 mm . . . . . 0 C--N 1.289 -2.031 0 N-CA-C 108.762 -0.829 . . . . 73.019999999999996 108.762 -173.418 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.289 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.314 0 N-CA-C 114.196 1.184 . . . . 60.43 114.196 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.9 t -141.79 159.02 43.08 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.767 -1.106 . . . . 61.130000000000003 110.349 -172.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 40.3 p90 -132.79 168.69 17.91 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 106.693 -1.595 . . . . 75.200000000000003 106.693 175.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.533 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 63.6 m-85 -115.74 155.74 27.23 Favored 'General case' 0 C--N 1.283 -2.284 0 C-N-CA 120.34 -0.544 . . . . 75.400000000000006 110.342 -175.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.21 126.19 46.51 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 105.717 -1.957 . . . . 62.039999999999999 105.717 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.401 ' HB2' HD11 ' A' ' 542' ' ' ILE . 42.4 tt0 -127.16 129.77 48.5 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 120.534 -0.467 . . . . 75.340000000000003 109.871 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.42 HG22 ' HB3' ' A' ' 539' ' ' TYR . 21.5 pt -98.96 136.2 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 N-CA-C 108.046 -1.094 . . . . 64.409999999999997 108.046 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.03 -177.87 52.13 Favored Glycine 0 N--CA 1.421 -2.365 0 CA-C-N 115.496 -0.775 . . . . 62.219999999999999 111.369 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -64.82 133.71 95.82 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 120.742 0.306 . . . . 74.340000000000003 111.497 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -69.01 124.09 11.02 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 122.697 2.265 . . . . 71.450000000000003 110.558 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -111.41 125.1 53.51 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 109.65 -0.5 . . . . 70.040000000000006 109.65 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.421 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 1.4 tm? -66.33 133.13 49.88 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 105.204 -2.147 . . . . 74.230000000000004 105.204 174.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.513 HG21 ' ND2' ' A' ' 534' ' ' ASN . 63.4 t . . . . . 0 C--N 1.3 -1.567 0 CA-C-O 121.759 0.79 . . . . 75.109999999999999 110.861 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 596' ' ' LEU . 36.7 Cg_endo . . . . . 0 C--O 1.243 0.756 0 CA-C-O 121.415 0.506 . . . . 75.430000000000007 112.389 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -126.71 164.08 27.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.591 -0.732 . . . . 72.140000000000001 109.89 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.53 173.56 7.56 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 112.875 0.694 . . . . 70.409999999999997 112.875 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.43 ' HA3' HG23 ' A' ' 504' ' ' ILE . . . -74.88 -171.89 28.8 Favored Glycine 0 N--CA 1.43 -1.709 0 CA-C-N 115.579 -0.737 . . . . 74.329999999999998 114.354 -176.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.73 -40.52 88.39 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.168 0.987 . . . . 74.25 109.744 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -133.3 138.51 46.44 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.904 -0.776 . . . . 70.329999999999998 108.904 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 19.1 p -136.53 88.17 2.35 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.746 0.784 . . . . 63.210000000000001 109.217 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -159.73 145.19 15.58 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.019 -0.991 . . . . 74.409999999999997 108.797 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.582 HD21 HG21 ' A' ' 523' ' ' VAL . 25.8 tp -136.14 120.55 18.08 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 108.717 -0.845 . . . . 72.099999999999994 108.717 176.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -91.68 105.33 17.65 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.831 -1.544 . . . . 72.400000000000006 106.831 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 36.7 t -98.69 106.25 18.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.468 -0.567 . . . . 72.120000000000005 109.468 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 53.6 mt -89.94 128.98 41.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 109.014 -0.736 . . . . 70.209999999999994 109.014 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 55.3 mt -104.4 103.55 15.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.238 -0.652 . . . . 73.239999999999995 109.238 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--N 1.288 -2.076 0 CA-C-N 115.892 -0.595 . . . . 74.420000000000002 109.478 178.544 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.085 0 N-CA-C 112.205 0.446 . . . . 61.420000000000002 112.205 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 135.91 -141.53 12.68 Favored Glycine 0 C--N 1.313 -0.697 0 C-N-CA 118.892 -1.623 . . . . 64.409999999999997 113.424 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.7 119.52 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 C-N-CA 122.893 0.477 . . . . 45.340000000000003 110.327 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -98.57 135.15 40.52 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.254 -1.387 . . . . 73.349999999999994 107.254 168.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 506' ' ' THR . . . . . 0.471 ' HA ' HG22 ' A' ' 640' ' ' THR . 12.9 t -169.41 -179.96 3.65 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.959 -0.756 . . . . 72.319999999999993 108.959 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 507' ' ' PHE . . . . . 0.454 ' CZ ' HG23 ' A' ' 591' ' ' ILE . 67.4 m-85 -84.4 151.84 24.42 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.937 -0.394 . . . . 75.030000000000001 109.937 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -67.0 -31.75 72.53 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.439 0.638 . . . . 62.450000000000003 110.059 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -135.0 141.53 38.66 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.532 -1.285 . . . . 71.099999999999994 107.532 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.59 -26.32 7.2 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 122.289 1.993 . . . . 73.219999999999999 112.459 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 61.1 t -139.73 132.31 35.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 106.853 -1.536 . . . . 65.400000000000006 106.853 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.8 t -127.68 138.71 52.89 Favored 'General case' 0 N--CA 1.414 -2.226 0 C-N-CA 120.252 -0.579 . . . . 72.209999999999994 109.994 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -103.64 116.44 32.35 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.541 -0.911 . . . . 74.349999999999994 108.541 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.6 m -117.44 165.5 12.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.418 -0.956 . . . . 75.109999999999999 108.418 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.606 ' O ' HG22 ' A' ' 518' ' ' ILE . 27.3 t -95.95 153.8 17.57 Favored 'General case' 0 N--CA 1.418 -2.072 0 C-N-CA 120.556 -0.457 . . . . 64.200000000000003 109.792 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.76 -34.45 75.61 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.176 -1.046 . . . . 70.129999999999995 108.176 170.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.7 m -98.39 20.34 12.83 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.77 -1.105 . . . . 75.239999999999995 111.966 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.606 HG22 ' O ' ' A' ' 515' ' ' SER . 9.4 tt -82.97 -26.68 7.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 CA-C-O 121.622 0.725 . . . . 73.219999999999999 109.372 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 91.97 -78.66 1.26 Allowed Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.305 -1.118 . . . . 70.450000000000003 110.305 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 520' ' ' ILE . . . . . 0.448 HD13 ' HA ' ' A' ' 574' ' ' LYS . 32.3 mm -128.99 141.14 47.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 106.839 -1.541 . . . . 73.439999999999998 106.839 -177.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.529 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -122.72 144.82 48.91 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.289 -0.634 . . . . 74.150000000000006 109.289 178.255 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 10.6 mp0 -115.33 130.5 56.92 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 123.819 0.699 . . . . 74.329999999999998 109.589 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.626 HG11 HD22 ' A' ' 642' ' ' LEU . 59.3 t -116.07 128.41 73.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 109.303 -0.629 . . . . 73.439999999999998 109.303 175.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -81.95 129.91 34.91 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 123.733 0.813 . . . . 74.329999999999998 109.839 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 568' ' ' VAL . 60.0 t -106.1 118.7 54.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.504 -0.924 . . . . 72.150000000000006 108.504 175.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.7 mt -67.44 122.44 17.96 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 123.863 0.727 . . . . 61.210000000000001 111.461 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 567' ' ' ILE . 21.7 tpt180 -68.01 145.69 54.24 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.518 -1.219 . . . . 75.439999999999998 108.946 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 12.4 t -56.5 143.41 35.32 Favored 'General case' 0 N--CA 1.406 -2.637 0 C-N-CA 124.917 1.287 . . . . 72.329999999999998 109.984 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 18.8 t -52.53 -36.14 54.9 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.737 0.815 . . . . 61.340000000000003 111.437 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -116.46 96.15 0.71 Allowed Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.022 -1.231 . . . . 52.43 110.022 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -84.87 101.67 12.49 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.648 -0.871 . . . . 63.520000000000003 108.648 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -124.77 116.88 23.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.822 -0.807 . . . . 71.040000000000006 108.822 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.432 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 77.72 -178.72 51.8 Favored Glycine 0 C--O 1.258 1.602 0 O-C-N 123.695 0.622 . . . . 64.140000000000001 113.84 176.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -90.95 125.83 35.89 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.893 -0.654 . . . . 74.049999999999997 109.522 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 72.6 t -133.16 134.58 57.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.745 -0.661 . . . . 61.229999999999997 109.26 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.58 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 37.8 mm -106.51 134.75 47.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 109.219 -0.66 . . . . 75.400000000000006 109.219 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.65 110.25 32.01 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.741 -0.466 . . . . 72.230000000000004 109.741 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 38.9 Cg_endo -70.65 158.04 56.94 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.338 2.026 . . . . 73.340000000000003 111.583 177.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.437 ' HB3' HG22 ' A' ' 591' ' ' ILE . 52.2 p90 -151.99 155.56 38.24 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.331 -0.618 . . . . 72.430000000000007 109.331 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.64 149.1 28.08 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 123.87 0.731 . . . . 72.530000000000001 112.174 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.1 p -83.44 131.16 35.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 116.003 -0.544 . . . . 75.540000000000006 109.933 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 57.9 mt -103.07 119.91 52.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.003 -1.11 . . . . 53.140000000000001 108.003 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.91 160.61 27.19 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.133 -0.692 . . . . 75.049999999999997 109.133 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 177.69 -97.6 0.11 Allowed Glycine 0 CA--C 1.473 -2.533 0 N-CA-C 110.504 -1.038 . . . . 74.230000000000004 110.504 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 545' ' ' THR . . . . . 0.489 ' HB ' ' H ' ' A' ' 586' ' ' THR . 0.2 OUTLIER -71.37 -31.53 67.44 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 109.355 -0.609 . . . . 74.319999999999993 109.355 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -107.67 155.75 19.82 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 108.494 -0.928 . . . . 61.109999999999999 108.494 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -101.01 137.85 38.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.543 0.687 . . . . 75.219999999999999 112.457 -176.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.98 -150.47 12.45 Favored Glycine 0 C--N 1.299 -1.498 0 C-N-CA 120.663 -0.779 . . . . 73.299999999999997 112.716 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 61.02 7.28 8.3 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 115.749 1.06 . . . . 65.010000000000005 115.749 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 90.44 14.59 58.37 Favored Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 118.209 1.005 . . . . 73.349999999999994 110.991 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -87.52 -55.44 3.79 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.165 -0.68 . . . . 71.530000000000001 109.165 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -107.04 -42.26 4.94 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.112 -1.44 . . . . 73.219999999999999 107.112 177.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -140.07 152.38 46.13 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.809 -1.182 . . . . 75.439999999999998 107.809 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.74 112.94 20.53 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.311 -0.996 . . . . 73.150000000000006 108.311 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.99 122.5 17.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.38 1.072 . . . . 55.310000000000002 111.675 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.7 t -131.66 142.35 49.82 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 121.786 0.803 . . . . 61.43 110.577 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 21.4 p -151.71 150.16 29.9 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.559 -1.275 . . . . 71.319999999999993 107.559 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 172.62 -164.03 36.16 Favored Glycine 0 CA--C 1.482 -2.013 0 N-CA-C 109.979 -1.248 . . . . 70.129999999999995 109.979 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.58 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 45.3 mt-10 -133.24 128.06 35.06 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.986 0.393 . . . . 73.219999999999999 111.134 -177.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.464 HD22 ' HB3' ' A' ' 569' ' ' LYS . 95.8 mt -89.44 141.18 28.8 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 123.463 0.705 . . . . 71.319999999999993 109.201 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.464 ' HA ' HD13 ' A' ' 536' ' ' ILE . 36.1 tt0 -103.54 118.28 36.37 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.292 0.568 . . . . 71.049999999999997 110.884 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -116.39 148.75 40.35 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.777 -0.823 . . . . 73.329999999999998 108.777 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.658 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 45.7 mt-30 -140.86 -178.97 5.8 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.826 -0.805 . . . . 53.130000000000003 108.826 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 564' ' ' ASN . . . . . 0.432 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 3.6 p-10 -71.48 -36.0 71.0 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.597 -0.441 . . . . 74.319999999999993 110.617 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -79.81 -39.3 31.09 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.109 -0.496 . . . . 75.319999999999993 110.167 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.658 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 64.5 mm-40 -63.64 151.86 40.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.556 -0.747 . . . . 73.120000000000005 111.736 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.549 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.2 pt -114.62 -92.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 113.447 0.906 . . . . 63.439999999999998 113.447 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.549 ' H ' HG13 ' A' ' 567' ' ' ILE . 11.7 p -107.86 146.64 13.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 120.885 0.374 . . . . 72.150000000000006 111.331 -174.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.464 ' HB3' HD22 ' A' ' 560' ' ' LEU . 5.3 mmpt? -114.99 165.19 13.15 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.146 -0.687 . . . . 73.140000000000001 109.146 173.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.2 p -131.41 140.35 49.62 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.973 -0.558 . . . . 51.109999999999999 112.088 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.0 mp -95.28 121.03 45.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.811 -1.181 . . . . 73.409999999999997 107.811 173.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 572' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 521' ' ' MET . 70.0 m -96.64 117.74 31.63 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 123.981 0.801 . . . . 64.310000000000002 109.035 176.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.474 HG23 HG22 ' A' ' 571' ' ' ILE . 89.6 t -119.31 133.42 66.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 110.239 -0.282 . . . . 71.140000000000001 110.239 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.448 ' HA ' HD13 ' A' ' 520' ' ' ILE . 22.1 tptm -86.37 120.71 28.0 Favored 'General case' 0 N--CA 1.435 -1.218 0 O-C-N 123.684 0.615 . . . . 65.150000000000006 109.363 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 31.0 t -96.05 127.39 48.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.81 -1.182 . . . . 64.129999999999995 107.81 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 34.5 mm . . . . . 0 C--N 1.306 -1.31 0 CA-C-O 120.999 0.428 . . . . 64.25 110.123 -175.459 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.414 0 CA-C-O 121.497 0.665 . . . . 72.319999999999993 112.448 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 586' ' ' THR . . . . . 0.489 ' H ' ' HB ' ' A' ' 545' ' ' THR . 5.3 t -153.47 153.3 32.2 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 115.434 -0.803 . . . . 70.239999999999995 109.02 -173.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -133.03 168.38 18.6 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.233 -1.395 . . . . 74.219999999999999 107.233 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.485 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 72.5 m-85 -117.73 151.27 37.61 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 120.084 -0.646 . . . . 74.030000000000001 109.451 -174.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.1 OUTLIER -121.39 128.1 51.87 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 106.378 -1.712 . . . . 72.099999999999994 106.378 178.21 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -124.93 133.94 52.85 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.991 -0.744 . . . . 74.349999999999994 108.991 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.454 HG23 ' CZ ' ' A' ' 507' ' ' PHE . 18.3 pt -97.84 135.84 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 N-CA-C 107.878 -1.156 . . . . 64.299999999999997 107.878 173.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -81.83 173.07 53.53 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 111.017 -0.833 . . . . 62.219999999999999 111.017 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 593' ' ' GLU . 6.1 mp0 -59.41 135.08 88.66 Favored Pre-proline 0 C--N 1.287 -2.122 0 C-N-CA 123.945 0.898 . . . . 74.329999999999998 110.688 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -70.87 122.06 8.47 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 122.495 2.13 . . . . 71.209999999999994 111.074 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 595' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 536' ' ' ILE . 1.8 ptm180 -104.51 119.57 39.29 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.591 -0.731 . . . . 75.409999999999997 109.134 -177.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.417 ' HB2' ' CD ' ' A' ' 634' ' ' PRO . 2.3 tm? -66.2 134.55 52.94 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.898 -1.149 . . . . 73.450000000000003 107.898 178.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.45 ' CG2' HG12 ' A' ' 536' ' ' ILE . 25.8 t . . . . . 0 C--N 1.297 -1.695 0 N-CA-C 105.875 -1.898 . . . . 75.120000000000005 105.875 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.417 ' CD ' ' HB2' ' A' ' 596' ' ' LEU . 72.3 Cg_endo . . . . . 0 N--CA 1.429 -2.281 0 N-CA-C 110.4 -0.654 . . . . 55.32 110.4 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 635' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 635' ' ' ILE . 0.1 OUTLIER -124.54 162.46 26.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.256 -1.016 . . . . 71.040000000000006 108.256 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.02 -178.43 3.71 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 120.056 -0.658 . . . . 74.319999999999993 111.928 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -75.1 -169.13 24.24 Favored Glycine 0 N--CA 1.445 -0.704 0 O-C-N 123.455 0.472 . . . . 61.439999999999998 112.794 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -68.99 -51.84 35.16 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.181 -0.674 . . . . 72.019999999999996 109.181 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -122.56 131.62 53.92 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.814 0.816 . . . . 75.109999999999999 111.937 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 640' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 506' ' ' THR . 16.8 p -126.64 90.06 3.1 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.394 -1.276 . . . . 75.409999999999997 109.781 177.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 641' ' ' LYS . . . . . 0.403 ' NZ ' ' HB3' ' A' ' 641' ' ' LYS . 5.7 ttpm? -159.54 148.18 17.75 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.519 -0.764 . . . . 74.030000000000001 109.609 -176.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.626 HD22 HG11 ' A' ' 523' ' ' VAL . 30.9 tp -129.51 129.17 44.19 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 108.025 -1.102 . . . . 73.230000000000004 108.025 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -97.58 106.25 18.53 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.894 -1.521 . . . . 63.240000000000002 106.894 175.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 39.6 t -98.55 106.86 19.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.358 -0.608 . . . . 62.119999999999997 109.358 -176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 73.0 mt -91.2 125.3 43.95 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.559 0 N-CA-C 109.35 -0.611 . . . . 73.530000000000001 109.35 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 69.8 mt -100.9 103.92 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 109.056 -0.72 . . . . 73.409999999999997 109.056 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 515' ' ' SER . 14.2 pt-20 . . . . . 0 C--N 1.284 -2.275 0 N-CA-C 108.317 -0.994 . . . . 73.299999999999997 108.317 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.937 0 N-CA-C 108.798 -0.816 . . . . 72.310000000000002 108.798 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 169.3 -159.13 31.94 Favored Glycine 0 N--CA 1.42 -2.376 0 N-CA-C 108.672 -1.771 . . . . 74.510000000000005 108.672 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.457 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.5 mp -114.23 110.83 33.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 117.211 0.505 . . . . 71.530000000000001 110.834 -175.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.475 ' CE2' HG23 ' A' ' 528' ' ' THR . 31.5 m-85 -90.67 124.5 35.12 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.655 -0.868 . . . . 74.109999999999999 108.655 169.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 506' ' ' THR . . . . . 0.433 ' HA ' HG22 ' A' ' 640' ' ' THR . 14.1 t -162.47 170.57 18.49 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.78 -0.822 . . . . 74.439999999999998 108.78 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -76.11 146.62 39.17 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 110.27 -0.27 . . . . 74.349999999999994 110.27 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.28 -30.78 71.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.267 0.556 . . . . 74.200000000000003 109.785 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -137.41 145.73 50.71 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 108.735 -0.839 . . . . 75.150000000000006 108.735 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -81.14 -22.64 5.82 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.654 2.236 . . . . 72.109999999999999 112.819 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 47.2 t -141.79 135.11 29.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 106.92 -1.511 . . . . 53.450000000000003 106.92 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.1 t -131.61 141.04 49.56 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 109.494 -0.558 . . . . 73.409999999999997 109.494 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -107.01 124.89 50.28 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.075 0.464 . . . . 75.219999999999999 110.207 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 17.6 m -124.3 163.42 24.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.177 -0.675 . . . . 62.009999999999998 109.177 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 19.2 t -93.64 154.42 17.84 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.954 -0.388 . . . . 74.299999999999997 109.954 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -59.59 -32.74 70.66 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 123.773 0.671 . . . . 75.030000000000001 109.523 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 23.3 t -129.43 65.39 1.47 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.907 0.861 . . . . 63.149999999999999 110.84 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 6.4 tt -98.3 -25.0 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 115.072 -0.967 . . . . 72.310000000000002 109.168 172.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 95.04 -81.05 0.87 Allowed Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.55 -0.75 . . . . 62.030000000000001 111.283 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.5 mm -129.36 127.52 65.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.002 -1.481 . . . . 70.549999999999997 107.002 -176.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.69 148.08 34.19 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.707 -1.22 . . . . 73.409999999999997 107.707 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 33.2 mt-10 -126.75 132.16 51.15 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 123.576 0.547 . . . . 74.129999999999995 111.989 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.609 HG11 HD22 ' A' ' 642' ' ' LEU . 21.5 t -112.91 129.3 68.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.944 -1.132 . . . . 64.329999999999998 107.944 178.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -86.04 134.77 33.82 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.795 -0.817 . . . . 71.319999999999993 108.795 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 568' ' ' VAL . 44.8 t -108.8 127.89 65.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.845 -0.798 . . . . 73.230000000000004 108.845 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.96 126.45 29.79 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.869 -0.605 . . . . 73.329999999999998 110.314 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -79.33 161.41 26.26 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.486 -1.234 . . . . 71.420000000000002 109.926 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.475 HG23 ' CE2' ' A' ' 505' ' ' PHE . 6.4 p -59.74 147.27 38.48 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 123.384 0.674 . . . . 72.530000000000001 111.633 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 29.5 t -59.14 -36.98 76.17 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.918 -0.771 . . . . 74.540000000000006 108.918 175.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -112.56 101.6 1.24 Allowed Glycine 0 N--CA 1.416 -2.683 0 N-CA-C 108.981 -1.647 . . . . 71.140000000000001 108.981 174.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -92.03 101.48 14.03 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.753 -1.203 . . . . 73.310000000000002 107.753 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -122.21 104.29 9.35 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.741 -0.466 . . . . 71.450000000000003 109.741 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 89.33 -151.39 21.95 Favored Glycine 0 C--N 1.304 -1.215 0 C-N-CA 120.456 -0.878 . . . . 70.140000000000001 112.031 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -113.09 127.69 56.28 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.394 0.616 . . . . 72.140000000000001 110.297 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 66.4 t -129.67 138.51 54.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 108.81 -0.811 . . . . 62.009999999999998 108.81 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.582 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 44.8 mm -107.94 133.84 51.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 109.35 -0.611 . . . . 74.140000000000001 109.35 177.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 25.6 t -120.45 109.06 36.96 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 109.208 -0.664 . . . . 63.229999999999997 109.208 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.61 153.94 54.68 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.108 1.872 . . . . 60.520000000000003 111.83 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.484 ' HB3' HG22 ' A' ' 591' ' ' ILE . 52.9 p90 -148.81 161.56 41.56 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.738 -0.467 . . . . 73.120000000000005 109.738 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -158.17 162.35 37.92 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.106 -0.497 . . . . 72.120000000000005 109.714 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 541' ' ' THR . . . . . 0.464 HG23 HG22 ' A' ' 556' ' ' THR . 6.8 p -88.39 149.29 23.8 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 116.027 -0.533 . . . . 64.200000000000003 110.677 173.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 86.7 mt -121.26 109.99 26.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.858 -1.164 . . . . 45.32 107.858 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.34 111.24 2.94 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 123.854 0.721 . . . . 72.549999999999997 110.593 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -100.54 -108.24 3.02 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.34 -1.104 . . . . 54.420000000000002 110.34 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 67.5 p -93.24 8.87 38.51 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 122.517 1.151 . . . . 62.140000000000001 107.967 175.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -119.88 136.53 54.46 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.148 -1.387 . . . . 71.019999999999996 109.509 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.534 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 82.0 mtm180 -82.9 135.4 34.93 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.543 1.137 . . . . 75.129999999999995 110.831 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -87.73 -161.28 36.6 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 115.153 -0.931 . . . . 74.209999999999994 113.533 -175.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 549' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 77.06 -55.99 3.57 Favored Glycine 0 C--O 1.224 -0.51 0 CA-C-N 115.488 -0.356 . . . . 64.129999999999995 113.576 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 550' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 554' ' ' GLU . . . 157.99 42.45 0.02 OUTLIER Glycine 0 C--N 1.284 -2.341 0 N-CA-C 109.415 -1.474 . . . . 70.319999999999993 109.415 -173.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.534 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 8.4 tt0 -116.92 -61.74 1.68 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.559 -0.534 . . . . 73.140000000000001 109.559 -176.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -98.57 -43.74 6.73 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.887 -1.523 . . . . 75.299999999999997 106.887 169.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -132.87 156.42 47.23 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 107.195 -1.409 . . . . 71.209999999999994 107.195 174.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.42 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 10.2 tt0 -84.3 131.11 34.75 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.635 -0.876 . . . . 75.219999999999999 108.635 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 555' ' ' ASP . . . . . 0.535 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 9.6 t70 -58.24 131.1 49.6 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.525 -0.546 . . . . 74.310000000000002 109.525 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.599 HG21 HG22 ' A' ' 573' ' ' VAL . 14.6 t -133.32 141.33 47.9 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-O 121.702 0.763 . . . . 75.439999999999998 109.146 174.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 3.2 p -156.55 161.32 39.98 Favored 'General case' 0 C--N 1.272 -2.763 0 N-CA-C 107.264 -1.384 . . . . 71.510000000000005 107.264 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 149.24 -167.11 29.56 Favored Glycine 0 N--CA 1.41 -3.071 0 N-CA-C 110.395 -1.082 . . . . 65.209999999999994 110.395 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.582 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 52.9 mt-10 -131.7 132.77 44.19 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 120.965 0.412 . . . . 70.219999999999999 110.567 -176.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.547 HD22 ' HB3' ' A' ' 569' ' ' LYS . 89.7 mt -92.94 140.81 29.1 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.883 -0.599 . . . . 74.0 109.512 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.447 ' HG3' ' CD1' ' A' ' 536' ' ' ILE . 27.9 tt0 -106.28 113.74 27.44 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 116.094 -0.503 . . . . 74.530000000000001 109.872 -177.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -111.92 149.31 32.07 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.128 -0.693 . . . . 72.129999999999995 109.128 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.573 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 49.4 mt-30 -146.99 -177.65 5.77 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.249 -0.648 . . . . 72.5 109.249 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -70.07 -31.17 68.64 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.629 -1.249 . . . . 72.519999999999996 107.629 170.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -77.0 -52.76 8.79 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.8 -1.091 . . . . 70.530000000000001 111.176 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.573 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 42.4 mm-40 -64.77 124.18 21.29 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 123.616 0.767 . . . . 73.549999999999997 111.854 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.584 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.2 pt -81.08 -62.24 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 124.159 0.912 . . . . 61.009999999999998 112.638 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.584 ' H ' HG13 ' A' ' 567' ' ' ILE . 7.8 p -143.31 160.24 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 109.522 -0.548 . . . . 64.019999999999996 109.522 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.547 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -127.6 158.69 36.83 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.43 -0.952 . . . . 64.109999999999999 108.43 171.773 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.5 p -127.34 144.58 51.03 Favored 'General case' 0 C--N 1.278 -2.504 0 O-C-N 124.03 0.831 . . . . 74.409999999999997 111.096 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.2 mp -94.68 119.31 42.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 106.829 -1.545 . . . . 51.229999999999997 106.829 172.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 24.4 p -92.34 116.14 28.71 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.543 -0.91 . . . . 75.299999999999997 108.543 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.599 HG22 HG21 ' A' ' 556' ' ' THR . 55.5 t -116.43 123.16 71.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.372 -0.603 . . . . 60.43 109.372 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 29.4 tptp -76.91 113.99 15.21 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.124 -0.944 . . . . 73.319999999999993 109.235 176.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.94 128.82 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 N-CA-C 104.887 -2.264 . . . . 51.329999999999998 104.887 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 46.5 mm . . . . . 0 C--N 1.301 -1.517 0 CA-C-O 122.35 1.071 . . . . 65.219999999999999 111.761 -175.379 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 73.5 mmtt . . . . . 0 C--O 1.211 -0.941 0 N-CA-C 106.346 -1.724 . . . . 72.540000000000006 106.346 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 11.4 t -131.41 137.96 48.89 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.578 -1.249 . . . . 74.099999999999994 111.012 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 44.2 p90 -135.07 179.13 6.51 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 107.74 -1.208 . . . . 72.140000000000001 107.74 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.549 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 92.6 m-85 -123.77 155.68 37.47 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 109.318 -0.623 . . . . 74.349999999999994 109.318 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.83 133.54 54.43 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 105.167 -2.16 . . . . 73.230000000000004 105.167 176.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.409 ' HB2' HD11 ' A' ' 542' ' ' ILE . 28.7 tt0 -133.92 136.5 44.3 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.613 -0.835 . . . . 70.439999999999998 110.328 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.484 HG22 ' HB3' ' A' ' 539' ' ' TYR . 16.0 pt -99.69 138.34 24.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 114.987 -1.006 . . . . 72.030000000000001 108.343 174.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.42 -173.55 49.78 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 111.225 -0.75 . . . . 55.329999999999998 111.225 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.94 130.35 88.48 Favored Pre-proline 0 C--N 1.305 -1.328 0 C-N-CA 120.702 -0.399 . . . . 74.5 111.168 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.524 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 17.8 Cg_endo -64.85 135.69 45.66 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.138 2.558 . . . . 65.420000000000002 112.21 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 595' ' ' ARG . . . . . 0.478 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 14.6 ptm180 -111.99 127.96 56.03 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.586 -0.733 . . . . 73.25 109.81 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -73.48 128.92 36.84 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 106.468 -1.679 . . . . 54.549999999999997 106.468 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.49 ' CG2' HG12 ' A' ' 536' ' ' ILE . 62.0 t . . . . . 0 C--N 1.299 -1.627 0 N-CA-C 109.155 -0.683 . . . . 73.209999999999994 109.155 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.524 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 17.4 Cg_endo . . . . . 0 N--CA 1.44 -1.647 0 N-CA-C 107.9 -1.615 . . . . 74.219999999999999 107.9 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.87 163.74 24.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 119.524 -0.871 . . . . 65.109999999999999 112.385 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.04 174.83 6.56 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.322 -0.854 . . . . 71.549999999999997 111.144 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.457 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -75.5 -169.28 25.89 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 116.018 -0.537 . . . . 51.240000000000002 113.876 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.53 -27.67 60.63 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.473 0.654 . . . . 75.430000000000007 109.686 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -139.82 133.56 30.53 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.03 -0.729 . . . . 73.019999999999996 109.03 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 640' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 506' ' ' THR . 22.6 p -133.81 90.27 2.68 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.398 0.618 . . . . 74.400000000000006 110.175 176.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -163.13 142.74 8.78 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.519 -0.919 . . . . 73.209999999999994 108.519 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.609 HD22 HG11 ' A' ' 523' ' ' VAL . 21.3 tp -126.52 128.65 47.22 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 108.872 -0.788 . . . . 64.030000000000001 108.872 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -95.34 110.07 22.14 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.639 -1.245 . . . . 74.140000000000001 107.639 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.07 114.16 36.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 109.02 -0.733 . . . . 73.129999999999995 109.02 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 55.7 mt -102.9 113.85 40.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 109.104 -0.702 . . . . 42.32 109.104 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 50.3 mt -93.7 107.56 19.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.598 -1.631 . . . . 73.409999999999997 106.598 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.291 -1.968 0 C-N-CA 119.381 -0.927 . . . . 65.519999999999996 110.538 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 502' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.442 -0.874 0 N-CA-C 109.403 -0.592 . . . . 65.340000000000003 109.403 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 172.34 -160.2 31.45 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 110.88 -0.888 . . . . 21.41 110.88 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.26 126.98 71.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 O-C-N 124.003 0.472 . . . . 73.219999999999999 111.364 -170.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.433 ' CE2' ' HB ' ' A' ' 528' ' ' THR . 61.9 m-85 -103.56 133.94 47.75 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.427 -0.583 . . . . 64.409999999999997 109.427 170.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.0 t -169.32 169.8 8.88 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.332 -0.988 . . . . 34.32 108.332 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -78.01 149.41 34.05 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.073 0.397 . . . . 63.0 111.53 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.93 -36.4 80.07 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.46 -0.941 . . . . 71.400000000000006 108.46 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -129.68 146.23 60.32 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 108.253 -1.017 . . . . 73.310000000000002 108.253 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.49 -29.03 2.54 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.153 1.902 . . . . 62.439999999999998 112.934 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 55.9 t -139.6 135.11 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 107.015 -1.476 . . . . 55.520000000000003 107.015 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.1 t -134.17 140.38 46.5 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 108.867 -0.79 . . . . 73.519999999999996 108.867 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -114.87 129.06 56.63 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.769 -1.197 . . . . 60.140000000000001 107.769 175.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.0 m -116.21 170.52 5.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 121.182 0.515 . . . . 70.450000000000003 110.607 -175.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.646 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 75.3 m -87.03 150.11 24.26 Favored 'General case' 0 N--CA 1.398 -3.066 0 CA-C-N 115.069 -0.968 . . . . 73.319999999999993 108.632 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -75.31 -41.94 55.76 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 120.922 0.391 . . . . 73.129999999999995 111.077 177.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 6.4 t -99.31 51.06 0.94 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.553 0.692 . . . . 73.230000000000004 109.743 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.646 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 10.2 tt -103.41 -20.76 5.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.466 0.651 . . . . 74.109999999999999 111.29 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.53 -75.41 2.32 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 110.584 -1.006 . . . . 21.440000000000001 110.584 -175.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 47.7 mm -132.02 127.82 58.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 107.939 -1.134 . . . . 75.150000000000006 107.939 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.469 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -107.58 150.86 26.37 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.78 -1.193 . . . . 63.240000000000002 107.78 176.372 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 30.7 mt-10 -131.66 123.11 27.12 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 123.654 0.596 . . . . 72.219999999999999 111.878 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.543 HG11 HD22 ' A' ' 642' ' ' LEU . 58.6 t -112.17 130.22 66.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.509 -0.922 . . . . 75.230000000000004 108.509 176.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.436 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 21.0 mtmm -87.39 134.87 33.52 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.43 0.633 . . . . 75.120000000000005 111.884 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 568' ' ' VAL . 59.0 t -105.64 127.85 60.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.805 -0.813 . . . . 55.43 108.805 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.22 124.19 22.41 Favored 'General case' 0 N--CA 1.432 -1.365 0 O-C-N 123.726 0.641 . . . . 74.219999999999999 109.725 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -72.27 158.56 35.61 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.663 -1.153 . . . . 74.140000000000001 109.417 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.433 ' HB ' ' CE2' ' A' ' 505' ' ' PHE . 2.9 t -56.01 133.1 51.53 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.429 -0.805 . . . . 73.349999999999994 109.904 175.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 5.1 m -51.17 -31.38 19.74 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.475 1.51 . . . . 71.420000000000002 111.165 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.0 95.39 0.4 Allowed Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 109.031 -1.628 . . . . 74.340000000000003 109.031 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.98 104.37 15.54 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.177 -0.675 . . . . 52.310000000000002 109.177 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -119.09 105.09 11.06 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.082 -0.508 . . . . 75.030000000000001 109.748 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 92.97 -139.24 14.52 Favored Glycine 0 N--CA 1.436 -1.356 0 O-C-N 123.747 0.655 . . . . 51.409999999999997 112.221 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -126.63 129.35 48.32 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.822 -0.806 . . . . 52.130000000000003 108.822 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 65.3 t -132.44 140.28 48.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.243 -0.435 . . . . 64.140000000000001 109.889 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.504 ' HB ' ' HG3' ' A' ' 595' ' ' ARG . 43.4 mm -109.24 137.59 40.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.078 -0.712 . . . . 74.040000000000006 109.078 176.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.98 110.47 29.32 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 109.666 -0.494 . . . . 62.329999999999998 109.666 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.58 155.28 59.43 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.389 2.059 . . . . 42.049999999999997 112.269 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.514 ' HB3' HG22 ' A' ' 591' ' ' ILE . 39.8 p90 -151.73 161.75 42.14 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.861 -0.422 . . . . 74.200000000000003 109.861 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -154.76 151.77 29.08 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.439 0.462 . . . . 70.019999999999996 110.974 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.3 p -85.91 132.49 34.07 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.222 -0.899 . . . . 72.150000000000006 110.088 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 59.0 mt -112.02 115.41 49.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.054 -1.091 . . . . 73.409999999999997 108.054 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.03 106.28 2.31 Favored 'General case' 0 C--N 1.312 -1.035 0 O-C-N 123.369 0.418 . . . . 74.329999999999998 110.979 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -85.14 -98.75 0.69 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 108.626 -1.789 . . . . 65.25 108.626 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 38.3 p -95.25 -25.61 16.28 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.767 -1.198 . . . . 73.5 107.767 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.551 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -75.71 128.38 35.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.545 -1.207 . . . . 72.150000000000006 107.839 175.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 99.8 mtt180 -109.12 159.36 16.95 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 115.287 1.588 . . . . 71.150000000000006 115.287 -171.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . 63.87 -174.2 12.18 Favored Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 112.361 -2.2 . . . . 43.409999999999997 117.454 168.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -115.97 66.86 0.3 Allowed Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 108.163 -1.975 . . . . 72.349999999999994 108.163 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 132.17 5.04 3.51 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 111.524 -0.631 . . . . 15.34 111.524 -174.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 27.3 tt0 -90.85 -74.38 0.5 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.851 -0.739 . . . . 75.349999999999994 109.904 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.407 ' OD1' ' HG3' ' A' ' 585' ' ' LYS . 21.2 m-20 -94.77 -35.56 12.06 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 122.218 1.009 . . . . 74.109999999999999 108.471 175.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -137.57 157.79 45.78 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.187 -1.783 . . . . 70.049999999999997 106.187 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 4.8 tt0 -91.2 135.84 33.51 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.624 -1.251 . . . . 55.439999999999998 107.624 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.37 141.7 47.02 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 120.431 0.158 . . . . 73.219999999999999 110.71 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.9 t -144.12 127.42 16.76 Favored 'General case' 0 N--CA 1.408 -2.569 0 CA-C-O 122.618 1.199 . . . . 72.439999999999998 108.525 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 5.3 p -149.89 115.69 5.61 Favored 'General case' 0 C--N 1.255 -3.505 0 CA-C-N 113.78 -1.554 . . . . 72.040000000000006 108.851 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -168.35 -142.7 3.57 Favored Glycine 0 N--CA 1.408 -3.2 0 N-CA-C 109.787 -1.325 . . . . 62.310000000000002 109.787 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.2 mt-10 -143.81 147.46 34.15 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.969 0.385 . . . . 71.299999999999997 110.776 -174.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.46 HD22 ' HB3' ' A' ' 569' ' ' LYS . 95.6 mt -106.02 144.95 32.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.806 -0.813 . . . . 63.210000000000001 108.806 176.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.405 ' HG3' ' CD1' ' A' ' 536' ' ' ILE . 29.6 tt0 -109.98 120.46 42.54 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.041 0.448 . . . . 73.230000000000004 110.341 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -115.4 147.59 40.35 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.999 -0.741 . . . . 73.140000000000001 108.999 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.437 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 45.9 mt-30 -138.36 177.92 7.52 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 109.479 -0.563 . . . . 75.430000000000007 109.479 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -68.71 -37.51 79.55 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.11 -0.95 . . . . 62.32 110.392 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -92.45 -12.0 33.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.459 -0.791 . . . . 73.299999999999997 111.733 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 0.0 OUTLIER -68.3 172.8 5.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.881 -0.6 . . . . 75.319999999999993 110.095 -178.659 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.606 HG13 ' H ' ' A' ' 568' ' ' VAL . 5.9 pt -115.91 -82.82 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 112.671 0.619 . . . . 73.239999999999995 112.671 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.606 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.9 p -143.84 151.73 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 N-CA-C 108.88 -0.785 . . . . 75.120000000000005 108.88 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.46 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -114.06 156.34 24.32 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.192 0.52 . . . . 62.009999999999998 110.519 175.568 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.4 p -125.01 147.94 48.7 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.564 -1.198 . . . . 72.239999999999995 110.96 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.484 HG22 HG23 ' A' ' 573' ' ' VAL . 2.6 mp -94.94 117.04 37.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 106.437 -1.69 . . . . 74.140000000000001 106.437 171.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 572' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 521' ' ' MET . 45.2 m -93.42 115.26 27.81 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 108.498 -0.927 . . . . 41.32 108.498 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.484 HG23 HG22 ' A' ' 571' ' ' ILE . 67.6 t -118.51 132.35 68.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.627 -0.509 . . . . 64.099999999999994 109.627 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 50.8 tptt -81.81 117.65 22.26 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.936 -1.135 . . . . 44.409999999999997 107.936 175.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 47.1 t -91.26 131.04 39.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 106.262 -1.755 . . . . 62.109999999999999 106.262 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 40.3 mm . . . . . 0 C--N 1.296 -1.737 0 CA-C-O 121.84 0.829 . . . . 73.450000000000003 109.528 -178.16 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 33.7 mmtp . . . . . 0 N--CA 1.432 -1.326 0 N-CA-C 109.878 -0.416 . . . . 71.120000000000005 109.878 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.7 t -141.93 143.14 33.12 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 109.025 -0.731 . . . . 63.420000000000002 109.025 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.503 ' HB3' ' HB3' ' A' ' 546' ' ' ALA . 46.7 p90 -135.76 174.65 10.38 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.154 -1.054 . . . . 74.430000000000007 108.154 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.483 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 78.2 m-85 -119.21 156.35 30.03 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 109.401 -0.592 . . . . 64.109999999999999 109.401 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.86 123.2 38.14 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 105.607 -1.997 . . . . 65.319999999999993 105.607 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.38 136.07 55.0 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.427 -0.583 . . . . 74.420000000000002 109.427 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.514 HG22 ' HB3' ' A' ' 539' ' ' TYR . 26.3 pt -106.06 137.79 34.56 Favored 'Isoleucine or valine' 0 C--O 1.261 1.695 0 N-CA-C 108.305 -0.998 . . . . 71.540000000000006 108.305 175.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.22 -177.01 49.85 Favored Glycine 0 N--CA 1.418 -2.54 0 CA-C-N 115.603 -0.726 . . . . 52.119999999999997 111.447 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.7 137.94 97.3 Favored Pre-proline 0 C--N 1.303 -1.416 0 CA-C-O 120.91 0.386 . . . . 75.219999999999999 111.371 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.488 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 32.0 Cg_endo -68.39 138.84 43.67 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 122.35 2.033 . . . . 72.340000000000003 111.083 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 595' ' ' ARG . . . . . 0.504 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.9 ptm180 -116.21 122.52 45.26 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.035 -0.728 . . . . 73.129999999999995 109.035 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.88 131.9 46.37 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.431 -1.322 . . . . 63.5 107.431 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.474 ' CG2' HG12 ' A' ' 536' ' ' ILE . 65.4 t . . . . . 0 C--N 1.304 -1.395 0 CA-C-O 121.226 0.536 . . . . 72.430000000000007 110.667 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 57.4 Cg_endo . . . . . 0 N--CA 1.442 -1.505 0 N-CA-C 108.345 -1.444 . . . . 65.120000000000005 108.345 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.3 166.3 21.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 C-N-CA 120.452 -0.499 . . . . 71.450000000000003 110.828 -177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.13 166.55 10.96 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.206 -0.598 . . . . 74.430000000000007 112.075 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -75.72 -166.96 21.73 Favored Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 115.234 -0.893 . . . . 60.219999999999999 113.584 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -68.08 -46.81 69.98 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 122.99 0.516 . . . . 74.219999999999999 110.382 -177.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -125.34 135.24 52.25 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.968 -0.753 . . . . 72.120000000000005 108.968 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 640' ' ' THR . . . . . 0.457 ' HB ' ' CG1' ' A' ' 591' ' ' ILE . 34.7 p -130.99 85.75 2.3 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.551 0.691 . . . . 72.120000000000005 110.01 175.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -163.38 143.59 8.86 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.155 -0.929 . . . . 54.530000000000001 109.782 -175.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.543 HD22 HG11 ' A' ' 523' ' ' VAL . 29.6 tp -128.43 142.96 50.94 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.412 -0.958 . . . . 75.019999999999996 108.412 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -110.19 111.35 22.62 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.527 -1.286 . . . . 73.040000000000006 107.527 176.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 47.6 t -102.45 117.15 47.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.985 -0.376 . . . . 63.399999999999999 109.985 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 52.5 mt -101.87 130.87 50.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 108.626 -0.879 . . . . 63.340000000000003 108.626 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 67.5 mt -105.06 112.19 37.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.654 -0.869 . . . . 75.530000000000001 108.654 178.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--N 1.298 -1.657 0 N-CA-C 107.439 -1.319 . . . . 74.319999999999993 107.439 175.44 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 502' ' ' ALA . . . . . 0.521 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 121.195 0.522 . . . . 64.519999999999996 111.719 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 133.37 -146.63 18.53 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.023 -1.084 . . . . 75.010000000000005 111.101 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.428 HG23 ' HA3' ' A' ' 637' ' ' GLY . 4.1 mp -120.88 110.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 116.857 0.328 . . . . 75.420000000000002 111.055 -175.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.512 ' CD2' HG23 ' A' ' 528' ' ' THR . 10.0 m-85 -90.0 131.31 35.95 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.128 -1.434 . . . . 75.200000000000003 107.128 168.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 506' ' ' THR . . . . . 0.411 ' HA ' HG22 ' A' ' 640' ' ' THR . 14.2 t -168.77 171.38 8.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.422 -0.584 . . . . 62.340000000000003 109.422 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -77.24 148.76 35.63 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 116.062 -0.517 . . . . 72.409999999999997 110.204 177.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -65.6 -32.1 73.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.387 0.613 . . . . 75.439999999999998 110.113 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -135.83 141.42 36.77 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 107.474 -1.306 . . . . 64.209999999999994 107.474 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.57 -28.21 10.19 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 122.425 2.084 . . . . 71.010000000000005 112.359 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 49.6 t -136.97 139.69 44.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 107.016 -1.476 . . . . 73.409999999999997 107.016 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.3 t -133.36 140.48 47.4 Favored 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 109.384 -0.599 . . . . 73.230000000000004 109.384 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -106.73 129.91 54.54 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.111 -1.07 . . . . 74.0 108.111 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.7 m -119.82 150.67 22.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 109.032 -0.729 . . . . 73.120000000000005 109.032 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 9.5 t -82.76 167.57 18.02 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.762 0.792 . . . . 71.129999999999995 110.816 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -90.54 -9.24 47.94 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.419 -1.697 . . . . 73.430000000000007 106.419 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 20.5 m -121.83 24.75 9.53 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 121.175 -0.953 . . . . 63.5 110.855 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 8.2 tt -88.63 -32.89 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.999 0.428 . . . . 70.319999999999993 111.532 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 519' ' ' GLY . . . . . 0.42 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 89.27 -80.08 1.56 Allowed Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 110.656 -0.978 . . . . 63.409999999999997 110.656 -176.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.1 mm -124.56 123.74 66.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.533 -0.914 . . . . 72.129999999999995 108.533 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -101.69 149.36 24.22 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 108.705 -0.85 . . . . 63.539999999999999 108.705 177.848 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 31.1 mt-10 -133.41 130.1 38.25 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 123.611 0.765 . . . . 75.340000000000003 110.242 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.585 HG11 HD22 ' A' ' 642' ' ' LEU . 38.8 t -113.9 126.35 71.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 108.265 -1.013 . . . . 75.530000000000001 108.265 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -77.84 131.16 37.43 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 124.053 0.846 . . . . 45.119999999999997 110.077 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 568' ' ' VAL . 46.0 t -110.46 125.44 67.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.266 -0.642 . . . . 75.329999999999998 109.266 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.7 mt -78.28 129.3 34.89 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.344 -0.844 . . . . 75.239999999999995 111.861 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 567' ' ' ILE . 15.6 tpt180 -76.58 153.01 35.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.716 -1.129 . . . . 52.229999999999997 108.853 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 5.5 p -59.28 146.2 40.34 Favored 'General case' 0 N--CA 1.426 -1.663 0 O-C-N 123.784 0.678 . . . . 65.230000000000004 111.813 176.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 28.1 t -55.6 -28.62 56.16 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.254 1.022 . . . . 74.349999999999994 110.285 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -112.66 99.13 1.01 Allowed Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 109.037 -1.625 . . . . 50.409999999999997 109.037 172.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.97 100.98 12.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.737 -0.838 . . . . 61.039999999999999 108.737 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -120.29 116.38 25.45 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.731 -0.668 . . . . 73.430000000000007 110.054 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 68.83 -169.54 41.95 Favored Glycine 0 N--CA 1.445 -0.744 0 O-C-N 123.95 0.781 . . . . 73.0 114.399 173.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -92.51 124.21 36.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 123.249 0.62 . . . . 72.549999999999997 109.749 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 57.7 t -132.5 133.68 59.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.734 -0.839 . . . . 64.120000000000005 108.734 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' ' 561' ' ' GLU . 42.4 mm -107.13 132.4 54.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 109.996 -0.372 . . . . 71.420000000000002 109.996 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 594' ' ' PRO . 41.2 t -121.12 110.21 34.77 Favored Pre-proline 0 N--CA 1.439 -1.01 0 N-CA-C 109.688 -0.486 . . . . 53.32 109.688 178.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 57.1 Cg_endo -75.03 158.57 42.02 Favored 'Trans proline' 0 C--N 1.334 -0.227 0 C-N-CA 122.505 2.137 . . . . 74.439999999999998 112.441 178.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.487 ' HB3' HG22 ' A' ' 591' ' ' ILE . 53.1 p90 -150.32 162.91 39.61 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.648 0.261 . . . . 73.510000000000005 110.557 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -155.33 150.32 26.69 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.605 -0.725 . . . . 75.099999999999994 110.092 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 15.0 p -83.45 134.65 34.85 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.175 -0.676 . . . . 75.129999999999995 109.175 173.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 87.1 mt -105.14 118.87 53.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.152 -1.055 . . . . 44.240000000000002 108.152 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -75.45 138.05 41.38 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 123.405 0.441 . . . . 75.239999999999995 110.029 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -138.72 -103.59 0.6 Allowed Glycine 0 CA--C 1.502 -0.757 0 N-CA-C 110.675 -0.97 . . . . 54.310000000000002 110.675 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 25.0 p -90.27 -9.06 49.32 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.88 0.848 . . . . 73.120000000000005 109.16 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -112.32 136.56 51.63 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 106.757 -1.571 . . . . 73.019999999999996 106.757 173.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 10.8 mtm-85 -108.0 149.9 27.8 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.265 0.839 . . . . 75.019999999999996 113.265 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -90.66 -147.25 18.25 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 114.71 -1.132 . . . . 73.140000000000001 111.048 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 63.54 28.33 72.28 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 111.858 -0.497 . . . . 73.030000000000001 111.858 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 71.97 24.99 75.77 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 121.61 -0.328 . . . . 74.150000000000006 112.422 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -89.92 -77.53 0.39 Allowed 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 117.508 0.654 . . . . 64.340000000000003 110.879 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -96.14 -34.67 11.6 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 108.218 -1.03 . . . . 65.5 108.218 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -144.24 159.11 43.23 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 108.254 -1.017 . . . . 74.319999999999993 108.254 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -89.1 112.24 23.17 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 104.983 -2.228 . . . . 71.230000000000004 104.983 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.0 129.47 35.32 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.545 0.688 . . . . 74.329999999999998 110.417 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 15.0 t -129.37 161.2 30.85 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 115.546 -0.752 . . . . 62.009999999999998 110.563 -171.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.6 p -151.99 161.93 41.87 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.392 -1.336 . . . . 71.219999999999999 107.392 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 165.01 -167.47 38.71 Favored Glycine 0 N--CA 1.419 -2.442 0 C-N-CA 120.103 -1.046 . . . . 54.299999999999997 110.579 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 538' ' ' PRO . 27.1 mt-10 -130.86 137.59 49.44 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 123.136 0.574 . . . . 73.109999999999999 109.614 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 569' ' ' LYS . 94.6 mt -102.87 133.63 47.63 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.205 -0.665 . . . . 71.340000000000003 109.205 178.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.437 ' HA ' HD13 ' A' ' 536' ' ' ILE . 34.3 tt0 -96.74 119.26 34.89 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.912 -0.585 . . . . 72.430000000000007 110.801 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -116.04 148.4 40.23 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.622 -0.881 . . . . 53.119999999999997 108.622 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.483 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 46.0 mt-30 -141.77 -172.32 3.53 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.098 -1.075 . . . . 73.420000000000002 108.098 -178.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -80.08 -28.17 39.17 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.559 -0.904 . . . . 73.239999999999995 108.559 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -84.24 -32.87 24.23 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.242 -0.89 . . . . 53.420000000000002 111.021 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.483 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 40.5 mm-40 -79.5 143.49 34.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.773 0.321 . . . . 73.120000000000005 111.38 177.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.572 ' O ' ' HB2' ' A' ' 527' ' ' ARG . 3.9 pt -112.0 -77.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 113.029 0.751 . . . . 71.120000000000005 113.029 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.551 ' H ' HG13 ' A' ' 567' ' ' ILE . 13.1 p -113.38 144.37 21.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.913 0.863 . . . . 75.409999999999997 112.171 -174.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.499 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -120.86 169.69 10.2 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.378 -0.828 . . . . 34.200000000000003 109.251 173.28 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.4 p -135.62 146.87 48.34 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 123.591 0.557 . . . . 71.129999999999995 112.443 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.2 mp -95.29 119.32 43.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.041 -1.466 . . . . 63.439999999999998 107.041 170.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 572' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 521' ' ' MET . 26.4 m -98.75 116.09 30.2 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.432 -0.581 . . . . 72.439999999999998 109.432 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.468 HG23 HG22 ' A' ' 571' ' ' ILE . 89.3 t -121.6 131.45 73.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 N-CA-C 109.92 -0.4 . . . . 71.409999999999997 109.92 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.42 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 23.4 tptm -85.83 115.6 23.57 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.974 -0.75 . . . . 75.030000000000001 108.974 176.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 36.4 t -86.62 125.31 40.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.15 -1.426 . . . . 51.140000000000001 107.15 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 35.8 mm . . . . . 0 CA--C 1.494 -1.194 0 N-CA-C 108.518 -0.919 . . . . 54.539999999999999 108.518 -175.943 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 13.5 pttt . . . . . 0 CA--C 1.484 -1.577 0 N-CA-C 108.829 -0.804 . . . . 70.030000000000001 108.829 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.7 t -144.29 150.07 37.28 Favored 'General case' 0 C--N 1.279 -2.457 0 C-N-CA 119.641 -0.824 . . . . 64.439999999999998 112.243 -175.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 45.4 p90 -133.59 166.79 21.78 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 106.317 -1.735 . . . . 64.519999999999996 106.317 175.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.444 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 89.1 m-85 -115.54 159.4 21.29 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 120.115 -0.634 . . . . 75.049999999999997 109.832 -175.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.09 124.71 42.46 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 106.227 -1.768 . . . . 73.299999999999997 106.227 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -122.65 129.68 52.11 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 120.961 0.41 . . . . 73.5 110.071 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.487 HG22 ' HB3' ' A' ' 539' ' ' TYR . 25.2 pt -100.23 143.83 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 107.868 -1.16 . . . . 54.520000000000003 107.868 175.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -84.88 -177.31 51.01 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 111.338 -0.705 . . . . 64.430000000000007 111.338 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -78.31 129.17 75.86 Favored Pre-proline 0 N--CA 1.416 -2.13 0 CA-C-O 120.889 0.376 . . . . 60.520000000000003 110.525 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.497 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.0 Cg_endo -59.56 127.74 24.75 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.615 2.877 . . . . 74.299999999999997 112.309 -175.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -106.26 131.98 52.85 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.378 -0.601 . . . . 64.109999999999999 109.378 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -73.75 134.54 43.48 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 105.034 -2.21 . . . . 73.049999999999997 105.034 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 19.2 t . . . . . 0 C--N 1.294 -1.817 0 CA-C-O 122.287 1.041 . . . . 73.219999999999999 108.842 179.552 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.497 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 21.3 Cg_endo . . . . . 0 N--CA 1.433 -2.066 0 N-CA-C 108.096 -1.54 . . . . 75.010000000000005 108.096 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.41 167.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 120.361 -0.535 . . . . 72.349999999999994 111.287 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.487 ' HB2' HG21 ' A' ' 640' ' ' THR . 1.0 OUTLIER -104.87 175.57 5.45 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.013 -0.539 . . . . 64.209999999999994 112.357 -177.861 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.428 ' HA3' HG23 ' A' ' 504' ' ' ILE . . . -74.18 -176.92 35.94 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.699 -0.682 . . . . 74.109999999999999 112.405 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.4 -39.94 77.66 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.985 0.422 . . . . 74.400000000000006 110.217 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -112.87 121.49 44.84 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.89 -0.595 . . . . 74.239999999999995 110.62 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 640' ' ' THR . . . . . 0.487 HG21 ' HB2' ' A' ' 636' ' ' LEU . 19.6 p -134.75 81.32 1.9 Allowed 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 122.149 0.976 . . . . 62.509999999999998 110.895 174.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -163.14 150.97 13.4 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.477 -1.305 . . . . 72.340000000000003 107.477 -175.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.585 HD22 HG11 ' A' ' 523' ' ' VAL . 27.8 tp -133.69 139.85 46.67 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 108.334 -0.988 . . . . 63.119999999999997 108.334 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.84 114.5 28.68 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.079 -1.452 . . . . 72.239999999999995 107.079 174.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 41.1 t -103.49 110.03 28.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 109.12 -0.696 . . . . 71.109999999999999 109.12 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 47.2 mt -96.65 120.8 46.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 109.413 -0.588 . . . . 53.399999999999999 109.413 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 63.4 mt -97.2 113.99 33.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 107.631 -1.248 . . . . 71.430000000000007 107.631 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 C--N 1.283 -2.3 0 N-CA-C 105.248 -2.13 . . . . 74.319999999999993 105.248 173.107 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 502' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.435 -1.191 0 N-CA-C 109.715 -0.476 . . . . 75.230000000000004 109.715 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.44 ' C ' HG22 ' A' ' 528' ' ' THR . . . -178.12 -166.37 34.41 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.814 -0.914 . . . . 65.420000000000002 110.814 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.5 mp -112.6 128.81 69.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 123.521 0.729 . . . . 62.229999999999997 110.928 -173.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.575 ' CE2' HG23 ' A' ' 528' ' ' THR . 41.7 m-85 -102.13 139.75 37.34 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.725 -0.472 . . . . 72.140000000000001 109.725 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.0 t -169.89 175.99 4.95 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.056 -1.09 . . . . 74.450000000000003 108.056 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -80.96 154.92 26.69 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 117.988 0.358 . . . . 74.010000000000005 110.734 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.92 -41.8 77.69 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.852 -0.613 . . . . 51.32 109.5 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -121.93 146.48 46.27 Favored Pre-proline 0 N--CA 1.417 -2.081 0 N-CA-C 108.376 -0.972 . . . . 74.549999999999997 108.376 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -77.63 -23.51 9.68 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.547 1.498 . . . . 73.530000000000001 111.249 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.0 t -141.01 132.92 29.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 107.764 -1.199 . . . . 53.130000000000003 107.764 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.7 t -126.46 139.73 53.02 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.633 -0.877 . . . . 72.439999999999998 108.633 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -108.24 118.03 35.71 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.228 -1.027 . . . . 71.420000000000002 108.228 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.64 153.94 17.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 121.138 0.494 . . . . 75.439999999999998 110.156 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.565 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 65.3 m -79.49 152.91 29.96 Favored 'General case' 0 N--CA 1.42 -1.928 0 C-N-CA 124.391 1.076 . . . . 52.409999999999997 111.133 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 516' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' A' ' 517' ' ' SER . 15.6 pt-20 -63.14 -49.89 72.61 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 120.954 0.407 . . . . 73.109999999999999 111.167 177.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 517' ' ' SER . . . . . 0.495 ' N ' ' HG3' ' A' ' 516' ' ' GLU . 52.5 m -109.34 69.21 0.7 Allowed 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.962 0.887 . . . . 41.119999999999997 110.108 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 13.3 tt -110.64 -27.24 2.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.058 -0.973 . . . . 73.329999999999998 110.836 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 519' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 90.63 -70.76 2.1 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.561 -0.828 . . . . 34.030000000000001 111.55 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.9 mm -135.42 125.07 42.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.049 -0.723 . . . . 63.020000000000003 109.049 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.517 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -108.09 150.06 27.67 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.898 -1.149 . . . . 74.299999999999997 107.898 176.436 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.8 mt-10 -129.56 121.75 27.78 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.588 0.708 . . . . 61.539999999999999 112.767 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.651 HG11 HD22 ' A' ' 642' ' ' LEU . 99.4 t -110.06 131.43 61.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.101 -0.954 . . . . 74.230000000000004 109.086 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -89.97 136.44 33.04 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.678 0.751 . . . . 72.219999999999999 111.931 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 47.3 t -105.54 124.53 60.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 114.649 -1.16 . . . . 63.549999999999997 108.109 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.4 mt -70.74 127.21 31.89 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 123.759 0.662 . . . . 71.109999999999999 110.703 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.405 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 43.4 ttp180 -74.7 162.55 28.61 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.426 -1.261 . . . . 72.430000000000007 110.346 -177.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.575 HG23 ' CE2' ' A' ' 505' ' ' PHE . 1.0 OUTLIER -55.83 139.05 46.92 Favored 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 124.892 1.277 . . . . 73.340000000000003 111.852 177.632 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 4.0 m -51.5 -37.8 50.91 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 125.434 1.494 . . . . 74.349999999999994 110.188 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -124.8 96.2 0.51 Allowed Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 108.701 -1.76 . . . . 53.350000000000001 108.701 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.18 107.95 17.48 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.945 -0.761 . . . . 73.109999999999999 108.945 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -124.51 108.09 11.75 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.034 -0.53 . . . . 54.109999999999999 109.898 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 89.69 -132.0 11.03 Favored Glycine 0 C--N 1.312 -0.761 0 C-N-CA 120.36 -0.924 . . . . 73.329999999999998 112.665 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -133.39 131.68 40.31 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 123.212 0.605 . . . . 74.299999999999997 109.492 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.0 t -132.55 143.72 38.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 123.631 0.772 . . . . 74.019999999999996 109.313 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.585 HG12 ' CG2' ' A' ' 597' ' ' VAL . 33.8 mm -112.56 132.1 62.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.891 -0.781 . . . . 73.319999999999993 108.891 173.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 25.7 t -120.67 110.3 35.45 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 109.019 -0.734 . . . . 75.129999999999995 109.019 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -74.7 158.38 43.38 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.221 1.947 . . . . 44.43 111.578 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.495 ' HB3' HG22 ' A' ' 591' ' ' ILE . 54.5 p90 -146.34 170.22 17.24 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 122.202 -0.311 . . . . 64.140000000000001 111.173 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -158.17 150.92 22.49 Favored 'General case' 0 C--O 1.245 0.822 0 O-C-N 123.614 0.571 . . . . 63.32 110.874 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.0 p -90.5 131.55 36.18 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.897 -0.592 . . . . 75.420000000000002 109.746 172.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.59 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 91.5 mt -105.08 116.14 48.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 109.169 -0.678 . . . . 74.230000000000004 109.169 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -75.66 103.35 5.73 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.54 -0.911 . . . . 75.019999999999996 108.54 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -113.8 -83.71 1.22 Allowed Glycine 0 CA--C 1.481 -2.086 0 C-N-CA 119.442 -1.361 . . . . 74.099999999999994 112.188 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.3 m -109.98 32.53 5.03 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 108.652 -0.869 . . . . 75.430000000000007 108.652 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -158.23 149.0 20.59 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.093 -0.958 . . . . 63.130000000000003 108.894 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 26.8 mtm180 -81.28 116.99 21.41 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.569 0.7 . . . . 74.150000000000006 112.522 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.29 -167.18 42.6 Favored Glycine 0 N--CA 1.437 -1.248 0 CA-C-N 115.27 -0.877 . . . . 64.329999999999998 111.515 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.7 20.01 79.76 Favored Glycine 0 C--N 1.312 -0.805 0 C-N-CA 120.805 -0.712 . . . . 54.210000000000001 111.841 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.0 43.95 6.93 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 120.45 -0.881 . . . . 70.510000000000005 111.959 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -118.0 -61.24 1.71 Allowed 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 119.453 -0.899 . . . . 43.32 109.961 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -99.36 -34.81 10.15 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 107.073 -1.454 . . . . 54.210000000000001 107.073 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -143.29 152.04 41.21 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.847 -1.168 . . . . 75.349999999999994 107.847 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -84.89 142.06 29.97 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.677 -1.231 . . . . 74.510000000000005 107.677 177.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -82.11 139.2 34.53 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.723 -0.843 . . . . 75.200000000000003 108.723 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.1 t -148.02 152.47 37.49 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.569 0.699 . . . . 62.310000000000002 110.458 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 25.6 p -156.11 169.48 24.4 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.964 -1.495 . . . . 73.540000000000006 106.964 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 159.75 -164.84 34.35 Favored Glycine 0 N--CA 1.419 -2.473 0 N-CA-C 110.106 -1.198 . . . . 53.409999999999997 110.106 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.443 ' HB3' HG23 ' A' ' 536' ' ' ILE . 43.4 mt-10 -131.75 130.65 42.17 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 123.845 0.379 . . . . 72.219999999999999 110.627 -176.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 569' ' ' LYS . 86.4 mt -100.12 132.79 45.28 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.377 -0.601 . . . . 52.509999999999998 109.377 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.428 ' HA ' HD13 ' A' ' 536' ' ' ILE . 34.1 tt0 -99.17 121.01 40.45 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.648 -0.705 . . . . 74.109999999999999 110.708 -177.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -118.36 151.96 36.74 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.185 -0.672 . . . . 75.510000000000005 109.185 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.64 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 50.5 mt-30 -149.51 -177.49 5.89 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.054 -0.721 . . . . 74.310000000000002 109.054 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -70.68 -37.65 73.66 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.06 -1.459 . . . . 62.409999999999997 107.06 171.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.66 -48.43 16.81 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.361 -1.29 . . . . 63.219999999999999 111.881 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.64 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 27.9 mm-40 -58.99 133.55 56.19 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 123.829 0.852 . . . . 72.219999999999999 111.392 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.606 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.1 pt -85.14 -81.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 112.723 0.638 . . . . 24.420000000000002 112.723 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.606 ' H ' HG13 ' A' ' 567' ' ' ILE . 7.6 p -134.44 160.96 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 108.907 -0.775 . . . . 71.219999999999999 108.907 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.528 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -126.6 159.6 33.07 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.767 0.317 . . . . 63.420000000000002 110.299 176.263 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.1 p -127.95 148.86 50.52 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.118 -0.946 . . . . 65.109999999999999 112.007 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.3 mp -99.32 127.94 51.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 106.7 -1.593 . . . . 71.450000000000003 106.7 172.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 17.0 m -100.96 115.13 29.73 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.693 -0.855 . . . . 71.319999999999993 108.693 178.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 96.9 t -117.51 130.0 73.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 120.7 -0.4 . . . . 75.5 110.659 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 16.2 tppt? -79.13 120.76 24.12 Favored 'General case' 0 N--CA 1.437 -1.102 0 O-C-N 124.037 0.835 . . . . 74.319999999999993 109.282 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 55.7 t -94.32 128.12 45.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 107.284 -1.376 . . . . 51.119999999999997 107.284 176.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 24.5 mm . . . . . 0 C--N 1.298 -1.64 0 N-CA-C 109.334 -0.617 . . . . 72.5 109.334 -175.128 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 N--CA 1.432 -1.372 0 CA-C-O 120.46 0.171 . . . . 54.420000000000002 110.6 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 7.5 t -152.88 135.07 14.92 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-O 121.375 0.607 . . . . 72.150000000000006 110.933 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 42.8 p90 -126.84 174.17 9.0 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.57 -1.27 . . . . 73.510000000000005 107.57 178.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.59 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 59.0 m-85 -119.83 151.6 38.6 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 109.267 -0.642 . . . . 72.549999999999997 109.267 -176.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.81 130.82 54.13 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 105.083 -2.191 . . . . 74.510000000000005 105.083 176.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' A' ' 542' ' ' ILE . 34.1 tt0 -132.25 144.3 50.52 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.075 -0.713 . . . . 74.120000000000005 109.075 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.495 HG22 ' HB3' ' A' ' 539' ' ' TYR . 13.0 pt -107.43 155.24 8.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.069 -0.715 . . . . 75.439999999999998 109.069 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -100.25 -174.68 30.13 Favored Glycine 0 C--N 1.295 -1.721 0 C-N-CA 121.055 -0.593 . . . . 22.34 112.035 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.408 ' OE1' ' HD2' ' A' ' 594' ' ' PRO . 2.9 mm-40 -61.91 126.96 88.42 Favored Pre-proline 0 C--N 1.313 -0.992 0 C-N-CA 123.198 0.599 . . . . 71.200000000000003 112.1 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.408 ' HD2' ' OE1' ' A' ' 593' ' ' GLU . 21.8 Cg_endo -70.0 118.67 5.82 Favored 'Trans proline' 0 N--CA 1.428 -2.351 0 C-N-CA 122.175 1.917 . . . . 73.430000000000007 110.311 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -104.3 119.56 39.24 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.15 -0.932 . . . . 74.140000000000001 109.328 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.8 129.27 40.2 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.922 -1.14 . . . . 72.109999999999999 107.922 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.585 ' CG2' HG12 ' A' ' 536' ' ' ILE . 45.0 t . . . . . 0 C--N 1.292 -1.935 0 N-CA-C 108.82 -0.808 . . . . 64.349999999999994 108.82 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.527 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 43.6 Cg_endo . . . . . 0 N--CA 1.447 -1.215 0 N-CA-C 108.934 -1.218 . . . . 64.200000000000003 108.934 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.03 161.17 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 109.686 -0.487 . . . . 74.530000000000001 109.686 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.512 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.6 OUTLIER -101.33 165.95 11.0 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 119.72 -0.792 . . . . 74.349999999999994 111.175 176.323 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.85 -172.19 29.23 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 115.654 -0.703 . . . . 53.100000000000001 114.645 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -67.93 -41.66 82.21 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.371 -0.915 . . . . 72.519999999999996 109.392 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -125.99 127.47 45.96 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.279 -0.873 . . . . 72.549999999999997 109.132 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 640' ' ' THR . . . . . 0.512 HG21 ' HB2' ' A' ' 636' ' ' LEU . 16.8 p -130.27 89.93 2.86 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.429 -0.582 . . . . 74.409999999999997 109.429 175.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -170.37 139.09 1.64 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.444 -0.798 . . . . 73.040000000000006 109.468 -175.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.651 HD22 HG11 ' A' ' 523' ' ' VAL . 28.0 tp -120.41 131.0 54.6 Favored 'General case' 0 C--N 1.273 -2.725 0 CA-C-N 114.985 -1.007 . . . . 64.439999999999998 109.06 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -93.87 110.8 22.44 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.52 -1.659 . . . . 71.409999999999997 106.52 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 43.7 t -101.6 110.37 28.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.914 -0.773 . . . . 74.219999999999999 108.914 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 67.1 mt -97.95 124.22 50.86 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 N-CA-C 108.819 -0.808 . . . . 74.400000000000006 108.819 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 54.2 mt -100.2 103.36 14.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 106.876 -1.527 . . . . 61.340000000000003 106.876 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 . . . . . 0 C--N 1.285 -2.216 0 CA-C-N 115.885 -0.598 . . . . 73.209999999999994 109.545 -176.531 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.534 0 N-CA-C 108.196 -1.039 . . . . 62.109999999999999 108.196 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.435 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . 160.36 -148.5 16.86 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.085 -1.206 . . . . 65.099999999999994 110.085 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.43 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.7 mp -123.3 130.02 74.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 117.131 0.466 . . . . 50.329999999999998 110.75 -174.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.506 ' H ' ' HA ' ' A' ' 636' ' ' LEU . 57.4 m-85 -112.24 136.48 51.61 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.47 -0.937 . . . . 74.329999999999998 108.47 169.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.2 t -170.71 -179.34 2.86 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.787 -0.82 . . . . 53.229999999999997 108.787 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -83.62 155.45 23.22 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 110.308 -0.256 . . . . 75.319999999999993 110.308 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.09 -45.25 85.99 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.551 -1.278 . . . . 33.509999999999998 107.551 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.74 146.14 51.93 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 108.606 -0.887 . . . . 72.530000000000001 108.606 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.91 -17.35 15.57 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.801 1.667 . . . . 63.32 111.949 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 58.4 t -141.64 127.74 19.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 107.92 -1.141 . . . . 62.420000000000002 107.92 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 13.8 t -123.65 140.54 52.89 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 109.398 -0.593 . . . . 41.409999999999997 109.398 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -109.52 119.33 39.1 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.977 -0.556 . . . . 75.340000000000003 109.705 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.2 m -115.74 162.28 13.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.809 -0.812 . . . . 70.120000000000005 108.809 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.546 ' O ' HG22 ' A' ' 518' ' ' ILE . 12.1 t -87.55 149.77 24.14 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.533 0.682 . . . . 71.120000000000005 111.157 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -60.98 -29.56 69.76 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 124.941 1.296 . . . . 71.299999999999997 109.166 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 32.1 t -116.53 26.02 10.18 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.758 -0.655 . . . . 54.439999999999998 111.231 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 515' ' ' SER . 7.9 tt -80.21 -30.28 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 119.437 -0.905 . . . . 71.299999999999997 111.026 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 519' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 88.31 -76.91 1.88 Allowed Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 119.89 -1.148 . . . . 61.240000000000002 111.335 -177.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.1 mm -123.63 124.98 70.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.139 -1.06 . . . . 74.239999999999995 108.139 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.512 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -109.89 147.66 32.98 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 108.451 -0.944 . . . . 72.409999999999997 108.451 177.536 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 39.3 mt-10 -123.54 134.03 53.91 Favored 'General case' 0 CA--C 1.497 -1.088 0 O-C-N 123.846 0.717 . . . . 65.310000000000002 111.198 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.569 HG21 HD21 ' A' ' 642' ' ' LEU . 66.7 t -118.69 125.1 74.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 107.931 -1.137 . . . . 75.510000000000005 107.931 176.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.434 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 36.1 mtmt -86.81 133.15 33.67 Favored 'General case' 0 N--CA 1.427 -1.617 0 O-C-N 123.638 0.586 . . . . 60.409999999999997 110.205 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 39.4 t -101.56 120.9 51.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.301 -0.999 . . . . 41.119999999999997 108.301 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.31 129.05 38.62 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 124.029 0.83 . . . . 64.409999999999997 110.169 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -85.09 158.89 20.3 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.635 -1.166 . . . . 62.420000000000002 109.18 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.435 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 1.6 t -56.22 147.57 20.45 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.725 1.21 . . . . 64.409999999999997 112.854 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.9 t -59.23 -35.43 73.63 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.696 1.199 . . . . 75.219999999999999 109.089 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.76 98.13 0.63 Allowed Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 109.13 -1.588 . . . . 55.439999999999998 109.13 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.36 103.91 16.55 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 109.36 -0.607 . . . . 74.519999999999996 109.36 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -123.53 119.86 31.19 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 116.077 -0.511 . . . . 71.409999999999997 110.557 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 87.19 -136.61 14.08 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.277 -0.874 . . . . 62.509999999999998 112.948 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -133.17 126.58 31.97 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.061 -1.088 . . . . 60.530000000000001 108.061 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 61.0 t -131.55 133.66 61.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.074 -0.713 . . . . 63.409999999999997 109.074 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.565 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 37.3 mm -104.73 136.06 39.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 109.096 -0.705 . . . . 73.219999999999999 109.096 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.407 HG22 ' HB3' ' A' ' 594' ' ' PRO . 40.5 t -120.93 108.32 36.86 Favored Pre-proline 0 C--N 1.306 -1.289 0 N-CA-C 109.948 -0.39 . . . . 63.049999999999997 109.948 178.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.2 156.95 50.9 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.567 2.178 . . . . 55.420000000000002 111.943 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.426 ' HB3' HG22 ' A' ' 591' ' ' ILE . 54.6 p90 -153.83 161.41 42.07 Favored 'General case' 0 C--O 1.25 1.11 0 N-CA-C 110.212 -0.292 . . . . 73.120000000000005 110.212 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -153.81 154.05 33.26 Favored 'General case' 0 C--O 1.25 1.111 0 O-C-N 123.657 0.598 . . . . 65.319999999999993 110.805 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.8 p -87.14 136.5 32.9 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.321 -0.854 . . . . 71.010000000000005 110.966 175.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 590' ' ' GLU . 69.7 mt -109.92 123.92 66.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.108 -1.071 . . . . 54.43 108.108 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -76.23 105.82 7.5 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.855 -0.424 . . . . 75.239999999999995 109.855 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -90.2 -119.64 2.03 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 109.844 -1.302 . . . . 55.439999999999998 109.844 177.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 13.4 t -86.16 -5.93 59.1 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.905 0.86 . . . . 60.240000000000002 109.311 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -97.75 137.28 36.87 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.578 -1.267 . . . . 74.129999999999995 107.578 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.535 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 76.5 mtm180 -86.26 137.07 32.89 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 123.738 0.815 . . . . 71.200000000000003 111.353 -176.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -91.83 -164.49 38.79 Favored Glycine 0 C--N 1.29 -2.0 0 CA-C-N 115.36 -0.836 . . . . 71.109999999999999 111.644 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.71 14.32 79.91 Favored Glycine 0 C--N 1.305 -1.165 0 CA-C-O 120.07 -0.295 . . . . 75.129999999999995 113.345 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 88.25 24.66 33.51 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.059 -0.816 . . . . 65.129999999999995 111.059 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.535 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 17.5 tt0 -96.39 -56.85 2.48 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.335 -0.617 . . . . 75.329999999999998 109.335 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -111.59 -33.07 6.47 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 108.579 -0.897 . . . . 75.420000000000002 108.579 171.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -140.32 149.8 43.2 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 108.302 -0.999 . . . . 64.129999999999995 108.302 175.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 2.0 tm-20 -88.93 123.71 33.54 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 106.18 -1.785 . . . . 71.319999999999993 106.18 177.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -67.87 154.01 42.49 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 112.643 0.609 . . . . 71.140000000000001 112.643 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.7 t -147.72 139.4 23.93 Favored 'General case' 0 N--CA 1.406 -2.628 0 CA-C-O 121.725 0.774 . . . . 63.329999999999998 108.934 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.6 p -148.88 143.81 26.49 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 107.197 -1.409 . . . . 63.310000000000002 107.197 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 161.63 -158.79 30.66 Favored Glycine 0 N--CA 1.413 -2.871 0 C-N-CA 119.69 -1.243 . . . . 72.510000000000005 110.57 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.565 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.7 mt-10 -137.28 140.13 41.38 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 120.784 0.325 . . . . 74.030000000000001 110.967 -174.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.5 139.31 36.37 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.418 0.687 . . . . 72.239999999999995 109.769 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.506 ' HA ' HD13 ' A' ' 536' ' ' ILE . 33.1 tt0 -100.85 110.02 22.04 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.167 0.508 . . . . 64.450000000000003 111.516 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -107.44 148.7 28.8 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.891 -0.595 . . . . 75.420000000000002 109.496 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.538 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 43.9 mt-30 -144.1 -177.28 5.37 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.734 -0.839 . . . . 71.030000000000001 108.734 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.88 -38.28 82.85 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 124.092 0.87 . . . . 71.420000000000002 108.655 177.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -85.25 -38.01 19.4 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.414 -0.812 . . . . 73.129999999999995 111.786 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.538 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 47.0 mm-40 -60.82 135.48 57.79 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.902 0.481 . . . . 65.340000000000003 112.079 -178.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.614 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.6 pt -78.51 -83.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 113.929 1.085 . . . . 74.109999999999999 113.929 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.614 ' H ' HG13 ' A' ' 567' ' ' ILE . 13.3 p -143.05 150.72 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.57 -0.9 . . . . 41.530000000000001 108.57 -177.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 524' ' ' LYS . 5.3 mmpt? -113.15 159.57 19.12 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.884 0.373 . . . . 74.040000000000006 110.134 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.1 p -128.87 147.39 50.82 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.159 -0.928 . . . . 61.530000000000001 112.088 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.8 mp -99.86 126.59 53.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 106.773 -1.565 . . . . 75.540000000000006 106.773 171.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 11.3 p -100.7 115.53 30.47 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.004 -0.739 . . . . 73.219999999999999 109.004 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 60.9 t -119.2 130.19 74.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 109.846 -0.427 . . . . 73.319999999999993 109.846 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 15.8 tppt? -82.87 122.13 27.84 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 123.731 0.645 . . . . 72.25 109.969 176.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 89.8 t -89.15 123.22 41.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 107.967 -1.123 . . . . 73.319999999999993 107.967 176.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 33.7 mm . . . . . 0 C--N 1.304 -1.391 0 CA-C-O 121.293 0.568 . . . . 75.120000000000005 109.604 -179.122 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.544 ' HB2' ' HB ' ' A' ' 646' ' ' ILE . 35.7 mmtp . . . . . 0 C--O 1.215 -0.754 0 N-CA-C 108.951 -0.759 . . . . 71.329999999999998 108.951 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 10.0 t -149.97 144.94 26.17 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.494 -0.482 . . . . 61.140000000000001 109.974 176.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 47.8 p90 -140.46 175.88 9.24 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.621 -1.251 . . . . 75.239999999999995 107.621 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.435 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 87.0 m-85 -122.6 153.97 38.59 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.451 -0.5 . . . . 74.450000000000003 110.601 -176.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.53 128.25 51.84 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 106.316 -1.735 . . . . 62.200000000000003 106.316 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.511 ' HB2' HD11 ' A' ' 542' ' ' ILE . 39.8 tt0 -124.57 131.79 53.47 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.807 -0.812 . . . . 74.319999999999993 108.807 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.426 HG22 ' HB3' ' A' ' 539' ' ' TYR . 17.8 pt -100.5 147.15 8.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.794 -0.817 . . . . 64.129999999999995 108.794 177.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.59 172.97 39.81 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 109.925 -1.27 . . . . 64.030000000000001 109.925 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.0 131.79 88.86 Favored Pre-proline 0 N--CA 1.426 -1.664 0 C-N-CA 120.665 -0.414 . . . . 63.240000000000002 110.838 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.431 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.2 Cg_endo -59.57 136.84 73.82 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.317 2.678 . . . . 63.439999999999998 112.03 -176.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 595' ' ' ARG . . . . . 0.471 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 3.1 ptm180 -116.63 125.09 51.28 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.305 -0.861 . . . . 73.329999999999998 110.152 -177.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 1.4 tm? -70.19 136.34 49.94 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.09 -1.078 . . . . 73.219999999999999 108.09 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.559 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.3 t . . . . . 0 C--N 1.305 -1.367 0 CA-C-O 121.649 0.738 . . . . 72.120000000000005 110.873 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.431 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 23.3 Cg_endo . . . . . 0 CA--C 1.512 -0.581 0 CA-C-O 120.541 0.142 . . . . 63.409999999999997 112.395 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 3.1 pt -124.07 177.5 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 0 CA-C-O 120.937 0.399 . . . . 73.409999999999997 110.03 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.506 ' HA ' ' H ' ' A' ' 505' ' ' PHE . 0.8 OUTLIER -113.86 174.52 5.89 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 115.665 -0.698 . . . . 52.409999999999997 112.322 177.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.43 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -74.31 174.13 50.29 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 115.415 -0.811 . . . . 70.349999999999994 113.923 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -66.79 -34.47 77.89 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 124.033 0.933 . . . . 71.420000000000002 110.408 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -124.06 121.48 35.3 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.33 -0.618 . . . . 73.420000000000002 109.33 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 7.8 p -134.78 95.4 3.33 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.752 -0.658 . . . . 73.329999999999998 110.013 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -166.54 143.34 4.88 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.75 -1.204 . . . . 53.299999999999997 107.75 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.569 HD21 HG21 ' A' ' 523' ' ' VAL . 26.7 tp -129.66 116.16 18.42 Favored 'General case' 0 N--CA 1.417 -2.084 0 O-C-N 123.825 0.703 . . . . 71.319999999999993 109.668 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -87.18 110.61 20.27 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.604 -1.628 . . . . 73.409999999999997 106.604 173.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 55.8 t -99.19 107.76 21.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.736 -0.838 . . . . 73.120000000000005 108.736 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 27.8 mt -99.28 121.47 49.94 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 N-CA-C 108.42 -0.956 . . . . 73.349999999999994 108.42 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 585' ' ' LYS . 62.6 mt -97.46 107.55 20.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.165 -1.42 . . . . 73.150000000000006 107.165 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 C--N 1.295 -1.77 0 N-CA-C 108.408 -0.96 . . . . 71.319999999999993 108.408 -179.168 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 502' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.41 -2.441 0 CA-C-O 121.174 0.512 . . . . 71.319999999999993 109.951 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -103.43 -114.72 3.97 Favored Glycine 0 C--N 1.278 -2.657 0 CA-C-N 114.672 -1.149 . . . . 43.200000000000003 112.955 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.81 127.69 70.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.219 -0.491 . . . . 70.209999999999994 110.573 -173.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -117.03 123.14 46.14 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.729 -1.211 . . . . 71.230000000000004 107.729 170.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.3 t -167.63 177.65 5.76 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.552 -0.536 . . . . 74.319999999999993 109.552 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -85.77 150.74 24.36 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.886 -0.412 . . . . 64.120000000000005 109.886 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 44.1 mt-10 -66.54 -34.03 77.0 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.348 0.594 . . . . 74.150000000000006 110.18 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -132.21 145.61 58.06 Favored Pre-proline 0 N--CA 1.421 -1.909 0 CA-C-N 114.959 -1.019 . . . . 74.019999999999996 108.499 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.0 -29.29 3.36 Favored 'Trans proline' 0 C--N 1.327 -0.557 0 C-N-CA 122.151 1.9 . . . . 61.299999999999997 112.127 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 26.0 t -134.92 131.79 53.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 107.909 -1.145 . . . . 64.129999999999995 107.909 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 15.3 t -126.68 136.43 52.46 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 109.42 -0.585 . . . . 72.25 109.42 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -109.98 109.42 20.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.793 0.806 . . . . 71.510000000000005 109.297 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.7 m -104.77 151.69 7.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 115.636 -0.711 . . . . 74.040000000000006 110.309 -175.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.544 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 67.4 m -79.56 155.06 28.34 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 115.349 -0.842 . . . . 74.310000000000002 110.328 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -67.08 -62.45 1.42 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.525 0.679 . . . . 71.400000000000006 111.068 176.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.3 m -79.09 26.85 0.25 Allowed 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.709 0.803 . . . . 52.299999999999997 112.666 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 12.8 tt -79.92 -27.91 12.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 122.021 -0.425 . . . . 63.030000000000001 110.509 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 519' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 89.2 -74.78 1.96 Allowed Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 110.467 -1.053 . . . . 63.219999999999999 110.467 -177.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.3 mm -129.41 122.88 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 108.425 -0.954 . . . . 75.109999999999999 108.425 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.444 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -103.37 147.51 27.02 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.695 -1.594 . . . . 65.420000000000002 106.695 175.645 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 35.1 mt-10 -133.64 128.26 34.71 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 123.655 0.597 . . . . 70.439999999999998 111.175 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.583 HG21 HD21 ' A' ' 642' ' ' LEU . 59.9 t -116.36 124.21 72.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 106.831 -1.544 . . . . 73.349999999999994 106.831 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.476 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 29.1 mtmm -84.65 139.88 31.74 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.071 0.462 . . . . 74.450000000000003 110.187 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 43.9 t -107.46 126.56 63.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 115.638 -0.71 . . . . 72.150000000000006 109.173 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.25 116.84 7.01 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 123.998 0.811 . . . . 71.439999999999998 110.093 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -77.79 150.53 34.28 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.022 -0.99 . . . . 65.219999999999999 109.96 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.3 t -55.34 132.93 49.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 124.904 1.282 . . . . 75.109999999999999 111.84 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 44.9 t -54.01 -35.5 61.98 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.538 1.135 . . . . 70.319999999999993 109.32 173.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -107.45 85.52 0.42 Allowed Glycine 0 N--CA 1.42 -2.403 0 N-CA-C 109.641 -1.384 . . . . 33.520000000000003 109.641 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.93 109.77 18.97 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.261 -1.015 . . . . 44.420000000000002 108.261 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -112.73 106.68 15.1 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.119 -0.491 . . . . 50.329999999999998 110.589 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 73.1 -116.76 5.67 Favored Glycine 0 N--CA 1.434 -1.47 0 CA-C-N 115.678 -0.692 . . . . 62.350000000000001 112.457 175.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 534' ' ' ASN . . . . . 0.442 ' ND2' HG21 ' A' ' 597' ' ' VAL . 47.8 t30 -133.17 127.05 33.0 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.276 -0.638 . . . . 62.0 109.276 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.05 137.55 55.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.924 -0.769 . . . . 71.329999999999998 108.924 -177.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.539 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 36.4 mm -107.84 135.04 47.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.265 -0.643 . . . . 53.32 109.265 177.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 594' ' ' PRO . 57.3 t -120.51 109.8 36.18 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.391 -0.596 . . . . 33.109999999999999 109.391 177.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 35.4 Cg_endo -71.43 153.72 60.83 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.993 1.795 . . . . 70.239999999999995 111.338 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -150.97 155.71 39.66 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.958 -0.756 . . . . 73.420000000000002 108.958 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.8 152.93 30.42 Favored 'General case' 0 C--O 1.254 1.335 0 O-C-N 123.807 0.692 . . . . 65.019999999999996 112.354 177.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.6 p -82.83 134.06 35.11 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.471 -0.786 . . . . 64.430000000000007 110.024 174.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 70.8 mt -108.72 113.92 45.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 107.316 -1.364 . . . . 72.329999999999998 107.316 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.54 132.54 47.12 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.165 0.507 . . . . 71.540000000000006 111.638 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -124.1 -114.74 2.11 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 108.408 -1.877 . . . . 63.32 108.408 177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 45.6 p -80.36 -23.89 40.18 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 122.084 0.945 . . . . 53.329999999999998 108.736 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -82.8 128.99 34.91 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 114.396 -1.275 . . . . 71.109999999999999 108.766 175.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.3 mtm105 -88.6 135.13 33.65 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 124.066 0.854 . . . . 74.239999999999995 110.651 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -83.42 -152.07 12.21 Favored Glycine 0 C--N 1.297 -1.619 0 CA-C-N 115.232 -0.895 . . . . 62.299999999999997 111.916 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 549' ' ' GLY . . . . . 0.432 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 62.17 22.97 63.57 Favored Glycine 0 C--N 1.308 -0.978 0 N-CA-C 114.796 0.679 . . . . 41.420000000000002 114.796 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 79.54 22.4 64.67 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.307 -0.949 . . . . 61.399999999999999 111.533 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -96.62 -62.83 1.21 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.996 -0.372 . . . . 74.420000000000002 109.996 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -98.77 -42.69 7.09 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 107.196 -1.409 . . . . 75.420000000000002 107.196 171.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -137.76 149.88 46.79 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 114.911 -1.04 . . . . 60.32 108.677 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.413 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 0.7 OUTLIER -76.69 122.65 25.0 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.678 -1.601 . . . . 65.120000000000005 106.678 173.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 555' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 29.1 t70 -74.71 117.99 17.16 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.244 -0.435 . . . . 70.530000000000001 111.234 -173.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.1 t -121.04 138.83 53.99 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 122.517 1.151 . . . . 71.230000000000004 111.664 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 12.2 p -145.54 143.52 30.0 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 105.606 -1.998 . . . . 74.129999999999995 105.606 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 176.13 -155.25 18.84 Favored Glycine 0 N--CA 1.413 -2.873 0 C-N-CA 119.278 -1.439 . . . . 73.129999999999995 110.746 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.539 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 51.4 mt-10 -143.69 129.93 19.79 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 123.985 0.462 . . . . 62.229999999999997 110.582 -175.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 569' ' ' LYS . 98.1 mt -92.51 140.77 29.22 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.937 -0.764 . . . . 71.439999999999998 108.937 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.48 ' HA ' HD13 ' A' ' 536' ' ' ILE . 27.1 tt0 -105.09 113.35 26.9 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.842 -0.429 . . . . 71.439999999999998 109.842 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -111.11 142.65 43.0 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.272 -0.64 . . . . 75.219999999999999 109.272 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.485 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 49.4 mt-30 -133.88 176.28 8.71 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.67 -0.493 . . . . 74.109999999999999 109.67 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -67.16 -37.51 83.87 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 124.464 1.102 . . . . 72.049999999999997 111.676 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -92.11 -13.92 30.0 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.707 -0.678 . . . . 54.310000000000002 112.035 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.485 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 19.9 mm-40 -73.59 167.49 21.23 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.422 0.527 . . . . 72.430000000000007 112.422 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.592 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.3 pt -105.27 -85.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 113.245 0.831 . . . . 70.140000000000001 113.245 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.592 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.3 p -142.96 153.24 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 109.338 -0.616 . . . . 71.349999999999994 109.338 -174.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.451 ' HB3' HD22 ' A' ' 560' ' ' LEU . 5.5 mmpt? -115.79 160.76 19.7 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.989 -0.374 . . . . 60.140000000000001 109.989 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.476 ' CG2' ' HG2' ' A' ' 524' ' ' LYS . 4.4 p -126.82 145.59 50.58 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.617 -0.719 . . . . 70.510000000000005 111.026 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.514 HG22 HG23 ' A' ' 573' ' ' VAL . 1.9 mp -94.11 114.7 31.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 105.36 -2.089 . . . . 73.430000000000007 105.36 170.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 16.5 m -94.33 115.21 27.4 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.232 -1.025 . . . . 75.299999999999997 108.232 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.514 HG23 HG22 ' A' ' 571' ' ' ILE . 98.5 t -117.06 127.67 74.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.268 -0.642 . . . . 73.150000000000006 109.268 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 24.2 tptm -78.21 107.58 10.9 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.389 -0.967 . . . . 74.120000000000005 108.389 175.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 45.9 t -85.38 124.74 40.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 106.24 -1.763 . . . . 64.0 106.24 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 29.8 mm . . . . . 0 C--N 1.291 -1.952 0 CA-C-O 122.035 0.921 . . . . 61.030000000000001 111.648 -173.652 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 33.3 mmtp . . . . . 0 CA--C 1.483 -1.6 0 N-CA-C 110.339 -0.245 . . . . 61.310000000000002 110.339 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 2.9 t -141.82 142.57 33.17 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 120.185 -0.606 . . . . 73.519999999999996 111.257 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 46.2 p90 -137.33 171.77 13.98 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 107.499 -1.297 . . . . 53.119999999999997 107.499 178.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.488 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 45.0 m-85 -117.52 153.05 33.85 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 109.239 -0.652 . . . . 72.420000000000002 109.239 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.29 126.78 51.42 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 106.033 -1.84 . . . . 64.409999999999997 106.033 177.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -127.92 124.44 37.38 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 120.055 -0.658 . . . . 55.539999999999999 110.313 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 20.3 pt -88.86 140.93 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.297 0 CA-C-N 114.836 -1.075 . . . . 74.430000000000007 108.132 174.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.79 173.24 47.04 Favored Glycine 0 N--CA 1.409 -3.164 0 N-CA-C 109.838 -1.305 . . . . 22.030000000000001 109.838 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -67.14 136.15 93.92 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 110.343 -0.243 . . . . 70.219999999999999 110.343 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.403 ' HB3' HG22 ' A' ' 537' ' ' VAL . 30.8 Cg_endo -63.2 131.33 31.9 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.258 2.638 . . . . 75.340000000000003 112.311 -176.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -109.59 120.45 42.54 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.035 -0.984 . . . . 75.299999999999997 108.919 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.482 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 2.7 tm? -66.15 135.3 54.35 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.752 -1.203 . . . . 65.530000000000001 107.752 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.518 ' CG2' HG12 ' A' ' 536' ' ' ILE . 47.0 t . . . . . 0 C--N 1.303 -1.449 0 N-CA-C 108.254 -1.017 . . . . 52.109999999999999 108.254 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 596' ' ' LEU . 29.9 Cg_endo . . . . . 0 N--CA 1.449 -1.094 0 CA-C-O 121.318 0.466 . . . . 73.549999999999997 112.423 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 635' ' ' ILE . . . . . 0.564 HD13 ' H ' ' A' ' 635' ' ' ILE . 0.1 OUTLIER -127.72 178.71 4.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.692 -1.225 . . . . 53.009999999999998 107.692 179.0 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.86 -173.9 2.37 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 112.828 0.677 . . . . 64.530000000000001 112.828 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -77.8 -159.25 11.67 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.95 -0.568 . . . . 63.200000000000003 114.376 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -78.59 -48.62 14.79 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.452 0.644 . . . . 74.140000000000001 109.603 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -129.6 130.47 45.69 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.931 -1.137 . . . . 72.030000000000001 107.931 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 18.7 p -129.94 96.09 4.12 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 120.9 0.381 . . . . 74.530000000000001 110.887 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -163.97 148.48 10.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.495 -1.298 . . . . 62.350000000000001 107.495 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.583 HD21 HG21 ' A' ' 523' ' ' VAL . 34.0 tp -133.65 127.85 33.84 Favored 'General case' 0 N--CA 1.414 -2.271 0 N-CA-C 108.379 -0.971 . . . . 63.340000000000003 108.379 175.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -98.0 109.92 22.59 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 107.484 -1.302 . . . . 63.520000000000003 107.484 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 46.0 t -101.17 119.33 49.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.361 -0.607 . . . . 73.239999999999995 109.361 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 49.9 mt -106.12 126.7 61.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.327 -0.99 . . . . 53.539999999999999 108.327 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 73.8 mt -97.82 112.01 28.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.841 -1.17 . . . . 73.420000000000002 107.841 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 515' ' ' SER . 14.3 pt-20 . . . . . 0 C--N 1.286 -2.166 0 CA-C-N 115.505 -0.77 . . . . 72.450000000000003 110.129 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 502' ' ' ALA . . . . . 0.422 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.435 -1.211 0 N-CA-C 107.7 -1.222 . . . . 54.020000000000003 107.7 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 168.85 -146.87 10.66 Favored Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 109.811 -1.316 . . . . 52.340000000000003 109.811 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -126.04 117.6 49.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 117.129 0.464 . . . . 72.140000000000001 110.469 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -102.4 124.69 48.42 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.261 -1.015 . . . . 72.200000000000003 108.261 169.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.7 t -165.07 -179.17 5.53 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.893 -0.78 . . . . 64.530000000000001 108.893 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -80.35 149.04 30.39 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.357 0.598 . . . . 71.040000000000006 112.534 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -74.18 -24.71 59.42 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 114.793 -1.094 . . . . 64.25 109.003 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.65 142.88 27.29 Favored Pre-proline 0 N--CA 1.435 -1.198 0 N-CA-C 107.474 -1.306 . . . . 75.099999999999994 107.474 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.81 -27.68 4.63 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.215 1.944 . . . . 73.030000000000001 112.483 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 53.7 t -137.96 136.37 45.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 107.007 -1.479 . . . . 74.430000000000007 107.007 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.6 t -130.42 139.55 50.6 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 109.371 -0.603 . . . . 71.310000000000002 109.371 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -106.11 124.05 48.97 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.964 -1.124 . . . . 61.350000000000001 107.964 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.6 m -120.99 155.74 24.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 108.267 -1.012 . . . . 71.129999999999995 108.267 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.577 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 68.1 m -80.88 166.5 20.84 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 108.676 -0.861 . . . . 64.209999999999994 108.676 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -89.8 -55.72 3.52 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.429 -0.908 . . . . 71.510000000000005 109.795 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 31.1 m -81.44 46.7 0.97 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.382 0.61 . . . . 50.340000000000003 110.843 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 11.5 tt -96.05 -29.91 3.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.306 0.574 . . . . 73.319999999999993 111.028 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 519' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 96.0 -82.25 0.81 Allowed Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.953 -1.259 . . . . 62.229999999999997 109.953 -176.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 520' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 573' ' ' VAL . 27.7 mm -129.67 134.96 62.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.885 -1.154 . . . . 75.0 107.885 -176.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -115.06 144.62 43.35 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.098 -0.705 . . . . 41.140000000000001 109.098 176.145 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 21.5 mp0 -116.22 128.45 55.62 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.723 0.639 . . . . 64.150000000000006 111.185 176.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 570' ' ' THR . 99.5 t -120.87 131.57 72.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.921 -0.77 . . . . 62.32 108.921 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 569' ' ' LYS . 26.5 mtmm -85.62 145.32 27.38 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.438 0.637 . . . . 70.510000000000005 112.023 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 568' ' ' VAL . 52.5 t -117.71 127.59 75.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.879 -0.786 . . . . 45.32 108.879 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 97.1 mt -70.39 124.88 25.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 123.762 0.664 . . . . 72.430000000000007 110.29 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -73.84 158.43 34.54 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.567 -1.197 . . . . 65.409999999999997 109.215 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.4 t -56.09 135.79 52.69 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 124.013 0.821 . . . . 41.409999999999997 110.643 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 3.7 m -60.09 -27.42 66.98 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 124.822 1.249 . . . . 62.409999999999997 110.108 177.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -122.23 90.38 0.44 Allowed Glycine 0 N--CA 1.424 -2.157 0 N-CA-C 109.098 -1.601 . . . . 43.310000000000002 109.098 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.54 105.25 17.69 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.716 -0.476 . . . . 61.409999999999997 109.716 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -120.2 101.97 8.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.852 -0.795 . . . . 74.099999999999994 108.852 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 90.93 -145.21 17.69 Favored Glycine 0 C--N 1.299 -1.489 0 CA-C-N 115.668 -0.696 . . . . 63.140000000000001 112.258 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -118.39 131.07 56.31 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.149 -0.685 . . . . 74.219999999999999 109.149 -178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.536 HG22 HD22 ' A' ' 596' ' ' LEU . 49.4 t -131.58 139.94 49.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 108.497 -0.927 . . . . 63.439999999999998 108.497 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.538 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 42.5 mm -109.6 135.79 47.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 109.036 -0.727 . . . . 64.120000000000005 109.036 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.7 t -122.98 108.43 32.54 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 108.957 -0.757 . . . . 53.240000000000002 108.957 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 39.4 Cg_endo -73.61 153.86 49.41 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.92 1.747 . . . . 61.32 111.465 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -140.46 155.87 46.54 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.951 -0.468 . . . . 55.229999999999997 109.888 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -147.31 148.83 31.8 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 123.714 0.634 . . . . 54.140000000000001 109.911 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.5 p -90.21 129.27 36.49 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.405 -0.361 . . . . 71.329999999999998 110.16 174.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.519 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 64.2 mt -102.62 119.75 51.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 107.162 -1.421 . . . . 74.349999999999994 107.162 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -72.86 114.95 11.58 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.522 -0.548 . . . . 74.329999999999998 109.522 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -96.8 -100.11 1.96 Allowed Glycine 0 CA--C 1.5 -0.874 0 N-CA-C 109.958 -1.257 . . . . 71.430000000000007 109.958 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 31.5 p -94.6 -22.21 18.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.984 -1.117 . . . . 62.329999999999998 107.984 173.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.47 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -86.05 135.64 33.55 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.758 -1.11 . . . . 73.299999999999997 108.468 177.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -98.72 143.55 28.96 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.217 0.532 . . . . 75.409999999999997 112.163 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.7 -150.65 17.61 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.1 -0.954 . . . . 72.239999999999995 111.442 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.93 -0.67 28.21 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 116.978 0.389 . . . . 41.439999999999998 113.383 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 93.54 29.09 10.4 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 111.041 -0.824 . . . . 52.32 111.041 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -99.91 -67.66 0.84 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 110.365 -0.235 . . . . 55.299999999999997 110.365 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -94.35 -45.62 7.39 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 107.979 -1.119 . . . . 73.420000000000002 107.979 174.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -136.77 158.95 43.26 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 114.965 -1.016 . . . . 74.040000000000006 108.453 177.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 9.1 tt0 -85.52 112.65 21.12 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 104.658 -2.349 . . . . 70.230000000000004 104.658 176.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -73.25 145.92 45.81 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.576 -0.85 . . . . 73.319999999999993 108.87 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.0 t -142.64 168.98 18.45 Favored 'General case' 0 N--CA 1.414 -2.227 0 C-N-CA 120.372 -0.531 . . . . 72.450000000000003 110.714 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 11.2 p -162.72 160.35 25.36 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 106.017 -1.846 . . . . 61.210000000000001 106.017 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 171.22 -172.98 44.72 Favored Glycine 0 CA--C 1.483 -1.934 0 N-CA-C 110.493 -1.043 . . . . 74.430000000000007 110.493 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 48.5 mt-10 -130.78 120.11 23.28 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.141 0.496 . . . . 75.150000000000006 111.532 -177.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 92.1 mt -85.75 135.92 33.54 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 115.459 -0.791 . . . . 74.129999999999995 109.259 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.463 ' HA ' HD13 ' A' ' 536' ' ' ILE . 36.0 tt0 -104.04 119.24 38.52 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-O 121.051 0.453 . . . . 72.340000000000003 110.035 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -118.81 139.22 51.95 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.517 -0.549 . . . . 65.5 109.517 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.565 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 35.8 mt-30 -134.95 172.23 13.29 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.743 -0.836 . . . . 71.209999999999994 108.743 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -62.19 -30.22 70.92 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 123.85 0.719 . . . . 74.540000000000006 109.734 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.01 -24.21 21.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.606 -1.179 . . . . 73.319999999999993 112.381 -177.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.565 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 68.5 mm-40 -75.38 173.37 11.01 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.139 -0.351 . . . . 65.340000000000003 111.28 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.644 HG13 ' H ' ' A' ' 568' ' ' VAL . 7.6 pt -117.06 -77.24 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 113.59 0.959 . . . . 70.420000000000002 113.59 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.644 ' H ' HG13 ' A' ' 567' ' ' ILE . 11.8 p -142.99 153.09 16.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 107.711 -1.218 . . . . 51.329999999999998 107.711 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 524' ' ' LYS . 17.0 mtpp -121.55 168.32 11.87 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.7 -0.4 . . . . 74.219999999999999 111.112 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 0.9 OUTLIER -129.92 147.09 51.64 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 123.853 0.72 . . . . 71.230000000000004 111.441 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 1.9 mp -94.91 128.08 46.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.033 -1.469 . . . . 62.0 107.033 172.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 572' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 521' ' ' MET . 10.1 p -106.74 115.32 29.99 Favored 'General case' 0 N--CA 1.428 -1.562 0 O-C-N 123.715 0.634 . . . . 73.219999999999999 109.835 176.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 571' ' ' ILE . 71.6 t -117.82 135.97 56.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 116.366 -0.379 . . . . 73.019999999999996 110.12 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 24.4 tptm -90.46 123.51 34.22 Favored 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 124.085 0.866 . . . . 72.400000000000006 109.0 177.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.07 136.18 31.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 106.445 -1.687 . . . . 55.450000000000003 106.445 176.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 41.5 mm . . . . . 0 C--N 1.303 -1.439 0 CA-C-O 121.401 0.62 . . . . 75.219999999999999 111.258 -173.618 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 24.0 mmtp . . . . . 0 C--O 1.215 -0.735 0 N-CA-C 107.164 -1.421 . . . . 64.5 107.164 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 7.8 t -149.97 146.09 26.83 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.08 -0.648 . . . . 62.100000000000001 110.643 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 48.5 p90 -140.43 172.06 13.26 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.643 -1.243 . . . . 72.150000000000006 107.643 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.514 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 85.7 m-85 -116.97 153.59 32.36 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.781 -0.451 . . . . 73.040000000000006 109.781 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.81 125.49 46.63 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 105.657 -1.979 . . . . 72.310000000000002 105.657 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.47 ' HB2' HD11 ' A' ' 542' ' ' ILE . 31.7 tt0 -126.15 136.68 53.16 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.599 -0.889 . . . . 74.109999999999999 108.599 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 12.3 pt -100.4 139.79 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.225 0 N-CA-C 108.45 -0.944 . . . . 71.209999999999994 108.45 175.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.25 173.16 51.67 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-N 115.167 -0.924 . . . . 63.340000000000003 111.426 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.08 125.85 91.96 Favored Pre-proline 0 N--CA 1.433 -1.307 0 CA-C-O 120.836 0.351 . . . . 75.040000000000006 111.556 -177.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.427 ' HB3' HG22 ' A' ' 537' ' ' VAL . 26.2 Cg_endo -62.1 139.71 80.01 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.692 2.928 . . . . 74.129999999999995 113.101 -174.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 595' ' ' ARG . . . . . 0.464 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 9.7 ptm180 -116.52 128.68 55.66 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.901 -1.045 . . . . 74.420000000000002 109.562 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.536 HD22 HG22 ' A' ' 535' ' ' VAL . 0.6 OUTLIER -74.58 135.86 42.07 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.953 -1.129 . . . . 72.430000000000007 107.953 179.585 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.524 ' CG2' HG12 ' A' ' 536' ' ' ILE . 37.4 t . . . . . 0 C--N 1.299 -1.611 0 N-CA-C 108.701 -0.852 . . . . 70.140000000000001 108.701 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.422 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 67.7 Cg_endo . . . . . 0 N--CA 1.434 -2.016 0 N-CA-C 110.565 -0.59 . . . . 75.329999999999998 110.565 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.8 pp -126.61 158.33 36.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.623 -0.717 . . . . 71.239999999999995 109.787 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.06 177.19 5.82 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 116.384 -0.371 . . . . 62.32 110.939 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -69.8 172.7 39.3 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 111.424 -0.67 . . . . 73.420000000000002 111.424 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -56.7 -50.02 73.4 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.791 0.805 . . . . 62.509999999999998 110.192 -175.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -123.63 125.85 45.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.076 -0.965 . . . . 60.030000000000001 109.618 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 19.9 p -123.06 95.28 4.55 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 115.733 -0.667 . . . . 54.43 110.005 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -158.52 138.05 11.81 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.907 -0.588 . . . . 61.329999999999998 109.811 -176.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.528 HD22 HG11 ' A' ' 523' ' ' VAL . 36.5 tp -122.56 129.27 51.75 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.124 -1.065 . . . . 71.129999999999995 108.124 177.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -95.67 108.86 21.18 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.19 -1.411 . . . . 71.120000000000005 107.19 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 43.3 t -99.02 108.86 23.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 109.314 -0.624 . . . . 71.329999999999998 109.314 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 65.3 mt -98.13 122.8 50.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 108.809 -0.811 . . . . 60.030000000000001 108.809 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' ' 585' ' ' LYS . 32.7 mt -99.74 108.31 22.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.486 -0.931 . . . . 74.5 108.486 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 515' ' ' SER . 10.4 pt-20 . . . . . 0 C--N 1.29 -1.992 0 CA-C-O 121.311 0.577 . . . . 74.129999999999995 110.753 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 502' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 C--O 1.214 -0.784 0 CA-C-O 121.309 0.576 . . . . 63.109999999999999 110.332 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 162.07 -159.79 31.86 Favored Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 109.904 -1.278 . . . . 70.540000000000006 109.904 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.53 110.86 33.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 116.687 0.244 . . . . 61.200000000000003 110.814 -176.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.726 ' CE1' ' HA ' ' A' ' 527' ' ' ARG . 5.8 m-85 -95.46 120.59 35.98 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.099 -0.704 . . . . 75.420000000000002 109.099 169.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.1 t -170.22 179.52 3.44 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.612 -0.884 . . . . 64.409999999999997 108.612 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -84.37 153.48 23.43 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.614 -0.513 . . . . 74.319999999999993 109.614 178.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -66.84 -36.04 81.43 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.575 0.702 . . . . 72.239999999999995 109.93 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.36 146.36 61.67 Favored Pre-proline 0 N--CA 1.42 -1.963 0 CA-C-N 115.014 -0.994 . . . . 61.340000000000003 108.444 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.67 -25.2 12.81 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.761 1.641 . . . . 74.109999999999999 112.007 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.05 135.37 54.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.454 -0.943 . . . . 65.329999999999998 108.454 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.6 t -129.33 139.18 51.83 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 109.239 -0.652 . . . . 63.100000000000001 109.239 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -103.66 123.2 46.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.661 -1.237 . . . . 61.439999999999998 107.661 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.6 m -113.11 151.92 14.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 120.463 -0.495 . . . . 73.099999999999994 109.912 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.545 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 0.4 OUTLIER -72.96 162.55 29.36 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 114.845 -1.071 . . . . 73.340000000000003 111.43 -178.256 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -83.78 -48.27 10.27 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.264 -1.384 . . . . 54.409999999999997 107.264 170.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.4 m -81.68 28.51 0.41 Allowed 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.685 -1.143 . . . . 71.400000000000006 112.297 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 15.2 tt -96.9 -32.15 4.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 112.6 0.593 . . . . 60.520000000000003 112.6 -174.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 519' ' ' GLY . . . . . 0.443 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 87.98 -78.49 1.79 Allowed Glycine 0 N--CA 1.428 -1.864 0 C-N-CA 120.011 -1.09 . . . . 63.439999999999998 110.532 -175.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 520' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 574' ' ' LYS . 35.1 mm -126.74 131.4 71.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 107.523 -1.288 . . . . 71.129999999999995 107.523 -175.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.554 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -108.55 146.68 32.9 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 109.349 -0.611 . . . . 72.319999999999993 109.349 177.524 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 15.1 mp0 -123.15 127.25 48.42 Favored 'General case' 0 CA--C 1.505 -0.764 0 O-C-N 123.955 0.784 . . . . 73.530000000000001 110.329 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.554 HG23 ' SD ' ' A' ' 521' ' ' MET . 66.0 t -112.09 130.64 65.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.98 -1.118 . . . . 72.219999999999999 107.98 173.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.475 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 35.8 mtmt -90.72 141.81 28.41 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.236 0.541 . . . . 72.230000000000004 110.833 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 568' ' ' VAL . 43.8 t -107.77 128.01 63.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.738 -0.664 . . . . 65.439999999999998 109.525 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 95.2 mt -66.5 116.49 7.53 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.276 0.63 . . . . 73.319999999999993 110.25 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.726 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 56.3 ttt-85 -73.26 154.14 40.31 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 124.619 1.167 . . . . 73.120000000000005 109.974 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.65 HG23 ' CD2' ' A' ' 505' ' ' PHE . 1.4 p -58.52 131.28 50.29 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 122.992 0.517 . . . . 72.430000000000007 110.415 175.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 46.4 t -47.39 -35.56 8.48 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 125.362 1.465 . . . . 75.040000000000006 110.917 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.56 85.85 0.32 Allowed Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.857 -1.297 . . . . 73.120000000000005 109.857 175.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -84.83 102.14 12.83 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.648 -0.871 . . . . 64.25 108.648 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -102.07 96.73 7.2 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.234 -0.894 . . . . 64.209999999999994 109.939 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 111.43 -145.16 17.64 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.997 -0.621 . . . . 61.350000000000001 112.294 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -118.86 131.92 56.09 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.803 -1.554 . . . . 71.450000000000003 106.803 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 42.8 t -133.94 140.59 46.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 110.104 -0.332 . . . . 70.129999999999995 110.104 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.532 HG12 ' CG2' ' A' ' 597' ' ' VAL . 38.3 mm -113.52 135.36 53.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 109.29 -0.633 . . . . 74.310000000000002 109.29 174.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 34.8 t -121.13 109.44 35.35 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 109.166 -0.679 . . . . 74.209999999999994 109.166 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.04 150.5 38.07 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.21 1.94 . . . . 74.209999999999994 112.27 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.489 ' HB3' HG22 ' A' ' 591' ' ' ILE . 46.1 p90 -145.18 167.43 22.78 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.835 0.35 . . . . 75.420000000000002 111.013 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -158.42 147.95 19.47 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-N 115.387 -0.824 . . . . 52.109999999999999 110.206 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 15.3 p -84.0 136.26 34.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.826 -0.805 . . . . 53.340000000000003 108.826 172.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 75.0 mt -104.43 114.68 44.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 108.942 -0.762 . . . . 64.129999999999995 108.942 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.63 99.12 2.48 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.843 -0.617 . . . . 75.430000000000007 109.927 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -112.13 -105.78 2.81 Favored Glycine 0 CA--C 1.479 -2.172 0 N-CA-C 110.411 -1.075 . . . . 75.219999999999999 110.411 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.24 42.69 1.05 Allowed 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 123.485 0.714 . . . . 73.230000000000004 109.473 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.518 ' HA ' ' HD2' ' A' ' 585' ' ' LYS . . . -160.1 147.13 16.17 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.475 0.71 . . . . 63.240000000000002 109.864 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.495 HH11 ' HG3' ' A' ' 551' ' ' GLU . 33.1 mtm105 -77.82 120.36 22.61 Favored 'General case' 0 C--O 1.251 1.157 0 CA-C-O 121.356 0.598 . . . . 73.310000000000002 111.727 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.28 -163.04 35.33 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.04 -0.982 . . . . 51.210000000000001 110.687 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 65.5 28.85 74.03 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 121.388 -0.434 . . . . 41.43 113.255 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 550' ' ' GLY . . . . . 0.407 ' C ' HG13 ' A' ' 576' ' ' ILE . . . 69.42 40.25 79.69 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 121.164 -0.541 . . . . 45.140000000000001 112.006 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.495 ' HG3' HH11 ' A' ' 547' ' ' ARG . 3.6 tp10 -113.05 -53.93 2.67 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 119.954 -0.698 . . . . 74.409999999999997 110.188 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -98.62 -39.54 8.64 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.459 -1.311 . . . . 74.450000000000003 107.459 169.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -142.56 149.0 38.48 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.753 -1.112 . . . . 75.400000000000006 108.629 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.66 111.93 21.13 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 105.361 -2.089 . . . . 64.230000000000004 105.361 176.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -75.19 146.7 41.02 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.176 -0.466 . . . . 72.030000000000001 109.976 -173.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.0 t -143.17 150.93 40.06 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.358 0.599 . . . . 61.130000000000003 110.502 -172.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.0 p -153.18 134.57 14.29 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.504 -0.924 . . . . 73.25 108.504 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -175.54 -168.32 35.8 Favored Glycine 0 N--CA 1.411 -2.987 0 N-CA-C 110.179 -1.169 . . . . 40.439999999999998 110.179 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.467 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 39.9 mt-10 -127.32 131.86 50.36 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.972 -0.381 . . . . 75.109999999999999 109.972 -175.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 569' ' ' LYS . 86.1 mt -94.63 132.11 39.7 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.564 -0.532 . . . . 62.350000000000001 109.564 177.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.486 ' HA ' HD13 ' A' ' 536' ' ' ILE . 19.4 tt0 -98.75 120.21 38.8 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.941 -0.572 . . . . 62.409999999999997 110.198 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.412 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 89.5 m-85 -120.71 156.55 31.54 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.671 -0.863 . . . . 52.210000000000001 108.671 177.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.459 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 65.4 mt-30 -150.11 -177.43 5.92 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.21 -1.033 . . . . 53.340000000000003 108.21 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -66.34 -42.67 87.78 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.397 -0.964 . . . . 71.129999999999995 108.397 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -81.8 -24.63 35.81 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.972 0.731 . . . . 74.299999999999997 112.972 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.459 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 37.1 mm-40 -76.34 146.5 38.77 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.857 -0.527 . . . . 71.439999999999998 112.062 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.611 HG13 ' H ' ' A' ' 568' ' ' VAL . 12.6 pt -90.47 -89.99 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 114.869 1.433 . . . . 75.519999999999996 114.869 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.611 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.7 p -134.76 145.64 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 109.664 -0.495 . . . . 64.420000000000002 109.664 -177.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.535 ' HB3' HD22 ' A' ' 560' ' ' LEU . 4.2 mmpt? -113.04 157.11 21.97 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 116.267 -0.424 . . . . 74.209999999999994 110.21 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.8 p -126.25 151.76 47.01 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.19 -0.914 . . . . 74.310000000000002 111.926 -177.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.3 mp -101.37 120.97 51.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.104 -1.443 . . . . 70.239999999999995 107.104 171.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 572' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 521' ' ' MET . 70.0 m -99.3 115.96 30.38 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 123.81 0.694 . . . . 45.5 109.967 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.41 HG23 HG22 ' A' ' 571' ' ' ILE . 68.1 t -122.63 128.27 75.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.462 -0.335 . . . . 72.310000000000002 110.291 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 29.1 tptp -80.66 118.2 22.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.67 -0.493 . . . . 73.239999999999995 109.67 176.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 58.3 t -81.27 117.22 26.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 105.557 -2.016 . . . . 72.340000000000003 105.557 174.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 576' ' ' ILE . . . . . 0.407 HG13 ' C ' ' A' ' 550' ' ' GLY . 43.5 mm . . . . . 0 C--N 1.298 -1.639 0 CA-C-O 121.762 0.791 . . . . 63.450000000000003 109.97 -174.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' A' ' 546' ' ' ALA . 34.2 mmtp . . . . . 0 N--CA 1.439 -0.987 0 CA-C-O 121.09 0.471 . . . . 74.519999999999996 111.416 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 7.0 t -153.93 135.5 14.33 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.436 0.636 . . . . 72.049999999999997 110.407 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -127.16 172.18 10.77 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.323 -0.991 . . . . 74.010000000000005 108.323 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.478 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 79.4 m-85 -118.96 153.8 34.05 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 109.515 -0.55 . . . . 72.010000000000005 109.515 -175.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.86 129.86 52.17 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.206 -1.775 . . . . 65.219999999999999 106.206 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -128.0 134.4 49.25 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.05 -0.66 . . . . 74.510000000000005 109.924 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.489 HG22 ' HB3' ' A' ' 539' ' ' TYR . 25.2 pt -106.84 140.51 24.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.39 -0.967 . . . . 50.43 108.39 176.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.21 -175.31 49.78 Favored Glycine 0 N--CA 1.425 -2.065 0 O-C-N 123.813 0.695 . . . . 63.240000000000002 111.469 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.81 137.3 82.63 Favored Pre-proline 0 N--CA 1.428 -1.529 0 C-N-CA 121.034 -0.266 . . . . 74.319999999999993 110.521 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.65 142.94 60.26 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 122.58 2.187 . . . . 72.439999999999998 111.08 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -121.93 123.42 41.66 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.674 -0.491 . . . . 74.230000000000004 109.674 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.482 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 2.2 tm? -67.97 125.56 26.7 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.844 -0.799 . . . . 74.140000000000001 108.844 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.532 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.6 t . . . . . 0 C--N 1.286 -2.179 0 N-CA-C 105.197 -2.149 . . . . 75.409999999999997 105.197 176.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.509 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 33.6 Cg_endo . . . . . 0 CA--C 1.512 -0.595 0 CA-C-O 121.148 0.395 . . . . 51.43 112.622 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.8 pp -134.56 157.97 41.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.139 -1.059 . . . . 71.239999999999995 108.139 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.54 172.84 8.42 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.314 -0.554 . . . . 64.200000000000003 111.725 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -73.01 -157.25 3.9 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-O 121.912 0.729 . . . . 74.049999999999997 114.475 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.93 -45.84 59.7 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.624 -0.788 . . . . 71.420000000000002 109.333 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -135.4 142.98 45.76 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.231 -0.895 . . . . 74.129999999999995 108.822 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 35.2 p -134.75 103.21 5.54 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.011 0.434 . . . . 43.439999999999998 111.034 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -170.22 150.65 3.68 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.822 -1.177 . . . . 64.409999999999997 107.822 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.522 HD21 HG21 ' A' ' 523' ' ' VAL . 26.1 tp -137.81 132.13 32.18 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.48 -0.933 . . . . 72.219999999999999 108.48 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -101.16 110.95 23.04 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.529 -1.286 . . . . 75.140000000000001 107.529 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 45.7 t -101.11 110.97 29.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.556 -0.535 . . . . 52.530000000000001 109.556 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 74.0 mt -96.58 125.66 49.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 N-CA-C 109.471 -0.566 . . . . 52.219999999999999 109.471 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 64.9 mt -101.17 107.59 21.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.823 -1.177 . . . . 73.310000000000002 107.823 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--N 1.283 -2.307 0 CA-C-O 121.173 0.511 . . . . 72.030000000000001 110.014 -179.935 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 74.1 t60 . . . . . 0 C--O 1.241 0.648 0 CA-C-O 121.697 0.76 . . . . 72.120000000000005 109.929 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.56 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . -85.21 -32.04 22.85 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.953 -1.022 . . . . 63.109999999999999 113.316 -175.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 124.58 -155.85 18.44 Favored Glycine 0 C--N 1.287 -2.167 0 C-N-CA 119.215 -1.469 . . . . 40.229999999999997 111.705 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.417 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.7 mp -114.66 110.96 33.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 112.069 0.396 . . . . 64.010000000000005 112.069 -172.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -92.52 119.98 32.53 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.068 -1.086 . . . . 75.019999999999996 108.068 168.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.5 t -160.41 171.79 18.43 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.122 -0.696 . . . . 74.510000000000005 109.122 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -76.83 147.06 37.39 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 122.513 -0.117 . . . . 71.209999999999994 111.149 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 524' ' ' LYS . 0.3 OUTLIER -65.9 -33.8 76.66 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 122.116 0.96 . . . . 64.439999999999998 108.69 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -130.23 140.17 37.86 Favored Pre-proline 0 C--N 1.291 -1.96 0 N-CA-C 108.008 -1.108 . . . . 72.5 108.008 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.81 -27.4 10.43 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.288 1.992 . . . . 62.509999999999998 111.672 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 60.0 t -140.63 134.52 33.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 106.232 -1.766 . . . . 75.430000000000007 106.232 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.2 t -128.95 139.91 51.9 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.952 -0.758 . . . . 72.540000000000006 108.952 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -106.39 136.3 46.38 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.563 -1.273 . . . . 71.099999999999994 107.563 175.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.2 m -125.9 147.24 30.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 108.897 -0.779 . . . . 62.530000000000001 108.897 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.478 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 27.1 m -79.29 143.64 35.03 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 112.709 0.633 . . . . 61.43 112.709 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 648' ' ' GLU . 9.8 tm-20 -56.2 -39.5 72.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.196 0.998 . . . . 73.140000000000001 110.374 175.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 27.5 t -116.01 73.25 0.84 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.905 0.859 . . . . 52.149999999999999 109.757 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 9.8 tt -120.16 -25.49 2.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.653 -0.703 . . . . 72.540000000000006 110.73 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 519' ' ' GLY . . . . . 0.457 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 91.74 -82.02 1.22 Allowed Glycine 0 N--CA 1.421 -2.342 0 N-CA-C 109.983 -1.247 . . . . 60.130000000000003 109.983 -175.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 520' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 574' ' ' LYS . 49.8 mm -127.96 135.13 63.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 107.993 -1.114 . . . . 64.209999999999994 107.993 -175.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.19 143.3 43.47 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.132 -1.062 . . . . 45.119999999999997 108.132 176.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.7 mt-10 -124.93 126.75 46.0 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 123.796 0.685 . . . . 74.299999999999997 111.358 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.545 HG11 HD22 ' A' ' 642' ' ' LEU . 24.2 t -105.53 125.34 60.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.908 -0.775 . . . . 75.25 108.908 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 508' ' ' GLU . 20.6 mmmt -81.34 130.18 34.93 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.328 -0.99 . . . . 64.340000000000003 108.328 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.501 ' O ' HG23 ' A' ' 568' ' ' VAL . 58.5 t -105.38 137.85 33.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 109.829 -0.434 . . . . 64.530000000000001 109.829 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.91 123.18 27.0 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.011 -0.541 . . . . 72.109999999999999 110.177 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 34.7 ttp85 -78.78 155.83 29.1 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.686 -1.143 . . . . 70.319999999999993 110.433 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 0.9 OUTLIER -58.37 140.4 53.65 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 124.438 1.095 . . . . 60.310000000000002 112.482 177.684 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.7 t -54.73 -35.33 63.59 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.934 1.294 . . . . 71.010000000000005 110.034 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -117.76 95.64 0.65 Allowed Glycine 0 N--CA 1.418 -2.501 0 N-CA-C 110.141 -1.184 . . . . 34.149999999999999 110.141 176.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -84.57 111.85 19.89 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.804 -0.813 . . . . 33.240000000000002 108.804 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -121.28 107.87 13.05 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.304 -0.862 . . . . 71.209999999999994 110.835 -173.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 74.76 -124.25 7.87 Favored Glycine 0 N--CA 1.441 -1.0 0 O-C-N 123.633 0.583 . . . . 72.129999999999995 112.92 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -134.17 126.38 29.83 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.299 0.64 . . . . 71.310000000000002 109.851 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.47 137.94 54.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 109.027 -0.731 . . . . 74.219999999999999 109.027 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.512 HG12 ' CG2' ' A' ' 597' ' ' VAL . 40.5 mm -107.76 136.65 42.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 109.358 -0.608 . . . . 74.109999999999999 109.358 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.25 108.07 38.55 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 109.488 -0.56 . . . . 62.450000000000003 109.488 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 53.5 Cg_endo -72.71 155.97 53.65 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.373 2.049 . . . . 63.030000000000001 111.752 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.497 ' HB3' HG22 ' A' ' 591' ' ' ILE . 54.2 p90 -152.87 163.0 40.59 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 110.481 -0.192 . . . . 71.129999999999995 110.481 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -158.03 158.36 34.69 Favored 'General case' 0 C--O 1.25 1.079 0 O-C-N 123.735 0.647 . . . . 72.299999999999997 109.457 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 5.2 p -84.35 158.15 21.23 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.145 -0.48 . . . . 75.540000000000006 110.05 172.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 89.6 mt -133.54 121.28 40.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.644 -1.243 . . . . 74.349999999999994 107.644 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -71.37 107.28 4.25 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 110.154 -0.313 . . . . 63.409999999999997 110.154 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -83.82 -89.75 0.76 Allowed Glycine 0 C--N 1.309 -0.93 0 N-CA-C 109.53 -1.428 . . . . 63.299999999999997 109.53 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 14.8 p -112.76 6.11 17.92 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.819 0.818 . . . . 75.140000000000001 109.112 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -99.45 142.76 30.52 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.635 -1.166 . . . . 71.519999999999996 110.281 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.427 ' HB3' ' OE1' ' A' ' 551' ' ' GLU . 76.9 mtt180 -79.34 127.0 31.54 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.694 0.759 . . . . 72.129999999999995 111.321 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -90.3 176.09 41.61 Favored Glycine 0 C--N 1.289 -2.074 0 CA-C-N 114.81 -1.086 . . . . 60.520000000000003 112.19 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 82.34 19.29 64.75 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.057 -0.592 . . . . 62.109999999999999 113.255 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 81.94 25.81 51.36 Favored Glycine 0 CA--C 1.504 -0.64 0 N-CA-C 110.458 -1.057 . . . . 54.140000000000001 110.458 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.427 ' OE1' ' HB3' ' A' ' 547' ' ' ARG . 21.3 tt0 -93.32 -60.81 1.7 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 108.801 -0.815 . . . . 72.5 108.801 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -102.12 -34.44 9.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.852 -1.166 . . . . 73.409999999999997 107.852 168.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -143.95 148.72 35.73 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.518 -0.919 . . . . 73.349999999999994 108.518 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -85.57 112.29 20.82 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 105.498 -2.038 . . . . 72.439999999999998 105.498 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -76.55 146.37 38.41 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.256 -0.429 . . . . 73.299999999999997 110.168 -175.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.5 t -145.55 157.0 44.05 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-O 121.411 0.624 . . . . 64.120000000000005 110.519 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.9 p -154.52 153.19 31.05 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.498 -1.297 . . . . 72.040000000000006 107.498 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 169.81 -160.64 33.75 Favored Glycine 0 N--CA 1.418 -2.503 0 N-CA-C 110.032 -1.227 . . . . 62.329999999999998 110.032 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.491 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.6 mt-10 -129.79 142.36 50.7 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 122.663 0.385 . . . . 75.420000000000002 110.631 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.574 HD22 ' HB3' ' A' ' 569' ' ' LYS . 74.9 mt -107.82 139.48 42.35 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.046 -0.525 . . . . 74.430000000000007 109.617 175.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.507 ' HA ' HD13 ' A' ' 536' ' ' ILE . 31.4 tt0 -102.79 117.25 34.23 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 116.031 -0.531 . . . . 71.030000000000001 110.913 -177.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -116.56 149.02 40.31 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.548 -0.908 . . . . 73.129999999999995 108.548 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.514 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 58.4 mt-30 -148.19 -175.01 4.73 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.941 -1.133 . . . . 71.329999999999998 107.941 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -69.18 -27.44 65.52 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.545 -0.909 . . . . 73.239999999999995 108.545 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.27 -51.66 5.06 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.136 -0.938 . . . . 51.420000000000002 112.317 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.514 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 51.0 mm-40 -55.67 125.77 22.6 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 122.349 0.259 . . . . 70.129999999999995 110.815 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.603 HG13 ' H ' ' A' ' 568' ' ' VAL . 7.1 pt -91.01 -78.67 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 112.855 0.687 . . . . 71.329999999999998 112.855 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.603 ' H ' HG13 ' A' ' 567' ' ' ILE . 10.9 p -119.71 150.18 22.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.813 -0.555 . . . . 63.439999999999998 110.004 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.574 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -122.83 160.32 26.28 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.911 -0.774 . . . . 70.519999999999996 108.911 173.489 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 6.8 p -127.33 144.61 51.02 Favored 'General case' 0 C--N 1.288 -2.095 0 O-C-N 123.898 0.749 . . . . 71.340000000000003 112.696 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.0 mp -94.66 122.74 46.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 106.369 -1.715 . . . . 74.430000000000007 106.369 171.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 15.6 m -100.92 119.24 38.42 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 123.731 0.645 . . . . 60.0 109.332 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.403 HG23 HG22 ' A' ' 571' ' ' ILE . 89.4 t -124.18 128.81 74.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 109.927 -0.397 . . . . 71.409999999999997 109.927 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.457 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 20.5 tptm -77.97 113.22 15.67 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.183 -0.673 . . . . 55.0 109.183 175.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.3 120.97 36.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 106.89 -1.522 . . . . 70.510000000000005 106.89 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 35.7 mm -84.96 149.75 4.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.911 -0.774 . . . . 72.409999999999997 108.911 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -65.17 143.33 57.93 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.802 -1.09 . . . . 72.400000000000006 110.614 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -51.51 146.88 6.8 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.493 1.121 . . . . 75.340000000000003 113.757 -173.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -74.57 -94.66 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 115.295 1.591 . . . . 63.329999999999998 115.295 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.8 -54.43 1.94 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.721 1.378 . . . . 74.219999999999999 114.721 -176.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -142.33 28.7 1.65 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.63 0.728 . . . . 74.219999999999999 110.233 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -71.32 139.95 50.09 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.619 -1.173 . . . . 71.140000000000001 110.973 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -83.37 -56.39 3.78 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.513 -0.767 . . . . 73.209999999999994 109.409 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -165.36 164.7 19.71 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.086 -1.45 . . . . 74.310000000000002 107.086 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 74.9 mmtt -134.18 159.36 41.14 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.443 -0.577 . . . . 73.409999999999997 109.443 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 586' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 644' ' ' VAL . 10.0 t -149.33 138.75 21.57 Favored 'General case' 0 N--CA 1.416 -2.143 0 C-N-CA 120.034 -0.666 . . . . 52.310000000000002 110.937 174.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 49.0 p90 -135.08 167.7 20.47 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.651 -1.241 . . . . 70.109999999999999 107.651 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.517 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 80.3 m-85 -114.44 159.39 20.38 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 120.572 -0.451 . . . . 74.430000000000007 109.889 -175.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.33 128.22 47.86 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 106.243 -1.762 . . . . 74.129999999999995 106.243 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.462 ' HB2' HD11 ' A' ' 542' ' ' ILE . 29.5 tt0 -122.19 123.37 41.35 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 110.238 -0.282 . . . . 75.319999999999993 110.238 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.497 HG22 ' HB3' ' A' ' 539' ' ' TYR . 23.5 pt -95.86 135.19 30.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.859 -1.163 . . . . 71.150000000000006 107.859 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -84.38 -177.55 51.29 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 111.429 -0.669 . . . . 75.430000000000007 111.429 -177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.75 133.95 92.37 Favored Pre-proline 0 N--CA 1.435 -1.19 0 C-N-CA 120.931 -0.308 . . . . 73.349999999999994 111.435 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.413 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 20.3 Cg_endo -62.7 129.48 26.44 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.947 2.432 . . . . 72.219999999999999 111.513 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 595' ' ' ARG . . . . . 0.466 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.1 ptp180 -107.81 119.95 40.89 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.458 -0.792 . . . . 71.239999999999995 109.902 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -66.07 132.1 47.74 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.967 -1.123 . . . . 74.530000000000001 107.967 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.512 ' CG2' HG12 ' A' ' 536' ' ' ILE . 98.1 t -81.99 115.7 24.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.707 0.765 . . . . 61.240000000000002 112.385 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -82.88 131.44 35.19 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 105.68 -1.97 . . . . 71.010000000000005 105.68 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 26.5 mmt -88.67 -12.35 42.68 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 120.947 0.403 . . . . 73.549999999999997 110.869 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 33.1 m -136.03 97.01 3.51 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.17 0.509 . . . . 54.240000000000002 111.941 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -30.22 22.8 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 105.63 -1.989 . . . . 73.200000000000003 105.63 170.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -83.49 100.02 10.48 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 113.577 -1.647 . . . . 71.209999999999994 108.19 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -99.92 -16.27 18.04 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.062 0.458 . . . . 64.409999999999997 110.428 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 161.75 -102.53 0.21 Allowed Glycine 0 N--CA 1.419 -2.476 0 N-CA-C 110.876 -0.889 . . . . 74.439999999999998 110.876 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 83.43 19.38 62.31 Favored Glycine 0 C--N 1.306 -1.103 0 C-N-CA 121.083 -0.58 . . . . 52.32 111.909 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -105.18 93.27 4.6 Favored 'General case' 0 CA--C 1.489 -1.397 0 CA-C-O 121.462 0.649 . . . . 62.32 109.717 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 6.4 t -132.65 141.2 48.52 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 107.93 -1.137 . . . . 71.239999999999995 107.93 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 10.7 tt -65.77 115.0 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 121.872 0.844 . . . . 71.140000000000001 111.552 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 21.0 m -90.89 107.51 19.24 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 105.244 -2.132 . . . . 73.299999999999997 105.244 174.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.96 76.31 10.05 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 122.317 1.056 . . . . 72.439999999999998 108.536 -175.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -166.66 134.97 2.77 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 104.721 -2.325 . . . . 72.239999999999995 104.721 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -86.04 101.47 12.97 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.548 0.689 . . . . 74.219999999999999 111.244 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 30.1 t70 72.98 88.43 0.1 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.231 -1.804 . . . . 72.200000000000003 112.508 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -157.46 144.6 18.4 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.727 -1.583 . . . . 71.099999999999994 106.727 172.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 615' ' ' LYS . . . . . 0.518 ' O ' ' HD3' ' A' ' 617' ' ' PRO . 15.5 ptmm? -104.0 3.59 33.57 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.36 0.874 . . . . 70.329999999999998 113.36 -173.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -107.89 98.87 27.44 Favored Pre-proline 0 C--O 1.241 0.636 0 C-N-CA 120.235 -0.586 . . . . 71.310000000000002 112.111 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 617' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 615' ' ' LYS . 1.0 OUTLIER -87.17 -7.79 6.82 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.383 2.055 . . . . 71.0 110.948 175.57 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 58.98 82.54 0.14 Allowed 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.994 1.317 . . . . 70.439999999999998 112.195 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 58.3 m -93.92 97.44 10.37 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.834 -1.172 . . . . 71.329999999999998 107.834 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 17.2 m -82.53 86.09 6.85 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.979 -0.555 . . . . 62.030000000000001 109.817 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -128.73 149.08 50.85 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 115.838 -0.619 . . . . 70.310000000000002 110.175 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -168.37 90.15 0.27 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.332 -0.988 . . . . 74.049999999999997 108.332 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -115.82 133.86 55.6 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.348 -0.612 . . . . 60.009999999999998 109.348 175.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -86.16 52.62 2.53 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 122.365 1.078 . . . . 70.439999999999998 108.285 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -66.6 -26.02 66.9 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.719 -1.128 . . . . 63.43 110.742 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -61.87 -36.63 81.8 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.971 -0.292 . . . . 71.200000000000003 111.364 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 627' ' ' ARG . . . . . 0.563 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 3.0 tmt_? -75.11 -34.23 61.69 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.624 -0.88 . . . . 74.200000000000003 108.624 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.51 ' O ' ' HG2' ' A' ' 631' ' ' MET . 70.4 mt -63.11 -38.01 80.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.564 0.697 . . . . 74.349999999999994 109.551 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -78.06 -21.41 50.67 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.623 -0.717 . . . . 64.0 111.541 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.585 ' HA ' ' HB3' ' A' ' 633' ' ' ARG . 0.0 OUTLIER -71.6 -11.52 60.89 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 111.762 0.282 . . . . 72.140000000000001 111.762 -175.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 25.0 ptt? -58.93 -23.76 61.75 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.243 0.544 . . . . 70.340000000000003 109.747 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -131.08 54.04 0.79 Allowed Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 108.541 -1.824 . . . . 74.299999999999997 108.541 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 633' ' ' ARG . . . . . 0.585 ' HB3' ' HA ' ' A' ' 630' ' ' GLU . 6.6 ptp180 -86.05 147.21 44.77 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-O 121.129 0.49 . . . . 75.540000000000006 111.066 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.453 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 42.6 Cg_endo -77.81 138.76 17.08 Favored 'Trans proline' 0 N--CA 1.43 -2.213 0 C-N-CA 121.281 1.32 . . . . 74.519999999999996 108.876 170.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.86 168.18 17.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 120.894 -0.323 . . . . 72.319999999999993 110.217 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.21 175.91 5.34 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 112.14 0.422 . . . . 73.319999999999993 112.14 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.417 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -72.53 -177.58 31.3 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 114.948 0.739 . . . . 74.439999999999998 114.948 -176.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -58.48 -47.35 84.36 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.476 1.111 . . . . 63.020000000000003 110.172 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -140.44 121.83 15.0 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.006 -0.739 . . . . 62.25 109.006 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 10.1 p -114.32 96.21 5.66 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 120.899 0.381 . . . . 73.209999999999994 111.004 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -171.16 134.0 0.9 Allowed 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.572 -0.74 . . . . 72.019999999999996 109.662 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.545 HD22 HG11 ' A' ' 523' ' ' VAL . 25.6 tp -117.42 132.35 56.59 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.896 -1.047 . . . . 70.310000000000002 108.769 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -99.71 111.91 24.2 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.946 -1.502 . . . . 73.349999999999994 106.946 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 586' ' ' THR . 41.3 t -100.41 111.1 29.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 109.338 -0.615 . . . . 74.319999999999993 109.338 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 51.1 mt -99.48 118.45 46.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 N-CA-C 109.177 -0.675 . . . . 74.319999999999993 109.177 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 69.0 mt -87.5 107.86 17.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 106.792 -1.559 . . . . 73.409999999999997 106.792 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -112.41 146.78 37.76 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 116.098 -0.501 . . . . 75.450000000000003 110.93 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.409 ' HA ' ' HB2' ' A' ' 516' ' ' GLU . 9.8 pt-20 -80.13 119.14 22.52 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 122.191 0.996 . . . . 71.430000000000007 112.304 -176.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 47.3 m -138.17 98.53 3.64 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 114.263 -1.335 . . . . 55.0 107.57 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -93.25 -3.99 52.69 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.322 -0.992 . . . . 60.210000000000001 108.322 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -65.41 -46.28 80.61 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.878 -1.056 . . . . 72.409999999999997 108.367 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -101.68 110.28 22.24 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 105.254 -2.128 . . . . 74.510000000000005 105.254 171.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -112.1 133.74 54.07 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 109.212 -0.662 . . . . 74.200000000000003 109.212 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 29.7 p -63.7 -31.87 73.18 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.845 -0.616 . . . . 73.340000000000003 110.767 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 26.8 m -74.77 103.25 4.96 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.615 -1.254 . . . . 62.409999999999997 107.615 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 61.1 t -73.29 131.34 35.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.727 -0.669 . . . . 72.340000000000003 111.561 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 C--N 1.304 -1.397 0 N-CA-C 108.387 -0.968 . . . . 75.030000000000001 108.387 175.367 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 . . . . . 0 N--CA 1.445 -0.685 0 CA-C-O 121.326 0.584 . . . . 74.420000000000002 110.361 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -80.29 -45.78 17.3 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.782 0.801 . . . . 75.439999999999998 109.158 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 174.9 -161.88 31.53 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 109.033 -1.627 . . . . 51.140000000000001 109.033 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.513 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.4 mp -116.25 121.37 67.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 117.202 0.501 . . . . 73.25 111.359 -174.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.558 ' CD2' HG23 ' A' ' 528' ' ' THR . 30.7 m-85 -95.86 135.65 37.31 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.011 -0.737 . . . . 73.099999999999994 109.011 168.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 506' ' ' THR . . . . . 0.435 ' HA ' HG22 ' A' ' 640' ' ' THR . 13.6 t -167.32 179.66 4.93 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.088 -0.708 . . . . 73.150000000000006 109.088 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.07 152.05 22.3 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.455 -0.572 . . . . 74.120000000000005 109.455 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.66 -37.12 84.13 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.79 -0.448 . . . . 74.540000000000006 109.79 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -125.97 149.73 67.08 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 109.62 -0.511 . . . . 70.109999999999999 109.62 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.01 -27.67 6.68 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.678 1.585 . . . . 75.219999999999999 111.771 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 47.4 t -135.48 135.26 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.883 -0.784 . . . . 74.140000000000001 108.883 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.9 t -132.28 140.45 48.62 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.724 -0.843 . . . . 64.230000000000004 108.724 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 44.9 p-80 -112.71 127.51 56.15 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.383 0.611 . . . . 75.049999999999997 109.496 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.7 m -112.18 165.2 7.33 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.453 -0.794 . . . . 64.439999999999998 109.211 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 15.4 t -101.2 166.35 10.82 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.666 0.746 . . . . 63.340000000000003 112.134 -172.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 648' ' ' GLU . 12.6 tp10 -80.11 -19.67 46.8 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.101 -1.409 . . . . 75.319999999999993 107.991 173.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 517' ' ' SER . . . . . 0.467 ' OG ' ' HA ' ' A' ' 650' ' ' TYR . 19.3 m -114.15 29.65 7.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.991 -0.55 . . . . 53.130000000000003 111.763 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.2 tt -97.86 -39.26 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 119.763 -0.775 . . . . 54.240000000000002 113.044 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 90.28 -72.95 1.94 Allowed Glycine 0 CA--C 1.506 -0.529 0 C-N-CA 120.662 -0.78 . . . . 52.119999999999997 111.645 -176.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 520' ' ' ILE . . . . . 0.543 HD11 ' HE3' ' A' ' 574' ' ' LYS . 33.8 mm -128.03 126.87 67.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.65 -1.241 . . . . 65.540000000000006 107.65 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.21 147.96 29.5 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.273 -1.01 . . . . 54.340000000000003 108.273 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 51.4 mp0 -122.41 131.9 54.1 Favored 'General case' 0 N--CA 1.434 -1.252 0 O-C-N 123.716 0.635 . . . . 61.009999999999998 110.304 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 570' ' ' THR . 25.3 t -110.95 129.51 66.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.785 -0.643 . . . . 73.120000000000005 109.47 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.407 ' HE3' HG11 ' A' ' 568' ' ' VAL . 6.5 mmmm -86.28 120.28 27.46 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 123.744 0.818 . . . . 74.239999999999995 109.437 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 568' ' ' VAL . 47.9 t -100.65 122.88 53.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 109.184 -0.673 . . . . 61.109999999999999 109.184 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.1 mt -69.82 126.7 30.5 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.855 -0.611 . . . . 71.340000000000003 110.173 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.434 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 57.0 ttp180 -74.32 160.82 30.55 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.69 -1.141 . . . . 64.019999999999996 108.997 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.558 HG23 ' CD2' ' A' ' 505' ' ' PHE . 2.5 p -56.98 139.09 53.18 Favored 'General case' 0 N--CA 1.421 -1.881 0 C-N-CA 123.125 0.57 . . . . 73.200000000000003 111.843 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.9 m -51.07 -33.84 27.47 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.863 1.265 . . . . 73.109999999999999 110.059 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -119.78 107.39 1.33 Allowed Glycine 0 N--CA 1.416 -2.646 0 N-CA-C 108.456 -1.858 . . . . 72.519999999999996 108.456 171.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 564' ' ' ASN . . . -88.69 101.28 13.84 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.081 -0.711 . . . . 71.200000000000003 109.081 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -116.9 102.02 9.02 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.674 -0.694 . . . . 75.219999999999999 110.798 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 86.1 -157.33 30.58 Favored Glycine 0 C--N 1.311 -0.818 0 C-N-CA 120.826 -0.702 . . . . 43.439999999999998 112.87 174.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -107.0 127.69 53.68 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.606 -0.887 . . . . 70.140000000000001 108.606 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.21 141.68 45.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 C-N-CA 122.768 0.427 . . . . 52.140000000000001 109.981 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.592 HG12 ' CG2' ' A' ' 597' ' ' VAL . 42.4 mm -108.79 134.28 51.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.571 -0.9 . . . . 72.439999999999998 108.571 173.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.55 107.2 43.21 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 109.106 -0.701 . . . . 64.329999999999998 109.106 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -70.36 152.17 66.07 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.871 1.714 . . . . 53.030000000000001 110.999 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -148.52 157.88 43.76 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.674 -0.491 . . . . 64.120000000000005 109.674 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 540' ' ' LYS . . . . . 0.441 ' HE2' ' HB3' ' A' ' 590' ' ' GLU . 0.0 OUTLIER -158.11 152.6 24.67 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.914 0.759 . . . . 74.349999999999994 110.441 178.289 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.9 p -85.22 143.4 28.78 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.0 -0.545 . . . . 63.240000000000002 109.965 176.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.562 HD11 ' HB2' ' A' ' 590' ' ' GLU . 82.5 mt -105.59 122.2 58.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 108.368 -0.975 . . . . 73.430000000000007 108.368 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -81.45 145.35 30.81 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 123.754 0.659 . . . . 71.230000000000004 109.909 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -175.03 -99.76 0.12 Allowed Glycine 0 CA--C 1.483 -1.921 0 N-CA-C 111.038 -0.825 . . . . 51.109999999999999 111.038 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 545' ' ' THR . . . . . 0.439 ' HB ' HG23 ' A' ' 586' ' ' THR . 0.9 OUTLIER -83.43 29.17 0.51 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.148 0.979 . . . . 74.310000000000002 110.37 -175.471 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.457 ' HA ' ' HD2' ' A' ' 585' ' ' LYS . . . -165.66 145.3 6.49 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.563 -1.643 . . . . 72.129999999999995 106.563 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -86.3 127.22 34.75 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 113.0 0.741 . . . . 74.230000000000004 113.0 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.79 -164.09 38.68 Favored Glycine 0 C--N 1.302 -1.324 0 CA-C-N 114.446 -1.252 . . . . 55.340000000000003 110.755 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.95 18.4 76.24 Favored Glycine 0 C--N 1.318 -0.441 0 CA-C-N 117.509 0.654 . . . . 73.430000000000007 112.796 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 75.71 44.8 19.25 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.627 -0.797 . . . . 71.540000000000006 111.133 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -114.75 -59.25 2.04 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.609 -0.436 . . . . 54.149999999999999 110.074 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -100.82 -37.12 8.83 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 107.417 -1.327 . . . . 73.239999999999995 107.417 171.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -141.38 150.88 42.97 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 114.661 -1.154 . . . . 75.510000000000005 107.939 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.58 113.67 20.45 Favored 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 106.446 -1.687 . . . . 52.409999999999997 106.446 174.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -76.21 131.89 39.59 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.752 -0.833 . . . . 61.119999999999997 108.752 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.9 t -128.34 148.21 50.67 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 121.688 0.756 . . . . 63.130000000000003 110.965 -172.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 25.3 p -141.39 151.39 43.44 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 106.294 -1.743 . . . . 74.400000000000006 106.294 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 171.48 -161.12 33.41 Favored Glycine 0 N--CA 1.417 -2.587 0 C-N-CA 119.972 -1.109 . . . . 63.340000000000003 110.978 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.537 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 47.1 mt-10 -139.39 130.96 27.17 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 122.497 0.319 . . . . 65.329999999999998 110.745 -176.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 98.7 mt -95.56 142.21 28.17 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.918 -0.771 . . . . 74.450000000000003 108.918 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -108.9 118.73 37.55 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.294 0.568 . . . . 74.530000000000001 110.824 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -117.53 156.49 27.97 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.538 -0.756 . . . . 65.200000000000003 109.51 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.498 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 47.3 mt-30 -148.54 178.74 8.36 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.118 -1.067 . . . . 52.119999999999997 108.118 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 564' ' ' ASN . . . . . 0.412 ' HA ' ' HB1' ' A' ' 531' ' ' ALA . 4.0 p-10 -67.83 -30.79 70.27 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.683 -0.858 . . . . 53.549999999999997 108.683 172.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -84.22 -44.86 13.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.228 -0.897 . . . . 74.140000000000001 110.429 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.498 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 70.5 mm-40 -65.72 136.97 56.95 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 123.587 0.755 . . . . 71.239999999999995 111.021 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.592 HG13 ' H ' ' A' ' 568' ' ' VAL . 9.5 pt -89.78 -92.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 114.055 1.131 . . . . 53.229999999999997 114.055 -177.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.592 ' H ' HG13 ' A' ' 567' ' ' ILE . 8.5 p -119.41 149.82 21.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.62 -0.511 . . . . 64.549999999999997 109.62 -176.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -115.1 157.05 24.1 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.175 -0.676 . . . . 63.119999999999997 109.175 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.6 p -122.5 137.75 54.78 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.232 -0.895 . . . . 54.149999999999999 110.925 177.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 24.3 mt -94.71 118.98 42.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 107.898 -1.149 . . . . 75.319999999999993 107.898 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 11.8 p -94.66 115.61 27.75 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 124.002 0.814 . . . . 72.010000000000005 110.611 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 89.2 t -119.79 129.61 75.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 CA-C-O 120.712 0.291 . . . . 63.420000000000002 110.46 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.543 ' HE3' HD11 ' A' ' 520' ' ' ILE . 4.1 tppp? -83.88 119.08 24.44 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.844 0.857 . . . . 64.140000000000001 110.158 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 29.9 t -88.49 121.78 39.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 106.03 -1.841 . . . . 74.439999999999998 106.03 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 48.3 mm -79.91 141.01 15.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.241 0.543 . . . . 64.430000000000007 111.191 -173.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -93.15 110.42 21.92 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.921 -1.14 . . . . 42.420000000000002 107.921 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -129.74 130.91 46.03 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 120.929 0.395 . . . . 70.420000000000002 110.586 -174.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -94.22 94.55 8.4 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.409 0.624 . . . . 74.430000000000007 109.728 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -141.12 -166.77 2.24 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 125.09 1.356 . . . . 60.329999999999998 107.425 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -118.95 67.19 0.78 Allowed 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 122.25 1.024 . . . . 65.319999999999993 108.513 174.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -95.06 145.35 25.02 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 115.24 1.57 . . . . 73.230000000000004 115.24 -171.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.409 ' HB3' ' HE2' ' A' ' 583' ' ' LYS . 38.3 ttpt -89.95 170.54 10.28 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 112.843 -1.98 . . . . 75.310000000000002 107.756 175.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 584' ' ' ASN . . . . . 0.486 ' ND2' ' HB3' ' A' ' 647' ' ' GLU . 27.0 t-20 -44.21 115.54 0.85 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.333 1.453 . . . . 34.200000000000003 112.51 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.457 ' HD2' ' HA ' ' A' ' 546' ' ' ALA . 38.5 mmtm -97.15 145.74 25.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.395 -0.82 . . . . 73.140000000000001 110.282 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 586' ' ' THR . . . . . 0.439 HG23 ' HB ' ' A' ' 545' ' ' THR . 5.0 t -156.65 136.6 12.63 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.188 0.518 . . . . 74.109999999999999 111.27 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -131.6 179.13 6.23 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.325 -0.991 . . . . 73.219999999999999 108.325 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.519 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 82.1 m-85 -125.2 155.33 40.2 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 109.19 -0.671 . . . . 64.310000000000002 109.19 -176.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.2 OUTLIER -121.51 131.1 53.95 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.613 -1.625 . . . . 63.32 106.613 178.113 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.562 ' HB2' HD11 ' A' ' 542' ' ' ILE . 33.4 tt0 -126.0 137.43 53.66 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.547 -0.538 . . . . 73.010000000000005 109.547 176.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 14.9 pt -104.53 142.1 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.175 0 N-CA-C 107.772 -1.195 . . . . 72.430000000000007 107.772 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.37 176.4 49.98 Favored Glycine 0 N--CA 1.414 -2.795 0 N-CA-C 110.398 -1.081 . . . . 74.099999999999994 110.398 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.97 128.62 92.71 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-O 120.883 0.373 . . . . 75.340000000000003 111.047 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.405 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 27.8 Cg_endo -61.13 128.24 24.61 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.728 2.952 . . . . 72.209999999999994 112.521 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -110.23 119.04 37.97 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.316 -0.856 . . . . 71.409999999999997 109.81 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.17 134.31 53.45 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.415 -0.957 . . . . 73.010000000000005 108.415 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.592 ' CG2' HG12 ' A' ' 536' ' ' ILE . 34.7 t -91.2 100.59 11.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.396 0.617 . . . . 72.420000000000002 109.853 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.49 117.9 28.74 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 105.454 -2.054 . . . . 63.439999999999998 105.454 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 23.6 ttt -66.17 -19.34 65.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.895 0.378 . . . . 74.409999999999997 111.451 -174.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 36.4 t -73.99 110.2 8.09 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 105.258 -2.127 . . . . 73.140000000000001 105.258 170.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -76.14 106.8 7.95 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-O 121.869 0.842 . . . . 53.350000000000001 109.933 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -102.85 119.32 38.63 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.376 -1.284 . . . . 75.510000000000005 109.961 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 603' ' ' LYS . . . . . 0.561 ' HA ' ' HE2' ' A' ' 603' ' ' LYS . 11.0 mmpt? -89.44 -38.74 13.85 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.707 -1.22 . . . . 74.109999999999999 107.707 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 68.78 -152.31 52.22 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 114.878 -1.055 . . . . 61.310000000000002 111.528 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 605' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 607' ' ' THR . . . -85.37 90.32 1.65 Allowed Glycine 0 N--CA 1.418 -2.526 0 N-CA-C 110.113 -1.195 . . . . 64.010000000000005 110.113 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -76.4 44.01 0.33 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-O 122.716 1.246 . . . . 74.549999999999997 110.659 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 607' ' ' THR . . . . . 0.469 ' O ' ' HG2' ' A' ' 621' ' ' LYS . 24.1 m -78.15 141.34 38.77 Favored 'General case' 0 N--CA 1.41 -2.467 0 CA-C-N 114.089 -1.414 . . . . 74.430000000000007 108.947 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 30.0 pt -95.74 151.59 3.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.769 -0.826 . . . . 71.510000000000005 108.769 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 19.5 m -68.36 -43.27 77.78 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.771 -0.826 . . . . 75.299999999999997 108.771 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 62.21 15.16 7.28 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.631 1.172 . . . . 72.129999999999995 112.23 174.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -86.03 112.57 21.36 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.346 -1.353 . . . . 73.129999999999995 107.346 175.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -76.4 89.78 3.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.342 -0.984 . . . . 71.450000000000003 108.342 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -146.19 -68.69 0.27 Allowed 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 107.076 -1.453 . . . . 71.140000000000001 107.076 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 4.5 p30 44.23 34.38 1.0 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.609 1.564 . . . . 65.400000000000006 114.342 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -78.15 2.65 17.38 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.102 0.953 . . . . 72.239999999999995 110.111 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -160.03 147.27 12.57 Favored Pre-proline 0 N--CA 1.425 -1.704 0 N-CA-C 105.33 -2.1 . . . . 54.399999999999999 105.33 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -69.02 92.6 0.45 Allowed 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 121.427 1.418 . . . . 53.200000000000003 110.719 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.5 tp -109.66 106.08 15.6 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.873 -0.603 . . . . 73.140000000000001 110.932 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 25.4 m -96.49 95.1 7.78 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.922 -0.581 . . . . 73.200000000000003 109.715 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 49.1 m -106.46 112.87 26.06 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.549 -0.537 . . . . 74.439999999999998 109.549 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 621' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 607' ' ' THR . 68.7 mttm -132.24 -176.32 4.04 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.629 -0.714 . . . . 75.420000000000002 109.302 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -75.28 130.1 38.52 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 123.636 0.585 . . . . 74.209999999999994 110.654 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 623' ' ' GLU . 0.8 OUTLIER -83.75 116.85 22.89 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.778 0.799 . . . . 65.400000000000006 109.866 177.197 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 624' ' ' GLU . . . . . 0.484 ' OE1' ' HD3' ' A' ' 626' ' ' ARG . 0.0 OUTLIER -96.93 73.38 2.58 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.041 -0.981 . . . . 74.099999999999994 111.472 -177.082 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 59.43 26.4 15.31 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.721 0.772 . . . . 70.430000000000007 109.46 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.484 ' HD3' ' OE1' ' A' ' 624' ' ' GLU . 13.3 tpt180 -56.94 -57.93 10.36 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 125.506 1.522 . . . . 73.239999999999995 112.377 -170.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 627' ' ' ARG . . . . . 0.539 ' HD3' ' O ' ' A' ' 627' ' ' ARG . 0.0 OUTLIER -62.15 -34.13 75.81 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.895 0.378 . . . . 52.340000000000003 110.373 -175.313 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.425 ' O ' ' HG2' ' A' ' 631' ' ' MET . 61.5 mt -70.22 -43.1 78.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.241 -0.652 . . . . 73.430000000000007 109.241 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 629' ' ' ALA . . . . . 0.524 ' O ' ' HG2' ' A' ' 633' ' ' ARG . . . -63.95 -45.28 89.87 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.31 -0.859 . . . . 75.109999999999999 111.363 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.52 ' HA ' ' CG ' ' A' ' 633' ' ' ARG . 51.6 mt-10 -59.64 -11.08 4.26 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 116.508 2.04 . . . . 72.510000000000005 116.508 -173.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 25.4 ptt? -79.64 -10.38 59.78 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.888 -0.725 . . . . 74.219999999999999 109.784 176.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -134.38 48.03 0.96 Allowed Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.283 -1.127 . . . . 65.430000000000007 110.283 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 633' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 629' ' ' ALA . 9.6 mmm180 -127.81 155.81 76.8 Favored Pre-proline 0 C--N 1.316 -0.887 0 N-CA-C 109.979 -0.378 . . . . 72.349999999999994 109.979 -176.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.468 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 43.9 Cg_endo -67.55 133.96 31.53 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.095 1.864 . . . . 62.009999999999998 110.252 174.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.86 162.87 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 108.928 -0.767 . . . . 74.519999999999996 108.928 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.548 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.8 OUTLIER -96.89 166.57 11.56 Favored 'General case' 0 N--CA 1.424 -1.733 0 C-N-CA 119.377 -0.929 . . . . 63.299999999999997 111.813 178.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.513 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -69.36 -168.25 5.86 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 116.182 1.233 . . . . 62.549999999999997 116.182 -175.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -70.83 -39.5 72.98 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.085 -1.058 . . . . 65.120000000000005 108.452 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -138.73 121.92 16.94 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.354 -0.839 . . . . 55.329999999999998 110.05 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 640' ' ' THR . . . . . 0.548 HG21 ' HB2' ' A' ' 636' ' ' LEU . 17.8 p -121.92 92.87 3.83 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.789 -0.641 . . . . 73.450000000000003 109.735 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -161.95 143.01 10.75 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.627 -1.249 . . . . 72.319999999999993 107.627 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.579 HD22 HG11 ' A' ' 523' ' ' VAL . 16.4 tp -128.69 125.7 38.56 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 107.726 -1.212 . . . . 71.299999999999997 107.726 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -93.86 111.48 23.19 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.098 -1.445 . . . . 64.140000000000001 107.098 176.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.86 113.56 39.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.208 -0.664 . . . . 71.219999999999999 109.208 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 38.3 mt -100.43 128.62 52.28 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.554 0 N-CA-C 108.298 -1.001 . . . . 73.540000000000006 108.298 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 57.9 mt -104.51 107.61 22.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 106.894 -1.521 . . . . 54.140000000000001 106.894 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.486 ' HB3' ' ND2' ' A' ' 584' ' ' ASN . 6.7 pt-20 -128.81 145.01 51.31 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 120.327 -0.549 . . . . 74.430000000000007 111.934 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 516' ' ' GLU . 35.9 mt-10 -71.09 118.41 13.83 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.853 -0.612 . . . . 72.540000000000006 111.979 -174.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.5 p -144.47 78.29 1.57 Allowed 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.044 -0.98 . . . . 70.310000000000002 108.826 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 650' ' ' TYR . . . . . 0.467 ' HA ' ' OG ' ' A' ' 517' ' ' SER . 35.7 m-85 -63.54 -54.99 27.5 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 114.414 -1.266 . . . . 65.439999999999998 112.463 -174.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -79.88 -27.06 40.06 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.734 -0.839 . . . . 73.319999999999993 108.734 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 34.5 t80 71.32 20.23 5.05 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.581 1.553 . . . . 73.319999999999993 108.592 -177.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -112.43 128.74 56.4 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.792 -1.549 . . . . 62.340000000000003 107.448 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 35.7 m -78.23 84.24 4.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.996 -0.742 . . . . 62.43 108.996 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 25.9 m -73.12 -41.43 64.01 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 108.673 -0.862 . . . . 52.030000000000001 108.673 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 55.0 t -121.37 116.11 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 N-CA-C 107.445 -1.317 . . . . 64.129999999999995 107.445 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 . . . . . 0 C--N 1.31 -1.136 0 N-CA-C 109.962 -0.384 . . . . 74.5 109.962 179.759 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 76.3 t60 . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 121.069 0.461 . . . . 72.230000000000004 110.195 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.491 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . -71.69 -91.58 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 113.864 1.061 . . . . 62.119999999999997 113.864 -174.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.433 ' HA3' ' H ' ' A' ' 529' ' ' SER . . . 159.32 -135.42 4.16 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 118.383 -1.865 . . . . 61.240000000000002 113.145 -173.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.4 120.08 55.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 122.075 0.15 . . . . 73.420000000000002 110.968 -173.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.445 ' CE2' ' HB ' ' A' ' 528' ' ' THR . 23.8 m-85 -108.68 126.53 53.09 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.25 -1.019 . . . . 72.099999999999994 108.25 169.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.6 t -171.2 -178.82 2.51 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.671 -0.863 . . . . 75.140000000000001 108.671 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -87.79 152.12 22.36 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 110.444 -0.206 . . . . 73.409999999999997 110.444 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -59.64 -41.11 89.78 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.648 0.737 . . . . 74.010000000000005 110.165 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -135.16 146.59 58.91 Favored Pre-proline 0 N--CA 1.42 -1.96 0 CA-C-N 114.741 -1.118 . . . . 73.420000000000002 108.227 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -71.08 -29.89 17.08 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.167 1.911 . . . . 74.310000000000002 112.665 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.13 136.79 55.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.639 -0.874 . . . . 54.329999999999998 108.639 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.2 t -133.65 141.24 47.53 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 108.39 -0.966 . . . . 74.329999999999998 108.39 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -109.44 132.94 53.66 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.073 -1.051 . . . . 54.240000000000002 109.352 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.3 m -124.34 165.99 20.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 109.044 -0.724 . . . . 73.200000000000003 109.044 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.539 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 72.4 m -93.78 152.61 18.81 Favored 'General case' 0 N--CA 1.394 -3.25 0 CA-C-N 115.649 -0.705 . . . . 75.430000000000007 110.774 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.428 ' HA ' HG11 ' A' ' 575' ' ' VAL . 1.8 tm-20 -68.22 -56.74 7.62 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.623 0.725 . . . . 65.030000000000001 109.073 173.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.69 40.68 0.6 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 125.121 1.368 . . . . 65.519999999999996 111.69 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 12.0 tt -104.71 -26.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.155 0.503 . . . . 60.32 111.73 -175.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 519' ' ' GLY . . . . . 0.437 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 91.76 -79.06 1.28 Allowed Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 110.839 -0.904 . . . . 65.230000000000004 110.839 -175.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 37.2 mm -129.79 133.45 64.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.674 -1.232 . . . . 75.099999999999994 107.674 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.584 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -109.91 146.5 35.06 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.445 -0.946 . . . . 74.120000000000005 108.445 175.456 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 26.4 mt-10 -125.7 120.12 29.83 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 123.645 0.591 . . . . 74.530000000000001 111.544 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.584 HG23 ' SD ' ' A' ' 521' ' ' MET . 65.9 t -112.55 129.23 68.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.628 -0.878 . . . . 74.329999999999998 108.628 177.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.613 ' HB3' HG21 ' A' ' 568' ' ' VAL . 29.1 mtmt -86.76 143.13 27.67 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 123.808 0.692 . . . . 75.329999999999998 110.698 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.546 ' O ' HG23 ' A' ' 568' ' ' VAL . 43.3 t -105.02 141.63 19.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.755 -0.657 . . . . 74.519999999999996 109.322 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.96 118.51 17.99 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.69 -0.856 . . . . 74.150000000000006 108.69 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -73.76 153.21 40.1 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.072 -0.714 . . . . 71.409999999999997 109.072 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.445 ' HB ' ' CE2' ' A' ' 505' ' ' PHE . 12.0 t -60.16 157.52 13.07 Favored 'General case' 0 N--CA 1.41 -2.435 0 C-N-CA 123.857 0.863 . . . . 72.239999999999995 110.727 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 529' ' ' SER . . . . . 0.433 ' H ' ' HA3' ' A' ' 503' ' ' GLY . 47.0 t -72.01 -26.95 62.42 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.711 0.767 . . . . 60.109999999999999 109.775 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.85 82.91 0.33 Allowed Glycine 0 N--CA 1.428 -1.842 0 CA-C-N 115.688 -0.687 . . . . 73.349999999999994 111.486 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.64 100.31 13.18 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.655 -1.239 . . . . 73.540000000000006 107.655 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.42 ' HD3' ' HA ' ' A' ' 532' ' ' ARG . 39.2 mmt180 -111.86 96.84 6.29 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.627 0.727 . . . . 55.299999999999997 111.882 -176.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 101.96 -122.84 7.69 Favored Glycine 0 N--CA 1.428 -1.859 0 CA-C-N 114.576 -1.193 . . . . 72.129999999999995 110.417 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -133.13 127.98 35.09 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.13 0.49 . . . . 52.43 110.295 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 64.5 t -130.39 136.54 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 108.837 -0.801 . . . . 72.010000000000005 108.837 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.521 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 40.3 mm -106.69 138.46 32.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 109.088 -0.708 . . . . 72.450000000000003 109.088 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.1 t -122.91 110.08 31.66 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 109.598 -0.519 . . . . 65.219999999999999 109.598 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.28 155.19 51.56 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.362 2.041 . . . . 71.409999999999997 111.903 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.456 ' HB3' HG22 ' A' ' 591' ' ' ILE . 31.5 p90 -150.84 156.15 40.66 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 110.153 -0.314 . . . . 55.340000000000003 110.153 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.59 156.21 40.93 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 123.714 0.634 . . . . 73.030000000000001 111.922 175.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 18.9 p -79.35 153.59 29.68 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 109.373 -0.603 . . . . 71.219999999999999 109.373 175.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 81.8 mt -117.54 113.91 43.95 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 107.313 -1.365 . . . . 74.420000000000002 107.313 176.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -84.2 147.58 27.21 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.305 -0.861 . . . . 75.400000000000006 108.732 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 178.31 -91.82 0.08 OUTLIER Glycine 0 C--N 1.307 -1.046 0 C-N-CA 120.601 -0.809 . . . . 73.409999999999997 111.526 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -2.6 30.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.679 0.752 . . . . 74.040000000000006 112.045 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 587' ' ' PHE . . . -144.43 141.52 29.68 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 104.536 -2.394 . . . . 31.010000000000002 104.536 171.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.498 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 71.9 mtt180 -104.05 145.69 29.81 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 121.912 0.863 . . . . 50.43 112.635 -173.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.73 -153.23 27.83 Favored Glycine 0 N--CA 1.421 -2.303 0 N-CA-C 109.371 -1.492 . . . . 63.25 109.371 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 549' ' ' GLY . . . . . 0.409 ' H ' ' CG ' ' A' ' 555' ' ' ASP . . . 78.0 8.75 87.3 Favored Glycine 0 C--N 1.292 -1.891 0 N-CA-C 111.429 -0.668 . . . . 65.239999999999995 111.429 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 79.05 29.6 50.36 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 110.647 -0.981 . . . . 73.099999999999994 110.647 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.498 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 32.1 tt0 -96.86 -60.99 1.48 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.712 -0.477 . . . . 64.109999999999999 109.712 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -103.3 -43.71 5.36 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 108.609 -0.886 . . . . 72.420000000000002 108.609 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -135.11 158.1 45.23 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.377 -0.829 . . . . 65.439999999999998 109.013 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.471 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 13.9 tt0 -84.19 138.3 33.06 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.604 -1.258 . . . . 71.239999999999995 107.604 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 555' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 549' ' ' GLY . 7.5 m-20 -71.81 121.19 18.53 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 109.682 -0.488 . . . . 61.520000000000003 109.682 -177.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.489 HG21 HG22 ' A' ' 573' ' ' VAL . 13.5 t -130.13 146.11 51.75 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-O 121.468 0.651 . . . . 73.099999999999994 109.411 176.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 5.0 p -167.52 155.27 8.94 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.973 -1.492 . . . . 73.319999999999993 106.973 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 165.01 -153.44 23.63 Favored Glycine 0 N--CA 1.41 -3.086 0 C-N-CA 119.789 -1.196 . . . . 72.340000000000003 110.484 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.521 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 46.7 mt-10 -139.55 133.09 30.31 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.117 0.484 . . . . 72.439999999999998 110.466 -175.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' ' 569' ' ' LYS . 96.5 mt -97.36 137.91 35.62 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.827 -0.624 . . . . 71.219999999999999 109.468 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.485 ' HA ' HD13 ' A' ' 536' ' ' ILE . 33.3 tt0 -99.18 115.47 29.16 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 121.203 0.525 . . . . 45.109999999999999 110.706 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -111.63 145.05 39.89 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.604 -0.887 . . . . 74.340000000000003 108.604 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.495 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 46.7 mt-30 -147.25 -176.3 5.17 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.582 -0.896 . . . . 73.230000000000004 108.582 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -68.4 -31.69 71.21 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.452 -0.944 . . . . 55.049999999999997 108.452 172.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -84.49 -38.39 20.15 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.572 -1.195 . . . . 61.43 111.671 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.495 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 36.5 mm-40 -75.67 129.33 36.96 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 116.674 -0.239 . . . . 74.030000000000001 111.064 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.584 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.8 pt -90.02 -72.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.897 -0.592 . . . . 55.399999999999999 111.804 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' ' 524' ' ' LYS . 12.5 p -130.96 149.23 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 CA-C-O 121.204 0.526 . . . . 54.329999999999998 110.347 -177.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.537 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -120.29 156.43 31.26 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 109.387 -0.597 . . . . 74.530000000000001 109.387 175.549 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.442 ' CG2' ' HG2' ' A' ' 524' ' ' LYS . 3.3 p -119.81 147.28 44.84 Favored 'General case' 0 C--N 1.283 -2.285 0 O-C-N 124.161 0.913 . . . . 43.329999999999998 112.721 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.2 mp -94.41 122.6 46.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 106.353 -1.721 . . . . 74.049999999999997 106.353 172.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 572' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 521' ' ' MET . 18.7 m -102.94 116.81 33.27 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 123.813 0.696 . . . . 62.140000000000001 109.127 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.489 HG22 HG21 ' A' ' 556' ' ' THR . 86.2 t -119.47 128.46 75.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 109.144 -0.688 . . . . 73.340000000000003 109.144 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 23.9 tptm -83.97 124.1 30.68 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.752 -0.832 . . . . 75.540000000000006 108.752 176.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 575' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 516' ' ' GLU . 47.9 t -94.26 127.36 46.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 108.61 -0.885 . . . . 72.230000000000004 108.61 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 45.5 mm -81.61 149.77 4.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.658 -0.867 . . . . 71.409999999999997 108.658 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -73.77 89.75 1.82 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.384 -0.969 . . . . 74.430000000000007 108.384 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -75.35 134.88 40.89 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.447 0.642 . . . . 72.230000000000004 112.448 -175.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -106.82 -19.57 13.6 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.206 -0.907 . . . . 73.430000000000007 109.246 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 582' ' ' GLU . 2.0 mp0 -96.19 44.08 1.07 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.296 -0.865 . . . . 72.510000000000005 109.495 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -75.06 34.17 0.1 Allowed 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 124.24 1.016 . . . . 64.519999999999996 112.111 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 580' ' ' GLU . 32.8 mt-10 -61.53 -41.83 97.92 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.587 1.555 . . . . 73.230000000000004 108.709 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.479 ' HD3' ' N ' ' A' ' 584' ' ' ASN . 8.4 tmtt? -118.62 141.34 48.69 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 105.918 -1.882 . . . . 72.299999999999997 105.918 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 584' ' ' ASN . . . . . 0.479 ' N ' ' HD3' ' A' ' 583' ' ' LYS . 3.8 t-20 -60.31 120.02 9.05 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.367 -0.975 . . . . 74.219999999999999 108.367 174.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -85.75 136.84 33.18 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.152 0.501 . . . . 73.5 111.098 -171.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.0 t -153.32 135.73 15.04 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 109.48 -0.563 . . . . 70.310000000000002 109.48 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.407 ' HB3' ' HB3' ' A' ' 546' ' ' ALA . 40.9 p90 -129.37 178.1 6.69 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.786 -1.19 . . . . 72.120000000000005 107.786 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.55 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 67.4 m-85 -123.43 154.59 38.84 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.806 -0.813 . . . . 75.319999999999993 108.806 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.81 131.3 53.56 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 106.191 -1.781 . . . . 53.32 106.191 178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.508 ' HB2' HD11 ' A' ' 542' ' ' ILE . 42.6 tt0 -126.97 139.06 53.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.589 -0.523 . . . . 72.510000000000005 109.589 177.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.456 HG22 ' HB3' ' A' ' 539' ' ' TYR . 20.3 pt -106.0 141.57 21.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.322 -0.992 . . . . 75.010000000000005 108.322 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.12 179.54 49.67 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 111.236 -0.746 . . . . 72.140000000000001 111.236 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.78 134.26 86.08 Favored Pre-proline 0 N--CA 1.435 -1.225 0 C-N-CA 120.912 -0.315 . . . . 73.519999999999996 110.632 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.415 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 21.7 Cg_endo -61.36 146.94 96.72 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.255 2.636 . . . . 74.230000000000004 112.064 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -124.47 125.04 43.6 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.024 -0.534 . . . . 71.219999999999999 109.562 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -72.08 129.17 37.86 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.664 -1.236 . . . . 75.129999999999995 107.664 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.51 ' CG2' HG12 ' A' ' 536' ' ' ILE . 48.6 t -82.07 106.07 12.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.766 -0.827 . . . . 65.049999999999997 108.766 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.468 ' HA ' ' OE1' ' A' ' 598' ' ' GLU . 4.4 mm-40 -80.04 118.32 21.66 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 114.939 -1.028 . . . . 73.409999999999997 113.725 -176.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 92.4 mmm -97.23 -2.21 43.26 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.29 -1.323 . . . . 73.549999999999997 107.452 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 52.3 m -131.78 132.87 44.15 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.277 -1.379 . . . . 55.130000000000003 107.277 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -84.06 154.02 23.46 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 110.343 -0.243 . . . . 74.230000000000004 110.343 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 602' ' ' LYS . . . . . 0.414 ' HE2' ' HG3' ' A' ' 598' ' ' GLU . 3.7 mptp? -81.6 147.0 29.81 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.87 -0.789 . . . . 72.109999999999999 108.87 176.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -72.5 107.56 5.1 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.849 -0.797 . . . . 65.299999999999997 108.849 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 143.95 -33.17 1.75 Allowed Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 108.565 -1.814 . . . . 63.350000000000001 108.565 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 102.39 -156.96 18.41 Favored Glycine 0 N--CA 1.429 -1.807 0 N-CA-C 111.487 -0.645 . . . . 50.310000000000002 111.487 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 59.24 17.35 5.65 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.717 1.207 . . . . 71.230000000000004 113.474 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 32.8 m -71.57 -8.01 51.3 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-O 121.481 0.658 . . . . 72.340000000000003 112.314 -174.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 24.8 pt -72.26 -5.73 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.628 -0.67 . . . . 71.540000000000006 111.24 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 21.3 m -145.94 158.54 43.86 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.69 -1.596 . . . . 75.299999999999997 106.69 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -82.06 -64.74 1.12 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 118.837 -1.145 . . . . 74.530000000000001 108.91 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -143.21 157.11 44.79 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.54 -0.541 . . . . 74.420000000000002 109.54 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -57.25 -65.89 0.55 Allowed 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.316 0.858 . . . . 72.129999999999995 113.316 -175.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 34.2 t70 176.69 117.56 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.474 -0.936 . . . . 75.140000000000001 108.474 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -158.23 170.37 22.42 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.426 -0.583 . . . . 75.030000000000001 109.426 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.9 163.42 33.01 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.874 -1.158 . . . . 70.310000000000002 107.874 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 69.8 165.66 0.13 Allowed Pre-proline 0 N--CA 1.485 1.308 0 O-C-N 124.401 1.063 . . . . 71.209999999999994 111.546 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.98 144.21 57.83 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.127 1.885 . . . . 75.430000000000007 110.726 172.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 94.0 mt -83.88 179.47 7.55 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.754 0.788 . . . . 61.140000000000001 113.009 -174.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 37.6 m -101.8 152.93 20.29 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 114.473 -1.239 . . . . 74.340000000000003 108.134 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.41 ' HA ' ' OE2' ' A' ' 625' ' ' GLU . 14.2 t -65.64 142.58 58.01 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.221 0.534 . . . . 71.030000000000001 111.266 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -144.14 155.43 43.93 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.125 -1.065 . . . . 62.100000000000001 108.125 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -87.08 73.43 9.84 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.625 0.726 . . . . 71.340000000000003 109.315 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -167.49 -173.02 2.09 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.246 -2.131 . . . . 62.240000000000002 105.246 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -73.38 93.08 1.9 Allowed 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 108.922 -0.77 . . . . 74.409999999999997 108.922 173.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.41 ' OE2' ' HA ' ' A' ' 620' ' ' SER . 40.3 mt-10 -60.81 155.59 19.11 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 108.521 -0.918 . . . . 74.099999999999994 108.521 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.528 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 65.1 ttt180 -62.86 -36.86 84.65 Favored 'General case' 0 C--O 1.2 -1.534 0 C-N-CA 119.968 -0.693 . . . . 73.040000000000006 111.072 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -62.27 -27.63 69.15 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 121.128 0.49 . . . . 74.400000000000006 110.607 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.529 ' O ' ' HG2' ' A' ' 631' ' ' MET . 69.7 mt -79.49 -44.85 23.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.208 -1.034 . . . . 71.140000000000001 108.208 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 629' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 633' ' ' ARG . . . -64.01 -37.63 88.14 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.933 -1.03 . . . . 72.010000000000005 111.887 -177.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 65.0 mm-40 -58.42 -18.43 28.28 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.902 1.075 . . . . 75.239999999999995 113.902 -178.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.529 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 24.6 ptt? -91.96 -10.5 39.15 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.711 -0.795 . . . . 72.319999999999993 110.331 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -110.4 -38.5 1.62 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.487 -0.863 . . . . 75.519999999999996 111.902 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 633' ' ' ARG . . . . . 0.513 ' HD2' ' OE2' ' A' ' 630' ' ' GLU . 4.9 ptp180 -79.29 158.24 74.46 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 110.158 -0.312 . . . . 72.019999999999996 110.158 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.491 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 53.3 Cg_endo -68.13 133.28 28.31 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 122.129 1.886 . . . . 65.319999999999993 110.922 174.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 635' ' ' ILE . . . . . 0.501 HD13 ' H ' ' A' ' 635' ' ' ILE . 0.1 OUTLIER -124.95 175.93 6.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.535 -0.913 . . . . 42.420000000000002 108.535 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.59 -176.3 3.03 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.267 -0.573 . . . . 73.519999999999996 112.086 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -80.62 -153.39 9.21 Favored Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 115.893 -0.594 . . . . 42.020000000000003 113.351 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -71.87 -57.13 4.59 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 123.392 0.677 . . . . 71.430000000000007 110.224 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -135.06 139.13 44.53 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 109.556 -0.535 . . . . 72.549999999999997 109.556 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 29.7 p -124.47 99.83 6.38 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.206 0.526 . . . . 73.310000000000002 111.249 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -165.8 150.73 8.57 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.082 -1.081 . . . . 74.420000000000002 108.082 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.479 HD21 HG21 ' A' ' 523' ' ' VAL . 34.8 tp -130.95 131.34 44.37 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.021 -1.103 . . . . 44.32 108.021 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -97.04 104.52 16.54 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.915 -1.513 . . . . 74.519999999999996 106.915 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 40.8 t -99.47 113.53 34.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 109.982 -0.377 . . . . 74.540000000000006 109.982 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 59.6 mt -99.11 126.97 52.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 109.027 -0.731 . . . . 52.039999999999999 109.027 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 57.2 mt -104.06 110.39 30.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.264 -1.013 . . . . 75.439999999999998 108.264 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -119.17 150.64 39.7 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 116.443 -0.344 . . . . 72.010000000000005 110.241 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -81.85 118.09 22.63 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.95 0.881 . . . . 72.049999999999997 109.34 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 17.8 m -122.15 79.42 1.59 Allowed 'General case' 0 N--CA 1.406 -2.66 0 CA-C-N 115.259 -0.882 . . . . 45.340000000000003 110.756 -173.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -94.03 -57.26 2.58 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.164 -1.421 . . . . 64.409999999999997 107.164 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -75.68 -46.22 32.54 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.566 -1.272 . . . . 72.129999999999995 107.566 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 51.9 t80 58.16 80.36 0.18 Allowed 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 114.119 -1.4 . . . . 51.520000000000003 111.035 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -95.71 95.76 8.54 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.006 -0.739 . . . . 74.450000000000003 109.006 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 5.9 t -97.09 85.55 3.75 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 106.737 -1.579 . . . . 74.540000000000006 106.737 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 91.2 m -153.18 137.26 16.39 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.32 -0.855 . . . . 70.430000000000007 109.015 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 48.4 t -90.3 112.45 24.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.749 -0.834 . . . . 72.200000000000003 108.749 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 120.891 0.377 . . . . 72.319999999999993 111.251 -179.541 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 80.6 t60 . . . . . 0 N--CA 1.432 -1.344 0 N-CA-C 107.533 -1.284 . . . . 55.450000000000003 107.533 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.54 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -93.62 -90.84 0.19 Allowed 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 116.44 -0.346 . . . . 75.349999999999994 111.656 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 160.94 -153.24 24.05 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 111.241 -0.743 . . . . 74.340000000000003 111.241 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.86 130.94 67.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 123.148 0.579 . . . . 72.340000000000003 112.049 -167.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -108.51 132.57 53.69 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.315 -0.624 . . . . 63.509999999999998 109.315 168.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.7 t -168.69 173.72 7.1 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.405 -0.591 . . . . 63.409999999999997 109.405 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -77.25 147.26 36.43 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 120.939 0.399 . . . . 73.200000000000003 110.751 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -67.98 -35.65 78.72 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.487 -0.779 . . . . 61.350000000000001 109.906 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -127.76 144.4 51.12 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.115 -1.069 . . . . 74.010000000000005 108.115 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.03 -31.34 6.24 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.146 1.897 . . . . 73.540000000000006 111.986 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.97 138.04 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 106.511 -1.663 . . . . 72.129999999999995 106.511 -177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.4 t -132.19 140.82 48.86 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 108.06 -1.089 . . . . 55.219999999999999 108.06 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -120.28 124.19 45.03 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 109.253 -0.647 . . . . 74.209999999999994 109.253 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.8 m -115.7 167.34 8.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.001 -1.0 . . . . 75.239999999999995 109.398 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.631 ' O ' HG22 ' A' ' 518' ' ' ILE . 23.2 t -97.04 153.89 17.65 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 120.96 0.41 . . . . 64.409999999999997 110.229 -176.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.522 ' CB ' ' HA ' ' A' ' 648' ' ' GLU . 4.3 tm-20 -65.51 -42.2 92.35 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.143 -1.429 . . . . 74.129999999999995 107.143 169.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 517' ' ' SER . . . . . 0.492 ' OG ' ' HB3' ' A' ' 649' ' ' SER . 14.4 m -90.66 23.98 2.85 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.995 -1.002 . . . . 64.420000000000002 112.432 -173.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 515' ' ' SER . 8.8 tt -90.94 -22.08 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 121.575 -0.703 . . . . 75.430000000000007 109.825 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 83.97 -75.6 2.35 Favored Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.677 -0.773 . . . . 71.310000000000002 111.234 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.0 mm -129.83 130.2 66.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 106.983 -1.488 . . . . 62.509999999999998 106.983 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.616 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -106.39 147.34 29.38 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 109.131 -0.692 . . . . 74.5 109.131 178.612 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.3 mt-10 -127.91 114.84 17.69 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 123.852 0.72 . . . . 54.439999999999998 110.945 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.55 HG21 HD21 ' A' ' 642' ' ' LEU . 90.7 t -102.33 127.96 55.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.778 -0.823 . . . . 73.099999999999994 108.778 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.409 ' HB3' HG21 ' A' ' 568' ' ' VAL . 25.7 mtmm -87.6 138.91 31.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 121.442 0.639 . . . . 53.240000000000002 110.667 -177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 61.0 t -108.2 129.93 61.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.443 -0.799 . . . . 63.299999999999997 108.847 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.5 130.01 41.77 Favored 'General case' 0 CA--C 1.501 -0.915 0 O-C-N 123.862 0.726 . . . . 74.109999999999999 109.87 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -82.65 155.1 24.56 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 115.151 -0.931 . . . . 74.239999999999995 110.024 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.2 t -56.05 145.48 25.51 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 124.763 1.225 . . . . 64.200000000000003 111.538 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.9 t -60.53 -31.77 70.84 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 124.375 1.07 . . . . 70.420000000000002 109.042 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -122.26 99.51 0.67 Allowed Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 109.71 -1.356 . . . . 53.439999999999998 109.71 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.44 101.6 12.76 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.948 -1.13 . . . . 63.5 107.948 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -107.75 100.77 10.13 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.261 -0.881 . . . . 52.030000000000001 110.389 -172.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 75.53 -114.68 4.33 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.395 -0.907 . . . . 62.439999999999998 112.36 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -133.99 129.18 35.8 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.143 0.577 . . . . 72.109999999999999 109.459 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 93.1 t -130.24 135.64 60.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 C-N-CA 123.56 0.744 . . . . 51.340000000000003 109.126 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.502 HG12 ' CG2' ' A' ' 597' ' ' VAL . 38.0 mm -108.74 131.25 59.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.88 -0.415 . . . . 63.399999999999999 109.88 176.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.43 HG22 ' HB3' ' A' ' 594' ' ' PRO . 26.6 t -119.23 105.9 43.79 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 109.21 -0.663 . . . . 75.109999999999999 109.21 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.86 153.19 58.57 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.317 2.011 . . . . 72.439999999999998 112.048 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.487 ' HB3' HG22 ' A' ' 591' ' ' ILE . 52.1 p90 -151.02 159.64 44.42 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.642 0.258 . . . . 72.140000000000001 110.786 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.03 157.05 33.94 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.463 -0.79 . . . . 75.340000000000003 112.084 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.6 p -84.86 139.68 31.71 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.866 -0.607 . . . . 75.120000000000005 109.828 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.528 HD11 ' HB2' ' A' ' 590' ' ' GLU . 69.1 mt -107.63 134.37 49.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.132 -0.692 . . . . 71.439999999999998 109.132 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -85.62 142.97 28.71 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.923 -0.58 . . . . 62.310000000000002 110.337 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 151.77 141.58 3.35 Favored Glycine 0 CA--C 1.471 -2.678 0 N-CA-C 107.924 -2.07 . . . . 61.310000000000002 107.924 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . 0.357 1.0 OUTLIER 61.11 -47.17 0.12 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 115.377 1.621 . . . . 64.409999999999997 115.377 -174.066 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.451 ' HA ' ' HD2' ' A' ' 585' ' ' LYS . . . -107.87 150.38 27.12 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.193 -1.04 . . . . 75.319999999999993 108.193 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -92.37 128.74 38.33 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.745 0.783 . . . . 75.209999999999994 111.347 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.78 -153.5 21.68 Favored Glycine 0 C--N 1.3 -1.421 0 CA-C-N 115.056 -0.975 . . . . 52.210000000000001 112.96 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 549' ' ' GLY . . . . . 0.467 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 57.12 30.84 61.24 Favored Glycine 0 C--N 1.317 -0.48 0 N-CA-C 113.76 0.264 . . . . 65.230000000000004 113.76 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 73.31 39.68 50.98 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.735 -0.745 . . . . 70.150000000000006 111.991 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -112.88 -51.77 2.81 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 122.363 -0.492 . . . . 74.340000000000003 110.869 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -111.14 -35.31 5.93 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.385 -1.339 . . . . 74.519999999999996 107.385 169.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -139.54 148.94 43.29 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.781 -1.192 . . . . 74.420000000000002 107.781 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.77 136.0 37.26 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.337 -1.357 . . . . 72.230000000000004 107.337 175.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 555' ' ' ASP . . . . . 0.467 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 17.5 t70 -90.69 119.9 31.31 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.592 -0.521 . . . . 63.329999999999998 109.592 -174.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.403 HG21 HG22 ' A' ' 573' ' ' VAL . 10.3 t -128.02 155.03 44.97 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.263 0.554 . . . . 64.120000000000005 111.04 -174.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 26.4 p -149.79 158.37 44.11 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.955 -1.498 . . . . 73.109999999999999 106.955 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 168.78 -167.7 40.57 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 109.893 -1.283 . . . . 74.400000000000006 109.893 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.478 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 43.6 mt-10 -132.64 138.42 47.34 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.804 -0.443 . . . . 70.040000000000006 109.804 -178.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.595 HD22 ' HB3' ' A' ' 569' ' ' LYS . 76.6 mt -95.7 133.93 39.22 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.726 -0.472 . . . . 44.340000000000003 109.726 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.495 ' HA ' HD13 ' A' ' 536' ' ' ILE . 24.8 tt0 -101.25 106.43 17.64 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.847 -0.615 . . . . 72.219999999999999 110.279 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -105.04 148.22 27.01 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.007 -0.738 . . . . 73.340000000000003 109.007 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.484 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 44.5 mt-30 -145.02 -178.04 5.84 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.944 -1.132 . . . . 72.109999999999999 107.944 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -68.84 -31.89 71.19 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.117 -1.068 . . . . 72.099999999999994 108.117 173.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.42 -52.33 7.79 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.109 -0.95 . . . . 71.409999999999997 111.809 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.484 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 14.7 mm-40 -55.25 125.62 21.45 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 123.449 0.7 . . . . 70.239999999999995 111.743 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.613 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.7 pt -84.63 -63.03 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.266 -0.879 . . . . 73.209999999999994 112.646 -175.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.613 ' H ' HG13 ' A' ' 567' ' ' ILE . 10.0 p -143.48 150.57 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 109.213 -0.662 . . . . 41.439999999999998 109.213 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.595 ' HB3' HD22 ' A' ' 560' ' ' LEU . 6.1 mmpt? -118.05 165.57 13.58 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.728 -0.471 . . . . 71.010000000000005 109.728 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.6 p -135.14 147.43 49.47 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 123.962 0.789 . . . . 45.329999999999998 112.363 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.463 HG22 HG23 ' A' ' 573' ' ' VAL . 3.0 mp -100.47 118.1 46.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 106.941 -1.503 . . . . 62.549999999999997 106.941 172.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 572' ' ' SER . . . . . 0.616 ' HA ' ' O ' ' A' ' 521' ' ' MET . 3.3 p -95.95 117.0 29.78 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 124.099 0.874 . . . . 55.409999999999997 110.399 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.463 HG23 HG22 ' A' ' 571' ' ' ILE . 89.0 t -124.79 132.17 71.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 O-C-N 122.239 -0.288 . . . . 62.439999999999998 110.792 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -79.62 123.0 27.22 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 123.856 0.723 . . . . 73.010000000000005 109.703 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 49.0 t -90.2 126.96 43.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.555 -0.905 . . . . 65.540000000000006 108.555 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 26.2 mm -96.66 153.11 3.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.9 -0.407 . . . . 71.409999999999997 109.9 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -75.75 123.95 26.46 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.122 -0.49 . . . . 52.43 111.181 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -73.77 141.82 46.25 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 105.598 -2.001 . . . . 61.350000000000001 105.598 171.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -50.96 -48.12 61.12 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 123.771 0.669 . . . . 73.439999999999998 111.028 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.452 ' HB2' ' H ' ' A' ' 581' ' ' TYR . 27.1 mm-40 -128.83 -76.35 0.56 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.533 -1.654 . . . . 71.219999999999999 106.533 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 581' ' ' TYR . . . . . 0.452 ' H ' ' HB2' ' A' ' 580' ' ' GLU . 26.0 t80 166.38 80.8 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 128.325 2.65 . . . . 73.200000000000003 104.409 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -64.19 -47.41 79.88 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.533 -1.212 . . . . 74.430000000000007 111.718 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.406 ' HA ' ' HE3' ' A' ' 583' ' ' LYS . 0.9 OUTLIER -150.71 160.91 43.52 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 105.207 -2.145 . . . . 63.439999999999998 105.207 -172.428 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -62.55 105.58 0.65 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 104.9 -2.259 . . . . 63.030000000000001 104.9 168.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.451 ' HD2' ' HA ' ' A' ' 546' ' ' ALA . 34.5 mmtp -85.25 121.1 27.5 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-O 121.448 0.642 . . . . 75.030000000000001 110.087 -171.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.7 t -150.0 146.89 27.26 Favored 'General case' 0 N--CA 1.402 -2.872 0 CA-C-N 114.696 -1.138 . . . . 44.140000000000001 107.93 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -138.03 178.77 6.87 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.788 -1.19 . . . . 74.030000000000001 107.788 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.455 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 85.5 m-85 -121.03 152.03 39.09 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.188 -0.605 . . . . 71.030000000000001 109.954 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.45 131.02 54.57 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.032 -1.84 . . . . 71.209999999999994 106.032 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.528 ' HB2' HD11 ' A' ' 542' ' ' ILE . 36.8 tt0 -127.69 136.31 51.39 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.065 0.459 . . . . 75.310000000000002 110.316 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.487 HG22 ' HB3' ' A' ' 539' ' ' TYR . 23.8 pt -105.56 142.45 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.12 0 N-CA-C 107.547 -1.279 . . . . 74.340000000000003 107.547 175.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -88.17 -176.0 47.68 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.665 -0.974 . . . . 60.109999999999999 110.665 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.47 130.38 89.19 Favored Pre-proline 0 C--N 1.301 -1.541 0 CA-C-O 120.809 0.338 . . . . 73.310000000000002 110.931 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.43 ' HB3' HG22 ' A' ' 537' ' ' VAL . 34.6 Cg_endo -66.97 130.88 23.98 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.103 2.535 . . . . 64.310000000000002 111.335 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -111.88 134.34 53.5 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.936 -0.394 . . . . 74.129999999999995 109.936 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.424 HD23 ' HD3' ' A' ' 634' ' ' PRO . 1.7 tm? -72.56 132.1 43.35 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.485 -1.302 . . . . 54.130000000000003 107.485 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.502 ' CG2' HG12 ' A' ' 536' ' ' ILE . 47.5 t -82.94 91.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 109.146 -0.687 . . . . 40.399999999999999 109.146 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -82.29 133.27 35.23 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.917 -1.038 . . . . 63.119999999999997 108.393 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 97.0 mmm -71.07 -28.22 64.2 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.297 0.57 . . . . 55.520000000000003 109.667 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 47.7 t 70.0 20.55 6.5 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.627 -1.17 . . . . 60.539999999999999 111.402 177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -71.18 -20.75 62.25 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 107.928 -1.138 . . . . 73.25 107.928 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -119.71 87.6 2.77 Favored 'General case' 0 N--CA 1.403 -2.786 0 N-CA-C 106.4 -1.704 . . . . 74.209999999999994 106.4 166.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -85.36 121.46 28.12 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.557 -0.905 . . . . 72.519999999999996 108.557 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -79.3 -51.1 5.44 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 109.02 -1.632 . . . . 63.420000000000002 109.02 176.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 143.37 -178.49 21.52 Favored Glycine 0 N--CA 1.414 -2.823 0 N-CA-C 109.628 -1.389 . . . . 74.150000000000006 109.628 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -115.89 157.6 24.24 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.481 -0.933 . . . . 74.310000000000002 108.481 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 24.2 m -91.93 147.27 23.09 Favored 'General case' 0 N--CA 1.408 -2.533 0 N-CA-C 106.638 -1.616 . . . . 64.239999999999995 106.638 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 23.5 pt -70.39 100.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.822 -1.177 . . . . 54.420000000000002 107.822 172.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . 0.258 29.0 p 64.84 101.67 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.597 1.559 . . . . 74.140000000000001 113.566 -174.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -77.44 -167.1 0.85 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.99 -0.745 . . . . 74.319999999999993 108.99 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -93.49 123.17 36.62 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.223 -1.029 . . . . 70.519999999999996 108.223 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -142.42 24.07 1.95 Allowed 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 112.133 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -99.38 -44.46 6.19 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.134 0.492 . . . . 72.340000000000003 111.796 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -84.29 145.42 28.29 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.797 -0.638 . . . . 73.549999999999997 111.559 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -133.79 30.48 3.73 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.832 0.825 . . . . 70.540000000000006 109.909 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -124.4 179.21 1.14 Allowed Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 108.443 -0.947 . . . . 75.140000000000001 108.443 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.25 118.27 5.38 Favored 'Trans proline' 0 C--N 1.349 0.588 0 N-CA-C 108.325 -1.452 . . . . 75.120000000000005 108.325 169.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 60.3 tp -98.27 122.74 41.8 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 122.278 -0.264 . . . . 74.340000000000003 111.118 -174.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 20.1 p -89.49 102.02 14.7 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.725 -0.472 . . . . 51.140000000000001 109.725 176.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 71.1 m -151.63 83.78 1.29 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.07 0.462 . . . . 61.350000000000001 111.754 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -92.92 69.86 4.6 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.895 0.855 . . . . 71.0 109.197 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -98.71 149.7 22.57 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.057 -1.429 . . . . 73.230000000000004 107.675 -178.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.43 73.02 10.21 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 122.094 0.95 . . . . 71.400000000000006 109.998 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 624' ' ' GLU . . . . . 0.522 ' OE1' ' HG3' ' A' ' 626' ' ' ARG . 0.3 OUTLIER -142.14 158.24 43.97 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 105.683 -1.969 . . . . 74.230000000000004 105.683 -177.571 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.22 -20.41 65.68 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.528 0.566 . . . . 50.520000000000003 112.528 -175.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.522 ' HG3' ' OE1' ' A' ' 624' ' ' GLU . 27.8 mtm180 -57.27 -54.48 46.36 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 110.114 -0.328 . . . . 73.319999999999993 110.114 175.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -41.84 81.16 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.844 -0.799 . . . . 75.340000000000003 108.844 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 64.5 mt -56.52 -42.85 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.971 -0.559 . . . . 75.549999999999997 111.098 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -75.08 -44.89 44.92 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.199 0.524 . . . . 73.099999999999994 110.66 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -64.22 -20.19 65.86 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.588 -0.733 . . . . 64.310000000000002 112.815 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -89.7 -17.38 28.43 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.656 -0.418 . . . . 72.010000000000005 111.226 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -100.19 -26.96 8.0 Favored Glycine 0 CA--C 1.5 -0.889 0 C-N-CA 120.139 -1.029 . . . . 74.109999999999999 111.712 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -69.35 161.22 75.11 Favored Pre-proline 0 C--N 1.307 -1.277 0 C-N-CA 123.143 0.577 . . . . 75.340000000000003 111.282 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.54 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 36.2 Cg_endo -67.29 141.03 55.2 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.56 2.174 . . . . 54.25 110.111 170.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.64 174.6 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 116.227 -0.442 . . . . 53.049999999999997 110.722 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.65 172.58 6.81 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 120.184 -0.607 . . . . 72.540000000000006 112.507 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -82.68 -164.86 35.95 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 115.166 0.826 . . . . 64.5 115.166 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -67.91 -50.19 57.63 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.965 -1.117 . . . . 75.120000000000005 110.514 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -129.06 120.64 26.31 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.946 -0.761 . . . . 73.439999999999998 108.946 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 14.0 p -118.68 80.76 1.59 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 122.567 1.175 . . . . 52.539999999999999 110.293 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -154.44 141.79 19.6 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 114.057 -1.428 . . . . 61.5 108.889 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.55 HD21 HG21 ' A' ' 523' ' ' VAL . 33.4 tp -129.93 122.96 29.59 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 108.787 -0.82 . . . . 72.140000000000001 108.787 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -92.54 112.32 24.23 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.132 -1.433 . . . . 73.310000000000002 107.132 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.68 110.33 28.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.514 -0.55 . . . . 54.109999999999999 109.514 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 50.5 mt -96.47 135.37 30.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 109.332 -0.618 . . . . 72.230000000000004 109.332 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 84.8 mt -103.05 110.01 28.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 109.034 -0.728 . . . . 73.25 109.034 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -107.28 132.86 52.63 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.202 -1.036 . . . . 74.519999999999996 108.202 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.752 ' O ' ' HA ' ' A' ' 653' ' ' LYS . 0.3 OUTLIER -68.5 176.7 2.75 Favored 'General case' 0 C--O 1.201 -1.492 0 C-N-CA 123.179 0.592 . . . . 74.019999999999996 112.479 -177.597 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 649' ' ' SER . . . . . 0.492 ' HB3' ' OG ' ' A' ' 517' ' ' SER . 8.5 t -149.4 32.01 0.73 Allowed 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.715 -0.794 . . . . 72.129999999999995 109.158 174.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -84.86 -61.27 1.82 Allowed 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.064 -0.717 . . . . 74.129999999999995 109.064 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -80.33 -47.75 14.03 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.706 -0.679 . . . . 73.299999999999997 111.218 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -146.56 -83.18 0.13 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.01 -1.107 . . . . 72.430000000000007 108.01 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 653' ' ' LYS . . . . . 0.752 ' HA ' ' O ' ' A' ' 648' ' ' GLU . 4.2 ttmp? 174.22 -57.38 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.198 0.999 . . . . 71.420000000000002 109.699 176.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 11.7 m -84.85 26.07 0.87 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.461 -0.791 . . . . 75.230000000000004 110.543 -177.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 1.5 m -77.32 88.75 3.73 Favored 'General case' 0 N--CA 1.424 -1.735 0 C-N-CA 123.63 0.772 . . . . 75.409999999999997 109.099 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 60.8 t -113.2 121.77 66.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 109.211 -0.663 . . . . 72.430000000000007 109.211 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 C--N 1.301 -1.533 0 CA-C-N 115.885 -0.598 . . . . 24.43 109.795 -179.755 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 61.0 m80 . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 109.318 -0.623 . . . . 73.530000000000001 109.318 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . -142.37 -139.46 0.12 Allowed 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 108.921 -0.77 . . . . 75.120000000000005 108.921 -178.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -172.26 -144.36 4.5 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 109.595 -1.402 . . . . 12.539999999999999 109.595 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.6 mp -103.53 114.29 42.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 116.79 0.295 . . . . 73.439999999999998 111.522 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -100.16 126.4 46.42 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.401 -0.963 . . . . 64.140000000000001 108.401 169.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.0 t -169.88 174.41 5.64 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.902 -0.777 . . . . 75.540000000000006 108.902 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -80.55 147.83 30.63 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 110.325 -0.25 . . . . 73.430000000000007 110.325 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -63.5 -40.78 97.96 Favored 'General case' 0 CA--C 1.492 -1.282 0 CA-C-O 122.238 1.018 . . . . 75.5 109.083 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -123.28 135.71 26.29 Favored Pre-proline 0 N--CA 1.401 -2.904 0 CA-C-N 113.948 -1.478 . . . . 73.540000000000006 107.218 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.34 -24.84 11.91 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.806 2.337 . . . . 45.549999999999997 111.519 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 61.7 t -136.25 132.99 49.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 107.142 -1.429 . . . . 75.140000000000001 107.142 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 7.1 t -128.48 133.07 48.4 Favored 'General case' 0 N--CA 1.402 -2.828 0 N-CA-C 108.569 -0.9 . . . . 44.130000000000003 108.569 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -105.8 121.87 44.92 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 109.045 -0.724 . . . . 74.019999999999996 109.045 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.6 m -113.56 174.52 2.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.418 -0.586 . . . . 64.510000000000005 109.418 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.634 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 57.9 m -92.43 165.6 12.97 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 123.254 0.621 . . . . 71.140000000000001 110.993 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.501 ' OE1' ' HA ' ' A' ' 648' ' ' GLU . 0.9 OUTLIER -78.99 -50.72 10.66 Favored 'General case' 0 CA--C 1.57 1.74 0 C-N-CA 124.789 1.236 . . . . 74.430000000000007 112.918 -175.163 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 48.9 m -105.89 27.32 8.65 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.05 0.94 . . . . 60.149999999999999 110.448 -176.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.634 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 12.1 tt -63.25 -32.92 58.19 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-N 115.447 -0.797 . . . . 74.25 112.831 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 103.79 -83.8 0.42 Allowed Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 109.927 -1.269 . . . . 74.310000000000002 109.927 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 520' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 574' ' ' LYS . 34.8 mm -133.9 136.57 53.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 105.979 -1.859 . . . . 61.520000000000003 105.979 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.524 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -112.96 141.5 46.72 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.45 -0.574 . . . . 75.439999999999998 109.45 177.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 7.3 mp0 -114.55 132.55 56.28 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 124.194 0.934 . . . . 74.519999999999996 110.08 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.524 HG23 ' SD ' ' A' ' 521' ' ' MET . 87.7 t -124.06 129.09 74.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 108.746 -0.835 . . . . 64.230000000000004 108.746 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.472 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 24.6 mtmm -86.51 139.07 31.22 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.146 0.498 . . . . 73.450000000000003 111.898 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.575 ' O ' HG23 ' A' ' 568' ' ' VAL . 39.6 t -104.18 126.26 58.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.255 -0.646 . . . . 74.439999999999998 109.255 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.18 121.46 12.59 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 123.777 0.673 . . . . 75.420000000000002 110.206 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.523 ' CZ ' ' HB3' ' A' ' 562' ' ' PHE . 10.2 tpt180 -68.93 148.37 50.29 Favored 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 115.198 -0.91 . . . . 71.109999999999999 110.91 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 11.4 p -56.97 139.1 53.12 Favored 'General case' 0 N--CA 1.408 -2.525 0 CA-C-N 114.749 -1.114 . . . . 74.120000000000005 111.916 175.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.7 m -56.19 -24.4 41.39 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 125.777 1.631 . . . . 73.109999999999999 110.746 175.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -122.99 114.25 2.37 Favored Glycine 0 N--CA 1.419 -2.446 0 N-CA-C 108.842 -1.703 . . . . 51.32 108.842 172.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -106.14 101.26 10.76 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.91 -0.774 . . . . 44.240000000000002 108.91 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -129.73 116.2 18.42 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.966 -0.561 . . . . 62.039999999999999 109.748 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 78.26 -164.64 51.3 Favored Glycine 0 C--N 1.316 -0.571 0 C-N-CA 120.901 -0.666 . . . . 61.329999999999998 112.379 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 534' ' ' ASN . . . . . 0.44 ' OD1' ' HG2' ' A' ' 563' ' ' GLN . 41.8 t30 -103.47 123.08 46.23 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.244 0.545 . . . . 73.340000000000003 109.878 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 48.1 t -126.48 136.97 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 N-CA-C 108.071 -1.085 . . . . 72.239999999999995 108.071 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.508 HG12 ' CG2' ' A' ' 597' ' ' VAL . 40.2 mm -107.98 135.29 47.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 109.205 -0.665 . . . . 71.129999999999995 109.205 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.51 109.74 36.23 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 109.232 -0.655 . . . . 70.049999999999997 109.232 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -75.9 159.24 38.26 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.124 1.883 . . . . 34.210000000000001 111.45 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -143.92 162.83 35.13 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.233 -0.655 . . . . 73.129999999999995 109.233 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -153.39 157.23 39.67 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 123.882 0.738 . . . . 73.329999999999998 109.739 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.3 p -93.41 139.25 30.9 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.626 0.727 . . . . 72.239999999999995 111.605 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 89.7 mt -109.53 122.74 64.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.573 -1.269 . . . . 71.329999999999998 107.573 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -78.81 117.73 20.2 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.677 -0.49 . . . . 53.409999999999997 109.677 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -102.85 -111.58 3.56 Favored Glycine 0 C--N 1.302 -1.355 0 N-CA-C 109.892 -1.283 . . . . 70.150000000000006 109.892 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 28.4 p -78.93 -32.63 45.66 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.508 -0.923 . . . . 64.319999999999993 108.508 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -84.46 141.48 30.76 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.753 -1.112 . . . . 72.219999999999999 109.207 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.481 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 64.6 mtt180 -101.58 146.2 28.01 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-O 121.334 0.588 . . . . 73.340000000000003 111.144 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -94.37 -161.18 34.75 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 114.993 -1.003 . . . . 65.109999999999999 112.137 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 549' ' ' GLY . . . . . 0.478 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 74.65 8.08 80.78 Favored Glycine 0 C--N 1.315 -0.621 0 N-CA-C 112.386 -0.286 . . . . 62.399999999999999 112.386 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 550' ' ' GLY . . . . . 0.412 ' C ' HG13 ' A' ' 576' ' ' ILE . . . 103.71 10.09 36.16 Favored Glycine 0 N--CA 1.419 -2.476 0 C-N-CA 120.263 -0.97 . . . . 73.099999999999994 112.865 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.481 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 28.0 tt0 -83.46 -66.29 0.91 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 118.991 -1.084 . . . . 73.219999999999999 110.355 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -101.37 -41.63 6.59 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.229 -1.026 . . . . 74.409999999999997 108.229 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -137.34 158.78 43.67 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.809 -1.182 . . . . 73.019999999999996 107.809 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.78 137.16 33.86 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 107.513 -1.292 . . . . 73.329999999999998 107.513 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 555' ' ' ASP . . . . . 0.478 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 33.0 t70 -84.46 103.84 13.95 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.787 -0.82 . . . . 72.150000000000006 108.787 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.484 ' CG2' HG22 ' A' ' 573' ' ' VAL . 11.5 t -110.72 146.01 37.03 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-O 122.234 1.016 . . . . 62.200000000000003 111.873 -172.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 21.8 p -145.56 147.5 32.16 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 105.931 -1.878 . . . . 64.140000000000001 105.931 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -170.06 -179.76 41.84 Favored Glycine 0 CA--C 1.477 -2.317 0 N-CA-C 110.199 -1.16 . . . . 63.229999999999997 110.199 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 39.2 mt-10 -129.6 114.4 16.0 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.103 0.478 . . . . 75.200000000000003 110.731 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 88.1 mt -85.5 138.29 32.32 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.311 -0.859 . . . . 62.210000000000001 109.448 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.498 ' HA ' HD13 ' A' ' 536' ' ' ILE . 34.4 tt0 -104.52 118.49 36.71 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.99 -0.55 . . . . 61.240000000000002 110.23 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 527' ' ' ARG . 97.9 m-85 -124.44 107.51 11.18 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.704 -0.48 . . . . 73.120000000000005 109.704 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.606 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 29.8 mt-30 -109.03 178.46 4.46 Favored 'General case' 0 C--O 1.197 -1.67 0 N-CA-C 108.752 -0.833 . . . . 71.420000000000002 108.752 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -52.93 -44.81 67.3 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 123.439 0.462 . . . . 51.219999999999999 110.82 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.52 -49.04 35.55 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.207 0.447 . . . . 75.319999999999993 112.207 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.606 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 14.0 mp0 -54.68 141.9 30.41 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.638 0.775 . . . . 75.219999999999999 111.804 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.549 HG13 ' H ' ' A' ' 568' ' ' VAL . 5.5 pt -101.8 -89.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 112.923 0.712 . . . . 61.329999999999998 112.923 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 525' ' ' VAL . 10.5 p -115.34 152.22 17.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 110.281 -0.266 . . . . 40.329999999999998 110.281 -175.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -126.96 164.56 21.21 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 122.824 0.45 . . . . 71.140000000000001 110.253 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.5 p -123.21 150.56 43.24 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 123.655 0.597 . . . . 72.420000000000002 112.071 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.1 mp -94.41 125.98 46.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 106.784 -1.562 . . . . 74.120000000000005 106.784 172.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 572' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 521' ' ' MET . 51.5 m -104.9 115.56 30.5 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 123.905 0.753 . . . . 62.420000000000002 110.155 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.484 HG22 ' CG2' ' A' ' 556' ' ' THR . 93.7 t -116.84 128.51 74.2 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 116.244 -0.435 . . . . 74.430000000000007 110.447 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.431 ' HA ' HD13 ' A' ' 520' ' ' ILE . 52.8 tptt -80.27 111.96 17.14 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 108.654 -0.869 . . . . 61.109999999999999 108.654 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 61.9 t -86.65 124.39 40.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 106.056 -1.831 . . . . 72.409999999999997 106.056 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 576' ' ' ILE . . . . . 0.412 HG13 ' C ' ' A' ' 550' ' ' GLY . 40.7 mm -78.28 124.45 36.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-O 121.903 0.859 . . . . 71.200000000000003 109.27 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 577' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 578' ' ' ASP . 9.9 t70 -106.45 94.3 5.06 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 114.539 -1.21 . . . . 71.239999999999995 111.909 -174.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 577' ' ' ASP . 33.0 t70 169.26 103.05 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.348 1.03 . . . . 70.099999999999994 111.554 170.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 63.31 85.8 0.13 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 116.294 1.961 . . . . 74.200000000000003 116.294 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.403 ' CD ' ' H ' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -94.17 -53.77 3.83 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.266 -1.753 . . . . 74.129999999999995 106.266 167.259 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 581' ' ' TYR . . . . . 0.403 ' H ' ' CD ' ' A' ' 580' ' ' GLU . 21.4 t80 52.54 24.93 3.31 Favored 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 125.973 1.709 . . . . 74.430000000000007 115.605 164.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 583' ' ' LYS . 13.5 pt-20 -134.11 -50.45 0.82 Allowed 'General case' 0 C--N 1.31 -1.124 0 O-C-N 120.706 -1.246 . . . . 72.109999999999999 113.876 -176.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.433 ' N ' ' HG3' ' A' ' 582' ' ' GLU . 14.0 tppt? -154.75 153.55 31.42 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.939 -1.134 . . . . 72.219999999999999 107.939 -170.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -72.46 93.33 1.54 Allowed 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.592 -2.003 . . . . 74.319999999999993 105.592 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -90.04 158.79 17.17 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 114.556 1.317 . . . . 62.409999999999997 114.556 -170.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.0 t -146.18 159.02 43.88 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 114.254 -1.339 . . . . 72.120000000000005 109.976 -174.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 46.8 p90 -141.26 176.9 8.47 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.13 -1.433 . . . . 72.310000000000002 107.13 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.567 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 85.1 m-85 -121.79 154.7 36.63 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.659 -0.816 . . . . 75.099999999999994 109.614 -177.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.1 OUTLIER -120.52 131.05 54.52 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.171 -1.788 . . . . 72.239999999999995 106.171 177.694 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.542 ' HB2' HD11 ' A' ' 542' ' ' ILE . 39.5 tt0 -125.91 134.12 51.68 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.269 -0.641 . . . . 64.409999999999997 109.269 177.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 13.9 pt -99.14 143.35 13.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.682 -0.859 . . . . 74.450000000000003 108.682 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.7 171.94 45.79 Favored Glycine 0 N--CA 1.413 -2.89 0 N-CA-C 111.452 -0.659 . . . . 70.400000000000006 111.452 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.63 131.57 89.66 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 123.615 0.244 . . . . 73.540000000000006 110.484 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.414 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.3 Cg_endo -59.25 125.99 19.62 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.381 2.721 . . . . 73.430000000000007 112.896 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -104.46 119.55 39.22 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.307 -0.86 . . . . 73.329999999999998 109.328 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.95 129.81 41.06 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.094 -0.957 . . . . 64.450000000000003 108.67 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.508 ' CG2' HG12 ' A' ' 536' ' ' ILE . 50.2 t -87.46 118.97 34.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.223 -1.029 . . . . 73.510000000000005 108.223 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.421 ' OE1' ' HG3' ' A' ' 602' ' ' LYS . 37.1 tt0 -54.46 107.98 0.33 Allowed 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 124.91 1.381 . . . . 74.150000000000006 111.173 -175.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -73.83 -48.43 31.29 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.682 -1.145 . . . . 74.010000000000005 109.275 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 13.4 t -89.63 68.58 7.68 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 105.593 -2.003 . . . . 70.549999999999997 105.593 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -63.58 120.59 12.03 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 113.692 -1.594 . . . . 65.209999999999994 111.197 -173.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 602' ' ' LYS . . . . . 0.421 ' HG3' ' OE1' ' A' ' 598' ' ' GLU . 0.0 OUTLIER -74.56 168.04 20.55 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.136 -0.938 . . . . 74.420000000000002 110.669 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -124.61 120.96 33.41 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 120.378 -0.529 . . . . 75.239999999999995 110.203 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -92.25 79.61 1.2 Allowed Glycine 0 C--N 1.301 -1.39 0 N-CA-C 107.964 -2.054 . . . . 64.530000000000001 107.964 173.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -66.08 151.15 52.03 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 121.411 -0.423 . . . . 74.109999999999999 113.665 -174.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -73.06 141.36 47.6 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 123.015 0.526 . . . . 74.409999999999997 110.224 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 2.3 p -85.42 -162.65 0.74 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 124.014 0.926 . . . . 70.129999999999995 111.117 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 35.5 pt -61.82 155.29 4.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.307 0.575 . . . . 61.219999999999999 111.966 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 9.0 p -77.46 130.03 36.5 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.741 -0.663 . . . . 71.049999999999997 110.687 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -157.66 175.13 14.32 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.389 -1.708 . . . . 63.310000000000002 106.389 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -87.22 107.13 18.35 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 119.673 -0.811 . . . . 72.299999999999997 109.109 173.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -118.4 163.69 16.36 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.921 -0.581 . . . . 75.219999999999999 110.196 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -95.67 154.35 17.26 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.049 -1.093 . . . . 61.0 108.049 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -65.41 101.62 0.6 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.476 -0.565 . . . . 74.439999999999998 109.476 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -127.95 116.32 19.89 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.092 -0.504 . . . . 74.209999999999994 111.87 -174.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 616' ' ' GLN . . . . . 0.453 ' CD ' ' H ' ' A' ' 616' ' ' GLN . 5.0 pm0 -85.94 167.88 22.07 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 106.885 -1.524 . . . . 73.209999999999994 106.885 172.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.49 90.08 0.18 Allowed 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.853 1.702 . . . . 73.230000000000004 113.044 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 5.4 tt -91.38 -52.41 4.81 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 105.756 -1.942 . . . . 73.019999999999996 105.756 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 28.7 m -86.23 96.19 9.85 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.121 -0.945 . . . . 73.310000000000002 108.629 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 55.0 m -111.16 86.66 2.37 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 112.931 0.715 . . . . 71.310000000000002 112.931 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -96.36 32.64 1.94 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.157 -1.423 . . . . 63.409999999999997 107.157 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -82.83 124.8 30.64 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 114.038 -1.437 . . . . 54.240000000000002 108.823 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -94.81 97.02 9.74 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.653 -1.24 . . . . 61.229999999999997 107.653 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -80.03 167.06 20.92 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.318 0.58 . . . . 73.439999999999998 109.704 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 625' ' ' GLU . 0.5 OUTLIER -99.78 25.51 7.17 Favored 'General case' 0 C--N 1.276 -2.6 0 CA-C-N 116.142 -0.481 . . . . 73.340000000000003 110.737 -178.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -73.02 -28.52 62.41 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 109.017 -0.734 . . . . 63.539999999999999 109.017 -177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 627' ' ' ARG . . . . . 0.65 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 3.0 tmm_? -74.0 -35.08 64.39 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 107.78 -1.193 . . . . 64.430000000000007 107.78 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.449 ' O ' ' HG3' ' A' ' 631' ' ' MET . 59.6 mt -73.06 -38.9 56.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.071 -0.714 . . . . 73.209999999999994 109.071 -178.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -81.08 -14.88 57.36 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.185 -0.916 . . . . 71.030000000000001 112.222 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 627' ' ' ARG . 9.7 pt-20 -67.77 -11.63 58.85 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.525 0.565 . . . . 72.230000000000004 112.525 -175.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 628' ' ' ILE . 0.0 OUTLIER -74.31 -13.52 60.77 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.082 0.467 . . . . 60.439999999999998 110.997 176.454 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -150.82 51.46 0.52 Allowed Glycine 0 N--CA 1.429 -1.801 0 N-CA-C 110.433 -1.067 . . . . 60.25 110.433 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -100.87 158.14 32.37 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 109.293 -0.632 . . . . 62.219999999999999 109.293 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.45 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 44.6 Cg_endo -69.58 137.6 36.38 Favored 'Trans proline' 0 N--CA 1.436 -1.891 0 C-N-CA 121.502 1.468 . . . . 75.430000000000007 111.279 175.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -124.84 171.13 14.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 115.403 -0.817 . . . . 64.040000000000006 110.176 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.91 -178.26 3.43 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 112.289 0.478 . . . . 62.049999999999997 112.289 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.49 -172.07 27.61 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 114.843 0.697 . . . . 74.129999999999995 114.843 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -68.3 -53.78 22.03 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.147 0.979 . . . . 72.129999999999995 110.385 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -120.12 121.34 38.61 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.954 -0.758 . . . . 62.43 108.954 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 18.3 p -120.75 94.08 4.24 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.498 0.666 . . . . 72.219999999999999 110.747 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -166.4 152.18 8.55 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.294 -1.373 . . . . 64.430000000000007 107.294 -177.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.447 HD21 HG21 ' A' ' 523' ' ' VAL . 48.5 tp -134.57 132.9 39.64 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.243 -1.021 . . . . 72.109999999999999 108.243 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -100.11 110.27 22.55 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 106.906 -1.516 . . . . 74.310000000000002 106.906 174.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 44.5 t -101.82 110.99 30.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 109.219 -0.66 . . . . 71.239999999999995 109.219 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 26.8 mt -98.67 127.47 51.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 108.315 -0.994 . . . . 74.430000000000007 108.315 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 66.6 mt -97.15 103.55 14.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 107.798 -1.186 . . . . 75.400000000000006 107.798 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 515' ' ' SER . 34.5 mt-10 -115.98 135.0 54.38 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.421 -0.511 . . . . 75.209999999999994 111.573 -173.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.501 ' HA ' ' OE1' ' A' ' 516' ' ' GLU . 36.9 tt0 -70.06 118.26 12.67 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.721 -0.844 . . . . 75.329999999999998 108.721 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 18.4 m -138.63 32.47 2.26 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 115.596 -0.729 . . . . 75.010000000000005 112.342 -170.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -53.87 -42.06 68.2 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.067 0.46 . . . . 64.549999999999997 110.936 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.59 -40.59 97.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.98 -1.009 . . . . 55.130000000000003 111.028 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -84.31 -65.32 1.02 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.995 -1.002 . . . . 71.010000000000005 111.406 -173.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -168.7 126.97 1.07 Allowed 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.719 -0.845 . . . . 74.310000000000002 108.719 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 50.4 m -83.43 -65.2 1.04 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.976 -0.556 . . . . 65.239999999999995 111.172 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 15.3 t -148.08 160.37 42.94 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.938 -0.705 . . . . 72.439999999999998 109.322 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.19 116.17 22.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.23 -1.396 . . . . 64.129999999999995 107.23 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 C--O 1.254 1.312 0 N-CA-C 110.163 -0.31 . . . . 73.340000000000003 110.163 179.342 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 51.7 t60 . . . . . 0 C--O 1.245 0.831 0 CA-C-O 121.344 0.593 . . . . 70.219999999999999 109.661 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -115.33 -59.98 1.94 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.702 -0.681 . . . . 51.109999999999999 111.417 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 160.11 -153.43 24.39 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 109.892 -1.283 . . . . 61.329999999999998 109.892 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -121.94 124.51 71.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 117.034 0.417 . . . . 74.439999999999998 111.503 -171.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -107.3 124.36 49.67 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.95 -0.759 . . . . 71.239999999999995 108.95 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.6 t -168.19 172.73 8.4 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.446 -0.575 . . . . 75.299999999999997 109.446 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -75.26 145.04 42.23 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.565 -0.289 . . . . 75.530000000000001 111.054 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.06 -29.63 70.01 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.53 0.681 . . . . 70.540000000000006 110.068 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -137.87 141.66 33.48 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 107.768 -1.197 . . . . 74.129999999999995 107.768 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.84 -24.65 15.24 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.697 2.265 . . . . 70.450000000000003 111.608 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 57.2 t -135.35 133.72 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 N-CA-C 106.611 -1.626 . . . . 61.149999999999999 106.611 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 512' ' ' THR . . . . . 0.429 ' HB ' HD11 ' A' ' 642' ' ' LEU . 7.1 t -125.11 140.7 52.65 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.51 -1.292 . . . . 70.439999999999998 107.51 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 513' ' ' HIS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 654' ' ' SER . 57.4 t-80 -110.6 137.92 47.65 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 107.596 -1.261 . . . . 74.120000000000005 107.596 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.77 158.13 43.25 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 N-CA-C 109.072 -0.714 . . . . 64.319999999999993 109.072 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.557 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 48.1 m -87.09 173.57 9.19 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-N 115.037 -0.983 . . . . 71.420000000000002 109.566 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -94.07 -59.11 2.05 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.922 -0.711 . . . . 75.329999999999998 110.017 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.6 m -84.55 53.99 2.86 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.763 0.792 . . . . 63.549999999999997 109.929 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 10.5 tt -102.87 -32.49 3.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.544 -0.753 . . . . 72.140000000000001 111.49 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 519' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 92.85 -78.39 1.15 Allowed Glycine 0 N--CA 1.425 -2.036 0 C-N-CA 120.717 -0.754 . . . . 75.450000000000003 111.356 -176.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 520' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 574' ' ' LYS . 40.3 mm -126.93 123.93 63.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.934 -0.765 . . . . 74.430000000000007 108.934 -176.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.73 149.43 25.0 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 107.383 -1.34 . . . . 75.109999999999999 107.383 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 31.3 mt-10 -130.8 132.54 45.32 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.32 0.581 . . . . 74.140000000000001 111.088 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 570' ' ' THR . 40.1 t -112.01 126.47 69.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.098 -1.075 . . . . 72.409999999999997 108.098 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -81.96 128.8 34.44 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.203 -0.666 . . . . 70.120000000000005 109.203 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 568' ' ' VAL . 48.4 t -105.78 129.21 59.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 109.853 -0.425 . . . . 75.400000000000006 109.853 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.41 126.88 30.82 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.257 -0.646 . . . . 62.039999999999999 109.257 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.649 ' CZ ' ' HD1' ' A' ' 562' ' ' PHE . 15.2 ttm180 -87.64 160.07 18.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 109.178 -0.675 . . . . 65.040000000000006 109.178 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.7 t -56.1 141.47 40.29 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 124.4 1.08 . . . . 63.049999999999997 111.813 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.5 t -54.76 -37.4 65.93 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.93 -1.032 . . . . 73.430000000000007 109.355 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -119.54 96.0 0.62 Allowed Glycine 0 N--CA 1.423 -2.209 0 N-CA-C 109.029 -1.628 . . . . 42.140000000000001 109.029 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.61 101.0 12.34 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.003 -1.11 . . . . 75.109999999999999 108.003 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -107.49 92.37 4.04 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.596 -0.729 . . . . 72.109999999999999 110.441 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 86.32 -139.33 16.63 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 119.56 -1.305 . . . . 53.420000000000002 111.774 174.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -113.39 121.1 43.31 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.265 0.555 . . . . 71.310000000000002 110.876 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 59.5 t -123.63 143.87 35.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 107.972 -1.121 . . . . 63.119999999999997 107.972 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.54 HD13 ' HA ' ' A' ' 561' ' ' GLU . 41.7 mm -117.28 137.09 52.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 109.596 -0.52 . . . . 71.540000000000006 109.596 177.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 594' ' ' PRO . 44.1 t -122.89 110.79 31.28 Favored Pre-proline 0 N--CA 1.44 -0.945 0 N-CA-C 109.853 -0.425 . . . . 74.219999999999999 109.853 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.7 156.83 48.78 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.769 2.313 . . . . 71.129999999999995 112.517 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.497 ' HB3' HG22 ' A' ' 591' ' ' ILE . 45.0 p90 -149.4 163.3 38.14 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 122.383 -0.198 . . . . 73.150000000000006 110.649 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -158.43 156.67 30.82 Favored 'General case' 0 C--O 1.252 1.211 0 O-C-N 123.966 0.791 . . . . 62.509999999999998 110.089 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.2 p -90.62 138.53 31.49 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 123.531 0.519 . . . . 72.299999999999997 111.342 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 51.2 mt -111.09 115.77 50.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.821 -0.807 . . . . 70.540000000000006 108.821 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.82 99.61 5.21 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.35 -0.611 . . . . 74.420000000000002 109.35 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -104.56 -89.17 2.1 Favored Glycine 0 CA--C 1.482 -2.008 0 C-N-CA 119.981 -1.104 . . . . 61.340000000000003 110.667 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 545' ' ' THR . . . . . 0.435 ' HB ' HG23 ' A' ' 586' ' ' THR . 3.8 m -102.53 29.86 5.0 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-O 122.324 1.059 . . . . 61.409999999999997 108.54 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -157.4 144.73 18.58 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 106.815 -1.55 . . . . 64.430000000000007 106.815 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.406 ' HD2' ' OE1' ' A' ' 551' ' ' GLU . 82.0 mtm180 -92.29 131.1 37.76 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.75 0.786 . . . . 65.120000000000005 112.126 -175.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -96.62 -167.15 33.64 Favored Glycine 0 C--N 1.294 -1.779 0 CA-C-N 114.908 -1.042 . . . . 14.44 112.93 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 549' ' ' GLY . . . . . 0.532 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 77.28 9.15 86.98 Favored Glycine 0 C--N 1.313 -0.734 0 CA-C-N 115.721 -0.24 . . . . 65.329999999999998 112.995 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 98.14 23.73 12.59 Favored Glycine 0 N--CA 1.427 -1.924 0 C-N-CA 120.368 -0.92 . . . . 63.299999999999997 111.422 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.406 ' OE1' ' HD2' ' A' ' 547' ' ' ARG . 26.3 tt0 -98.63 -63.27 1.14 Allowed 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.096 -0.641 . . . . 64.040000000000006 109.825 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -100.72 -42.01 6.67 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 107.411 -1.329 . . . . 75.150000000000006 107.411 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -132.9 155.09 49.69 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.006 -1.109 . . . . 73.510000000000005 108.006 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.79 137.38 35.32 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.476 -1.305 . . . . 74.25 107.476 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 555' ' ' ASP . . . . . 0.532 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 29.4 t70 -87.3 121.36 29.65 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.682 -0.859 . . . . 71.430000000000007 108.682 -176.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.8 t -130.65 164.98 23.81 Favored 'General case' 0 N--CA 1.414 -2.254 0 CA-C-O 121.742 0.782 . . . . 62.420000000000002 110.787 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 19.9 p -161.2 163.55 31.08 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.316 -1.735 . . . . 63.340000000000003 106.316 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 167.18 -169.59 41.05 Favored Glycine 0 N--CA 1.421 -2.329 0 C-N-CA 119.929 -1.129 . . . . 42.210000000000001 111.054 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.526 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 42.3 mt-10 -136.07 119.75 17.2 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 123.338 0.655 . . . . 72.5 110.196 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 569' ' ' LYS . 77.3 mt -86.82 128.75 35.05 Favored 'General case' 0 CA--C 1.484 -1.592 0 CA-C-N 115.745 -0.661 . . . . 72.239999999999995 110.087 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.54 ' HA ' HD13 ' A' ' 536' ' ' ILE . 25.5 tt0 -87.79 123.39 32.53 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.455 -0.793 . . . . 71.120000000000005 109.911 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.649 ' HD1' ' CZ ' ' A' ' 527' ' ' ARG . 82.2 m-85 -123.3 98.2 5.76 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 121.463 0.649 . . . . 73.299999999999997 110.612 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 533' ' ' GLY . 42.3 mt-30 -96.78 -175.87 3.41 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.722 -0.672 . . . . 70.439999999999998 110.44 174.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -78.92 -21.75 46.86 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.631 -0.713 . . . . 73.409999999999997 109.428 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -72.57 -52.38 15.81 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.076 -0.966 . . . . 65.109999999999999 112.768 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.496 ' HB2' HH12 ' A' ' 527' ' ' ARG . 41.4 mm-40 -69.7 169.29 13.17 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.441 1.274 . . . . 73.150000000000006 114.441 -177.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.589 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.0 pt -105.95 -63.3 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 114.574 -1.193 . . . . 74.099999999999994 112.465 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.589 ' H ' HG13 ' A' ' 567' ' ' ILE . 14.4 p -139.88 162.56 25.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 108.834 -0.802 . . . . 73.120000000000005 108.834 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.415 ' HB3' HD22 ' A' ' 560' ' ' LEU . 1.8 mtpt -131.1 164.04 26.32 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.445 -0.946 . . . . 72.209999999999994 108.445 171.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 12.9 p -129.7 152.57 49.06 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 123.794 0.683 . . . . 63.210000000000001 111.153 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.498 HG22 HG23 ' A' ' 573' ' ' VAL . 2.5 mp -94.59 121.76 45.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 105.545 -2.02 . . . . 72.540000000000006 105.545 170.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 5.9 m -99.45 114.89 28.11 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.596 -0.89 . . . . 53.43 108.596 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.498 HG23 HG22 ' A' ' 571' ' ' ILE . 91.3 t -118.89 127.65 75.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.771 -0.455 . . . . 72.439999999999998 109.771 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 16.1 tppt? -77.42 108.84 10.85 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.207 -1.035 . . . . 75.409999999999997 108.207 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.75 122.52 36.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 104.55 -2.389 . . . . 71.099999999999994 104.55 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 42.1 mm -67.04 127.75 29.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-O 121.352 0.596 . . . . 71.209999999999994 109.467 -174.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.66 82.8 5.72 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.55 -1.205 . . . . 65.299999999999997 107.85 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -127.03 106.89 9.58 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.438 -1.255 . . . . 65.239999999999995 109.943 -175.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -74.57 87.68 2.14 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.366 -0.834 . . . . 63.530000000000001 109.817 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.501 ' HG3' ' HG3' ' A' ' 582' ' ' GLU . 11.1 tp10 -153.8 136.83 15.51 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.67 -0.863 . . . . 72.150000000000006 108.67 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -120.33 102.05 8.21 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.752 -1.203 . . . . 65.439999999999998 107.752 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.501 ' HG3' ' HG3' ' A' ' 580' ' ' GLU . 34.9 mt-10 -117.77 -58.74 1.99 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.925 0.869 . . . . 70.120000000000005 109.643 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -158.74 149.95 20.52 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 105.42 -2.067 . . . . 64.25 105.42 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -59.82 117.37 4.93 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 108.499 -0.926 . . . . 63.539999999999999 108.499 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -86.72 119.83 27.37 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.474 -1.306 . . . . 75.530000000000001 107.474 -176.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 586' ' ' THR . . . . . 0.435 HG23 ' HB ' ' A' ' 545' ' ' THR . 4.4 t -135.18 125.18 25.8 Favored 'General case' 0 C--N 1.281 -2.413 0 CA-C-O 121.946 0.879 . . . . 75.310000000000002 111.582 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 44.3 p90 -119.94 177.78 4.85 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.131 -0.94 . . . . 64.310000000000002 109.235 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.424 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 77.9 m-85 -123.19 149.66 44.34 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 109.404 -0.591 . . . . 63.5 109.404 -176.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.2 OUTLIER -120.4 131.81 54.98 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.442 -1.688 . . . . 45.539999999999999 106.442 179.216 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -125.58 128.47 47.98 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.022 -0.671 . . . . 71.140000000000001 110.341 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.497 HG22 ' HB3' ' A' ' 539' ' ' TYR . 26.5 pt -99.84 139.77 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 107.911 -1.144 . . . . 72.049999999999997 107.911 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.34 -178.08 50.65 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 115.825 -0.625 . . . . 64.120000000000005 112.083 -176.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.05 129.63 86.07 Favored Pre-proline 0 N--CA 1.426 -1.641 0 CA-C-N 115.499 -0.35 . . . . 75.340000000000003 110.772 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.517 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 11.7 Cg_endo -59.6 129.07 29.33 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.197 2.598 . . . . 61.310000000000002 112.666 -176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 595' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 536' ' ' ILE . 8.3 ptm180 -104.72 119.65 39.51 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.09 -0.959 . . . . 71.0 109.008 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.403 HD23 ' HD3' ' A' ' 634' ' ' PRO . 2.1 tm? -67.28 128.88 38.05 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.082 -1.451 . . . . 72.209999999999994 107.082 175.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.468 ' CG2' HG12 ' A' ' 536' ' ' ILE . 51.5 t -83.26 95.63 3.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 121.397 0.618 . . . . 61.539999999999999 110.835 -177.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.75 132.92 48.35 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 103.983 -2.599 . . . . 73.540000000000006 103.983 172.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -60.76 -30.21 69.88 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.667 0.617 . . . . 53.5 112.667 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 53.9 m 51.87 54.51 10.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.125 0.97 . . . . 71.540000000000006 113.42 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.13 138.92 37.0 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 120.02 -0.672 . . . . 62.25 109.538 177.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 602' ' ' LYS . . . . . 0.6 ' HA ' ' HE2' ' A' ' 602' ' ' LYS . 10.5 mmpt? -81.77 112.47 18.96 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 114.62 1.341 . . . . 42.140000000000001 114.62 -170.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -95.57 -19.41 19.8 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 113.453 -1.703 . . . . 73.400000000000006 109.001 174.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -124.85 -119.17 2.37 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 110.509 -1.036 . . . . 72.329999999999998 110.509 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -155.88 39.33 0.6 Allowed Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.447 -0.882 . . . . 74.230000000000004 112.445 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -126.98 103.75 7.64 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.07 -0.715 . . . . 75.219999999999999 109.07 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 12.4 t -96.69 177.13 5.75 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.683 -0.858 . . . . 64.120000000000005 108.683 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 48.1 mm -80.72 115.25 22.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.982 -1.118 . . . . 73.129999999999995 107.982 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 6.5 t -105.11 89.36 3.11 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-O 122.343 1.068 . . . . 72.120000000000005 110.218 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -97.61 151.46 20.05 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 114.853 -1.067 . . . . 72.299999999999997 108.485 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -134.18 -64.75 0.68 Allowed 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 120.966 -0.293 . . . . 71.409999999999997 110.571 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -129.35 127.08 40.33 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.296 0.569 . . . . 73.530000000000001 111.567 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -101.27 77.61 1.81 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.407 1.098 . . . . 53.219999999999999 109.741 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -131.56 92.82 3.22 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.715 -1.584 . . . . 55.420000000000002 107.907 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 64.15 78.74 0.28 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.388 -1.278 . . . . 72.25 112.108 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -108.76 135.98 20.03 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 115.622 -0.717 . . . . 62.039999999999999 109.739 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.65 138.92 33.01 Favored 'Trans proline' 0 C--O 1.256 1.395 0 C-N-CA 121.829 1.686 . . . . 72.230000000000004 109.736 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -86.05 -175.65 5.64 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.67 -0.492 . . . . 54.32 109.67 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 22.6 p -70.9 122.13 19.39 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 120.889 0.376 . . . . 70.519999999999996 110.533 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 14.3 m -69.02 141.94 54.73 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.338 -0.846 . . . . 74.010000000000005 110.094 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.59 89.12 3.31 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.506 0.67 . . . . 62.149999999999999 112.334 -176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.09 156.49 38.19 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.308 -1.367 . . . . 74.540000000000006 107.308 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -81.71 67.01 7.52 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.564 0.697 . . . . 62.43 112.079 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -93.75 172.29 8.34 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 105.237 -2.134 . . . . 73.010000000000005 105.237 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -63.03 -16.99 61.72 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 119.61 -0.836 . . . . 71.209999999999994 110.607 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 626' ' ' ARG . 18.2 mtp-105 -57.69 -25.42 60.27 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 114.996 -1.002 . . . . 74.400000000000006 111.784 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -60.22 -26.51 66.45 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.856 0.36 . . . . 72.310000000000002 110.847 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 68.4 mt -73.51 -40.96 56.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.74 -0.837 . . . . 74.519999999999996 108.74 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.13 -30.08 68.27 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.723 -0.671 . . . . 73.400000000000006 111.019 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -58.22 -35.96 72.46 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.188 0.595 . . . . 73.099999999999994 112.007 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -93.14 -12.37 30.56 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.261 -0.576 . . . . 74.010000000000005 109.551 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -104.66 26.1 23.59 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 115.122 -0.945 . . . . 74.010000000000005 111.009 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -95.37 161.57 27.48 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 108.184 -1.043 . . . . 75.120000000000005 108.184 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 33.3 Cg_endo -70.81 137.74 33.02 Favored 'Trans proline' 0 N--CA 1.427 -2.388 0 N-CA-C 105.352 -2.595 . . . . 73.430000000000007 105.352 161.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.04 168.74 16.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 118.502 -1.279 . . . . 74.5 112.678 -173.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.26 171.93 7.68 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.57 -0.741 . . . . 74.25 111.959 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -71.69 -171.99 15.3 Favored Glycine 0 N--CA 1.431 -1.7 0 CA-C-N 115.307 -0.861 . . . . 64.340000000000003 113.144 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -62.12 -41.29 98.09 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 122.365 0.266 . . . . 74.25 110.331 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -140.89 133.23 28.27 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.969 0.414 . . . . 64.120000000000005 110.039 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 15.4 p -120.88 95.4 4.69 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-O 121.709 0.766 . . . . 70.400000000000006 109.985 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -162.58 142.98 9.75 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.523 -1.288 . . . . 33.240000000000002 107.523 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.5 HD21 HG21 ' A' ' 523' ' ' VAL . 34.7 tp -132.65 132.81 42.83 Favored 'General case' 0 N--CA 1.416 -2.167 0 O-C-N 123.658 0.599 . . . . 52.240000000000002 109.423 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -98.35 118.59 35.34 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.057 -1.46 . . . . 71.340000000000003 107.057 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 44.3 t -106.7 117.43 52.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 109.006 -0.738 . . . . 71.430000000000007 109.006 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 58.1 mt -103.4 123.11 56.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 110.62 -0.141 . . . . 73.219999999999999 110.62 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 41.6 mt -107.43 107.65 23.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.153 -0.684 . . . . 72.540000000000006 109.153 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.427 ' HG2' ' NE2' ' A' ' 513' ' ' HIS . 8.0 pt-20 -136.14 150.08 48.91 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 105.383 -2.081 . . . . 75.150000000000006 105.383 166.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -63.47 128.8 37.47 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.056 -1.058 . . . . 70.439999999999998 110.674 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 649' ' ' SER . . . . . 0.533 ' HB2' ' O ' ' A' ' 652' ' ' PHE . 5.2 p -150.3 107.91 3.66 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 114.881 -1.054 . . . . 54.43 111.035 -173.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -93.64 -53.6 3.98 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.082 -0.508 . . . . 72.510000000000005 110.571 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -74.78 -39.53 61.71 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.376 -0.829 . . . . 73.129999999999995 111.001 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 652' ' ' PHE . . . . . 0.533 ' O ' ' HB2' ' A' ' 649' ' ' SER . 96.2 m-85 -109.91 162.32 14.62 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.293 -0.632 . . . . 63.130000000000003 109.293 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.53 7.56 3.05 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.417 -0.956 . . . . 64.349999999999994 108.417 172.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 654' ' ' SER . . . . . 0.453 ' HA ' ' HB3' ' A' ' 513' ' ' HIS . 21.9 m -138.78 162.05 35.7 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.702 -1.221 . . . . 63.219999999999999 107.702 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 13.3 t -124.5 144.03 50.33 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.626 -0.879 . . . . 53.520000000000003 108.626 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.51 116.69 26.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 108.553 -0.906 . . . . 63.32 108.553 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 C--N 1.304 -1.405 0 CA-C-N 115.824 -0.625 . . . . 64.150000000000006 111.054 -178.014 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 501' ' ' HIS . . . . . 0.441 ' CG ' ' HA ' ' A' ' 631' ' ' MET . 85.3 m-70 . . . . . 0 CA--C 1.506 -0.712 0 CA-C-O 122.461 1.124 . . . . 65.329999999999998 108.306 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.631 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . -125.12 2.61 7.93 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 113.601 -1.636 . . . . 63.329999999999998 107.967 173.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 116.26 -159.64 13.79 Favored Glycine 0 N--CA 1.416 -2.655 0 C-N-CA 120.167 -1.016 . . . . 62.219999999999999 111.619 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.34 111.39 28.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 122.388 0.275 . . . . 74.140000000000001 110.569 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.604 ' CD2' HG23 ' A' ' 528' ' ' THR . 5.8 m-85 -92.35 126.11 37.3 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 109.093 -0.706 . . . . 72.239999999999995 109.093 170.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.4 t -167.54 176.33 6.57 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.831 -0.803 . . . . 74.030000000000001 108.831 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -81.11 147.05 30.27 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 110.147 -0.316 . . . . 72.140000000000001 110.147 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.78 -33.53 75.88 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.36 0.6 . . . . 72.129999999999995 109.879 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -136.28 140.93 34.19 Favored Pre-proline 0 N--CA 1.427 -1.605 0 N-CA-C 107.573 -1.269 . . . . 54.409999999999997 107.573 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 510' ' ' PRO . . . . . 0.438 ' O ' ' HA ' ' A' ' 642' ' ' LEU . 59.2 Cg_endo -75.26 -26.01 10.93 Favored 'Trans proline' 0 C--N 1.33 -0.414 0 C-N-CA 122.447 2.098 . . . . 60.340000000000003 112.258 -178.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 59.8 t -134.77 136.59 52.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 106.715 -1.587 . . . . 51.100000000000001 106.715 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 15.0 t -129.18 135.39 48.79 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 108.591 -0.892 . . . . 72.109999999999999 108.591 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -108.03 119.04 38.34 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.915 -0.772 . . . . 63.350000000000001 108.915 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.37 160.28 14.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.419 -0.81 . . . . 64.040000000000006 109.194 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.534 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 74.4 m -88.17 159.84 18.0 Favored 'General case' 0 N--CA 1.411 -2.413 0 C-N-CA 123.345 0.658 . . . . 61.420000000000002 110.486 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -49.22 16.32 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 120.731 -0.388 . . . . 75.230000000000004 110.692 176.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 9.8 m -86.83 39.84 0.87 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.27 0.557 . . . . 51.140000000000001 111.5 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 13.4 tt -97.67 -25.15 4.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.305 0.574 . . . . 71.519999999999996 111.626 -176.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 519' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 86.86 -74.28 2.35 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.86 -0.896 . . . . 71.219999999999999 110.86 -176.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 43.4 mm -129.97 132.2 65.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.459 -1.312 . . . . 75.420000000000002 107.459 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.4 150.47 34.6 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.002 -1.481 . . . . 73.510000000000005 107.002 175.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 31.7 mt-10 -130.09 142.53 50.59 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.227 0.537 . . . . 73.439999999999998 111.631 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.586 HG11 HD22 ' A' ' 642' ' ' LEU . 42.7 t -121.24 127.7 75.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.397 -0.964 . . . . 64.340000000000003 108.397 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -82.51 127.8 33.66 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.746 -0.835 . . . . 63.310000000000002 108.746 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.39 123.92 58.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 108.806 -0.812 . . . . 74.439999999999998 108.806 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.03 115.63 10.38 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.542 -0.754 . . . . 70.040000000000006 109.928 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.481 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 50.9 ttp180 -67.85 155.28 39.71 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.6 -1.182 . . . . 74.109999999999999 108.9 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 0.7 OUTLIER -56.55 141.99 40.95 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-O 121.786 0.803 . . . . 63.310000000000002 111.37 176.182 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.2 m -61.92 -16.93 54.63 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 125.996 1.718 . . . . 60.25 110.769 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -139.47 79.16 0.29 Allowed Glycine 0 N--CA 1.425 -2.084 0 N-CA-C 110.304 -1.118 . . . . 61.210000000000001 110.304 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -83.73 101.49 11.6 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.232 -1.025 . . . . 63.229999999999997 108.232 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -100.83 93.13 5.38 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.908 -1.042 . . . . 63.439999999999998 110.217 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 97.53 -119.55 6.44 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.162 -1.018 . . . . 75.430000000000007 111.277 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 534' ' ' ASN . . . . . 0.456 ' HB3' ' HB ' ' A' ' 597' ' ' VAL . 50.5 t30 -133.52 134.25 43.19 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.084 -0.71 . . . . 71.150000000000006 109.084 177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 62.1 t -132.83 137.98 52.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.111 -1.07 . . . . 65.109999999999999 108.111 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.482 HG12 ' CG2' ' A' ' 597' ' ' VAL . 41.3 mm -107.35 136.46 42.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 109.563 -0.532 . . . . 63.409999999999997 109.563 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.34 110.94 32.12 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 110.046 -0.353 . . . . 64.310000000000002 110.046 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -73.5 150.6 46.27 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.205 1.937 . . . . 72.140000000000001 111.468 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.423 ' HB3' HG22 ' A' ' 591' ' ' ILE . 53.2 p90 -149.08 163.45 37.52 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 110.405 -0.22 . . . . 74.310000000000002 110.405 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -157.93 158.33 34.8 Favored 'General case' 0 C--O 1.252 1.236 0 O-C-N 123.923 0.764 . . . . 62.109999999999999 109.745 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.7 p -87.36 154.12 20.92 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 109.038 -0.727 . . . . 61.509999999999998 109.038 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 60.1 mt -128.39 119.01 49.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.204 -1.406 . . . . 65.209999999999994 107.204 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -66.41 120.99 14.3 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 122.631 0.372 . . . . 63.340000000000003 110.453 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -102.71 -104.54 2.85 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 108.663 -1.775 . . . . 72.209999999999994 108.663 176.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 34.3 p -89.91 -22.51 21.96 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.276 -1.009 . . . . 72.049999999999997 108.276 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.613 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -81.91 136.95 35.28 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.423 -1.262 . . . . 44.399999999999999 110.067 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -90.49 144.25 25.97 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.382 0.611 . . . . 71.409999999999997 111.912 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.7 -158.03 33.87 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.005 -1.238 . . . . 32.039999999999999 110.005 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.75 26.47 73.98 Favored Glycine 0 C--N 1.315 -0.594 0 C-N-CA 120.929 -0.653 . . . . 73.450000000000003 112.257 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 550' ' ' GLY . . . . . 0.416 ' C ' HG13 ' A' ' 576' ' ' ILE . . . 67.92 34.55 82.48 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 121.597 -0.335 . . . . 72.049999999999997 112.264 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -104.48 -63.43 1.21 Allowed 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 120.814 -0.355 . . . . 63.149999999999999 111.409 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -101.77 -45.61 5.18 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 108.179 -1.045 . . . . 75.340000000000003 108.179 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -133.93 152.31 51.81 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 107.639 -1.245 . . . . 64.439999999999998 107.639 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.403 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 8.4 tt0 -85.6 112.69 21.21 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 105.858 -1.904 . . . . 73.439999999999998 105.858 176.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.26 140.7 56.02 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 120.941 0.401 . . . . 64.340000000000003 110.203 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.6 t -142.65 148.3 37.18 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-O 121.506 0.67 . . . . 75.400000000000006 111.33 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 11.8 p -148.62 157.28 43.35 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.093 -1.447 . . . . 54.439999999999998 107.093 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 168.3 -163.43 37.16 Favored Glycine 0 N--CA 1.421 -2.338 0 C-N-CA 120.114 -1.041 . . . . 62.43 110.665 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.448 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 40.5 mt-10 -132.72 124.91 29.06 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 122.869 0.468 . . . . 74.430000000000007 110.697 -177.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.533 HD22 ' HB3' ' A' ' 569' ' ' LYS . 76.0 mt -91.04 135.09 33.99 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 115.713 -0.676 . . . . 34.130000000000003 109.403 177.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.475 ' HA ' HD13 ' A' ' 536' ' ' ILE . 32.1 tt0 -102.06 109.48 21.2 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.837 -0.619 . . . . 64.109999999999999 110.54 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -106.07 104.4 14.09 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.661 0.743 . . . . 70.340000000000003 110.534 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.536 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 64.9 mm-40 -87.75 173.3 9.07 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.469 -1.308 . . . . 63.310000000000002 107.469 174.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -72.03 -25.91 61.99 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.498 -0.927 . . . . 65.329999999999998 108.498 172.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.66 -46.22 39.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.592 -1.185 . . . . 73.340000000000003 110.822 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.536 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 37.0 mm-40 -61.01 130.58 47.11 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 123.72 0.808 . . . . 72.120000000000005 111.663 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.548 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.3 pt -86.74 -59.69 2.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 116.004 -0.544 . . . . 61.350000000000001 111.746 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.548 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.2 p -141.78 155.17 19.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.769 -0.456 . . . . 75.439999999999998 109.769 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.533 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -123.19 157.28 33.38 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.988 -0.745 . . . . 73.140000000000001 108.988 171.132 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.0 OUTLIER -125.36 149.85 47.74 Favored 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 115.351 -0.841 . . . . 62.310000000000002 111.574 179.049 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.3 mp -98.91 120.56 48.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 106.662 -1.607 . . . . 60.25 106.662 169.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 5.1 p -96.11 115.09 26.89 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 123.747 0.654 . . . . 71.019999999999996 109.405 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.435 HG23 HG22 ' A' ' 571' ' ' ILE . 93.4 t -114.62 128.58 71.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.705 -0.398 . . . . 64.209999999999994 109.935 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 22.2 tptm -79.84 115.23 19.32 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.985 -1.007 . . . . 74.219999999999999 109.226 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.66 126.28 40.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 104.935 -2.246 . . . . 51.329999999999998 104.935 174.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 576' ' ' ILE . . . . . 0.416 HG13 ' C ' ' A' ' 550' ' ' GLY . 45.2 mm -74.16 123.17 28.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 122.272 1.034 . . . . 74.150000000000006 110.771 -173.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -98.19 80.77 2.71 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-N 113.801 -1.545 . . . . 75.129999999999995 108.648 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 32.5 t70 176.23 136.19 0.05 Allowed 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 123.952 0.783 . . . . 73.430000000000007 110.182 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 66.19 22.01 11.05 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 115.273 1.583 . . . . 73.430000000000007 115.273 173.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -79.6 94.52 5.68 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 118.396 -1.322 . . . . 65.510000000000005 108.772 173.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -145.68 27.01 1.24 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.659 -1.978 . . . . 75.450000000000003 105.659 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -112.4 -70.91 0.78 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.782 -0.645 . . . . 62.32 112.303 -172.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.418 ' HB2' ' NZ ' ' A' ' 583' ' ' LYS . 0.0 OUTLIER -173.72 171.04 3.88 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.787 -1.19 . . . . 75.310000000000002 107.787 -171.242 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -61.7 128.21 35.17 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.942 -0.762 . . . . 64.329999999999998 108.942 172.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.613 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 30.1 mmtp -107.87 135.31 49.47 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.511 -0.552 . . . . 72.319999999999993 109.511 -175.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 9.2 t -140.53 145.94 37.46 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 120.411 -0.515 . . . . 73.239999999999995 109.912 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 49.8 p90 -141.81 175.92 9.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.837 -1.172 . . . . 74.049999999999997 107.837 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.576 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 79.1 m-85 -121.4 160.64 23.66 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.73 -0.47 . . . . 73.450000000000003 109.73 -176.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.2 OUTLIER -127.97 131.27 49.28 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 105.798 -1.927 . . . . 55.340000000000003 105.798 177.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.405 ' HB2' HD11 ' A' ' 542' ' ' ILE . 42.5 tt0 -129.68 137.98 50.92 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.893 -0.41 . . . . 74.510000000000005 109.893 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.423 HG22 ' HB3' ' A' ' 539' ' ' TYR . 21.3 pt -108.74 142.81 20.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 108.103 -1.073 . . . . 65.049999999999997 108.103 176.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.52 -177.4 45.62 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 111.004 -0.838 . . . . 74.219999999999999 111.004 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -69.74 132.18 89.12 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 120.895 0.378 . . . . 65.019999999999996 111.345 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.97 129.47 26.04 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.488 2.792 . . . . 64.010000000000005 112.759 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 595' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 536' ' ' ILE . 1.2 ptm85 -106.54 119.49 39.42 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.967 -0.561 . . . . 74.129999999999995 110.212 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.39 137.9 57.79 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 124.567 1.147 . . . . 53.32 111.025 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.482 ' CG2' HG12 ' A' ' 536' ' ' ILE . 21.6 t -113.86 114.79 47.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 105.838 -1.912 . . . . 51.140000000000001 105.838 174.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 600' ' ' SER . 32.5 tt0 -60.83 157.08 15.77 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 122.908 0.483 . . . . 73.239999999999995 110.837 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 23.1 ptp -71.66 12.22 0.4 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.386 1.074 . . . . 65.129999999999995 112.572 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 598' ' ' GLU . 40.4 t -102.81 -160.75 0.8 Allowed 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 105.92 -1.881 . . . . 75.310000000000002 105.92 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.92 153.72 27.4 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 120.119 -0.632 . . . . 71.239999999999995 109.537 173.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -64.67 107.51 1.44 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.341 -0.985 . . . . 73.25 108.341 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -135.83 158.37 44.57 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.691 -0.686 . . . . 75.239999999999995 109.513 -174.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 115.73 150.12 9.59 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.84 -0.695 . . . . 54.43 111.426 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -85.54 82.46 1.67 Allowed Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.592 -1.003 . . . . 52.100000000000001 110.592 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -81.08 70.43 7.91 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.797 0.808 . . . . 64.430000000000007 111.173 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 21.2 m -79.9 145.53 32.63 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 107.519 -1.289 . . . . 72.230000000000004 107.519 176.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 7.0 tp -69.95 98.9 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.802 -0.814 . . . . 72.439999999999998 108.802 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 2.3 p -74.98 -23.17 58.23 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.611 -0.722 . . . . 71.019999999999996 112.265 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 610' ' ' GLU . . . . . 0.53 ' HG2' ' HA ' ' A' ' 616' ' ' GLN . 4.8 mp0 -82.45 117.48 22.51 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.756 -0.831 . . . . 72.319999999999993 108.756 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -96.82 -8.59 30.67 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.212 0.53 . . . . 74.439999999999998 110.965 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -118.51 115.95 25.65 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 107.733 -1.21 . . . . 70.150000000000006 107.733 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.85 -21.27 62.45 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 120.801 0.334 . . . . 75.349999999999994 110.891 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -85.02 -3.58 58.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.065 -0.516 . . . . 75.120000000000005 110.884 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -132.5 28.31 4.33 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.786 -1.19 . . . . 65.140000000000001 107.786 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 616' ' ' GLN . . . . . 0.53 ' HA ' ' HG2' ' A' ' 610' ' ' GLU . 33.3 tt0 -73.13 -53.07 5.12 Favored Pre-proline 0 N--CA 1.427 -1.605 0 CA-C-N 113.965 -1.47 . . . . 73.409999999999997 110.536 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -85.28 137.65 6.17 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 N-CA-C 107.539 -1.754 . . . . 71.299999999999997 107.539 164.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 58.0 mt -68.67 124.77 24.55 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.023 -0.671 . . . . 74.329999999999998 110.928 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 8.9 t -88.09 5.28 41.89 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.341 -0.845 . . . . 44.219999999999999 110.389 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 15.0 m -71.2 104.96 3.25 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.915 -0.584 . . . . 70.019999999999996 110.568 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 621' ' ' LYS . . . . . 0.584 ' HD3' ' H ' ' A' ' 621' ' ' LYS . 0.3 OUTLIER -98.47 74.04 2.13 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.134 -1.061 . . . . 70.109999999999999 108.134 175.416 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -164.78 155.39 14.38 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.039 -1.437 . . . . 75.239999999999995 107.594 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.28 160.95 21.61 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 120.215 -0.594 . . . . 72.239999999999995 111.94 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 624' ' ' GLU . . . . . 0.407 ' O ' HG13 ' A' ' 628' ' ' ILE . 36.1 tt0 -163.1 154.51 17.36 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.051 -1.833 . . . . 73.349999999999994 106.051 -178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -66.61 -31.01 71.42 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 118.622 0.646 . . . . 74.109999999999999 112.191 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.582 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 4.1 tmm_? -63.47 -37.7 88.32 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 109.398 -0.593 . . . . 72.120000000000005 109.398 173.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 627' ' ' ARG . . . . . 0.502 ' HA ' ' OE1' ' A' ' 630' ' ' GLU . 0.0 OUTLIER -69.39 -31.41 69.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.763 -0.829 . . . . 75.209999999999994 108.763 -177.535 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 624' ' ' GLU . 66.2 mt -74.32 -40.59 50.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.154 -0.684 . . . . 74.409999999999997 109.154 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.09 -15.89 63.55 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.535 -0.757 . . . . 70.140000000000001 110.996 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 45.9 mt-10 -63.63 -9.83 15.72 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 113.31 0.855 . . . . 63.340000000000003 113.31 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.441 ' HA ' ' CG ' ' A' ' 501' ' ' HIS . 0.0 OUTLIER -53.62 -23.29 10.64 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.276 0.843 . . . . 75.439999999999998 113.276 178.174 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -91.99 -10.79 60.88 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.917 -0.658 . . . . 61.0 112.966 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -110.63 167.21 9.39 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.637 -0.875 . . . . 74.409999999999997 108.637 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.463 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 73.8 Cg_endo -84.14 142.87 9.98 Favored 'Trans proline' 0 N--CA 1.427 -2.398 0 C-N-CA 121.384 1.39 . . . . 62.439999999999998 111.333 174.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.5 pp -129.85 168.94 21.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-N 115.807 -0.633 . . . . 75.109999999999999 110.675 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.83 178.92 4.81 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 112.249 0.463 . . . . 73.409999999999997 112.249 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -77.79 -156.06 8.08 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 114.888 0.715 . . . . 74.239999999999995 114.888 -175.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -70.77 -48.57 53.59 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.156 0.582 . . . . 74.120000000000005 109.794 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -140.2 144.15 36.44 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.295 -1.002 . . . . 64.319999999999993 108.295 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 14.0 p -133.23 95.88 3.62 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 123.604 0.565 . . . . 62.340000000000003 109.849 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -164.1 138.46 5.66 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.75 -0.833 . . . . 74.510000000000005 108.75 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.586 HD22 HG11 ' A' ' 523' ' ' VAL . 26.6 tp -125.75 134.44 51.75 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.442 -0.947 . . . . 71.129999999999995 108.442 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -104.3 113.8 27.6 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.391 -1.337 . . . . 71.209999999999994 107.391 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.36 110.15 28.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.144 -0.688 . . . . 73.150000000000006 109.144 -178.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 59.2 mt -102.24 120.39 51.88 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 108.619 -0.882 . . . . 62.43 108.619 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 45.5 mt -95.38 106.95 18.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 107.979 -1.119 . . . . 73.209999999999994 107.979 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 515' ' ' SER . 8.9 pt-20 -112.45 130.49 55.97 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.243 0.544 . . . . 70.140000000000001 110.463 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.14 118.05 8.63 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.738 1.256 . . . . 74.219999999999999 110.702 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 649' ' ' SER . . . . . 0.405 ' HB3' ' HG2' ' A' ' 651' ' ' GLU . 24.2 m -136.65 106.68 6.31 Favored 'General case' 0 N--CA 1.4 -2.951 0 CA-C-N 113.651 -1.613 . . . . 73.530000000000001 107.367 -172.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -93.7 11.36 29.29 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.034 -0.985 . . . . 75.299999999999997 108.452 -173.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 651' ' ' GLU . . . . . 0.405 ' HG2' ' HB3' ' A' ' 649' ' ' SER . 3.1 mm-40 -62.2 -47.7 83.3 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.613 -1.176 . . . . 75.349999999999994 111.14 -170.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -96.66 100.72 12.26 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-O 122.355 1.074 . . . . 55.420000000000002 112.029 -177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -169.14 -48.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.153 -1.84 . . . . 71.0 106.174 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 11.3 p -87.96 -53.31 4.81 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 107.5 -1.296 . . . . 64.129999999999995 107.5 172.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 20.6 m -111.23 97.75 7.01 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 115.806 -0.634 . . . . 43.340000000000003 110.021 176.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 47.7 t -98.25 -34.47 4.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.986 -1.116 . . . . 75.140000000000001 107.986 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 17.9 t70 . . . . . 0 C--N 1.311 -1.096 0 CA-C-N 114.824 -1.08 . . . . 65.209999999999994 109.496 178.35 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 61.7 t60 . . . . . 0 N--CA 1.443 -0.804 0 CA-C-O 121.297 0.57 . . . . 65.540000000000006 110.215 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -86.21 -59.66 2.23 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.466 -0.788 . . . . 44.350000000000001 109.552 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.422 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . 165.03 -150.91 19.45 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 120.477 -0.868 . . . . 73.239999999999995 111.119 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.434 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.9 mp -126.13 113.32 33.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 116.852 0.326 . . . . 65.010000000000005 110.67 -173.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -97.33 130.34 44.51 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.487 -0.931 . . . . 74.439999999999998 108.487 170.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 506' ' ' THR . . . . . 0.413 ' HA ' HG22 ' A' ' 640' ' ' THR . 13.7 t -166.31 175.29 8.36 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.147 -0.686 . . . . 72.099999999999994 109.147 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 507' ' ' PHE . . . . . 0.458 ' CZ ' HG23 ' A' ' 591' ' ' ILE . 79.9 m-85 -84.55 152.9 23.59 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 110.135 -0.32 . . . . 72.430000000000007 110.135 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -64.68 -37.67 88.39 Favored 'General case' 0 C--O 1.245 0.821 0 O-C-N 123.544 0.528 . . . . 53.530000000000001 110.367 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.65 149.98 75.0 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 108.942 -0.762 . . . . 73.109999999999999 108.942 174.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -74.39 -28.73 10.06 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.894 1.729 . . . . 73.319999999999993 112.154 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 46.0 t -137.57 132.51 45.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 107.802 -1.185 . . . . 63.43 107.802 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 13.2 t -128.92 140.8 51.51 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 109.623 -0.51 . . . . 44.219999999999999 109.623 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -108.98 127.87 54.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.481 -0.563 . . . . 72.349999999999994 109.481 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 23.9 m -123.06 177.33 4.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.097 -0.705 . . . . 73.120000000000005 109.097 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.537 ' HB3' ' HB ' ' A' ' 518' ' ' ILE . 32.7 t -103.99 159.28 15.8 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.129 0.49 . . . . 73.439999999999998 110.902 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -70.29 -39.22 75.02 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.877 -1.056 . . . . 55.420000000000002 109.776 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 68.1 m -104.19 20.85 17.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.606 0.595 . . . . 72.129999999999995 112.606 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' A' ' 515' ' ' SER . 11.3 tt -70.01 -35.59 64.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 C-N-CA 119.762 -0.775 . . . . 64.120000000000005 110.229 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 519' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 95.06 -78.86 0.87 Allowed Glycine 0 CA--C 1.479 -2.156 0 N-CA-C 110.858 -0.897 . . . . 74.349999999999994 110.858 -177.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 520' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 573' ' ' VAL . 33.8 mm -127.63 133.18 68.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.966 -1.494 . . . . 75.310000000000002 106.966 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.516 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -118.59 144.77 45.89 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.432 -0.581 . . . . 74.109999999999999 109.432 177.499 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -112.1 125.06 53.7 Favored 'General case' 0 C--O 1.241 0.643 0 O-C-N 123.638 0.586 . . . . 73.010000000000005 110.996 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.632 HG11 HD22 ' A' ' 642' ' ' LEU . 47.3 t -104.64 126.29 59.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 109.298 -0.631 . . . . 54.340000000000003 109.298 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -80.38 128.32 33.43 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.538 0.524 . . . . 75.430000000000007 109.686 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 568' ' ' VAL . 62.3 t -106.66 115.39 48.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.798 -0.816 . . . . 70.319999999999993 108.798 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.05 123.8 19.5 Favored 'General case' 0 C--O 1.251 1.144 0 O-C-N 123.991 0.807 . . . . 64.219999999999999 110.206 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -73.59 159.62 32.83 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 114.947 -1.024 . . . . 74.409999999999997 110.238 -177.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.422 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 4.3 t -62.46 140.89 58.59 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.687 -0.688 . . . . 62.210000000000001 110.387 175.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.6 t -59.3 -37.06 76.77 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 123.644 0.778 . . . . 71.510000000000005 109.381 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -110.84 87.66 0.48 Allowed Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.132 -1.187 . . . . 52.039999999999999 110.132 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.0 100.46 13.28 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.994 -0.743 . . . . 52.43 108.994 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -108.58 92.22 3.97 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.617 -0.72 . . . . 64.230000000000004 111.044 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 95.72 -122.15 7.17 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.317 -0.944 . . . . 65.230000000000004 112.796 175.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -132.9 130.83 40.18 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 123.062 0.545 . . . . 73.519999999999996 109.755 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.467 HG22 HD22 ' A' ' 596' ' ' LEU . 60.3 t -134.26 138.36 50.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 123.841 0.856 . . . . 74.109999999999999 109.228 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.535 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 46.6 mm -106.7 133.96 49.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.261 -0.644 . . . . 74.049999999999997 109.261 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.475 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.8 t -122.5 110.85 31.91 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 108.983 -0.747 . . . . 73.019999999999996 108.983 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 51.6 Cg_endo -72.53 157.65 52.37 Favored 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.283 1.989 . . . . 74.25 111.893 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.476 ' HB3' HG22 ' A' ' 591' ' ' ILE . 47.4 p90 -149.65 160.55 43.42 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.645 -0.502 . . . . 64.540000000000006 109.645 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -158.42 154.69 27.32 Favored 'General case' 0 C--O 1.248 1.024 0 O-C-N 123.709 0.631 . . . . 75.450000000000003 111.121 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.3 p -86.95 140.69 29.34 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.884 -0.598 . . . . 63.310000000000002 110.449 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 49.0 mt -114.54 125.54 71.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.436 -0.95 . . . . 73.209999999999994 108.436 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.77 154.61 19.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.312 0.577 . . . . 74.310000000000002 112.454 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 176.4 -73.32 0.08 OUTLIER Glycine 0 C--N 1.305 -1.16 0 N-CA-C 110.731 -0.948 . . . . 72.519999999999996 110.731 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.32 5.86 18.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.101 0.953 . . . . 72.129999999999995 111.342 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -153.5 142.18 20.94 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 105.447 -2.057 . . . . 50.43 105.447 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 38.6 mtp85 -96.05 130.25 43.12 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.115 0.484 . . . . 63.340000000000003 111.452 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.4 -145.8 12.8 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 120.477 -0.868 . . . . 40.119999999999997 112.726 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 549' ' ' GLY . . . . . 0.429 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 65.05 10.1 44.8 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 113.982 0.353 . . . . 71.25 113.982 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 100.43 15.94 28.45 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.164 -1.017 . . . . 51.229999999999997 111.847 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -91.95 -72.48 0.59 Allowed 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 119.713 -0.795 . . . . 60.329999999999998 110.178 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -89.77 -39.16 13.31 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 108.527 -0.916 . . . . 64.420000000000002 108.527 175.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -140.98 155.2 46.27 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.92 -1.037 . . . . 71.530000000000001 108.363 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.04 137.09 33.28 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.779 -1.563 . . . . 41.240000000000002 106.779 177.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 555' ' ' ASP . . . . . 0.429 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 19.5 t70 -87.17 132.09 33.98 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 110.188 -0.301 . . . . 72.109999999999999 110.188 -172.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 15.0 t -136.43 145.48 45.31 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.685 0.755 . . . . 73.209999999999994 110.841 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 52.1 t -154.29 148.15 25.52 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.985 -1.858 . . . . 42.329999999999998 105.985 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 175.27 -164.82 35.49 Favored Glycine 0 C--N 1.287 -2.191 0 N-CA-C 109.997 -1.241 . . . . 61.039999999999999 109.997 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.535 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 87.0 mt-10 -135.56 127.8 30.09 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.987 0.394 . . . . 74.310000000000002 110.646 -177.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.416 HD22 ' HB3' ' A' ' 569' ' ' LYS . 91.7 mt -92.01 134.18 35.04 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.78 -0.645 . . . . 75.010000000000005 109.469 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.415 ' HA ' HD13 ' A' ' 536' ' ' ILE . 31.3 tt0 -98.84 116.33 30.83 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.775 -0.648 . . . . 71.409999999999997 109.57 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -111.56 145.65 38.75 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.335 -0.617 . . . . 74.519999999999996 109.335 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.514 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 49.7 mt-30 -142.7 179.58 6.91 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 109.183 -0.673 . . . . 71.430000000000007 109.183 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -70.52 -37.92 74.18 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.571 -0.9 . . . . 74.209999999999994 108.571 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.68 -27.29 37.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.729 -1.123 . . . . 75.329999999999998 111.979 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.514 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 8.7 mm-40 -78.62 146.97 33.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.283 -0.636 . . . . 71.140000000000001 109.283 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.596 HG13 ' H ' ' A' ' 568' ' ' VAL . 4.0 pt -95.57 -80.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 112.45 0.537 . . . . 65.099999999999994 112.45 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.596 ' H ' HG13 ' A' ' 567' ' ' ILE . 8.3 p -135.73 148.97 27.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 108.619 -0.882 . . . . 72.120000000000005 108.619 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.416 ' HB3' HD22 ' A' ' 560' ' ' LEU . 1.8 mtpt -114.95 159.96 20.12 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.545 -0.539 . . . . 74.420000000000002 109.545 175.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 16.2 p -128.26 150.15 50.17 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.877 -0.601 . . . . 74.230000000000004 111.009 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.42 HG22 HG23 ' A' ' 573' ' ' VAL . 3.3 mp -99.51 123.28 52.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 106.518 -1.66 . . . . 72.209999999999994 106.518 171.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 572' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 521' ' ' MET . 4.6 p -97.77 115.98 29.08 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.913 0.758 . . . . 70.239999999999995 109.502 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 520' ' ' ILE . 95.9 t -117.33 133.92 62.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 116.619 -0.264 . . . . 74.219999999999999 110.807 -178.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 46.7 tptt -85.6 112.46 20.99 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 109.054 -0.721 . . . . 73.310000000000002 109.054 175.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.63 125.62 40.29 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 104.924 -2.25 . . . . 72.109999999999999 104.924 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 37.9 mm -77.82 120.8 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-O 122.054 0.93 . . . . 72.510000000000005 109.978 -175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.04 130.21 34.88 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 113.186 -1.824 . . . . 73.040000000000006 108.373 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -156.34 -83.54 0.06 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.703 -0.681 . . . . 75.340000000000003 111.655 -174.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -154.85 164.82 38.28 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.374 -0.973 . . . . 64.439999999999998 108.374 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -104.33 15.16 28.83 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 123.41 0.684 . . . . 72.510000000000005 109.484 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -74.76 -13.63 60.62 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 113.787 1.032 . . . . 72.400000000000006 113.787 -170.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 583' ' ' LYS 0.316 0.0 OUTLIER -79.47 -95.73 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 116.163 1.912 . . . . 73.219999999999999 116.163 -175.206 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.455 ' H ' ' CD ' ' A' ' 582' ' ' GLU . 54.3 tttm -147.94 -71.18 0.22 Allowed 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.333 -0.854 . . . . 72.109999999999999 110.747 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 169.1 110.1 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 103.874 -2.639 . . . . 75.519999999999996 103.874 -173.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -96.87 147.09 24.31 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.554 -0.858 . . . . 75.340000000000003 111.016 -176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.5 t -153.14 138.44 17.51 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.879 -0.415 . . . . 74.120000000000005 109.879 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -135.25 176.0 9.07 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.479 -0.934 . . . . 74.040000000000006 108.479 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.487 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 74.0 m-85 -122.47 152.67 40.05 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.042 -0.663 . . . . 53.350000000000001 109.872 -175.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.07 130.86 53.64 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.484 -1.672 . . . . 63.240000000000002 106.484 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.424 ' HB2' HD11 ' A' ' 542' ' ' ILE . 30.2 tt0 -121.63 136.48 54.94 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.745 -0.465 . . . . 75.219999999999999 109.745 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.476 HG22 ' HB3' ' A' ' 539' ' ' TYR . 21.1 pt -107.94 132.93 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 107.04 -1.467 . . . . 63.340000000000003 107.04 169.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.52 -166.48 42.01 Favored Glycine 0 N--CA 1.423 -2.206 0 CA-C-N 115.577 -0.738 . . . . 61.5 112.713 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.69 131.71 73.4 Favored Pre-proline 0 N--CA 1.427 -1.603 0 CA-C-O 120.997 0.427 . . . . 70.25 111.629 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.475 ' HB3' HG22 ' A' ' 537' ' ' VAL . 47.3 Cg_endo -69.42 147.3 64.73 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.952 2.434 . . . . 63.039999999999999 111.973 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -125.03 137.3 54.23 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.934 -0.765 . . . . 72.329999999999998 108.934 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.467 HD22 HG22 ' A' ' 535' ' ' VAL . 0.8 OUTLIER -78.99 128.68 33.57 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 107.122 -1.436 . . . . 64.120000000000005 107.122 179.087 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.459 ' CG2' HG12 ' A' ' 536' ' ' ILE . 37.8 t -85.96 89.07 2.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 109.056 -0.72 . . . . 61.420000000000002 109.056 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -115.24 -77.81 0.57 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.466 -1.309 . . . . 64.010000000000005 107.466 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 65.0 mtt -78.89 -16.92 56.39 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.924 -0.769 . . . . 72.230000000000004 108.924 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 11.7 m 66.01 24.52 11.06 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.195 1.398 . . . . 45.43 111.196 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -88.09 99.89 12.53 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.832 -0.622 . . . . 71.439999999999998 110.85 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.05 104.95 10.04 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.079 -1.823 . . . . 71.120000000000005 106.079 173.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -70.16 -34.38 72.94 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.334 -0.394 . . . . 71.450000000000003 111.809 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 157.39 -47.38 0.47 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 119.628 -1.272 . . . . 74.239999999999995 111.99 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 87.24 53.63 2.76 Favored Glycine 0 C--N 1.305 -1.176 0 N-CA-C 109.21 -1.556 . . . . 65.310000000000002 109.21 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -68.8 105.01 2.18 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.395 0.617 . . . . 51.109999999999999 110.556 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 14.9 m -107.27 110.1 22.05 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 107.291 -1.374 . . . . 74.209999999999994 107.291 177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 16.8 tt -87.87 -31.28 5.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.273 0.559 . . . . 71.25 110.284 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 36.3 m -94.91 100.53 12.38 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.92 -1.511 . . . . 65.030000000000001 106.92 175.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -91.89 -25.13 19.07 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.291 -0.413 . . . . 72.5 111.403 -174.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.53 116.7 32.55 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 104.989 -2.226 . . . . 74.409999999999997 104.989 172.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -137.0 112.87 9.58 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 113.562 0.949 . . . . 74.25 113.562 -177.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -84.51 -16.07 43.69 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.568 -1.271 . . . . 74.010000000000005 107.568 172.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -108.12 94.54 5.13 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.7 -1.222 . . . . 73.329999999999998 107.7 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -68.47 -45.02 73.53 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.006 -0.543 . . . . 73.420000000000002 111.953 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -133.74 146.04 58.61 Favored Pre-proline 0 C--N 1.303 -1.439 0 CA-C-N 116.113 -0.494 . . . . 72.099999999999994 109.837 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -50.76 123.64 11.98 Favored 'Trans proline' 0 C--O 1.252 1.181 0 C-N-CA 123.505 2.804 . . . . 75.049999999999997 112.463 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 60.9 tp -70.97 -61.54 1.73 Allowed 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.13 -0.941 . . . . 71.219999999999999 110.528 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 3.0 p -138.89 118.57 13.07 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.377 0.608 . . . . 73.209999999999994 112.533 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 38.7 t -87.25 117.07 25.77 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 105.554 -2.017 . . . . 64.340000000000003 105.554 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 621' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' A' ' 621' ' ' LYS . 9.9 mptt -82.49 -59.8 2.41 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.273 -1.38 . . . . 73.129999999999995 107.273 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -91.74 123.33 35.05 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 105.36 -2.089 . . . . 72.530000000000001 105.36 171.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -59.13 108.72 0.72 Allowed 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 123.624 0.578 . . . . 73.510000000000005 111.293 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -59.22 120.59 9.51 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.071 -0.968 . . . . 72.430000000000007 110.08 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -25.62 63.18 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.452 0.644 . . . . 74.140000000000001 110.753 177.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -52.37 -54.75 27.8 Favored 'General case' 0 C--O 1.196 -1.718 0 CA-C-N 114.349 -1.296 . . . . 74.420000000000002 110.82 171.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 627' ' ' ARG . . . . . 0.466 ' HA ' ' HB2' ' A' ' 630' ' ' GLU . 7.3 tmm_? -69.21 -25.07 64.13 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.993 0.425 . . . . 73.030000000000001 110.473 -175.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.51 ' O ' ' HG2' ' A' ' 631' ' ' MET . 65.0 mt -69.77 -29.99 42.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.787 0.803 . . . . 52.43 109.248 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -86.94 -34.59 19.28 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.433 0.635 . . . . 63.149999999999999 109.607 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 627' ' ' ARG . 45.3 mt-10 -74.48 -11.41 60.22 Favored 'General case' 0 C--O 1.211 -0.968 0 N-CA-C 112.712 0.634 . . . . 74.140000000000001 112.712 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 26.4 ptt? -73.17 -15.01 61.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.119 -1.067 . . . . 75.140000000000001 108.119 173.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -87.46 8.25 77.85 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 115.136 -0.938 . . . . 64.340000000000003 111.39 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 33.9 ptt85 -130.46 161.17 62.29 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 107.043 -1.465 . . . . 71.540000000000006 107.043 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -68.81 137.12 37.49 Favored 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 121.154 1.236 . . . . 72.420000000000002 111.041 174.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.39 167.46 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-N 115.179 -0.918 . . . . 75.299999999999997 109.545 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.35 -176.24 3.16 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 112.199 0.444 . . . . 72.120000000000005 112.199 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.434 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -77.83 -150.18 4.26 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-O 121.646 0.581 . . . . 32.229999999999997 113.84 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -80.97 -48.34 12.41 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.09 0.472 . . . . 75.239999999999995 109.947 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -133.12 131.64 40.75 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.821 -0.807 . . . . 71.099999999999994 108.821 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 640' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 506' ' ' THR . 23.9 p -119.97 88.95 3.03 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 121.755 0.788 . . . . 54.140000000000001 110.136 175.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -159.79 137.6 9.99 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.286 -0.87 . . . . 75.299999999999997 109.567 -175.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.632 HD22 HG11 ' A' ' 523' ' ' VAL . 15.6 tp -123.32 128.64 50.21 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 107.974 -1.121 . . . . 74.319999999999993 107.974 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -97.71 111.7 23.88 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.396 -1.335 . . . . 74.349999999999994 107.396 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.7 112.86 34.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.448 -0.575 . . . . 72.049999999999997 109.448 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 68.6 mt -101.6 121.42 52.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 109.636 -0.505 . . . . 72.530000000000001 109.636 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 69.1 mt -95.17 113.89 30.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.877 -1.157 . . . . 50.130000000000003 107.877 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 515' ' ' SER . 40.3 mt-10 -118.63 156.28 29.49 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.627 -1.249 . . . . 72.319999999999993 107.627 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -77.7 145.39 36.63 Favored 'General case' 0 N--CA 1.404 -2.73 0 N-CA-C 106.902 -1.518 . . . . 73.150000000000006 106.902 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 649' ' ' SER . . . . . 0.433 ' HB2' ' OG ' ' A' ' 515' ' ' SER . 66.2 m -133.74 49.09 2.3 Favored 'General case' 0 C--N 1.252 -3.634 0 C-N-CA 119.564 -0.854 . . . . 75.430000000000007 110.684 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -84.06 -52.31 6.4 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 105.865 -1.902 . . . . 73.010000000000005 105.865 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -77.54 -48.32 17.3 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.727 -1.579 . . . . 73.319999999999993 110.55 -175.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 25.1 t80 35.1 73.45 0.08 Allowed 'General case' 0 C--O 1.242 0.67 0 O-C-N 125.456 1.722 . . . . 74.540000000000006 110.866 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -147.81 155.53 41.75 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.594 -0.73 . . . . 72.450000000000003 110.793 -170.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 47.4 t -87.03 103.62 15.54 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.312 -0.996 . . . . 74.120000000000005 108.312 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 15.2 t -156.46 130.32 8.42 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 121.59 0.71 . . . . 71.540000000000006 110.997 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.84 162.1 19.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 106.735 -1.58 . . . . 63.340000000000003 106.735 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 C--N 1.304 -1.394 0 C-N-CA 120.039 -0.664 . . . . 53.009999999999998 110.404 179.749 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 7.3 t60 . . . . . 0 N--CA 1.439 -1.003 0 N-CA-C 107.344 -1.354 . . . . 74.040000000000006 107.344 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.551 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . -90.29 -43.45 10.36 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.158 0.504 . . . . 71.219999999999999 112.293 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 128.02 -136.78 9.36 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 119.417 -1.373 . . . . 63.539999999999999 112.186 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.74 112.48 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 111.171 0.063 . . . . 64.239999999999995 111.171 -174.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.483 ' CD2' HG23 ' A' ' 528' ' ' THR . 11.4 m-85 -99.75 120.69 40.13 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.666 -1.235 . . . . 71.420000000000002 107.666 167.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.3 t -163.96 178.65 7.57 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.647 -0.501 . . . . 65.209999999999994 109.647 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -81.39 143.61 32.03 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.885 -0.413 . . . . 71.25 109.885 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -61.31 -37.78 84.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 123.723 0.639 . . . . 74.430000000000007 109.89 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -125.34 144.83 48.87 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 108.089 -1.078 . . . . 72.409999999999997 108.089 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.88 -27.68 2.96 Favored 'Trans proline' 0 C--N 1.329 -0.448 0 C-N-CA 122.163 1.909 . . . . 72.129999999999995 112.389 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.6 t -137.39 135.32 46.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.901 -1.518 . . . . 72.140000000000001 106.901 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.6 t -133.68 136.53 44.79 Favored 'General case' 0 N--CA 1.409 -2.49 0 N-CA-C 108.99 -0.745 . . . . 54.229999999999997 108.99 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -109.48 120.09 41.43 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.135 -0.691 . . . . 74.430000000000007 109.135 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 25.2 m -108.19 174.48 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 115.548 -0.751 . . . . 71.340000000000003 109.983 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.432 ' OG ' ' HB ' ' A' ' 518' ' ' ILE . 0.0 OUTLIER -96.8 164.06 12.72 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.4 -0.818 . . . . 65.140000000000001 110.495 -178.845 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -82.24 -54.29 5.37 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.248 -1.019 . . . . 61.32 108.248 171.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 12.1 m -80.71 31.79 0.3 Allowed 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.512 0.725 . . . . 74.530000000000001 112.1 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.432 ' HB ' ' OG ' ' A' ' 515' ' ' SER . 10.1 tt -94.34 -24.81 4.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 O-C-N 121.762 -0.586 . . . . 72.510000000000005 111.062 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.81 -80.53 1.79 Allowed Glycine 0 N--CA 1.417 -2.597 0 C-N-CA 120.329 -0.938 . . . . 71.340000000000003 111.128 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 43.0 mm -128.12 131.5 69.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.739 -1.208 . . . . 71.140000000000001 107.739 -174.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.546 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -109.41 145.1 36.69 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.093 -0.706 . . . . 60.43 109.093 176.11 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 23.9 mt-10 -124.19 119.57 29.76 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 123.667 0.604 . . . . 72.420000000000002 111.747 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.62 HG11 HD22 ' A' ' 642' ' ' LEU . 95.5 t -103.56 128.86 56.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 116.029 -0.532 . . . . 74.120000000000005 110.423 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -80.31 137.45 36.59 Favored 'General case' 0 C--O 1.248 0.981 0 O-C-N 123.515 0.51 . . . . 65.209999999999994 110.502 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 568' ' ' VAL . 59.9 t -112.75 132.82 60.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 116.147 -0.479 . . . . 73.549999999999997 109.741 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.81 126.68 31.4 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 122.928 0.491 . . . . 65.450000000000003 110.074 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -81.32 157.09 25.2 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.307 -0.861 . . . . 62.039999999999999 109.314 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 0.9 OUTLIER -59.97 145.8 44.84 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 123.333 0.653 . . . . 63.140000000000001 112.295 177.623 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 41.4 t -60.15 -34.98 74.3 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.153 -0.931 . . . . 74.239999999999995 110.093 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.41 81.04 0.35 Allowed Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.638 -0.985 . . . . 34.43 110.638 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.06 114.02 21.9 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.305 -0.998 . . . . 61.340000000000003 108.305 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -119.15 97.91 5.91 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.499 0.666 . . . . 75.109999999999999 110.711 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 108.89 -130.8 10.22 Favored Glycine 0 N--CA 1.427 -1.965 0 CA-C-N 115.397 -0.82 . . . . 55.25 112.772 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -133.15 127.74 34.53 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.892 -0.781 . . . . 70.439999999999998 108.892 -177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 61.3 t -132.18 141.82 44.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 123.185 0.594 . . . . 74.140000000000001 110.135 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.434 HG12 ' CG2' ' A' ' 597' ' ' VAL . 36.8 mm -111.35 129.99 65.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.197 -0.668 . . . . 74.030000000000001 109.197 175.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.407 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.2 t -115.04 105.96 52.19 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 109.203 -0.666 . . . . 73.140000000000001 109.203 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.82 152.35 36.95 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.319 2.013 . . . . 43.0 112.287 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.643 ' HB3' HG22 ' A' ' 591' ' ' ILE . 49.9 p90 -147.33 164.97 31.56 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.526 -0.306 . . . . 72.439999999999998 111.057 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -156.39 158.1 36.76 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.709 0.63 . . . . 72.219999999999999 109.916 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.3 p -87.78 141.75 28.36 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 115.656 -0.702 . . . . 71.25 110.102 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.533 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 90.3 mt -116.84 132.53 66.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.555 -1.276 . . . . 73.219999999999999 107.555 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -81.0 148.22 29.84 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 109.801 -0.444 . . . . 62.020000000000003 109.801 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -141.88 -117.3 1.3 Allowed Glycine 0 C--N 1.292 -1.88 0 N-CA-C 108.671 -1.772 . . . . 72.030000000000001 108.671 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 545' ' ' THR . . . . . 0.412 ' O ' ' HD3' ' A' ' 585' ' ' LYS . 16.7 p -78.34 -23.87 46.78 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.127 -1.064 . . . . 72.409999999999997 108.127 173.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 587' ' ' PHE . . . -91.84 135.52 33.86 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 106.982 -1.488 . . . . 71.329999999999998 106.982 172.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -106.81 151.99 24.46 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 113.717 1.006 . . . . 65.129999999999995 113.717 -174.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -91.24 -176.41 43.47 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 114.899 -1.046 . . . . 51.509999999999998 111.707 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 91.63 22.77 30.32 Favored Glycine 0 C--N 1.294 -1.77 0 N-CA-C 110.152 -1.179 . . . . 62.100000000000001 110.152 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 70.54 33.98 67.62 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 109.539 -1.424 . . . . 74.430000000000007 109.539 -176.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -95.66 -66.88 0.88 Allowed 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 110.08 -0.341 . . . . 64.329999999999998 110.08 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -104.41 -38.29 6.88 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.19 -1.041 . . . . 62.240000000000002 108.19 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -132.91 158.35 42.8 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.246 -0.888 . . . . 65.230000000000004 108.693 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.53 129.12 37.56 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.589 -1.263 . . . . 73.439999999999998 107.589 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.36 136.99 50.16 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 123.367 0.667 . . . . 74.409999999999997 110.175 -175.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.405 HG21 HG22 ' A' ' 573' ' ' VAL . 9.0 t -139.76 144.87 37.63 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.413 0.625 . . . . 65.0 110.03 176.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 14.2 p -143.94 133.29 23.24 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 106.275 -1.75 . . . . 41.219999999999999 106.275 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -159.49 -169.89 23.38 Favored Glycine 0 N--CA 1.404 -3.459 0 C-N-CA 118.602 -1.761 . . . . 74.129999999999995 112.385 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -139.82 115.23 9.91 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 124.659 0.858 . . . . 63.43 108.751 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.481 HD22 ' HB3' ' A' ' 569' ' ' LYS . 86.7 mt -89.54 133.55 34.54 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.571 -0.529 . . . . 63.229999999999997 109.571 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -101.95 119.34 38.63 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.173 0.511 . . . . 73.030000000000001 110.815 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -119.03 150.06 40.6 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.826 -0.805 . . . . 71.230000000000004 108.826 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.539 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 64.4 mt-30 -146.42 179.01 7.82 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.364 -1.347 . . . . 61.229999999999997 107.364 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -70.19 -25.77 63.58 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 123.64 0.588 . . . . 60.509999999999998 110.423 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -90.75 -33.61 15.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.988 -0.551 . . . . 60.340000000000003 111.915 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.539 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 72.5 mm-40 -66.84 152.61 45.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.918 0.39 . . . . 72.25 111.706 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.561 HG13 ' H ' ' A' ' 568' ' ' VAL . 5.8 pt -103.52 -86.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 113.38 0.881 . . . . 63.149999999999999 113.38 -177.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.561 ' H ' HG13 ' A' ' 567' ' ' ILE . 13.2 p -132.26 148.87 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 120.789 0.328 . . . . 71.400000000000006 110.221 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.481 ' HB3' HD22 ' A' ' 560' ' ' LEU . 1.5 mtpt -120.66 160.97 22.2 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 116.105 -0.498 . . . . 74.140000000000001 109.66 175.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 5.5 p -125.61 153.78 43.23 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.69 -0.687 . . . . 61.25 111.033 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.4 mp -100.91 122.74 53.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.21 -1.774 . . . . 60.549999999999997 106.21 170.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 572' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 521' ' ' MET . 14.8 p -100.91 115.11 29.65 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 123.622 0.577 . . . . 74.219999999999999 109.948 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.42 HG23 HG22 ' A' ' 571' ' ' ILE . 84.3 t -119.43 134.23 63.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.066 -0.515 . . . . 74.420000000000002 110.405 -177.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -84.54 118.86 24.59 Favored 'General case' 0 N--CA 1.428 -1.567 0 O-C-N 123.645 0.591 . . . . 73.219999999999999 109.568 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.05 120.71 36.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 105.953 -1.869 . . . . 73.349999999999994 105.953 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 48.2 mm -69.58 132.2 33.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.484 0.659 . . . . 43.509999999999998 109.883 -176.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 577' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 579' ' ' GLU . 9.7 m-20 -76.51 152.68 35.98 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.167 -1.378 . . . . 71.109999999999999 108.046 -177.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -45.98 121.56 3.3 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.837 1.051 . . . . 75.140000000000001 113.837 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 577' ' ' ASP . 51.9 mm-40 -129.3 -55.21 1.18 Allowed 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 125.218 1.407 . . . . 70.450000000000003 109.849 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -103.13 -70.74 0.75 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.443 -0.799 . . . . 73.340000000000003 110.118 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -178.22 75.42 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 125.311 1.445 . . . . 74.040000000000006 108.17 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -80.92 147.73 30.17 Favored 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 113.958 -1.473 . . . . 74.409999999999997 107.358 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -145.81 177.47 8.89 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.471 -1.307 . . . . 75.140000000000001 107.471 -170.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -63.11 98.23 0.13 Allowed 'General case' 0 C--O 1.246 0.878 0 N-CA-C 107.703 -1.221 . . . . 60.439999999999998 107.703 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.412 ' HD3' ' O ' ' A' ' 545' ' ' THR . 94.8 mttt -131.54 169.0 16.71 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.647 -1.612 . . . . 75.340000000000003 106.647 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.8 t -143.1 148.77 37.18 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 121.248 0.546 . . . . 62.219999999999999 110.721 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.533 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 43.1 p90 -130.57 172.4 11.97 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 106.747 -1.575 . . . . 70.040000000000006 106.747 176.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.514 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 87.2 m-85 -120.24 154.51 34.79 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.195 -0.602 . . . . 73.239999999999995 109.981 -175.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.49 128.7 51.16 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 105.418 -2.067 . . . . 71.109999999999999 105.418 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.517 ' HB2' HD11 ' A' ' 542' ' ' ILE . 35.0 tt0 -129.19 137.08 50.93 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.598 -0.519 . . . . 74.219999999999999 109.598 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.643 HG22 ' HB3' ' A' ' 539' ' ' TYR . 15.1 pt -104.9 141.58 19.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.535 -0.913 . . . . 74.349999999999994 108.535 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -87.78 -176.58 48.12 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.66 -0.976 . . . . 74.519999999999996 110.66 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -68.47 130.97 91.81 Favored Pre-proline 0 N--CA 1.434 -1.251 0 C-N-CA 120.543 -0.463 . . . . 72.030000000000001 110.847 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.459 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 24.8 Cg_endo -66.95 137.24 44.1 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.013 2.475 . . . . 62.32 111.642 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -112.94 133.61 54.83 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.332 -0.395 . . . . 74.420000000000002 110.425 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -76.02 130.55 38.57 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.066 -1.457 . . . . 72.140000000000001 107.066 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.434 ' CG2' HG12 ' A' ' 536' ' ' ILE . 39.0 t -84.61 87.86 2.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 107.84 -1.17 . . . . 65.25 107.84 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -91.46 141.22 28.98 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 114.492 -1.231 . . . . 64.329999999999998 109.8 -176.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 82.2 mmm -88.95 -35.4 16.46 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.493 -1.299 . . . . 60.149999999999999 107.493 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 33.6 t -97.26 42.07 1.1 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.192 -1.41 . . . . 52.310000000000002 107.192 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.68 119.89 7.93 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.343 -0.844 . . . . 73.129999999999995 112.597 -175.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -107.41 121.88 45.49 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 108.033 -1.099 . . . . 64.439999999999998 108.033 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -58.12 126.72 28.68 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 124.09 0.869 . . . . 64.310000000000002 110.561 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -71.03 -50.73 21.74 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 107.248 -2.341 . . . . 51.200000000000003 107.248 171.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 73.57 -66.18 1.68 Allowed Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 114.351 -0.924 . . . . 64.25 114.474 172.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -85.03 81.79 8.73 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.506 0.67 . . . . 73.409999999999997 111.698 -173.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 36.9 p -109.26 156.29 20.11 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.424 -1.324 . . . . 71.120000000000005 107.424 173.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 42.4 mm -87.1 72.97 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.927 -1.138 . . . . 73.430000000000007 107.927 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 29.2 m -155.01 108.93 2.9 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.702 -1.135 . . . . 62.32 108.356 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -106.45 13.67 28.2 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.749 -0.834 . . . . 64.510000000000005 108.749 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -96.79 117.99 32.27 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.761 -1.109 . . . . 61.119999999999997 108.593 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -67.04 -29.35 69.13 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.398 0.679 . . . . 73.530000000000001 111.104 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.11 -31.07 69.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.046 -0.525 . . . . 70.340000000000003 112.118 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 57.42 42.81 24.13 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 123.837 0.71 . . . . 71.409999999999997 109.482 -172.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -78.07 -56.51 4.42 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.543 -1.28 . . . . 73.319999999999993 107.543 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -135.99 96.94 12.63 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-N 115.735 -0.666 . . . . 71.310000000000002 110.578 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.15 158.61 55.91 Favored 'Trans proline' 0 C--O 1.244 0.803 0 C-N-CA 122.554 2.17 . . . . 73.140000000000001 111.25 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.2 173.26 7.81 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.32 -1.363 . . . . 74.349999999999994 107.32 175.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 54.7 p -69.3 124.72 24.6 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.334 -0.547 . . . . 65.230000000000004 109.79 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 19.3 m -105.44 87.64 2.66 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.509 -1.293 . . . . 70.0 107.509 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -104.72 91.24 3.77 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.781 -1.1 . . . . 75.299999999999997 111.024 -174.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 622' ' ' GLU . . . . . 0.521 ' HB2' ' HD3' ' A' ' 626' ' ' ARG . 1.1 mp0 -74.29 167.39 21.72 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.852 -1.166 . . . . 75.409999999999997 107.852 173.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -77.08 -5.59 49.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.507 0.67 . . . . 75.109999999999999 111.143 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.9 166.29 23.61 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.791 -1.095 . . . . 72.140000000000001 109.662 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -77.42 90.47 3.83 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.22 -1.029 . . . . 71.310000000000002 108.22 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.521 ' HD3' ' HB2' ' A' ' 622' ' ' GLU . 28.5 mmm180 -69.27 -43.75 73.25 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 111.904 0.335 . . . . 70.120000000000005 111.904 -173.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 627' ' ' ARG . . . . . 0.648 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 16.3 mmt180 -63.7 -31.28 72.4 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.457 0.646 . . . . 74.140000000000001 111.697 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.505 ' O ' ' HG2' ' A' ' 631' ' ' MET . 52.3 mt -88.62 -26.55 5.57 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-O 121.701 0.762 . . . . 54.240000000000002 110.219 -177.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -78.0 -20.08 53.24 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.093 -0.503 . . . . 61.399999999999999 110.2 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.648 ' HG2' ' O ' ' A' ' 627' ' ' ARG . 5.5 pt-20 -69.72 -10.97 60.4 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 116.09 -0.505 . . . . 72.099999999999994 111.737 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 27.1 ptt? -78.73 -18.41 54.3 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.785 -0.45 . . . . 64.310000000000002 109.785 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -86.89 0.17 86.16 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.584 -0.606 . . . . 73.230000000000004 111.584 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -126.93 149.16 68.29 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 106.63 -1.618 . . . . 54.229999999999997 106.63 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.459 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 24.9 Cg_endo -69.64 136.41 33.23 Favored 'Trans proline' 0 N--CA 1.44 -1.623 0 C-N-CA 121.119 1.212 . . . . 72.319999999999993 110.293 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.61 160.72 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 116.397 -0.365 . . . . 70.329999999999998 111.208 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.1 -176.36 3.97 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.822 -0.626 . . . . 62.229999999999997 112.278 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.66 -163.16 9.97 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 116.447 -0.342 . . . . 75.239999999999995 113.455 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -76.14 -46.62 27.85 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.789 -0.449 . . . . 75.420000000000002 109.789 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -136.57 120.94 18.06 Favored 'General case' 0 CA--C 1.49 -1.354 0 CA-C-O 121.063 0.459 . . . . 62.039999999999999 109.822 174.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 31.3 p -108.14 94.65 5.18 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-O 121.778 0.799 . . . . 60.109999999999999 109.774 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -151.31 146.73 26.22 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.972 -1.013 . . . . 72.439999999999998 108.638 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.62 HD22 HG11 ' A' ' 523' ' ' VAL . 26.3 tp -134.92 120.4 19.21 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 107.924 -1.139 . . . . 64.530000000000001 107.924 175.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -91.38 108.56 19.97 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.206 -1.405 . . . . 72.230000000000004 107.206 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 39.5 t -100.42 109.46 25.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 109.526 -0.546 . . . . 61.039999999999999 109.526 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 47.3 mt -93.87 129.64 43.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.343 -0.984 . . . . 61.509999999999998 108.343 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 77.1 mt -99.91 107.33 20.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.973 -0.751 . . . . 72.209999999999994 108.973 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 515' ' ' SER . 38.2 mt-10 -114.31 125.99 54.5 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.628 0.728 . . . . 60.130000000000003 111.725 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -70.86 118.25 13.39 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.762 -1.199 . . . . 73.420000000000002 107.762 175.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 44.8 t -147.76 110.2 4.64 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.547 -1.279 . . . . 65.430000000000007 107.547 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -94.77 -12.08 27.78 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.474 0.654 . . . . 73.5 109.507 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -58.66 -26.78 64.14 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.312 0.856 . . . . 64.019999999999996 113.312 -174.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -89.07 -14.94 35.2 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 120.568 -0.453 . . . . 74.420000000000002 110.87 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -161.67 98.96 1.12 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.711 -0.848 . . . . 73.209999999999994 108.711 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 26.3 m -107.84 -163.94 0.93 Allowed 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.786 -0.82 . . . . 61.32 108.786 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 28.4 m -71.47 -41.76 68.96 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 108.82 -0.807 . . . . 71.519999999999996 108.82 176.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 23.7 m -137.61 165.06 27.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 115.248 -0.887 . . . . 73.519999999999996 108.651 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 C--N 1.306 -1.298 0 N-CA-C 109.586 -0.524 . . . . 75.230000000000004 109.586 179.693 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 501' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' A' ' 631' ' ' MET . 8.1 t60 . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 106.528 -1.656 . . . . 71.400000000000006 106.528 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -70.23 -78.27 0.08 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 121.128 -0.229 . . . . 63.100000000000001 111.48 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 163.36 -145.76 10.89 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.695 -1.24 . . . . 74.510000000000005 112.134 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.15 121.69 58.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 122.428 0.291 . . . . 65.129999999999995 110.923 -174.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -105.44 125.44 50.99 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.204 -0.665 . . . . 72.430000000000007 109.204 169.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 506' ' ' THR . . . . . 0.466 ' HA ' HG22 ' A' ' 640' ' ' THR . 9.0 t -162.79 169.01 20.58 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.393 -0.595 . . . . 72.319999999999993 109.393 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -74.6 148.36 40.82 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.477 0.18 . . . . 74.439999999999998 110.714 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -68.13 -26.8 65.97 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.529 0.681 . . . . 72.519999999999996 110.124 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -140.76 141.01 23.18 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 107.33 -1.359 . . . . 53.350000000000001 107.33 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.48 -28.86 8.05 Favored 'Trans proline' 0 C--N 1.328 -0.539 0 C-N-CA 122.426 2.084 . . . . 70.150000000000006 111.637 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.9 t -132.69 136.34 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 106.293 -1.743 . . . . 62.32 106.293 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 7.5 t -131.71 140.76 49.37 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 108.82 -0.807 . . . . 74.540000000000006 108.82 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -113.07 123.35 50.09 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.073 -0.651 . . . . 44.43 109.677 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 20.8 m -112.66 174.34 2.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 115.249 -0.887 . . . . 62.020000000000003 108.897 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.568 ' O ' HG22 ' A' ' 518' ' ' ILE . 36.1 t -107.29 151.17 25.83 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.652 0.739 . . . . 21.210000000000001 111.882 -175.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.537 ' CB ' ' HA ' ' A' ' 648' ' ' GLU . 14.2 tt0 -62.19 -23.51 66.66 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 125.732 1.613 . . . . 44.340000000000003 109.705 170.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 4.2 t -123.17 26.35 8.05 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 120.977 0.418 . . . . 71.409999999999997 111.402 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 515' ' ' SER . 8.5 tt -84.11 -27.87 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.55 -0.719 . . . . 63.219999999999999 110.664 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.21 -80.04 1.57 Allowed Glycine 0 N--CA 1.428 -1.856 0 N-CA-C 111.056 -0.817 . . . . 71.129999999999995 111.056 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 520' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 574' ' ' LYS . 40.2 mm -127.92 133.17 67.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 106.471 -1.677 . . . . 63.140000000000001 106.471 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.607 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -109.86 144.07 38.85 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.767 -0.457 . . . . 64.140000000000001 109.767 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 7.8 mp0 -117.9 118.12 31.11 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 124.185 0.928 . . . . 62.43 109.916 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.577 HG23 ' SD ' ' A' ' 521' ' ' MET . 87.4 t -109.45 130.71 62.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.176 -0.676 . . . . 61.409999999999997 109.176 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -88.75 145.16 25.79 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 121.942 0.877 . . . . 74.120000000000005 112.626 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 38.9 t -113.26 137.55 45.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-N 114.437 -1.256 . . . . 65.310000000000002 107.926 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.7 mt -78.22 114.64 17.3 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.813 -0.81 . . . . 73.319999999999993 108.813 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -68.65 157.44 36.19 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.595 -1.184 . . . . 71.239999999999995 109.24 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.1 t -55.57 133.01 50.1 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 123.825 0.703 . . . . 55.439999999999998 111.568 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.7 m -54.59 -28.06 43.55 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.611 1.564 . . . . 55.340000000000003 111.026 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.58 91.93 0.48 Allowed Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 108.748 -1.741 . . . . 71.420000000000002 108.748 174.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -92.7 104.13 16.44 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.972 0.415 . . . . 63.409999999999997 110.411 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -130.27 104.68 7.43 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.069 -0.514 . . . . 71.129999999999995 109.85 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 101.18 -138.79 14.06 Favored Glycine 0 C--N 1.307 -1.08 0 C-N-CA 120.86 -0.686 . . . . 42.240000000000002 112.16 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -133.24 130.56 39.18 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.419 -0.585 . . . . 74.030000000000001 109.419 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.28 134.04 57.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.03 -1.1 . . . . 73.329999999999998 108.03 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.513 HG12 ' CG2' ' A' ' 597' ' ' VAL . 46.3 mm -102.95 135.11 41.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.205 -0.665 . . . . 53.310000000000002 109.205 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 42.8 t -120.11 108.79 37.94 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.577 -0.527 . . . . 73.209999999999994 109.577 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 48.4 Cg_endo -74.3 154.06 45.89 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.277 1.984 . . . . 74.329999999999998 111.748 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.478 ' HB3' HG22 ' A' ' 591' ' ' ILE . 33.1 p90 -145.59 164.2 32.44 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.942 -0.303 . . . . 60.210000000000001 110.709 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -157.02 156.85 33.61 Favored 'General case' 0 C--O 1.248 0.978 0 O-C-N 123.835 0.709 . . . . 74.439999999999998 110.225 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.2 p -89.15 139.84 30.06 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 116.075 -0.511 . . . . 73.120000000000005 110.109 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 78.0 mt -112.01 129.24 67.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.812 -0.81 . . . . 74.540000000000006 108.812 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -83.02 164.7 20.19 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.156 -0.683 . . . . 65.099999999999994 109.156 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 172.1 -82.73 0.08 OUTLIER Glycine 0 CA--C 1.474 -2.469 0 C-N-CA 120.031 -1.081 . . . . 60.109999999999999 111.749 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.8 m -101.92 19.4 18.44 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.513 1.149 . . . . 63.439999999999998 108.402 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -162.84 148.82 12.29 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 106.169 -1.789 . . . . 51.200000000000003 106.169 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -104.59 141.07 37.07 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 123.712 0.805 . . . . 75.439999999999998 112.116 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.63 -160.41 36.46 Favored Glycine 0 C--N 1.306 -1.116 0 CA-C-N 115.433 -0.803 . . . . 64.329999999999998 112.704 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 71.65 12.66 74.2 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.751 -0.261 . . . . 30.129999999999999 113.499 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 90.11 19.36 46.85 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.459 -0.877 . . . . 64.439999999999998 111.043 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -89.18 -67.32 0.85 Allowed 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.59 -0.522 . . . . 74.439999999999998 109.59 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -102.13 -33.69 9.57 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.657 -1.238 . . . . 72.209999999999994 107.657 172.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -141.33 154.99 45.99 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.591 -0.892 . . . . 72.430000000000007 108.591 176.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.14 120.28 27.35 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.596 -1.631 . . . . 74.450000000000003 106.596 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -80.66 124.58 29.12 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.064 -0.516 . . . . 73.340000000000003 110.531 -171.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.7 t -136.2 168.68 18.95 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.35 0.595 . . . . 64.349999999999994 111.199 -172.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 14.8 p -158.52 164.44 36.13 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.97 -1.122 . . . . 64.430000000000007 107.97 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 173.57 -169.44 42.53 Favored Glycine 0 CA--C 1.482 -1.982 0 C-N-CA 120.156 -1.021 . . . . 74.010000000000005 110.853 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 46.1 mt-10 -137.14 125.42 23.22 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 123.428 0.691 . . . . 73.209999999999994 109.319 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.485 HD22 ' HB3' ' A' ' 569' ' ' LYS . 96.5 mt -96.05 132.42 41.44 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.257 -0.429 . . . . 75.109999999999999 109.862 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.43 ' HA ' HD13 ' A' ' 536' ' ' ILE . 29.0 tt0 -94.91 111.23 23.04 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.22 0.534 . . . . 72.209999999999994 110.806 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 81.9 m-85 -107.98 142.59 37.87 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.063 0.459 . . . . 75.230000000000004 110.002 177.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.486 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 43.0 mt-30 -140.42 179.9 6.39 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.45 -0.574 . . . . 74.420000000000002 109.45 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -68.36 -34.61 76.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.82 -1.082 . . . . 72.549999999999997 108.894 173.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -85.14 -39.99 17.25 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.033 -0.985 . . . . 73.549999999999997 111.692 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.486 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 52.2 mm-40 -65.49 135.08 54.72 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.084 0.402 . . . . 64.299999999999997 112.084 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.617 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.8 pt -83.76 -81.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.227 0.825 . . . . 73.319999999999993 113.227 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.617 ' H ' HG13 ' A' ' 567' ' ' ILE . 9.0 p -128.79 158.48 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 109.555 -0.535 . . . . 70.120000000000005 109.555 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.485 ' HB3' HD22 ' A' ' 560' ' ' LEU . 4.5 mmpt? -125.94 159.26 33.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.078 -1.082 . . . . 72.340000000000003 108.078 172.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 5.8 p -130.14 149.07 52.01 Favored 'General case' 0 C--N 1.286 -2.194 0 O-C-N 123.832 0.707 . . . . 71.030000000000001 111.673 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.9 mp -94.79 125.53 47.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 106.825 -1.546 . . . . 73.400000000000006 106.825 172.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 572' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 521' ' ' MET . 48.6 m -107.07 118.36 36.5 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 123.958 0.786 . . . . 73.409999999999997 110.068 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.401 HG23 HG22 ' A' ' 571' ' ' ILE . 76.4 t -125.45 134.42 66.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.097 -0.501 . . . . 54.109999999999999 109.874 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.408 ' HA ' HD13 ' A' ' 520' ' ' ILE . 27.5 tptp -79.87 115.02 19.22 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.883 -0.784 . . . . 64.239999999999995 108.883 174.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.24 130.19 36.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.604 -1.258 . . . . 72.25 107.604 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 44.1 mm -87.49 129.57 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.895 0 N-CA-C 108.174 -1.047 . . . . 73.340000000000003 108.174 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -83.36 80.31 9.13 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 122.951 1.358 . . . . 62.030000000000001 109.577 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' A' ' 580' ' ' GLU . 36.9 t70 -84.26 140.62 31.54 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 113.344 -1.753 . . . . 70.120000000000005 110.204 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -93.9 -0.34 55.74 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.973 -0.558 . . . . 63.119999999999997 111.395 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.482 ' HB3' ' OD2' ' A' ' 578' ' ' ASP . 28.2 tt0 -98.49 85.31 3.35 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.713 -0.847 . . . . 71.120000000000005 108.713 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . 0.309 7.1 p90 -114.19 65.55 0.67 Allowed 'General case' 0 C--N 1.28 -2.426 0 CA-C-O 122.767 1.27 . . . . 72.540000000000006 112.042 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -80.02 -34.03 38.7 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 112.953 -1.931 . . . . 64.349999999999994 108.032 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -145.98 141.76 28.01 Favored 'General case' 0 N--CA 1.409 -2.52 0 N-CA-C 104.891 -2.263 . . . . 75.019999999999996 104.891 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 584' ' ' ASN . . . . . 0.488 ' ND2' ' HA ' ' A' ' 647' ' ' GLU . 14.3 m120 -60.13 131.92 52.32 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 123.902 0.751 . . . . 73.430000000000007 110.636 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -86.02 120.6 27.58 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 107.819 -1.178 . . . . 71.219999999999999 107.819 -176.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.7 t -132.73 130.64 40.27 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.626 0.727 . . . . 64.140000000000001 111.402 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -121.37 172.42 8.05 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.418 -0.956 . . . . 72.219999999999999 108.418 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.506 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 90.8 m-85 -118.7 152.48 36.05 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.947 -0.701 . . . . 75.030000000000001 109.855 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.54 130.22 54.14 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.304 -1.739 . . . . 72.109999999999999 106.304 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.474 ' HB2' HD11 ' A' ' 542' ' ' ILE . 43.3 tt0 -127.02 134.44 50.32 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.624 -0.43 . . . . 62.310000000000002 109.865 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.478 HG22 ' HB3' ' A' ' 539' ' ' TYR . 21.3 pt -102.56 139.78 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 107.673 -1.232 . . . . 72.010000000000005 107.673 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.45 177.2 52.73 Favored Glycine 0 N--CA 1.421 -2.343 0 C-N-CA 120.997 -0.62 . . . . 43.450000000000003 111.622 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.16 129.06 94.18 Favored Pre-proline 0 N--CA 1.428 -1.531 0 CA-C-O 120.86 0.362 . . . . 73.319999999999993 110.631 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.405 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 23.3 Cg_endo -60.24 132.94 46.72 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.485 2.79 . . . . 71.519999999999996 112.291 -175.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 595' ' ' ARG . . . . . 0.403 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.0 ptp180 -110.41 119.96 40.9 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 120.993 0.425 . . . . 64.109999999999999 110.658 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.49 131.82 47.38 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.731 0.813 . . . . 70.140000000000001 108.858 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.513 ' CG2' HG12 ' A' ' 536' ' ' ILE . 61.0 t -92.81 103.95 15.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.46 -0.57 . . . . 74.409999999999997 109.46 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.78 114.81 18.03 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.538 -1.653 . . . . 63.32 106.538 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 25.2 mmt -84.54 -64.9 1.08 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.024 0.44 . . . . 75.519999999999996 110.333 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 39.3 t -165.68 87.38 0.39 Allowed 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.578 -0.737 . . . . 74.239999999999995 109.109 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -133.24 142.77 48.72 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.353 -1.351 . . . . 73.209999999999994 107.353 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -81.19 78.69 7.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.866 0.841 . . . . 63.229999999999997 110.184 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 603' ' ' LYS . . . . . 0.45 ' HB2' ' HE3' ' A' ' 603' ' ' LYS . 37.3 ttmt -155.08 106.83 2.65 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.347 -1.353 . . . . 73.349999999999994 107.347 -175.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -128.47 175.69 18.51 Favored Glycine 0 N--CA 1.427 -1.937 0 C-N-CA 120.717 -0.754 . . . . 71.25 112.376 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 152.53 -162.15 29.8 Favored Glycine 0 N--CA 1.422 -2.236 0 N-CA-C 109.136 -1.586 . . . . 30.329999999999998 109.136 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -115.89 118.46 33.03 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 117.255 0.528 . . . . 70.010000000000005 110.982 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 5.1 p -60.29 -33.62 72.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.34 -0.845 . . . . 73.400000000000006 110.814 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 59.4 mt -86.01 80.24 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 106.885 -1.524 . . . . 63.009999999999998 106.885 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 7.1 m -83.2 -37.19 23.95 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.489 -0.56 . . . . 74.420000000000002 109.489 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -79.4 105.82 10.99 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.251 -1.018 . . . . 55.420000000000002 108.251 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -97.36 85.13 3.58 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 107.944 -1.132 . . . . 62.25 107.944 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.404 ' HD2' ' O ' ' A' ' 614' ' ' ASP . 15.8 p90 -92.43 132.7 36.56 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.094 -0.957 . . . . 74.129999999999995 111.484 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -90.54 -12.65 36.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.873 -0.603 . . . . 72.140000000000001 110.95 -177.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 614' ' ' ASP . . . . . 0.404 ' O ' ' HD2' ' A' ' 612' ' ' TYR . 14.8 t70 -95.96 179.11 5.2 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.123 -1.806 . . . . 64.010000000000005 106.123 173.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -87.49 -14.48 40.26 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 119.137 0.881 . . . . 65.140000000000001 109.914 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -141.3 128.54 11.79 Favored Pre-proline 0 N--CA 1.431 -1.387 0 N-CA-C 113.66 0.985 . . . . 73.510000000000005 113.66 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 617' ' ' PRO . . . . . 0.402 ' HG2' ' OG1' ' A' ' 619' ' ' THR . 19.2 Cg_endo -100.83 173.06 0.32 Allowed 'Trans proline' 0 N--CA 1.44 -1.659 0 C-N-CA 122.198 1.932 . . . . 65.239999999999995 109.83 167.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.2 pp -91.36 32.85 1.02 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.481 -0.762 . . . . 62.399999999999999 111.477 178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 619' ' ' THR . . . . . 0.562 ' HA ' ' OE2' ' A' ' 622' ' ' GLU . 25.0 m -46.66 99.64 0.02 OUTLIER 'General case' 0 C--O 1.24 0.565 0 C-N-CA 125.517 1.527 . . . . 74.409999999999997 112.442 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 24.1 p -178.02 -19.5 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.739 0.644 . . . . 74.030000000000001 112.739 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -138.53 19.99 2.72 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.278 -0.569 . . . . 62.350000000000001 112.344 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 622' ' ' GLU . . . . . 0.562 ' OE2' ' HA ' ' A' ' 619' ' ' THR . 1.3 mp0 -74.84 -66.84 0.7 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.84 0.352 . . . . 74.549999999999997 110.651 -177.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 626' ' ' ARG . 16.1 mm-40 -143.02 114.96 8.25 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 109.086 -0.709 . . . . 75.219999999999999 109.086 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -67.51 -8.26 32.36 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.648 0.737 . . . . 64.099999999999994 110.999 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -51.45 -33.37 30.64 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.776 0.83 . . . . 75.430000000000007 110.556 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 623' ' ' GLU . 5.9 ptp180 -64.57 -28.8 69.88 Favored 'General case' 0 C--O 1.195 -1.802 0 CA-C-N 116.444 -0.344 . . . . 71.420000000000002 111.128 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 627' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 64.8 ttt180 -74.37 -19.63 60.37 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.863 0.84 . . . . 74.409999999999997 109.667 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.648 ' O ' ' HG2' ' A' ' 631' ' ' MET . 57.1 mt -88.22 -46.25 15.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.426 -1.324 . . . . 62.100000000000001 107.426 175.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -66.17 -20.12 66.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.54 -0.754 . . . . 73.030000000000001 112.265 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 627' ' ' ARG . 10.4 pt-20 -67.61 -16.68 64.3 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 116.586 -0.279 . . . . 72.109999999999999 111.262 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.648 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 24.7 ptt? -78.83 -16.81 56.63 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.595 -0.442 . . . . 74.0 109.823 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -82.02 -14.11 77.88 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 111.053 -0.819 . . . . 41.310000000000002 111.053 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -115.03 159.32 38.17 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 106.771 -1.566 . . . . 73.530000000000001 106.771 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.405 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 55.5 Cg_endo -76.39 135.46 16.62 Favored 'Trans proline' 0 N--CA 1.435 -1.913 0 C-N-CA 120.77 0.98 . . . . 70.319999999999993 111.016 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.93 170.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 116.174 -0.466 . . . . 73.540000000000006 110.876 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.34 170.65 7.82 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 112.786 0.661 . . . . 75.349999999999994 112.786 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -78.51 -158.08 11.38 Favored Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 114.834 -1.075 . . . . 73.329999999999998 115.283 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -66.78 -54.52 21.83 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.082 -1.059 . . . . 71.409999999999997 110.853 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -126.81 137.49 53.21 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.56 -0.904 . . . . 73.019999999999996 108.56 175.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 640' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 506' ' ' THR . 8.7 p -127.12 73.68 1.44 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 122.344 1.069 . . . . 72.120000000000005 111.336 174.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -157.42 141.2 15.88 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 114.475 -1.239 . . . . 60.149999999999999 107.962 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.544 HD22 HG11 ' A' ' 523' ' ' VAL . 38.5 tp -124.4 130.24 52.12 Favored 'General case' 0 C--N 1.279 -2.484 0 O-C-N 124.181 0.926 . . . . 75.219999999999999 109.35 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -94.46 107.38 19.35 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.059 -1.46 . . . . 63.140000000000001 107.059 174.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.1 109.63 24.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.269 -0.641 . . . . 74.0 109.269 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 52.6 mt -96.76 122.91 48.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 109.012 -0.736 . . . . 73.310000000000002 109.012 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 82.2 mt -87.72 111.82 22.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 106.9 -1.519 . . . . 74.430000000000007 106.9 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.488 ' HA ' ' ND2' ' A' ' 584' ' ' ASN . 46.2 mt-10 -107.94 138.86 43.46 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 109.364 -0.606 . . . . 65.310000000000002 109.364 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.55 ' CD ' ' H ' ' A' ' 648' ' ' GLU . 0.2 OUTLIER -73.78 120.61 19.61 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 115.034 -0.984 . . . . 73.129999999999995 109.013 178.539 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 649' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 652' ' ' PHE . 58.1 m -155.78 84.68 1.03 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 112.862 0.69 . . . . 53.109999999999999 112.862 -173.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -89.89 -42.96 10.92 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.546 -1.279 . . . . 55.509999999999998 107.546 167.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -79.27 -46.26 18.12 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.644 -1.162 . . . . 64.109999999999999 109.476 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 652' ' ' PHE . . . . . 0.443 ' O ' ' HB3' ' A' ' 649' ' ' SER . 60.6 t80 -78.39 144.09 36.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.636 -0.711 . . . . 65.310000000000002 109.705 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -154.37 174.1 15.3 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.033 -1.099 . . . . 44.549999999999997 108.033 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 17.3 m -69.86 85.75 0.5 Allowed 'General case' 0 C--N 1.314 -0.949 0 O-C-N 123.465 0.478 . . . . 73.109999999999999 110.318 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 35.8 m -103.17 121.23 42.23 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.179 0.514 . . . . 72.200000000000003 110.795 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 15.8 m -95.64 114.97 33.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 121.571 0.701 . . . . 52.049999999999997 110.418 177.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 15.8 t70 . . . . . 0 C--N 1.299 -1.628 0 CA-C-N 115.447 -0.797 . . . . 75.420000000000002 110.669 -179.359 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 75.3 m80 . . . . . 0 C--O 1.242 0.709 0 N-CA-C 110.522 -0.177 . . . . 54.409999999999997 110.522 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.533 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . -58.48 -46.29 86.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.385 0.612 . . . . 75.019999999999996 110.993 178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 139.88 -149.51 20.86 Favored Glycine 0 N--CA 1.419 -2.486 0 C-N-CA 120.304 -0.95 . . . . 72.049999999999997 110.875 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.43 HG23 ' HA3' ' A' ' 637' ' ' GLY . 3.8 mp -117.24 113.43 42.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 123.687 0.287 . . . . 51.100000000000001 111.237 -174.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.435 ' CD2' HG23 ' A' ' 528' ' ' THR . 21.8 m-85 -92.04 124.82 36.43 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.725 -1.213 . . . . 71.109999999999999 107.725 169.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.7 t -168.72 171.46 8.64 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 120.554 -0.458 . . . . 62.439999999999998 109.883 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -80.55 157.39 26.1 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.839 -0.801 . . . . 71.25 108.839 175.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.74 -35.51 80.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.506 0.67 . . . . 64.239999999999995 110.32 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -140.18 149.36 57.92 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.487 -0.931 . . . . 75.420000000000002 108.487 -176.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 510' ' ' PRO . . . . . 0.434 ' O ' ' HA ' ' A' ' 642' ' ' LEU . 60.9 Cg_endo -75.53 -24.97 11.51 Favored 'Trans proline' 0 C--O 1.219 -0.437 0 C-N-CA 122.158 1.906 . . . . 75.129999999999995 112.77 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.75 135.76 58.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.981 -0.748 . . . . 74.230000000000004 108.981 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 9.5 t -135.03 140.08 45.32 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 107.714 -1.217 . . . . 64.239999999999995 107.714 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -108.73 138.41 45.09 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.651 -0.87 . . . . 73.540000000000006 108.651 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.8 m -128.65 156.38 41.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.953 -0.758 . . . . 62.310000000000002 108.953 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.592 ' O ' HG22 ' A' ' 518' ' ' ILE . 33.0 t -83.48 150.84 25.76 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.795 -0.639 . . . . 75.019999999999996 109.323 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.699 ' HB3' ' HA ' ' A' ' 648' ' ' GLU . 1.8 tm-20 -66.89 -32.64 74.04 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.494 -0.558 . . . . 64.530000000000001 109.494 170.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.7 m -99.29 20.46 13.56 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 116.142 -0.481 . . . . 65.409999999999997 112.117 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 515' ' ' SER . 9.9 tt -79.23 -27.52 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.542 -0.724 . . . . 74.209999999999994 111.529 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 92.3 -77.16 1.26 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.29 -0.957 . . . . 51.229999999999997 111.327 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 520' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 574' ' ' LYS . 42.4 mm -130.53 123.58 55.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 106.719 -1.586 . . . . 72.319999999999993 106.719 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -101.43 150.52 22.95 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.798 -0.816 . . . . 74.219999999999999 108.798 177.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.7 mt-10 -132.06 129.18 39.68 Favored 'General case' 0 CA--C 1.493 -1.247 0 O-C-N 123.702 0.626 . . . . 73.230000000000004 111.033 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.582 HG21 HD21 ' A' ' 642' ' ' LEU . 60.9 t -116.4 132.04 67.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.282 -0.872 . . . . 54.200000000000003 108.978 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -85.45 127.82 34.52 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 124.138 0.975 . . . . 71.340000000000003 110.252 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 60.3 t -110.41 128.57 66.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.885 -0.598 . . . . 72.219999999999999 109.645 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 77.9 mt -81.75 127.97 33.5 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.012 -0.994 . . . . 62.420000000000002 112.031 -173.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -72.12 162.18 29.83 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.387 -0.968 . . . . 74.310000000000002 108.387 172.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 19.4 p -58.7 154.52 14.45 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 123.503 0.721 . . . . 71.299999999999997 112.341 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 41.0 t -53.83 -35.18 61.18 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.793 1.237 . . . . 62.32 109.498 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -114.82 103.7 1.29 Allowed Glycine 0 N--CA 1.42 -2.407 0 N-CA-C 108.841 -1.704 . . . . 54.509999999999998 108.841 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.71 101.7 12.99 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.194 -0.669 . . . . 70.329999999999998 109.194 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -127.02 117.99 23.57 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.796 -0.816 . . . . 64.439999999999998 108.796 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 77.22 172.04 36.56 Favored Glycine 0 C--N 1.298 -1.562 0 N-CA-C 115.016 0.767 . . . . 63.009999999999998 115.016 173.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 534' ' ' ASN . . . . . 0.513 ' ND2' HG21 ' A' ' 597' ' ' VAL . 49.9 t30 -86.01 123.23 31.1 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.519 -0.84 . . . . 72.519999999999996 109.127 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.402 HG22 HD22 ' A' ' 596' ' ' LEU . 58.0 t -132.01 132.9 61.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 114.8 -1.091 . . . . 72.129999999999995 108.204 -175.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.484 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 43.8 mm -102.81 132.25 49.34 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 109.375 -0.602 . . . . 71.209999999999994 109.375 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.53 105.77 43.27 Favored Pre-proline 0 N--CA 1.427 -1.594 0 N-CA-C 108.736 -0.839 . . . . 75.140000000000001 108.736 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 34.8 Cg_endo -72.55 151.98 53.54 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.169 1.912 . . . . 71.120000000000005 111.672 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.42 ' HB3' HG22 ' A' ' 591' ' ' ILE . 32.3 p90 -142.6 163.27 33.28 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.459 -0.496 . . . . 72.310000000000002 110.104 177.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -153.67 151.37 29.59 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 123.929 0.768 . . . . 75.239999999999995 110.01 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 11.1 p -85.78 133.13 34.01 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 109.377 -0.601 . . . . 75.319999999999993 109.377 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 67.5 mt -108.08 124.2 64.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 108.178 -1.045 . . . . 73.209999999999994 108.178 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -73.14 136.03 44.77 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 120.945 0.402 . . . . 74.5 110.321 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -126.61 -104.43 1.35 Allowed Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 109.352 -1.499 . . . . 54.219999999999999 109.352 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.7 p -94.57 -21.32 18.92 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.489 0.662 . . . . 64.420000000000002 109.61 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -84.01 142.29 30.58 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 108.44 -0.948 . . . . 72.209999999999994 108.44 175.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -87.32 123.3 32.15 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 114.305 1.224 . . . . 73.230000000000004 114.305 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -81.92 -158.8 23.26 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 115.043 -0.981 . . . . 53.109999999999999 112.101 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.36 14.36 71.66 Favored Glycine 0 C--N 1.306 -1.1 0 C-N-CA 121.312 -0.471 . . . . 52.439999999999998 112.837 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 550' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 554' ' ' GLU . . . 77.92 39.02 25.4 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.905 -0.664 . . . . 33.409999999999997 111.836 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -111.9 -50.97 2.88 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.441 0.639 . . . . 62.409999999999997 109.949 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -104.07 -47.14 4.25 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 105.821 -1.918 . . . . 63.009999999999998 105.821 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -134.11 154.21 51.34 Favored 'General case' 0 C--O 1.256 1.421 0 CA-C-N 114.329 -1.305 . . . . 75.030000000000001 108.152 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.417 ' HA ' ' HA2' ' A' ' 550' ' ' GLY . 16.4 tt0 -81.21 119.38 23.54 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.25 -1.389 . . . . 70.420000000000002 107.25 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.88 125.15 28.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.093 -1.077 . . . . 74.349999999999994 108.093 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.409 HG21 HG22 ' A' ' 573' ' ' VAL . 12.0 t -140.02 159.41 42.25 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-O 121.618 0.723 . . . . 45.009999999999998 110.609 -171.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 23.0 p -147.22 165.74 29.12 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 107.331 -1.359 . . . . 75.420000000000002 107.331 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 176.16 -174.32 46.86 Favored Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 120.044 -1.074 . . . . 42.229999999999997 110.82 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.484 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 51.7 mt-10 -134.38 119.55 18.75 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 123.271 0.628 . . . . 75.420000000000002 109.325 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' A' ' 569' ' ' LYS . 88.7 mt -86.53 132.47 33.91 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.985 -0.552 . . . . 62.109999999999999 109.811 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.483 ' HA ' HD13 ' A' ' 536' ' ' ILE . 34.9 tt0 -101.53 106.38 17.47 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.745 -0.661 . . . . 73.409999999999997 110.019 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -105.42 149.68 25.93 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.75 -0.833 . . . . 72.25 108.75 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.576 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 37.3 mt-30 -143.96 -169.16 3.04 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.204 -1.406 . . . . 64.010000000000005 107.204 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -76.12 -19.48 58.48 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.595 -0.891 . . . . 71.219999999999999 108.595 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -88.54 -45.1 10.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.31 -1.314 . . . . 62.25 110.521 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.576 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 6.0 mm-40 -74.9 122.51 23.53 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.943 0.401 . . . . 74.409999999999997 111.817 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.493 HD12 HG12 ' A' ' 568' ' ' VAL . 1.8 pp -106.99 -32.51 2.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 115.122 -0.944 . . . . 54.25 113.16 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.493 HG12 HD12 ' A' ' 567' ' ' ILE . 9.4 p -143.43 145.76 22.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 120.275 -0.57 . . . . 71.129999999999995 110.494 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.443 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.1 OUTLIER -127.59 162.18 27.09 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.798 -0.637 . . . . 64.420000000000002 109.612 174.06 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.7 p -122.32 143.33 49.7 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.588 0.588 . . . . 53.009999999999998 112.588 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.6 mp -94.63 117.84 39.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 106.591 -1.633 . . . . 63.210000000000001 106.591 170.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 572' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 521' ' ' MET . 8.1 p -98.31 115.52 28.59 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.712 0.632 . . . . 65.310000000000002 109.498 178.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.557 HG23 HG22 ' A' ' 571' ' ' ILE . 60.1 t -121.52 124.66 72.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 116.295 -0.412 . . . . 74.430000000000007 110.66 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.42 ' HA ' HD13 ' A' ' 520' ' ' ILE . 13.6 tppt? -71.91 120.83 18.07 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.965 -1.016 . . . . 72.040000000000006 108.678 173.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 28.2 t -92.37 130.33 41.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 104.73 -2.322 . . . . 53.140000000000001 104.73 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 44.0 mm -83.31 152.09 3.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 108.762 -0.829 . . . . 73.019999999999996 108.762 -173.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.9 88.95 0.76 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.201 -1.407 . . . . 74.340000000000003 107.201 174.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.14 105.12 2.8 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.11 -1.404 . . . . 73.319999999999993 112.191 -173.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -78.88 -44.61 22.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.278 -1.328 . . . . 75.150000000000006 109.918 -175.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -85.67 -167.95 2.04 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.086 -1.45 . . . . 75.519999999999996 107.086 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -169.48 170.06 8.5 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 118.845 0.748 . . . . 75.340000000000003 111.605 176.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -147.11 147.98 31.13 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 104.443 -2.428 . . . . 73.200000000000003 104.443 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -63.34 100.12 0.23 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 123.752 0.657 . . . . 74.239999999999995 111.7 -177.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 57.78 84.83 0.09 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.846 1.258 . . . . 73.540000000000006 111.404 177.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.289 0.0 OUTLIER -111.02 147.87 33.82 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 114.196 1.184 . . . . 60.43 114.196 -178.552 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.9 t -141.79 159.02 43.08 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.767 -1.106 . . . . 61.130000000000003 110.349 -172.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 40.3 p90 -132.79 168.69 17.91 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 106.693 -1.595 . . . . 75.200000000000003 106.693 175.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.533 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 63.6 m-85 -115.74 155.74 27.23 Favored 'General case' 0 C--N 1.283 -2.284 0 C-N-CA 120.34 -0.544 . . . . 75.400000000000006 110.342 -175.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.21 126.19 46.51 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 105.717 -1.957 . . . . 62.039999999999999 105.717 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.401 ' HB2' HD11 ' A' ' 542' ' ' ILE . 42.4 tt0 -127.16 129.77 48.5 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 120.534 -0.467 . . . . 75.340000000000003 109.871 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.42 HG22 ' HB3' ' A' ' 539' ' ' TYR . 21.5 pt -98.96 136.2 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 N-CA-C 108.046 -1.094 . . . . 64.409999999999997 108.046 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.03 -177.87 52.13 Favored Glycine 0 N--CA 1.421 -2.365 0 CA-C-N 115.496 -0.775 . . . . 62.219999999999999 111.369 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -64.82 133.71 95.82 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 120.742 0.306 . . . . 74.340000000000003 111.497 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -69.01 124.09 11.02 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 122.697 2.265 . . . . 71.450000000000003 110.558 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -111.41 125.1 53.51 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 109.65 -0.5 . . . . 70.040000000000006 109.65 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.421 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 1.4 tm? -66.33 133.13 49.88 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 105.204 -2.147 . . . . 74.230000000000004 105.204 174.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.513 HG21 ' ND2' ' A' ' 534' ' ' ASN . 63.4 t -65.5 100.76 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.759 0.79 . . . . 75.109999999999999 110.861 -177.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -149.88 152.89 35.81 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 104.921 -2.252 . . . . 74.450000000000003 104.921 -174.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 41.0 ttp -101.74 12.54 36.92 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.481 0.658 . . . . 75.430000000000007 111.228 -175.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 15.7 m -71.83 96.86 1.71 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.247 0.546 . . . . 74.239999999999995 110.524 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -141.94 172.68 12.35 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.993 -0.549 . . . . 73.150000000000006 109.775 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -144.89 93.66 2.43 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.992 -1.484 . . . . 73.239999999999995 106.992 172.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -118.8 92.68 3.87 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.478 0.656 . . . . 71.219999999999999 109.704 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -116.94 -94.81 1.82 Allowed Glycine 0 C--N 1.293 -1.849 0 N-CA-C 110.23 -1.148 . . . . 71.430000000000007 110.23 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 605' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 620' ' ' SER . . . 141.82 -99.15 0.23 Allowed Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 110.768 -0.933 . . . . 61.439999999999998 110.768 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 606' ' ' PHE . . . . . 0.619 ' HA ' ' O ' ' A' ' 619' ' ' THR . 20.9 p90 -93.63 104.99 17.07 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.424 0.631 . . . . 74.129999999999995 111.088 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 23.9 m -80.15 -48.92 12.42 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.315 -0.857 . . . . 75.510000000000005 109.545 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 608' ' ' ILE . . . . . 0.558 ' O ' ' HB ' ' A' ' 619' ' ' THR . 67.1 mt -118.52 138.34 49.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 107.077 -1.453 . . . . 71.230000000000004 107.077 178.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 6.3 m -146.27 35.13 0.98 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.69 -1.596 . . . . 61.399999999999999 106.69 176.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.5 -46.28 64.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.15 -1.841 . . . . 74.340000000000003 109.743 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -113.71 141.77 46.85 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 115.621 -0.718 . . . . 74.430000000000007 109.444 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -107.11 101.44 10.85 Favored 'General case' 0 N--CA 1.405 -2.686 0 CA-C-O 122.242 1.02 . . . . 63.020000000000003 110.529 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -86.67 13.77 8.11 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 123.073 1.416 . . . . 73.040000000000006 109.143 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -156.19 -166.98 2.31 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 101.82 -3.4 . . . . 71.219999999999999 101.82 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -82.02 -53.88 5.76 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 121.035 1.743 . . . . 55.509999999999998 107.744 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -132.49 91.66 30.03 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 106.47 -1.678 . . . . 53.329999999999998 106.47 171.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -81.62 -37.79 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.04 1.826 . . . . 60.020000000000003 114.172 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 54.44 70.66 0.59 Allowed 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.864 0.727 . . . . 73.040000000000006 109.202 -171.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 619' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 606' ' ' PHE . 4.1 m -50.9 101.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.387 1.475 . . . . 71.030000000000001 111.735 -175.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.488 ' O ' ' HD2' ' A' ' 621' ' ' LYS . 13.8 m -87.89 108.91 19.4 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.549 -0.75 . . . . 72.109999999999999 112.249 -172.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 621' ' ' LYS . . . . . 0.488 ' HD2' ' O ' ' A' ' 620' ' ' SER . 14.3 mptt -136.22 141.68 43.99 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.488 0.715 . . . . 64.329999999999998 110.41 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.48 -177.74 6.82 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.075 -1.824 . . . . 73.0 106.075 175.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.31 159.31 42.49 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.274 -1.38 . . . . 74.329999999999998 107.274 170.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -111.96 124.27 52.04 Favored 'General case' 0 N--CA 1.403 -2.793 0 C-N-CA 119.078 -1.049 . . . . 65.310000000000002 108.366 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -115.96 18.34 15.58 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 106.214 -1.773 . . . . 63.549999999999997 106.214 174.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 38.8 mtt180 -73.69 -37.96 65.03 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.357 -1.747 . . . . 72.329999999999998 109.032 -175.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 627' ' ' ARG . . . . . 0.609 ' HD3' ' O ' ' A' ' 627' ' ' ARG . 0.9 OUTLIER -56.03 -33.77 65.24 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.627 0.771 . . . . 72.450000000000003 111.37 -177.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 62.5 mt -58.53 -31.69 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-O 121.724 0.773 . . . . 75.019999999999996 109.807 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 629' ' ' ALA . . . . . 0.494 ' O ' ' HG2' ' A' ' 633' ' ' ARG . . . -91.43 -39.57 11.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.857 -0.61 . . . . 65.200000000000003 109.827 175.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.591 ' HA ' ' CG ' ' A' ' 633' ' ' ARG . 50.6 mt-10 -63.45 -11.03 20.26 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.876 1.065 . . . . 62.219999999999999 113.876 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -66.66 -15.63 63.62 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.814 0.34 . . . . 73.430000000000007 110.845 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -142.07 59.01 0.55 Allowed Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.589 -1.004 . . . . 53.119999999999997 110.589 177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 633' ' ' ARG . . . . . 0.591 ' CG ' ' HA ' ' A' ' 630' ' ' GLU . 36.1 mmt180 -131.73 168.01 19.45 Favored Pre-proline 0 C--N 1.32 -0.715 0 C-N-CA 123.301 0.64 . . . . 74.549999999999997 110.138 -176.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 633' ' ' ARG . 36.7 Cg_endo -65.57 140.11 61.34 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.399 2.066 . . . . 75.430000000000007 112.389 175.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -126.71 164.08 27.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.591 -0.732 . . . . 72.140000000000001 109.89 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.53 173.56 7.56 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 112.875 0.694 . . . . 70.409999999999997 112.875 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.43 ' HA3' HG23 ' A' ' 504' ' ' ILE . . . -74.88 -171.89 28.8 Favored Glycine 0 N--CA 1.43 -1.709 0 CA-C-N 115.579 -0.737 . . . . 74.329999999999998 114.354 -176.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.73 -40.52 88.39 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.168 0.987 . . . . 74.25 109.744 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -133.3 138.51 46.44 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.904 -0.776 . . . . 70.329999999999998 108.904 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 19.1 p -136.53 88.17 2.35 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.746 0.784 . . . . 63.210000000000001 109.217 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -159.73 145.19 15.58 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.019 -0.991 . . . . 74.409999999999997 108.797 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.582 HD21 HG21 ' A' ' 523' ' ' VAL . 25.8 tp -136.14 120.55 18.08 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 108.717 -0.845 . . . . 72.099999999999994 108.717 176.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -91.68 105.33 17.65 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.831 -1.544 . . . . 72.400000000000006 106.831 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 36.7 t -98.69 106.25 18.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.468 -0.567 . . . . 72.120000000000005 109.468 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 53.6 mt -89.94 128.98 41.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 109.014 -0.736 . . . . 70.209999999999994 109.014 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 55.3 mt -104.4 103.55 15.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.238 -0.652 . . . . 73.239999999999995 109.238 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -95.33 129.9 42.31 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.892 -0.595 . . . . 74.420000000000002 109.478 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.699 ' HA ' ' HB3' ' A' ' 516' ' ' GLU . 0.4 OUTLIER -72.66 143.09 48.26 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.62 -0.718 . . . . 61.039999999999999 111.316 -174.402 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 66.8 m -138.86 41.28 2.14 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 112.471 0.545 . . . . 73.540000000000006 112.471 -168.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -57.12 -37.44 71.98 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 123.029 0.531 . . . . 70.129999999999995 111.553 176.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.77 -20.3 58.37 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.461 -0.791 . . . . 71.420000000000002 111.39 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 70.04 71.84 0.22 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 124.919 1.288 . . . . 74.109999999999999 111.618 -174.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -151.46 75.5 1.17 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.62 -1.173 . . . . 71.340000000000003 109.967 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 35.3 t -176.9 -168.45 0.22 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.053 -1.091 . . . . 73.400000000000006 108.053 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 3.9 t -81.0 75.27 7.98 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 122.282 1.039 . . . . 35.450000000000003 109.802 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 40.8 t -77.27 -22.13 14.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.753 -1.112 . . . . 73.329999999999998 108.92 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 . . . . . 0 C--O 1.258 1.529 0 CA-C-N 115.214 -0.903 . . . . 63.229999999999997 109.23 177.986 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 33.3 t60 . . . . . 0 C--O 1.241 0.626 0 N-CA-C 108.72 -0.844 . . . . 73.099999999999994 108.72 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -68.75 -51.09 45.06 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.954 -1.021 . . . . 61.420000000000002 112.205 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 135.91 -141.53 12.68 Favored Glycine 0 C--N 1.313 -0.697 0 C-N-CA 118.892 -1.623 . . . . 64.409999999999997 113.424 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.7 119.52 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 C-N-CA 122.893 0.477 . . . . 45.340000000000003 110.327 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -98.57 135.15 40.52 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.254 -1.387 . . . . 73.349999999999994 107.254 168.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 506' ' ' THR . . . . . 0.471 ' HA ' HG22 ' A' ' 640' ' ' THR . 12.9 t -169.41 -179.96 3.65 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.959 -0.756 . . . . 72.319999999999993 108.959 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 507' ' ' PHE . . . . . 0.454 ' CZ ' HG23 ' A' ' 591' ' ' ILE . 67.4 m-85 -84.4 151.84 24.42 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.937 -0.394 . . . . 75.030000000000001 109.937 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -67.0 -31.75 72.53 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.439 0.638 . . . . 62.450000000000003 110.059 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -135.0 141.53 38.66 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.532 -1.285 . . . . 71.099999999999994 107.532 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.59 -26.32 7.2 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 122.289 1.993 . . . . 73.219999999999999 112.459 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 61.1 t -139.73 132.31 35.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 106.853 -1.536 . . . . 65.400000000000006 106.853 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.8 t -127.68 138.71 52.89 Favored 'General case' 0 N--CA 1.414 -2.226 0 C-N-CA 120.252 -0.579 . . . . 72.209999999999994 109.994 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -103.64 116.44 32.35 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.541 -0.911 . . . . 74.349999999999994 108.541 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.6 m -117.44 165.5 12.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.418 -0.956 . . . . 75.109999999999999 108.418 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.606 ' O ' HG22 ' A' ' 518' ' ' ILE . 27.3 t -95.95 153.8 17.57 Favored 'General case' 0 N--CA 1.418 -2.072 0 C-N-CA 120.556 -0.457 . . . . 64.200000000000003 109.792 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.76 -34.45 75.61 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.176 -1.046 . . . . 70.129999999999995 108.176 170.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.7 m -98.39 20.34 12.83 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.77 -1.105 . . . . 75.239999999999995 111.966 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.606 HG22 ' O ' ' A' ' 515' ' ' SER . 9.4 tt -82.97 -26.68 7.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 CA-C-O 121.622 0.725 . . . . 73.219999999999999 109.372 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 91.97 -78.66 1.26 Allowed Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.305 -1.118 . . . . 70.450000000000003 110.305 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 520' ' ' ILE . . . . . 0.448 HD13 ' HA ' ' A' ' 574' ' ' LYS . 32.3 mm -128.99 141.14 47.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 106.839 -1.541 . . . . 73.439999999999998 106.839 -177.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.529 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -122.72 144.82 48.91 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.289 -0.634 . . . . 74.150000000000006 109.289 178.255 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 10.6 mp0 -115.33 130.5 56.92 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 123.819 0.699 . . . . 74.329999999999998 109.589 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.626 HG11 HD22 ' A' ' 642' ' ' LEU . 59.3 t -116.07 128.41 73.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 109.303 -0.629 . . . . 73.439999999999998 109.303 175.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -81.95 129.91 34.91 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 123.733 0.813 . . . . 74.329999999999998 109.839 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 568' ' ' VAL . 60.0 t -106.1 118.7 54.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.504 -0.924 . . . . 72.150000000000006 108.504 175.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.7 mt -67.44 122.44 17.96 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 123.863 0.727 . . . . 61.210000000000001 111.461 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 567' ' ' ILE . 21.7 tpt180 -68.01 145.69 54.24 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.518 -1.219 . . . . 75.439999999999998 108.946 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 12.4 t -56.5 143.41 35.32 Favored 'General case' 0 N--CA 1.406 -2.637 0 C-N-CA 124.917 1.287 . . . . 72.329999999999998 109.984 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 18.8 t -52.53 -36.14 54.9 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.737 0.815 . . . . 61.340000000000003 111.437 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -116.46 96.15 0.71 Allowed Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.022 -1.231 . . . . 52.43 110.022 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -84.87 101.67 12.49 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.648 -0.871 . . . . 63.520000000000003 108.648 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -124.77 116.88 23.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.822 -0.807 . . . . 71.040000000000006 108.822 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.432 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 77.72 -178.72 51.8 Favored Glycine 0 C--O 1.258 1.602 0 O-C-N 123.695 0.622 . . . . 64.140000000000001 113.84 176.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -90.95 125.83 35.89 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.893 -0.654 . . . . 74.049999999999997 109.522 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 72.6 t -133.16 134.58 57.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.745 -0.661 . . . . 61.229999999999997 109.26 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.58 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 37.8 mm -106.51 134.75 47.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 109.219 -0.66 . . . . 75.400000000000006 109.219 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.65 110.25 32.01 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.741 -0.466 . . . . 72.230000000000004 109.741 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 38.9 Cg_endo -70.65 158.04 56.94 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.338 2.026 . . . . 73.340000000000003 111.583 177.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.437 ' HB3' HG22 ' A' ' 591' ' ' ILE . 52.2 p90 -151.99 155.56 38.24 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.331 -0.618 . . . . 72.430000000000007 109.331 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.64 149.1 28.08 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 123.87 0.731 . . . . 72.530000000000001 112.174 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.1 p -83.44 131.16 35.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 116.003 -0.544 . . . . 75.540000000000006 109.933 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 57.9 mt -103.07 119.91 52.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.003 -1.11 . . . . 53.140000000000001 108.003 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.91 160.61 27.19 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.133 -0.692 . . . . 75.049999999999997 109.133 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 177.69 -97.6 0.11 Allowed Glycine 0 CA--C 1.473 -2.533 0 N-CA-C 110.504 -1.038 . . . . 74.230000000000004 110.504 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 545' ' ' THR . . . . . 0.489 ' HB ' ' H ' ' A' ' 586' ' ' THR . 0.2 OUTLIER -71.37 -31.53 67.44 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 109.355 -0.609 . . . . 74.319999999999993 109.355 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -107.67 155.75 19.82 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 108.494 -0.928 . . . . 61.109999999999999 108.494 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -101.01 137.85 38.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.543 0.687 . . . . 75.219999999999999 112.457 -176.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.98 -150.47 12.45 Favored Glycine 0 C--N 1.299 -1.498 0 C-N-CA 120.663 -0.779 . . . . 73.299999999999997 112.716 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 61.02 7.28 8.3 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 115.749 1.06 . . . . 65.010000000000005 115.749 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 90.44 14.59 58.37 Favored Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 118.209 1.005 . . . . 73.349999999999994 110.991 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -87.52 -55.44 3.79 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.165 -0.68 . . . . 71.530000000000001 109.165 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -107.04 -42.26 4.94 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.112 -1.44 . . . . 73.219999999999999 107.112 177.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -140.07 152.38 46.13 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.809 -1.182 . . . . 75.439999999999998 107.809 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.74 112.94 20.53 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.311 -0.996 . . . . 73.150000000000006 108.311 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.99 122.5 17.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.38 1.072 . . . . 55.310000000000002 111.675 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.7 t -131.66 142.35 49.82 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 121.786 0.803 . . . . 61.43 110.577 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 21.4 p -151.71 150.16 29.9 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.559 -1.275 . . . . 71.319999999999993 107.559 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 172.62 -164.03 36.16 Favored Glycine 0 CA--C 1.482 -2.013 0 N-CA-C 109.979 -1.248 . . . . 70.129999999999995 109.979 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.58 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 45.3 mt-10 -133.24 128.06 35.06 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.986 0.393 . . . . 73.219999999999999 111.134 -177.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.464 HD22 ' HB3' ' A' ' 569' ' ' LYS . 95.8 mt -89.44 141.18 28.8 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 123.463 0.705 . . . . 71.319999999999993 109.201 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.464 ' HA ' HD13 ' A' ' 536' ' ' ILE . 36.1 tt0 -103.54 118.28 36.37 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.292 0.568 . . . . 71.049999999999997 110.884 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -116.39 148.75 40.35 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.777 -0.823 . . . . 73.329999999999998 108.777 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.658 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 45.7 mt-30 -140.86 -178.97 5.8 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.826 -0.805 . . . . 53.130000000000003 108.826 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 564' ' ' ASN . . . . . 0.432 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 3.6 p-10 -71.48 -36.0 71.0 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.597 -0.441 . . . . 74.319999999999993 110.617 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -79.81 -39.3 31.09 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.109 -0.496 . . . . 75.319999999999993 110.167 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.658 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 64.5 mm-40 -63.64 151.86 40.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.556 -0.747 . . . . 73.120000000000005 111.736 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.549 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.2 pt -114.62 -92.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 113.447 0.906 . . . . 63.439999999999998 113.447 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.549 ' H ' HG13 ' A' ' 567' ' ' ILE . 11.7 p -107.86 146.64 13.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 120.885 0.374 . . . . 72.150000000000006 111.331 -174.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.464 ' HB3' HD22 ' A' ' 560' ' ' LEU . 5.3 mmpt? -114.99 165.19 13.15 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.146 -0.687 . . . . 73.140000000000001 109.146 173.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.2 p -131.41 140.35 49.62 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.973 -0.558 . . . . 51.109999999999999 112.088 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.0 mp -95.28 121.03 45.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.811 -1.181 . . . . 73.409999999999997 107.811 173.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 572' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 521' ' ' MET . 70.0 m -96.64 117.74 31.63 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 123.981 0.801 . . . . 64.310000000000002 109.035 176.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.474 HG23 HG22 ' A' ' 571' ' ' ILE . 89.6 t -119.31 133.42 66.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 110.239 -0.282 . . . . 71.140000000000001 110.239 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.448 ' HA ' HD13 ' A' ' 520' ' ' ILE . 22.1 tptm -86.37 120.71 28.0 Favored 'General case' 0 N--CA 1.435 -1.218 0 O-C-N 123.684 0.615 . . . . 65.150000000000006 109.363 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 31.0 t -96.05 127.39 48.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.81 -1.182 . . . . 64.129999999999995 107.81 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 34.5 mm -87.07 147.87 5.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-O 120.999 0.428 . . . . 64.25 110.123 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -65.68 138.65 58.12 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 124.88 1.272 . . . . 75.409999999999997 110.624 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -89.58 -164.85 1.21 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.63 -0.878 . . . . 74.349999999999994 108.63 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -90.77 -43.46 10.07 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.936 -1.135 . . . . 72.349999999999994 107.936 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -158.32 -67.26 0.09 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 105.798 -1.927 . . . . 75.310000000000002 105.798 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -173.83 69.19 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 124.696 1.248 . . . . 71.430000000000007 110.216 176.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -51.83 -62.97 1.3 Allowed 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.624 0.726 . . . . 60.549999999999997 111.766 -177.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -143.16 150.05 38.88 Favored 'General case' 0 N--CA 1.408 -2.533 0 N-CA-C 107.849 -1.167 . . . . 75.400000000000006 107.849 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -75.59 87.11 2.68 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.341 -1.725 . . . . 74.299999999999997 106.341 169.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.47 161.96 14.01 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.888 -1.051 . . . . 72.319999999999993 112.448 -176.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 586' ' ' THR . . . . . 0.489 ' H ' ' HB ' ' A' ' 545' ' ' THR . 5.3 t -153.47 153.3 32.2 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 115.434 -0.803 . . . . 70.239999999999995 109.02 -173.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -133.03 168.38 18.6 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.233 -1.395 . . . . 74.219999999999999 107.233 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.485 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 72.5 m-85 -117.73 151.27 37.61 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 120.084 -0.646 . . . . 74.030000000000001 109.451 -174.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.1 OUTLIER -121.39 128.1 51.87 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 106.378 -1.712 . . . . 72.099999999999994 106.378 178.21 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -124.93 133.94 52.85 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.991 -0.744 . . . . 74.349999999999994 108.991 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.454 HG23 ' CZ ' ' A' ' 507' ' ' PHE . 18.3 pt -97.84 135.84 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 N-CA-C 107.878 -1.156 . . . . 64.299999999999997 107.878 173.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -81.83 173.07 53.53 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 111.017 -0.833 . . . . 62.219999999999999 111.017 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 593' ' ' GLU . 6.1 mp0 -59.41 135.08 88.66 Favored Pre-proline 0 C--N 1.287 -2.122 0 C-N-CA 123.945 0.898 . . . . 74.329999999999998 110.688 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -70.87 122.06 8.47 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 122.495 2.13 . . . . 71.209999999999994 111.074 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 595' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 536' ' ' ILE . 1.8 ptm180 -104.51 119.57 39.29 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.591 -0.731 . . . . 75.409999999999997 109.134 -177.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.417 ' HB2' ' CD ' ' A' ' 634' ' ' PRO . 2.3 tm? -66.2 134.55 52.94 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.898 -1.149 . . . . 73.450000000000003 107.898 178.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.45 ' CG2' HG12 ' A' ' 536' ' ' ILE . 25.8 t -82.73 85.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 105.875 -1.898 . . . . 75.120000000000005 105.875 175.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -80.0 120.29 23.98 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 114.747 -1.115 . . . . 74.420000000000002 112.309 -169.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 27.7 ttt -114.85 -20.55 10.54 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.549 -1.205 . . . . 72.209999999999994 109.853 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 19.9 m -87.74 -4.87 58.88 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 112.464 0.542 . . . . 72.400000000000006 112.464 -173.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -96.33 147.4 23.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.651 -0.87 . . . . 75.329999999999998 108.651 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.33 81.1 7.59 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 106.438 -1.69 . . . . 73.099999999999994 106.438 172.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.74 119.0 10.42 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 114.165 -1.38 . . . . 75.150000000000006 111.825 -177.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -142.04 20.68 2.48 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 110.075 -1.21 . . . . 64.219999999999999 110.075 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -137.44 118.33 1.67 Allowed Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 109.784 -1.326 . . . . 75.430000000000007 109.784 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -71.08 121.16 17.76 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.204 -0.665 . . . . 74.219999999999999 109.204 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 19.2 p -78.41 85.7 4.51 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.325 0.584 . . . . 74.230000000000004 109.819 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 5.4 tp -77.68 88.13 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 122.076 0.941 . . . . 72.450000000000003 109.51 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 9.7 t -98.96 94.29 6.47 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 122.323 1.058 . . . . 60.549999999999997 110.695 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -105.08 -68.55 0.85 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.585 -1.265 . . . . 70.549999999999997 107.585 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -164.74 101.51 0.79 Allowed 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 106.411 -1.7 . . . . 74.340000000000003 106.411 -176.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -88.46 145.86 25.53 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.066 -0.516 . . . . 71.400000000000006 110.54 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -64.87 -41.67 95.46 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.587 0.554 . . . . 72.420000000000002 109.971 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -125.38 91.66 3.46 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 106.868 -1.531 . . . . 55.509999999999998 106.868 171.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -84.95 -21.26 29.66 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 119.867 -0.733 . . . . 41.219999999999999 109.767 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -67.85 160.3 74.46 Favored Pre-proline 0 C--O 1.245 0.845 0 CA-C-N 115.289 -0.869 . . . . 74.209999999999994 109.853 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.18 118.16 5.44 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.842 1.695 . . . . 73.430000000000007 109.36 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.421 ' H ' ' NH2' ' A' ' 626' ' ' ARG . 49.7 tp -161.24 153.46 20.01 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.063 -0.717 . . . . 71.049999999999997 109.063 -177.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 39.4 m -144.85 132.93 21.46 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.818 -1.919 . . . . 71.400000000000006 105.818 175.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 10.7 t -113.43 -7.67 13.44 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.091 -0.644 . . . . 72.420000000000002 111.717 -176.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -106.3 162.75 13.4 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.943 -1.132 . . . . 55.310000000000002 107.943 174.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -88.66 62.25 6.4 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 122.508 1.147 . . . . 72.030000000000001 111.031 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -97.0 -155.92 0.51 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.291 -1.744 . . . . 71.420000000000002 106.291 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.97 104.01 8.27 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 104.885 -2.265 . . . . 63.240000000000002 104.885 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -58.17 129.64 42.92 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.712 -0.847 . . . . 74.439999999999998 108.712 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.421 ' NH2' ' H ' ' A' ' 618' ' ' LEU . 41.7 mtm180 -52.84 -42.09 64.84 Favored 'General case' 0 C--O 1.187 -2.197 0 N-CA-C 113.097 0.777 . . . . 61.310000000000002 113.097 -173.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.74 -27.59 29.46 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.543 0.737 . . . . 71.25 111.233 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 71.7 mt -80.71 -47.92 20.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.851 0.358 . . . . 75.540000000000006 110.5 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -84.26 -24.49 29.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.221 0.534 . . . . 74.200000000000003 111.632 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . 0.287 62.3 mt-10 -65.84 -8.75 23.51 Favored 'General case' 0 C--O 1.2 -1.538 0 N-CA-C 114.465 1.283 . . . . 54.409999999999997 114.465 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -58.69 -21.57 54.91 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 121.512 0.672 . . . . 62.32 109.371 172.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -83.42 5.75 76.03 Favored Glycine 0 C--O 1.222 -0.636 0 CA-C-N 116.218 -0.446 . . . . 72.230000000000004 112.491 178.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 633' ' ' ARG . . . . . 0.469 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 11.2 ptm180 -134.11 167.72 21.47 Favored Pre-proline 0 C--N 1.311 -1.09 0 N-CA-C 106.956 -1.498 . . . . 73.340000000000003 106.956 175.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 633' ' ' ARG . 72.3 Cg_endo -80.94 136.42 10.45 Favored 'Trans proline' 0 N--CA 1.429 -2.281 0 C-N-CA 121.012 1.142 . . . . 55.32 110.4 174.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 635' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 635' ' ' ILE . 0.1 OUTLIER -124.54 162.46 26.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.256 -1.016 . . . . 71.040000000000006 108.256 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.02 -178.43 3.71 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 120.056 -0.658 . . . . 74.319999999999993 111.928 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -75.1 -169.13 24.24 Favored Glycine 0 N--CA 1.445 -0.704 0 O-C-N 123.455 0.472 . . . . 61.439999999999998 112.794 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -68.99 -51.84 35.16 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.181 -0.674 . . . . 72.019999999999996 109.181 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -122.56 131.62 53.92 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.814 0.816 . . . . 75.109999999999999 111.937 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 640' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 506' ' ' THR . 16.8 p -126.64 90.06 3.1 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.394 -1.276 . . . . 75.409999999999997 109.781 177.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 641' ' ' LYS . . . . . 0.403 ' NZ ' ' HB3' ' A' ' 641' ' ' LYS . 5.7 ttpm? -159.54 148.18 17.75 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.519 -0.764 . . . . 74.030000000000001 109.609 -176.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.626 HD22 HG11 ' A' ' 523' ' ' VAL . 30.9 tp -129.51 129.17 44.19 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 108.025 -1.102 . . . . 73.230000000000004 108.025 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -97.58 106.25 18.53 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.894 -1.521 . . . . 63.240000000000002 106.894 175.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 39.6 t -98.55 106.86 19.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.358 -0.608 . . . . 62.119999999999997 109.358 -176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 73.0 mt -91.2 125.3 43.95 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.559 0 N-CA-C 109.35 -0.611 . . . . 73.530000000000001 109.35 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 69.8 mt -100.9 103.92 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 109.056 -0.72 . . . . 73.409999999999997 109.056 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 515' ' ' SER . 14.2 pt-20 -119.39 150.36 40.31 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.317 -0.994 . . . . 73.299999999999997 108.317 175.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.96 141.15 30.56 Favored 'General case' 0 N--CA 1.41 -2.473 0 CA-C-O 122.026 0.917 . . . . 73.540000000000006 112.331 -177.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 70.5 m -155.99 87.7 1.08 Allowed 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 104.823 -2.288 . . . . 74.140000000000001 104.823 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -55.81 -48.09 76.01 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 114.997 -1.002 . . . . 72.519999999999996 112.969 -170.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -72.38 -32.51 66.48 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.783 -0.644 . . . . 54.340000000000003 110.324 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 59.3 t80 54.78 66.64 1.18 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.388 -1.278 . . . . 73.310000000000002 108.398 -172.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -74.14 -69.03 0.47 Allowed 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 113.799 -1.546 . . . . 72.129999999999995 108.006 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 16.6 m 50.19 37.51 14.94 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.578 0.704 . . . . 71.310000000000002 111.588 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 27.3 m -84.43 111.89 19.87 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.783 -0.644 . . . . 71.409999999999997 110.014 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 29.9 m -86.39 141.73 14.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.881 -0.599 . . . . 64.420000000000002 109.433 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--N 1.292 -1.926 0 N-CA-C 109.403 -0.591 . . . . 54.229999999999997 109.403 -179.942 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 47.8 t60 . . . . . 0 N--CA 1.438 -1.044 0 CA-C-O 121.265 0.555 . . . . 65.010000000000005 109.793 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -93.92 -63.03 1.24 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.798 -0.816 . . . . 72.310000000000002 108.798 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 169.3 -159.13 31.94 Favored Glycine 0 N--CA 1.42 -2.376 0 N-CA-C 108.672 -1.771 . . . . 74.510000000000005 108.672 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.457 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.5 mp -114.23 110.83 33.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 117.211 0.505 . . . . 71.530000000000001 110.834 -175.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.475 ' CE2' HG23 ' A' ' 528' ' ' THR . 31.5 m-85 -90.67 124.5 35.12 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.655 -0.868 . . . . 74.109999999999999 108.655 169.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 506' ' ' THR . . . . . 0.433 ' HA ' HG22 ' A' ' 640' ' ' THR . 14.1 t -162.47 170.57 18.49 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.78 -0.822 . . . . 74.439999999999998 108.78 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -76.11 146.62 39.17 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 110.27 -0.27 . . . . 74.349999999999994 110.27 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.28 -30.78 71.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.267 0.556 . . . . 74.200000000000003 109.785 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -137.41 145.73 50.71 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 108.735 -0.839 . . . . 75.150000000000006 108.735 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -81.14 -22.64 5.82 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.654 2.236 . . . . 72.109999999999999 112.819 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 47.2 t -141.79 135.11 29.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 106.92 -1.511 . . . . 53.450000000000003 106.92 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.1 t -131.61 141.04 49.56 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 109.494 -0.558 . . . . 73.409999999999997 109.494 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -107.01 124.89 50.28 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.075 0.464 . . . . 75.219999999999999 110.207 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 17.6 m -124.3 163.42 24.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.177 -0.675 . . . . 62.009999999999998 109.177 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 19.2 t -93.64 154.42 17.84 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.954 -0.388 . . . . 74.299999999999997 109.954 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -59.59 -32.74 70.66 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 123.773 0.671 . . . . 75.030000000000001 109.523 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 23.3 t -129.43 65.39 1.47 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.907 0.861 . . . . 63.149999999999999 110.84 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 6.4 tt -98.3 -25.0 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 115.072 -0.967 . . . . 72.310000000000002 109.168 172.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 95.04 -81.05 0.87 Allowed Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.55 -0.75 . . . . 62.030000000000001 111.283 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.5 mm -129.36 127.52 65.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.002 -1.481 . . . . 70.549999999999997 107.002 -176.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.69 148.08 34.19 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.707 -1.22 . . . . 73.409999999999997 107.707 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 33.2 mt-10 -126.75 132.16 51.15 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 123.576 0.547 . . . . 74.129999999999995 111.989 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.609 HG11 HD22 ' A' ' 642' ' ' LEU . 21.5 t -112.91 129.3 68.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.944 -1.132 . . . . 64.329999999999998 107.944 178.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -86.04 134.77 33.82 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.795 -0.817 . . . . 71.319999999999993 108.795 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 568' ' ' VAL . 44.8 t -108.8 127.89 65.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.845 -0.798 . . . . 73.230000000000004 108.845 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.96 126.45 29.79 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.869 -0.605 . . . . 73.329999999999998 110.314 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -79.33 161.41 26.26 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.486 -1.234 . . . . 71.420000000000002 109.926 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.475 HG23 ' CE2' ' A' ' 505' ' ' PHE . 6.4 p -59.74 147.27 38.48 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 123.384 0.674 . . . . 72.530000000000001 111.633 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 29.5 t -59.14 -36.98 76.17 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.918 -0.771 . . . . 74.540000000000006 108.918 175.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -112.56 101.6 1.24 Allowed Glycine 0 N--CA 1.416 -2.683 0 N-CA-C 108.981 -1.647 . . . . 71.140000000000001 108.981 174.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -92.03 101.48 14.03 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.753 -1.203 . . . . 73.310000000000002 107.753 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -122.21 104.29 9.35 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.741 -0.466 . . . . 71.450000000000003 109.741 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 89.33 -151.39 21.95 Favored Glycine 0 C--N 1.304 -1.215 0 C-N-CA 120.456 -0.878 . . . . 70.140000000000001 112.031 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -113.09 127.69 56.28 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.394 0.616 . . . . 72.140000000000001 110.297 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 66.4 t -129.67 138.51 54.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 108.81 -0.811 . . . . 62.009999999999998 108.81 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.582 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 44.8 mm -107.94 133.84 51.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 109.35 -0.611 . . . . 74.140000000000001 109.35 177.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 25.6 t -120.45 109.06 36.96 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 109.208 -0.664 . . . . 63.229999999999997 109.208 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.61 153.94 54.68 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.108 1.872 . . . . 60.520000000000003 111.83 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.484 ' HB3' HG22 ' A' ' 591' ' ' ILE . 52.9 p90 -148.81 161.56 41.56 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.738 -0.467 . . . . 73.120000000000005 109.738 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -158.17 162.35 37.92 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.106 -0.497 . . . . 72.120000000000005 109.714 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 541' ' ' THR . . . . . 0.464 HG23 HG22 ' A' ' 556' ' ' THR . 6.8 p -88.39 149.29 23.8 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 116.027 -0.533 . . . . 64.200000000000003 110.677 173.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 86.7 mt -121.26 109.99 26.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.858 -1.164 . . . . 45.32 107.858 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.34 111.24 2.94 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 123.854 0.721 . . . . 72.549999999999997 110.593 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -100.54 -108.24 3.02 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.34 -1.104 . . . . 54.420000000000002 110.34 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 67.5 p -93.24 8.87 38.51 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 122.517 1.151 . . . . 62.140000000000001 107.967 175.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -119.88 136.53 54.46 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.148 -1.387 . . . . 71.019999999999996 109.509 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.534 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 82.0 mtm180 -82.9 135.4 34.93 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.543 1.137 . . . . 75.129999999999995 110.831 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -87.73 -161.28 36.6 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 115.153 -0.931 . . . . 74.209999999999994 113.533 -175.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 549' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 77.06 -55.99 3.57 Favored Glycine 0 C--O 1.224 -0.51 0 CA-C-N 115.488 -0.356 . . . . 64.129999999999995 113.576 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 550' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 554' ' ' GLU . . . 157.99 42.45 0.02 OUTLIER Glycine 0 C--N 1.284 -2.341 0 N-CA-C 109.415 -1.474 . . . . 70.319999999999993 109.415 -173.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.534 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 8.4 tt0 -116.92 -61.74 1.68 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.559 -0.534 . . . . 73.140000000000001 109.559 -176.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -98.57 -43.74 6.73 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.887 -1.523 . . . . 75.299999999999997 106.887 169.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -132.87 156.42 47.23 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 107.195 -1.409 . . . . 71.209999999999994 107.195 174.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.42 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 10.2 tt0 -84.3 131.11 34.75 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.635 -0.876 . . . . 75.219999999999999 108.635 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 555' ' ' ASP . . . . . 0.535 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 9.6 t70 -58.24 131.1 49.6 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.525 -0.546 . . . . 74.310000000000002 109.525 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.599 HG21 HG22 ' A' ' 573' ' ' VAL . 14.6 t -133.32 141.33 47.9 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-O 121.702 0.763 . . . . 75.439999999999998 109.146 174.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 3.2 p -156.55 161.32 39.98 Favored 'General case' 0 C--N 1.272 -2.763 0 N-CA-C 107.264 -1.384 . . . . 71.510000000000005 107.264 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 149.24 -167.11 29.56 Favored Glycine 0 N--CA 1.41 -3.071 0 N-CA-C 110.395 -1.082 . . . . 65.209999999999994 110.395 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.582 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 52.9 mt-10 -131.7 132.77 44.19 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 120.965 0.412 . . . . 70.219999999999999 110.567 -176.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.547 HD22 ' HB3' ' A' ' 569' ' ' LYS . 89.7 mt -92.94 140.81 29.1 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.883 -0.599 . . . . 74.0 109.512 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.447 ' HG3' ' CD1' ' A' ' 536' ' ' ILE . 27.9 tt0 -106.28 113.74 27.44 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 116.094 -0.503 . . . . 74.530000000000001 109.872 -177.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -111.92 149.31 32.07 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.128 -0.693 . . . . 72.129999999999995 109.128 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.573 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 49.4 mt-30 -146.99 -177.65 5.77 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.249 -0.648 . . . . 72.5 109.249 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -70.07 -31.17 68.64 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.629 -1.249 . . . . 72.519999999999996 107.629 170.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -77.0 -52.76 8.79 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.8 -1.091 . . . . 70.530000000000001 111.176 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.573 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 42.4 mm-40 -64.77 124.18 21.29 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 123.616 0.767 . . . . 73.549999999999997 111.854 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.584 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.2 pt -81.08 -62.24 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 124.159 0.912 . . . . 61.009999999999998 112.638 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.584 ' H ' HG13 ' A' ' 567' ' ' ILE . 7.8 p -143.31 160.24 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 109.522 -0.548 . . . . 64.019999999999996 109.522 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.547 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -127.6 158.69 36.83 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.43 -0.952 . . . . 64.109999999999999 108.43 171.773 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.5 p -127.34 144.58 51.03 Favored 'General case' 0 C--N 1.278 -2.504 0 O-C-N 124.03 0.831 . . . . 74.409999999999997 111.096 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.2 mp -94.68 119.31 42.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 106.829 -1.545 . . . . 51.229999999999997 106.829 172.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 24.4 p -92.34 116.14 28.71 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.543 -0.91 . . . . 75.299999999999997 108.543 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.599 HG22 HG21 ' A' ' 556' ' ' THR . 55.5 t -116.43 123.16 71.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.372 -0.603 . . . . 60.43 109.372 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 29.4 tptp -76.91 113.99 15.21 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.124 -0.944 . . . . 73.319999999999993 109.235 176.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.94 128.82 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 N-CA-C 104.887 -2.264 . . . . 51.329999999999998 104.887 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 46.5 mm -69.28 123.0 21.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 122.35 1.071 . . . . 65.219999999999999 111.761 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -115.57 109.8 18.31 Favored 'General case' 0 C--N 1.274 -2.675 0 CA-C-N 112.752 -2.022 . . . . 73.230000000000004 107.804 -175.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -157.47 156.47 32.16 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.485 -1.302 . . . . 71.439999999999998 107.485 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -74.37 76.43 1.88 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.008 0.908 . . . . 61.310000000000002 112.766 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -140.1 130.65 25.57 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 105.079 -2.193 . . . . 71.340000000000003 105.079 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -90.02 95.49 10.24 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.287 -0.635 . . . . 74.239999999999995 109.287 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -99.79 -162.35 0.94 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.396 -0.82 . . . . 63.140000000000001 111.358 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 585' ' ' LYS . 0.5 OUTLIER -148.82 -171.47 3.87 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.565 -1.272 . . . . 64.329999999999998 107.565 -174.337 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 584' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 646' ' ' ILE . 35.4 t-20 -52.88 115.67 1.95 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.733 1.213 . . . . 72.230000000000004 112.301 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 73.5 mmtt -121.3 133.01 55.12 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.346 -1.724 . . . . 72.540000000000006 106.346 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 11.4 t -131.41 137.96 48.89 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.578 -1.249 . . . . 74.099999999999994 111.012 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 44.2 p90 -135.07 179.13 6.51 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 107.74 -1.208 . . . . 72.140000000000001 107.74 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.549 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 92.6 m-85 -123.77 155.68 37.47 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 109.318 -0.623 . . . . 74.349999999999994 109.318 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.83 133.54 54.43 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 105.167 -2.16 . . . . 73.230000000000004 105.167 176.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.409 ' HB2' HD11 ' A' ' 542' ' ' ILE . 28.7 tt0 -133.92 136.5 44.3 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.613 -0.835 . . . . 70.439999999999998 110.328 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.484 HG22 ' HB3' ' A' ' 539' ' ' TYR . 16.0 pt -99.69 138.34 24.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 114.987 -1.006 . . . . 72.030000000000001 108.343 174.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.42 -173.55 49.78 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 111.225 -0.75 . . . . 55.329999999999998 111.225 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.94 130.35 88.48 Favored Pre-proline 0 C--N 1.305 -1.328 0 C-N-CA 120.702 -0.399 . . . . 74.5 111.168 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.524 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 17.8 Cg_endo -64.85 135.69 45.66 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.138 2.558 . . . . 65.420000000000002 112.21 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 595' ' ' ARG . . . . . 0.478 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 14.6 ptm180 -111.99 127.96 56.03 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.586 -0.733 . . . . 73.25 109.81 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -73.48 128.92 36.84 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 106.468 -1.679 . . . . 54.549999999999997 106.468 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.49 ' CG2' HG12 ' A' ' 536' ' ' ILE . 62.0 t -75.48 121.46 27.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.155 -0.683 . . . . 73.209999999999994 109.155 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 68.67 85.58 0.14 Allowed 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 125.097 1.359 . . . . 73.540000000000006 109.417 -171.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 17.1 tpt -66.99 -38.27 85.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 113.32 -1.764 . . . . 53.109999999999999 111.379 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 34.7 t -130.24 177.76 7.08 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.68 -1.6 . . . . 73.140000000000001 106.68 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -69.59 -29.42 66.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.754 0.787 . . . . 73.230000000000004 109.394 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 602' ' ' LYS . . . . . 0.553 ' H ' ' HD2' ' A' ' 602' ' ' LYS . 0.0 OUTLIER -105.23 167.08 9.96 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.05 -1.463 . . . . 71.109999999999999 107.05 174.805 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -80.17 95.78 6.36 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 120.25 -0.58 . . . . 74.349999999999994 109.741 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -70.33 138.9 29.84 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 114.693 -1.139 . . . . 72.530000000000001 112.607 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 110.76 -138.43 14.93 Favored Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 109.641 -1.384 . . . . 54.200000000000003 109.641 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 59.16 83.64 0.12 Allowed 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.256 1.022 . . . . 64.319999999999993 112.411 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 9.8 t -151.45 168.28 25.36 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 105.377 -2.083 . . . . 62.32 105.377 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.61 97.19 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 CA-C-O 122.481 1.134 . . . . 74.420000000000002 110.2 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 91.1 m -149.91 121.09 7.78 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.049 -1.093 . . . . 73.329999999999998 108.049 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -137.58 109.9 7.38 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.686 0.624 . . . . 70.120000000000005 112.686 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -103.43 111.74 24.32 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.143 -1.429 . . . . 74.230000000000004 107.143 170.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -88.16 -17.98 29.74 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.235 -0.439 . . . . 74.230000000000004 111.897 -172.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -88.87 117.36 27.82 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 116.367 -0.379 . . . . 72.030000000000001 110.953 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -100.44 71.75 1.55 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.188 0.994 . . . . 65.030000000000001 109.314 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.11 90.1 2.01 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 106.23 -1.767 . . . . 73.349999999999994 106.23 174.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 78.23 98.69 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 114.214 -1.357 . . . . 71.209999999999994 109.704 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.57 112.12 1.86 Allowed 'Trans proline' 0 C--O 1.256 1.389 0 C-N-CA 122.723 2.282 . . . . 63.32 110.779 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.2 pp -75.07 152.94 38.57 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.68 -0.691 . . . . 75.349999999999994 111.389 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 4.9 t -107.58 129.1 55.02 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.754 -0.462 . . . . 65.340000000000003 109.754 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 15.2 m -79.34 107.31 12.0 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.044 -1.095 . . . . 75.120000000000005 108.044 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -108.38 101.61 10.79 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.768 0.794 . . . . 72.439999999999998 111.681 -175.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -140.1 140.6 36.09 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 104.382 -2.451 . . . . 74.209999999999994 104.382 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.62 70.29 2.43 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.75 0.786 . . . . 72.140000000000001 111.872 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.62 173.67 6.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.942 -1.503 . . . . 64.299999999999997 106.942 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.21 -23.57 64.83 Favored 'General case' 0 C--O 1.214 -0.774 0 C-N-CA 119.825 -0.75 . . . . 74.129999999999995 109.701 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 40.3 tpt85 -63.41 -38.63 91.9 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.642 -0.708 . . . . 74.129999999999995 110.461 173.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 627' ' ' ARG . . . . . 0.7 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 0.0 OUTLIER -75.59 -36.05 60.43 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.883 -0.784 . . . . 74.120000000000005 108.883 177.149 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 71.2 mt -59.67 -45.58 94.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.498 0.666 . . . . 74.219999999999999 109.327 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -71.92 -16.54 62.11 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.371 -0.831 . . . . 75.019999999999996 112.618 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.7 ' HG2' ' O ' ' A' ' 627' ' ' ARG . 20.0 pt-20 -72.88 -10.72 60.11 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 120.407 -0.517 . . . . 72.340000000000003 112.096 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -60.79 -31.98 71.34 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 108.71 -0.848 . . . . 63.420000000000002 108.71 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -93.05 55.81 2.52 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 115.663 -0.699 . . . . 30.100000000000001 111.514 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -126.61 151.99 73.94 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 107.701 -1.222 . . . . 75.329999999999998 107.701 175.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.524 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 17.4 Cg_endo -63.34 142.35 85.32 Favored 'Trans proline' 0 N--CA 1.44 -1.647 0 C-N-CA 121.97 1.78 . . . . 74.219999999999999 107.9 170.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.87 163.74 24.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 119.524 -0.871 . . . . 65.109999999999999 112.385 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.04 174.83 6.56 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.322 -0.854 . . . . 71.549999999999997 111.144 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.457 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -75.5 -169.28 25.89 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 116.018 -0.537 . . . . 51.240000000000002 113.876 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.53 -27.67 60.63 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.473 0.654 . . . . 75.430000000000007 109.686 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -139.82 133.56 30.53 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.03 -0.729 . . . . 73.019999999999996 109.03 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 640' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 506' ' ' THR . 22.6 p -133.81 90.27 2.68 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.398 0.618 . . . . 74.400000000000006 110.175 176.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -163.13 142.74 8.78 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.519 -0.919 . . . . 73.209999999999994 108.519 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.609 HD22 HG11 ' A' ' 523' ' ' VAL . 21.3 tp -126.52 128.65 47.22 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 108.872 -0.788 . . . . 64.030000000000001 108.872 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -95.34 110.07 22.14 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.639 -1.245 . . . . 74.140000000000001 107.639 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.07 114.16 36.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 109.02 -0.733 . . . . 73.129999999999995 109.02 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 55.7 mt -102.9 113.85 40.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 109.104 -0.702 . . . . 42.32 109.104 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 584' ' ' ASN . 50.3 mt -93.7 107.56 19.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.598 -1.631 . . . . 73.409999999999997 106.598 176.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.4 150.52 37.65 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.381 -0.927 . . . . 65.519999999999996 110.538 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.75 118.07 19.75 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-O 122.289 1.042 . . . . 71.340000000000003 110.76 -175.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 1.7 p -143.02 29.35 1.49 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 113.209 -1.814 . . . . 64.540000000000006 106.293 175.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.91 -37.93 11.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.542 -2.117 . . . . 71.129999999999995 109.679 -175.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -71.16 -27.76 63.77 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.67 -0.695 . . . . 72.120000000000005 109.492 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -72.27 -29.32 63.78 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.422 -0.808 . . . . 74.439999999999998 111.669 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 653' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 653' ' ' LYS . 6.1 mmpt? -126.75 98.8 5.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.644 0.735 . . . . 74.200000000000003 112.776 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 22.8 t -109.99 134.91 51.61 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.077 -1.083 . . . . 64.319999999999993 108.077 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 15.2 p -116.11 -77.71 0.57 Allowed 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 120.708 0.29 . . . . 72.299999999999997 110.586 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 30.6 m -134.1 149.64 30.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 116.533 -0.303 . . . . 72.310000000000002 110.237 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 18.5 t70 . . . . . 0 C--N 1.307 -1.265 0 CA-C-N 116.153 -0.476 . . . . 71.129999999999995 109.724 177.568 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 501' ' ' HIS . . . . . 0.487 ' CD2' ' HA ' ' A' ' 631' ' ' MET . 80.5 m80 . . . . . 0 CA--C 1.5 -0.981 0 N-CA-C 108.686 -0.857 . . . . 75.400000000000006 108.686 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -63.02 -60.77 3.0 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.403 -0.592 . . . . 65.340000000000003 109.403 177.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 172.34 -160.2 31.45 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 110.88 -0.888 . . . . 21.41 110.88 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.26 126.98 71.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 O-C-N 124.003 0.472 . . . . 73.219999999999999 111.364 -170.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.433 ' CE2' ' HB ' ' A' ' 528' ' ' THR . 61.9 m-85 -103.56 133.94 47.75 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.427 -0.583 . . . . 64.409999999999997 109.427 170.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.0 t -169.32 169.8 8.88 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.332 -0.988 . . . . 34.32 108.332 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -78.01 149.41 34.05 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.073 0.397 . . . . 63.0 111.53 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.93 -36.4 80.07 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.46 -0.941 . . . . 71.400000000000006 108.46 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -129.68 146.23 60.32 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 108.253 -1.017 . . . . 73.310000000000002 108.253 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.49 -29.03 2.54 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.153 1.902 . . . . 62.439999999999998 112.934 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 55.9 t -139.6 135.11 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 107.015 -1.476 . . . . 55.520000000000003 107.015 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.1 t -134.17 140.38 46.5 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 108.867 -0.79 . . . . 73.519999999999996 108.867 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -114.87 129.06 56.63 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.769 -1.197 . . . . 60.140000000000001 107.769 175.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.0 m -116.21 170.52 5.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 121.182 0.515 . . . . 70.450000000000003 110.607 -175.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.646 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 75.3 m -87.03 150.11 24.26 Favored 'General case' 0 N--CA 1.398 -3.066 0 CA-C-N 115.069 -0.968 . . . . 73.319999999999993 108.632 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.7 ' HB3' ' HA ' ' A' ' 648' ' ' GLU . 3.8 tm-20 -75.31 -41.94 55.76 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 120.922 0.391 . . . . 73.129999999999995 111.077 177.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 6.4 t -99.31 51.06 0.94 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.553 0.692 . . . . 73.230000000000004 109.743 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.646 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 10.2 tt -103.41 -20.76 5.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.466 0.651 . . . . 74.109999999999999 111.29 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.53 -75.41 2.32 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 110.584 -1.006 . . . . 21.440000000000001 110.584 -175.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 47.7 mm -132.02 127.82 58.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 107.939 -1.134 . . . . 75.150000000000006 107.939 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.469 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -107.58 150.86 26.37 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.78 -1.193 . . . . 63.240000000000002 107.78 176.372 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 30.7 mt-10 -131.66 123.11 27.12 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 123.654 0.596 . . . . 72.219999999999999 111.878 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.543 HG11 HD22 ' A' ' 642' ' ' LEU . 58.6 t -112.17 130.22 66.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.509 -0.922 . . . . 75.230000000000004 108.509 176.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.436 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 21.0 mtmm -87.39 134.87 33.52 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.43 0.633 . . . . 75.120000000000005 111.884 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 568' ' ' VAL . 59.0 t -105.64 127.85 60.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.805 -0.813 . . . . 55.43 108.805 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.22 124.19 22.41 Favored 'General case' 0 N--CA 1.432 -1.365 0 O-C-N 123.726 0.641 . . . . 74.219999999999999 109.725 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -72.27 158.56 35.61 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.663 -1.153 . . . . 74.140000000000001 109.417 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.433 ' HB ' ' CE2' ' A' ' 505' ' ' PHE . 2.9 t -56.01 133.1 51.53 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.429 -0.805 . . . . 73.349999999999994 109.904 175.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 5.1 m -51.17 -31.38 19.74 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.475 1.51 . . . . 71.420000000000002 111.165 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.0 95.39 0.4 Allowed Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 109.031 -1.628 . . . . 74.340000000000003 109.031 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.98 104.37 15.54 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.177 -0.675 . . . . 52.310000000000002 109.177 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -119.09 105.09 11.06 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.082 -0.508 . . . . 75.030000000000001 109.748 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 92.97 -139.24 14.52 Favored Glycine 0 N--CA 1.436 -1.356 0 O-C-N 123.747 0.655 . . . . 51.409999999999997 112.221 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -126.63 129.35 48.32 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.822 -0.806 . . . . 52.130000000000003 108.822 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 65.3 t -132.44 140.28 48.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.243 -0.435 . . . . 64.140000000000001 109.889 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.504 ' HB ' ' HG3' ' A' ' 595' ' ' ARG . 43.4 mm -109.24 137.59 40.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.078 -0.712 . . . . 74.040000000000006 109.078 176.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.98 110.47 29.32 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 109.666 -0.494 . . . . 62.329999999999998 109.666 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.58 155.28 59.43 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.389 2.059 . . . . 42.049999999999997 112.269 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.514 ' HB3' HG22 ' A' ' 591' ' ' ILE . 39.8 p90 -151.73 161.75 42.14 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.861 -0.422 . . . . 74.200000000000003 109.861 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -154.76 151.77 29.08 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.439 0.462 . . . . 70.019999999999996 110.974 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.3 p -85.91 132.49 34.07 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.222 -0.899 . . . . 72.150000000000006 110.088 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 59.0 mt -112.02 115.41 49.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.054 -1.091 . . . . 73.409999999999997 108.054 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.03 106.28 2.31 Favored 'General case' 0 C--N 1.312 -1.035 0 O-C-N 123.369 0.418 . . . . 74.329999999999998 110.979 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -85.14 -98.75 0.69 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 108.626 -1.789 . . . . 65.25 108.626 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 38.3 p -95.25 -25.61 16.28 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.767 -1.198 . . . . 73.5 107.767 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.551 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -75.71 128.38 35.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.545 -1.207 . . . . 72.150000000000006 107.839 175.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 99.8 mtt180 -109.12 159.36 16.95 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 115.287 1.588 . . . . 71.150000000000006 115.287 -171.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . 63.87 -174.2 12.18 Favored Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 112.361 -2.2 . . . . 43.409999999999997 117.454 168.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -115.97 66.86 0.3 Allowed Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 108.163 -1.975 . . . . 72.349999999999994 108.163 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 132.17 5.04 3.51 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 111.524 -0.631 . . . . 15.34 111.524 -174.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 27.3 tt0 -90.85 -74.38 0.5 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.851 -0.739 . . . . 75.349999999999994 109.904 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.407 ' OD1' ' HG3' ' A' ' 585' ' ' LYS . 21.2 m-20 -94.77 -35.56 12.06 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 122.218 1.009 . . . . 74.109999999999999 108.471 175.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -137.57 157.79 45.78 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.187 -1.783 . . . . 70.049999999999997 106.187 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 4.8 tt0 -91.2 135.84 33.51 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.624 -1.251 . . . . 55.439999999999998 107.624 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.37 141.7 47.02 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 120.431 0.158 . . . . 73.219999999999999 110.71 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.9 t -144.12 127.42 16.76 Favored 'General case' 0 N--CA 1.408 -2.569 0 CA-C-O 122.618 1.199 . . . . 72.439999999999998 108.525 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 5.3 p -149.89 115.69 5.61 Favored 'General case' 0 C--N 1.255 -3.505 0 CA-C-N 113.78 -1.554 . . . . 72.040000000000006 108.851 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -168.35 -142.7 3.57 Favored Glycine 0 N--CA 1.408 -3.2 0 N-CA-C 109.787 -1.325 . . . . 62.310000000000002 109.787 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.2 mt-10 -143.81 147.46 34.15 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.969 0.385 . . . . 71.299999999999997 110.776 -174.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.46 HD22 ' HB3' ' A' ' 569' ' ' LYS . 95.6 mt -106.02 144.95 32.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.806 -0.813 . . . . 63.210000000000001 108.806 176.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.405 ' HG3' ' CD1' ' A' ' 536' ' ' ILE . 29.6 tt0 -109.98 120.46 42.54 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.041 0.448 . . . . 73.230000000000004 110.341 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -115.4 147.59 40.35 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.999 -0.741 . . . . 73.140000000000001 108.999 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.437 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 45.9 mt-30 -138.36 177.92 7.52 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 109.479 -0.563 . . . . 75.430000000000007 109.479 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -68.71 -37.51 79.55 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.11 -0.95 . . . . 62.32 110.392 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -92.45 -12.0 33.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.459 -0.791 . . . . 73.299999999999997 111.733 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 0.0 OUTLIER -68.3 172.8 5.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.881 -0.6 . . . . 75.319999999999993 110.095 -178.659 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.606 HG13 ' H ' ' A' ' 568' ' ' VAL . 5.9 pt -115.91 -82.82 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 112.671 0.619 . . . . 73.239999999999995 112.671 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.606 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.9 p -143.84 151.73 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 N-CA-C 108.88 -0.785 . . . . 75.120000000000005 108.88 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.46 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -114.06 156.34 24.32 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.192 0.52 . . . . 62.009999999999998 110.519 175.568 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.4 p -125.01 147.94 48.7 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.564 -1.198 . . . . 72.239999999999995 110.96 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.484 HG22 HG23 ' A' ' 573' ' ' VAL . 2.6 mp -94.94 117.04 37.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 106.437 -1.69 . . . . 74.140000000000001 106.437 171.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 572' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 521' ' ' MET . 45.2 m -93.42 115.26 27.81 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 108.498 -0.927 . . . . 41.32 108.498 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.484 HG23 HG22 ' A' ' 571' ' ' ILE . 67.6 t -118.51 132.35 68.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.627 -0.509 . . . . 64.099999999999994 109.627 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 50.8 tptt -81.81 117.65 22.26 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.936 -1.135 . . . . 44.409999999999997 107.936 175.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 47.1 t -91.26 131.04 39.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 106.262 -1.755 . . . . 62.109999999999999 106.262 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 40.3 mm -77.96 123.63 35.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.84 0.829 . . . . 73.450000000000003 109.528 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -77.45 119.13 20.62 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 113.811 -1.54 . . . . 74.209999999999994 107.973 -176.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -164.24 148.02 9.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.712 0.292 . . . . 54.450000000000003 110.508 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -128.46 13.47 6.54 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.643 0.609 . . . . 75.510000000000005 112.643 -175.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -115.71 123.22 47.75 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 114.864 1.431 . . . . 64.510000000000005 114.864 -171.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 34.1 t80 75.43 -43.13 0.49 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 116.415 2.006 . . . . 73.120000000000005 116.415 166.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -70.33 148.15 48.8 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.17 0.509 . . . . 73.510000000000005 111.48 -175.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -98.84 -61.76 1.33 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.25 -0.886 . . . . 61.130000000000003 111.347 -174.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -153.65 134.92 14.11 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 108.773 -0.825 . . . . 75.530000000000001 108.773 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 33.7 mmtp -127.23 139.33 53.0 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.878 -0.416 . . . . 71.120000000000005 109.878 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.7 t -141.93 143.14 33.12 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 109.025 -0.731 . . . . 63.420000000000002 109.025 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.503 ' HB3' ' HB3' ' A' ' 546' ' ' ALA . 46.7 p90 -135.76 174.65 10.38 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.154 -1.054 . . . . 74.430000000000007 108.154 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.483 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 78.2 m-85 -119.21 156.35 30.03 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 109.401 -0.592 . . . . 64.109999999999999 109.401 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.86 123.2 38.14 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 105.607 -1.997 . . . . 65.319999999999993 105.607 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.38 136.07 55.0 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.427 -0.583 . . . . 74.420000000000002 109.427 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.514 HG22 ' HB3' ' A' ' 539' ' ' TYR . 26.3 pt -106.06 137.79 34.56 Favored 'Isoleucine or valine' 0 C--O 1.261 1.695 0 N-CA-C 108.305 -0.998 . . . . 71.540000000000006 108.305 175.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.22 -177.01 49.85 Favored Glycine 0 N--CA 1.418 -2.54 0 CA-C-N 115.603 -0.726 . . . . 52.119999999999997 111.447 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.7 137.94 97.3 Favored Pre-proline 0 C--N 1.303 -1.416 0 CA-C-O 120.91 0.386 . . . . 75.219999999999999 111.371 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.488 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 32.0 Cg_endo -68.39 138.84 43.67 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 122.35 2.033 . . . . 72.340000000000003 111.083 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 595' ' ' ARG . . . . . 0.504 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.9 ptm180 -116.21 122.52 45.26 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.035 -0.728 . . . . 73.129999999999995 109.035 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.88 131.9 46.37 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.431 -1.322 . . . . 63.5 107.431 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.474 ' CG2' HG12 ' A' ' 536' ' ' ILE . 65.4 t -76.09 114.11 15.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.226 0.536 . . . . 72.430000000000007 110.667 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -72.44 104.32 3.75 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.12 -0.946 . . . . 71.239999999999995 112.491 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 49.5 tpp -69.04 -27.65 65.84 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.525 -1.216 . . . . 74.030000000000001 107.914 175.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 47.8 t -87.99 86.91 7.19 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.581 -1.637 . . . . 75.010000000000005 106.581 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -79.78 132.61 36.19 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.016 -0.538 . . . . 73.230000000000004 110.135 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -95.79 161.94 13.81 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.695 -1.224 . . . . 74.409999999999997 107.695 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -85.22 90.9 8.01 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.843 0.83 . . . . 73.400000000000006 110.557 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -120.9 -50.24 0.27 Allowed Glycine 0 N--CA 1.422 -2.281 0 CA-C-N 114.484 -1.234 . . . . 61.310000000000002 110.875 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 73.88 -77.06 0.98 Allowed Glycine 0 N--CA 1.434 -1.478 0 O-C-N 123.879 0.399 . . . . 72.430000000000007 112.359 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -77.81 108.01 10.73 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 121.581 0.705 . . . . 75.420000000000002 111.482 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 46.4 m -104.28 94.98 5.65 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 105.568 -2.012 . . . . 75.25 105.568 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 66.3 mt -71.26 113.48 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 115.382 -0.826 . . . . 61.119999999999997 109.735 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 27.6 m -90.28 -36.91 14.43 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.185 -0.916 . . . . 71.219999999999999 109.628 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -90.32 86.41 6.48 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.087 -1.079 . . . . 60.350000000000001 108.087 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -113.89 -39.13 4.04 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.85 -1.068 . . . . 73.209999999999994 111.37 -173.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -158.6 169.66 23.91 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.123 -1.066 . . . . 75.510000000000005 108.123 -177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -67.77 -41.28 83.53 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.899 0.857 . . . . 70.400000000000006 109.108 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -98.31 -156.36 0.54 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.851 -1.537 . . . . 74.439999999999998 106.851 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -73.91 173.2 10.29 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.028 0.442 . . . . 55.329999999999998 111.519 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -107.42 144.52 29.39 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 116.361 -0.381 . . . . 33.329999999999998 110.308 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -71.97 107.39 2.21 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 122.233 1.955 . . . . 73.109999999999999 111.56 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 94.9 mt -80.32 155.23 27.34 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.876 -0.602 . . . . 62.149999999999999 111.034 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 10.1 t -95.13 14.66 21.31 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.311 1.053 . . . . 50.329999999999998 108.337 177.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 15.7 m -88.45 14.62 9.32 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 114.632 -1.167 . . . . 72.239999999999995 110.182 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.05 -49.02 71.74 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.416 -0.957 . . . . 74.319999999999993 108.416 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -84.35 110.23 18.44 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 106.495 -1.668 . . . . 72.409999999999997 106.495 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -125.35 169.48 12.28 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.796 -0.638 . . . . 73.200000000000003 110.785 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -118.06 83.3 1.98 Allowed 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.809 -0.812 . . . . 64.319999999999993 108.809 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 58.55 28.21 16.72 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.376 1.071 . . . . 62.32 110.885 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -64.43 -34.7 78.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 63.149999999999999 111.899 -174.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 627' ' ' ARG . . . . . 0.538 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 0.7 OUTLIER -66.58 -37.64 85.36 Favored 'General case' 0 C--O 1.203 -1.373 0 C-N-CA 120.292 -0.563 . . . . 62.130000000000003 109.905 176.291 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.616 ' O ' ' HG3' ' A' ' 631' ' ' MET . 59.0 mt -65.02 -34.33 69.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.619 -0.882 . . . . 61.409999999999997 108.619 177.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -68.21 -14.57 63.08 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.207 -0.906 . . . . 53.310000000000002 112.584 178.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 627' ' ' ARG . 8.5 pt-20 -60.97 -27.26 68.14 Favored 'General case' 0 C--N 1.362 1.147 0 CA-C-N 118.302 0.501 . . . . 75.030000000000001 111.275 -177.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.616 ' HG3' ' O ' ' A' ' 628' ' ' ILE . 0.0 OUTLIER -73.9 -7.71 53.33 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.952 -0.567 . . . . 54.350000000000001 112.23 -179.5 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -107.63 -0.56 34.62 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.09 -0.804 . . . . 31.329999999999998 111.09 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 633' ' ' ARG . . . . . 0.466 ' HG3' ' HA ' ' A' ' 630' ' ' GLU . 60.9 mtt180 -92.79 165.86 17.97 Favored Pre-proline 0 C--O 1.248 1.001 0 N-CA-C 108.704 -0.85 . . . . 65.409999999999997 108.704 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 57.4 Cg_endo -73.86 131.87 16.3 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 N-CA-C 108.345 -1.444 . . . . 65.120000000000005 108.345 166.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.3 166.3 21.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 C-N-CA 120.452 -0.499 . . . . 71.450000000000003 110.828 -177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.13 166.55 10.96 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.206 -0.598 . . . . 74.430000000000007 112.075 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -75.72 -166.96 21.73 Favored Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 115.234 -0.893 . . . . 60.219999999999999 113.584 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -68.08 -46.81 69.98 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 122.99 0.516 . . . . 74.219999999999999 110.382 -177.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -125.34 135.24 52.25 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.968 -0.753 . . . . 72.120000000000005 108.968 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 640' ' ' THR . . . . . 0.457 ' HB ' ' CG1' ' A' ' 591' ' ' ILE . 34.7 p -130.99 85.75 2.3 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.551 0.691 . . . . 72.120000000000005 110.01 175.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -163.38 143.59 8.86 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.155 -0.929 . . . . 54.530000000000001 109.782 -175.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.543 HD22 HG11 ' A' ' 523' ' ' VAL . 29.6 tp -128.43 142.96 50.94 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.412 -0.958 . . . . 75.019999999999996 108.412 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -110.19 111.35 22.62 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.527 -1.286 . . . . 73.040000000000006 107.527 176.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 47.6 t -102.45 117.15 47.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.985 -0.376 . . . . 63.399999999999999 109.985 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 52.5 mt -101.87 130.87 50.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 108.626 -0.879 . . . . 63.340000000000003 108.626 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 67.5 mt -105.06 112.19 37.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.654 -0.869 . . . . 75.530000000000001 108.654 178.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -109.83 148.78 30.89 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.439 -1.319 . . . . 74.319999999999993 107.439 175.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.7 ' HA ' ' HB3' ' A' ' 516' ' ' GLU . 0.1 OUTLIER -80.87 172.1 14.16 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 118.162 0.437 . . . . 72.230000000000004 111.855 -172.429 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 64.9 m -145.85 16.58 1.42 Allowed 'General case' 0 N--CA 1.416 -2.168 0 C-N-CA 119.12 -1.032 . . . . 52.200000000000003 112.822 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -93.89 -60.62 1.71 Allowed 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 120.394 -0.522 . . . . 74.450000000000003 111.424 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -79.92 -48.44 13.43 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 107.988 -1.115 . . . . 74.019999999999996 107.988 -175.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 52.5 t80 16.13 63.96 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.566 2.347 . . . . 73.400000000000006 114.645 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 2.08 18.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 123.043 1.402 . . . . 75.120000000000005 107.742 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 52.5 p -166.9 -170.91 1.67 Allowed 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 101.131 -3.655 . . . . 61.240000000000002 101.131 174.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 18.9 m -78.64 119.89 22.53 Favored 'General case' 0 C--N 1.283 -2.306 0 C-N-CA 118.071 -1.452 . . . . 71.129999999999995 107.901 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.493 ' HA ' ' CG ' ' A' ' 648' ' ' GLU 0.381 8.8 p 71.66 -32.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 126.997 2.119 . . . . 64.209999999999994 114.647 178.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 17.5 t70 . . . . . 0 C--N 1.29 -1.979 0 O-C-N 121.732 -0.605 . . . . 74.400000000000006 110.624 178.304 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 . . . . . 0 CA--C 1.498 -1.043 0 N-CA-C 108.619 -0.882 . . . . 74.409999999999997 108.619 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.521 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . -71.29 -30.59 66.44 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.036 -1.438 . . . . 64.519999999999996 111.719 -177.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 133.37 -146.63 18.53 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.023 -1.084 . . . . 75.010000000000005 111.101 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.428 HG23 ' HA3' ' A' ' 637' ' ' GLY . 4.1 mp -120.88 110.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 116.857 0.328 . . . . 75.420000000000002 111.055 -175.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.512 ' CD2' HG23 ' A' ' 528' ' ' THR . 10.0 m-85 -90.0 131.31 35.95 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.128 -1.434 . . . . 75.200000000000003 107.128 168.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 506' ' ' THR . . . . . 0.411 ' HA ' HG22 ' A' ' 640' ' ' THR . 14.2 t -168.77 171.38 8.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.422 -0.584 . . . . 62.340000000000003 109.422 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -77.24 148.76 35.63 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 116.062 -0.517 . . . . 72.409999999999997 110.204 177.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -65.6 -32.1 73.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.387 0.613 . . . . 75.439999999999998 110.113 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -135.83 141.42 36.77 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 107.474 -1.306 . . . . 64.209999999999994 107.474 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.57 -28.21 10.19 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 122.425 2.084 . . . . 71.010000000000005 112.359 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 49.6 t -136.97 139.69 44.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 107.016 -1.476 . . . . 73.409999999999997 107.016 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.3 t -133.36 140.48 47.4 Favored 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 109.384 -0.599 . . . . 73.230000000000004 109.384 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -106.73 129.91 54.54 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.111 -1.07 . . . . 74.0 108.111 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.7 m -119.82 150.67 22.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 109.032 -0.729 . . . . 73.120000000000005 109.032 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.424 ' HB2' ' HB3' ' A' ' 649' ' ' SER . 9.5 t -82.76 167.57 18.02 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.762 0.792 . . . . 71.129999999999995 110.816 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -90.54 -9.24 47.94 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.419 -1.697 . . . . 73.430000000000007 106.419 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 20.5 m -121.83 24.75 9.53 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 121.175 -0.953 . . . . 63.5 110.855 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 8.2 tt -88.63 -32.89 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.999 0.428 . . . . 70.319999999999993 111.532 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 519' ' ' GLY . . . . . 0.42 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 89.27 -80.08 1.56 Allowed Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 110.656 -0.978 . . . . 63.409999999999997 110.656 -176.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.1 mm -124.56 123.74 66.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.533 -0.914 . . . . 72.129999999999995 108.533 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -101.69 149.36 24.22 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 108.705 -0.85 . . . . 63.539999999999999 108.705 177.848 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 31.1 mt-10 -133.41 130.1 38.25 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 123.611 0.765 . . . . 75.340000000000003 110.242 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.585 HG11 HD22 ' A' ' 642' ' ' LEU . 38.8 t -113.9 126.35 71.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 108.265 -1.013 . . . . 75.530000000000001 108.265 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -77.84 131.16 37.43 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 124.053 0.846 . . . . 45.119999999999997 110.077 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 568' ' ' VAL . 46.0 t -110.46 125.44 67.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.266 -0.642 . . . . 75.329999999999998 109.266 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.7 mt -78.28 129.3 34.89 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.344 -0.844 . . . . 75.239999999999995 111.861 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 567' ' ' ILE . 15.6 tpt180 -76.58 153.01 35.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.716 -1.129 . . . . 52.229999999999997 108.853 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 5.5 p -59.28 146.2 40.34 Favored 'General case' 0 N--CA 1.426 -1.663 0 O-C-N 123.784 0.678 . . . . 65.230000000000004 111.813 176.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 28.1 t -55.6 -28.62 56.16 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.254 1.022 . . . . 74.349999999999994 110.285 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -112.66 99.13 1.01 Allowed Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 109.037 -1.625 . . . . 50.409999999999997 109.037 172.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.97 100.98 12.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.737 -0.838 . . . . 61.039999999999999 108.737 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -120.29 116.38 25.45 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.731 -0.668 . . . . 73.430000000000007 110.054 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 68.83 -169.54 41.95 Favored Glycine 0 N--CA 1.445 -0.744 0 O-C-N 123.95 0.781 . . . . 73.0 114.399 173.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -92.51 124.21 36.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 123.249 0.62 . . . . 72.549999999999997 109.749 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 57.7 t -132.5 133.68 59.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.734 -0.839 . . . . 64.120000000000005 108.734 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' ' 561' ' ' GLU . 42.4 mm -107.13 132.4 54.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 109.996 -0.372 . . . . 71.420000000000002 109.996 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 594' ' ' PRO . 41.2 t -121.12 110.21 34.77 Favored Pre-proline 0 N--CA 1.439 -1.01 0 N-CA-C 109.688 -0.486 . . . . 53.32 109.688 178.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 57.1 Cg_endo -75.03 158.57 42.02 Favored 'Trans proline' 0 C--N 1.334 -0.227 0 C-N-CA 122.505 2.137 . . . . 74.439999999999998 112.441 178.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.487 ' HB3' HG22 ' A' ' 591' ' ' ILE . 53.1 p90 -150.32 162.91 39.61 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.648 0.261 . . . . 73.510000000000005 110.557 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -155.33 150.32 26.69 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.605 -0.725 . . . . 75.099999999999994 110.092 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 15.0 p -83.45 134.65 34.85 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.175 -0.676 . . . . 75.129999999999995 109.175 173.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 87.1 mt -105.14 118.87 53.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.152 -1.055 . . . . 44.240000000000002 108.152 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -75.45 138.05 41.38 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 123.405 0.441 . . . . 75.239999999999995 110.029 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -138.72 -103.59 0.6 Allowed Glycine 0 CA--C 1.502 -0.757 0 N-CA-C 110.675 -0.97 . . . . 54.310000000000002 110.675 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 25.0 p -90.27 -9.06 49.32 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.88 0.848 . . . . 73.120000000000005 109.16 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -112.32 136.56 51.63 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 106.757 -1.571 . . . . 73.019999999999996 106.757 173.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 10.8 mtm-85 -108.0 149.9 27.8 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.265 0.839 . . . . 75.019999999999996 113.265 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -90.66 -147.25 18.25 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 114.71 -1.132 . . . . 73.140000000000001 111.048 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 63.54 28.33 72.28 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 111.858 -0.497 . . . . 73.030000000000001 111.858 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 71.97 24.99 75.77 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 121.61 -0.328 . . . . 74.150000000000006 112.422 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -89.92 -77.53 0.39 Allowed 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 117.508 0.654 . . . . 64.340000000000003 110.879 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -96.14 -34.67 11.6 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 108.218 -1.03 . . . . 65.5 108.218 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -144.24 159.11 43.23 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 108.254 -1.017 . . . . 74.319999999999993 108.254 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -89.1 112.24 23.17 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 104.983 -2.228 . . . . 71.230000000000004 104.983 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.0 129.47 35.32 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.545 0.688 . . . . 74.329999999999998 110.417 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 15.0 t -129.37 161.2 30.85 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 115.546 -0.752 . . . . 62.009999999999998 110.563 -171.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.6 p -151.99 161.93 41.87 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.392 -1.336 . . . . 71.219999999999999 107.392 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 165.01 -167.47 38.71 Favored Glycine 0 N--CA 1.419 -2.442 0 C-N-CA 120.103 -1.046 . . . . 54.299999999999997 110.579 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 538' ' ' PRO . 27.1 mt-10 -130.86 137.59 49.44 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 123.136 0.574 . . . . 73.109999999999999 109.614 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 569' ' ' LYS . 94.6 mt -102.87 133.63 47.63 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.205 -0.665 . . . . 71.340000000000003 109.205 178.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.437 ' HA ' HD13 ' A' ' 536' ' ' ILE . 34.3 tt0 -96.74 119.26 34.89 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.912 -0.585 . . . . 72.430000000000007 110.801 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -116.04 148.4 40.23 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.622 -0.881 . . . . 53.119999999999997 108.622 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.483 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 46.0 mt-30 -141.77 -172.32 3.53 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.098 -1.075 . . . . 73.420000000000002 108.098 -178.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -80.08 -28.17 39.17 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.559 -0.904 . . . . 73.239999999999995 108.559 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -84.24 -32.87 24.23 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.242 -0.89 . . . . 53.420000000000002 111.021 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.483 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 40.5 mm-40 -79.5 143.49 34.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.773 0.321 . . . . 73.120000000000005 111.38 177.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.572 ' O ' ' HB2' ' A' ' 527' ' ' ARG . 3.9 pt -112.0 -77.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 113.029 0.751 . . . . 71.120000000000005 113.029 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.551 ' H ' HG13 ' A' ' 567' ' ' ILE . 13.1 p -113.38 144.37 21.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.913 0.863 . . . . 75.409999999999997 112.171 -174.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.499 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -120.86 169.69 10.2 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.378 -0.828 . . . . 34.200000000000003 109.251 173.28 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.4 p -135.62 146.87 48.34 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 123.591 0.557 . . . . 71.129999999999995 112.443 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.2 mp -95.29 119.32 43.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.041 -1.466 . . . . 63.439999999999998 107.041 170.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 572' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 521' ' ' MET . 26.4 m -98.75 116.09 30.2 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.432 -0.581 . . . . 72.439999999999998 109.432 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.468 HG23 HG22 ' A' ' 571' ' ' ILE . 89.3 t -121.6 131.45 73.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 N-CA-C 109.92 -0.4 . . . . 71.409999999999997 109.92 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.42 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 23.4 tptm -85.83 115.6 23.57 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.974 -0.75 . . . . 75.030000000000001 108.974 176.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 36.4 t -86.62 125.31 40.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.15 -1.426 . . . . 51.140000000000001 107.15 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 35.8 mm -84.21 152.39 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 108.518 -0.919 . . . . 54.539999999999999 108.518 -175.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -59.31 130.19 45.74 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 123.812 0.695 . . . . 75.329999999999998 110.017 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -39.5 115.29 0.49 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 116.304 1.964 . . . . 63.109999999999999 116.304 -171.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -80.29 143.46 33.62 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.98 -1.009 . . . . 71.230000000000004 110.113 171.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.62 -10.02 56.52 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 115.298 1.592 . . . . 73.140000000000001 115.298 -169.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -64.33 -65.3 0.7 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 118.049 0.386 . . . . 41.009999999999998 111.851 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.461 ' HB2' ' HD3' ' A' ' 585' ' ' LYS . 62.1 mm-40 -114.2 144.11 43.74 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.94 -1.133 . . . . 73.540000000000006 107.94 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -88.41 -66.14 0.95 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.331 -0.988 . . . . 53.240000000000002 108.331 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -101.16 132.02 46.84 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 107.03 -1.47 . . . . 60.509999999999998 107.03 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.461 ' HD3' ' HB2' ' A' ' 582' ' ' GLU . 13.5 pttt -151.21 163.29 39.2 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 115.151 -0.931 . . . . 70.030000000000001 108.829 -169.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.7 t -144.29 150.07 37.28 Favored 'General case' 0 C--N 1.279 -2.457 0 C-N-CA 119.641 -0.824 . . . . 64.439999999999998 112.243 -175.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 45.4 p90 -133.59 166.79 21.78 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 106.317 -1.735 . . . . 64.519999999999996 106.317 175.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.444 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 89.1 m-85 -115.54 159.4 21.29 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 120.115 -0.634 . . . . 75.049999999999997 109.832 -175.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.09 124.71 42.46 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 106.227 -1.768 . . . . 73.299999999999997 106.227 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -122.65 129.68 52.11 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 120.961 0.41 . . . . 73.5 110.071 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.487 HG22 ' HB3' ' A' ' 539' ' ' TYR . 25.2 pt -100.23 143.83 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 107.868 -1.16 . . . . 54.520000000000003 107.868 175.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -84.88 -177.31 51.01 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 111.338 -0.705 . . . . 64.430000000000007 111.338 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -78.31 129.17 75.86 Favored Pre-proline 0 N--CA 1.416 -2.13 0 CA-C-O 120.889 0.376 . . . . 60.520000000000003 110.525 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.497 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.0 Cg_endo -59.56 127.74 24.75 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.615 2.877 . . . . 74.299999999999997 112.309 -175.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -106.26 131.98 52.85 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.378 -0.601 . . . . 64.109999999999999 109.378 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -73.75 134.54 43.48 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 105.034 -2.21 . . . . 73.049999999999997 105.034 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 19.2 t -82.57 71.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.287 1.041 . . . . 73.219999999999999 108.842 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.78 164.71 21.5 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.432 -1.258 . . . . 74.420000000000002 107.667 -176.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -110.63 -23.29 11.17 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 120.81 0.338 . . . . 74.519999999999996 111.233 -174.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 11.5 m -98.3 139.17 34.47 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.999 0.428 . . . . 65.230000000000004 111.459 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 601' ' ' GLU . . . . . 0.429 ' HB2' ' HE2' ' A' ' 603' ' ' LYS . 46.2 mt-10 -95.52 145.23 25.36 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.597 -1.631 . . . . 72.049999999999997 106.597 171.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -78.81 113.39 16.86 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.665 -0.814 . . . . 73.319999999999993 109.867 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 603' ' ' LYS . . . . . 0.429 ' HE2' ' HB2' ' A' ' 601' ' ' GLU . 75.3 mmtt -117.49 23.81 11.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.759 -0.655 . . . . 74.239999999999995 111.054 -175.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -80.68 2.24 79.87 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.985 -0.626 . . . . 73.530000000000001 111.8 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -85.14 66.93 3.75 Favored Glycine 0 N--CA 1.425 -2.065 0 N-CA-C 112.335 -0.306 . . . . 53.539999999999999 112.335 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -77.55 153.78 33.02 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.602 -1.259 . . . . 72.129999999999995 107.602 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 9.0 t -67.31 107.6 2.45 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 122.044 0.926 . . . . 73.109999999999999 109.65 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 608' ' ' ILE . . . . . 0.416 ' O ' HG12 ' A' ' 608' ' ' ILE . 11.2 tt -140.31 10.01 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.424 -0.807 . . . . 74.239999999999995 110.566 -173.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 28.5 m -66.85 128.87 37.94 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.276 -0.638 . . . . 71.340000000000003 109.276 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -126.42 -170.53 2.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.438 -0.346 . . . . 63.340000000000003 110.567 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -63.27 128.78 37.43 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.768 -0.651 . . . . 73.049999999999997 111.726 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -87.23 -35.6 18.44 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 105.099 -2.186 . . . . 73.430000000000007 105.099 171.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 35.0 t70 41.02 90.47 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 126.752 2.021 . . . . 64.150000000000006 114.531 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 36.6 t70 172.56 -50.29 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 106.212 -1.773 . . . . 72.409999999999997 106.212 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -173.13 105.82 0.14 Allowed 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 105.646 -1.983 . . . . 70.340000000000003 105.646 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -67.71 130.64 92.97 Favored Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 120.363 -0.535 . . . . 73.450000000000003 109.786 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 617' ' ' PRO . . . . . 0.422 ' HB2' ' O ' ' A' ' 619' ' ' THR . 55.3 Cg_endo -69.18 114.39 3.59 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.493 2.129 . . . . 71.340000000000003 114.039 -174.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.23 -41.09 90.54 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.793 -0.817 . . . . 73.349999999999994 108.793 174.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 619' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 617' ' ' PRO . 10.3 t -87.3 122.06 30.57 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 105.346 -2.094 . . . . 73.25 105.346 172.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 7.9 t -80.23 175.54 10.55 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-O 122.613 1.197 . . . . 61.130000000000003 113.169 -166.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 621' ' ' LYS . . . . . 0.634 ' HD2' ' O ' ' A' ' 621' ' ' LYS . 0.1 OUTLIER -119.75 162.8 18.44 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 113.177 -1.828 . . . . 74.450000000000003 109.574 -173.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -118.65 102.98 9.27 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.718 -1.215 . . . . 62.140000000000001 107.718 173.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.45 ' HG2' ' OE2' ' A' ' 624' ' ' GLU 0.254 1.0 OUTLIER -75.32 -18.95 59.9 Favored 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 120.145 -0.622 . . . . 64.400000000000006 112.335 179.424 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 624' ' ' GLU . . . . . 0.45 ' OE2' ' HG2' ' A' ' 623' ' ' GLU . 9.6 mp0 -110.69 89.71 3.12 Favored 'General case' 0 C--O 1.248 0.979 0 N-CA-C 106.314 -1.735 . . . . 75.349999999999994 106.314 168.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.86 126.75 30.75 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.925 -0.58 . . . . 74.030000000000001 111.002 -175.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 19.4 tpp180 -56.82 -36.72 70.27 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.623 1.169 . . . . 75.310000000000002 111.006 -178.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 627' ' ' ARG . . . . . 0.433 ' HA ' ' OE1' ' A' ' 630' ' ' GLU . 2.7 tmt_? -57.65 -26.89 62.28 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.679 0.792 . . . . 54.43 111.816 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.482 ' O ' ' HG2' ' A' ' 631' ' ' MET . 69.8 mt -65.74 -27.37 41.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.548 0.69 . . . . 65.239999999999995 110.445 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -85.89 -22.88 27.28 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.291 0.567 . . . . 72.140000000000001 109.737 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 633' ' ' ARG . 45.0 mt-10 -81.83 -15.42 54.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.376 -0.829 . . . . 75.25 111.728 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 26.9 ptt? -76.27 -16.89 59.7 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.299 -0.63 . . . . 71.109999999999999 109.299 176.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -110.37 37.31 3.81 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.461 -1.055 . . . . 72.540000000000006 110.461 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 633' ' ' ARG . . . . . 0.468 ' HD3' ' HA ' ' A' ' 630' ' ' GLU . 63.3 mtp180 -125.81 155.16 73.19 Favored Pre-proline 0 N--CA 1.425 -1.688 0 C-N-CA 123.033 0.533 . . . . 72.549999999999997 109.636 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.497 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 21.3 Cg_endo -66.26 137.71 48.57 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 C-N-CA 122.064 1.843 . . . . 75.010000000000005 108.096 169.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.41 167.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 120.361 -0.535 . . . . 72.349999999999994 111.287 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.487 ' HB2' HG21 ' A' ' 640' ' ' THR . 1.0 OUTLIER -104.87 175.57 5.45 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.013 -0.539 . . . . 64.209999999999994 112.357 -177.861 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.428 ' HA3' HG23 ' A' ' 504' ' ' ILE . . . -74.18 -176.92 35.94 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.699 -0.682 . . . . 74.109999999999999 112.405 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.4 -39.94 77.66 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.985 0.422 . . . . 74.400000000000006 110.217 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -112.87 121.49 44.84 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.89 -0.595 . . . . 74.239999999999995 110.62 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 640' ' ' THR . . . . . 0.487 HG21 ' HB2' ' A' ' 636' ' ' LEU . 19.6 p -134.75 81.32 1.9 Allowed 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 122.149 0.976 . . . . 62.509999999999998 110.895 174.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -163.14 150.97 13.4 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.477 -1.305 . . . . 72.340000000000003 107.477 -175.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.585 HD22 HG11 ' A' ' 523' ' ' VAL . 27.8 tp -133.69 139.85 46.67 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 108.334 -0.988 . . . . 63.119999999999997 108.334 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.84 114.5 28.68 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.079 -1.452 . . . . 72.239999999999995 107.079 174.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 41.1 t -103.49 110.03 28.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 109.12 -0.696 . . . . 71.109999999999999 109.12 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 47.2 mt -96.65 120.8 46.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 109.413 -0.588 . . . . 53.399999999999999 109.413 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 63.4 mt -97.2 113.99 33.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 107.631 -1.248 . . . . 71.430000000000007 107.631 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -147.32 -179.5 6.89 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 105.248 -2.13 . . . . 74.319999999999993 105.248 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -83.56 135.62 34.56 Favored 'General case' 0 C--N 1.289 -2.054 0 C-N-CA 117.093 -1.843 . . . . 73.329999999999998 110.45 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 649' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 515' ' ' SER . 8.3 t -114.5 23.79 12.45 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.391 -2.077 . . . . 44.409999999999997 105.391 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -63.33 -53.59 50.36 Favored 'General case' 0 N--CA 1.387 -3.578 0 C-N-CA 126.633 1.973 . . . . 64.340000000000003 110.697 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.46 -34.25 41.68 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.388 -0.925 . . . . 75.319999999999993 112.301 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -126.83 132.01 51.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.779 -0.452 . . . . 74.340000000000003 109.779 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -91.61 -25.21 19.29 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.302 0.572 . . . . 71.510000000000005 110.407 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 25.4 m -133.12 141.93 48.42 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.422 -0.585 . . . . 71.010000000000005 109.422 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 12.3 m -78.67 138.0 38.08 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.0 -0.741 . . . . 74.25 109.0 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 56.5 t -77.32 -38.03 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 107.998 -1.112 . . . . 64.510000000000005 107.998 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--N 1.311 -1.102 0 CA-C-N 114.799 -1.091 . . . . 64.409999999999997 111.068 176.783 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 501' ' ' HIS . . . . . 0.581 ' N ' ' HA2' ' A' ' 632' ' ' GLY . 43.3 t60 . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 109.903 -0.406 . . . . 63.450000000000003 109.903 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -93.59 -68.23 0.81 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.715 -0.476 . . . . 75.230000000000004 109.715 175.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.44 ' C ' HG22 ' A' ' 528' ' ' THR . . . -178.12 -166.37 34.41 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.814 -0.914 . . . . 65.420000000000002 110.814 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.5 mp -112.6 128.81 69.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 123.521 0.729 . . . . 62.229999999999997 110.928 -173.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.575 ' CE2' HG23 ' A' ' 528' ' ' THR . 41.7 m-85 -102.13 139.75 37.34 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.725 -0.472 . . . . 72.140000000000001 109.725 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.0 t -169.89 175.99 4.95 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.056 -1.09 . . . . 74.450000000000003 108.056 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -80.96 154.92 26.69 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 117.988 0.358 . . . . 74.010000000000005 110.734 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.92 -41.8 77.69 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.852 -0.613 . . . . 51.32 109.5 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -121.93 146.48 46.27 Favored Pre-proline 0 N--CA 1.417 -2.081 0 N-CA-C 108.376 -0.972 . . . . 74.549999999999997 108.376 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -77.63 -23.51 9.68 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.547 1.498 . . . . 73.530000000000001 111.249 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.0 t -141.01 132.92 29.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 107.764 -1.199 . . . . 53.130000000000003 107.764 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.7 t -126.46 139.73 53.02 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.633 -0.877 . . . . 72.439999999999998 108.633 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -108.24 118.03 35.71 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.228 -1.027 . . . . 71.420000000000002 108.228 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.64 153.94 17.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 121.138 0.494 . . . . 75.439999999999998 110.156 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.565 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 65.3 m -79.49 152.91 29.96 Favored 'General case' 0 N--CA 1.42 -1.928 0 C-N-CA 124.391 1.076 . . . . 52.409999999999997 111.133 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.595 ' HB3' ' HA ' ' A' ' 648' ' ' GLU . 15.6 pt-20 -63.14 -49.89 72.61 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 120.954 0.407 . . . . 73.109999999999999 111.167 177.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 517' ' ' SER . . . . . 0.495 ' N ' ' HG3' ' A' ' 516' ' ' GLU . 52.5 m -109.34 69.21 0.7 Allowed 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.962 0.887 . . . . 41.119999999999997 110.108 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 13.3 tt -110.64 -27.24 2.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.058 -0.973 . . . . 73.329999999999998 110.836 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 519' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 90.63 -70.76 2.1 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.561 -0.828 . . . . 34.030000000000001 111.55 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.9 mm -135.42 125.07 42.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.049 -0.723 . . . . 63.020000000000003 109.049 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.517 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -108.09 150.06 27.67 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.898 -1.149 . . . . 74.299999999999997 107.898 176.436 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.8 mt-10 -129.56 121.75 27.78 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.588 0.708 . . . . 61.539999999999999 112.767 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.651 HG11 HD22 ' A' ' 642' ' ' LEU . 99.4 t -110.06 131.43 61.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.101 -0.954 . . . . 74.230000000000004 109.086 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -89.97 136.44 33.04 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.678 0.751 . . . . 72.219999999999999 111.931 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 47.3 t -105.54 124.53 60.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 114.649 -1.16 . . . . 63.549999999999997 108.109 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.4 mt -70.74 127.21 31.89 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 123.759 0.662 . . . . 71.109999999999999 110.703 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.405 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 43.4 ttp180 -74.7 162.55 28.61 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.426 -1.261 . . . . 72.430000000000007 110.346 -177.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.575 HG23 ' CE2' ' A' ' 505' ' ' PHE . 1.0 OUTLIER -55.83 139.05 46.92 Favored 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 124.892 1.277 . . . . 73.340000000000003 111.852 177.632 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 4.0 m -51.5 -37.8 50.91 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 125.434 1.494 . . . . 74.349999999999994 110.188 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -124.8 96.2 0.51 Allowed Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 108.701 -1.76 . . . . 53.350000000000001 108.701 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.18 107.95 17.48 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.945 -0.761 . . . . 73.109999999999999 108.945 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -124.51 108.09 11.75 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.034 -0.53 . . . . 54.109999999999999 109.898 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 89.69 -132.0 11.03 Favored Glycine 0 C--N 1.312 -0.761 0 C-N-CA 120.36 -0.924 . . . . 73.329999999999998 112.665 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -133.39 131.68 40.31 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 123.212 0.605 . . . . 74.299999999999997 109.492 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.0 t -132.55 143.72 38.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 123.631 0.772 . . . . 74.019999999999996 109.313 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.585 HG12 ' CG2' ' A' ' 597' ' ' VAL . 33.8 mm -112.56 132.1 62.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.891 -0.781 . . . . 73.319999999999993 108.891 173.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 25.7 t -120.67 110.3 35.45 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 109.019 -0.734 . . . . 75.129999999999995 109.019 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -74.7 158.38 43.38 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.221 1.947 . . . . 44.43 111.578 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.495 ' HB3' HG22 ' A' ' 591' ' ' ILE . 54.5 p90 -146.34 170.22 17.24 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 122.202 -0.311 . . . . 64.140000000000001 111.173 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -158.17 150.92 22.49 Favored 'General case' 0 C--O 1.245 0.822 0 O-C-N 123.614 0.571 . . . . 63.32 110.874 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.0 p -90.5 131.55 36.18 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.897 -0.592 . . . . 75.420000000000002 109.746 172.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.59 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 91.5 mt -105.08 116.14 48.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 109.169 -0.678 . . . . 74.230000000000004 109.169 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -75.66 103.35 5.73 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.54 -0.911 . . . . 75.019999999999996 108.54 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -113.8 -83.71 1.22 Allowed Glycine 0 CA--C 1.481 -2.086 0 C-N-CA 119.442 -1.361 . . . . 74.099999999999994 112.188 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.3 m -109.98 32.53 5.03 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 108.652 -0.869 . . . . 75.430000000000007 108.652 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -158.23 149.0 20.59 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.093 -0.958 . . . . 63.130000000000003 108.894 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 26.8 mtm180 -81.28 116.99 21.41 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.569 0.7 . . . . 74.150000000000006 112.522 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.29 -167.18 42.6 Favored Glycine 0 N--CA 1.437 -1.248 0 CA-C-N 115.27 -0.877 . . . . 64.329999999999998 111.515 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.7 20.01 79.76 Favored Glycine 0 C--N 1.312 -0.805 0 C-N-CA 120.805 -0.712 . . . . 54.210000000000001 111.841 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.0 43.95 6.93 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 120.45 -0.881 . . . . 70.510000000000005 111.959 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -118.0 -61.24 1.71 Allowed 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 119.453 -0.899 . . . . 43.32 109.961 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -99.36 -34.81 10.15 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 107.073 -1.454 . . . . 54.210000000000001 107.073 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -143.29 152.04 41.21 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.847 -1.168 . . . . 75.349999999999994 107.847 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -84.89 142.06 29.97 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.677 -1.231 . . . . 74.510000000000005 107.677 177.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -82.11 139.2 34.53 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.723 -0.843 . . . . 75.200000000000003 108.723 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.1 t -148.02 152.47 37.49 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.569 0.699 . . . . 62.310000000000002 110.458 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 25.6 p -156.11 169.48 24.4 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.964 -1.495 . . . . 73.540000000000006 106.964 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 159.75 -164.84 34.35 Favored Glycine 0 N--CA 1.419 -2.473 0 N-CA-C 110.106 -1.198 . . . . 53.409999999999997 110.106 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.443 ' HB3' HG23 ' A' ' 536' ' ' ILE . 43.4 mt-10 -131.75 130.65 42.17 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 123.845 0.379 . . . . 72.219999999999999 110.627 -176.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 569' ' ' LYS . 86.4 mt -100.12 132.79 45.28 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.377 -0.601 . . . . 52.509999999999998 109.377 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.428 ' HA ' HD13 ' A' ' 536' ' ' ILE . 34.1 tt0 -99.17 121.01 40.45 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.648 -0.705 . . . . 74.109999999999999 110.708 -177.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -118.36 151.96 36.74 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.185 -0.672 . . . . 75.510000000000005 109.185 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.64 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 50.5 mt-30 -149.51 -177.49 5.89 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.054 -0.721 . . . . 74.310000000000002 109.054 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -70.68 -37.65 73.66 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.06 -1.459 . . . . 62.409999999999997 107.06 171.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.66 -48.43 16.81 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.361 -1.29 . . . . 63.219999999999999 111.881 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.64 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 27.9 mm-40 -58.99 133.55 56.19 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 123.829 0.852 . . . . 72.219999999999999 111.392 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.606 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.1 pt -85.14 -81.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 112.723 0.638 . . . . 24.420000000000002 112.723 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.606 ' H ' HG13 ' A' ' 567' ' ' ILE . 7.6 p -134.44 160.96 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 108.907 -0.775 . . . . 71.219999999999999 108.907 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.528 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -126.6 159.6 33.07 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.767 0.317 . . . . 63.420000000000002 110.299 176.263 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.1 p -127.95 148.86 50.52 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.118 -0.946 . . . . 65.109999999999999 112.007 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.3 mp -99.32 127.94 51.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 106.7 -1.593 . . . . 71.450000000000003 106.7 172.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 17.0 m -100.96 115.13 29.73 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.693 -0.855 . . . . 71.319999999999993 108.693 178.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 96.9 t -117.51 130.0 73.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 120.7 -0.4 . . . . 75.5 110.659 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 16.2 tppt? -79.13 120.76 24.12 Favored 'General case' 0 N--CA 1.437 -1.102 0 O-C-N 124.037 0.835 . . . . 74.319999999999993 109.282 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 55.7 t -94.32 128.12 45.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 107.284 -1.376 . . . . 51.119999999999997 107.284 176.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 24.5 mm -94.66 138.35 20.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 109.334 -0.617 . . . . 72.5 109.334 -175.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -91.25 83.28 5.49 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.963 -0.562 . . . . 74.230000000000004 111.509 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -96.11 102.76 14.59 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.895 -1.52 . . . . 53.409999999999997 106.895 172.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.19 81.23 6.49 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.757 0.789 . . . . 72.319999999999993 111.389 -174.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -140.65 123.23 16.12 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.379 -1.282 . . . . 74.109999999999999 108.03 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -75.16 109.69 8.86 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 122.066 0.936 . . . . 65.019999999999996 110.357 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.603 ' OE2' ' HE2' ' A' ' 585' ' ' LYS . 37.9 tt0 -140.14 -174.06 3.83 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 104.446 -2.428 . . . . 74.430000000000007 104.446 -176.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.489 ' H ' ' HG2' ' A' ' 582' ' ' GLU . 41.0 ttmt -67.65 147.83 52.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.272 -0.64 . . . . 72.019999999999996 109.272 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -46.8 124.32 6.05 Favored 'General case' 0 C--O 1.247 0.931 0 O-C-N 124.52 1.137 . . . . 63.520000000000003 109.354 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.603 ' HE2' ' OE2' ' A' ' 582' ' ' GLU . 32.9 mmtp -86.83 134.88 33.51 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.459 -1.246 . . . . 54.420000000000002 110.6 -167.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 7.5 t -152.88 135.07 14.92 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-O 121.375 0.607 . . . . 72.150000000000006 110.933 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 42.8 p90 -126.84 174.17 9.0 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.57 -1.27 . . . . 73.510000000000005 107.57 178.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.59 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 59.0 m-85 -119.83 151.6 38.6 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 109.267 -0.642 . . . . 72.549999999999997 109.267 -176.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.81 130.82 54.13 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 105.083 -2.191 . . . . 74.510000000000005 105.083 176.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' A' ' 542' ' ' ILE . 34.1 tt0 -132.25 144.3 50.52 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.075 -0.713 . . . . 74.120000000000005 109.075 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.495 HG22 ' HB3' ' A' ' 539' ' ' TYR . 13.0 pt -107.43 155.24 8.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.069 -0.715 . . . . 75.439999999999998 109.069 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -100.25 -174.68 30.13 Favored Glycine 0 C--N 1.295 -1.721 0 C-N-CA 121.055 -0.593 . . . . 22.34 112.035 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.408 ' OE1' ' HD2' ' A' ' 594' ' ' PRO . 2.9 mm-40 -61.91 126.96 88.42 Favored Pre-proline 0 C--N 1.313 -0.992 0 C-N-CA 123.198 0.599 . . . . 71.200000000000003 112.1 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.408 ' HD2' ' OE1' ' A' ' 593' ' ' GLU . 21.8 Cg_endo -70.0 118.67 5.82 Favored 'Trans proline' 0 N--CA 1.428 -2.351 0 C-N-CA 122.175 1.917 . . . . 73.430000000000007 110.311 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -104.3 119.56 39.24 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.15 -0.932 . . . . 74.140000000000001 109.328 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.8 129.27 40.2 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.922 -1.14 . . . . 72.109999999999999 107.922 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.585 ' CG2' HG12 ' A' ' 536' ' ' ILE . 45.0 t -85.81 94.85 4.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 108.82 -0.808 . . . . 64.349999999999994 108.82 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -89.54 123.99 34.13 Favored 'General case' 0 N--CA 1.402 -2.846 0 N-CA-C 106.774 -1.565 . . . . 63.200000000000003 106.774 174.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 48.0 ttm -76.72 -17.09 59.29 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.393 0.616 . . . . 75.510000000000005 109.613 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 47.7 t -75.72 -10.21 59.25 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.433 -0.803 . . . . 53.219999999999999 110.408 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.85 113.65 2.16 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 107.497 -1.297 . . . . 75.209999999999994 107.497 176.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -101.02 131.08 47.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.395 0.617 . . . . 72.209999999999994 112.326 -170.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.93 175.44 9.58 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.409 -1.33 . . . . 75.329999999999998 107.409 171.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 169.85 -158.62 30.87 Favored Glycine 0 N--CA 1.421 -2.345 0 C-N-CA 120.124 -1.036 . . . . 73.299999999999997 111.307 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -155.26 59.25 0.38 Allowed Glycine 0 N--CA 1.425 -2.095 0 N-CA-C 110.514 -1.034 . . . . 73.530000000000001 110.514 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -76.08 167.29 22.14 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-O 120.604 0.24 . . . . 63.310000000000002 110.609 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 607' ' ' THR . . . . . 0.425 ' HA ' ' OE1' ' A' ' 610' ' ' GLU . 89.9 m -74.23 78.97 1.8 Allowed 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 122.457 1.122 . . . . 72.310000000000002 110.941 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 68.0 mt -137.45 99.31 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 106.986 -1.487 . . . . 63.439999999999998 106.986 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 5.8 m 68.08 21.94 8.55 Favored 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 121.653 0.74 . . . . 74.549999999999997 111.646 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 610' ' ' GLU . . . . . 0.425 ' OE1' ' HA ' ' A' ' 607' ' ' THR . 9.3 pt-20 -83.29 -5.93 59.3 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.331 -0.989 . . . . 74.420000000000002 108.331 175.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -67.01 97.61 0.51 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.768 1.627 . . . . 71.129999999999995 107.886 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . 0.265 54.9 m-85 70.31 69.89 0.21 Allowed 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.154 1.382 . . . . 74.329999999999998 112.242 -173.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -174.95 138.1 0.45 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 105.582 -2.007 . . . . 74.299999999999997 105.582 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -114.47 -31.4 6.24 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 114.211 1.189 . . . . 75.319999999999993 114.211 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -89.12 -66.52 0.91 Allowed 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 118.97 -1.092 . . . . 72.209999999999994 113.163 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -139.32 122.26 10.54 Favored Pre-proline 0 C--N 1.296 -1.724 0 C-N-CA 120.738 -0.385 . . . . 72.209999999999994 110.625 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.04 153.41 67.67 Favored 'Trans proline' 0 C--O 1.25 1.098 0 C-N-CA 122.095 1.863 . . . . 74.209999999999994 111.361 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 76.4 mt -68.27 90.14 0.34 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 122.01 0.909 . . . . 75.439999999999998 110.899 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 25.9 m -142.79 98.17 3.24 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 107.119 -1.437 . . . . 75.319999999999993 107.119 175.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 21.8 t -91.96 152.8 19.85 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.293 -1.002 . . . . 75.450000000000003 108.293 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -75.24 103.67 5.49 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.427 0.632 . . . . 65.510000000000005 110.661 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -112.28 157.19 21.24 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.328 -1.36 . . . . 72.239999999999995 107.328 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 63.6 41.8 6.95 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.797 0.686 . . . . 72.209999999999994 111.287 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -74.03 -173.89 1.73 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.326 -0.852 . . . . 65.420000000000002 110.915 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.401 ' HB2' HD12 ' A' ' 628' ' ' ILE . 8.6 pt-20 -134.81 34.74 3.14 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.747 0.784 . . . . 72.030000000000001 110.725 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -63.71 -41.61 98.08 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.035 -0.984 . . . . 71.340000000000003 108.644 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -64.68 -25.04 67.77 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.137 -0.938 . . . . 75.530000000000001 111.446 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.598 ' O ' ' HG3' ' A' ' 631' ' ' MET . 54.3 mt -74.86 -37.17 41.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 108.688 -0.856 . . . . 70.329999999999998 108.688 175.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -70.7 -25.66 63.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.081 -0.509 . . . . 72.409999999999997 110.679 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -55.72 -24.06 32.56 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.108 1.151 . . . . 50.25 114.108 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.598 ' HG3' ' O ' ' A' ' 628' ' ' ILE . 0.0 OUTLIER -75.15 -11.19 60.03 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.281 -0.568 . . . . 74.120000000000005 112.189 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 632' ' ' GLY . . . . . 0.581 ' HA2' ' N ' ' A' ' 501' ' ' HIS . . . -165.45 56.36 0.26 Allowed Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 111.102 -0.799 . . . . 72.329999999999998 111.102 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -89.82 148.18 39.22 Favored Pre-proline 0 C--O 1.245 0.841 0 C-N-CA 120.323 -0.551 . . . . 75.109999999999999 111.469 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.527 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 43.6 Cg_endo -71.35 133.73 23.27 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.62 2.213 . . . . 64.200000000000003 108.934 172.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.03 161.17 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 109.686 -0.487 . . . . 74.530000000000001 109.686 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.512 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.6 OUTLIER -101.33 165.95 11.0 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 119.72 -0.792 . . . . 74.349999999999994 111.175 176.323 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.85 -172.19 29.23 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 115.654 -0.703 . . . . 53.100000000000001 114.645 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -67.93 -41.66 82.21 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.371 -0.915 . . . . 72.519999999999996 109.392 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -125.99 127.47 45.96 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.279 -0.873 . . . . 72.549999999999997 109.132 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 640' ' ' THR . . . . . 0.512 HG21 ' HB2' ' A' ' 636' ' ' LEU . 16.8 p -130.27 89.93 2.86 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.429 -0.582 . . . . 74.409999999999997 109.429 175.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -170.37 139.09 1.64 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.444 -0.798 . . . . 73.040000000000006 109.468 -175.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.651 HD22 HG11 ' A' ' 523' ' ' VAL . 28.0 tp -120.41 131.0 54.6 Favored 'General case' 0 C--N 1.273 -2.725 0 CA-C-N 114.985 -1.007 . . . . 64.439999999999998 109.06 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -93.87 110.8 22.44 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.52 -1.659 . . . . 71.409999999999997 106.52 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 43.7 t -101.6 110.37 28.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.914 -0.773 . . . . 74.219999999999999 108.914 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 67.1 mt -97.95 124.22 50.86 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 N-CA-C 108.819 -0.808 . . . . 74.400000000000006 108.819 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 54.2 mt -100.2 103.36 14.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 106.876 -1.527 . . . . 61.340000000000003 106.876 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -100.44 129.26 46.38 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.885 -0.598 . . . . 73.209999999999994 109.545 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.595 ' HA ' ' HB3' ' A' ' 516' ' ' GLU . 0.0 OUTLIER -68.92 117.8 11.04 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-O 122.016 0.912 . . . . 61.450000000000003 109.374 174.71 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 25.9 m -134.7 99.5 4.34 Favored 'General case' 0 N--CA 1.404 -2.731 0 CA-C-N 114.676 -1.147 . . . . 70.120000000000005 108.874 -168.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -91.99 -33.72 14.73 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.14 -1.059 . . . . 70.129999999999995 108.14 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -74.63 -46.4 38.55 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.354 -1.294 . . . . 53.450000000000003 108.798 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -92.89 105.69 17.77 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.665 -0.698 . . . . 73.150000000000006 109.498 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -95.36 158.47 15.44 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.178 -0.919 . . . . 74.430000000000007 110.149 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 15.0 m -140.27 149.07 42.37 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.184 -1.043 . . . . 63.299999999999997 108.184 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 8.3 t -141.64 131.01 23.66 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.544 -0.539 . . . . 74.010000000000005 109.544 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 48.6 t -101.45 89.07 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.565 -1.272 . . . . 64.349999999999994 107.565 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--N 1.301 -1.521 0 CA-C-N 115.181 -0.918 . . . . 63.020000000000003 110.16 -176.555 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 108.289 -1.004 . . . . 65.109999999999999 108.289 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . 175.88 -53.48 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 125.48 1.512 . . . . 62.109999999999999 108.196 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.435 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . 160.36 -148.5 16.86 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.085 -1.206 . . . . 65.099999999999994 110.085 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.43 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.7 mp -123.3 130.02 74.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 117.131 0.466 . . . . 50.329999999999998 110.75 -174.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.506 ' H ' ' HA ' ' A' ' 636' ' ' LEU . 57.4 m-85 -112.24 136.48 51.61 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.47 -0.937 . . . . 74.329999999999998 108.47 169.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.2 t -170.71 -179.34 2.86 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.787 -0.82 . . . . 53.229999999999997 108.787 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -83.62 155.45 23.22 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 110.308 -0.256 . . . . 75.319999999999993 110.308 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.09 -45.25 85.99 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.551 -1.278 . . . . 33.509999999999998 107.551 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.74 146.14 51.93 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 108.606 -0.887 . . . . 72.530000000000001 108.606 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.91 -17.35 15.57 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.801 1.667 . . . . 63.32 111.949 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 58.4 t -141.64 127.74 19.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 107.92 -1.141 . . . . 62.420000000000002 107.92 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 13.8 t -123.65 140.54 52.89 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 109.398 -0.593 . . . . 41.409999999999997 109.398 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -109.52 119.33 39.1 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.977 -0.556 . . . . 75.340000000000003 109.705 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.2 m -115.74 162.28 13.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.809 -0.812 . . . . 70.120000000000005 108.809 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.546 ' O ' HG22 ' A' ' 518' ' ' ILE . 12.1 t -87.55 149.77 24.14 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.533 0.682 . . . . 71.120000000000005 111.157 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -60.98 -29.56 69.76 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 124.941 1.296 . . . . 71.299999999999997 109.166 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 32.1 t -116.53 26.02 10.18 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.758 -0.655 . . . . 54.439999999999998 111.231 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 515' ' ' SER . 7.9 tt -80.21 -30.28 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 119.437 -0.905 . . . . 71.299999999999997 111.026 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 519' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 88.31 -76.91 1.88 Allowed Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 119.89 -1.148 . . . . 61.240000000000002 111.335 -177.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.1 mm -123.63 124.98 70.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.139 -1.06 . . . . 74.239999999999995 108.139 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.512 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -109.89 147.66 32.98 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 108.451 -0.944 . . . . 72.409999999999997 108.451 177.536 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 39.3 mt-10 -123.54 134.03 53.91 Favored 'General case' 0 CA--C 1.497 -1.088 0 O-C-N 123.846 0.717 . . . . 65.310000000000002 111.198 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.569 HG21 HD21 ' A' ' 642' ' ' LEU . 66.7 t -118.69 125.1 74.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 107.931 -1.137 . . . . 75.510000000000005 107.931 176.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.434 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 36.1 mtmt -86.81 133.15 33.67 Favored 'General case' 0 N--CA 1.427 -1.617 0 O-C-N 123.638 0.586 . . . . 60.409999999999997 110.205 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 39.4 t -101.56 120.9 51.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.301 -0.999 . . . . 41.119999999999997 108.301 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.31 129.05 38.62 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 124.029 0.83 . . . . 64.409999999999997 110.169 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -85.09 158.89 20.3 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.635 -1.166 . . . . 62.420000000000002 109.18 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.435 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 1.6 t -56.22 147.57 20.45 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.725 1.21 . . . . 64.409999999999997 112.854 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.9 t -59.23 -35.43 73.63 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.696 1.199 . . . . 75.219999999999999 109.089 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.76 98.13 0.63 Allowed Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 109.13 -1.588 . . . . 55.439999999999998 109.13 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.36 103.91 16.55 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 109.36 -0.607 . . . . 74.519999999999996 109.36 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -123.53 119.86 31.19 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 116.077 -0.511 . . . . 71.409999999999997 110.557 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 87.19 -136.61 14.08 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.277 -0.874 . . . . 62.509999999999998 112.948 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -133.17 126.58 31.97 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.061 -1.088 . . . . 60.530000000000001 108.061 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 61.0 t -131.55 133.66 61.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.074 -0.713 . . . . 63.409999999999997 109.074 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.565 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 37.3 mm -104.73 136.06 39.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 109.096 -0.705 . . . . 73.219999999999999 109.096 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.407 HG22 ' HB3' ' A' ' 594' ' ' PRO . 40.5 t -120.93 108.32 36.86 Favored Pre-proline 0 C--N 1.306 -1.289 0 N-CA-C 109.948 -0.39 . . . . 63.049999999999997 109.948 178.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.2 156.95 50.9 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.567 2.178 . . . . 55.420000000000002 111.943 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.426 ' HB3' HG22 ' A' ' 591' ' ' ILE . 54.6 p90 -153.83 161.41 42.07 Favored 'General case' 0 C--O 1.25 1.11 0 N-CA-C 110.212 -0.292 . . . . 73.120000000000005 110.212 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -153.81 154.05 33.26 Favored 'General case' 0 C--O 1.25 1.111 0 O-C-N 123.657 0.598 . . . . 65.319999999999993 110.805 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.8 p -87.14 136.5 32.9 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.321 -0.854 . . . . 71.010000000000005 110.966 175.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 590' ' ' GLU . 69.7 mt -109.92 123.92 66.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.108 -1.071 . . . . 54.43 108.108 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -76.23 105.82 7.5 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.855 -0.424 . . . . 75.239999999999995 109.855 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -90.2 -119.64 2.03 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 109.844 -1.302 . . . . 55.439999999999998 109.844 177.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 13.4 t -86.16 -5.93 59.1 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.905 0.86 . . . . 60.240000000000002 109.311 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -97.75 137.28 36.87 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.578 -1.267 . . . . 74.129999999999995 107.578 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.535 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 76.5 mtm180 -86.26 137.07 32.89 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 123.738 0.815 . . . . 71.200000000000003 111.353 -176.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -91.83 -164.49 38.79 Favored Glycine 0 C--N 1.29 -2.0 0 CA-C-N 115.36 -0.836 . . . . 71.109999999999999 111.644 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.71 14.32 79.91 Favored Glycine 0 C--N 1.305 -1.165 0 CA-C-O 120.07 -0.295 . . . . 75.129999999999995 113.345 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 88.25 24.66 33.51 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.059 -0.816 . . . . 65.129999999999995 111.059 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.535 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 17.5 tt0 -96.39 -56.85 2.48 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.335 -0.617 . . . . 75.329999999999998 109.335 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -111.59 -33.07 6.47 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 108.579 -0.897 . . . . 75.420000000000002 108.579 171.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -140.32 149.8 43.2 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 108.302 -0.999 . . . . 64.129999999999995 108.302 175.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 2.0 tm-20 -88.93 123.71 33.54 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 106.18 -1.785 . . . . 71.319999999999993 106.18 177.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -67.87 154.01 42.49 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 112.643 0.609 . . . . 71.140000000000001 112.643 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.7 t -147.72 139.4 23.93 Favored 'General case' 0 N--CA 1.406 -2.628 0 CA-C-O 121.725 0.774 . . . . 63.329999999999998 108.934 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.6 p -148.88 143.81 26.49 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 107.197 -1.409 . . . . 63.310000000000002 107.197 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 161.63 -158.79 30.66 Favored Glycine 0 N--CA 1.413 -2.871 0 C-N-CA 119.69 -1.243 . . . . 72.510000000000005 110.57 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.565 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.7 mt-10 -137.28 140.13 41.38 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 120.784 0.325 . . . . 74.030000000000001 110.967 -174.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.5 139.31 36.37 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.418 0.687 . . . . 72.239999999999995 109.769 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.506 ' HA ' HD13 ' A' ' 536' ' ' ILE . 33.1 tt0 -100.85 110.02 22.04 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.167 0.508 . . . . 64.450000000000003 111.516 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -107.44 148.7 28.8 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.891 -0.595 . . . . 75.420000000000002 109.496 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.538 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 43.9 mt-30 -144.1 -177.28 5.37 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.734 -0.839 . . . . 71.030000000000001 108.734 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.88 -38.28 82.85 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 124.092 0.87 . . . . 71.420000000000002 108.655 177.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -85.25 -38.01 19.4 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.414 -0.812 . . . . 73.129999999999995 111.786 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.538 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 47.0 mm-40 -60.82 135.48 57.79 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.902 0.481 . . . . 65.340000000000003 112.079 -178.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.614 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.6 pt -78.51 -83.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 113.929 1.085 . . . . 74.109999999999999 113.929 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.614 ' H ' HG13 ' A' ' 567' ' ' ILE . 13.3 p -143.05 150.72 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.57 -0.9 . . . . 41.530000000000001 108.57 -177.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 524' ' ' LYS . 5.3 mmpt? -113.15 159.57 19.12 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.884 0.373 . . . . 74.040000000000006 110.134 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.1 p -128.87 147.39 50.82 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.159 -0.928 . . . . 61.530000000000001 112.088 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.8 mp -99.86 126.59 53.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 106.773 -1.565 . . . . 75.540000000000006 106.773 171.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 11.3 p -100.7 115.53 30.47 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.004 -0.739 . . . . 73.219999999999999 109.004 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 60.9 t -119.2 130.19 74.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 109.846 -0.427 . . . . 73.319999999999993 109.846 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 15.8 tppt? -82.87 122.13 27.84 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 123.731 0.645 . . . . 72.25 109.969 176.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 89.8 t -89.15 123.22 41.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 107.967 -1.123 . . . . 73.319999999999993 107.967 176.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 33.7 mm -90.09 132.39 34.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.293 0.568 . . . . 75.120000000000005 109.604 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -73.81 110.38 8.06 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.51 -1.223 . . . . 75.120000000000005 108.984 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -134.19 125.35 27.66 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.06 0.393 . . . . 73.409999999999997 112.06 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -136.01 78.68 1.73 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.693 -0.685 . . . . 63.439999999999998 111.583 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -99.87 -46.82 5.25 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.588 -0.893 . . . . 73.109999999999999 108.588 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -178.91 -91.76 0.0 OUTLIER 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.911 -1.144 . . . . 73.120000000000005 107.911 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 54.81 -174.6 0.04 OUTLIER 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.571 1.148 . . . . 73.420000000000002 113.757 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -123.39 -53.68 1.8 Allowed 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 115.796 -0.638 . . . . 71.209999999999994 109.57 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -153.61 139.34 17.97 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.459 -0.571 . . . . 41.229999999999997 109.459 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.544 ' HB2' ' HB ' ' A' ' 646' ' ' ILE . 35.7 mmtp -103.54 120.65 41.28 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.951 -0.759 . . . . 71.329999999999998 108.951 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 10.0 t -149.97 144.94 26.17 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.494 -0.482 . . . . 61.140000000000001 109.974 176.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 47.8 p90 -140.46 175.88 9.24 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.621 -1.251 . . . . 75.239999999999995 107.621 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.435 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 87.0 m-85 -122.6 153.97 38.59 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.451 -0.5 . . . . 74.450000000000003 110.601 -176.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.53 128.25 51.84 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 106.316 -1.735 . . . . 62.200000000000003 106.316 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.511 ' HB2' HD11 ' A' ' 542' ' ' ILE . 39.8 tt0 -124.57 131.79 53.47 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.807 -0.812 . . . . 74.319999999999993 108.807 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.426 HG22 ' HB3' ' A' ' 539' ' ' TYR . 17.8 pt -100.5 147.15 8.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.794 -0.817 . . . . 64.129999999999995 108.794 177.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.59 172.97 39.81 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 109.925 -1.27 . . . . 64.030000000000001 109.925 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.0 131.79 88.86 Favored Pre-proline 0 N--CA 1.426 -1.664 0 C-N-CA 120.665 -0.414 . . . . 63.240000000000002 110.838 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.431 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.2 Cg_endo -59.57 136.84 73.82 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.317 2.678 . . . . 63.439999999999998 112.03 -176.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 595' ' ' ARG . . . . . 0.471 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 3.1 ptm180 -116.63 125.09 51.28 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.305 -0.861 . . . . 73.329999999999998 110.152 -177.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.466 HD12 ' HB2' ' A' ' 598' ' ' GLU . 1.4 tm? -70.19 136.34 49.94 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.09 -1.078 . . . . 73.219999999999999 108.09 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.559 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.3 t -94.08 94.8 4.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.649 0.738 . . . . 72.120000000000005 110.873 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.466 ' HB2' HD12 ' A' ' 596' ' ' LEU . 0.2 OUTLIER -151.38 164.05 37.57 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 105.005 -2.22 . . . . 75.150000000000006 105.005 178.745 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 22.0 ptp -78.3 -8.68 58.68 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.069 0.462 . . . . 55.310000000000002 111.001 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 17.3 m -92.73 100.76 13.19 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 121.202 0.525 . . . . 74.409999999999997 111.009 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -147.99 97.24 2.77 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.83 -0.804 . . . . 72.430000000000007 108.83 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -68.92 115.83 8.69 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.369 -0.975 . . . . 74.120000000000005 108.369 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -125.89 121.24 32.61 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.602 -0.726 . . . . 70.420000000000002 109.803 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -105.67 -179.71 23.65 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.657 -0.701 . . . . 73.439999999999998 113.119 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.16 157.23 10.5 Favored Glycine 0 N--CA 1.433 -1.502 0 N-CA-C 109.814 -1.314 . . . . 74.340000000000003 109.814 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -159.69 122.36 3.48 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.856 -0.794 . . . . 64.109999999999999 108.856 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 25.4 p -93.38 104.04 16.22 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 121.002 0.429 . . . . 74.099999999999994 110.147 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 64.0 mt -66.01 96.26 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.453 -0.943 . . . . 72.310000000000002 108.453 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 18.7 m -84.79 93.42 8.47 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 108.146 -1.057 . . . . 74.510000000000005 108.146 -177.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 179.44 -37.38 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 105.438 -2.06 . . . . 61.329999999999998 105.438 -173.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -98.0 124.97 42.73 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 105.239 -2.134 . . . . 75.540000000000006 105.239 172.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -100.04 96.1 7.29 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.188 -0.605 . . . . 74.450000000000003 111.682 -171.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -175.12 -179.85 1.43 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 106.39 -1.707 . . . . 73.150000000000006 106.39 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -76.4 102.27 5.89 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.1 0.476 . . . . 64.299999999999997 109.957 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -93.78 40.74 1.08 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.014 0.911 . . . . 64.230000000000004 109.706 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -67.27 -55.72 14.76 Favored Pre-proline 0 CA--C 1.561 1.392 0 CA-C-N 114.609 -1.178 . . . . 75.340000000000003 112.705 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -83.71 38.65 0.73 Allowed 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 122.231 1.954 . . . . 72.140000000000001 112.608 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.58 107.5 8.91 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.109 -0.7 . . . . 61.450000000000003 109.109 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 619' ' ' THR . . . . . 0.406 ' OG1' ' HG2' ' A' ' 622' ' ' GLU . 5.7 t -153.18 131.79 12.26 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.378 -0.828 . . . . 65.310000000000002 109.633 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 19.8 m -95.56 -32.24 12.93 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.266 -1.753 . . . . 74.319999999999993 106.266 172.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 22.4 tptm 167.05 66.66 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 127.517 2.327 . . . . 75.239999999999995 105.634 172.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 622' ' ' GLU . . . . . 0.406 ' HG2' ' OG1' ' A' ' 619' ' ' THR . 7.0 mm-40 -76.43 134.71 39.5 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 107.172 -1.418 . . . . 74.209999999999994 107.172 -178.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -55.27 126.74 26.21 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 124.299 0.999 . . . . 73.030000000000001 111.638 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 624' ' ' GLU . . . . . 0.411 ' OE1' ' HB2' ' A' ' 627' ' ' ARG . 0.5 OUTLIER -91.29 93.52 9.11 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 105.701 -1.963 . . . . 63.130000000000003 105.701 178.79 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -108.97 3.06 21.79 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.412 -1.267 . . . . 72.140000000000001 111.03 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.579 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 97.7 mtt180 -64.44 -34.54 78.43 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 108.128 -1.064 . . . . 74.25 108.128 177.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 627' ' ' ARG . . . . . 0.425 ' HD3' ' O ' ' A' ' 627' ' ' ARG . 1.5 tmt_? -59.95 -34.0 72.68 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.271 1.029 . . . . 73.150000000000006 109.87 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 65.4 mt -68.37 -35.99 73.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.12 -0.696 . . . . 73.340000000000003 109.12 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -78.42 -27.24 46.55 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.829 -0.623 . . . . 33.340000000000003 111.1 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 7.0 mm-40 -53.08 -36.88 61.16 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.881 0.872 . . . . 43.310000000000002 112.445 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -81.65 -8.72 59.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.151 0.5 . . . . 61.100000000000001 111.054 -177.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -119.1 6.05 13.31 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.905 -0.664 . . . . 44.229999999999997 112.056 -177.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -123.51 151.65 63.63 Favored Pre-proline 0 N--CA 1.433 -1.291 0 N-CA-C 109.379 -0.6 . . . . 63.509999999999998 109.379 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.431 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 23.3 Cg_endo -59.51 139.83 91.17 Favored 'Trans proline' 0 CA--C 1.512 -0.581 0 C-N-CA 123.43 2.754 . . . . 63.409999999999997 112.395 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 3.1 pt -124.07 177.5 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 0 CA-C-O 120.937 0.399 . . . . 73.409999999999997 110.03 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.506 ' HA ' ' H ' ' A' ' 505' ' ' PHE . 0.8 OUTLIER -113.86 174.52 5.89 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 115.665 -0.698 . . . . 52.409999999999997 112.322 177.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.43 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -74.31 174.13 50.29 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 115.415 -0.811 . . . . 70.349999999999994 113.923 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -66.79 -34.47 77.89 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 124.033 0.933 . . . . 71.420000000000002 110.408 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -124.06 121.48 35.3 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.33 -0.618 . . . . 73.420000000000002 109.33 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 7.8 p -134.78 95.4 3.33 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.752 -0.658 . . . . 73.329999999999998 110.013 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -166.54 143.34 4.88 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.75 -1.204 . . . . 53.299999999999997 107.75 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.569 HD21 HG21 ' A' ' 523' ' ' VAL . 26.7 tp -129.66 116.16 18.42 Favored 'General case' 0 N--CA 1.417 -2.084 0 O-C-N 123.825 0.703 . . . . 71.319999999999993 109.668 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -87.18 110.61 20.27 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.604 -1.628 . . . . 73.409999999999997 106.604 173.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 55.8 t -99.19 107.76 21.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.736 -0.838 . . . . 73.120000000000005 108.736 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 27.8 mt -99.28 121.47 49.94 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 N-CA-C 108.42 -0.956 . . . . 73.349999999999994 108.42 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 585' ' ' LYS . 62.6 mt -97.46 107.55 20.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.165 -1.42 . . . . 73.150000000000006 107.165 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -119.4 145.54 46.13 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.408 -0.96 . . . . 71.319999999999993 108.408 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -77.19 115.03 16.63 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.138 -1.801 . . . . 72.299999999999997 106.138 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 649' ' ' SER . . . . . 0.533 ' HB3' ' HA ' ' A' ' 652' ' ' PHE . 57.4 m -164.15 112.33 1.14 Allowed 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 114.564 -1.198 . . . . 52.130000000000003 107.82 -176.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -93.69 -42.11 9.34 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.263 -1.754 . . . . 74.420000000000002 106.263 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 651' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 651' ' ' GLU . 0.2 OUTLIER -79.01 -32.79 45.21 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 112.518 -2.128 . . . . 62.219999999999999 110.888 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 652' ' ' PHE . . . . . 0.533 ' HA ' ' HB3' ' A' ' 649' ' ' SER . 76.1 m-85 67.97 68.07 0.34 Allowed 'General case' 0 CA--C 1.495 -1.164 0 CA-C-O 122.426 1.108 . . . . 71.010000000000005 110.677 -173.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 653' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 655' ' ' THR . 27.2 tptp -68.18 122.78 19.03 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 112.714 -2.039 . . . . 73.319999999999993 107.554 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 15.0 m -64.25 -51.64 62.62 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.045 0.45 . . . . 63.299999999999997 110.876 -175.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 655' ' ' THR . . . . . 0.452 ' O ' ' HG3' ' A' ' 653' ' ' LYS . 5.2 t -121.89 138.79 54.26 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 107.781 -1.192 . . . . 62.030000000000001 107.781 175.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 31.7 m -117.4 150.86 19.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 120.818 0.342 . . . . 54.149999999999999 111.439 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 . . . . . 0 C--N 1.307 -1.255 0 N-CA-C 109.495 -0.557 . . . . 75.510000000000005 109.495 178.681 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 . . . . . 0 N--CA 1.434 -1.253 0 N-CA-C 107.272 -1.381 . . . . 72.430000000000007 107.272 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -136.61 -163.72 1.46 Allowed 'General case' 0 N--CA 1.41 -2.441 0 CA-C-O 121.174 0.512 . . . . 71.319999999999993 109.951 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -103.43 -114.72 3.97 Favored Glycine 0 C--N 1.278 -2.657 0 CA-C-N 114.672 -1.149 . . . . 43.200000000000003 112.955 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.81 127.69 70.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.219 -0.491 . . . . 70.209999999999994 110.573 -173.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -117.03 123.14 46.14 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.729 -1.211 . . . . 71.230000000000004 107.729 170.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.3 t -167.63 177.65 5.76 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.552 -0.536 . . . . 74.319999999999993 109.552 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -85.77 150.74 24.36 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.886 -0.412 . . . . 64.120000000000005 109.886 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 44.1 mt-10 -66.54 -34.03 77.0 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.348 0.594 . . . . 74.150000000000006 110.18 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -132.21 145.61 58.06 Favored Pre-proline 0 N--CA 1.421 -1.909 0 CA-C-N 114.959 -1.019 . . . . 74.019999999999996 108.499 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.0 -29.29 3.36 Favored 'Trans proline' 0 C--N 1.327 -0.557 0 C-N-CA 122.151 1.9 . . . . 61.299999999999997 112.127 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 26.0 t -134.92 131.79 53.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 107.909 -1.145 . . . . 64.129999999999995 107.909 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 15.3 t -126.68 136.43 52.46 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 109.42 -0.585 . . . . 72.25 109.42 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -109.98 109.42 20.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.793 0.806 . . . . 71.510000000000005 109.297 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.7 m -104.77 151.69 7.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 115.636 -0.711 . . . . 74.040000000000006 110.309 -175.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.544 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 67.4 m -79.56 155.06 28.34 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 115.349 -0.842 . . . . 74.310000000000002 110.328 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -67.08 -62.45 1.42 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.525 0.679 . . . . 71.400000000000006 111.068 176.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.3 m -79.09 26.85 0.25 Allowed 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.709 0.803 . . . . 52.299999999999997 112.666 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 12.8 tt -79.92 -27.91 12.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 122.021 -0.425 . . . . 63.030000000000001 110.509 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 519' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 89.2 -74.78 1.96 Allowed Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 110.467 -1.053 . . . . 63.219999999999999 110.467 -177.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.3 mm -129.41 122.88 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 108.425 -0.954 . . . . 75.109999999999999 108.425 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.444 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -103.37 147.51 27.02 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.695 -1.594 . . . . 65.420000000000002 106.695 175.645 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 35.1 mt-10 -133.64 128.26 34.71 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 123.655 0.597 . . . . 70.439999999999998 111.175 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.583 HG21 HD21 ' A' ' 642' ' ' LEU . 59.9 t -116.36 124.21 72.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 106.831 -1.544 . . . . 73.349999999999994 106.831 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.476 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 29.1 mtmm -84.65 139.88 31.74 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.071 0.462 . . . . 74.450000000000003 110.187 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 43.9 t -107.46 126.56 63.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 115.638 -0.71 . . . . 72.150000000000006 109.173 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.25 116.84 7.01 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 123.998 0.811 . . . . 71.439999999999998 110.093 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -77.79 150.53 34.28 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.022 -0.99 . . . . 65.219999999999999 109.96 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.3 t -55.34 132.93 49.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 124.904 1.282 . . . . 75.109999999999999 111.84 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 44.9 t -54.01 -35.5 61.98 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.538 1.135 . . . . 70.319999999999993 109.32 173.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -107.45 85.52 0.42 Allowed Glycine 0 N--CA 1.42 -2.403 0 N-CA-C 109.641 -1.384 . . . . 33.520000000000003 109.641 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.93 109.77 18.97 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.261 -1.015 . . . . 44.420000000000002 108.261 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -112.73 106.68 15.1 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.119 -0.491 . . . . 50.329999999999998 110.589 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 73.1 -116.76 5.67 Favored Glycine 0 N--CA 1.434 -1.47 0 CA-C-N 115.678 -0.692 . . . . 62.350000000000001 112.457 175.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 534' ' ' ASN . . . . . 0.442 ' ND2' HG21 ' A' ' 597' ' ' VAL . 47.8 t30 -133.17 127.05 33.0 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.276 -0.638 . . . . 62.0 109.276 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.05 137.55 55.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.924 -0.769 . . . . 71.329999999999998 108.924 -177.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.539 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 36.4 mm -107.84 135.04 47.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.265 -0.643 . . . . 53.32 109.265 177.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 594' ' ' PRO . 57.3 t -120.51 109.8 36.18 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.391 -0.596 . . . . 33.109999999999999 109.391 177.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 35.4 Cg_endo -71.43 153.72 60.83 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.993 1.795 . . . . 70.239999999999995 111.338 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -150.97 155.71 39.66 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.958 -0.756 . . . . 73.420000000000002 108.958 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.8 152.93 30.42 Favored 'General case' 0 C--O 1.254 1.335 0 O-C-N 123.807 0.692 . . . . 65.019999999999996 112.354 177.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.6 p -82.83 134.06 35.11 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.471 -0.786 . . . . 64.430000000000007 110.024 174.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 70.8 mt -108.72 113.92 45.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 107.316 -1.364 . . . . 72.329999999999998 107.316 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.54 132.54 47.12 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.165 0.507 . . . . 71.540000000000006 111.638 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -124.1 -114.74 2.11 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 108.408 -1.877 . . . . 63.32 108.408 177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 45.6 p -80.36 -23.89 40.18 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 122.084 0.945 . . . . 53.329999999999998 108.736 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -82.8 128.99 34.91 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 114.396 -1.275 . . . . 71.109999999999999 108.766 175.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.3 mtm105 -88.6 135.13 33.65 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 124.066 0.854 . . . . 74.239999999999995 110.651 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -83.42 -152.07 12.21 Favored Glycine 0 C--N 1.297 -1.619 0 CA-C-N 115.232 -0.895 . . . . 62.299999999999997 111.916 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 549' ' ' GLY . . . . . 0.432 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 62.17 22.97 63.57 Favored Glycine 0 C--N 1.308 -0.978 0 N-CA-C 114.796 0.679 . . . . 41.420000000000002 114.796 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 79.54 22.4 64.67 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.307 -0.949 . . . . 61.399999999999999 111.533 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -96.62 -62.83 1.21 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.996 -0.372 . . . . 74.420000000000002 109.996 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -98.77 -42.69 7.09 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 107.196 -1.409 . . . . 75.420000000000002 107.196 171.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -137.76 149.88 46.79 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 114.911 -1.04 . . . . 60.32 108.677 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.413 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 0.7 OUTLIER -76.69 122.65 25.0 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.678 -1.601 . . . . 65.120000000000005 106.678 173.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 555' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 29.1 t70 -74.71 117.99 17.16 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.244 -0.435 . . . . 70.530000000000001 111.234 -173.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.1 t -121.04 138.83 53.99 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 122.517 1.151 . . . . 71.230000000000004 111.664 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 12.2 p -145.54 143.52 30.0 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 105.606 -1.998 . . . . 74.129999999999995 105.606 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 176.13 -155.25 18.84 Favored Glycine 0 N--CA 1.413 -2.873 0 C-N-CA 119.278 -1.439 . . . . 73.129999999999995 110.746 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.539 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 51.4 mt-10 -143.69 129.93 19.79 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 123.985 0.462 . . . . 62.229999999999997 110.582 -175.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 569' ' ' LYS . 98.1 mt -92.51 140.77 29.22 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.937 -0.764 . . . . 71.439999999999998 108.937 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.48 ' HA ' HD13 ' A' ' 536' ' ' ILE . 27.1 tt0 -105.09 113.35 26.9 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.842 -0.429 . . . . 71.439999999999998 109.842 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -111.11 142.65 43.0 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.272 -0.64 . . . . 75.219999999999999 109.272 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.485 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 49.4 mt-30 -133.88 176.28 8.71 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.67 -0.493 . . . . 74.109999999999999 109.67 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -67.16 -37.51 83.87 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 124.464 1.102 . . . . 72.049999999999997 111.676 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -92.11 -13.92 30.0 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.707 -0.678 . . . . 54.310000000000002 112.035 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.485 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 19.9 mm-40 -73.59 167.49 21.23 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.422 0.527 . . . . 72.430000000000007 112.422 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.592 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.3 pt -105.27 -85.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 113.245 0.831 . . . . 70.140000000000001 113.245 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.592 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.3 p -142.96 153.24 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 109.338 -0.616 . . . . 71.349999999999994 109.338 -174.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.451 ' HB3' HD22 ' A' ' 560' ' ' LEU . 5.5 mmpt? -115.79 160.76 19.7 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.989 -0.374 . . . . 60.140000000000001 109.989 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.476 ' CG2' ' HG2' ' A' ' 524' ' ' LYS . 4.4 p -126.82 145.59 50.58 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.617 -0.719 . . . . 70.510000000000005 111.026 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.514 HG22 HG23 ' A' ' 573' ' ' VAL . 1.9 mp -94.11 114.7 31.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 105.36 -2.089 . . . . 73.430000000000007 105.36 170.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 16.5 m -94.33 115.21 27.4 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.232 -1.025 . . . . 75.299999999999997 108.232 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.514 HG23 HG22 ' A' ' 571' ' ' ILE . 98.5 t -117.06 127.67 74.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.268 -0.642 . . . . 73.150000000000006 109.268 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 24.2 tptm -78.21 107.58 10.9 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.389 -0.967 . . . . 74.120000000000005 108.389 175.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 45.9 t -85.38 124.74 40.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 106.24 -1.763 . . . . 64.0 106.24 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 29.8 mm -79.04 123.07 35.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 122.035 0.921 . . . . 61.030000000000001 111.648 -173.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -89.3 101.8 14.46 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 113.507 -1.679 . . . . 75.420000000000002 108.33 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -116.64 -65.09 1.22 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.276 -0.569 . . . . 74.310000000000002 109.628 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 173.6 169.22 0.18 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.999 1.319 . . . . 75.129999999999995 107.966 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.09 20.31 0.11 Allowed 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 113.253 0.834 . . . . 72.230000000000004 113.253 -178.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -71.22 -34.45 70.81 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 123.633 0.773 . . . . 72.409999999999997 109.205 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -80.26 113.04 18.15 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.513 -0.767 . . . . 71.530000000000001 110.523 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -82.16 103.53 11.83 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.348 -0.842 . . . . 55.329999999999998 111.889 -176.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 43.86 86.71 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.067 1.747 . . . . 62.409999999999997 112.504 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 33.3 mmtp -98.02 135.56 39.55 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.259 -0.577 . . . . 61.310000000000002 110.339 -176.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 2.9 t -141.82 142.57 33.17 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 120.185 -0.606 . . . . 73.519999999999996 111.257 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 46.2 p90 -137.33 171.77 13.98 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 107.499 -1.297 . . . . 53.119999999999997 107.499 178.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.488 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 45.0 m-85 -117.52 153.05 33.85 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 109.239 -0.652 . . . . 72.420000000000002 109.239 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.29 126.78 51.42 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 106.033 -1.84 . . . . 64.409999999999997 106.033 177.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -127.92 124.44 37.38 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 120.055 -0.658 . . . . 55.539999999999999 110.313 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 20.3 pt -88.86 140.93 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.297 0 CA-C-N 114.836 -1.075 . . . . 74.430000000000007 108.132 174.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.79 173.24 47.04 Favored Glycine 0 N--CA 1.409 -3.164 0 N-CA-C 109.838 -1.305 . . . . 22.030000000000001 109.838 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -67.14 136.15 93.92 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 110.343 -0.243 . . . . 70.219999999999999 110.343 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.403 ' HB3' HG22 ' A' ' 537' ' ' VAL . 30.8 Cg_endo -63.2 131.33 31.9 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.258 2.638 . . . . 75.340000000000003 112.311 -176.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -109.59 120.45 42.54 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.035 -0.984 . . . . 75.299999999999997 108.919 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.482 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 2.7 tm? -66.15 135.3 54.35 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.752 -1.203 . . . . 65.530000000000001 107.752 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.518 ' CG2' HG12 ' A' ' 536' ' ' ILE . 47.0 t -81.08 81.69 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.254 -1.017 . . . . 52.109999999999999 108.254 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -79.26 124.12 28.08 Favored 'General case' 0 N--CA 1.403 -2.812 0 CA-C-N 113.907 -1.497 . . . . 72.0 108.316 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 64.9 mtt -91.88 -16.76 26.23 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.119 -0.946 . . . . 65.209999999999994 109.366 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 27.3 t -78.56 87.23 4.53 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.156 -1.424 . . . . 61.310000000000002 107.156 174.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -113.54 175.03 5.63 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.034 -0.985 . . . . 73.120000000000005 109.52 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -113.35 152.92 29.35 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.314 -0.995 . . . . 71.430000000000007 108.314 175.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -89.39 166.71 13.55 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.121 -0.696 . . . . 74.209999999999994 109.121 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -72.34 -69.92 1.31 Allowed Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 108.419 -1.873 . . . . 74.109999999999999 108.419 174.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 66.35 22.03 70.83 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.285 -0.458 . . . . 62.32 113.307 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -91.96 98.9 11.86 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 108.94 -0.763 . . . . 73.150000000000006 108.94 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 41.7 m -75.09 100.57 4.26 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 107.44 -1.319 . . . . 73.140000000000001 107.44 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 2.5 pp -94.91 153.57 3.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.262 -0.881 . . . . 72.340000000000003 112.021 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 8.8 t -108.27 154.54 21.64 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.144 -1.798 . . . . 44.310000000000002 106.144 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . 0.339 10.3 pt-20 -83.23 66.03 8.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 122.593 1.187 . . . . 53.109999999999999 114.114 -177.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -115.03 111.99 21.96 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 105.546 -2.02 . . . . 64.420000000000002 105.546 174.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . 0.256 8.9 p90 -83.65 61.09 6.09 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.306 1.051 . . . . 74.040000000000006 113.044 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 19.7 t70 159.3 104.16 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 128.987 2.915 . . . . 53.530000000000001 106.073 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -139.74 134.43 31.86 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.448 -0.575 . . . . 72.239999999999995 109.448 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -71.66 107.4 4.49 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.183 0.516 . . . . 72.209999999999994 111.052 -173.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -136.15 114.06 10.66 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 107.692 -1.225 . . . . 73.019999999999996 107.692 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.32 113.91 1.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.694 2.263 . . . . 72.109999999999999 111.451 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.62 136.7 45.77 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.552 -0.536 . . . . 71.099999999999994 109.552 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 30.3 m -108.35 113.78 27.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.106 0.479 . . . . 54.439999999999998 110.404 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 1.7 p -87.21 -167.21 1.81 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.462 -0.79 . . . . 72.5 109.581 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -81.65 79.91 8.11 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.848 0.833 . . . . 74.040000000000006 108.981 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.43 159.64 24.23 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.673 -1.149 . . . . 71.239999999999995 109.598 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.86 78.64 2.77 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.391 0.615 . . . . 73.420000000000002 112.419 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 624' ' ' GLU . . . . . 0.411 ' HB2' ' HG2' ' A' ' 626' ' ' ARG . 47.8 mt-10 -92.58 -167.55 1.77 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.979 -1.01 . . . . 53.399999999999999 108.986 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -83.21 29.97 0.47 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.466 1.106 . . . . 55.420000000000002 111.391 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.411 ' HG2' ' HB2' ' A' ' 624' ' ' GLU . 18.3 mmt180 -63.27 -40.09 96.41 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.099 0.407 . . . . 75.140000000000001 112.099 -175.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 627' ' ' ARG . . . . . 0.548 ' O ' ' HD2' ' A' ' 627' ' ' ARG . 2.5 tmm_? -73.95 -24.18 59.61 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.413 -0.588 . . . . 73.25 109.413 -175.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.93 -31.87 55.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.394 -0.595 . . . . 71.420000000000002 109.394 176.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 629' ' ' ALA . . . . . 0.419 ' O ' ' HG2' ' A' ' 633' ' ' ARG . . . -80.21 -49.34 11.78 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.033 -0.728 . . . . 64.239999999999995 109.033 175.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.492 ' HA ' ' CG ' ' A' ' 633' ' ' ARG . 12.3 mm-40 -64.7 -11.79 39.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 114.233 1.198 . . . . 71.420000000000002 114.233 -176.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -19.42 58.77 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.218 -0.593 . . . . 73.319999999999993 110.815 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -116.84 45.9 1.22 Allowed Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 109.078 -1.609 . . . . 33.439999999999998 109.078 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 633' ' ' ARG . . . . . 0.492 ' CG ' ' HA ' ' A' ' 630' ' ' GLU . 24.8 mmt85 -134.47 161.05 66.06 Favored Pre-proline 0 C--N 1.311 -1.077 0 C-N-CA 123.83 0.852 . . . . 73.420000000000002 108.823 -177.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 596' ' ' LEU . 29.9 Cg_endo -62.42 139.1 74.91 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.759 2.306 . . . . 73.549999999999997 112.423 177.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 635' ' ' ILE . . . . . 0.564 HD13 ' H ' ' A' ' 635' ' ' ILE . 0.1 OUTLIER -127.72 178.71 4.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.692 -1.225 . . . . 53.009999999999998 107.692 179.0 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.86 -173.9 2.37 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 112.828 0.677 . . . . 64.530000000000001 112.828 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -77.8 -159.25 11.67 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.95 -0.568 . . . . 63.200000000000003 114.376 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -78.59 -48.62 14.79 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.452 0.644 . . . . 74.140000000000001 109.603 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -129.6 130.47 45.69 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.931 -1.137 . . . . 72.030000000000001 107.931 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 18.7 p -129.94 96.09 4.12 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 120.9 0.381 . . . . 74.530000000000001 110.887 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -163.97 148.48 10.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.495 -1.298 . . . . 62.350000000000001 107.495 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.583 HD21 HG21 ' A' ' 523' ' ' VAL . 34.0 tp -133.65 127.85 33.84 Favored 'General case' 0 N--CA 1.414 -2.271 0 N-CA-C 108.379 -0.971 . . . . 63.340000000000003 108.379 175.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -98.0 109.92 22.59 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 107.484 -1.302 . . . . 63.520000000000003 107.484 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 46.0 t -101.17 119.33 49.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.361 -0.607 . . . . 73.239999999999995 109.361 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 49.9 mt -106.12 126.7 61.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.327 -0.99 . . . . 53.539999999999999 108.327 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 73.8 mt -97.82 112.01 28.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.841 -1.17 . . . . 73.420000000000002 107.841 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 515' ' ' SER . 14.3 pt-20 -121.49 142.5 49.99 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.505 -0.77 . . . . 72.450000000000003 110.129 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.44 127.13 32.25 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 108.921 -0.77 . . . . 73.510000000000005 108.921 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 56.0 m -148.18 93.83 2.23 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.147 -1.057 . . . . 71.340000000000003 108.147 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -93.69 -10.35 34.69 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.793 -0.639 . . . . 75.319999999999993 109.306 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -77.91 -34.71 51.29 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.3 -0.863 . . . . 73.430000000000007 112.704 -174.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -85.88 79.89 9.09 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.622 0.725 . . . . 70.099999999999994 110.606 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 653' ' ' LYS . . . . . 0.414 ' HA ' ' HB ' ' A' ' 656' ' ' VAL . 54.4 mtmt -88.04 69.72 9.34 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 122.727 1.251 . . . . 71.420000000000002 113.284 -175.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 24.2 m -157.67 -41.36 0.07 Allowed 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 104.879 -2.267 . . . . 64.120000000000005 104.879 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 34.6 m -71.49 -38.67 71.18 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.229 -1.397 . . . . 74.319999999999993 107.229 170.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 653' ' ' LYS . 96.3 t -70.61 110.78 3.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.075 0 N-CA-C 106.989 -1.486 . . . . 53.020000000000003 106.989 169.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 108.132 -1.062 . . . . 62.420000000000002 108.132 -176.04 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 56.9 m80 . . . . . 0 CA--C 1.499 -1.002 0 N-CA-C 110.085 -0.339 . . . . 72.409999999999997 110.085 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.422 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . -87.98 -59.67 2.18 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.7 -1.222 . . . . 54.020000000000003 107.7 170.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 168.85 -146.87 10.66 Favored Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 109.811 -1.316 . . . . 52.340000000000003 109.811 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.543 HD11 ' HA ' ' A' ' 609' ' ' THR . 3.4 mp -126.04 117.6 49.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 117.129 0.464 . . . . 72.140000000000001 110.469 -175.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -102.4 124.69 48.42 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.261 -1.015 . . . . 72.200000000000003 108.261 169.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.7 t -165.07 -179.17 5.53 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.893 -0.78 . . . . 64.530000000000001 108.893 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -80.35 149.04 30.39 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.357 0.598 . . . . 71.040000000000006 112.534 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -74.18 -24.71 59.42 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 114.793 -1.094 . . . . 64.25 109.003 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.65 142.88 27.29 Favored Pre-proline 0 N--CA 1.435 -1.198 0 N-CA-C 107.474 -1.306 . . . . 75.099999999999994 107.474 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.81 -27.68 4.63 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.215 1.944 . . . . 73.030000000000001 112.483 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 53.7 t -137.96 136.37 45.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 107.007 -1.479 . . . . 74.430000000000007 107.007 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.6 t -130.42 139.55 50.6 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 109.371 -0.603 . . . . 71.310000000000002 109.371 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -106.11 124.05 48.97 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.964 -1.124 . . . . 61.350000000000001 107.964 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.6 m -120.99 155.74 24.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 108.267 -1.012 . . . . 71.129999999999995 108.267 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.577 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 68.1 m -80.88 166.5 20.84 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 108.676 -0.861 . . . . 64.209999999999994 108.676 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.429 ' OE2' ' HB3' ' A' ' 580' ' ' GLU . 20.1 tt0 -89.8 -55.72 3.52 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.429 -0.908 . . . . 71.510000000000005 109.795 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 31.1 m -81.44 46.7 0.97 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.382 0.61 . . . . 50.340000000000003 110.843 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 11.5 tt -96.05 -29.91 3.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.306 0.574 . . . . 73.319999999999993 111.028 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 519' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 96.0 -82.25 0.81 Allowed Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.953 -1.259 . . . . 62.229999999999997 109.953 -176.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 520' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 573' ' ' VAL . 27.7 mm -129.67 134.96 62.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.885 -1.154 . . . . 75.0 107.885 -176.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -115.06 144.62 43.35 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.098 -0.705 . . . . 41.140000000000001 109.098 176.145 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 21.5 mp0 -116.22 128.45 55.62 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.723 0.639 . . . . 64.150000000000006 111.185 176.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 570' ' ' THR . 99.5 t -120.87 131.57 72.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.921 -0.77 . . . . 62.32 108.921 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 569' ' ' LYS . 26.5 mtmm -85.62 145.32 27.38 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.438 0.637 . . . . 70.510000000000005 112.023 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 568' ' ' VAL . 52.5 t -117.71 127.59 75.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.879 -0.786 . . . . 45.32 108.879 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 97.1 mt -70.39 124.88 25.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 123.762 0.664 . . . . 72.430000000000007 110.29 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -73.84 158.43 34.54 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.567 -1.197 . . . . 65.409999999999997 109.215 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.4 t -56.09 135.79 52.69 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 124.013 0.821 . . . . 41.409999999999997 110.643 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 3.7 m -60.09 -27.42 66.98 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 124.822 1.249 . . . . 62.409999999999997 110.108 177.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -122.23 90.38 0.44 Allowed Glycine 0 N--CA 1.424 -2.157 0 N-CA-C 109.098 -1.601 . . . . 43.310000000000002 109.098 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.54 105.25 17.69 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.716 -0.476 . . . . 61.409999999999997 109.716 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -120.2 101.97 8.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.852 -0.795 . . . . 74.099999999999994 108.852 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 90.93 -145.21 17.69 Favored Glycine 0 C--N 1.299 -1.489 0 CA-C-N 115.668 -0.696 . . . . 63.140000000000001 112.258 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -118.39 131.07 56.31 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.149 -0.685 . . . . 74.219999999999999 109.149 -178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.536 HG22 HD22 ' A' ' 596' ' ' LEU . 49.4 t -131.58 139.94 49.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 108.497 -0.927 . . . . 63.439999999999998 108.497 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.538 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 42.5 mm -109.6 135.79 47.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 109.036 -0.727 . . . . 64.120000000000005 109.036 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.7 t -122.98 108.43 32.54 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 108.957 -0.757 . . . . 53.240000000000002 108.957 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 39.4 Cg_endo -73.61 153.86 49.41 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.92 1.747 . . . . 61.32 111.465 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -140.46 155.87 46.54 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.951 -0.468 . . . . 55.229999999999997 109.888 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -147.31 148.83 31.8 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 123.714 0.634 . . . . 54.140000000000001 109.911 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.5 p -90.21 129.27 36.49 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.405 -0.361 . . . . 71.329999999999998 110.16 174.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.519 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 64.2 mt -102.62 119.75 51.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 107.162 -1.421 . . . . 74.349999999999994 107.162 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -72.86 114.95 11.58 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.522 -0.548 . . . . 74.329999999999998 109.522 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -96.8 -100.11 1.96 Allowed Glycine 0 CA--C 1.5 -0.874 0 N-CA-C 109.958 -1.257 . . . . 71.430000000000007 109.958 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 31.5 p -94.6 -22.21 18.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.984 -1.117 . . . . 62.329999999999998 107.984 173.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.47 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -86.05 135.64 33.55 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.758 -1.11 . . . . 73.299999999999997 108.468 177.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -98.72 143.55 28.96 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.217 0.532 . . . . 75.409999999999997 112.163 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.7 -150.65 17.61 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.1 -0.954 . . . . 72.239999999999995 111.442 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.93 -0.67 28.21 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 116.978 0.389 . . . . 41.439999999999998 113.383 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 93.54 29.09 10.4 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 111.041 -0.824 . . . . 52.32 111.041 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -99.91 -67.66 0.84 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 110.365 -0.235 . . . . 55.299999999999997 110.365 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -94.35 -45.62 7.39 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 107.979 -1.119 . . . . 73.420000000000002 107.979 174.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -136.77 158.95 43.26 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 114.965 -1.016 . . . . 74.040000000000006 108.453 177.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 9.1 tt0 -85.52 112.65 21.12 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 104.658 -2.349 . . . . 70.230000000000004 104.658 176.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -73.25 145.92 45.81 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.576 -0.85 . . . . 73.319999999999993 108.87 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.0 t -142.64 168.98 18.45 Favored 'General case' 0 N--CA 1.414 -2.227 0 C-N-CA 120.372 -0.531 . . . . 72.450000000000003 110.714 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 11.2 p -162.72 160.35 25.36 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 106.017 -1.846 . . . . 61.210000000000001 106.017 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 171.22 -172.98 44.72 Favored Glycine 0 CA--C 1.483 -1.934 0 N-CA-C 110.493 -1.043 . . . . 74.430000000000007 110.493 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 48.5 mt-10 -130.78 120.11 23.28 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.141 0.496 . . . . 75.150000000000006 111.532 -177.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 92.1 mt -85.75 135.92 33.54 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 115.459 -0.791 . . . . 74.129999999999995 109.259 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.463 ' HA ' HD13 ' A' ' 536' ' ' ILE . 36.0 tt0 -104.04 119.24 38.52 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-O 121.051 0.453 . . . . 72.340000000000003 110.035 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -118.81 139.22 51.95 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.517 -0.549 . . . . 65.5 109.517 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.565 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 35.8 mt-30 -134.95 172.23 13.29 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.743 -0.836 . . . . 71.209999999999994 108.743 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -62.19 -30.22 70.92 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 123.85 0.719 . . . . 74.540000000000006 109.734 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.01 -24.21 21.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.606 -1.179 . . . . 73.319999999999993 112.381 -177.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.565 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 68.5 mm-40 -75.38 173.37 11.01 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.139 -0.351 . . . . 65.340000000000003 111.28 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.644 HG13 ' H ' ' A' ' 568' ' ' VAL . 7.6 pt -117.06 -77.24 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 113.59 0.959 . . . . 70.420000000000002 113.59 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.644 ' H ' HG13 ' A' ' 567' ' ' ILE . 11.8 p -142.99 153.09 16.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 107.711 -1.218 . . . . 51.329999999999998 107.711 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 524' ' ' LYS . 17.0 mtpp -121.55 168.32 11.87 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.7 -0.4 . . . . 74.219999999999999 111.112 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 0.9 OUTLIER -129.92 147.09 51.64 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 123.853 0.72 . . . . 71.230000000000004 111.441 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 1.9 mp -94.91 128.08 46.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.033 -1.469 . . . . 62.0 107.033 172.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 572' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 521' ' ' MET . 10.1 p -106.74 115.32 29.99 Favored 'General case' 0 N--CA 1.428 -1.562 0 O-C-N 123.715 0.634 . . . . 73.219999999999999 109.835 176.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 571' ' ' ILE . 71.6 t -117.82 135.97 56.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 116.366 -0.379 . . . . 73.019999999999996 110.12 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 24.4 tptm -90.46 123.51 34.22 Favored 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 124.085 0.866 . . . . 72.400000000000006 109.0 177.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.07 136.18 31.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 106.445 -1.687 . . . . 55.450000000000003 106.445 176.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 41.5 mm -84.27 135.31 25.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.401 0.62 . . . . 75.219999999999999 111.258 -173.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -98.29 80.83 2.69 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.076 -0.966 . . . . 55.100000000000001 108.967 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 28.6 t70 178.84 159.69 0.6 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.49 0.716 . . . . 75.299999999999997 109.175 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 61.8 24.57 14.64 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.197 0.999 . . . . 64.200000000000003 112.615 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.429 ' HB3' ' OE2' ' A' ' 516' ' ' GLU . 0.0 OUTLIER -75.08 28.69 0.09 Allowed 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 124.752 1.221 . . . . 71.099999999999994 112.766 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -85.3 -16.69 39.21 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 123.31 0.644 . . . . 73.010000000000005 109.868 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -84.49 -160.82 0.5 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.266 -0.425 . . . . 73.319999999999993 111.782 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.513 ' HG2' ' H ' ' A' ' 584' ' ' ASN . 58.4 tttp -112.17 -179.71 3.76 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.154 -1.054 . . . . 75.209999999999994 108.154 -174.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 584' ' ' ASN . . . . . 0.513 ' H ' ' HG2' ' A' ' 583' ' ' LYS . 24.5 t-20 -37.99 128.0 1.26 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.19 1.796 . . . . 73.140000000000001 113.224 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 24.0 mmtp -109.18 148.18 31.33 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.164 -1.421 . . . . 64.5 107.164 -176.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 7.8 t -149.97 146.09 26.83 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.08 -0.648 . . . . 62.100000000000001 110.643 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 48.5 p90 -140.43 172.06 13.26 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.643 -1.243 . . . . 72.150000000000006 107.643 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.514 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 85.7 m-85 -116.97 153.59 32.36 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.781 -0.451 . . . . 73.040000000000006 109.781 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.81 125.49 46.63 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 105.657 -1.979 . . . . 72.310000000000002 105.657 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.47 ' HB2' HD11 ' A' ' 542' ' ' ILE . 31.7 tt0 -126.15 136.68 53.16 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.599 -0.889 . . . . 74.109999999999999 108.599 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 12.3 pt -100.4 139.79 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.225 0 N-CA-C 108.45 -0.944 . . . . 71.209999999999994 108.45 175.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.25 173.16 51.67 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-N 115.167 -0.924 . . . . 63.340000000000003 111.426 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.08 125.85 91.96 Favored Pre-proline 0 N--CA 1.433 -1.307 0 CA-C-O 120.836 0.351 . . . . 75.040000000000006 111.556 -177.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.427 ' HB3' HG22 ' A' ' 537' ' ' VAL . 26.2 Cg_endo -62.1 139.71 80.01 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.692 2.928 . . . . 74.129999999999995 113.101 -174.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 595' ' ' ARG . . . . . 0.464 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 9.7 ptm180 -116.52 128.68 55.66 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.901 -1.045 . . . . 74.420000000000002 109.562 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.536 HD22 HG22 ' A' ' 535' ' ' VAL . 0.6 OUTLIER -74.58 135.86 42.07 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.953 -1.129 . . . . 72.430000000000007 107.953 179.585 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.524 ' CG2' HG12 ' A' ' 536' ' ' ILE . 37.4 t -97.86 101.07 11.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.701 -0.852 . . . . 70.140000000000001 108.701 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -142.84 156.8 45.0 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.194 -0.457 . . . . 73.549999999999997 111.12 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 65.5 mtm -112.76 -5.67 13.9 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.379 -0.828 . . . . 71.030000000000001 109.832 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 49.9 m -143.68 -72.27 0.29 Allowed 'General case' 0 C--O 1.247 0.966 0 N-CA-C 112.502 0.556 . . . . 54.530000000000001 112.502 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -152.52 149.73 28.83 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.143 -0.348 . . . . 74.420000000000002 110.135 -172.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 602' ' ' LYS . . . . . 0.526 ' HD3' ' H ' ' A' ' 602' ' ' LYS . 0.0 OUTLIER -118.36 -179.12 3.69 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.735 0.302 . . . . 72.019999999999996 111.808 -174.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -132.13 157.9 43.05 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.635 -0.876 . . . . 73.230000000000004 108.635 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -104.13 174.13 22.02 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 110.979 -0.848 . . . . 73.230000000000004 110.979 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -104.32 -34.2 3.72 Favored Glycine 0 C--N 1.306 -1.128 0 N-CA-C 111.338 -0.705 . . . . 65.540000000000006 111.338 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 59.41 89.75 0.06 Allowed 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.717 1.207 . . . . 74.510000000000005 112.427 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 8.8 t -146.95 162.64 38.32 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.804 -1.554 . . . . 74.230000000000004 106.804 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 608' ' ' ILE . . . . . 0.406 HD13 ' N ' ' A' ' 609' ' ' THR . 0.0 OUTLIER -80.68 134.7 26.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.953 -1.128 . . . . 53.409999999999997 107.953 -179.14 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 609' ' ' THR . . . . . 0.543 ' HA ' HD11 ' A' ' 504' ' ' ILE . 7.2 p -73.18 92.74 1.76 Allowed 'General case' 0 N--CA 1.434 -1.267 0 CA-C-O 121.317 0.579 . . . . 52.219999999999999 111.911 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -70.09 128.8 37.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.283 -0.871 . . . . 54.200000000000003 111.461 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.525 ' OE2' ' HA ' ' A' ' 614' ' ' ASP . 10.6 pt-20 -122.09 145.86 47.75 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.662 -0.866 . . . . 33.439999999999998 108.662 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -79.71 -33.37 41.01 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.917 0.865 . . . . 74.019999999999996 109.448 -177.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -148.29 146.19 28.48 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.697 -1.223 . . . . 71.530000000000001 107.697 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 614' ' ' ASP . . . . . 0.525 ' HA ' ' OE2' ' A' ' 611' ' ' GLU . 6.8 p-10 -59.92 109.95 1.06 Allowed 'General case' 0 C--O 1.218 -0.582 0 O-C-N 124.057 0.848 . . . . 72.239999999999995 108.976 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.1 156.28 47.28 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 121.247 0.546 . . . . 74.439999999999998 110.72 -175.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -125.0 124.68 25.41 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 105.774 -1.936 . . . . 72.120000000000005 105.774 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 617' ' ' PRO . . . . . 0.404 ' HD3' ' OE1' ' A' ' 638' ' ' GLU . 9.2 Cg_endo -50.5 133.37 37.51 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 123.7 2.933 . . . . 61.100000000000001 114.355 -171.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 84.4 mt -82.98 -17.51 43.21 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.951 -1.022 . . . . 73.140000000000001 109.292 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 6.5 p -71.42 -68.77 0.42 Allowed 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.424 -0.807 . . . . 55.109999999999999 110.642 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 15.0 p -159.78 125.8 4.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 116.039 -0.528 . . . . 54.030000000000001 110.88 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -129.01 151.84 49.26 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.941 -1.503 . . . . 63.329999999999998 106.941 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 622' ' ' GLU . . . . . 0.414 ' HG3' ' HB2' ' A' ' 627' ' ' ARG . 11.3 pt-20 -151.07 177.52 10.1 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.758 -0.777 . . . . 75.409999999999997 112.054 -174.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -142.13 82.83 1.81 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 106.289 -1.745 . . . . 55.0 106.289 170.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 624' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 625' ' ' GLU . 0.9 OUTLIER -153.67 -175.06 5.19 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.492 -1.67 . . . . 73.219999999999999 106.492 -176.205 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 624' ' ' GLU . 47.3 mt-10 -79.01 -16.77 56.43 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 122.43 0.292 . . . . 70.510000000000005 111.274 -176.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -70.33 -31.69 69.09 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.541 -0.54 . . . . 61.299999999999997 109.541 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 627' ' ' ARG . . . . . 0.414 ' HB2' ' HG3' ' A' ' 622' ' ' GLU . 78.8 ttt180 -66.67 -44.4 81.95 Favored 'General case' 0 C--O 1.177 -2.723 0 CA-C-N 115.121 -0.945 . . . . 72.430000000000007 109.651 171.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.33 -38.75 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.337 0.589 . . . . 74.150000000000006 110.231 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.01 -13.93 62.74 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.169 0.987 . . . . 54.200000000000003 113.429 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -51.84 -27.29 12.1 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.04 0.936 . . . . 74.150000000000006 110.948 -177.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -16.12 63.93 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.464 0.913 . . . . 63.219999999999999 113.464 -175.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -111.11 8.66 29.16 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 119.98 -1.105 . . . . 40.030000000000001 113.342 -176.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -134.3 162.1 59.71 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 109.023 -0.732 . . . . 73.120000000000005 109.023 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.422 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 67.7 Cg_endo -77.35 130.1 10.74 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 121.406 1.404 . . . . 75.329999999999998 110.565 174.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.8 pp -126.61 158.33 36.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.623 -0.717 . . . . 71.239999999999995 109.787 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.06 177.19 5.82 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 116.384 -0.371 . . . . 62.32 110.939 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -69.8 172.7 39.3 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 111.424 -0.67 . . . . 73.420000000000002 111.424 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 638' ' ' GLU . . . . . 0.404 ' OE1' ' HD3' ' A' ' 617' ' ' PRO . 4.2 tp10 -56.7 -50.02 73.4 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.791 0.805 . . . . 62.509999999999998 110.192 -175.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -123.63 125.85 45.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.076 -0.965 . . . . 60.030000000000001 109.618 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 19.9 p -123.06 95.28 4.55 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 115.733 -0.667 . . . . 54.43 110.005 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -158.52 138.05 11.81 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.907 -0.588 . . . . 61.329999999999998 109.811 -176.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.528 HD22 HG11 ' A' ' 523' ' ' VAL . 36.5 tp -122.56 129.27 51.75 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.124 -1.065 . . . . 71.129999999999995 108.124 177.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -95.67 108.86 21.18 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.19 -1.411 . . . . 71.120000000000005 107.19 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 43.3 t -99.02 108.86 23.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 109.314 -0.624 . . . . 71.329999999999998 109.314 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 65.3 mt -98.13 122.8 50.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 108.809 -0.811 . . . . 60.030000000000001 108.809 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' ' 585' ' ' LYS . 32.7 mt -99.74 108.31 22.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.486 -0.931 . . . . 74.5 108.486 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 515' ' ' SER . 10.4 pt-20 -111.38 119.9 40.37 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.311 0.577 . . . . 74.129999999999995 110.753 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -74.6 117.16 16.11 Favored 'General case' 0 CA--C 1.479 -1.778 0 CA-C-O 122.456 1.122 . . . . 74.430000000000007 108.927 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 40.4 m -112.52 105.1 13.24 Favored 'General case' 0 C--N 1.252 -3.644 0 N-CA-C 105.547 -2.02 . . . . 70.530000000000001 105.547 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -67.94 -47.67 68.04 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.569 -0.741 . . . . 73.140000000000001 112.368 -172.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -75.14 -26.39 59.14 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 119.848 -0.741 . . . . 74.519999999999996 109.183 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 39.6 t80 74.95 8.42 4.14 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.976 1.71 . . . . 64.439999999999998 111.171 176.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -85.68 102.46 13.63 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.688 -1.597 . . . . 75.439999999999998 106.688 177.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 33.3 m -74.22 86.36 1.92 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.951 0.882 . . . . 71.109999999999999 112.861 -174.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 3.4 t -160.52 92.24 0.96 Allowed 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.339 -1.301 . . . . 63.340000000000003 108.303 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . 0.353 14.7 p 49.76 70.05 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 126.212 1.805 . . . . 74.219999999999999 113.9 -177.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 C--O 1.248 1.019 0 CA-C-N 114.035 -1.439 . . . . 74.340000000000003 108.895 176.775 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 14.7 t60 . . . . . 0 N--CA 1.436 -1.148 0 CA-C-O 121.568 0.699 . . . . 74.450000000000003 109.852 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -74.47 -34.62 63.17 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.679 -0.691 . . . . 63.109999999999999 110.332 178.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 162.07 -159.79 31.86 Favored Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 109.904 -1.278 . . . . 70.540000000000006 109.904 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.53 110.86 33.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 116.687 0.244 . . . . 61.200000000000003 110.814 -176.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.726 ' CE1' ' HA ' ' A' ' 527' ' ' ARG . 5.8 m-85 -95.46 120.59 35.98 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.099 -0.704 . . . . 75.420000000000002 109.099 169.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.1 t -170.22 179.52 3.44 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.612 -0.884 . . . . 64.409999999999997 108.612 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -84.37 153.48 23.43 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.614 -0.513 . . . . 74.319999999999993 109.614 178.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -66.84 -36.04 81.43 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.575 0.702 . . . . 72.239999999999995 109.93 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.36 146.36 61.67 Favored Pre-proline 0 N--CA 1.42 -1.963 0 CA-C-N 115.014 -0.994 . . . . 61.340000000000003 108.444 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.67 -25.2 12.81 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.761 1.641 . . . . 74.109999999999999 112.007 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.05 135.37 54.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.454 -0.943 . . . . 65.329999999999998 108.454 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.6 t -129.33 139.18 51.83 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 109.239 -0.652 . . . . 63.100000000000001 109.239 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -103.66 123.2 46.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.661 -1.237 . . . . 61.439999999999998 107.661 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.6 m -113.11 151.92 14.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 120.463 -0.495 . . . . 73.099999999999994 109.912 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.545 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 0.4 OUTLIER -72.96 162.55 29.36 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 114.845 -1.071 . . . . 73.340000000000003 111.43 -178.256 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -83.78 -48.27 10.27 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.264 -1.384 . . . . 54.409999999999997 107.264 170.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.4 m -81.68 28.51 0.41 Allowed 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.685 -1.143 . . . . 71.400000000000006 112.297 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 15.2 tt -96.9 -32.15 4.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 112.6 0.593 . . . . 60.520000000000003 112.6 -174.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 519' ' ' GLY . . . . . 0.443 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 87.98 -78.49 1.79 Allowed Glycine 0 N--CA 1.428 -1.864 0 C-N-CA 120.011 -1.09 . . . . 63.439999999999998 110.532 -175.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 520' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 574' ' ' LYS . 35.1 mm -126.74 131.4 71.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 107.523 -1.288 . . . . 71.129999999999995 107.523 -175.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.554 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -108.55 146.68 32.9 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 109.349 -0.611 . . . . 72.319999999999993 109.349 177.524 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 15.1 mp0 -123.15 127.25 48.42 Favored 'General case' 0 CA--C 1.505 -0.764 0 O-C-N 123.955 0.784 . . . . 73.530000000000001 110.329 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.554 HG23 ' SD ' ' A' ' 521' ' ' MET . 66.0 t -112.09 130.64 65.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.98 -1.118 . . . . 72.219999999999999 107.98 173.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.475 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 35.8 mtmt -90.72 141.81 28.41 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.236 0.541 . . . . 72.230000000000004 110.833 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 568' ' ' VAL . 43.8 t -107.77 128.01 63.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.738 -0.664 . . . . 65.439999999999998 109.525 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 95.2 mt -66.5 116.49 7.53 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.276 0.63 . . . . 73.319999999999993 110.25 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.726 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 56.3 ttt-85 -73.26 154.14 40.31 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 124.619 1.167 . . . . 73.120000000000005 109.974 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.65 HG23 ' CD2' ' A' ' 505' ' ' PHE . 1.4 p -58.52 131.28 50.29 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 122.992 0.517 . . . . 72.430000000000007 110.415 175.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 46.4 t -47.39 -35.56 8.48 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 125.362 1.465 . . . . 75.040000000000006 110.917 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.56 85.85 0.32 Allowed Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.857 -1.297 . . . . 73.120000000000005 109.857 175.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -84.83 102.14 12.83 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.648 -0.871 . . . . 64.25 108.648 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -102.07 96.73 7.2 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.234 -0.894 . . . . 64.209999999999994 109.939 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 111.43 -145.16 17.64 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.997 -0.621 . . . . 61.350000000000001 112.294 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -118.86 131.92 56.09 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.803 -1.554 . . . . 71.450000000000003 106.803 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 42.8 t -133.94 140.59 46.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 110.104 -0.332 . . . . 70.129999999999995 110.104 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.532 HG12 ' CG2' ' A' ' 597' ' ' VAL . 38.3 mm -113.52 135.36 53.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 109.29 -0.633 . . . . 74.310000000000002 109.29 174.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 34.8 t -121.13 109.44 35.35 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 109.166 -0.679 . . . . 74.209999999999994 109.166 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.04 150.5 38.07 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.21 1.94 . . . . 74.209999999999994 112.27 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.489 ' HB3' HG22 ' A' ' 591' ' ' ILE . 46.1 p90 -145.18 167.43 22.78 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.835 0.35 . . . . 75.420000000000002 111.013 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -158.42 147.95 19.47 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-N 115.387 -0.824 . . . . 52.109999999999999 110.206 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 15.3 p -84.0 136.26 34.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.826 -0.805 . . . . 53.340000000000003 108.826 172.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 75.0 mt -104.43 114.68 44.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 108.942 -0.762 . . . . 64.129999999999995 108.942 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.63 99.12 2.48 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.843 -0.617 . . . . 75.430000000000007 109.927 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -112.13 -105.78 2.81 Favored Glycine 0 CA--C 1.479 -2.172 0 N-CA-C 110.411 -1.075 . . . . 75.219999999999999 110.411 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.24 42.69 1.05 Allowed 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 123.485 0.714 . . . . 73.230000000000004 109.473 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.518 ' HA ' ' HD2' ' A' ' 585' ' ' LYS . . . -160.1 147.13 16.17 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.475 0.71 . . . . 63.240000000000002 109.864 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.495 HH11 ' HG3' ' A' ' 551' ' ' GLU . 33.1 mtm105 -77.82 120.36 22.61 Favored 'General case' 0 C--O 1.251 1.157 0 CA-C-O 121.356 0.598 . . . . 73.310000000000002 111.727 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.28 -163.04 35.33 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.04 -0.982 . . . . 51.210000000000001 110.687 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 65.5 28.85 74.03 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 121.388 -0.434 . . . . 41.43 113.255 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 550' ' ' GLY . . . . . 0.407 ' C ' HG13 ' A' ' 576' ' ' ILE . . . 69.42 40.25 79.69 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 121.164 -0.541 . . . . 45.140000000000001 112.006 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.495 ' HG3' HH11 ' A' ' 547' ' ' ARG . 3.6 tp10 -113.05 -53.93 2.67 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 119.954 -0.698 . . . . 74.409999999999997 110.188 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -98.62 -39.54 8.64 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.459 -1.311 . . . . 74.450000000000003 107.459 169.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -142.56 149.0 38.48 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.753 -1.112 . . . . 75.400000000000006 108.629 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.66 111.93 21.13 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 105.361 -2.089 . . . . 64.230000000000004 105.361 176.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -75.19 146.7 41.02 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.176 -0.466 . . . . 72.030000000000001 109.976 -173.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.0 t -143.17 150.93 40.06 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.358 0.599 . . . . 61.130000000000003 110.502 -172.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.0 p -153.18 134.57 14.29 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.504 -0.924 . . . . 73.25 108.504 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -175.54 -168.32 35.8 Favored Glycine 0 N--CA 1.411 -2.987 0 N-CA-C 110.179 -1.169 . . . . 40.439999999999998 110.179 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.467 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 39.9 mt-10 -127.32 131.86 50.36 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.972 -0.381 . . . . 75.109999999999999 109.972 -175.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 569' ' ' LYS . 86.1 mt -94.63 132.11 39.7 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.564 -0.532 . . . . 62.350000000000001 109.564 177.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.486 ' HA ' HD13 ' A' ' 536' ' ' ILE . 19.4 tt0 -98.75 120.21 38.8 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.941 -0.572 . . . . 62.409999999999997 110.198 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.412 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 89.5 m-85 -120.71 156.55 31.54 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.671 -0.863 . . . . 52.210000000000001 108.671 177.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.459 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 65.4 mt-30 -150.11 -177.43 5.92 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.21 -1.033 . . . . 53.340000000000003 108.21 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -66.34 -42.67 87.78 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.397 -0.964 . . . . 71.129999999999995 108.397 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -81.8 -24.63 35.81 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.972 0.731 . . . . 74.299999999999997 112.972 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.459 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 37.1 mm-40 -76.34 146.5 38.77 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.857 -0.527 . . . . 71.439999999999998 112.062 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.611 HG13 ' H ' ' A' ' 568' ' ' VAL . 12.6 pt -90.47 -89.99 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 114.869 1.433 . . . . 75.519999999999996 114.869 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.611 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.7 p -134.76 145.64 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 109.664 -0.495 . . . . 64.420000000000002 109.664 -177.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.535 ' HB3' HD22 ' A' ' 560' ' ' LEU . 4.2 mmpt? -113.04 157.11 21.97 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 116.267 -0.424 . . . . 74.209999999999994 110.21 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.8 p -126.25 151.76 47.01 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.19 -0.914 . . . . 74.310000000000002 111.926 -177.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.3 mp -101.37 120.97 51.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.104 -1.443 . . . . 70.239999999999995 107.104 171.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 572' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 521' ' ' MET . 70.0 m -99.3 115.96 30.38 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 123.81 0.694 . . . . 45.5 109.967 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.41 HG23 HG22 ' A' ' 571' ' ' ILE . 68.1 t -122.63 128.27 75.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.462 -0.335 . . . . 72.310000000000002 110.291 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 29.1 tptp -80.66 118.2 22.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.67 -0.493 . . . . 73.239999999999995 109.67 176.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 58.3 t -81.27 117.22 26.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 105.557 -2.016 . . . . 72.340000000000003 105.557 174.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 576' ' ' ILE . . . . . 0.407 HG13 ' C ' ' A' ' 550' ' ' GLY . 43.5 mm -76.28 139.04 19.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.762 0.791 . . . . 63.450000000000003 109.97 -174.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.59 80.03 7.11 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-N 114.282 -1.327 . . . . 62.030000000000001 108.038 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -82.61 135.94 34.93 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.614 -1.176 . . . . 73.010000000000005 108.865 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -86.02 -42.42 14.0 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 110.13 -0.322 . . . . 72.319999999999993 110.13 -175.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.16 168.06 18.02 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.412 0.625 . . . . 65.120000000000005 111.442 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -136.56 133.07 36.03 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.152 -0.684 . . . . 73.319999999999993 109.152 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -131.14 -65.04 0.79 Allowed 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.15 0.5 . . . . 64.219999999999999 109.912 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -158.92 170.38 22.23 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.81 -1.552 . . . . 43.030000000000001 106.81 -173.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -61.86 118.61 7.44 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.459 -0.571 . . . . 64.340000000000003 109.459 174.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' A' ' 546' ' ' ALA . 34.2 mmtp -90.58 136.31 33.14 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.995 -0.548 . . . . 74.519999999999996 111.416 -175.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 7.0 t -153.93 135.5 14.33 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.436 0.636 . . . . 72.049999999999997 110.407 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -127.16 172.18 10.77 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.323 -0.991 . . . . 74.010000000000005 108.323 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.478 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 79.4 m-85 -118.96 153.8 34.05 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 109.515 -0.55 . . . . 72.010000000000005 109.515 -175.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.86 129.86 52.17 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.206 -1.775 . . . . 65.219999999999999 106.206 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -128.0 134.4 49.25 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.05 -0.66 . . . . 74.510000000000005 109.924 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.489 HG22 ' HB3' ' A' ' 539' ' ' TYR . 25.2 pt -106.84 140.51 24.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.39 -0.967 . . . . 50.43 108.39 176.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.21 -175.31 49.78 Favored Glycine 0 N--CA 1.425 -2.065 0 O-C-N 123.813 0.695 . . . . 63.240000000000002 111.469 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.81 137.3 82.63 Favored Pre-proline 0 N--CA 1.428 -1.529 0 C-N-CA 121.034 -0.266 . . . . 74.319999999999993 110.521 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.65 142.94 60.26 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 122.58 2.187 . . . . 72.439999999999998 111.08 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -121.93 123.42 41.66 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.674 -0.491 . . . . 74.230000000000004 109.674 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.482 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 2.2 tm? -67.97 125.56 26.7 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.844 -0.799 . . . . 74.140000000000001 108.844 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.532 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.6 t -93.41 107.77 19.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 105.197 -2.149 . . . . 75.409999999999997 105.197 176.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' A' ' 601' ' ' GLU . 34.7 mt-10 -61.59 112.86 2.4 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.912 -1.04 . . . . 72.420000000000002 108.843 -176.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -67.11 -28.44 68.16 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.463 0.649 . . . . 74.519999999999996 110.906 -175.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 8.4 t -104.51 90.34 3.49 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 102.541 -3.133 . . . . 51.130000000000003 102.541 168.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 601' ' ' GLU . . . . . 0.536 ' HB3' ' O ' ' A' ' 598' ' ' GLU . 9.0 pt-20 -99.95 153.9 18.81 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 114.601 1.334 . . . . 74.120000000000005 114.601 -166.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -102.64 130.46 49.54 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 104.886 -2.264 . . . . 53.450000000000003 104.886 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -71.52 94.1 1.26 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.062 0.934 . . . . 73.340000000000003 110.611 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 150.18 -139.48 7.36 Favored Glycine 0 N--CA 1.415 -2.762 0 N-CA-C 108.289 -1.924 . . . . 72.239999999999995 108.289 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 71.19 33.57 64.84 Favored Glycine 0 C--N 1.315 -0.603 0 N-CA-C 110.585 -1.006 . . . . 71.129999999999995 110.585 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -155.06 139.52 16.84 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 109.087 -0.709 . . . . 74.420000000000002 109.087 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 7.6 t -138.47 141.28 39.45 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.131 -1.433 . . . . 71.299999999999997 107.131 174.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 64.3 mt -75.4 110.01 9.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.19 -0.67 . . . . 71.230000000000004 109.19 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 8.9 t -163.06 140.96 7.99 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 109.772 -0.455 . . . . 51.399999999999999 109.772 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -136.27 107.83 6.96 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 104.691 -2.337 . . . . 62.030000000000001 104.691 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -73.02 125.23 27.14 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.391 -0.524 . . . . 71.109999999999999 111.859 -172.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -75.72 141.63 42.62 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 108.502 -0.925 . . . . 73.340000000000003 108.502 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 613' ' ' ASP . . . . . 0.415 ' OD1' ' HD3' ' A' ' 617' ' ' PRO . 20.9 t70 -143.34 130.2 20.47 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.943 -0.571 . . . . 74.420000000000002 111.089 -174.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -113.46 -7.42 13.43 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.109 -0.496 . . . . 70.519999999999996 110.46 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 615' ' ' LYS . . . . . 0.51 ' HE2' ' HA ' ' A' ' 615' ' ' LYS . 0.6 OUTLIER 174.54 -47.41 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.751 1.22 . . . . 74.150000000000006 108.454 178.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -162.62 121.21 1.34 Allowed Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 115.455 -0.793 . . . . 75.519999999999996 109.136 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 617' ' ' PRO . . . . . 0.415 ' HD3' ' OD1' ' A' ' 613' ' ' ASP . 6.3 Cg_exo -74.29 108.06 2.59 Favored 'Trans proline' 0 N--CA 1.44 -1.647 0 C-N-CA 121.564 1.509 . . . . 75.120000000000005 109.303 174.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 88.9 mt -76.23 -12.29 60.06 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.442 0.639 . . . . 55.039999999999999 111.111 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 26.8 m -76.23 -18.83 58.84 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.7 -0.852 . . . . 63.109999999999999 108.7 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 38.3 t -100.49 117.81 35.41 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 108.073 -1.084 . . . . 61.219999999999999 108.073 178.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -94.27 134.76 36.4 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.192 -0.67 . . . . 72.439999999999998 109.192 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -80.65 86.68 5.86 Favored 'General case' 0 C--O 1.25 1.097 0 CA-C-O 122.04 0.924 . . . . 72.209999999999994 109.125 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 626' ' ' ARG . 10.1 tp10 -74.66 116.42 15.34 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 113.948 -1.478 . . . . 73.430000000000007 111.156 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 624' ' ' GLU . . . . . 0.439 ' O ' HG13 ' A' ' 628' ' ' ILE . 40.1 mt-10 -66.65 -27.82 67.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.669 -0.696 . . . . 73.310000000000002 110.942 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.97 -31.43 72.61 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 120.825 0.345 . . . . 53.409999999999997 110.313 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.644 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 28.1 mmt180 -63.76 -47.41 81.1 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 109.03 -0.729 . . . . 74.519999999999996 109.03 174.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -58.89 -41.07 86.29 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.666 0.604 . . . . 73.5 111.646 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 624' ' ' GLU . 69.0 mt -65.24 -35.37 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.416 0.627 . . . . 71.519999999999996 109.873 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -75.31 -29.33 60.0 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.37 -0.377 . . . . 62.140000000000001 111.007 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 7.6 mm-40 -61.55 -29.68 70.17 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 116.215 -0.448 . . . . 71.219999999999999 111.896 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' A' ' 628' ' ' ILE . 0.0 OUTLIER -75.87 -1.59 26.06 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.173 0.805 . . . . 64.219999999999999 113.173 -177.683 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -101.2 1.7 54.48 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.775 -0.93 . . . . 74.239999999999995 110.775 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 633' ' ' ARG . . . . . 0.505 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 5.3 ptp180 -135.03 168.88 15.54 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 123.572 0.749 . . . . 74.120000000000005 109.06 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.509 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 33.6 Cg_endo -60.04 139.5 87.99 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.586 2.191 . . . . 51.43 112.622 177.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.8 pp -134.56 157.97 41.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.139 -1.059 . . . . 71.239999999999995 108.139 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.54 172.84 8.42 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.314 -0.554 . . . . 64.200000000000003 111.725 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -73.01 -157.25 3.9 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-O 121.912 0.729 . . . . 74.049999999999997 114.475 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.93 -45.84 59.7 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.624 -0.788 . . . . 71.420000000000002 109.333 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -135.4 142.98 45.76 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.231 -0.895 . . . . 74.129999999999995 108.822 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 35.2 p -134.75 103.21 5.54 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.011 0.434 . . . . 43.439999999999998 111.034 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -170.22 150.65 3.68 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.822 -1.177 . . . . 64.409999999999997 107.822 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.522 HD21 HG21 ' A' ' 523' ' ' VAL . 26.1 tp -137.81 132.13 32.18 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.48 -0.933 . . . . 72.219999999999999 108.48 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -101.16 110.95 23.04 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.529 -1.286 . . . . 75.140000000000001 107.529 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 45.7 t -101.11 110.97 29.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.556 -0.535 . . . . 52.530000000000001 109.556 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 74.0 mt -96.58 125.66 49.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 N-CA-C 109.471 -0.566 . . . . 52.219999999999999 109.471 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 64.9 mt -101.17 107.59 21.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.823 -1.177 . . . . 73.310000000000002 107.823 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 650' ' ' TYR . 8.5 pt-20 -121.18 153.16 37.92 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.173 0.511 . . . . 72.030000000000001 110.014 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.35 138.72 45.28 Favored 'General case' 0 N--CA 1.387 -3.578 0 N-CA-C 106.66 -1.607 . . . . 75.239999999999995 106.66 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 50.0 m 69.52 43.4 1.02 Allowed 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.906 -1.516 . . . . 52.030000000000001 106.906 -172.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 650' ' ' TYR . . . . . 0.486 ' HB2' ' HG3' ' A' ' 647' ' ' GLU . 0.1 OUTLIER -59.04 -35.45 73.34 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 113.44 -1.709 . . . . 44.310000000000002 112.72 -174.27 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -20.58 61.46 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.744 -0.662 . . . . 70.340000000000003 111.702 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -87.41 77.88 8.79 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 122.248 1.023 . . . . 75.319999999999993 111.589 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -163.55 -169.43 1.93 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 105.581 -2.007 . . . . 71.219999999999999 105.581 176.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 15.0 m -86.51 89.5 7.92 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.556 -0.905 . . . . 73.530000000000001 108.556 174.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 34.9 m -76.5 115.76 16.55 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 108.984 -0.747 . . . . 73.209999999999994 108.984 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.81 116.82 10.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.13 -0.487 . . . . 73.420000000000002 111.672 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 C--O 1.253 1.278 0 CA-C-N 114.924 -1.035 . . . . 73.310000000000002 112.317 177.384 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 502' ' ' ALA . . . . . 0.56 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . . . . . . 0 C--O 1.211 -0.95 0 N-CA-C 113.316 0.858 . . . . 63.109999999999999 113.316 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 124.58 -155.85 18.44 Favored Glycine 0 C--N 1.287 -2.167 0 C-N-CA 119.215 -1.469 . . . . 40.229999999999997 111.705 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.417 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.7 mp -114.66 110.96 33.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 112.069 0.396 . . . . 64.010000000000005 112.069 -172.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -92.52 119.98 32.53 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.068 -1.086 . . . . 75.019999999999996 108.068 168.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.5 t -160.41 171.79 18.43 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.122 -0.696 . . . . 74.510000000000005 109.122 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -76.83 147.06 37.39 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 122.513 -0.117 . . . . 71.209999999999994 111.149 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 524' ' ' LYS . 0.3 OUTLIER -65.9 -33.8 76.66 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 122.116 0.96 . . . . 64.439999999999998 108.69 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -130.23 140.17 37.86 Favored Pre-proline 0 C--N 1.291 -1.96 0 N-CA-C 108.008 -1.108 . . . . 72.5 108.008 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.81 -27.4 10.43 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.288 1.992 . . . . 62.509999999999998 111.672 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 60.0 t -140.63 134.52 33.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 106.232 -1.766 . . . . 75.430000000000007 106.232 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.2 t -128.95 139.91 51.9 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.952 -0.758 . . . . 72.540000000000006 108.952 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -106.39 136.3 46.38 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.563 -1.273 . . . . 71.099999999999994 107.563 175.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.2 m -125.9 147.24 30.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 108.897 -0.779 . . . . 62.530000000000001 108.897 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.478 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 27.1 m -79.29 143.64 35.03 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 112.709 0.633 . . . . 61.43 112.709 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -56.2 -39.5 72.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.196 0.998 . . . . 73.140000000000001 110.374 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 27.5 t -116.01 73.25 0.84 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.905 0.859 . . . . 52.149999999999999 109.757 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 9.8 tt -120.16 -25.49 2.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.653 -0.703 . . . . 72.540000000000006 110.73 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . 0.457 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 91.74 -82.02 1.22 Allowed Glycine 0 N--CA 1.421 -2.342 0 N-CA-C 109.983 -1.247 . . . . 60.130000000000003 109.983 -175.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 574' ' ' LYS . 49.8 mm -127.96 135.13 63.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 107.993 -1.114 . . . . 64.209999999999994 107.993 -175.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.19 143.3 43.47 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.132 -1.062 . . . . 45.119999999999997 108.132 176.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.7 mt-10 -124.93 126.75 46.0 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 123.796 0.685 . . . . 74.299999999999997 111.358 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.545 HG11 HD22 ' A' ' 642' ' ' LEU . 24.2 t -105.53 125.34 60.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.908 -0.775 . . . . 75.25 108.908 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 508' ' ' GLU . 20.6 mmmt -81.34 130.18 34.93 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.328 -0.99 . . . . 64.340000000000003 108.328 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.501 ' O ' HG23 ' A' ' 568' ' ' VAL . 58.5 t -105.38 137.85 33.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 109.829 -0.434 . . . . 64.530000000000001 109.829 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.91 123.18 27.0 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.011 -0.541 . . . . 72.109999999999999 110.177 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 34.7 ttp85 -78.78 155.83 29.1 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.686 -1.143 . . . . 70.319999999999993 110.433 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 0.9 OUTLIER -58.37 140.4 53.65 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 124.438 1.095 . . . . 60.310000000000002 112.482 177.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.7 t -54.73 -35.33 63.59 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.934 1.294 . . . . 71.010000000000005 110.034 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -117.76 95.64 0.65 Allowed Glycine 0 N--CA 1.418 -2.501 0 N-CA-C 110.141 -1.184 . . . . 34.149999999999999 110.141 176.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -84.57 111.85 19.89 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.804 -0.813 . . . . 33.240000000000002 108.804 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -121.28 107.87 13.05 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.304 -0.862 . . . . 71.209999999999994 110.835 -173.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 74.76 -124.25 7.87 Favored Glycine 0 N--CA 1.441 -1.0 0 O-C-N 123.633 0.583 . . . . 72.129999999999995 112.92 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.526 HD22 ' HG2' ' A' ' 563' ' ' GLN . 2.5 t-20 -134.17 126.38 29.83 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.299 0.64 . . . . 71.310000000000002 109.851 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.47 137.94 54.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 109.027 -0.731 . . . . 74.219999999999999 109.027 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.512 HG12 ' CG2' ' A' ' 597' ' ' VAL . 40.5 mm -107.76 136.65 42.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 109.358 -0.608 . . . . 74.109999999999999 109.358 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.25 108.07 38.55 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 109.488 -0.56 . . . . 62.450000000000003 109.488 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 53.5 Cg_endo -72.71 155.97 53.65 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.373 2.049 . . . . 63.030000000000001 111.752 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.497 ' HB3' HG22 ' A' ' 591' ' ' ILE . 54.2 p90 -152.87 163.0 40.59 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 110.481 -0.192 . . . . 71.129999999999995 110.481 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -158.03 158.36 34.69 Favored 'General case' 0 C--O 1.25 1.079 0 O-C-N 123.735 0.647 . . . . 72.299999999999997 109.457 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 5.2 p -84.35 158.15 21.23 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.145 -0.48 . . . . 75.540000000000006 110.05 172.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 89.6 mt -133.54 121.28 40.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.644 -1.243 . . . . 74.349999999999994 107.644 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -71.37 107.28 4.25 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 110.154 -0.313 . . . . 63.409999999999997 110.154 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -83.82 -89.75 0.76 Allowed Glycine 0 C--N 1.309 -0.93 0 N-CA-C 109.53 -1.428 . . . . 63.299999999999997 109.53 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 14.8 p -112.76 6.11 17.92 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.819 0.818 . . . . 75.140000000000001 109.112 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -99.45 142.76 30.52 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.635 -1.166 . . . . 71.519999999999996 110.281 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.427 ' HB3' ' OE1' ' A' ' 551' ' ' GLU . 76.9 mtt180 -79.34 127.0 31.54 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.694 0.759 . . . . 72.129999999999995 111.321 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -90.3 176.09 41.61 Favored Glycine 0 C--N 1.289 -2.074 0 CA-C-N 114.81 -1.086 . . . . 60.520000000000003 112.19 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 82.34 19.29 64.75 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.057 -0.592 . . . . 62.109999999999999 113.255 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 81.94 25.81 51.36 Favored Glycine 0 CA--C 1.504 -0.64 0 N-CA-C 110.458 -1.057 . . . . 54.140000000000001 110.458 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.427 ' OE1' ' HB3' ' A' ' 547' ' ' ARG . 21.3 tt0 -93.32 -60.81 1.7 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 108.801 -0.815 . . . . 72.5 108.801 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -102.12 -34.44 9.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.852 -1.166 . . . . 73.409999999999997 107.852 168.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -143.95 148.72 35.73 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.518 -0.919 . . . . 73.349999999999994 108.518 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -85.57 112.29 20.82 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 105.498 -2.038 . . . . 72.439999999999998 105.498 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -76.55 146.37 38.41 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.256 -0.429 . . . . 73.299999999999997 110.168 -175.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.5 t -145.55 157.0 44.05 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-O 121.411 0.624 . . . . 64.120000000000005 110.519 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.9 p -154.52 153.19 31.05 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.498 -1.297 . . . . 72.040000000000006 107.498 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 169.81 -160.64 33.75 Favored Glycine 0 N--CA 1.418 -2.503 0 N-CA-C 110.032 -1.227 . . . . 62.329999999999998 110.032 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.491 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.6 mt-10 -129.79 142.36 50.7 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 122.663 0.385 . . . . 75.420000000000002 110.631 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.574 HD22 ' HB3' ' A' ' 569' ' ' LYS . 74.9 mt -107.82 139.48 42.35 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.046 -0.525 . . . . 74.430000000000007 109.617 175.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.507 ' HA ' HD13 ' A' ' 536' ' ' ILE . 31.4 tt0 -102.79 117.25 34.23 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 116.031 -0.531 . . . . 71.030000000000001 110.913 -177.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -116.56 149.02 40.31 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.548 -0.908 . . . . 73.129999999999995 108.548 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.526 ' HG2' HD22 ' A' ' 534' ' ' ASN . 14.0 mt-30 -148.19 -175.01 4.73 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.941 -1.133 . . . . 71.329999999999998 107.941 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -69.18 -27.44 65.52 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.545 -0.909 . . . . 73.239999999999995 108.545 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.27 -51.66 5.06 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.136 -0.938 . . . . 51.420000000000002 112.317 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.514 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 51.0 mm-40 -55.67 125.77 22.6 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 122.349 0.259 . . . . 70.129999999999995 110.815 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.603 HG13 ' H ' ' A' ' 568' ' ' VAL . 7.1 pt -91.01 -78.67 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 112.855 0.687 . . . . 71.329999999999998 112.855 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.603 ' H ' HG13 ' A' ' 567' ' ' ILE . 10.9 p -119.71 150.18 22.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.813 -0.555 . . . . 63.439999999999998 110.004 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.574 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -122.83 160.32 26.28 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.911 -0.774 . . . . 70.519999999999996 108.911 173.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 6.8 p -127.33 144.61 51.02 Favored 'General case' 0 C--N 1.288 -2.095 0 O-C-N 123.898 0.749 . . . . 71.340000000000003 112.696 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.0 mp -94.66 122.74 46.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 106.369 -1.715 . . . . 74.430000000000007 106.369 171.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 15.6 m -100.92 119.24 38.42 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 123.731 0.645 . . . . 60.0 109.332 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.403 HG23 HG22 ' A' ' 571' ' ' ILE . 89.4 t -124.18 128.81 74.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 109.927 -0.397 . . . . 71.409999999999997 109.927 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.457 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 20.5 tptm -77.97 113.22 15.67 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.183 -0.673 . . . . 55.0 109.183 175.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.3 120.97 36.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 106.89 -1.522 . . . . 70.510000000000005 106.89 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 35.7 mm . . . . . 0 C--N 1.292 -1.922 0 N-CA-C 108.911 -0.774 . . . . 72.409999999999997 108.911 -176.565 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 74.9 mmtt . . . . . 0 CA--C 1.482 -1.648 0 N-CA-C 109.443 -0.577 . . . . 73.409999999999997 109.443 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 644' ' ' VAL . 10.0 t -149.33 138.75 21.57 Favored 'General case' 0 N--CA 1.416 -2.143 0 C-N-CA 120.034 -0.666 . . . . 52.310000000000002 110.937 174.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 49.0 p90 -135.08 167.7 20.47 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.651 -1.241 . . . . 70.109999999999999 107.651 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.517 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 80.3 m-85 -114.44 159.39 20.38 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 120.572 -0.451 . . . . 74.430000000000007 109.889 -175.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.33 128.22 47.86 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 106.243 -1.762 . . . . 74.129999999999995 106.243 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.462 ' HB2' HD11 ' A' ' 542' ' ' ILE . 29.5 tt0 -122.19 123.37 41.35 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 110.238 -0.282 . . . . 75.319999999999993 110.238 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.497 HG22 ' HB3' ' A' ' 539' ' ' TYR . 23.5 pt -95.86 135.19 30.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.859 -1.163 . . . . 71.150000000000006 107.859 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -84.38 -177.55 51.29 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 111.429 -0.669 . . . . 75.430000000000007 111.429 -177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.75 133.95 92.37 Favored Pre-proline 0 N--CA 1.435 -1.19 0 C-N-CA 120.931 -0.308 . . . . 73.349999999999994 111.435 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.413 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 20.3 Cg_endo -62.7 129.48 26.44 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.947 2.432 . . . . 72.219999999999999 111.513 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . 0.466 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.1 ptp180 -107.81 119.95 40.89 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.458 -0.792 . . . . 71.239999999999995 109.902 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -66.07 132.1 47.74 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.967 -1.123 . . . . 74.530000000000001 107.967 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.512 ' CG2' HG12 ' A' ' 536' ' ' ILE . 98.1 t . . . . . 0 C--N 1.307 -1.255 0 CA-C-O 121.707 0.765 . . . . 61.240000000000002 112.385 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.453 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 42.6 Cg_endo . . . . . 0 N--CA 1.43 -2.213 0 N-CA-C 108.876 -1.24 . . . . 74.519999999999996 108.876 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.86 168.18 17.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 120.894 -0.323 . . . . 72.319999999999993 110.217 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.21 175.91 5.34 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 112.14 0.422 . . . . 73.319999999999993 112.14 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.417 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -72.53 -177.58 31.3 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 114.948 0.739 . . . . 74.439999999999998 114.948 -176.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -58.48 -47.35 84.36 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.476 1.111 . . . . 63.020000000000003 110.172 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -140.44 121.83 15.0 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.006 -0.739 . . . . 62.25 109.006 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 10.1 p -114.32 96.21 5.66 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 120.899 0.381 . . . . 73.209999999999994 111.004 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -171.16 134.0 0.9 Allowed 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.572 -0.74 . . . . 72.019999999999996 109.662 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.545 HD22 HG11 ' A' ' 523' ' ' VAL . 25.6 tp -117.42 132.35 56.59 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.896 -1.047 . . . . 70.310000000000002 108.769 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -99.71 111.91 24.2 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.946 -1.502 . . . . 73.349999999999994 106.946 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 586' ' ' THR . 41.3 t -100.41 111.1 29.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 109.338 -0.615 . . . . 74.319999999999993 109.338 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 51.1 mt -99.48 118.45 46.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 N-CA-C 109.177 -0.675 . . . . 74.319999999999993 109.177 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 69.0 mt -87.5 107.86 17.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 106.792 -1.559 . . . . 73.409999999999997 106.792 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? . . . . . 0 C--N 1.292 -1.921 0 CA-C-N 116.098 -0.501 . . . . 75.450000000000003 110.93 -178.648 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 502' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 121.782 0.801 . . . . 75.439999999999998 109.158 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 174.9 -161.88 31.53 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 109.033 -1.627 . . . . 51.140000000000001 109.033 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.513 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.4 mp -116.25 121.37 67.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 117.202 0.501 . . . . 73.25 111.359 -174.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.558 ' CD2' HG23 ' A' ' 528' ' ' THR . 30.7 m-85 -95.86 135.65 37.31 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.011 -0.737 . . . . 73.099999999999994 109.011 168.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . 0.435 ' HA ' HG22 ' A' ' 640' ' ' THR . 13.6 t -167.32 179.66 4.93 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.088 -0.708 . . . . 73.150000000000006 109.088 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.07 152.05 22.3 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.455 -0.572 . . . . 74.120000000000005 109.455 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.66 -37.12 84.13 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.79 -0.448 . . . . 74.540000000000006 109.79 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -125.97 149.73 67.08 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 109.62 -0.511 . . . . 70.109999999999999 109.62 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.01 -27.67 6.68 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.678 1.585 . . . . 75.219999999999999 111.771 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 47.4 t -135.48 135.26 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.883 -0.784 . . . . 74.140000000000001 108.883 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.9 t -132.28 140.45 48.62 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.724 -0.843 . . . . 64.230000000000004 108.724 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 44.9 p-80 -112.71 127.51 56.15 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.383 0.611 . . . . 75.049999999999997 109.496 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.7 m -112.18 165.2 7.33 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.453 -0.794 . . . . 64.439999999999998 109.211 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 15.4 t -101.2 166.35 10.82 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.666 0.746 . . . . 63.340000000000003 112.134 -172.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -80.11 -19.67 46.8 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.101 -1.409 . . . . 75.319999999999993 107.991 173.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 19.3 m -114.15 29.65 7.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.991 -0.55 . . . . 53.130000000000003 111.763 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.2 tt -97.86 -39.26 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 119.763 -0.775 . . . . 54.240000000000002 113.044 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 90.28 -72.95 1.94 Allowed Glycine 0 CA--C 1.506 -0.529 0 C-N-CA 120.662 -0.78 . . . . 52.119999999999997 111.645 -176.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . 0.543 HD11 ' HE3' ' A' ' 574' ' ' LYS . 33.8 mm -128.03 126.87 67.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.65 -1.241 . . . . 65.540000000000006 107.65 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.21 147.96 29.5 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.273 -1.01 . . . . 54.340000000000003 108.273 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 51.4 mp0 -122.41 131.9 54.1 Favored 'General case' 0 N--CA 1.434 -1.252 0 O-C-N 123.716 0.635 . . . . 61.009999999999998 110.304 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 570' ' ' THR . 25.3 t -110.95 129.51 66.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.785 -0.643 . . . . 73.120000000000005 109.47 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.407 ' HE3' HG11 ' A' ' 568' ' ' VAL . 6.5 mmmm -86.28 120.28 27.46 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 123.744 0.818 . . . . 74.239999999999995 109.437 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 568' ' ' VAL . 47.9 t -100.65 122.88 53.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 109.184 -0.673 . . . . 61.109999999999999 109.184 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.1 mt -69.82 126.7 30.5 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.855 -0.611 . . . . 71.340000000000003 110.173 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.434 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 57.0 ttp180 -74.32 160.82 30.55 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.69 -1.141 . . . . 64.019999999999996 108.997 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.558 HG23 ' CD2' ' A' ' 505' ' ' PHE . 2.5 p -56.98 139.09 53.18 Favored 'General case' 0 N--CA 1.421 -1.881 0 C-N-CA 123.125 0.57 . . . . 73.200000000000003 111.843 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.9 m -51.07 -33.84 27.47 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.863 1.265 . . . . 73.109999999999999 110.059 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -119.78 107.39 1.33 Allowed Glycine 0 N--CA 1.416 -2.646 0 N-CA-C 108.456 -1.858 . . . . 72.519999999999996 108.456 171.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 564' ' ' ASN . . . -88.69 101.28 13.84 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.081 -0.711 . . . . 71.200000000000003 109.081 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -116.9 102.02 9.02 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.674 -0.694 . . . . 75.219999999999999 110.798 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 86.1 -157.33 30.58 Favored Glycine 0 C--N 1.311 -0.818 0 C-N-CA 120.826 -0.702 . . . . 43.439999999999998 112.87 174.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -107.0 127.69 53.68 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.606 -0.887 . . . . 70.140000000000001 108.606 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.21 141.68 45.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 C-N-CA 122.768 0.427 . . . . 52.140000000000001 109.981 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.592 HG12 ' CG2' ' A' ' 597' ' ' VAL . 42.4 mm -108.79 134.28 51.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.571 -0.9 . . . . 72.439999999999998 108.571 173.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.55 107.2 43.21 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 109.106 -0.701 . . . . 64.329999999999998 109.106 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -70.36 152.17 66.07 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.871 1.714 . . . . 53.030000000000001 110.999 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -148.52 157.88 43.76 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.674 -0.491 . . . . 64.120000000000005 109.674 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . 0.441 ' HE2' ' HB3' ' A' ' 590' ' ' GLU . 0.0 OUTLIER -158.11 152.6 24.67 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.914 0.759 . . . . 74.349999999999994 110.441 178.289 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.9 p -85.22 143.4 28.78 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.0 -0.545 . . . . 63.240000000000002 109.965 176.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.562 HD11 ' HB2' ' A' ' 590' ' ' GLU . 82.5 mt -105.59 122.2 58.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 108.368 -0.975 . . . . 73.430000000000007 108.368 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -81.45 145.35 30.81 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 123.754 0.659 . . . . 71.230000000000004 109.909 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -175.03 -99.76 0.12 Allowed Glycine 0 CA--C 1.483 -1.921 0 N-CA-C 111.038 -0.825 . . . . 51.109999999999999 111.038 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . 0.439 ' HB ' HG23 ' A' ' 586' ' ' THR . 0.9 OUTLIER -83.43 29.17 0.51 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.148 0.979 . . . . 74.310000000000002 110.37 -175.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.457 ' HA ' ' HD2' ' A' ' 585' ' ' LYS . . . -165.66 145.3 6.49 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.563 -1.643 . . . . 72.129999999999995 106.563 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -86.3 127.22 34.75 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 113.0 0.741 . . . . 74.230000000000004 113.0 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.79 -164.09 38.68 Favored Glycine 0 C--N 1.302 -1.324 0 CA-C-N 114.446 -1.252 . . . . 55.340000000000003 110.755 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.95 18.4 76.24 Favored Glycine 0 C--N 1.318 -0.441 0 CA-C-N 117.509 0.654 . . . . 73.430000000000007 112.796 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 75.71 44.8 19.25 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.627 -0.797 . . . . 71.540000000000006 111.133 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -114.75 -59.25 2.04 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.609 -0.436 . . . . 54.149999999999999 110.074 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -100.82 -37.12 8.83 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 107.417 -1.327 . . . . 73.239999999999995 107.417 171.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -141.38 150.88 42.97 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 114.661 -1.154 . . . . 75.510000000000005 107.939 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.58 113.67 20.45 Favored 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 106.446 -1.687 . . . . 52.409999999999997 106.446 174.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -76.21 131.89 39.59 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.752 -0.833 . . . . 61.119999999999997 108.752 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.9 t -128.34 148.21 50.67 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 121.688 0.756 . . . . 63.130000000000003 110.965 -172.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 25.3 p -141.39 151.39 43.44 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 106.294 -1.743 . . . . 74.400000000000006 106.294 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 171.48 -161.12 33.41 Favored Glycine 0 N--CA 1.417 -2.587 0 C-N-CA 119.972 -1.109 . . . . 63.340000000000003 110.978 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.537 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 47.1 mt-10 -139.39 130.96 27.17 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 122.497 0.319 . . . . 65.329999999999998 110.745 -176.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 98.7 mt -95.56 142.21 28.17 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.918 -0.771 . . . . 74.450000000000003 108.918 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -108.9 118.73 37.55 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.294 0.568 . . . . 74.530000000000001 110.824 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -117.53 156.49 27.97 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.538 -0.756 . . . . 65.200000000000003 109.51 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.498 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 47.3 mt-30 -148.54 178.74 8.36 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.118 -1.067 . . . . 52.119999999999997 108.118 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . 0.412 ' HA ' ' HB1' ' A' ' 531' ' ' ALA . 4.0 p-10 -67.83 -30.79 70.27 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.683 -0.858 . . . . 53.549999999999997 108.683 172.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -84.22 -44.86 13.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.228 -0.897 . . . . 74.140000000000001 110.429 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.498 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 70.5 mm-40 -65.72 136.97 56.95 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 123.587 0.755 . . . . 71.239999999999995 111.021 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.592 HG13 ' H ' ' A' ' 568' ' ' VAL . 9.5 pt -89.78 -92.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 114.055 1.131 . . . . 53.229999999999997 114.055 -177.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.592 ' H ' HG13 ' A' ' 567' ' ' ILE . 8.5 p -119.41 149.82 21.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.62 -0.511 . . . . 64.549999999999997 109.62 -176.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -115.1 157.05 24.1 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.175 -0.676 . . . . 63.119999999999997 109.175 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.6 p -122.5 137.75 54.78 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.232 -0.895 . . . . 54.149999999999999 110.925 177.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 24.3 mt -94.71 118.98 42.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 107.898 -1.149 . . . . 75.319999999999993 107.898 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 11.8 p -94.66 115.61 27.75 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 124.002 0.814 . . . . 72.010000000000005 110.611 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 89.2 t -119.79 129.61 75.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 CA-C-O 120.712 0.291 . . . . 63.420000000000002 110.46 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.543 ' HE3' HD11 ' A' ' 520' ' ' ILE . 4.1 tppp? -83.88 119.08 24.44 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.844 0.857 . . . . 64.140000000000001 110.158 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 29.9 t -88.49 121.78 39.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 106.03 -1.841 . . . . 74.439999999999998 106.03 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 48.3 mm . . . . . 0 C--N 1.304 -1.396 0 CA-C-O 121.241 0.543 . . . . 64.430000000000007 111.191 -173.191 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.457 ' HD2' ' HA ' ' A' ' 546' ' ' ALA . 38.5 mmtm . . . . . 0 C--O 1.21 -1.015 0 N-CA-C 110.282 -0.266 . . . . 73.140000000000001 110.282 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . 0.439 HG23 ' HB ' ' A' ' 545' ' ' THR . 5.0 t -156.65 136.6 12.63 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.188 0.518 . . . . 74.109999999999999 111.27 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -131.6 179.13 6.23 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.325 -0.991 . . . . 73.219999999999999 108.325 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.519 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 82.1 m-85 -125.2 155.33 40.2 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 109.19 -0.671 . . . . 64.310000000000002 109.19 -176.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.2 OUTLIER -121.51 131.1 53.95 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.613 -1.625 . . . . 63.32 106.613 178.113 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.562 ' HB2' HD11 ' A' ' 542' ' ' ILE . 33.4 tt0 -126.0 137.43 53.66 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.547 -0.538 . . . . 73.010000000000005 109.547 176.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 14.9 pt -104.53 142.1 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.175 0 N-CA-C 107.772 -1.195 . . . . 72.430000000000007 107.772 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.37 176.4 49.98 Favored Glycine 0 N--CA 1.414 -2.795 0 N-CA-C 110.398 -1.081 . . . . 74.099999999999994 110.398 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.97 128.62 92.71 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-O 120.883 0.373 . . . . 75.340000000000003 111.047 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.405 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 27.8 Cg_endo -61.13 128.24 24.61 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.728 2.952 . . . . 72.209999999999994 112.521 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -110.23 119.04 37.97 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.316 -0.856 . . . . 71.409999999999997 109.81 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.17 134.31 53.45 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.415 -0.957 . . . . 73.010000000000005 108.415 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.592 ' CG2' HG12 ' A' ' 536' ' ' ILE . 34.7 t . . . . . 0 C--N 1.298 -1.652 0 CA-C-O 121.396 0.617 . . . . 72.420000000000002 109.853 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.468 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 43.9 Cg_endo . . . . . 0 N--CA 1.457 -0.669 0 N-CA-C 110.252 -0.711 . . . . 62.009999999999998 110.252 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.86 162.87 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 108.928 -0.767 . . . . 74.519999999999996 108.928 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.548 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.8 OUTLIER -96.89 166.57 11.56 Favored 'General case' 0 N--CA 1.424 -1.733 0 C-N-CA 119.377 -0.929 . . . . 63.299999999999997 111.813 178.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.513 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -69.36 -168.25 5.86 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 116.182 1.233 . . . . 62.549999999999997 116.182 -175.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -70.83 -39.5 72.98 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.085 -1.058 . . . . 65.120000000000005 108.452 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -138.73 121.92 16.94 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.354 -0.839 . . . . 55.329999999999998 110.05 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . 0.548 HG21 ' HB2' ' A' ' 636' ' ' LEU . 17.8 p -121.92 92.87 3.83 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.789 -0.641 . . . . 73.450000000000003 109.735 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -161.95 143.01 10.75 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.627 -1.249 . . . . 72.319999999999993 107.627 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.579 HD22 HG11 ' A' ' 523' ' ' VAL . 16.4 tp -128.69 125.7 38.56 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 107.726 -1.212 . . . . 71.299999999999997 107.726 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -93.86 111.48 23.19 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.098 -1.445 . . . . 64.140000000000001 107.098 176.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.86 113.56 39.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.208 -0.664 . . . . 71.219999999999999 109.208 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 38.3 mt -100.43 128.62 52.28 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.554 0 N-CA-C 108.298 -1.001 . . . . 73.540000000000006 108.298 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 57.9 mt -104.51 107.61 22.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 106.894 -1.521 . . . . 54.140000000000001 106.894 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 C--N 1.29 -2.014 0 C-N-CA 120.327 -0.549 . . . . 74.430000000000007 111.934 179.464 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 502' ' ' ALA . . . . . 0.491 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.438 -1.07 0 N-CA-C 113.864 1.061 . . . . 62.119999999999997 113.864 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.433 ' HA3' ' H ' ' A' ' 529' ' ' SER . . . 159.32 -135.42 4.16 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 118.383 -1.865 . . . . 61.240000000000002 113.145 -173.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.4 120.08 55.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 122.075 0.15 . . . . 73.420000000000002 110.968 -173.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.445 ' CE2' ' HB ' ' A' ' 528' ' ' THR . 23.8 m-85 -108.68 126.53 53.09 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.25 -1.019 . . . . 72.099999999999994 108.25 169.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.6 t -171.2 -178.82 2.51 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.671 -0.863 . . . . 75.140000000000001 108.671 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -87.79 152.12 22.36 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 110.444 -0.206 . . . . 73.409999999999997 110.444 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -59.64 -41.11 89.78 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.648 0.737 . . . . 74.010000000000005 110.165 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -135.16 146.59 58.91 Favored Pre-proline 0 N--CA 1.42 -1.96 0 CA-C-N 114.741 -1.118 . . . . 73.420000000000002 108.227 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -71.08 -29.89 17.08 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.167 1.911 . . . . 74.310000000000002 112.665 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.13 136.79 55.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.639 -0.874 . . . . 54.329999999999998 108.639 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.2 t -133.65 141.24 47.53 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 108.39 -0.966 . . . . 74.329999999999998 108.39 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -109.44 132.94 53.66 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.073 -1.051 . . . . 54.240000000000002 109.352 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.3 m -124.34 165.99 20.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 109.044 -0.724 . . . . 73.200000000000003 109.044 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.539 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 72.4 m -93.78 152.61 18.81 Favored 'General case' 0 N--CA 1.394 -3.25 0 CA-C-N 115.649 -0.705 . . . . 75.430000000000007 110.774 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . 0.428 ' HA ' HG11 ' A' ' 575' ' ' VAL . 1.8 tm-20 -68.22 -56.74 7.62 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.623 0.725 . . . . 65.030000000000001 109.073 173.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.69 40.68 0.6 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 125.121 1.368 . . . . 65.519999999999996 111.69 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 12.0 tt -104.71 -26.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.155 0.503 . . . . 60.32 111.73 -175.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . 0.437 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 91.76 -79.06 1.28 Allowed Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 110.839 -0.904 . . . . 65.230000000000004 110.839 -175.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 37.2 mm -129.79 133.45 64.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.674 -1.232 . . . . 75.099999999999994 107.674 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.584 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -109.91 146.5 35.06 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.445 -0.946 . . . . 74.120000000000005 108.445 175.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 26.4 mt-10 -125.7 120.12 29.83 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 123.645 0.591 . . . . 74.530000000000001 111.544 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.584 HG23 ' SD ' ' A' ' 521' ' ' MET . 65.9 t -112.55 129.23 68.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.628 -0.878 . . . . 74.329999999999998 108.628 177.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.613 ' HB3' HG21 ' A' ' 568' ' ' VAL . 29.1 mtmt -86.76 143.13 27.67 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 123.808 0.692 . . . . 75.329999999999998 110.698 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.546 ' O ' HG23 ' A' ' 568' ' ' VAL . 43.3 t -105.02 141.63 19.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.755 -0.657 . . . . 74.519999999999996 109.322 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.96 118.51 17.99 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.69 -0.856 . . . . 74.150000000000006 108.69 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -73.76 153.21 40.1 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.072 -0.714 . . . . 71.409999999999997 109.072 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.445 ' HB ' ' CE2' ' A' ' 505' ' ' PHE . 12.0 t -60.16 157.52 13.07 Favored 'General case' 0 N--CA 1.41 -2.435 0 C-N-CA 123.857 0.863 . . . . 72.239999999999995 110.727 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . 0.433 ' H ' ' HA3' ' A' ' 503' ' ' GLY . 47.0 t -72.01 -26.95 62.42 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.711 0.767 . . . . 60.109999999999999 109.775 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.85 82.91 0.33 Allowed Glycine 0 N--CA 1.428 -1.842 0 CA-C-N 115.688 -0.687 . . . . 73.349999999999994 111.486 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.64 100.31 13.18 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.655 -1.239 . . . . 73.540000000000006 107.655 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.42 ' HD3' ' HA ' ' A' ' 532' ' ' ARG . 39.2 mmt180 -111.86 96.84 6.29 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.627 0.727 . . . . 55.299999999999997 111.882 -176.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 101.96 -122.84 7.69 Favored Glycine 0 N--CA 1.428 -1.859 0 CA-C-N 114.576 -1.193 . . . . 72.129999999999995 110.417 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.472 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.5 t-20 -133.13 127.98 35.09 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.13 0.49 . . . . 52.43 110.295 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 64.5 t -130.39 136.54 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 108.837 -0.801 . . . . 72.010000000000005 108.837 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.521 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 40.3 mm -106.69 138.46 32.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 109.088 -0.708 . . . . 72.450000000000003 109.088 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.1 t -122.91 110.08 31.66 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 109.598 -0.519 . . . . 65.219999999999999 109.598 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.28 155.19 51.56 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.362 2.041 . . . . 71.409999999999997 111.903 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.456 ' HB3' HG22 ' A' ' 591' ' ' ILE . 31.5 p90 -150.84 156.15 40.66 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 110.153 -0.314 . . . . 55.340000000000003 110.153 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.59 156.21 40.93 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 123.714 0.634 . . . . 73.030000000000001 111.922 175.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 18.9 p -79.35 153.59 29.68 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 109.373 -0.603 . . . . 71.219999999999999 109.373 175.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 81.8 mt -117.54 113.91 43.95 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 107.313 -1.365 . . . . 74.420000000000002 107.313 176.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -84.2 147.58 27.21 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.305 -0.861 . . . . 75.400000000000006 108.732 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 178.31 -91.82 0.08 OUTLIER Glycine 0 C--N 1.307 -1.046 0 C-N-CA 120.601 -0.809 . . . . 73.409999999999997 111.526 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -2.6 30.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.679 0.752 . . . . 74.040000000000006 112.045 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 587' ' ' PHE . . . -144.43 141.52 29.68 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 104.536 -2.394 . . . . 31.010000000000002 104.536 171.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.498 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 71.9 mtt180 -104.05 145.69 29.81 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 121.912 0.863 . . . . 50.43 112.635 -173.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.73 -153.23 27.83 Favored Glycine 0 N--CA 1.421 -2.303 0 N-CA-C 109.371 -1.492 . . . . 63.25 109.371 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . 0.409 ' H ' ' CG ' ' A' ' 555' ' ' ASP . . . 78.0 8.75 87.3 Favored Glycine 0 C--N 1.292 -1.891 0 N-CA-C 111.429 -0.668 . . . . 65.239999999999995 111.429 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 79.05 29.6 50.36 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 110.647 -0.981 . . . . 73.099999999999994 110.647 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.498 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 32.1 tt0 -96.86 -60.99 1.48 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.712 -0.477 . . . . 64.109999999999999 109.712 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -103.3 -43.71 5.36 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 108.609 -0.886 . . . . 72.420000000000002 108.609 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -135.11 158.1 45.23 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.377 -0.829 . . . . 65.439999999999998 109.013 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.471 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 13.9 tt0 -84.19 138.3 33.06 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.604 -1.258 . . . . 71.239999999999995 107.604 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 549' ' ' GLY . 7.5 m-20 -71.81 121.19 18.53 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 109.682 -0.488 . . . . 61.520000000000003 109.682 -177.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.489 HG21 HG22 ' A' ' 573' ' ' VAL . 13.5 t -130.13 146.11 51.75 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-O 121.468 0.651 . . . . 73.099999999999994 109.411 176.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 5.0 p -167.52 155.27 8.94 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.973 -1.492 . . . . 73.319999999999993 106.973 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 165.01 -153.44 23.63 Favored Glycine 0 N--CA 1.41 -3.086 0 C-N-CA 119.789 -1.196 . . . . 72.340000000000003 110.484 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.521 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 46.7 mt-10 -139.55 133.09 30.31 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.117 0.484 . . . . 72.439999999999998 110.466 -175.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' ' 569' ' ' LYS . 96.5 mt -97.36 137.91 35.62 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.827 -0.624 . . . . 71.219999999999999 109.468 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.485 ' HA ' HD13 ' A' ' 536' ' ' ILE . 33.3 tt0 -99.18 115.47 29.16 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 121.203 0.525 . . . . 45.109999999999999 110.706 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -111.63 145.05 39.89 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.604 -0.887 . . . . 74.340000000000003 108.604 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.495 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 46.7 mt-30 -147.25 -176.3 5.17 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.582 -0.896 . . . . 73.230000000000004 108.582 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -68.4 -31.69 71.21 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.452 -0.944 . . . . 55.049999999999997 108.452 172.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -84.49 -38.39 20.15 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.572 -1.195 . . . . 61.43 111.671 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.495 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 36.5 mm-40 -75.67 129.33 36.96 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 116.674 -0.239 . . . . 74.030000000000001 111.064 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.584 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.8 pt -90.02 -72.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.897 -0.592 . . . . 55.399999999999999 111.804 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' ' 524' ' ' LYS . 12.5 p -130.96 149.23 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 CA-C-O 121.204 0.526 . . . . 54.329999999999998 110.347 -177.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.537 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -120.29 156.43 31.26 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 109.387 -0.597 . . . . 74.530000000000001 109.387 175.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.442 ' CG2' ' HG2' ' A' ' 524' ' ' LYS . 3.3 p -119.81 147.28 44.84 Favored 'General case' 0 C--N 1.283 -2.285 0 O-C-N 124.161 0.913 . . . . 43.329999999999998 112.721 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.2 mp -94.41 122.6 46.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 106.353 -1.721 . . . . 74.049999999999997 106.353 172.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 521' ' ' MET . 18.7 m -102.94 116.81 33.27 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 123.813 0.696 . . . . 62.140000000000001 109.127 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.489 HG22 HG21 ' A' ' 556' ' ' THR . 86.2 t -119.47 128.46 75.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 109.144 -0.688 . . . . 73.340000000000003 109.144 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 23.9 tptm -83.97 124.1 30.68 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.752 -0.832 . . . . 75.540000000000006 108.752 176.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 516' ' ' GLU . 47.9 t -94.26 127.36 46.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 108.61 -0.885 . . . . 72.230000000000004 108.61 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 45.5 mm . . . . . 0 C--N 1.304 -1.37 0 N-CA-C 108.658 -0.867 . . . . 71.409999999999997 108.658 -178.517 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp . . . . . 0 C--O 1.211 -0.949 0 CA-C-O 121.152 0.501 . . . . 73.5 111.098 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.0 t -153.32 135.73 15.04 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 109.48 -0.563 . . . . 70.310000000000002 109.48 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.407 ' HB3' ' HB3' ' A' ' 546' ' ' ALA . 40.9 p90 -129.37 178.1 6.69 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.786 -1.19 . . . . 72.120000000000005 107.786 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.55 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 67.4 m-85 -123.43 154.59 38.84 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.806 -0.813 . . . . 75.319999999999993 108.806 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.81 131.3 53.56 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 106.191 -1.781 . . . . 53.32 106.191 178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.508 ' HB2' HD11 ' A' ' 542' ' ' ILE . 42.6 tt0 -126.97 139.06 53.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.589 -0.523 . . . . 72.510000000000005 109.589 177.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.456 HG22 ' HB3' ' A' ' 539' ' ' TYR . 20.3 pt -106.0 141.57 21.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.322 -0.992 . . . . 75.010000000000005 108.322 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.12 179.54 49.67 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 111.236 -0.746 . . . . 72.140000000000001 111.236 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.78 134.26 86.08 Favored Pre-proline 0 N--CA 1.435 -1.225 0 C-N-CA 120.912 -0.315 . . . . 73.519999999999996 110.632 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.415 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 21.7 Cg_endo -61.36 146.94 96.72 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.255 2.636 . . . . 74.230000000000004 112.064 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -124.47 125.04 43.6 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.024 -0.534 . . . . 71.219999999999999 109.562 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -72.08 129.17 37.86 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.664 -1.236 . . . . 75.129999999999995 107.664 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.51 ' CG2' HG12 ' A' ' 536' ' ' ILE . 48.6 t . . . . . 0 C--N 1.3 -1.56 0 N-CA-C 108.766 -0.827 . . . . 65.049999999999997 108.766 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.491 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 53.3 Cg_endo . . . . . 0 N--CA 1.444 -1.435 0 N-CA-C 110.922 -0.453 . . . . 65.319999999999993 110.922 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . 0.501 HD13 ' H ' ' A' ' 635' ' ' ILE . 0.1 OUTLIER -124.95 175.93 6.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.535 -0.913 . . . . 42.420000000000002 108.535 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.59 -176.3 3.03 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.267 -0.573 . . . . 73.519999999999996 112.086 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -80.62 -153.39 9.21 Favored Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 115.893 -0.594 . . . . 42.020000000000003 113.351 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . 0.515 ' HG2' ' CD2' ' A' ' 639' ' ' HIS . 37.4 tt0 -71.87 -57.13 4.59 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 123.392 0.677 . . . . 71.430000000000007 110.224 -177.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . 0.515 ' CD2' ' HG2' ' A' ' 638' ' ' GLU . 96.6 m-70 -135.06 139.13 44.53 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 109.556 -0.535 . . . . 72.549999999999997 109.556 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 29.7 p -124.47 99.83 6.38 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.206 0.526 . . . . 73.310000000000002 111.249 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -165.8 150.73 8.57 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.082 -1.081 . . . . 74.420000000000002 108.082 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.479 HD21 HG21 ' A' ' 523' ' ' VAL . 34.8 tp -130.95 131.34 44.37 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.021 -1.103 . . . . 44.32 108.021 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -97.04 104.52 16.54 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.915 -1.513 . . . . 74.519999999999996 106.915 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 40.8 t -99.47 113.53 34.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 109.982 -0.377 . . . . 74.540000000000006 109.982 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 59.6 mt -99.11 126.97 52.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 109.027 -0.731 . . . . 52.039999999999999 109.027 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 57.2 mt -104.06 110.39 30.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.264 -1.013 . . . . 75.439999999999998 108.264 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 C--N 1.288 -2.068 0 CA-C-N 116.443 -0.344 . . . . 72.010000000000005 110.241 178.136 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 502' ' ' ALA . . . . . 0.54 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.421 -1.925 0 N-CA-C 111.656 0.243 . . . . 75.349999999999994 111.656 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 160.94 -153.24 24.05 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 111.241 -0.743 . . . . 74.340000000000003 111.241 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.86 130.94 67.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 123.148 0.579 . . . . 72.340000000000003 112.049 -167.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -108.51 132.57 53.69 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.315 -0.624 . . . . 63.509999999999998 109.315 168.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.7 t -168.69 173.72 7.1 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.405 -0.591 . . . . 63.409999999999997 109.405 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -77.25 147.26 36.43 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 120.939 0.399 . . . . 73.200000000000003 110.751 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -67.98 -35.65 78.72 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.487 -0.779 . . . . 61.350000000000001 109.906 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -127.76 144.4 51.12 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.115 -1.069 . . . . 74.010000000000005 108.115 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.03 -31.34 6.24 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.146 1.897 . . . . 73.540000000000006 111.986 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.97 138.04 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 106.511 -1.663 . . . . 72.129999999999995 106.511 -177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.4 t -132.19 140.82 48.86 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 108.06 -1.089 . . . . 55.219999999999999 108.06 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -120.28 124.19 45.03 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 109.253 -0.647 . . . . 74.209999999999994 109.253 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.8 m -115.7 167.34 8.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.001 -1.0 . . . . 75.239999999999995 109.398 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.631 ' O ' HG22 ' A' ' 518' ' ' ILE . 23.2 t -97.04 153.89 17.65 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 120.96 0.41 . . . . 64.409999999999997 110.229 -176.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -65.51 -42.2 92.35 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.143 -1.429 . . . . 74.129999999999995 107.143 169.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.4 m -90.66 23.98 2.85 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.995 -1.002 . . . . 64.420000000000002 112.432 -173.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 515' ' ' SER . 8.8 tt -90.94 -22.08 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 121.575 -0.703 . . . . 75.430000000000007 109.825 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 83.97 -75.6 2.35 Favored Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.677 -0.773 . . . . 71.310000000000002 111.234 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.0 mm -129.83 130.2 66.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 106.983 -1.488 . . . . 62.509999999999998 106.983 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.616 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -106.39 147.34 29.38 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 109.131 -0.692 . . . . 74.5 109.131 178.612 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.3 mt-10 -127.91 114.84 17.69 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 123.852 0.72 . . . . 54.439999999999998 110.945 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.55 HG21 HD21 ' A' ' 642' ' ' LEU . 90.7 t -102.33 127.96 55.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.778 -0.823 . . . . 73.099999999999994 108.778 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.409 ' HB3' HG21 ' A' ' 568' ' ' VAL . 25.7 mtmm -87.6 138.91 31.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 121.442 0.639 . . . . 53.240000000000002 110.667 -177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 61.0 t -108.2 129.93 61.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.443 -0.799 . . . . 63.299999999999997 108.847 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.5 130.01 41.77 Favored 'General case' 0 CA--C 1.501 -0.915 0 O-C-N 123.862 0.726 . . . . 74.109999999999999 109.87 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -82.65 155.1 24.56 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 115.151 -0.931 . . . . 74.239999999999995 110.024 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.2 t -56.05 145.48 25.51 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 124.763 1.225 . . . . 64.200000000000003 111.538 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.9 t -60.53 -31.77 70.84 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 124.375 1.07 . . . . 70.420000000000002 109.042 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -122.26 99.51 0.67 Allowed Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 109.71 -1.356 . . . . 53.439999999999998 109.71 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.44 101.6 12.76 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.948 -1.13 . . . . 63.5 107.948 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -107.75 100.77 10.13 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.261 -0.881 . . . . 52.030000000000001 110.389 -172.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 75.53 -114.68 4.33 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.395 -0.907 . . . . 62.439999999999998 112.36 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.444 HD22 ' HG2' ' A' ' 563' ' ' GLN . 2.7 t-20 -133.99 129.18 35.8 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.143 0.577 . . . . 72.109999999999999 109.459 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 93.1 t -130.24 135.64 60.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 C-N-CA 123.56 0.744 . . . . 51.340000000000003 109.126 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.502 HG12 ' CG2' ' A' ' 597' ' ' VAL . 38.0 mm -108.74 131.25 59.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.88 -0.415 . . . . 63.399999999999999 109.88 176.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.43 HG22 ' HB3' ' A' ' 594' ' ' PRO . 26.6 t -119.23 105.9 43.79 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 109.21 -0.663 . . . . 75.109999999999999 109.21 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.86 153.19 58.57 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.317 2.011 . . . . 72.439999999999998 112.048 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.487 ' HB3' HG22 ' A' ' 591' ' ' ILE . 52.1 p90 -151.02 159.64 44.42 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.642 0.258 . . . . 72.140000000000001 110.786 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.03 157.05 33.94 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.463 -0.79 . . . . 75.340000000000003 112.084 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.6 p -84.86 139.68 31.71 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.866 -0.607 . . . . 75.120000000000005 109.828 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.528 HD11 ' HB2' ' A' ' 590' ' ' GLU . 69.1 mt -107.63 134.37 49.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.132 -0.692 . . . . 71.439999999999998 109.132 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -85.62 142.97 28.71 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.923 -0.58 . . . . 62.310000000000002 110.337 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 151.77 141.58 3.35 Favored Glycine 0 CA--C 1.471 -2.678 0 N-CA-C 107.924 -2.07 . . . . 61.310000000000002 107.924 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . 0.357 1.0 OUTLIER 61.11 -47.17 0.12 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 115.377 1.621 . . . . 64.409999999999997 115.377 -174.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.451 ' HA ' ' HD2' ' A' ' 585' ' ' LYS . . . -107.87 150.38 27.12 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.193 -1.04 . . . . 75.319999999999993 108.193 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -92.37 128.74 38.33 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.745 0.783 . . . . 75.209999999999994 111.347 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.78 -153.5 21.68 Favored Glycine 0 C--N 1.3 -1.421 0 CA-C-N 115.056 -0.975 . . . . 52.210000000000001 112.96 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . 0.467 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 57.12 30.84 61.24 Favored Glycine 0 C--N 1.317 -0.48 0 N-CA-C 113.76 0.264 . . . . 65.230000000000004 113.76 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 73.31 39.68 50.98 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.735 -0.745 . . . . 70.150000000000006 111.991 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -112.88 -51.77 2.81 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 122.363 -0.492 . . . . 74.340000000000003 110.869 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -111.14 -35.31 5.93 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.385 -1.339 . . . . 74.519999999999996 107.385 169.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -139.54 148.94 43.29 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.781 -1.192 . . . . 74.420000000000002 107.781 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.77 136.0 37.26 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.337 -1.357 . . . . 72.230000000000004 107.337 175.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . 0.467 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 17.5 t70 -90.69 119.9 31.31 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.592 -0.521 . . . . 63.329999999999998 109.592 -174.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.403 HG21 HG22 ' A' ' 573' ' ' VAL . 10.3 t -128.02 155.03 44.97 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.263 0.554 . . . . 64.120000000000005 111.04 -174.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 26.4 p -149.79 158.37 44.11 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.955 -1.498 . . . . 73.109999999999999 106.955 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 168.78 -167.7 40.57 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 109.893 -1.283 . . . . 74.400000000000006 109.893 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.478 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 43.6 mt-10 -132.64 138.42 47.34 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.804 -0.443 . . . . 70.040000000000006 109.804 -178.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.595 HD22 ' HB3' ' A' ' 569' ' ' LYS . 76.6 mt -95.7 133.93 39.22 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.726 -0.472 . . . . 44.340000000000003 109.726 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.495 ' HA ' HD13 ' A' ' 536' ' ' ILE . 24.8 tt0 -101.25 106.43 17.64 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.847 -0.615 . . . . 72.219999999999999 110.279 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -105.04 148.22 27.01 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.007 -0.738 . . . . 73.340000000000003 109.007 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.484 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 8.8 mt-30 -145.02 -178.04 5.84 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.944 -1.132 . . . . 72.109999999999999 107.944 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -68.84 -31.89 71.19 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.117 -1.068 . . . . 72.099999999999994 108.117 173.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.42 -52.33 7.79 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.109 -0.95 . . . . 71.409999999999997 111.809 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.484 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 14.7 mm-40 -55.25 125.62 21.45 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 123.449 0.7 . . . . 70.239999999999995 111.743 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.613 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.7 pt -84.63 -63.03 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.266 -0.879 . . . . 73.209999999999994 112.646 -175.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.613 ' H ' HG13 ' A' ' 567' ' ' ILE . 10.0 p -143.48 150.57 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 109.213 -0.662 . . . . 41.439999999999998 109.213 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.595 ' HB3' HD22 ' A' ' 560' ' ' LEU . 6.1 mmpt? -118.05 165.57 13.58 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.728 -0.471 . . . . 71.010000000000005 109.728 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.6 p -135.14 147.43 49.47 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 123.962 0.789 . . . . 45.329999999999998 112.363 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.463 HG22 HG23 ' A' ' 573' ' ' VAL . 3.0 mp -100.47 118.1 46.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 106.941 -1.503 . . . . 62.549999999999997 106.941 172.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . 0.616 ' HA ' ' O ' ' A' ' 521' ' ' MET . 3.3 p -95.95 117.0 29.78 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 124.099 0.874 . . . . 55.409999999999997 110.399 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.463 HG23 HG22 ' A' ' 571' ' ' ILE . 89.0 t -124.79 132.17 71.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 O-C-N 122.239 -0.288 . . . . 62.439999999999998 110.792 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -79.62 123.0 27.22 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 123.856 0.723 . . . . 73.010000000000005 109.703 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 49.0 t -90.2 126.96 43.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.555 -0.905 . . . . 65.540000000000006 108.555 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 26.2 mm . . . . . 0 C--N 1.315 -0.93 0 N-CA-C 109.9 -0.407 . . . . 71.409999999999997 109.9 -177.682 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.451 ' HD2' ' HA ' ' A' ' 546' ' ' ALA . 34.5 mmtp . . . . . 0 N--CA 1.422 -1.838 0 CA-C-O 121.448 0.642 . . . . 75.030000000000001 110.087 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.7 t -150.0 146.89 27.26 Favored 'General case' 0 N--CA 1.402 -2.872 0 CA-C-N 114.696 -1.138 . . . . 44.140000000000001 107.93 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -138.03 178.77 6.87 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.788 -1.19 . . . . 74.030000000000001 107.788 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.455 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 85.5 m-85 -121.03 152.03 39.09 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.188 -0.605 . . . . 71.030000000000001 109.954 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.45 131.02 54.57 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.032 -1.84 . . . . 71.209999999999994 106.032 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.528 ' HB2' HD11 ' A' ' 542' ' ' ILE . 36.8 tt0 -127.69 136.31 51.39 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.065 0.459 . . . . 75.310000000000002 110.316 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.487 HG22 ' HB3' ' A' ' 539' ' ' TYR . 23.8 pt -105.56 142.45 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.12 0 N-CA-C 107.547 -1.279 . . . . 74.340000000000003 107.547 175.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -88.17 -176.0 47.68 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.665 -0.974 . . . . 60.109999999999999 110.665 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.47 130.38 89.19 Favored Pre-proline 0 C--N 1.301 -1.541 0 CA-C-O 120.809 0.338 . . . . 73.310000000000002 110.931 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.43 ' HB3' HG22 ' A' ' 537' ' ' VAL . 34.6 Cg_endo -66.97 130.88 23.98 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.103 2.535 . . . . 64.310000000000002 111.335 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -111.88 134.34 53.5 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.936 -0.394 . . . . 74.129999999999995 109.936 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.424 HD23 ' HD3' ' A' ' 634' ' ' PRO . 1.7 tm? -72.56 132.1 43.35 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.485 -1.302 . . . . 54.130000000000003 107.485 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.502 ' CG2' HG12 ' A' ' 536' ' ' ILE . 47.5 t . . . . . 0 C--N 1.302 -1.49 0 N-CA-C 109.146 -0.687 . . . . 40.399999999999999 109.146 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.54 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 36.2 Cg_endo . . . . . 0 N--CA 1.451 -1.02 0 N-CA-C 110.111 -0.765 . . . . 54.25 110.111 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.64 174.6 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 116.227 -0.442 . . . . 53.049999999999997 110.722 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.65 172.58 6.81 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 120.184 -0.607 . . . . 72.540000000000006 112.507 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -82.68 -164.86 35.95 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 115.166 0.826 . . . . 64.5 115.166 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -67.91 -50.19 57.63 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.965 -1.117 . . . . 75.120000000000005 110.514 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -129.06 120.64 26.31 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.946 -0.761 . . . . 73.439999999999998 108.946 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 14.0 p -118.68 80.76 1.59 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 122.567 1.175 . . . . 52.539999999999999 110.293 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -154.44 141.79 19.6 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 114.057 -1.428 . . . . 61.5 108.889 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.55 HD21 HG21 ' A' ' 523' ' ' VAL . 33.4 tp -129.93 122.96 29.59 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 108.787 -0.82 . . . . 72.140000000000001 108.787 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -92.54 112.32 24.23 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.132 -1.433 . . . . 73.310000000000002 107.132 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.68 110.33 28.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.514 -0.55 . . . . 54.109999999999999 109.514 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 50.5 mt -96.47 135.37 30.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 109.332 -0.618 . . . . 72.230000000000004 109.332 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 84.8 mt -103.05 110.01 28.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 109.034 -0.728 . . . . 73.25 109.034 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 C--N 1.289 -2.038 0 N-CA-C 108.202 -1.036 . . . . 74.519999999999996 108.202 176.855 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 502' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.428 -1.57 0 N-CA-C 108.921 -0.77 . . . . 75.120000000000005 108.921 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -172.26 -144.36 4.5 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 109.595 -1.402 . . . . 12.539999999999999 109.595 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.6 mp -103.53 114.29 42.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 116.79 0.295 . . . . 73.439999999999998 111.522 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -100.16 126.4 46.42 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.401 -0.963 . . . . 64.140000000000001 108.401 169.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.0 t -169.88 174.41 5.64 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.902 -0.777 . . . . 75.540000000000006 108.902 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -80.55 147.83 30.63 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 110.325 -0.25 . . . . 73.430000000000007 110.325 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -63.5 -40.78 97.96 Favored 'General case' 0 CA--C 1.492 -1.282 0 CA-C-O 122.238 1.018 . . . . 75.5 109.083 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -123.28 135.71 26.29 Favored Pre-proline 0 N--CA 1.401 -2.904 0 CA-C-N 113.948 -1.478 . . . . 73.540000000000006 107.218 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.34 -24.84 11.91 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.806 2.337 . . . . 45.549999999999997 111.519 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 61.7 t -136.25 132.99 49.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 107.142 -1.429 . . . . 75.140000000000001 107.142 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 7.1 t -128.48 133.07 48.4 Favored 'General case' 0 N--CA 1.402 -2.828 0 N-CA-C 108.569 -0.9 . . . . 44.130000000000003 108.569 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -105.8 121.87 44.92 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 109.045 -0.724 . . . . 74.019999999999996 109.045 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.6 m -113.56 174.52 2.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.418 -0.586 . . . . 64.510000000000005 109.418 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.634 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 57.9 m -92.43 165.6 12.97 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 123.254 0.621 . . . . 71.140000000000001 110.993 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.99 -50.72 10.66 Favored 'General case' 0 CA--C 1.57 1.74 0 C-N-CA 124.789 1.236 . . . . 74.430000000000007 112.918 -175.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 48.9 m -105.89 27.32 8.65 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.05 0.94 . . . . 60.149999999999999 110.448 -176.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.634 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 12.1 tt -63.25 -32.92 58.19 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-N 115.447 -0.797 . . . . 74.25 112.831 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 103.79 -83.8 0.42 Allowed Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 109.927 -1.269 . . . . 74.310000000000002 109.927 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 574' ' ' LYS . 34.8 mm -133.9 136.57 53.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 105.979 -1.859 . . . . 61.520000000000003 105.979 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.524 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -112.96 141.5 46.72 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.45 -0.574 . . . . 75.439999999999998 109.45 177.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 7.3 mp0 -114.55 132.55 56.28 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 124.194 0.934 . . . . 74.519999999999996 110.08 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.524 HG23 ' SD ' ' A' ' 521' ' ' MET . 87.7 t -124.06 129.09 74.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 108.746 -0.835 . . . . 64.230000000000004 108.746 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.472 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 24.6 mtmm -86.51 139.07 31.22 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.146 0.498 . . . . 73.450000000000003 111.898 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.575 ' O ' HG23 ' A' ' 568' ' ' VAL . 39.6 t -104.18 126.26 58.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.255 -0.646 . . . . 74.439999999999998 109.255 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.18 121.46 12.59 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 123.777 0.673 . . . . 75.420000000000002 110.206 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.523 ' CZ ' ' HB3' ' A' ' 562' ' ' PHE . 10.2 tpt180 -68.93 148.37 50.29 Favored 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 115.198 -0.91 . . . . 71.109999999999999 110.91 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 11.4 p -56.97 139.1 53.12 Favored 'General case' 0 N--CA 1.408 -2.525 0 CA-C-N 114.749 -1.114 . . . . 74.120000000000005 111.916 175.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.7 m -56.19 -24.4 41.39 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 125.777 1.631 . . . . 73.109999999999999 110.746 175.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -122.99 114.25 2.37 Favored Glycine 0 N--CA 1.419 -2.446 0 N-CA-C 108.842 -1.703 . . . . 51.32 108.842 172.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -106.14 101.26 10.76 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.91 -0.774 . . . . 44.240000000000002 108.91 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -129.73 116.2 18.42 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.966 -0.561 . . . . 62.039999999999999 109.748 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 78.26 -164.64 51.3 Favored Glycine 0 C--N 1.316 -0.571 0 C-N-CA 120.901 -0.666 . . . . 61.329999999999998 112.379 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.59 ' ND2' ' HG2' ' A' ' 563' ' ' GLN . 2.5 t-20 -103.47 123.08 46.23 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.244 0.545 . . . . 73.340000000000003 109.878 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 48.1 t -126.48 136.97 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 N-CA-C 108.071 -1.085 . . . . 72.239999999999995 108.071 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.508 HG12 ' CG2' ' A' ' 597' ' ' VAL . 40.2 mm -107.98 135.29 47.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 109.205 -0.665 . . . . 71.129999999999995 109.205 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.51 109.74 36.23 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 109.232 -0.655 . . . . 70.049999999999997 109.232 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -75.9 159.24 38.26 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.124 1.883 . . . . 34.210000000000001 111.45 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -143.92 162.83 35.13 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.233 -0.655 . . . . 73.129999999999995 109.233 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -153.39 157.23 39.67 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 123.882 0.738 . . . . 73.329999999999998 109.739 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.3 p -93.41 139.25 30.9 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.626 0.727 . . . . 72.239999999999995 111.605 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 89.7 mt -109.53 122.74 64.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.573 -1.269 . . . . 71.329999999999998 107.573 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -78.81 117.73 20.2 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.677 -0.49 . . . . 53.409999999999997 109.677 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -102.85 -111.58 3.56 Favored Glycine 0 C--N 1.302 -1.355 0 N-CA-C 109.892 -1.283 . . . . 70.150000000000006 109.892 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 28.4 p -78.93 -32.63 45.66 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.508 -0.923 . . . . 64.319999999999993 108.508 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -84.46 141.48 30.76 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.753 -1.112 . . . . 72.219999999999999 109.207 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.481 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 64.6 mtt180 -101.58 146.2 28.01 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-O 121.334 0.588 . . . . 73.340000000000003 111.144 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -94.37 -161.18 34.75 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 114.993 -1.003 . . . . 65.109999999999999 112.137 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . 0.478 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 74.65 8.08 80.78 Favored Glycine 0 C--N 1.315 -0.621 0 N-CA-C 112.386 -0.286 . . . . 62.399999999999999 112.386 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . 0.412 ' C ' HG13 ' A' ' 576' ' ' ILE . . . 103.71 10.09 36.16 Favored Glycine 0 N--CA 1.419 -2.476 0 C-N-CA 120.263 -0.97 . . . . 73.099999999999994 112.865 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.481 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 28.0 tt0 -83.46 -66.29 0.91 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 118.991 -1.084 . . . . 73.219999999999999 110.355 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -101.37 -41.63 6.59 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.229 -1.026 . . . . 74.409999999999997 108.229 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -137.34 158.78 43.67 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.809 -1.182 . . . . 73.019999999999996 107.809 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.78 137.16 33.86 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 107.513 -1.292 . . . . 73.329999999999998 107.513 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . 0.478 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 33.0 t70 -84.46 103.84 13.95 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.787 -0.82 . . . . 72.150000000000006 108.787 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.484 ' CG2' HG22 ' A' ' 573' ' ' VAL . 11.5 t -110.72 146.01 37.03 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-O 122.234 1.016 . . . . 62.200000000000003 111.873 -172.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 21.8 p -145.56 147.5 32.16 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 105.931 -1.878 . . . . 64.140000000000001 105.931 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -170.06 -179.76 41.84 Favored Glycine 0 CA--C 1.477 -2.317 0 N-CA-C 110.199 -1.16 . . . . 63.229999999999997 110.199 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 39.2 mt-10 -129.6 114.4 16.0 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.103 0.478 . . . . 75.200000000000003 110.731 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 88.1 mt -85.5 138.29 32.32 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.311 -0.859 . . . . 62.210000000000001 109.448 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.498 ' HA ' HD13 ' A' ' 536' ' ' ILE . 34.4 tt0 -104.52 118.49 36.71 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.99 -0.55 . . . . 61.240000000000002 110.23 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 527' ' ' ARG . 97.9 m-85 -124.44 107.51 11.18 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.704 -0.48 . . . . 73.120000000000005 109.704 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.606 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 5.5 mt-30 -109.03 178.46 4.46 Favored 'General case' 0 C--O 1.197 -1.67 0 N-CA-C 108.752 -0.833 . . . . 71.420000000000002 108.752 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -52.93 -44.81 67.3 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 123.439 0.462 . . . . 51.219999999999999 110.82 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.52 -49.04 35.55 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.207 0.447 . . . . 75.319999999999993 112.207 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.606 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 14.0 mp0 -54.68 141.9 30.41 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.638 0.775 . . . . 75.219999999999999 111.804 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.549 HG13 ' H ' ' A' ' 568' ' ' VAL . 5.5 pt -101.8 -89.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 112.923 0.712 . . . . 61.329999999999998 112.923 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 525' ' ' VAL . 10.5 p -115.34 152.22 17.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 110.281 -0.266 . . . . 40.329999999999998 110.281 -175.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -126.96 164.56 21.21 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 122.824 0.45 . . . . 71.140000000000001 110.253 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.5 p -123.21 150.56 43.24 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 123.655 0.597 . . . . 72.420000000000002 112.071 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.1 mp -94.41 125.98 46.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 106.784 -1.562 . . . . 74.120000000000005 106.784 172.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 521' ' ' MET . 51.5 m -104.9 115.56 30.5 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 123.905 0.753 . . . . 62.420000000000002 110.155 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.484 HG22 ' CG2' ' A' ' 556' ' ' THR . 93.7 t -116.84 128.51 74.2 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 116.244 -0.435 . . . . 74.430000000000007 110.447 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.431 ' HA ' HD13 ' A' ' 520' ' ' ILE . 52.8 tptt -80.27 111.96 17.14 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 108.654 -0.869 . . . . 61.109999999999999 108.654 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 61.9 t -86.65 124.39 40.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 106.056 -1.831 . . . . 72.409999999999997 106.056 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . 0.412 HG13 ' C ' ' A' ' 550' ' ' GLY . 40.7 mm . . . . . 0 C--N 1.296 -1.725 0 CA-C-O 121.903 0.859 . . . . 71.200000000000003 109.27 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt . . . . . 0 CA--C 1.499 -0.987 0 N-CA-C 114.556 1.317 . . . . 62.409999999999997 114.556 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.0 t -146.18 159.02 43.88 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 114.254 -1.339 . . . . 72.120000000000005 109.976 -174.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 46.8 p90 -141.26 176.9 8.47 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.13 -1.433 . . . . 72.310000000000002 107.13 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.567 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 85.1 m-85 -121.79 154.7 36.63 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.659 -0.816 . . . . 75.099999999999994 109.614 -177.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.1 OUTLIER -120.52 131.05 54.52 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.171 -1.788 . . . . 72.239999999999995 106.171 177.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.542 ' HB2' HD11 ' A' ' 542' ' ' ILE . 39.5 tt0 -125.91 134.12 51.68 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.269 -0.641 . . . . 64.409999999999997 109.269 177.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 13.9 pt -99.14 143.35 13.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.682 -0.859 . . . . 74.450000000000003 108.682 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.7 171.94 45.79 Favored Glycine 0 N--CA 1.413 -2.89 0 N-CA-C 111.452 -0.659 . . . . 70.400000000000006 111.452 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.63 131.57 89.66 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 123.615 0.244 . . . . 73.540000000000006 110.484 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.414 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.3 Cg_endo -59.25 125.99 19.62 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.381 2.721 . . . . 73.430000000000007 112.896 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -104.46 119.55 39.22 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.307 -0.86 . . . . 73.329999999999998 109.328 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.95 129.81 41.06 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.094 -0.957 . . . . 64.450000000000003 108.67 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.508 ' CG2' HG12 ' A' ' 536' ' ' ILE . 50.2 t . . . . . 0 C--N 1.3 -1.55 0 N-CA-C 108.223 -1.029 . . . . 73.510000000000005 108.223 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.45 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 44.6 Cg_endo . . . . . 0 N--CA 1.436 -1.891 0 CA-C-O 121.344 0.477 . . . . 75.430000000000007 111.279 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -124.84 171.13 14.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 115.403 -0.817 . . . . 64.040000000000006 110.176 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.91 -178.26 3.43 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 112.289 0.478 . . . . 62.049999999999997 112.289 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.49 -172.07 27.61 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 114.843 0.697 . . . . 74.129999999999995 114.843 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -68.3 -53.78 22.03 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.147 0.979 . . . . 72.129999999999995 110.385 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -120.12 121.34 38.61 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.954 -0.758 . . . . 62.43 108.954 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 18.3 p -120.75 94.08 4.24 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.498 0.666 . . . . 72.219999999999999 110.747 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -166.4 152.18 8.55 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.294 -1.373 . . . . 64.430000000000007 107.294 -177.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.447 HD21 HG21 ' A' ' 523' ' ' VAL . 48.5 tp -134.57 132.9 39.64 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.243 -1.021 . . . . 72.109999999999999 108.243 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -100.11 110.27 22.55 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 106.906 -1.516 . . . . 74.310000000000002 106.906 174.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 44.5 t -101.82 110.99 30.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 109.219 -0.66 . . . . 71.239999999999995 109.219 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 26.8 mt -98.67 127.47 51.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 108.315 -0.994 . . . . 74.430000000000007 108.315 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 66.6 mt -97.15 103.55 14.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 107.798 -1.186 . . . . 75.400000000000006 107.798 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 515' ' ' SER . 34.5 mt-10 . . . . . 0 C--N 1.303 -1.43 0 C-N-CA 120.421 -0.511 . . . . 75.209999999999994 111.573 -173.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 502' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.437 -1.105 0 CA-C-O 120.887 0.375 . . . . 51.109999999999999 111.417 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 160.11 -153.43 24.39 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 109.892 -1.283 . . . . 61.329999999999998 109.892 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -121.94 124.51 71.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 117.034 0.417 . . . . 74.439999999999998 111.503 -171.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -107.3 124.36 49.67 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.95 -0.759 . . . . 71.239999999999995 108.95 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.6 t -168.19 172.73 8.4 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.446 -0.575 . . . . 75.299999999999997 109.446 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -75.26 145.04 42.23 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.565 -0.289 . . . . 75.530000000000001 111.054 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.06 -29.63 70.01 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.53 0.681 . . . . 70.540000000000006 110.068 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -137.87 141.66 33.48 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 107.768 -1.197 . . . . 74.129999999999995 107.768 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.84 -24.65 15.24 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.697 2.265 . . . . 70.450000000000003 111.608 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 57.2 t -135.35 133.72 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 N-CA-C 106.611 -1.626 . . . . 61.149999999999999 106.611 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . 0.429 ' HB ' HD11 ' A' ' 642' ' ' LEU . 7.1 t -125.11 140.7 52.65 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.51 -1.292 . . . . 70.439999999999998 107.51 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . 0.427 ' NE2' ' HG2' ' A' ' 647' ' ' GLU . 57.4 t-80 -110.6 137.92 47.65 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 107.596 -1.261 . . . . 74.120000000000005 107.596 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.77 158.13 43.25 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 N-CA-C 109.072 -0.714 . . . . 64.319999999999993 109.072 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.557 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 48.1 m -87.09 173.57 9.19 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-N 115.037 -0.983 . . . . 71.420000000000002 109.566 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -94.07 -59.11 2.05 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.922 -0.711 . . . . 75.329999999999998 110.017 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.6 m -84.55 53.99 2.86 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.763 0.792 . . . . 63.549999999999997 109.929 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 10.5 tt -102.87 -32.49 3.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.544 -0.753 . . . . 72.140000000000001 111.49 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 92.85 -78.39 1.15 Allowed Glycine 0 N--CA 1.425 -2.036 0 C-N-CA 120.717 -0.754 . . . . 75.450000000000003 111.356 -176.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 574' ' ' LYS . 40.3 mm -126.93 123.93 63.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.934 -0.765 . . . . 74.430000000000007 108.934 -176.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.73 149.43 25.0 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 107.383 -1.34 . . . . 75.109999999999999 107.383 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 31.3 mt-10 -130.8 132.54 45.32 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.32 0.581 . . . . 74.140000000000001 111.088 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 570' ' ' THR . 40.1 t -112.01 126.47 69.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.098 -1.075 . . . . 72.409999999999997 108.098 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -81.96 128.8 34.44 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.203 -0.666 . . . . 70.120000000000005 109.203 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 568' ' ' VAL . 48.4 t -105.78 129.21 59.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 109.853 -0.425 . . . . 75.400000000000006 109.853 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.41 126.88 30.82 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.257 -0.646 . . . . 62.039999999999999 109.257 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.649 ' CZ ' ' HD1' ' A' ' 562' ' ' PHE . 15.2 ttm180 -87.64 160.07 18.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 109.178 -0.675 . . . . 65.040000000000006 109.178 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.7 t -56.1 141.47 40.29 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 124.4 1.08 . . . . 63.049999999999997 111.813 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.5 t -54.76 -37.4 65.93 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.93 -1.032 . . . . 73.430000000000007 109.355 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -119.54 96.0 0.62 Allowed Glycine 0 N--CA 1.423 -2.209 0 N-CA-C 109.029 -1.628 . . . . 42.140000000000001 109.029 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.61 101.0 12.34 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.003 -1.11 . . . . 75.109999999999999 108.003 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -107.49 92.37 4.04 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.596 -0.729 . . . . 72.109999999999999 110.441 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 86.32 -139.33 16.63 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 119.56 -1.305 . . . . 53.420000000000002 111.774 174.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -113.39 121.1 43.31 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.265 0.555 . . . . 71.310000000000002 110.876 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 59.5 t -123.63 143.87 35.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 107.972 -1.121 . . . . 63.119999999999997 107.972 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.54 HD13 ' HA ' ' A' ' 561' ' ' GLU . 41.7 mm -117.28 137.09 52.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 109.596 -0.52 . . . . 71.540000000000006 109.596 177.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 594' ' ' PRO . 44.1 t -122.89 110.79 31.28 Favored Pre-proline 0 N--CA 1.44 -0.945 0 N-CA-C 109.853 -0.425 . . . . 74.219999999999999 109.853 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.7 156.83 48.78 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.769 2.313 . . . . 71.129999999999995 112.517 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.497 ' HB3' HG22 ' A' ' 591' ' ' ILE . 45.0 p90 -149.4 163.3 38.14 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 122.383 -0.198 . . . . 73.150000000000006 110.649 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -158.43 156.67 30.82 Favored 'General case' 0 C--O 1.252 1.211 0 O-C-N 123.966 0.791 . . . . 62.509999999999998 110.089 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.2 p -90.62 138.53 31.49 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 123.531 0.519 . . . . 72.299999999999997 111.342 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 51.2 mt -111.09 115.77 50.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.821 -0.807 . . . . 70.540000000000006 108.821 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.82 99.61 5.21 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.35 -0.611 . . . . 74.420000000000002 109.35 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -104.56 -89.17 2.1 Favored Glycine 0 CA--C 1.482 -2.008 0 C-N-CA 119.981 -1.104 . . . . 61.340000000000003 110.667 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . 0.435 ' HB ' HG23 ' A' ' 586' ' ' THR . 3.8 m -102.53 29.86 5.0 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-O 122.324 1.059 . . . . 61.409999999999997 108.54 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -157.4 144.73 18.58 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 106.815 -1.55 . . . . 64.430000000000007 106.815 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.406 ' HD2' ' OE1' ' A' ' 551' ' ' GLU . 82.0 mtm180 -92.29 131.1 37.76 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.75 0.786 . . . . 65.120000000000005 112.126 -175.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -96.62 -167.15 33.64 Favored Glycine 0 C--N 1.294 -1.779 0 CA-C-N 114.908 -1.042 . . . . 14.44 112.93 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . 0.532 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 77.28 9.15 86.98 Favored Glycine 0 C--N 1.313 -0.734 0 CA-C-N 115.721 -0.24 . . . . 65.329999999999998 112.995 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 98.14 23.73 12.59 Favored Glycine 0 N--CA 1.427 -1.924 0 C-N-CA 120.368 -0.92 . . . . 63.299999999999997 111.422 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.406 ' OE1' ' HD2' ' A' ' 547' ' ' ARG . 26.3 tt0 -98.63 -63.27 1.14 Allowed 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.096 -0.641 . . . . 64.040000000000006 109.825 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -100.72 -42.01 6.67 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 107.411 -1.329 . . . . 75.150000000000006 107.411 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -132.9 155.09 49.69 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.006 -1.109 . . . . 73.510000000000005 108.006 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.79 137.38 35.32 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.476 -1.305 . . . . 74.25 107.476 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . 0.532 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 29.4 t70 -87.3 121.36 29.65 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.682 -0.859 . . . . 71.430000000000007 108.682 -176.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.8 t -130.65 164.98 23.81 Favored 'General case' 0 N--CA 1.414 -2.254 0 CA-C-O 121.742 0.782 . . . . 62.420000000000002 110.787 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 19.9 p -161.2 163.55 31.08 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.316 -1.735 . . . . 63.340000000000003 106.316 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 167.18 -169.59 41.05 Favored Glycine 0 N--CA 1.421 -2.329 0 C-N-CA 119.929 -1.129 . . . . 42.210000000000001 111.054 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.526 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 42.3 mt-10 -136.07 119.75 17.2 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 123.338 0.655 . . . . 72.5 110.196 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 569' ' ' LYS . 77.3 mt -86.82 128.75 35.05 Favored 'General case' 0 CA--C 1.484 -1.592 0 CA-C-N 115.745 -0.661 . . . . 72.239999999999995 110.087 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.54 ' HA ' HD13 ' A' ' 536' ' ' ILE . 25.5 tt0 -87.79 123.39 32.53 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.455 -0.793 . . . . 71.120000000000005 109.911 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.649 ' HD1' ' CZ ' ' A' ' 527' ' ' ARG . 82.2 m-85 -123.3 98.2 5.76 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 121.463 0.649 . . . . 73.299999999999997 110.612 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 533' ' ' GLY . 42.3 mt-30 -96.78 -175.87 3.41 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.722 -0.672 . . . . 70.439999999999998 110.44 174.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -78.92 -21.75 46.86 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.631 -0.713 . . . . 73.409999999999997 109.428 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -72.57 -52.38 15.81 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.076 -0.966 . . . . 65.109999999999999 112.768 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.496 ' HB2' HH12 ' A' ' 527' ' ' ARG . 41.4 mm-40 -69.7 169.29 13.17 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.441 1.274 . . . . 73.150000000000006 114.441 -177.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.589 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.0 pt -105.95 -63.3 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 114.574 -1.193 . . . . 74.099999999999994 112.465 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.589 ' H ' HG13 ' A' ' 567' ' ' ILE . 14.4 p -139.88 162.56 25.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 108.834 -0.802 . . . . 73.120000000000005 108.834 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.415 ' HB3' HD22 ' A' ' 560' ' ' LEU . 1.8 mtpt -131.1 164.04 26.32 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.445 -0.946 . . . . 72.209999999999994 108.445 171.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 12.9 p -129.7 152.57 49.06 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 123.794 0.683 . . . . 63.210000000000001 111.153 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.498 HG22 HG23 ' A' ' 573' ' ' VAL . 2.5 mp -94.59 121.76 45.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 105.545 -2.02 . . . . 72.540000000000006 105.545 170.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 5.9 m -99.45 114.89 28.11 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.596 -0.89 . . . . 53.43 108.596 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.498 HG23 HG22 ' A' ' 571' ' ' ILE . 91.3 t -118.89 127.65 75.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.771 -0.455 . . . . 72.439999999999998 109.771 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 16.1 tppt? -77.42 108.84 10.85 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.207 -1.035 . . . . 75.409999999999997 108.207 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.75 122.52 36.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 104.55 -2.389 . . . . 71.099999999999994 104.55 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 42.1 mm . . . . . 0 C--N 1.295 -1.796 0 CA-C-O 121.352 0.596 . . . . 71.209999999999994 109.467 -174.072 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp . . . . . 0 N--CA 1.425 -1.676 0 N-CA-C 107.474 -1.306 . . . . 75.530000000000001 107.474 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . 0.435 HG23 ' HB ' ' A' ' 545' ' ' THR . 4.4 t -135.18 125.18 25.8 Favored 'General case' 0 C--N 1.281 -2.413 0 CA-C-O 121.946 0.879 . . . . 75.310000000000002 111.582 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 44.3 p90 -119.94 177.78 4.85 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.131 -0.94 . . . . 64.310000000000002 109.235 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.424 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 77.9 m-85 -123.19 149.66 44.34 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 109.404 -0.591 . . . . 63.5 109.404 -176.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.2 OUTLIER -120.4 131.81 54.98 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.442 -1.688 . . . . 45.539999999999999 106.442 179.216 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -125.58 128.47 47.98 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.022 -0.671 . . . . 71.140000000000001 110.341 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.497 HG22 ' HB3' ' A' ' 539' ' ' TYR . 26.5 pt -99.84 139.77 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 107.911 -1.144 . . . . 72.049999999999997 107.911 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.34 -178.08 50.65 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 115.825 -0.625 . . . . 64.120000000000005 112.083 -176.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.05 129.63 86.07 Favored Pre-proline 0 N--CA 1.426 -1.641 0 CA-C-N 115.499 -0.35 . . . . 75.340000000000003 110.772 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.517 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 11.7 Cg_endo -59.6 129.07 29.33 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.197 2.598 . . . . 61.310000000000002 112.666 -176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 536' ' ' ILE . 8.3 ptm180 -104.72 119.65 39.51 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.09 -0.959 . . . . 71.0 109.008 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.403 HD23 ' HD3' ' A' ' 634' ' ' PRO . 2.1 tm? -67.28 128.88 38.05 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.082 -1.451 . . . . 72.209999999999994 107.082 175.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.468 ' CG2' HG12 ' A' ' 536' ' ' ILE . 51.5 t . . . . . 0 C--N 1.299 -1.629 0 CA-C-O 121.397 0.618 . . . . 61.539999999999999 110.835 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 33.3 Cg_endo . . . . . 0 N--CA 1.427 -2.388 0 N-CA-C 105.352 -2.595 . . . . 73.430000000000007 105.352 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.04 168.74 16.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 118.502 -1.279 . . . . 74.5 112.678 -173.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.26 171.93 7.68 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.57 -0.741 . . . . 74.25 111.959 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -71.69 -171.99 15.3 Favored Glycine 0 N--CA 1.431 -1.7 0 CA-C-N 115.307 -0.861 . . . . 64.340000000000003 113.144 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -62.12 -41.29 98.09 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 122.365 0.266 . . . . 74.25 110.331 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -140.89 133.23 28.27 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.969 0.414 . . . . 64.120000000000005 110.039 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 15.4 p -120.88 95.4 4.69 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-O 121.709 0.766 . . . . 70.400000000000006 109.985 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -162.58 142.98 9.75 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.523 -1.288 . . . . 33.240000000000002 107.523 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.5 HD21 HG21 ' A' ' 523' ' ' VAL . 34.7 tp -132.65 132.81 42.83 Favored 'General case' 0 N--CA 1.416 -2.167 0 O-C-N 123.658 0.599 . . . . 52.240000000000002 109.423 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -98.35 118.59 35.34 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.057 -1.46 . . . . 71.340000000000003 107.057 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 44.3 t -106.7 117.43 52.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 109.006 -0.738 . . . . 71.430000000000007 109.006 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 58.1 mt -103.4 123.11 56.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 110.62 -0.141 . . . . 73.219999999999999 110.62 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 41.6 mt -107.43 107.65 23.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.153 -0.684 . . . . 72.540000000000006 109.153 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.427 ' HG2' ' NE2' ' A' ' 513' ' ' HIS . 8.0 pt-20 . . . . . 0 C--N 1.296 -1.753 0 N-CA-C 105.383 -2.081 . . . . 75.150000000000006 105.383 166.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 502' ' ' ALA . . . . . 0.631 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 107.967 -1.123 . . . . 63.329999999999998 107.967 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 116.26 -159.64 13.79 Favored Glycine 0 N--CA 1.416 -2.655 0 C-N-CA 120.167 -1.016 . . . . 62.219999999999999 111.619 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.34 111.39 28.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 122.388 0.275 . . . . 74.140000000000001 110.569 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.604 ' CD2' HG23 ' A' ' 528' ' ' THR . 5.8 m-85 -92.35 126.11 37.3 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 109.093 -0.706 . . . . 72.239999999999995 109.093 170.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.4 t -167.54 176.33 6.57 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.831 -0.803 . . . . 74.030000000000001 108.831 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -81.11 147.05 30.27 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 110.147 -0.316 . . . . 72.140000000000001 110.147 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.78 -33.53 75.88 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.36 0.6 . . . . 72.129999999999995 109.879 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -136.28 140.93 34.19 Favored Pre-proline 0 N--CA 1.427 -1.605 0 N-CA-C 107.573 -1.269 . . . . 54.409999999999997 107.573 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . 0.438 ' O ' ' HA ' ' A' ' 642' ' ' LEU . 59.2 Cg_endo -75.26 -26.01 10.93 Favored 'Trans proline' 0 C--N 1.33 -0.414 0 C-N-CA 122.447 2.098 . . . . 60.340000000000003 112.258 -178.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 59.8 t -134.77 136.59 52.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 106.715 -1.587 . . . . 51.100000000000001 106.715 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 15.0 t -129.18 135.39 48.79 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 108.591 -0.892 . . . . 72.109999999999999 108.591 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -108.03 119.04 38.34 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.915 -0.772 . . . . 63.350000000000001 108.915 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.37 160.28 14.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.419 -0.81 . . . . 64.040000000000006 109.194 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.534 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 74.4 m -88.17 159.84 18.0 Favored 'General case' 0 N--CA 1.411 -2.413 0 C-N-CA 123.345 0.658 . . . . 61.420000000000002 110.486 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -49.22 16.32 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 120.731 -0.388 . . . . 75.230000000000004 110.692 176.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 9.8 m -86.83 39.84 0.87 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.27 0.557 . . . . 51.140000000000001 111.5 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 13.4 tt -97.67 -25.15 4.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.305 0.574 . . . . 71.519999999999996 111.626 -176.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 86.86 -74.28 2.35 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.86 -0.896 . . . . 71.219999999999999 110.86 -176.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 43.4 mm -129.97 132.2 65.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.459 -1.312 . . . . 75.420000000000002 107.459 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.4 150.47 34.6 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.002 -1.481 . . . . 73.510000000000005 107.002 175.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 31.7 mt-10 -130.09 142.53 50.59 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.227 0.537 . . . . 73.439999999999998 111.631 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.586 HG11 HD22 ' A' ' 642' ' ' LEU . 42.7 t -121.24 127.7 75.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.397 -0.964 . . . . 64.340000000000003 108.397 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -82.51 127.8 33.66 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.746 -0.835 . . . . 63.310000000000002 108.746 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.39 123.92 58.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 108.806 -0.812 . . . . 74.439999999999998 108.806 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.03 115.63 10.38 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.542 -0.754 . . . . 70.040000000000006 109.928 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.481 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 50.9 ttp180 -67.85 155.28 39.71 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.6 -1.182 . . . . 74.109999999999999 108.9 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 0.7 OUTLIER -56.55 141.99 40.95 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-O 121.786 0.803 . . . . 63.310000000000002 111.37 176.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.2 m -61.92 -16.93 54.63 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 125.996 1.718 . . . . 60.25 110.769 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -139.47 79.16 0.29 Allowed Glycine 0 N--CA 1.425 -2.084 0 N-CA-C 110.304 -1.118 . . . . 61.210000000000001 110.304 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -83.73 101.49 11.6 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.232 -1.025 . . . . 63.229999999999997 108.232 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -100.83 93.13 5.38 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.908 -1.042 . . . . 63.439999999999998 110.217 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 97.53 -119.55 6.44 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.162 -1.018 . . . . 75.430000000000007 111.277 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.456 ' HB3' ' HB ' ' A' ' 597' ' ' VAL . 3.3 t-20 -133.52 134.25 43.19 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.084 -0.71 . . . . 71.150000000000006 109.084 177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 62.1 t -132.83 137.98 52.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.111 -1.07 . . . . 65.109999999999999 108.111 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.482 HG12 ' CG2' ' A' ' 597' ' ' VAL . 41.3 mm -107.35 136.46 42.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 109.563 -0.532 . . . . 63.409999999999997 109.563 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.34 110.94 32.12 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 110.046 -0.353 . . . . 64.310000000000002 110.046 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -73.5 150.6 46.27 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.205 1.937 . . . . 72.140000000000001 111.468 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.423 ' HB3' HG22 ' A' ' 591' ' ' ILE . 53.2 p90 -149.08 163.45 37.52 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 110.405 -0.22 . . . . 74.310000000000002 110.405 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -157.93 158.33 34.8 Favored 'General case' 0 C--O 1.252 1.236 0 O-C-N 123.923 0.764 . . . . 62.109999999999999 109.745 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.7 p -87.36 154.12 20.92 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 109.038 -0.727 . . . . 61.509999999999998 109.038 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 60.1 mt -128.39 119.01 49.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.204 -1.406 . . . . 65.209999999999994 107.204 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -66.41 120.99 14.3 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 122.631 0.372 . . . . 63.340000000000003 110.453 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -102.71 -104.54 2.85 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 108.663 -1.775 . . . . 72.209999999999994 108.663 176.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 34.3 p -89.91 -22.51 21.96 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.276 -1.009 . . . . 72.049999999999997 108.276 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.613 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -81.91 136.95 35.28 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.423 -1.262 . . . . 44.399999999999999 110.067 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -90.49 144.25 25.97 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.382 0.611 . . . . 71.409999999999997 111.912 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.7 -158.03 33.87 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.005 -1.238 . . . . 32.039999999999999 110.005 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.75 26.47 73.98 Favored Glycine 0 C--N 1.315 -0.594 0 C-N-CA 120.929 -0.653 . . . . 73.450000000000003 112.257 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . 0.416 ' C ' HG13 ' A' ' 576' ' ' ILE . . . 67.92 34.55 82.48 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 121.597 -0.335 . . . . 72.049999999999997 112.264 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -104.48 -63.43 1.21 Allowed 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 120.814 -0.355 . . . . 63.149999999999999 111.409 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -101.77 -45.61 5.18 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 108.179 -1.045 . . . . 75.340000000000003 108.179 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -133.93 152.31 51.81 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 107.639 -1.245 . . . . 64.439999999999998 107.639 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.403 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 8.4 tt0 -85.6 112.69 21.21 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 105.858 -1.904 . . . . 73.439999999999998 105.858 176.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.26 140.7 56.02 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 120.941 0.401 . . . . 64.340000000000003 110.203 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.6 t -142.65 148.3 37.18 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-O 121.506 0.67 . . . . 75.400000000000006 111.33 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 11.8 p -148.62 157.28 43.35 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.093 -1.447 . . . . 54.439999999999998 107.093 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 168.3 -163.43 37.16 Favored Glycine 0 N--CA 1.421 -2.338 0 C-N-CA 120.114 -1.041 . . . . 62.43 110.665 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.448 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 40.5 mt-10 -132.72 124.91 29.06 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 122.869 0.468 . . . . 74.430000000000007 110.697 -177.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.533 HD22 ' HB3' ' A' ' 569' ' ' LYS . 76.0 mt -91.04 135.09 33.99 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 115.713 -0.676 . . . . 34.130000000000003 109.403 177.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.475 ' HA ' HD13 ' A' ' 536' ' ' ILE . 32.1 tt0 -102.06 109.48 21.2 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.837 -0.619 . . . . 64.109999999999999 110.54 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -106.07 104.4 14.09 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.661 0.743 . . . . 70.340000000000003 110.534 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.536 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 8.2 mm100 -87.75 173.3 9.07 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.469 -1.308 . . . . 63.310000000000002 107.469 174.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -72.03 -25.91 61.99 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.498 -0.927 . . . . 65.329999999999998 108.498 172.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.66 -46.22 39.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.592 -1.185 . . . . 73.340000000000003 110.822 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.536 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 37.0 mm-40 -61.01 130.58 47.11 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 123.72 0.808 . . . . 72.120000000000005 111.663 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.548 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.3 pt -86.74 -59.69 2.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 116.004 -0.544 . . . . 61.350000000000001 111.746 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.548 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.2 p -141.78 155.17 19.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.769 -0.456 . . . . 75.439999999999998 109.769 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.533 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -123.19 157.28 33.38 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.988 -0.745 . . . . 73.140000000000001 108.988 171.132 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.0 OUTLIER -125.36 149.85 47.74 Favored 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 115.351 -0.841 . . . . 62.310000000000002 111.574 179.049 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.3 mp -98.91 120.56 48.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 106.662 -1.607 . . . . 60.25 106.662 169.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 5.1 p -96.11 115.09 26.89 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 123.747 0.654 . . . . 71.019999999999996 109.405 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.435 HG23 HG22 ' A' ' 571' ' ' ILE . 93.4 t -114.62 128.58 71.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.705 -0.398 . . . . 64.209999999999994 109.935 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 22.2 tptm -79.84 115.23 19.32 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.985 -1.007 . . . . 74.219999999999999 109.226 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.66 126.28 40.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 104.935 -2.246 . . . . 51.329999999999998 104.935 174.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . 0.416 HG13 ' C ' ' A' ' 550' ' ' GLY . 45.2 mm . . . . . 0 C--N 1.298 -1.639 0 CA-C-O 122.272 1.034 . . . . 74.150000000000006 110.771 -173.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.613 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 30.1 mmtp . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 109.511 -0.552 . . . . 72.319999999999993 109.511 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 9.2 t -140.53 145.94 37.46 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 120.411 -0.515 . . . . 73.239999999999995 109.912 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 49.8 p90 -141.81 175.92 9.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.837 -1.172 . . . . 74.049999999999997 107.837 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.576 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 79.1 m-85 -121.4 160.64 23.66 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.73 -0.47 . . . . 73.450000000000003 109.73 -176.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.2 OUTLIER -127.97 131.27 49.28 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 105.798 -1.927 . . . . 55.340000000000003 105.798 177.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.405 ' HB2' HD11 ' A' ' 542' ' ' ILE . 42.5 tt0 -129.68 137.98 50.92 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.893 -0.41 . . . . 74.510000000000005 109.893 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.423 HG22 ' HB3' ' A' ' 539' ' ' TYR . 21.3 pt -108.74 142.81 20.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 108.103 -1.073 . . . . 65.049999999999997 108.103 176.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.52 -177.4 45.62 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 111.004 -0.838 . . . . 74.219999999999999 111.004 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -69.74 132.18 89.12 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 120.895 0.378 . . . . 65.019999999999996 111.345 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.97 129.47 26.04 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.488 2.792 . . . . 64.010000000000005 112.759 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 536' ' ' ILE . 1.2 ptm85 -106.54 119.49 39.42 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.967 -0.561 . . . . 74.129999999999995 110.212 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.39 137.9 57.79 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 124.567 1.147 . . . . 53.32 111.025 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.482 ' CG2' HG12 ' A' ' 536' ' ' ILE . 21.6 t . . . . . 0 C--N 1.303 -1.447 0 N-CA-C 105.838 -1.912 . . . . 51.140000000000001 105.838 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.463 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 73.8 Cg_endo . . . . . 0 N--CA 1.427 -2.398 0 CA-C-O 121.119 0.383 . . . . 62.439999999999998 111.333 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.5 pp -129.85 168.94 21.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-N 115.807 -0.633 . . . . 75.109999999999999 110.675 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.83 178.92 4.81 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 112.249 0.463 . . . . 73.409999999999997 112.249 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -77.79 -156.06 8.08 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 114.888 0.715 . . . . 74.239999999999995 114.888 -175.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -70.77 -48.57 53.59 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.156 0.582 . . . . 74.120000000000005 109.794 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -140.2 144.15 36.44 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.295 -1.002 . . . . 64.319999999999993 108.295 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 14.0 p -133.23 95.88 3.62 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 123.604 0.565 . . . . 62.340000000000003 109.849 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -164.1 138.46 5.66 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.75 -0.833 . . . . 74.510000000000005 108.75 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.586 HD22 HG11 ' A' ' 523' ' ' VAL . 26.6 tp -125.75 134.44 51.75 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.442 -0.947 . . . . 71.129999999999995 108.442 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -104.3 113.8 27.6 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.391 -1.337 . . . . 71.209999999999994 107.391 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.36 110.15 28.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.144 -0.688 . . . . 73.150000000000006 109.144 -178.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 59.2 mt -102.24 120.39 51.88 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 108.619 -0.882 . . . . 62.43 108.619 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 45.5 mt -95.38 106.95 18.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 107.979 -1.119 . . . . 73.209999999999994 107.979 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 515' ' ' SER . 8.9 pt-20 . . . . . 0 C--N 1.296 -1.759 0 CA-C-O 121.243 0.544 . . . . 70.140000000000001 110.463 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 109.552 -0.536 . . . . 44.350000000000001 109.552 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.422 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . 165.03 -150.91 19.45 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 120.477 -0.868 . . . . 73.239999999999995 111.119 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.434 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.9 mp -126.13 113.32 33.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 116.852 0.326 . . . . 65.010000000000005 110.67 -173.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -97.33 130.34 44.51 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.487 -0.931 . . . . 74.439999999999998 108.487 170.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . 0.413 ' HA ' HG22 ' A' ' 640' ' ' THR . 13.7 t -166.31 175.29 8.36 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.147 -0.686 . . . . 72.099999999999994 109.147 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . 0.458 ' CZ ' HG23 ' A' ' 591' ' ' ILE . 79.9 m-85 -84.55 152.9 23.59 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 110.135 -0.32 . . . . 72.430000000000007 110.135 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -64.68 -37.67 88.39 Favored 'General case' 0 C--O 1.245 0.821 0 O-C-N 123.544 0.528 . . . . 53.530000000000001 110.367 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.65 149.98 75.0 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 108.942 -0.762 . . . . 73.109999999999999 108.942 174.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -74.39 -28.73 10.06 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.894 1.729 . . . . 73.319999999999993 112.154 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 46.0 t -137.57 132.51 45.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 107.802 -1.185 . . . . 63.43 107.802 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 13.2 t -128.92 140.8 51.51 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 109.623 -0.51 . . . . 44.219999999999999 109.623 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -108.98 127.87 54.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.481 -0.563 . . . . 72.349999999999994 109.481 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 23.9 m -123.06 177.33 4.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.097 -0.705 . . . . 73.120000000000005 109.097 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.537 ' HB3' ' HB ' ' A' ' 518' ' ' ILE . 32.7 t -103.99 159.28 15.8 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.129 0.49 . . . . 73.439999999999998 110.902 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -70.29 -39.22 75.02 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.877 -1.056 . . . . 55.420000000000002 109.776 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 68.1 m -104.19 20.85 17.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.606 0.595 . . . . 72.129999999999995 112.606 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' A' ' 515' ' ' SER . 11.3 tt -70.01 -35.59 64.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 C-N-CA 119.762 -0.775 . . . . 64.120000000000005 110.229 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 95.06 -78.86 0.87 Allowed Glycine 0 CA--C 1.479 -2.156 0 N-CA-C 110.858 -0.897 . . . . 74.349999999999994 110.858 -177.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 573' ' ' VAL . 33.8 mm -127.63 133.18 68.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.966 -1.494 . . . . 75.310000000000002 106.966 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.516 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -118.59 144.77 45.89 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.432 -0.581 . . . . 74.109999999999999 109.432 177.499 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -112.1 125.06 53.7 Favored 'General case' 0 C--O 1.241 0.643 0 O-C-N 123.638 0.586 . . . . 73.010000000000005 110.996 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.632 HG11 HD22 ' A' ' 642' ' ' LEU . 47.3 t -104.64 126.29 59.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 109.298 -0.631 . . . . 54.340000000000003 109.298 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -80.38 128.32 33.43 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.538 0.524 . . . . 75.430000000000007 109.686 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 568' ' ' VAL . 62.3 t -106.66 115.39 48.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.798 -0.816 . . . . 70.319999999999993 108.798 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.05 123.8 19.5 Favored 'General case' 0 C--O 1.251 1.144 0 O-C-N 123.991 0.807 . . . . 64.219999999999999 110.206 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -73.59 159.62 32.83 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 114.947 -1.024 . . . . 74.409999999999997 110.238 -177.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.422 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 4.3 t -62.46 140.89 58.59 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.687 -0.688 . . . . 62.210000000000001 110.387 175.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.6 t -59.3 -37.06 76.77 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 123.644 0.778 . . . . 71.510000000000005 109.381 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -110.84 87.66 0.48 Allowed Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.132 -1.187 . . . . 52.039999999999999 110.132 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.0 100.46 13.28 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.994 -0.743 . . . . 52.43 108.994 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -108.58 92.22 3.97 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.617 -0.72 . . . . 64.230000000000004 111.044 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 95.72 -122.15 7.17 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.317 -0.944 . . . . 65.230000000000004 112.796 175.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -132.9 130.83 40.18 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 123.062 0.545 . . . . 73.519999999999996 109.755 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.467 HG22 HD22 ' A' ' 596' ' ' LEU . 60.3 t -134.26 138.36 50.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 123.841 0.856 . . . . 74.109999999999999 109.228 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.535 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 46.6 mm -106.7 133.96 49.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.261 -0.644 . . . . 74.049999999999997 109.261 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.475 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.8 t -122.5 110.85 31.91 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 108.983 -0.747 . . . . 73.019999999999996 108.983 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 51.6 Cg_endo -72.53 157.65 52.37 Favored 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.283 1.989 . . . . 74.25 111.893 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.476 ' HB3' HG22 ' A' ' 591' ' ' ILE . 47.4 p90 -149.65 160.55 43.42 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.645 -0.502 . . . . 64.540000000000006 109.645 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -158.42 154.69 27.32 Favored 'General case' 0 C--O 1.248 1.024 0 O-C-N 123.709 0.631 . . . . 75.450000000000003 111.121 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.3 p -86.95 140.69 29.34 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.884 -0.598 . . . . 63.310000000000002 110.449 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 49.0 mt -114.54 125.54 71.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.436 -0.95 . . . . 73.209999999999994 108.436 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.77 154.61 19.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.312 0.577 . . . . 74.310000000000002 112.454 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 176.4 -73.32 0.08 OUTLIER Glycine 0 C--N 1.305 -1.16 0 N-CA-C 110.731 -0.948 . . . . 72.519999999999996 110.731 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.32 5.86 18.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.101 0.953 . . . . 72.129999999999995 111.342 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -153.5 142.18 20.94 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 105.447 -2.057 . . . . 50.43 105.447 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 38.6 mtp85 -96.05 130.25 43.12 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.115 0.484 . . . . 63.340000000000003 111.452 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.4 -145.8 12.8 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 120.477 -0.868 . . . . 40.119999999999997 112.726 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . 0.429 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 65.05 10.1 44.8 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 113.982 0.353 . . . . 71.25 113.982 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 100.43 15.94 28.45 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.164 -1.017 . . . . 51.229999999999997 111.847 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -91.95 -72.48 0.59 Allowed 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 119.713 -0.795 . . . . 60.329999999999998 110.178 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -89.77 -39.16 13.31 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 108.527 -0.916 . . . . 64.420000000000002 108.527 175.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -140.98 155.2 46.27 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.92 -1.037 . . . . 71.530000000000001 108.363 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.04 137.09 33.28 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.779 -1.563 . . . . 41.240000000000002 106.779 177.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . 0.429 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 19.5 t70 -87.17 132.09 33.98 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 110.188 -0.301 . . . . 72.109999999999999 110.188 -172.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 15.0 t -136.43 145.48 45.31 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.685 0.755 . . . . 73.209999999999994 110.841 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 52.1 t -154.29 148.15 25.52 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.985 -1.858 . . . . 42.329999999999998 105.985 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 175.27 -164.82 35.49 Favored Glycine 0 C--N 1.287 -2.191 0 N-CA-C 109.997 -1.241 . . . . 61.039999999999999 109.997 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.535 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 87.0 mt-10 -135.56 127.8 30.09 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.987 0.394 . . . . 74.310000000000002 110.646 -177.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.416 HD22 ' HB3' ' A' ' 569' ' ' LYS . 91.7 mt -92.01 134.18 35.04 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.78 -0.645 . . . . 75.010000000000005 109.469 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.415 ' HA ' HD13 ' A' ' 536' ' ' ILE . 31.3 tt0 -98.84 116.33 30.83 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.775 -0.648 . . . . 71.409999999999997 109.57 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -111.56 145.65 38.75 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.335 -0.617 . . . . 74.519999999999996 109.335 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.514 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 49.7 mt-30 -142.7 179.58 6.91 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 109.183 -0.673 . . . . 71.430000000000007 109.183 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -70.52 -37.92 74.18 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.571 -0.9 . . . . 74.209999999999994 108.571 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.68 -27.29 37.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.729 -1.123 . . . . 75.329999999999998 111.979 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.514 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 8.7 mm-40 -78.62 146.97 33.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.283 -0.636 . . . . 71.140000000000001 109.283 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.596 HG13 ' H ' ' A' ' 568' ' ' VAL . 4.0 pt -95.57 -80.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 112.45 0.537 . . . . 65.099999999999994 112.45 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.596 ' H ' HG13 ' A' ' 567' ' ' ILE . 8.3 p -135.73 148.97 27.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 108.619 -0.882 . . . . 72.120000000000005 108.619 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.416 ' HB3' HD22 ' A' ' 560' ' ' LEU . 1.8 mtpt -114.95 159.96 20.12 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.545 -0.539 . . . . 74.420000000000002 109.545 175.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 16.2 p -128.26 150.15 50.17 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.877 -0.601 . . . . 74.230000000000004 111.009 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.42 HG22 HG23 ' A' ' 573' ' ' VAL . 3.3 mp -99.51 123.28 52.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 106.518 -1.66 . . . . 72.209999999999994 106.518 171.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 521' ' ' MET . 4.6 p -97.77 115.98 29.08 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.913 0.758 . . . . 70.239999999999995 109.502 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 520' ' ' ILE . 95.9 t -117.33 133.92 62.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 116.619 -0.264 . . . . 74.219999999999999 110.807 -178.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 46.7 tptt -85.6 112.46 20.99 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 109.054 -0.721 . . . . 73.310000000000002 109.054 175.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.63 125.62 40.29 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 104.924 -2.25 . . . . 72.109999999999999 104.924 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 37.9 mm . . . . . 0 N--CA 1.425 -1.688 0 CA-C-O 122.054 0.93 . . . . 72.510000000000005 109.978 -175.261 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 CA--C 1.49 -1.334 0 CA-C-O 120.899 0.38 . . . . 75.340000000000003 111.016 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.5 t -153.14 138.44 17.51 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.879 -0.415 . . . . 74.120000000000005 109.879 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -135.25 176.0 9.07 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.479 -0.934 . . . . 74.040000000000006 108.479 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.487 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 74.0 m-85 -122.47 152.67 40.05 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.042 -0.663 . . . . 53.350000000000001 109.872 -175.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.07 130.86 53.64 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.484 -1.672 . . . . 63.240000000000002 106.484 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.424 ' HB2' HD11 ' A' ' 542' ' ' ILE . 30.2 tt0 -121.63 136.48 54.94 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.745 -0.465 . . . . 75.219999999999999 109.745 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.476 HG22 ' HB3' ' A' ' 539' ' ' TYR . 21.1 pt -107.94 132.93 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 107.04 -1.467 . . . . 63.340000000000003 107.04 169.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.52 -166.48 42.01 Favored Glycine 0 N--CA 1.423 -2.206 0 CA-C-N 115.577 -0.738 . . . . 61.5 112.713 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.69 131.71 73.4 Favored Pre-proline 0 N--CA 1.427 -1.603 0 CA-C-O 120.997 0.427 . . . . 70.25 111.629 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.475 ' HB3' HG22 ' A' ' 537' ' ' VAL . 47.3 Cg_endo -69.42 147.3 64.73 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.952 2.434 . . . . 63.039999999999999 111.973 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -125.03 137.3 54.23 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.934 -0.765 . . . . 72.329999999999998 108.934 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.467 HD22 HG22 ' A' ' 535' ' ' VAL . 0.8 OUTLIER -78.99 128.68 33.57 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 107.122 -1.436 . . . . 64.120000000000005 107.122 179.087 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.459 ' CG2' HG12 ' A' ' 536' ' ' ILE . 37.8 t . . . . . 0 C--N 1.29 -2.007 0 N-CA-C 109.056 -0.72 . . . . 61.420000000000002 109.056 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo . . . . . 0 N--CA 1.436 -1.868 0 CA-C-O 121.25 0.437 . . . . 72.420000000000002 111.041 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.39 167.46 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-N 115.179 -0.918 . . . . 75.299999999999997 109.545 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.35 -176.24 3.16 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 112.199 0.444 . . . . 72.120000000000005 112.199 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.434 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -77.83 -150.18 4.26 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-O 121.646 0.581 . . . . 32.229999999999997 113.84 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -80.97 -48.34 12.41 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.09 0.472 . . . . 75.239999999999995 109.947 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -133.12 131.64 40.75 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.821 -0.807 . . . . 71.099999999999994 108.821 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 506' ' ' THR . 23.9 p -119.97 88.95 3.03 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 121.755 0.788 . . . . 54.140000000000001 110.136 175.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -159.79 137.6 9.99 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.286 -0.87 . . . . 75.299999999999997 109.567 -175.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.632 HD22 HG11 ' A' ' 523' ' ' VAL . 15.6 tp -123.32 128.64 50.21 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 107.974 -1.121 . . . . 74.319999999999993 107.974 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -97.71 111.7 23.88 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.396 -1.335 . . . . 74.349999999999994 107.396 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.7 112.86 34.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.448 -0.575 . . . . 72.049999999999997 109.448 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 68.6 mt -101.6 121.42 52.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 109.636 -0.505 . . . . 72.530000000000001 109.636 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 69.1 mt -95.17 113.89 30.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.877 -1.157 . . . . 50.130000000000003 107.877 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 515' ' ' SER . 40.3 mt-10 . . . . . 0 C--N 1.285 -2.199 0 N-CA-C 107.627 -1.249 . . . . 72.319999999999993 107.627 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 502' ' ' ALA . . . . . 0.551 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 121.158 0.504 . . . . 71.219999999999999 112.293 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 128.02 -136.78 9.36 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 119.417 -1.373 . . . . 63.539999999999999 112.186 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.74 112.48 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 111.171 0.063 . . . . 64.239999999999995 111.171 -174.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.483 ' CD2' HG23 ' A' ' 528' ' ' THR . 11.4 m-85 -99.75 120.69 40.13 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.666 -1.235 . . . . 71.420000000000002 107.666 167.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.3 t -163.96 178.65 7.57 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.647 -0.501 . . . . 65.209999999999994 109.647 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -81.39 143.61 32.03 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.885 -0.413 . . . . 71.25 109.885 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -61.31 -37.78 84.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 123.723 0.639 . . . . 74.430000000000007 109.89 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -125.34 144.83 48.87 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 108.089 -1.078 . . . . 72.409999999999997 108.089 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.88 -27.68 2.96 Favored 'Trans proline' 0 C--N 1.329 -0.448 0 C-N-CA 122.163 1.909 . . . . 72.129999999999995 112.389 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.6 t -137.39 135.32 46.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.901 -1.518 . . . . 72.140000000000001 106.901 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.6 t -133.68 136.53 44.79 Favored 'General case' 0 N--CA 1.409 -2.49 0 N-CA-C 108.99 -0.745 . . . . 54.229999999999997 108.99 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -109.48 120.09 41.43 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.135 -0.691 . . . . 74.430000000000007 109.135 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 25.2 m -108.19 174.48 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 115.548 -0.751 . . . . 71.340000000000003 109.983 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.432 ' OG ' ' HB ' ' A' ' 518' ' ' ILE . 0.0 OUTLIER -96.8 164.06 12.72 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.4 -0.818 . . . . 65.140000000000001 110.495 -178.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -82.24 -54.29 5.37 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.248 -1.019 . . . . 61.32 108.248 171.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 12.1 m -80.71 31.79 0.3 Allowed 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.512 0.725 . . . . 74.530000000000001 112.1 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.432 ' HB ' ' OG ' ' A' ' 515' ' ' SER . 10.1 tt -94.34 -24.81 4.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 O-C-N 121.762 -0.586 . . . . 72.510000000000005 111.062 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.81 -80.53 1.79 Allowed Glycine 0 N--CA 1.417 -2.597 0 C-N-CA 120.329 -0.938 . . . . 71.340000000000003 111.128 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 43.0 mm -128.12 131.5 69.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.739 -1.208 . . . . 71.140000000000001 107.739 -174.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.546 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -109.41 145.1 36.69 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.093 -0.706 . . . . 60.43 109.093 176.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 23.9 mt-10 -124.19 119.57 29.76 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 123.667 0.604 . . . . 72.420000000000002 111.747 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.62 HG11 HD22 ' A' ' 642' ' ' LEU . 95.5 t -103.56 128.86 56.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 116.029 -0.532 . . . . 74.120000000000005 110.423 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -80.31 137.45 36.59 Favored 'General case' 0 C--O 1.248 0.981 0 O-C-N 123.515 0.51 . . . . 65.209999999999994 110.502 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 568' ' ' VAL . 59.9 t -112.75 132.82 60.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 116.147 -0.479 . . . . 73.549999999999997 109.741 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.81 126.68 31.4 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 122.928 0.491 . . . . 65.450000000000003 110.074 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -81.32 157.09 25.2 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.307 -0.861 . . . . 62.039999999999999 109.314 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 0.9 OUTLIER -59.97 145.8 44.84 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 123.333 0.653 . . . . 63.140000000000001 112.295 177.623 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 41.4 t -60.15 -34.98 74.3 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.153 -0.931 . . . . 74.239999999999995 110.093 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.41 81.04 0.35 Allowed Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.638 -0.985 . . . . 34.43 110.638 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.06 114.02 21.9 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.305 -0.998 . . . . 61.340000000000003 108.305 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -119.15 97.91 5.91 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.499 0.666 . . . . 75.109999999999999 110.711 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 108.89 -130.8 10.22 Favored Glycine 0 N--CA 1.427 -1.965 0 CA-C-N 115.397 -0.82 . . . . 55.25 112.772 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.509 HD22 ' HG2' ' A' ' 563' ' ' GLN . 2.6 t-20 -133.15 127.74 34.53 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.892 -0.781 . . . . 70.439999999999998 108.892 -177.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 61.3 t -132.18 141.82 44.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 123.185 0.594 . . . . 74.140000000000001 110.135 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.434 HG12 ' CG2' ' A' ' 597' ' ' VAL . 36.8 mm -111.35 129.99 65.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.197 -0.668 . . . . 74.030000000000001 109.197 175.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.407 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.2 t -115.04 105.96 52.19 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 109.203 -0.666 . . . . 73.140000000000001 109.203 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.82 152.35 36.95 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.319 2.013 . . . . 43.0 112.287 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.643 ' HB3' HG22 ' A' ' 591' ' ' ILE . 49.9 p90 -147.33 164.97 31.56 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.526 -0.306 . . . . 72.439999999999998 111.057 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -156.39 158.1 36.76 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.709 0.63 . . . . 72.219999999999999 109.916 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.3 p -87.78 141.75 28.36 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 115.656 -0.702 . . . . 71.25 110.102 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.533 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 90.3 mt -116.84 132.53 66.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.555 -1.276 . . . . 73.219999999999999 107.555 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -81.0 148.22 29.84 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 109.801 -0.444 . . . . 62.020000000000003 109.801 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -141.88 -117.3 1.3 Allowed Glycine 0 C--N 1.292 -1.88 0 N-CA-C 108.671 -1.772 . . . . 72.030000000000001 108.671 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . 0.412 ' O ' ' HD3' ' A' ' 585' ' ' LYS . 16.7 p -78.34 -23.87 46.78 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.127 -1.064 . . . . 72.409999999999997 108.127 173.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 587' ' ' PHE . . . -91.84 135.52 33.86 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 106.982 -1.488 . . . . 71.329999999999998 106.982 172.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -106.81 151.99 24.46 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 113.717 1.006 . . . . 65.129999999999995 113.717 -174.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -91.24 -176.41 43.47 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 114.899 -1.046 . . . . 51.509999999999998 111.707 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 91.63 22.77 30.32 Favored Glycine 0 C--N 1.294 -1.77 0 N-CA-C 110.152 -1.179 . . . . 62.100000000000001 110.152 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 70.54 33.98 67.62 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 109.539 -1.424 . . . . 74.430000000000007 109.539 -176.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -95.66 -66.88 0.88 Allowed 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 110.08 -0.341 . . . . 64.329999999999998 110.08 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -104.41 -38.29 6.88 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.19 -1.041 . . . . 62.240000000000002 108.19 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -132.91 158.35 42.8 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.246 -0.888 . . . . 65.230000000000004 108.693 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.53 129.12 37.56 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.589 -1.263 . . . . 73.439999999999998 107.589 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.36 136.99 50.16 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 123.367 0.667 . . . . 74.409999999999997 110.175 -175.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.405 HG21 HG22 ' A' ' 573' ' ' VAL . 9.0 t -139.76 144.87 37.63 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.413 0.625 . . . . 65.0 110.03 176.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 14.2 p -143.94 133.29 23.24 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 106.275 -1.75 . . . . 41.219999999999999 106.275 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -159.49 -169.89 23.38 Favored Glycine 0 N--CA 1.404 -3.459 0 C-N-CA 118.602 -1.761 . . . . 74.129999999999995 112.385 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -139.82 115.23 9.91 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 124.659 0.858 . . . . 63.43 108.751 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.481 HD22 ' HB3' ' A' ' 569' ' ' LYS . 86.7 mt -89.54 133.55 34.54 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.571 -0.529 . . . . 63.229999999999997 109.571 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -101.95 119.34 38.63 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.173 0.511 . . . . 73.030000000000001 110.815 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -119.03 150.06 40.6 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.826 -0.805 . . . . 71.230000000000004 108.826 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.539 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 16.9 mt-30 -146.42 179.01 7.82 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.364 -1.347 . . . . 61.229999999999997 107.364 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -70.19 -25.77 63.58 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 123.64 0.588 . . . . 60.509999999999998 110.423 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -90.75 -33.61 15.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.988 -0.551 . . . . 60.340000000000003 111.915 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.539 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 72.5 mm-40 -66.84 152.61 45.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.918 0.39 . . . . 72.25 111.706 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.561 HG13 ' H ' ' A' ' 568' ' ' VAL . 5.8 pt -103.52 -86.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 113.38 0.881 . . . . 63.149999999999999 113.38 -177.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.561 ' H ' HG13 ' A' ' 567' ' ' ILE . 13.2 p -132.26 148.87 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 120.789 0.328 . . . . 71.400000000000006 110.221 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.481 ' HB3' HD22 ' A' ' 560' ' ' LEU . 1.5 mtpt -120.66 160.97 22.2 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 116.105 -0.498 . . . . 74.140000000000001 109.66 175.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 5.5 p -125.61 153.78 43.23 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.69 -0.687 . . . . 61.25 111.033 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.4 mp -100.91 122.74 53.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.21 -1.774 . . . . 60.549999999999997 106.21 170.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 521' ' ' MET . 14.8 p -100.91 115.11 29.65 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 123.622 0.577 . . . . 74.219999999999999 109.948 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.42 HG23 HG22 ' A' ' 571' ' ' ILE . 84.3 t -119.43 134.23 63.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.066 -0.515 . . . . 74.420000000000002 110.405 -177.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -84.54 118.86 24.59 Favored 'General case' 0 N--CA 1.428 -1.567 0 O-C-N 123.645 0.591 . . . . 73.219999999999999 109.568 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.05 120.71 36.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 105.953 -1.869 . . . . 73.349999999999994 105.953 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 48.2 mm . . . . . 0 C--N 1.305 -1.358 0 CA-C-O 121.484 0.659 . . . . 43.509999999999998 109.883 -176.066 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.412 ' HD3' ' O ' ' A' ' 545' ' ' THR . 94.8 mttt . . . . . 0 N--CA 1.425 -1.678 0 N-CA-C 106.647 -1.612 . . . . 75.340000000000003 106.647 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.8 t -143.1 148.77 37.18 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 121.248 0.546 . . . . 62.219999999999999 110.721 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.533 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 43.1 p90 -130.57 172.4 11.97 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 106.747 -1.575 . . . . 70.040000000000006 106.747 176.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.514 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 87.2 m-85 -120.24 154.51 34.79 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.195 -0.602 . . . . 73.239999999999995 109.981 -175.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.49 128.7 51.16 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 105.418 -2.067 . . . . 71.109999999999999 105.418 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.517 ' HB2' HD11 ' A' ' 542' ' ' ILE . 35.0 tt0 -129.19 137.08 50.93 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.598 -0.519 . . . . 74.219999999999999 109.598 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.643 HG22 ' HB3' ' A' ' 539' ' ' TYR . 15.1 pt -104.9 141.58 19.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.535 -0.913 . . . . 74.349999999999994 108.535 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -87.78 -176.58 48.12 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.66 -0.976 . . . . 74.519999999999996 110.66 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -68.47 130.97 91.81 Favored Pre-proline 0 N--CA 1.434 -1.251 0 C-N-CA 120.543 -0.463 . . . . 72.030000000000001 110.847 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.459 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 24.8 Cg_endo -66.95 137.24 44.1 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.013 2.475 . . . . 62.32 111.642 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -112.94 133.61 54.83 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.332 -0.395 . . . . 74.420000000000002 110.425 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -76.02 130.55 38.57 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.066 -1.457 . . . . 72.140000000000001 107.066 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.434 ' CG2' HG12 ' A' ' 536' ' ' ILE . 39.0 t . . . . . 0 C--N 1.293 -1.886 0 N-CA-C 107.84 -1.17 . . . . 65.25 107.84 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.459 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 24.9 Cg_endo . . . . . 0 N--CA 1.44 -1.623 0 N-CA-C 110.293 -0.695 . . . . 72.319999999999993 110.293 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.61 160.72 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 116.397 -0.365 . . . . 70.329999999999998 111.208 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.1 -176.36 3.97 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.822 -0.626 . . . . 62.229999999999997 112.278 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.66 -163.16 9.97 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 116.447 -0.342 . . . . 75.239999999999995 113.455 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -76.14 -46.62 27.85 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.789 -0.449 . . . . 75.420000000000002 109.789 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -136.57 120.94 18.06 Favored 'General case' 0 CA--C 1.49 -1.354 0 CA-C-O 121.063 0.459 . . . . 62.039999999999999 109.822 174.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 31.3 p -108.14 94.65 5.18 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-O 121.778 0.799 . . . . 60.109999999999999 109.774 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -151.31 146.73 26.22 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.972 -1.013 . . . . 72.439999999999998 108.638 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.62 HD22 HG11 ' A' ' 523' ' ' VAL . 26.3 tp -134.92 120.4 19.21 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 107.924 -1.139 . . . . 64.530000000000001 107.924 175.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -91.38 108.56 19.97 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.206 -1.405 . . . . 72.230000000000004 107.206 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 39.5 t -100.42 109.46 25.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 109.526 -0.546 . . . . 61.039999999999999 109.526 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 47.3 mt -93.87 129.64 43.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.343 -0.984 . . . . 61.509999999999998 108.343 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 77.1 mt -99.91 107.33 20.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.973 -0.751 . . . . 72.209999999999994 108.973 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 515' ' ' SER . 38.2 mt-10 . . . . . 0 C--N 1.307 -1.245 0 CA-C-O 121.628 0.728 . . . . 60.130000000000003 111.725 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.633 0 N-CA-C 111.48 0.178 . . . . 63.100000000000001 111.48 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 163.36 -145.76 10.89 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.695 -1.24 . . . . 74.510000000000005 112.134 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.15 121.69 58.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 122.428 0.291 . . . . 65.129999999999995 110.923 -174.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -105.44 125.44 50.99 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.204 -0.665 . . . . 72.430000000000007 109.204 169.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . 0.466 ' HA ' HG22 ' A' ' 640' ' ' THR . 9.0 t -162.79 169.01 20.58 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.393 -0.595 . . . . 72.319999999999993 109.393 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -74.6 148.36 40.82 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.477 0.18 . . . . 74.439999999999998 110.714 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -68.13 -26.8 65.97 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.529 0.681 . . . . 72.519999999999996 110.124 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -140.76 141.01 23.18 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 107.33 -1.359 . . . . 53.350000000000001 107.33 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.48 -28.86 8.05 Favored 'Trans proline' 0 C--N 1.328 -0.539 0 C-N-CA 122.426 2.084 . . . . 70.150000000000006 111.637 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.9 t -132.69 136.34 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 106.293 -1.743 . . . . 62.32 106.293 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 7.5 t -131.71 140.76 49.37 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 108.82 -0.807 . . . . 74.540000000000006 108.82 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -113.07 123.35 50.09 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.073 -0.651 . . . . 44.43 109.677 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 20.8 m -112.66 174.34 2.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 115.249 -0.887 . . . . 62.020000000000003 108.897 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.568 ' O ' HG22 ' A' ' 518' ' ' ILE . 36.1 t -107.29 151.17 25.83 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.652 0.739 . . . . 21.210000000000001 111.882 -175.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -62.19 -23.51 66.66 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 125.732 1.613 . . . . 44.340000000000003 109.705 170.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 4.2 t -123.17 26.35 8.05 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 120.977 0.418 . . . . 71.409999999999997 111.402 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 515' ' ' SER . 8.5 tt -84.11 -27.87 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.55 -0.719 . . . . 63.219999999999999 110.664 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.21 -80.04 1.57 Allowed Glycine 0 N--CA 1.428 -1.856 0 N-CA-C 111.056 -0.817 . . . . 71.129999999999995 111.056 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 574' ' ' LYS . 40.2 mm -127.92 133.17 67.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 106.471 -1.677 . . . . 63.140000000000001 106.471 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.607 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -109.86 144.07 38.85 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.767 -0.457 . . . . 64.140000000000001 109.767 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 7.8 mp0 -117.9 118.12 31.11 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 124.185 0.928 . . . . 62.43 109.916 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.577 HG23 ' SD ' ' A' ' 521' ' ' MET . 87.4 t -109.45 130.71 62.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.176 -0.676 . . . . 61.409999999999997 109.176 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -88.75 145.16 25.79 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 121.942 0.877 . . . . 74.120000000000005 112.626 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 38.9 t -113.26 137.55 45.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-N 114.437 -1.256 . . . . 65.310000000000002 107.926 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.7 mt -78.22 114.64 17.3 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.813 -0.81 . . . . 73.319999999999993 108.813 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -68.65 157.44 36.19 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.595 -1.184 . . . . 71.239999999999995 109.24 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.1 t -55.57 133.01 50.1 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 123.825 0.703 . . . . 55.439999999999998 111.568 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.7 m -54.59 -28.06 43.55 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.611 1.564 . . . . 55.340000000000003 111.026 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.58 91.93 0.48 Allowed Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 108.748 -1.741 . . . . 71.420000000000002 108.748 174.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -92.7 104.13 16.44 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.972 0.415 . . . . 63.409999999999997 110.411 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -130.27 104.68 7.43 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.069 -0.514 . . . . 71.129999999999995 109.85 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 101.18 -138.79 14.06 Favored Glycine 0 C--N 1.307 -1.08 0 C-N-CA 120.86 -0.686 . . . . 42.240000000000002 112.16 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.47 HD21 ' CG ' ' A' ' 561' ' ' GLU . 2.7 t-20 -133.24 130.56 39.18 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.419 -0.585 . . . . 74.030000000000001 109.419 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.28 134.04 57.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.03 -1.1 . . . . 73.329999999999998 108.03 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.513 HG12 ' CG2' ' A' ' 597' ' ' VAL . 46.3 mm -102.95 135.11 41.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.205 -0.665 . . . . 53.310000000000002 109.205 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 42.8 t -120.11 108.79 37.94 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.577 -0.527 . . . . 73.209999999999994 109.577 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 48.4 Cg_endo -74.3 154.06 45.89 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.277 1.984 . . . . 74.329999999999998 111.748 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.478 ' HB3' HG22 ' A' ' 591' ' ' ILE . 33.1 p90 -145.59 164.2 32.44 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.942 -0.303 . . . . 60.210000000000001 110.709 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -157.02 156.85 33.61 Favored 'General case' 0 C--O 1.248 0.978 0 O-C-N 123.835 0.709 . . . . 74.439999999999998 110.225 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.2 p -89.15 139.84 30.06 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 116.075 -0.511 . . . . 73.120000000000005 110.109 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 78.0 mt -112.01 129.24 67.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.812 -0.81 . . . . 74.540000000000006 108.812 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -83.02 164.7 20.19 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.156 -0.683 . . . . 65.099999999999994 109.156 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 172.1 -82.73 0.08 OUTLIER Glycine 0 CA--C 1.474 -2.469 0 C-N-CA 120.031 -1.081 . . . . 60.109999999999999 111.749 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.8 m -101.92 19.4 18.44 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.513 1.149 . . . . 63.439999999999998 108.402 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -162.84 148.82 12.29 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 106.169 -1.789 . . . . 51.200000000000003 106.169 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -104.59 141.07 37.07 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 123.712 0.805 . . . . 75.439999999999998 112.116 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.63 -160.41 36.46 Favored Glycine 0 C--N 1.306 -1.116 0 CA-C-N 115.433 -0.803 . . . . 64.329999999999998 112.704 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 71.65 12.66 74.2 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.751 -0.261 . . . . 30.129999999999999 113.499 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 90.11 19.36 46.85 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.459 -0.877 . . . . 64.439999999999998 111.043 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -89.18 -67.32 0.85 Allowed 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.59 -0.522 . . . . 74.439999999999998 109.59 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -102.13 -33.69 9.57 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.657 -1.238 . . . . 72.209999999999994 107.657 172.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -141.33 154.99 45.99 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.591 -0.892 . . . . 72.430000000000007 108.591 176.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.14 120.28 27.35 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.596 -1.631 . . . . 74.450000000000003 106.596 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -80.66 124.58 29.12 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.064 -0.516 . . . . 73.340000000000003 110.531 -171.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.7 t -136.2 168.68 18.95 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.35 0.595 . . . . 64.349999999999994 111.199 -172.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 14.8 p -158.52 164.44 36.13 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.97 -1.122 . . . . 64.430000000000007 107.97 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 173.57 -169.44 42.53 Favored Glycine 0 CA--C 1.482 -1.982 0 C-N-CA 120.156 -1.021 . . . . 74.010000000000005 110.853 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 46.1 mt-10 -137.14 125.42 23.22 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 123.428 0.691 . . . . 73.209999999999994 109.319 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.485 HD22 ' HB3' ' A' ' 569' ' ' LYS . 96.5 mt -96.05 132.42 41.44 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.257 -0.429 . . . . 75.109999999999999 109.862 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.47 ' CG ' HD21 ' A' ' 534' ' ' ASN . 29.0 tt0 -94.91 111.23 23.04 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.22 0.534 . . . . 72.209999999999994 110.806 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 81.9 m-85 -107.98 142.59 37.87 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.063 0.459 . . . . 75.230000000000004 110.002 177.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.486 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 43.0 mt-30 -140.42 179.9 6.39 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.45 -0.574 . . . . 74.420000000000002 109.45 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -68.36 -34.61 76.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.82 -1.082 . . . . 72.549999999999997 108.894 173.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -85.14 -39.99 17.25 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.033 -0.985 . . . . 73.549999999999997 111.692 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.486 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 52.2 mm-40 -65.49 135.08 54.72 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.084 0.402 . . . . 64.299999999999997 112.084 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.617 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.8 pt -83.76 -81.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.227 0.825 . . . . 73.319999999999993 113.227 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.617 ' H ' HG13 ' A' ' 567' ' ' ILE . 9.0 p -128.79 158.48 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 109.555 -0.535 . . . . 70.120000000000005 109.555 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.485 ' HB3' HD22 ' A' ' 560' ' ' LEU . 4.5 mmpt? -125.94 159.26 33.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.078 -1.082 . . . . 72.340000000000003 108.078 172.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 5.8 p -130.14 149.07 52.01 Favored 'General case' 0 C--N 1.286 -2.194 0 O-C-N 123.832 0.707 . . . . 71.030000000000001 111.673 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.9 mp -94.79 125.53 47.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 106.825 -1.546 . . . . 73.400000000000006 106.825 172.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 521' ' ' MET . 48.6 m -107.07 118.36 36.5 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 123.958 0.786 . . . . 73.409999999999997 110.068 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.401 HG23 HG22 ' A' ' 571' ' ' ILE . 76.4 t -125.45 134.42 66.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.097 -0.501 . . . . 54.109999999999999 109.874 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.408 ' HA ' HD13 ' A' ' 520' ' ' ILE . 27.5 tptp -79.87 115.02 19.22 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.883 -0.784 . . . . 64.239999999999995 108.883 174.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.24 130.19 36.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.604 -1.258 . . . . 72.25 107.604 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 44.1 mm . . . . . 0 N--CA 1.421 -1.895 0 N-CA-C 108.174 -1.047 . . . . 73.340000000000003 108.174 179.144 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp . . . . . 0 N--CA 1.421 -1.915 0 N-CA-C 107.819 -1.178 . . . . 71.219999999999999 107.819 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.7 t -132.73 130.64 40.27 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.626 0.727 . . . . 64.140000000000001 111.402 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -121.37 172.42 8.05 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.418 -0.956 . . . . 72.219999999999999 108.418 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.506 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 90.8 m-85 -118.7 152.48 36.05 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.947 -0.701 . . . . 75.030000000000001 109.855 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.54 130.22 54.14 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.304 -1.739 . . . . 72.109999999999999 106.304 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.474 ' HB2' HD11 ' A' ' 542' ' ' ILE . 43.3 tt0 -127.02 134.44 50.32 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.624 -0.43 . . . . 62.310000000000002 109.865 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.478 HG22 ' HB3' ' A' ' 539' ' ' TYR . 21.3 pt -102.56 139.78 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 107.673 -1.232 . . . . 72.010000000000005 107.673 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.45 177.2 52.73 Favored Glycine 0 N--CA 1.421 -2.343 0 C-N-CA 120.997 -0.62 . . . . 43.450000000000003 111.622 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.16 129.06 94.18 Favored Pre-proline 0 N--CA 1.428 -1.531 0 CA-C-O 120.86 0.362 . . . . 73.319999999999993 110.631 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.405 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 23.3 Cg_endo -60.24 132.94 46.72 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.485 2.79 . . . . 71.519999999999996 112.291 -175.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . 0.403 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.0 ptp180 -110.41 119.96 40.9 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 120.993 0.425 . . . . 64.109999999999999 110.658 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.49 131.82 47.38 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.731 0.813 . . . . 70.140000000000001 108.858 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.513 ' CG2' HG12 ' A' ' 536' ' ' ILE . 61.0 t . . . . . 0 C--N 1.298 -1.672 0 N-CA-C 109.46 -0.57 . . . . 74.409999999999997 109.46 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.405 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 55.5 Cg_endo . . . . . 0 N--CA 1.435 -1.913 0 N-CA-C 111.016 -0.417 . . . . 70.319999999999993 111.016 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.93 170.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 116.174 -0.466 . . . . 73.540000000000006 110.876 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.34 170.65 7.82 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 112.786 0.661 . . . . 75.349999999999994 112.786 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -78.51 -158.08 11.38 Favored Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 114.834 -1.075 . . . . 73.329999999999998 115.283 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -66.78 -54.52 21.83 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.082 -1.059 . . . . 71.409999999999997 110.853 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -126.81 137.49 53.21 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.56 -0.904 . . . . 73.019999999999996 108.56 175.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 506' ' ' THR . 8.7 p -127.12 73.68 1.44 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 122.344 1.069 . . . . 72.120000000000005 111.336 174.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -157.42 141.2 15.88 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 114.475 -1.239 . . . . 60.149999999999999 107.962 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.544 HD22 HG11 ' A' ' 523' ' ' VAL . 38.5 tp -124.4 130.24 52.12 Favored 'General case' 0 C--N 1.279 -2.484 0 O-C-N 124.181 0.926 . . . . 75.219999999999999 109.35 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -94.46 107.38 19.35 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.059 -1.46 . . . . 63.140000000000001 107.059 174.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.1 109.63 24.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.269 -0.641 . . . . 74.0 109.269 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 52.6 mt -96.76 122.91 48.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 109.012 -0.736 . . . . 73.310000000000002 109.012 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 82.2 mt -87.72 111.82 22.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 106.9 -1.519 . . . . 74.430000000000007 106.9 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 N--CA 1.422 -1.83 0 N-CA-C 109.364 -0.606 . . . . 65.310000000000002 109.364 178.342 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 502' ' ' ALA . . . . . 0.533 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 121.385 0.612 . . . . 75.019999999999996 110.993 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 139.88 -149.51 20.86 Favored Glycine 0 N--CA 1.419 -2.486 0 C-N-CA 120.304 -0.95 . . . . 72.049999999999997 110.875 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.43 HG23 ' HA3' ' A' ' 637' ' ' GLY . 3.8 mp -117.24 113.43 42.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 123.687 0.287 . . . . 51.100000000000001 111.237 -174.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.435 ' CD2' HG23 ' A' ' 528' ' ' THR . 21.8 m-85 -92.04 124.82 36.43 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.725 -1.213 . . . . 71.109999999999999 107.725 169.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.7 t -168.72 171.46 8.64 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 120.554 -0.458 . . . . 62.439999999999998 109.883 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -80.55 157.39 26.1 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.839 -0.801 . . . . 71.25 108.839 175.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.74 -35.51 80.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.506 0.67 . . . . 64.239999999999995 110.32 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -140.18 149.36 57.92 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.487 -0.931 . . . . 75.420000000000002 108.487 -176.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . 0.434 ' O ' ' HA ' ' A' ' 642' ' ' LEU . 60.9 Cg_endo -75.53 -24.97 11.51 Favored 'Trans proline' 0 C--O 1.219 -0.437 0 C-N-CA 122.158 1.906 . . . . 75.129999999999995 112.77 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.75 135.76 58.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.981 -0.748 . . . . 74.230000000000004 108.981 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 9.5 t -135.03 140.08 45.32 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 107.714 -1.217 . . . . 64.239999999999995 107.714 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -108.73 138.41 45.09 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.651 -0.87 . . . . 73.540000000000006 108.651 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.8 m -128.65 156.38 41.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.953 -0.758 . . . . 62.310000000000002 108.953 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.592 ' O ' HG22 ' A' ' 518' ' ' ILE . 33.0 t -83.48 150.84 25.76 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.795 -0.639 . . . . 75.019999999999996 109.323 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -66.89 -32.64 74.04 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.494 -0.558 . . . . 64.530000000000001 109.494 170.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.7 m -99.29 20.46 13.56 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 116.142 -0.481 . . . . 65.409999999999997 112.117 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 515' ' ' SER . 9.9 tt -79.23 -27.52 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.542 -0.724 . . . . 74.209999999999994 111.529 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 92.3 -77.16 1.26 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.29 -0.957 . . . . 51.229999999999997 111.327 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 574' ' ' LYS . 42.4 mm -130.53 123.58 55.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 106.719 -1.586 . . . . 72.319999999999993 106.719 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -101.43 150.52 22.95 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.798 -0.816 . . . . 74.219999999999999 108.798 177.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.7 mt-10 -132.06 129.18 39.68 Favored 'General case' 0 CA--C 1.493 -1.247 0 O-C-N 123.702 0.626 . . . . 73.230000000000004 111.033 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.582 HG21 HD21 ' A' ' 642' ' ' LEU . 60.9 t -116.4 132.04 67.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.282 -0.872 . . . . 54.200000000000003 108.978 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -85.45 127.82 34.52 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 124.138 0.975 . . . . 71.340000000000003 110.252 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 60.3 t -110.41 128.57 66.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.885 -0.598 . . . . 72.219999999999999 109.645 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 77.9 mt -81.75 127.97 33.5 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.012 -0.994 . . . . 62.420000000000002 112.031 -173.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -72.12 162.18 29.83 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.387 -0.968 . . . . 74.310000000000002 108.387 172.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 19.4 p -58.7 154.52 14.45 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 123.503 0.721 . . . . 71.299999999999997 112.341 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 41.0 t -53.83 -35.18 61.18 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.793 1.237 . . . . 62.32 109.498 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -114.82 103.7 1.29 Allowed Glycine 0 N--CA 1.42 -2.407 0 N-CA-C 108.841 -1.704 . . . . 54.509999999999998 108.841 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.71 101.7 12.99 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.194 -0.669 . . . . 70.329999999999998 109.194 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -127.02 117.99 23.57 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.796 -0.816 . . . . 64.439999999999998 108.796 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 77.22 172.04 36.56 Favored Glycine 0 C--N 1.298 -1.562 0 N-CA-C 115.016 0.767 . . . . 63.009999999999998 115.016 173.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.411 HD22 ' HG2' ' A' ' 563' ' ' GLN . 2.7 t-20 -86.01 123.23 31.1 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.519 -0.84 . . . . 72.519999999999996 109.127 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.402 HG22 HD22 ' A' ' 596' ' ' LEU . 58.0 t -132.01 132.9 61.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 114.8 -1.091 . . . . 72.129999999999995 108.204 -175.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.484 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 43.8 mm -102.81 132.25 49.34 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 109.375 -0.602 . . . . 71.209999999999994 109.375 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.53 105.77 43.27 Favored Pre-proline 0 N--CA 1.427 -1.594 0 N-CA-C 108.736 -0.839 . . . . 75.140000000000001 108.736 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 34.8 Cg_endo -72.55 151.98 53.54 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.169 1.912 . . . . 71.120000000000005 111.672 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.42 ' HB3' HG22 ' A' ' 591' ' ' ILE . 32.3 p90 -142.6 163.27 33.28 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.459 -0.496 . . . . 72.310000000000002 110.104 177.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -153.67 151.37 29.59 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 123.929 0.768 . . . . 75.239999999999995 110.01 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 11.1 p -85.78 133.13 34.01 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 109.377 -0.601 . . . . 75.319999999999993 109.377 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 67.5 mt -108.08 124.2 64.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 108.178 -1.045 . . . . 73.209999999999994 108.178 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -73.14 136.03 44.77 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 120.945 0.402 . . . . 74.5 110.321 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -126.61 -104.43 1.35 Allowed Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 109.352 -1.499 . . . . 54.219999999999999 109.352 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.7 p -94.57 -21.32 18.92 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.489 0.662 . . . . 64.420000000000002 109.61 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -84.01 142.29 30.58 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 108.44 -0.948 . . . . 72.209999999999994 108.44 175.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -87.32 123.3 32.15 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 114.305 1.224 . . . . 73.230000000000004 114.305 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -81.92 -158.8 23.26 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 115.043 -0.981 . . . . 53.109999999999999 112.101 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.36 14.36 71.66 Favored Glycine 0 C--N 1.306 -1.1 0 C-N-CA 121.312 -0.471 . . . . 52.439999999999998 112.837 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 554' ' ' GLU . . . 77.92 39.02 25.4 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.905 -0.664 . . . . 33.409999999999997 111.836 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -111.9 -50.97 2.88 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.441 0.639 . . . . 62.409999999999997 109.949 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -104.07 -47.14 4.25 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 105.821 -1.918 . . . . 63.009999999999998 105.821 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -134.11 154.21 51.34 Favored 'General case' 0 C--O 1.256 1.421 0 CA-C-N 114.329 -1.305 . . . . 75.030000000000001 108.152 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.417 ' HA ' ' HA2' ' A' ' 550' ' ' GLY . 16.4 tt0 -81.21 119.38 23.54 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.25 -1.389 . . . . 70.420000000000002 107.25 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.88 125.15 28.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.093 -1.077 . . . . 74.349999999999994 108.093 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.409 HG21 HG22 ' A' ' 573' ' ' VAL . 12.0 t -140.02 159.41 42.25 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-O 121.618 0.723 . . . . 45.009999999999998 110.609 -171.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 23.0 p -147.22 165.74 29.12 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 107.331 -1.359 . . . . 75.420000000000002 107.331 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 176.16 -174.32 46.86 Favored Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 120.044 -1.074 . . . . 42.229999999999997 110.82 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.484 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 51.7 mt-10 -134.38 119.55 18.75 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 123.271 0.628 . . . . 75.420000000000002 109.325 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' A' ' 569' ' ' LYS . 88.7 mt -86.53 132.47 33.91 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.985 -0.552 . . . . 62.109999999999999 109.811 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.483 ' HA ' HD13 ' A' ' 536' ' ' ILE . 34.9 tt0 -101.53 106.38 17.47 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.745 -0.661 . . . . 73.409999999999997 110.019 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -105.42 149.68 25.93 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.75 -0.833 . . . . 72.25 108.75 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.576 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 6.3 mt-30 -143.96 -169.16 3.04 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.204 -1.406 . . . . 64.010000000000005 107.204 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -76.12 -19.48 58.48 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.595 -0.891 . . . . 71.219999999999999 108.595 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -88.54 -45.1 10.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.31 -1.314 . . . . 62.25 110.521 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.576 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 6.0 mm-40 -74.9 122.51 23.53 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.943 0.401 . . . . 74.409999999999997 111.817 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.493 HD12 HG12 ' A' ' 568' ' ' VAL . 1.8 pp -106.99 -32.51 2.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 115.122 -0.944 . . . . 54.25 113.16 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.493 HG12 HD12 ' A' ' 567' ' ' ILE . 9.4 p -143.43 145.76 22.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 120.275 -0.57 . . . . 71.129999999999995 110.494 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.443 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.1 OUTLIER -127.59 162.18 27.09 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.798 -0.637 . . . . 64.420000000000002 109.612 174.06 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.7 p -122.32 143.33 49.7 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.588 0.588 . . . . 53.009999999999998 112.588 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.6 mp -94.63 117.84 39.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 106.591 -1.633 . . . . 63.210000000000001 106.591 170.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 521' ' ' MET . 8.1 p -98.31 115.52 28.59 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.712 0.632 . . . . 65.310000000000002 109.498 178.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.557 HG23 HG22 ' A' ' 571' ' ' ILE . 60.1 t -121.52 124.66 72.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 116.295 -0.412 . . . . 74.430000000000007 110.66 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.42 ' HA ' HD13 ' A' ' 520' ' ' ILE . 13.6 tppt? -71.91 120.83 18.07 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.965 -1.016 . . . . 72.040000000000006 108.678 173.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 28.2 t -92.37 130.33 41.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 104.73 -2.322 . . . . 53.140000000000001 104.73 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 44.0 mm . . . . . 0 C--N 1.289 -2.031 0 N-CA-C 108.762 -0.829 . . . . 73.019999999999996 108.762 -173.418 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.289 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.314 0 N-CA-C 114.196 1.184 . . . . 60.43 114.196 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.9 t -141.79 159.02 43.08 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.767 -1.106 . . . . 61.130000000000003 110.349 -172.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 40.3 p90 -132.79 168.69 17.91 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 106.693 -1.595 . . . . 75.200000000000003 106.693 175.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.533 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 63.6 m-85 -115.74 155.74 27.23 Favored 'General case' 0 C--N 1.283 -2.284 0 C-N-CA 120.34 -0.544 . . . . 75.400000000000006 110.342 -175.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.21 126.19 46.51 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 105.717 -1.957 . . . . 62.039999999999999 105.717 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.401 ' HB2' HD11 ' A' ' 542' ' ' ILE . 42.4 tt0 -127.16 129.77 48.5 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 120.534 -0.467 . . . . 75.340000000000003 109.871 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.42 HG22 ' HB3' ' A' ' 539' ' ' TYR . 21.5 pt -98.96 136.2 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 N-CA-C 108.046 -1.094 . . . . 64.409999999999997 108.046 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.03 -177.87 52.13 Favored Glycine 0 N--CA 1.421 -2.365 0 CA-C-N 115.496 -0.775 . . . . 62.219999999999999 111.369 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -64.82 133.71 95.82 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 120.742 0.306 . . . . 74.340000000000003 111.497 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -69.01 124.09 11.02 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 122.697 2.265 . . . . 71.450000000000003 110.558 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -111.41 125.1 53.51 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 109.65 -0.5 . . . . 70.040000000000006 109.65 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.421 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 1.4 tm? -66.33 133.13 49.88 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 105.204 -2.147 . . . . 74.230000000000004 105.204 174.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.435 HG22 HG12 ' A' ' 536' ' ' ILE . 63.4 t . . . . . 0 C--N 1.3 -1.567 0 CA-C-O 121.759 0.79 . . . . 75.109999999999999 110.861 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 596' ' ' LEU . 36.7 Cg_endo . . . . . 0 C--O 1.243 0.756 0 CA-C-O 121.415 0.506 . . . . 75.430000000000007 112.389 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -126.71 164.08 27.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.591 -0.732 . . . . 72.140000000000001 109.89 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.53 173.56 7.56 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 112.875 0.694 . . . . 70.409999999999997 112.875 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.43 ' HA3' HG23 ' A' ' 504' ' ' ILE . . . -74.88 -171.89 28.8 Favored Glycine 0 N--CA 1.43 -1.709 0 CA-C-N 115.579 -0.737 . . . . 74.329999999999998 114.354 -176.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.73 -40.52 88.39 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.168 0.987 . . . . 74.25 109.744 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -133.3 138.51 46.44 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.904 -0.776 . . . . 70.329999999999998 108.904 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 19.1 p -136.53 88.17 2.35 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.746 0.784 . . . . 63.210000000000001 109.217 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -159.73 145.19 15.58 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.019 -0.991 . . . . 74.409999999999997 108.797 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.582 HD21 HG21 ' A' ' 523' ' ' VAL . 25.8 tp -136.14 120.55 18.08 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 108.717 -0.845 . . . . 72.099999999999994 108.717 176.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -91.68 105.33 17.65 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.831 -1.544 . . . . 72.400000000000006 106.831 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 36.7 t -98.69 106.25 18.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.468 -0.567 . . . . 72.120000000000005 109.468 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 53.6 mt -89.94 128.98 41.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 109.014 -0.736 . . . . 70.209999999999994 109.014 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 55.3 mt -104.4 103.55 15.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.238 -0.652 . . . . 73.239999999999995 109.238 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--N 1.288 -2.076 0 CA-C-N 115.892 -0.595 . . . . 74.420000000000002 109.478 178.544 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.085 0 N-CA-C 112.205 0.446 . . . . 61.420000000000002 112.205 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 135.91 -141.53 12.68 Favored Glycine 0 C--N 1.313 -0.697 0 C-N-CA 118.892 -1.623 . . . . 64.409999999999997 113.424 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.7 119.52 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 C-N-CA 122.893 0.477 . . . . 45.340000000000003 110.327 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -98.57 135.15 40.52 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.254 -1.387 . . . . 73.349999999999994 107.254 168.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . 0.471 ' HA ' HG22 ' A' ' 640' ' ' THR . 12.9 t -169.41 -179.96 3.65 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.959 -0.756 . . . . 72.319999999999993 108.959 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . 0.454 ' CZ ' HG23 ' A' ' 591' ' ' ILE . 67.4 m-85 -84.4 151.84 24.42 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.937 -0.394 . . . . 75.030000000000001 109.937 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -67.0 -31.75 72.53 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.439 0.638 . . . . 62.450000000000003 110.059 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -135.0 141.53 38.66 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.532 -1.285 . . . . 71.099999999999994 107.532 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.59 -26.32 7.2 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 122.289 1.993 . . . . 73.219999999999999 112.459 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 61.1 t -139.73 132.31 35.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 106.853 -1.536 . . . . 65.400000000000006 106.853 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.8 t -127.68 138.71 52.89 Favored 'General case' 0 N--CA 1.414 -2.226 0 C-N-CA 120.252 -0.579 . . . . 72.209999999999994 109.994 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -103.64 116.44 32.35 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.541 -0.911 . . . . 74.349999999999994 108.541 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.6 m -117.44 165.5 12.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.418 -0.956 . . . . 75.109999999999999 108.418 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.606 ' O ' HG22 ' A' ' 518' ' ' ILE . 27.3 t -95.95 153.8 17.57 Favored 'General case' 0 N--CA 1.418 -2.072 0 C-N-CA 120.556 -0.457 . . . . 64.200000000000003 109.792 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.76 -34.45 75.61 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.176 -1.046 . . . . 70.129999999999995 108.176 170.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.7 m -98.39 20.34 12.83 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.77 -1.105 . . . . 75.239999999999995 111.966 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.606 HG22 ' O ' ' A' ' 515' ' ' SER . 9.4 tt -82.97 -26.68 7.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 CA-C-O 121.622 0.725 . . . . 73.219999999999999 109.372 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 91.97 -78.66 1.26 Allowed Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.305 -1.118 . . . . 70.450000000000003 110.305 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . 0.448 HD13 ' HA ' ' A' ' 574' ' ' LYS . 32.3 mm -128.99 141.14 47.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 106.839 -1.541 . . . . 73.439999999999998 106.839 -177.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.529 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -122.72 144.82 48.91 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.289 -0.634 . . . . 74.150000000000006 109.289 178.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 10.6 mp0 -115.33 130.5 56.92 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 123.819 0.699 . . . . 74.329999999999998 109.589 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.626 HG11 HD22 ' A' ' 642' ' ' LEU . 59.3 t -116.07 128.41 73.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 109.303 -0.629 . . . . 73.439999999999998 109.303 175.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -81.95 129.91 34.91 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 123.733 0.813 . . . . 74.329999999999998 109.839 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 568' ' ' VAL . 60.0 t -106.1 118.7 54.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.504 -0.924 . . . . 72.150000000000006 108.504 175.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.7 mt -67.44 122.44 17.96 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 123.863 0.727 . . . . 61.210000000000001 111.461 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 567' ' ' ILE . 21.7 tpt180 -68.01 145.69 54.24 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.518 -1.219 . . . . 75.439999999999998 108.946 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 12.4 t -56.5 143.41 35.32 Favored 'General case' 0 N--CA 1.406 -2.637 0 C-N-CA 124.917 1.287 . . . . 72.329999999999998 109.984 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 18.8 t -52.53 -36.14 54.9 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.737 0.815 . . . . 61.340000000000003 111.437 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -116.46 96.15 0.71 Allowed Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.022 -1.231 . . . . 52.43 110.022 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -84.87 101.67 12.49 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.648 -0.871 . . . . 63.520000000000003 108.648 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -124.77 116.88 23.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.822 -0.807 . . . . 71.040000000000006 108.822 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.432 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 77.72 -178.72 51.8 Favored Glycine 0 C--O 1.258 1.602 0 O-C-N 123.695 0.622 . . . . 64.140000000000001 113.84 176.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -90.95 125.83 35.89 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.893 -0.654 . . . . 74.049999999999997 109.522 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 72.6 t -133.16 134.58 57.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.745 -0.661 . . . . 61.229999999999997 109.26 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.58 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 37.8 mm -106.51 134.75 47.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 109.219 -0.66 . . . . 75.400000000000006 109.219 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.65 110.25 32.01 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.741 -0.466 . . . . 72.230000000000004 109.741 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 38.9 Cg_endo -70.65 158.04 56.94 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.338 2.026 . . . . 73.340000000000003 111.583 177.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.437 ' HB3' HG22 ' A' ' 591' ' ' ILE . 52.2 p90 -151.99 155.56 38.24 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.331 -0.618 . . . . 72.430000000000007 109.331 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.64 149.1 28.08 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 123.87 0.731 . . . . 72.530000000000001 112.174 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.1 p -83.44 131.16 35.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 116.003 -0.544 . . . . 75.540000000000006 109.933 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 57.9 mt -103.07 119.91 52.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.003 -1.11 . . . . 53.140000000000001 108.003 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.91 160.61 27.19 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.133 -0.692 . . . . 75.049999999999997 109.133 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 177.69 -97.6 0.11 Allowed Glycine 0 CA--C 1.473 -2.533 0 N-CA-C 110.504 -1.038 . . . . 74.230000000000004 110.504 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . 0.489 ' HB ' ' H ' ' A' ' 586' ' ' THR . 0.2 OUTLIER -71.37 -31.53 67.44 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 109.355 -0.609 . . . . 74.319999999999993 109.355 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -107.67 155.75 19.82 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 108.494 -0.928 . . . . 61.109999999999999 108.494 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -101.01 137.85 38.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.543 0.687 . . . . 75.219999999999999 112.457 -176.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.98 -150.47 12.45 Favored Glycine 0 C--N 1.299 -1.498 0 C-N-CA 120.663 -0.779 . . . . 73.299999999999997 112.716 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 61.02 7.28 8.3 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 115.749 1.06 . . . . 65.010000000000005 115.749 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 90.44 14.59 58.37 Favored Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 118.209 1.005 . . . . 73.349999999999994 110.991 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -87.52 -55.44 3.79 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.165 -0.68 . . . . 71.530000000000001 109.165 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -107.04 -42.26 4.94 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.112 -1.44 . . . . 73.219999999999999 107.112 177.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -140.07 152.38 46.13 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.809 -1.182 . . . . 75.439999999999998 107.809 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.74 112.94 20.53 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.311 -0.996 . . . . 73.150000000000006 108.311 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.99 122.5 17.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.38 1.072 . . . . 55.310000000000002 111.675 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.7 t -131.66 142.35 49.82 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 121.786 0.803 . . . . 61.43 110.577 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 21.4 p -151.71 150.16 29.9 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.559 -1.275 . . . . 71.319999999999993 107.559 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 172.62 -164.03 36.16 Favored Glycine 0 CA--C 1.482 -2.013 0 N-CA-C 109.979 -1.248 . . . . 70.129999999999995 109.979 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.58 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 45.3 mt-10 -133.24 128.06 35.06 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.986 0.393 . . . . 73.219999999999999 111.134 -177.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.464 HD22 ' HB3' ' A' ' 569' ' ' LYS . 95.8 mt -89.44 141.18 28.8 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 123.463 0.705 . . . . 71.319999999999993 109.201 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.464 ' HA ' HD13 ' A' ' 536' ' ' ILE . 36.1 tt0 -103.54 118.28 36.37 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.292 0.568 . . . . 71.049999999999997 110.884 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -116.39 148.75 40.35 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.777 -0.823 . . . . 73.329999999999998 108.777 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.658 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 45.7 mt-30 -140.86 -178.97 5.8 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.826 -0.805 . . . . 53.130000000000003 108.826 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . 0.432 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 3.6 p-10 -71.48 -36.0 71.0 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.597 -0.441 . . . . 74.319999999999993 110.617 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -79.81 -39.3 31.09 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.109 -0.496 . . . . 75.319999999999993 110.167 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.658 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 64.5 mm-40 -63.64 151.86 40.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.556 -0.747 . . . . 73.120000000000005 111.736 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.549 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.2 pt -114.62 -92.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 113.447 0.906 . . . . 63.439999999999998 113.447 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.549 ' H ' HG13 ' A' ' 567' ' ' ILE . 11.7 p -107.86 146.64 13.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 120.885 0.374 . . . . 72.150000000000006 111.331 -174.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.464 ' HB3' HD22 ' A' ' 560' ' ' LEU . 5.3 mmpt? -114.99 165.19 13.15 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.146 -0.687 . . . . 73.140000000000001 109.146 173.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.2 p -131.41 140.35 49.62 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.973 -0.558 . . . . 51.109999999999999 112.088 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.0 mp -95.28 121.03 45.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.811 -1.181 . . . . 73.409999999999997 107.811 173.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 521' ' ' MET . 70.0 m -96.64 117.74 31.63 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 123.981 0.801 . . . . 64.310000000000002 109.035 176.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.474 HG23 HG22 ' A' ' 571' ' ' ILE . 89.6 t -119.31 133.42 66.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 110.239 -0.282 . . . . 71.140000000000001 110.239 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.448 ' HA ' HD13 ' A' ' 520' ' ' ILE . 22.1 tptm -86.37 120.71 28.0 Favored 'General case' 0 N--CA 1.435 -1.218 0 O-C-N 123.684 0.615 . . . . 65.150000000000006 109.363 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 31.0 t -96.05 127.39 48.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.81 -1.182 . . . . 64.129999999999995 107.81 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 34.5 mm . . . . . 0 C--N 1.306 -1.31 0 CA-C-O 120.999 0.428 . . . . 64.25 110.123 -175.459 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.414 0 CA-C-O 121.497 0.665 . . . . 72.319999999999993 112.448 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . 0.489 ' H ' ' HB ' ' A' ' 545' ' ' THR . 5.3 t -153.47 153.3 32.2 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 115.434 -0.803 . . . . 70.239999999999995 109.02 -173.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -133.03 168.38 18.6 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.233 -1.395 . . . . 74.219999999999999 107.233 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.485 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 72.5 m-85 -117.73 151.27 37.61 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 120.084 -0.646 . . . . 74.030000000000001 109.451 -174.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.1 OUTLIER -121.39 128.1 51.87 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 106.378 -1.712 . . . . 72.099999999999994 106.378 178.21 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -124.93 133.94 52.85 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.991 -0.744 . . . . 74.349999999999994 108.991 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.454 HG23 ' CZ ' ' A' ' 507' ' ' PHE . 18.3 pt -97.84 135.84 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 N-CA-C 107.878 -1.156 . . . . 64.299999999999997 107.878 173.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -81.83 173.07 53.53 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 111.017 -0.833 . . . . 62.219999999999999 111.017 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 593' ' ' GLU . 6.1 mp0 -59.41 135.08 88.66 Favored Pre-proline 0 C--N 1.287 -2.122 0 C-N-CA 123.945 0.898 . . . . 74.329999999999998 110.688 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -70.87 122.06 8.47 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 122.495 2.13 . . . . 71.209999999999994 111.074 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 536' ' ' ILE . 1.8 ptm180 -104.51 119.57 39.29 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.591 -0.731 . . . . 75.409999999999997 109.134 -177.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.417 ' HB2' ' CD ' ' A' ' 634' ' ' PRO . 2.3 tm? -66.2 134.55 52.94 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.898 -1.149 . . . . 73.450000000000003 107.898 178.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.45 ' CG2' HG12 ' A' ' 536' ' ' ILE . 25.8 t . . . . . 0 C--N 1.297 -1.695 0 N-CA-C 105.875 -1.898 . . . . 75.120000000000005 105.875 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.417 ' CD ' ' HB2' ' A' ' 596' ' ' LEU . 72.3 Cg_endo . . . . . 0 N--CA 1.429 -2.281 0 N-CA-C 110.4 -0.654 . . . . 55.32 110.4 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 635' ' ' ILE . 0.1 OUTLIER -124.54 162.46 26.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.256 -1.016 . . . . 71.040000000000006 108.256 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.02 -178.43 3.71 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 120.056 -0.658 . . . . 74.319999999999993 111.928 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -75.1 -169.13 24.24 Favored Glycine 0 N--CA 1.445 -0.704 0 O-C-N 123.455 0.472 . . . . 61.439999999999998 112.794 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -68.99 -51.84 35.16 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.181 -0.674 . . . . 72.019999999999996 109.181 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -122.56 131.62 53.92 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.814 0.816 . . . . 75.109999999999999 111.937 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 506' ' ' THR . 16.8 p -126.64 90.06 3.1 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.394 -1.276 . . . . 75.409999999999997 109.781 177.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . 0.403 ' NZ ' ' HB3' ' A' ' 641' ' ' LYS . 5.7 ttpm? -159.54 148.18 17.75 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.519 -0.764 . . . . 74.030000000000001 109.609 -176.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.626 HD22 HG11 ' A' ' 523' ' ' VAL . 30.9 tp -129.51 129.17 44.19 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 108.025 -1.102 . . . . 73.230000000000004 108.025 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -97.58 106.25 18.53 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.894 -1.521 . . . . 63.240000000000002 106.894 175.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 39.6 t -98.55 106.86 19.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.358 -0.608 . . . . 62.119999999999997 109.358 -176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 73.0 mt -91.2 125.3 43.95 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.559 0 N-CA-C 109.35 -0.611 . . . . 73.530000000000001 109.35 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 69.8 mt -100.9 103.92 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 109.056 -0.72 . . . . 73.409999999999997 109.056 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 515' ' ' SER . 14.2 pt-20 . . . . . 0 C--N 1.284 -2.275 0 N-CA-C 108.317 -0.994 . . . . 73.299999999999997 108.317 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.937 0 N-CA-C 108.798 -0.816 . . . . 72.310000000000002 108.798 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 169.3 -159.13 31.94 Favored Glycine 0 N--CA 1.42 -2.376 0 N-CA-C 108.672 -1.771 . . . . 74.510000000000005 108.672 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.457 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.5 mp -114.23 110.83 33.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 117.211 0.505 . . . . 71.530000000000001 110.834 -175.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.475 ' CE2' HG23 ' A' ' 528' ' ' THR . 31.5 m-85 -90.67 124.5 35.12 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.655 -0.868 . . . . 74.109999999999999 108.655 169.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . 0.433 ' HA ' HG22 ' A' ' 640' ' ' THR . 14.1 t -162.47 170.57 18.49 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.78 -0.822 . . . . 74.439999999999998 108.78 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -76.11 146.62 39.17 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 110.27 -0.27 . . . . 74.349999999999994 110.27 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.28 -30.78 71.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.267 0.556 . . . . 74.200000000000003 109.785 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -137.41 145.73 50.71 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 108.735 -0.839 . . . . 75.150000000000006 108.735 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -81.14 -22.64 5.82 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.654 2.236 . . . . 72.109999999999999 112.819 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 47.2 t -141.79 135.11 29.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 106.92 -1.511 . . . . 53.450000000000003 106.92 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.1 t -131.61 141.04 49.56 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 109.494 -0.558 . . . . 73.409999999999997 109.494 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -107.01 124.89 50.28 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.075 0.464 . . . . 75.219999999999999 110.207 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 17.6 m -124.3 163.42 24.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.177 -0.675 . . . . 62.009999999999998 109.177 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 19.2 t -93.64 154.42 17.84 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.954 -0.388 . . . . 74.299999999999997 109.954 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -59.59 -32.74 70.66 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 123.773 0.671 . . . . 75.030000000000001 109.523 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 23.3 t -129.43 65.39 1.47 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.907 0.861 . . . . 63.149999999999999 110.84 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 6.4 tt -98.3 -25.0 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 115.072 -0.967 . . . . 72.310000000000002 109.168 172.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 95.04 -81.05 0.87 Allowed Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.55 -0.75 . . . . 62.030000000000001 111.283 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.5 mm -129.36 127.52 65.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.002 -1.481 . . . . 70.549999999999997 107.002 -176.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.69 148.08 34.19 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.707 -1.22 . . . . 73.409999999999997 107.707 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 33.2 mt-10 -126.75 132.16 51.15 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 123.576 0.547 . . . . 74.129999999999995 111.989 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.609 HG11 HD22 ' A' ' 642' ' ' LEU . 21.5 t -112.91 129.3 68.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.944 -1.132 . . . . 64.329999999999998 107.944 178.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -86.04 134.77 33.82 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.795 -0.817 . . . . 71.319999999999993 108.795 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 568' ' ' VAL . 44.8 t -108.8 127.89 65.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.845 -0.798 . . . . 73.230000000000004 108.845 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.96 126.45 29.79 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.869 -0.605 . . . . 73.329999999999998 110.314 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -79.33 161.41 26.26 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.486 -1.234 . . . . 71.420000000000002 109.926 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.475 HG23 ' CE2' ' A' ' 505' ' ' PHE . 6.4 p -59.74 147.27 38.48 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 123.384 0.674 . . . . 72.530000000000001 111.633 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 29.5 t -59.14 -36.98 76.17 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.918 -0.771 . . . . 74.540000000000006 108.918 175.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -112.56 101.6 1.24 Allowed Glycine 0 N--CA 1.416 -2.683 0 N-CA-C 108.981 -1.647 . . . . 71.140000000000001 108.981 174.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -92.03 101.48 14.03 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.753 -1.203 . . . . 73.310000000000002 107.753 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -122.21 104.29 9.35 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.741 -0.466 . . . . 71.450000000000003 109.741 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 89.33 -151.39 21.95 Favored Glycine 0 C--N 1.304 -1.215 0 C-N-CA 120.456 -0.878 . . . . 70.140000000000001 112.031 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.494 HD21 ' CG ' ' A' ' 561' ' ' GLU . 2.5 t-20 -113.09 127.69 56.28 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.394 0.616 . . . . 72.140000000000001 110.297 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 66.4 t -129.67 138.51 54.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 108.81 -0.811 . . . . 62.009999999999998 108.81 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.582 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 44.8 mm -107.94 133.84 51.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 109.35 -0.611 . . . . 74.140000000000001 109.35 177.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 25.6 t -120.45 109.06 36.96 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 109.208 -0.664 . . . . 63.229999999999997 109.208 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.61 153.94 54.68 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.108 1.872 . . . . 60.520000000000003 111.83 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.484 ' HB3' HG22 ' A' ' 591' ' ' ILE . 52.9 p90 -148.81 161.56 41.56 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.738 -0.467 . . . . 73.120000000000005 109.738 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -158.17 162.35 37.92 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.106 -0.497 . . . . 72.120000000000005 109.714 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . 0.464 HG23 HG22 ' A' ' 556' ' ' THR . 6.8 p -88.39 149.29 23.8 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 116.027 -0.533 . . . . 64.200000000000003 110.677 173.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 86.7 mt -121.26 109.99 26.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.858 -1.164 . . . . 45.32 107.858 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.34 111.24 2.94 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 123.854 0.721 . . . . 72.549999999999997 110.593 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -100.54 -108.24 3.02 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.34 -1.104 . . . . 54.420000000000002 110.34 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 67.5 p -93.24 8.87 38.51 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 122.517 1.151 . . . . 62.140000000000001 107.967 175.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -119.88 136.53 54.46 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.148 -1.387 . . . . 71.019999999999996 109.509 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.534 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 82.0 mtm180 -82.9 135.4 34.93 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.543 1.137 . . . . 75.129999999999995 110.831 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -87.73 -161.28 36.6 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 115.153 -0.931 . . . . 74.209999999999994 113.533 -175.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 77.06 -55.99 3.57 Favored Glycine 0 C--O 1.224 -0.51 0 CA-C-N 115.488 -0.356 . . . . 64.129999999999995 113.576 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 554' ' ' GLU . . . 157.99 42.45 0.02 OUTLIER Glycine 0 C--N 1.284 -2.341 0 N-CA-C 109.415 -1.474 . . . . 70.319999999999993 109.415 -173.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.534 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 8.4 tt0 -116.92 -61.74 1.68 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.559 -0.534 . . . . 73.140000000000001 109.559 -176.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -98.57 -43.74 6.73 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.887 -1.523 . . . . 75.299999999999997 106.887 169.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -132.87 156.42 47.23 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 107.195 -1.409 . . . . 71.209999999999994 107.195 174.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.42 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 10.2 tt0 -84.3 131.11 34.75 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.635 -0.876 . . . . 75.219999999999999 108.635 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . 0.535 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 9.6 t70 -58.24 131.1 49.6 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.525 -0.546 . . . . 74.310000000000002 109.525 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.599 HG21 HG22 ' A' ' 573' ' ' VAL . 14.6 t -133.32 141.33 47.9 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-O 121.702 0.763 . . . . 75.439999999999998 109.146 174.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 3.2 p -156.55 161.32 39.98 Favored 'General case' 0 C--N 1.272 -2.763 0 N-CA-C 107.264 -1.384 . . . . 71.510000000000005 107.264 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 149.24 -167.11 29.56 Favored Glycine 0 N--CA 1.41 -3.071 0 N-CA-C 110.395 -1.082 . . . . 65.209999999999994 110.395 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.582 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 52.9 mt-10 -131.7 132.77 44.19 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 120.965 0.412 . . . . 70.219999999999999 110.567 -176.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.547 HD22 ' HB3' ' A' ' 569' ' ' LYS . 89.7 mt -92.94 140.81 29.1 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.883 -0.599 . . . . 74.0 109.512 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.494 ' CG ' HD21 ' A' ' 534' ' ' ASN . 27.9 tt0 -106.28 113.74 27.44 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 116.094 -0.503 . . . . 74.530000000000001 109.872 -177.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -111.92 149.31 32.07 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.128 -0.693 . . . . 72.129999999999995 109.128 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.573 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 49.4 mt-30 -146.99 -177.65 5.77 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.249 -0.648 . . . . 72.5 109.249 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -70.07 -31.17 68.64 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.629 -1.249 . . . . 72.519999999999996 107.629 170.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -77.0 -52.76 8.79 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.8 -1.091 . . . . 70.530000000000001 111.176 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.573 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 42.4 mm-40 -64.77 124.18 21.29 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 123.616 0.767 . . . . 73.549999999999997 111.854 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.584 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.2 pt -81.08 -62.24 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 124.159 0.912 . . . . 61.009999999999998 112.638 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.584 ' H ' HG13 ' A' ' 567' ' ' ILE . 7.8 p -143.31 160.24 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 109.522 -0.548 . . . . 64.019999999999996 109.522 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.547 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -127.6 158.69 36.83 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.43 -0.952 . . . . 64.109999999999999 108.43 171.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.5 p -127.34 144.58 51.03 Favored 'General case' 0 C--N 1.278 -2.504 0 O-C-N 124.03 0.831 . . . . 74.409999999999997 111.096 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.2 mp -94.68 119.31 42.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 106.829 -1.545 . . . . 51.229999999999997 106.829 172.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 24.4 p -92.34 116.14 28.71 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.543 -0.91 . . . . 75.299999999999997 108.543 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.599 HG22 HG21 ' A' ' 556' ' ' THR . 55.5 t -116.43 123.16 71.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.372 -0.603 . . . . 60.43 109.372 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 29.4 tptp -76.91 113.99 15.21 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.124 -0.944 . . . . 73.319999999999993 109.235 176.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.94 128.82 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 N-CA-C 104.887 -2.264 . . . . 51.329999999999998 104.887 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 46.5 mm . . . . . 0 C--N 1.301 -1.517 0 CA-C-O 122.35 1.071 . . . . 65.219999999999999 111.761 -175.379 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 73.5 mmtt . . . . . 0 C--O 1.211 -0.941 0 N-CA-C 106.346 -1.724 . . . . 72.540000000000006 106.346 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 11.4 t -131.41 137.96 48.89 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.578 -1.249 . . . . 74.099999999999994 111.012 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 44.2 p90 -135.07 179.13 6.51 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 107.74 -1.208 . . . . 72.140000000000001 107.74 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.549 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 92.6 m-85 -123.77 155.68 37.47 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 109.318 -0.623 . . . . 74.349999999999994 109.318 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.83 133.54 54.43 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 105.167 -2.16 . . . . 73.230000000000004 105.167 176.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.409 ' HB2' HD11 ' A' ' 542' ' ' ILE . 28.7 tt0 -133.92 136.5 44.3 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.613 -0.835 . . . . 70.439999999999998 110.328 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.484 HG22 ' HB3' ' A' ' 539' ' ' TYR . 16.0 pt -99.69 138.34 24.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 114.987 -1.006 . . . . 72.030000000000001 108.343 174.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.42 -173.55 49.78 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 111.225 -0.75 . . . . 55.329999999999998 111.225 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.94 130.35 88.48 Favored Pre-proline 0 C--N 1.305 -1.328 0 C-N-CA 120.702 -0.399 . . . . 74.5 111.168 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.524 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 17.8 Cg_endo -64.85 135.69 45.66 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.138 2.558 . . . . 65.420000000000002 112.21 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . 0.478 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 14.6 ptm180 -111.99 127.96 56.03 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.586 -0.733 . . . . 73.25 109.81 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -73.48 128.92 36.84 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 106.468 -1.679 . . . . 54.549999999999997 106.468 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.49 ' CG2' HG12 ' A' ' 536' ' ' ILE . 62.0 t . . . . . 0 C--N 1.299 -1.627 0 N-CA-C 109.155 -0.683 . . . . 73.209999999999994 109.155 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.524 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 17.4 Cg_endo . . . . . 0 N--CA 1.44 -1.647 0 N-CA-C 107.9 -1.615 . . . . 74.219999999999999 107.9 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.87 163.74 24.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 119.524 -0.871 . . . . 65.109999999999999 112.385 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.04 174.83 6.56 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.322 -0.854 . . . . 71.549999999999997 111.144 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.457 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -75.5 -169.28 25.89 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 116.018 -0.537 . . . . 51.240000000000002 113.876 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.53 -27.67 60.63 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.473 0.654 . . . . 75.430000000000007 109.686 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -139.82 133.56 30.53 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.03 -0.729 . . . . 73.019999999999996 109.03 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 506' ' ' THR . 22.6 p -133.81 90.27 2.68 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.398 0.618 . . . . 74.400000000000006 110.175 176.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -163.13 142.74 8.78 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.519 -0.919 . . . . 73.209999999999994 108.519 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.609 HD22 HG11 ' A' ' 523' ' ' VAL . 21.3 tp -126.52 128.65 47.22 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 108.872 -0.788 . . . . 64.030000000000001 108.872 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -95.34 110.07 22.14 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.639 -1.245 . . . . 74.140000000000001 107.639 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.07 114.16 36.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 109.02 -0.733 . . . . 73.129999999999995 109.02 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 55.7 mt -102.9 113.85 40.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 109.104 -0.702 . . . . 42.32 109.104 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 50.3 mt -93.7 107.56 19.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.598 -1.631 . . . . 73.409999999999997 106.598 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.291 -1.968 0 C-N-CA 119.381 -0.927 . . . . 65.519999999999996 110.538 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 502' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.442 -0.874 0 N-CA-C 109.403 -0.592 . . . . 65.340000000000003 109.403 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 172.34 -160.2 31.45 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 110.88 -0.888 . . . . 21.41 110.88 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.26 126.98 71.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 O-C-N 124.003 0.472 . . . . 73.219999999999999 111.364 -170.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.433 ' CE2' ' HB ' ' A' ' 528' ' ' THR . 61.9 m-85 -103.56 133.94 47.75 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.427 -0.583 . . . . 64.409999999999997 109.427 170.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.0 t -169.32 169.8 8.88 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.332 -0.988 . . . . 34.32 108.332 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -78.01 149.41 34.05 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.073 0.397 . . . . 63.0 111.53 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.93 -36.4 80.07 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.46 -0.941 . . . . 71.400000000000006 108.46 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -129.68 146.23 60.32 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 108.253 -1.017 . . . . 73.310000000000002 108.253 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.49 -29.03 2.54 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.153 1.902 . . . . 62.439999999999998 112.934 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 55.9 t -139.6 135.11 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 107.015 -1.476 . . . . 55.520000000000003 107.015 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.1 t -134.17 140.38 46.5 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 108.867 -0.79 . . . . 73.519999999999996 108.867 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -114.87 129.06 56.63 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.769 -1.197 . . . . 60.140000000000001 107.769 175.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.0 m -116.21 170.52 5.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 121.182 0.515 . . . . 70.450000000000003 110.607 -175.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.646 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 75.3 m -87.03 150.11 24.26 Favored 'General case' 0 N--CA 1.398 -3.066 0 CA-C-N 115.069 -0.968 . . . . 73.319999999999993 108.632 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -75.31 -41.94 55.76 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 120.922 0.391 . . . . 73.129999999999995 111.077 177.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 6.4 t -99.31 51.06 0.94 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.553 0.692 . . . . 73.230000000000004 109.743 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.646 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 10.2 tt -103.41 -20.76 5.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.466 0.651 . . . . 74.109999999999999 111.29 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.53 -75.41 2.32 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 110.584 -1.006 . . . . 21.440000000000001 110.584 -175.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 47.7 mm -132.02 127.82 58.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 107.939 -1.134 . . . . 75.150000000000006 107.939 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.469 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -107.58 150.86 26.37 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.78 -1.193 . . . . 63.240000000000002 107.78 176.372 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 30.7 mt-10 -131.66 123.11 27.12 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 123.654 0.596 . . . . 72.219999999999999 111.878 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.543 HG11 HD22 ' A' ' 642' ' ' LEU . 58.6 t -112.17 130.22 66.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.509 -0.922 . . . . 75.230000000000004 108.509 176.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.436 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 21.0 mtmm -87.39 134.87 33.52 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.43 0.633 . . . . 75.120000000000005 111.884 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 568' ' ' VAL . 59.0 t -105.64 127.85 60.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.805 -0.813 . . . . 55.43 108.805 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.22 124.19 22.41 Favored 'General case' 0 N--CA 1.432 -1.365 0 O-C-N 123.726 0.641 . . . . 74.219999999999999 109.725 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -72.27 158.56 35.61 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.663 -1.153 . . . . 74.140000000000001 109.417 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.433 ' HB ' ' CE2' ' A' ' 505' ' ' PHE . 2.9 t -56.01 133.1 51.53 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.429 -0.805 . . . . 73.349999999999994 109.904 175.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 5.1 m -51.17 -31.38 19.74 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.475 1.51 . . . . 71.420000000000002 111.165 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.0 95.39 0.4 Allowed Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 109.031 -1.628 . . . . 74.340000000000003 109.031 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.98 104.37 15.54 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.177 -0.675 . . . . 52.310000000000002 109.177 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -119.09 105.09 11.06 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.082 -0.508 . . . . 75.030000000000001 109.748 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 92.97 -139.24 14.52 Favored Glycine 0 N--CA 1.436 -1.356 0 O-C-N 123.747 0.655 . . . . 51.409999999999997 112.221 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.482 HD21 ' CG ' ' A' ' 561' ' ' GLU . 2.8 t-20 -126.63 129.35 48.32 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.822 -0.806 . . . . 52.130000000000003 108.822 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 65.3 t -132.44 140.28 48.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.243 -0.435 . . . . 64.140000000000001 109.889 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.504 ' HB ' ' HG3' ' A' ' 595' ' ' ARG . 43.4 mm -109.24 137.59 40.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.078 -0.712 . . . . 74.040000000000006 109.078 176.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.98 110.47 29.32 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 109.666 -0.494 . . . . 62.329999999999998 109.666 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.58 155.28 59.43 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.389 2.059 . . . . 42.049999999999997 112.269 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.514 ' HB3' HG22 ' A' ' 591' ' ' ILE . 39.8 p90 -151.73 161.75 42.14 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.861 -0.422 . . . . 74.200000000000003 109.861 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -154.76 151.77 29.08 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.439 0.462 . . . . 70.019999999999996 110.974 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.3 p -85.91 132.49 34.07 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.222 -0.899 . . . . 72.150000000000006 110.088 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 59.0 mt -112.02 115.41 49.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.054 -1.091 . . . . 73.409999999999997 108.054 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.03 106.28 2.31 Favored 'General case' 0 C--N 1.312 -1.035 0 O-C-N 123.369 0.418 . . . . 74.329999999999998 110.979 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -85.14 -98.75 0.69 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 108.626 -1.789 . . . . 65.25 108.626 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 38.3 p -95.25 -25.61 16.28 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.767 -1.198 . . . . 73.5 107.767 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.551 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -75.71 128.38 35.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.545 -1.207 . . . . 72.150000000000006 107.839 175.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 99.8 mtt180 -109.12 159.36 16.95 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 115.287 1.588 . . . . 71.150000000000006 115.287 -171.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . 63.87 -174.2 12.18 Favored Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 112.361 -2.2 . . . . 43.409999999999997 117.454 168.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -115.97 66.86 0.3 Allowed Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 108.163 -1.975 . . . . 72.349999999999994 108.163 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 132.17 5.04 3.51 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 111.524 -0.631 . . . . 15.34 111.524 -174.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 27.3 tt0 -90.85 -74.38 0.5 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.851 -0.739 . . . . 75.349999999999994 109.904 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.407 ' OD1' ' HG3' ' A' ' 585' ' ' LYS . 21.2 m-20 -94.77 -35.56 12.06 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 122.218 1.009 . . . . 74.109999999999999 108.471 175.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -137.57 157.79 45.78 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.187 -1.783 . . . . 70.049999999999997 106.187 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 4.8 tt0 -91.2 135.84 33.51 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.624 -1.251 . . . . 55.439999999999998 107.624 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.37 141.7 47.02 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 120.431 0.158 . . . . 73.219999999999999 110.71 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.9 t -144.12 127.42 16.76 Favored 'General case' 0 N--CA 1.408 -2.569 0 CA-C-O 122.618 1.199 . . . . 72.439999999999998 108.525 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 5.3 p -149.89 115.69 5.61 Favored 'General case' 0 C--N 1.255 -3.505 0 CA-C-N 113.78 -1.554 . . . . 72.040000000000006 108.851 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -168.35 -142.7 3.57 Favored Glycine 0 N--CA 1.408 -3.2 0 N-CA-C 109.787 -1.325 . . . . 62.310000000000002 109.787 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.2 mt-10 -143.81 147.46 34.15 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.969 0.385 . . . . 71.299999999999997 110.776 -174.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.46 HD22 ' HB3' ' A' ' 569' ' ' LYS . 95.6 mt -106.02 144.95 32.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.806 -0.813 . . . . 63.210000000000001 108.806 176.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.482 ' CG ' HD21 ' A' ' 534' ' ' ASN . 29.6 tt0 -109.98 120.46 42.54 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.041 0.448 . . . . 73.230000000000004 110.341 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -115.4 147.59 40.35 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.999 -0.741 . . . . 73.140000000000001 108.999 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.437 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 45.9 mt-30 -138.36 177.92 7.52 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 109.479 -0.563 . . . . 75.430000000000007 109.479 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -68.71 -37.51 79.55 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.11 -0.95 . . . . 62.32 110.392 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -92.45 -12.0 33.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.459 -0.791 . . . . 73.299999999999997 111.733 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 0.0 OUTLIER -68.3 172.8 5.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.881 -0.6 . . . . 75.319999999999993 110.095 -178.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.606 HG13 ' H ' ' A' ' 568' ' ' VAL . 5.9 pt -115.91 -82.82 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 112.671 0.619 . . . . 73.239999999999995 112.671 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.606 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.9 p -143.84 151.73 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 N-CA-C 108.88 -0.785 . . . . 75.120000000000005 108.88 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.46 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -114.06 156.34 24.32 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.192 0.52 . . . . 62.009999999999998 110.519 175.568 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.4 p -125.01 147.94 48.7 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.564 -1.198 . . . . 72.239999999999995 110.96 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.484 HG22 HG23 ' A' ' 573' ' ' VAL . 2.6 mp -94.94 117.04 37.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 106.437 -1.69 . . . . 74.140000000000001 106.437 171.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 521' ' ' MET . 45.2 m -93.42 115.26 27.81 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 108.498 -0.927 . . . . 41.32 108.498 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.484 HG23 HG22 ' A' ' 571' ' ' ILE . 67.6 t -118.51 132.35 68.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.627 -0.509 . . . . 64.099999999999994 109.627 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 50.8 tptt -81.81 117.65 22.26 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.936 -1.135 . . . . 44.409999999999997 107.936 175.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 47.1 t -91.26 131.04 39.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 106.262 -1.755 . . . . 62.109999999999999 106.262 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 40.3 mm . . . . . 0 C--N 1.296 -1.737 0 CA-C-O 121.84 0.829 . . . . 73.450000000000003 109.528 -178.16 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 33.7 mmtp . . . . . 0 N--CA 1.432 -1.326 0 N-CA-C 109.878 -0.416 . . . . 71.120000000000005 109.878 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.7 t -141.93 143.14 33.12 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 109.025 -0.731 . . . . 63.420000000000002 109.025 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.503 ' HB3' ' HB3' ' A' ' 546' ' ' ALA . 46.7 p90 -135.76 174.65 10.38 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.154 -1.054 . . . . 74.430000000000007 108.154 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.483 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 78.2 m-85 -119.21 156.35 30.03 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 109.401 -0.592 . . . . 64.109999999999999 109.401 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.86 123.2 38.14 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 105.607 -1.997 . . . . 65.319999999999993 105.607 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.38 136.07 55.0 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.427 -0.583 . . . . 74.420000000000002 109.427 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.514 HG22 ' HB3' ' A' ' 539' ' ' TYR . 26.3 pt -106.06 137.79 34.56 Favored 'Isoleucine or valine' 0 C--O 1.261 1.695 0 N-CA-C 108.305 -0.998 . . . . 71.540000000000006 108.305 175.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.22 -177.01 49.85 Favored Glycine 0 N--CA 1.418 -2.54 0 CA-C-N 115.603 -0.726 . . . . 52.119999999999997 111.447 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.7 137.94 97.3 Favored Pre-proline 0 C--N 1.303 -1.416 0 CA-C-O 120.91 0.386 . . . . 75.219999999999999 111.371 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.488 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 32.0 Cg_endo -68.39 138.84 43.67 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 122.35 2.033 . . . . 72.340000000000003 111.083 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . 0.504 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.9 ptm180 -116.21 122.52 45.26 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.035 -0.728 . . . . 73.129999999999995 109.035 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.88 131.9 46.37 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.431 -1.322 . . . . 63.5 107.431 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.474 ' CG2' HG12 ' A' ' 536' ' ' ILE . 65.4 t . . . . . 0 C--N 1.304 -1.395 0 CA-C-O 121.226 0.536 . . . . 72.430000000000007 110.667 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 57.4 Cg_endo . . . . . 0 N--CA 1.442 -1.505 0 N-CA-C 108.345 -1.444 . . . . 65.120000000000005 108.345 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.3 166.3 21.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 C-N-CA 120.452 -0.499 . . . . 71.450000000000003 110.828 -177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.13 166.55 10.96 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.206 -0.598 . . . . 74.430000000000007 112.075 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -75.72 -166.96 21.73 Favored Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 115.234 -0.893 . . . . 60.219999999999999 113.584 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -68.08 -46.81 69.98 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 122.99 0.516 . . . . 74.219999999999999 110.382 -177.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -125.34 135.24 52.25 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.968 -0.753 . . . . 72.120000000000005 108.968 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . 0.457 ' HB ' ' CG1' ' A' ' 591' ' ' ILE . 34.7 p -130.99 85.75 2.3 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.551 0.691 . . . . 72.120000000000005 110.01 175.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -163.38 143.59 8.86 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.155 -0.929 . . . . 54.530000000000001 109.782 -175.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.543 HD22 HG11 ' A' ' 523' ' ' VAL . 29.6 tp -128.43 142.96 50.94 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.412 -0.958 . . . . 75.019999999999996 108.412 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -110.19 111.35 22.62 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.527 -1.286 . . . . 73.040000000000006 107.527 176.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 47.6 t -102.45 117.15 47.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.985 -0.376 . . . . 63.399999999999999 109.985 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 52.5 mt -101.87 130.87 50.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 108.626 -0.879 . . . . 63.340000000000003 108.626 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 67.5 mt -105.06 112.19 37.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.654 -0.869 . . . . 75.530000000000001 108.654 178.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--N 1.298 -1.657 0 N-CA-C 107.439 -1.319 . . . . 74.319999999999993 107.439 175.44 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 502' ' ' ALA . . . . . 0.521 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 121.195 0.522 . . . . 64.519999999999996 111.719 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 133.37 -146.63 18.53 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.023 -1.084 . . . . 75.010000000000005 111.101 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.428 HG23 ' HA3' ' A' ' 637' ' ' GLY . 4.1 mp -120.88 110.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 116.857 0.328 . . . . 75.420000000000002 111.055 -175.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.512 ' CD2' HG23 ' A' ' 528' ' ' THR . 10.0 m-85 -90.0 131.31 35.95 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.128 -1.434 . . . . 75.200000000000003 107.128 168.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . 0.411 ' HA ' HG22 ' A' ' 640' ' ' THR . 14.2 t -168.77 171.38 8.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.422 -0.584 . . . . 62.340000000000003 109.422 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -77.24 148.76 35.63 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 116.062 -0.517 . . . . 72.409999999999997 110.204 177.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -65.6 -32.1 73.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.387 0.613 . . . . 75.439999999999998 110.113 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -135.83 141.42 36.77 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 107.474 -1.306 . . . . 64.209999999999994 107.474 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.57 -28.21 10.19 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 122.425 2.084 . . . . 71.010000000000005 112.359 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 49.6 t -136.97 139.69 44.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 107.016 -1.476 . . . . 73.409999999999997 107.016 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.3 t -133.36 140.48 47.4 Favored 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 109.384 -0.599 . . . . 73.230000000000004 109.384 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -106.73 129.91 54.54 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.111 -1.07 . . . . 74.0 108.111 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.7 m -119.82 150.67 22.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 109.032 -0.729 . . . . 73.120000000000005 109.032 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 9.5 t -82.76 167.57 18.02 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.762 0.792 . . . . 71.129999999999995 110.816 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -90.54 -9.24 47.94 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.419 -1.697 . . . . 73.430000000000007 106.419 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 20.5 m -121.83 24.75 9.53 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 121.175 -0.953 . . . . 63.5 110.855 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 8.2 tt -88.63 -32.89 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.999 0.428 . . . . 70.319999999999993 111.532 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . 0.42 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 89.27 -80.08 1.56 Allowed Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 110.656 -0.978 . . . . 63.409999999999997 110.656 -176.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.1 mm -124.56 123.74 66.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.533 -0.914 . . . . 72.129999999999995 108.533 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -101.69 149.36 24.22 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 108.705 -0.85 . . . . 63.539999999999999 108.705 177.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 31.1 mt-10 -133.41 130.1 38.25 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 123.611 0.765 . . . . 75.340000000000003 110.242 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.585 HG11 HD22 ' A' ' 642' ' ' LEU . 38.8 t -113.9 126.35 71.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 108.265 -1.013 . . . . 75.530000000000001 108.265 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -77.84 131.16 37.43 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 124.053 0.846 . . . . 45.119999999999997 110.077 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 568' ' ' VAL . 46.0 t -110.46 125.44 67.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.266 -0.642 . . . . 75.329999999999998 109.266 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.7 mt -78.28 129.3 34.89 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.344 -0.844 . . . . 75.239999999999995 111.861 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 567' ' ' ILE . 15.6 tpt180 -76.58 153.01 35.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.716 -1.129 . . . . 52.229999999999997 108.853 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 5.5 p -59.28 146.2 40.34 Favored 'General case' 0 N--CA 1.426 -1.663 0 O-C-N 123.784 0.678 . . . . 65.230000000000004 111.813 176.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 28.1 t -55.6 -28.62 56.16 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.254 1.022 . . . . 74.349999999999994 110.285 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -112.66 99.13 1.01 Allowed Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 109.037 -1.625 . . . . 50.409999999999997 109.037 172.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.97 100.98 12.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.737 -0.838 . . . . 61.039999999999999 108.737 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -120.29 116.38 25.45 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.731 -0.668 . . . . 73.430000000000007 110.054 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 68.83 -169.54 41.95 Favored Glycine 0 N--CA 1.445 -0.744 0 O-C-N 123.95 0.781 . . . . 73.0 114.399 173.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -92.51 124.21 36.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 123.249 0.62 . . . . 72.549999999999997 109.749 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 57.7 t -132.5 133.68 59.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.734 -0.839 . . . . 64.120000000000005 108.734 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' ' 561' ' ' GLU . 42.4 mm -107.13 132.4 54.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 109.996 -0.372 . . . . 71.420000000000002 109.996 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 594' ' ' PRO . 41.2 t -121.12 110.21 34.77 Favored Pre-proline 0 N--CA 1.439 -1.01 0 N-CA-C 109.688 -0.486 . . . . 53.32 109.688 178.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 57.1 Cg_endo -75.03 158.57 42.02 Favored 'Trans proline' 0 C--N 1.334 -0.227 0 C-N-CA 122.505 2.137 . . . . 74.439999999999998 112.441 178.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.487 ' HB3' HG22 ' A' ' 591' ' ' ILE . 53.1 p90 -150.32 162.91 39.61 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.648 0.261 . . . . 73.510000000000005 110.557 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -155.33 150.32 26.69 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.605 -0.725 . . . . 75.099999999999994 110.092 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 15.0 p -83.45 134.65 34.85 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.175 -0.676 . . . . 75.129999999999995 109.175 173.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 87.1 mt -105.14 118.87 53.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.152 -1.055 . . . . 44.240000000000002 108.152 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -75.45 138.05 41.38 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 123.405 0.441 . . . . 75.239999999999995 110.029 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -138.72 -103.59 0.6 Allowed Glycine 0 CA--C 1.502 -0.757 0 N-CA-C 110.675 -0.97 . . . . 54.310000000000002 110.675 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 25.0 p -90.27 -9.06 49.32 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.88 0.848 . . . . 73.120000000000005 109.16 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -112.32 136.56 51.63 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 106.757 -1.571 . . . . 73.019999999999996 106.757 173.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 10.8 mtm-85 -108.0 149.9 27.8 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.265 0.839 . . . . 75.019999999999996 113.265 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -90.66 -147.25 18.25 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 114.71 -1.132 . . . . 73.140000000000001 111.048 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 63.54 28.33 72.28 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 111.858 -0.497 . . . . 73.030000000000001 111.858 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 71.97 24.99 75.77 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 121.61 -0.328 . . . . 74.150000000000006 112.422 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -89.92 -77.53 0.39 Allowed 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 117.508 0.654 . . . . 64.340000000000003 110.879 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -96.14 -34.67 11.6 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 108.218 -1.03 . . . . 65.5 108.218 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -144.24 159.11 43.23 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 108.254 -1.017 . . . . 74.319999999999993 108.254 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -89.1 112.24 23.17 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 104.983 -2.228 . . . . 71.230000000000004 104.983 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.0 129.47 35.32 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.545 0.688 . . . . 74.329999999999998 110.417 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 15.0 t -129.37 161.2 30.85 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 115.546 -0.752 . . . . 62.009999999999998 110.563 -171.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.6 p -151.99 161.93 41.87 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.392 -1.336 . . . . 71.219999999999999 107.392 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 165.01 -167.47 38.71 Favored Glycine 0 N--CA 1.419 -2.442 0 C-N-CA 120.103 -1.046 . . . . 54.299999999999997 110.579 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 538' ' ' PRO . 27.1 mt-10 -130.86 137.59 49.44 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 123.136 0.574 . . . . 73.109999999999999 109.614 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 569' ' ' LYS . 94.6 mt -102.87 133.63 47.63 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.205 -0.665 . . . . 71.340000000000003 109.205 178.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.437 ' HA ' HD13 ' A' ' 536' ' ' ILE . 34.3 tt0 -96.74 119.26 34.89 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.912 -0.585 . . . . 72.430000000000007 110.801 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -116.04 148.4 40.23 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.622 -0.881 . . . . 53.119999999999997 108.622 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.483 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 46.0 mt-30 -141.77 -172.32 3.53 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.098 -1.075 . . . . 73.420000000000002 108.098 -178.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -80.08 -28.17 39.17 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.559 -0.904 . . . . 73.239999999999995 108.559 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -84.24 -32.87 24.23 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.242 -0.89 . . . . 53.420000000000002 111.021 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.483 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 40.5 mm-40 -79.5 143.49 34.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.773 0.321 . . . . 73.120000000000005 111.38 177.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.572 ' O ' ' HB2' ' A' ' 527' ' ' ARG . 3.9 pt -112.0 -77.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 113.029 0.751 . . . . 71.120000000000005 113.029 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.551 ' H ' HG13 ' A' ' 567' ' ' ILE . 13.1 p -113.38 144.37 21.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.913 0.863 . . . . 75.409999999999997 112.171 -174.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.499 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -120.86 169.69 10.2 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.378 -0.828 . . . . 34.200000000000003 109.251 173.28 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.4 p -135.62 146.87 48.34 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 123.591 0.557 . . . . 71.129999999999995 112.443 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.2 mp -95.29 119.32 43.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.041 -1.466 . . . . 63.439999999999998 107.041 170.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 521' ' ' MET . 26.4 m -98.75 116.09 30.2 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.432 -0.581 . . . . 72.439999999999998 109.432 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.468 HG23 HG22 ' A' ' 571' ' ' ILE . 89.3 t -121.6 131.45 73.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 N-CA-C 109.92 -0.4 . . . . 71.409999999999997 109.92 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.42 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 23.4 tptm -85.83 115.6 23.57 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.974 -0.75 . . . . 75.030000000000001 108.974 176.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 36.4 t -86.62 125.31 40.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.15 -1.426 . . . . 51.140000000000001 107.15 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 35.8 mm . . . . . 0 CA--C 1.494 -1.194 0 N-CA-C 108.518 -0.919 . . . . 54.539999999999999 108.518 -175.943 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 13.5 pttt . . . . . 0 CA--C 1.484 -1.577 0 N-CA-C 108.829 -0.804 . . . . 70.030000000000001 108.829 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.7 t -144.29 150.07 37.28 Favored 'General case' 0 C--N 1.279 -2.457 0 C-N-CA 119.641 -0.824 . . . . 64.439999999999998 112.243 -175.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 45.4 p90 -133.59 166.79 21.78 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 106.317 -1.735 . . . . 64.519999999999996 106.317 175.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.444 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 89.1 m-85 -115.54 159.4 21.29 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 120.115 -0.634 . . . . 75.049999999999997 109.832 -175.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.09 124.71 42.46 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 106.227 -1.768 . . . . 73.299999999999997 106.227 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -122.65 129.68 52.11 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 120.961 0.41 . . . . 73.5 110.071 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.487 HG22 ' HB3' ' A' ' 539' ' ' TYR . 25.2 pt -100.23 143.83 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 107.868 -1.16 . . . . 54.520000000000003 107.868 175.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -84.88 -177.31 51.01 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 111.338 -0.705 . . . . 64.430000000000007 111.338 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -78.31 129.17 75.86 Favored Pre-proline 0 N--CA 1.416 -2.13 0 CA-C-O 120.889 0.376 . . . . 60.520000000000003 110.525 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.497 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.0 Cg_endo -59.56 127.74 24.75 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.615 2.877 . . . . 74.299999999999997 112.309 -175.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -106.26 131.98 52.85 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.378 -0.601 . . . . 64.109999999999999 109.378 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -73.75 134.54 43.48 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 105.034 -2.21 . . . . 73.049999999999997 105.034 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 19.2 t . . . . . 0 C--N 1.294 -1.817 0 CA-C-O 122.287 1.041 . . . . 73.219999999999999 108.842 179.552 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.497 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 21.3 Cg_endo . . . . . 0 N--CA 1.433 -2.066 0 N-CA-C 108.096 -1.54 . . . . 75.010000000000005 108.096 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.41 167.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 120.361 -0.535 . . . . 72.349999999999994 111.287 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.487 ' HB2' HG21 ' A' ' 640' ' ' THR . 1.0 OUTLIER -104.87 175.57 5.45 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.013 -0.539 . . . . 64.209999999999994 112.357 -177.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.428 ' HA3' HG23 ' A' ' 504' ' ' ILE . . . -74.18 -176.92 35.94 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.699 -0.682 . . . . 74.109999999999999 112.405 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.4 -39.94 77.66 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.985 0.422 . . . . 74.400000000000006 110.217 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -112.87 121.49 44.84 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.89 -0.595 . . . . 74.239999999999995 110.62 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . 0.487 HG21 ' HB2' ' A' ' 636' ' ' LEU . 19.6 p -134.75 81.32 1.9 Allowed 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 122.149 0.976 . . . . 62.509999999999998 110.895 174.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -163.14 150.97 13.4 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.477 -1.305 . . . . 72.340000000000003 107.477 -175.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.585 HD22 HG11 ' A' ' 523' ' ' VAL . 27.8 tp -133.69 139.85 46.67 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 108.334 -0.988 . . . . 63.119999999999997 108.334 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.84 114.5 28.68 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.079 -1.452 . . . . 72.239999999999995 107.079 174.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 41.1 t -103.49 110.03 28.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 109.12 -0.696 . . . . 71.109999999999999 109.12 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 47.2 mt -96.65 120.8 46.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 109.413 -0.588 . . . . 53.399999999999999 109.413 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 63.4 mt -97.2 113.99 33.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 107.631 -1.248 . . . . 71.430000000000007 107.631 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 C--N 1.283 -2.3 0 N-CA-C 105.248 -2.13 . . . . 74.319999999999993 105.248 173.107 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 502' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.435 -1.191 0 N-CA-C 109.715 -0.476 . . . . 75.230000000000004 109.715 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.44 ' C ' HG22 ' A' ' 528' ' ' THR . . . -178.12 -166.37 34.41 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.814 -0.914 . . . . 65.420000000000002 110.814 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.5 mp -112.6 128.81 69.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 123.521 0.729 . . . . 62.229999999999997 110.928 -173.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.575 ' CE2' HG23 ' A' ' 528' ' ' THR . 41.7 m-85 -102.13 139.75 37.34 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.725 -0.472 . . . . 72.140000000000001 109.725 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.0 t -169.89 175.99 4.95 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.056 -1.09 . . . . 74.450000000000003 108.056 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -80.96 154.92 26.69 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 117.988 0.358 . . . . 74.010000000000005 110.734 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.92 -41.8 77.69 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.852 -0.613 . . . . 51.32 109.5 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -121.93 146.48 46.27 Favored Pre-proline 0 N--CA 1.417 -2.081 0 N-CA-C 108.376 -0.972 . . . . 74.549999999999997 108.376 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -77.63 -23.51 9.68 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.547 1.498 . . . . 73.530000000000001 111.249 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.0 t -141.01 132.92 29.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 107.764 -1.199 . . . . 53.130000000000003 107.764 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.7 t -126.46 139.73 53.02 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.633 -0.877 . . . . 72.439999999999998 108.633 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -108.24 118.03 35.71 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.228 -1.027 . . . . 71.420000000000002 108.228 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.64 153.94 17.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 121.138 0.494 . . . . 75.439999999999998 110.156 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.565 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 65.3 m -79.49 152.91 29.96 Favored 'General case' 0 N--CA 1.42 -1.928 0 C-N-CA 124.391 1.076 . . . . 52.409999999999997 111.133 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' A' ' 517' ' ' SER . 15.6 pt-20 -63.14 -49.89 72.61 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 120.954 0.407 . . . . 73.109999999999999 111.167 177.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . 0.495 ' N ' ' HG3' ' A' ' 516' ' ' GLU . 52.5 m -109.34 69.21 0.7 Allowed 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.962 0.887 . . . . 41.119999999999997 110.108 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 13.3 tt -110.64 -27.24 2.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.058 -0.973 . . . . 73.329999999999998 110.836 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 90.63 -70.76 2.1 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.561 -0.828 . . . . 34.030000000000001 111.55 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.9 mm -135.42 125.07 42.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.049 -0.723 . . . . 63.020000000000003 109.049 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.517 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -108.09 150.06 27.67 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.898 -1.149 . . . . 74.299999999999997 107.898 176.436 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.8 mt-10 -129.56 121.75 27.78 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.588 0.708 . . . . 61.539999999999999 112.767 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.651 HG11 HD22 ' A' ' 642' ' ' LEU . 99.4 t -110.06 131.43 61.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.101 -0.954 . . . . 74.230000000000004 109.086 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -89.97 136.44 33.04 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.678 0.751 . . . . 72.219999999999999 111.931 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 47.3 t -105.54 124.53 60.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 114.649 -1.16 . . . . 63.549999999999997 108.109 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.4 mt -70.74 127.21 31.89 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 123.759 0.662 . . . . 71.109999999999999 110.703 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.405 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 43.4 ttp180 -74.7 162.55 28.61 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.426 -1.261 . . . . 72.430000000000007 110.346 -177.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.575 HG23 ' CE2' ' A' ' 505' ' ' PHE . 1.0 OUTLIER -55.83 139.05 46.92 Favored 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 124.892 1.277 . . . . 73.340000000000003 111.852 177.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 4.0 m -51.5 -37.8 50.91 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 125.434 1.494 . . . . 74.349999999999994 110.188 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -124.8 96.2 0.51 Allowed Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 108.701 -1.76 . . . . 53.350000000000001 108.701 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.18 107.95 17.48 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.945 -0.761 . . . . 73.109999999999999 108.945 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -124.51 108.09 11.75 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.034 -0.53 . . . . 54.109999999999999 109.898 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 89.69 -132.0 11.03 Favored Glycine 0 C--N 1.312 -0.761 0 C-N-CA 120.36 -0.924 . . . . 73.329999999999998 112.665 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -133.39 131.68 40.31 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 123.212 0.605 . . . . 74.299999999999997 109.492 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.0 t -132.55 143.72 38.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 123.631 0.772 . . . . 74.019999999999996 109.313 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.585 HG12 ' CG2' ' A' ' 597' ' ' VAL . 33.8 mm -112.56 132.1 62.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.891 -0.781 . . . . 73.319999999999993 108.891 173.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 25.7 t -120.67 110.3 35.45 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 109.019 -0.734 . . . . 75.129999999999995 109.019 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -74.7 158.38 43.38 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.221 1.947 . . . . 44.43 111.578 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.495 ' HB3' HG22 ' A' ' 591' ' ' ILE . 54.5 p90 -146.34 170.22 17.24 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 122.202 -0.311 . . . . 64.140000000000001 111.173 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -158.17 150.92 22.49 Favored 'General case' 0 C--O 1.245 0.822 0 O-C-N 123.614 0.571 . . . . 63.32 110.874 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.0 p -90.5 131.55 36.18 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.897 -0.592 . . . . 75.420000000000002 109.746 172.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.59 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 91.5 mt -105.08 116.14 48.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 109.169 -0.678 . . . . 74.230000000000004 109.169 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -75.66 103.35 5.73 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.54 -0.911 . . . . 75.019999999999996 108.54 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -113.8 -83.71 1.22 Allowed Glycine 0 CA--C 1.481 -2.086 0 C-N-CA 119.442 -1.361 . . . . 74.099999999999994 112.188 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.3 m -109.98 32.53 5.03 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 108.652 -0.869 . . . . 75.430000000000007 108.652 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -158.23 149.0 20.59 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.093 -0.958 . . . . 63.130000000000003 108.894 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 26.8 mtm180 -81.28 116.99 21.41 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.569 0.7 . . . . 74.150000000000006 112.522 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.29 -167.18 42.6 Favored Glycine 0 N--CA 1.437 -1.248 0 CA-C-N 115.27 -0.877 . . . . 64.329999999999998 111.515 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.7 20.01 79.76 Favored Glycine 0 C--N 1.312 -0.805 0 C-N-CA 120.805 -0.712 . . . . 54.210000000000001 111.841 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.0 43.95 6.93 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 120.45 -0.881 . . . . 70.510000000000005 111.959 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -118.0 -61.24 1.71 Allowed 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 119.453 -0.899 . . . . 43.32 109.961 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -99.36 -34.81 10.15 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 107.073 -1.454 . . . . 54.210000000000001 107.073 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -143.29 152.04 41.21 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.847 -1.168 . . . . 75.349999999999994 107.847 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -84.89 142.06 29.97 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.677 -1.231 . . . . 74.510000000000005 107.677 177.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -82.11 139.2 34.53 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.723 -0.843 . . . . 75.200000000000003 108.723 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.1 t -148.02 152.47 37.49 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.569 0.699 . . . . 62.310000000000002 110.458 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 25.6 p -156.11 169.48 24.4 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.964 -1.495 . . . . 73.540000000000006 106.964 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 159.75 -164.84 34.35 Favored Glycine 0 N--CA 1.419 -2.473 0 N-CA-C 110.106 -1.198 . . . . 53.409999999999997 110.106 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.443 ' HB3' HG23 ' A' ' 536' ' ' ILE . 43.4 mt-10 -131.75 130.65 42.17 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 123.845 0.379 . . . . 72.219999999999999 110.627 -176.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 569' ' ' LYS . 86.4 mt -100.12 132.79 45.28 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.377 -0.601 . . . . 52.509999999999998 109.377 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.428 ' HA ' HD13 ' A' ' 536' ' ' ILE . 34.1 tt0 -99.17 121.01 40.45 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.648 -0.705 . . . . 74.109999999999999 110.708 -177.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -118.36 151.96 36.74 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.185 -0.672 . . . . 75.510000000000005 109.185 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.64 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 50.5 mt-30 -149.51 -177.49 5.89 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.054 -0.721 . . . . 74.310000000000002 109.054 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -70.68 -37.65 73.66 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.06 -1.459 . . . . 62.409999999999997 107.06 171.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.66 -48.43 16.81 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.361 -1.29 . . . . 63.219999999999999 111.881 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.64 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 27.9 mm-40 -58.99 133.55 56.19 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 123.829 0.852 . . . . 72.219999999999999 111.392 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.606 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.1 pt -85.14 -81.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 112.723 0.638 . . . . 24.420000000000002 112.723 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.606 ' H ' HG13 ' A' ' 567' ' ' ILE . 7.6 p -134.44 160.96 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 108.907 -0.775 . . . . 71.219999999999999 108.907 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.528 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -126.6 159.6 33.07 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.767 0.317 . . . . 63.420000000000002 110.299 176.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.1 p -127.95 148.86 50.52 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.118 -0.946 . . . . 65.109999999999999 112.007 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.3 mp -99.32 127.94 51.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 106.7 -1.593 . . . . 71.450000000000003 106.7 172.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 17.0 m -100.96 115.13 29.73 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.693 -0.855 . . . . 71.319999999999993 108.693 178.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 96.9 t -117.51 130.0 73.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 120.7 -0.4 . . . . 75.5 110.659 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 16.2 tppt? -79.13 120.76 24.12 Favored 'General case' 0 N--CA 1.437 -1.102 0 O-C-N 124.037 0.835 . . . . 74.319999999999993 109.282 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 55.7 t -94.32 128.12 45.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 107.284 -1.376 . . . . 51.119999999999997 107.284 176.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 24.5 mm . . . . . 0 C--N 1.298 -1.64 0 N-CA-C 109.334 -0.617 . . . . 72.5 109.334 -175.128 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 N--CA 1.432 -1.372 0 CA-C-O 120.46 0.171 . . . . 54.420000000000002 110.6 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 7.5 t -152.88 135.07 14.92 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-O 121.375 0.607 . . . . 72.150000000000006 110.933 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 42.8 p90 -126.84 174.17 9.0 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.57 -1.27 . . . . 73.510000000000005 107.57 178.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.59 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 59.0 m-85 -119.83 151.6 38.6 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 109.267 -0.642 . . . . 72.549999999999997 109.267 -176.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.81 130.82 54.13 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 105.083 -2.191 . . . . 74.510000000000005 105.083 176.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' A' ' 542' ' ' ILE . 34.1 tt0 -132.25 144.3 50.52 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.075 -0.713 . . . . 74.120000000000005 109.075 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.495 HG22 ' HB3' ' A' ' 539' ' ' TYR . 13.0 pt -107.43 155.24 8.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.069 -0.715 . . . . 75.439999999999998 109.069 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -100.25 -174.68 30.13 Favored Glycine 0 C--N 1.295 -1.721 0 C-N-CA 121.055 -0.593 . . . . 22.34 112.035 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.408 ' OE1' ' HD2' ' A' ' 594' ' ' PRO . 2.9 mm-40 -61.91 126.96 88.42 Favored Pre-proline 0 C--N 1.313 -0.992 0 C-N-CA 123.198 0.599 . . . . 71.200000000000003 112.1 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.408 ' HD2' ' OE1' ' A' ' 593' ' ' GLU . 21.8 Cg_endo -70.0 118.67 5.82 Favored 'Trans proline' 0 N--CA 1.428 -2.351 0 C-N-CA 122.175 1.917 . . . . 73.430000000000007 110.311 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -104.3 119.56 39.24 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.15 -0.932 . . . . 74.140000000000001 109.328 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.8 129.27 40.2 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.922 -1.14 . . . . 72.109999999999999 107.922 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.585 ' CG2' HG12 ' A' ' 536' ' ' ILE . 45.0 t . . . . . 0 C--N 1.292 -1.935 0 N-CA-C 108.82 -0.808 . . . . 64.349999999999994 108.82 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.527 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 43.6 Cg_endo . . . . . 0 N--CA 1.447 -1.215 0 N-CA-C 108.934 -1.218 . . . . 64.200000000000003 108.934 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.03 161.17 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 109.686 -0.487 . . . . 74.530000000000001 109.686 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.512 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.6 OUTLIER -101.33 165.95 11.0 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 119.72 -0.792 . . . . 74.349999999999994 111.175 176.323 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.85 -172.19 29.23 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 115.654 -0.703 . . . . 53.100000000000001 114.645 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -67.93 -41.66 82.21 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.371 -0.915 . . . . 72.519999999999996 109.392 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -125.99 127.47 45.96 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.279 -0.873 . . . . 72.549999999999997 109.132 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . 0.512 HG21 ' HB2' ' A' ' 636' ' ' LEU . 16.8 p -130.27 89.93 2.86 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.429 -0.582 . . . . 74.409999999999997 109.429 175.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -170.37 139.09 1.64 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.444 -0.798 . . . . 73.040000000000006 109.468 -175.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.651 HD22 HG11 ' A' ' 523' ' ' VAL . 28.0 tp -120.41 131.0 54.6 Favored 'General case' 0 C--N 1.273 -2.725 0 CA-C-N 114.985 -1.007 . . . . 64.439999999999998 109.06 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -93.87 110.8 22.44 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.52 -1.659 . . . . 71.409999999999997 106.52 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 43.7 t -101.6 110.37 28.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.914 -0.773 . . . . 74.219999999999999 108.914 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 67.1 mt -97.95 124.22 50.86 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 N-CA-C 108.819 -0.808 . . . . 74.400000000000006 108.819 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 54.2 mt -100.2 103.36 14.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 106.876 -1.527 . . . . 61.340000000000003 106.876 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 . . . . . 0 C--N 1.285 -2.216 0 CA-C-N 115.885 -0.598 . . . . 73.209999999999994 109.545 -176.531 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.534 0 N-CA-C 108.196 -1.039 . . . . 62.109999999999999 108.196 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.435 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . 160.36 -148.5 16.86 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.085 -1.206 . . . . 65.099999999999994 110.085 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.43 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.7 mp -123.3 130.02 74.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 117.131 0.466 . . . . 50.329999999999998 110.75 -174.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.506 ' H ' ' HA ' ' A' ' 636' ' ' LEU . 57.4 m-85 -112.24 136.48 51.61 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.47 -0.937 . . . . 74.329999999999998 108.47 169.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.2 t -170.71 -179.34 2.86 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.787 -0.82 . . . . 53.229999999999997 108.787 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -83.62 155.45 23.22 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 110.308 -0.256 . . . . 75.319999999999993 110.308 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.09 -45.25 85.99 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.551 -1.278 . . . . 33.509999999999998 107.551 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.74 146.14 51.93 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 108.606 -0.887 . . . . 72.530000000000001 108.606 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.91 -17.35 15.57 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.801 1.667 . . . . 63.32 111.949 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 58.4 t -141.64 127.74 19.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 107.92 -1.141 . . . . 62.420000000000002 107.92 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 13.8 t -123.65 140.54 52.89 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 109.398 -0.593 . . . . 41.409999999999997 109.398 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -109.52 119.33 39.1 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.977 -0.556 . . . . 75.340000000000003 109.705 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.2 m -115.74 162.28 13.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.809 -0.812 . . . . 70.120000000000005 108.809 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.546 ' O ' HG22 ' A' ' 518' ' ' ILE . 12.1 t -87.55 149.77 24.14 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.533 0.682 . . . . 71.120000000000005 111.157 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -60.98 -29.56 69.76 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 124.941 1.296 . . . . 71.299999999999997 109.166 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 32.1 t -116.53 26.02 10.18 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.758 -0.655 . . . . 54.439999999999998 111.231 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 515' ' ' SER . 7.9 tt -80.21 -30.28 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 119.437 -0.905 . . . . 71.299999999999997 111.026 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 88.31 -76.91 1.88 Allowed Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 119.89 -1.148 . . . . 61.240000000000002 111.335 -177.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.1 mm -123.63 124.98 70.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.139 -1.06 . . . . 74.239999999999995 108.139 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.512 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -109.89 147.66 32.98 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 108.451 -0.944 . . . . 72.409999999999997 108.451 177.536 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 39.3 mt-10 -123.54 134.03 53.91 Favored 'General case' 0 CA--C 1.497 -1.088 0 O-C-N 123.846 0.717 . . . . 65.310000000000002 111.198 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.569 HG21 HD21 ' A' ' 642' ' ' LEU . 66.7 t -118.69 125.1 74.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 107.931 -1.137 . . . . 75.510000000000005 107.931 176.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.434 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 36.1 mtmt -86.81 133.15 33.67 Favored 'General case' 0 N--CA 1.427 -1.617 0 O-C-N 123.638 0.586 . . . . 60.409999999999997 110.205 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 39.4 t -101.56 120.9 51.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.301 -0.999 . . . . 41.119999999999997 108.301 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.31 129.05 38.62 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 124.029 0.83 . . . . 64.409999999999997 110.169 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -85.09 158.89 20.3 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.635 -1.166 . . . . 62.420000000000002 109.18 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.435 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 1.6 t -56.22 147.57 20.45 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.725 1.21 . . . . 64.409999999999997 112.854 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.9 t -59.23 -35.43 73.63 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.696 1.199 . . . . 75.219999999999999 109.089 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.76 98.13 0.63 Allowed Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 109.13 -1.588 . . . . 55.439999999999998 109.13 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.36 103.91 16.55 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 109.36 -0.607 . . . . 74.519999999999996 109.36 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -123.53 119.86 31.19 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 116.077 -0.511 . . . . 71.409999999999997 110.557 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 87.19 -136.61 14.08 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.277 -0.874 . . . . 62.509999999999998 112.948 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -133.17 126.58 31.97 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.061 -1.088 . . . . 60.530000000000001 108.061 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 61.0 t -131.55 133.66 61.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.074 -0.713 . . . . 63.409999999999997 109.074 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.565 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 37.3 mm -104.73 136.06 39.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 109.096 -0.705 . . . . 73.219999999999999 109.096 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.407 HG22 ' HB3' ' A' ' 594' ' ' PRO . 40.5 t -120.93 108.32 36.86 Favored Pre-proline 0 C--N 1.306 -1.289 0 N-CA-C 109.948 -0.39 . . . . 63.049999999999997 109.948 178.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.2 156.95 50.9 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.567 2.178 . . . . 55.420000000000002 111.943 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.426 ' HB3' HG22 ' A' ' 591' ' ' ILE . 54.6 p90 -153.83 161.41 42.07 Favored 'General case' 0 C--O 1.25 1.11 0 N-CA-C 110.212 -0.292 . . . . 73.120000000000005 110.212 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -153.81 154.05 33.26 Favored 'General case' 0 C--O 1.25 1.111 0 O-C-N 123.657 0.598 . . . . 65.319999999999993 110.805 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.8 p -87.14 136.5 32.9 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.321 -0.854 . . . . 71.010000000000005 110.966 175.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 590' ' ' GLU . 69.7 mt -109.92 123.92 66.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.108 -1.071 . . . . 54.43 108.108 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -76.23 105.82 7.5 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.855 -0.424 . . . . 75.239999999999995 109.855 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -90.2 -119.64 2.03 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 109.844 -1.302 . . . . 55.439999999999998 109.844 177.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 13.4 t -86.16 -5.93 59.1 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.905 0.86 . . . . 60.240000000000002 109.311 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -97.75 137.28 36.87 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.578 -1.267 . . . . 74.129999999999995 107.578 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.535 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 76.5 mtm180 -86.26 137.07 32.89 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 123.738 0.815 . . . . 71.200000000000003 111.353 -176.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -91.83 -164.49 38.79 Favored Glycine 0 C--N 1.29 -2.0 0 CA-C-N 115.36 -0.836 . . . . 71.109999999999999 111.644 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.71 14.32 79.91 Favored Glycine 0 C--N 1.305 -1.165 0 CA-C-O 120.07 -0.295 . . . . 75.129999999999995 113.345 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 88.25 24.66 33.51 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.059 -0.816 . . . . 65.129999999999995 111.059 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.535 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 17.5 tt0 -96.39 -56.85 2.48 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.335 -0.617 . . . . 75.329999999999998 109.335 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -111.59 -33.07 6.47 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 108.579 -0.897 . . . . 75.420000000000002 108.579 171.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -140.32 149.8 43.2 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 108.302 -0.999 . . . . 64.129999999999995 108.302 175.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 2.0 tm-20 -88.93 123.71 33.54 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 106.18 -1.785 . . . . 71.319999999999993 106.18 177.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -67.87 154.01 42.49 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 112.643 0.609 . . . . 71.140000000000001 112.643 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.7 t -147.72 139.4 23.93 Favored 'General case' 0 N--CA 1.406 -2.628 0 CA-C-O 121.725 0.774 . . . . 63.329999999999998 108.934 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.6 p -148.88 143.81 26.49 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 107.197 -1.409 . . . . 63.310000000000002 107.197 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 161.63 -158.79 30.66 Favored Glycine 0 N--CA 1.413 -2.871 0 C-N-CA 119.69 -1.243 . . . . 72.510000000000005 110.57 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.565 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.7 mt-10 -137.28 140.13 41.38 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 120.784 0.325 . . . . 74.030000000000001 110.967 -174.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.5 139.31 36.37 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.418 0.687 . . . . 72.239999999999995 109.769 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.506 ' HA ' HD13 ' A' ' 536' ' ' ILE . 33.1 tt0 -100.85 110.02 22.04 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.167 0.508 . . . . 64.450000000000003 111.516 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -107.44 148.7 28.8 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.891 -0.595 . . . . 75.420000000000002 109.496 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.538 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 43.9 mt-30 -144.1 -177.28 5.37 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.734 -0.839 . . . . 71.030000000000001 108.734 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.88 -38.28 82.85 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 124.092 0.87 . . . . 71.420000000000002 108.655 177.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -85.25 -38.01 19.4 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.414 -0.812 . . . . 73.129999999999995 111.786 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.538 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 47.0 mm-40 -60.82 135.48 57.79 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.902 0.481 . . . . 65.340000000000003 112.079 -178.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.614 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.6 pt -78.51 -83.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 113.929 1.085 . . . . 74.109999999999999 113.929 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.614 ' H ' HG13 ' A' ' 567' ' ' ILE . 13.3 p -143.05 150.72 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.57 -0.9 . . . . 41.530000000000001 108.57 -177.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 524' ' ' LYS . 5.3 mmpt? -113.15 159.57 19.12 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.884 0.373 . . . . 74.040000000000006 110.134 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.1 p -128.87 147.39 50.82 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.159 -0.928 . . . . 61.530000000000001 112.088 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.8 mp -99.86 126.59 53.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 106.773 -1.565 . . . . 75.540000000000006 106.773 171.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 11.3 p -100.7 115.53 30.47 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.004 -0.739 . . . . 73.219999999999999 109.004 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 60.9 t -119.2 130.19 74.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 109.846 -0.427 . . . . 73.319999999999993 109.846 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 15.8 tppt? -82.87 122.13 27.84 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 123.731 0.645 . . . . 72.25 109.969 176.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 89.8 t -89.15 123.22 41.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 107.967 -1.123 . . . . 73.319999999999993 107.967 176.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 33.7 mm . . . . . 0 C--N 1.304 -1.391 0 CA-C-O 121.293 0.568 . . . . 75.120000000000005 109.604 -179.122 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.544 ' HB2' ' HB ' ' A' ' 646' ' ' ILE . 35.7 mmtp . . . . . 0 C--O 1.215 -0.754 0 N-CA-C 108.951 -0.759 . . . . 71.329999999999998 108.951 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 10.0 t -149.97 144.94 26.17 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.494 -0.482 . . . . 61.140000000000001 109.974 176.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 47.8 p90 -140.46 175.88 9.24 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.621 -1.251 . . . . 75.239999999999995 107.621 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.435 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 87.0 m-85 -122.6 153.97 38.59 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.451 -0.5 . . . . 74.450000000000003 110.601 -176.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.53 128.25 51.84 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 106.316 -1.735 . . . . 62.200000000000003 106.316 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.511 ' HB2' HD11 ' A' ' 542' ' ' ILE . 39.8 tt0 -124.57 131.79 53.47 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.807 -0.812 . . . . 74.319999999999993 108.807 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.426 HG22 ' HB3' ' A' ' 539' ' ' TYR . 17.8 pt -100.5 147.15 8.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.794 -0.817 . . . . 64.129999999999995 108.794 177.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.59 172.97 39.81 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 109.925 -1.27 . . . . 64.030000000000001 109.925 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.0 131.79 88.86 Favored Pre-proline 0 N--CA 1.426 -1.664 0 C-N-CA 120.665 -0.414 . . . . 63.240000000000002 110.838 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.431 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.2 Cg_endo -59.57 136.84 73.82 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.317 2.678 . . . . 63.439999999999998 112.03 -176.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . 0.471 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 3.1 ptm180 -116.63 125.09 51.28 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.305 -0.861 . . . . 73.329999999999998 110.152 -177.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 1.4 tm? -70.19 136.34 49.94 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.09 -1.078 . . . . 73.219999999999999 108.09 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.559 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.3 t . . . . . 0 C--N 1.305 -1.367 0 CA-C-O 121.649 0.738 . . . . 72.120000000000005 110.873 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.431 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 23.3 Cg_endo . . . . . 0 CA--C 1.512 -0.581 0 CA-C-O 120.541 0.142 . . . . 63.409999999999997 112.395 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 3.1 pt -124.07 177.5 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 0 CA-C-O 120.937 0.399 . . . . 73.409999999999997 110.03 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.506 ' HA ' ' H ' ' A' ' 505' ' ' PHE . 0.8 OUTLIER -113.86 174.52 5.89 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 115.665 -0.698 . . . . 52.409999999999997 112.322 177.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.43 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -74.31 174.13 50.29 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 115.415 -0.811 . . . . 70.349999999999994 113.923 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -66.79 -34.47 77.89 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 124.033 0.933 . . . . 71.420000000000002 110.408 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -124.06 121.48 35.3 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.33 -0.618 . . . . 73.420000000000002 109.33 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 7.8 p -134.78 95.4 3.33 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.752 -0.658 . . . . 73.329999999999998 110.013 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -166.54 143.34 4.88 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.75 -1.204 . . . . 53.299999999999997 107.75 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.569 HD21 HG21 ' A' ' 523' ' ' VAL . 26.7 tp -129.66 116.16 18.42 Favored 'General case' 0 N--CA 1.417 -2.084 0 O-C-N 123.825 0.703 . . . . 71.319999999999993 109.668 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -87.18 110.61 20.27 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.604 -1.628 . . . . 73.409999999999997 106.604 173.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 55.8 t -99.19 107.76 21.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.736 -0.838 . . . . 73.120000000000005 108.736 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 27.8 mt -99.28 121.47 49.94 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 N-CA-C 108.42 -0.956 . . . . 73.349999999999994 108.42 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 585' ' ' LYS . 62.6 mt -97.46 107.55 20.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.165 -1.42 . . . . 73.150000000000006 107.165 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 C--N 1.295 -1.77 0 N-CA-C 108.408 -0.96 . . . . 71.319999999999993 108.408 -179.168 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 502' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.41 -2.441 0 CA-C-O 121.174 0.512 . . . . 71.319999999999993 109.951 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -103.43 -114.72 3.97 Favored Glycine 0 C--N 1.278 -2.657 0 CA-C-N 114.672 -1.149 . . . . 43.200000000000003 112.955 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.81 127.69 70.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.219 -0.491 . . . . 70.209999999999994 110.573 -173.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -117.03 123.14 46.14 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.729 -1.211 . . . . 71.230000000000004 107.729 170.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.3 t -167.63 177.65 5.76 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.552 -0.536 . . . . 74.319999999999993 109.552 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -85.77 150.74 24.36 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.886 -0.412 . . . . 64.120000000000005 109.886 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 44.1 mt-10 -66.54 -34.03 77.0 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.348 0.594 . . . . 74.150000000000006 110.18 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -132.21 145.61 58.06 Favored Pre-proline 0 N--CA 1.421 -1.909 0 CA-C-N 114.959 -1.019 . . . . 74.019999999999996 108.499 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.0 -29.29 3.36 Favored 'Trans proline' 0 C--N 1.327 -0.557 0 C-N-CA 122.151 1.9 . . . . 61.299999999999997 112.127 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 26.0 t -134.92 131.79 53.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 107.909 -1.145 . . . . 64.129999999999995 107.909 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 15.3 t -126.68 136.43 52.46 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 109.42 -0.585 . . . . 72.25 109.42 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -109.98 109.42 20.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.793 0.806 . . . . 71.510000000000005 109.297 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.7 m -104.77 151.69 7.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 115.636 -0.711 . . . . 74.040000000000006 110.309 -175.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.544 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 67.4 m -79.56 155.06 28.34 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 115.349 -0.842 . . . . 74.310000000000002 110.328 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -67.08 -62.45 1.42 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.525 0.679 . . . . 71.400000000000006 111.068 176.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.3 m -79.09 26.85 0.25 Allowed 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.709 0.803 . . . . 52.299999999999997 112.666 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 12.8 tt -79.92 -27.91 12.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 122.021 -0.425 . . . . 63.030000000000001 110.509 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 89.2 -74.78 1.96 Allowed Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 110.467 -1.053 . . . . 63.219999999999999 110.467 -177.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.3 mm -129.41 122.88 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 108.425 -0.954 . . . . 75.109999999999999 108.425 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.444 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -103.37 147.51 27.02 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.695 -1.594 . . . . 65.420000000000002 106.695 175.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 35.1 mt-10 -133.64 128.26 34.71 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 123.655 0.597 . . . . 70.439999999999998 111.175 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.583 HG21 HD21 ' A' ' 642' ' ' LEU . 59.9 t -116.36 124.21 72.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 106.831 -1.544 . . . . 73.349999999999994 106.831 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.476 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 29.1 mtmm -84.65 139.88 31.74 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.071 0.462 . . . . 74.450000000000003 110.187 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 43.9 t -107.46 126.56 63.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 115.638 -0.71 . . . . 72.150000000000006 109.173 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.25 116.84 7.01 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 123.998 0.811 . . . . 71.439999999999998 110.093 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -77.79 150.53 34.28 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.022 -0.99 . . . . 65.219999999999999 109.96 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.3 t -55.34 132.93 49.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 124.904 1.282 . . . . 75.109999999999999 111.84 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 44.9 t -54.01 -35.5 61.98 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.538 1.135 . . . . 70.319999999999993 109.32 173.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -107.45 85.52 0.42 Allowed Glycine 0 N--CA 1.42 -2.403 0 N-CA-C 109.641 -1.384 . . . . 33.520000000000003 109.641 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.93 109.77 18.97 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.261 -1.015 . . . . 44.420000000000002 108.261 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -112.73 106.68 15.1 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.119 -0.491 . . . . 50.329999999999998 110.589 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 73.1 -116.76 5.67 Favored Glycine 0 N--CA 1.434 -1.47 0 CA-C-N 115.678 -0.692 . . . . 62.350000000000001 112.457 175.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -133.17 127.05 33.0 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.276 -0.638 . . . . 62.0 109.276 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.05 137.55 55.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.924 -0.769 . . . . 71.329999999999998 108.924 -177.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.539 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 36.4 mm -107.84 135.04 47.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.265 -0.643 . . . . 53.32 109.265 177.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 594' ' ' PRO . 57.3 t -120.51 109.8 36.18 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.391 -0.596 . . . . 33.109999999999999 109.391 177.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 35.4 Cg_endo -71.43 153.72 60.83 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.993 1.795 . . . . 70.239999999999995 111.338 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -150.97 155.71 39.66 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.958 -0.756 . . . . 73.420000000000002 108.958 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.8 152.93 30.42 Favored 'General case' 0 C--O 1.254 1.335 0 O-C-N 123.807 0.692 . . . . 65.019999999999996 112.354 177.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.6 p -82.83 134.06 35.11 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.471 -0.786 . . . . 64.430000000000007 110.024 174.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 70.8 mt -108.72 113.92 45.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 107.316 -1.364 . . . . 72.329999999999998 107.316 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.54 132.54 47.12 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.165 0.507 . . . . 71.540000000000006 111.638 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -124.1 -114.74 2.11 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 108.408 -1.877 . . . . 63.32 108.408 177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 45.6 p -80.36 -23.89 40.18 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 122.084 0.945 . . . . 53.329999999999998 108.736 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -82.8 128.99 34.91 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 114.396 -1.275 . . . . 71.109999999999999 108.766 175.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.3 mtm105 -88.6 135.13 33.65 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 124.066 0.854 . . . . 74.239999999999995 110.651 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -83.42 -152.07 12.21 Favored Glycine 0 C--N 1.297 -1.619 0 CA-C-N 115.232 -0.895 . . . . 62.299999999999997 111.916 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . 0.432 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 62.17 22.97 63.57 Favored Glycine 0 C--N 1.308 -0.978 0 N-CA-C 114.796 0.679 . . . . 41.420000000000002 114.796 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 79.54 22.4 64.67 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.307 -0.949 . . . . 61.399999999999999 111.533 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -96.62 -62.83 1.21 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.996 -0.372 . . . . 74.420000000000002 109.996 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -98.77 -42.69 7.09 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 107.196 -1.409 . . . . 75.420000000000002 107.196 171.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -137.76 149.88 46.79 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 114.911 -1.04 . . . . 60.32 108.677 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.413 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 0.7 OUTLIER -76.69 122.65 25.0 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.678 -1.601 . . . . 65.120000000000005 106.678 173.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 29.1 t70 -74.71 117.99 17.16 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.244 -0.435 . . . . 70.530000000000001 111.234 -173.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.1 t -121.04 138.83 53.99 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 122.517 1.151 . . . . 71.230000000000004 111.664 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 12.2 p -145.54 143.52 30.0 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 105.606 -1.998 . . . . 74.129999999999995 105.606 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 176.13 -155.25 18.84 Favored Glycine 0 N--CA 1.413 -2.873 0 C-N-CA 119.278 -1.439 . . . . 73.129999999999995 110.746 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.539 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 51.4 mt-10 -143.69 129.93 19.79 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 123.985 0.462 . . . . 62.229999999999997 110.582 -175.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 569' ' ' LYS . 98.1 mt -92.51 140.77 29.22 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.937 -0.764 . . . . 71.439999999999998 108.937 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.48 ' HA ' HD13 ' A' ' 536' ' ' ILE . 27.1 tt0 -105.09 113.35 26.9 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.842 -0.429 . . . . 71.439999999999998 109.842 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -111.11 142.65 43.0 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.272 -0.64 . . . . 75.219999999999999 109.272 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.485 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 49.4 mt-30 -133.88 176.28 8.71 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.67 -0.493 . . . . 74.109999999999999 109.67 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -67.16 -37.51 83.87 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 124.464 1.102 . . . . 72.049999999999997 111.676 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -92.11 -13.92 30.0 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.707 -0.678 . . . . 54.310000000000002 112.035 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.485 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 19.9 mm-40 -73.59 167.49 21.23 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.422 0.527 . . . . 72.430000000000007 112.422 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.592 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.3 pt -105.27 -85.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 113.245 0.831 . . . . 70.140000000000001 113.245 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.592 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.3 p -142.96 153.24 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 109.338 -0.616 . . . . 71.349999999999994 109.338 -174.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.451 ' HB3' HD22 ' A' ' 560' ' ' LEU . 5.5 mmpt? -115.79 160.76 19.7 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.989 -0.374 . . . . 60.140000000000001 109.989 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.476 ' CG2' ' HG2' ' A' ' 524' ' ' LYS . 4.4 p -126.82 145.59 50.58 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.617 -0.719 . . . . 70.510000000000005 111.026 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.514 HG22 HG23 ' A' ' 573' ' ' VAL . 1.9 mp -94.11 114.7 31.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 105.36 -2.089 . . . . 73.430000000000007 105.36 170.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 16.5 m -94.33 115.21 27.4 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.232 -1.025 . . . . 75.299999999999997 108.232 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.514 HG23 HG22 ' A' ' 571' ' ' ILE . 98.5 t -117.06 127.67 74.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.268 -0.642 . . . . 73.150000000000006 109.268 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 24.2 tptm -78.21 107.58 10.9 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.389 -0.967 . . . . 74.120000000000005 108.389 175.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 45.9 t -85.38 124.74 40.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 106.24 -1.763 . . . . 64.0 106.24 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 29.8 mm . . . . . 0 C--N 1.291 -1.952 0 CA-C-O 122.035 0.921 . . . . 61.030000000000001 111.648 -173.652 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 33.3 mmtp . . . . . 0 CA--C 1.483 -1.6 0 N-CA-C 110.339 -0.245 . . . . 61.310000000000002 110.339 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 2.9 t -141.82 142.57 33.17 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 120.185 -0.606 . . . . 73.519999999999996 111.257 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 46.2 p90 -137.33 171.77 13.98 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 107.499 -1.297 . . . . 53.119999999999997 107.499 178.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.488 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 45.0 m-85 -117.52 153.05 33.85 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 109.239 -0.652 . . . . 72.420000000000002 109.239 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.29 126.78 51.42 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 106.033 -1.84 . . . . 64.409999999999997 106.033 177.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -127.92 124.44 37.38 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 120.055 -0.658 . . . . 55.539999999999999 110.313 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 20.3 pt -88.86 140.93 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.297 0 CA-C-N 114.836 -1.075 . . . . 74.430000000000007 108.132 174.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.79 173.24 47.04 Favored Glycine 0 N--CA 1.409 -3.164 0 N-CA-C 109.838 -1.305 . . . . 22.030000000000001 109.838 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -67.14 136.15 93.92 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 110.343 -0.243 . . . . 70.219999999999999 110.343 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.403 ' HB3' HG22 ' A' ' 537' ' ' VAL . 30.8 Cg_endo -63.2 131.33 31.9 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.258 2.638 . . . . 75.340000000000003 112.311 -176.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -109.59 120.45 42.54 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.035 -0.984 . . . . 75.299999999999997 108.919 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.482 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 2.7 tm? -66.15 135.3 54.35 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.752 -1.203 . . . . 65.530000000000001 107.752 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.518 ' CG2' HG12 ' A' ' 536' ' ' ILE . 47.0 t . . . . . 0 C--N 1.303 -1.449 0 N-CA-C 108.254 -1.017 . . . . 52.109999999999999 108.254 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 596' ' ' LEU . 29.9 Cg_endo . . . . . 0 N--CA 1.449 -1.094 0 CA-C-O 121.318 0.466 . . . . 73.549999999999997 112.423 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . 0.564 HD13 ' H ' ' A' ' 635' ' ' ILE . 0.1 OUTLIER -127.72 178.71 4.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.692 -1.225 . . . . 53.009999999999998 107.692 179.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.86 -173.9 2.37 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 112.828 0.677 . . . . 64.530000000000001 112.828 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -77.8 -159.25 11.67 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.95 -0.568 . . . . 63.200000000000003 114.376 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -78.59 -48.62 14.79 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.452 0.644 . . . . 74.140000000000001 109.603 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -129.6 130.47 45.69 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.931 -1.137 . . . . 72.030000000000001 107.931 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 18.7 p -129.94 96.09 4.12 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 120.9 0.381 . . . . 74.530000000000001 110.887 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -163.97 148.48 10.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.495 -1.298 . . . . 62.350000000000001 107.495 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.583 HD21 HG21 ' A' ' 523' ' ' VAL . 34.0 tp -133.65 127.85 33.84 Favored 'General case' 0 N--CA 1.414 -2.271 0 N-CA-C 108.379 -0.971 . . . . 63.340000000000003 108.379 175.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -98.0 109.92 22.59 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 107.484 -1.302 . . . . 63.520000000000003 107.484 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 46.0 t -101.17 119.33 49.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.361 -0.607 . . . . 73.239999999999995 109.361 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 49.9 mt -106.12 126.7 61.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.327 -0.99 . . . . 53.539999999999999 108.327 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 73.8 mt -97.82 112.01 28.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.841 -1.17 . . . . 73.420000000000002 107.841 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 515' ' ' SER . 14.3 pt-20 . . . . . 0 C--N 1.286 -2.166 0 CA-C-N 115.505 -0.77 . . . . 72.450000000000003 110.129 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 502' ' ' ALA . . . . . 0.422 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 N--CA 1.435 -1.211 0 N-CA-C 107.7 -1.222 . . . . 54.020000000000003 107.7 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 168.85 -146.87 10.66 Favored Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 109.811 -1.316 . . . . 52.340000000000003 109.811 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -126.04 117.6 49.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 117.129 0.464 . . . . 72.140000000000001 110.469 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -102.4 124.69 48.42 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.261 -1.015 . . . . 72.200000000000003 108.261 169.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.7 t -165.07 -179.17 5.53 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.893 -0.78 . . . . 64.530000000000001 108.893 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -80.35 149.04 30.39 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.357 0.598 . . . . 71.040000000000006 112.534 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -74.18 -24.71 59.42 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 114.793 -1.094 . . . . 64.25 109.003 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.65 142.88 27.29 Favored Pre-proline 0 N--CA 1.435 -1.198 0 N-CA-C 107.474 -1.306 . . . . 75.099999999999994 107.474 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.81 -27.68 4.63 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.215 1.944 . . . . 73.030000000000001 112.483 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 53.7 t -137.96 136.37 45.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 107.007 -1.479 . . . . 74.430000000000007 107.007 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.6 t -130.42 139.55 50.6 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 109.371 -0.603 . . . . 71.310000000000002 109.371 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -106.11 124.05 48.97 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.964 -1.124 . . . . 61.350000000000001 107.964 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.6 m -120.99 155.74 24.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 108.267 -1.012 . . . . 71.129999999999995 108.267 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.577 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 68.1 m -80.88 166.5 20.84 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 108.676 -0.861 . . . . 64.209999999999994 108.676 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -89.8 -55.72 3.52 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.429 -0.908 . . . . 71.510000000000005 109.795 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 31.1 m -81.44 46.7 0.97 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.382 0.61 . . . . 50.340000000000003 110.843 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 11.5 tt -96.05 -29.91 3.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.306 0.574 . . . . 73.319999999999993 111.028 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 96.0 -82.25 0.81 Allowed Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.953 -1.259 . . . . 62.229999999999997 109.953 -176.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 573' ' ' VAL . 27.7 mm -129.67 134.96 62.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.885 -1.154 . . . . 75.0 107.885 -176.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -115.06 144.62 43.35 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.098 -0.705 . . . . 41.140000000000001 109.098 176.145 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 21.5 mp0 -116.22 128.45 55.62 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.723 0.639 . . . . 64.150000000000006 111.185 176.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 570' ' ' THR . 99.5 t -120.87 131.57 72.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.921 -0.77 . . . . 62.32 108.921 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 569' ' ' LYS . 26.5 mtmm -85.62 145.32 27.38 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.438 0.637 . . . . 70.510000000000005 112.023 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 568' ' ' VAL . 52.5 t -117.71 127.59 75.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.879 -0.786 . . . . 45.32 108.879 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 97.1 mt -70.39 124.88 25.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 123.762 0.664 . . . . 72.430000000000007 110.29 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -73.84 158.43 34.54 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.567 -1.197 . . . . 65.409999999999997 109.215 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.4 t -56.09 135.79 52.69 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 124.013 0.821 . . . . 41.409999999999997 110.643 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 3.7 m -60.09 -27.42 66.98 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 124.822 1.249 . . . . 62.409999999999997 110.108 177.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -122.23 90.38 0.44 Allowed Glycine 0 N--CA 1.424 -2.157 0 N-CA-C 109.098 -1.601 . . . . 43.310000000000002 109.098 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.54 105.25 17.69 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.716 -0.476 . . . . 61.409999999999997 109.716 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -120.2 101.97 8.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.852 -0.795 . . . . 74.099999999999994 108.852 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 90.93 -145.21 17.69 Favored Glycine 0 C--N 1.299 -1.489 0 CA-C-N 115.668 -0.696 . . . . 63.140000000000001 112.258 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.54 ' ND2' ' HG2' ' A' ' 563' ' ' GLN . 2.6 t-20 -118.39 131.07 56.31 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.149 -0.685 . . . . 74.219999999999999 109.149 -178.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.536 HG22 HD22 ' A' ' 596' ' ' LEU . 49.4 t -131.58 139.94 49.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 108.497 -0.927 . . . . 63.439999999999998 108.497 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.538 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 42.5 mm -109.6 135.79 47.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 109.036 -0.727 . . . . 64.120000000000005 109.036 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.7 t -122.98 108.43 32.54 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 108.957 -0.757 . . . . 53.240000000000002 108.957 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 39.4 Cg_endo -73.61 153.86 49.41 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.92 1.747 . . . . 61.32 111.465 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -140.46 155.87 46.54 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.951 -0.468 . . . . 55.229999999999997 109.888 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -147.31 148.83 31.8 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 123.714 0.634 . . . . 54.140000000000001 109.911 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.5 p -90.21 129.27 36.49 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.405 -0.361 . . . . 71.329999999999998 110.16 174.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.519 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 64.2 mt -102.62 119.75 51.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 107.162 -1.421 . . . . 74.349999999999994 107.162 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -72.86 114.95 11.58 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.522 -0.548 . . . . 74.329999999999998 109.522 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -96.8 -100.11 1.96 Allowed Glycine 0 CA--C 1.5 -0.874 0 N-CA-C 109.958 -1.257 . . . . 71.430000000000007 109.958 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 31.5 p -94.6 -22.21 18.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.984 -1.117 . . . . 62.329999999999998 107.984 173.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.47 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -86.05 135.64 33.55 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.758 -1.11 . . . . 73.299999999999997 108.468 177.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -98.72 143.55 28.96 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.217 0.532 . . . . 75.409999999999997 112.163 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.7 -150.65 17.61 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.1 -0.954 . . . . 72.239999999999995 111.442 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.93 -0.67 28.21 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 116.978 0.389 . . . . 41.439999999999998 113.383 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 93.54 29.09 10.4 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 111.041 -0.824 . . . . 52.32 111.041 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -99.91 -67.66 0.84 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 110.365 -0.235 . . . . 55.299999999999997 110.365 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -94.35 -45.62 7.39 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 107.979 -1.119 . . . . 73.420000000000002 107.979 174.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -136.77 158.95 43.26 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 114.965 -1.016 . . . . 74.040000000000006 108.453 177.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 9.1 tt0 -85.52 112.65 21.12 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 104.658 -2.349 . . . . 70.230000000000004 104.658 176.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -73.25 145.92 45.81 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.576 -0.85 . . . . 73.319999999999993 108.87 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.0 t -142.64 168.98 18.45 Favored 'General case' 0 N--CA 1.414 -2.227 0 C-N-CA 120.372 -0.531 . . . . 72.450000000000003 110.714 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 11.2 p -162.72 160.35 25.36 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 106.017 -1.846 . . . . 61.210000000000001 106.017 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 171.22 -172.98 44.72 Favored Glycine 0 CA--C 1.483 -1.934 0 N-CA-C 110.493 -1.043 . . . . 74.430000000000007 110.493 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 48.5 mt-10 -130.78 120.11 23.28 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.141 0.496 . . . . 75.150000000000006 111.532 -177.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 92.1 mt -85.75 135.92 33.54 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 115.459 -0.791 . . . . 74.129999999999995 109.259 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.463 ' HA ' HD13 ' A' ' 536' ' ' ILE . 36.0 tt0 -104.04 119.24 38.52 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-O 121.051 0.453 . . . . 72.340000000000003 110.035 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -118.81 139.22 51.95 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.517 -0.549 . . . . 65.5 109.517 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.565 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 6.6 mt-30 -134.95 172.23 13.29 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.743 -0.836 . . . . 71.209999999999994 108.743 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -62.19 -30.22 70.92 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 123.85 0.719 . . . . 74.540000000000006 109.734 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.01 -24.21 21.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.606 -1.179 . . . . 73.319999999999993 112.381 -177.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.565 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 68.5 mm-40 -75.38 173.37 11.01 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.139 -0.351 . . . . 65.340000000000003 111.28 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.644 HG13 ' H ' ' A' ' 568' ' ' VAL . 7.6 pt -117.06 -77.24 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 113.59 0.959 . . . . 70.420000000000002 113.59 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.644 ' H ' HG13 ' A' ' 567' ' ' ILE . 11.8 p -142.99 153.09 16.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 107.711 -1.218 . . . . 51.329999999999998 107.711 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 524' ' ' LYS . 17.0 mtpp -121.55 168.32 11.87 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.7 -0.4 . . . . 74.219999999999999 111.112 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 0.9 OUTLIER -129.92 147.09 51.64 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 123.853 0.72 . . . . 71.230000000000004 111.441 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 1.9 mp -94.91 128.08 46.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.033 -1.469 . . . . 62.0 107.033 172.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 521' ' ' MET . 10.1 p -106.74 115.32 29.99 Favored 'General case' 0 N--CA 1.428 -1.562 0 O-C-N 123.715 0.634 . . . . 73.219999999999999 109.835 176.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 571' ' ' ILE . 71.6 t -117.82 135.97 56.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 116.366 -0.379 . . . . 73.019999999999996 110.12 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 24.4 tptm -90.46 123.51 34.22 Favored 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 124.085 0.866 . . . . 72.400000000000006 109.0 177.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.07 136.18 31.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 106.445 -1.687 . . . . 55.450000000000003 106.445 176.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 41.5 mm . . . . . 0 C--N 1.303 -1.439 0 CA-C-O 121.401 0.62 . . . . 75.219999999999999 111.258 -173.618 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 24.0 mmtp . . . . . 0 C--O 1.215 -0.735 0 N-CA-C 107.164 -1.421 . . . . 64.5 107.164 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 7.8 t -149.97 146.09 26.83 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.08 -0.648 . . . . 62.100000000000001 110.643 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 48.5 p90 -140.43 172.06 13.26 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.643 -1.243 . . . . 72.150000000000006 107.643 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.514 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 85.7 m-85 -116.97 153.59 32.36 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.781 -0.451 . . . . 73.040000000000006 109.781 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.81 125.49 46.63 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 105.657 -1.979 . . . . 72.310000000000002 105.657 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.47 ' HB2' HD11 ' A' ' 542' ' ' ILE . 31.7 tt0 -126.15 136.68 53.16 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.599 -0.889 . . . . 74.109999999999999 108.599 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 12.3 pt -100.4 139.79 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.225 0 N-CA-C 108.45 -0.944 . . . . 71.209999999999994 108.45 175.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.25 173.16 51.67 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-N 115.167 -0.924 . . . . 63.340000000000003 111.426 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.08 125.85 91.96 Favored Pre-proline 0 N--CA 1.433 -1.307 0 CA-C-O 120.836 0.351 . . . . 75.040000000000006 111.556 -177.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.427 ' HB3' HG22 ' A' ' 537' ' ' VAL . 26.2 Cg_endo -62.1 139.71 80.01 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.692 2.928 . . . . 74.129999999999995 113.101 -174.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . 0.464 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 9.7 ptm180 -116.52 128.68 55.66 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.901 -1.045 . . . . 74.420000000000002 109.562 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.536 HD22 HG22 ' A' ' 535' ' ' VAL . 0.6 OUTLIER -74.58 135.86 42.07 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.953 -1.129 . . . . 72.430000000000007 107.953 179.585 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.524 ' CG2' HG12 ' A' ' 536' ' ' ILE . 37.4 t . . . . . 0 C--N 1.299 -1.611 0 N-CA-C 108.701 -0.852 . . . . 70.140000000000001 108.701 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.422 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 67.7 Cg_endo . . . . . 0 N--CA 1.434 -2.016 0 N-CA-C 110.565 -0.59 . . . . 75.329999999999998 110.565 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.8 pp -126.61 158.33 36.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.623 -0.717 . . . . 71.239999999999995 109.787 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.06 177.19 5.82 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 116.384 -0.371 . . . . 62.32 110.939 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -69.8 172.7 39.3 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 111.424 -0.67 . . . . 73.420000000000002 111.424 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -56.7 -50.02 73.4 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.791 0.805 . . . . 62.509999999999998 110.192 -175.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -123.63 125.85 45.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.076 -0.965 . . . . 60.030000000000001 109.618 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 19.9 p -123.06 95.28 4.55 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 115.733 -0.667 . . . . 54.43 110.005 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -158.52 138.05 11.81 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.907 -0.588 . . . . 61.329999999999998 109.811 -176.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.528 HD22 HG11 ' A' ' 523' ' ' VAL . 36.5 tp -122.56 129.27 51.75 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.124 -1.065 . . . . 71.129999999999995 108.124 177.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -95.67 108.86 21.18 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.19 -1.411 . . . . 71.120000000000005 107.19 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 43.3 t -99.02 108.86 23.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 109.314 -0.624 . . . . 71.329999999999998 109.314 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 65.3 mt -98.13 122.8 50.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 108.809 -0.811 . . . . 60.030000000000001 108.809 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' ' 585' ' ' LYS . 32.7 mt -99.74 108.31 22.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.486 -0.931 . . . . 74.5 108.486 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 515' ' ' SER . 10.4 pt-20 . . . . . 0 C--N 1.29 -1.992 0 CA-C-O 121.311 0.577 . . . . 74.129999999999995 110.753 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 502' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . . . . . . 0 C--O 1.214 -0.784 0 CA-C-O 121.309 0.576 . . . . 63.109999999999999 110.332 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 162.07 -159.79 31.86 Favored Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 109.904 -1.278 . . . . 70.540000000000006 109.904 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.53 110.86 33.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 116.687 0.244 . . . . 61.200000000000003 110.814 -176.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.726 ' CE1' ' HA ' ' A' ' 527' ' ' ARG . 5.8 m-85 -95.46 120.59 35.98 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.099 -0.704 . . . . 75.420000000000002 109.099 169.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.1 t -170.22 179.52 3.44 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.612 -0.884 . . . . 64.409999999999997 108.612 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -84.37 153.48 23.43 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.614 -0.513 . . . . 74.319999999999993 109.614 178.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -66.84 -36.04 81.43 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.575 0.702 . . . . 72.239999999999995 109.93 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.36 146.36 61.67 Favored Pre-proline 0 N--CA 1.42 -1.963 0 CA-C-N 115.014 -0.994 . . . . 61.340000000000003 108.444 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.67 -25.2 12.81 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.761 1.641 . . . . 74.109999999999999 112.007 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.05 135.37 54.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.454 -0.943 . . . . 65.329999999999998 108.454 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.6 t -129.33 139.18 51.83 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 109.239 -0.652 . . . . 63.100000000000001 109.239 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -103.66 123.2 46.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.661 -1.237 . . . . 61.439999999999998 107.661 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.6 m -113.11 151.92 14.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 120.463 -0.495 . . . . 73.099999999999994 109.912 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.545 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 0.4 OUTLIER -72.96 162.55 29.36 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 114.845 -1.071 . . . . 73.340000000000003 111.43 -178.256 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -83.78 -48.27 10.27 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.264 -1.384 . . . . 54.409999999999997 107.264 170.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.4 m -81.68 28.51 0.41 Allowed 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.685 -1.143 . . . . 71.400000000000006 112.297 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 15.2 tt -96.9 -32.15 4.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 112.6 0.593 . . . . 60.520000000000003 112.6 -174.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . 0.443 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 87.98 -78.49 1.79 Allowed Glycine 0 N--CA 1.428 -1.864 0 C-N-CA 120.011 -1.09 . . . . 63.439999999999998 110.532 -175.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 574' ' ' LYS . 35.1 mm -126.74 131.4 71.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 107.523 -1.288 . . . . 71.129999999999995 107.523 -175.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.554 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -108.55 146.68 32.9 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 109.349 -0.611 . . . . 72.319999999999993 109.349 177.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 15.1 mp0 -123.15 127.25 48.42 Favored 'General case' 0 CA--C 1.505 -0.764 0 O-C-N 123.955 0.784 . . . . 73.530000000000001 110.329 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.554 HG23 ' SD ' ' A' ' 521' ' ' MET . 66.0 t -112.09 130.64 65.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.98 -1.118 . . . . 72.219999999999999 107.98 173.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.475 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 35.8 mtmt -90.72 141.81 28.41 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.236 0.541 . . . . 72.230000000000004 110.833 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 568' ' ' VAL . 43.8 t -107.77 128.01 63.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.738 -0.664 . . . . 65.439999999999998 109.525 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 95.2 mt -66.5 116.49 7.53 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.276 0.63 . . . . 73.319999999999993 110.25 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.726 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 56.3 ttt-85 -73.26 154.14 40.31 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 124.619 1.167 . . . . 73.120000000000005 109.974 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.65 HG23 ' CD2' ' A' ' 505' ' ' PHE . 1.4 p -58.52 131.28 50.29 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 122.992 0.517 . . . . 72.430000000000007 110.415 175.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 46.4 t -47.39 -35.56 8.48 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 125.362 1.465 . . . . 75.040000000000006 110.917 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.56 85.85 0.32 Allowed Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.857 -1.297 . . . . 73.120000000000005 109.857 175.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -84.83 102.14 12.83 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.648 -0.871 . . . . 64.25 108.648 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -102.07 96.73 7.2 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.234 -0.894 . . . . 64.209999999999994 109.939 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 111.43 -145.16 17.64 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.997 -0.621 . . . . 61.350000000000001 112.294 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.562 HD22 ' HG2' ' A' ' 563' ' ' GLN . 2.4 t-20 -118.86 131.92 56.09 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.803 -1.554 . . . . 71.450000000000003 106.803 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 42.8 t -133.94 140.59 46.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 110.104 -0.332 . . . . 70.129999999999995 110.104 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.532 HG12 ' CG2' ' A' ' 597' ' ' VAL . 38.3 mm -113.52 135.36 53.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 109.29 -0.633 . . . . 74.310000000000002 109.29 174.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 34.8 t -121.13 109.44 35.35 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 109.166 -0.679 . . . . 74.209999999999994 109.166 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.04 150.5 38.07 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.21 1.94 . . . . 74.209999999999994 112.27 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.489 ' HB3' HG22 ' A' ' 591' ' ' ILE . 46.1 p90 -145.18 167.43 22.78 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.835 0.35 . . . . 75.420000000000002 111.013 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -158.42 147.95 19.47 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-N 115.387 -0.824 . . . . 52.109999999999999 110.206 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 15.3 p -84.0 136.26 34.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.826 -0.805 . . . . 53.340000000000003 108.826 172.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 75.0 mt -104.43 114.68 44.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 108.942 -0.762 . . . . 64.129999999999995 108.942 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.63 99.12 2.48 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.843 -0.617 . . . . 75.430000000000007 109.927 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -112.13 -105.78 2.81 Favored Glycine 0 CA--C 1.479 -2.172 0 N-CA-C 110.411 -1.075 . . . . 75.219999999999999 110.411 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.24 42.69 1.05 Allowed 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 123.485 0.714 . . . . 73.230000000000004 109.473 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.518 ' HA ' ' HD2' ' A' ' 585' ' ' LYS . . . -160.1 147.13 16.17 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.475 0.71 . . . . 63.240000000000002 109.864 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.495 HH11 ' HG3' ' A' ' 551' ' ' GLU . 33.1 mtm105 -77.82 120.36 22.61 Favored 'General case' 0 C--O 1.251 1.157 0 CA-C-O 121.356 0.598 . . . . 73.310000000000002 111.727 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.28 -163.04 35.33 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.04 -0.982 . . . . 51.210000000000001 110.687 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 65.5 28.85 74.03 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 121.388 -0.434 . . . . 41.43 113.255 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . 0.407 ' C ' HG13 ' A' ' 576' ' ' ILE . . . 69.42 40.25 79.69 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 121.164 -0.541 . . . . 45.140000000000001 112.006 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.495 ' HG3' HH11 ' A' ' 547' ' ' ARG . 3.6 tp10 -113.05 -53.93 2.67 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 119.954 -0.698 . . . . 74.409999999999997 110.188 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -98.62 -39.54 8.64 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.459 -1.311 . . . . 74.450000000000003 107.459 169.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -142.56 149.0 38.48 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.753 -1.112 . . . . 75.400000000000006 108.629 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.66 111.93 21.13 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 105.361 -2.089 . . . . 64.230000000000004 105.361 176.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -75.19 146.7 41.02 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.176 -0.466 . . . . 72.030000000000001 109.976 -173.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.0 t -143.17 150.93 40.06 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.358 0.599 . . . . 61.130000000000003 110.502 -172.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.0 p -153.18 134.57 14.29 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.504 -0.924 . . . . 73.25 108.504 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -175.54 -168.32 35.8 Favored Glycine 0 N--CA 1.411 -2.987 0 N-CA-C 110.179 -1.169 . . . . 40.439999999999998 110.179 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.467 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 39.9 mt-10 -127.32 131.86 50.36 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.972 -0.381 . . . . 75.109999999999999 109.972 -175.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 569' ' ' LYS . 86.1 mt -94.63 132.11 39.7 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.564 -0.532 . . . . 62.350000000000001 109.564 177.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.486 ' HA ' HD13 ' A' ' 536' ' ' ILE . 19.4 tt0 -98.75 120.21 38.8 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.941 -0.572 . . . . 62.409999999999997 110.198 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.412 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 89.5 m-85 -120.71 156.55 31.54 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.671 -0.863 . . . . 52.210000000000001 108.671 177.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.562 ' HG2' HD22 ' A' ' 534' ' ' ASN . 16.8 mt-30 -150.11 -177.43 5.92 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.21 -1.033 . . . . 53.340000000000003 108.21 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -66.34 -42.67 87.78 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.397 -0.964 . . . . 71.129999999999995 108.397 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -81.8 -24.63 35.81 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.972 0.731 . . . . 74.299999999999997 112.972 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.459 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 37.1 mm-40 -76.34 146.5 38.77 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.857 -0.527 . . . . 71.439999999999998 112.062 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.611 HG13 ' H ' ' A' ' 568' ' ' VAL . 12.6 pt -90.47 -89.99 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 114.869 1.433 . . . . 75.519999999999996 114.869 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.611 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.7 p -134.76 145.64 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 109.664 -0.495 . . . . 64.420000000000002 109.664 -177.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.535 ' HB3' HD22 ' A' ' 560' ' ' LEU . 4.2 mmpt? -113.04 157.11 21.97 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 116.267 -0.424 . . . . 74.209999999999994 110.21 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.8 p -126.25 151.76 47.01 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.19 -0.914 . . . . 74.310000000000002 111.926 -177.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.3 mp -101.37 120.97 51.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.104 -1.443 . . . . 70.239999999999995 107.104 171.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 521' ' ' MET . 70.0 m -99.3 115.96 30.38 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 123.81 0.694 . . . . 45.5 109.967 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.41 HG23 HG22 ' A' ' 571' ' ' ILE . 68.1 t -122.63 128.27 75.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.462 -0.335 . . . . 72.310000000000002 110.291 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 29.1 tptp -80.66 118.2 22.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.67 -0.493 . . . . 73.239999999999995 109.67 176.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 58.3 t -81.27 117.22 26.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 105.557 -2.016 . . . . 72.340000000000003 105.557 174.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . 0.407 HG13 ' C ' ' A' ' 550' ' ' GLY . 43.5 mm . . . . . 0 C--N 1.298 -1.639 0 CA-C-O 121.762 0.791 . . . . 63.450000000000003 109.97 -174.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' A' ' 546' ' ' ALA . 34.2 mmtp . . . . . 0 N--CA 1.439 -0.987 0 CA-C-O 121.09 0.471 . . . . 74.519999999999996 111.416 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 7.0 t -153.93 135.5 14.33 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.436 0.636 . . . . 72.049999999999997 110.407 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -127.16 172.18 10.77 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.323 -0.991 . . . . 74.010000000000005 108.323 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.478 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 79.4 m-85 -118.96 153.8 34.05 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 109.515 -0.55 . . . . 72.010000000000005 109.515 -175.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.86 129.86 52.17 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.206 -1.775 . . . . 65.219999999999999 106.206 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -128.0 134.4 49.25 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.05 -0.66 . . . . 74.510000000000005 109.924 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.489 HG22 ' HB3' ' A' ' 539' ' ' TYR . 25.2 pt -106.84 140.51 24.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.39 -0.967 . . . . 50.43 108.39 176.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.21 -175.31 49.78 Favored Glycine 0 N--CA 1.425 -2.065 0 O-C-N 123.813 0.695 . . . . 63.240000000000002 111.469 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.81 137.3 82.63 Favored Pre-proline 0 N--CA 1.428 -1.529 0 C-N-CA 121.034 -0.266 . . . . 74.319999999999993 110.521 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.65 142.94 60.26 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 122.58 2.187 . . . . 72.439999999999998 111.08 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -121.93 123.42 41.66 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.674 -0.491 . . . . 74.230000000000004 109.674 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.482 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 2.2 tm? -67.97 125.56 26.7 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.844 -0.799 . . . . 74.140000000000001 108.844 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.532 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.6 t . . . . . 0 C--N 1.286 -2.179 0 N-CA-C 105.197 -2.149 . . . . 75.409999999999997 105.197 176.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.509 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 33.6 Cg_endo . . . . . 0 CA--C 1.512 -0.595 0 CA-C-O 121.148 0.395 . . . . 51.43 112.622 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.8 pp -134.56 157.97 41.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.139 -1.059 . . . . 71.239999999999995 108.139 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.54 172.84 8.42 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.314 -0.554 . . . . 64.200000000000003 111.725 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -73.01 -157.25 3.9 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-O 121.912 0.729 . . . . 74.049999999999997 114.475 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.93 -45.84 59.7 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.624 -0.788 . . . . 71.420000000000002 109.333 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -135.4 142.98 45.76 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.231 -0.895 . . . . 74.129999999999995 108.822 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 35.2 p -134.75 103.21 5.54 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.011 0.434 . . . . 43.439999999999998 111.034 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -170.22 150.65 3.68 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.822 -1.177 . . . . 64.409999999999997 107.822 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.522 HD21 HG21 ' A' ' 523' ' ' VAL . 26.1 tp -137.81 132.13 32.18 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.48 -0.933 . . . . 72.219999999999999 108.48 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -101.16 110.95 23.04 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.529 -1.286 . . . . 75.140000000000001 107.529 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 45.7 t -101.11 110.97 29.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.556 -0.535 . . . . 52.530000000000001 109.556 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 74.0 mt -96.58 125.66 49.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 N-CA-C 109.471 -0.566 . . . . 52.219999999999999 109.471 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 64.9 mt -101.17 107.59 21.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.823 -1.177 . . . . 73.310000000000002 107.823 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--N 1.283 -2.307 0 CA-C-O 121.173 0.511 . . . . 72.030000000000001 110.014 -179.935 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 74.1 t60 . . . . . 0 C--O 1.241 0.648 0 CA-C-O 121.697 0.76 . . . . 72.120000000000005 109.929 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.56 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . -85.21 -32.04 22.85 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.953 -1.022 . . . . 63.109999999999999 113.316 -175.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 124.58 -155.85 18.44 Favored Glycine 0 C--N 1.287 -2.167 0 C-N-CA 119.215 -1.469 . . . . 40.229999999999997 111.705 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.417 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.7 mp -114.66 110.96 33.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 112.069 0.396 . . . . 64.010000000000005 112.069 -172.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -92.52 119.98 32.53 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.068 -1.086 . . . . 75.019999999999996 108.068 168.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.5 t -160.41 171.79 18.43 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.122 -0.696 . . . . 74.510000000000005 109.122 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -76.83 147.06 37.39 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 122.513 -0.117 . . . . 71.209999999999994 111.149 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 524' ' ' LYS . 0.3 OUTLIER -65.9 -33.8 76.66 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 122.116 0.96 . . . . 64.439999999999998 108.69 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -130.23 140.17 37.86 Favored Pre-proline 0 C--N 1.291 -1.96 0 N-CA-C 108.008 -1.108 . . . . 72.5 108.008 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.81 -27.4 10.43 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.288 1.992 . . . . 62.509999999999998 111.672 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 60.0 t -140.63 134.52 33.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 106.232 -1.766 . . . . 75.430000000000007 106.232 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.2 t -128.95 139.91 51.9 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.952 -0.758 . . . . 72.540000000000006 108.952 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -106.39 136.3 46.38 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.563 -1.273 . . . . 71.099999999999994 107.563 175.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.2 m -125.9 147.24 30.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 108.897 -0.779 . . . . 62.530000000000001 108.897 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.478 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 27.1 m -79.29 143.64 35.03 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 112.709 0.633 . . . . 61.43 112.709 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 648' ' ' GLU . 9.8 tm-20 -56.2 -39.5 72.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.196 0.998 . . . . 73.140000000000001 110.374 175.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 27.5 t -116.01 73.25 0.84 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.905 0.859 . . . . 52.149999999999999 109.757 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 9.8 tt -120.16 -25.49 2.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.653 -0.703 . . . . 72.540000000000006 110.73 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . 0.457 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 91.74 -82.02 1.22 Allowed Glycine 0 N--CA 1.421 -2.342 0 N-CA-C 109.983 -1.247 . . . . 60.130000000000003 109.983 -175.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 574' ' ' LYS . 49.8 mm -127.96 135.13 63.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 107.993 -1.114 . . . . 64.209999999999994 107.993 -175.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.19 143.3 43.47 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.132 -1.062 . . . . 45.119999999999997 108.132 176.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.7 mt-10 -124.93 126.75 46.0 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 123.796 0.685 . . . . 74.299999999999997 111.358 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.545 HG11 HD22 ' A' ' 642' ' ' LEU . 24.2 t -105.53 125.34 60.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.908 -0.775 . . . . 75.25 108.908 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 508' ' ' GLU . 20.6 mmmt -81.34 130.18 34.93 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.328 -0.99 . . . . 64.340000000000003 108.328 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.501 ' O ' HG23 ' A' ' 568' ' ' VAL . 58.5 t -105.38 137.85 33.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 109.829 -0.434 . . . . 64.530000000000001 109.829 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.91 123.18 27.0 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.011 -0.541 . . . . 72.109999999999999 110.177 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 34.7 ttp85 -78.78 155.83 29.1 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.686 -1.143 . . . . 70.319999999999993 110.433 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 0.9 OUTLIER -58.37 140.4 53.65 Favored 'General case' 0 N--CA 1.418 -2.049 0 C-N-CA 124.438 1.095 . . . . 60.310000000000002 112.482 177.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.7 t -54.73 -35.33 63.59 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.934 1.294 . . . . 71.010000000000005 110.034 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -117.76 95.64 0.65 Allowed Glycine 0 N--CA 1.418 -2.501 0 N-CA-C 110.141 -1.184 . . . . 34.149999999999999 110.141 176.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -84.57 111.85 19.89 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.804 -0.813 . . . . 33.240000000000002 108.804 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -121.28 107.87 13.05 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.304 -0.862 . . . . 71.209999999999994 110.835 -173.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 74.76 -124.25 7.87 Favored Glycine 0 N--CA 1.441 -1.0 0 O-C-N 123.633 0.583 . . . . 72.129999999999995 112.92 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.526 HD22 ' HG2' ' A' ' 563' ' ' GLN . 2.5 t-20 -134.17 126.38 29.83 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.299 0.64 . . . . 71.310000000000002 109.851 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.47 137.94 54.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 109.027 -0.731 . . . . 74.219999999999999 109.027 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.512 HG12 ' CG2' ' A' ' 597' ' ' VAL . 40.5 mm -107.76 136.65 42.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 109.358 -0.608 . . . . 74.109999999999999 109.358 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.25 108.07 38.55 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 109.488 -0.56 . . . . 62.450000000000003 109.488 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 53.5 Cg_endo -72.71 155.97 53.65 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.373 2.049 . . . . 63.030000000000001 111.752 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.497 ' HB3' HG22 ' A' ' 591' ' ' ILE . 54.2 p90 -152.87 163.0 40.59 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 110.481 -0.192 . . . . 71.129999999999995 110.481 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -158.03 158.36 34.69 Favored 'General case' 0 C--O 1.25 1.079 0 O-C-N 123.735 0.647 . . . . 72.299999999999997 109.457 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 5.2 p -84.35 158.15 21.23 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.145 -0.48 . . . . 75.540000000000006 110.05 172.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 89.6 mt -133.54 121.28 40.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.644 -1.243 . . . . 74.349999999999994 107.644 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -71.37 107.28 4.25 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 110.154 -0.313 . . . . 63.409999999999997 110.154 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -83.82 -89.75 0.76 Allowed Glycine 0 C--N 1.309 -0.93 0 N-CA-C 109.53 -1.428 . . . . 63.299999999999997 109.53 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 14.8 p -112.76 6.11 17.92 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.819 0.818 . . . . 75.140000000000001 109.112 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -99.45 142.76 30.52 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.635 -1.166 . . . . 71.519999999999996 110.281 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.427 ' HB3' ' OE1' ' A' ' 551' ' ' GLU . 76.9 mtt180 -79.34 127.0 31.54 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.694 0.759 . . . . 72.129999999999995 111.321 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -90.3 176.09 41.61 Favored Glycine 0 C--N 1.289 -2.074 0 CA-C-N 114.81 -1.086 . . . . 60.520000000000003 112.19 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 82.34 19.29 64.75 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.057 -0.592 . . . . 62.109999999999999 113.255 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 81.94 25.81 51.36 Favored Glycine 0 CA--C 1.504 -0.64 0 N-CA-C 110.458 -1.057 . . . . 54.140000000000001 110.458 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.427 ' OE1' ' HB3' ' A' ' 547' ' ' ARG . 21.3 tt0 -93.32 -60.81 1.7 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 108.801 -0.815 . . . . 72.5 108.801 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -102.12 -34.44 9.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.852 -1.166 . . . . 73.409999999999997 107.852 168.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -143.95 148.72 35.73 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.518 -0.919 . . . . 73.349999999999994 108.518 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -85.57 112.29 20.82 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 105.498 -2.038 . . . . 72.439999999999998 105.498 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -76.55 146.37 38.41 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.256 -0.429 . . . . 73.299999999999997 110.168 -175.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.5 t -145.55 157.0 44.05 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-O 121.411 0.624 . . . . 64.120000000000005 110.519 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.9 p -154.52 153.19 31.05 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.498 -1.297 . . . . 72.040000000000006 107.498 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 169.81 -160.64 33.75 Favored Glycine 0 N--CA 1.418 -2.503 0 N-CA-C 110.032 -1.227 . . . . 62.329999999999998 110.032 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.491 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.6 mt-10 -129.79 142.36 50.7 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 122.663 0.385 . . . . 75.420000000000002 110.631 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.574 HD22 ' HB3' ' A' ' 569' ' ' LYS . 74.9 mt -107.82 139.48 42.35 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.046 -0.525 . . . . 74.430000000000007 109.617 175.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.507 ' HA ' HD13 ' A' ' 536' ' ' ILE . 31.4 tt0 -102.79 117.25 34.23 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 116.031 -0.531 . . . . 71.030000000000001 110.913 -177.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -116.56 149.02 40.31 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.548 -0.908 . . . . 73.129999999999995 108.548 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.526 ' HG2' HD22 ' A' ' 534' ' ' ASN . 14.0 mt-30 -148.19 -175.01 4.73 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.941 -1.133 . . . . 71.329999999999998 107.941 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -69.18 -27.44 65.52 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.545 -0.909 . . . . 73.239999999999995 108.545 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.27 -51.66 5.06 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.136 -0.938 . . . . 51.420000000000002 112.317 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.514 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 51.0 mm-40 -55.67 125.77 22.6 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 122.349 0.259 . . . . 70.129999999999995 110.815 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.603 HG13 ' H ' ' A' ' 568' ' ' VAL . 7.1 pt -91.01 -78.67 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 112.855 0.687 . . . . 71.329999999999998 112.855 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.603 ' H ' HG13 ' A' ' 567' ' ' ILE . 10.9 p -119.71 150.18 22.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.813 -0.555 . . . . 63.439999999999998 110.004 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.574 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -122.83 160.32 26.28 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.911 -0.774 . . . . 70.519999999999996 108.911 173.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 6.8 p -127.33 144.61 51.02 Favored 'General case' 0 C--N 1.288 -2.095 0 O-C-N 123.898 0.749 . . . . 71.340000000000003 112.696 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.0 mp -94.66 122.74 46.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 106.369 -1.715 . . . . 74.430000000000007 106.369 171.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 15.6 m -100.92 119.24 38.42 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 123.731 0.645 . . . . 60.0 109.332 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.403 HG23 HG22 ' A' ' 571' ' ' ILE . 89.4 t -124.18 128.81 74.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 109.927 -0.397 . . . . 71.409999999999997 109.927 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.457 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 20.5 tptm -77.97 113.22 15.67 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 109.183 -0.673 . . . . 55.0 109.183 175.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.3 120.97 36.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 106.89 -1.522 . . . . 70.510000000000005 106.89 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 35.7 mm -84.96 149.75 4.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.911 -0.774 . . . . 72.409999999999997 108.911 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -65.17 143.33 57.93 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.802 -1.09 . . . . 72.400000000000006 110.614 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -51.51 146.88 6.8 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.493 1.121 . . . . 75.340000000000003 113.757 -173.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -74.57 -94.66 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 115.295 1.591 . . . . 63.329999999999998 115.295 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.8 -54.43 1.94 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.721 1.378 . . . . 74.219999999999999 114.721 -176.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -142.33 28.7 1.65 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.63 0.728 . . . . 74.219999999999999 110.233 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -71.32 139.95 50.09 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.619 -1.173 . . . . 71.140000000000001 110.973 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -83.37 -56.39 3.78 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.513 -0.767 . . . . 73.209999999999994 109.409 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -165.36 164.7 19.71 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.086 -1.45 . . . . 74.310000000000002 107.086 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 74.9 mmtt -134.18 159.36 41.14 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.443 -0.577 . . . . 73.409999999999997 109.443 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 644' ' ' VAL . 10.0 t -149.33 138.75 21.57 Favored 'General case' 0 N--CA 1.416 -2.143 0 C-N-CA 120.034 -0.666 . . . . 52.310000000000002 110.937 174.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 49.0 p90 -135.08 167.7 20.47 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.651 -1.241 . . . . 70.109999999999999 107.651 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.517 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 80.3 m-85 -114.44 159.39 20.38 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 120.572 -0.451 . . . . 74.430000000000007 109.889 -175.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.33 128.22 47.86 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 106.243 -1.762 . . . . 74.129999999999995 106.243 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.462 ' HB2' HD11 ' A' ' 542' ' ' ILE . 29.5 tt0 -122.19 123.37 41.35 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 110.238 -0.282 . . . . 75.319999999999993 110.238 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.497 HG22 ' HB3' ' A' ' 539' ' ' TYR . 23.5 pt -95.86 135.19 30.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.859 -1.163 . . . . 71.150000000000006 107.859 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -84.38 -177.55 51.29 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 111.429 -0.669 . . . . 75.430000000000007 111.429 -177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.75 133.95 92.37 Favored Pre-proline 0 N--CA 1.435 -1.19 0 C-N-CA 120.931 -0.308 . . . . 73.349999999999994 111.435 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.413 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 20.3 Cg_endo -62.7 129.48 26.44 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.947 2.432 . . . . 72.219999999999999 111.513 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . 0.466 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.1 ptp180 -107.81 119.95 40.89 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.458 -0.792 . . . . 71.239999999999995 109.902 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -66.07 132.1 47.74 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.967 -1.123 . . . . 74.530000000000001 107.967 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.512 ' CG2' HG12 ' A' ' 536' ' ' ILE . 98.1 t -81.99 115.7 24.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.707 0.765 . . . . 61.240000000000002 112.385 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -82.88 131.44 35.19 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 105.68 -1.97 . . . . 71.010000000000005 105.68 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 26.5 mmt -88.67 -12.35 42.68 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 120.947 0.403 . . . . 73.549999999999997 110.869 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 33.1 m -136.03 97.01 3.51 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.17 0.509 . . . . 54.240000000000002 111.941 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -30.22 22.8 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 105.63 -1.989 . . . . 73.200000000000003 105.63 170.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -83.49 100.02 10.48 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 113.577 -1.647 . . . . 71.209999999999994 108.19 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -99.92 -16.27 18.04 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.062 0.458 . . . . 64.409999999999997 110.428 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 161.75 -102.53 0.21 Allowed Glycine 0 N--CA 1.419 -2.476 0 N-CA-C 110.876 -0.889 . . . . 74.439999999999998 110.876 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 83.43 19.38 62.31 Favored Glycine 0 C--N 1.306 -1.103 0 C-N-CA 121.083 -0.58 . . . . 52.32 111.909 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -105.18 93.27 4.6 Favored 'General case' 0 CA--C 1.489 -1.397 0 CA-C-O 121.462 0.649 . . . . 62.32 109.717 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 6.4 t -132.65 141.2 48.52 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 107.93 -1.137 . . . . 71.239999999999995 107.93 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 10.7 tt -65.77 115.0 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 121.872 0.844 . . . . 71.140000000000001 111.552 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 21.0 m -90.89 107.51 19.24 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 105.244 -2.132 . . . . 73.299999999999997 105.244 174.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.96 76.31 10.05 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 122.317 1.056 . . . . 72.439999999999998 108.536 -175.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -166.66 134.97 2.77 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 104.721 -2.325 . . . . 72.239999999999995 104.721 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -86.04 101.47 12.97 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.548 0.689 . . . . 74.219999999999999 111.244 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 30.1 t70 72.98 88.43 0.1 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.231 -1.804 . . . . 72.200000000000003 112.508 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -157.46 144.6 18.4 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.727 -1.583 . . . . 71.099999999999994 106.727 172.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . 0.518 ' O ' ' HD3' ' A' ' 617' ' ' PRO . 15.5 ptmm? -104.0 3.59 33.57 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.36 0.874 . . . . 70.329999999999998 113.36 -173.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -107.89 98.87 27.44 Favored Pre-proline 0 C--O 1.241 0.636 0 C-N-CA 120.235 -0.586 . . . . 71.310000000000002 112.111 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 615' ' ' LYS . 1.0 OUTLIER -87.17 -7.79 6.82 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.383 2.055 . . . . 71.0 110.948 175.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 58.98 82.54 0.14 Allowed 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.994 1.317 . . . . 70.439999999999998 112.195 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 58.3 m -93.92 97.44 10.37 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.834 -1.172 . . . . 71.329999999999998 107.834 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 17.2 m -82.53 86.09 6.85 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.979 -0.555 . . . . 62.030000000000001 109.817 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -128.73 149.08 50.85 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 115.838 -0.619 . . . . 70.310000000000002 110.175 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -168.37 90.15 0.27 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.332 -0.988 . . . . 74.049999999999997 108.332 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -115.82 133.86 55.6 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.348 -0.612 . . . . 60.009999999999998 109.348 175.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -86.16 52.62 2.53 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 122.365 1.078 . . . . 70.439999999999998 108.285 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -66.6 -26.02 66.9 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.719 -1.128 . . . . 63.43 110.742 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -61.87 -36.63 81.8 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.971 -0.292 . . . . 71.200000000000003 111.364 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . 0.563 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 3.0 tmt_? -75.11 -34.23 61.69 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.624 -0.88 . . . . 74.200000000000003 108.624 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.51 ' O ' ' HG2' ' A' ' 631' ' ' MET . 70.4 mt -63.11 -38.01 80.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.564 0.697 . . . . 74.349999999999994 109.551 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -78.06 -21.41 50.67 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.623 -0.717 . . . . 64.0 111.541 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.585 ' HA ' ' HB3' ' A' ' 633' ' ' ARG . 0.0 OUTLIER -71.6 -11.52 60.89 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 111.762 0.282 . . . . 72.140000000000001 111.762 -175.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 25.0 ptt? -58.93 -23.76 61.75 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.243 0.544 . . . . 70.340000000000003 109.747 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -131.08 54.04 0.79 Allowed Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 108.541 -1.824 . . . . 74.299999999999997 108.541 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . 0.585 ' HB3' ' HA ' ' A' ' 630' ' ' GLU . 6.6 ptp180 -86.05 147.21 44.77 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-O 121.129 0.49 . . . . 75.540000000000006 111.066 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.453 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 42.6 Cg_endo -77.81 138.76 17.08 Favored 'Trans proline' 0 N--CA 1.43 -2.213 0 C-N-CA 121.281 1.32 . . . . 74.519999999999996 108.876 170.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.86 168.18 17.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 120.894 -0.323 . . . . 72.319999999999993 110.217 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.21 175.91 5.34 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 112.14 0.422 . . . . 73.319999999999993 112.14 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.417 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -72.53 -177.58 31.3 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 114.948 0.739 . . . . 74.439999999999998 114.948 -176.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -58.48 -47.35 84.36 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.476 1.111 . . . . 63.020000000000003 110.172 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -140.44 121.83 15.0 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.006 -0.739 . . . . 62.25 109.006 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 10.1 p -114.32 96.21 5.66 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 120.899 0.381 . . . . 73.209999999999994 111.004 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -171.16 134.0 0.9 Allowed 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.572 -0.74 . . . . 72.019999999999996 109.662 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.545 HD22 HG11 ' A' ' 523' ' ' VAL . 25.6 tp -117.42 132.35 56.59 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.896 -1.047 . . . . 70.310000000000002 108.769 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -99.71 111.91 24.2 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.946 -1.502 . . . . 73.349999999999994 106.946 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 586' ' ' THR . 41.3 t -100.41 111.1 29.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 109.338 -0.615 . . . . 74.319999999999993 109.338 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 51.1 mt -99.48 118.45 46.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 N-CA-C 109.177 -0.675 . . . . 74.319999999999993 109.177 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 69.0 mt -87.5 107.86 17.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 106.792 -1.559 . . . . 73.409999999999997 106.792 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -112.41 146.78 37.76 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 116.098 -0.501 . . . . 75.450000000000003 110.93 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.409 ' HA ' ' HB2' ' A' ' 516' ' ' GLU . 9.8 pt-20 -80.13 119.14 22.52 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 122.191 0.996 . . . . 71.430000000000007 112.304 -176.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 47.3 m -138.17 98.53 3.64 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 114.263 -1.335 . . . . 55.0 107.57 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -93.25 -3.99 52.69 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.322 -0.992 . . . . 60.210000000000001 108.322 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -65.41 -46.28 80.61 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.878 -1.056 . . . . 72.409999999999997 108.367 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -101.68 110.28 22.24 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 105.254 -2.128 . . . . 74.510000000000005 105.254 171.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -112.1 133.74 54.07 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 109.212 -0.662 . . . . 74.200000000000003 109.212 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 29.7 p -63.7 -31.87 73.18 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.845 -0.616 . . . . 73.340000000000003 110.767 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 26.8 m -74.77 103.25 4.96 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.615 -1.254 . . . . 62.409999999999997 107.615 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 61.1 t -73.29 131.34 35.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.727 -0.669 . . . . 72.340000000000003 111.561 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 C--N 1.304 -1.397 0 N-CA-C 108.387 -0.968 . . . . 75.030000000000001 108.387 175.367 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 11.9 t60 . . . . . 0 N--CA 1.445 -0.685 0 CA-C-O 121.326 0.584 . . . . 74.420000000000002 110.361 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -80.29 -45.78 17.3 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.782 0.801 . . . . 75.439999999999998 109.158 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 174.9 -161.88 31.53 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 109.033 -1.627 . . . . 51.140000000000001 109.033 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.513 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.4 mp -116.25 121.37 67.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 117.202 0.501 . . . . 73.25 111.359 -174.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.558 ' CD2' HG23 ' A' ' 528' ' ' THR . 30.7 m-85 -95.86 135.65 37.31 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.011 -0.737 . . . . 73.099999999999994 109.011 168.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . 0.435 ' HA ' HG22 ' A' ' 640' ' ' THR . 13.6 t -167.32 179.66 4.93 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.088 -0.708 . . . . 73.150000000000006 109.088 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.07 152.05 22.3 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.455 -0.572 . . . . 74.120000000000005 109.455 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.66 -37.12 84.13 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.79 -0.448 . . . . 74.540000000000006 109.79 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -125.97 149.73 67.08 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 109.62 -0.511 . . . . 70.109999999999999 109.62 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.01 -27.67 6.68 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.678 1.585 . . . . 75.219999999999999 111.771 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 47.4 t -135.48 135.26 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.883 -0.784 . . . . 74.140000000000001 108.883 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.9 t -132.28 140.45 48.62 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.724 -0.843 . . . . 64.230000000000004 108.724 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 44.9 p-80 -112.71 127.51 56.15 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.383 0.611 . . . . 75.049999999999997 109.496 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.7 m -112.18 165.2 7.33 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.453 -0.794 . . . . 64.439999999999998 109.211 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 15.4 t -101.2 166.35 10.82 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.666 0.746 . . . . 63.340000000000003 112.134 -172.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 648' ' ' GLU . 12.6 tp10 -80.11 -19.67 46.8 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.101 -1.409 . . . . 75.319999999999993 107.991 173.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . 0.467 ' OG ' ' HA ' ' A' ' 650' ' ' TYR . 19.3 m -114.15 29.65 7.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.991 -0.55 . . . . 53.130000000000003 111.763 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.2 tt -97.86 -39.26 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 119.763 -0.775 . . . . 54.240000000000002 113.044 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 90.28 -72.95 1.94 Allowed Glycine 0 CA--C 1.506 -0.529 0 C-N-CA 120.662 -0.78 . . . . 52.119999999999997 111.645 -176.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . 0.543 HD11 ' HE3' ' A' ' 574' ' ' LYS . 33.8 mm -128.03 126.87 67.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.65 -1.241 . . . . 65.540000000000006 107.65 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.21 147.96 29.5 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.273 -1.01 . . . . 54.340000000000003 108.273 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 51.4 mp0 -122.41 131.9 54.1 Favored 'General case' 0 N--CA 1.434 -1.252 0 O-C-N 123.716 0.635 . . . . 61.009999999999998 110.304 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 570' ' ' THR . 25.3 t -110.95 129.51 66.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.785 -0.643 . . . . 73.120000000000005 109.47 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.407 ' HE3' HG11 ' A' ' 568' ' ' VAL . 6.5 mmmm -86.28 120.28 27.46 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 123.744 0.818 . . . . 74.239999999999995 109.437 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 568' ' ' VAL . 47.9 t -100.65 122.88 53.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 109.184 -0.673 . . . . 61.109999999999999 109.184 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.1 mt -69.82 126.7 30.5 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.855 -0.611 . . . . 71.340000000000003 110.173 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.434 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 57.0 ttp180 -74.32 160.82 30.55 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.69 -1.141 . . . . 64.019999999999996 108.997 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.558 HG23 ' CD2' ' A' ' 505' ' ' PHE . 2.5 p -56.98 139.09 53.18 Favored 'General case' 0 N--CA 1.421 -1.881 0 C-N-CA 123.125 0.57 . . . . 73.200000000000003 111.843 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.9 m -51.07 -33.84 27.47 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 124.863 1.265 . . . . 73.109999999999999 110.059 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -119.78 107.39 1.33 Allowed Glycine 0 N--CA 1.416 -2.646 0 N-CA-C 108.456 -1.858 . . . . 72.519999999999996 108.456 171.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 564' ' ' ASN . . . -88.69 101.28 13.84 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.081 -0.711 . . . . 71.200000000000003 109.081 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -116.9 102.02 9.02 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.674 -0.694 . . . . 75.219999999999999 110.798 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 86.1 -157.33 30.58 Favored Glycine 0 C--N 1.311 -0.818 0 C-N-CA 120.826 -0.702 . . . . 43.439999999999998 112.87 174.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -107.0 127.69 53.68 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.606 -0.887 . . . . 70.140000000000001 108.606 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.21 141.68 45.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 C-N-CA 122.768 0.427 . . . . 52.140000000000001 109.981 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.592 HG12 ' CG2' ' A' ' 597' ' ' VAL . 42.4 mm -108.79 134.28 51.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.571 -0.9 . . . . 72.439999999999998 108.571 173.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.55 107.2 43.21 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 109.106 -0.701 . . . . 64.329999999999998 109.106 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -70.36 152.17 66.07 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.871 1.714 . . . . 53.030000000000001 110.999 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -148.52 157.88 43.76 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.674 -0.491 . . . . 64.120000000000005 109.674 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . 0.441 ' HE2' ' HB3' ' A' ' 590' ' ' GLU . 0.0 OUTLIER -158.11 152.6 24.67 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.914 0.759 . . . . 74.349999999999994 110.441 178.289 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.9 p -85.22 143.4 28.78 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.0 -0.545 . . . . 63.240000000000002 109.965 176.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.562 HD11 ' HB2' ' A' ' 590' ' ' GLU . 82.5 mt -105.59 122.2 58.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 108.368 -0.975 . . . . 73.430000000000007 108.368 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -81.45 145.35 30.81 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 123.754 0.659 . . . . 71.230000000000004 109.909 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -175.03 -99.76 0.12 Allowed Glycine 0 CA--C 1.483 -1.921 0 N-CA-C 111.038 -0.825 . . . . 51.109999999999999 111.038 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . 0.439 ' HB ' HG23 ' A' ' 586' ' ' THR . 0.9 OUTLIER -83.43 29.17 0.51 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.148 0.979 . . . . 74.310000000000002 110.37 -175.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.457 ' HA ' ' HD2' ' A' ' 585' ' ' LYS . . . -165.66 145.3 6.49 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.563 -1.643 . . . . 72.129999999999995 106.563 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -86.3 127.22 34.75 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 113.0 0.741 . . . . 74.230000000000004 113.0 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.79 -164.09 38.68 Favored Glycine 0 C--N 1.302 -1.324 0 CA-C-N 114.446 -1.252 . . . . 55.340000000000003 110.755 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.95 18.4 76.24 Favored Glycine 0 C--N 1.318 -0.441 0 CA-C-N 117.509 0.654 . . . . 73.430000000000007 112.796 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 75.71 44.8 19.25 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.627 -0.797 . . . . 71.540000000000006 111.133 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -114.75 -59.25 2.04 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.609 -0.436 . . . . 54.149999999999999 110.074 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -100.82 -37.12 8.83 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 107.417 -1.327 . . . . 73.239999999999995 107.417 171.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -141.38 150.88 42.97 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 114.661 -1.154 . . . . 75.510000000000005 107.939 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.58 113.67 20.45 Favored 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 106.446 -1.687 . . . . 52.409999999999997 106.446 174.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -76.21 131.89 39.59 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.752 -0.833 . . . . 61.119999999999997 108.752 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.9 t -128.34 148.21 50.67 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 121.688 0.756 . . . . 63.130000000000003 110.965 -172.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 25.3 p -141.39 151.39 43.44 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 106.294 -1.743 . . . . 74.400000000000006 106.294 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 171.48 -161.12 33.41 Favored Glycine 0 N--CA 1.417 -2.587 0 C-N-CA 119.972 -1.109 . . . . 63.340000000000003 110.978 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.537 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 47.1 mt-10 -139.39 130.96 27.17 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 122.497 0.319 . . . . 65.329999999999998 110.745 -176.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 98.7 mt -95.56 142.21 28.17 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.918 -0.771 . . . . 74.450000000000003 108.918 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -108.9 118.73 37.55 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.294 0.568 . . . . 74.530000000000001 110.824 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -117.53 156.49 27.97 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.538 -0.756 . . . . 65.200000000000003 109.51 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.498 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 47.3 mt-30 -148.54 178.74 8.36 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.118 -1.067 . . . . 52.119999999999997 108.118 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . 0.412 ' HA ' ' HB1' ' A' ' 531' ' ' ALA . 4.0 p-10 -67.83 -30.79 70.27 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.683 -0.858 . . . . 53.549999999999997 108.683 172.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -84.22 -44.86 13.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.228 -0.897 . . . . 74.140000000000001 110.429 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.498 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 70.5 mm-40 -65.72 136.97 56.95 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 123.587 0.755 . . . . 71.239999999999995 111.021 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.592 HG13 ' H ' ' A' ' 568' ' ' VAL . 9.5 pt -89.78 -92.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 114.055 1.131 . . . . 53.229999999999997 114.055 -177.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.592 ' H ' HG13 ' A' ' 567' ' ' ILE . 8.5 p -119.41 149.82 21.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.62 -0.511 . . . . 64.549999999999997 109.62 -176.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -115.1 157.05 24.1 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.175 -0.676 . . . . 63.119999999999997 109.175 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.6 p -122.5 137.75 54.78 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.232 -0.895 . . . . 54.149999999999999 110.925 177.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 24.3 mt -94.71 118.98 42.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 107.898 -1.149 . . . . 75.319999999999993 107.898 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 11.8 p -94.66 115.61 27.75 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 124.002 0.814 . . . . 72.010000000000005 110.611 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 89.2 t -119.79 129.61 75.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 CA-C-O 120.712 0.291 . . . . 63.420000000000002 110.46 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.543 ' HE3' HD11 ' A' ' 520' ' ' ILE . 4.1 tppp? -83.88 119.08 24.44 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.844 0.857 . . . . 64.140000000000001 110.158 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 29.9 t -88.49 121.78 39.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 106.03 -1.841 . . . . 74.439999999999998 106.03 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 48.3 mm -79.91 141.01 15.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.241 0.543 . . . . 64.430000000000007 111.191 -173.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -93.15 110.42 21.92 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.921 -1.14 . . . . 42.420000000000002 107.921 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -129.74 130.91 46.03 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 120.929 0.395 . . . . 70.420000000000002 110.586 -174.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -94.22 94.55 8.4 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.409 0.624 . . . . 74.430000000000007 109.728 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -141.12 -166.77 2.24 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 125.09 1.356 . . . . 60.329999999999998 107.425 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -118.95 67.19 0.78 Allowed 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 122.25 1.024 . . . . 65.319999999999993 108.513 174.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -95.06 145.35 25.02 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 115.24 1.57 . . . . 73.230000000000004 115.24 -171.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.409 ' HB3' ' HE2' ' A' ' 583' ' ' LYS . 38.3 ttpt -89.95 170.54 10.28 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 112.843 -1.98 . . . . 75.310000000000002 107.756 175.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . 0.486 ' ND2' ' HB3' ' A' ' 647' ' ' GLU . 27.0 t-20 -44.21 115.54 0.85 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.333 1.453 . . . . 34.200000000000003 112.51 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.457 ' HD2' ' HA ' ' A' ' 546' ' ' ALA . 38.5 mmtm -97.15 145.74 25.73 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.395 -0.82 . . . . 73.140000000000001 110.282 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . 0.439 HG23 ' HB ' ' A' ' 545' ' ' THR . 5.0 t -156.65 136.6 12.63 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.188 0.518 . . . . 74.109999999999999 111.27 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -131.6 179.13 6.23 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.325 -0.991 . . . . 73.219999999999999 108.325 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.519 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 82.1 m-85 -125.2 155.33 40.2 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 109.19 -0.671 . . . . 64.310000000000002 109.19 -176.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.2 OUTLIER -121.51 131.1 53.95 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.613 -1.625 . . . . 63.32 106.613 178.113 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.562 ' HB2' HD11 ' A' ' 542' ' ' ILE . 33.4 tt0 -126.0 137.43 53.66 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.547 -0.538 . . . . 73.010000000000005 109.547 176.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 14.9 pt -104.53 142.1 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.175 0 N-CA-C 107.772 -1.195 . . . . 72.430000000000007 107.772 173.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.37 176.4 49.98 Favored Glycine 0 N--CA 1.414 -2.795 0 N-CA-C 110.398 -1.081 . . . . 74.099999999999994 110.398 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.97 128.62 92.71 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-O 120.883 0.373 . . . . 75.340000000000003 111.047 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.405 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 27.8 Cg_endo -61.13 128.24 24.61 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.728 2.952 . . . . 72.209999999999994 112.521 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -110.23 119.04 37.97 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.316 -0.856 . . . . 71.409999999999997 109.81 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.17 134.31 53.45 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.415 -0.957 . . . . 73.010000000000005 108.415 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.592 ' CG2' HG12 ' A' ' 536' ' ' ILE . 34.7 t -91.2 100.59 11.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.396 0.617 . . . . 72.420000000000002 109.853 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.49 117.9 28.74 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 105.454 -2.054 . . . . 63.439999999999998 105.454 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 23.6 ttt -66.17 -19.34 65.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.895 0.378 . . . . 74.409999999999997 111.451 -174.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 36.4 t -73.99 110.2 8.09 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 105.258 -2.127 . . . . 73.140000000000001 105.258 170.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -76.14 106.8 7.95 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-O 121.869 0.842 . . . . 53.350000000000001 109.933 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -102.85 119.32 38.63 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.376 -1.284 . . . . 75.510000000000005 109.961 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . 0.561 ' HA ' ' HE2' ' A' ' 603' ' ' LYS . 11.0 mmpt? -89.44 -38.74 13.85 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.707 -1.22 . . . . 74.109999999999999 107.707 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 68.78 -152.31 52.22 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 114.878 -1.055 . . . . 61.310000000000002 111.528 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 607' ' ' THR . . . -85.37 90.32 1.65 Allowed Glycine 0 N--CA 1.418 -2.526 0 N-CA-C 110.113 -1.195 . . . . 64.010000000000005 110.113 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -76.4 44.01 0.33 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-O 122.716 1.246 . . . . 74.549999999999997 110.659 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . 0.469 ' O ' ' HG2' ' A' ' 621' ' ' LYS . 24.1 m -78.15 141.34 38.77 Favored 'General case' 0 N--CA 1.41 -2.467 0 CA-C-N 114.089 -1.414 . . . . 74.430000000000007 108.947 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 30.0 pt -95.74 151.59 3.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.769 -0.826 . . . . 71.510000000000005 108.769 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 19.5 m -68.36 -43.27 77.78 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.771 -0.826 . . . . 75.299999999999997 108.771 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 62.21 15.16 7.28 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.631 1.172 . . . . 72.129999999999995 112.23 174.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -86.03 112.57 21.36 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.346 -1.353 . . . . 73.129999999999995 107.346 175.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -76.4 89.78 3.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.342 -0.984 . . . . 71.450000000000003 108.342 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -146.19 -68.69 0.27 Allowed 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 107.076 -1.453 . . . . 71.140000000000001 107.076 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 4.5 p30 44.23 34.38 1.0 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.609 1.564 . . . . 65.400000000000006 114.342 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -78.15 2.65 17.38 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.102 0.953 . . . . 72.239999999999995 110.111 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -160.03 147.27 12.57 Favored Pre-proline 0 N--CA 1.425 -1.704 0 N-CA-C 105.33 -2.1 . . . . 54.399999999999999 105.33 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -69.02 92.6 0.45 Allowed 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 121.427 1.418 . . . . 53.200000000000003 110.719 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.5 tp -109.66 106.08 15.6 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.873 -0.603 . . . . 73.140000000000001 110.932 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 25.4 m -96.49 95.1 7.78 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.922 -0.581 . . . . 73.200000000000003 109.715 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 49.1 m -106.46 112.87 26.06 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.549 -0.537 . . . . 74.439999999999998 109.549 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 607' ' ' THR . 68.7 mttm -132.24 -176.32 4.04 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.629 -0.714 . . . . 75.420000000000002 109.302 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -75.28 130.1 38.52 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 123.636 0.585 . . . . 74.209999999999994 110.654 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 623' ' ' GLU . 0.8 OUTLIER -83.75 116.85 22.89 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.778 0.799 . . . . 65.400000000000006 109.866 177.197 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . 0.484 ' OE1' ' HD3' ' A' ' 626' ' ' ARG . 0.0 OUTLIER -96.93 73.38 2.58 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.041 -0.981 . . . . 74.099999999999994 111.472 -177.082 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 59.43 26.4 15.31 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.721 0.772 . . . . 70.430000000000007 109.46 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.484 ' HD3' ' OE1' ' A' ' 624' ' ' GLU . 13.3 tpt180 -56.94 -57.93 10.36 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 125.506 1.522 . . . . 73.239999999999995 112.377 -170.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . 0.539 ' HD3' ' O ' ' A' ' 627' ' ' ARG . 0.0 OUTLIER -62.15 -34.13 75.81 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.895 0.378 . . . . 52.340000000000003 110.373 -175.313 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.425 ' O ' ' HG2' ' A' ' 631' ' ' MET . 61.5 mt -70.22 -43.1 78.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.241 -0.652 . . . . 73.430000000000007 109.241 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . 0.524 ' O ' ' HG2' ' A' ' 633' ' ' ARG . . . -63.95 -45.28 89.87 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.31 -0.859 . . . . 75.109999999999999 111.363 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.52 ' HA ' ' CG ' ' A' ' 633' ' ' ARG . 51.6 mt-10 -59.64 -11.08 4.26 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 116.508 2.04 . . . . 72.510000000000005 116.508 -173.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 25.4 ptt? -79.64 -10.38 59.78 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.888 -0.725 . . . . 74.219999999999999 109.784 176.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -134.38 48.03 0.96 Allowed Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.283 -1.127 . . . . 65.430000000000007 110.283 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 629' ' ' ALA . 9.6 mmm180 -127.81 155.81 76.8 Favored Pre-proline 0 C--N 1.316 -0.887 0 N-CA-C 109.979 -0.378 . . . . 72.349999999999994 109.979 -176.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.468 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 43.9 Cg_endo -67.55 133.96 31.53 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.095 1.864 . . . . 62.009999999999998 110.252 174.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.86 162.87 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 108.928 -0.767 . . . . 74.519999999999996 108.928 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.548 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.8 OUTLIER -96.89 166.57 11.56 Favored 'General case' 0 N--CA 1.424 -1.733 0 C-N-CA 119.377 -0.929 . . . . 63.299999999999997 111.813 178.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.513 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -69.36 -168.25 5.86 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 116.182 1.233 . . . . 62.549999999999997 116.182 -175.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -70.83 -39.5 72.98 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.085 -1.058 . . . . 65.120000000000005 108.452 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -138.73 121.92 16.94 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.354 -0.839 . . . . 55.329999999999998 110.05 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . 0.548 HG21 ' HB2' ' A' ' 636' ' ' LEU . 17.8 p -121.92 92.87 3.83 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.789 -0.641 . . . . 73.450000000000003 109.735 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -161.95 143.01 10.75 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.627 -1.249 . . . . 72.319999999999993 107.627 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.579 HD22 HG11 ' A' ' 523' ' ' VAL . 16.4 tp -128.69 125.7 38.56 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 107.726 -1.212 . . . . 71.299999999999997 107.726 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -93.86 111.48 23.19 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.098 -1.445 . . . . 64.140000000000001 107.098 176.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.86 113.56 39.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.208 -0.664 . . . . 71.219999999999999 109.208 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 38.3 mt -100.43 128.62 52.28 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.554 0 N-CA-C 108.298 -1.001 . . . . 73.540000000000006 108.298 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 57.9 mt -104.51 107.61 22.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 106.894 -1.521 . . . . 54.140000000000001 106.894 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.486 ' HB3' ' ND2' ' A' ' 584' ' ' ASN . 6.7 pt-20 -128.81 145.01 51.31 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 120.327 -0.549 . . . . 74.430000000000007 111.934 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 516' ' ' GLU . 35.9 mt-10 -71.09 118.41 13.83 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.853 -0.612 . . . . 72.540000000000006 111.979 -174.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.5 p -144.47 78.29 1.57 Allowed 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.044 -0.98 . . . . 70.310000000000002 108.826 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . 0.467 ' HA ' ' OG ' ' A' ' 517' ' ' SER . 35.7 m-85 -63.54 -54.99 27.5 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 114.414 -1.266 . . . . 65.439999999999998 112.463 -174.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -79.88 -27.06 40.06 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.734 -0.839 . . . . 73.319999999999993 108.734 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 34.5 t80 71.32 20.23 5.05 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.581 1.553 . . . . 73.319999999999993 108.592 -177.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -112.43 128.74 56.4 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.792 -1.549 . . . . 62.340000000000003 107.448 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 35.7 m -78.23 84.24 4.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.996 -0.742 . . . . 62.43 108.996 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 25.9 m -73.12 -41.43 64.01 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 108.673 -0.862 . . . . 52.030000000000001 108.673 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 55.0 t -121.37 116.11 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 N-CA-C 107.445 -1.317 . . . . 64.129999999999995 107.445 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 . . . . . 0 C--N 1.31 -1.136 0 N-CA-C 109.962 -0.384 . . . . 74.5 109.962 179.759 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 76.3 t60 . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 121.069 0.461 . . . . 72.230000000000004 110.195 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.491 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . -71.69 -91.58 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 113.864 1.061 . . . . 62.119999999999997 113.864 -174.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.433 ' HA3' ' H ' ' A' ' 529' ' ' SER . . . 159.32 -135.42 4.16 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 118.383 -1.865 . . . . 61.240000000000002 113.145 -173.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.4 120.08 55.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 122.075 0.15 . . . . 73.420000000000002 110.968 -173.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.445 ' CE2' ' HB ' ' A' ' 528' ' ' THR . 23.8 m-85 -108.68 126.53 53.09 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.25 -1.019 . . . . 72.099999999999994 108.25 169.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.6 t -171.2 -178.82 2.51 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.671 -0.863 . . . . 75.140000000000001 108.671 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -87.79 152.12 22.36 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 110.444 -0.206 . . . . 73.409999999999997 110.444 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -59.64 -41.11 89.78 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.648 0.737 . . . . 74.010000000000005 110.165 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -135.16 146.59 58.91 Favored Pre-proline 0 N--CA 1.42 -1.96 0 CA-C-N 114.741 -1.118 . . . . 73.420000000000002 108.227 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -71.08 -29.89 17.08 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.167 1.911 . . . . 74.310000000000002 112.665 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.13 136.79 55.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.639 -0.874 . . . . 54.329999999999998 108.639 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.2 t -133.65 141.24 47.53 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 108.39 -0.966 . . . . 74.329999999999998 108.39 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -109.44 132.94 53.66 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.073 -1.051 . . . . 54.240000000000002 109.352 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.3 m -124.34 165.99 20.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 109.044 -0.724 . . . . 73.200000000000003 109.044 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.539 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 72.4 m -93.78 152.61 18.81 Favored 'General case' 0 N--CA 1.394 -3.25 0 CA-C-N 115.649 -0.705 . . . . 75.430000000000007 110.774 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.428 ' HA ' HG11 ' A' ' 575' ' ' VAL . 1.8 tm-20 -68.22 -56.74 7.62 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.623 0.725 . . . . 65.030000000000001 109.073 173.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.69 40.68 0.6 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 125.121 1.368 . . . . 65.519999999999996 111.69 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 12.0 tt -104.71 -26.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.155 0.503 . . . . 60.32 111.73 -175.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . 0.437 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 91.76 -79.06 1.28 Allowed Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 110.839 -0.904 . . . . 65.230000000000004 110.839 -175.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 37.2 mm -129.79 133.45 64.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.674 -1.232 . . . . 75.099999999999994 107.674 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.584 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -109.91 146.5 35.06 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.445 -0.946 . . . . 74.120000000000005 108.445 175.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 26.4 mt-10 -125.7 120.12 29.83 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 123.645 0.591 . . . . 74.530000000000001 111.544 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.584 HG23 ' SD ' ' A' ' 521' ' ' MET . 65.9 t -112.55 129.23 68.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.628 -0.878 . . . . 74.329999999999998 108.628 177.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.613 ' HB3' HG21 ' A' ' 568' ' ' VAL . 29.1 mtmt -86.76 143.13 27.67 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 123.808 0.692 . . . . 75.329999999999998 110.698 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.546 ' O ' HG23 ' A' ' 568' ' ' VAL . 43.3 t -105.02 141.63 19.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.755 -0.657 . . . . 74.519999999999996 109.322 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.96 118.51 17.99 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.69 -0.856 . . . . 74.150000000000006 108.69 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -73.76 153.21 40.1 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.072 -0.714 . . . . 71.409999999999997 109.072 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.445 ' HB ' ' CE2' ' A' ' 505' ' ' PHE . 12.0 t -60.16 157.52 13.07 Favored 'General case' 0 N--CA 1.41 -2.435 0 C-N-CA 123.857 0.863 . . . . 72.239999999999995 110.727 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . 0.433 ' H ' ' HA3' ' A' ' 503' ' ' GLY . 47.0 t -72.01 -26.95 62.42 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.711 0.767 . . . . 60.109999999999999 109.775 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.85 82.91 0.33 Allowed Glycine 0 N--CA 1.428 -1.842 0 CA-C-N 115.688 -0.687 . . . . 73.349999999999994 111.486 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.64 100.31 13.18 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.655 -1.239 . . . . 73.540000000000006 107.655 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.42 ' HD3' ' HA ' ' A' ' 532' ' ' ARG . 39.2 mmt180 -111.86 96.84 6.29 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.627 0.727 . . . . 55.299999999999997 111.882 -176.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 101.96 -122.84 7.69 Favored Glycine 0 N--CA 1.428 -1.859 0 CA-C-N 114.576 -1.193 . . . . 72.129999999999995 110.417 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.472 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.5 t-20 -133.13 127.98 35.09 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.13 0.49 . . . . 52.43 110.295 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 64.5 t -130.39 136.54 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 108.837 -0.801 . . . . 72.010000000000005 108.837 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.521 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 40.3 mm -106.69 138.46 32.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 109.088 -0.708 . . . . 72.450000000000003 109.088 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.1 t -122.91 110.08 31.66 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 109.598 -0.519 . . . . 65.219999999999999 109.598 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.28 155.19 51.56 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.362 2.041 . . . . 71.409999999999997 111.903 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.456 ' HB3' HG22 ' A' ' 591' ' ' ILE . 31.5 p90 -150.84 156.15 40.66 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 110.153 -0.314 . . . . 55.340000000000003 110.153 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.59 156.21 40.93 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 123.714 0.634 . . . . 73.030000000000001 111.922 175.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 18.9 p -79.35 153.59 29.68 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 109.373 -0.603 . . . . 71.219999999999999 109.373 175.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 81.8 mt -117.54 113.91 43.95 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 107.313 -1.365 . . . . 74.420000000000002 107.313 176.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -84.2 147.58 27.21 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.305 -0.861 . . . . 75.400000000000006 108.732 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 178.31 -91.82 0.08 OUTLIER Glycine 0 C--N 1.307 -1.046 0 C-N-CA 120.601 -0.809 . . . . 73.409999999999997 111.526 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -2.6 30.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.679 0.752 . . . . 74.040000000000006 112.045 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 587' ' ' PHE . . . -144.43 141.52 29.68 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 104.536 -2.394 . . . . 31.010000000000002 104.536 171.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.498 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 71.9 mtt180 -104.05 145.69 29.81 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 121.912 0.863 . . . . 50.43 112.635 -173.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.73 -153.23 27.83 Favored Glycine 0 N--CA 1.421 -2.303 0 N-CA-C 109.371 -1.492 . . . . 63.25 109.371 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . 0.409 ' H ' ' CG ' ' A' ' 555' ' ' ASP . . . 78.0 8.75 87.3 Favored Glycine 0 C--N 1.292 -1.891 0 N-CA-C 111.429 -0.668 . . . . 65.239999999999995 111.429 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 79.05 29.6 50.36 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 110.647 -0.981 . . . . 73.099999999999994 110.647 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.498 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 32.1 tt0 -96.86 -60.99 1.48 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.712 -0.477 . . . . 64.109999999999999 109.712 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -103.3 -43.71 5.36 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 108.609 -0.886 . . . . 72.420000000000002 108.609 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -135.11 158.1 45.23 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.377 -0.829 . . . . 65.439999999999998 109.013 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.471 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 13.9 tt0 -84.19 138.3 33.06 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.604 -1.258 . . . . 71.239999999999995 107.604 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 549' ' ' GLY . 7.5 m-20 -71.81 121.19 18.53 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 109.682 -0.488 . . . . 61.520000000000003 109.682 -177.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.489 HG21 HG22 ' A' ' 573' ' ' VAL . 13.5 t -130.13 146.11 51.75 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-O 121.468 0.651 . . . . 73.099999999999994 109.411 176.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 5.0 p -167.52 155.27 8.94 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.973 -1.492 . . . . 73.319999999999993 106.973 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 165.01 -153.44 23.63 Favored Glycine 0 N--CA 1.41 -3.086 0 C-N-CA 119.789 -1.196 . . . . 72.340000000000003 110.484 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.521 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 46.7 mt-10 -139.55 133.09 30.31 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.117 0.484 . . . . 72.439999999999998 110.466 -175.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' ' 569' ' ' LYS . 96.5 mt -97.36 137.91 35.62 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.827 -0.624 . . . . 71.219999999999999 109.468 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.485 ' HA ' HD13 ' A' ' 536' ' ' ILE . 33.3 tt0 -99.18 115.47 29.16 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 121.203 0.525 . . . . 45.109999999999999 110.706 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -111.63 145.05 39.89 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.604 -0.887 . . . . 74.340000000000003 108.604 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.495 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 46.7 mt-30 -147.25 -176.3 5.17 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.582 -0.896 . . . . 73.230000000000004 108.582 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -68.4 -31.69 71.21 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.452 -0.944 . . . . 55.049999999999997 108.452 172.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -84.49 -38.39 20.15 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.572 -1.195 . . . . 61.43 111.671 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.495 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 36.5 mm-40 -75.67 129.33 36.96 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 116.674 -0.239 . . . . 74.030000000000001 111.064 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.584 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.8 pt -90.02 -72.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.897 -0.592 . . . . 55.399999999999999 111.804 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' ' 524' ' ' LYS . 12.5 p -130.96 149.23 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 CA-C-O 121.204 0.526 . . . . 54.329999999999998 110.347 -177.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.537 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -120.29 156.43 31.26 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 109.387 -0.597 . . . . 74.530000000000001 109.387 175.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.442 ' CG2' ' HG2' ' A' ' 524' ' ' LYS . 3.3 p -119.81 147.28 44.84 Favored 'General case' 0 C--N 1.283 -2.285 0 O-C-N 124.161 0.913 . . . . 43.329999999999998 112.721 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.2 mp -94.41 122.6 46.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 106.353 -1.721 . . . . 74.049999999999997 106.353 172.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 521' ' ' MET . 18.7 m -102.94 116.81 33.27 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 123.813 0.696 . . . . 62.140000000000001 109.127 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.489 HG22 HG21 ' A' ' 556' ' ' THR . 86.2 t -119.47 128.46 75.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 109.144 -0.688 . . . . 73.340000000000003 109.144 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 23.9 tptm -83.97 124.1 30.68 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.752 -0.832 . . . . 75.540000000000006 108.752 176.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 516' ' ' GLU . 47.9 t -94.26 127.36 46.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 108.61 -0.885 . . . . 72.230000000000004 108.61 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 45.5 mm -81.61 149.77 4.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.658 -0.867 . . . . 71.409999999999997 108.658 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -73.77 89.75 1.82 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.384 -0.969 . . . . 74.430000000000007 108.384 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -75.35 134.88 40.89 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.447 0.642 . . . . 72.230000000000004 112.448 -175.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -106.82 -19.57 13.6 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.206 -0.907 . . . . 73.430000000000007 109.246 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 582' ' ' GLU . 2.0 mp0 -96.19 44.08 1.07 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.296 -0.865 . . . . 72.510000000000005 109.495 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -75.06 34.17 0.1 Allowed 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 124.24 1.016 . . . . 64.519999999999996 112.111 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 580' ' ' GLU . 32.8 mt-10 -61.53 -41.83 97.92 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.587 1.555 . . . . 73.230000000000004 108.709 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.479 ' HD3' ' N ' ' A' ' 584' ' ' ASN . 8.4 tmtt? -118.62 141.34 48.69 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 105.918 -1.882 . . . . 72.299999999999997 105.918 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . 0.479 ' N ' ' HD3' ' A' ' 583' ' ' LYS . 3.8 t-20 -60.31 120.02 9.05 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.367 -0.975 . . . . 74.219999999999999 108.367 174.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -85.75 136.84 33.18 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.152 0.501 . . . . 73.5 111.098 -171.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.0 t -153.32 135.73 15.04 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 109.48 -0.563 . . . . 70.310000000000002 109.48 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.407 ' HB3' ' HB3' ' A' ' 546' ' ' ALA . 40.9 p90 -129.37 178.1 6.69 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.786 -1.19 . . . . 72.120000000000005 107.786 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.55 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 67.4 m-85 -123.43 154.59 38.84 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.806 -0.813 . . . . 75.319999999999993 108.806 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.81 131.3 53.56 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 106.191 -1.781 . . . . 53.32 106.191 178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.508 ' HB2' HD11 ' A' ' 542' ' ' ILE . 42.6 tt0 -126.97 139.06 53.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.589 -0.523 . . . . 72.510000000000005 109.589 177.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.456 HG22 ' HB3' ' A' ' 539' ' ' TYR . 20.3 pt -106.0 141.57 21.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.322 -0.992 . . . . 75.010000000000005 108.322 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.12 179.54 49.67 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 111.236 -0.746 . . . . 72.140000000000001 111.236 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.78 134.26 86.08 Favored Pre-proline 0 N--CA 1.435 -1.225 0 C-N-CA 120.912 -0.315 . . . . 73.519999999999996 110.632 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.415 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 21.7 Cg_endo -61.36 146.94 96.72 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.255 2.636 . . . . 74.230000000000004 112.064 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -124.47 125.04 43.6 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.024 -0.534 . . . . 71.219999999999999 109.562 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -72.08 129.17 37.86 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.664 -1.236 . . . . 75.129999999999995 107.664 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.51 ' CG2' HG12 ' A' ' 536' ' ' ILE . 48.6 t -82.07 106.07 12.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.766 -0.827 . . . . 65.049999999999997 108.766 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.468 ' HA ' ' OE1' ' A' ' 598' ' ' GLU . 4.4 mm-40 -80.04 118.32 21.66 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 114.939 -1.028 . . . . 73.409999999999997 113.725 -176.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 92.4 mmm -97.23 -2.21 43.26 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.29 -1.323 . . . . 73.549999999999997 107.452 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 52.3 m -131.78 132.87 44.15 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.277 -1.379 . . . . 55.130000000000003 107.277 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -84.06 154.02 23.46 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 110.343 -0.243 . . . . 74.230000000000004 110.343 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . 0.414 ' HE2' ' HG3' ' A' ' 598' ' ' GLU . 3.7 mptp? -81.6 147.0 29.81 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.87 -0.789 . . . . 72.109999999999999 108.87 176.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -72.5 107.56 5.1 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.849 -0.797 . . . . 65.299999999999997 108.849 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 143.95 -33.17 1.75 Allowed Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 108.565 -1.814 . . . . 63.350000000000001 108.565 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 102.39 -156.96 18.41 Favored Glycine 0 N--CA 1.429 -1.807 0 N-CA-C 111.487 -0.645 . . . . 50.310000000000002 111.487 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 59.24 17.35 5.65 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.717 1.207 . . . . 71.230000000000004 113.474 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 32.8 m -71.57 -8.01 51.3 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-O 121.481 0.658 . . . . 72.340000000000003 112.314 -174.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 24.8 pt -72.26 -5.73 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.628 -0.67 . . . . 71.540000000000006 111.24 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 21.3 m -145.94 158.54 43.86 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.69 -1.596 . . . . 75.299999999999997 106.69 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -82.06 -64.74 1.12 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 118.837 -1.145 . . . . 74.530000000000001 108.91 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -143.21 157.11 44.79 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.54 -0.541 . . . . 74.420000000000002 109.54 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -57.25 -65.89 0.55 Allowed 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.316 0.858 . . . . 72.129999999999995 113.316 -175.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 34.2 t70 176.69 117.56 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.474 -0.936 . . . . 75.140000000000001 108.474 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -158.23 170.37 22.42 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.426 -0.583 . . . . 75.030000000000001 109.426 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.9 163.42 33.01 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.874 -1.158 . . . . 70.310000000000002 107.874 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 69.8 165.66 0.13 Allowed Pre-proline 0 N--CA 1.485 1.308 0 O-C-N 124.401 1.063 . . . . 71.209999999999994 111.546 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.98 144.21 57.83 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.127 1.885 . . . . 75.430000000000007 110.726 172.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 94.0 mt -83.88 179.47 7.55 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.754 0.788 . . . . 61.140000000000001 113.009 -174.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 37.6 m -101.8 152.93 20.29 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 114.473 -1.239 . . . . 74.340000000000003 108.134 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.41 ' HA ' ' OE2' ' A' ' 625' ' ' GLU . 14.2 t -65.64 142.58 58.01 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.221 0.534 . . . . 71.030000000000001 111.266 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -144.14 155.43 43.93 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.125 -1.065 . . . . 62.100000000000001 108.125 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -87.08 73.43 9.84 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.625 0.726 . . . . 71.340000000000003 109.315 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -167.49 -173.02 2.09 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.246 -2.131 . . . . 62.240000000000002 105.246 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -73.38 93.08 1.9 Allowed 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 108.922 -0.77 . . . . 74.409999999999997 108.922 173.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.41 ' OE2' ' HA ' ' A' ' 620' ' ' SER . 40.3 mt-10 -60.81 155.59 19.11 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 108.521 -0.918 . . . . 74.099999999999994 108.521 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.528 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 65.1 ttt180 -62.86 -36.86 84.65 Favored 'General case' 0 C--O 1.2 -1.534 0 C-N-CA 119.968 -0.693 . . . . 73.040000000000006 111.072 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -62.27 -27.63 69.15 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 121.128 0.49 . . . . 74.400000000000006 110.607 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.529 ' O ' ' HG2' ' A' ' 631' ' ' MET . 69.7 mt -79.49 -44.85 23.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.208 -1.034 . . . . 71.140000000000001 108.208 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 633' ' ' ARG . . . -64.01 -37.63 88.14 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.933 -1.03 . . . . 72.010000000000005 111.887 -177.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 65.0 mm-40 -58.42 -18.43 28.28 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.902 1.075 . . . . 75.239999999999995 113.902 -178.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.529 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 24.6 ptt? -91.96 -10.5 39.15 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.711 -0.795 . . . . 72.319999999999993 110.331 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -110.4 -38.5 1.62 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.487 -0.863 . . . . 75.519999999999996 111.902 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . 0.513 ' HD2' ' OE2' ' A' ' 630' ' ' GLU . 4.9 ptp180 -79.29 158.24 74.46 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 110.158 -0.312 . . . . 72.019999999999996 110.158 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.491 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 53.3 Cg_endo -68.13 133.28 28.31 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 122.129 1.886 . . . . 65.319999999999993 110.922 174.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . 0.501 HD13 ' H ' ' A' ' 635' ' ' ILE . 0.1 OUTLIER -124.95 175.93 6.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.535 -0.913 . . . . 42.420000000000002 108.535 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.59 -176.3 3.03 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.267 -0.573 . . . . 73.519999999999996 112.086 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -80.62 -153.39 9.21 Favored Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 115.893 -0.594 . . . . 42.020000000000003 113.351 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . 0.515 ' HG2' ' CD2' ' A' ' 639' ' ' HIS . 37.4 tt0 -71.87 -57.13 4.59 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 123.392 0.677 . . . . 71.430000000000007 110.224 -177.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . 0.515 ' CD2' ' HG2' ' A' ' 638' ' ' GLU . 96.6 m-70 -135.06 139.13 44.53 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 109.556 -0.535 . . . . 72.549999999999997 109.556 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 29.7 p -124.47 99.83 6.38 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 121.206 0.526 . . . . 73.310000000000002 111.249 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -165.8 150.73 8.57 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.082 -1.081 . . . . 74.420000000000002 108.082 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.479 HD21 HG21 ' A' ' 523' ' ' VAL . 34.8 tp -130.95 131.34 44.37 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.021 -1.103 . . . . 44.32 108.021 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -97.04 104.52 16.54 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.915 -1.513 . . . . 74.519999999999996 106.915 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 40.8 t -99.47 113.53 34.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 109.982 -0.377 . . . . 74.540000000000006 109.982 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 59.6 mt -99.11 126.97 52.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 109.027 -0.731 . . . . 52.039999999999999 109.027 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 57.2 mt -104.06 110.39 30.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.264 -1.013 . . . . 75.439999999999998 108.264 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -119.17 150.64 39.7 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 116.443 -0.344 . . . . 72.010000000000005 110.241 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -81.85 118.09 22.63 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.95 0.881 . . . . 72.049999999999997 109.34 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 17.8 m -122.15 79.42 1.59 Allowed 'General case' 0 N--CA 1.406 -2.66 0 CA-C-N 115.259 -0.882 . . . . 45.340000000000003 110.756 -173.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -94.03 -57.26 2.58 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.164 -1.421 . . . . 64.409999999999997 107.164 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -75.68 -46.22 32.54 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.566 -1.272 . . . . 72.129999999999995 107.566 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 51.9 t80 58.16 80.36 0.18 Allowed 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 114.119 -1.4 . . . . 51.520000000000003 111.035 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -95.71 95.76 8.54 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.006 -0.739 . . . . 74.450000000000003 109.006 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 5.9 t -97.09 85.55 3.75 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 106.737 -1.579 . . . . 74.540000000000006 106.737 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 91.2 m -153.18 137.26 16.39 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.32 -0.855 . . . . 70.430000000000007 109.015 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 48.4 t -90.3 112.45 24.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.749 -0.834 . . . . 72.200000000000003 108.749 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 120.891 0.377 . . . . 72.319999999999993 111.251 -179.541 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 80.6 t60 . . . . . 0 N--CA 1.432 -1.344 0 N-CA-C 107.533 -1.284 . . . . 55.450000000000003 107.533 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.54 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -93.62 -90.84 0.19 Allowed 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 116.44 -0.346 . . . . 75.349999999999994 111.656 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 160.94 -153.24 24.05 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 111.241 -0.743 . . . . 74.340000000000003 111.241 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.86 130.94 67.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 123.148 0.579 . . . . 72.340000000000003 112.049 -167.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -108.51 132.57 53.69 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.315 -0.624 . . . . 63.509999999999998 109.315 168.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.7 t -168.69 173.72 7.1 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.405 -0.591 . . . . 63.409999999999997 109.405 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -77.25 147.26 36.43 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 120.939 0.399 . . . . 73.200000000000003 110.751 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -67.98 -35.65 78.72 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.487 -0.779 . . . . 61.350000000000001 109.906 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -127.76 144.4 51.12 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.115 -1.069 . . . . 74.010000000000005 108.115 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.03 -31.34 6.24 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.146 1.897 . . . . 73.540000000000006 111.986 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.97 138.04 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 106.511 -1.663 . . . . 72.129999999999995 106.511 -177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.4 t -132.19 140.82 48.86 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 108.06 -1.089 . . . . 55.219999999999999 108.06 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -120.28 124.19 45.03 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 109.253 -0.647 . . . . 74.209999999999994 109.253 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.8 m -115.7 167.34 8.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.001 -1.0 . . . . 75.239999999999995 109.398 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.631 ' O ' HG22 ' A' ' 518' ' ' ILE . 23.2 t -97.04 153.89 17.65 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 120.96 0.41 . . . . 64.409999999999997 110.229 -176.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.522 ' CB ' ' HA ' ' A' ' 648' ' ' GLU . 4.3 tm-20 -65.51 -42.2 92.35 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.143 -1.429 . . . . 74.129999999999995 107.143 169.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . 0.492 ' OG ' ' HB3' ' A' ' 649' ' ' SER . 14.4 m -90.66 23.98 2.85 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.995 -1.002 . . . . 64.420000000000002 112.432 -173.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 515' ' ' SER . 8.8 tt -90.94 -22.08 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 121.575 -0.703 . . . . 75.430000000000007 109.825 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 83.97 -75.6 2.35 Favored Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.677 -0.773 . . . . 71.310000000000002 111.234 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.0 mm -129.83 130.2 66.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 106.983 -1.488 . . . . 62.509999999999998 106.983 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.616 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -106.39 147.34 29.38 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 109.131 -0.692 . . . . 74.5 109.131 178.612 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.3 mt-10 -127.91 114.84 17.69 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 123.852 0.72 . . . . 54.439999999999998 110.945 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.55 HG21 HD21 ' A' ' 642' ' ' LEU . 90.7 t -102.33 127.96 55.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.778 -0.823 . . . . 73.099999999999994 108.778 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.409 ' HB3' HG21 ' A' ' 568' ' ' VAL . 25.7 mtmm -87.6 138.91 31.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 121.442 0.639 . . . . 53.240000000000002 110.667 -177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 61.0 t -108.2 129.93 61.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.443 -0.799 . . . . 63.299999999999997 108.847 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.5 130.01 41.77 Favored 'General case' 0 CA--C 1.501 -0.915 0 O-C-N 123.862 0.726 . . . . 74.109999999999999 109.87 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -82.65 155.1 24.56 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 115.151 -0.931 . . . . 74.239999999999995 110.024 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.2 t -56.05 145.48 25.51 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 124.763 1.225 . . . . 64.200000000000003 111.538 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.9 t -60.53 -31.77 70.84 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 124.375 1.07 . . . . 70.420000000000002 109.042 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -122.26 99.51 0.67 Allowed Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 109.71 -1.356 . . . . 53.439999999999998 109.71 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.44 101.6 12.76 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.948 -1.13 . . . . 63.5 107.948 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -107.75 100.77 10.13 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.261 -0.881 . . . . 52.030000000000001 110.389 -172.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 75.53 -114.68 4.33 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.395 -0.907 . . . . 62.439999999999998 112.36 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.444 HD22 ' HG2' ' A' ' 563' ' ' GLN . 2.7 t-20 -133.99 129.18 35.8 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.143 0.577 . . . . 72.109999999999999 109.459 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 93.1 t -130.24 135.64 60.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 C-N-CA 123.56 0.744 . . . . 51.340000000000003 109.126 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.502 HG12 ' CG2' ' A' ' 597' ' ' VAL . 38.0 mm -108.74 131.25 59.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.88 -0.415 . . . . 63.399999999999999 109.88 176.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.43 HG22 ' HB3' ' A' ' 594' ' ' PRO . 26.6 t -119.23 105.9 43.79 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 109.21 -0.663 . . . . 75.109999999999999 109.21 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.86 153.19 58.57 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.317 2.011 . . . . 72.439999999999998 112.048 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.487 ' HB3' HG22 ' A' ' 591' ' ' ILE . 52.1 p90 -151.02 159.64 44.42 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.642 0.258 . . . . 72.140000000000001 110.786 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.03 157.05 33.94 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.463 -0.79 . . . . 75.340000000000003 112.084 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.6 p -84.86 139.68 31.71 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.866 -0.607 . . . . 75.120000000000005 109.828 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.528 HD11 ' HB2' ' A' ' 590' ' ' GLU . 69.1 mt -107.63 134.37 49.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.132 -0.692 . . . . 71.439999999999998 109.132 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -85.62 142.97 28.71 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.923 -0.58 . . . . 62.310000000000002 110.337 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 151.77 141.58 3.35 Favored Glycine 0 CA--C 1.471 -2.678 0 N-CA-C 107.924 -2.07 . . . . 61.310000000000002 107.924 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . 0.357 1.0 OUTLIER 61.11 -47.17 0.12 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 115.377 1.621 . . . . 64.409999999999997 115.377 -174.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.451 ' HA ' ' HD2' ' A' ' 585' ' ' LYS . . . -107.87 150.38 27.12 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.193 -1.04 . . . . 75.319999999999993 108.193 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -92.37 128.74 38.33 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.745 0.783 . . . . 75.209999999999994 111.347 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.78 -153.5 21.68 Favored Glycine 0 C--N 1.3 -1.421 0 CA-C-N 115.056 -0.975 . . . . 52.210000000000001 112.96 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . 0.467 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 57.12 30.84 61.24 Favored Glycine 0 C--N 1.317 -0.48 0 N-CA-C 113.76 0.264 . . . . 65.230000000000004 113.76 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 73.31 39.68 50.98 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.735 -0.745 . . . . 70.150000000000006 111.991 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -112.88 -51.77 2.81 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 122.363 -0.492 . . . . 74.340000000000003 110.869 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -111.14 -35.31 5.93 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.385 -1.339 . . . . 74.519999999999996 107.385 169.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -139.54 148.94 43.29 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.781 -1.192 . . . . 74.420000000000002 107.781 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.77 136.0 37.26 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.337 -1.357 . . . . 72.230000000000004 107.337 175.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . 0.467 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 17.5 t70 -90.69 119.9 31.31 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.592 -0.521 . . . . 63.329999999999998 109.592 -174.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.403 HG21 HG22 ' A' ' 573' ' ' VAL . 10.3 t -128.02 155.03 44.97 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.263 0.554 . . . . 64.120000000000005 111.04 -174.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 26.4 p -149.79 158.37 44.11 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.955 -1.498 . . . . 73.109999999999999 106.955 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 168.78 -167.7 40.57 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 109.893 -1.283 . . . . 74.400000000000006 109.893 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.478 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 43.6 mt-10 -132.64 138.42 47.34 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.804 -0.443 . . . . 70.040000000000006 109.804 -178.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.595 HD22 ' HB3' ' A' ' 569' ' ' LYS . 76.6 mt -95.7 133.93 39.22 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.726 -0.472 . . . . 44.340000000000003 109.726 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.495 ' HA ' HD13 ' A' ' 536' ' ' ILE . 24.8 tt0 -101.25 106.43 17.64 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.847 -0.615 . . . . 72.219999999999999 110.279 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -105.04 148.22 27.01 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.007 -0.738 . . . . 73.340000000000003 109.007 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.484 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 8.8 mt-30 -145.02 -178.04 5.84 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.944 -1.132 . . . . 72.109999999999999 107.944 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -68.84 -31.89 71.19 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.117 -1.068 . . . . 72.099999999999994 108.117 173.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.42 -52.33 7.79 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.109 -0.95 . . . . 71.409999999999997 111.809 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.484 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 14.7 mm-40 -55.25 125.62 21.45 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 123.449 0.7 . . . . 70.239999999999995 111.743 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.613 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.7 pt -84.63 -63.03 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.266 -0.879 . . . . 73.209999999999994 112.646 -175.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.613 ' H ' HG13 ' A' ' 567' ' ' ILE . 10.0 p -143.48 150.57 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 109.213 -0.662 . . . . 41.439999999999998 109.213 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.595 ' HB3' HD22 ' A' ' 560' ' ' LEU . 6.1 mmpt? -118.05 165.57 13.58 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.728 -0.471 . . . . 71.010000000000005 109.728 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.6 p -135.14 147.43 49.47 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 123.962 0.789 . . . . 45.329999999999998 112.363 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.463 HG22 HG23 ' A' ' 573' ' ' VAL . 3.0 mp -100.47 118.1 46.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 106.941 -1.503 . . . . 62.549999999999997 106.941 172.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . 0.616 ' HA ' ' O ' ' A' ' 521' ' ' MET . 3.3 p -95.95 117.0 29.78 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 124.099 0.874 . . . . 55.409999999999997 110.399 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.463 HG23 HG22 ' A' ' 571' ' ' ILE . 89.0 t -124.79 132.17 71.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 O-C-N 122.239 -0.288 . . . . 62.439999999999998 110.792 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -79.62 123.0 27.22 Favored 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 123.856 0.723 . . . . 73.010000000000005 109.703 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 49.0 t -90.2 126.96 43.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.555 -0.905 . . . . 65.540000000000006 108.555 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 26.2 mm -96.66 153.11 3.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.9 -0.407 . . . . 71.409999999999997 109.9 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -75.75 123.95 26.46 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.122 -0.49 . . . . 52.43 111.181 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -73.77 141.82 46.25 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 105.598 -2.001 . . . . 61.350000000000001 105.598 171.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -50.96 -48.12 61.12 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 123.771 0.669 . . . . 73.439999999999998 111.028 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.452 ' HB2' ' H ' ' A' ' 581' ' ' TYR . 27.1 mm-40 -128.83 -76.35 0.56 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.533 -1.654 . . . . 71.219999999999999 106.533 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . 0.452 ' H ' ' HB2' ' A' ' 580' ' ' GLU . 26.0 t80 166.38 80.8 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 128.325 2.65 . . . . 73.200000000000003 104.409 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -64.19 -47.41 79.88 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.533 -1.212 . . . . 74.430000000000007 111.718 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.406 ' HA ' ' HE3' ' A' ' 583' ' ' LYS . 0.9 OUTLIER -150.71 160.91 43.52 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 105.207 -2.145 . . . . 63.439999999999998 105.207 -172.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -62.55 105.58 0.65 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 104.9 -2.259 . . . . 63.030000000000001 104.9 168.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.451 ' HD2' ' HA ' ' A' ' 546' ' ' ALA . 34.5 mmtp -85.25 121.1 27.5 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-O 121.448 0.642 . . . . 75.030000000000001 110.087 -171.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.7 t -150.0 146.89 27.26 Favored 'General case' 0 N--CA 1.402 -2.872 0 CA-C-N 114.696 -1.138 . . . . 44.140000000000001 107.93 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -138.03 178.77 6.87 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.788 -1.19 . . . . 74.030000000000001 107.788 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.455 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 85.5 m-85 -121.03 152.03 39.09 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.188 -0.605 . . . . 71.030000000000001 109.954 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.45 131.02 54.57 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.032 -1.84 . . . . 71.209999999999994 106.032 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.528 ' HB2' HD11 ' A' ' 542' ' ' ILE . 36.8 tt0 -127.69 136.31 51.39 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.065 0.459 . . . . 75.310000000000002 110.316 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.487 HG22 ' HB3' ' A' ' 539' ' ' TYR . 23.8 pt -105.56 142.45 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.12 0 N-CA-C 107.547 -1.279 . . . . 74.340000000000003 107.547 175.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -88.17 -176.0 47.68 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.665 -0.974 . . . . 60.109999999999999 110.665 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.47 130.38 89.19 Favored Pre-proline 0 C--N 1.301 -1.541 0 CA-C-O 120.809 0.338 . . . . 73.310000000000002 110.931 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.43 ' HB3' HG22 ' A' ' 537' ' ' VAL . 34.6 Cg_endo -66.97 130.88 23.98 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.103 2.535 . . . . 64.310000000000002 111.335 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -111.88 134.34 53.5 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.936 -0.394 . . . . 74.129999999999995 109.936 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.424 HD23 ' HD3' ' A' ' 634' ' ' PRO . 1.7 tm? -72.56 132.1 43.35 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.485 -1.302 . . . . 54.130000000000003 107.485 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.502 ' CG2' HG12 ' A' ' 536' ' ' ILE . 47.5 t -82.94 91.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 109.146 -0.687 . . . . 40.399999999999999 109.146 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -82.29 133.27 35.23 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.917 -1.038 . . . . 63.119999999999997 108.393 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 97.0 mmm -71.07 -28.22 64.2 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.297 0.57 . . . . 55.520000000000003 109.667 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 47.7 t 70.0 20.55 6.5 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.627 -1.17 . . . . 60.539999999999999 111.402 177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -71.18 -20.75 62.25 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 107.928 -1.138 . . . . 73.25 107.928 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -119.71 87.6 2.77 Favored 'General case' 0 N--CA 1.403 -2.786 0 N-CA-C 106.4 -1.704 . . . . 74.209999999999994 106.4 166.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -85.36 121.46 28.12 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.557 -0.905 . . . . 72.519999999999996 108.557 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -79.3 -51.1 5.44 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 109.02 -1.632 . . . . 63.420000000000002 109.02 176.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 143.37 -178.49 21.52 Favored Glycine 0 N--CA 1.414 -2.823 0 N-CA-C 109.628 -1.389 . . . . 74.150000000000006 109.628 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -115.89 157.6 24.24 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.481 -0.933 . . . . 74.310000000000002 108.481 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 24.2 m -91.93 147.27 23.09 Favored 'General case' 0 N--CA 1.408 -2.533 0 N-CA-C 106.638 -1.616 . . . . 64.239999999999995 106.638 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 23.5 pt -70.39 100.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.822 -1.177 . . . . 54.420000000000002 107.822 172.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . 0.258 29.0 p 64.84 101.67 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.597 1.559 . . . . 74.140000000000001 113.566 -174.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -77.44 -167.1 0.85 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.99 -0.745 . . . . 74.319999999999993 108.99 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -93.49 123.17 36.62 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.223 -1.029 . . . . 70.519999999999996 108.223 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -142.42 24.07 1.95 Allowed 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 112.133 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -99.38 -44.46 6.19 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.134 0.492 . . . . 72.340000000000003 111.796 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -84.29 145.42 28.29 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.797 -0.638 . . . . 73.549999999999997 111.559 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -133.79 30.48 3.73 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.832 0.825 . . . . 70.540000000000006 109.909 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -124.4 179.21 1.14 Allowed Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 108.443 -0.947 . . . . 75.140000000000001 108.443 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.25 118.27 5.38 Favored 'Trans proline' 0 C--N 1.349 0.588 0 N-CA-C 108.325 -1.452 . . . . 75.120000000000005 108.325 169.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 60.3 tp -98.27 122.74 41.8 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 122.278 -0.264 . . . . 74.340000000000003 111.118 -174.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 20.1 p -89.49 102.02 14.7 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.725 -0.472 . . . . 51.140000000000001 109.725 176.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 71.1 m -151.63 83.78 1.29 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.07 0.462 . . . . 61.350000000000001 111.754 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -92.92 69.86 4.6 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.895 0.855 . . . . 71.0 109.197 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -98.71 149.7 22.57 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.057 -1.429 . . . . 73.230000000000004 107.675 -178.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.43 73.02 10.21 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 122.094 0.95 . . . . 71.400000000000006 109.998 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . 0.522 ' OE1' ' HG3' ' A' ' 626' ' ' ARG . 0.3 OUTLIER -142.14 158.24 43.97 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 105.683 -1.969 . . . . 74.230000000000004 105.683 -177.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.22 -20.41 65.68 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.528 0.566 . . . . 50.520000000000003 112.528 -175.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.522 ' HG3' ' OE1' ' A' ' 624' ' ' GLU . 27.8 mtm180 -57.27 -54.48 46.36 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 110.114 -0.328 . . . . 73.319999999999993 110.114 175.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -41.84 81.16 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.844 -0.799 . . . . 75.340000000000003 108.844 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 64.5 mt -56.52 -42.85 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.971 -0.559 . . . . 75.549999999999997 111.098 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -75.08 -44.89 44.92 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.199 0.524 . . . . 73.099999999999994 110.66 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -64.22 -20.19 65.86 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.588 -0.733 . . . . 64.310000000000002 112.815 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -89.7 -17.38 28.43 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.656 -0.418 . . . . 72.010000000000005 111.226 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -100.19 -26.96 8.0 Favored Glycine 0 CA--C 1.5 -0.889 0 C-N-CA 120.139 -1.029 . . . . 74.109999999999999 111.712 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -69.35 161.22 75.11 Favored Pre-proline 0 C--N 1.307 -1.277 0 C-N-CA 123.143 0.577 . . . . 75.340000000000003 111.282 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.54 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 36.2 Cg_endo -67.29 141.03 55.2 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.56 2.174 . . . . 54.25 110.111 170.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.64 174.6 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 116.227 -0.442 . . . . 53.049999999999997 110.722 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.65 172.58 6.81 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 120.184 -0.607 . . . . 72.540000000000006 112.507 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -82.68 -164.86 35.95 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 115.166 0.826 . . . . 64.5 115.166 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -67.91 -50.19 57.63 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.965 -1.117 . . . . 75.120000000000005 110.514 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -129.06 120.64 26.31 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.946 -0.761 . . . . 73.439999999999998 108.946 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 14.0 p -118.68 80.76 1.59 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 122.567 1.175 . . . . 52.539999999999999 110.293 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -154.44 141.79 19.6 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 114.057 -1.428 . . . . 61.5 108.889 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.55 HD21 HG21 ' A' ' 523' ' ' VAL . 33.4 tp -129.93 122.96 29.59 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 108.787 -0.82 . . . . 72.140000000000001 108.787 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -92.54 112.32 24.23 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.132 -1.433 . . . . 73.310000000000002 107.132 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.68 110.33 28.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.514 -0.55 . . . . 54.109999999999999 109.514 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 50.5 mt -96.47 135.37 30.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 109.332 -0.618 . . . . 72.230000000000004 109.332 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 84.8 mt -103.05 110.01 28.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 109.034 -0.728 . . . . 73.25 109.034 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -107.28 132.86 52.63 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.202 -1.036 . . . . 74.519999999999996 108.202 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.752 ' O ' ' HA ' ' A' ' 653' ' ' LYS . 0.3 OUTLIER -68.5 176.7 2.75 Favored 'General case' 0 C--O 1.201 -1.492 0 C-N-CA 123.179 0.592 . . . . 74.019999999999996 112.479 -177.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . 0.492 ' HB3' ' OG ' ' A' ' 517' ' ' SER . 8.5 t -149.4 32.01 0.73 Allowed 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.715 -0.794 . . . . 72.129999999999995 109.158 174.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -84.86 -61.27 1.82 Allowed 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.064 -0.717 . . . . 74.129999999999995 109.064 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -80.33 -47.75 14.03 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.706 -0.679 . . . . 73.299999999999997 111.218 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -146.56 -83.18 0.13 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.01 -1.107 . . . . 72.430000000000007 108.01 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . 0.752 ' HA ' ' O ' ' A' ' 648' ' ' GLU . 4.2 ttmp? 174.22 -57.38 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.198 0.999 . . . . 71.420000000000002 109.699 176.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 11.7 m -84.85 26.07 0.87 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.461 -0.791 . . . . 75.230000000000004 110.543 -177.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 1.5 m -77.32 88.75 3.73 Favored 'General case' 0 N--CA 1.424 -1.735 0 C-N-CA 123.63 0.772 . . . . 75.409999999999997 109.099 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 60.8 t -113.2 121.77 66.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 109.211 -0.663 . . . . 72.430000000000007 109.211 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 C--N 1.301 -1.533 0 CA-C-N 115.885 -0.598 . . . . 24.43 109.795 -179.755 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 61.0 m80 . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 109.318 -0.623 . . . . 73.530000000000001 109.318 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . -142.37 -139.46 0.12 Allowed 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 108.921 -0.77 . . . . 75.120000000000005 108.921 -178.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -172.26 -144.36 4.5 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 109.595 -1.402 . . . . 12.539999999999999 109.595 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.6 mp -103.53 114.29 42.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 116.79 0.295 . . . . 73.439999999999998 111.522 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -100.16 126.4 46.42 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.401 -0.963 . . . . 64.140000000000001 108.401 169.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.0 t -169.88 174.41 5.64 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.902 -0.777 . . . . 75.540000000000006 108.902 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -80.55 147.83 30.63 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 110.325 -0.25 . . . . 73.430000000000007 110.325 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -63.5 -40.78 97.96 Favored 'General case' 0 CA--C 1.492 -1.282 0 CA-C-O 122.238 1.018 . . . . 75.5 109.083 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -123.28 135.71 26.29 Favored Pre-proline 0 N--CA 1.401 -2.904 0 CA-C-N 113.948 -1.478 . . . . 73.540000000000006 107.218 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.34 -24.84 11.91 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.806 2.337 . . . . 45.549999999999997 111.519 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 61.7 t -136.25 132.99 49.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 107.142 -1.429 . . . . 75.140000000000001 107.142 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 7.1 t -128.48 133.07 48.4 Favored 'General case' 0 N--CA 1.402 -2.828 0 N-CA-C 108.569 -0.9 . . . . 44.130000000000003 108.569 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -105.8 121.87 44.92 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 109.045 -0.724 . . . . 74.019999999999996 109.045 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.6 m -113.56 174.52 2.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.418 -0.586 . . . . 64.510000000000005 109.418 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.634 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 57.9 m -92.43 165.6 12.97 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 123.254 0.621 . . . . 71.140000000000001 110.993 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.501 ' OE1' ' HA ' ' A' ' 648' ' ' GLU . 0.9 OUTLIER -78.99 -50.72 10.66 Favored 'General case' 0 CA--C 1.57 1.74 0 C-N-CA 124.789 1.236 . . . . 74.430000000000007 112.918 -175.163 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 48.9 m -105.89 27.32 8.65 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.05 0.94 . . . . 60.149999999999999 110.448 -176.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.634 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 12.1 tt -63.25 -32.92 58.19 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-N 115.447 -0.797 . . . . 74.25 112.831 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 103.79 -83.8 0.42 Allowed Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 109.927 -1.269 . . . . 74.310000000000002 109.927 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 574' ' ' LYS . 34.8 mm -133.9 136.57 53.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 105.979 -1.859 . . . . 61.520000000000003 105.979 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.524 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -112.96 141.5 46.72 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.45 -0.574 . . . . 75.439999999999998 109.45 177.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 7.3 mp0 -114.55 132.55 56.28 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 124.194 0.934 . . . . 74.519999999999996 110.08 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.524 HG23 ' SD ' ' A' ' 521' ' ' MET . 87.7 t -124.06 129.09 74.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 108.746 -0.835 . . . . 64.230000000000004 108.746 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.472 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 24.6 mtmm -86.51 139.07 31.22 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.146 0.498 . . . . 73.450000000000003 111.898 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.575 ' O ' HG23 ' A' ' 568' ' ' VAL . 39.6 t -104.18 126.26 58.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.255 -0.646 . . . . 74.439999999999998 109.255 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.18 121.46 12.59 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 123.777 0.673 . . . . 75.420000000000002 110.206 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.523 ' CZ ' ' HB3' ' A' ' 562' ' ' PHE . 10.2 tpt180 -68.93 148.37 50.29 Favored 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 115.198 -0.91 . . . . 71.109999999999999 110.91 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 11.4 p -56.97 139.1 53.12 Favored 'General case' 0 N--CA 1.408 -2.525 0 CA-C-N 114.749 -1.114 . . . . 74.120000000000005 111.916 175.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.7 m -56.19 -24.4 41.39 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 125.777 1.631 . . . . 73.109999999999999 110.746 175.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -122.99 114.25 2.37 Favored Glycine 0 N--CA 1.419 -2.446 0 N-CA-C 108.842 -1.703 . . . . 51.32 108.842 172.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -106.14 101.26 10.76 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.91 -0.774 . . . . 44.240000000000002 108.91 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -129.73 116.2 18.42 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.966 -0.561 . . . . 62.039999999999999 109.748 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 78.26 -164.64 51.3 Favored Glycine 0 C--N 1.316 -0.571 0 C-N-CA 120.901 -0.666 . . . . 61.329999999999998 112.379 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.59 ' ND2' ' HG2' ' A' ' 563' ' ' GLN . 2.5 t-20 -103.47 123.08 46.23 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.244 0.545 . . . . 73.340000000000003 109.878 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 48.1 t -126.48 136.97 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 N-CA-C 108.071 -1.085 . . . . 72.239999999999995 108.071 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.508 HG12 ' CG2' ' A' ' 597' ' ' VAL . 40.2 mm -107.98 135.29 47.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 109.205 -0.665 . . . . 71.129999999999995 109.205 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.51 109.74 36.23 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 109.232 -0.655 . . . . 70.049999999999997 109.232 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -75.9 159.24 38.26 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.124 1.883 . . . . 34.210000000000001 111.45 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -143.92 162.83 35.13 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.233 -0.655 . . . . 73.129999999999995 109.233 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -153.39 157.23 39.67 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 123.882 0.738 . . . . 73.329999999999998 109.739 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.3 p -93.41 139.25 30.9 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.626 0.727 . . . . 72.239999999999995 111.605 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 89.7 mt -109.53 122.74 64.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.573 -1.269 . . . . 71.329999999999998 107.573 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -78.81 117.73 20.2 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.677 -0.49 . . . . 53.409999999999997 109.677 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -102.85 -111.58 3.56 Favored Glycine 0 C--N 1.302 -1.355 0 N-CA-C 109.892 -1.283 . . . . 70.150000000000006 109.892 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 28.4 p -78.93 -32.63 45.66 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.508 -0.923 . . . . 64.319999999999993 108.508 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -84.46 141.48 30.76 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.753 -1.112 . . . . 72.219999999999999 109.207 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.481 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 64.6 mtt180 -101.58 146.2 28.01 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-O 121.334 0.588 . . . . 73.340000000000003 111.144 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -94.37 -161.18 34.75 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 114.993 -1.003 . . . . 65.109999999999999 112.137 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . 0.478 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 74.65 8.08 80.78 Favored Glycine 0 C--N 1.315 -0.621 0 N-CA-C 112.386 -0.286 . . . . 62.399999999999999 112.386 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . 0.412 ' C ' HG13 ' A' ' 576' ' ' ILE . . . 103.71 10.09 36.16 Favored Glycine 0 N--CA 1.419 -2.476 0 C-N-CA 120.263 -0.97 . . . . 73.099999999999994 112.865 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.481 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 28.0 tt0 -83.46 -66.29 0.91 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 118.991 -1.084 . . . . 73.219999999999999 110.355 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -101.37 -41.63 6.59 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.229 -1.026 . . . . 74.409999999999997 108.229 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -137.34 158.78 43.67 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.809 -1.182 . . . . 73.019999999999996 107.809 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.78 137.16 33.86 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 107.513 -1.292 . . . . 73.329999999999998 107.513 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . 0.478 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 33.0 t70 -84.46 103.84 13.95 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.787 -0.82 . . . . 72.150000000000006 108.787 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.484 ' CG2' HG22 ' A' ' 573' ' ' VAL . 11.5 t -110.72 146.01 37.03 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-O 122.234 1.016 . . . . 62.200000000000003 111.873 -172.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 21.8 p -145.56 147.5 32.16 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 105.931 -1.878 . . . . 64.140000000000001 105.931 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -170.06 -179.76 41.84 Favored Glycine 0 CA--C 1.477 -2.317 0 N-CA-C 110.199 -1.16 . . . . 63.229999999999997 110.199 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 39.2 mt-10 -129.6 114.4 16.0 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.103 0.478 . . . . 75.200000000000003 110.731 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 88.1 mt -85.5 138.29 32.32 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.311 -0.859 . . . . 62.210000000000001 109.448 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.498 ' HA ' HD13 ' A' ' 536' ' ' ILE . 34.4 tt0 -104.52 118.49 36.71 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.99 -0.55 . . . . 61.240000000000002 110.23 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 527' ' ' ARG . 97.9 m-85 -124.44 107.51 11.18 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.704 -0.48 . . . . 73.120000000000005 109.704 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.606 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 5.5 mt-30 -109.03 178.46 4.46 Favored 'General case' 0 C--O 1.197 -1.67 0 N-CA-C 108.752 -0.833 . . . . 71.420000000000002 108.752 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -52.93 -44.81 67.3 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 123.439 0.462 . . . . 51.219999999999999 110.82 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.52 -49.04 35.55 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.207 0.447 . . . . 75.319999999999993 112.207 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.606 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 14.0 mp0 -54.68 141.9 30.41 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.638 0.775 . . . . 75.219999999999999 111.804 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.549 HG13 ' H ' ' A' ' 568' ' ' VAL . 5.5 pt -101.8 -89.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 112.923 0.712 . . . . 61.329999999999998 112.923 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 525' ' ' VAL . 10.5 p -115.34 152.22 17.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 110.281 -0.266 . . . . 40.329999999999998 110.281 -175.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -126.96 164.56 21.21 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 122.824 0.45 . . . . 71.140000000000001 110.253 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.5 p -123.21 150.56 43.24 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 123.655 0.597 . . . . 72.420000000000002 112.071 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.1 mp -94.41 125.98 46.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 106.784 -1.562 . . . . 74.120000000000005 106.784 172.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 521' ' ' MET . 51.5 m -104.9 115.56 30.5 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 123.905 0.753 . . . . 62.420000000000002 110.155 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.484 HG22 ' CG2' ' A' ' 556' ' ' THR . 93.7 t -116.84 128.51 74.2 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 116.244 -0.435 . . . . 74.430000000000007 110.447 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.431 ' HA ' HD13 ' A' ' 520' ' ' ILE . 52.8 tptt -80.27 111.96 17.14 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 108.654 -0.869 . . . . 61.109999999999999 108.654 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 61.9 t -86.65 124.39 40.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 106.056 -1.831 . . . . 72.409999999999997 106.056 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . 0.412 HG13 ' C ' ' A' ' 550' ' ' GLY . 40.7 mm -78.28 124.45 36.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-O 121.903 0.859 . . . . 71.200000000000003 109.27 -176.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 578' ' ' ASP . 9.9 t70 -106.45 94.3 5.06 Favored 'General case' 0 C--N 1.271 -2.838 0 CA-C-N 114.539 -1.21 . . . . 71.239999999999995 111.909 -174.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 577' ' ' ASP . 33.0 t70 169.26 103.05 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.348 1.03 . . . . 70.099999999999994 111.554 170.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 63.31 85.8 0.13 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 116.294 1.961 . . . . 74.200000000000003 116.294 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.403 ' CD ' ' H ' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -94.17 -53.77 3.83 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.266 -1.753 . . . . 74.129999999999995 106.266 167.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . 0.403 ' H ' ' CD ' ' A' ' 580' ' ' GLU . 21.4 t80 52.54 24.93 3.31 Favored 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 125.973 1.709 . . . . 74.430000000000007 115.605 164.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 583' ' ' LYS . 13.5 pt-20 -134.11 -50.45 0.82 Allowed 'General case' 0 C--N 1.31 -1.124 0 O-C-N 120.706 -1.246 . . . . 72.109999999999999 113.876 -176.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.433 ' N ' ' HG3' ' A' ' 582' ' ' GLU . 14.0 tppt? -154.75 153.55 31.42 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.939 -1.134 . . . . 72.219999999999999 107.939 -170.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -72.46 93.33 1.54 Allowed 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 105.592 -2.003 . . . . 74.319999999999993 105.592 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -90.04 158.79 17.17 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 114.556 1.317 . . . . 62.409999999999997 114.556 -170.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.0 t -146.18 159.02 43.88 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 114.254 -1.339 . . . . 72.120000000000005 109.976 -174.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 46.8 p90 -141.26 176.9 8.47 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.13 -1.433 . . . . 72.310000000000002 107.13 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.567 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 85.1 m-85 -121.79 154.7 36.63 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.659 -0.816 . . . . 75.099999999999994 109.614 -177.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.1 OUTLIER -120.52 131.05 54.52 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.171 -1.788 . . . . 72.239999999999995 106.171 177.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.542 ' HB2' HD11 ' A' ' 542' ' ' ILE . 39.5 tt0 -125.91 134.12 51.68 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.269 -0.641 . . . . 64.409999999999997 109.269 177.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 13.9 pt -99.14 143.35 13.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.682 -0.859 . . . . 74.450000000000003 108.682 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.7 171.94 45.79 Favored Glycine 0 N--CA 1.413 -2.89 0 N-CA-C 111.452 -0.659 . . . . 70.400000000000006 111.452 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.63 131.57 89.66 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 123.615 0.244 . . . . 73.540000000000006 110.484 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.414 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.3 Cg_endo -59.25 125.99 19.62 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.381 2.721 . . . . 73.430000000000007 112.896 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -104.46 119.55 39.22 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.307 -0.86 . . . . 73.329999999999998 109.328 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.95 129.81 41.06 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.094 -0.957 . . . . 64.450000000000003 108.67 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.508 ' CG2' HG12 ' A' ' 536' ' ' ILE . 50.2 t -87.46 118.97 34.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.223 -1.029 . . . . 73.510000000000005 108.223 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.421 ' OE1' ' HG3' ' A' ' 602' ' ' LYS . 37.1 tt0 -54.46 107.98 0.33 Allowed 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 124.91 1.381 . . . . 74.150000000000006 111.173 -175.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -73.83 -48.43 31.29 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.682 -1.145 . . . . 74.010000000000005 109.275 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 13.4 t -89.63 68.58 7.68 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 105.593 -2.003 . . . . 70.549999999999997 105.593 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -63.58 120.59 12.03 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 113.692 -1.594 . . . . 65.209999999999994 111.197 -173.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . 0.421 ' HG3' ' OE1' ' A' ' 598' ' ' GLU . 0.0 OUTLIER -74.56 168.04 20.55 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.136 -0.938 . . . . 74.420000000000002 110.669 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -124.61 120.96 33.41 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 120.378 -0.529 . . . . 75.239999999999995 110.203 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -92.25 79.61 1.2 Allowed Glycine 0 C--N 1.301 -1.39 0 N-CA-C 107.964 -2.054 . . . . 64.530000000000001 107.964 173.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -66.08 151.15 52.03 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 121.411 -0.423 . . . . 74.109999999999999 113.665 -174.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -73.06 141.36 47.6 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 123.015 0.526 . . . . 74.409999999999997 110.224 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 2.3 p -85.42 -162.65 0.74 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 124.014 0.926 . . . . 70.129999999999995 111.117 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 35.5 pt -61.82 155.29 4.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.307 0.575 . . . . 61.219999999999999 111.966 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 9.0 p -77.46 130.03 36.5 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.741 -0.663 . . . . 71.049999999999997 110.687 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -157.66 175.13 14.32 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.389 -1.708 . . . . 63.310000000000002 106.389 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -87.22 107.13 18.35 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 119.673 -0.811 . . . . 72.299999999999997 109.109 173.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -118.4 163.69 16.36 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.921 -0.581 . . . . 75.219999999999999 110.196 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -95.67 154.35 17.26 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.049 -1.093 . . . . 61.0 108.049 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -65.41 101.62 0.6 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.476 -0.565 . . . . 74.439999999999998 109.476 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -127.95 116.32 19.89 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.092 -0.504 . . . . 74.209999999999994 111.87 -174.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . 0.453 ' CD ' ' H ' ' A' ' 616' ' ' GLN . 5.0 pm0 -85.94 167.88 22.07 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 106.885 -1.524 . . . . 73.209999999999994 106.885 172.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.49 90.08 0.18 Allowed 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.853 1.702 . . . . 73.230000000000004 113.044 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 5.4 tt -91.38 -52.41 4.81 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 105.756 -1.942 . . . . 73.019999999999996 105.756 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 28.7 m -86.23 96.19 9.85 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.121 -0.945 . . . . 73.310000000000002 108.629 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 55.0 m -111.16 86.66 2.37 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 112.931 0.715 . . . . 71.310000000000002 112.931 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -96.36 32.64 1.94 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.157 -1.423 . . . . 63.409999999999997 107.157 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -82.83 124.8 30.64 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 114.038 -1.437 . . . . 54.240000000000002 108.823 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -94.81 97.02 9.74 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.653 -1.24 . . . . 61.229999999999997 107.653 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -80.03 167.06 20.92 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.318 0.58 . . . . 73.439999999999998 109.704 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 625' ' ' GLU . 0.5 OUTLIER -99.78 25.51 7.17 Favored 'General case' 0 C--N 1.276 -2.6 0 CA-C-N 116.142 -0.481 . . . . 73.340000000000003 110.737 -178.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -73.02 -28.52 62.41 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 109.017 -0.734 . . . . 63.539999999999999 109.017 -177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . 0.65 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 3.0 tmm_? -74.0 -35.08 64.39 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 107.78 -1.193 . . . . 64.430000000000007 107.78 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.449 ' O ' ' HG3' ' A' ' 631' ' ' MET . 59.6 mt -73.06 -38.9 56.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.071 -0.714 . . . . 73.209999999999994 109.071 -178.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -81.08 -14.88 57.36 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.185 -0.916 . . . . 71.030000000000001 112.222 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 627' ' ' ARG . 9.7 pt-20 -67.77 -11.63 58.85 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.525 0.565 . . . . 72.230000000000004 112.525 -175.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 628' ' ' ILE . 0.0 OUTLIER -74.31 -13.52 60.77 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.082 0.467 . . . . 60.439999999999998 110.997 176.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -150.82 51.46 0.52 Allowed Glycine 0 N--CA 1.429 -1.801 0 N-CA-C 110.433 -1.067 . . . . 60.25 110.433 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -100.87 158.14 32.37 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 109.293 -0.632 . . . . 62.219999999999999 109.293 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.45 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 44.6 Cg_endo -69.58 137.6 36.38 Favored 'Trans proline' 0 N--CA 1.436 -1.891 0 C-N-CA 121.502 1.468 . . . . 75.430000000000007 111.279 175.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -124.84 171.13 14.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 115.403 -0.817 . . . . 64.040000000000006 110.176 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.91 -178.26 3.43 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 112.289 0.478 . . . . 62.049999999999997 112.289 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.49 -172.07 27.61 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 114.843 0.697 . . . . 74.129999999999995 114.843 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -68.3 -53.78 22.03 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.147 0.979 . . . . 72.129999999999995 110.385 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -120.12 121.34 38.61 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.954 -0.758 . . . . 62.43 108.954 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 18.3 p -120.75 94.08 4.24 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.498 0.666 . . . . 72.219999999999999 110.747 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -166.4 152.18 8.55 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.294 -1.373 . . . . 64.430000000000007 107.294 -177.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.447 HD21 HG21 ' A' ' 523' ' ' VAL . 48.5 tp -134.57 132.9 39.64 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.243 -1.021 . . . . 72.109999999999999 108.243 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -100.11 110.27 22.55 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 106.906 -1.516 . . . . 74.310000000000002 106.906 174.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 44.5 t -101.82 110.99 30.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 109.219 -0.66 . . . . 71.239999999999995 109.219 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 26.8 mt -98.67 127.47 51.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 108.315 -0.994 . . . . 74.430000000000007 108.315 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 66.6 mt -97.15 103.55 14.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 107.798 -1.186 . . . . 75.400000000000006 107.798 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 515' ' ' SER . 34.5 mt-10 -115.98 135.0 54.38 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.421 -0.511 . . . . 75.209999999999994 111.573 -173.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.501 ' HA ' ' OE1' ' A' ' 516' ' ' GLU . 36.9 tt0 -70.06 118.26 12.67 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.721 -0.844 . . . . 75.329999999999998 108.721 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 18.4 m -138.63 32.47 2.26 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 115.596 -0.729 . . . . 75.010000000000005 112.342 -170.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -53.87 -42.06 68.2 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.067 0.46 . . . . 64.549999999999997 110.936 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.59 -40.59 97.32 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.98 -1.009 . . . . 55.130000000000003 111.028 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -84.31 -65.32 1.02 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.995 -1.002 . . . . 71.010000000000005 111.406 -173.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -168.7 126.97 1.07 Allowed 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.719 -0.845 . . . . 74.310000000000002 108.719 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 50.4 m -83.43 -65.2 1.04 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.976 -0.556 . . . . 65.239999999999995 111.172 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 15.3 t -148.08 160.37 42.94 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.938 -0.705 . . . . 72.439999999999998 109.322 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.19 116.17 22.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.23 -1.396 . . . . 64.129999999999995 107.23 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 C--O 1.254 1.312 0 N-CA-C 110.163 -0.31 . . . . 73.340000000000003 110.163 179.342 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 51.7 t60 . . . . . 0 C--O 1.245 0.831 0 CA-C-O 121.344 0.593 . . . . 70.219999999999999 109.661 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -115.33 -59.98 1.94 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.702 -0.681 . . . . 51.109999999999999 111.417 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 160.11 -153.43 24.39 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 109.892 -1.283 . . . . 61.329999999999998 109.892 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -121.94 124.51 71.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 117.034 0.417 . . . . 74.439999999999998 111.503 -171.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -107.3 124.36 49.67 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.95 -0.759 . . . . 71.239999999999995 108.95 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.6 t -168.19 172.73 8.4 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.446 -0.575 . . . . 75.299999999999997 109.446 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -75.26 145.04 42.23 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.565 -0.289 . . . . 75.530000000000001 111.054 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.06 -29.63 70.01 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.53 0.681 . . . . 70.540000000000006 110.068 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -137.87 141.66 33.48 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 107.768 -1.197 . . . . 74.129999999999995 107.768 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.84 -24.65 15.24 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.697 2.265 . . . . 70.450000000000003 111.608 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 57.2 t -135.35 133.72 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 N-CA-C 106.611 -1.626 . . . . 61.149999999999999 106.611 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . 0.429 ' HB ' HD11 ' A' ' 642' ' ' LEU . 7.1 t -125.11 140.7 52.65 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.51 -1.292 . . . . 70.439999999999998 107.51 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 654' ' ' SER . 57.4 t-80 -110.6 137.92 47.65 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 107.596 -1.261 . . . . 74.120000000000005 107.596 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.77 158.13 43.25 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 N-CA-C 109.072 -0.714 . . . . 64.319999999999993 109.072 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.557 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 48.1 m -87.09 173.57 9.19 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-N 115.037 -0.983 . . . . 71.420000000000002 109.566 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -94.07 -59.11 2.05 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.922 -0.711 . . . . 75.329999999999998 110.017 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.6 m -84.55 53.99 2.86 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.763 0.792 . . . . 63.549999999999997 109.929 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 10.5 tt -102.87 -32.49 3.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.544 -0.753 . . . . 72.140000000000001 111.49 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 92.85 -78.39 1.15 Allowed Glycine 0 N--CA 1.425 -2.036 0 C-N-CA 120.717 -0.754 . . . . 75.450000000000003 111.356 -176.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 574' ' ' LYS . 40.3 mm -126.93 123.93 63.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.934 -0.765 . . . . 74.430000000000007 108.934 -176.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.73 149.43 25.0 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 107.383 -1.34 . . . . 75.109999999999999 107.383 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 31.3 mt-10 -130.8 132.54 45.32 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.32 0.581 . . . . 74.140000000000001 111.088 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 570' ' ' THR . 40.1 t -112.01 126.47 69.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.098 -1.075 . . . . 72.409999999999997 108.098 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -81.96 128.8 34.44 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.203 -0.666 . . . . 70.120000000000005 109.203 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 568' ' ' VAL . 48.4 t -105.78 129.21 59.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 109.853 -0.425 . . . . 75.400000000000006 109.853 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.41 126.88 30.82 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.257 -0.646 . . . . 62.039999999999999 109.257 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.649 ' CZ ' ' HD1' ' A' ' 562' ' ' PHE . 15.2 ttm180 -87.64 160.07 18.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 109.178 -0.675 . . . . 65.040000000000006 109.178 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.7 t -56.1 141.47 40.29 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 124.4 1.08 . . . . 63.049999999999997 111.813 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.5 t -54.76 -37.4 65.93 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.93 -1.032 . . . . 73.430000000000007 109.355 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -119.54 96.0 0.62 Allowed Glycine 0 N--CA 1.423 -2.209 0 N-CA-C 109.029 -1.628 . . . . 42.140000000000001 109.029 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.61 101.0 12.34 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 108.003 -1.11 . . . . 75.109999999999999 108.003 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -107.49 92.37 4.04 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.596 -0.729 . . . . 72.109999999999999 110.441 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 86.32 -139.33 16.63 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 119.56 -1.305 . . . . 53.420000000000002 111.774 174.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -113.39 121.1 43.31 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.265 0.555 . . . . 71.310000000000002 110.876 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 59.5 t -123.63 143.87 35.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 107.972 -1.121 . . . . 63.119999999999997 107.972 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.54 HD13 ' HA ' ' A' ' 561' ' ' GLU . 41.7 mm -117.28 137.09 52.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 109.596 -0.52 . . . . 71.540000000000006 109.596 177.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 594' ' ' PRO . 44.1 t -122.89 110.79 31.28 Favored Pre-proline 0 N--CA 1.44 -0.945 0 N-CA-C 109.853 -0.425 . . . . 74.219999999999999 109.853 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.7 156.83 48.78 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.769 2.313 . . . . 71.129999999999995 112.517 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.497 ' HB3' HG22 ' A' ' 591' ' ' ILE . 45.0 p90 -149.4 163.3 38.14 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 122.383 -0.198 . . . . 73.150000000000006 110.649 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -158.43 156.67 30.82 Favored 'General case' 0 C--O 1.252 1.211 0 O-C-N 123.966 0.791 . . . . 62.509999999999998 110.089 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.2 p -90.62 138.53 31.49 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 123.531 0.519 . . . . 72.299999999999997 111.342 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 51.2 mt -111.09 115.77 50.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.821 -0.807 . . . . 70.540000000000006 108.821 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.82 99.61 5.21 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.35 -0.611 . . . . 74.420000000000002 109.35 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -104.56 -89.17 2.1 Favored Glycine 0 CA--C 1.482 -2.008 0 C-N-CA 119.981 -1.104 . . . . 61.340000000000003 110.667 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . 0.435 ' HB ' HG23 ' A' ' 586' ' ' THR . 3.8 m -102.53 29.86 5.0 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-O 122.324 1.059 . . . . 61.409999999999997 108.54 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -157.4 144.73 18.58 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 106.815 -1.55 . . . . 64.430000000000007 106.815 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.406 ' HD2' ' OE1' ' A' ' 551' ' ' GLU . 82.0 mtm180 -92.29 131.1 37.76 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.75 0.786 . . . . 65.120000000000005 112.126 -175.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -96.62 -167.15 33.64 Favored Glycine 0 C--N 1.294 -1.779 0 CA-C-N 114.908 -1.042 . . . . 14.44 112.93 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . 0.532 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 77.28 9.15 86.98 Favored Glycine 0 C--N 1.313 -0.734 0 CA-C-N 115.721 -0.24 . . . . 65.329999999999998 112.995 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 98.14 23.73 12.59 Favored Glycine 0 N--CA 1.427 -1.924 0 C-N-CA 120.368 -0.92 . . . . 63.299999999999997 111.422 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.406 ' OE1' ' HD2' ' A' ' 547' ' ' ARG . 26.3 tt0 -98.63 -63.27 1.14 Allowed 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.096 -0.641 . . . . 64.040000000000006 109.825 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -100.72 -42.01 6.67 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 107.411 -1.329 . . . . 75.150000000000006 107.411 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -132.9 155.09 49.69 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.006 -1.109 . . . . 73.510000000000005 108.006 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.79 137.38 35.32 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.476 -1.305 . . . . 74.25 107.476 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . 0.532 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 29.4 t70 -87.3 121.36 29.65 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.682 -0.859 . . . . 71.430000000000007 108.682 -176.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.8 t -130.65 164.98 23.81 Favored 'General case' 0 N--CA 1.414 -2.254 0 CA-C-O 121.742 0.782 . . . . 62.420000000000002 110.787 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 19.9 p -161.2 163.55 31.08 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.316 -1.735 . . . . 63.340000000000003 106.316 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 167.18 -169.59 41.05 Favored Glycine 0 N--CA 1.421 -2.329 0 C-N-CA 119.929 -1.129 . . . . 42.210000000000001 111.054 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.526 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 42.3 mt-10 -136.07 119.75 17.2 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 123.338 0.655 . . . . 72.5 110.196 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 569' ' ' LYS . 77.3 mt -86.82 128.75 35.05 Favored 'General case' 0 CA--C 1.484 -1.592 0 CA-C-N 115.745 -0.661 . . . . 72.239999999999995 110.087 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.54 ' HA ' HD13 ' A' ' 536' ' ' ILE . 25.5 tt0 -87.79 123.39 32.53 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.455 -0.793 . . . . 71.120000000000005 109.911 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.649 ' HD1' ' CZ ' ' A' ' 527' ' ' ARG . 82.2 m-85 -123.3 98.2 5.76 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 121.463 0.649 . . . . 73.299999999999997 110.612 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 533' ' ' GLY . 42.3 mt-30 -96.78 -175.87 3.41 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.722 -0.672 . . . . 70.439999999999998 110.44 174.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -78.92 -21.75 46.86 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.631 -0.713 . . . . 73.409999999999997 109.428 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -72.57 -52.38 15.81 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.076 -0.966 . . . . 65.109999999999999 112.768 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.496 ' HB2' HH12 ' A' ' 527' ' ' ARG . 41.4 mm-40 -69.7 169.29 13.17 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.441 1.274 . . . . 73.150000000000006 114.441 -177.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.589 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.0 pt -105.95 -63.3 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 114.574 -1.193 . . . . 74.099999999999994 112.465 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.589 ' H ' HG13 ' A' ' 567' ' ' ILE . 14.4 p -139.88 162.56 25.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 108.834 -0.802 . . . . 73.120000000000005 108.834 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.415 ' HB3' HD22 ' A' ' 560' ' ' LEU . 1.8 mtpt -131.1 164.04 26.32 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.445 -0.946 . . . . 72.209999999999994 108.445 171.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 12.9 p -129.7 152.57 49.06 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 123.794 0.683 . . . . 63.210000000000001 111.153 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.498 HG22 HG23 ' A' ' 573' ' ' VAL . 2.5 mp -94.59 121.76 45.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 105.545 -2.02 . . . . 72.540000000000006 105.545 170.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 5.9 m -99.45 114.89 28.11 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.596 -0.89 . . . . 53.43 108.596 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.498 HG23 HG22 ' A' ' 571' ' ' ILE . 91.3 t -118.89 127.65 75.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.771 -0.455 . . . . 72.439999999999998 109.771 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 16.1 tppt? -77.42 108.84 10.85 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.207 -1.035 . . . . 75.409999999999997 108.207 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.75 122.52 36.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 104.55 -2.389 . . . . 71.099999999999994 104.55 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 42.1 mm -67.04 127.75 29.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-O 121.352 0.596 . . . . 71.209999999999994 109.467 -174.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.66 82.8 5.72 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.55 -1.205 . . . . 65.299999999999997 107.85 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -127.03 106.89 9.58 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.438 -1.255 . . . . 65.239999999999995 109.943 -175.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -74.57 87.68 2.14 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.366 -0.834 . . . . 63.530000000000001 109.817 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.501 ' HG3' ' HG3' ' A' ' 582' ' ' GLU . 11.1 tp10 -153.8 136.83 15.51 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.67 -0.863 . . . . 72.150000000000006 108.67 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -120.33 102.05 8.21 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.752 -1.203 . . . . 65.439999999999998 107.752 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.501 ' HG3' ' HG3' ' A' ' 580' ' ' GLU . 34.9 mt-10 -117.77 -58.74 1.99 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.925 0.869 . . . . 70.120000000000005 109.643 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -158.74 149.95 20.52 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 105.42 -2.067 . . . . 64.25 105.42 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -59.82 117.37 4.93 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 108.499 -0.926 . . . . 63.539999999999999 108.499 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -86.72 119.83 27.37 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.474 -1.306 . . . . 75.530000000000001 107.474 -176.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . 0.435 HG23 ' HB ' ' A' ' 545' ' ' THR . 4.4 t -135.18 125.18 25.8 Favored 'General case' 0 C--N 1.281 -2.413 0 CA-C-O 121.946 0.879 . . . . 75.310000000000002 111.582 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 44.3 p90 -119.94 177.78 4.85 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.131 -0.94 . . . . 64.310000000000002 109.235 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.424 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 77.9 m-85 -123.19 149.66 44.34 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 109.404 -0.591 . . . . 63.5 109.404 -176.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.2 OUTLIER -120.4 131.81 54.98 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.442 -1.688 . . . . 45.539999999999999 106.442 179.216 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -125.58 128.47 47.98 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.022 -0.671 . . . . 71.140000000000001 110.341 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.497 HG22 ' HB3' ' A' ' 539' ' ' TYR . 26.5 pt -99.84 139.77 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 107.911 -1.144 . . . . 72.049999999999997 107.911 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.34 -178.08 50.65 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 115.825 -0.625 . . . . 64.120000000000005 112.083 -176.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.05 129.63 86.07 Favored Pre-proline 0 N--CA 1.426 -1.641 0 CA-C-N 115.499 -0.35 . . . . 75.340000000000003 110.772 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.517 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 11.7 Cg_endo -59.6 129.07 29.33 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.197 2.598 . . . . 61.310000000000002 112.666 -176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 536' ' ' ILE . 8.3 ptm180 -104.72 119.65 39.51 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.09 -0.959 . . . . 71.0 109.008 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.403 HD23 ' HD3' ' A' ' 634' ' ' PRO . 2.1 tm? -67.28 128.88 38.05 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.082 -1.451 . . . . 72.209999999999994 107.082 175.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.468 ' CG2' HG12 ' A' ' 536' ' ' ILE . 51.5 t -83.26 95.63 3.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 121.397 0.618 . . . . 61.539999999999999 110.835 -177.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.75 132.92 48.35 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 103.983 -2.599 . . . . 73.540000000000006 103.983 172.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -60.76 -30.21 69.88 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.667 0.617 . . . . 53.5 112.667 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 53.9 m 51.87 54.51 10.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.125 0.97 . . . . 71.540000000000006 113.42 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.13 138.92 37.0 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 120.02 -0.672 . . . . 62.25 109.538 177.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . 0.6 ' HA ' ' HE2' ' A' ' 602' ' ' LYS . 10.5 mmpt? -81.77 112.47 18.96 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 114.62 1.341 . . . . 42.140000000000001 114.62 -170.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -95.57 -19.41 19.8 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 113.453 -1.703 . . . . 73.400000000000006 109.001 174.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -124.85 -119.17 2.37 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 110.509 -1.036 . . . . 72.329999999999998 110.509 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -155.88 39.33 0.6 Allowed Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.447 -0.882 . . . . 74.230000000000004 112.445 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -126.98 103.75 7.64 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.07 -0.715 . . . . 75.219999999999999 109.07 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 12.4 t -96.69 177.13 5.75 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.683 -0.858 . . . . 64.120000000000005 108.683 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 48.1 mm -80.72 115.25 22.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.982 -1.118 . . . . 73.129999999999995 107.982 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 6.5 t -105.11 89.36 3.11 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-O 122.343 1.068 . . . . 72.120000000000005 110.218 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -97.61 151.46 20.05 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 114.853 -1.067 . . . . 72.299999999999997 108.485 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -134.18 -64.75 0.68 Allowed 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 120.966 -0.293 . . . . 71.409999999999997 110.571 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -129.35 127.08 40.33 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.296 0.569 . . . . 73.530000000000001 111.567 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . 0.508 ' HA ' HE21 ' A' ' 616' ' ' GLN . 24.8 t70 -101.27 77.61 1.81 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.407 1.098 . . . . 53.219999999999999 109.741 175.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -131.56 92.82 3.22 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.715 -1.584 . . . . 55.420000000000002 107.907 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 64.15 78.74 0.28 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.388 -1.278 . . . . 72.25 112.108 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . 0.508 HE21 ' HA ' ' A' ' 613' ' ' ASP . 65.5 mt-30 -108.76 135.98 20.03 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 115.622 -0.717 . . . . 62.039999999999999 109.739 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.65 138.92 33.01 Favored 'Trans proline' 0 C--O 1.256 1.395 0 C-N-CA 121.829 1.686 . . . . 72.230000000000004 109.736 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -86.05 -175.65 5.64 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.67 -0.492 . . . . 54.32 109.67 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 22.6 p -70.9 122.13 19.39 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 120.889 0.376 . . . . 70.519999999999996 110.533 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 14.3 m -69.02 141.94 54.73 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.338 -0.846 . . . . 74.010000000000005 110.094 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.59 89.12 3.31 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.506 0.67 . . . . 62.149999999999999 112.334 -176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.09 156.49 38.19 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.308 -1.367 . . . . 74.540000000000006 107.308 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -81.71 67.01 7.52 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.564 0.697 . . . . 62.43 112.079 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -93.75 172.29 8.34 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 105.237 -2.134 . . . . 73.010000000000005 105.237 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -63.03 -16.99 61.72 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 119.61 -0.836 . . . . 71.209999999999994 110.607 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 626' ' ' ARG . 18.2 mtp-105 -57.69 -25.42 60.27 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 114.996 -1.002 . . . . 74.400000000000006 111.784 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -60.22 -26.51 66.45 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.856 0.36 . . . . 72.310000000000002 110.847 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 68.4 mt -73.51 -40.96 56.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.74 -0.837 . . . . 74.519999999999996 108.74 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.13 -30.08 68.27 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.723 -0.671 . . . . 73.400000000000006 111.019 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -58.22 -35.96 72.46 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.188 0.595 . . . . 73.099999999999994 112.007 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -93.14 -12.37 30.56 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.261 -0.576 . . . . 74.010000000000005 109.551 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -104.66 26.1 23.59 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 115.122 -0.945 . . . . 74.010000000000005 111.009 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -95.37 161.57 27.48 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 108.184 -1.043 . . . . 75.120000000000005 108.184 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 33.3 Cg_endo -70.81 137.74 33.02 Favored 'Trans proline' 0 N--CA 1.427 -2.388 0 N-CA-C 105.352 -2.595 . . . . 73.430000000000007 105.352 161.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.04 168.74 16.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 118.502 -1.279 . . . . 74.5 112.678 -173.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.26 171.93 7.68 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.57 -0.741 . . . . 74.25 111.959 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -71.69 -171.99 15.3 Favored Glycine 0 N--CA 1.431 -1.7 0 CA-C-N 115.307 -0.861 . . . . 64.340000000000003 113.144 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -62.12 -41.29 98.09 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 122.365 0.266 . . . . 74.25 110.331 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -140.89 133.23 28.27 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.969 0.414 . . . . 64.120000000000005 110.039 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 15.4 p -120.88 95.4 4.69 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-O 121.709 0.766 . . . . 70.400000000000006 109.985 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -162.58 142.98 9.75 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.523 -1.288 . . . . 33.240000000000002 107.523 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.5 HD21 HG21 ' A' ' 523' ' ' VAL . 34.7 tp -132.65 132.81 42.83 Favored 'General case' 0 N--CA 1.416 -2.167 0 O-C-N 123.658 0.599 . . . . 52.240000000000002 109.423 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -98.35 118.59 35.34 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.057 -1.46 . . . . 71.340000000000003 107.057 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 44.3 t -106.7 117.43 52.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 109.006 -0.738 . . . . 71.430000000000007 109.006 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 58.1 mt -103.4 123.11 56.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 110.62 -0.141 . . . . 73.219999999999999 110.62 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 41.6 mt -107.43 107.65 23.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.153 -0.684 . . . . 72.540000000000006 109.153 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.427 ' HG2' ' NE2' ' A' ' 513' ' ' HIS . 8.0 pt-20 -136.14 150.08 48.91 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 105.383 -2.081 . . . . 75.150000000000006 105.383 166.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -63.47 128.8 37.47 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.056 -1.058 . . . . 70.439999999999998 110.674 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . 0.533 ' HB2' ' O ' ' A' ' 652' ' ' PHE . 5.2 p -150.3 107.91 3.66 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-N 114.881 -1.054 . . . . 54.43 111.035 -173.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -93.64 -53.6 3.98 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.082 -0.508 . . . . 72.510000000000005 110.571 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -74.78 -39.53 61.71 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.376 -0.829 . . . . 73.129999999999995 111.001 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . 0.533 ' O ' ' HB2' ' A' ' 649' ' ' SER . 96.2 m-85 -109.91 162.32 14.62 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.293 -0.632 . . . . 63.130000000000003 109.293 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.53 7.56 3.05 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.417 -0.956 . . . . 64.349999999999994 108.417 172.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . 0.453 ' HA ' ' HB3' ' A' ' 513' ' ' HIS . 21.9 m -138.78 162.05 35.7 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.702 -1.221 . . . . 63.219999999999999 107.702 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 13.3 t -124.5 144.03 50.33 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.626 -0.879 . . . . 53.520000000000003 108.626 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.51 116.69 26.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 108.553 -0.906 . . . . 63.32 108.553 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 C--N 1.304 -1.405 0 CA-C-N 115.824 -0.625 . . . . 64.150000000000006 111.054 -178.014 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.441 ' CG ' ' HA ' ' A' ' 631' ' ' MET . 85.3 m-70 . . . . . 0 CA--C 1.506 -0.712 0 CA-C-O 122.461 1.124 . . . . 65.329999999999998 108.306 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.631 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . -125.12 2.61 7.93 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 113.601 -1.636 . . . . 63.329999999999998 107.967 173.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 116.26 -159.64 13.79 Favored Glycine 0 N--CA 1.416 -2.655 0 C-N-CA 120.167 -1.016 . . . . 62.219999999999999 111.619 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.34 111.39 28.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 122.388 0.275 . . . . 74.140000000000001 110.569 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.604 ' CD2' HG23 ' A' ' 528' ' ' THR . 5.8 m-85 -92.35 126.11 37.3 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 109.093 -0.706 . . . . 72.239999999999995 109.093 170.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.4 t -167.54 176.33 6.57 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.831 -0.803 . . . . 74.030000000000001 108.831 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -81.11 147.05 30.27 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 110.147 -0.316 . . . . 72.140000000000001 110.147 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.78 -33.53 75.88 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.36 0.6 . . . . 72.129999999999995 109.879 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -136.28 140.93 34.19 Favored Pre-proline 0 N--CA 1.427 -1.605 0 N-CA-C 107.573 -1.269 . . . . 54.409999999999997 107.573 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . 0.438 ' O ' ' HA ' ' A' ' 642' ' ' LEU . 59.2 Cg_endo -75.26 -26.01 10.93 Favored 'Trans proline' 0 C--N 1.33 -0.414 0 C-N-CA 122.447 2.098 . . . . 60.340000000000003 112.258 -178.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 59.8 t -134.77 136.59 52.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 106.715 -1.587 . . . . 51.100000000000001 106.715 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 15.0 t -129.18 135.39 48.79 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 108.591 -0.892 . . . . 72.109999999999999 108.591 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -108.03 119.04 38.34 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.915 -0.772 . . . . 63.350000000000001 108.915 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.37 160.28 14.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.419 -0.81 . . . . 64.040000000000006 109.194 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.534 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 74.4 m -88.17 159.84 18.0 Favored 'General case' 0 N--CA 1.411 -2.413 0 C-N-CA 123.345 0.658 . . . . 61.420000000000002 110.486 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -49.22 16.32 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 120.731 -0.388 . . . . 75.230000000000004 110.692 176.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 9.8 m -86.83 39.84 0.87 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.27 0.557 . . . . 51.140000000000001 111.5 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 13.4 tt -97.67 -25.15 4.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.305 0.574 . . . . 71.519999999999996 111.626 -176.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 86.86 -74.28 2.35 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.86 -0.896 . . . . 71.219999999999999 110.86 -176.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 43.4 mm -129.97 132.2 65.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.459 -1.312 . . . . 75.420000000000002 107.459 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.4 150.47 34.6 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.002 -1.481 . . . . 73.510000000000005 107.002 175.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 31.7 mt-10 -130.09 142.53 50.59 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.227 0.537 . . . . 73.439999999999998 111.631 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.586 HG11 HD22 ' A' ' 642' ' ' LEU . 42.7 t -121.24 127.7 75.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.397 -0.964 . . . . 64.340000000000003 108.397 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -82.51 127.8 33.66 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.746 -0.835 . . . . 63.310000000000002 108.746 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.39 123.92 58.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 108.806 -0.812 . . . . 74.439999999999998 108.806 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.03 115.63 10.38 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.542 -0.754 . . . . 70.040000000000006 109.928 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.481 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 50.9 ttp180 -67.85 155.28 39.71 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.6 -1.182 . . . . 74.109999999999999 108.9 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 0.7 OUTLIER -56.55 141.99 40.95 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-O 121.786 0.803 . . . . 63.310000000000002 111.37 176.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.2 m -61.92 -16.93 54.63 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 125.996 1.718 . . . . 60.25 110.769 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -139.47 79.16 0.29 Allowed Glycine 0 N--CA 1.425 -2.084 0 N-CA-C 110.304 -1.118 . . . . 61.210000000000001 110.304 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -83.73 101.49 11.6 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.232 -1.025 . . . . 63.229999999999997 108.232 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -100.83 93.13 5.38 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.908 -1.042 . . . . 63.439999999999998 110.217 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 97.53 -119.55 6.44 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.162 -1.018 . . . . 75.430000000000007 111.277 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.456 ' HB3' ' HB ' ' A' ' 597' ' ' VAL . 3.3 t-20 -133.52 134.25 43.19 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.084 -0.71 . . . . 71.150000000000006 109.084 177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 62.1 t -132.83 137.98 52.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.111 -1.07 . . . . 65.109999999999999 108.111 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.482 HG12 ' CG2' ' A' ' 597' ' ' VAL . 41.3 mm -107.35 136.46 42.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 109.563 -0.532 . . . . 63.409999999999997 109.563 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.34 110.94 32.12 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 110.046 -0.353 . . . . 64.310000000000002 110.046 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -73.5 150.6 46.27 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.205 1.937 . . . . 72.140000000000001 111.468 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.423 ' HB3' HG22 ' A' ' 591' ' ' ILE . 53.2 p90 -149.08 163.45 37.52 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 110.405 -0.22 . . . . 74.310000000000002 110.405 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -157.93 158.33 34.8 Favored 'General case' 0 C--O 1.252 1.236 0 O-C-N 123.923 0.764 . . . . 62.109999999999999 109.745 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.7 p -87.36 154.12 20.92 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 109.038 -0.727 . . . . 61.509999999999998 109.038 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 60.1 mt -128.39 119.01 49.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.204 -1.406 . . . . 65.209999999999994 107.204 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -66.41 120.99 14.3 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 122.631 0.372 . . . . 63.340000000000003 110.453 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -102.71 -104.54 2.85 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 108.663 -1.775 . . . . 72.209999999999994 108.663 176.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 34.3 p -89.91 -22.51 21.96 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.276 -1.009 . . . . 72.049999999999997 108.276 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.613 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -81.91 136.95 35.28 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.423 -1.262 . . . . 44.399999999999999 110.067 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -90.49 144.25 25.97 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.382 0.611 . . . . 71.409999999999997 111.912 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.7 -158.03 33.87 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.005 -1.238 . . . . 32.039999999999999 110.005 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.75 26.47 73.98 Favored Glycine 0 C--N 1.315 -0.594 0 C-N-CA 120.929 -0.653 . . . . 73.450000000000003 112.257 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . 0.416 ' C ' HG13 ' A' ' 576' ' ' ILE . . . 67.92 34.55 82.48 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 121.597 -0.335 . . . . 72.049999999999997 112.264 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -104.48 -63.43 1.21 Allowed 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 120.814 -0.355 . . . . 63.149999999999999 111.409 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -101.77 -45.61 5.18 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 108.179 -1.045 . . . . 75.340000000000003 108.179 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -133.93 152.31 51.81 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 107.639 -1.245 . . . . 64.439999999999998 107.639 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.403 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 8.4 tt0 -85.6 112.69 21.21 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 105.858 -1.904 . . . . 73.439999999999998 105.858 176.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.26 140.7 56.02 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 120.941 0.401 . . . . 64.340000000000003 110.203 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.6 t -142.65 148.3 37.18 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-O 121.506 0.67 . . . . 75.400000000000006 111.33 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 11.8 p -148.62 157.28 43.35 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.093 -1.447 . . . . 54.439999999999998 107.093 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 168.3 -163.43 37.16 Favored Glycine 0 N--CA 1.421 -2.338 0 C-N-CA 120.114 -1.041 . . . . 62.43 110.665 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.448 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 40.5 mt-10 -132.72 124.91 29.06 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 122.869 0.468 . . . . 74.430000000000007 110.697 -177.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.533 HD22 ' HB3' ' A' ' 569' ' ' LYS . 76.0 mt -91.04 135.09 33.99 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 115.713 -0.676 . . . . 34.130000000000003 109.403 177.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.475 ' HA ' HD13 ' A' ' 536' ' ' ILE . 32.1 tt0 -102.06 109.48 21.2 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.837 -0.619 . . . . 64.109999999999999 110.54 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -106.07 104.4 14.09 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.661 0.743 . . . . 70.340000000000003 110.534 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.536 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 8.2 mm100 -87.75 173.3 9.07 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.469 -1.308 . . . . 63.310000000000002 107.469 174.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -72.03 -25.91 61.99 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.498 -0.927 . . . . 65.329999999999998 108.498 172.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.66 -46.22 39.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.592 -1.185 . . . . 73.340000000000003 110.822 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.536 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 37.0 mm-40 -61.01 130.58 47.11 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 123.72 0.808 . . . . 72.120000000000005 111.663 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.548 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.3 pt -86.74 -59.69 2.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 116.004 -0.544 . . . . 61.350000000000001 111.746 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.548 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.2 p -141.78 155.17 19.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.769 -0.456 . . . . 75.439999999999998 109.769 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.533 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -123.19 157.28 33.38 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.988 -0.745 . . . . 73.140000000000001 108.988 171.132 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.0 OUTLIER -125.36 149.85 47.74 Favored 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 115.351 -0.841 . . . . 62.310000000000002 111.574 179.049 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.3 mp -98.91 120.56 48.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 106.662 -1.607 . . . . 60.25 106.662 169.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 5.1 p -96.11 115.09 26.89 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 123.747 0.654 . . . . 71.019999999999996 109.405 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.435 HG23 HG22 ' A' ' 571' ' ' ILE . 93.4 t -114.62 128.58 71.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.705 -0.398 . . . . 64.209999999999994 109.935 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 22.2 tptm -79.84 115.23 19.32 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 114.985 -1.007 . . . . 74.219999999999999 109.226 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.66 126.28 40.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 104.935 -2.246 . . . . 51.329999999999998 104.935 174.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . 0.416 HG13 ' C ' ' A' ' 550' ' ' GLY . 45.2 mm -74.16 123.17 28.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 122.272 1.034 . . . . 74.150000000000006 110.771 -173.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -98.19 80.77 2.71 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-N 113.801 -1.545 . . . . 75.129999999999995 108.648 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 32.5 t70 176.23 136.19 0.05 Allowed 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 123.952 0.783 . . . . 73.430000000000007 110.182 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 66.19 22.01 11.05 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 115.273 1.583 . . . . 73.430000000000007 115.273 173.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -79.6 94.52 5.68 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 118.396 -1.322 . . . . 65.510000000000005 108.772 173.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -145.68 27.01 1.24 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.659 -1.978 . . . . 75.450000000000003 105.659 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -112.4 -70.91 0.78 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.782 -0.645 . . . . 62.32 112.303 -172.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.418 ' HB2' ' NZ ' ' A' ' 583' ' ' LYS . 0.0 OUTLIER -173.72 171.04 3.88 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.787 -1.19 . . . . 75.310000000000002 107.787 -171.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -61.7 128.21 35.17 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.942 -0.762 . . . . 64.329999999999998 108.942 172.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.613 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 30.1 mmtp -107.87 135.31 49.47 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.511 -0.552 . . . . 72.319999999999993 109.511 -175.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 9.2 t -140.53 145.94 37.46 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 120.411 -0.515 . . . . 73.239999999999995 109.912 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 49.8 p90 -141.81 175.92 9.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.837 -1.172 . . . . 74.049999999999997 107.837 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.576 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 79.1 m-85 -121.4 160.64 23.66 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.73 -0.47 . . . . 73.450000000000003 109.73 -176.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.2 OUTLIER -127.97 131.27 49.28 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 105.798 -1.927 . . . . 55.340000000000003 105.798 177.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.405 ' HB2' HD11 ' A' ' 542' ' ' ILE . 42.5 tt0 -129.68 137.98 50.92 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 109.893 -0.41 . . . . 74.510000000000005 109.893 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.423 HG22 ' HB3' ' A' ' 539' ' ' TYR . 21.3 pt -108.74 142.81 20.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 108.103 -1.073 . . . . 65.049999999999997 108.103 176.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.52 -177.4 45.62 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 111.004 -0.838 . . . . 74.219999999999999 111.004 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -69.74 132.18 89.12 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 120.895 0.378 . . . . 65.019999999999996 111.345 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.97 129.47 26.04 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.488 2.792 . . . . 64.010000000000005 112.759 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 536' ' ' ILE . 1.2 ptm85 -106.54 119.49 39.42 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.967 -0.561 . . . . 74.129999999999995 110.212 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.39 137.9 57.79 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 124.567 1.147 . . . . 53.32 111.025 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.482 ' CG2' HG12 ' A' ' 536' ' ' ILE . 21.6 t -113.86 114.79 47.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 105.838 -1.912 . . . . 51.140000000000001 105.838 174.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 600' ' ' SER . 32.5 tt0 -60.83 157.08 15.77 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 122.908 0.483 . . . . 73.239999999999995 110.837 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 23.1 ptp -71.66 12.22 0.4 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.386 1.074 . . . . 65.129999999999995 112.572 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 598' ' ' GLU . 40.4 t -102.81 -160.75 0.8 Allowed 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 105.92 -1.881 . . . . 75.310000000000002 105.92 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.92 153.72 27.4 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 120.119 -0.632 . . . . 71.239999999999995 109.537 173.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -64.67 107.51 1.44 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.341 -0.985 . . . . 73.25 108.341 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -135.83 158.37 44.57 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.691 -0.686 . . . . 75.239999999999995 109.513 -174.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 115.73 150.12 9.59 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.84 -0.695 . . . . 54.43 111.426 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -85.54 82.46 1.67 Allowed Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.592 -1.003 . . . . 52.100000000000001 110.592 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -81.08 70.43 7.91 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.797 0.808 . . . . 64.430000000000007 111.173 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 21.2 m -79.9 145.53 32.63 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 107.519 -1.289 . . . . 72.230000000000004 107.519 176.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 7.0 tp -69.95 98.9 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.802 -0.814 . . . . 72.439999999999998 108.802 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 2.3 p -74.98 -23.17 58.23 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.611 -0.722 . . . . 71.019999999999996 112.265 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . 0.53 ' HG2' ' HA ' ' A' ' 616' ' ' GLN . 4.8 mp0 -82.45 117.48 22.51 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.756 -0.831 . . . . 72.319999999999993 108.756 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -96.82 -8.59 30.67 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.212 0.53 . . . . 74.439999999999998 110.965 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -118.51 115.95 25.65 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 107.733 -1.21 . . . . 70.150000000000006 107.733 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.85 -21.27 62.45 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 120.801 0.334 . . . . 75.349999999999994 110.891 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -85.02 -3.58 58.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.065 -0.516 . . . . 75.120000000000005 110.884 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -132.5 28.31 4.33 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.786 -1.19 . . . . 65.140000000000001 107.786 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . 0.53 ' HA ' ' HG2' ' A' ' 610' ' ' GLU . 33.3 tt0 -73.13 -53.07 5.12 Favored Pre-proline 0 N--CA 1.427 -1.605 0 CA-C-N 113.965 -1.47 . . . . 73.409999999999997 110.536 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -85.28 137.65 6.17 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 N-CA-C 107.539 -1.754 . . . . 71.299999999999997 107.539 164.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 58.0 mt -68.67 124.77 24.55 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.023 -0.671 . . . . 74.329999999999998 110.928 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 8.9 t -88.09 5.28 41.89 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.341 -0.845 . . . . 44.219999999999999 110.389 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 15.0 m -71.2 104.96 3.25 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.915 -0.584 . . . . 70.019999999999996 110.568 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . 0.584 ' HD3' ' H ' ' A' ' 621' ' ' LYS . 0.3 OUTLIER -98.47 74.04 2.13 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.134 -1.061 . . . . 70.109999999999999 108.134 175.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -164.78 155.39 14.38 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.039 -1.437 . . . . 75.239999999999995 107.594 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.28 160.95 21.61 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 120.215 -0.594 . . . . 72.239999999999995 111.94 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . 0.407 ' O ' HG13 ' A' ' 628' ' ' ILE . 36.1 tt0 -163.1 154.51 17.36 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.051 -1.833 . . . . 73.349999999999994 106.051 -178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -66.61 -31.01 71.42 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 118.622 0.646 . . . . 74.109999999999999 112.191 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.582 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 4.1 tmm_? -63.47 -37.7 88.32 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 109.398 -0.593 . . . . 72.120000000000005 109.398 173.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . 0.502 ' HA ' ' OE1' ' A' ' 630' ' ' GLU . 0.0 OUTLIER -69.39 -31.41 69.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.763 -0.829 . . . . 75.209999999999994 108.763 -177.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 624' ' ' GLU . 66.2 mt -74.32 -40.59 50.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.154 -0.684 . . . . 74.409999999999997 109.154 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.09 -15.89 63.55 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.535 -0.757 . . . . 70.140000000000001 110.996 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 45.9 mt-10 -63.63 -9.83 15.72 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 113.31 0.855 . . . . 63.340000000000003 113.31 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.441 ' HA ' ' CG ' ' A' ' 501' ' ' HIS . 0.0 OUTLIER -53.62 -23.29 10.64 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.276 0.843 . . . . 75.439999999999998 113.276 178.174 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -91.99 -10.79 60.88 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.917 -0.658 . . . . 61.0 112.966 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -110.63 167.21 9.39 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.637 -0.875 . . . . 74.409999999999997 108.637 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.463 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 73.8 Cg_endo -84.14 142.87 9.98 Favored 'Trans proline' 0 N--CA 1.427 -2.398 0 C-N-CA 121.384 1.39 . . . . 62.439999999999998 111.333 174.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.5 pp -129.85 168.94 21.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-N 115.807 -0.633 . . . . 75.109999999999999 110.675 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.83 178.92 4.81 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 112.249 0.463 . . . . 73.409999999999997 112.249 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -77.79 -156.06 8.08 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 114.888 0.715 . . . . 74.239999999999995 114.888 -175.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -70.77 -48.57 53.59 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.156 0.582 . . . . 74.120000000000005 109.794 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -140.2 144.15 36.44 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.295 -1.002 . . . . 64.319999999999993 108.295 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 14.0 p -133.23 95.88 3.62 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 123.604 0.565 . . . . 62.340000000000003 109.849 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -164.1 138.46 5.66 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.75 -0.833 . . . . 74.510000000000005 108.75 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.586 HD22 HG11 ' A' ' 523' ' ' VAL . 26.6 tp -125.75 134.44 51.75 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.442 -0.947 . . . . 71.129999999999995 108.442 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -104.3 113.8 27.6 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.391 -1.337 . . . . 71.209999999999994 107.391 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.36 110.15 28.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.144 -0.688 . . . . 73.150000000000006 109.144 -178.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 59.2 mt -102.24 120.39 51.88 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 108.619 -0.882 . . . . 62.43 108.619 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 45.5 mt -95.38 106.95 18.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 107.979 -1.119 . . . . 73.209999999999994 107.979 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 515' ' ' SER . 8.9 pt-20 -112.45 130.49 55.97 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.243 0.544 . . . . 70.140000000000001 110.463 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.14 118.05 8.63 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.738 1.256 . . . . 74.219999999999999 110.702 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . 0.405 ' HB3' ' HG2' ' A' ' 651' ' ' GLU . 24.2 m -136.65 106.68 6.31 Favored 'General case' 0 N--CA 1.4 -2.951 0 CA-C-N 113.651 -1.613 . . . . 73.530000000000001 107.367 -172.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -93.7 11.36 29.29 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.034 -0.985 . . . . 75.299999999999997 108.452 -173.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . 0.405 ' HG2' ' HB3' ' A' ' 649' ' ' SER . 3.1 mm-40 -62.2 -47.7 83.3 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.613 -1.176 . . . . 75.349999999999994 111.14 -170.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -96.66 100.72 12.26 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-O 122.355 1.074 . . . . 55.420000000000002 112.029 -177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -169.14 -48.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.153 -1.84 . . . . 71.0 106.174 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 11.3 p -87.96 -53.31 4.81 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 107.5 -1.296 . . . . 64.129999999999995 107.5 172.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 20.6 m -111.23 97.75 7.01 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 115.806 -0.634 . . . . 43.340000000000003 110.021 176.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 47.7 t -98.25 -34.47 4.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.986 -1.116 . . . . 75.140000000000001 107.986 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 17.9 t70 . . . . . 0 C--N 1.311 -1.096 0 CA-C-N 114.824 -1.08 . . . . 65.209999999999994 109.496 178.35 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 61.7 t60 . . . . . 0 N--CA 1.443 -0.804 0 CA-C-O 121.297 0.57 . . . . 65.540000000000006 110.215 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -86.21 -59.66 2.23 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.466 -0.788 . . . . 44.350000000000001 109.552 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.422 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . 165.03 -150.91 19.45 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 120.477 -0.868 . . . . 73.239999999999995 111.119 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.434 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.9 mp -126.13 113.32 33.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 116.852 0.326 . . . . 65.010000000000005 110.67 -173.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -97.33 130.34 44.51 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.487 -0.931 . . . . 74.439999999999998 108.487 170.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . 0.413 ' HA ' HG22 ' A' ' 640' ' ' THR . 13.7 t -166.31 175.29 8.36 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.147 -0.686 . . . . 72.099999999999994 109.147 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . 0.458 ' CZ ' HG23 ' A' ' 591' ' ' ILE . 79.9 m-85 -84.55 152.9 23.59 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 110.135 -0.32 . . . . 72.430000000000007 110.135 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -64.68 -37.67 88.39 Favored 'General case' 0 C--O 1.245 0.821 0 O-C-N 123.544 0.528 . . . . 53.530000000000001 110.367 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.65 149.98 75.0 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 108.942 -0.762 . . . . 73.109999999999999 108.942 174.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -74.39 -28.73 10.06 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.894 1.729 . . . . 73.319999999999993 112.154 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 46.0 t -137.57 132.51 45.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 107.802 -1.185 . . . . 63.43 107.802 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 13.2 t -128.92 140.8 51.51 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 109.623 -0.51 . . . . 44.219999999999999 109.623 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -108.98 127.87 54.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.481 -0.563 . . . . 72.349999999999994 109.481 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 23.9 m -123.06 177.33 4.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.097 -0.705 . . . . 73.120000000000005 109.097 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.537 ' HB3' ' HB ' ' A' ' 518' ' ' ILE . 32.7 t -103.99 159.28 15.8 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.129 0.49 . . . . 73.439999999999998 110.902 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -70.29 -39.22 75.02 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.877 -1.056 . . . . 55.420000000000002 109.776 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 68.1 m -104.19 20.85 17.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.606 0.595 . . . . 72.129999999999995 112.606 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' A' ' 515' ' ' SER . 11.3 tt -70.01 -35.59 64.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 C-N-CA 119.762 -0.775 . . . . 64.120000000000005 110.229 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 95.06 -78.86 0.87 Allowed Glycine 0 CA--C 1.479 -2.156 0 N-CA-C 110.858 -0.897 . . . . 74.349999999999994 110.858 -177.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 573' ' ' VAL . 33.8 mm -127.63 133.18 68.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.966 -1.494 . . . . 75.310000000000002 106.966 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.516 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -118.59 144.77 45.89 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.432 -0.581 . . . . 74.109999999999999 109.432 177.499 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -112.1 125.06 53.7 Favored 'General case' 0 C--O 1.241 0.643 0 O-C-N 123.638 0.586 . . . . 73.010000000000005 110.996 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.632 HG11 HD22 ' A' ' 642' ' ' LEU . 47.3 t -104.64 126.29 59.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 109.298 -0.631 . . . . 54.340000000000003 109.298 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -80.38 128.32 33.43 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.538 0.524 . . . . 75.430000000000007 109.686 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 568' ' ' VAL . 62.3 t -106.66 115.39 48.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.798 -0.816 . . . . 70.319999999999993 108.798 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.05 123.8 19.5 Favored 'General case' 0 C--O 1.251 1.144 0 O-C-N 123.991 0.807 . . . . 64.219999999999999 110.206 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -73.59 159.62 32.83 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 114.947 -1.024 . . . . 74.409999999999997 110.238 -177.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.422 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 4.3 t -62.46 140.89 58.59 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.687 -0.688 . . . . 62.210000000000001 110.387 175.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.6 t -59.3 -37.06 76.77 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 123.644 0.778 . . . . 71.510000000000005 109.381 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -110.84 87.66 0.48 Allowed Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.132 -1.187 . . . . 52.039999999999999 110.132 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.0 100.46 13.28 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.994 -0.743 . . . . 52.43 108.994 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -108.58 92.22 3.97 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.617 -0.72 . . . . 64.230000000000004 111.044 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 95.72 -122.15 7.17 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.317 -0.944 . . . . 65.230000000000004 112.796 175.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -132.9 130.83 40.18 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 123.062 0.545 . . . . 73.519999999999996 109.755 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.467 HG22 HD22 ' A' ' 596' ' ' LEU . 60.3 t -134.26 138.36 50.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 123.841 0.856 . . . . 74.109999999999999 109.228 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.535 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 46.6 mm -106.7 133.96 49.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.261 -0.644 . . . . 74.049999999999997 109.261 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.475 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.8 t -122.5 110.85 31.91 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 108.983 -0.747 . . . . 73.019999999999996 108.983 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 51.6 Cg_endo -72.53 157.65 52.37 Favored 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.283 1.989 . . . . 74.25 111.893 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.476 ' HB3' HG22 ' A' ' 591' ' ' ILE . 47.4 p90 -149.65 160.55 43.42 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.645 -0.502 . . . . 64.540000000000006 109.645 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -158.42 154.69 27.32 Favored 'General case' 0 C--O 1.248 1.024 0 O-C-N 123.709 0.631 . . . . 75.450000000000003 111.121 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.3 p -86.95 140.69 29.34 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.884 -0.598 . . . . 63.310000000000002 110.449 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 49.0 mt -114.54 125.54 71.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.436 -0.95 . . . . 73.209999999999994 108.436 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.77 154.61 19.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.312 0.577 . . . . 74.310000000000002 112.454 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 176.4 -73.32 0.08 OUTLIER Glycine 0 C--N 1.305 -1.16 0 N-CA-C 110.731 -0.948 . . . . 72.519999999999996 110.731 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.32 5.86 18.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.101 0.953 . . . . 72.129999999999995 111.342 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -153.5 142.18 20.94 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 105.447 -2.057 . . . . 50.43 105.447 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 38.6 mtp85 -96.05 130.25 43.12 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.115 0.484 . . . . 63.340000000000003 111.452 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.4 -145.8 12.8 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 120.477 -0.868 . . . . 40.119999999999997 112.726 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . 0.429 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 65.05 10.1 44.8 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 113.982 0.353 . . . . 71.25 113.982 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 100.43 15.94 28.45 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.164 -1.017 . . . . 51.229999999999997 111.847 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -91.95 -72.48 0.59 Allowed 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 119.713 -0.795 . . . . 60.329999999999998 110.178 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -89.77 -39.16 13.31 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 108.527 -0.916 . . . . 64.420000000000002 108.527 175.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -140.98 155.2 46.27 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.92 -1.037 . . . . 71.530000000000001 108.363 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.04 137.09 33.28 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.779 -1.563 . . . . 41.240000000000002 106.779 177.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . 0.429 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 19.5 t70 -87.17 132.09 33.98 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 110.188 -0.301 . . . . 72.109999999999999 110.188 -172.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 15.0 t -136.43 145.48 45.31 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.685 0.755 . . . . 73.209999999999994 110.841 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 52.1 t -154.29 148.15 25.52 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.985 -1.858 . . . . 42.329999999999998 105.985 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 175.27 -164.82 35.49 Favored Glycine 0 C--N 1.287 -2.191 0 N-CA-C 109.997 -1.241 . . . . 61.039999999999999 109.997 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.535 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 87.0 mt-10 -135.56 127.8 30.09 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.987 0.394 . . . . 74.310000000000002 110.646 -177.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.416 HD22 ' HB3' ' A' ' 569' ' ' LYS . 91.7 mt -92.01 134.18 35.04 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.78 -0.645 . . . . 75.010000000000005 109.469 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.415 ' HA ' HD13 ' A' ' 536' ' ' ILE . 31.3 tt0 -98.84 116.33 30.83 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.775 -0.648 . . . . 71.409999999999997 109.57 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -111.56 145.65 38.75 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.335 -0.617 . . . . 74.519999999999996 109.335 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.514 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 49.7 mt-30 -142.7 179.58 6.91 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 109.183 -0.673 . . . . 71.430000000000007 109.183 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -70.52 -37.92 74.18 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.571 -0.9 . . . . 74.209999999999994 108.571 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.68 -27.29 37.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.729 -1.123 . . . . 75.329999999999998 111.979 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.514 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 8.7 mm-40 -78.62 146.97 33.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.283 -0.636 . . . . 71.140000000000001 109.283 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.596 HG13 ' H ' ' A' ' 568' ' ' VAL . 4.0 pt -95.57 -80.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 112.45 0.537 . . . . 65.099999999999994 112.45 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.596 ' H ' HG13 ' A' ' 567' ' ' ILE . 8.3 p -135.73 148.97 27.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 108.619 -0.882 . . . . 72.120000000000005 108.619 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.416 ' HB3' HD22 ' A' ' 560' ' ' LEU . 1.8 mtpt -114.95 159.96 20.12 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.545 -0.539 . . . . 74.420000000000002 109.545 175.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 16.2 p -128.26 150.15 50.17 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.877 -0.601 . . . . 74.230000000000004 111.009 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.42 HG22 HG23 ' A' ' 573' ' ' VAL . 3.3 mp -99.51 123.28 52.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 106.518 -1.66 . . . . 72.209999999999994 106.518 171.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 521' ' ' MET . 4.6 p -97.77 115.98 29.08 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.913 0.758 . . . . 70.239999999999995 109.502 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 520' ' ' ILE . 95.9 t -117.33 133.92 62.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 116.619 -0.264 . . . . 74.219999999999999 110.807 -178.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 46.7 tptt -85.6 112.46 20.99 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 109.054 -0.721 . . . . 73.310000000000002 109.054 175.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.63 125.62 40.29 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 104.924 -2.25 . . . . 72.109999999999999 104.924 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 37.9 mm -77.82 120.8 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-O 122.054 0.93 . . . . 72.510000000000005 109.978 -175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.04 130.21 34.88 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 113.186 -1.824 . . . . 73.040000000000006 108.373 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -156.34 -83.54 0.06 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.703 -0.681 . . . . 75.340000000000003 111.655 -174.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -154.85 164.82 38.28 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.374 -0.973 . . . . 64.439999999999998 108.374 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -104.33 15.16 28.83 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 123.41 0.684 . . . . 72.510000000000005 109.484 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -74.76 -13.63 60.62 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 113.787 1.032 . . . . 72.400000000000006 113.787 -170.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 583' ' ' LYS 0.316 0.0 OUTLIER -79.47 -95.73 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 116.163 1.912 . . . . 73.219999999999999 116.163 -175.206 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.455 ' H ' ' CD ' ' A' ' 582' ' ' GLU . 54.3 tttm -147.94 -71.18 0.22 Allowed 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.333 -0.854 . . . . 72.109999999999999 110.747 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 169.1 110.1 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 103.874 -2.639 . . . . 75.519999999999996 103.874 -173.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -96.87 147.09 24.31 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.554 -0.858 . . . . 75.340000000000003 111.016 -176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.5 t -153.14 138.44 17.51 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.879 -0.415 . . . . 74.120000000000005 109.879 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -135.25 176.0 9.07 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.479 -0.934 . . . . 74.040000000000006 108.479 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.487 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 74.0 m-85 -122.47 152.67 40.05 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.042 -0.663 . . . . 53.350000000000001 109.872 -175.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.07 130.86 53.64 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.484 -1.672 . . . . 63.240000000000002 106.484 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.424 ' HB2' HD11 ' A' ' 542' ' ' ILE . 30.2 tt0 -121.63 136.48 54.94 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.745 -0.465 . . . . 75.219999999999999 109.745 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.476 HG22 ' HB3' ' A' ' 539' ' ' TYR . 21.1 pt -107.94 132.93 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 107.04 -1.467 . . . . 63.340000000000003 107.04 169.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.52 -166.48 42.01 Favored Glycine 0 N--CA 1.423 -2.206 0 CA-C-N 115.577 -0.738 . . . . 61.5 112.713 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.69 131.71 73.4 Favored Pre-proline 0 N--CA 1.427 -1.603 0 CA-C-O 120.997 0.427 . . . . 70.25 111.629 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.475 ' HB3' HG22 ' A' ' 537' ' ' VAL . 47.3 Cg_endo -69.42 147.3 64.73 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.952 2.434 . . . . 63.039999999999999 111.973 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -125.03 137.3 54.23 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.934 -0.765 . . . . 72.329999999999998 108.934 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.467 HD22 HG22 ' A' ' 535' ' ' VAL . 0.8 OUTLIER -78.99 128.68 33.57 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 107.122 -1.436 . . . . 64.120000000000005 107.122 179.087 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.459 ' CG2' HG12 ' A' ' 536' ' ' ILE . 37.8 t -85.96 89.07 2.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 109.056 -0.72 . . . . 61.420000000000002 109.056 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -115.24 -77.81 0.57 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.466 -1.309 . . . . 64.010000000000005 107.466 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 65.0 mtt -78.89 -16.92 56.39 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.924 -0.769 . . . . 72.230000000000004 108.924 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 11.7 m 66.01 24.52 11.06 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.195 1.398 . . . . 45.43 111.196 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -88.09 99.89 12.53 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.832 -0.622 . . . . 71.439999999999998 110.85 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.05 104.95 10.04 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.079 -1.823 . . . . 71.120000000000005 106.079 173.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -70.16 -34.38 72.94 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.334 -0.394 . . . . 71.450000000000003 111.809 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 157.39 -47.38 0.47 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 119.628 -1.272 . . . . 74.239999999999995 111.99 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 87.24 53.63 2.76 Favored Glycine 0 C--N 1.305 -1.176 0 N-CA-C 109.21 -1.556 . . . . 65.310000000000002 109.21 -176.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -68.8 105.01 2.18 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.395 0.617 . . . . 51.109999999999999 110.556 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 14.9 m -107.27 110.1 22.05 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 107.291 -1.374 . . . . 74.209999999999994 107.291 177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 16.8 tt -87.87 -31.28 5.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.273 0.559 . . . . 71.25 110.284 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 36.3 m -94.91 100.53 12.38 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.92 -1.511 . . . . 65.030000000000001 106.92 175.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -91.89 -25.13 19.07 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.291 -0.413 . . . . 72.5 111.403 -174.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.53 116.7 32.55 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 104.989 -2.226 . . . . 74.409999999999997 104.989 172.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -137.0 112.87 9.58 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 113.562 0.949 . . . . 74.25 113.562 -177.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -84.51 -16.07 43.69 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.568 -1.271 . . . . 74.010000000000005 107.568 172.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -108.12 94.54 5.13 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.7 -1.222 . . . . 73.329999999999998 107.7 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -68.47 -45.02 73.53 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.006 -0.543 . . . . 73.420000000000002 111.953 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -133.74 146.04 58.61 Favored Pre-proline 0 C--N 1.303 -1.439 0 CA-C-N 116.113 -0.494 . . . . 72.099999999999994 109.837 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -50.76 123.64 11.98 Favored 'Trans proline' 0 C--O 1.252 1.181 0 C-N-CA 123.505 2.804 . . . . 75.049999999999997 112.463 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 60.9 tp -70.97 -61.54 1.73 Allowed 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.13 -0.941 . . . . 71.219999999999999 110.528 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 3.0 p -138.89 118.57 13.07 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.377 0.608 . . . . 73.209999999999994 112.533 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 38.7 t -87.25 117.07 25.77 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 105.554 -2.017 . . . . 64.340000000000003 105.554 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' A' ' 621' ' ' LYS . 9.9 mptt -82.49 -59.8 2.41 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.273 -1.38 . . . . 73.129999999999995 107.273 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -91.74 123.33 35.05 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 105.36 -2.089 . . . . 72.530000000000001 105.36 171.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -59.13 108.72 0.72 Allowed 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 123.624 0.578 . . . . 73.510000000000005 111.293 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -59.22 120.59 9.51 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.071 -0.968 . . . . 72.430000000000007 110.08 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -25.62 63.18 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.452 0.644 . . . . 74.140000000000001 110.753 177.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -52.37 -54.75 27.8 Favored 'General case' 0 C--O 1.196 -1.718 0 CA-C-N 114.349 -1.296 . . . . 74.420000000000002 110.82 171.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . 0.466 ' HA ' ' HB2' ' A' ' 630' ' ' GLU . 7.3 tmm_? -69.21 -25.07 64.13 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.993 0.425 . . . . 73.030000000000001 110.473 -175.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.51 ' O ' ' HG2' ' A' ' 631' ' ' MET . 65.0 mt -69.77 -29.99 42.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.787 0.803 . . . . 52.43 109.248 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -86.94 -34.59 19.28 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.433 0.635 . . . . 63.149999999999999 109.607 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 627' ' ' ARG . 45.3 mt-10 -74.48 -11.41 60.22 Favored 'General case' 0 C--O 1.211 -0.968 0 N-CA-C 112.712 0.634 . . . . 74.140000000000001 112.712 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 26.4 ptt? -73.17 -15.01 61.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.119 -1.067 . . . . 75.140000000000001 108.119 173.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -87.46 8.25 77.85 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 115.136 -0.938 . . . . 64.340000000000003 111.39 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 33.9 ptt85 -130.46 161.17 62.29 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 107.043 -1.465 . . . . 71.540000000000006 107.043 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -68.81 137.12 37.49 Favored 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 121.154 1.236 . . . . 72.420000000000002 111.041 174.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.39 167.46 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-N 115.179 -0.918 . . . . 75.299999999999997 109.545 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.35 -176.24 3.16 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 112.199 0.444 . . . . 72.120000000000005 112.199 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.434 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -77.83 -150.18 4.26 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-O 121.646 0.581 . . . . 32.229999999999997 113.84 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -80.97 -48.34 12.41 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.09 0.472 . . . . 75.239999999999995 109.947 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -133.12 131.64 40.75 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.821 -0.807 . . . . 71.099999999999994 108.821 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 506' ' ' THR . 23.9 p -119.97 88.95 3.03 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 121.755 0.788 . . . . 54.140000000000001 110.136 175.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -159.79 137.6 9.99 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.286 -0.87 . . . . 75.299999999999997 109.567 -175.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.632 HD22 HG11 ' A' ' 523' ' ' VAL . 15.6 tp -123.32 128.64 50.21 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 107.974 -1.121 . . . . 74.319999999999993 107.974 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -97.71 111.7 23.88 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.396 -1.335 . . . . 74.349999999999994 107.396 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.7 112.86 34.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.448 -0.575 . . . . 72.049999999999997 109.448 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 68.6 mt -101.6 121.42 52.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 109.636 -0.505 . . . . 72.530000000000001 109.636 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 69.1 mt -95.17 113.89 30.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.877 -1.157 . . . . 50.130000000000003 107.877 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 515' ' ' SER . 40.3 mt-10 -118.63 156.28 29.49 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.627 -1.249 . . . . 72.319999999999993 107.627 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -77.7 145.39 36.63 Favored 'General case' 0 N--CA 1.404 -2.73 0 N-CA-C 106.902 -1.518 . . . . 73.150000000000006 106.902 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . 0.433 ' HB2' ' OG ' ' A' ' 515' ' ' SER . 66.2 m -133.74 49.09 2.3 Favored 'General case' 0 C--N 1.252 -3.634 0 C-N-CA 119.564 -0.854 . . . . 75.430000000000007 110.684 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -84.06 -52.31 6.4 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 105.865 -1.902 . . . . 73.010000000000005 105.865 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -77.54 -48.32 17.3 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.727 -1.579 . . . . 73.319999999999993 110.55 -175.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 25.1 t80 35.1 73.45 0.08 Allowed 'General case' 0 C--O 1.242 0.67 0 O-C-N 125.456 1.722 . . . . 74.540000000000006 110.866 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -147.81 155.53 41.75 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.594 -0.73 . . . . 72.450000000000003 110.793 -170.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 47.4 t -87.03 103.62 15.54 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.312 -0.996 . . . . 74.120000000000005 108.312 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 15.2 t -156.46 130.32 8.42 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 121.59 0.71 . . . . 71.540000000000006 110.997 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.84 162.1 19.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 106.735 -1.58 . . . . 63.340000000000003 106.735 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 C--N 1.304 -1.394 0 C-N-CA 120.039 -0.664 . . . . 53.009999999999998 110.404 179.749 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 7.3 t60 . . . . . 0 N--CA 1.439 -1.003 0 N-CA-C 107.344 -1.354 . . . . 74.040000000000006 107.344 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.551 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . -90.29 -43.45 10.36 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.158 0.504 . . . . 71.219999999999999 112.293 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 128.02 -136.78 9.36 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 119.417 -1.373 . . . . 63.539999999999999 112.186 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.74 112.48 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 111.171 0.063 . . . . 64.239999999999995 111.171 -174.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.483 ' CD2' HG23 ' A' ' 528' ' ' THR . 11.4 m-85 -99.75 120.69 40.13 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.666 -1.235 . . . . 71.420000000000002 107.666 167.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.3 t -163.96 178.65 7.57 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.647 -0.501 . . . . 65.209999999999994 109.647 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -81.39 143.61 32.03 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.885 -0.413 . . . . 71.25 109.885 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -61.31 -37.78 84.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 123.723 0.639 . . . . 74.430000000000007 109.89 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -125.34 144.83 48.87 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 108.089 -1.078 . . . . 72.409999999999997 108.089 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.88 -27.68 2.96 Favored 'Trans proline' 0 C--N 1.329 -0.448 0 C-N-CA 122.163 1.909 . . . . 72.129999999999995 112.389 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.6 t -137.39 135.32 46.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.901 -1.518 . . . . 72.140000000000001 106.901 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.6 t -133.68 136.53 44.79 Favored 'General case' 0 N--CA 1.409 -2.49 0 N-CA-C 108.99 -0.745 . . . . 54.229999999999997 108.99 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -109.48 120.09 41.43 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.135 -0.691 . . . . 74.430000000000007 109.135 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 25.2 m -108.19 174.48 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 115.548 -0.751 . . . . 71.340000000000003 109.983 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.432 ' OG ' ' HB ' ' A' ' 518' ' ' ILE . 0.0 OUTLIER -96.8 164.06 12.72 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.4 -0.818 . . . . 65.140000000000001 110.495 -178.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -82.24 -54.29 5.37 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.248 -1.019 . . . . 61.32 108.248 171.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 12.1 m -80.71 31.79 0.3 Allowed 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.512 0.725 . . . . 74.530000000000001 112.1 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.432 ' HB ' ' OG ' ' A' ' 515' ' ' SER . 10.1 tt -94.34 -24.81 4.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 O-C-N 121.762 -0.586 . . . . 72.510000000000005 111.062 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.81 -80.53 1.79 Allowed Glycine 0 N--CA 1.417 -2.597 0 C-N-CA 120.329 -0.938 . . . . 71.340000000000003 111.128 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 43.0 mm -128.12 131.5 69.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.739 -1.208 . . . . 71.140000000000001 107.739 -174.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.546 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -109.41 145.1 36.69 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.093 -0.706 . . . . 60.43 109.093 176.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 23.9 mt-10 -124.19 119.57 29.76 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 123.667 0.604 . . . . 72.420000000000002 111.747 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.62 HG11 HD22 ' A' ' 642' ' ' LEU . 95.5 t -103.56 128.86 56.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 116.029 -0.532 . . . . 74.120000000000005 110.423 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -80.31 137.45 36.59 Favored 'General case' 0 C--O 1.248 0.981 0 O-C-N 123.515 0.51 . . . . 65.209999999999994 110.502 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 568' ' ' VAL . 59.9 t -112.75 132.82 60.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 116.147 -0.479 . . . . 73.549999999999997 109.741 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.81 126.68 31.4 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 122.928 0.491 . . . . 65.450000000000003 110.074 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -81.32 157.09 25.2 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.307 -0.861 . . . . 62.039999999999999 109.314 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 0.9 OUTLIER -59.97 145.8 44.84 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 123.333 0.653 . . . . 63.140000000000001 112.295 177.623 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 41.4 t -60.15 -34.98 74.3 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.153 -0.931 . . . . 74.239999999999995 110.093 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.41 81.04 0.35 Allowed Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.638 -0.985 . . . . 34.43 110.638 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.06 114.02 21.9 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.305 -0.998 . . . . 61.340000000000003 108.305 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -119.15 97.91 5.91 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.499 0.666 . . . . 75.109999999999999 110.711 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 108.89 -130.8 10.22 Favored Glycine 0 N--CA 1.427 -1.965 0 CA-C-N 115.397 -0.82 . . . . 55.25 112.772 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.509 HD22 ' HG2' ' A' ' 563' ' ' GLN . 2.6 t-20 -133.15 127.74 34.53 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.892 -0.781 . . . . 70.439999999999998 108.892 -177.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 61.3 t -132.18 141.82 44.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 123.185 0.594 . . . . 74.140000000000001 110.135 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.434 HG12 ' CG2' ' A' ' 597' ' ' VAL . 36.8 mm -111.35 129.99 65.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.197 -0.668 . . . . 74.030000000000001 109.197 175.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.407 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.2 t -115.04 105.96 52.19 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 109.203 -0.666 . . . . 73.140000000000001 109.203 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.82 152.35 36.95 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.319 2.013 . . . . 43.0 112.287 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.643 ' HB3' HG22 ' A' ' 591' ' ' ILE . 49.9 p90 -147.33 164.97 31.56 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.526 -0.306 . . . . 72.439999999999998 111.057 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -156.39 158.1 36.76 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.709 0.63 . . . . 72.219999999999999 109.916 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.3 p -87.78 141.75 28.36 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 115.656 -0.702 . . . . 71.25 110.102 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.533 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 90.3 mt -116.84 132.53 66.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.555 -1.276 . . . . 73.219999999999999 107.555 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -81.0 148.22 29.84 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 109.801 -0.444 . . . . 62.020000000000003 109.801 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -141.88 -117.3 1.3 Allowed Glycine 0 C--N 1.292 -1.88 0 N-CA-C 108.671 -1.772 . . . . 72.030000000000001 108.671 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . 0.412 ' O ' ' HD3' ' A' ' 585' ' ' LYS . 16.7 p -78.34 -23.87 46.78 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.127 -1.064 . . . . 72.409999999999997 108.127 173.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 587' ' ' PHE . . . -91.84 135.52 33.86 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 106.982 -1.488 . . . . 71.329999999999998 106.982 172.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -106.81 151.99 24.46 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 113.717 1.006 . . . . 65.129999999999995 113.717 -174.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -91.24 -176.41 43.47 Favored Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 114.899 -1.046 . . . . 51.509999999999998 111.707 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 91.63 22.77 30.32 Favored Glycine 0 C--N 1.294 -1.77 0 N-CA-C 110.152 -1.179 . . . . 62.100000000000001 110.152 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 70.54 33.98 67.62 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 109.539 -1.424 . . . . 74.430000000000007 109.539 -176.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -95.66 -66.88 0.88 Allowed 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 110.08 -0.341 . . . . 64.329999999999998 110.08 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -104.41 -38.29 6.88 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.19 -1.041 . . . . 62.240000000000002 108.19 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -132.91 158.35 42.8 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.246 -0.888 . . . . 65.230000000000004 108.693 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.53 129.12 37.56 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.589 -1.263 . . . . 73.439999999999998 107.589 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.36 136.99 50.16 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 123.367 0.667 . . . . 74.409999999999997 110.175 -175.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.405 HG21 HG22 ' A' ' 573' ' ' VAL . 9.0 t -139.76 144.87 37.63 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.413 0.625 . . . . 65.0 110.03 176.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 14.2 p -143.94 133.29 23.24 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 106.275 -1.75 . . . . 41.219999999999999 106.275 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -159.49 -169.89 23.38 Favored Glycine 0 N--CA 1.404 -3.459 0 C-N-CA 118.602 -1.761 . . . . 74.129999999999995 112.385 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -139.82 115.23 9.91 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 124.659 0.858 . . . . 63.43 108.751 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.481 HD22 ' HB3' ' A' ' 569' ' ' LYS . 86.7 mt -89.54 133.55 34.54 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.571 -0.529 . . . . 63.229999999999997 109.571 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -101.95 119.34 38.63 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.173 0.511 . . . . 73.030000000000001 110.815 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -119.03 150.06 40.6 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.826 -0.805 . . . . 71.230000000000004 108.826 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.539 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 16.9 mt-30 -146.42 179.01 7.82 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.364 -1.347 . . . . 61.229999999999997 107.364 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -70.19 -25.77 63.58 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 123.64 0.588 . . . . 60.509999999999998 110.423 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -90.75 -33.61 15.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.988 -0.551 . . . . 60.340000000000003 111.915 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.539 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 72.5 mm-40 -66.84 152.61 45.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.918 0.39 . . . . 72.25 111.706 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.561 HG13 ' H ' ' A' ' 568' ' ' VAL . 5.8 pt -103.52 -86.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 113.38 0.881 . . . . 63.149999999999999 113.38 -177.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.561 ' H ' HG13 ' A' ' 567' ' ' ILE . 13.2 p -132.26 148.87 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 120.789 0.328 . . . . 71.400000000000006 110.221 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.481 ' HB3' HD22 ' A' ' 560' ' ' LEU . 1.5 mtpt -120.66 160.97 22.2 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 116.105 -0.498 . . . . 74.140000000000001 109.66 175.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 5.5 p -125.61 153.78 43.23 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.69 -0.687 . . . . 61.25 111.033 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.4 mp -100.91 122.74 53.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.21 -1.774 . . . . 60.549999999999997 106.21 170.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 521' ' ' MET . 14.8 p -100.91 115.11 29.65 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 123.622 0.577 . . . . 74.219999999999999 109.948 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.42 HG23 HG22 ' A' ' 571' ' ' ILE . 84.3 t -119.43 134.23 63.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.066 -0.515 . . . . 74.420000000000002 110.405 -177.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -84.54 118.86 24.59 Favored 'General case' 0 N--CA 1.428 -1.567 0 O-C-N 123.645 0.591 . . . . 73.219999999999999 109.568 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.05 120.71 36.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 105.953 -1.869 . . . . 73.349999999999994 105.953 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 48.2 mm -69.58 132.2 33.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.484 0.659 . . . . 43.509999999999998 109.883 -176.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 579' ' ' GLU . 9.7 m-20 -76.51 152.68 35.98 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.167 -1.378 . . . . 71.109999999999999 108.046 -177.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -45.98 121.56 3.3 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.837 1.051 . . . . 75.140000000000001 113.837 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 577' ' ' ASP . 51.9 mm-40 -129.3 -55.21 1.18 Allowed 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 125.218 1.407 . . . . 70.450000000000003 109.849 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -103.13 -70.74 0.75 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.443 -0.799 . . . . 73.340000000000003 110.118 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -178.22 75.42 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 125.311 1.445 . . . . 74.040000000000006 108.17 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -80.92 147.73 30.17 Favored 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 113.958 -1.473 . . . . 74.409999999999997 107.358 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -145.81 177.47 8.89 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.471 -1.307 . . . . 75.140000000000001 107.471 -170.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -63.11 98.23 0.13 Allowed 'General case' 0 C--O 1.246 0.878 0 N-CA-C 107.703 -1.221 . . . . 60.439999999999998 107.703 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.412 ' HD3' ' O ' ' A' ' 545' ' ' THR . 94.8 mttt -131.54 169.0 16.71 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.647 -1.612 . . . . 75.340000000000003 106.647 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.8 t -143.1 148.77 37.18 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 121.248 0.546 . . . . 62.219999999999999 110.721 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.533 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 43.1 p90 -130.57 172.4 11.97 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 106.747 -1.575 . . . . 70.040000000000006 106.747 176.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.514 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 87.2 m-85 -120.24 154.51 34.79 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.195 -0.602 . . . . 73.239999999999995 109.981 -175.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.49 128.7 51.16 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 105.418 -2.067 . . . . 71.109999999999999 105.418 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.517 ' HB2' HD11 ' A' ' 542' ' ' ILE . 35.0 tt0 -129.19 137.08 50.93 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.598 -0.519 . . . . 74.219999999999999 109.598 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.643 HG22 ' HB3' ' A' ' 539' ' ' TYR . 15.1 pt -104.9 141.58 19.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.535 -0.913 . . . . 74.349999999999994 108.535 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -87.78 -176.58 48.12 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.66 -0.976 . . . . 74.519999999999996 110.66 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -68.47 130.97 91.81 Favored Pre-proline 0 N--CA 1.434 -1.251 0 C-N-CA 120.543 -0.463 . . . . 72.030000000000001 110.847 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.459 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 24.8 Cg_endo -66.95 137.24 44.1 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.013 2.475 . . . . 62.32 111.642 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -112.94 133.61 54.83 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.332 -0.395 . . . . 74.420000000000002 110.425 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -76.02 130.55 38.57 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.066 -1.457 . . . . 72.140000000000001 107.066 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.434 ' CG2' HG12 ' A' ' 536' ' ' ILE . 39.0 t -84.61 87.86 2.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 107.84 -1.17 . . . . 65.25 107.84 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -91.46 141.22 28.98 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 114.492 -1.231 . . . . 64.329999999999998 109.8 -176.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 82.2 mmm -88.95 -35.4 16.46 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.493 -1.299 . . . . 60.149999999999999 107.493 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 33.6 t -97.26 42.07 1.1 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.192 -1.41 . . . . 52.310000000000002 107.192 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.68 119.89 7.93 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.343 -0.844 . . . . 73.129999999999995 112.597 -175.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -107.41 121.88 45.49 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 108.033 -1.099 . . . . 64.439999999999998 108.033 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -58.12 126.72 28.68 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 124.09 0.869 . . . . 64.310000000000002 110.561 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -71.03 -50.73 21.74 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 107.248 -2.341 . . . . 51.200000000000003 107.248 171.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 73.57 -66.18 1.68 Allowed Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 114.351 -0.924 . . . . 64.25 114.474 172.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -85.03 81.79 8.73 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.506 0.67 . . . . 73.409999999999997 111.698 -173.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 36.9 p -109.26 156.29 20.11 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.424 -1.324 . . . . 71.120000000000005 107.424 173.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 42.4 mm -87.1 72.97 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.927 -1.138 . . . . 73.430000000000007 107.927 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 29.2 m -155.01 108.93 2.9 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.702 -1.135 . . . . 62.32 108.356 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -106.45 13.67 28.2 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.749 -0.834 . . . . 64.510000000000005 108.749 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -96.79 117.99 32.27 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.761 -1.109 . . . . 61.119999999999997 108.593 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -67.04 -29.35 69.13 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.398 0.679 . . . . 73.530000000000001 111.104 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.11 -31.07 69.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.046 -0.525 . . . . 70.340000000000003 112.118 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 57.42 42.81 24.13 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 123.837 0.71 . . . . 71.409999999999997 109.482 -172.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -78.07 -56.51 4.42 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.543 -1.28 . . . . 73.319999999999993 107.543 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -135.99 96.94 12.63 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-N 115.735 -0.666 . . . . 71.310000000000002 110.578 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.15 158.61 55.91 Favored 'Trans proline' 0 C--O 1.244 0.803 0 C-N-CA 122.554 2.17 . . . . 73.140000000000001 111.25 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.2 173.26 7.81 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.32 -1.363 . . . . 74.349999999999994 107.32 175.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 54.7 p -69.3 124.72 24.6 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.334 -0.547 . . . . 65.230000000000004 109.79 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 19.3 m -105.44 87.64 2.66 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.509 -1.293 . . . . 70.0 107.509 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -104.72 91.24 3.77 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.781 -1.1 . . . . 75.299999999999997 111.024 -174.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . 0.521 ' HB2' ' HD3' ' A' ' 626' ' ' ARG . 1.1 mp0 -74.29 167.39 21.72 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.852 -1.166 . . . . 75.409999999999997 107.852 173.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -77.08 -5.59 49.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.507 0.67 . . . . 75.109999999999999 111.143 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.9 166.29 23.61 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.791 -1.095 . . . . 72.140000000000001 109.662 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -77.42 90.47 3.83 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.22 -1.029 . . . . 71.310000000000002 108.22 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.521 ' HD3' ' HB2' ' A' ' 622' ' ' GLU . 28.5 mmm180 -69.27 -43.75 73.25 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 111.904 0.335 . . . . 70.120000000000005 111.904 -173.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . 0.648 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 16.3 mmt180 -63.7 -31.28 72.4 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.457 0.646 . . . . 74.140000000000001 111.697 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.505 ' O ' ' HG2' ' A' ' 631' ' ' MET . 52.3 mt -88.62 -26.55 5.57 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-O 121.701 0.762 . . . . 54.240000000000002 110.219 -177.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -78.0 -20.08 53.24 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.093 -0.503 . . . . 61.399999999999999 110.2 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.648 ' HG2' ' O ' ' A' ' 627' ' ' ARG . 5.5 pt-20 -69.72 -10.97 60.4 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 116.09 -0.505 . . . . 72.099999999999994 111.737 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 27.1 ptt? -78.73 -18.41 54.3 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.785 -0.45 . . . . 64.310000000000002 109.785 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -86.89 0.17 86.16 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.584 -0.606 . . . . 73.230000000000004 111.584 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -126.93 149.16 68.29 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 106.63 -1.618 . . . . 54.229999999999997 106.63 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.459 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 24.9 Cg_endo -69.64 136.41 33.23 Favored 'Trans proline' 0 N--CA 1.44 -1.623 0 C-N-CA 121.119 1.212 . . . . 72.319999999999993 110.293 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.61 160.72 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 116.397 -0.365 . . . . 70.329999999999998 111.208 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.1 -176.36 3.97 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.822 -0.626 . . . . 62.229999999999997 112.278 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.66 -163.16 9.97 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 116.447 -0.342 . . . . 75.239999999999995 113.455 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -76.14 -46.62 27.85 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.789 -0.449 . . . . 75.420000000000002 109.789 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -136.57 120.94 18.06 Favored 'General case' 0 CA--C 1.49 -1.354 0 CA-C-O 121.063 0.459 . . . . 62.039999999999999 109.822 174.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 31.3 p -108.14 94.65 5.18 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-O 121.778 0.799 . . . . 60.109999999999999 109.774 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -151.31 146.73 26.22 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.972 -1.013 . . . . 72.439999999999998 108.638 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.62 HD22 HG11 ' A' ' 523' ' ' VAL . 26.3 tp -134.92 120.4 19.21 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 107.924 -1.139 . . . . 64.530000000000001 107.924 175.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -91.38 108.56 19.97 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.206 -1.405 . . . . 72.230000000000004 107.206 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 39.5 t -100.42 109.46 25.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 109.526 -0.546 . . . . 61.039999999999999 109.526 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 47.3 mt -93.87 129.64 43.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.343 -0.984 . . . . 61.509999999999998 108.343 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 77.1 mt -99.91 107.33 20.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.973 -0.751 . . . . 72.209999999999994 108.973 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 515' ' ' SER . 38.2 mt-10 -114.31 125.99 54.5 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.628 0.728 . . . . 60.130000000000003 111.725 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -70.86 118.25 13.39 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.762 -1.199 . . . . 73.420000000000002 107.762 175.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 44.8 t -147.76 110.2 4.64 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.547 -1.279 . . . . 65.430000000000007 107.547 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -94.77 -12.08 27.78 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.474 0.654 . . . . 73.5 109.507 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -58.66 -26.78 64.14 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.312 0.856 . . . . 64.019999999999996 113.312 -174.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -89.07 -14.94 35.2 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 120.568 -0.453 . . . . 74.420000000000002 110.87 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -161.67 98.96 1.12 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.711 -0.848 . . . . 73.209999999999994 108.711 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 26.3 m -107.84 -163.94 0.93 Allowed 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.786 -0.82 . . . . 61.32 108.786 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 28.4 m -71.47 -41.76 68.96 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 108.82 -0.807 . . . . 71.519999999999996 108.82 176.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 23.7 m -137.61 165.06 27.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 115.248 -0.887 . . . . 73.519999999999996 108.651 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 C--N 1.306 -1.298 0 N-CA-C 109.586 -0.524 . . . . 75.230000000000004 109.586 179.693 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' A' ' 631' ' ' MET . 8.1 t60 . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 106.528 -1.656 . . . . 71.400000000000006 106.528 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -70.23 -78.27 0.08 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 121.128 -0.229 . . . . 63.100000000000001 111.48 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 163.36 -145.76 10.89 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.695 -1.24 . . . . 74.510000000000005 112.134 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.15 121.69 58.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 122.428 0.291 . . . . 65.129999999999995 110.923 -174.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -105.44 125.44 50.99 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.204 -0.665 . . . . 72.430000000000007 109.204 169.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . 0.466 ' HA ' HG22 ' A' ' 640' ' ' THR . 9.0 t -162.79 169.01 20.58 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.393 -0.595 . . . . 72.319999999999993 109.393 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -74.6 148.36 40.82 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.477 0.18 . . . . 74.439999999999998 110.714 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -68.13 -26.8 65.97 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.529 0.681 . . . . 72.519999999999996 110.124 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -140.76 141.01 23.18 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 107.33 -1.359 . . . . 53.350000000000001 107.33 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.48 -28.86 8.05 Favored 'Trans proline' 0 C--N 1.328 -0.539 0 C-N-CA 122.426 2.084 . . . . 70.150000000000006 111.637 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.9 t -132.69 136.34 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 106.293 -1.743 . . . . 62.32 106.293 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 7.5 t -131.71 140.76 49.37 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 108.82 -0.807 . . . . 74.540000000000006 108.82 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -113.07 123.35 50.09 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.073 -0.651 . . . . 44.43 109.677 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 20.8 m -112.66 174.34 2.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 115.249 -0.887 . . . . 62.020000000000003 108.897 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.568 ' O ' HG22 ' A' ' 518' ' ' ILE . 36.1 t -107.29 151.17 25.83 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.652 0.739 . . . . 21.210000000000001 111.882 -175.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.537 ' CB ' ' HA ' ' A' ' 648' ' ' GLU . 14.2 tt0 -62.19 -23.51 66.66 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 125.732 1.613 . . . . 44.340000000000003 109.705 170.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 4.2 t -123.17 26.35 8.05 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 120.977 0.418 . . . . 71.409999999999997 111.402 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 515' ' ' SER . 8.5 tt -84.11 -27.87 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.55 -0.719 . . . . 63.219999999999999 110.664 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.21 -80.04 1.57 Allowed Glycine 0 N--CA 1.428 -1.856 0 N-CA-C 111.056 -0.817 . . . . 71.129999999999995 111.056 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 574' ' ' LYS . 40.2 mm -127.92 133.17 67.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 106.471 -1.677 . . . . 63.140000000000001 106.471 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.607 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -109.86 144.07 38.85 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.767 -0.457 . . . . 64.140000000000001 109.767 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 7.8 mp0 -117.9 118.12 31.11 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 124.185 0.928 . . . . 62.43 109.916 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.577 HG23 ' SD ' ' A' ' 521' ' ' MET . 87.4 t -109.45 130.71 62.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.176 -0.676 . . . . 61.409999999999997 109.176 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -88.75 145.16 25.79 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 121.942 0.877 . . . . 74.120000000000005 112.626 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 38.9 t -113.26 137.55 45.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-N 114.437 -1.256 . . . . 65.310000000000002 107.926 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.7 mt -78.22 114.64 17.3 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.813 -0.81 . . . . 73.319999999999993 108.813 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -68.65 157.44 36.19 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.595 -1.184 . . . . 71.239999999999995 109.24 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.1 t -55.57 133.01 50.1 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 123.825 0.703 . . . . 55.439999999999998 111.568 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 1.7 m -54.59 -28.06 43.55 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.611 1.564 . . . . 55.340000000000003 111.026 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.58 91.93 0.48 Allowed Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 108.748 -1.741 . . . . 71.420000000000002 108.748 174.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -92.7 104.13 16.44 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.972 0.415 . . . . 63.409999999999997 110.411 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -130.27 104.68 7.43 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.069 -0.514 . . . . 71.129999999999995 109.85 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 101.18 -138.79 14.06 Favored Glycine 0 C--N 1.307 -1.08 0 C-N-CA 120.86 -0.686 . . . . 42.240000000000002 112.16 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.47 HD21 ' CG ' ' A' ' 561' ' ' GLU . 2.7 t-20 -133.24 130.56 39.18 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.419 -0.585 . . . . 74.030000000000001 109.419 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.28 134.04 57.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.03 -1.1 . . . . 73.329999999999998 108.03 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.513 HG12 ' CG2' ' A' ' 597' ' ' VAL . 46.3 mm -102.95 135.11 41.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.205 -0.665 . . . . 53.310000000000002 109.205 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 42.8 t -120.11 108.79 37.94 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.577 -0.527 . . . . 73.209999999999994 109.577 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 48.4 Cg_endo -74.3 154.06 45.89 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.277 1.984 . . . . 74.329999999999998 111.748 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.478 ' HB3' HG22 ' A' ' 591' ' ' ILE . 33.1 p90 -145.59 164.2 32.44 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.942 -0.303 . . . . 60.210000000000001 110.709 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -157.02 156.85 33.61 Favored 'General case' 0 C--O 1.248 0.978 0 O-C-N 123.835 0.709 . . . . 74.439999999999998 110.225 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.2 p -89.15 139.84 30.06 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 116.075 -0.511 . . . . 73.120000000000005 110.109 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 78.0 mt -112.01 129.24 67.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.812 -0.81 . . . . 74.540000000000006 108.812 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -83.02 164.7 20.19 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.156 -0.683 . . . . 65.099999999999994 109.156 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 172.1 -82.73 0.08 OUTLIER Glycine 0 CA--C 1.474 -2.469 0 C-N-CA 120.031 -1.081 . . . . 60.109999999999999 111.749 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.8 m -101.92 19.4 18.44 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.513 1.149 . . . . 63.439999999999998 108.402 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -162.84 148.82 12.29 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 106.169 -1.789 . . . . 51.200000000000003 106.169 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -104.59 141.07 37.07 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 123.712 0.805 . . . . 75.439999999999998 112.116 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.63 -160.41 36.46 Favored Glycine 0 C--N 1.306 -1.116 0 CA-C-N 115.433 -0.803 . . . . 64.329999999999998 112.704 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 71.65 12.66 74.2 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.751 -0.261 . . . . 30.129999999999999 113.499 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 90.11 19.36 46.85 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.459 -0.877 . . . . 64.439999999999998 111.043 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -89.18 -67.32 0.85 Allowed 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.59 -0.522 . . . . 74.439999999999998 109.59 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -102.13 -33.69 9.57 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.657 -1.238 . . . . 72.209999999999994 107.657 172.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -141.33 154.99 45.99 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.591 -0.892 . . . . 72.430000000000007 108.591 176.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.14 120.28 27.35 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.596 -1.631 . . . . 74.450000000000003 106.596 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -80.66 124.58 29.12 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.064 -0.516 . . . . 73.340000000000003 110.531 -171.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.7 t -136.2 168.68 18.95 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.35 0.595 . . . . 64.349999999999994 111.199 -172.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 14.8 p -158.52 164.44 36.13 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.97 -1.122 . . . . 64.430000000000007 107.97 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 173.57 -169.44 42.53 Favored Glycine 0 CA--C 1.482 -1.982 0 C-N-CA 120.156 -1.021 . . . . 74.010000000000005 110.853 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 46.1 mt-10 -137.14 125.42 23.22 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 123.428 0.691 . . . . 73.209999999999994 109.319 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.485 HD22 ' HB3' ' A' ' 569' ' ' LYS . 96.5 mt -96.05 132.42 41.44 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.257 -0.429 . . . . 75.109999999999999 109.862 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.47 ' CG ' HD21 ' A' ' 534' ' ' ASN . 29.0 tt0 -94.91 111.23 23.04 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.22 0.534 . . . . 72.209999999999994 110.806 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 81.9 m-85 -107.98 142.59 37.87 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.063 0.459 . . . . 75.230000000000004 110.002 177.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.486 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 43.0 mt-30 -140.42 179.9 6.39 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.45 -0.574 . . . . 74.420000000000002 109.45 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -68.36 -34.61 76.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.82 -1.082 . . . . 72.549999999999997 108.894 173.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -85.14 -39.99 17.25 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.033 -0.985 . . . . 73.549999999999997 111.692 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.486 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 52.2 mm-40 -65.49 135.08 54.72 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.084 0.402 . . . . 64.299999999999997 112.084 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.617 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.8 pt -83.76 -81.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.227 0.825 . . . . 73.319999999999993 113.227 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.617 ' H ' HG13 ' A' ' 567' ' ' ILE . 9.0 p -128.79 158.48 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 109.555 -0.535 . . . . 70.120000000000005 109.555 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.485 ' HB3' HD22 ' A' ' 560' ' ' LEU . 4.5 mmpt? -125.94 159.26 33.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.078 -1.082 . . . . 72.340000000000003 108.078 172.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 5.8 p -130.14 149.07 52.01 Favored 'General case' 0 C--N 1.286 -2.194 0 O-C-N 123.832 0.707 . . . . 71.030000000000001 111.673 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.9 mp -94.79 125.53 47.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 106.825 -1.546 . . . . 73.400000000000006 106.825 172.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 521' ' ' MET . 48.6 m -107.07 118.36 36.5 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 123.958 0.786 . . . . 73.409999999999997 110.068 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.401 HG23 HG22 ' A' ' 571' ' ' ILE . 76.4 t -125.45 134.42 66.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.097 -0.501 . . . . 54.109999999999999 109.874 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.408 ' HA ' HD13 ' A' ' 520' ' ' ILE . 27.5 tptp -79.87 115.02 19.22 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.883 -0.784 . . . . 64.239999999999995 108.883 174.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.24 130.19 36.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.604 -1.258 . . . . 72.25 107.604 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 44.1 mm -87.49 129.57 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.895 0 N-CA-C 108.174 -1.047 . . . . 73.340000000000003 108.174 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -83.36 80.31 9.13 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 122.951 1.358 . . . . 62.030000000000001 109.577 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' A' ' 580' ' ' GLU . 36.9 t70 -84.26 140.62 31.54 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 113.344 -1.753 . . . . 70.120000000000005 110.204 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -93.9 -0.34 55.74 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.973 -0.558 . . . . 63.119999999999997 111.395 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.482 ' HB3' ' OD2' ' A' ' 578' ' ' ASP . 28.2 tt0 -98.49 85.31 3.35 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.713 -0.847 . . . . 71.120000000000005 108.713 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . 0.309 7.1 p90 -114.19 65.55 0.67 Allowed 'General case' 0 C--N 1.28 -2.426 0 CA-C-O 122.767 1.27 . . . . 72.540000000000006 112.042 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -80.02 -34.03 38.7 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 112.953 -1.931 . . . . 64.349999999999994 108.032 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -145.98 141.76 28.01 Favored 'General case' 0 N--CA 1.409 -2.52 0 N-CA-C 104.891 -2.263 . . . . 75.019999999999996 104.891 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . 0.488 ' ND2' ' HA ' ' A' ' 647' ' ' GLU . 14.3 m120 -60.13 131.92 52.32 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 123.902 0.751 . . . . 73.430000000000007 110.636 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -86.02 120.6 27.58 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 107.819 -1.178 . . . . 71.219999999999999 107.819 -176.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.7 t -132.73 130.64 40.27 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.626 0.727 . . . . 64.140000000000001 111.402 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -121.37 172.42 8.05 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.418 -0.956 . . . . 72.219999999999999 108.418 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.506 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 90.8 m-85 -118.7 152.48 36.05 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.947 -0.701 . . . . 75.030000000000001 109.855 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.54 130.22 54.14 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.304 -1.739 . . . . 72.109999999999999 106.304 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.474 ' HB2' HD11 ' A' ' 542' ' ' ILE . 43.3 tt0 -127.02 134.44 50.32 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.624 -0.43 . . . . 62.310000000000002 109.865 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.478 HG22 ' HB3' ' A' ' 539' ' ' TYR . 21.3 pt -102.56 139.78 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 107.673 -1.232 . . . . 72.010000000000005 107.673 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.45 177.2 52.73 Favored Glycine 0 N--CA 1.421 -2.343 0 C-N-CA 120.997 -0.62 . . . . 43.450000000000003 111.622 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.16 129.06 94.18 Favored Pre-proline 0 N--CA 1.428 -1.531 0 CA-C-O 120.86 0.362 . . . . 73.319999999999993 110.631 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.405 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 23.3 Cg_endo -60.24 132.94 46.72 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.485 2.79 . . . . 71.519999999999996 112.291 -175.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . 0.403 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.0 ptp180 -110.41 119.96 40.9 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 120.993 0.425 . . . . 64.109999999999999 110.658 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.49 131.82 47.38 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 123.731 0.813 . . . . 70.140000000000001 108.858 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.513 ' CG2' HG12 ' A' ' 536' ' ' ILE . 61.0 t -92.81 103.95 15.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.46 -0.57 . . . . 74.409999999999997 109.46 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.78 114.81 18.03 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.538 -1.653 . . . . 63.32 106.538 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 25.2 mmt -84.54 -64.9 1.08 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.024 0.44 . . . . 75.519999999999996 110.333 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 39.3 t -165.68 87.38 0.39 Allowed 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.578 -0.737 . . . . 74.239999999999995 109.109 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -133.24 142.77 48.72 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.353 -1.351 . . . . 73.209999999999994 107.353 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -81.19 78.69 7.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.866 0.841 . . . . 63.229999999999997 110.184 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . 0.45 ' HB2' ' HE3' ' A' ' 603' ' ' LYS . 37.3 ttmt -155.08 106.83 2.65 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.347 -1.353 . . . . 73.349999999999994 107.347 -175.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -128.47 175.69 18.51 Favored Glycine 0 N--CA 1.427 -1.937 0 C-N-CA 120.717 -0.754 . . . . 71.25 112.376 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 152.53 -162.15 29.8 Favored Glycine 0 N--CA 1.422 -2.236 0 N-CA-C 109.136 -1.586 . . . . 30.329999999999998 109.136 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -115.89 118.46 33.03 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 117.255 0.528 . . . . 70.010000000000005 110.982 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 5.1 p -60.29 -33.62 72.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.34 -0.845 . . . . 73.400000000000006 110.814 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 59.4 mt -86.01 80.24 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 106.885 -1.524 . . . . 63.009999999999998 106.885 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 7.1 m -83.2 -37.19 23.95 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.489 -0.56 . . . . 74.420000000000002 109.489 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -79.4 105.82 10.99 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.251 -1.018 . . . . 55.420000000000002 108.251 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -97.36 85.13 3.58 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 107.944 -1.132 . . . . 62.25 107.944 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.404 ' HD2' ' O ' ' A' ' 614' ' ' ASP . 15.8 p90 -92.43 132.7 36.56 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.094 -0.957 . . . . 74.129999999999995 111.484 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -90.54 -12.65 36.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.873 -0.603 . . . . 72.140000000000001 110.95 -177.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . 0.404 ' O ' ' HD2' ' A' ' 612' ' ' TYR . 14.8 t70 -95.96 179.11 5.2 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.123 -1.806 . . . . 64.010000000000005 106.123 173.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -87.49 -14.48 40.26 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 119.137 0.881 . . . . 65.140000000000001 109.914 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -141.3 128.54 11.79 Favored Pre-proline 0 N--CA 1.431 -1.387 0 N-CA-C 113.66 0.985 . . . . 73.510000000000005 113.66 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . 0.402 ' HG2' ' OG1' ' A' ' 619' ' ' THR . 19.2 Cg_endo -100.83 173.06 0.32 Allowed 'Trans proline' 0 N--CA 1.44 -1.659 0 C-N-CA 122.198 1.932 . . . . 65.239999999999995 109.83 167.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.2 pp -91.36 32.85 1.02 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.481 -0.762 . . . . 62.399999999999999 111.477 178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . 0.562 ' HA ' ' OE2' ' A' ' 622' ' ' GLU . 25.0 m -46.66 99.64 0.02 OUTLIER 'General case' 0 C--O 1.24 0.565 0 C-N-CA 125.517 1.527 . . . . 74.409999999999997 112.442 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 24.1 p -178.02 -19.5 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.739 0.644 . . . . 74.030000000000001 112.739 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -138.53 19.99 2.72 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.278 -0.569 . . . . 62.350000000000001 112.344 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . 0.562 ' OE2' ' HA ' ' A' ' 619' ' ' THR . 1.3 mp0 -74.84 -66.84 0.7 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.84 0.352 . . . . 74.549999999999997 110.651 -177.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 626' ' ' ARG . 16.1 mm-40 -143.02 114.96 8.25 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 109.086 -0.709 . . . . 75.219999999999999 109.086 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -67.51 -8.26 32.36 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.648 0.737 . . . . 64.099999999999994 110.999 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -51.45 -33.37 30.64 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.776 0.83 . . . . 75.430000000000007 110.556 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 623' ' ' GLU . 5.9 ptp180 -64.57 -28.8 69.88 Favored 'General case' 0 C--O 1.195 -1.802 0 CA-C-N 116.444 -0.344 . . . . 71.420000000000002 111.128 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 64.8 ttt180 -74.37 -19.63 60.37 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.863 0.84 . . . . 74.409999999999997 109.667 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.648 ' O ' ' HG2' ' A' ' 631' ' ' MET . 57.1 mt -88.22 -46.25 15.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.426 -1.324 . . . . 62.100000000000001 107.426 175.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -66.17 -20.12 66.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.54 -0.754 . . . . 73.030000000000001 112.265 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 627' ' ' ARG . 10.4 pt-20 -67.61 -16.68 64.3 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 116.586 -0.279 . . . . 72.109999999999999 111.262 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.648 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 24.7 ptt? -78.83 -16.81 56.63 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.595 -0.442 . . . . 74.0 109.823 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -82.02 -14.11 77.88 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 111.053 -0.819 . . . . 41.310000000000002 111.053 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -115.03 159.32 38.17 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 106.771 -1.566 . . . . 73.530000000000001 106.771 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.405 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 55.5 Cg_endo -76.39 135.46 16.62 Favored 'Trans proline' 0 N--CA 1.435 -1.913 0 C-N-CA 120.77 0.98 . . . . 70.319999999999993 111.016 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.93 170.91 14.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 116.174 -0.466 . . . . 73.540000000000006 110.876 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.34 170.65 7.82 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 112.786 0.661 . . . . 75.349999999999994 112.786 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -78.51 -158.08 11.38 Favored Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 114.834 -1.075 . . . . 73.329999999999998 115.283 -174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -66.78 -54.52 21.83 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.082 -1.059 . . . . 71.409999999999997 110.853 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -126.81 137.49 53.21 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.56 -0.904 . . . . 73.019999999999996 108.56 175.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 506' ' ' THR . 8.7 p -127.12 73.68 1.44 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 122.344 1.069 . . . . 72.120000000000005 111.336 174.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -157.42 141.2 15.88 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 114.475 -1.239 . . . . 60.149999999999999 107.962 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.544 HD22 HG11 ' A' ' 523' ' ' VAL . 38.5 tp -124.4 130.24 52.12 Favored 'General case' 0 C--N 1.279 -2.484 0 O-C-N 124.181 0.926 . . . . 75.219999999999999 109.35 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -94.46 107.38 19.35 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.059 -1.46 . . . . 63.140000000000001 107.059 174.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.1 109.63 24.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.269 -0.641 . . . . 74.0 109.269 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 52.6 mt -96.76 122.91 48.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 109.012 -0.736 . . . . 73.310000000000002 109.012 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 82.2 mt -87.72 111.82 22.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 106.9 -1.519 . . . . 74.430000000000007 106.9 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.488 ' HA ' ' ND2' ' A' ' 584' ' ' ASN . 46.2 mt-10 -107.94 138.86 43.46 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 109.364 -0.606 . . . . 65.310000000000002 109.364 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.55 ' CD ' ' H ' ' A' ' 648' ' ' GLU . 0.2 OUTLIER -73.78 120.61 19.61 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 115.034 -0.984 . . . . 73.129999999999995 109.013 178.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 652' ' ' PHE . 58.1 m -155.78 84.68 1.03 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 112.862 0.69 . . . . 53.109999999999999 112.862 -173.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -89.89 -42.96 10.92 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.546 -1.279 . . . . 55.509999999999998 107.546 167.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -79.27 -46.26 18.12 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.644 -1.162 . . . . 64.109999999999999 109.476 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . 0.443 ' O ' ' HB3' ' A' ' 649' ' ' SER . 60.6 t80 -78.39 144.09 36.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.636 -0.711 . . . . 65.310000000000002 109.705 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -154.37 174.1 15.3 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.033 -1.099 . . . . 44.549999999999997 108.033 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 17.3 m -69.86 85.75 0.5 Allowed 'General case' 0 C--N 1.314 -0.949 0 O-C-N 123.465 0.478 . . . . 73.109999999999999 110.318 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 35.8 m -103.17 121.23 42.23 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.179 0.514 . . . . 72.200000000000003 110.795 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 15.8 m -95.64 114.97 33.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 121.571 0.701 . . . . 52.049999999999997 110.418 177.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 15.8 t70 . . . . . 0 C--N 1.299 -1.628 0 CA-C-N 115.447 -0.797 . . . . 75.420000000000002 110.669 -179.359 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 75.3 m80 . . . . . 0 C--O 1.242 0.709 0 N-CA-C 110.522 -0.177 . . . . 54.409999999999997 110.522 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.533 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . -58.48 -46.29 86.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.385 0.612 . . . . 75.019999999999996 110.993 178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 139.88 -149.51 20.86 Favored Glycine 0 N--CA 1.419 -2.486 0 C-N-CA 120.304 -0.95 . . . . 72.049999999999997 110.875 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.43 HG23 ' HA3' ' A' ' 637' ' ' GLY . 3.8 mp -117.24 113.43 42.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 123.687 0.287 . . . . 51.100000000000001 111.237 -174.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.435 ' CD2' HG23 ' A' ' 528' ' ' THR . 21.8 m-85 -92.04 124.82 36.43 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 107.725 -1.213 . . . . 71.109999999999999 107.725 169.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.7 t -168.72 171.46 8.64 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 120.554 -0.458 . . . . 62.439999999999998 109.883 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -80.55 157.39 26.1 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.839 -0.801 . . . . 71.25 108.839 175.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -63.74 -35.51 80.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.506 0.67 . . . . 64.239999999999995 110.32 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -140.18 149.36 57.92 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.487 -0.931 . . . . 75.420000000000002 108.487 -176.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . 0.434 ' O ' ' HA ' ' A' ' 642' ' ' LEU . 60.9 Cg_endo -75.53 -24.97 11.51 Favored 'Trans proline' 0 C--O 1.219 -0.437 0 C-N-CA 122.158 1.906 . . . . 75.129999999999995 112.77 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.75 135.76 58.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.981 -0.748 . . . . 74.230000000000004 108.981 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 9.5 t -135.03 140.08 45.32 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 107.714 -1.217 . . . . 64.239999999999995 107.714 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -108.73 138.41 45.09 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.651 -0.87 . . . . 73.540000000000006 108.651 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.8 m -128.65 156.38 41.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.953 -0.758 . . . . 62.310000000000002 108.953 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.592 ' O ' HG22 ' A' ' 518' ' ' ILE . 33.0 t -83.48 150.84 25.76 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.795 -0.639 . . . . 75.019999999999996 109.323 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.699 ' HB3' ' HA ' ' A' ' 648' ' ' GLU . 1.8 tm-20 -66.89 -32.64 74.04 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.494 -0.558 . . . . 64.530000000000001 109.494 170.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.7 m -99.29 20.46 13.56 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 116.142 -0.481 . . . . 65.409999999999997 112.117 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 515' ' ' SER . 9.9 tt -79.23 -27.52 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.542 -0.724 . . . . 74.209999999999994 111.529 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 92.3 -77.16 1.26 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.29 -0.957 . . . . 51.229999999999997 111.327 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 574' ' ' LYS . 42.4 mm -130.53 123.58 55.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 106.719 -1.586 . . . . 72.319999999999993 106.719 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -101.43 150.52 22.95 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.798 -0.816 . . . . 74.219999999999999 108.798 177.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.7 mt-10 -132.06 129.18 39.68 Favored 'General case' 0 CA--C 1.493 -1.247 0 O-C-N 123.702 0.626 . . . . 73.230000000000004 111.033 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.582 HG21 HD21 ' A' ' 642' ' ' LEU . 60.9 t -116.4 132.04 67.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.282 -0.872 . . . . 54.200000000000003 108.978 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -85.45 127.82 34.52 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 124.138 0.975 . . . . 71.340000000000003 110.252 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 60.3 t -110.41 128.57 66.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.885 -0.598 . . . . 72.219999999999999 109.645 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 77.9 mt -81.75 127.97 33.5 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.012 -0.994 . . . . 62.420000000000002 112.031 -173.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -72.12 162.18 29.83 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.387 -0.968 . . . . 74.310000000000002 108.387 172.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 19.4 p -58.7 154.52 14.45 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 123.503 0.721 . . . . 71.299999999999997 112.341 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 41.0 t -53.83 -35.18 61.18 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.793 1.237 . . . . 62.32 109.498 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -114.82 103.7 1.29 Allowed Glycine 0 N--CA 1.42 -2.407 0 N-CA-C 108.841 -1.704 . . . . 54.509999999999998 108.841 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.71 101.7 12.99 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.194 -0.669 . . . . 70.329999999999998 109.194 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -127.02 117.99 23.57 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.796 -0.816 . . . . 64.439999999999998 108.796 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 77.22 172.04 36.56 Favored Glycine 0 C--N 1.298 -1.562 0 N-CA-C 115.016 0.767 . . . . 63.009999999999998 115.016 173.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.411 HD22 ' HG2' ' A' ' 563' ' ' GLN . 2.7 t-20 -86.01 123.23 31.1 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.519 -0.84 . . . . 72.519999999999996 109.127 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.402 HG22 HD22 ' A' ' 596' ' ' LEU . 58.0 t -132.01 132.9 61.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 114.8 -1.091 . . . . 72.129999999999995 108.204 -175.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.484 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 43.8 mm -102.81 132.25 49.34 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 109.375 -0.602 . . . . 71.209999999999994 109.375 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.53 105.77 43.27 Favored Pre-proline 0 N--CA 1.427 -1.594 0 N-CA-C 108.736 -0.839 . . . . 75.140000000000001 108.736 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 34.8 Cg_endo -72.55 151.98 53.54 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.169 1.912 . . . . 71.120000000000005 111.672 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.42 ' HB3' HG22 ' A' ' 591' ' ' ILE . 32.3 p90 -142.6 163.27 33.28 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.459 -0.496 . . . . 72.310000000000002 110.104 177.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -153.67 151.37 29.59 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 123.929 0.768 . . . . 75.239999999999995 110.01 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 11.1 p -85.78 133.13 34.01 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 109.377 -0.601 . . . . 75.319999999999993 109.377 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 67.5 mt -108.08 124.2 64.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 108.178 -1.045 . . . . 73.209999999999994 108.178 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -73.14 136.03 44.77 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 120.945 0.402 . . . . 74.5 110.321 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -126.61 -104.43 1.35 Allowed Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 109.352 -1.499 . . . . 54.219999999999999 109.352 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.7 p -94.57 -21.32 18.92 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.489 0.662 . . . . 64.420000000000002 109.61 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -84.01 142.29 30.58 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 108.44 -0.948 . . . . 72.209999999999994 108.44 175.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -87.32 123.3 32.15 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 114.305 1.224 . . . . 73.230000000000004 114.305 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -81.92 -158.8 23.26 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 115.043 -0.981 . . . . 53.109999999999999 112.101 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.36 14.36 71.66 Favored Glycine 0 C--N 1.306 -1.1 0 C-N-CA 121.312 -0.471 . . . . 52.439999999999998 112.837 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 554' ' ' GLU . . . 77.92 39.02 25.4 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.905 -0.664 . . . . 33.409999999999997 111.836 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -111.9 -50.97 2.88 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.441 0.639 . . . . 62.409999999999997 109.949 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -104.07 -47.14 4.25 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 105.821 -1.918 . . . . 63.009999999999998 105.821 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -134.11 154.21 51.34 Favored 'General case' 0 C--O 1.256 1.421 0 CA-C-N 114.329 -1.305 . . . . 75.030000000000001 108.152 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.417 ' HA ' ' HA2' ' A' ' 550' ' ' GLY . 16.4 tt0 -81.21 119.38 23.54 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.25 -1.389 . . . . 70.420000000000002 107.25 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.88 125.15 28.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.093 -1.077 . . . . 74.349999999999994 108.093 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.409 HG21 HG22 ' A' ' 573' ' ' VAL . 12.0 t -140.02 159.41 42.25 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-O 121.618 0.723 . . . . 45.009999999999998 110.609 -171.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 23.0 p -147.22 165.74 29.12 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 107.331 -1.359 . . . . 75.420000000000002 107.331 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 176.16 -174.32 46.86 Favored Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 120.044 -1.074 . . . . 42.229999999999997 110.82 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.484 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 51.7 mt-10 -134.38 119.55 18.75 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 123.271 0.628 . . . . 75.420000000000002 109.325 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' A' ' 569' ' ' LYS . 88.7 mt -86.53 132.47 33.91 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.985 -0.552 . . . . 62.109999999999999 109.811 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.483 ' HA ' HD13 ' A' ' 536' ' ' ILE . 34.9 tt0 -101.53 106.38 17.47 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.745 -0.661 . . . . 73.409999999999997 110.019 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -105.42 149.68 25.93 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.75 -0.833 . . . . 72.25 108.75 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.576 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 6.3 mt-30 -143.96 -169.16 3.04 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.204 -1.406 . . . . 64.010000000000005 107.204 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -76.12 -19.48 58.48 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.595 -0.891 . . . . 71.219999999999999 108.595 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -88.54 -45.1 10.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.31 -1.314 . . . . 62.25 110.521 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.576 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 6.0 mm-40 -74.9 122.51 23.53 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.943 0.401 . . . . 74.409999999999997 111.817 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.493 HD12 HG12 ' A' ' 568' ' ' VAL . 1.8 pp -106.99 -32.51 2.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 115.122 -0.944 . . . . 54.25 113.16 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.493 HG12 HD12 ' A' ' 567' ' ' ILE . 9.4 p -143.43 145.76 22.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 120.275 -0.57 . . . . 71.129999999999995 110.494 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.443 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.1 OUTLIER -127.59 162.18 27.09 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.798 -0.637 . . . . 64.420000000000002 109.612 174.06 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.7 p -122.32 143.33 49.7 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.588 0.588 . . . . 53.009999999999998 112.588 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.6 mp -94.63 117.84 39.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 106.591 -1.633 . . . . 63.210000000000001 106.591 170.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 521' ' ' MET . 8.1 p -98.31 115.52 28.59 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.712 0.632 . . . . 65.310000000000002 109.498 178.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.557 HG23 HG22 ' A' ' 571' ' ' ILE . 60.1 t -121.52 124.66 72.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 116.295 -0.412 . . . . 74.430000000000007 110.66 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.42 ' HA ' HD13 ' A' ' 520' ' ' ILE . 13.6 tppt? -71.91 120.83 18.07 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.965 -1.016 . . . . 72.040000000000006 108.678 173.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 28.2 t -92.37 130.33 41.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 104.73 -2.322 . . . . 53.140000000000001 104.73 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 44.0 mm -83.31 152.09 3.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 108.762 -0.829 . . . . 73.019999999999996 108.762 -173.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.9 88.95 0.76 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.201 -1.407 . . . . 74.340000000000003 107.201 174.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.14 105.12 2.8 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.11 -1.404 . . . . 73.319999999999993 112.191 -173.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -78.88 -44.61 22.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.278 -1.328 . . . . 75.150000000000006 109.918 -175.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -85.67 -167.95 2.04 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.086 -1.45 . . . . 75.519999999999996 107.086 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -169.48 170.06 8.5 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 118.845 0.748 . . . . 75.340000000000003 111.605 176.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -147.11 147.98 31.13 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 104.443 -2.428 . . . . 73.200000000000003 104.443 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -63.34 100.12 0.23 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 123.752 0.657 . . . . 74.239999999999995 111.7 -177.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 57.78 84.83 0.09 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.846 1.258 . . . . 73.540000000000006 111.404 177.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.289 0.0 OUTLIER -111.02 147.87 33.82 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 114.196 1.184 . . . . 60.43 114.196 -178.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.9 t -141.79 159.02 43.08 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.767 -1.106 . . . . 61.130000000000003 110.349 -172.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 40.3 p90 -132.79 168.69 17.91 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 106.693 -1.595 . . . . 75.200000000000003 106.693 175.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.533 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 63.6 m-85 -115.74 155.74 27.23 Favored 'General case' 0 C--N 1.283 -2.284 0 C-N-CA 120.34 -0.544 . . . . 75.400000000000006 110.342 -175.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.21 126.19 46.51 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 105.717 -1.957 . . . . 62.039999999999999 105.717 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.401 ' HB2' HD11 ' A' ' 542' ' ' ILE . 42.4 tt0 -127.16 129.77 48.5 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 120.534 -0.467 . . . . 75.340000000000003 109.871 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.42 HG22 ' HB3' ' A' ' 539' ' ' TYR . 21.5 pt -98.96 136.2 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 N-CA-C 108.046 -1.094 . . . . 64.409999999999997 108.046 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.03 -177.87 52.13 Favored Glycine 0 N--CA 1.421 -2.365 0 CA-C-N 115.496 -0.775 . . . . 62.219999999999999 111.369 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -64.82 133.71 95.82 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 120.742 0.306 . . . . 74.340000000000003 111.497 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -69.01 124.09 11.02 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 122.697 2.265 . . . . 71.450000000000003 110.558 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -111.41 125.1 53.51 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 109.65 -0.5 . . . . 70.040000000000006 109.65 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.421 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 1.4 tm? -66.33 133.13 49.88 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 105.204 -2.147 . . . . 74.230000000000004 105.204 174.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.435 HG22 HG12 ' A' ' 536' ' ' ILE . 63.4 t -65.5 100.76 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.759 0.79 . . . . 75.109999999999999 110.861 -177.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -149.88 152.89 35.81 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 104.921 -2.252 . . . . 74.450000000000003 104.921 -174.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 41.0 ttp -101.74 12.54 36.92 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.481 0.658 . . . . 75.430000000000007 111.228 -175.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 15.7 m -71.83 96.86 1.71 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.247 0.546 . . . . 74.239999999999995 110.524 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -141.94 172.68 12.35 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.993 -0.549 . . . . 73.150000000000006 109.775 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -144.89 93.66 2.43 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.992 -1.484 . . . . 73.239999999999995 106.992 172.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -118.8 92.68 3.87 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.478 0.656 . . . . 71.219999999999999 109.704 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -116.94 -94.81 1.82 Allowed Glycine 0 C--N 1.293 -1.849 0 N-CA-C 110.23 -1.148 . . . . 71.430000000000007 110.23 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 620' ' ' SER . . . 141.82 -99.15 0.23 Allowed Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 110.768 -0.933 . . . . 61.439999999999998 110.768 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . 0.619 ' HA ' ' O ' ' A' ' 619' ' ' THR . 20.9 p90 -93.63 104.99 17.07 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.424 0.631 . . . . 74.129999999999995 111.088 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 23.9 m -80.15 -48.92 12.42 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.315 -0.857 . . . . 75.510000000000005 109.545 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . 0.558 ' O ' ' HB ' ' A' ' 619' ' ' THR . 67.1 mt -118.52 138.34 49.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 107.077 -1.453 . . . . 71.230000000000004 107.077 178.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 6.3 m -146.27 35.13 0.98 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.69 -1.596 . . . . 61.399999999999999 106.69 176.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.5 -46.28 64.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.15 -1.841 . . . . 74.340000000000003 109.743 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -113.71 141.77 46.85 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 115.621 -0.718 . . . . 74.430000000000007 109.444 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -107.11 101.44 10.85 Favored 'General case' 0 N--CA 1.405 -2.686 0 CA-C-O 122.242 1.02 . . . . 63.020000000000003 110.529 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -86.67 13.77 8.11 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 123.073 1.416 . . . . 73.040000000000006 109.143 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -156.19 -166.98 2.31 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 101.82 -3.4 . . . . 71.219999999999999 101.82 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -82.02 -53.88 5.76 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 121.035 1.743 . . . . 55.509999999999998 107.744 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -132.49 91.66 30.03 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 106.47 -1.678 . . . . 53.329999999999998 106.47 171.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -81.62 -37.79 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.04 1.826 . . . . 60.020000000000003 114.172 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 54.44 70.66 0.59 Allowed 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.864 0.727 . . . . 73.040000000000006 109.202 -171.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 606' ' ' PHE . 4.1 m -50.9 101.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.387 1.475 . . . . 71.030000000000001 111.735 -175.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.488 ' O ' ' HD2' ' A' ' 621' ' ' LYS . 13.8 m -87.89 108.91 19.4 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.549 -0.75 . . . . 72.109999999999999 112.249 -172.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . 0.488 ' HD2' ' O ' ' A' ' 620' ' ' SER . 14.3 mptt -136.22 141.68 43.99 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.488 0.715 . . . . 64.329999999999998 110.41 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.48 -177.74 6.82 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.075 -1.824 . . . . 73.0 106.075 175.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.31 159.31 42.49 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.274 -1.38 . . . . 74.329999999999998 107.274 170.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -111.96 124.27 52.04 Favored 'General case' 0 N--CA 1.403 -2.793 0 C-N-CA 119.078 -1.049 . . . . 65.310000000000002 108.366 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -115.96 18.34 15.58 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 106.214 -1.773 . . . . 63.549999999999997 106.214 174.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 38.8 mtt180 -73.69 -37.96 65.03 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.357 -1.747 . . . . 72.329999999999998 109.032 -175.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . 0.609 ' HD3' ' O ' ' A' ' 627' ' ' ARG . 0.9 OUTLIER -56.03 -33.77 65.24 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.627 0.771 . . . . 72.450000000000003 111.37 -177.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 62.5 mt -58.53 -31.69 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-O 121.724 0.773 . . . . 75.019999999999996 109.807 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . 0.494 ' O ' ' HG2' ' A' ' 633' ' ' ARG . . . -91.43 -39.57 11.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.857 -0.61 . . . . 65.200000000000003 109.827 175.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.591 ' HA ' ' CG ' ' A' ' 633' ' ' ARG . 50.6 mt-10 -63.45 -11.03 20.26 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.876 1.065 . . . . 62.219999999999999 113.876 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -66.66 -15.63 63.62 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.814 0.34 . . . . 73.430000000000007 110.845 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -142.07 59.01 0.55 Allowed Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.589 -1.004 . . . . 53.119999999999997 110.589 177.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . 0.591 ' CG ' ' HA ' ' A' ' 630' ' ' GLU . 36.1 mmt180 -131.73 168.01 19.45 Favored Pre-proline 0 C--N 1.32 -0.715 0 C-N-CA 123.301 0.64 . . . . 74.549999999999997 110.138 -176.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 633' ' ' ARG . 36.7 Cg_endo -65.57 140.11 61.34 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.399 2.066 . . . . 75.430000000000007 112.389 175.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -126.71 164.08 27.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.591 -0.732 . . . . 72.140000000000001 109.89 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.53 173.56 7.56 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 112.875 0.694 . . . . 70.409999999999997 112.875 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.43 ' HA3' HG23 ' A' ' 504' ' ' ILE . . . -74.88 -171.89 28.8 Favored Glycine 0 N--CA 1.43 -1.709 0 CA-C-N 115.579 -0.737 . . . . 74.329999999999998 114.354 -176.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.73 -40.52 88.39 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.168 0.987 . . . . 74.25 109.744 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -133.3 138.51 46.44 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.904 -0.776 . . . . 70.329999999999998 108.904 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 19.1 p -136.53 88.17 2.35 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.746 0.784 . . . . 63.210000000000001 109.217 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -159.73 145.19 15.58 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.019 -0.991 . . . . 74.409999999999997 108.797 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.582 HD21 HG21 ' A' ' 523' ' ' VAL . 25.8 tp -136.14 120.55 18.08 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 108.717 -0.845 . . . . 72.099999999999994 108.717 176.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -91.68 105.33 17.65 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.831 -1.544 . . . . 72.400000000000006 106.831 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 36.7 t -98.69 106.25 18.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.468 -0.567 . . . . 72.120000000000005 109.468 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 53.6 mt -89.94 128.98 41.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 109.014 -0.736 . . . . 70.209999999999994 109.014 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 55.3 mt -104.4 103.55 15.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.238 -0.652 . . . . 73.239999999999995 109.238 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -95.33 129.9 42.31 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.892 -0.595 . . . . 74.420000000000002 109.478 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.699 ' HA ' ' HB3' ' A' ' 516' ' ' GLU . 0.4 OUTLIER -72.66 143.09 48.26 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.62 -0.718 . . . . 61.039999999999999 111.316 -174.402 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 66.8 m -138.86 41.28 2.14 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 112.471 0.545 . . . . 73.540000000000006 112.471 -168.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -57.12 -37.44 71.98 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 123.029 0.531 . . . . 70.129999999999995 111.553 176.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.77 -20.3 58.37 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.461 -0.791 . . . . 71.420000000000002 111.39 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 70.04 71.84 0.22 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 124.919 1.288 . . . . 74.109999999999999 111.618 -174.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -151.46 75.5 1.17 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.62 -1.173 . . . . 71.340000000000003 109.967 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 35.3 t -176.9 -168.45 0.22 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.053 -1.091 . . . . 73.400000000000006 108.053 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 3.9 t -81.0 75.27 7.98 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 122.282 1.039 . . . . 35.450000000000003 109.802 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 40.8 t -77.27 -22.13 14.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.753 -1.112 . . . . 73.329999999999998 108.92 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 . . . . . 0 C--O 1.258 1.529 0 CA-C-N 115.214 -0.903 . . . . 63.229999999999997 109.23 177.986 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 33.3 t60 . . . . . 0 C--O 1.241 0.626 0 N-CA-C 108.72 -0.844 . . . . 73.099999999999994 108.72 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -68.75 -51.09 45.06 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.954 -1.021 . . . . 61.420000000000002 112.205 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 135.91 -141.53 12.68 Favored Glycine 0 C--N 1.313 -0.697 0 C-N-CA 118.892 -1.623 . . . . 64.409999999999997 113.424 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.7 119.52 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 C-N-CA 122.893 0.477 . . . . 45.340000000000003 110.327 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -98.57 135.15 40.52 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.254 -1.387 . . . . 73.349999999999994 107.254 168.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . 0.471 ' HA ' HG22 ' A' ' 640' ' ' THR . 12.9 t -169.41 -179.96 3.65 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.959 -0.756 . . . . 72.319999999999993 108.959 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . 0.454 ' CZ ' HG23 ' A' ' 591' ' ' ILE . 67.4 m-85 -84.4 151.84 24.42 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.937 -0.394 . . . . 75.030000000000001 109.937 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -67.0 -31.75 72.53 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.439 0.638 . . . . 62.450000000000003 110.059 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -135.0 141.53 38.66 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.532 -1.285 . . . . 71.099999999999994 107.532 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.59 -26.32 7.2 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 122.289 1.993 . . . . 73.219999999999999 112.459 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 61.1 t -139.73 132.31 35.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 106.853 -1.536 . . . . 65.400000000000006 106.853 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.8 t -127.68 138.71 52.89 Favored 'General case' 0 N--CA 1.414 -2.226 0 C-N-CA 120.252 -0.579 . . . . 72.209999999999994 109.994 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -103.64 116.44 32.35 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.541 -0.911 . . . . 74.349999999999994 108.541 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.6 m -117.44 165.5 12.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.418 -0.956 . . . . 75.109999999999999 108.418 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.606 ' O ' HG22 ' A' ' 518' ' ' ILE . 27.3 t -95.95 153.8 17.57 Favored 'General case' 0 N--CA 1.418 -2.072 0 C-N-CA 120.556 -0.457 . . . . 64.200000000000003 109.792 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.76 -34.45 75.61 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.176 -1.046 . . . . 70.129999999999995 108.176 170.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.7 m -98.39 20.34 12.83 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.77 -1.105 . . . . 75.239999999999995 111.966 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.606 HG22 ' O ' ' A' ' 515' ' ' SER . 9.4 tt -82.97 -26.68 7.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 CA-C-O 121.622 0.725 . . . . 73.219999999999999 109.372 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 91.97 -78.66 1.26 Allowed Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.305 -1.118 . . . . 70.450000000000003 110.305 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . 0.448 HD13 ' HA ' ' A' ' 574' ' ' LYS . 32.3 mm -128.99 141.14 47.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 106.839 -1.541 . . . . 73.439999999999998 106.839 -177.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.529 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -122.72 144.82 48.91 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.289 -0.634 . . . . 74.150000000000006 109.289 178.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 10.6 mp0 -115.33 130.5 56.92 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 123.819 0.699 . . . . 74.329999999999998 109.589 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.626 HG11 HD22 ' A' ' 642' ' ' LEU . 59.3 t -116.07 128.41 73.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 109.303 -0.629 . . . . 73.439999999999998 109.303 175.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -81.95 129.91 34.91 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 123.733 0.813 . . . . 74.329999999999998 109.839 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 568' ' ' VAL . 60.0 t -106.1 118.7 54.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.504 -0.924 . . . . 72.150000000000006 108.504 175.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.7 mt -67.44 122.44 17.96 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 123.863 0.727 . . . . 61.210000000000001 111.461 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 567' ' ' ILE . 21.7 tpt180 -68.01 145.69 54.24 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.518 -1.219 . . . . 75.439999999999998 108.946 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 12.4 t -56.5 143.41 35.32 Favored 'General case' 0 N--CA 1.406 -2.637 0 C-N-CA 124.917 1.287 . . . . 72.329999999999998 109.984 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 18.8 t -52.53 -36.14 54.9 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.737 0.815 . . . . 61.340000000000003 111.437 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -116.46 96.15 0.71 Allowed Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.022 -1.231 . . . . 52.43 110.022 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -84.87 101.67 12.49 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.648 -0.871 . . . . 63.520000000000003 108.648 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -124.77 116.88 23.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.822 -0.807 . . . . 71.040000000000006 108.822 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.432 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 77.72 -178.72 51.8 Favored Glycine 0 C--O 1.258 1.602 0 O-C-N 123.695 0.622 . . . . 64.140000000000001 113.84 176.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -90.95 125.83 35.89 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.893 -0.654 . . . . 74.049999999999997 109.522 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 72.6 t -133.16 134.58 57.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.745 -0.661 . . . . 61.229999999999997 109.26 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.58 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 37.8 mm -106.51 134.75 47.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 109.219 -0.66 . . . . 75.400000000000006 109.219 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.65 110.25 32.01 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.741 -0.466 . . . . 72.230000000000004 109.741 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 38.9 Cg_endo -70.65 158.04 56.94 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.338 2.026 . . . . 73.340000000000003 111.583 177.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.437 ' HB3' HG22 ' A' ' 591' ' ' ILE . 52.2 p90 -151.99 155.56 38.24 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.331 -0.618 . . . . 72.430000000000007 109.331 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.64 149.1 28.08 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 123.87 0.731 . . . . 72.530000000000001 112.174 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.1 p -83.44 131.16 35.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 116.003 -0.544 . . . . 75.540000000000006 109.933 174.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 57.9 mt -103.07 119.91 52.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.003 -1.11 . . . . 53.140000000000001 108.003 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.91 160.61 27.19 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.133 -0.692 . . . . 75.049999999999997 109.133 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 177.69 -97.6 0.11 Allowed Glycine 0 CA--C 1.473 -2.533 0 N-CA-C 110.504 -1.038 . . . . 74.230000000000004 110.504 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . 0.489 ' HB ' ' H ' ' A' ' 586' ' ' THR . 0.2 OUTLIER -71.37 -31.53 67.44 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 109.355 -0.609 . . . . 74.319999999999993 109.355 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -107.67 155.75 19.82 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 108.494 -0.928 . . . . 61.109999999999999 108.494 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -101.01 137.85 38.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.543 0.687 . . . . 75.219999999999999 112.457 -176.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.98 -150.47 12.45 Favored Glycine 0 C--N 1.299 -1.498 0 C-N-CA 120.663 -0.779 . . . . 73.299999999999997 112.716 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 61.02 7.28 8.3 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 115.749 1.06 . . . . 65.010000000000005 115.749 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 90.44 14.59 58.37 Favored Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 118.209 1.005 . . . . 73.349999999999994 110.991 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -87.52 -55.44 3.79 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.165 -0.68 . . . . 71.530000000000001 109.165 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -107.04 -42.26 4.94 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.112 -1.44 . . . . 73.219999999999999 107.112 177.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -140.07 152.38 46.13 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.809 -1.182 . . . . 75.439999999999998 107.809 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.74 112.94 20.53 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.311 -0.996 . . . . 73.150000000000006 108.311 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.99 122.5 17.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.38 1.072 . . . . 55.310000000000002 111.675 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.7 t -131.66 142.35 49.82 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 121.786 0.803 . . . . 61.43 110.577 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 21.4 p -151.71 150.16 29.9 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.559 -1.275 . . . . 71.319999999999993 107.559 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 172.62 -164.03 36.16 Favored Glycine 0 CA--C 1.482 -2.013 0 N-CA-C 109.979 -1.248 . . . . 70.129999999999995 109.979 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.58 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 45.3 mt-10 -133.24 128.06 35.06 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.986 0.393 . . . . 73.219999999999999 111.134 -177.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.464 HD22 ' HB3' ' A' ' 569' ' ' LYS . 95.8 mt -89.44 141.18 28.8 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 123.463 0.705 . . . . 71.319999999999993 109.201 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.464 ' HA ' HD13 ' A' ' 536' ' ' ILE . 36.1 tt0 -103.54 118.28 36.37 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.292 0.568 . . . . 71.049999999999997 110.884 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -116.39 148.75 40.35 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.777 -0.823 . . . . 73.329999999999998 108.777 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.658 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 45.7 mt-30 -140.86 -178.97 5.8 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.826 -0.805 . . . . 53.130000000000003 108.826 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . 0.432 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 3.6 p-10 -71.48 -36.0 71.0 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.597 -0.441 . . . . 74.319999999999993 110.617 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -79.81 -39.3 31.09 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.109 -0.496 . . . . 75.319999999999993 110.167 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.658 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 64.5 mm-40 -63.64 151.86 40.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.556 -0.747 . . . . 73.120000000000005 111.736 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.549 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.2 pt -114.62 -92.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 113.447 0.906 . . . . 63.439999999999998 113.447 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.549 ' H ' HG13 ' A' ' 567' ' ' ILE . 11.7 p -107.86 146.64 13.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 120.885 0.374 . . . . 72.150000000000006 111.331 -174.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.464 ' HB3' HD22 ' A' ' 560' ' ' LEU . 5.3 mmpt? -114.99 165.19 13.15 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.146 -0.687 . . . . 73.140000000000001 109.146 173.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.2 p -131.41 140.35 49.62 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.973 -0.558 . . . . 51.109999999999999 112.088 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.0 mp -95.28 121.03 45.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.811 -1.181 . . . . 73.409999999999997 107.811 173.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 521' ' ' MET . 70.0 m -96.64 117.74 31.63 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 123.981 0.801 . . . . 64.310000000000002 109.035 176.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.474 HG23 HG22 ' A' ' 571' ' ' ILE . 89.6 t -119.31 133.42 66.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 110.239 -0.282 . . . . 71.140000000000001 110.239 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.448 ' HA ' HD13 ' A' ' 520' ' ' ILE . 22.1 tptm -86.37 120.71 28.0 Favored 'General case' 0 N--CA 1.435 -1.218 0 O-C-N 123.684 0.615 . . . . 65.150000000000006 109.363 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 31.0 t -96.05 127.39 48.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.81 -1.182 . . . . 64.129999999999995 107.81 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 34.5 mm -87.07 147.87 5.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-O 120.999 0.428 . . . . 64.25 110.123 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -65.68 138.65 58.12 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 124.88 1.272 . . . . 75.409999999999997 110.624 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -89.58 -164.85 1.21 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.63 -0.878 . . . . 74.349999999999994 108.63 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -90.77 -43.46 10.07 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.936 -1.135 . . . . 72.349999999999994 107.936 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -158.32 -67.26 0.09 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 105.798 -1.927 . . . . 75.310000000000002 105.798 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -173.83 69.19 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 124.696 1.248 . . . . 71.430000000000007 110.216 176.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -51.83 -62.97 1.3 Allowed 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.624 0.726 . . . . 60.549999999999997 111.766 -177.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -143.16 150.05 38.88 Favored 'General case' 0 N--CA 1.408 -2.533 0 N-CA-C 107.849 -1.167 . . . . 75.400000000000006 107.849 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -75.59 87.11 2.68 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.341 -1.725 . . . . 74.299999999999997 106.341 169.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.47 161.96 14.01 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.888 -1.051 . . . . 72.319999999999993 112.448 -176.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . 0.489 ' H ' ' HB ' ' A' ' 545' ' ' THR . 5.3 t -153.47 153.3 32.2 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 115.434 -0.803 . . . . 70.239999999999995 109.02 -173.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -133.03 168.38 18.6 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.233 -1.395 . . . . 74.219999999999999 107.233 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.485 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 72.5 m-85 -117.73 151.27 37.61 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 120.084 -0.646 . . . . 74.030000000000001 109.451 -174.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.1 OUTLIER -121.39 128.1 51.87 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 106.378 -1.712 . . . . 72.099999999999994 106.378 178.21 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -124.93 133.94 52.85 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.991 -0.744 . . . . 74.349999999999994 108.991 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.454 HG23 ' CZ ' ' A' ' 507' ' ' PHE . 18.3 pt -97.84 135.84 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 N-CA-C 107.878 -1.156 . . . . 64.299999999999997 107.878 173.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -81.83 173.07 53.53 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 111.017 -0.833 . . . . 62.219999999999999 111.017 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 593' ' ' GLU . 6.1 mp0 -59.41 135.08 88.66 Favored Pre-proline 0 C--N 1.287 -2.122 0 C-N-CA 123.945 0.898 . . . . 74.329999999999998 110.688 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -70.87 122.06 8.47 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 122.495 2.13 . . . . 71.209999999999994 111.074 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 536' ' ' ILE . 1.8 ptm180 -104.51 119.57 39.29 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.591 -0.731 . . . . 75.409999999999997 109.134 -177.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.417 ' HB2' ' CD ' ' A' ' 634' ' ' PRO . 2.3 tm? -66.2 134.55 52.94 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.898 -1.149 . . . . 73.450000000000003 107.898 178.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.45 ' CG2' HG12 ' A' ' 536' ' ' ILE . 25.8 t -82.73 85.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 105.875 -1.898 . . . . 75.120000000000005 105.875 175.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -80.0 120.29 23.98 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 114.747 -1.115 . . . . 74.420000000000002 112.309 -169.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 27.7 ttt -114.85 -20.55 10.54 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.549 -1.205 . . . . 72.209999999999994 109.853 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 19.9 m -87.74 -4.87 58.88 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 112.464 0.542 . . . . 72.400000000000006 112.464 -173.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -96.33 147.4 23.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.651 -0.87 . . . . 75.329999999999998 108.651 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.33 81.1 7.59 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 106.438 -1.69 . . . . 73.099999999999994 106.438 172.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.74 119.0 10.42 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 114.165 -1.38 . . . . 75.150000000000006 111.825 -177.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -142.04 20.68 2.48 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 110.075 -1.21 . . . . 64.219999999999999 110.075 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -137.44 118.33 1.67 Allowed Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 109.784 -1.326 . . . . 75.430000000000007 109.784 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -71.08 121.16 17.76 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.204 -0.665 . . . . 74.219999999999999 109.204 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 19.2 p -78.41 85.7 4.51 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.325 0.584 . . . . 74.230000000000004 109.819 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 5.4 tp -77.68 88.13 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 122.076 0.941 . . . . 72.450000000000003 109.51 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 9.7 t -98.96 94.29 6.47 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 122.323 1.058 . . . . 60.549999999999997 110.695 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -105.08 -68.55 0.85 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.585 -1.265 . . . . 70.549999999999997 107.585 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -164.74 101.51 0.79 Allowed 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 106.411 -1.7 . . . . 74.340000000000003 106.411 -176.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -88.46 145.86 25.53 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.066 -0.516 . . . . 71.400000000000006 110.54 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -64.87 -41.67 95.46 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.587 0.554 . . . . 72.420000000000002 109.971 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -125.38 91.66 3.46 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 106.868 -1.531 . . . . 55.509999999999998 106.868 171.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -84.95 -21.26 29.66 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 119.867 -0.733 . . . . 41.219999999999999 109.767 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -67.85 160.3 74.46 Favored Pre-proline 0 C--O 1.245 0.845 0 CA-C-N 115.289 -0.869 . . . . 74.209999999999994 109.853 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.18 118.16 5.44 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.842 1.695 . . . . 73.430000000000007 109.36 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.421 ' H ' ' NH2' ' A' ' 626' ' ' ARG . 49.7 tp -161.24 153.46 20.01 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.063 -0.717 . . . . 71.049999999999997 109.063 -177.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 39.4 m -144.85 132.93 21.46 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.818 -1.919 . . . . 71.400000000000006 105.818 175.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 10.7 t -113.43 -7.67 13.44 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.091 -0.644 . . . . 72.420000000000002 111.717 -176.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -106.3 162.75 13.4 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.943 -1.132 . . . . 55.310000000000002 107.943 174.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -88.66 62.25 6.4 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 122.508 1.147 . . . . 72.030000000000001 111.031 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -97.0 -155.92 0.51 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.291 -1.744 . . . . 71.420000000000002 106.291 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.97 104.01 8.27 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 104.885 -2.265 . . . . 63.240000000000002 104.885 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -58.17 129.64 42.92 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.712 -0.847 . . . . 74.439999999999998 108.712 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.421 ' NH2' ' H ' ' A' ' 618' ' ' LEU . 41.7 mtm180 -52.84 -42.09 64.84 Favored 'General case' 0 C--O 1.187 -2.197 0 N-CA-C 113.097 0.777 . . . . 61.310000000000002 113.097 -173.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.74 -27.59 29.46 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.543 0.737 . . . . 71.25 111.233 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 71.7 mt -80.71 -47.92 20.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.851 0.358 . . . . 75.540000000000006 110.5 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -84.26 -24.49 29.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.221 0.534 . . . . 74.200000000000003 111.632 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . 0.287 62.3 mt-10 -65.84 -8.75 23.51 Favored 'General case' 0 C--O 1.2 -1.538 0 N-CA-C 114.465 1.283 . . . . 54.409999999999997 114.465 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -58.69 -21.57 54.91 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 121.512 0.672 . . . . 62.32 109.371 172.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -83.42 5.75 76.03 Favored Glycine 0 C--O 1.222 -0.636 0 CA-C-N 116.218 -0.446 . . . . 72.230000000000004 112.491 178.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . 0.469 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 11.2 ptm180 -134.11 167.72 21.47 Favored Pre-proline 0 C--N 1.311 -1.09 0 N-CA-C 106.956 -1.498 . . . . 73.340000000000003 106.956 175.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 633' ' ' ARG . 72.3 Cg_endo -80.94 136.42 10.45 Favored 'Trans proline' 0 N--CA 1.429 -2.281 0 C-N-CA 121.012 1.142 . . . . 55.32 110.4 174.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 635' ' ' ILE . 0.1 OUTLIER -124.54 162.46 26.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.256 -1.016 . . . . 71.040000000000006 108.256 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.02 -178.43 3.71 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 120.056 -0.658 . . . . 74.319999999999993 111.928 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -75.1 -169.13 24.24 Favored Glycine 0 N--CA 1.445 -0.704 0 O-C-N 123.455 0.472 . . . . 61.439999999999998 112.794 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -68.99 -51.84 35.16 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.181 -0.674 . . . . 72.019999999999996 109.181 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -122.56 131.62 53.92 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.814 0.816 . . . . 75.109999999999999 111.937 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 506' ' ' THR . 16.8 p -126.64 90.06 3.1 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.394 -1.276 . . . . 75.409999999999997 109.781 177.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . 0.403 ' NZ ' ' HB3' ' A' ' 641' ' ' LYS . 5.7 ttpm? -159.54 148.18 17.75 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.519 -0.764 . . . . 74.030000000000001 109.609 -176.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.626 HD22 HG11 ' A' ' 523' ' ' VAL . 30.9 tp -129.51 129.17 44.19 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 108.025 -1.102 . . . . 73.230000000000004 108.025 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -97.58 106.25 18.53 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.894 -1.521 . . . . 63.240000000000002 106.894 175.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 39.6 t -98.55 106.86 19.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.358 -0.608 . . . . 62.119999999999997 109.358 -176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 73.0 mt -91.2 125.3 43.95 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.559 0 N-CA-C 109.35 -0.611 . . . . 73.530000000000001 109.35 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 69.8 mt -100.9 103.92 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 109.056 -0.72 . . . . 73.409999999999997 109.056 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 515' ' ' SER . 14.2 pt-20 -119.39 150.36 40.31 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.317 -0.994 . . . . 73.299999999999997 108.317 175.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.96 141.15 30.56 Favored 'General case' 0 N--CA 1.41 -2.473 0 CA-C-O 122.026 0.917 . . . . 73.540000000000006 112.331 -177.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 70.5 m -155.99 87.7 1.08 Allowed 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 104.823 -2.288 . . . . 74.140000000000001 104.823 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -55.81 -48.09 76.01 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 114.997 -1.002 . . . . 72.519999999999996 112.969 -170.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -72.38 -32.51 66.48 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.783 -0.644 . . . . 54.340000000000003 110.324 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 59.3 t80 54.78 66.64 1.18 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.388 -1.278 . . . . 73.310000000000002 108.398 -172.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -74.14 -69.03 0.47 Allowed 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 113.799 -1.546 . . . . 72.129999999999995 108.006 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 16.6 m 50.19 37.51 14.94 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.578 0.704 . . . . 71.310000000000002 111.588 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 27.3 m -84.43 111.89 19.87 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.783 -0.644 . . . . 71.409999999999997 110.014 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 29.9 m -86.39 141.73 14.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.881 -0.599 . . . . 64.420000000000002 109.433 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--N 1.292 -1.926 0 N-CA-C 109.403 -0.591 . . . . 54.229999999999997 109.403 -179.942 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 47.8 t60 . . . . . 0 N--CA 1.438 -1.044 0 CA-C-O 121.265 0.555 . . . . 65.010000000000005 109.793 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -93.92 -63.03 1.24 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.798 -0.816 . . . . 72.310000000000002 108.798 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 169.3 -159.13 31.94 Favored Glycine 0 N--CA 1.42 -2.376 0 N-CA-C 108.672 -1.771 . . . . 74.510000000000005 108.672 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.457 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.5 mp -114.23 110.83 33.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 117.211 0.505 . . . . 71.530000000000001 110.834 -175.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.475 ' CE2' HG23 ' A' ' 528' ' ' THR . 31.5 m-85 -90.67 124.5 35.12 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.655 -0.868 . . . . 74.109999999999999 108.655 169.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . 0.433 ' HA ' HG22 ' A' ' 640' ' ' THR . 14.1 t -162.47 170.57 18.49 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.78 -0.822 . . . . 74.439999999999998 108.78 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -76.11 146.62 39.17 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 110.27 -0.27 . . . . 74.349999999999994 110.27 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.28 -30.78 71.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.267 0.556 . . . . 74.200000000000003 109.785 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -137.41 145.73 50.71 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 108.735 -0.839 . . . . 75.150000000000006 108.735 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -81.14 -22.64 5.82 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.654 2.236 . . . . 72.109999999999999 112.819 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 47.2 t -141.79 135.11 29.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 106.92 -1.511 . . . . 53.450000000000003 106.92 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.1 t -131.61 141.04 49.56 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 109.494 -0.558 . . . . 73.409999999999997 109.494 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -107.01 124.89 50.28 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.075 0.464 . . . . 75.219999999999999 110.207 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 17.6 m -124.3 163.42 24.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.177 -0.675 . . . . 62.009999999999998 109.177 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 19.2 t -93.64 154.42 17.84 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.954 -0.388 . . . . 74.299999999999997 109.954 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -59.59 -32.74 70.66 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 123.773 0.671 . . . . 75.030000000000001 109.523 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 23.3 t -129.43 65.39 1.47 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.907 0.861 . . . . 63.149999999999999 110.84 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 6.4 tt -98.3 -25.0 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 115.072 -0.967 . . . . 72.310000000000002 109.168 172.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 95.04 -81.05 0.87 Allowed Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.55 -0.75 . . . . 62.030000000000001 111.283 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.5 mm -129.36 127.52 65.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.002 -1.481 . . . . 70.549999999999997 107.002 -176.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.69 148.08 34.19 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.707 -1.22 . . . . 73.409999999999997 107.707 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 33.2 mt-10 -126.75 132.16 51.15 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 123.576 0.547 . . . . 74.129999999999995 111.989 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.609 HG11 HD22 ' A' ' 642' ' ' LEU . 21.5 t -112.91 129.3 68.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.944 -1.132 . . . . 64.329999999999998 107.944 178.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -86.04 134.77 33.82 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.795 -0.817 . . . . 71.319999999999993 108.795 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 568' ' ' VAL . 44.8 t -108.8 127.89 65.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.845 -0.798 . . . . 73.230000000000004 108.845 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.96 126.45 29.79 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.869 -0.605 . . . . 73.329999999999998 110.314 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -79.33 161.41 26.26 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.486 -1.234 . . . . 71.420000000000002 109.926 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.475 HG23 ' CE2' ' A' ' 505' ' ' PHE . 6.4 p -59.74 147.27 38.48 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 123.384 0.674 . . . . 72.530000000000001 111.633 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 29.5 t -59.14 -36.98 76.17 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.918 -0.771 . . . . 74.540000000000006 108.918 175.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -112.56 101.6 1.24 Allowed Glycine 0 N--CA 1.416 -2.683 0 N-CA-C 108.981 -1.647 . . . . 71.140000000000001 108.981 174.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -92.03 101.48 14.03 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.753 -1.203 . . . . 73.310000000000002 107.753 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -122.21 104.29 9.35 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.741 -0.466 . . . . 71.450000000000003 109.741 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 89.33 -151.39 21.95 Favored Glycine 0 C--N 1.304 -1.215 0 C-N-CA 120.456 -0.878 . . . . 70.140000000000001 112.031 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.494 HD21 ' CG ' ' A' ' 561' ' ' GLU . 2.5 t-20 -113.09 127.69 56.28 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.394 0.616 . . . . 72.140000000000001 110.297 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 66.4 t -129.67 138.51 54.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 108.81 -0.811 . . . . 62.009999999999998 108.81 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.582 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 44.8 mm -107.94 133.84 51.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 109.35 -0.611 . . . . 74.140000000000001 109.35 177.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 25.6 t -120.45 109.06 36.96 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 109.208 -0.664 . . . . 63.229999999999997 109.208 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.61 153.94 54.68 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.108 1.872 . . . . 60.520000000000003 111.83 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.484 ' HB3' HG22 ' A' ' 591' ' ' ILE . 52.9 p90 -148.81 161.56 41.56 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.738 -0.467 . . . . 73.120000000000005 109.738 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -158.17 162.35 37.92 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.106 -0.497 . . . . 72.120000000000005 109.714 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . 0.464 HG23 HG22 ' A' ' 556' ' ' THR . 6.8 p -88.39 149.29 23.8 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 116.027 -0.533 . . . . 64.200000000000003 110.677 173.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 86.7 mt -121.26 109.99 26.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.858 -1.164 . . . . 45.32 107.858 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.34 111.24 2.94 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 123.854 0.721 . . . . 72.549999999999997 110.593 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -100.54 -108.24 3.02 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.34 -1.104 . . . . 54.420000000000002 110.34 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 67.5 p -93.24 8.87 38.51 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 122.517 1.151 . . . . 62.140000000000001 107.967 175.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -119.88 136.53 54.46 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.148 -1.387 . . . . 71.019999999999996 109.509 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.534 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 82.0 mtm180 -82.9 135.4 34.93 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.543 1.137 . . . . 75.129999999999995 110.831 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -87.73 -161.28 36.6 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 115.153 -0.931 . . . . 74.209999999999994 113.533 -175.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 77.06 -55.99 3.57 Favored Glycine 0 C--O 1.224 -0.51 0 CA-C-N 115.488 -0.356 . . . . 64.129999999999995 113.576 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 554' ' ' GLU . . . 157.99 42.45 0.02 OUTLIER Glycine 0 C--N 1.284 -2.341 0 N-CA-C 109.415 -1.474 . . . . 70.319999999999993 109.415 -173.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.534 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 8.4 tt0 -116.92 -61.74 1.68 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.559 -0.534 . . . . 73.140000000000001 109.559 -176.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -98.57 -43.74 6.73 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.887 -1.523 . . . . 75.299999999999997 106.887 169.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -132.87 156.42 47.23 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 107.195 -1.409 . . . . 71.209999999999994 107.195 174.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.42 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 10.2 tt0 -84.3 131.11 34.75 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.635 -0.876 . . . . 75.219999999999999 108.635 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . 0.535 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 9.6 t70 -58.24 131.1 49.6 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.525 -0.546 . . . . 74.310000000000002 109.525 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.599 HG21 HG22 ' A' ' 573' ' ' VAL . 14.6 t -133.32 141.33 47.9 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-O 121.702 0.763 . . . . 75.439999999999998 109.146 174.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 3.2 p -156.55 161.32 39.98 Favored 'General case' 0 C--N 1.272 -2.763 0 N-CA-C 107.264 -1.384 . . . . 71.510000000000005 107.264 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 149.24 -167.11 29.56 Favored Glycine 0 N--CA 1.41 -3.071 0 N-CA-C 110.395 -1.082 . . . . 65.209999999999994 110.395 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.582 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 52.9 mt-10 -131.7 132.77 44.19 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 120.965 0.412 . . . . 70.219999999999999 110.567 -176.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.547 HD22 ' HB3' ' A' ' 569' ' ' LYS . 89.7 mt -92.94 140.81 29.1 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.883 -0.599 . . . . 74.0 109.512 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.494 ' CG ' HD21 ' A' ' 534' ' ' ASN . 27.9 tt0 -106.28 113.74 27.44 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 116.094 -0.503 . . . . 74.530000000000001 109.872 -177.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -111.92 149.31 32.07 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.128 -0.693 . . . . 72.129999999999995 109.128 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.573 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 49.4 mt-30 -146.99 -177.65 5.77 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.249 -0.648 . . . . 72.5 109.249 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -70.07 -31.17 68.64 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.629 -1.249 . . . . 72.519999999999996 107.629 170.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -77.0 -52.76 8.79 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.8 -1.091 . . . . 70.530000000000001 111.176 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.573 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 42.4 mm-40 -64.77 124.18 21.29 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 123.616 0.767 . . . . 73.549999999999997 111.854 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.584 HG13 ' H ' ' A' ' 568' ' ' VAL . 3.2 pt -81.08 -62.24 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 124.159 0.912 . . . . 61.009999999999998 112.638 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.584 ' H ' HG13 ' A' ' 567' ' ' ILE . 7.8 p -143.31 160.24 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 109.522 -0.548 . . . . 64.019999999999996 109.522 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.547 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -127.6 158.69 36.83 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.43 -0.952 . . . . 64.109999999999999 108.43 171.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.5 p -127.34 144.58 51.03 Favored 'General case' 0 C--N 1.278 -2.504 0 O-C-N 124.03 0.831 . . . . 74.409999999999997 111.096 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.2 mp -94.68 119.31 42.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 106.829 -1.545 . . . . 51.229999999999997 106.829 172.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 24.4 p -92.34 116.14 28.71 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.543 -0.91 . . . . 75.299999999999997 108.543 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.599 HG22 HG21 ' A' ' 556' ' ' THR . 55.5 t -116.43 123.16 71.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.372 -0.603 . . . . 60.43 109.372 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 29.4 tptp -76.91 113.99 15.21 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.124 -0.944 . . . . 73.319999999999993 109.235 176.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.94 128.82 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 N-CA-C 104.887 -2.264 . . . . 51.329999999999998 104.887 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 46.5 mm -69.28 123.0 21.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 122.35 1.071 . . . . 65.219999999999999 111.761 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -115.57 109.8 18.31 Favored 'General case' 0 C--N 1.274 -2.675 0 CA-C-N 112.752 -2.022 . . . . 73.230000000000004 107.804 -175.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -157.47 156.47 32.16 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.485 -1.302 . . . . 71.439999999999998 107.485 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -74.37 76.43 1.88 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.008 0.908 . . . . 61.310000000000002 112.766 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -140.1 130.65 25.57 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 105.079 -2.193 . . . . 71.340000000000003 105.079 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -90.02 95.49 10.24 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.287 -0.635 . . . . 74.239999999999995 109.287 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -99.79 -162.35 0.94 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.396 -0.82 . . . . 63.140000000000001 111.358 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 585' ' ' LYS . 0.5 OUTLIER -148.82 -171.47 3.87 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.565 -1.272 . . . . 64.329999999999998 107.565 -174.337 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 646' ' ' ILE . 35.4 t-20 -52.88 115.67 1.95 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.733 1.213 . . . . 72.230000000000004 112.301 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 73.5 mmtt -121.3 133.01 55.12 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.346 -1.724 . . . . 72.540000000000006 106.346 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 11.4 t -131.41 137.96 48.89 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.578 -1.249 . . . . 74.099999999999994 111.012 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 44.2 p90 -135.07 179.13 6.51 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 107.74 -1.208 . . . . 72.140000000000001 107.74 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.549 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 92.6 m-85 -123.77 155.68 37.47 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 109.318 -0.623 . . . . 74.349999999999994 109.318 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.83 133.54 54.43 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 105.167 -2.16 . . . . 73.230000000000004 105.167 176.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.409 ' HB2' HD11 ' A' ' 542' ' ' ILE . 28.7 tt0 -133.92 136.5 44.3 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.613 -0.835 . . . . 70.439999999999998 110.328 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.484 HG22 ' HB3' ' A' ' 539' ' ' TYR . 16.0 pt -99.69 138.34 24.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 114.987 -1.006 . . . . 72.030000000000001 108.343 174.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.42 -173.55 49.78 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 111.225 -0.75 . . . . 55.329999999999998 111.225 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.94 130.35 88.48 Favored Pre-proline 0 C--N 1.305 -1.328 0 C-N-CA 120.702 -0.399 . . . . 74.5 111.168 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.524 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 17.8 Cg_endo -64.85 135.69 45.66 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.138 2.558 . . . . 65.420000000000002 112.21 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . 0.478 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 14.6 ptm180 -111.99 127.96 56.03 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.586 -0.733 . . . . 73.25 109.81 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -73.48 128.92 36.84 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 106.468 -1.679 . . . . 54.549999999999997 106.468 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.49 ' CG2' HG12 ' A' ' 536' ' ' ILE . 62.0 t -75.48 121.46 27.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.155 -0.683 . . . . 73.209999999999994 109.155 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 68.67 85.58 0.14 Allowed 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 125.097 1.359 . . . . 73.540000000000006 109.417 -171.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 17.1 tpt -66.99 -38.27 85.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 113.32 -1.764 . . . . 53.109999999999999 111.379 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 34.7 t -130.24 177.76 7.08 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.68 -1.6 . . . . 73.140000000000001 106.68 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -69.59 -29.42 66.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.754 0.787 . . . . 73.230000000000004 109.394 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . 0.553 ' H ' ' HD2' ' A' ' 602' ' ' LYS . 0.0 OUTLIER -105.23 167.08 9.96 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.05 -1.463 . . . . 71.109999999999999 107.05 174.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -80.17 95.78 6.36 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 120.25 -0.58 . . . . 74.349999999999994 109.741 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -70.33 138.9 29.84 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 114.693 -1.139 . . . . 72.530000000000001 112.607 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 110.76 -138.43 14.93 Favored Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 109.641 -1.384 . . . . 54.200000000000003 109.641 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 59.16 83.64 0.12 Allowed 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.256 1.022 . . . . 64.319999999999993 112.411 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 9.8 t -151.45 168.28 25.36 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 105.377 -2.083 . . . . 62.32 105.377 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.61 97.19 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 CA-C-O 122.481 1.134 . . . . 74.420000000000002 110.2 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 91.1 m -149.91 121.09 7.78 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.049 -1.093 . . . . 73.329999999999998 108.049 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -137.58 109.9 7.38 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.686 0.624 . . . . 70.120000000000005 112.686 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -103.43 111.74 24.32 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.143 -1.429 . . . . 74.230000000000004 107.143 170.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -88.16 -17.98 29.74 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.235 -0.439 . . . . 74.230000000000004 111.897 -172.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -88.87 117.36 27.82 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 116.367 -0.379 . . . . 72.030000000000001 110.953 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -100.44 71.75 1.55 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.188 0.994 . . . . 65.030000000000001 109.314 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.11 90.1 2.01 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 106.23 -1.767 . . . . 73.349999999999994 106.23 174.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 78.23 98.69 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 114.214 -1.357 . . . . 71.209999999999994 109.704 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.57 112.12 1.86 Allowed 'Trans proline' 0 C--O 1.256 1.389 0 C-N-CA 122.723 2.282 . . . . 63.32 110.779 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.2 pp -75.07 152.94 38.57 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.68 -0.691 . . . . 75.349999999999994 111.389 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 4.9 t -107.58 129.1 55.02 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.754 -0.462 . . . . 65.340000000000003 109.754 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 15.2 m -79.34 107.31 12.0 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.044 -1.095 . . . . 75.120000000000005 108.044 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -108.38 101.61 10.79 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.768 0.794 . . . . 72.439999999999998 111.681 -175.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -140.1 140.6 36.09 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 104.382 -2.451 . . . . 74.209999999999994 104.382 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.62 70.29 2.43 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.75 0.786 . . . . 72.140000000000001 111.872 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.62 173.67 6.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.942 -1.503 . . . . 64.299999999999997 106.942 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.21 -23.57 64.83 Favored 'General case' 0 C--O 1.214 -0.774 0 C-N-CA 119.825 -0.75 . . . . 74.129999999999995 109.701 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 40.3 tpt85 -63.41 -38.63 91.9 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.642 -0.708 . . . . 74.129999999999995 110.461 173.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . 0.7 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 0.0 OUTLIER -75.59 -36.05 60.43 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.883 -0.784 . . . . 74.120000000000005 108.883 177.149 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 71.2 mt -59.67 -45.58 94.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.498 0.666 . . . . 74.219999999999999 109.327 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -71.92 -16.54 62.11 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.371 -0.831 . . . . 75.019999999999996 112.618 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.7 ' HG2' ' O ' ' A' ' 627' ' ' ARG . 20.0 pt-20 -72.88 -10.72 60.11 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 120.407 -0.517 . . . . 72.340000000000003 112.096 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -60.79 -31.98 71.34 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 108.71 -0.848 . . . . 63.420000000000002 108.71 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -93.05 55.81 2.52 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 115.663 -0.699 . . . . 30.100000000000001 111.514 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -126.61 151.99 73.94 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 107.701 -1.222 . . . . 75.329999999999998 107.701 175.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.524 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 17.4 Cg_endo -63.34 142.35 85.32 Favored 'Trans proline' 0 N--CA 1.44 -1.647 0 C-N-CA 121.97 1.78 . . . . 74.219999999999999 107.9 170.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.87 163.74 24.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 119.524 -0.871 . . . . 65.109999999999999 112.385 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.04 174.83 6.56 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.322 -0.854 . . . . 71.549999999999997 111.144 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.457 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -75.5 -169.28 25.89 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 116.018 -0.537 . . . . 51.240000000000002 113.876 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.53 -27.67 60.63 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.473 0.654 . . . . 75.430000000000007 109.686 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -139.82 133.56 30.53 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.03 -0.729 . . . . 73.019999999999996 109.03 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 506' ' ' THR . 22.6 p -133.81 90.27 2.68 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.398 0.618 . . . . 74.400000000000006 110.175 176.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -163.13 142.74 8.78 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.519 -0.919 . . . . 73.209999999999994 108.519 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.609 HD22 HG11 ' A' ' 523' ' ' VAL . 21.3 tp -126.52 128.65 47.22 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 108.872 -0.788 . . . . 64.030000000000001 108.872 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -95.34 110.07 22.14 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.639 -1.245 . . . . 74.140000000000001 107.639 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.07 114.16 36.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 109.02 -0.733 . . . . 73.129999999999995 109.02 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 55.7 mt -102.9 113.85 40.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 109.104 -0.702 . . . . 42.32 109.104 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 584' ' ' ASN . 50.3 mt -93.7 107.56 19.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.598 -1.631 . . . . 73.409999999999997 106.598 176.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.4 150.52 37.65 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.381 -0.927 . . . . 65.519999999999996 110.538 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.75 118.07 19.75 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-O 122.289 1.042 . . . . 71.340000000000003 110.76 -175.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 1.7 p -143.02 29.35 1.49 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 113.209 -1.814 . . . . 64.540000000000006 106.293 175.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.91 -37.93 11.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.542 -2.117 . . . . 71.129999999999995 109.679 -175.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -71.16 -27.76 63.77 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.67 -0.695 . . . . 72.120000000000005 109.492 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -72.27 -29.32 63.78 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.422 -0.808 . . . . 74.439999999999998 111.669 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 653' ' ' LYS . 6.1 mmpt? -126.75 98.8 5.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.644 0.735 . . . . 74.200000000000003 112.776 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 22.8 t -109.99 134.91 51.61 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.077 -1.083 . . . . 64.319999999999993 108.077 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 15.2 p -116.11 -77.71 0.57 Allowed 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 120.708 0.29 . . . . 72.299999999999997 110.586 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 30.6 m -134.1 149.64 30.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 116.533 -0.303 . . . . 72.310000000000002 110.237 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 18.5 t70 . . . . . 0 C--N 1.307 -1.265 0 CA-C-N 116.153 -0.476 . . . . 71.129999999999995 109.724 177.568 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.487 ' CD2' ' HA ' ' A' ' 631' ' ' MET . 80.5 m80 . . . . . 0 CA--C 1.5 -0.981 0 N-CA-C 108.686 -0.857 . . . . 75.400000000000006 108.686 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -63.02 -60.77 3.0 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.403 -0.592 . . . . 65.340000000000003 109.403 177.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 172.34 -160.2 31.45 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 110.88 -0.888 . . . . 21.41 110.88 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.26 126.98 71.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 O-C-N 124.003 0.472 . . . . 73.219999999999999 111.364 -170.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.433 ' CE2' ' HB ' ' A' ' 528' ' ' THR . 61.9 m-85 -103.56 133.94 47.75 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.427 -0.583 . . . . 64.409999999999997 109.427 170.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.0 t -169.32 169.8 8.88 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.332 -0.988 . . . . 34.32 108.332 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -78.01 149.41 34.05 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.073 0.397 . . . . 63.0 111.53 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.93 -36.4 80.07 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.46 -0.941 . . . . 71.400000000000006 108.46 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -129.68 146.23 60.32 Favored Pre-proline 0 C--N 1.31 -1.117 0 N-CA-C 108.253 -1.017 . . . . 73.310000000000002 108.253 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.49 -29.03 2.54 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.153 1.902 . . . . 62.439999999999998 112.934 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 55.9 t -139.6 135.11 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 107.015 -1.476 . . . . 55.520000000000003 107.015 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.1 t -134.17 140.38 46.5 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 108.867 -0.79 . . . . 73.519999999999996 108.867 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -114.87 129.06 56.63 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.769 -1.197 . . . . 60.140000000000001 107.769 175.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.0 m -116.21 170.52 5.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 121.182 0.515 . . . . 70.450000000000003 110.607 -175.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.646 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 75.3 m -87.03 150.11 24.26 Favored 'General case' 0 N--CA 1.398 -3.066 0 CA-C-N 115.069 -0.968 . . . . 73.319999999999993 108.632 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.7 ' HB3' ' HA ' ' A' ' 648' ' ' GLU . 3.8 tm-20 -75.31 -41.94 55.76 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 120.922 0.391 . . . . 73.129999999999995 111.077 177.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 6.4 t -99.31 51.06 0.94 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.553 0.692 . . . . 73.230000000000004 109.743 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.646 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 10.2 tt -103.41 -20.76 5.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.466 0.651 . . . . 74.109999999999999 111.29 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.53 -75.41 2.32 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 110.584 -1.006 . . . . 21.440000000000001 110.584 -175.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 47.7 mm -132.02 127.82 58.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 107.939 -1.134 . . . . 75.150000000000006 107.939 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.469 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -107.58 150.86 26.37 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.78 -1.193 . . . . 63.240000000000002 107.78 176.372 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 30.7 mt-10 -131.66 123.11 27.12 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 123.654 0.596 . . . . 72.219999999999999 111.878 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.543 HG11 HD22 ' A' ' 642' ' ' LEU . 58.6 t -112.17 130.22 66.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.509 -0.922 . . . . 75.230000000000004 108.509 176.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.436 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 21.0 mtmm -87.39 134.87 33.52 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.43 0.633 . . . . 75.120000000000005 111.884 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 568' ' ' VAL . 59.0 t -105.64 127.85 60.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.805 -0.813 . . . . 55.43 108.805 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.22 124.19 22.41 Favored 'General case' 0 N--CA 1.432 -1.365 0 O-C-N 123.726 0.641 . . . . 74.219999999999999 109.725 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -72.27 158.56 35.61 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.663 -1.153 . . . . 74.140000000000001 109.417 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.433 ' HB ' ' CE2' ' A' ' 505' ' ' PHE . 2.9 t -56.01 133.1 51.53 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.429 -0.805 . . . . 73.349999999999994 109.904 175.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 5.1 m -51.17 -31.38 19.74 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.475 1.51 . . . . 71.420000000000002 111.165 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.0 95.39 0.4 Allowed Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 109.031 -1.628 . . . . 74.340000000000003 109.031 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.98 104.37 15.54 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.177 -0.675 . . . . 52.310000000000002 109.177 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -119.09 105.09 11.06 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.082 -0.508 . . . . 75.030000000000001 109.748 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 92.97 -139.24 14.52 Favored Glycine 0 N--CA 1.436 -1.356 0 O-C-N 123.747 0.655 . . . . 51.409999999999997 112.221 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.482 HD21 ' CG ' ' A' ' 561' ' ' GLU . 2.8 t-20 -126.63 129.35 48.32 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.822 -0.806 . . . . 52.130000000000003 108.822 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 65.3 t -132.44 140.28 48.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.243 -0.435 . . . . 64.140000000000001 109.889 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.504 ' HB ' ' HG3' ' A' ' 595' ' ' ARG . 43.4 mm -109.24 137.59 40.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.078 -0.712 . . . . 74.040000000000006 109.078 176.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.98 110.47 29.32 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 109.666 -0.494 . . . . 62.329999999999998 109.666 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.58 155.28 59.43 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.389 2.059 . . . . 42.049999999999997 112.269 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.514 ' HB3' HG22 ' A' ' 591' ' ' ILE . 39.8 p90 -151.73 161.75 42.14 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.861 -0.422 . . . . 74.200000000000003 109.861 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -154.76 151.77 29.08 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.439 0.462 . . . . 70.019999999999996 110.974 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.3 p -85.91 132.49 34.07 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.222 -0.899 . . . . 72.150000000000006 110.088 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 59.0 mt -112.02 115.41 49.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.054 -1.091 . . . . 73.409999999999997 108.054 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.03 106.28 2.31 Favored 'General case' 0 C--N 1.312 -1.035 0 O-C-N 123.369 0.418 . . . . 74.329999999999998 110.979 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -85.14 -98.75 0.69 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 108.626 -1.789 . . . . 65.25 108.626 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 38.3 p -95.25 -25.61 16.28 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.767 -1.198 . . . . 73.5 107.767 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.551 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -75.71 128.38 35.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.545 -1.207 . . . . 72.150000000000006 107.839 175.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 99.8 mtt180 -109.12 159.36 16.95 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 115.287 1.588 . . . . 71.150000000000006 115.287 -171.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . 63.87 -174.2 12.18 Favored Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 112.361 -2.2 . . . . 43.409999999999997 117.454 168.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -115.97 66.86 0.3 Allowed Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 108.163 -1.975 . . . . 72.349999999999994 108.163 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 132.17 5.04 3.51 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 111.524 -0.631 . . . . 15.34 111.524 -174.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 27.3 tt0 -90.85 -74.38 0.5 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.851 -0.739 . . . . 75.349999999999994 109.904 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.407 ' OD1' ' HG3' ' A' ' 585' ' ' LYS . 21.2 m-20 -94.77 -35.56 12.06 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 122.218 1.009 . . . . 74.109999999999999 108.471 175.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -137.57 157.79 45.78 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.187 -1.783 . . . . 70.049999999999997 106.187 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 4.8 tt0 -91.2 135.84 33.51 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.624 -1.251 . . . . 55.439999999999998 107.624 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.37 141.7 47.02 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 120.431 0.158 . . . . 73.219999999999999 110.71 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.9 t -144.12 127.42 16.76 Favored 'General case' 0 N--CA 1.408 -2.569 0 CA-C-O 122.618 1.199 . . . . 72.439999999999998 108.525 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 5.3 p -149.89 115.69 5.61 Favored 'General case' 0 C--N 1.255 -3.505 0 CA-C-N 113.78 -1.554 . . . . 72.040000000000006 108.851 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -168.35 -142.7 3.57 Favored Glycine 0 N--CA 1.408 -3.2 0 N-CA-C 109.787 -1.325 . . . . 62.310000000000002 109.787 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.2 mt-10 -143.81 147.46 34.15 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.969 0.385 . . . . 71.299999999999997 110.776 -174.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.46 HD22 ' HB3' ' A' ' 569' ' ' LYS . 95.6 mt -106.02 144.95 32.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.806 -0.813 . . . . 63.210000000000001 108.806 176.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.482 ' CG ' HD21 ' A' ' 534' ' ' ASN . 29.6 tt0 -109.98 120.46 42.54 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.041 0.448 . . . . 73.230000000000004 110.341 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -115.4 147.59 40.35 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.999 -0.741 . . . . 73.140000000000001 108.999 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.437 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 45.9 mt-30 -138.36 177.92 7.52 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 109.479 -0.563 . . . . 75.430000000000007 109.479 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -68.71 -37.51 79.55 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.11 -0.95 . . . . 62.32 110.392 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -92.45 -12.0 33.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.459 -0.791 . . . . 73.299999999999997 111.733 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 0.0 OUTLIER -68.3 172.8 5.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.881 -0.6 . . . . 75.319999999999993 110.095 -178.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.606 HG13 ' H ' ' A' ' 568' ' ' VAL . 5.9 pt -115.91 -82.82 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 112.671 0.619 . . . . 73.239999999999995 112.671 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.606 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.9 p -143.84 151.73 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 N-CA-C 108.88 -0.785 . . . . 75.120000000000005 108.88 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.46 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -114.06 156.34 24.32 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.192 0.52 . . . . 62.009999999999998 110.519 175.568 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.4 p -125.01 147.94 48.7 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.564 -1.198 . . . . 72.239999999999995 110.96 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.484 HG22 HG23 ' A' ' 573' ' ' VAL . 2.6 mp -94.94 117.04 37.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 106.437 -1.69 . . . . 74.140000000000001 106.437 171.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 521' ' ' MET . 45.2 m -93.42 115.26 27.81 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 108.498 -0.927 . . . . 41.32 108.498 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.484 HG23 HG22 ' A' ' 571' ' ' ILE . 67.6 t -118.51 132.35 68.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.627 -0.509 . . . . 64.099999999999994 109.627 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 50.8 tptt -81.81 117.65 22.26 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.936 -1.135 . . . . 44.409999999999997 107.936 175.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 47.1 t -91.26 131.04 39.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 106.262 -1.755 . . . . 62.109999999999999 106.262 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 40.3 mm -77.96 123.63 35.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.84 0.829 . . . . 73.450000000000003 109.528 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -77.45 119.13 20.62 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 113.811 -1.54 . . . . 74.209999999999994 107.973 -176.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -164.24 148.02 9.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.712 0.292 . . . . 54.450000000000003 110.508 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -128.46 13.47 6.54 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.643 0.609 . . . . 75.510000000000005 112.643 -175.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -115.71 123.22 47.75 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 114.864 1.431 . . . . 64.510000000000005 114.864 -171.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 34.1 t80 75.43 -43.13 0.49 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 116.415 2.006 . . . . 73.120000000000005 116.415 166.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -70.33 148.15 48.8 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.17 0.509 . . . . 73.510000000000005 111.48 -175.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -98.84 -61.76 1.33 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.25 -0.886 . . . . 61.130000000000003 111.347 -174.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -153.65 134.92 14.11 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 108.773 -0.825 . . . . 75.530000000000001 108.773 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 33.7 mmtp -127.23 139.33 53.0 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.878 -0.416 . . . . 71.120000000000005 109.878 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.7 t -141.93 143.14 33.12 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 109.025 -0.731 . . . . 63.420000000000002 109.025 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.503 ' HB3' ' HB3' ' A' ' 546' ' ' ALA . 46.7 p90 -135.76 174.65 10.38 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.154 -1.054 . . . . 74.430000000000007 108.154 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.483 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 78.2 m-85 -119.21 156.35 30.03 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 109.401 -0.592 . . . . 64.109999999999999 109.401 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.86 123.2 38.14 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 105.607 -1.997 . . . . 65.319999999999993 105.607 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.38 136.07 55.0 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.427 -0.583 . . . . 74.420000000000002 109.427 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.514 HG22 ' HB3' ' A' ' 539' ' ' TYR . 26.3 pt -106.06 137.79 34.56 Favored 'Isoleucine or valine' 0 C--O 1.261 1.695 0 N-CA-C 108.305 -0.998 . . . . 71.540000000000006 108.305 175.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.22 -177.01 49.85 Favored Glycine 0 N--CA 1.418 -2.54 0 CA-C-N 115.603 -0.726 . . . . 52.119999999999997 111.447 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.7 137.94 97.3 Favored Pre-proline 0 C--N 1.303 -1.416 0 CA-C-O 120.91 0.386 . . . . 75.219999999999999 111.371 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.488 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 32.0 Cg_endo -68.39 138.84 43.67 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 122.35 2.033 . . . . 72.340000000000003 111.083 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . 0.504 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.9 ptm180 -116.21 122.52 45.26 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.035 -0.728 . . . . 73.129999999999995 109.035 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.88 131.9 46.37 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.431 -1.322 . . . . 63.5 107.431 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.474 ' CG2' HG12 ' A' ' 536' ' ' ILE . 65.4 t -76.09 114.11 15.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.226 0.536 . . . . 72.430000000000007 110.667 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -72.44 104.32 3.75 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.12 -0.946 . . . . 71.239999999999995 112.491 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 49.5 tpp -69.04 -27.65 65.84 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.525 -1.216 . . . . 74.030000000000001 107.914 175.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 47.8 t -87.99 86.91 7.19 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.581 -1.637 . . . . 75.010000000000005 106.581 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -79.78 132.61 36.19 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.016 -0.538 . . . . 73.230000000000004 110.135 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -95.79 161.94 13.81 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.695 -1.224 . . . . 74.409999999999997 107.695 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -85.22 90.9 8.01 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.843 0.83 . . . . 73.400000000000006 110.557 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -120.9 -50.24 0.27 Allowed Glycine 0 N--CA 1.422 -2.281 0 CA-C-N 114.484 -1.234 . . . . 61.310000000000002 110.875 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 73.88 -77.06 0.98 Allowed Glycine 0 N--CA 1.434 -1.478 0 O-C-N 123.879 0.399 . . . . 72.430000000000007 112.359 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -77.81 108.01 10.73 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 121.581 0.705 . . . . 75.420000000000002 111.482 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 46.4 m -104.28 94.98 5.65 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 105.568 -2.012 . . . . 75.25 105.568 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 66.3 mt -71.26 113.48 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 115.382 -0.826 . . . . 61.119999999999997 109.735 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 27.6 m -90.28 -36.91 14.43 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.185 -0.916 . . . . 71.219999999999999 109.628 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -90.32 86.41 6.48 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.087 -1.079 . . . . 60.350000000000001 108.087 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -113.89 -39.13 4.04 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.85 -1.068 . . . . 73.209999999999994 111.37 -173.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -158.6 169.66 23.91 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.123 -1.066 . . . . 75.510000000000005 108.123 -177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -67.77 -41.28 83.53 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.899 0.857 . . . . 70.400000000000006 109.108 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -98.31 -156.36 0.54 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.851 -1.537 . . . . 74.439999999999998 106.851 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -73.91 173.2 10.29 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.028 0.442 . . . . 55.329999999999998 111.519 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -107.42 144.52 29.39 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 116.361 -0.381 . . . . 33.329999999999998 110.308 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -71.97 107.39 2.21 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 122.233 1.955 . . . . 73.109999999999999 111.56 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 94.9 mt -80.32 155.23 27.34 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.876 -0.602 . . . . 62.149999999999999 111.034 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 10.1 t -95.13 14.66 21.31 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.311 1.053 . . . . 50.329999999999998 108.337 177.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 15.7 m -88.45 14.62 9.32 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 114.632 -1.167 . . . . 72.239999999999995 110.182 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.05 -49.02 71.74 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.416 -0.957 . . . . 74.319999999999993 108.416 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -84.35 110.23 18.44 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 106.495 -1.668 . . . . 72.409999999999997 106.495 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -125.35 169.48 12.28 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.796 -0.638 . . . . 73.200000000000003 110.785 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -118.06 83.3 1.98 Allowed 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.809 -0.812 . . . . 64.319999999999993 108.809 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 58.55 28.21 16.72 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.376 1.071 . . . . 62.32 110.885 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -64.43 -34.7 78.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 63.149999999999999 111.899 -174.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . 0.538 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 0.7 OUTLIER -66.58 -37.64 85.36 Favored 'General case' 0 C--O 1.203 -1.373 0 C-N-CA 120.292 -0.563 . . . . 62.130000000000003 109.905 176.291 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.616 ' O ' ' HG3' ' A' ' 631' ' ' MET . 59.0 mt -65.02 -34.33 69.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.619 -0.882 . . . . 61.409999999999997 108.619 177.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -68.21 -14.57 63.08 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.207 -0.906 . . . . 53.310000000000002 112.584 178.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 627' ' ' ARG . 8.5 pt-20 -60.97 -27.26 68.14 Favored 'General case' 0 C--N 1.362 1.147 0 CA-C-N 118.302 0.501 . . . . 75.030000000000001 111.275 -177.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.616 ' HG3' ' O ' ' A' ' 628' ' ' ILE . 0.0 OUTLIER -73.9 -7.71 53.33 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.952 -0.567 . . . . 54.350000000000001 112.23 -179.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -107.63 -0.56 34.62 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.09 -0.804 . . . . 31.329999999999998 111.09 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . 0.466 ' HG3' ' HA ' ' A' ' 630' ' ' GLU . 60.9 mtt180 -92.79 165.86 17.97 Favored Pre-proline 0 C--O 1.248 1.001 0 N-CA-C 108.704 -0.85 . . . . 65.409999999999997 108.704 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 57.4 Cg_endo -73.86 131.87 16.3 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 N-CA-C 108.345 -1.444 . . . . 65.120000000000005 108.345 166.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.3 166.3 21.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 C-N-CA 120.452 -0.499 . . . . 71.450000000000003 110.828 -177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.13 166.55 10.96 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.206 -0.598 . . . . 74.430000000000007 112.075 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -75.72 -166.96 21.73 Favored Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 115.234 -0.893 . . . . 60.219999999999999 113.584 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -68.08 -46.81 69.98 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 122.99 0.516 . . . . 74.219999999999999 110.382 -177.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -125.34 135.24 52.25 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.968 -0.753 . . . . 72.120000000000005 108.968 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . 0.457 ' HB ' ' CG1' ' A' ' 591' ' ' ILE . 34.7 p -130.99 85.75 2.3 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.551 0.691 . . . . 72.120000000000005 110.01 175.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -163.38 143.59 8.86 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.155 -0.929 . . . . 54.530000000000001 109.782 -175.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.543 HD22 HG11 ' A' ' 523' ' ' VAL . 29.6 tp -128.43 142.96 50.94 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.412 -0.958 . . . . 75.019999999999996 108.412 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -110.19 111.35 22.62 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.527 -1.286 . . . . 73.040000000000006 107.527 176.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 47.6 t -102.45 117.15 47.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.985 -0.376 . . . . 63.399999999999999 109.985 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 52.5 mt -101.87 130.87 50.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 108.626 -0.879 . . . . 63.340000000000003 108.626 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 67.5 mt -105.06 112.19 37.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.654 -0.869 . . . . 75.530000000000001 108.654 178.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -109.83 148.78 30.89 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.439 -1.319 . . . . 74.319999999999993 107.439 175.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.7 ' HA ' ' HB3' ' A' ' 516' ' ' GLU . 0.1 OUTLIER -80.87 172.1 14.16 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 118.162 0.437 . . . . 72.230000000000004 111.855 -172.429 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 64.9 m -145.85 16.58 1.42 Allowed 'General case' 0 N--CA 1.416 -2.168 0 C-N-CA 119.12 -1.032 . . . . 52.200000000000003 112.822 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -93.89 -60.62 1.71 Allowed 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 120.394 -0.522 . . . . 74.450000000000003 111.424 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -79.92 -48.44 13.43 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 107.988 -1.115 . . . . 74.019999999999996 107.988 -175.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 52.5 t80 16.13 63.96 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.566 2.347 . . . . 73.400000000000006 114.645 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 2.08 18.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 123.043 1.402 . . . . 75.120000000000005 107.742 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 52.5 p -166.9 -170.91 1.67 Allowed 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 101.131 -3.655 . . . . 61.240000000000002 101.131 174.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 18.9 m -78.64 119.89 22.53 Favored 'General case' 0 C--N 1.283 -2.306 0 C-N-CA 118.071 -1.452 . . . . 71.129999999999995 107.901 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.493 ' HA ' ' CG ' ' A' ' 648' ' ' GLU 0.381 8.8 p 71.66 -32.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 126.997 2.119 . . . . 64.209999999999994 114.647 178.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 17.5 t70 . . . . . 0 C--N 1.29 -1.979 0 O-C-N 121.732 -0.605 . . . . 74.400000000000006 110.624 178.304 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 . . . . . 0 CA--C 1.498 -1.043 0 N-CA-C 108.619 -0.882 . . . . 74.409999999999997 108.619 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.521 ' O ' ' HB ' ' A' ' 528' ' ' THR . . . -71.29 -30.59 66.44 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.036 -1.438 . . . . 64.519999999999996 111.719 -177.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 133.37 -146.63 18.53 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.023 -1.084 . . . . 75.010000000000005 111.101 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.428 HG23 ' HA3' ' A' ' 637' ' ' GLY . 4.1 mp -120.88 110.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 116.857 0.328 . . . . 75.420000000000002 111.055 -175.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.512 ' CD2' HG23 ' A' ' 528' ' ' THR . 10.0 m-85 -90.0 131.31 35.95 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.128 -1.434 . . . . 75.200000000000003 107.128 168.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . 0.411 ' HA ' HG22 ' A' ' 640' ' ' THR . 14.2 t -168.77 171.38 8.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.422 -0.584 . . . . 62.340000000000003 109.422 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -77.24 148.76 35.63 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 116.062 -0.517 . . . . 72.409999999999997 110.204 177.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -65.6 -32.1 73.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.387 0.613 . . . . 75.439999999999998 110.113 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -135.83 141.42 36.77 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 107.474 -1.306 . . . . 64.209999999999994 107.474 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.57 -28.21 10.19 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 122.425 2.084 . . . . 71.010000000000005 112.359 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 49.6 t -136.97 139.69 44.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 107.016 -1.476 . . . . 73.409999999999997 107.016 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.3 t -133.36 140.48 47.4 Favored 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 109.384 -0.599 . . . . 73.230000000000004 109.384 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -106.73 129.91 54.54 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.111 -1.07 . . . . 74.0 108.111 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.7 m -119.82 150.67 22.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 109.032 -0.729 . . . . 73.120000000000005 109.032 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.424 ' HB2' ' HB3' ' A' ' 649' ' ' SER . 9.5 t -82.76 167.57 18.02 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.762 0.792 . . . . 71.129999999999995 110.816 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -90.54 -9.24 47.94 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.419 -1.697 . . . . 73.430000000000007 106.419 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 20.5 m -121.83 24.75 9.53 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 121.175 -0.953 . . . . 63.5 110.855 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 8.2 tt -88.63 -32.89 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.999 0.428 . . . . 70.319999999999993 111.532 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . 0.42 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 89.27 -80.08 1.56 Allowed Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 110.656 -0.978 . . . . 63.409999999999997 110.656 -176.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.1 mm -124.56 123.74 66.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.533 -0.914 . . . . 72.129999999999995 108.533 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -101.69 149.36 24.22 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 108.705 -0.85 . . . . 63.539999999999999 108.705 177.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 31.1 mt-10 -133.41 130.1 38.25 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 123.611 0.765 . . . . 75.340000000000003 110.242 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.585 HG11 HD22 ' A' ' 642' ' ' LEU . 38.8 t -113.9 126.35 71.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 108.265 -1.013 . . . . 75.530000000000001 108.265 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -77.84 131.16 37.43 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 124.053 0.846 . . . . 45.119999999999997 110.077 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 568' ' ' VAL . 46.0 t -110.46 125.44 67.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.266 -0.642 . . . . 75.329999999999998 109.266 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.7 mt -78.28 129.3 34.89 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.344 -0.844 . . . . 75.239999999999995 111.861 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 567' ' ' ILE . 15.6 tpt180 -76.58 153.01 35.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.716 -1.129 . . . . 52.229999999999997 108.853 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 502' ' ' ALA . 5.5 p -59.28 146.2 40.34 Favored 'General case' 0 N--CA 1.426 -1.663 0 O-C-N 123.784 0.678 . . . . 65.230000000000004 111.813 176.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 28.1 t -55.6 -28.62 56.16 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.254 1.022 . . . . 74.349999999999994 110.285 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -112.66 99.13 1.01 Allowed Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 109.037 -1.625 . . . . 50.409999999999997 109.037 172.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.97 100.98 12.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.737 -0.838 . . . . 61.039999999999999 108.737 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -120.29 116.38 25.45 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.731 -0.668 . . . . 73.430000000000007 110.054 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 68.83 -169.54 41.95 Favored Glycine 0 N--CA 1.445 -0.744 0 O-C-N 123.95 0.781 . . . . 73.0 114.399 173.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -92.51 124.21 36.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 123.249 0.62 . . . . 72.549999999999997 109.749 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 57.7 t -132.5 133.68 59.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.734 -0.839 . . . . 64.120000000000005 108.734 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' ' 561' ' ' GLU . 42.4 mm -107.13 132.4 54.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 109.996 -0.372 . . . . 71.420000000000002 109.996 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 594' ' ' PRO . 41.2 t -121.12 110.21 34.77 Favored Pre-proline 0 N--CA 1.439 -1.01 0 N-CA-C 109.688 -0.486 . . . . 53.32 109.688 178.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 57.1 Cg_endo -75.03 158.57 42.02 Favored 'Trans proline' 0 C--N 1.334 -0.227 0 C-N-CA 122.505 2.137 . . . . 74.439999999999998 112.441 178.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.487 ' HB3' HG22 ' A' ' 591' ' ' ILE . 53.1 p90 -150.32 162.91 39.61 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.648 0.261 . . . . 73.510000000000005 110.557 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -155.33 150.32 26.69 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.605 -0.725 . . . . 75.099999999999994 110.092 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 15.0 p -83.45 134.65 34.85 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.175 -0.676 . . . . 75.129999999999995 109.175 173.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 87.1 mt -105.14 118.87 53.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.152 -1.055 . . . . 44.240000000000002 108.152 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -75.45 138.05 41.38 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 123.405 0.441 . . . . 75.239999999999995 110.029 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -138.72 -103.59 0.6 Allowed Glycine 0 CA--C 1.502 -0.757 0 N-CA-C 110.675 -0.97 . . . . 54.310000000000002 110.675 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 25.0 p -90.27 -9.06 49.32 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.88 0.848 . . . . 73.120000000000005 109.16 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -112.32 136.56 51.63 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 106.757 -1.571 . . . . 73.019999999999996 106.757 173.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 10.8 mtm-85 -108.0 149.9 27.8 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.265 0.839 . . . . 75.019999999999996 113.265 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -90.66 -147.25 18.25 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 114.71 -1.132 . . . . 73.140000000000001 111.048 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 63.54 28.33 72.28 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 111.858 -0.497 . . . . 73.030000000000001 111.858 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 71.97 24.99 75.77 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 121.61 -0.328 . . . . 74.150000000000006 112.422 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -89.92 -77.53 0.39 Allowed 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 117.508 0.654 . . . . 64.340000000000003 110.879 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -96.14 -34.67 11.6 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 108.218 -1.03 . . . . 65.5 108.218 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -144.24 159.11 43.23 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 108.254 -1.017 . . . . 74.319999999999993 108.254 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -89.1 112.24 23.17 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 104.983 -2.228 . . . . 71.230000000000004 104.983 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.0 129.47 35.32 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.545 0.688 . . . . 74.329999999999998 110.417 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 15.0 t -129.37 161.2 30.85 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 115.546 -0.752 . . . . 62.009999999999998 110.563 -171.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.6 p -151.99 161.93 41.87 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.392 -1.336 . . . . 71.219999999999999 107.392 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 165.01 -167.47 38.71 Favored Glycine 0 N--CA 1.419 -2.442 0 C-N-CA 120.103 -1.046 . . . . 54.299999999999997 110.579 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 538' ' ' PRO . 27.1 mt-10 -130.86 137.59 49.44 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 123.136 0.574 . . . . 73.109999999999999 109.614 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 569' ' ' LYS . 94.6 mt -102.87 133.63 47.63 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.205 -0.665 . . . . 71.340000000000003 109.205 178.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.437 ' HA ' HD13 ' A' ' 536' ' ' ILE . 34.3 tt0 -96.74 119.26 34.89 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.912 -0.585 . . . . 72.430000000000007 110.801 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -116.04 148.4 40.23 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.622 -0.881 . . . . 53.119999999999997 108.622 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.483 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 46.0 mt-30 -141.77 -172.32 3.53 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.098 -1.075 . . . . 73.420000000000002 108.098 -178.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -80.08 -28.17 39.17 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.559 -0.904 . . . . 73.239999999999995 108.559 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -84.24 -32.87 24.23 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.242 -0.89 . . . . 53.420000000000002 111.021 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.483 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 40.5 mm-40 -79.5 143.49 34.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.773 0.321 . . . . 73.120000000000005 111.38 177.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.572 ' O ' ' HB2' ' A' ' 527' ' ' ARG . 3.9 pt -112.0 -77.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 113.029 0.751 . . . . 71.120000000000005 113.029 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.551 ' H ' HG13 ' A' ' 567' ' ' ILE . 13.1 p -113.38 144.37 21.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.913 0.863 . . . . 75.409999999999997 112.171 -174.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.499 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -120.86 169.69 10.2 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.378 -0.828 . . . . 34.200000000000003 109.251 173.28 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.4 p -135.62 146.87 48.34 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 123.591 0.557 . . . . 71.129999999999995 112.443 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.2 mp -95.29 119.32 43.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.041 -1.466 . . . . 63.439999999999998 107.041 170.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 521' ' ' MET . 26.4 m -98.75 116.09 30.2 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.432 -0.581 . . . . 72.439999999999998 109.432 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.468 HG23 HG22 ' A' ' 571' ' ' ILE . 89.3 t -121.6 131.45 73.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 N-CA-C 109.92 -0.4 . . . . 71.409999999999997 109.92 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.42 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 23.4 tptm -85.83 115.6 23.57 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.974 -0.75 . . . . 75.030000000000001 108.974 176.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 36.4 t -86.62 125.31 40.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.15 -1.426 . . . . 51.140000000000001 107.15 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 35.8 mm -84.21 152.39 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 108.518 -0.919 . . . . 54.539999999999999 108.518 -175.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -59.31 130.19 45.74 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 123.812 0.695 . . . . 75.329999999999998 110.017 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -39.5 115.29 0.49 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 116.304 1.964 . . . . 63.109999999999999 116.304 -171.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -80.29 143.46 33.62 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.98 -1.009 . . . . 71.230000000000004 110.113 171.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.62 -10.02 56.52 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 115.298 1.592 . . . . 73.140000000000001 115.298 -169.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -64.33 -65.3 0.7 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 118.049 0.386 . . . . 41.009999999999998 111.851 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.461 ' HB2' ' HD3' ' A' ' 585' ' ' LYS . 62.1 mm-40 -114.2 144.11 43.74 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.94 -1.133 . . . . 73.540000000000006 107.94 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -88.41 -66.14 0.95 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.331 -0.988 . . . . 53.240000000000002 108.331 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -101.16 132.02 46.84 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 107.03 -1.47 . . . . 60.509999999999998 107.03 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.461 ' HD3' ' HB2' ' A' ' 582' ' ' GLU . 13.5 pttt -151.21 163.29 39.2 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 115.151 -0.931 . . . . 70.030000000000001 108.829 -169.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.7 t -144.29 150.07 37.28 Favored 'General case' 0 C--N 1.279 -2.457 0 C-N-CA 119.641 -0.824 . . . . 64.439999999999998 112.243 -175.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 45.4 p90 -133.59 166.79 21.78 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 106.317 -1.735 . . . . 64.519999999999996 106.317 175.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.444 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 89.1 m-85 -115.54 159.4 21.29 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 120.115 -0.634 . . . . 75.049999999999997 109.832 -175.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.09 124.71 42.46 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 106.227 -1.768 . . . . 73.299999999999997 106.227 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -122.65 129.68 52.11 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 120.961 0.41 . . . . 73.5 110.071 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.487 HG22 ' HB3' ' A' ' 539' ' ' TYR . 25.2 pt -100.23 143.83 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 107.868 -1.16 . . . . 54.520000000000003 107.868 175.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -84.88 -177.31 51.01 Favored Glycine 0 N--CA 1.42 -2.378 0 N-CA-C 111.338 -0.705 . . . . 64.430000000000007 111.338 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -78.31 129.17 75.86 Favored Pre-proline 0 N--CA 1.416 -2.13 0 CA-C-O 120.889 0.376 . . . . 60.520000000000003 110.525 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.497 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.0 Cg_endo -59.56 127.74 24.75 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.615 2.877 . . . . 74.299999999999997 112.309 -175.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -106.26 131.98 52.85 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.378 -0.601 . . . . 64.109999999999999 109.378 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -73.75 134.54 43.48 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 105.034 -2.21 . . . . 73.049999999999997 105.034 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 19.2 t -82.57 71.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.287 1.041 . . . . 73.219999999999999 108.842 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.78 164.71 21.5 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.432 -1.258 . . . . 74.420000000000002 107.667 -176.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -110.63 -23.29 11.17 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 120.81 0.338 . . . . 74.519999999999996 111.233 -174.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 11.5 m -98.3 139.17 34.47 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.999 0.428 . . . . 65.230000000000004 111.459 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . 0.429 ' HB2' ' HE2' ' A' ' 603' ' ' LYS . 46.2 mt-10 -95.52 145.23 25.36 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.597 -1.631 . . . . 72.049999999999997 106.597 171.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -78.81 113.39 16.86 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.665 -0.814 . . . . 73.319999999999993 109.867 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . 0.429 ' HE2' ' HB2' ' A' ' 601' ' ' GLU . 75.3 mmtt -117.49 23.81 11.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.759 -0.655 . . . . 74.239999999999995 111.054 -175.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -80.68 2.24 79.87 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.985 -0.626 . . . . 73.530000000000001 111.8 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -85.14 66.93 3.75 Favored Glycine 0 N--CA 1.425 -2.065 0 N-CA-C 112.335 -0.306 . . . . 53.539999999999999 112.335 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -77.55 153.78 33.02 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.602 -1.259 . . . . 72.129999999999995 107.602 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 9.0 t -67.31 107.6 2.45 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 122.044 0.926 . . . . 73.109999999999999 109.65 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . 0.416 ' O ' HG12 ' A' ' 608' ' ' ILE . 11.2 tt -140.31 10.01 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.424 -0.807 . . . . 74.239999999999995 110.566 -173.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 28.5 m -66.85 128.87 37.94 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.276 -0.638 . . . . 71.340000000000003 109.276 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -126.42 -170.53 2.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.438 -0.346 . . . . 63.340000000000003 110.567 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -63.27 128.78 37.43 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.768 -0.651 . . . . 73.049999999999997 111.726 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -87.23 -35.6 18.44 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 105.099 -2.186 . . . . 73.430000000000007 105.099 171.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 35.0 t70 41.02 90.47 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 126.752 2.021 . . . . 64.150000000000006 114.531 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 36.6 t70 172.56 -50.29 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 106.212 -1.773 . . . . 72.409999999999997 106.212 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -173.13 105.82 0.14 Allowed 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 105.646 -1.983 . . . . 70.340000000000003 105.646 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -67.71 130.64 92.97 Favored Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 120.363 -0.535 . . . . 73.450000000000003 109.786 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . 0.422 ' HB2' ' O ' ' A' ' 619' ' ' THR . 55.3 Cg_endo -69.18 114.39 3.59 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.493 2.129 . . . . 71.340000000000003 114.039 -174.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.23 -41.09 90.54 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.793 -0.817 . . . . 73.349999999999994 108.793 174.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 617' ' ' PRO . 10.3 t -87.3 122.06 30.57 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 105.346 -2.094 . . . . 73.25 105.346 172.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 7.9 t -80.23 175.54 10.55 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-O 122.613 1.197 . . . . 61.130000000000003 113.169 -166.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . 0.634 ' HD2' ' O ' ' A' ' 621' ' ' LYS . 0.1 OUTLIER -119.75 162.8 18.44 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 113.177 -1.828 . . . . 74.450000000000003 109.574 -173.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -118.65 102.98 9.27 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.718 -1.215 . . . . 62.140000000000001 107.718 173.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.45 ' HG2' ' OE2' ' A' ' 624' ' ' GLU 0.254 1.0 OUTLIER -75.32 -18.95 59.9 Favored 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 120.145 -0.622 . . . . 64.400000000000006 112.335 179.424 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . 0.45 ' OE2' ' HG2' ' A' ' 623' ' ' GLU . 9.6 mp0 -110.69 89.71 3.12 Favored 'General case' 0 C--O 1.248 0.979 0 N-CA-C 106.314 -1.735 . . . . 75.349999999999994 106.314 168.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.86 126.75 30.75 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.925 -0.58 . . . . 74.030000000000001 111.002 -175.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 19.4 tpp180 -56.82 -36.72 70.27 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.623 1.169 . . . . 75.310000000000002 111.006 -178.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . 0.433 ' HA ' ' OE1' ' A' ' 630' ' ' GLU . 2.7 tmt_? -57.65 -26.89 62.28 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.679 0.792 . . . . 54.43 111.816 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.482 ' O ' ' HG2' ' A' ' 631' ' ' MET . 69.8 mt -65.74 -27.37 41.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.548 0.69 . . . . 65.239999999999995 110.445 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -85.89 -22.88 27.28 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.291 0.567 . . . . 72.140000000000001 109.737 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 633' ' ' ARG . 45.0 mt-10 -81.83 -15.42 54.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.376 -0.829 . . . . 75.25 111.728 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 26.9 ptt? -76.27 -16.89 59.7 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.299 -0.63 . . . . 71.109999999999999 109.299 176.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -110.37 37.31 3.81 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.461 -1.055 . . . . 72.540000000000006 110.461 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . 0.468 ' HD3' ' HA ' ' A' ' 630' ' ' GLU . 63.3 mtp180 -125.81 155.16 73.19 Favored Pre-proline 0 N--CA 1.425 -1.688 0 C-N-CA 123.033 0.533 . . . . 72.549999999999997 109.636 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.497 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 21.3 Cg_endo -66.26 137.71 48.57 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 C-N-CA 122.064 1.843 . . . . 75.010000000000005 108.096 169.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.41 167.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 120.361 -0.535 . . . . 72.349999999999994 111.287 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.487 ' HB2' HG21 ' A' ' 640' ' ' THR . 1.0 OUTLIER -104.87 175.57 5.45 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.013 -0.539 . . . . 64.209999999999994 112.357 -177.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.428 ' HA3' HG23 ' A' ' 504' ' ' ILE . . . -74.18 -176.92 35.94 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.699 -0.682 . . . . 74.109999999999999 112.405 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.4 -39.94 77.66 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.985 0.422 . . . . 74.400000000000006 110.217 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -112.87 121.49 44.84 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.89 -0.595 . . . . 74.239999999999995 110.62 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . 0.487 HG21 ' HB2' ' A' ' 636' ' ' LEU . 19.6 p -134.75 81.32 1.9 Allowed 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 122.149 0.976 . . . . 62.509999999999998 110.895 174.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -163.14 150.97 13.4 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.477 -1.305 . . . . 72.340000000000003 107.477 -175.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.585 HD22 HG11 ' A' ' 523' ' ' VAL . 27.8 tp -133.69 139.85 46.67 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 108.334 -0.988 . . . . 63.119999999999997 108.334 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -105.84 114.5 28.68 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.079 -1.452 . . . . 72.239999999999995 107.079 174.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 41.1 t -103.49 110.03 28.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 109.12 -0.696 . . . . 71.109999999999999 109.12 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 47.2 mt -96.65 120.8 46.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 109.413 -0.588 . . . . 53.399999999999999 109.413 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 63.4 mt -97.2 113.99 33.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 107.631 -1.248 . . . . 71.430000000000007 107.631 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -147.32 -179.5 6.89 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 105.248 -2.13 . . . . 74.319999999999993 105.248 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -83.56 135.62 34.56 Favored 'General case' 0 C--N 1.289 -2.054 0 C-N-CA 117.093 -1.843 . . . . 73.329999999999998 110.45 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 515' ' ' SER . 8.3 t -114.5 23.79 12.45 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.391 -2.077 . . . . 44.409999999999997 105.391 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -63.33 -53.59 50.36 Favored 'General case' 0 N--CA 1.387 -3.578 0 C-N-CA 126.633 1.973 . . . . 64.340000000000003 110.697 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.46 -34.25 41.68 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.388 -0.925 . . . . 75.319999999999993 112.301 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -126.83 132.01 51.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.779 -0.452 . . . . 74.340000000000003 109.779 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -91.61 -25.21 19.29 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.302 0.572 . . . . 71.510000000000005 110.407 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 25.4 m -133.12 141.93 48.42 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.422 -0.585 . . . . 71.010000000000005 109.422 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 12.3 m -78.67 138.0 38.08 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.0 -0.741 . . . . 74.25 109.0 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 56.5 t -77.32 -38.03 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 107.998 -1.112 . . . . 64.510000000000005 107.998 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--N 1.311 -1.102 0 CA-C-N 114.799 -1.091 . . . . 64.409999999999997 111.068 176.783 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.581 ' N ' ' HA2' ' A' ' 632' ' ' GLY . 43.3 t60 . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 109.903 -0.406 . . . . 63.450000000000003 109.903 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -93.59 -68.23 0.81 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.715 -0.476 . . . . 75.230000000000004 109.715 175.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.44 ' C ' HG22 ' A' ' 528' ' ' THR . . . -178.12 -166.37 34.41 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.814 -0.914 . . . . 65.420000000000002 110.814 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.5 mp -112.6 128.81 69.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 123.521 0.729 . . . . 62.229999999999997 110.928 -173.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.575 ' CE2' HG23 ' A' ' 528' ' ' THR . 41.7 m-85 -102.13 139.75 37.34 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.725 -0.472 . . . . 72.140000000000001 109.725 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.0 t -169.89 175.99 4.95 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.056 -1.09 . . . . 74.450000000000003 108.056 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -80.96 154.92 26.69 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 117.988 0.358 . . . . 74.010000000000005 110.734 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.92 -41.8 77.69 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.852 -0.613 . . . . 51.32 109.5 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -121.93 146.48 46.27 Favored Pre-proline 0 N--CA 1.417 -2.081 0 N-CA-C 108.376 -0.972 . . . . 74.549999999999997 108.376 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -77.63 -23.51 9.68 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.547 1.498 . . . . 73.530000000000001 111.249 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.0 t -141.01 132.92 29.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 107.764 -1.199 . . . . 53.130000000000003 107.764 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.7 t -126.46 139.73 53.02 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.633 -0.877 . . . . 72.439999999999998 108.633 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -108.24 118.03 35.71 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.228 -1.027 . . . . 71.420000000000002 108.228 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.64 153.94 17.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 121.138 0.494 . . . . 75.439999999999998 110.156 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.565 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 65.3 m -79.49 152.91 29.96 Favored 'General case' 0 N--CA 1.42 -1.928 0 C-N-CA 124.391 1.076 . . . . 52.409999999999997 111.133 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.595 ' HB3' ' HA ' ' A' ' 648' ' ' GLU . 15.6 pt-20 -63.14 -49.89 72.61 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 120.954 0.407 . . . . 73.109999999999999 111.167 177.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . 0.495 ' N ' ' HG3' ' A' ' 516' ' ' GLU . 52.5 m -109.34 69.21 0.7 Allowed 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.962 0.887 . . . . 41.119999999999997 110.108 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 13.3 tt -110.64 -27.24 2.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.058 -0.973 . . . . 73.329999999999998 110.836 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 90.63 -70.76 2.1 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.561 -0.828 . . . . 34.030000000000001 111.55 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.9 mm -135.42 125.07 42.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.049 -0.723 . . . . 63.020000000000003 109.049 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.517 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -108.09 150.06 27.67 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.898 -1.149 . . . . 74.299999999999997 107.898 176.436 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 29.8 mt-10 -129.56 121.75 27.78 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.588 0.708 . . . . 61.539999999999999 112.767 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.651 HG11 HD22 ' A' ' 642' ' ' LEU . 99.4 t -110.06 131.43 61.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.101 -0.954 . . . . 74.230000000000004 109.086 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -89.97 136.44 33.04 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.678 0.751 . . . . 72.219999999999999 111.931 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 47.3 t -105.54 124.53 60.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 114.649 -1.16 . . . . 63.549999999999997 108.109 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.4 mt -70.74 127.21 31.89 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 123.759 0.662 . . . . 71.109999999999999 110.703 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.405 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 43.4 ttp180 -74.7 162.55 28.61 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.426 -1.261 . . . . 72.430000000000007 110.346 -177.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.575 HG23 ' CE2' ' A' ' 505' ' ' PHE . 1.0 OUTLIER -55.83 139.05 46.92 Favored 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 124.892 1.277 . . . . 73.340000000000003 111.852 177.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 4.0 m -51.5 -37.8 50.91 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 125.434 1.494 . . . . 74.349999999999994 110.188 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -124.8 96.2 0.51 Allowed Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 108.701 -1.76 . . . . 53.350000000000001 108.701 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.18 107.95 17.48 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.945 -0.761 . . . . 73.109999999999999 108.945 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -124.51 108.09 11.75 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.034 -0.53 . . . . 54.109999999999999 109.898 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 89.69 -132.0 11.03 Favored Glycine 0 C--N 1.312 -0.761 0 C-N-CA 120.36 -0.924 . . . . 73.329999999999998 112.665 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -133.39 131.68 40.31 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 123.212 0.605 . . . . 74.299999999999997 109.492 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.0 t -132.55 143.72 38.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 123.631 0.772 . . . . 74.019999999999996 109.313 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.585 HG12 ' CG2' ' A' ' 597' ' ' VAL . 33.8 mm -112.56 132.1 62.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.891 -0.781 . . . . 73.319999999999993 108.891 173.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 25.7 t -120.67 110.3 35.45 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 109.019 -0.734 . . . . 75.129999999999995 109.019 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -74.7 158.38 43.38 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.221 1.947 . . . . 44.43 111.578 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.495 ' HB3' HG22 ' A' ' 591' ' ' ILE . 54.5 p90 -146.34 170.22 17.24 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 122.202 -0.311 . . . . 64.140000000000001 111.173 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -158.17 150.92 22.49 Favored 'General case' 0 C--O 1.245 0.822 0 O-C-N 123.614 0.571 . . . . 63.32 110.874 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.0 p -90.5 131.55 36.18 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.897 -0.592 . . . . 75.420000000000002 109.746 172.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.59 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 91.5 mt -105.08 116.14 48.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 109.169 -0.678 . . . . 74.230000000000004 109.169 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -75.66 103.35 5.73 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.54 -0.911 . . . . 75.019999999999996 108.54 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -113.8 -83.71 1.22 Allowed Glycine 0 CA--C 1.481 -2.086 0 C-N-CA 119.442 -1.361 . . . . 74.099999999999994 112.188 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.3 m -109.98 32.53 5.03 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 108.652 -0.869 . . . . 75.430000000000007 108.652 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -158.23 149.0 20.59 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.093 -0.958 . . . . 63.130000000000003 108.894 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 26.8 mtm180 -81.28 116.99 21.41 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.569 0.7 . . . . 74.150000000000006 112.522 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.29 -167.18 42.6 Favored Glycine 0 N--CA 1.437 -1.248 0 CA-C-N 115.27 -0.877 . . . . 64.329999999999998 111.515 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.7 20.01 79.76 Favored Glycine 0 C--N 1.312 -0.805 0 C-N-CA 120.805 -0.712 . . . . 54.210000000000001 111.841 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.0 43.95 6.93 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 120.45 -0.881 . . . . 70.510000000000005 111.959 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -118.0 -61.24 1.71 Allowed 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 119.453 -0.899 . . . . 43.32 109.961 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -99.36 -34.81 10.15 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 107.073 -1.454 . . . . 54.210000000000001 107.073 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -143.29 152.04 41.21 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.847 -1.168 . . . . 75.349999999999994 107.847 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -84.89 142.06 29.97 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.677 -1.231 . . . . 74.510000000000005 107.677 177.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -82.11 139.2 34.53 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.723 -0.843 . . . . 75.200000000000003 108.723 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.1 t -148.02 152.47 37.49 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.569 0.699 . . . . 62.310000000000002 110.458 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 25.6 p -156.11 169.48 24.4 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.964 -1.495 . . . . 73.540000000000006 106.964 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 159.75 -164.84 34.35 Favored Glycine 0 N--CA 1.419 -2.473 0 N-CA-C 110.106 -1.198 . . . . 53.409999999999997 110.106 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.443 ' HB3' HG23 ' A' ' 536' ' ' ILE . 43.4 mt-10 -131.75 130.65 42.17 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 123.845 0.379 . . . . 72.219999999999999 110.627 -176.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 569' ' ' LYS . 86.4 mt -100.12 132.79 45.28 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.377 -0.601 . . . . 52.509999999999998 109.377 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.428 ' HA ' HD13 ' A' ' 536' ' ' ILE . 34.1 tt0 -99.17 121.01 40.45 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.648 -0.705 . . . . 74.109999999999999 110.708 -177.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -118.36 151.96 36.74 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.185 -0.672 . . . . 75.510000000000005 109.185 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.64 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 50.5 mt-30 -149.51 -177.49 5.89 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.054 -0.721 . . . . 74.310000000000002 109.054 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -70.68 -37.65 73.66 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.06 -1.459 . . . . 62.409999999999997 107.06 171.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.66 -48.43 16.81 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.361 -1.29 . . . . 63.219999999999999 111.881 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.64 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 27.9 mm-40 -58.99 133.55 56.19 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 123.829 0.852 . . . . 72.219999999999999 111.392 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.606 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.1 pt -85.14 -81.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 112.723 0.638 . . . . 24.420000000000002 112.723 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.606 ' H ' HG13 ' A' ' 567' ' ' ILE . 7.6 p -134.44 160.96 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 108.907 -0.775 . . . . 71.219999999999999 108.907 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.528 ' HB3' HD22 ' A' ' 560' ' ' LEU . 0.0 OUTLIER -126.6 159.6 33.07 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.767 0.317 . . . . 63.420000000000002 110.299 176.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.1 p -127.95 148.86 50.52 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.118 -0.946 . . . . 65.109999999999999 112.007 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.3 mp -99.32 127.94 51.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 106.7 -1.593 . . . . 71.450000000000003 106.7 172.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 17.0 m -100.96 115.13 29.73 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.693 -0.855 . . . . 71.319999999999993 108.693 178.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 96.9 t -117.51 130.0 73.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 120.7 -0.4 . . . . 75.5 110.659 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 16.2 tppt? -79.13 120.76 24.12 Favored 'General case' 0 N--CA 1.437 -1.102 0 O-C-N 124.037 0.835 . . . . 74.319999999999993 109.282 175.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 55.7 t -94.32 128.12 45.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 107.284 -1.376 . . . . 51.119999999999997 107.284 176.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 24.5 mm -94.66 138.35 20.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 109.334 -0.617 . . . . 72.5 109.334 -175.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -91.25 83.28 5.49 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.963 -0.562 . . . . 74.230000000000004 111.509 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -96.11 102.76 14.59 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.895 -1.52 . . . . 53.409999999999997 106.895 172.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.19 81.23 6.49 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.757 0.789 . . . . 72.319999999999993 111.389 -174.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -140.65 123.23 16.12 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.379 -1.282 . . . . 74.109999999999999 108.03 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -75.16 109.69 8.86 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 122.066 0.936 . . . . 65.019999999999996 110.357 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.603 ' OE2' ' HE2' ' A' ' 585' ' ' LYS . 37.9 tt0 -140.14 -174.06 3.83 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 104.446 -2.428 . . . . 74.430000000000007 104.446 -176.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.489 ' H ' ' HG2' ' A' ' 582' ' ' GLU . 41.0 ttmt -67.65 147.83 52.17 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.272 -0.64 . . . . 72.019999999999996 109.272 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -46.8 124.32 6.05 Favored 'General case' 0 C--O 1.247 0.931 0 O-C-N 124.52 1.137 . . . . 63.520000000000003 109.354 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.603 ' HE2' ' OE2' ' A' ' 582' ' ' GLU . 32.9 mmtp -86.83 134.88 33.51 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 114.459 -1.246 . . . . 54.420000000000002 110.6 -167.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 7.5 t -152.88 135.07 14.92 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-O 121.375 0.607 . . . . 72.150000000000006 110.933 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 42.8 p90 -126.84 174.17 9.0 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.57 -1.27 . . . . 73.510000000000005 107.57 178.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.59 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 59.0 m-85 -119.83 151.6 38.6 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 109.267 -0.642 . . . . 72.549999999999997 109.267 -176.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.81 130.82 54.13 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 105.083 -2.191 . . . . 74.510000000000005 105.083 176.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' A' ' 542' ' ' ILE . 34.1 tt0 -132.25 144.3 50.52 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.075 -0.713 . . . . 74.120000000000005 109.075 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.495 HG22 ' HB3' ' A' ' 539' ' ' TYR . 13.0 pt -107.43 155.24 8.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.069 -0.715 . . . . 75.439999999999998 109.069 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -100.25 -174.68 30.13 Favored Glycine 0 C--N 1.295 -1.721 0 C-N-CA 121.055 -0.593 . . . . 22.34 112.035 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.408 ' OE1' ' HD2' ' A' ' 594' ' ' PRO . 2.9 mm-40 -61.91 126.96 88.42 Favored Pre-proline 0 C--N 1.313 -0.992 0 C-N-CA 123.198 0.599 . . . . 71.200000000000003 112.1 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.408 ' HD2' ' OE1' ' A' ' 593' ' ' GLU . 21.8 Cg_endo -70.0 118.67 5.82 Favored 'Trans proline' 0 N--CA 1.428 -2.351 0 C-N-CA 122.175 1.917 . . . . 73.430000000000007 110.311 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -104.3 119.56 39.24 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.15 -0.932 . . . . 74.140000000000001 109.328 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.8 129.27 40.2 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.922 -1.14 . . . . 72.109999999999999 107.922 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.585 ' CG2' HG12 ' A' ' 536' ' ' ILE . 45.0 t -85.81 94.85 4.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 108.82 -0.808 . . . . 64.349999999999994 108.82 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -89.54 123.99 34.13 Favored 'General case' 0 N--CA 1.402 -2.846 0 N-CA-C 106.774 -1.565 . . . . 63.200000000000003 106.774 174.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 48.0 ttm -76.72 -17.09 59.29 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.393 0.616 . . . . 75.510000000000005 109.613 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 47.7 t -75.72 -10.21 59.25 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.433 -0.803 . . . . 53.219999999999999 110.408 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.85 113.65 2.16 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 107.497 -1.297 . . . . 75.209999999999994 107.497 176.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -101.02 131.08 47.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.395 0.617 . . . . 72.209999999999994 112.326 -170.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.93 175.44 9.58 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.409 -1.33 . . . . 75.329999999999998 107.409 171.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 169.85 -158.62 30.87 Favored Glycine 0 N--CA 1.421 -2.345 0 C-N-CA 120.124 -1.036 . . . . 73.299999999999997 111.307 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -155.26 59.25 0.38 Allowed Glycine 0 N--CA 1.425 -2.095 0 N-CA-C 110.514 -1.034 . . . . 73.530000000000001 110.514 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -76.08 167.29 22.14 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-O 120.604 0.24 . . . . 63.310000000000002 110.609 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . 0.425 ' HA ' ' OE1' ' A' ' 610' ' ' GLU . 89.9 m -74.23 78.97 1.8 Allowed 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 122.457 1.122 . . . . 72.310000000000002 110.941 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 68.0 mt -137.45 99.31 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 106.986 -1.487 . . . . 63.439999999999998 106.986 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 5.8 m 68.08 21.94 8.55 Favored 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 121.653 0.74 . . . . 74.549999999999997 111.646 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . 0.425 ' OE1' ' HA ' ' A' ' 607' ' ' THR . 9.3 pt-20 -83.29 -5.93 59.3 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.331 -0.989 . . . . 74.420000000000002 108.331 175.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -67.01 97.61 0.51 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.768 1.627 . . . . 71.129999999999995 107.886 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . 0.265 54.9 m-85 70.31 69.89 0.21 Allowed 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.154 1.382 . . . . 74.329999999999998 112.242 -173.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -174.95 138.1 0.45 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 105.582 -2.007 . . . . 74.299999999999997 105.582 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -114.47 -31.4 6.24 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 114.211 1.189 . . . . 75.319999999999993 114.211 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -89.12 -66.52 0.91 Allowed 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 118.97 -1.092 . . . . 72.209999999999994 113.163 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -139.32 122.26 10.54 Favored Pre-proline 0 C--N 1.296 -1.724 0 C-N-CA 120.738 -0.385 . . . . 72.209999999999994 110.625 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.04 153.41 67.67 Favored 'Trans proline' 0 C--O 1.25 1.098 0 C-N-CA 122.095 1.863 . . . . 74.209999999999994 111.361 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 76.4 mt -68.27 90.14 0.34 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 122.01 0.909 . . . . 75.439999999999998 110.899 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 25.9 m -142.79 98.17 3.24 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 107.119 -1.437 . . . . 75.319999999999993 107.119 175.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 21.8 t -91.96 152.8 19.85 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.293 -1.002 . . . . 75.450000000000003 108.293 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -75.24 103.67 5.49 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.427 0.632 . . . . 65.510000000000005 110.661 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -112.28 157.19 21.24 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.328 -1.36 . . . . 72.239999999999995 107.328 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 63.6 41.8 6.95 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.797 0.686 . . . . 72.209999999999994 111.287 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -74.03 -173.89 1.73 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.326 -0.852 . . . . 65.420000000000002 110.915 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.401 ' HB2' HD12 ' A' ' 628' ' ' ILE . 8.6 pt-20 -134.81 34.74 3.14 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.747 0.784 . . . . 72.030000000000001 110.725 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -63.71 -41.61 98.08 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.035 -0.984 . . . . 71.340000000000003 108.644 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -64.68 -25.04 67.77 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.137 -0.938 . . . . 75.530000000000001 111.446 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.598 ' O ' ' HG3' ' A' ' 631' ' ' MET . 54.3 mt -74.86 -37.17 41.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 108.688 -0.856 . . . . 70.329999999999998 108.688 175.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -70.7 -25.66 63.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.081 -0.509 . . . . 72.409999999999997 110.679 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -55.72 -24.06 32.56 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.108 1.151 . . . . 50.25 114.108 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.598 ' HG3' ' O ' ' A' ' 628' ' ' ILE . 0.0 OUTLIER -75.15 -11.19 60.03 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.281 -0.568 . . . . 74.120000000000005 112.189 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . 0.581 ' HA2' ' N ' ' A' ' 501' ' ' HIS . . . -165.45 56.36 0.26 Allowed Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 111.102 -0.799 . . . . 72.329999999999998 111.102 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -89.82 148.18 39.22 Favored Pre-proline 0 C--O 1.245 0.841 0 C-N-CA 120.323 -0.551 . . . . 75.109999999999999 111.469 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.527 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 43.6 Cg_endo -71.35 133.73 23.27 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.62 2.213 . . . . 64.200000000000003 108.934 172.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.03 161.17 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 109.686 -0.487 . . . . 74.530000000000001 109.686 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.512 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.6 OUTLIER -101.33 165.95 11.0 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 119.72 -0.792 . . . . 74.349999999999994 111.175 176.323 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.85 -172.19 29.23 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 115.654 -0.703 . . . . 53.100000000000001 114.645 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -67.93 -41.66 82.21 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.371 -0.915 . . . . 72.519999999999996 109.392 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -125.99 127.47 45.96 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.279 -0.873 . . . . 72.549999999999997 109.132 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . 0.512 HG21 ' HB2' ' A' ' 636' ' ' LEU . 16.8 p -130.27 89.93 2.86 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.429 -0.582 . . . . 74.409999999999997 109.429 175.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -170.37 139.09 1.64 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.444 -0.798 . . . . 73.040000000000006 109.468 -175.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.651 HD22 HG11 ' A' ' 523' ' ' VAL . 28.0 tp -120.41 131.0 54.6 Favored 'General case' 0 C--N 1.273 -2.725 0 CA-C-N 114.985 -1.007 . . . . 64.439999999999998 109.06 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -93.87 110.8 22.44 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.52 -1.659 . . . . 71.409999999999997 106.52 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 43.7 t -101.6 110.37 28.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.914 -0.773 . . . . 74.219999999999999 108.914 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 67.1 mt -97.95 124.22 50.86 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 N-CA-C 108.819 -0.808 . . . . 74.400000000000006 108.819 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 54.2 mt -100.2 103.36 14.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 106.876 -1.527 . . . . 61.340000000000003 106.876 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -100.44 129.26 46.38 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.885 -0.598 . . . . 73.209999999999994 109.545 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.595 ' HA ' ' HB3' ' A' ' 516' ' ' GLU . 0.0 OUTLIER -68.92 117.8 11.04 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-O 122.016 0.912 . . . . 61.450000000000003 109.374 174.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 25.9 m -134.7 99.5 4.34 Favored 'General case' 0 N--CA 1.404 -2.731 0 CA-C-N 114.676 -1.147 . . . . 70.120000000000005 108.874 -168.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -91.99 -33.72 14.73 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.14 -1.059 . . . . 70.129999999999995 108.14 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -74.63 -46.4 38.55 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.354 -1.294 . . . . 53.450000000000003 108.798 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -92.89 105.69 17.77 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.665 -0.698 . . . . 73.150000000000006 109.498 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -95.36 158.47 15.44 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.178 -0.919 . . . . 74.430000000000007 110.149 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 15.0 m -140.27 149.07 42.37 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.184 -1.043 . . . . 63.299999999999997 108.184 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 8.3 t -141.64 131.01 23.66 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.544 -0.539 . . . . 74.010000000000005 109.544 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 48.6 t -101.45 89.07 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.565 -1.272 . . . . 64.349999999999994 107.565 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--N 1.301 -1.521 0 CA-C-N 115.181 -0.918 . . . . 63.020000000000003 110.16 -176.555 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 108.289 -1.004 . . . . 65.109999999999999 108.289 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . 175.88 -53.48 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 125.48 1.512 . . . . 62.109999999999999 108.196 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.435 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . 160.36 -148.5 16.86 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.085 -1.206 . . . . 65.099999999999994 110.085 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.43 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.7 mp -123.3 130.02 74.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 117.131 0.466 . . . . 50.329999999999998 110.75 -174.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.506 ' H ' ' HA ' ' A' ' 636' ' ' LEU . 57.4 m-85 -112.24 136.48 51.61 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.47 -0.937 . . . . 74.329999999999998 108.47 169.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.2 t -170.71 -179.34 2.86 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.787 -0.82 . . . . 53.229999999999997 108.787 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -83.62 155.45 23.22 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 110.308 -0.256 . . . . 75.319999999999993 110.308 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.09 -45.25 85.99 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.551 -1.278 . . . . 33.509999999999998 107.551 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.74 146.14 51.93 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 108.606 -0.887 . . . . 72.530000000000001 108.606 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.91 -17.35 15.57 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.801 1.667 . . . . 63.32 111.949 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 58.4 t -141.64 127.74 19.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 107.92 -1.141 . . . . 62.420000000000002 107.92 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 13.8 t -123.65 140.54 52.89 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 109.398 -0.593 . . . . 41.409999999999997 109.398 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -109.52 119.33 39.1 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.977 -0.556 . . . . 75.340000000000003 109.705 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.2 m -115.74 162.28 13.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 108.809 -0.812 . . . . 70.120000000000005 108.809 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.546 ' O ' HG22 ' A' ' 518' ' ' ILE . 12.1 t -87.55 149.77 24.14 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.533 0.682 . . . . 71.120000000000005 111.157 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -60.98 -29.56 69.76 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 124.941 1.296 . . . . 71.299999999999997 109.166 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 32.1 t -116.53 26.02 10.18 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.758 -0.655 . . . . 54.439999999999998 111.231 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 515' ' ' SER . 7.9 tt -80.21 -30.28 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 119.437 -0.905 . . . . 71.299999999999997 111.026 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 88.31 -76.91 1.88 Allowed Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 119.89 -1.148 . . . . 61.240000000000002 111.335 -177.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.1 mm -123.63 124.98 70.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.139 -1.06 . . . . 74.239999999999995 108.139 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.512 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -109.89 147.66 32.98 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 108.451 -0.944 . . . . 72.409999999999997 108.451 177.536 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 39.3 mt-10 -123.54 134.03 53.91 Favored 'General case' 0 CA--C 1.497 -1.088 0 O-C-N 123.846 0.717 . . . . 65.310000000000002 111.198 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.569 HG21 HD21 ' A' ' 642' ' ' LEU . 66.7 t -118.69 125.1 74.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 107.931 -1.137 . . . . 75.510000000000005 107.931 176.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.434 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 36.1 mtmt -86.81 133.15 33.67 Favored 'General case' 0 N--CA 1.427 -1.617 0 O-C-N 123.638 0.586 . . . . 60.409999999999997 110.205 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 39.4 t -101.56 120.9 51.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.301 -0.999 . . . . 41.119999999999997 108.301 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.31 129.05 38.62 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 124.029 0.83 . . . . 64.409999999999997 110.169 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -85.09 158.89 20.3 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.635 -1.166 . . . . 62.420000000000002 109.18 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.435 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 1.6 t -56.22 147.57 20.45 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.725 1.21 . . . . 64.409999999999997 112.854 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.9 t -59.23 -35.43 73.63 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.696 1.199 . . . . 75.219999999999999 109.089 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.76 98.13 0.63 Allowed Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 109.13 -1.588 . . . . 55.439999999999998 109.13 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.36 103.91 16.55 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 109.36 -0.607 . . . . 74.519999999999996 109.36 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -123.53 119.86 31.19 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 116.077 -0.511 . . . . 71.409999999999997 110.557 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 87.19 -136.61 14.08 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.277 -0.874 . . . . 62.509999999999998 112.948 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -133.17 126.58 31.97 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.061 -1.088 . . . . 60.530000000000001 108.061 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 61.0 t -131.55 133.66 61.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.074 -0.713 . . . . 63.409999999999997 109.074 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.565 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 37.3 mm -104.73 136.06 39.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 109.096 -0.705 . . . . 73.219999999999999 109.096 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.407 HG22 ' HB3' ' A' ' 594' ' ' PRO . 40.5 t -120.93 108.32 36.86 Favored Pre-proline 0 C--N 1.306 -1.289 0 N-CA-C 109.948 -0.39 . . . . 63.049999999999997 109.948 178.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.2 156.95 50.9 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.567 2.178 . . . . 55.420000000000002 111.943 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.426 ' HB3' HG22 ' A' ' 591' ' ' ILE . 54.6 p90 -153.83 161.41 42.07 Favored 'General case' 0 C--O 1.25 1.11 0 N-CA-C 110.212 -0.292 . . . . 73.120000000000005 110.212 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -153.81 154.05 33.26 Favored 'General case' 0 C--O 1.25 1.111 0 O-C-N 123.657 0.598 . . . . 65.319999999999993 110.805 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.8 p -87.14 136.5 32.9 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.321 -0.854 . . . . 71.010000000000005 110.966 175.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 590' ' ' GLU . 69.7 mt -109.92 123.92 66.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.108 -1.071 . . . . 54.43 108.108 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -76.23 105.82 7.5 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.855 -0.424 . . . . 75.239999999999995 109.855 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -90.2 -119.64 2.03 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 109.844 -1.302 . . . . 55.439999999999998 109.844 177.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 13.4 t -86.16 -5.93 59.1 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.905 0.86 . . . . 60.240000000000002 109.311 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -97.75 137.28 36.87 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.578 -1.267 . . . . 74.129999999999995 107.578 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.535 ' HD2' ' OE2' ' A' ' 551' ' ' GLU . 76.5 mtm180 -86.26 137.07 32.89 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 123.738 0.815 . . . . 71.200000000000003 111.353 -176.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -91.83 -164.49 38.79 Favored Glycine 0 C--N 1.29 -2.0 0 CA-C-N 115.36 -0.836 . . . . 71.109999999999999 111.644 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.71 14.32 79.91 Favored Glycine 0 C--N 1.305 -1.165 0 CA-C-O 120.07 -0.295 . . . . 75.129999999999995 113.345 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 88.25 24.66 33.51 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.059 -0.816 . . . . 65.129999999999995 111.059 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.535 ' OE2' ' HD2' ' A' ' 547' ' ' ARG . 17.5 tt0 -96.39 -56.85 2.48 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.335 -0.617 . . . . 75.329999999999998 109.335 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -111.59 -33.07 6.47 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 108.579 -0.897 . . . . 75.420000000000002 108.579 171.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -140.32 149.8 43.2 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 108.302 -0.999 . . . . 64.129999999999995 108.302 175.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 2.0 tm-20 -88.93 123.71 33.54 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 106.18 -1.785 . . . . 71.319999999999993 106.18 177.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -67.87 154.01 42.49 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 112.643 0.609 . . . . 71.140000000000001 112.643 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.7 t -147.72 139.4 23.93 Favored 'General case' 0 N--CA 1.406 -2.628 0 CA-C-O 121.725 0.774 . . . . 63.329999999999998 108.934 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.6 p -148.88 143.81 26.49 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 107.197 -1.409 . . . . 63.310000000000002 107.197 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 161.63 -158.79 30.66 Favored Glycine 0 N--CA 1.413 -2.871 0 C-N-CA 119.69 -1.243 . . . . 72.510000000000005 110.57 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.565 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.7 mt-10 -137.28 140.13 41.38 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 120.784 0.325 . . . . 74.030000000000001 110.967 -174.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.5 139.31 36.37 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.418 0.687 . . . . 72.239999999999995 109.769 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.506 ' HA ' HD13 ' A' ' 536' ' ' ILE . 33.1 tt0 -100.85 110.02 22.04 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.167 0.508 . . . . 64.450000000000003 111.516 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -107.44 148.7 28.8 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.891 -0.595 . . . . 75.420000000000002 109.496 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.538 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 43.9 mt-30 -144.1 -177.28 5.37 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.734 -0.839 . . . . 71.030000000000001 108.734 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.88 -38.28 82.85 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 124.092 0.87 . . . . 71.420000000000002 108.655 177.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -85.25 -38.01 19.4 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.414 -0.812 . . . . 73.129999999999995 111.786 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.538 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 47.0 mm-40 -60.82 135.48 57.79 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.902 0.481 . . . . 65.340000000000003 112.079 -178.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.614 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.6 pt -78.51 -83.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 113.929 1.085 . . . . 74.109999999999999 113.929 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.614 ' H ' HG13 ' A' ' 567' ' ' ILE . 13.3 p -143.05 150.72 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.57 -0.9 . . . . 41.530000000000001 108.57 -177.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 524' ' ' LYS . 5.3 mmpt? -113.15 159.57 19.12 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.884 0.373 . . . . 74.040000000000006 110.134 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.1 p -128.87 147.39 50.82 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.159 -0.928 . . . . 61.530000000000001 112.088 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.8 mp -99.86 126.59 53.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 106.773 -1.565 . . . . 75.540000000000006 106.773 171.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 11.3 p -100.7 115.53 30.47 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.004 -0.739 . . . . 73.219999999999999 109.004 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 60.9 t -119.2 130.19 74.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 109.846 -0.427 . . . . 73.319999999999993 109.846 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 15.8 tppt? -82.87 122.13 27.84 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 123.731 0.645 . . . . 72.25 109.969 176.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 89.8 t -89.15 123.22 41.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 107.967 -1.123 . . . . 73.319999999999993 107.967 176.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 33.7 mm -90.09 132.39 34.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.293 0.568 . . . . 75.120000000000005 109.604 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -73.81 110.38 8.06 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.51 -1.223 . . . . 75.120000000000005 108.984 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -134.19 125.35 27.66 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.06 0.393 . . . . 73.409999999999997 112.06 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -136.01 78.68 1.73 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.693 -0.685 . . . . 63.439999999999998 111.583 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -99.87 -46.82 5.25 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.588 -0.893 . . . . 73.109999999999999 108.588 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -178.91 -91.76 0.0 OUTLIER 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.911 -1.144 . . . . 73.120000000000005 107.911 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 54.81 -174.6 0.04 OUTLIER 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.571 1.148 . . . . 73.420000000000002 113.757 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -123.39 -53.68 1.8 Allowed 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 115.796 -0.638 . . . . 71.209999999999994 109.57 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -153.61 139.34 17.97 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.459 -0.571 . . . . 41.229999999999997 109.459 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.544 ' HB2' ' HB ' ' A' ' 646' ' ' ILE . 35.7 mmtp -103.54 120.65 41.28 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.951 -0.759 . . . . 71.329999999999998 108.951 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 10.0 t -149.97 144.94 26.17 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.494 -0.482 . . . . 61.140000000000001 109.974 176.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 47.8 p90 -140.46 175.88 9.24 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.621 -1.251 . . . . 75.239999999999995 107.621 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.435 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 87.0 m-85 -122.6 153.97 38.59 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.451 -0.5 . . . . 74.450000000000003 110.601 -176.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.53 128.25 51.84 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 106.316 -1.735 . . . . 62.200000000000003 106.316 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.511 ' HB2' HD11 ' A' ' 542' ' ' ILE . 39.8 tt0 -124.57 131.79 53.47 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.807 -0.812 . . . . 74.319999999999993 108.807 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.426 HG22 ' HB3' ' A' ' 539' ' ' TYR . 17.8 pt -100.5 147.15 8.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.794 -0.817 . . . . 64.129999999999995 108.794 177.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.59 172.97 39.81 Favored Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 109.925 -1.27 . . . . 64.030000000000001 109.925 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.0 131.79 88.86 Favored Pre-proline 0 N--CA 1.426 -1.664 0 C-N-CA 120.665 -0.414 . . . . 63.240000000000002 110.838 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.431 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.2 Cg_endo -59.57 136.84 73.82 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.317 2.678 . . . . 63.439999999999998 112.03 -176.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . 0.471 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 3.1 ptm180 -116.63 125.09 51.28 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.305 -0.861 . . . . 73.329999999999998 110.152 -177.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.466 HD12 ' HB2' ' A' ' 598' ' ' GLU . 1.4 tm? -70.19 136.34 49.94 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.09 -1.078 . . . . 73.219999999999999 108.09 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.559 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.3 t -94.08 94.8 4.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.649 0.738 . . . . 72.120000000000005 110.873 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.466 ' HB2' HD12 ' A' ' 596' ' ' LEU . 0.2 OUTLIER -151.38 164.05 37.57 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 105.005 -2.22 . . . . 75.150000000000006 105.005 178.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 22.0 ptp -78.3 -8.68 58.68 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.069 0.462 . . . . 55.310000000000002 111.001 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 17.3 m -92.73 100.76 13.19 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 121.202 0.525 . . . . 74.409999999999997 111.009 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -147.99 97.24 2.77 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.83 -0.804 . . . . 72.430000000000007 108.83 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -68.92 115.83 8.69 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.369 -0.975 . . . . 74.120000000000005 108.369 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -125.89 121.24 32.61 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.602 -0.726 . . . . 70.420000000000002 109.803 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -105.67 -179.71 23.65 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.657 -0.701 . . . . 73.439999999999998 113.119 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.16 157.23 10.5 Favored Glycine 0 N--CA 1.433 -1.502 0 N-CA-C 109.814 -1.314 . . . . 74.340000000000003 109.814 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -159.69 122.36 3.48 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.856 -0.794 . . . . 64.109999999999999 108.856 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 25.4 p -93.38 104.04 16.22 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 121.002 0.429 . . . . 74.099999999999994 110.147 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 64.0 mt -66.01 96.26 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.453 -0.943 . . . . 72.310000000000002 108.453 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 18.7 m -84.79 93.42 8.47 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 108.146 -1.057 . . . . 74.510000000000005 108.146 -177.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 179.44 -37.38 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 105.438 -2.06 . . . . 61.329999999999998 105.438 -173.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -98.0 124.97 42.73 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 105.239 -2.134 . . . . 75.540000000000006 105.239 172.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -100.04 96.1 7.29 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.188 -0.605 . . . . 74.450000000000003 111.682 -171.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -175.12 -179.85 1.43 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 106.39 -1.707 . . . . 73.150000000000006 106.39 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -76.4 102.27 5.89 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.1 0.476 . . . . 64.299999999999997 109.957 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -93.78 40.74 1.08 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.014 0.911 . . . . 64.230000000000004 109.706 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -67.27 -55.72 14.76 Favored Pre-proline 0 CA--C 1.561 1.392 0 CA-C-N 114.609 -1.178 . . . . 75.340000000000003 112.705 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -83.71 38.65 0.73 Allowed 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 122.231 1.954 . . . . 72.140000000000001 112.608 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.58 107.5 8.91 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.109 -0.7 . . . . 61.450000000000003 109.109 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . 0.406 ' OG1' ' HG2' ' A' ' 622' ' ' GLU . 5.7 t -153.18 131.79 12.26 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.378 -0.828 . . . . 65.310000000000002 109.633 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 19.8 m -95.56 -32.24 12.93 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.266 -1.753 . . . . 74.319999999999993 106.266 172.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 22.4 tptm 167.05 66.66 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 127.517 2.327 . . . . 75.239999999999995 105.634 172.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . 0.406 ' HG2' ' OG1' ' A' ' 619' ' ' THR . 7.0 mm-40 -76.43 134.71 39.5 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 107.172 -1.418 . . . . 74.209999999999994 107.172 -178.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -55.27 126.74 26.21 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 124.299 0.999 . . . . 73.030000000000001 111.638 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . 0.411 ' OE1' ' HB2' ' A' ' 627' ' ' ARG . 0.5 OUTLIER -91.29 93.52 9.11 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 105.701 -1.963 . . . . 63.130000000000003 105.701 178.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -108.97 3.06 21.79 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.412 -1.267 . . . . 72.140000000000001 111.03 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.579 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 97.7 mtt180 -64.44 -34.54 78.43 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 108.128 -1.064 . . . . 74.25 108.128 177.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . 0.425 ' HD3' ' O ' ' A' ' 627' ' ' ARG . 1.5 tmt_? -59.95 -34.0 72.68 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.271 1.029 . . . . 73.150000000000006 109.87 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 65.4 mt -68.37 -35.99 73.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.12 -0.696 . . . . 73.340000000000003 109.12 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -78.42 -27.24 46.55 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.829 -0.623 . . . . 33.340000000000003 111.1 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 7.0 mm-40 -53.08 -36.88 61.16 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.881 0.872 . . . . 43.310000000000002 112.445 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -81.65 -8.72 59.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.151 0.5 . . . . 61.100000000000001 111.054 -177.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -119.1 6.05 13.31 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.905 -0.664 . . . . 44.229999999999997 112.056 -177.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -123.51 151.65 63.63 Favored Pre-proline 0 N--CA 1.433 -1.291 0 N-CA-C 109.379 -0.6 . . . . 63.509999999999998 109.379 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.431 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 23.3 Cg_endo -59.51 139.83 91.17 Favored 'Trans proline' 0 CA--C 1.512 -0.581 0 C-N-CA 123.43 2.754 . . . . 63.409999999999997 112.395 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 3.1 pt -124.07 177.5 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 0 CA-C-O 120.937 0.399 . . . . 73.409999999999997 110.03 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.506 ' HA ' ' H ' ' A' ' 505' ' ' PHE . 0.8 OUTLIER -113.86 174.52 5.89 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 115.665 -0.698 . . . . 52.409999999999997 112.322 177.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.43 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -74.31 174.13 50.29 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 115.415 -0.811 . . . . 70.349999999999994 113.923 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -66.79 -34.47 77.89 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 124.033 0.933 . . . . 71.420000000000002 110.408 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -124.06 121.48 35.3 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.33 -0.618 . . . . 73.420000000000002 109.33 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 7.8 p -134.78 95.4 3.33 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.752 -0.658 . . . . 73.329999999999998 110.013 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -166.54 143.34 4.88 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.75 -1.204 . . . . 53.299999999999997 107.75 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.569 HD21 HG21 ' A' ' 523' ' ' VAL . 26.7 tp -129.66 116.16 18.42 Favored 'General case' 0 N--CA 1.417 -2.084 0 O-C-N 123.825 0.703 . . . . 71.319999999999993 109.668 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -87.18 110.61 20.27 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.604 -1.628 . . . . 73.409999999999997 106.604 173.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 55.8 t -99.19 107.76 21.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.736 -0.838 . . . . 73.120000000000005 108.736 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 27.8 mt -99.28 121.47 49.94 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 N-CA-C 108.42 -0.956 . . . . 73.349999999999994 108.42 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 585' ' ' LYS . 62.6 mt -97.46 107.55 20.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.165 -1.42 . . . . 73.150000000000006 107.165 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -119.4 145.54 46.13 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.408 -0.96 . . . . 71.319999999999993 108.408 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -77.19 115.03 16.63 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.138 -1.801 . . . . 72.299999999999997 106.138 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . 0.533 ' HB3' ' HA ' ' A' ' 652' ' ' PHE . 57.4 m -164.15 112.33 1.14 Allowed 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 114.564 -1.198 . . . . 52.130000000000003 107.82 -176.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -93.69 -42.11 9.34 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.263 -1.754 . . . . 74.420000000000002 106.263 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 651' ' ' GLU . 0.2 OUTLIER -79.01 -32.79 45.21 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 112.518 -2.128 . . . . 62.219999999999999 110.888 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . 0.533 ' HA ' ' HB3' ' A' ' 649' ' ' SER . 76.1 m-85 67.97 68.07 0.34 Allowed 'General case' 0 CA--C 1.495 -1.164 0 CA-C-O 122.426 1.108 . . . . 71.010000000000005 110.677 -173.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 655' ' ' THR . 27.2 tptp -68.18 122.78 19.03 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 112.714 -2.039 . . . . 73.319999999999993 107.554 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 15.0 m -64.25 -51.64 62.62 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.045 0.45 . . . . 63.299999999999997 110.876 -175.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . 0.452 ' O ' ' HG3' ' A' ' 653' ' ' LYS . 5.2 t -121.89 138.79 54.26 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 107.781 -1.192 . . . . 62.030000000000001 107.781 175.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 31.7 m -117.4 150.86 19.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 120.818 0.342 . . . . 54.149999999999999 111.439 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 . . . . . 0 C--N 1.307 -1.255 0 N-CA-C 109.495 -0.557 . . . . 75.510000000000005 109.495 178.681 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 . . . . . 0 N--CA 1.434 -1.253 0 N-CA-C 107.272 -1.381 . . . . 72.430000000000007 107.272 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -136.61 -163.72 1.46 Allowed 'General case' 0 N--CA 1.41 -2.441 0 CA-C-O 121.174 0.512 . . . . 71.319999999999993 109.951 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -103.43 -114.72 3.97 Favored Glycine 0 C--N 1.278 -2.657 0 CA-C-N 114.672 -1.149 . . . . 43.200000000000003 112.955 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.81 127.69 70.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.219 -0.491 . . . . 70.209999999999994 110.573 -173.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -117.03 123.14 46.14 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.729 -1.211 . . . . 71.230000000000004 107.729 170.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.3 t -167.63 177.65 5.76 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.552 -0.536 . . . . 74.319999999999993 109.552 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -85.77 150.74 24.36 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.886 -0.412 . . . . 64.120000000000005 109.886 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 44.1 mt-10 -66.54 -34.03 77.0 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.348 0.594 . . . . 74.150000000000006 110.18 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -132.21 145.61 58.06 Favored Pre-proline 0 N--CA 1.421 -1.909 0 CA-C-N 114.959 -1.019 . . . . 74.019999999999996 108.499 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.0 -29.29 3.36 Favored 'Trans proline' 0 C--N 1.327 -0.557 0 C-N-CA 122.151 1.9 . . . . 61.299999999999997 112.127 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 26.0 t -134.92 131.79 53.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 107.909 -1.145 . . . . 64.129999999999995 107.909 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 15.3 t -126.68 136.43 52.46 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 109.42 -0.585 . . . . 72.25 109.42 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -109.98 109.42 20.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.793 0.806 . . . . 71.510000000000005 109.297 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.7 m -104.77 151.69 7.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 115.636 -0.711 . . . . 74.040000000000006 110.309 -175.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.544 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 67.4 m -79.56 155.06 28.34 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 115.349 -0.842 . . . . 74.310000000000002 110.328 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -67.08 -62.45 1.42 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.525 0.679 . . . . 71.400000000000006 111.068 176.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.3 m -79.09 26.85 0.25 Allowed 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.709 0.803 . . . . 52.299999999999997 112.666 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 12.8 tt -79.92 -27.91 12.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 122.021 -0.425 . . . . 63.030000000000001 110.509 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 89.2 -74.78 1.96 Allowed Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 110.467 -1.053 . . . . 63.219999999999999 110.467 -177.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.3 mm -129.41 122.88 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 108.425 -0.954 . . . . 75.109999999999999 108.425 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.444 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -103.37 147.51 27.02 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.695 -1.594 . . . . 65.420000000000002 106.695 175.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 35.1 mt-10 -133.64 128.26 34.71 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 123.655 0.597 . . . . 70.439999999999998 111.175 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.583 HG21 HD21 ' A' ' 642' ' ' LEU . 59.9 t -116.36 124.21 72.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 106.831 -1.544 . . . . 73.349999999999994 106.831 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.476 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 29.1 mtmm -84.65 139.88 31.74 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 121.071 0.462 . . . . 74.450000000000003 110.187 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 43.9 t -107.46 126.56 63.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 115.638 -0.71 . . . . 72.150000000000006 109.173 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.25 116.84 7.01 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 123.998 0.811 . . . . 71.439999999999998 110.093 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -77.79 150.53 34.28 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.022 -0.99 . . . . 65.219999999999999 109.96 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.3 t -55.34 132.93 49.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 124.904 1.282 . . . . 75.109999999999999 111.84 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 44.9 t -54.01 -35.5 61.98 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.538 1.135 . . . . 70.319999999999993 109.32 173.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -107.45 85.52 0.42 Allowed Glycine 0 N--CA 1.42 -2.403 0 N-CA-C 109.641 -1.384 . . . . 33.520000000000003 109.641 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -85.93 109.77 18.97 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.261 -1.015 . . . . 44.420000000000002 108.261 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -112.73 106.68 15.1 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.119 -0.491 . . . . 50.329999999999998 110.589 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 73.1 -116.76 5.67 Favored Glycine 0 N--CA 1.434 -1.47 0 CA-C-N 115.678 -0.692 . . . . 62.350000000000001 112.457 175.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -133.17 127.05 33.0 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.276 -0.638 . . . . 62.0 109.276 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.05 137.55 55.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.924 -0.769 . . . . 71.329999999999998 108.924 -177.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.539 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 36.4 mm -107.84 135.04 47.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.265 -0.643 . . . . 53.32 109.265 177.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 594' ' ' PRO . 57.3 t -120.51 109.8 36.18 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.391 -0.596 . . . . 33.109999999999999 109.391 177.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 35.4 Cg_endo -71.43 153.72 60.83 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.993 1.795 . . . . 70.239999999999995 111.338 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -150.97 155.71 39.66 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.958 -0.756 . . . . 73.420000000000002 108.958 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.8 152.93 30.42 Favored 'General case' 0 C--O 1.254 1.335 0 O-C-N 123.807 0.692 . . . . 65.019999999999996 112.354 177.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.6 p -82.83 134.06 35.11 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.471 -0.786 . . . . 64.430000000000007 110.024 174.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 70.8 mt -108.72 113.92 45.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 107.316 -1.364 . . . . 72.329999999999998 107.316 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.54 132.54 47.12 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.165 0.507 . . . . 71.540000000000006 111.638 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -124.1 -114.74 2.11 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 108.408 -1.877 . . . . 63.32 108.408 177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 45.6 p -80.36 -23.89 40.18 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 122.084 0.945 . . . . 53.329999999999998 108.736 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -82.8 128.99 34.91 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 114.396 -1.275 . . . . 71.109999999999999 108.766 175.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.3 mtm105 -88.6 135.13 33.65 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 124.066 0.854 . . . . 74.239999999999995 110.651 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -83.42 -152.07 12.21 Favored Glycine 0 C--N 1.297 -1.619 0 CA-C-N 115.232 -0.895 . . . . 62.299999999999997 111.916 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . 0.432 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 62.17 22.97 63.57 Favored Glycine 0 C--N 1.308 -0.978 0 N-CA-C 114.796 0.679 . . . . 41.420000000000002 114.796 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 79.54 22.4 64.67 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.307 -0.949 . . . . 61.399999999999999 111.533 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -96.62 -62.83 1.21 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.996 -0.372 . . . . 74.420000000000002 109.996 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -98.77 -42.69 7.09 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 107.196 -1.409 . . . . 75.420000000000002 107.196 171.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -137.76 149.88 46.79 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 114.911 -1.04 . . . . 60.32 108.677 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.413 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 0.7 OUTLIER -76.69 122.65 25.0 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.678 -1.601 . . . . 65.120000000000005 106.678 173.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 29.1 t70 -74.71 117.99 17.16 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.244 -0.435 . . . . 70.530000000000001 111.234 -173.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.1 t -121.04 138.83 53.99 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 122.517 1.151 . . . . 71.230000000000004 111.664 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 12.2 p -145.54 143.52 30.0 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 105.606 -1.998 . . . . 74.129999999999995 105.606 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 176.13 -155.25 18.84 Favored Glycine 0 N--CA 1.413 -2.873 0 C-N-CA 119.278 -1.439 . . . . 73.129999999999995 110.746 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.539 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 51.4 mt-10 -143.69 129.93 19.79 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 123.985 0.462 . . . . 62.229999999999997 110.582 -175.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 569' ' ' LYS . 98.1 mt -92.51 140.77 29.22 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.937 -0.764 . . . . 71.439999999999998 108.937 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.48 ' HA ' HD13 ' A' ' 536' ' ' ILE . 27.1 tt0 -105.09 113.35 26.9 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.842 -0.429 . . . . 71.439999999999998 109.842 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -111.11 142.65 43.0 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.272 -0.64 . . . . 75.219999999999999 109.272 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.485 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 49.4 mt-30 -133.88 176.28 8.71 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.67 -0.493 . . . . 74.109999999999999 109.67 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -67.16 -37.51 83.87 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 124.464 1.102 . . . . 72.049999999999997 111.676 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -92.11 -13.92 30.0 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.707 -0.678 . . . . 54.310000000000002 112.035 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.485 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 19.9 mm-40 -73.59 167.49 21.23 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.422 0.527 . . . . 72.430000000000007 112.422 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.592 HG13 ' H ' ' A' ' 568' ' ' VAL . 6.3 pt -105.27 -85.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 113.245 0.831 . . . . 70.140000000000001 113.245 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.592 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.3 p -142.96 153.24 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 109.338 -0.616 . . . . 71.349999999999994 109.338 -174.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.451 ' HB3' HD22 ' A' ' 560' ' ' LEU . 5.5 mmpt? -115.79 160.76 19.7 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.989 -0.374 . . . . 60.140000000000001 109.989 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.476 ' CG2' ' HG2' ' A' ' 524' ' ' LYS . 4.4 p -126.82 145.59 50.58 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.617 -0.719 . . . . 70.510000000000005 111.026 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.514 HG22 HG23 ' A' ' 573' ' ' VAL . 1.9 mp -94.11 114.7 31.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 105.36 -2.089 . . . . 73.430000000000007 105.36 170.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 16.5 m -94.33 115.21 27.4 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.232 -1.025 . . . . 75.299999999999997 108.232 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.514 HG23 HG22 ' A' ' 571' ' ' ILE . 98.5 t -117.06 127.67 74.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.268 -0.642 . . . . 73.150000000000006 109.268 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 24.2 tptm -78.21 107.58 10.9 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.389 -0.967 . . . . 74.120000000000005 108.389 175.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 45.9 t -85.38 124.74 40.28 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 106.24 -1.763 . . . . 64.0 106.24 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 29.8 mm -79.04 123.07 35.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 122.035 0.921 . . . . 61.030000000000001 111.648 -173.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -89.3 101.8 14.46 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 113.507 -1.679 . . . . 75.420000000000002 108.33 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -116.64 -65.09 1.22 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.276 -0.569 . . . . 74.310000000000002 109.628 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 173.6 169.22 0.18 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.999 1.319 . . . . 75.129999999999995 107.966 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.09 20.31 0.11 Allowed 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 113.253 0.834 . . . . 72.230000000000004 113.253 -178.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -71.22 -34.45 70.81 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 123.633 0.773 . . . . 72.409999999999997 109.205 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -80.26 113.04 18.15 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.513 -0.767 . . . . 71.530000000000001 110.523 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -82.16 103.53 11.83 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.348 -0.842 . . . . 55.329999999999998 111.889 -176.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 43.86 86.71 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.067 1.747 . . . . 62.409999999999997 112.504 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 33.3 mmtp -98.02 135.56 39.55 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.259 -0.577 . . . . 61.310000000000002 110.339 -176.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 2.9 t -141.82 142.57 33.17 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 120.185 -0.606 . . . . 73.519999999999996 111.257 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 46.2 p90 -137.33 171.77 13.98 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 107.499 -1.297 . . . . 53.119999999999997 107.499 178.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.488 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 45.0 m-85 -117.52 153.05 33.85 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 109.239 -0.652 . . . . 72.420000000000002 109.239 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.29 126.78 51.42 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 106.033 -1.84 . . . . 64.409999999999997 106.033 177.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -127.92 124.44 37.38 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 120.055 -0.658 . . . . 55.539999999999999 110.313 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 20.3 pt -88.86 140.93 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.297 0 CA-C-N 114.836 -1.075 . . . . 74.430000000000007 108.132 174.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -85.79 173.24 47.04 Favored Glycine 0 N--CA 1.409 -3.164 0 N-CA-C 109.838 -1.305 . . . . 22.030000000000001 109.838 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -67.14 136.15 93.92 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 110.343 -0.243 . . . . 70.219999999999999 110.343 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.403 ' HB3' HG22 ' A' ' 537' ' ' VAL . 30.8 Cg_endo -63.2 131.33 31.9 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.258 2.638 . . . . 75.340000000000003 112.311 -176.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -109.59 120.45 42.54 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.035 -0.984 . . . . 75.299999999999997 108.919 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.482 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 2.7 tm? -66.15 135.3 54.35 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.752 -1.203 . . . . 65.530000000000001 107.752 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.518 ' CG2' HG12 ' A' ' 536' ' ' ILE . 47.0 t -81.08 81.69 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.254 -1.017 . . . . 52.109999999999999 108.254 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -79.26 124.12 28.08 Favored 'General case' 0 N--CA 1.403 -2.812 0 CA-C-N 113.907 -1.497 . . . . 72.0 108.316 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 64.9 mtt -91.88 -16.76 26.23 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.119 -0.946 . . . . 65.209999999999994 109.366 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 27.3 t -78.56 87.23 4.53 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.156 -1.424 . . . . 61.310000000000002 107.156 174.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -113.54 175.03 5.63 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.034 -0.985 . . . . 73.120000000000005 109.52 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -113.35 152.92 29.35 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.314 -0.995 . . . . 71.430000000000007 108.314 175.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -89.39 166.71 13.55 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.121 -0.696 . . . . 74.209999999999994 109.121 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -72.34 -69.92 1.31 Allowed Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 108.419 -1.873 . . . . 74.109999999999999 108.419 174.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 66.35 22.03 70.83 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.285 -0.458 . . . . 62.32 113.307 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -91.96 98.9 11.86 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 108.94 -0.763 . . . . 73.150000000000006 108.94 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 41.7 m -75.09 100.57 4.26 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 107.44 -1.319 . . . . 73.140000000000001 107.44 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 2.5 pp -94.91 153.57 3.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.262 -0.881 . . . . 72.340000000000003 112.021 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 8.8 t -108.27 154.54 21.64 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.144 -1.798 . . . . 44.310000000000002 106.144 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . 0.339 10.3 pt-20 -83.23 66.03 8.55 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 122.593 1.187 . . . . 53.109999999999999 114.114 -177.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -115.03 111.99 21.96 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 105.546 -2.02 . . . . 64.420000000000002 105.546 174.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . 0.256 8.9 p90 -83.65 61.09 6.09 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.306 1.051 . . . . 74.040000000000006 113.044 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 19.7 t70 159.3 104.16 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 128.987 2.915 . . . . 53.530000000000001 106.073 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -139.74 134.43 31.86 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.448 -0.575 . . . . 72.239999999999995 109.448 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -71.66 107.4 4.49 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.183 0.516 . . . . 72.209999999999994 111.052 -173.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -136.15 114.06 10.66 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 107.692 -1.225 . . . . 73.019999999999996 107.692 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.32 113.91 1.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.694 2.263 . . . . 72.109999999999999 111.451 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.62 136.7 45.77 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.552 -0.536 . . . . 71.099999999999994 109.552 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 30.3 m -108.35 113.78 27.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.106 0.479 . . . . 54.439999999999998 110.404 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 1.7 p -87.21 -167.21 1.81 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.462 -0.79 . . . . 72.5 109.581 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -81.65 79.91 8.11 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.848 0.833 . . . . 74.040000000000006 108.981 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.43 159.64 24.23 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.673 -1.149 . . . . 71.239999999999995 109.598 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.86 78.64 2.77 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.391 0.615 . . . . 73.420000000000002 112.419 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . 0.411 ' HB2' ' HG2' ' A' ' 626' ' ' ARG . 47.8 mt-10 -92.58 -167.55 1.77 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.979 -1.01 . . . . 53.399999999999999 108.986 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -83.21 29.97 0.47 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.466 1.106 . . . . 55.420000000000002 111.391 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.411 ' HG2' ' HB2' ' A' ' 624' ' ' GLU . 18.3 mmt180 -63.27 -40.09 96.41 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.099 0.407 . . . . 75.140000000000001 112.099 -175.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . 0.548 ' O ' ' HD2' ' A' ' 627' ' ' ARG . 2.5 tmm_? -73.95 -24.18 59.61 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.413 -0.588 . . . . 73.25 109.413 -175.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.93 -31.87 55.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.394 -0.595 . . . . 71.420000000000002 109.394 176.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . 0.419 ' O ' ' HG2' ' A' ' 633' ' ' ARG . . . -80.21 -49.34 11.78 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.033 -0.728 . . . . 64.239999999999995 109.033 175.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.492 ' HA ' ' CG ' ' A' ' 633' ' ' ARG . 12.3 mm-40 -64.7 -11.79 39.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 114.233 1.198 . . . . 71.420000000000002 114.233 -176.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -19.42 58.77 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.218 -0.593 . . . . 73.319999999999993 110.815 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -116.84 45.9 1.22 Allowed Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 109.078 -1.609 . . . . 33.439999999999998 109.078 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . 0.492 ' CG ' ' HA ' ' A' ' 630' ' ' GLU . 24.8 mmt85 -134.47 161.05 66.06 Favored Pre-proline 0 C--N 1.311 -1.077 0 C-N-CA 123.83 0.852 . . . . 73.420000000000002 108.823 -177.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 596' ' ' LEU . 29.9 Cg_endo -62.42 139.1 74.91 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.759 2.306 . . . . 73.549999999999997 112.423 177.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . 0.564 HD13 ' H ' ' A' ' 635' ' ' ILE . 0.1 OUTLIER -127.72 178.71 4.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.692 -1.225 . . . . 53.009999999999998 107.692 179.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.86 -173.9 2.37 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 112.828 0.677 . . . . 64.530000000000001 112.828 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -77.8 -159.25 11.67 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.95 -0.568 . . . . 63.200000000000003 114.376 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -78.59 -48.62 14.79 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.452 0.644 . . . . 74.140000000000001 109.603 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -129.6 130.47 45.69 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.931 -1.137 . . . . 72.030000000000001 107.931 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 18.7 p -129.94 96.09 4.12 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 120.9 0.381 . . . . 74.530000000000001 110.887 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -163.97 148.48 10.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.495 -1.298 . . . . 62.350000000000001 107.495 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.583 HD21 HG21 ' A' ' 523' ' ' VAL . 34.0 tp -133.65 127.85 33.84 Favored 'General case' 0 N--CA 1.414 -2.271 0 N-CA-C 108.379 -0.971 . . . . 63.340000000000003 108.379 175.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -98.0 109.92 22.59 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 107.484 -1.302 . . . . 63.520000000000003 107.484 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 46.0 t -101.17 119.33 49.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.361 -0.607 . . . . 73.239999999999995 109.361 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 49.9 mt -106.12 126.7 61.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.327 -0.99 . . . . 53.539999999999999 108.327 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 73.8 mt -97.82 112.01 28.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.841 -1.17 . . . . 73.420000000000002 107.841 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 515' ' ' SER . 14.3 pt-20 -121.49 142.5 49.99 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.505 -0.77 . . . . 72.450000000000003 110.129 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.44 127.13 32.25 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 108.921 -0.77 . . . . 73.510000000000005 108.921 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 56.0 m -148.18 93.83 2.23 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.147 -1.057 . . . . 71.340000000000003 108.147 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -93.69 -10.35 34.69 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.793 -0.639 . . . . 75.319999999999993 109.306 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -77.91 -34.71 51.29 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.3 -0.863 . . . . 73.430000000000007 112.704 -174.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -85.88 79.89 9.09 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.622 0.725 . . . . 70.099999999999994 110.606 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . 0.414 ' HA ' ' HB ' ' A' ' 656' ' ' VAL . 54.4 mtmt -88.04 69.72 9.34 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 122.727 1.251 . . . . 71.420000000000002 113.284 -175.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 24.2 m -157.67 -41.36 0.07 Allowed 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 104.879 -2.267 . . . . 64.120000000000005 104.879 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 34.6 m -71.49 -38.67 71.18 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.229 -1.397 . . . . 74.319999999999993 107.229 170.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 653' ' ' LYS . 96.3 t -70.61 110.78 3.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.075 0 N-CA-C 106.989 -1.486 . . . . 53.020000000000003 106.989 169.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 108.132 -1.062 . . . . 62.420000000000002 108.132 -176.04 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 56.9 m80 . . . . . 0 CA--C 1.499 -1.002 0 N-CA-C 110.085 -0.339 . . . . 72.409999999999997 110.085 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.422 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . -87.98 -59.67 2.18 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.7 -1.222 . . . . 54.020000000000003 107.7 170.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 168.85 -146.87 10.66 Favored Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 109.811 -1.316 . . . . 52.340000000000003 109.811 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.543 HD11 ' HA ' ' A' ' 609' ' ' THR . 3.4 mp -126.04 117.6 49.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 117.129 0.464 . . . . 72.140000000000001 110.469 -175.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -102.4 124.69 48.42 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.261 -1.015 . . . . 72.200000000000003 108.261 169.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.7 t -165.07 -179.17 5.53 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.893 -0.78 . . . . 64.530000000000001 108.893 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -80.35 149.04 30.39 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.357 0.598 . . . . 71.040000000000006 112.534 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -74.18 -24.71 59.42 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 114.793 -1.094 . . . . 64.25 109.003 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.65 142.88 27.29 Favored Pre-proline 0 N--CA 1.435 -1.198 0 N-CA-C 107.474 -1.306 . . . . 75.099999999999994 107.474 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.81 -27.68 4.63 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.215 1.944 . . . . 73.030000000000001 112.483 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 53.7 t -137.96 136.37 45.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 107.007 -1.479 . . . . 74.430000000000007 107.007 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.6 t -130.42 139.55 50.6 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 109.371 -0.603 . . . . 71.310000000000002 109.371 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -106.11 124.05 48.97 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.964 -1.124 . . . . 61.350000000000001 107.964 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.6 m -120.99 155.74 24.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 108.267 -1.012 . . . . 71.129999999999995 108.267 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.577 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 68.1 m -80.88 166.5 20.84 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 108.676 -0.861 . . . . 64.209999999999994 108.676 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.429 ' OE2' ' HB3' ' A' ' 580' ' ' GLU . 20.1 tt0 -89.8 -55.72 3.52 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.429 -0.908 . . . . 71.510000000000005 109.795 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 31.1 m -81.44 46.7 0.97 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.382 0.61 . . . . 50.340000000000003 110.843 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 11.5 tt -96.05 -29.91 3.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.306 0.574 . . . . 73.319999999999993 111.028 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . 96.0 -82.25 0.81 Allowed Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.953 -1.259 . . . . 62.229999999999997 109.953 -176.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 573' ' ' VAL . 27.7 mm -129.67 134.96 62.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.885 -1.154 . . . . 75.0 107.885 -176.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' ' 572' ' ' SER . 0.0 OUTLIER -115.06 144.62 43.35 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.098 -0.705 . . . . 41.140000000000001 109.098 176.145 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 21.5 mp0 -116.22 128.45 55.62 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.723 0.639 . . . . 64.150000000000006 111.185 176.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 570' ' ' THR . 99.5 t -120.87 131.57 72.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.921 -0.77 . . . . 62.32 108.921 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 569' ' ' LYS . 26.5 mtmm -85.62 145.32 27.38 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.438 0.637 . . . . 70.510000000000005 112.023 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 568' ' ' VAL . 52.5 t -117.71 127.59 75.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.879 -0.786 . . . . 45.32 108.879 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 97.1 mt -70.39 124.88 25.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 123.762 0.664 . . . . 72.430000000000007 110.29 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -73.84 158.43 34.54 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.567 -1.197 . . . . 65.409999999999997 109.215 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.4 t -56.09 135.79 52.69 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 124.013 0.821 . . . . 41.409999999999997 110.643 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 3.7 m -60.09 -27.42 66.98 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 124.822 1.249 . . . . 62.409999999999997 110.108 177.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -122.23 90.38 0.44 Allowed Glycine 0 N--CA 1.424 -2.157 0 N-CA-C 109.098 -1.601 . . . . 43.310000000000002 109.098 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.54 105.25 17.69 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.716 -0.476 . . . . 61.409999999999997 109.716 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -120.2 101.97 8.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.852 -0.795 . . . . 74.099999999999994 108.852 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 90.93 -145.21 17.69 Favored Glycine 0 C--N 1.299 -1.489 0 CA-C-N 115.668 -0.696 . . . . 63.140000000000001 112.258 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.54 ' ND2' ' HG2' ' A' ' 563' ' ' GLN . 2.6 t-20 -118.39 131.07 56.31 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.149 -0.685 . . . . 74.219999999999999 109.149 -178.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.536 HG22 HD22 ' A' ' 596' ' ' LEU . 49.4 t -131.58 139.94 49.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 108.497 -0.927 . . . . 63.439999999999998 108.497 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.538 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 42.5 mm -109.6 135.79 47.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 109.036 -0.727 . . . . 64.120000000000005 109.036 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.7 t -122.98 108.43 32.54 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 108.957 -0.757 . . . . 53.240000000000002 108.957 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 39.4 Cg_endo -73.61 153.86 49.41 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.92 1.747 . . . . 61.32 111.465 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -140.46 155.87 46.54 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.951 -0.468 . . . . 55.229999999999997 109.888 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -147.31 148.83 31.8 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 123.714 0.634 . . . . 54.140000000000001 109.911 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.5 p -90.21 129.27 36.49 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.405 -0.361 . . . . 71.329999999999998 110.16 174.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.519 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 64.2 mt -102.62 119.75 51.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 107.162 -1.421 . . . . 74.349999999999994 107.162 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -72.86 114.95 11.58 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.522 -0.548 . . . . 74.329999999999998 109.522 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -96.8 -100.11 1.96 Allowed Glycine 0 CA--C 1.5 -0.874 0 N-CA-C 109.958 -1.257 . . . . 71.430000000000007 109.958 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 31.5 p -94.6 -22.21 18.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.984 -1.117 . . . . 62.329999999999998 107.984 173.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.47 ' HB2' ' HB3' ' A' ' 585' ' ' LYS . . . -86.05 135.64 33.55 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.758 -1.11 . . . . 73.299999999999997 108.468 177.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -98.72 143.55 28.96 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.217 0.532 . . . . 75.409999999999997 112.163 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.7 -150.65 17.61 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.1 -0.954 . . . . 72.239999999999995 111.442 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 70.93 -0.67 28.21 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 116.978 0.389 . . . . 41.439999999999998 113.383 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 93.54 29.09 10.4 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 111.041 -0.824 . . . . 52.32 111.041 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -99.91 -67.66 0.84 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 110.365 -0.235 . . . . 55.299999999999997 110.365 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -94.35 -45.62 7.39 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 107.979 -1.119 . . . . 73.420000000000002 107.979 174.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -136.77 158.95 43.26 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 114.965 -1.016 . . . . 74.040000000000006 108.453 177.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 9.1 tt0 -85.52 112.65 21.12 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 104.658 -2.349 . . . . 70.230000000000004 104.658 176.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -73.25 145.92 45.81 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.576 -0.85 . . . . 73.319999999999993 108.87 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.0 t -142.64 168.98 18.45 Favored 'General case' 0 N--CA 1.414 -2.227 0 C-N-CA 120.372 -0.531 . . . . 72.450000000000003 110.714 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 11.2 p -162.72 160.35 25.36 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 106.017 -1.846 . . . . 61.210000000000001 106.017 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 171.22 -172.98 44.72 Favored Glycine 0 CA--C 1.483 -1.934 0 N-CA-C 110.493 -1.043 . . . . 74.430000000000007 110.493 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 48.5 mt-10 -130.78 120.11 23.28 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.141 0.496 . . . . 75.150000000000006 111.532 -177.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 92.1 mt -85.75 135.92 33.54 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 115.459 -0.791 . . . . 74.129999999999995 109.259 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.463 ' HA ' HD13 ' A' ' 536' ' ' ILE . 36.0 tt0 -104.04 119.24 38.52 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-O 121.051 0.453 . . . . 72.340000000000003 110.035 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -118.81 139.22 51.95 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.517 -0.549 . . . . 65.5 109.517 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.565 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 6.6 mt-30 -134.95 172.23 13.29 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.743 -0.836 . . . . 71.209999999999994 108.743 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -62.19 -30.22 70.92 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 123.85 0.719 . . . . 74.540000000000006 109.734 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.01 -24.21 21.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.606 -1.179 . . . . 73.319999999999993 112.381 -177.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.565 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 68.5 mm-40 -75.38 173.37 11.01 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.139 -0.351 . . . . 65.340000000000003 111.28 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.644 HG13 ' H ' ' A' ' 568' ' ' VAL . 7.6 pt -117.06 -77.24 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 113.59 0.959 . . . . 70.420000000000002 113.59 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.644 ' H ' HG13 ' A' ' 567' ' ' ILE . 11.8 p -142.99 153.09 16.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 107.711 -1.218 . . . . 51.329999999999998 107.711 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 524' ' ' LYS . 17.0 mtpp -121.55 168.32 11.87 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.7 -0.4 . . . . 74.219999999999999 111.112 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 0.9 OUTLIER -129.92 147.09 51.64 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 123.853 0.72 . . . . 71.230000000000004 111.441 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 1.9 mp -94.91 128.08 46.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.033 -1.469 . . . . 62.0 107.033 172.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 521' ' ' MET . 10.1 p -106.74 115.32 29.99 Favored 'General case' 0 N--CA 1.428 -1.562 0 O-C-N 123.715 0.634 . . . . 73.219999999999999 109.835 176.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 571' ' ' ILE . 71.6 t -117.82 135.97 56.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 116.366 -0.379 . . . . 73.019999999999996 110.12 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 24.4 tptm -90.46 123.51 34.22 Favored 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 124.085 0.866 . . . . 72.400000000000006 109.0 177.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.07 136.18 31.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 106.445 -1.687 . . . . 55.450000000000003 106.445 176.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 41.5 mm -84.27 135.31 25.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.401 0.62 . . . . 75.219999999999999 111.258 -173.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -98.29 80.83 2.69 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.076 -0.966 . . . . 55.100000000000001 108.967 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 28.6 t70 178.84 159.69 0.6 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.49 0.716 . . . . 75.299999999999997 109.175 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 61.8 24.57 14.64 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.197 0.999 . . . . 64.200000000000003 112.615 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.429 ' HB3' ' OE2' ' A' ' 516' ' ' GLU . 0.0 OUTLIER -75.08 28.69 0.09 Allowed 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 124.752 1.221 . . . . 71.099999999999994 112.766 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -85.3 -16.69 39.21 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 123.31 0.644 . . . . 73.010000000000005 109.868 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -84.49 -160.82 0.5 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.266 -0.425 . . . . 73.319999999999993 111.782 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.513 ' HG2' ' H ' ' A' ' 584' ' ' ASN . 58.4 tttp -112.17 -179.71 3.76 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.154 -1.054 . . . . 75.209999999999994 108.154 -174.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . 0.513 ' H ' ' HG2' ' A' ' 583' ' ' LYS . 24.5 t-20 -37.99 128.0 1.26 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.19 1.796 . . . . 73.140000000000001 113.224 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 24.0 mmtp -109.18 148.18 31.33 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.164 -1.421 . . . . 64.5 107.164 -176.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 7.8 t -149.97 146.09 26.83 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.08 -0.648 . . . . 62.100000000000001 110.643 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 48.5 p90 -140.43 172.06 13.26 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.643 -1.243 . . . . 72.150000000000006 107.643 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.514 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 85.7 m-85 -116.97 153.59 32.36 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 109.781 -0.451 . . . . 73.040000000000006 109.781 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.81 125.49 46.63 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 105.657 -1.979 . . . . 72.310000000000002 105.657 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.47 ' HB2' HD11 ' A' ' 542' ' ' ILE . 31.7 tt0 -126.15 136.68 53.16 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.599 -0.889 . . . . 74.109999999999999 108.599 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 12.3 pt -100.4 139.79 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.225 0 N-CA-C 108.45 -0.944 . . . . 71.209999999999994 108.45 175.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -83.25 173.16 51.67 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-N 115.167 -0.924 . . . . 63.340000000000003 111.426 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.08 125.85 91.96 Favored Pre-proline 0 N--CA 1.433 -1.307 0 CA-C-O 120.836 0.351 . . . . 75.040000000000006 111.556 -177.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.427 ' HB3' HG22 ' A' ' 537' ' ' VAL . 26.2 Cg_endo -62.1 139.71 80.01 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.692 2.928 . . . . 74.129999999999995 113.101 -174.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . 0.464 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 9.7 ptm180 -116.52 128.68 55.66 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.901 -1.045 . . . . 74.420000000000002 109.562 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.536 HD22 HG22 ' A' ' 535' ' ' VAL . 0.6 OUTLIER -74.58 135.86 42.07 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.953 -1.129 . . . . 72.430000000000007 107.953 179.585 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.524 ' CG2' HG12 ' A' ' 536' ' ' ILE . 37.4 t -97.86 101.07 11.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.701 -0.852 . . . . 70.140000000000001 108.701 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -142.84 156.8 45.0 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.194 -0.457 . . . . 73.549999999999997 111.12 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 65.5 mtm -112.76 -5.67 13.9 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.379 -0.828 . . . . 71.030000000000001 109.832 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 49.9 m -143.68 -72.27 0.29 Allowed 'General case' 0 C--O 1.247 0.966 0 N-CA-C 112.502 0.556 . . . . 54.530000000000001 112.502 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -152.52 149.73 28.83 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.143 -0.348 . . . . 74.420000000000002 110.135 -172.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . 0.526 ' HD3' ' H ' ' A' ' 602' ' ' LYS . 0.0 OUTLIER -118.36 -179.12 3.69 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.735 0.302 . . . . 72.019999999999996 111.808 -174.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -132.13 157.9 43.05 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.635 -0.876 . . . . 73.230000000000004 108.635 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -104.13 174.13 22.02 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 110.979 -0.848 . . . . 73.230000000000004 110.979 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -104.32 -34.2 3.72 Favored Glycine 0 C--N 1.306 -1.128 0 N-CA-C 111.338 -0.705 . . . . 65.540000000000006 111.338 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 59.41 89.75 0.06 Allowed 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.717 1.207 . . . . 74.510000000000005 112.427 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 8.8 t -146.95 162.64 38.32 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.804 -1.554 . . . . 74.230000000000004 106.804 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . 0.406 HD13 ' N ' ' A' ' 609' ' ' THR . 0.0 OUTLIER -80.68 134.7 26.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.953 -1.128 . . . . 53.409999999999997 107.953 -179.14 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . 0.543 ' HA ' HD11 ' A' ' 504' ' ' ILE . 7.2 p -73.18 92.74 1.76 Allowed 'General case' 0 N--CA 1.434 -1.267 0 CA-C-O 121.317 0.579 . . . . 52.219999999999999 111.911 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -70.09 128.8 37.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.283 -0.871 . . . . 54.200000000000003 111.461 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.525 ' OE2' ' HA ' ' A' ' 614' ' ' ASP . 10.6 pt-20 -122.09 145.86 47.75 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.662 -0.866 . . . . 33.439999999999998 108.662 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -79.71 -33.37 41.01 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.917 0.865 . . . . 74.019999999999996 109.448 -177.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -148.29 146.19 28.48 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.697 -1.223 . . . . 71.530000000000001 107.697 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . 0.525 ' HA ' ' OE2' ' A' ' 611' ' ' GLU . 6.8 p-10 -59.92 109.95 1.06 Allowed 'General case' 0 C--O 1.218 -0.582 0 O-C-N 124.057 0.848 . . . . 72.239999999999995 108.976 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . 0.499 ' HD3' ' CE1' ' A' ' 639' ' ' HIS . 0.0 OUTLIER -139.1 156.28 47.28 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 121.247 0.546 . . . . 74.439999999999998 110.72 -175.716 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -125.0 124.68 25.41 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 105.774 -1.936 . . . . 72.120000000000005 105.774 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . 0.404 ' HD3' ' OE1' ' A' ' 638' ' ' GLU . 9.2 Cg_endo -50.5 133.37 37.51 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 123.7 2.933 . . . . 61.100000000000001 114.355 -171.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 84.4 mt -82.98 -17.51 43.21 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.951 -1.022 . . . . 73.140000000000001 109.292 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 6.5 p -71.42 -68.77 0.42 Allowed 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.424 -0.807 . . . . 55.109999999999999 110.642 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 15.0 p -159.78 125.8 4.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 116.039 -0.528 . . . . 54.030000000000001 110.88 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -129.01 151.84 49.26 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.941 -1.503 . . . . 63.329999999999998 106.941 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . 0.414 ' HG3' ' HB2' ' A' ' 627' ' ' ARG . 11.3 pt-20 -151.07 177.52 10.1 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.758 -0.777 . . . . 75.409999999999997 112.054 -174.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -142.13 82.83 1.81 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 106.289 -1.745 . . . . 55.0 106.289 170.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 625' ' ' GLU . 0.9 OUTLIER -153.67 -175.06 5.19 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.492 -1.67 . . . . 73.219999999999999 106.492 -176.205 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 624' ' ' GLU . 47.3 mt-10 -79.01 -16.77 56.43 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 122.43 0.292 . . . . 70.510000000000005 111.274 -176.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -70.33 -31.69 69.09 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.541 -0.54 . . . . 61.299999999999997 109.541 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . 0.414 ' HB2' ' HG3' ' A' ' 622' ' ' GLU . 78.8 ttt180 -66.67 -44.4 81.95 Favored 'General case' 0 C--O 1.177 -2.723 0 CA-C-N 115.121 -0.945 . . . . 72.430000000000007 109.651 171.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.33 -38.75 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.337 0.589 . . . . 74.150000000000006 110.231 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.01 -13.93 62.74 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.169 0.987 . . . . 54.200000000000003 113.429 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -51.84 -27.29 12.1 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.04 0.936 . . . . 74.150000000000006 110.948 -177.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -16.12 63.93 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.464 0.913 . . . . 63.219999999999999 113.464 -175.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -111.11 8.66 29.16 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 119.98 -1.105 . . . . 40.030000000000001 113.342 -176.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -134.3 162.1 59.71 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 109.023 -0.732 . . . . 73.120000000000005 109.023 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.422 ' HA ' ' CB ' ' A' ' 502' ' ' ALA . 67.7 Cg_endo -77.35 130.1 10.74 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 121.406 1.404 . . . . 75.329999999999998 110.565 174.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.8 pp -126.61 158.33 36.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.623 -0.717 . . . . 71.239999999999995 109.787 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.06 177.19 5.82 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 116.384 -0.371 . . . . 62.32 110.939 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -69.8 172.7 39.3 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 111.424 -0.67 . . . . 73.420000000000002 111.424 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . 0.404 ' OE1' ' HD3' ' A' ' 617' ' ' PRO . 4.2 tp10 -56.7 -50.02 73.4 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.791 0.805 . . . . 62.509999999999998 110.192 -175.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . 0.499 ' CE1' ' HD3' ' A' ' 615' ' ' LYS . 8.2 m170 -123.63 125.85 45.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.076 -0.965 . . . . 60.030000000000001 109.618 176.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 19.9 p -123.06 95.28 4.55 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 115.733 -0.667 . . . . 54.43 110.005 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -158.52 138.05 11.81 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.907 -0.588 . . . . 61.329999999999998 109.811 -176.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.528 HD22 HG11 ' A' ' 523' ' ' VAL . 36.5 tp -122.56 129.27 51.75 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.124 -1.065 . . . . 71.129999999999995 108.124 177.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -95.67 108.86 21.18 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.19 -1.411 . . . . 71.120000000000005 107.19 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 43.3 t -99.02 108.86 23.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 109.314 -0.624 . . . . 71.329999999999998 109.314 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 65.3 mt -98.13 122.8 50.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 108.809 -0.811 . . . . 60.030000000000001 108.809 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' ' 585' ' ' LYS . 32.7 mt -99.74 108.31 22.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.486 -0.931 . . . . 74.5 108.486 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 515' ' ' SER . 10.4 pt-20 -111.38 119.9 40.37 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.311 0.577 . . . . 74.129999999999995 110.753 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -74.6 117.16 16.11 Favored 'General case' 0 CA--C 1.479 -1.778 0 CA-C-O 122.456 1.122 . . . . 74.430000000000007 108.927 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 40.4 m -112.52 105.1 13.24 Favored 'General case' 0 C--N 1.252 -3.644 0 N-CA-C 105.547 -2.02 . . . . 70.530000000000001 105.547 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -67.94 -47.67 68.04 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.569 -0.741 . . . . 73.140000000000001 112.368 -172.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -75.14 -26.39 59.14 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 119.848 -0.741 . . . . 74.519999999999996 109.183 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 39.6 t80 74.95 8.42 4.14 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.976 1.71 . . . . 64.439999999999998 111.171 176.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -85.68 102.46 13.63 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.688 -1.597 . . . . 75.439999999999998 106.688 177.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 33.3 m -74.22 86.36 1.92 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.951 0.882 . . . . 71.109999999999999 112.861 -174.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 3.4 t -160.52 92.24 0.96 Allowed 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.339 -1.301 . . . . 63.340000000000003 108.303 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . 0.353 14.7 p 49.76 70.05 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 126.212 1.805 . . . . 74.219999999999999 113.9 -177.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 C--O 1.248 1.019 0 CA-C-N 114.035 -1.439 . . . . 74.340000000000003 108.895 176.775 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 14.7 t60 . . . . . 0 N--CA 1.436 -1.148 0 CA-C-O 121.568 0.699 . . . . 74.450000000000003 109.852 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -74.47 -34.62 63.17 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.679 -0.691 . . . . 63.109999999999999 110.332 178.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 162.07 -159.79 31.86 Favored Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 109.904 -1.278 . . . . 70.540000000000006 109.904 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.53 110.86 33.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 116.687 0.244 . . . . 61.200000000000003 110.814 -176.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.726 ' CE1' ' HA ' ' A' ' 527' ' ' ARG . 5.8 m-85 -95.46 120.59 35.98 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.099 -0.704 . . . . 75.420000000000002 109.099 169.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.1 t -170.22 179.52 3.44 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.612 -0.884 . . . . 64.409999999999997 108.612 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -84.37 153.48 23.43 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.614 -0.513 . . . . 74.319999999999993 109.614 178.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -66.84 -36.04 81.43 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.575 0.702 . . . . 72.239999999999995 109.93 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.36 146.36 61.67 Favored Pre-proline 0 N--CA 1.42 -1.963 0 CA-C-N 115.014 -0.994 . . . . 61.340000000000003 108.444 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.67 -25.2 12.81 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.761 1.641 . . . . 74.109999999999999 112.007 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.05 135.37 54.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.454 -0.943 . . . . 65.329999999999998 108.454 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.6 t -129.33 139.18 51.83 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 109.239 -0.652 . . . . 63.100000000000001 109.239 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -103.66 123.2 46.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.661 -1.237 . . . . 61.439999999999998 107.661 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.6 m -113.11 151.92 14.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 120.463 -0.495 . . . . 73.099999999999994 109.912 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.545 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 0.4 OUTLIER -72.96 162.55 29.36 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 114.845 -1.071 . . . . 73.340000000000003 111.43 -178.256 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -83.78 -48.27 10.27 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.264 -1.384 . . . . 54.409999999999997 107.264 170.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.4 m -81.68 28.51 0.41 Allowed 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.685 -1.143 . . . . 71.400000000000006 112.297 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 15.2 tt -96.9 -32.15 4.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 112.6 0.593 . . . . 60.520000000000003 112.6 -174.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . 0.443 ' O ' ' HD2' ' A' ' 574' ' ' LYS . . . 87.98 -78.49 1.79 Allowed Glycine 0 N--CA 1.428 -1.864 0 C-N-CA 120.011 -1.09 . . . . 63.439999999999998 110.532 -175.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 574' ' ' LYS . 35.1 mm -126.74 131.4 71.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 107.523 -1.288 . . . . 71.129999999999995 107.523 -175.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.554 ' SD ' HG23 ' A' ' 523' ' ' VAL . 0.0 OUTLIER -108.55 146.68 32.9 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 109.349 -0.611 . . . . 72.319999999999993 109.349 177.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 15.1 mp0 -123.15 127.25 48.42 Favored 'General case' 0 CA--C 1.505 -0.764 0 O-C-N 123.955 0.784 . . . . 73.530000000000001 110.329 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.554 HG23 ' SD ' ' A' ' 521' ' ' MET . 66.0 t -112.09 130.64 65.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.98 -1.118 . . . . 72.219999999999999 107.98 173.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.475 ' HG2' ' CG2' ' A' ' 570' ' ' THR . 35.8 mtmt -90.72 141.81 28.41 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.236 0.541 . . . . 72.230000000000004 110.833 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 568' ' ' VAL . 43.8 t -107.77 128.01 63.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.738 -0.664 . . . . 65.439999999999998 109.525 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 95.2 mt -66.5 116.49 7.53 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.276 0.63 . . . . 73.319999999999993 110.25 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.726 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 56.3 ttt-85 -73.26 154.14 40.31 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 124.619 1.167 . . . . 73.120000000000005 109.974 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.65 HG23 ' CD2' ' A' ' 505' ' ' PHE . 1.4 p -58.52 131.28 50.29 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 122.992 0.517 . . . . 72.430000000000007 110.415 175.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 46.4 t -47.39 -35.56 8.48 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 125.362 1.465 . . . . 75.040000000000006 110.917 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -128.56 85.85 0.32 Allowed Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.857 -1.297 . . . . 73.120000000000005 109.857 175.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -84.83 102.14 12.83 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.648 -0.871 . . . . 64.25 108.648 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -102.07 96.73 7.2 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.234 -0.894 . . . . 64.209999999999994 109.939 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 111.43 -145.16 17.64 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.997 -0.621 . . . . 61.350000000000001 112.294 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.562 HD22 ' HG2' ' A' ' 563' ' ' GLN . 2.4 t-20 -118.86 131.92 56.09 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.803 -1.554 . . . . 71.450000000000003 106.803 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 42.8 t -133.94 140.59 46.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 110.104 -0.332 . . . . 70.129999999999995 110.104 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.532 HG12 ' CG2' ' A' ' 597' ' ' VAL . 38.3 mm -113.52 135.36 53.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 109.29 -0.633 . . . . 74.310000000000002 109.29 174.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 34.8 t -121.13 109.44 35.35 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 109.166 -0.679 . . . . 74.209999999999994 109.166 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.04 150.5 38.07 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.21 1.94 . . . . 74.209999999999994 112.27 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.489 ' HB3' HG22 ' A' ' 591' ' ' ILE . 46.1 p90 -145.18 167.43 22.78 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.835 0.35 . . . . 75.420000000000002 111.013 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -158.42 147.95 19.47 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-N 115.387 -0.824 . . . . 52.109999999999999 110.206 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 15.3 p -84.0 136.26 34.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.826 -0.805 . . . . 53.340000000000003 108.826 172.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 75.0 mt -104.43 114.68 44.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 108.942 -0.762 . . . . 64.129999999999995 108.942 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.63 99.12 2.48 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.843 -0.617 . . . . 75.430000000000007 109.927 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -112.13 -105.78 2.81 Favored Glycine 0 CA--C 1.479 -2.172 0 N-CA-C 110.411 -1.075 . . . . 75.219999999999999 110.411 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.24 42.69 1.05 Allowed 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 123.485 0.714 . . . . 73.230000000000004 109.473 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.518 ' HA ' ' HD2' ' A' ' 585' ' ' LYS . . . -160.1 147.13 16.17 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.475 0.71 . . . . 63.240000000000002 109.864 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.495 HH11 ' HG3' ' A' ' 551' ' ' GLU . 33.1 mtm105 -77.82 120.36 22.61 Favored 'General case' 0 C--O 1.251 1.157 0 CA-C-O 121.356 0.598 . . . . 73.310000000000002 111.727 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.28 -163.04 35.33 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.04 -0.982 . . . . 51.210000000000001 110.687 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 65.5 28.85 74.03 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 121.388 -0.434 . . . . 41.43 113.255 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . 0.407 ' C ' HG13 ' A' ' 576' ' ' ILE . . . 69.42 40.25 79.69 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 121.164 -0.541 . . . . 45.140000000000001 112.006 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.495 ' HG3' HH11 ' A' ' 547' ' ' ARG . 3.6 tp10 -113.05 -53.93 2.67 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 119.954 -0.698 . . . . 74.409999999999997 110.188 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -98.62 -39.54 8.64 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.459 -1.311 . . . . 74.450000000000003 107.459 169.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -142.56 149.0 38.48 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.753 -1.112 . . . . 75.400000000000006 108.629 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.66 111.93 21.13 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 105.361 -2.089 . . . . 64.230000000000004 105.361 176.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -75.19 146.7 41.02 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.176 -0.466 . . . . 72.030000000000001 109.976 -173.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 14.0 t -143.17 150.93 40.06 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.358 0.599 . . . . 61.130000000000003 110.502 -172.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.0 p -153.18 134.57 14.29 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.504 -0.924 . . . . 73.25 108.504 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -175.54 -168.32 35.8 Favored Glycine 0 N--CA 1.411 -2.987 0 N-CA-C 110.179 -1.169 . . . . 40.439999999999998 110.179 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.467 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 39.9 mt-10 -127.32 131.86 50.36 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.972 -0.381 . . . . 75.109999999999999 109.972 -175.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 569' ' ' LYS . 86.1 mt -94.63 132.11 39.7 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.564 -0.532 . . . . 62.350000000000001 109.564 177.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.486 ' HA ' HD13 ' A' ' 536' ' ' ILE . 19.4 tt0 -98.75 120.21 38.8 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.941 -0.572 . . . . 62.409999999999997 110.198 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.412 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 89.5 m-85 -120.71 156.55 31.54 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.671 -0.863 . . . . 52.210000000000001 108.671 177.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.562 ' HG2' HD22 ' A' ' 534' ' ' ASN . 16.8 mt-30 -150.11 -177.43 5.92 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.21 -1.033 . . . . 53.340000000000003 108.21 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -66.34 -42.67 87.78 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.397 -0.964 . . . . 71.129999999999995 108.397 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -81.8 -24.63 35.81 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.972 0.731 . . . . 74.299999999999997 112.972 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.459 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 37.1 mm-40 -76.34 146.5 38.77 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.857 -0.527 . . . . 71.439999999999998 112.062 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.611 HG13 ' H ' ' A' ' 568' ' ' VAL . 12.6 pt -90.47 -89.99 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 114.869 1.433 . . . . 75.519999999999996 114.869 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.611 ' H ' HG13 ' A' ' 567' ' ' ILE . 12.7 p -134.76 145.64 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 109.664 -0.495 . . . . 64.420000000000002 109.664 -177.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.535 ' HB3' HD22 ' A' ' 560' ' ' LEU . 4.2 mmpt? -113.04 157.11 21.97 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 116.267 -0.424 . . . . 74.209999999999994 110.21 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 2.8 p -126.25 151.76 47.01 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.19 -0.914 . . . . 74.310000000000002 111.926 -177.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.3 mp -101.37 120.97 51.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.104 -1.443 . . . . 70.239999999999995 107.104 171.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 521' ' ' MET . 70.0 m -99.3 115.96 30.38 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 123.81 0.694 . . . . 45.5 109.967 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.41 HG23 HG22 ' A' ' 571' ' ' ILE . 68.1 t -122.63 128.27 75.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.462 -0.335 . . . . 72.310000000000002 110.291 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 519' ' ' GLY . 29.1 tptp -80.66 118.2 22.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.67 -0.493 . . . . 73.239999999999995 109.67 176.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 58.3 t -81.27 117.22 26.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 105.557 -2.016 . . . . 72.340000000000003 105.557 174.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . 0.407 HG13 ' C ' ' A' ' 550' ' ' GLY . 43.5 mm -76.28 139.04 19.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.762 0.791 . . . . 63.450000000000003 109.97 -174.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.59 80.03 7.11 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-N 114.282 -1.327 . . . . 62.030000000000001 108.038 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -82.61 135.94 34.93 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.614 -1.176 . . . . 73.010000000000005 108.865 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -86.02 -42.42 14.0 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 110.13 -0.322 . . . . 72.319999999999993 110.13 -175.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.16 168.06 18.02 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.412 0.625 . . . . 65.120000000000005 111.442 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -136.56 133.07 36.03 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.152 -0.684 . . . . 73.319999999999993 109.152 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -131.14 -65.04 0.79 Allowed 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.15 0.5 . . . . 64.219999999999999 109.912 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -158.92 170.38 22.23 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.81 -1.552 . . . . 43.030000000000001 106.81 -173.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -61.86 118.61 7.44 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.459 -0.571 . . . . 64.340000000000003 109.459 174.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' A' ' 546' ' ' ALA . 34.2 mmtp -90.58 136.31 33.14 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.995 -0.548 . . . . 74.519999999999996 111.416 -175.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 7.0 t -153.93 135.5 14.33 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.436 0.636 . . . . 72.049999999999997 110.407 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -127.16 172.18 10.77 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.323 -0.991 . . . . 74.010000000000005 108.323 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.478 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 79.4 m-85 -118.96 153.8 34.05 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 109.515 -0.55 . . . . 72.010000000000005 109.515 -175.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.86 129.86 52.17 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 106.206 -1.775 . . . . 65.219999999999999 106.206 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -128.0 134.4 49.25 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.05 -0.66 . . . . 74.510000000000005 109.924 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.489 HG22 ' HB3' ' A' ' 539' ' ' TYR . 25.2 pt -106.84 140.51 24.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.39 -0.967 . . . . 50.43 108.39 176.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.21 -175.31 49.78 Favored Glycine 0 N--CA 1.425 -2.065 0 O-C-N 123.813 0.695 . . . . 63.240000000000002 111.469 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.81 137.3 82.63 Favored Pre-proline 0 N--CA 1.428 -1.529 0 C-N-CA 121.034 -0.266 . . . . 74.319999999999993 110.521 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.65 142.94 60.26 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 122.58 2.187 . . . . 72.439999999999998 111.08 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -121.93 123.42 41.66 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.674 -0.491 . . . . 74.230000000000004 109.674 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.482 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 2.2 tm? -67.97 125.56 26.7 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.844 -0.799 . . . . 74.140000000000001 108.844 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.532 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.6 t -93.41 107.77 19.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 105.197 -2.149 . . . . 75.409999999999997 105.197 176.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' A' ' 601' ' ' GLU . 34.7 mt-10 -61.59 112.86 2.4 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.912 -1.04 . . . . 72.420000000000002 108.843 -176.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -67.11 -28.44 68.16 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.463 0.649 . . . . 74.519999999999996 110.906 -175.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 8.4 t -104.51 90.34 3.49 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 102.541 -3.133 . . . . 51.130000000000003 102.541 168.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . 0.536 ' HB3' ' O ' ' A' ' 598' ' ' GLU . 9.0 pt-20 -99.95 153.9 18.81 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 114.601 1.334 . . . . 74.120000000000005 114.601 -166.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -102.64 130.46 49.54 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 104.886 -2.264 . . . . 53.450000000000003 104.886 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -71.52 94.1 1.26 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.062 0.934 . . . . 73.340000000000003 110.611 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 150.18 -139.48 7.36 Favored Glycine 0 N--CA 1.415 -2.762 0 N-CA-C 108.289 -1.924 . . . . 72.239999999999995 108.289 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 71.19 33.57 64.84 Favored Glycine 0 C--N 1.315 -0.603 0 N-CA-C 110.585 -1.006 . . . . 71.129999999999995 110.585 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -155.06 139.52 16.84 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 109.087 -0.709 . . . . 74.420000000000002 109.087 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 7.6 t -138.47 141.28 39.45 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.131 -1.433 . . . . 71.299999999999997 107.131 174.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 64.3 mt -75.4 110.01 9.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.19 -0.67 . . . . 71.230000000000004 109.19 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 8.9 t -163.06 140.96 7.99 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 109.772 -0.455 . . . . 51.399999999999999 109.772 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -136.27 107.83 6.96 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 104.691 -2.337 . . . . 62.030000000000001 104.691 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -73.02 125.23 27.14 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.391 -0.524 . . . . 71.109999999999999 111.859 -172.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -75.72 141.63 42.62 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 108.502 -0.925 . . . . 73.340000000000003 108.502 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . 0.415 ' OD1' ' HD3' ' A' ' 617' ' ' PRO . 20.9 t70 -143.34 130.2 20.47 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.943 -0.571 . . . . 74.420000000000002 111.089 -174.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -113.46 -7.42 13.43 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.109 -0.496 . . . . 70.519999999999996 110.46 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . 0.51 ' HE2' ' HA ' ' A' ' 615' ' ' LYS . 0.6 OUTLIER 174.54 -47.41 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.751 1.22 . . . . 74.150000000000006 108.454 178.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -162.62 121.21 1.34 Allowed Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 115.455 -0.793 . . . . 75.519999999999996 109.136 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . 0.415 ' HD3' ' OD1' ' A' ' 613' ' ' ASP . 6.3 Cg_exo -74.29 108.06 2.59 Favored 'Trans proline' 0 N--CA 1.44 -1.647 0 C-N-CA 121.564 1.509 . . . . 75.120000000000005 109.303 174.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 88.9 mt -76.23 -12.29 60.06 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.442 0.639 . . . . 55.039999999999999 111.111 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 26.8 m -76.23 -18.83 58.84 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.7 -0.852 . . . . 63.109999999999999 108.7 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 38.3 t -100.49 117.81 35.41 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 108.073 -1.084 . . . . 61.219999999999999 108.073 178.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -94.27 134.76 36.4 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.192 -0.67 . . . . 72.439999999999998 109.192 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -80.65 86.68 5.86 Favored 'General case' 0 C--O 1.25 1.097 0 CA-C-O 122.04 0.924 . . . . 72.209999999999994 109.125 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 626' ' ' ARG . 10.1 tp10 -74.66 116.42 15.34 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 113.948 -1.478 . . . . 73.430000000000007 111.156 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . 0.439 ' O ' HG13 ' A' ' 628' ' ' ILE . 40.1 mt-10 -66.65 -27.82 67.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.669 -0.696 . . . . 73.310000000000002 110.942 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.97 -31.43 72.61 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 120.825 0.345 . . . . 53.409999999999997 110.313 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.644 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 28.1 mmt180 -63.76 -47.41 81.1 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 109.03 -0.729 . . . . 74.519999999999996 109.03 174.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -58.89 -41.07 86.29 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.666 0.604 . . . . 73.5 111.646 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 624' ' ' GLU . 69.0 mt -65.24 -35.37 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.416 0.627 . . . . 71.519999999999996 109.873 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -75.31 -29.33 60.0 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.37 -0.377 . . . . 62.140000000000001 111.007 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 7.6 mm-40 -61.55 -29.68 70.17 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 116.215 -0.448 . . . . 71.219999999999999 111.896 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' A' ' 628' ' ' ILE . 0.0 OUTLIER -75.87 -1.59 26.06 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.173 0.805 . . . . 64.219999999999999 113.173 -177.683 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -101.2 1.7 54.48 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.775 -0.93 . . . . 74.239999999999995 110.775 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . 0.505 ' HB2' ' HD2' ' A' ' 634' ' ' PRO . 5.3 ptp180 -135.03 168.88 15.54 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 123.572 0.749 . . . . 74.120000000000005 109.06 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.509 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 33.6 Cg_endo -60.04 139.5 87.99 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.586 2.191 . . . . 51.43 112.622 177.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.8 pp -134.56 157.97 41.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.139 -1.059 . . . . 71.239999999999995 108.139 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.54 172.84 8.42 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.314 -0.554 . . . . 64.200000000000003 111.725 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -73.01 -157.25 3.9 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-O 121.912 0.729 . . . . 74.049999999999997 114.475 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.93 -45.84 59.7 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.624 -0.788 . . . . 71.420000000000002 109.333 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -135.4 142.98 45.76 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.231 -0.895 . . . . 74.129999999999995 108.822 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 35.2 p -134.75 103.21 5.54 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.011 0.434 . . . . 43.439999999999998 111.034 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -170.22 150.65 3.68 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.822 -1.177 . . . . 64.409999999999997 107.822 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.522 HD21 HG21 ' A' ' 523' ' ' VAL . 26.1 tp -137.81 132.13 32.18 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.48 -0.933 . . . . 72.219999999999999 108.48 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -101.16 110.95 23.04 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.529 -1.286 . . . . 75.140000000000001 107.529 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 45.7 t -101.11 110.97 29.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.556 -0.535 . . . . 52.530000000000001 109.556 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 74.0 mt -96.58 125.66 49.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 N-CA-C 109.471 -0.566 . . . . 52.219999999999999 109.471 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 64.9 mt -101.17 107.59 21.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.823 -1.177 . . . . 73.310000000000002 107.823 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 650' ' ' TYR . 8.5 pt-20 -121.18 153.16 37.92 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.173 0.511 . . . . 72.030000000000001 110.014 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.35 138.72 45.28 Favored 'General case' 0 N--CA 1.387 -3.578 0 N-CA-C 106.66 -1.607 . . . . 75.239999999999995 106.66 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 50.0 m 69.52 43.4 1.02 Allowed 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.906 -1.516 . . . . 52.030000000000001 106.906 -172.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . 0.486 ' HB2' ' HG3' ' A' ' 647' ' ' GLU . 0.1 OUTLIER -59.04 -35.45 73.34 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 113.44 -1.709 . . . . 44.310000000000002 112.72 -174.27 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -20.58 61.46 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.744 -0.662 . . . . 70.340000000000003 111.702 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -87.41 77.88 8.79 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 122.248 1.023 . . . . 75.319999999999993 111.589 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -163.55 -169.43 1.93 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 105.581 -2.007 . . . . 71.219999999999999 105.581 176.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 15.0 m -86.51 89.5 7.92 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.556 -0.905 . . . . 73.530000000000001 108.556 174.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 34.9 m -76.5 115.76 16.55 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 108.984 -0.747 . . . . 73.209999999999994 108.984 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.81 116.82 10.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.13 -0.487 . . . . 73.420000000000002 111.672 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 C--O 1.253 1.278 0 CA-C-N 114.924 -1.035 . . . . 73.310000000000002 112.317 177.384 . . . . . . . . 0 0 . 1 stop_ save_